PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Leroux, AE; Haanstra, JR; Bakker, BM; Krauth-Siegel, RL				Leroux, Alejandro E.; Haanstra, Jurgen R.; Bakker, Barbara M.; Krauth-Siegel, R. Luise			Dissecting the Catalytic Mechanism of Trypanosoma brucei Trypanothione Synthetase by Kinetic Analysis and Computational Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; ESCHERICHIA-COLI; IN-VIVO; AFRICAN TRYPANOSOMES; METABOLITE CONCENTRATIONS; CRITHIDIA-FASCICULATA; PARASITIC PROTOZOA; LEISHMANIA-MAJOR	In pathogenic trypanosomes, trypanothione synthetase (TryS) catalyzes the synthesis of both glutathionylspermidine (Gsp) and trypanothione (bis(glutathionyl) spermidine (T(SH)(2))). Here we present a thorough kinetic analysis of Trypanosoma brucei TryS in a newly developed phosphate buffer system at pH 7.0 and 37 degrees C, mimicking the physiological environment of the enzyme in the cytosol of bloodstream parasites. Under these conditions, TryS displays K-m values for GSH, ATP, spermidine, and Gsp of 34, 18, 687, and 32 mu M, respectively, as well as K-i values for GSH and T(SH) 2 of 1 mM and 360 mu M, respectively. As Gsp hydrolysis has a K-m value of 5.6 mM, the in vivo amidase activity is probably negligible. To obtain deeper insight in the molecular mechanism of TryS, we have formulated alternative kinetic models, with elementary reaction steps represented by linear kinetic equations. The model parameters were fitted to the extensive matrix of steady-state data obtained for different substrate/product combinations under the in vivo-like conditions. The best model describes the full kinetic profile and is able to predict time course data that were not used for fitting. This system's biology approach to enzyme kinetics led us to conclude that (i) TryS follows a ter-reactant mechanism, (ii) the intermediate Gsp dissociates from the enzyme between the two catalytic steps, and (iii) T(SH)(2) inhibits the enzyme by remaining bound at its product site and, as does the inhibitory GSH, by binding to the activated enzyme complex. The newly detected concerted substrate and product inhibition suggests that TryS activity is tightly regulated.	[Leroux, Alejandro E.; Krauth-Siegel, R. Luise] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Haanstra, Jurgen R.; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands; [Haanstra, Jurgen R.; Bakker, Barbara M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; University of Groningen; Vrije Universiteit Amsterdam	Bakker, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, CA84,Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	b.m.bakker01@umcg.nl; luise.krauth-siegel@bzh.uni-heidelberg.de	Leroux, Alejandro E./W-3153-2019	Leroux, Alejandro E./0000-0001-6149-3572; Haanstra, Jurgen/0000-0001-9652-0219; Bakker, Barbara/0000-0001-6274-3633	Bundesministerium fur Bildung und Forschung (BMBF), Germany; Netherlands Organization for Scientific Research (NWO), The Netherlands; SysMo2; European Union; University of Groningen	Bundesministerium fur Bildung und Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Netherlands Organization for Scientific Research (NWO), The Netherlands; SysMo2; European Union(European Commission); University of Groningen	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF), Germany, and the Netherlands Organization for Scientific Research (NWO), The Netherlands, within the framework of the SysMo2-funded SilicoTryp project of the European Union (work packages 4 (to B. M. B.) and 6 (to R.L.K.-S.).; Recipient of a Rosalind Franklin Fellowship from the University of Groningen. To whom correspondence may be addressed: Dept. of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University of Groningen, University Medical Centre Groningen CA84, Hanzeplein 1, NL-9713 GZ Groningen, The Netherlands. Tel.: 31-50-3080407; Fax: 31-50-361-1746; E-mail: b.m.bakker01@umcg.nl.	Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; BUCHLI R, 1994, MAGN RESON MED, V32, P453, DOI 10.1002/mrm.1910320405; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2009, INT J PARASITOL, V39, P1059, DOI 10.1016/j.ijpara.2009.05.002; DAVIS TME, 1993, T ROY SOC TROP MED H, V87, P49, DOI 10.1016/0035-9203(93)90416-N; Diechtierow M, 2011, FREE RADICAL BIO MED, V51, P856, DOI 10.1016/j.freeradbiomed.2011.05.014; DUBIN DT, 1959, BIOCHEM BIOPH RES CO, V1, P262, DOI 10.1016/0006-291X(59)90034-8; Flohe L, 2012, BIOTECHNOL ADV, V30, P294, DOI 10.1016/j.biotechadv.2011.05.012; Fuad FAA, 2011, METALLOMICS, V3, P1310, DOI 10.1039/c1mt00119a; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Haldane J. B. S., 1930, ENZYMES, P84; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; KIMBERLY MM, 1981, ANAL CHEM, V53, P789, DOI 10.1021/ac00229a011; Koch O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056788; Koenig K, 1997, J BIOL CHEM, V272, P11908, DOI 10.1074/jbc.272.18.11908; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lin CH, 1997, BIOCHEMISTRY-US, V36, P14930, DOI 10.1021/bi9714464; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Mouat MF, 1998, COMP HAEMATOL INT, V8, P58, DOI 10.1007/BF02628107; Nolan DP, 2000, EUR J BIOCHEM, V267, P4601, DOI 10.1046/j.1432-1327.2000.01476.x; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; NOLAN DP, 1990, BIOCHEM SOC T, V18, P735, DOI 10.1042/bst0180735; Olin-Sandoval V, 2012, FEBS J, V279, P1811, DOI 10.1111/j.1742-4658.2012.08557.x; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Oza SL, 2008, FEBS J, V275, P5408, DOI 10.1111/j.1742-4658.2008.06670.x; Oza SL, 2002, BIOCHEM J, V364, P679, DOI 10.1042/BJ20011370; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; RUBEN L, 1991, J BIOL CHEM, V266, P24351; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Shahi SK, 2002, MOL MICROBIOL, V43, P1129, DOI 10.1046/j.1365-2958.2002.02831.x; TABOR H, 1975, J BIOL CHEM, V250, P2648; THISSEN JA, 1991, EXP PARASITOL, V72, P243, DOI 10.1016/0014-4894(91)90143-K; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van Eunen K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002483; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x	55	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23751	23764		10.1074/jbc.M113.483289	http://dx.doi.org/10.1074/jbc.M113.483289			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814051	hybrid, Green Published			2022-12-25	WOS:000330611400015
J	Chakrabarty, P; Rosario, A; Cruz, P; Siemienski, Z; Ceballos-Diaz, C; Crosby, K; Jansen, K; Borchelt, DR; Kim, JY; Jankowsky, JL; Golde, TE; Levites, Y				Chakrabarty, Paramita; Rosario, Awilda; Cruz, Pedro; Siemienski, Zoe; Ceballos-Diaz, Carolina; Crosby, Keith; Jansen, Karen; Borchelt, David R.; Kim, Ji-Yoen; Jankowsky, Joanna L.; Golde, Todd E.; Levites, Yona			Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; WIDESPREAD GENE DELIVERY; AMYLOID-BETA; MOUSE-BRAIN; EXPRESSION; DISEASE; CNS; EFFICIENT; PATTERNS; THERAPY	Adeno-associated virus (AAV) mediated gene expression is a powerful tool for gene therapy and preclinical studies. A comprehensive analysis of CNS cell type tropism, expression levels and biodistribution of different capsid serotypes has not yet been undertaken in neonatal rodents. Our previous studies show that intracerebroventricular injection with AAV2/1 on neonatal day P0 results in widespread CNS expression but the biodistribution is limited if injected beyond neonatal day P1. To extend these observations we explored the effect of timing of injection on tropism and biodistribution of six commonly used pseudotyped AAVs delivered in the cerebral ventricles of neonatal mice. We demonstrate that AAV2/8 and 2/9 resulted in the most widespread biodistribution in the brain. Most serotypes showed varying biodistribution depending on the day of injection. Injection on neonatal day P0 resulted in mostly neuronal transduction, whereas administration in later periods of development (24-84 hours postnatal) resulted in more non-neuronal transduction. AAV2/5 showed widespread transduction of astrocytes irrespective of the time of injection. None of the serotypes tested showed any microglial transduction. This study demonstrates that both capsid serotype and timing of injection influence the regional and cell-type distribution of AAV in neonatal rodents, and emphasizes the utility of pseudotyped AAV vectors for translational gene therapy paradigms.	[Chakrabarty, Paramita; Rosario, Awilda; Cruz, Pedro; Siemienski, Zoe; Ceballos-Diaz, Carolina; Crosby, Keith; Borchelt, David R.; Golde, Todd E.; Levites, Yona] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Chakrabarty, Paramita; Rosario, Awilda; Cruz, Pedro; Siemienski, Zoe; Ceballos-Diaz, Carolina; Crosby, Keith; Borchelt, David R.; Golde, Todd E.; Levites, Yona] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Jansen, Karen] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kim, Ji-Yoen; Jankowsky, Joanna L.] Baylor Coll Med, Huffington Ctr Aging, Dept Neurosci, Houston, TX 77030 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; Baylor College of Medicine	Levites, Y (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	levites.yona@ufl.edu			NIH-NINDS; Alzheimer's Association; Ellison Foundation; NATIONAL INSTITUTE ON AGING [R21AG038856] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by: NIH-NINDS, Alzheimer's Association and the Ellison Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Conlon TJ, 2004, EXPERT OPIN BIOL TH, V4, P1093, DOI 10.1517/14712598.4.7.1093; Cucchiarini M, 2003, GENE THER, V10, P657, DOI 10.1038/sj.gt.3301925; Fleming J, 2005, HUM GENE THER, V16, P947, DOI 10.1089/hum.2005.16.947; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Homs J, 2011, GENE THER, V18, P622, DOI 10.1038/gt.2011.7; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Liu G, 2005, GENE THER, V12, P1503, DOI 10.1038/sj.gt.3302554; Maguire CA, 2008, MOL THER, V16, P1695, DOI 10.1038/mt.2008.168; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; McCown TJ, 2011, CURR GENE THER, V11, P181; McCown TJ, 2005, CURR GENE THER, V5, P333, DOI 10.2174/1566523054064995; Miyake N, 2011, BRAIN RES, V1389, P19, DOI 10.1016/j.brainres.2011.03.014; Passini MA, 2002, J NEUROSCI, V22, P6437; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Rafi MA, 2005, MOL THER, V11, P734, DOI 10.1016/j.ymthe.2004.12.020; Rahim AA, 2012, GENE THER, V19, P936, DOI 10.1038/gt.2011.157; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Verbeeck C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-53; Weinberg MS, 2011, GENE THER, V18, P961, DOI 10.1038/gt.2011.49; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	40	102	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67680	10.1371/journal.pone.0067680	http://dx.doi.org/10.1371/journal.pone.0067680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825679	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000114
J	Kemmett, K; Humphrey, T; Rushton, S; Close, A; Wigley, P; Williams, NJ				Kemmett, Kirsty; Humphrey, Tom; Rushton, Steven; Close, Andrew; Wigley, Paul; Williams, Nicola J.			A Longitudinal Study Simultaneously Exploring the Carriage of APEC Virulence Associated Genes and the Molecular Epidemiology of Faecal and Systemic E. coli in Commercial Broiler Chickens	PLOS ONE			English	Article							PATHOGENIC-ESCHERICHIA-COLI; STRAINS; SALMONELLA; IDENTIFICATION; EXPRESSION; SEQUENCE; COLONIZATION; PERSISTENCE; MENINGITIS; MICROFLORA	Colibacillosis is an economically important syndromic disease of poultry caused by extra-intestinal avian pathogenic Escherichia coli (APEC) but the pathotype remains poorly defined. Combinations of virulence-associated genes (VAGs) have aided APEC identification. The intestinal microbiota is a potential APEC reservoir. Broiler chickens are selectively bred for fast, uniform growth. Here we simultaneously investigate intestinal E. coli VAG carriage in apparently healthy birds and characterise systemic E. coli from diseased broiler chickens from the same flocks. Four flocks were sampled longitudinally from chick placement until slaughter. Phylogrouping, macro-restriction pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were performed on an isolate subset from one flock to investigate the population structure of faecal and systemic E. coli. Early in production, VAG carriage among chick intestinal E. coli populations was diverse (average Simpson's D value = 0.73); 24.05% of intestinal E. coli (n = 160) from 1 day old chicks were carrying >= 5 VAGs. Generalised Linear models demonstrated VAG prevalence in potential APEC populations declined with age; 1% of E. coli carrying >= 5 VAGs at slaughter and demonstrated high strain diversity. A variety of VAG profiles and high strain diversity were observed among systemic E. coli. Thirty three new MLST sequence types were identified among 50 isolates and a new sequence type representing 22.2% (ST-2999) of the systemic population was found, differing from the pre-defined pathogenic ST-117 at a single locus. For the first time, this study takes a longitudinal approach to unravelling the APEC paradigm. Our findings, supported by other studies, highlight the difficulty in defining the APEC pathotype. Here we report a high genetic diversity among systemic E. coli between and within diseased broilers, harbouring diverse VAG profiles rather than single and/or highly related pathogenic clones suggesting host susceptibility in broilers plays an important role in APEC pathogenesis.	[Kemmett, Kirsty; Humphrey, Tom; Wigley, Paul] Univ Liverpool, Sch Vet Sci, Dept Infect Biol, Inst Infect & Global Hlth, Neston, Cheshire, England; [Williams, Nicola J.] Univ Liverpool, Sch Vet Sci, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Neston, Cheshire, England; [Rushton, Steven; Close, Andrew] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Liverpool; University of Liverpool; Newcastle University - UK	Kemmett, K (corresponding author), Univ Liverpool, Sch Vet Sci, Dept Infect Biol, Inst Infect & Global Hlth, Neston, Cheshire, England.	K.Kemmett@liv.ac.uk		Humphrey, Tom/0000-0001-7965-8988; Wigley, Paul/0000-0001-6563-0773; Williams, Nicola/0000-0003-4709-4190	Biotechnical and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/I024674/1] Funding Source: researchfish; BBSRC [BB/I024674/1] Funding Source: UKRI	Biotechnical and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnical and Biological Sciences Research Council (BBSRC). www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; Barnes H.J., 1999, DIS POULTRY, P131; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Christensen JP, 2003, P 13 C WORLD VET POU, P83; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; DOMINICK MA, 1984, AM J VET RES, V45, P2331; Dziva F., 2010, CURRENT RES TECHNOLO, V1, P746; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2005, AVIAN DIS, V49, P269, DOI 10.1637/7293-102604R; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Fasenko GM, 2009, POULTRY SCI, V88, P1121, DOI 10.3382/ps.2008-00359; Francis Dziva HH, 2012, INFECT IMMUNITY; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kariyawasam S, 2006, AVIAN DIS, V50, P405, DOI 10.1637/7462-102705R.1; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Manges AR, CLIN INFECT IN PRESS; McDaniels AE, 1996, APPL ENVIRON MICROB, V62, P3350, DOI 10.1128/AEM.62.9.3350-3354.1996; McPeake SJM, 2005, VET MICROBIOL, V110, P245, DOI 10.1016/j.vetmic.2005.08.001; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Mora A, 2012, VET MICROBIOL, V156, P347, DOI 10.1016/j.vetmic.2011.10.033; Morris JG, 1997, EMERG INFECT DIS, V3, P435, DOI 10.3201/eid0304.970404; NAGARAJA KV, 1984, AM J VET RES, V45, P392; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ozawa M, 2010, J VET MED SCI, V72, P1517, DOI 10.1292/jvms.10-0174; Petersen A, 2006, VET MICROBIOL, V116, P120, DOI 10.1016/j.vetmic.2006.03.015; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Skyberg JA, 2003, AVIAN DIS, V47, P1441, DOI 10.1637/7030; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; SYED S A, 1970, Infection and Immunity, V2, P376; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Timothy S, 2008, AVIAN PATHOL, V37, P375, DOI 10.1080/03079450802216579; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wells LL, 1998, DEV COMP IMMUNOL, V22, P103, DOI 10.1016/S0145-305X(97)00024-4; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Yassin H, 2009, POULTRY SCI, V88, P798, DOI 10.3382/ps.2008-00292	61	44	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67749	10.1371/journal.pone.0067749	http://dx.doi.org/10.1371/journal.pone.0067749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825682	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000116
J	Walsh, SA; Iwaniuk, AN; Knoll, MA; Bourdon, E; Barrett, PM; Milner, AC; Nudds, RL; Abel, RL; Dello Sterpaio, P				Walsh, Stig A.; Iwaniuk, Andrew N.; Knoll, Monja A.; Bourdon, Estelle; Barrett, Paul M.; Milner, Angela C.; Nudds, Robert L.; Abel, Richard L.; Dello Sterpaio, Patricia			Avian Cerebellar Floccular Fossa Size Is Not a Proxy for Flying Ability in Birds	PLOS ONE			English	Article							LOWER EOCENE; EVOLUTION; THEROPOD; BRAIN; REPTILES; FLIGHT; HEAD; ORGANIZATION; DINOSAURS; MOVEMENT	Extinct animal behavior has often been inferred from qualitative assessments of relative brain region size in fossil endocranial casts. For instance, flight capability in pterosaurs and early birds has been inferred from the relative size of the cerebellar flocculus, which in life protrudes from the lateral surface of the cerebellum. A primary role of the flocculus is to integrate sensory information about head rotation and translation to stabilize visual gaze via the vestibulo-occular reflex (VOR). Because gaze stabilization is a critical aspect of flight, some authors have suggested that the flocculus is enlarged in flying species. Whether this can be further extended to a floccular expansion in highly maneuverable flying species or floccular reduction in flightless species is unknown. Here, we used micro computed-tomography to reconstruct "virtual" endocranial casts of 60 extant bird species, to extract the same level of anatomical information offered by fossils. Volumes of the floccular fossa and entire brain cavity were measured and these values correlated with four indices of flying behavior. Although a weak positive relationship was found between floccular fossa size and brachial index, no significant relationship was found between floccular fossa size and any other flight mode classification. These findings could be the result of the bony endocranium inaccurately reflecting the size of the neural flocculus, but might also reflect the importance of the flocculus for all modes of locomotion in birds. We therefore conclude that the relative size of the flocculus of endocranial casts is an unreliable predictor of locomotor behavior in extinct birds, and probably also pterosaurs and non-avian dinosaurs.	[Walsh, Stig A.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Iwaniuk, Andrew N.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Knoll, Monja A.] Univ West Scotland, Sch Social Sci, Paisley, Renfrew, Scotland; [Bourdon, Estelle; Barrett, Paul M.; Milner, Angela C.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Nudds, Robert L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Abel, Richard L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Dello Sterpaio, Patricia] Univ Abertay, Sch Engn Comp & Appl Math, Dundee, Scotland	University of Lethbridge; University of West Scotland; Natural History Museum London; University of Manchester; Imperial College London; University of Abertay Dundee	Walsh, SA (corresponding author), Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland.	s.walsh@nms.ac.uk	Bourdon, Estelle/B-1115-2011; Iwaniuk, Andrew/H-7255-2019; Barrett, Paul M/A-2648-2010	Bourdon, Estelle/0000-0002-5989-1982; Iwaniuk, Andrew/0000-0001-9273-3655; Barrett, Paul M/0000-0003-0412-3000; Walsh, Stig/0000-0002-7002-1005	Natural Environment Research Council [NE/H012176/1]; NERC [NE/H012176/1, NE/E008380/1] Funding Source: UKRI; Natural Environment Research Council [NE/E008380/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by Natural Environment Research Council (http://www.nerc.ac.uk/) Small Grant NE/H012176/1 to SAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15, P1, DOI DOI 10.26879/284; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P407; Burnham DA, 2004, LIFE O PAST, P67; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; Corfield JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022945; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Dyke GJ, 2005, ACTA PALAEONTOL POL, V50, P101; Feduccia A, 2011, RIDDLE FEATHERED DRA; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; Fujita M, 2002, J ZOOL, V257, P373, DOI 10.1017/S0952836902000973; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2007, BRAIN BEHAV EVOLUT, V69, P196, DOI 10.1159/000096987; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kavanau JL, 2010, MED HYPOTHESES, V74, P275, DOI 10.1016/j.mehy.2009.09.015; Kennedy M, 2002, AUK, V119, P88, DOI 10.1642/0004-8038(2002)119[0088:SSCPEO]2.0.CO;2; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; Larsell O, 1926, J COMP NEUROL, V41, P59, DOI 10.1002/cne.900410103; Larsell O, 1932, J COMP NEUROL, V56, P299, DOI 10.1002/cne.900560204; Larsell O, 1967, COMP ANATOMY HISTOLO; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison, 2019, MESQUITE MODULAR SYS; Midford PE, 2008, PDAP MESQUITE TRANSL; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Muir GD, 2005, J NEUROPHYSIOL, V94, P3691, DOI 10.1152/jn.01121.2004; Necker R, 2007, J COMP PHYSIOL A, V193, P1177, DOI 10.1007/s00359-007-0281-3; Norberg U., 1990, VERTEBRATE FLIGHT ME; Norell MA, 2009, AM MUS NOVIT, P1; Northcutt RG, 2001, BRAIN RES BULL, V55, P663, DOI 10.1016/S0361-9230(01)00560-3; Nudds RL, 2007, J ZOOL, V272, P218, DOI 10.1111/j.1469-7998.2006.00261.x; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; Pakan JMP, 2011, VISUAL NEUROSCI, V28, P163, DOI 10.1017/S0952523810000532; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Ridgely R, 2008, J VERTEBR PALEONTOL, V28, p131A; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Voogd J, 2004, J COMP NEUROL, V470, P107, DOI 10.1002/cne.11022; Walsh SA, 2013, SPRINGER HDB AUDITOR; Walsh SA, 2011, LIVING DINOSAURS EVO, P282; Walsh S, 2011, J SYST PALAEONTOL, V9, P173, DOI 10.1080/14772019.2010.513703; Walsh SA, 2011, SPEC PAP PALAEONTOL, P263, DOI 10.1111/j.1475-4983.2011.01085.x; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Wang Xia, 2011, PLoS ONE, V6, P1, DOI 10.1371/journal.pone.0028672; Warrick DR, 2002, INTEGR COMP BIOL, V42, P141, DOI 10.1093/icb/42.1.141; Witmer LM, 2007, J MORPHOL, V268, P1150; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Wylie Douglas R., 2012, P289; Wylie DRW, 1999, J NEUROPHYSIOL, V81, P256, DOI 10.1152/jn.1999.81.1.256; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238	61	37	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67176	10.1371/journal.pone.0067176	http://dx.doi.org/10.1371/journal.pone.0067176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825638	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000086
J	Ball, ST; Kelly, ML; Robson, JE; Turner, MD; Harrison, J; Jones, L; Napper, D; Beechey, CV; Hough, T; Plagge, A; Cattanach, BM; Cox, RD; Peters, J				Ball, Simon T.; Kelly, Michelle L.; Robson, Joan E.; Turner, Martin D.; Harrison, Jackie; Jones, Lynn; Napper, Diane; Beechey, Colin V.; Hough, Tertius; Plagge, Antonius; Cattanach, Bruce M.; Cox, Roger D.; Peters, Jo			Gene Dosage Effects at the Imprinted Gnas Cluster	PLOS ONE			English	Article							XL-ALPHA-S; PSEUDOHYPOPARATHYROIDISM TYPE-IB; ALBRIGHTS HEREDITARY OSTEODYSTROPHY; EXTRA-LARGE VARIANT; MOUSE-CHROMOSOME 2; G-PROTEIN; CONTROL REGION; GS-ALPHA; HORMONE RESISTANCE; EPIGENETIC DEFECTS	Genomic imprinting results in parent-of-origin-dependent monoallelic gene expression. Early work showed that distal mouse chromosome 2 is imprinted, as maternal and paternal duplications of the region (with corresponding paternal and maternal deficiencies) give rise to different anomalous phenotypes with early postnatal lethalities. Newborns with maternal duplication (MatDp(dist2)) are long, thin and hypoactive whereas those with paternal duplication (PatDp(dist2)) are chunky, oedematous, and hyperactive. Here we focus on PatDp(dist2). Loss of expression of the maternally expressed Gnas transcript at the Gnas cluster has been thought to account for the PatDp(dist2) phenotype. But PatDp(dist2) also have two expressed doses of the paternally expressed Gnasxl transcript. Through the use of targeted mutations, we have generated PatDp(dist2) mice predicted to have 1 or 2 expressed doses of Gnasxl, and 0, 1 or 2 expressed doses of Gnas. We confirm that oedema is due to lack of expression of imprinted Gnas alone. We show that it is the combination of a double dose of Gnasxl, with no dose of imprinted Gnas, that gives rise to the characteristic hyperactive, chunky, oedematous, lethal PatDp(dist2) phenotype, which is also hypoglycaemic. However PatDp(dist2) mice in which the dosage of the Gnasxl and Gnas is balanced (either 2: 2 or 1:1) are neither dysmorphic nor hyperactive, have normal glucose levels, and are fully viable. But PatDp(dist2) with biallelic expression of both Gnasxl and Gnas show a marked postnatal growth retardation. Our results show that most of the PatDp(dist2) phenotype is due to overexpression of Gnasxl combined with loss of expression of Gnas, and suggest that Gnasxl and Gnas may act antagonistically in a number of tissues and to cause a wide range of phenotypic effects. It can be concluded that monoallelic expression of both Gnasxl and Gnas is a requirement for normal postnatal growth and development.	[Ball, Simon T.; Kelly, Michelle L.; Robson, Joan E.; Turner, Martin D.; Cattanach, Bruce M.; Cox, Roger D.; Peters, Jo] MRC, Mammalian Genet Unit, Harwell, Oxon, England; [Harrison, Jackie; Jones, Lynn; Napper, Diane; Beechey, Colin V.; Hough, Tertius] MRC, Mary Lyon Ctr, Harwell, Oxon, England; [Plagge, Antonius] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Peters, J (corresponding author), MRC, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Harwell, Oxon, England.	j.peters@har.mrc.ac.uk	Plagge, Antonius/AAH-3877-2019	Plagge, Antonius/0000-0001-6592-1343; Cox, Roger/0000-0001-7170-5014	UK Medical Research Council; Medical Research Council [MC_UP_1502/1, MC_U142661184, MC_U142636336] Funding Source: researchfish; MRC [MC_U142636336, MC_U142661184, MC_UP_1502/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Aydin C, 2009, ENDOCRINOLOGY, V150, P3567, DOI 10.1210/en.2009-0318; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2012, HORM METAB RES, V44, P732, DOI 10.1055/s-0032-1316331; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Bastepe M, 2011, BONE, V48, P659, DOI 10.1016/j.bone.2010.10.168; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; Cattanach BM, 2006, CYTOGENET GENOME RES, V113, P17, DOI 10.1159/000090810; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Cattanach BM, 1990, DEV S, V1990, P63; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; CRAWFORD JA, 1993, J BIOL CHEM, V268, P9879; de Nanclares GP, 2007, J CLIN ENDOCR METAB, V92, P2370, DOI 10.1210/jc.2006-2287; Dixit A, 2013, J CLIN ENDOCR METAB, V98, pE103, DOI 10.1210/jc.2012-2639; Eaton SA, 2012, MOL CELL BIOL, V32, P1017, DOI 10.1128/MCB.06174-11; Fernandez-Rebollo E, 2012, P NATL ACAD SCI USA, V109, P6638, DOI 10.1073/pnas.1117608109; Fernandez-Rebollo E, 2010, EUR J ENDOCRINOL, V163, P953, DOI 10.1530/EJE-10-0435; Frohlich LF, 2010, P NATL ACAD SCI USA, V107, P9275, DOI 10.1073/pnas.0910224107; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kelsey G, 2010, AM J MED GENET C, V154C, P377, DOI 10.1002/ajmg.c.30271; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Krechowec SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029753; Lecumberri B, 2010, J MED GENET, V47, P276, DOI 10.1136/jmg.2009.071001; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Mantovani G, 2010, J CLIN ENDOCR METAB, V95, P651, DOI 10.1210/jc.2009-0176; Mariot V, 2008, J CLIN ENDOCR METAB, V93, P661, DOI 10.1210/jc.2007-0927; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; SEARLE AG, 1971, GENET RES, V18, P215, DOI 10.1017/S0016672300012611; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Unluturk U, 2008, AM J MED SCI, V336, P84, DOI 10.1097/MAJ.0b013e31815b218f; Williamson CM, 1998, GENET RES, V72, P255, DOI 10.1017/S0016672398003528; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	52	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65639	10.1371/journal.pone.0065639	http://dx.doi.org/10.1371/journal.pone.0065639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822972	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400015
J	Bianchelli, S; Pusceddu, A; Canese, S; Greco, S; Danovaro, R				Bianchelli, Silvia; Pusceddu, Antonio; Canese, Simone; Greco, Silvio; Danovaro, Roberto			High Meiofaunal and Nematodes Diversity around Mesophotic Coral Oases in the Mediterranean Sea	PLOS ONE			English	Article							LIGURIAN SEA; VERTICAL CLIFF; ORGANIC-MATTER; BIODIVERSITY; ASSEMBLAGES; ECOSYSTEM; SEDIMENTS; HABITAT; BAY	Although the mesophotic zone of the Mediterranean Sea has been poorly investigated, there is an increasing awareness about its ecological importance for its biodiversity, as fish nursery and for the recruitment of shallow water species. Along with coastal rocky cliffs, isolated coralligenous concretions emerging from muddy bottoms are typical structures of the Mediterranean Sea mesophotic zone. Coralligenous concretions at mesophotic depths in the South Tyrrhenian Sea were investigated to assess the role of these coralligenous oases in relation to the biodiversity of surrounding soft sediments. We show here that the complex structures of the coralligenous concretions at ca. 110 m depth influence the trophic conditions, the biodiversity and assemblage composition in the surrounding sediments even at considerable distances. Coral concretions not only represent deep oases of coral biodiversity but they also promote a higher biodiversity of the fauna inhabiting the surrounding soft sediments. Using the biodiversity of nematodes as a proxy of the total benthic biodiversity, a high turnover biodiversity within a 200 m distance from the coralligenous concretions was observed. Such turnover is even more evident when only rare taxa are considered and seems related to specific trophic conditions, which are influenced by the presence of the coralligenous structures. The presence of a high topographic complexity and the trophic enrichment make these habitats highly biodiverse, nowadays endangered by human activities ( such as exploitation of commercial species such as Corallium rubrum, or trawling fisheries, which directly causes habitat destruction or indirectly causes modification in the sedimentation and re-suspension rates). We stress that the protection of the coralligenous sea concretions is a priority for future conservation policies at the scale of large marine ecosystems and that a complete census of these mesophotic oases of biodiversity should be a priority for future investigations in the Mediterranean Sea.	[Bianchelli, Silvia; Pusceddu, Antonio; Danovaro, Roberto] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Canese, Simone; Greco, Silvio] ISPRA, Ist Super Ric Ambientale, Rome, Italy	Marche Polytechnic University; Italian Institute for Environmental Protection & Research (ISPRA)	Pusceddu, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	a.pusceddu@univpm.it	Bianchelli, Silvia/F-3954-2018; Canese, Simonepietro/AAA-5499-2019	Bianchelli, Silvia/0000-0002-1957-3269; Canese, Simonepietro/0000-0001-6049-4506	Calabrian Regional Council for the Environment; EU project HERMIONE [226354]; National Flag Project RITMARE (Marine Italian Research); Department of Life and Environmental Sciences (Polytechnic University of Marche) [327 MoBioMarCal]; Institute for Environmental Protection and Research ISPRA) [327 MoBioMarCal]	Calabrian Regional Council for the Environment; EU project HERMIONE; National Flag Project RITMARE (Marine Italian Research); Department of Life and Environmental Sciences (Polytechnic University of Marche); Institute for Environmental Protection and Research ISPRA)	This study was supported by Project no. 327 MoBioMarCal financed by the Calabrian Regional Council for the Environment, EU project HERMIONE (grant agreement n. 226354), and National Flag Project RITMARE (Marine Italian Research) coordinated by the CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was carried out in the framework of a collaboration between the Department of Life and Environmental Sciences (Polytechnic University of Marche) and the Institute for Environmental Protection and Research ISPRA), in the framework of the project no. 327 MoBioMarCal. This study is a contribution to the EU project HERMIONE and National Flag Project RITMARE (Marine Italian Research) coordinated by the CNR.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; BAVESTRELLO G, 1995, J COASTAL RES, V11, P690; BAVESTRELLO G, 1991, MAR ECOL-P S Z N I, V12, P281, DOI 10.1111/j.1439-0485.1991.tb00259.x; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Bo M, 2012, PLOS ONE IN PRESS; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Bruno JF, 2000, OECOLOGIA, V122, P98, DOI 10.1007/PL00008841; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Canals M, 1997, DEEP-SEA RES PT II, V44, P611, DOI 10.1016/S0967-0645(96)00095-1; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; DEPREZ T, 2005, NEMYS; Emig C.C., 1997, PUBL ESPEC I ESP OCE, V23, P23; Feller R.J., 1988, P181; Ferdeghini F, 2000, HYDROBIOLOGIA, V440, P27, DOI 10.1023/A:1004124423718; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gambi C., 2010, ADV OCEANOGR LIMNOL, V1, P167, DOI [10.4081/aiol.2010.5299, DOI 10.4081/AIOL.2010.5299]; Gambi C, 2009, BIODIVERS CONSERV, V18, P33, DOI 10.1007/s10531-008-9433-1; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hasemann C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029152; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kiriakoulakis K, 2004, DEEP-SEA RES PT I, V51, P1937, DOI 10.1016/j.dsr.2004.07.010; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LEVIN LA, 1991, AM ZOOL, V31, P886; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mirto S, 2010, MAR ENVIRON RES, V69, P38, DOI 10.1016/j.marenvres.2009.07.005; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Platt HM., 1983, SYNOPSIS FREE LIVI 1; Platt HM, 1988, SYNOPSIS FREE LIVI 2; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Previati M, 2010, J EXP MAR BIOL ECOL, V390, P39, DOI 10.1016/j.jembe.2010.04.025; Pusceddu A, 2000, POLAR BIOL, V23, P288, DOI 10.1007/s003000050446; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, MAR ECOL PROG SER, V375, P41, DOI 10.3354/meps07735; Raes M, 2008, J BIOGEOGR, V35, P2207, DOI 10.1111/j.1365-2699.2008.01945.x; Schottner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032093; Seinhorst J. W., 1959, Nematologica, V4, P67; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Warwick RM, 1998, SYNOPSIS FREE LIVI 3; WIESER W, 1960, LIMNOL OCEANOGR, V5, P121, DOI 10.4319/lo.1960.5.2.0121; WIESER W., 1953, ARKIV ZOOL, V4, P439	58	18	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66553	10.1371/journal.pone.0066553	http://dx.doi.org/10.1371/journal.pone.0066553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823621	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400127
J	Kono, T; Korenaga, H				Kono, Tomoya; Korenaga, Hiroki			Cytokine Gene Expression in CD4 Positive Cells of the Japanese Pufferfish, Takifugu rubripes	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; MOLECULAR-CLONING; T-CELLS; TELEOST FISH; MESSENGER-RNA; TGF-BETA; FUGU; HOMOLOG; ACTIVATION; INTERFERON	CD4(+) T (Th) cells are a central component of the adaptive immune response and are divided into distinct sets based on their specific cytokine production pattern. Several reports have suggested that fish possess Th subset activity similar to that of mammals. The aim of the present study was to isolate CD4(+) T cells from the blood of Japanese pufferfish, Fugu rubripes, and to characterize their cytokine expression profile. We produced a specific antibody against Fugu CD4 and performed cell sorting with the magnetic activated cell sorting system. Sorted Fugu CD4(+) cells were characterized by morphology and expression analysis of cell marker genes. Fugu CD4(+) cells expressed T-cell marker genes but not macrophage or B-cell marker genes. In addition, peripheral blood lymphocytes were stimulated with lipopolysaccharide (LPS), polycytidylic acid (polyI: C), concanavalin A ( ConA) prior to sorting, and then Multiplex RT-PCR was used to examine the expression of Th cytokines by the stimulated Fugu CD4(+) cells. LPS and polyI: C stimulation upregulated the expression of Th1, Th17 and Treg cytokines and downregulated the expression of Th2 cytokines. ConA stimulation upregulated the expression of all Th cytokines. These results suggest that fish exhibit the same upregulation of Th-specific cytokine expression as in mammals.	[Kono, Tomoya] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Korenaga, Hiroki] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki, Japan	University of Miyazaki; University of Miyazaki	Kono, T (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	tkono@cc.miyazaki-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23780199]; University of Miyazaki	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki	TK was supported financially by the Improvement of Research Environment for Young Researchers program of the Japanese Ministry of Education, Culture, Sports, Science and Technology, a Grant-in-Aid for Young Scientists (23780199) and a grant for Scientific Research on Priority Areas from the University of Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejo A, 2011, DEV COMP IMMUNOL, V35, P1215, DOI 10.1016/j.dci.2011.03.011; Alisa A, 2008, J IMMUNOL, V180, P5109, DOI 10.4049/jimmunol.180.7.5109; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Bialecki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026919; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Boschi I, 2011, FISH SHELLFISH IMMUN, V31, P655, DOI 10.1016/j.fsi.2010.10.001; Buonocore F, 2008, MOL IMMUNOL, V45, P3168, DOI 10.1016/j.molimm.2008.02.024; Castro R, 2011, FISH SHELLFISH IMMUN, V30, P215, DOI 10.1016/j.fsi.2010.10.010; Corripio-Miyar Y, 2007, MOL IMMUNOL, V44, P1361, DOI 10.1016/j.molimm.2006.05.010; Edholm ES, 2007, DEV COMP IMMUNOL, V31, P172, DOI 10.1016/j.dci.2006.05.012; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; HAANEN JBAG, 1991, J EXP MED, V174, P583, DOI 10.1084/jem.174.3.583; Harms CA, 2000, FISH SHELLFISH IMMUN, V10, P61, DOI 10.1006/fsim.1999.0230; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; Kitao Y, 2009, MOL IMMUNOL, V46, P2548, DOI 10.1016/j.molimm.2009.05.012; Kobayashi I, 2006, DEV COMP IMMUNOL, V30, P1034, DOI 10.1016/j.dci.2006.01.005; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; Kono T, 2013, VET IMMUNOL IMMUNOP, V151, P90, DOI 10.1016/j.vetimm.2012.10.012; Korenaga H, 2012, TAKIFUGUM RUBRIPES G; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Kuo CH, 2011, J MOL MED, V89, P29, DOI 10.1007/s00109-010-0694-2; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Laing KJ, 2011, DEV COMP IMMUNOL, V35, P1282, DOI 10.1016/j.dci.2011.03.004; Laurent C, 2010, HAEMATOL-HEMATOL J, V95, P356, DOI 10.3324/haematol.2009.019133; Li J, 2004, DEV COMP IMMUNOL, V28, P1005, DOI 10.1016/j.dci.2004.03.004; Lynch GW, 2006, IMMUNOL CELL BIOL, V84, P154, DOI 10.1111/j.1440-1711.2005.01403.x; Malmhall C, 2007, ALLERGY, V62, P1007, DOI 10.1111/j.1398-9995.2007.01420.x; Nonaka S, 2008, FISHERIES SCI, V74, P341, DOI 10.1111/j.1444-2906.2008.01530.x; Odaka T, 2011, FISH SHELLFISH IMMUN, V30, P682, DOI 10.1016/j.fsi.2010.12.018; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Patel S, 2009, FISH SHELLFISH IMMUN, V26, P377, DOI 10.1016/j.fsi.2008.11.013; Pouw N, 2010, MOL IMMUNOL, V47, P1411, DOI 10.1016/j.molimm.2010.02.022; Rendon JL, 2012, J LEUKOCYTE BIOL, V92, P529, DOI 10.1189/jlb.0212083; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Savan R, 2005, IMMUNOGENETICS, V57, P140, DOI 10.1007/s00251-005-0768-4; Savan R, 2006, COMP BIOCHEM PHYS D, V1, P89, DOI 10.1016/j.cbd.2005.08.005; Hernandez AS, 2009, REUMATOL CLIN, V5, P1, DOI 10.1016/j.reuma.2008.11.012; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Suetake H, 2004, IMMUNOGENETICS, V56, P368, DOI 10.1007/s00251-004-0694-x; Sugamata R, 2009, J IMMUNOL, V182, P6799, DOI 10.4049/jimmunol.0803371; Sun XF, 2007, FISH SHELLFISH IMMUN, V23, P1242, DOI 10.1016/j.fsi.2007.06.004; Takizawa F, 2008, MOL IMMUNOL, V45, P127, DOI 10.1016/j.molimm.2007.05.005; Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014; Toda H, 2011, DEV COMP IMMUNOL, V35, P650, DOI 10.1016/j.dci.2011.01.013; Venkatesh B, 1996, J MOL BIOL, V259, P655, DOI 10.1006/jmbi.1996.0347; Wang TH, 2013, MOL IMMUNOL, V53, P398, DOI 10.1016/j.molimm.2012.09.008; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031809; Wen Y, 2006, COMP BIOCHEM PHYS B, V144, P159, DOI 10.1016/j.cbpb.2006.02.012; Wen Y, 2011, CELL MOL LIFE SCI, V68, P2615, DOI 10.1007/s00018-010-0574-5; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Yamaguchi T, 2011, DEV COMP IMMUNOL, V35, P193, DOI 10.1016/j.dci.2010.09.007; Yang H, 2010, INFLAMM RES, V59, P197, DOI 10.1007/s00011-009-0087-6; Yang Jing, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P213; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Yu YM, 2002, CELL IMMUNOL, V215, P78, DOI 10.1016/S0008-8749(02)00003-5; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Zou J, 2004, FISH SHELLFISH IMMUN, V17, P403, DOI 10.1016/j.fsi.2004.04.015	65	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66364	10.1371/journal.pone.0066364	http://dx.doi.org/10.1371/journal.pone.0066364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823320	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400092
J	Nguyen, HD; Becker, J; Thu, YM; Costanzo, M; Koch, EN; Smith, S; Myung, K; Myers, CL; Boone, C; Bielinsky, AK				Nguyen, Hai Dang; Becker, Jordan; Thu, Yee Mon; Costanzo, Michael; Koch, Elizabeth N.; Smith, Stephanie; Myung, Kyungjae; Myers, Chad L.; Boone, Charles; Bielinsky, Anja-Katrin			Unligated Okazaki Fragments Induce PCNA Ubiquitination and a Requirement for Rad59-Dependent Replication Fork Progression	PLOS ONE			English	Article							DNA-LIGASE-I; NEARBY INVERTED REPEATS; CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; COMPLEX-FORMATION; CDC9 GENE; YEAST	Deficiency in DNA ligase I, encoded by CDC9 in budding yeast, leads to the accumulation of unligated Okazaki fragments and triggers PCNA ubiquitination at a non-canonical lysine residue. This signal is crucial to activate the S phase checkpoint, which promotes cell cycle delay. We report here that a pol30-K107 mutation alleviated cell cycle delay in cdc9 mutants, consistent with the idea that the modification of PCNA at K107 affects the rate of DNA synthesis at replication forks. To determine whether PCNA ubiquitination occurred in response to nicks or was triggered by the lack of PCNA-DNA ligase interaction, we complemented cdc9 cells with either wild-type DNA ligase I or a mutant form, which fails to interact with PCNA. Both enzymes reversed PCNA ubiquitination, arguing that the modification is likely an integral part of a novel nick-sensory mechanism and not due to non-specific secondary mutations that could have occurred spontaneously in cdc9 mutants. To further understand how cells cope with the accumulation of nicks during DNA replication, we utilized cdc9-1 in a genome-wide synthetic lethality screen, which identified RAD59 as a strong negative interactor. In comparison to cdc9 single mutants, cdc9 rad59D double mutants did not alter PCNA ubiquitination but enhanced phosphorylation of the mediator of the replication checkpoint, Mrc1. Since Mrc1 resides at the replication fork and is phosphorylated in response to fork stalling, these results indicate that Rad59 alleviates nick-induced replication fork slowdown. Thus, we propose that Rad59 promotes fork progression when Okazaki fragment processing is compromised and counteracts PCNA-K107 mediated cell cycle arrest.	[Nguyen, Hai Dang; Becker, Jordan; Thu, Yee Mon; Bielinsky, Anja-Katrin] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Costanzo, Michael; Boone, Charles] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON, Canada; [Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Koch, Elizabeth N.; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Smith, Stephanie; Myung, Kyungjae] Natl Inst Hlth, Natl Human Genome Res Inst, Genet & Mol Biol Branch, Genome Instabil Sect, Bethesda, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bielinsky, AK (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bieli003@umn.edu		Becker, Jordan/0000-0002-6827-0002; Bielinsky, Anja/0000-0003-1783-619X	National Institutes of Health (NIH) [GM074917]; National Human Genome Research Institute; NIH [HG005084, HG005853]; NSF [DBI0953881]; Canadian Institutes of Health Research [MOP-102629, MOP-97939]; Ontario Research Fund [GL2-0122]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074917] Funding Source: NIH RePORTER; Direct For Biological Sciences [0953881] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health (NIH) grant GM074917 to AKB, who is a Scholar of the Leukemia and Lymphoma Society. The intramural Research Programs of the National Human Genome Research Institute supported KM. EK is a National Science Foundation (NSF) Graduate Research Fellow. EK and CLM were supported by a grant from the NIH (HG005084), and the NSF (DBI0953881). CB and CLM are supported by a grant from the NIH (HG005853). CB is supported by grants from the Canadian Institutes of Health Research (MOP-102629 and MOP-97939) and the Ontario Research Fund (GL2-0122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273; Barlow JH, 2009, EMBO J, V28, P1121, DOI 10.1038/emboj.2009.43; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Ben-Aroya S, 2010, METHOD ENZYMOL, V470, P181, DOI 10.1016/S0076-6879(10)70008-2; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Brachmann CB, 1998, YEAST, V14, P115; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Budd ME, 2011, CELL CYCLE, V10, P1690, DOI 10.4161/cc.10.10.15643; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Chen C, 1999, MOL CELL BIOL, V19, P7801; COLLINGE MA, 1994, MOL GEN GENET, V245, P686, DOI 10.1007/BF00297275; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Das-Bradoo S, 2010, CELL CYCLE, V9, P3674, DOI 10.4161/cc.9.18.13121; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; GAME JC, 1979, P NATL ACAD SCI USA, V76, P4589, DOI 10.1073/pnas.76.9.4589; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Guzder SN, 2006, MOL CELL BIOL, V26, P1135, DOI 10.1128/MCB.26.3.1135-1141.2006; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; MONTELONE BA, 1981, J BACTERIOL, V147, P517, DOI 10.1128/JB.147.2.517-525.1981; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Motegi A, 2007, METHODS, V41, P168, DOI 10.1016/j.ymeth.2006.07.025; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Naiki T, 2004, MOL CELL BIOL, V24, P3277, DOI 10.1128/MCB.24.8.3277-3285.2004; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nakada D, 2004, MOL CELL BIOL, V24, P10016, DOI 10.1128/MCB.24.22.10016-10025.2004; Naylor ML, 2009, P NATL ACAD SCI USA, V106, P12765, DOI 10.1073/pnas.0904623106; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Szyjka SJ, 2008, GENE DEV, V22, P1906, DOI 10.1101/gad.1660408; Toh GWL, 2010, DNA REPAIR, V9, P718, DOI 10.1016/j.dnarep.2010.02.013; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; WEINERT TA, 1993, GENETICS, V134, P63; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wu XH, 1999, BIOCHEMISTRY-US, V38, P2628, DOI 10.1021/bi982592s; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	64	15	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66379	10.1371/journal.pone.0066379	http://dx.doi.org/10.1371/journal.pone.0066379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824283	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400098
J	Zhang, T; Watson, DG; Wang, LJ; Abbas, M; Murdoch, L; Bashford, L; Ahmad, I; Lam, NY; Ng, ACF; Leung, HY				Zhang, Tong; Watson, David G.; Wang, Lijie; Abbas, Muhammad; Murdoch, Laura; Bashford, Lisa; Ahmad, Imran; Lam, Nga-Yee; Ng, Anthony C. F.; Leung, Hing Y.			Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery	PLOS ONE			English	Article							PROFILING PROCEDURES; GAS-CHROMATOGRAPHY; SERUM SARCOSINE; DEFICIENCY; ACCURACY; MARKER; DAMAGE; ACID	Human exhibit wide variations in their metabolic profiles because of differences in genetic factors, diet and lifestyle. Therefore in order to detect metabolic differences between individuals robust analytical methods are required. A protocol was produced based on the use of Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) in combination with orthogonal Hydrophilic Interaction (HILIC) and Reversed Phase (RP) liquid chromatography methods for the analysis of the urinary metabolome, which was then evaluated as a diagnostic tool for prostate cancer (a common but highly heterogeneous condition). The LC-HRMS method was found to be robust and exhibited excellent repeatability for retention times (<+/- 1%), and mass accuracy (<+/- 1 ppm). Based on normalised data (against creatinine levels, osmolality or MS total useful signals/MSTUS) coupled with supervised multivariate analysis using Orthogonal Partial Least Square-Discriminant Analysis (OPLS-DA), we were able to discriminate urine samples from men with or without prostate cancer with R2Y(cum) >0.9. In addition, using the receiver operator characteristics (ROC) test, the area under curve (AUC) for the combination of the four best characterised biomarker compounds was 0.896. The four biomarker compounds were also found to differ significantly (P<0.05) between an independent patient cohort and controls. This is the first time such a rigorous test has been applied to this type of model. If validated, the established protocol provides a robust approach with a potentially wide application to metabolite profiling of human biofluids in health and disease.	[Zhang, Tong; Watson, David G.; Wang, Lijie; Abbas, Muhammad] Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Ahmad, Imran; Leung, Hing Y.] Gartnavel Royal Hosp, Dept Urol, Glasgow, Lanark, Scotland; [Bashford, Lisa; Ahmad, Imran; Leung, Hing Y.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Murdoch, Laura] Glasgow Clin Res Facil, Glasgow, Lanark, Scotland; [Lam, Nga-Yee; Ng, Anthony C. F.] Chinese Univ Hong Kong, Dept Urol, Hong Kong, Hong Kong, Peoples R China	University of Strathclyde; Gartnavel Royal Hospital; Beatson Institute; Chinese University of Hong Kong	Zhang, T (corresponding author), Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	tong.zhang.101@strath.ac.uk	Ahmad, Imran/GRJ-0536-2022; Chi-fai, NG/AAV-8270-2021; Ng, Chi-Fai/E-5134-2011	Ng, Chi-Fai/0000-0002-1723-9646; Leung, Hing Y./0000-0002-3933-3975; Ahmad, Imran/0000-0002-4404-1926	Cancer Research UK [15151] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Abdenur JE, 2006, MOL GENET METAB, V87, P48, DOI 10.1016/j.ymgme.2005.09.007; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Bohm L, 2012, SAMJ S AFR MED J, V102, P677, DOI 10.7196/SAMJ.5768; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cavaliere B, 2011, ANAL BIOANAL CHEM, V400, P2903, DOI 10.1007/s00216-011-4960-0; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Chen J, 2009, ANAL CHIM ACTA, V650, P3, DOI 10.1016/j.aca.2009.03.039; Claudino WM, 2012, CRIT REV ONCOL HEMAT, V84, P1, DOI 10.1016/j.critrevonc.2012.02.009; Darbon JM, 2009, B CANCER, V96, P355, DOI 10.1684/bdc.2009.0849; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Huang Z., 2012, METABOLOMICS; IDE H, 1991, J BIOL CHEM, V266, P1469; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Issaq HJ, 2011, J SEP SCI, V34, P3619, DOI 10.1002/jssc.201100572; Issaq HJ, 2011, J SEP SCI, V34, P3484, DOI 10.1002/jssc.201100528; Jentzmik F, 2011, J UROLOGY, V185, P706, DOI 10.1016/j.juro.2010.09.077; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Kuhara T, 2009, J MASS SPECTROM, V44, P214, DOI 10.1002/jms.1500; Lucarelli G, 2012, PROSTATE, V72, P1611, DOI 10.1002/pros.22514; Marklova E, 1999, AMINO ACIDS, V17, P401, DOI 10.1007/BF01361665; Martinez-Lozano P, 2011, METABOLOMICS; Palacios DA, 2012, BIOMARK MED, V6, P513; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Schalken JA, 2010, EUR UROL, V58, P19, DOI 10.1016/j.eururo.2010.02.025; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Theodoridis G, 2011, MASS SPECTROM REV, V30, P884, DOI 10.1002/mas.20306; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Trock BJ, 2011, UROL ONCOL-SEMIN ORI, V29, P572, DOI 10.1016/j.urolonc.2011.08.002; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; Woo HM, 2009, CLIN CHIM ACTA, V400, P63, DOI 10.1016/j.cca.2008.10.014; Wu H, 2011, ANAL BIOANAL CHEM, V401, P635, DOI 10.1007/s00216-011-5098-9; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738	40	42	42	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65880	10.1371/journal.pone.0065880	http://dx.doi.org/10.1371/journal.pone.0065880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823321	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000320576400027
J	Chew, TW; Liu, XJ; Liu, L; Spitsbergen, J; Gong, Z; Low, BC				Chew, T. W.; Liu, X. J.; Liu, L.; Spitsbergen, J. M.; Gong, Z.; Low, B. C.			Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models	ONCOGENE			English	Article						hepatocellular carcinoma; zebrafish; RhoA; Ras; signaling crosstalk; Akt	CELL-PROLIFERATION; SIGNALING PATHWAYS; IN-VIVO; DEPENDENT PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; DOWN-REGULATION; KINASE PATHWAY; TET-ON; AKT	RAS and Rho small GTPases are key molecular switches that control cell dynamics, cell growth and tissue development through their distinct signaling pathways. Although much has been learnt about their individual functions in both cell and animal models, the physiological and pathophysiological consequences of their signaling crosstalk in multi-cellular context in vivo remain largely unknown, especially in liver development and liver tumorigenesis. Furthermore, the roles of RhoA in RAS-mediated transformation and their crosstalk in vitro remain highly controversial. When challenged with carcinogens, zebrafish developed liver cancer that resembles the human liver cancer both molecularly and histopathologically. Capitalizing on the growing importance and relevance of zebrafish ( Danio rerio) as an alternate cancer model, we have generated liver-specific, Tet-on-inducible transgenic lines expressing oncogenic Kras(G12V), RhoA, constitutively active RhoA(G14V) or dominant-negative Rho(AT19N). Double-transgenic lines expressing Kras(G12V) with one of the three RhoA genes were also generated. Based on quantitative bioimaging and molecular markers for genetic and signaling aberrations, we showed that the induced expression of oncogenic Kras during early development led to liver enlargement and hepatocyte proliferation, associated with elevated Erk phosphorylation, activation of Akt2 and modulation of its two downstream targets, p21Cip and S6 kinase. Such an increase in liver size and Akt2 expression was augmented by dominant-negative Rho(AT19N), but was abrogated by the constitutive-active Rho(AG14V). Consequently, induced expression of the oncogenic Kras in adult transgenic fish led to the development of hepatocellular carcinomas. Survival studies further revealed that the co-expression of dominant-negative Rho(AT19N) with oncogenic Kras increased the mortality rate compared with the other single or double-transgenic lines. This study provides evidence of the previously unappreciated signaling crosstalk between Kras and RhoA in regulating liver overgrowth and liver tumorigenesis. Our results also implicate that activating Rho could be beneficial to suppress the Kras-induced liver malignancies.	[Chew, T. W.; Liu, L.; Low, B. C.] Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117548, Singapore; [Chew, T. W.; Low, B. C.] Natl Univ Singapore, Mechanobiol Inst, T Lab Level 10,5A Engn Dr, Singapore 117411, Singapore; [Liu, X. J.; Gong, Z.] Natl Univ Singapore, Dept Biol Sci, Mol Biol Lab, Singapore 117548, Singapore; [Spitsbergen, J. M.] Oregon State Univ, Dept Microbiol & Marine, Corvallis, OR 97331 USA; [Spitsbergen, J. M.] Oregon State Univ, Freshwater Biomed Sci Ctr, Corvallis, OR 97331 USA	National University of Singapore; National University of Singapore; National University of Singapore; Oregon State University; Oregon State University	Low, BC (corresponding author), Natl Univ Singapore, Mechanobiol Inst, T Lab Level 10,5A Engn Dr, Singapore 117411, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Gong, Zhiyuan/H-8794-2012; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Gong, Zhiyuan/0000-0002-9660-5260; Low, Boon Chuan/0000-0003-0756-096X	NUS graduate research scholarship; Biomedical Research Council of Singapore; National Medical Research Council; Mechanobiology Institute of Singapore; National Research Foundation; Ministry of Education, Singapore	NUS graduate research scholarship; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mechanobiology Institute of Singapore; National Research Foundation; Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by the NUS graduate research scholarship awarded to TWC and in part by grants from the Biomedical Research Council of Singapore (ZG and BCL), National Medical Research Council (ZG and BCL) and the Mechanobiology Institute of Singapore (BCL), which is co-funded through the National Research Foundation and the Ministry of Education, Singapore.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Beis D, 2006, TRENDS CELL BIOL, V16, P105, DOI 10.1016/j.tcb.2005.12.001; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Cox Adrienne D, 2010, Small GTPases, V1, P2; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Dreissigacker U, 2006, CELL SIGNAL, V18, P1156, DOI 10.1016/j.cellsig.2005.09.004; Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fleming YM, 2009, ONCOGENE, V28, P983, DOI 10.1038/onc.2008.449; Forti FL, 2007, ENDOCR-RELAT CANCER, V14, P1117, DOI 10.1677/ERC-07-0154; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Fukui K, 2006, J CANCER RES CLIN, V132, P627, DOI 10.1007/s00432-006-0107-7; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Ghosh PM, 2002, CANCER RES, V62, P2630; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Gupta S, 2000, MOL CELL BIOL, V20, P9294, DOI 10.1128/MCB.20.24.9294-9306.2000; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Izawa I, 1998, ONCOGENE, V17, P2863, DOI 10.1038/sj.onc.1202213; Jackson LN, 2008, AM J PHYSIOL-GASTR L, V294, pG1401, DOI 10.1152/ajpgi.00062.2008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karaguni IM, 2002, CANCER RES, V62, P1718; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Li XR, 2006, EJSO-EUR J SURG ONC, V32, P1130, DOI 10.1016/j.ejso.2006.05.012; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; Man JH, 2010, J CLIN INVEST, V120, P2829, DOI 10.1172/JCI42542; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Morin P, 2009, EUR J CELL BIOL, V88, P495, DOI 10.1016/j.ejcb.2009.04.005; Mullany LK, 2007, J BIOL CHEM, V282, P21244, DOI 10.1074/jbc.M702110200; Mure H, 2010, NEURO-ONCOLOGY, V12, P221, DOI 10.1093/neuonc/nop026; O'Shaughnessy RFL, 2007, CANCER RES, V67, P8207, DOI 10.1158/0008-5472.CAN-07-0755; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Pal I, 2012, ACTA PHARMACOL SIN, V33, P1441, DOI 10.1038/aps.2012.72; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Ravichandran A, 2012, MOL BIOL CELL, V23; Reboredo M, 2008, HUM GENE THER, V19, P1233, DOI 10.1089/hum.2008.057; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Shah V, 2001, ONCOGENE, V20, P2112, DOI 10.1038/sj.onc.1204291; Skinner J, 2004, ONCOGENE, V23, P5994, DOI 10.1038/sj.onc.1207798; Spitsbergen JM, 2012, ILAR J, V53, P114, DOI 10.1093/ilar.53.2.114; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vidal A, 2002, J BIOL CHEM, V277, P16433, DOI 10.1074/jbc.M112090200; Wang DS, 2007, J GASTROEN HEPATOL, V22, P1916, DOI 10.1111/j.1440-1746.2006.04534.x; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Xu XD, 2004, ONCOL REP, V11, P25; Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhu SZ, 2012, METHODS MOL BIOL, V827, P321, DOI 10.1007/978-1-61779-442-1_21; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	76	65	67	1	32	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2717	2727		10.1038/onc.2013.240	http://dx.doi.org/10.1038/onc.2013.240			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23812423				2022-12-25	WOS:000337231700005
J	Milam, SL; Erickson, HP				Milam, Sara L.; Erickson, Harold P.			Rapid in Vitro Assembly of Caulobacter crescentus FtsZ Protein at pH 6.5 and 7.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; BACTERIAL CYTOKINESIS; RINGS; REGULATOR; RIBBONS	FtsZ from most bacteria assembles rapidly in vitro, reaching a steady-state plateau in 5-10 s after addition of GTP. A recent study used a novel dynamic light-scattering technique to assay the assembly of FtsZ from Caulobacter crescentus (CcFtsZ) and reported that assembly required 10 min, similar to 100 times slower than for related bacteria. Previous studies had indicated normal, rapid assembly of CcFtsZ. We have reinvestigated the assembly kinetics using a mutant L72W, where assembly of subunits into protofilaments results in a significant increase in tryptophan fluorescence. Wefound that assembly reached a plateau in 5-10 s and showed no change in the following 10 min. This was confirmed by 90 light scattering and negative-stain electron microscopy. The very slow kinetics in the dynamic light-scattering study may be related to a refractory state induced when the FtsZ protein is stored without nucleotide, a phenomenon that we had observed in a previous study of EcFtsZ. Weconclude that CcFtsZ is not an outlier, but shows rapid assembly kinetics similar to FtsZ from related bacteria.	[Milam, Sara L.; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27701 USA; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27701 USA	Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu			National Institutes of Health [GM66014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM66014 (to H. P. E.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hou S, 2012, J BIOL CHEM, V287, P23878, DOI 10.1074/jbc.M111.309492; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038	23	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23675	23679		10.1074/jbc.M113.491845	http://dx.doi.org/10.1074/jbc.M113.491845			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824192	Green Published, hybrid			2022-12-25	WOS:000330611400007
J	Pan, X; Siloto, RMP; Wickramarathna, AD; Mietkiewska, E; Weselake, RJ				Pan, Xue; Siloto, Rodrigo M. P.; Wickramarathna, Aruna D.; Mietkiewska, Elzbieta; Weselake, Randall J.			Identification of a Pair of Phospholipid: Diacylglycerol Acyltransferases from Developing Flax (Linum usitatissimum L.) Seed Catalyzing the Selective Production of Trilinolenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; ALPHA-LINOLENIC ACID; ARABIDOPSIS-THALIANA; TRIACYLGLYCEROL BIOSYNTHESIS; LIPID-SYNTHESIS; GENE; ACCUMULATION; EXPRESSION; CLONING; PATHWAY	The oil from flax (Linum usitatissimum L.) has high amounts of alpha-linolenic acid (ALA; 18:3(cis Delta 9,12,15)) and is one of the richest sources of omega-3 polyunsaturated fatty acids (omega-3-PUFAs). To produce similar to 57% ALA in triacylglycerol (TAG), it is likely that flax contains enzymes that can efficiently transfer ALA to TAG. To test this hypothesis, we conducted a systematic characterization of TAG-synthesizing enzymes from flax. We identified several genes encoding acyl-CoA: diacylglycerol acyltransferases (DGATs) and phospholipid: diacylglycerol acyltransferases (PDATs) from the flax genome database. Due to recent genome duplication, duplicated gene pairs have been identified for all genes except DGAT2-2. Analysis of gene expression indicated that two DGAT1, two DGAT2, and four PDAT genes were preferentially expressed in flax embryos. Yeast functional analysis showed that DGAT1, DGAT2, and two PDAT enzymes restored TAG synthesis when produced recombinantly in yeast H1246 strain. The activity of particular PDAT enzymes (LuPDAT1 and LuPDAT2) was stimulated by the presence of ALA. Further seed-specific expression of flax genes in Arabidopsis thaliana indicated that DGAT1, PDAT1, and PDAT2 had significant effects on seed oil phenotype. Overall, this study indicated the existence of unique PDAT enzymes from flax that are able to preferentially catalyze the synthesis of TAG containing ALA acyl moieties. The identified LuPDATs may have practical applications for increasing the accumulation of ALA and other polyunsaturated fatty acids in oilseeds for food and industrial applications.	[Pan, Xue; Siloto, Rodrigo M. P.; Wickramarathna, Aruna D.; Mietkiewska, Elzbieta; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada	University of Alberta	Weselake, RJ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca	pan, xue/AAE-3374-2019	pan, xue/0000-0001-9415-8316	Genome Alberta/Genome Canada; Canada Research Chairs Program; Canada Foundation for Innovation; Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Graduate Student Scholarship	Genome Alberta/Genome Canada(Genome Canada); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Graduate Student Scholarship	This work was supported in part by grants from Genome Alberta/Genome Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation, the Research Capacity Program of Alberta Enterprise and Advanced Education, AVAC Ltd., Alberta Innovates Bio Solutions, and the Natural Sciences and Engineering Research Council of Canada (to R. J. W.); Recipient of the Alberta Innovates Graduate Student Scholarship.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Ahmad A, 2010, MOL PLANT, V3, P719, DOI 10.1093/mp/ssq026; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Ciftci ON, 2012, EUR J LIPID SCI TECH, V114, P794, DOI 10.1002/ejlt.201100207; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dahmen JL, 2013, EUKARYOT CELL, V12, P923, DOI 10.1128/EC.00332-12; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GREEN AG, 1986, CAN J PLANT SCI, V66, P499, DOI 10.4141/cjps86-068; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jhala A. J., 2010, Australian Journal of Basic and Applied Sciences, V4, P4304; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lee J, 2011, PLANT BIOTECHNOL J, V9, P359, DOI 10.1111/j.1467-7652.2010.00562.x; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Lock YY, 2009, PHYSIOL PLANTARUM, V137, P61, DOI 10.1111/j.1399-3054.2009.01258.x; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Mhaske V, 2005, PLANT PHYSIOL BIOCH, V43, P413, DOI 10.1016/j.plaphy.2005.01.013; Mietkiewska E, 2011, FEBS J, V278, P764, DOI 10.1111/j.1742-4658.2010.07995.x; Pereira SL, 2004, BIOCHEM J, V378, P665, DOI 10.1042/BJ20031319; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Rao S, 2008, LIPIDS, V43, P749, DOI 10.1007/s11745-008-3207-0; ROWLAND GG, 1991, CAN J PLANT SCI, V71, P393, DOI 10.4141/cjps91-054; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Ruiz-Lopez N, 2009, PLANT BIOTECHNOL J, V7, P704, DOI 10.1111/j.1467-7652.2009.00436.x; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Siloto RMP, 2009, PLANT PHYSIOL BIOCH, V47, P456, DOI 10.1016/j.plaphy.2008.12.019; Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang JH, 2003, MOL BREEDING, V12, P71, DOI 10.1023/A:1025495000264; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Weigel D., 2002, ARABIDOPSIS LAB MANU; WEISS SB, 1960, J BIOL CHEM, V235, P40; Xu JY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-4; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	58	74	82	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24173	24188		10.1074/jbc.M113.475699	http://dx.doi.org/10.1074/jbc.M113.475699			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824186	hybrid, Green Published			2022-12-25	WOS:000330611400056
J	Krejsa, CM; Holly, RD; Heipel, M; Bannink, KM; Johnson, R; Roque, R; Heffernan, J; Hill, J; Chin, L; Wagener, F; Shiota, F; Henderson, K; Sivakumar, PV; Ren, HP; Barahmand-pour, F; Foster, D; Clegg, C; Kindsvogel, W; Ponce, R; Hughes, SD; Waggie, K				Krejsa, Cecile M.; Holly, Rick D.; Heipel, Mark; Bannink, Ken M.; Johnson, Rebecca; Roque, Richard; Heffernan, Jane; Hill, Julie; Chin, Lay; Wagener, Felecia; Shiota, Faith; Henderson, Katherine; Sivakumar, Pallavur V.; Ren, Hong-Ping; Barahmand-pour, Fariba; Foster, Don; Clegg, Chris; Kindsvogel, Wayne; Ponce, Rafael; Hughes, Steven D.; Waggie, Kim			Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ANTI-CD20 MONOCLONAL-ANTIBODY; COMMON GAMMA-CHAIN; IN-VIVO; IL-21 RECEPTOR; RECOMBINANT INTERLEUKIN-2; MACACA-FASCICULARIS; ANTITUMOR-ACTIVITY; PHASE-I; ACTIVATION	Rituximab, a monoclonal antibody targeting CD20 on B cells, is currently used to treat many subtypes of B cell lymphomas. However, treatment is not curative and response rates are variable. Recombinant interleukin-21 (rIL-21) is a cytokine that enhances immune effector function and affects both primary and transformed B cell differentiation. We hypothesized that the combination of rIL-21 plus rituximab would be a more efficacious treatment for B cell malignancies than rituximab alone. We cultured human and cynomolgus monkey NK cells with rIL-21 and found that their activity was increased and proteins associated with antibody dependent cytotoxicity were up-regulated. Studies in cynomolgus monkeys modeled the effects of rIL-21 on rituximab activity against CD20 B cells. In these studies, rIL-21 activated innate immune effectors, increased ADCC and mobilized B cells into peripheral blood. When rIL-21 was combined with rituximab, deeper and more durable B cell depletion was observed. In another series of experiments, IL-21 was shown to have direct antiproliferative activity against a subset of human lymphoma cell lines, and combination of murine IL-21 with rituximab yielded significant survival benefits over either agent alone in xenogeneic mouse tumor models of disseminated lymphoma. Therefore, our results do suggest that the therapeutic efficacy of rituximab may be improved when used in combination with rIL-21.	[Krejsa, Cecile M.; Bannink, Ken M.; Roque, Richard; Heffernan, Jane; Hill, Julie; Chin, Lay; Wagener, Felecia; Ren, Hong-Ping; Ponce, Rafael; Hughes, Steven D.; Waggie, Kim] ZymoGenetics Inc, Dept Preclin Dev, Seattle, WA USA; [Holly, Rick D.; Heipel, Mark; Johnson, Rebecca; Shiota, Faith; Henderson, Katherine; Sivakumar, Pallavur V.; Barahmand-pour, Fariba; Foster, Don; Clegg, Chris; Kindsvogel, Wayne] ZymoGenetics Inc, Dept Res, Seattle, WA USA	Zymogenet Inc.; Zymogenet Inc.	Waggie, K (corresponding author), ZymoGenetics Inc, Dept Preclin Dev, Seattle, WA USA.	Kim.Waggie@bms.com			ZymoGenetics, Inc.	ZymoGenetics, Inc.	The authors have read the journal's policy and have the following conflicts: at the time this research was conducted all the authors were employees of ZymoGenetics, Inc., the commercial funder of the research. However, this does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Andorsky DJ, 2008, EXPERT OPIN BIOL TH, V8, P1295, DOI [10.1517/14712598.8.9.1295, 10.1517/14712598.8.9.1295 ]; Ansell SM, 2006, CLIN CANCER RES, V12, P6056, DOI 10.1158/1078-0432.CCR-06-1245; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Boye J, 2003, ANN ONCOL, V14, P520, DOI 10.1093/annonc/mdg175; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; de Menezes DEL, 2007, J IMMUNOTHER, V30, P64, DOI 10.1097/01.cji.0000211315.21116.07; de Totero D, 2006, BLOOD, V107, P3708, DOI 10.1182/blood-2005-09-3535; Eskelund CW, 2011, LEUKEMIA RES, V35, P914, DOI 10.1016/j.leukres.2011.02.006; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; FRASER CC, 1995, BLOOD, V86, P183, DOI 10.1182/blood.V86.1.183.bloodjournal861183; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Hamaguchi Y, 2005, J IMMUNOL, V174, P4389, DOI 10.4049/jimmunol.174.7.4389; Hashmi MH, 2010, EXPERT OPIN BIOL TH, V10, P807, DOI 10.1517/14712598.2010.480971; Hernandez-Ilizaliturri FJ, 2003, CLIN CANCER RES, V9, P5866; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Jungel A, 2004, ARTHRITIS RHEUM, V50, P1468, DOI 10.1002/art.20218; Khan KD, 2006, CLIN CANCER RES, V12, P7046, DOI 10.1158/1078-0432.CCR-06-1571; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Manches O, 2003, BLOOD, V101, P949, DOI 10.1182/blood-2002-02-0469; McEarchern JA, 2007, BLOOD, V109, P1185, DOI 10.1182/blood-2006-07-034017; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pelletier M, 2004, J IMMUNOL, V173, P7521, DOI 10.4049/jimmunol.173.12.7521; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Rastetter W, 2004, ANNU REV MED, V55, P477, DOI 10.1146/annurev.med.55.091902.104249; REFF ME, 1994, BLOOD, V83, P435; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Sarosiek KA, 2010, BLOOD, V115, P570, DOI 10.1182/blood-2009-08-239996; Shan D, 1998, BLOOD, V91, P1644, DOI 10.1182/blood.V91.5.1644.1644_1644_1652; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sondergaard H, 2007, CANCER IMMUNOL IMMUN, V56, P1417, DOI 10.1007/s00262-007-0285-4; Strengell M, 2006, J LEUKOCYTE BIOL, V79, P1279, DOI 10.1189/jlb.0905503; Tedder TF, 2006, SPRINGER SEMIN IMMUN, V28, P351, DOI 10.1007/s00281-006-0057-9; Timmerman JM, 2012, CLIN CANCER RES, V18, P5752, DOI 10.1158/1078-0432.CCR-12-0456; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Vugmeyster Y, 2004, CYTOM PART A, V61A, P69, DOI 10.1002/cyto.a.20039; Vugmeyster Y, 2003, INT IMMUNOPHARMACOL, V3, P1477, DOI 10.1016/S1567-5769(03)00147-4; Vugmeyster Y, 2003, CYTOM PART A, V52A, P101, DOI 10.1002/cyto.a.10030; Waggie KS, 2012, INT J TOXICOL, V31, P303, DOI 10.1177/1091581812449661; Wang G, 2003, CANCER RES, V63, P9016	41	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67256	10.1371/journal.pone.0067256	http://dx.doi.org/10.1371/journal.pone.0067256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825648	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000093
J	Lekva, T; Berg, JP; Heck, A; Fougner, SL; Olstad, OK; Ringstad, G; Bollerslev, J; Ueland, T				Lekva, Tove; Berg, Jens Petter; Heck, Ansgar; Fougner, Stine Lyngvi; Olstad, Ole Kristoffer; Ringstad, Geir; Bollerslev, Jens; Ueland, Thor			Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VIVO; CANCER-THERAPY; STEM-CELLS; RECEPTOR; DOWNSTREAM; INHIBITOR; REGULATOR; MIGRATION; PATHWAYS	Somatostatin analogs (SA) have been established as the first line medical treatment for acromegaly, but following long-term treatment, SA normalizes GH and IGF-I levels in only 40-60% of patients. The epithelial marker E-cadherin plays a crucial role in the epithelial mesenchymal transition (EMT) and is associated with a poor response to SA treatment. We hypothesized that the characterization of transcripts regulated by SA in somatotroph adenomas with high and low E-cadherin expression may identify signaling pathways and mediators that can explain the poor response to SA treatment. We performed a microarray analysis of sixteen adenomas with different levels of E-cadherin and SA treatment to identify regulated transcripts. Candidate transcripts were further explored in vivo in sixty-five adenomas, and interactions between SA treatment and EMT progression on mRNA expression profiles and associations with clinical recovery were assessed. Finally, the effects of SA treatment on adenoma cells in vitro from acromegalic patients were determined. Microarray analysis of selected adenomas with differential E-cadherin expression, as a marker of EMT progression, identified 172 genes that displayed differential expression that was dependent on SA treatment. The validation of selected candidates in the entire cohort identified 9 transcripts that showed an interaction between E-cadherin expression and SA treatment. Further analysis of the impact of these genes suggests that attenuated RORC expression in somatotroph adenomas is associated with increased tumor size and a blunted clinical response. Our study indicates that attenuated RORC may be involved in the poor clinical response to SA treatment in patients with acromegaly.	[Lekva, Tove; Heck, Ansgar; Bollerslev, Jens] Oslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway; [Lekva, Tove; Ueland, Thor] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Lekva, Tove; Heck, Ansgar; Bollerslev, Jens; Ueland, Thor] Univ Oslo, Fac Med, Oslo, Norway; [Berg, Jens Petter] Oslo Univ Hosp, Inst Clin Med, Oslo, Norway; [Berg, Jens Petter; Olstad, Ole Kristoffer] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Fougner, Stine Lyngvi] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Ringstad, Geir] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo	Lekva, T (corresponding author), Oslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway.	tove.lekva@medisin.uio.no	Heck, Ansgar/E-6757-2018; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Berg, Jens P/G-1455-2012	Heck, Ansgar/0000-0002-3443-884X; Berg, Jens P/0000-0003-0157-5888; Ringstad, Geir/0000-0003-0919-4510; Lekva, Tove/0000-0002-7962-4726				Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Casarini APM, 2009, PITUITARY, V12, P297, DOI 10.1007/s11102-009-0175-1; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Delassus GS, 2010, J CELL PHYSIOL, V224, P549, DOI 10.1002/jcp.22157; Feng QT, 2010, MOL CELL BIOL, V30, P3711, DOI 10.1128/MCB.00420-10; Fougner SL, 2008, CLIN ENDOCRINOL, V68, P458, DOI 10.1111/j.1365-2265.2007.03065.x; Fougner SL, 2012, CLIN ENDOCRINOL, V76, P96, DOI 10.1111/j.1365-2265.2011.04163.x; Fougner SL, 2010, J CLIN ENDOCR METAB, V95, P2334, DOI 10.1210/jc.2009-2197; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Heck A, 2012, CLIN ENDOCRINOL, V77, P72, DOI 10.1111/j.1365-2265.2011.04286.x; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Himes AD, 2011, MOL ENDOCRINOL, V25, P482, DOI 10.1210/me.2010-0313; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hofland LJ, 2004, J CLIN ENDOCR METAB, V89, P1577, DOI 10.1210/jc.2003-031344; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Jang C, 2011, FASEB J, V25, P4174, DOI 10.1096/fj.11-185926; Jetten AM, 2009, NUCL RECEPT SIGNAL, V7, pe003; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Jung YS, 2012, PLOS ONE, V7; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Lekva T, 2012, J CLIN ENDOCR METAB, V97, pE1506, DOI 10.1210/jc.2012-1760; Li WQ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-86; McAlhany SJ, 2004, PROSTATE, V61, P182, DOI 10.1002/pros.20085; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Petrucci C, 2000, BRIT J PHARMACOL, V129, P471, DOI 10.1038/sj.bjp.0703075; Saveanu A, 2001, J CLIN ENDOCR METAB, V86, P140, DOI 10.1210/jc.86.1.140; Sherlock M, 2011, NAT REV ENDOCRINOL, V7, P291, DOI 10.1038/nrendo.2011.42; Sours-Brothers S, 2009, FRONT BIOSCI-LANDMRK, V14, P1851, DOI 10.2741/3346; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Taboada GF, 2008, EUR J ENDOCRINOL, V158, P295, DOI 10.1530/EJE-07-0562; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; Takeda Y, 2011, NUCLEIC ACIDS RES, V39, P4769, DOI 10.1093/nar/gkq1335; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Xiao L, 2012, FREE RADICAL RES, V46, P174, DOI 10.3109/10715762.2011.647688; Yakovlev S, 2012, BLOOD, V119, P637, DOI 10.1182/blood-2011-09-382580	36	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66927	10.1371/journal.pone.0066927	http://dx.doi.org/10.1371/journal.pone.0066927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825587	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000044
J	Liang, L; Shen, YY; Pan, XW; Zhou, TC; Yang, C; Irwin, DM; Zhang, YP				Liang, Lu; Shen, Yong-Yi; Pan, Xiao-Wei; Zhou, Tai-Cheng; Yang, Chao; Irwin, David M.; Zhang, Ya-Ping			Adaptive Evolution of the Hox Gene Family for Development in Bats and Dolphins	PLOS ONE			English	Article							TAILED FRUIT BAT; BROWN BAT; HOMEOBOX GENES; EXPRESSION; FLIGHT; ORIGIN; SELECTION; MUSCLE; PHYLOGENETICS; PLASTICITY	Bats and cetaceans (i.e., whales, dolphins, porpoises) are two kinds of mammals with unique locomotive styles and occupy novel niches. Bats are the only mammals capable of sustained flight in the sky, while cetaceans have returned to the aquatic environment and are specialized for swimming. Associated with these novel adaptations to their environment, various development changes have occurred to their body plans and associated structures. Given the importance of Hox genes in many aspects of embryonic development, we conducted an analysis of the coding regions of all Hox gene family members from bats (represented by Pteropus vampyrus, Pteropus alecto, Myotis lucifugus and Myotis davidii) and cetaceans (represented by Tursiops truncatus) for adaptive evolution using the available draft genome sequences. Differences in the selective pressures acting on many Hox genes in bats and cetaceans were found compared to other mammals. Positive selection, however, was not found to act on any of the Hox genes in the common ancestor of bats and only upon Hoxb9 in cetaceans. PCR amplification data from additional bat and cetacean species, and application of the branch-site test 2, showed that the Hoxb2 gene within bats had significant evidence of positive selection. Thus, our study, with genomic and newly sequenced Hox genes, identifies two candidate Hox genes that may be closely linked with developmental changes in bats and cetaceans, such as those associated with the pancreatic, neuronal, thymus shape and forelimb. In addition, the difference in our results from the genome-wide scan and newly sequenced data reveals that great care must be taken in interpreting results from draft genome data from a limited number of species, and deep genetic sampling of a particular clade is a powerful tool for generating complementary data to address this limitation.	[Liang, Lu; Shen, Yong-Yi; Irwin, David M.; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Shen, Yong-Yi] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Liang, Lu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Pan, Xiao-Wei; Zhou, Tai-Cheng; Yang, Chao; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Xiamen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; University of Toronto; University of Toronto	Shen, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shenyy@xmu.edu.cn; zhangyp@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022	Irwin, David/0000-0001-6131-4933	National Basic Research Program of China (973 Program) [2007CB411600]; National Natural Science Foundation of China [30621092, 31172080]; Key Program of West Light Foundation of the Chinese Academy of Sciences [Y102281081]; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of West Light Foundation of the Chinese Academy of Sciences; Bureau of Science and Technology of Yunnan Province	This work was supported by the National Basic Research Program of China to Y-PZ (973 Program, 2007CB411600), National Natural Science Foundation of China (30621092 and 31172080), Key Program of West Light Foundation of the Chinese Academy of Sciences to YYS (Y102281081), and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R. A., 2000, ONTOGENY FUNCTIONAL; ADAMS RA, 1992, J MAMMAL, V73, P160, DOI 10.2307/1381878; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BERTA A, 2006, MARINE MAMMALS EVOLU; BRIGHAM RM, 1990, J COMP PHYSIOL B, V160, P183, DOI 10.1007/BF00300951; Chen CH, 2005, EVOL DEV, V7, P130, DOI 10.1111/j.1525-142X.2005.05015.x; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chew KY, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-2; Cooper LN, 2007, ANAT REC, V290, P654, DOI 10.1002/ar.20532; Cretekos CJ, 2007, INT J DEV BIOL, V51, P333, DOI 10.1387/ijdb.062257cc; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; DeLynn R, 2011, J WILDLIFE DIS, V47, P979, DOI 10.7589/0090-3558-47.4.979; Di Bonito M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003249; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; JONES FS, 1993, P NATL ACAD SCI USA, V90, P6557, DOI 10.1073/pnas.90.14.6557; Kanwisher J, 1966, THERMAL REGULATION C; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kunz TH, 2003, BAT ECOLOGY, P3; MAINA JN, 1984, J EXP BIOL, V111, P43; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; POWERS LV, 1991, J COMP PHYSIOL A, V168, P675; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHUTT WA, 1994, J MORPHOL, V220, P295, DOI 10.1002/jmor.1052200308; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Taghon T, 2002, BLOOD, V99, P1197, DOI 10.1182/blood.V99.4.1197; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; THEWISSEN JGM, 1992, BIOSCIENCE, V42, P340, DOI 10.2307/1311780; Thim VV, 2005, HUM MUTAT, V25, P384, DOI 10.1002/humu.20155; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaughan T. A., 2010, MAMMALOGY; Wang Z, 2009, MOL BIOL EVOL, V26, P613, DOI 10.1093/molbev/msn282; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wyngaarden LA, 2008, DEV BIOL, V313, P225, DOI 10.1016/j.ydbio.2007.10.039; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	60	15	18	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65944	10.1371/journal.pone.0065944	http://dx.doi.org/10.1371/journal.pone.0065944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825528	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000007
J	McCormick, SA; Causer, J; Holmes, PS				McCormick, Sheree A.; Causer, Joe; Holmes, Paul S.			Active Vision during Action Execution, Observation and Imagery: Evidence for Shared Motor Representations	PLOS ONE			English	Article							MENTAL-IMAGERY; EYE-MOVEMENTS; FITTSS LAW; PERFORMANCE; PERCEPTION; MIRROR; BRAIN; TASK; COORDINATION; MECHANISMS	The concept of shared motor representations between action execution and various covert conditions has been demonstrated through a number of psychophysiological modalities over the past two decades. Rarely, however, have researchers considered the congruence of physical, imaginary and observed movement markers in a single paradigm and never in a design where eye movement metrics are the markers. In this study, participants were required to perform a forward reach and point Fitts' Task on a digitizing tablet whilst wearing an eye movement system. Gaze metrics were used to compare behaviour congruence between action execution, action observation, and guided and unguided movement imagery conditions. The data showed that participants attended the same task-related visual cues between conditions but the strategy was different. Specifically, the number of fixations was significantly different between action execution and all covert conditions. In addition, fixation duration was congruent between action execution and action observation only, and both conditions displayed an indirect Fitts' Law effect. We therefore extend the understanding of the common motor representation by demonstrating, for the first time, common spatial eye movement metrics across simulation conditions and some specific temporal congruence for action execution and action observation. Our findings suggest that action observation may be an effective technique in supporting motor processes. The use of video as an adjunct to physical techniques may be beneficial in supporting motor planning in both performance and clinical rehabilitation environments.	[McCormick, Sheree A.; Holmes, Paul S.] Manchester Metropolitan Univ, Inst Performance Res, Crewe, England; [Causer, Joe] Liverpool John Moores Univ, Brain & Behav Lab, Liverpool L3 5UX, Merseyside, England	Manchester Metropolitan University; Liverpool John Moores University	Holmes, PS (corresponding author), Manchester Metropolitan Univ, Inst Performance Res, Crewe, England.	p.s.holmes@mmu.ac.uk	McCormick, Sheree/AAW-6493-2021; McCormick, Sheree/GWR-5720-2022; Causer, Joe/M-1502-2019	Causer, Joe/0000-0002-8939-8769; Holmes, Paul/0000-0003-0821-3580				ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Bandura A., 1962, NEBRASKA S MOTIVATIO; Borst G, 2008, MEM COGNITION, V36, P849, DOI 10.3758/MC.36.4.849; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; Calmels C, 2006, J MOTOR BEHAV, V38, P339, DOI 10.3200/JMBR.38.5.339-348; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gesierich B, 2008, ACTA PSYCHOL, V128, P324, DOI 10.1016/j.actpsy.2008.03.006; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Gueugneau N, 2008, BRAIN RES, V1187, P95, DOI 10.1016/j.brainres.2007.10.042; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; Heremans E, 2011, NEUROSCIENCE, V195, P37, DOI 10.1016/j.neuroscience.2011.07.030; Heremans E, 2008, BEHAV BRAIN RES, V187, P351, DOI 10.1016/j.bbr.2007.09.028; Heremans E, 2009, BRAIN RES, V1278, P50, DOI 10.1016/j.brainres.2009.04.041; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; JEANNEROD M, 1986, NEUROPSYCHOLOGIA, V24, P41, DOI 10.1016/0028-3932(86)90042-4; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; KOSSLYN SM, 1975, COGNITIVE PSYCHOL, V7, P341, DOI 10.1016/0010-0285(75)90015-8; Kourtis D, 2012, PSYCHOL RES-PSYCH FO, V76, P514, DOI 10.1007/s00426-012-0418-z; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; Lankford C, 2000, P EYE TRACK RES APPL, P57; Lotze M, 2010, NEUROPHYSIOLOGICAL F, P31, DOI [10.1093/acprof:oso/9780199546251.003.0003, DOI 10.1093/ACPROF:OSO/9780199546251.003.0003]; Macuga KL, 2011, NEUROIMAGE, P2798, DOI DOI 10.1016/J.NEUROIMAGE.2011.09.083; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; McCormick SA, 2012, BRAIN COGNITION, V80, P83, DOI 10.1016/j.bandc.2012.04.010; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Mulder T, 2005, EXP BRAIN RES, V163, P344, DOI 10.1007/s00221-004-2179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; Ram N, 2007, J SPORT SCI, V25, P587, DOI 10.1080/02640410600947132; Richardson DC, 2000, COGNITION, V76, P269, DOI 10.1016/S0010-0277(00)00084-6; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roure R, 1999, PHYSIOL BEHAV, V66, P63, DOI 10.1016/S0031-9384(99)00026-8; Ryan JD, 2009, VIS COGN, V17, P254, DOI 10.1080/13506280802336362; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Vickers J. N., 2007, HUMAN KINETICS; Viviani P, 1990, Rev Oculomot Res, V4, P353; Williams AM, 2002, J MOTOR BEHAV, V34, P197, DOI 10.1080/00222890209601941	53	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67761	10.1371/journal.pone.0067761	http://dx.doi.org/10.1371/journal.pone.0067761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825683	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000117
J	Orlicky, DJ; Monks, J; Stefanski, AL; McManaman, JL				Orlicky, David J.; Monks, Jenifer; Stefanski, Adrianne L.; McManaman, James L.			Dynamics and Molecular Determinants of Cytoplasmic Lipid Droplet Clustering and Dispersion	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; PROTEIN-KINASE; PERILIPIN-A; ANCHORING PROTEIN; STIMULATED LIPOLYSIS; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; GAMMA-TUBULIN; MICROTUBULE; ADIPOCYTES	Perilipin-1 (Plin1), a prominent cytoplasmic lipid droplet (CLD) binding phosphoprotein and key physiological regulator of triglyceride storage and lipolysis in adipocytes, is thought to regulate the fragmentation and dispersion of CLD that occurs in response to beta-adrenergic activation of adenylate cyclase. Here we investigate the dynamics and molecular determinants of these processes using cell lines stably expressing recombinant forms of Plin1 and/or other members of the perilipin family. Plin1 and a C-terminal CLD-binding fragment of Plin1 (Plin1CT) induced formation of single dense CLD clusters near the microtubule organizing center, whereas neither an N-terminal CLD-binding fragment of Plin1, nor Plin2 or Plin3 induced clustering. Clustered CLD coated by Plin1, or Plin1CT, dispersed in response to isoproterenol, or other agents that activate adenylate cyclase, in a process inhibited by the protein kinase A inhibitor, H89, and blocked by microtubule disruption. Isoproterenol-stimulated phosphorylation of CLD-associated Plin1 on serine 492 preceded their dispersion, and live cell imaging showed that cluster dispersion involved initial fragmentation of tight clusters into multiple smaller clusters, which then fragmented into well-dispersed individual CLD. siRNA knockdown of the cortical actin binding protein, moesin, induced disaggregation of tight clusters into multiple smaller clusters, and inhibited the reaggregation of dispersed CLD into tight clusters. Together these data suggest that the clustering and dispersion processes involve a complex orchestration of phosphorylation-dependent, microtubule-dependent and independent, and microfilament dependent steps.	[Orlicky, David J.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Monks, Jenifer; Stefanski, Adrianne L.; McManaman, James L.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Div Basic Reprod Sci, Aurora, CO USA; [Stefanski, Adrianne L.; McManaman, James L.] Univ Colorado, Sch Med, Grad Program Reprod Sci, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Sch Med, Dept Obstet & Gynecol, Div Basic Reprod Sci, Aurora, CO USA.	jim.mcmanaman@ucdenver.edu	Monks, Jenifer/GLS-6662-2022	Monks, Jenifer/0000-0002-7990-3389	National Institutes of Health [RO1-HD045962, PO1-HD38129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045965, P01HD038129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institutes of Health grants RO1-HD045962 and PO1-HD38129 to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Diviani D, 2001, J CELL SCI, V114, P1431; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2004, AM J PHYSIOL-ENDOC M, V287, pE574, DOI 10.1152/ajpendo.00567.2003; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Greenwald EC, 2011, J CARDIOVASC PHARM, V58, P462, DOI 10.1097/FJC.0b013e31822001e3; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Haedicke J, 2008, J VIROL, V82, P4665, DOI 10.1128/JVI.02403-07; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; LI QQ, 1995, J CELL BIOL, V131, P207, DOI 10.1083/jcb.131.1.207; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P49, DOI 10.1161/01.ATV.0000191639.08082.04; Semenova I, 2009, TRAFFIC, V10, P153, DOI 10.1111/j.1600-0854.2008.00852.x; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	48	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66837	10.1371/journal.pone.0066837	http://dx.doi.org/10.1371/journal.pone.0066837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825572	gold, Green Submitted, Green Published			2022-12-25	WOS:000321223000033
J	Underwood, JG; Silbernagle, M; Nishimoto, M; Uyehara, K				Underwood, Jared G.; Silbernagle, Mike; Nishimoto, Mike; Uyehara, Kim			Managing Conservation Reliant Species: Hawai'i's Endangered Endemic Waterbirds	PLOS ONE			English	Article								Hawai'I's coastal plain wetlands are inhabited by five endangered endemic waterbird species. These include the Hawaiian Coot ('alae ke'oke'o), Hawaiian Duck (koloa maoli), Hawaiian Stilt (ae'o), Hawaiian Gallinule (Moorhen) ('alae 'ula), and Hawaiian Goose (nene). All five species are categorized as being "conservation reliant." The current strategy to recover these endangered birds includes land protection and active management of wetlands. To assess the effectiveness of the current management paradigm, we compared species population trends across the state to those on six actively managed wetland national wildlife refuges (Refuges) thought to be critical for the survival of these endangered species. To perform the evaluation we relied on systematic semiannual population counts that have been conducted across most wetlands in the state and monthly population counts that have occurred on Refuges during the same time period. We found that statewide and Refuge populations of the Hawaiian Coot, Stilt and Gallinule have rebounded from historic lows and over the last 20 years have slowly increased or remained stable. We also documented that Refuges are important to each species year-round and that a disproportionately larger percentage of the population for each species is found on them. Understanding of why Refuges successfully house a disproportionate percentage of these "conservation reliant" species can inform current and future conservation efforts as well as ensure long-term population viability for these species.	[Underwood, Jared G.] US Fish & Wildlife Serv, Honolulu, HI USA; [Silbernagle, Mike] US Fish & Wildlife Serv, Haleiwa, HI USA; [Nishimoto, Mike] US Fish & Wildlife Serv, Kihei, HI USA; [Uyehara, Kim] US Fish & Wildlife Serv, Kilauea, HI USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Underwood, JG (corresponding author), US Fish & Wildlife Serv, Pacific Reefs Natl Wildlife Refuge Complex, Honolulu, HI USA.	Jared_Underwood@fws.gov		Underwood, Jared/0000-0002-8608-190X				[Anonymous], 2010, R LANG ENV STAT COMP; CHANG PR, 1990, THESIS U MASSACHUSET; Clough JS, 2010, APPL SEA LEVEL AFFEC; DesRochers DW, 2008, J FIELD ORNITHOL, V79, P448, DOI 10.1111/j.1557-9263.2008.00190.x; Ducks Unlimited Inc., 2001, CONS PLAN HAW STILT; ENGILIS A, 1993, WILSON BULL, V105, P142; Hatch G, 1950, ELEPAIO, V10, P45; Hawai'i Audubon Society, 2005, ELEPAIO, V65, P41; Hawai'i Division of Forestry and Wildlife, 1980, SEM HAW WAT SURV DAT; Hawai'i Division of Forestry and Wildlife (DOFAW), 2005, HAW WAT SURV INSTR I; Intergovernmental Panel on Climate Cahnge, 2007, CONTRIBUTION WORKING; Kaigler C. G., 1970, Elepaio, V30, P70; North American Bird Conservation Initiative (NBCI) U.S. Committee, 2011, STAT BIRDS 2011 REP; Pannekoek J., 2001, TRIM 3 0 WINDOWS TRE; Pannekoek J, 2006, TRIM 3 53 MANUAL TRE; Peterson HD, 1951, ELEPAIO, V11, P42; Reed JM, 2012, BIOSCIENCE, V62, P881, DOI 10.1525/bio.2012.62.10.8; Reed JM, 2011, POPUL ECOL, V53, P473, DOI 10.1007/s10144-011-0262-9; Reed JM, 1998, AUK, V115, P791, DOI 10.2307/4089431; REED JM, 2007, ANAL ECOLOGICAL DATA, P615; Robinson J., 1999, BIRDS N AM ONLINE; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Shallenberger RJ, 1989, FRESHWATER WETLANDS, P1165; State of Hawai'i, 1996, HAW COAST NONP POL 2; U.S. Fish and Wildlife Service (USFWS), 2004, REV REC PLA IN PRESS; USFWS, 2011, REC PLAN HAW WAT 2 R; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106	28	21	21	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67872	10.1371/journal.pone.0067872	http://dx.doi.org/10.1371/journal.pone.0067872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825687	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000121
J	Tang, JLW; Nicolle, A; Pantelic, J; Klettner, CA; Su, R; Kalliomaki, P; Saarinen, P; Koskela, H; Reijula, K; Mustakallio, P; Cheong, DKW; Sekhar, C; Tham, KW				Tang, Julian W.; Nicolle, Andre; Pantelic, Jovan; Klettner, Christian A.; Su, Ruikun; Kalliomaki, Petri; Saarinen, Pekka; Koskela, Hannu; Reijula, Kari; Mustakallio, Panu; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai			Different Types of Door-Opening Motions as Contributing Factors to Containment Failures in Hospital Isolation Rooms	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFECTION-CONTROL; TUBERCULOSIS; VENTILATION; MODEL; SARS	Hospital isolation rooms are vital for the containment (when under negative pressure) of patients with, or the protection (when under positive pressure) of patients, from airborne infectious agents. Such facilities were essential for the management of highly contagious patients during the 2003 severe acute respiratory syndrome (SARS) outbreaks and the more recent 2009 A/H1N1 influenza pandemic. Many different types of door designs are used in the construction of such isolation rooms, which may be related to the space available and affordability. Using colored food dye as a tracer, the qualitative effects of door-opening motions on the dissemination of potentially contaminated air into and out of a single isolation room were visualized and filmed using Reynolds-number-equivalent, small-scale, water-tank models fitted with programmable door-opening and moving human figure motions. Careful scaling considerations involved in the design and construction of these water-tank models enabled these results to be accurately extrapolated to the full-scale situation. Four simple types of door design were tested: variable speed single and double, sliding and hinged doors, in combination with the moving human figure. The resulting video footage was edited, synchronized and presented in a series of split-screen formats. From these experiments, it is clear that double-hinged doors pose the greatest risk of leakage into or out of the room, followed by (in order of decreasing risk) single-hinged, double-sliding and single-sliding doors. The relative effect of the moving human figure on spreading any potential contamination was greatest with the sliding doors, as the bulk airflows induced were large relative to those resulting from these door-opening motions. However, with the hinged doors, the airflows induced by these door-opening motions were significantly greater. Further experiments involving a simulated ventilated environment are required, but from these findings alone, it appears that sliding-doors are far more effective for hospital isolation room containment.	[Tang, Julian W.; Nicolle, Andre; Klettner, Christian A.; Su, Ruikun] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Tang, Julian W.] Alberta Prov Lab Publ Hlth, Edmonton, AB, Canada; [Tang, Julian W.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Pantelic, Jovan; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai] Natl Univ Singapore, Sch Design & Environm, Dept Bldg, Singapore 117548, Singapore; [Kalliomaki, Petri; Saarinen, Pekka; Koskela, Hannu; Reijula, Kari] Finnish Inst Occupat Hlth, Helsinki, Finland; [Mustakallio, Panu] Oy Halton Grp Ltd, Vantaa, Finland	National University of Singapore; University of Alberta; National University of Singapore; Finnish Institute of Occupational Health	Tang, JLW (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Sekhar, Chandra/0000-0002-0814-8662; Mustakallio, Panu/0000-0002-9042-8240; Tang, Julian/0000-0002-4963-1028; Pantelic, Jovan/0000-0001-7541-8274; Saarinen, Pekka/0000-0003-0152-7237; Cheong, David/0000-0001-7680-4281	Agency for Science, Technology and Research (A*STAR) in Singapore [SERC 1021290099]	Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR))	Funding for this study (and support for post-doctoral research fellow, C.A. Klettner) was provided by a grant to JWT from the Agency for Science, Technology and Research (A*STAR grant no.: SERC 1021290099) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 2011, AM J INFECT CONTROL, V39, P91, DOI 10.1016/j.ajic.2010.05.025; Beauchene C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-58; Eames I, 2009, J R SOC INTERFACE, V6, pS757, DOI 10.1098/rsif.2009.0319.focus; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Fung CP, 2004, INFECT CONT HOSP EP, V25, P1026, DOI 10.1086/502339; Fusco FM, 2009, J HOSP INFECT, V73, P15, DOI 10.1016/j.jhin.2009.06.009; Harries AD, 1997, B WORLD HEALTH ORGAN, V75, P477; Harrison JP, 2010, HEALTH CARE MANAG, V29, P11, DOI 10.1097/HCM.0b013e3181cd8ab1; Hayden CS, 2007, J OCCUP ENVIRON HYG, V4, P198, DOI 10.1080/15459620601177370; Humphreys H, 2007, J HOSP INFECT, V66, P1, DOI 10.1016/j.jhin.2007.01.007; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Johnson DL, 2009, AM J INFECT CONTROL, V37, P94, DOI 10.1016/j.ajic.2008.05.011; Lee NE, 2004, AM J INFECT CONTROL, V32, P377, DOI 10.1016/j.ajic.2004.03.005; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Leung TF, 2004, J HOSP INFECT, V56, P215, DOI 10.1016/j.jhin.2003.11.004; Liu JW, 2006, INFECT CONT HOSP EP, V27, P466, DOI 10.1086/504501; Rice N, 2001, INFECT CONT HOSP EP, V22, P19, DOI 10.1086/501819; Rydock James P, 2002, Appl Occup Environ Hyg, V17, P486, DOI 10.1080/10473220290035688; Rydock JP, 2004, J HOSP INFECT, V57, P228, DOI 10.1016/j.jhin.2004.01.032; Saravia SA, 2007, AM J INFECT CONTROL, V35, P324, DOI 10.1016/j.ajic.2006.10.012; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2005, J HOSP INFECT, V61, P283, DOI 10.1016/j.jhin.2005.05.017; Wojgani H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040171	25	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66663	10.1371/journal.pone.0066663	http://dx.doi.org/10.1371/journal.pone.0066663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826109	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400029
J	Zhou, L; Ni, YY; Pineyro, P; Cossaboom, CM; Subramaniam, S; Sanford, BJ; Dryman, BA; Huang, YW; Meng, XJ				Zhou, Lei; Ni, Yan-Yan; Pineyro, Pablo; Cossaboom, Caitlin M.; Subramaniam, Sakthivel; Sanford, Brenton J.; Dryman, Barbara A.; Huang, Yao-Wei; Meng, Xiang-Jin			Broadening the Heterologous Cross-Neutralizing Antibody Inducing Ability of Porcine Reproductive and Respiratory Syndrome Virus by Breeding the GP4 or M genes	PLOS ONE			English	Article							MYSTERY SWINE DISEASE; INFECTIOUS CDNA-CLONE; NORTH-AMERICAN; LELYSTAD-VIRUS; STRUCTURAL PROTEINS; UNITED-STATES; BIOLOGICAL CHARACTERISTICS; EPIDEMIC ABORTION; VACCINE EFFICACY; ECONOMIC-IMPACT	Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically important swine pathogens, which causes reproductive failure in sows and respiratory disease in piglets. A major hurdle to control PRRSV is the ineffectiveness of the current vaccines to confer protection against heterologous strains. Since both GP4 and M genes of PRRSV induce neutralizing antibodies, in this study we molecularly bred PRRSV through DNA shuffling of the GP4 and M genes, separately, from six genetically different strains of PRRSV in an attempt to identify chimeras with improved heterologous cross-neutralizing capability. The shuffled GP4 and M genes libraries were each cloned into the backbone of PRRSV strain VR2385 infectious clone pIR-VR2385-CA. Three GP4-shuffled chimeras and five M-shuffled chimeras, each representing sequences from all six parental strains, were selected and further characterized in vitro and in pigs. These eight chimeric viruses showed similar levels of replication with their backbone strain VR2385 both in vitro and in vivo, indicating that the DNA shuffling of GP4 and M genes did not significantly impair the replication ability of these chimeras. Cross-neutralization test revealed that the GP4-shuffled chimera GP4TS14 induced significantly higher cross-neutralizing antibodies against heterologous strains FL-12 and NADC20, and similarly that the M-shuffled chimera MTS57 also induced significantly higher levels of cross-neutralizing antibodies against heterologous strains MN184B and NADC20, when compared with their backbone parental strain VR2385 in infected pigs. The results suggest that DNA shuffling of the GP4 or M genes from different parental viruses can broaden the cross-neutralizing antibody-inducing ability of the chimeric viruses against heterologous PRRSV strains. The study has important implications for future development of a broadly protective vaccine against PRRSV.	[Zhou, Lei; Ni, Yan-Yan; Pineyro, Pablo; Cossaboom, Caitlin M.; Subramaniam, Sakthivel; Sanford, Brenton J.; Dryman, Barbara A.; Huang, Yao-Wei; Meng, Xiang-Jin] Virginia Polytech Inst & State Univ, Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Zhou, Lei] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China; [Zhou, Lei] China Agr Univ, State Key Lab Agribiotechnol, Beijing 100094, Peoples R China	Virginia Polytechnic Institute & State University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Meng, XJ (corresponding author), Virginia Polytech Inst & State Univ, Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	xjmeng@vt.edu	Huang, Yao-Wei/Q-9409-2019; Meng, X.J./B-8769-2009; Subramaniam, Sakthivel/L-2265-2016; Huang, Yaowei/B-1468-2009; Subramaniam, Sakthivel/AAQ-8092-2020	Huang, Yao-Wei/0000-0001-9755-8411; Meng, X.J./0000-0002-2739-1334; Subramaniam, Sakthivel/0000-0001-6299-3835; Huang, Yaowei/0000-0001-9755-8411; Zhou, Lei/0000-0002-8837-3965; Tripp, Ralph/0000-0002-2924-9956	U.S. Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) program [USDA-NIFA-2011-67015-30165]; USDA Porcine Reproductive and Respiratory Syndrome CAP (PRRS CAP) [USDA-NIFA-2008-55620-19132]	U.S. Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) program; USDA Porcine Reproductive and Respiratory Syndrome CAP (PRRS CAP)	This project was supported in part by grants from the U.S. Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) program (USDA-NIFA-2011-67015-30165) and the USDA Porcine Reproductive and Respiratory Syndrome CAP (PRRS CAP) (USDA-NIFA-2008-55620-19132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Callison S, 2005, VIRUS GENES, V31, P5, DOI 10.1007/s11262-004-2194-3; Cancel-Tirado SM, 2004, VET IMMUNOL IMMUNOP, V102, P249, DOI 10.1016/j.vetimm.2004.09.017; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Costers S, 2010, VIRUS RES, V154, P104, DOI 10.1016/j.virusres.2010.08.026; Costers S, 2010, ARCH VIROL, V155, P371, DOI 10.1007/s00705-009-0582-7; Das PB, 2011, VIROLOGY, V410, P385, DOI 10.1016/j.virol.2010.12.002; Das PB, 2010, J VIROL, V84, P1731, DOI 10.1128/JVI.01774-09; de Lima M, 2009, VIROLOGY, V390, P31, DOI 10.1016/j.virol.2009.04.017; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Du YJ, 2012, VIROLOGY, V424, P18, DOI 10.1016/j.virol.2011.12.009; Dwivedi V, 2011, VACCINE; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051794; Fang Y, 2007, ARCH VIROL, V152, P1009, DOI 10.1007/s00705-007-0936-y; Fang Y, 2006, J VIROL, V80, P11447, DOI 10.1128/JVI.01032-06; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Forsberg R, 2002, VIROLOGY, V299, P38, DOI 10.1006/viro.2002.1450; Garner MG, 2001, REV SCI TECH OIE, V20, P671, DOI 10.20506/rst.20.3.1303; Guo BQ, 2013, VIROLOGY, V435, P372, DOI 10.1016/j.virol.2012.09.013; Han K, 2012, VET J; Han K, 2012, CLIN VACCINE IMMUNOL, V19, P319, DOI 10.1128/CVI.05639-11; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; Jiang YB, 2006, VACCINE, V24, P2869, DOI 10.1016/j.vaccine.2005.12.049; Johnson CR, 2011, J GEN VIROL; Keffaber K, 1989, AM ASS SWINE PRACT N, V1, P9; Kim WI, 2008, VIRUS GENES, V37, P380, DOI 10.1007/s11262-008-0278-1; Kim WI, 2008, J CLIN MICROBIOL, V46, P1758, DOI 10.1128/JCM.01927-07; Lee CH, 2004, VET IMMUNOL IMMUNOP, V102, P189, DOI 10.1016/j.vetimm.2004.09.020; Li J, 2012, VIROLOGY, V433, P367, DOI 10.1016/j.virol.2012.08.026; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Locher CP, 2005, DNA CELL BIOL, V24, P256, DOI 10.1089/dna.2005.24.256; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Lunney JK, 2010, VIRUS RES, V154, P1, DOI 10.1016/j.virusres.2010.10.009; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; MARDASSI H, 1995, ARCH VIROL, V140, P1405, DOI 10.1007/BF01322667; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Meng XJ, 1996, J VET DIAGN INVEST, V8, P374, DOI 10.1177/104063879600800317; Meulenberg JJM, 1996, VIROLOGY, V225, P44, DOI 10.1006/viro.1996.0573; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meulenberg JJM, 1998, ADV EXP MED BIOL, V440, P199; Murtaugh MP, 1998, ADV EXP MED BIOL, V440, P787; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Nelson E A, 1995, Adv Exp Med Biol, V380, P321; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni YY, 2013, J VIROL, V87, P304, DOI 10.1128/JVI.01789-12; Ni YY, 2011, VIRUS RES, V160, P264, DOI 10.1016/j.virusres.2011.06.027; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Pejsak Z, 1997, VET MICROBIOL, V55, P317, DOI 10.1016/S0378-1135(96)01326-0; Pekrun K, 2002, J VIROL, V76, P2924, DOI 10.1128/JVI.76.6.2924-2935.2002; Renukaradhya Gourapura J., 2012, Animal Health Research Reviews, V13, P21, DOI 10.1017/S1466252312000023; Ropp SL, 2004, J VIROL, V78, P3684, DOI 10.1128/JVI.78.7.3684-3703.2004; Shi M, 2010, J VIROL; Shi M, 2010, J VIROL, V84, P8700, DOI 10.1128/JVI.02551-09; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Soong NW, 2000, NAT GENET, V25, P436, DOI 10.1038/78132; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Truong HM, 2004, VIROLOGY, V325, P308, DOI 10.1016/j.virol.2004.04.046; Vanhee M, 2011, VACCINE, V29, P4794, DOI 10.1016/j.vaccine.2011.04.071; Vanhee M, 2010, VIRAL IMMUNOL, V23, P403, DOI 10.1089/vim.2010.0025; vanNieuwstadt AP, 1996, J VIROL, V70, P4767, DOI 10.1128/JVI.70.7.4767-4772.1996; Weiand E, 1999, VET MICROBIOL, V66, P171, DOI 10.1016/S0378-1135(99)00006-1; WENSVOORT G, 1992, VET MICROBIOL, V33, P185, DOI 10.1016/0378-1135(92)90046-V; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wieringa R, 2004, J VIROL, V78, P13019, DOI 10.1128/JVI.78.23.13019-13027.2004; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Yang L, 2000, ARCH VIROL, V145, P1599, DOI 10.1007/s007050070079; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504; Zhou L, 2012, VIROLOGY, V434, P96, DOI 10.1016/j.virol.2012.09.005; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	79	22	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66645	10.1371/journal.pone.0066645	http://dx.doi.org/10.1371/journal.pone.0066645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826108	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400028
J	Ali, I; O'Brien, P; Kumar, G; Zheng, T; Jones, NC; Pinault, D; French, C; Morris, MJ; Salzberg, MR; O'Brien, TJ				Ali, Idrish; O'Brien, Patrick; Kumar, Gaurav; Zheng, Thomas; Jones, Nigel C.; Pinault, Didier; French, Chris; Morris, Margaret J.; Salzberg, Michael R.; O'Brien, Terence J.			Enduring Effects of Early Life Stress on Firing Patterns of Hippocampal and Thalamocortical Neurons in Rats: Implications for Limbic Epilepsy	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; LOW-DOSE CORTICOSTERONE; KINDLING EPILEPTOGENESIS; ELECTRICAL-STIMULATION; NEONATAL ISOLATION; PILOCARPINE MODEL; ELEVATED ANXIETY; IN-VITRO; SEIZURES; NETWORK	Early life stress results in an enduring vulnerability to kindling-induced epileptogenesis in rats, but the underlying mechanisms are not well understood. Recent studies indicate the involvement of thalamocortical neuronal circuits in the progression of kindling epileptogenesis. Therefore, we sought to determine in vivo the effects of early life stress and amygdala kindling on the firing pattern of hippocampus as well as thalamic and cortical neurons. Eight week old male Wistar rats, previously exposed to maternal separation (MS) early life stress or early handling (EH), underwent amygdala kindling (or sham kindling). Once fully kindled, in vivo juxtacellular recordings in hippocampal, thalamic and cortical regions were performed under neuroleptic analgesia. In the thalamic reticular nucleus cells both kindling and MS independently lowered firing frequency and enhanced burst firing. Further, burst firing in the thalamic reticular nucleus was significantly increased in kindled MS rats compared to kindled EH rats (p<0.05). In addition, MS enhanced burst firing of hippocampal pyramidal neurons. Following a stimulation-induced seizure, somatosensory cortical neurons exhibited a more pronounced increase in burst firing in MS rats than in EH rats. These data demonstrate changes in firing patterns in thalamocortical and hippocampal regions resulting from both MS and amygdala kindling, which may reflect cellular changes underlying the enhanced vulnerability to kindling in rats that have been exposed to early life stress.	[Ali, Idrish; O'Brien, Patrick; Kumar, Gaurav; Zheng, Thomas; Jones, Nigel C.; French, Chris; Salzberg, Michael R.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Pinault, Didier] INSERM, U1114, Strasbourg, France; [Pinault, Didier] Univ Strasbourg, Federat Med Translat Strasbourg, Strasbourg, France; [Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Salzberg, Michael R.] Univ Melbourne, Dept Psychiat, St Vincents Hosp, Melbourne, Vic 3010, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of New South Wales Sydney; St Vincent's Hospital Melbourne; University of Melbourne; Royal Melbourne Hospital	O'Brien, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia.	obrientj@unimelb.edu.au	Morris, Margaret J/J-4285-2013; Ali, Idrish/P-4989-2018; Didier, Pinault/E-5090-2013; Ali, Idrish/K-1706-2015; French, Chris/AHA-1801-2022; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Pinault, Didier/H-7816-2016	Ali, Idrish/0000-0002-0971-4654; Ali, Idrish/0000-0002-0971-4654; O'Brien, Terence/0000-0002-7198-8621; Pinault, Didier/0000-0003-3807-4817; French, Christopher/0000-0002-1445-8704; Kumar, Gaurav/0000-0002-2638-6429; Jones, Nigel/0000-0002-1080-8439; Morris, Margaret/0000-0003-2285-5117	NHMRC [566843]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the NHMRC (Project Grants #566843). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC RE, 1981, ELECTROEN CLIN NEURO, V52, P451, DOI 10.1016/0013-4694(81)90029-8; ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; Ali I, 2011, PSYCHOPHARMACOLOGY, V214, P155, DOI 10.1007/s00213-010-2125-z; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; BONHAUS DW, 1986, J NEUROSCI, V6, P3024; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brooks-Kayal AR, 1998, J NEUROCHEM, V70, P1017; Cain SM, 2010, CHANNELS, V4, P475, DOI 10.4161/chan.4.6.14106; Cavdar S, 2008, J ANAT, V212, P249, DOI 10.1111/j.1469-7580.2008.00858.x; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Crunelli V, 2011, PHILOS T R SOC A, V369, P3820, DOI 10.1098/rsta.2011.0126; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cymerblit-Sabba A, 2012, J NEUROPHYSIOL, V107, P1718, DOI 10.1152/jn.00327.2011; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Faas GC, 1996, NEUROSCIENCE, V75, P57, DOI 10.1016/0306-4522(96)00254-0; Freeman-Daniels E, 2011, PSYCHOPHARMACOLOGY, V213, P453, DOI 10.1007/s00213-010-2030-5; Graef JD, 2009, J NEUROSCI, V29, P4430, DOI 10.1523/JNEUROSCI.0198-09.2009; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; HIYOSHI T, 1988, ELECTROEN CLIN NEURO, V70, P339, DOI 10.1016/0013-4694(88)90052-1; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jones NC, 2009, BEHAV BRAIN RES, V203, P81, DOI 10.1016/j.bbr.2009.04.023; Jouny CC, 2007, EPILEPSIA, V48, P297, DOI 10.1111/j.1528-1167.2006.00963.x; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kapus GL, 2008, PSYCHOPHARMACOLOGY, V198, P231, DOI 10.1007/s00213-008-1121-z; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Koe AS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.024.2009; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Kumar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024033; Lai Ming-Chi, 2008, Pediatr Neonatol, V49, P19, DOI 10.1016/S1875-9572(08)60006-6; Lai MC, 2009, PEDIATR RES, V66, P441, DOI 10.1203/PDR.0b013e3181b337d2; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; McFarlane Alexander, 2005, Journal of Integrative Neuroscience, V4, P27, DOI 10.1142/S0219635205000689; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mraovitch S, 1999, J COMP NEUROL, V411, P145; MRAOVITCH S, 1995, NEUROREPORT, V6, P519, DOI 10.1097/00001756-199502000-00028; Nanobashvili Z, 2003, EXP NEUROL, V181, P224, DOI 10.1016/S0014-4886(03)00045-1; Nazer F, 2009, J NEUROPHYSIOL, V102, P1880, DOI 10.1152/jn.90795.2008; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Parr LA, 2012, DEV COGN NEUROS-NETH, V2, P181, DOI 10.1016/j.dcn.2011.09.003; PATEL S, 1988, EXP NEUROL, V101, P63, DOI 10.1016/0014-4886(88)90065-9; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Pinault D, 2005, J NEUROSCI METH, V141, P231, DOI 10.1016/j.jneumeth.2004.06.015; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; Sanabria ERG, 2002, EPILEPSIA, V43, P96, DOI 10.1046/j.1528-1157.43.s.5.31.x; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Scharfman HE, 2007, NEUROBIOLOGY OF DISEASE, P349, DOI 10.1016/B978-012088592-3/50035-9; SIGGINS GR, 1985, FED PROC, V44, P237; Skilbeck KJ, 2010, J NEUROCHEM, V112, P1115, DOI 10.1111/j.1471-4159.2009.06539.x; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Suarez M, 1998, PHYSIOL BEHAV, V64, P111, DOI 10.1016/S0031-9384(98)00028-6; Sutula TP, 2005, ADV BEHAV BIOL, V55, P147; Taher TR, 2005, NEUROPSYCHOPHARMACOL, V30, P1610, DOI 10.1038/sj.npp.1300709; TESKEY GC, 1993, BRAIN RES, V624, P11; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Tjong YW, 2010, NEUROENDOCRINOL LETT, V31, P215; Tringham E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003120; TSURU N, 1985, EPILEPSIA, V26, P488, DOI 10.1111/j.1528-1157.1985.tb05685.x; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Wang HL, 1998, EUR J NEUROSCI, V10, P3428, DOI 10.1046/j.1460-9568.1998.00352.x; Wimmer RD, 2012, J NEUROSCI, V32, P13917, DOI 10.1523/JNEUROSCI.2313-12.2012; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Xu C, 2012, BRAIN STIMUL; Xu L, 1997, EUR J PHARMACOL, V323, P59, DOI 10.1016/S0014-2999(97)00022-8	73	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66962	10.1371/journal.pone.0066962	http://dx.doi.org/10.1371/journal.pone.0066962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825595	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400171
J	Brunner, JL; Duerr, S; Keesing, F; Killilea, M; Vuong, H; Ostfeld, RS				Brunner, Jesse L.; Duerr, Shannon; Keesing, Felicia; Killilea, Mary; Vuong, Holly; Ostfeld, Richard S.			An Experimental Test of Competition among Mice, Chipmunks, and Squirrels in Deciduous Forest Fragments	PLOS ONE			English	Article							LONG-TERM DYNAMICS; PEROMYSCUS-LEUCOPUS; ACORN MAST; RODENT; COMMUNITY; PREDATION; POPULATIONS; LANDSCAPE; MAMMALS; RESPONSES	Mixed hardwood forests of the northeast United States support a guild of granivorous/omnivorous rodents including gray squirrels (Sciurus carolinensis), eastern chipmunks (Tamias striatus), and white-footed mice (Peromyscus leucopus). These species coincide geographically, co-occur locally, and consume similar food resources. Despite their idiosyncratic responses to landscape and patch variables, patch occupancy models suggest that competition may influence their respective distributions and abundances, and accordingly their influence on the rest of the forest community. Experimental studies, however, are wanting. We present the result of a large-scale experiment in which we removed white-footed mice or gray squirrels from small, isolated forest fragments in Dutchess County, New York, and added these mammals to other fragments in order to alter the abundance of these two species. We then used mark-recapture analyses to quantify the population-level and individual-level effects on resident mice, squirrels, and chipmunks. Overall, we found little evidence of competition. There were essentially no within-season numerical responses to changes in the abundance of putative competitors. Moreover, while individual-level responses (apparent survival and capture probability) did vary with competitor densities in some models, these effects were often better explained by site-specific parameters and were restricted to few of the 19 sites we studied. With only weak or nonexistent competition among these three common rodent species, we expect their patterns of habitat occupancy and population dynamics to be largely independent of one another.	[Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Brunner, Jesse L.; Duerr, Shannon; Vuong, Holly; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Keesing, Felicia] Bard Coll, Dept Biol, Annandale On Hudson, NY USA; [Killilea, Mary] NYU, Dept Biol, New York, NY 10003 USA; [Vuong, Holly] Rutgers State Univ, Dept Ecol & Evolut, New Brunswick, NJ 08903 USA	Washington State University; Cary Institute of Ecosystem Studies; New York University; Rutgers State University New Brunswick	Brunner, JL (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	jesse.brunner@wsu.edu	Brunner, Jesse L./B-1692-2013	Brunner, Jesse L./0000-0003-4894-8274; Ostfeld, Richard/0000-0002-3707-9301	Environmental Protection Agency (STAR) [83377601]; National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases [EF0813035]; Division Of Environmental Biology [0949702] Funding Source: National Science Foundation	Environmental Protection Agency (STAR)(United States Environmental Protection Agency); National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the Environmental Protection Agency (STAR Grant 83377601) and the National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases (EF0813035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; Burns CE, 2005, BEHAV ECOL, V16, P898, DOI 10.1093/beheco/ari070; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Cole RJ, 2009, BIOTROPICA, V41, P319, DOI 10.1111/j.1744-7429.2009.00490.x; DOUGLAS B, 2012, IME4 LINEAR MIXED EF; Elias SP, 2004, J MAMMAL, V85, P743, DOI 10.1644/BER-025; Ernest SKM, 2008, AM NAT, V172, pE257, DOI 10.1086/592402; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goheen JR, 2003, CAN J ZOOL, V81, P1636, DOI 10.1139/Z03-143; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Klinger R, 2009, ECOLOGY, V90, P1549, DOI 10.1890/07-2146.1; Koenker R., 2012, QUANTREG QUANTILE RE; Koprowski JL, 1996, J MAMMAL, V77, P1006, DOI 10.2307/1382781; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Manson RH, 1999, LANDSCAPE ECOL, V14, P355, DOI 10.1023/A:1008093823391; Manson RH, 2001, ECOLOGY, V82, P3320, DOI 10.2307/2680155; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Mendoza E, 2007, OIKOS, V116, P1841, DOI [10.1111/j.2007.0030-1299.15878.x, 10.1111/j.0030-1299.2007.15878.x]; MOEN J, 1993, OIKOS, V68, P401, DOI 10.2307/3544908; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Moore JE, 2007, OECOLOGIA, V151, P663, DOI 10.1007/s00442-006-0616-8; Nupp TE, 2001, MAMM BIOL, V66, P345; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; Ostfeld RS, 1997, ECOLOGY, V78, P1531, DOI 10.1890/0012-9658(1997)078[1531:EOROSO]2.0.CO;2; Parker TS, 2012, LANDSCAPE URBAN PLAN, V106, P316, DOI 10.1016/j.landurbplan.2012.04.003; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; R Core Team, 2016, R FDN STAT COMP; RIEGE DA, 1991, J MAMMAL, V72, P152, DOI 10.2307/1381990; Schauber EM, 2009, ECOLOGY, V90, P240, DOI 10.1890/07-0980.1; Schmidt KA, 2003, OIKOS, V103, P548, DOI 10.1034/j.1600-0706.2003.12462.x; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Schnurr JL, 2004, ECOLOGY, V85, P741, DOI 10.1890/02-0644; Schnurr JL, 2002, OIKOS, V96, P402, DOI 10.1034/j.1600-0706.2002.960302.x; Seamon J, 1997, ACTA OECOL, V18, P637, DOI 10.1016/S1146-609X(97)80048-3; Thibault KM, 2010, J MAMMAL, V91, P787, DOI 10.1644/09-MAMM-S-142.1; Vandegrift KJ, 2009, J ANIM ECOL, V78, P202, DOI 10.1111/j.1365-2656.2008.01456.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2; [No title captured]	58	16	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66798	10.1371/journal.pone.0066798	http://dx.doi.org/10.1371/journal.pone.0066798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824654	Green Published, gold			2022-12-25	WOS:000320576400160
J	Eriksson, P; Aine, M; Sjodahl, G; Staaf, J; Lindgren, D; Hoglund, M				Eriksson, Pontus; Aine, Mattias; Sjodahl, Gottfrid; Staaf, Johan; Lindgren, David; Hoglund, Mattias			Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; INVASIVE BLADDER-CANCER; DNA-FORMING SEQUENCES; ARRAY-CGH DATA; COPY-NUMBER; HEPATOCELLULAR-CARCINOMA; MAMMALIAN-CELLS; GENE-EXPRESSION; HYBRIDIZATION; TUMORS	Background: Urothelial carcinoma shows frequent amplifications at 6p22 and 1q21-24. The main target gene at 6p22 is believed to be E2F3, frequently co-amplified with CDKAL1 and SOX4. There are however reports on 6p22 amplifications that do not include E2F3. Previous analyses have identified frequent aberrations occurring at 1q21-24. However, due to complex rearrangements it has been difficult to identify specific 1q21-24 target regions and genes. Methods: We selected 29 cases with 6p and 37 cases with 1q focal genomic amplifications from 261 cases of urothelial carcinoma analyzed by array-CGH for high resolution zoom-in oligonucleotide array analyses. Genomic analyses were combined with gene expression data and genomic sequence analyses to characterize and fine map 6p22 and 1q21-24 amplifications. Results: We show that the most frequently amplified gene at 6p22 is SOX4 and that SOX4 can be amplified and overexpressed without the E2F3 or CDKAL1 genes being included in the amplicon. Hence, our data point to SOX4 as an auxiliary amplification target at 6p22. We further show that at least three amplified regions are observed at 1q21-24. Copy number data, combined with gene expression data, highlighted BCL9 and CHD1L as possible targets in the most proximal region and MCL1, SETDB1, and HIF1B as putative targets in the middle region, whereas no obvious targets could be determined in the most distal amplicon. We highlight enrichment of G4 quadruplex sequence motifs and a high number of intraregional sequence duplications, both known to contribute to genomic instability, as prominent features of the 1q21-24 region. Conclusions: Our detailed analyses of the 6p22 amplicon suggest SOX4 as an auxiliary target gene for amplification. We further demonstrate three separate target regions for amplification at 1q21-24 and identified BCL9, CHD1L, and MCL1, SETDB1, and HIF1B as putative target genes within these regions.	[Eriksson, Pontus; Aine, Mattias; Sjodahl, Gottfrid; Staaf, Johan; Hoglund, Mattias] Lund Univ, Dept Oncol, Skane Univ Hosp, Lund, Sweden; [Staaf, Johan] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden; [Lindgren, David] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Hoglund, M (corresponding author), Lund Univ, Dept Oncol, Skane Univ Hosp, Lund, Sweden.	mattias.hoglund@med.lu.se	Aine, Mattias/Q-3205-2019; Aine, Mattias/AAU-7281-2020	Aine, Mattias/0000-0002-0851-5952; Sjodahl, Gottfrid/0000-0002-7869-0473; Hoglund, Mattias/0000-0001-9283-4421; Eriksson, Pontus/0000-0003-3317-865X	Swedish Cancer Society; Swedish Research Council [2011-17816-83790-87]; Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	This work supported by The Swedish Cancer Society, http://www.vr.se/(grant number 10 0517) The Swedish Research Council, (www.cancerfonden.se/) (grant number 2011-17816-83790-87), The Crafoord Foundation, (http://www.crafoord.se/vetenskaplig_forskning.asp), The Gunnar Nilsson Foundation, (http://www.cancerstiftelsen.com/), The Medical Faculty of Lund University Hospital, (http://www.med.lu.se/), and The Swedish Society for Medical Research, (http://www.ssmf.se/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Boan F, 2010, CHEMBIOCHEM, V11, P331, DOI 10.1002/cbic.200900612; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen LL, 2010, ACTA PHARMACOL SIN, V31, P1165, DOI 10.1038/aps.2010.94; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006727; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fadl-Elmula Imad, 2005, Cell Chromosome, V4, P1, DOI 10.1186/1475-9268-4-1; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hoglund M, 2001, CANCER RES, V61, P8241; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Hurst CD, 2012, CLIN CANC RES; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Knowles MA, 2001, J CLIN PATHOL-MOL PA, V54, P215, DOI 10.1136/mp.54.4.215; Knowles MA, 1999, ELECTROPHORESIS, V20, P269, DOI 10.1002/(SICI)1522-2683(19990201)20:2<269::AID-ELPS269>3.3.CO;2-Z; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lauss M, 2012, EPIGENETICS, V7; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Oeggerli M, 2006, ONCOGENE, V25, P6538, DOI 10.1038/sj.onc.1209946; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Richter J, 1998, AM J PATHOL, V153, P1615, DOI 10.1016/S0002-9440(10)65750-1; Richter J, 1997, CANCER RES, V57, P2860; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHEN MR, 1991, J MOL EVOL, V33, P311; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sjodahl G., 2012, CLIN CANC RES; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Staaf J, 2008, HUM MUTAT, V29, P555, DOI 10.1002/humu.20678; Staaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-382; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Veltman JA, 2003, CANCER RES, V63, P2872; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zhao JM, 1999, CANCER RES, V59, P4658; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	68	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67222	10.1371/journal.pone.0067222	http://dx.doi.org/10.1371/journal.pone.0067222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825644	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400179
J	Ligasova, A; Strunin, D; Koberna, K				Ligasova, Anna; Strunin, Dmytro; Koberna, Karel			A New Method of the Visualization of the Double-Stranded Mitochondrial and Nuclear DNA	PLOS ONE			English	Article							DAPI; REPLICATION; BINDING; CELLS	The study describes the method of a sensitive detection of double-stranded DNA molecules in situ. It is based on the oxidative attack on the deoxyribose moiety by copper(I) in the presence of oxygen. We have shown previously that the oxidative attack leads to the formation of frequent gaps in DNA. Here we have demonstrated that the gaps can be utilized as the origins for an efficient synthesis of complementary labeled strands by DNA polymerase I and that such enzymatic detection of the double-stranded DNA is a sensitive approach enabling in-situ detection of both the nuclear and mitochondrial genomes in formaldehyde-fixed human cells.	[Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] Palacky Univ, Expt Med Lab, Inst Mol & Translat Med, Fac Med, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Ligasova, A (corresponding author), Palacky Univ, Expt Med Lab, Inst Mol & Translat Med, Fac Med, CR-77147 Olomouc, Czech Republic.	ligasova@gmail.com	Ligasová, Anna/P-5460-2015; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298	Technology Agency of the Czech Republic [TA03010598, TA03010719]; Operational Program Research and Development for Innovations [CZ.1.05/2.1.00/01.0030]	Technology Agency of the Czech Republic; Operational Program Research and Development for Innovations(European Commission)	This work has been supported by the Technology Agency of the Czech Republic (TA03010598 and TA03010719). The infrastructural part of the project (Institute of Molecular and Translational Medicine) has been supported from the Operational Program Research and Development for Innovations (project CZ.1.05/2.1.00/01.0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLSON P, 1995, J BIOMOL STRUCT DYN, V13, P351, DOI 10.1080/07391102.1995.10508845; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; HIRONS GT, 1994, CYTOMETRY, V15, P129, DOI 10.1002/cyto.990150206; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Lentz SI, 2010, J VIS EXP; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq619; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; vandeCorput MPC, 1997, J HISTOCHEM CYTOCHEM, V45, P55; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200	16	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66864	10.1371/journal.pone.0066864	http://dx.doi.org/10.1371/journal.pone.0066864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825578	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400163
J	Pereiro, C; Pino, C; Florez, G; Arrojo, M; Becona, E				Pereiro, Cesar; Pino, Carlos; Florez, Gerardo; Arrojo, Manuel; Becona, Elisardo		COPSIAD Grp	Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; SEVERE MENTAL-ILLNESS; ANTISOCIAL PERSONALITY-DISORDER; DSM-IV DISORDERS; DUAL DIAGNOSIS; COOCCURRING DISORDERS; BORDERLINE PERSONALITY; SURVEY REPLICATION; ALCOHOL-ABUSE; PREVALENCE	The objective of this study is to assess the prevalence of psychiatric comorbidity in patients under treatment within the addictive disorders assistance units of Galicia (Spain). Material and Methods: A total of 64 healthcare professionals performed clinical diagnosis of mental disorders (on DSM IV-TR criteria) in 2300 patients treated throughout March 2010 in 21 addictive disorders assistance units. Results: 56.3% of patients with substance abuse/dependency also showed some other mental disorder, 42.2% of patients suffering from at least an Axis I condition and 20.2% from some Axis II condition. Mood and anxiety disorders and borderline and antisocial personality disorders were the most frequent disorders in both axes. Conclusions: A high comorbidity was found between mental and substance use disorders (SUD) in patients seen at the addictive disorders assistance units of Galicia.	[Pereiro, Cesar] Drug Dependency Unit, La Coruna, Spain; [Pino, Carlos] Drug Dependency Unit, Pontevedra, Spain; [Florez, Gerardo] Addict Behav Unit, Orense, Spain; [Arrojo, Manuel] Galician Hlth Serv, Mental Hlth & Drug Dependency Assistance Serv, Direct Sanit Assistance, Galicia, Spain; [Becona, Elisardo] Univ Santiago Compostela, Fac Psychol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Pereiro, C (corresponding author), Drug Dependency Unit, La Coruna, Spain.	cesar.pereiro.gomez@sergas.es	Arrojo, Manuel/AAA-2163-2019; fraga, jaime/C-4791-2013; Becoña, Elisardo/F-9716-2010; lopez-duran, ana/ABE-1205-2021; lopez-duran, ana/N-1645-2014	Becoña, Elisardo/0000-0002-6639-3834; lopez-duran, ana/0000-0001-7661-8972; lopez-duran, ana/0000-0001-7661-8972; Carou, Maria/0000-0002-3162-1382; Arrojo-Romero, manuel/0000-0002-5609-7134				ABRAM KM, 1991, AM PSYCHOL, V46, P1036, DOI 10.1037/0003-066X.46.10.1036; Aharonovich E, 2002, AM J PSYCHIAT, V159, P1600, DOI 10.1176/appi.ajp.159.9.1600; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANTHENELLI RM, 1994, PSYCHIAT ANN, V24, P407, DOI 10.3928/0048-5713-19940801-08; Baena M. R., 2006, TRASTORNOS ADICTIVOS, V8, P176, DOI DOI 10.1016/S1575-0973(06)75118-2; Barea J, 2010, ADICCIONES, V22, P15, DOI 10.20882/adicciones.210; BARTELS SJ, 1992, AM J PSYCHIAT, V149, P394; Bornovalova MA, 2005, CLIN PSYCHOL REV, V25, P790, DOI 10.1016/j.cpr.2005.05.005; Cohen WR, 2007, UPPERS DOWNERS ALL A; CUFFEL BJ, 1994, J NERV MENT DIS, V182, P704, DOI 10.1097/00005053-199412000-00005; Darke S, 2004, DRUG ALCOHOL DEPEN, V74, P77, DOI 10.1016/j.drugalcdep.2003.12.002; Drake RE, 2007, WORLD PSYCHIATRY, V6, P131; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; Grant BF, 2004, J CLIN PSYCHIAT, V65, P948; Griffin ML, 2009, ADDICT BEHAV, V34, P826, DOI 10.1016/j.addbeh.2009.03.002; Gual A, 2007, DRUG ALCOHOL REV, V26, P65, DOI 10.1080/09595230601037000; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim T, 2003, DHA GUIDE EFFECTIVE; Madden P, 2007, BRIT J PSYCHIAT, V183, P304; Martin-Santos R, 2006, EUR J PSYCHIAT, V20, P147, DOI 10.4321/s0213-61632006000300002; McHugo GJ, 2006, SCHIZOPHRENIA BULL, V32, P655, DOI 10.1093/schbul/sbl009; Mueser KT, 1997, J ABNORM PSYCHOL, V106, P473, DOI 10.1037/0021-843X.106.3.473; Mueser KT, 2001, SCHIZOPHR RES, V48, P93, DOI 10.1016/S0920-9964(00)00065-7; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rosenberg SD, 2001, COMPR PSYCHIAT, V42, P263, DOI 10.1053/comp.2001.24576; ROSS HE, 1994, J NERV MENT DIS, V182, P556, DOI 10.1097/00005053-199410000-00005; ROUNSAVILLE BJ, 1987, ARCH GEN PSYCHIAT, V44, P505; Rounsaville BJ, 2003, DRUG ALCOHOL DEPEN, V70, P117, DOI 10.1016/S0376-8716(03)00033-4; Rush B, 2008, CAN J PSYCHIAT, V53, P810, DOI 10.1177/070674370805301207; Rush B, 2013, J SUBST ABUSE TREAT, V44, P375, DOI 10.1016/j.jsat.2012.08.221; Salyers MP, 2001, SCHIZOPHR RES, V48, P109, DOI 10.1016/S0920-9964(00)00063-3; SATEL SL, 1991, AM J PSYCHIAT, V148, P1708; STOWELL RJA, 1991, PSYCHIAT ANN, V21, P98, DOI 10.3928/0048-5713-19910201-09; Bolotner NS, 2011, ADICCIONES, V23, P249, DOI 10.20882/adicciones.149; Tiet QQ, 2007, ALCOHOL CLIN EXP RES, V31, P513, DOI 10.1111/j.1530-0277.2007.00336.x; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Torrens Melich Marta, 2008, Adicciones, V20, P315; Volkow ND, 2007, NIDA NOTES, V21, P2; Watkins KE, 2004, AM J DRUG ALCOHOL AB, V30, P749, DOI 10.1081/ADA-200037538	41	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66451	10.1371/journal.pone.0066451	http://dx.doi.org/10.1371/journal.pone.0066451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823135	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400110
J	Summa, KC; Voigt, RM; Forsyth, CB; Shaikh, M; Cavanaugh, K; Tang, YM; Vitaterna, MH; Song, SW; Turek, FW; Keshavarzian, A				Summa, Keith C.; Voigt, Robin M.; Forsyth, Christopher B.; Shaikh, Maliha; Cavanaugh, Kate; Tang, Yueming; Vitaterna, Martha Hotz; Song, Shiwen; Turek, Fred W.; Keshavarzian, Ali			Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SHIFT WORK; GASTROINTESTINAL PERMEABILITY; INSULIN-RESISTANCE; POSSIBLE MECHANISM; METABOLIC SYNDROME; IMMUNE ACTIVATION; LIVER-DISEASE; MOUSE MODEL; GUT	The circadian clock orchestrates temporal patterns of physiology and behavior relative to the environmental light: dark cycle by generating and organizing transcriptional and biochemical rhythms in cells and tissues throughout the body. Circadian clock genes have been shown to regulate the physiology and function of the gastrointestinal tract. Disruption of the intestinal epithelial barrier enables the translocation of proinflammatory bacterial products, such as endotoxin, across the intestinal wall and into systemic circulation; a process that has been linked to pathologic inflammatory states associated with metabolic, hepatic, cardiovascular and neurodegenerative diseases - many of which are commonly reported in shift workers. Here we report, for the first time, that circadian disorganization, using independent genetic and environmental strategies, increases permeability of the intestinal epithelial barrier (i.e., gut leakiness) in mice. Utilizing chronic alcohol consumption as a well-established model of induced intestinal hyperpermeability, we also found that both genetic and environmental circadian disruption promote alcohol-induced gut leakiness, endotoxemia and steatohepatitis, possibly through a mechanism involving the tight junction protein occludin. Circadian organization thus appears critical for the maintenance of intestinal barrier integrity, especially in the context of injurious agents, such as alcohol. Circadian disruption may therefore represent a previously unrecognized risk factor underlying the susceptibility to or development of alcoholic liver disease, as well as other conditions associated with intestinal hyperpermeability and an endotoxin-triggered inflammatory state.	[Summa, Keith C.; Cavanaugh, Kate; Vitaterna, Martha Hotz; Turek, Fred W.] Northwestern Univ, Ctr Sleep & Circadian Biol, Dept Neurobiol, Evanston, IL 60208 USA; [Summa, Keith C.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Voigt, Robin M.; Forsyth, Christopher B.; Shaikh, Maliha; Tang, Yueming; Keshavarzian, Ali] Rush Univ, Div Digest Dis & Nutr, Dept Internal Med, Med Ctr, Chicago, IL 60612 USA; [Forsyth, Christopher B.] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA; [Song, Shiwen] Amer Soc Clin Pathologists, Chicago, IL USA; [Keshavarzian, Ali] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Mol Biophys & Physiol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands	Northwestern University; Northwestern University; Feinberg School of Medicine; Rush University; Rush University; Rush University; Rush University; Utrecht University	Summa, KC (corresponding author), Northwestern Univ, Ctr Sleep & Circadian Biol, Dept Neurobiol, Evanston, IL 60208 USA.	ksumma@fsm.northwestern.edu		Cavanaugh, Kate/0000-0001-9293-0296; Summa, Keith/0000-0001-9541-8458	National Institutes of Health [5R01AA020216]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) through a Northwestern University Clinical and Translational Sciences Institute Predoctoral Training Grant [8UL1TR000150]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH) through a Northwestern University Clinical and Translational Sciences Institute Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the National Institutes of Health (5R01AA020216 to FWT and AK). KCS was supported in part by the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) through a Northwestern University Clinical and Translational Sciences Institute Predoctoral Training Grant (8UL1TR000150). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Del Valle-Pinero AY, 2013, CLIN CHIM ACTA, V418, P97, DOI 10.1016/j.cca.2012.12.032; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Donohue TM, 2007, ALCOHOL CLIN EXP RES, V31, P1053, DOI 10.1111/j.1530-0277.2007.00393.x; Douris N, 2011, CURR BIOL, V21, P1347, DOI 10.1016/j.cub.2011.07.018; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Keshavarzian A, 2000, AM J GASTROENTEROL, V95, P1124; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; Kirpich IA, 2008, ALCOHOL, V42, P675, DOI 10.1016/j.alcohol.2008.08.006; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KLION FM, 1966, AM J PATHOL, V48, P755; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; MARRA G, 1994, GASTROENTEROLOGY, V106, P982, DOI 10.1016/0016-5085(94)90757-9; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mcclung CA, 2007, COLD SPRING HARB SYM, V72, P637, DOI 10.1101/sqb.2007.72.031; Meddings JB, 1998, GASTROENTEROLOGY, V114, P83, DOI 10.1016/S0016-5085(98)70636-5; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Morris CJ, 2012, PROG BRAIN RES, V199, P337, DOI 10.1016/B978-0-444-59427-3.00019-8; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Naylor E, 2000, J NEUROSCI, V20, P8138; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Nojkov B, 2010, AM J GASTROENTEROL, V105, P842, DOI 10.1038/ajg.2010.48; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Summa KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037668; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Takeda N, 2010, HYPERTENS RES, V33, P645, DOI 10.1038/hr.2010.68; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; Tipoe GL, 2008, ALCOHOL CLIN EXP RES, V32, P669, DOI 10.1111/j.1530-0277.2008.00623.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang HJ, 2010, WORLD J GASTROENTERO, V16, P1304, DOI 10.3748/wjg.v16.i11.1304; Wimberly AL, 2013, ALCOHOL CLIN EXP RES, V37, pE199, DOI 10.1111/j.1530-0277.2012.01894.x; Wong RK, 2013, ALIMENT PHARM THER; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017	82	152	158	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67102	10.1371/journal.pone.0067102	http://dx.doi.org/10.1371/journal.pone.0067102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825629	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400176
J	Toyoda, D; Taguchi, A; Chiga, M; Ohmori, T; Nishinakamura, R				Toyoda, Daichi; Taguchi, Atsuhiro; Chiga, Masahiko; Ohmori, Tomoko; Nishinakamura, Ryuichi			Sall4 Is Transiently Expressed in the Caudal Wolffian Duct and the Ureteric Bud, but Dispensable for Kidney Development	PLOS ONE			English	Article							TOWNES-BROCKS-SYNDROME; ZINC-FINGER PROTEIN; STEM-CELLS; OKIHIRO-SYNDROME; CAUSATIVE GENE; MURINE HOMOLOG; REGION; PROLIFERATION; PLURIPOTENCY; DROSOPHILA	The kidney, the metanephros, is formed by reciprocal interactions between the metanephric mesenchyme and the ureteric bud, the latter of which is derived from the Wolffian duct that elongates in the rostral-to-caudal direction. Sall1 expressed in the metanephric mesenchyme is essential for ureteric bud attraction in kidney development. Sall4, another member of the Sall gene family, is required for maintenance of embryonic stem cells and establishment of induced pluripotent stem cells, and is thus considered to be one of the stemness genes. Sall4 is also a causative gene for Okihiro syndrome and is essential for the formation of many organs in both humans and mice. However, its expression and role in kidney development remain unknown, despite the essential role of Sall1 in the metanephric mesenchyme. Here, we report that mouse Sall4 is expressed transiently in the Wolffian duct-derived lineage, and is nearly complementary to Sall1 expression. While Sall4 expression is excluded from the Wolffian duct at embryonic (E) day 9.5, Sall4 is expressed in the Wolffian duct weakly in the mesonephric region at E10.5 and more abundantly in the caudal metanephric region where ureteric budding occurs. Sall4 expression is highest at E11.5 in the Wolffian duct and ureteric bud, but disappears by E13.5. We further demonstrate that Sall4 deletion in the Wolffian duct and ureteric bud does not cause any apparent kidney phenotypes. Therefore, Sall4 is expressed transiently in the caudal Wolffian duct and the ureteric bud, but is dispensable for kidney development in mice.	[Toyoda, Daichi; Taguchi, Atsuhiro; Chiga, Masahiko; Ohmori, Tomoko; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan; [Nishinakamura, Ryuichi] Kumamoto Univ, Japan Sci Promot Agcy, CREST, Kumamoto, Japan	Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University	Nishinakamura, R (corresponding author), Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan.	ryuichi@kumamoto-u.ac.jp		Taguchi, Atsuhiro/0000-0003-1741-2987	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; CREST	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Science and Technology Agency, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Nishinakamura R, 2008, KIDNEY INT, V73, P913, DOI 10.1038/sj.ki.5002784; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Sato A, 2003, MOL CELL BIOL, V23, P62, DOI 10.1128/MCB.23.1.62-69.2003; Srinivas S, 1999, DEV GENET, V24, P241; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Yu J, 2002, DEVELOPMENT, V129, P5301; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14	24	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68508	10.1371/journal.pone.0068508	http://dx.doi.org/10.1371/journal.pone.0068508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825698	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400197
J	Zhang, W; Nie, L; Wang, Y; Wang, XP; Zhao, H; Dongol, S; Maharjan, S; Cheng, L				Zhang, Wen; Nie, Lin; Wang, Yan; Wang, Xu-ping; Zhao, Hua; Dongol, Samina; Maharjan, Sailendra; Cheng, Lei			CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues	PLOS ONE			English	Article							INTERVERTEBRAL DISC; T-CELLS; NITRIC-OXIDE; TNF-ALPHA; EXPRESSION; INTERLEUKIN-17; DISTINCT; PROFILE; IL-17; INFLAMMATION	Background: Studies elucidated that Th17 cells are important contributors to the pathogenesis of many immune-mediated diseases, and IL-17A is present in pathologic intervertebral disc (IVD) tissues. However, the mechanisms, how these cells traffic into the degenerate discs are not clear. Materials and Methods: The samples collected from 53 patients had been divided into 3 groups: Group P (annulus fibrosus was intact), Group E (annulus fibrosus was reptured) and normal control. Immunohistochemistry was used to detect the expression of CCL20, CCR6, IL-17A, TNF-alpha and CD4 in IVD tissues. Moreover, nucleus pulposus (NP) cells had been cultured in the presence and absence of Th17 associated cytokines. The supernatants were detected for CCL20 concentrations by ELISA, and the NP cells for the expression of CCL20 mRNA. Additionally, peripheral blood (PB) samples had undergone detection for the expression of CCR6 mRNA and the proportion of IL-17-producing cells, including the surface expression of CCR6. Results: Immunohistochemistry revealed that CCL20 and TNF-alpha were expressed in degenerated NP cells. Double-labeled immunofluorescence elaborated, IL-17-producing cells (CD4(+)IL-17A(+) and CD4(+)CCR6(+)) appeared in the Group E samples, but no traces or expression in Group P and normal control. IL-17A and TNF-alpha, alone or combined, could enhance CCL20 secretion in a dose-dependent manner, which was obtained through RT-PCR results. There was a notable difference of CCR6 mRNA expression between patients and normal controls. In comparison to controls, flow cytometry data indicated that the proportion of IL-17- producing cells and the CCR6 expression in PB were significantly increased. Conclusion: Our results provide a potential explanation for involvement of the CCL20-CCR6 system in the trafficking of IL-17-producing cells to degenerated IVD tissues. Additionally, our results explain the contribution of Th17 associated cytokines to the development of degenerated discs via the up-regulation of CCL20 secretion from NP cells, which forms a positive chemotactic feedback loop.	[Zhang, Wen; Nie, Lin; Zhao, Hua; Maharjan, Sailendra; Cheng, Lei] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China; [Wang, Yan] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Wang, Xu-ping] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Wang, Xu-ping] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Dongol, Samina] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Cheng, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China.	chengleiyx@126.com			Ministry of education of new funds for teachers [20110131120079]; Independent Innovation Foundation of Shandong University [2009TS004]; natural science foundation of Shandong Province [Q2008C09]; National Nature Science Foundation of China [80200212]; Department of Science and the Technology of Shandong Province of China [ZR2012HQ029]	Ministry of education of new funds for teachers; Independent Innovation Foundation of Shandong University; natural science foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and the Technology of Shandong Province of China	This study was partially supported by research funding from The Ministry of education of new funds for teachers (20110131120079), Independent Innovation Foundation of Shandong University (2009TS004), the natural science foundation of Shandong Province (Q2008C09), the National Nature Science Foundation of China (80200212) and the Department of Science and the Technology of Shandong Province of China (ZR2012HQ029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Awad JN, 2006, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000198724.54891.3a; BOBECHKO W P, 1965, J Bone Joint Surg Br, V47, P574; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; GRONBLAD M, 1994, SPINE, V19, P2744; Haro H, 2002, J ORTHOP RES, V20, P409, DOI 10.1016/S0736-0266(01)00150-4; Haro H, 1996, SPINE, V21, P1647, DOI 10.1097/00007632-199607150-00006; Haro H, 2000, J CLIN INVEST, V105, P133, DOI 10.1172/JCI7090; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Kawaguchi S, 2002, SPINE, V27, P1511, DOI 10.1097/00007632-200207150-00006; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NAYLOR A, 1975, ORTHOP CLIN N AM, V6, P51; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Studer RK, 2011, SPINE, V36, P593, DOI 10.1097/BRS.0b013e3181da38d5; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Wang F, 2011, ASIAN SPINE J, V5, P73, DOI 10.4184/asj.2011.5.2.73; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zhang ZL, 2007, INT IMMUNOPHARMACOL, V7, P409, DOI 10.1016/j.intimp.2006.09.024	40	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66286	10.1371/journal.pone.0066286	http://dx.doi.org/10.1371/journal.pone.0066286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823618	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400078
J	Yang, HP; Zheng, YH; Li, TWH; Peng, H; Fernandez-Ramos, D; Martinez-Chantar, ML; Rojas, AL; Mato, JM; Lu, SC				Yang, Heping; Zheng, Yuhua; Li, Tony W. H.; Peng, Hui; Fernandez-Ramos, David; Martinez-Chantar, Maria L.; Rojas, Adriana L.; Mato, Jose M.; Lu, Shelly C.			Methionine Adenosyltransferase 2B, HuR, and Sirtuin 1 Protein Cross-talk Impacts on the Effect of Resveratrol on Apoptosis and Growth in Liver Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; HEPATOCELLULAR-CARCINOMA; SPLICING VARIANTS; HEPATOMA-CELLS; IN-VIVO; EXPRESSION; CHEMOPREVENTION; ACTIVATORS; MECHANISM; MICE	Resveratrol is growth-suppressive and pro-apoptotic in liver cancer cells. Methionine adenosyltransferase 2B (MAT2B) encodes for two dominant variants V1 and V2 that positively regulate growth, and V1 is anti-apoptotic when overexpressed. Interestingly, crystal structure analysis of MAT2B protein (MAT beta) protomer revealed two resveratrol binding pockets, which raises the question of the role of MAT2B in resveratrol biological activities. We found that resveratrol induced the expression of MAT2BV1 and V2 in a time-and dose-dependent manner by increasing transcription, mRNA, and protein stabilization. Following resveratrol treatment, HuR expression increased first, followed by SIRT1 and MAT2B. SIRT1 induction contributes to increased MAT2B transcription whereas HuR induction increased MAT2B mRNA stability. MAT beta interacts with HuR and SIRT1, and resveratrol treatment enhanced these interactions while reducing the interaction between MAT beta and MAT alpha 2. Because MAT beta lowers the K-i of MAT alpha 2 for S-adenosylmethionine (AdoMet), this allowed steady-state AdoMet level to rise. Interaction among MAT beta, SIRT1, and HuR increased stability of these proteins. Induction of MAT2B is a compensatory response to resveratrol as knocking down MAT2BV1 potentiated the resveratrol pro-apoptotic and growth-suppressive effects, whereas the opposite occurred with V1 overexpression. The same effect on growth occurred with MAT2BV2. In conclusion, resveratrol induces HuR, SIRT1, and MAT2B expression; the last may represent a compensatory response against apoptosis and growth inhibition. However, MAT beta induction also facilitates SIRT1 activation, as the interaction stabilizes SIRT1. This complex interplay among MAT beta, HuR, and SIRT1 has not been previously reported and suggests that these proteins may regulate each other's signaling.	[Yang, Heping; Li, Tony W. H.; Peng, Hui; Lu, Shelly C.] Univ So Calif, Keck Sch Med, Div Gastroenterol & Liver Dis, Res Ctr Liver Dis,Southern Calif Res Ctr Alcohol, Los Angeles, CA 90033 USA; [Zheng, Yuhua] Childrens Hosp Los Angeles, Dept Pediat Gastroenterol, Los Angeles, CA 90027 USA; [Fernandez-Ramos, David; Martinez-Chantar, Maria L.; Rojas, Adriana L.; Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC BioGUNE, Derio 48160, Bizkaia, Spain	University of Southern California; Children's Hospital Los Angeles; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Lu, SC (corresponding author), Univ So Calif, Keck Sch Med, Div Gastroenterol & Liver Dis, HMR 415,2011 Zonal Ave, Los Angeles, CA 90033 USA.	shellylu@usc.edu	Chantar, Maria Luz Martinez/F-5190-2011; Fernández-Ramos, David/S-5231-2016; Fernández-Ramos, David/ABD-1274-2021; MATO, JOSE/A-5187-2011; Rojas, Adriana/G-2403-2011	Chantar, Maria Luz Martinez/0000-0002-6446-9911; Fernández-Ramos, David/0000-0003-4651-195X; Fernández-Ramos, David/0000-0003-4651-195X; MATO, JOSE/0000-0003-1264-3153; Rojas, Adriana/0000-0002-7358-3505	National Institutes of Health [R01DK51719]; Plan Nacional of I + D SAF [2011-29851]; ETORTEK; Sanidad Gobierno Vasco; Educacion Gobierno Vasco [PI2011/29]; Fondo de Investigacion Sanitaria [PI11/01588]; Cell Culture Core of the University of Southern California Research Center for Liver Diseases [P30DK48522]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051719, P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I + D SAF; ETORTEK; Sanidad Gobierno Vasco; Educacion Gobierno Vasco; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Cell Culture Core of the University of Southern California Research Center for Liver Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK51719 (to S. C. L., H. Y., and J. M. M.). This work was also supported by Plan Nacional of I + D SAF 2011-29851 (to J. M. M.), ETORTEK-2011, Sanidad Gobierno Vasco 2008, Educacion Gobierno Vasco 2011 (PI2011/29), and Fondo de Investigacion Sanitaria (PI11/01588) (to M. L. M.-C.). Huh7 and HepG2 cells were provided by the Cell Culture Core of the University of Southern California Research Center for Liver Diseases under Grant P30DK48522.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Costa CD, 2011, OBES SURG, V21, P356, DOI 10.1007/s11695-010-0251-7; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Li JP, 2010, AM J PATHOL, V176, P2456, DOI 10.2353/ajpath.2010.090810; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lu SC, 2009, HEPATOLOGY, V50, P462, DOI 10.1002/hep.22990; Mbimba T, 2012, CURR PHARM BIOTECHNO, V13, P229, DOI 10.2174/138920112798868575; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Nordgren KKS, 2011, DRUG METAB DISPOS, V39, P2135, DOI 10.1124/dmd.111.040857; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Ramani Komal, 2011, Cancers (Basel), V3, P1480, DOI 10.3390/cancers3021480; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Vetterli L, 2011, AGING-US, V3, P444, DOI 10.18632/aging.100304; Xia M, 2010, J BIOL CHEM, V285, P20015, DOI 10.1074/jbc.M109.094821; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Yeh CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079406, 10.1371/journal.pone.0056661]	29	30	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23161	23170		10.1074/jbc.M113.487157	http://dx.doi.org/10.1074/jbc.M113.487157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814050	hybrid, Green Published			2022-12-25	WOS:000330598200023
J	Wang, FF; Qiao, YD; Yu, J; Ren, XL; Wang, JM; Ding, Y; Zhang, XJ; Ma, WH; Ding, YQ; Liang, L				Wang, Feifei; Qiao, Yudan; Yu, Jiang; Ren, Xiaoli; Wang, Jianmei; Ding, Yi; Zhang, Xiaojing; Ma, Wenhui; Ding, Yanqing; Liang, Li			FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							F-BOX PROTEINS; GENE-EXPRESSION; CYCLIN-E; C-MYC; CANCER; FAMILY; DEGRADATION; PROGRESSION; PREDICTORS; RECURRENCE	Background: F-box only protein 8 (FBX8), a novel component of F-box proteins, is lost in several cancers and has been associated with invasiveness of cancer cells. However, its expression pattern and role in the progression of hepatocellular carcinoma remain unclear. This study investigated the prognostic significance of FBX8 in hepatocellular carcinoma samples and analyzed FBX8 function in hepatocellular carcinoma cells by gene manipulation. Methodology: The expression of FBX8 was detected in 120 cases of clinical paraffin-embedded hepatocellular carcinoma tissues, 20 matched pairs of fresh tissues and five hepatocellular carcinoma cell lines by immunohistochemistry with clinicopathological analyses, real-time RT-PCR or Western blot. The correlation of FBX8 expression with cell proliferation and invasion in five HCC cell lines was analyzed. Moreover, loss of function and gain of function assays were performed to evaluate the effect of FBX8 on cell proliferation, motility, invasion in vitro and metastasis in vivo. Conclusions: We found that FBX8 was obviously down-regulated in HCC tissues and cell lines (P<0.05). The FBX8 down-regulation correlated significantly with poor prognosis, and FBX8 status was identified as an independent significant prognostic factor. Over-expression of FBX8 decreased proliferation, migration and invasion in HepG2 and 97H cells, while knock-down of FBX8 in 7721 cells showed the opposite effect. FBX8 negatively correlated with cell proliferation and invasion in 7701, M3, HepG2 and 97H cell lines. In vivo functional assays showed FBX8 suppressed tumor growth and pulmonary metastatic potential in mice. Our results indicate that down-regulation of FBX8 significantly correlates with invasion, metastasis and poor survival in hepatocellular carcinoma patients. It may be a useful biomarker for therapeutic strategy and control in hepatocellular carcinoma treatment.	[Wang, Feifei; Qiao, Yudan; Ren, Xiaoli; Wang, Jianmei; Ding, Yanqing; Liang, Li] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Feifei; Qiao, Yudan; Ren, Xiaoli; Wang, Jianmei; Ding, Yanqing; Liang, Li] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yu, Jiang; Ma, Wenhui] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Zhang, Xiaojing] Shenzhen Univ, Dept Pathol, Shenzhen, Guangdong, Peoples R China; [Ding, Yi] Southern Med Univ, Nanfang Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Shenzhen University; Southern Medical University - China	Liang, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	redsnow007@hotmail.com	Ding, Yi/CAG-6304-2022; liang, li/AAB-9126-2022; Wang, Jianmei/HHZ-0585-2022; ma, wenhui/GQZ-0052-2022		National Natural Science Foundation of China [81272759, 81172382, 81071735]; Major projects of National Natural Science Foundation of China [81090422]; Natural Science Foundation of Guangdong Province [S2012010009669]; Research Fund for Subject and Profession development of Higher Education of Guangdong Province [2012KJCX0026]; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province [2011J2200074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Fund for Subject and Profession development of Higher Education of Guangdong Province; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province	National Natural Science Foundation of China (81272759, 81172382, 81071735); Major projects of National Natural Science Foundation of China (81090422); Natural Science Foundation of Guangdong Province (S2012010009669); Research Fund for Subject and Profession development of Higher Education of Guangdong Province (2012KJCX0026); Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province (2011J2200074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen BB, 2012, ONCOGENE, V31, P2566, DOI 10.1038/onc.2011.432; Cheng YB, 2012, CANCER METAST REV, V31, P75, DOI 10.1007/s10555-011-9330-z; Cho HJ, 2010, MOL CELLS, V30, P355, DOI 10.1007/s10059-010-0134-8; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Guo Z, 2012, BIOCHEM BIOPH RES CO, V418, P426, DOI 10.1016/j.bbrc.2012.01.054; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Jiang YF, 2000, WORLD J GASTROENTERO, V6, P61, DOI 10.3748/wjg.v6.i1.61; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li JH, 2012, J CANCER RES CLIN, V138, P763, DOI 10.1007/s00432-012-1154-x; Li JQ, 2004, INT J ONCOL, V25, P87; Li KW, 2012, HEPATO-GASTROENTEROL, V59, P1944, DOI 10.5754/hge11845; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Sakata J, 2008, EJSO-EUR J SURG ONC, V34, P900, DOI 10.1016/j.ejso.2008.01.031; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Vaites LP, 2011, MOL CELL BIOL, V31, P4513, DOI 10.1128/MCB.05733-11; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yang YB, 2007, SURGERY, V141, P196, DOI 10.1016/j.surg.2006.06.033; Yano H, 2008, MOL BIOL CELL, V19, P822, DOI 10.1091/mbc.E07-08-0763; Yokobori T, 2012, INT J ONCOL, V41, P253, DOI 10.3892/ijo.2012.1436; Zhou J, 2006, HEPATO-GASTROENTEROL, V53, P275	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e65495	10.1371/journal.pone.0065495	http://dx.doi.org/10.1371/journal.pone.0065495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826080	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000004
J	Benkwitt, CE				Benkwitt, Cassandra E.			Density-Dependent Growth in Invasive Lionfish (Pterois volitans)	PLOS ONE			English	Article							POPULATION REGULATION; LIFE-HISTORY; FISH; MORTALITY; PREDATION; CONSEQUENCES; SCALE; SPP.	Direct demographic density dependence is necessary for population regulation and is a central concept in ecology, yet has not been studied in many invasive species, including any invasive marine fish. The red lionfish (Pterois volitans) is an invasive predatory marine fish that is undergoing exponential population growth throughout the tropical western Atlantic. Invasive lionfish threaten coral-reef ecosystems, but there is currently no evidence of any natural population control. Therefore, a manipulative field experiment was conducted to test for density dependence in lionfish. Juvenile lionfish densities were adjusted on small reefs and several demographic rates (growth, recruitment, immigration, and loss) were measured throughout an 8-week period. Invasive lionfish exhibited direct density dependence in individual growth rates, as lionfish grew slower at higher densities throughout the study. Individual growth in length declined linearly with increasing lionfish density, while growth in mass declined exponentially with increasing density. There was no evidence, however, for density dependence in recruitment, immigration, or loss (mortality plus emigration) of invasive lionfish. The observed density-dependent growth rates may have implications for which native species are susceptible to lionfish predation, as the size and type of prey that lionfish consume is directly related to their body size. The absence of density-dependent loss, however, contrasts with many native coral-reef fish species and suggests that for the foreseeable future manual removals may be the only effective local control of this invasion.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University	Benkwitt, CE (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	benkwitc@science.oregonstate.edu		Benkwitt, Cassandra/0000-0001-6756-7958	National Science Foundation [08-51162, 12-33027]; Division Of Ocean Sciences [1233027] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by a National Science Foundation Graduate Research Fellowship awarded to CEB and National Science Foundation research grants (08-51162 and 12-33027) awarded to M. Hixon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Allen G.R., 1973, Pacific Discovery, V26, P3; Almany GR, 2003, ECOLOGY, V84, P1920, DOI 10.1890/0012-9658(2003)084[1920:PEICRF]2.0.CO;2; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Britton JR, 2008, J APPL ICHTHYOL, V24, P694, DOI 10.1111/j.1439-0426.2008.01163.x; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Carr MH, 2002, P NATL ACAD SCI USA, V99, P11241, DOI 10.1073/pnas.162653499; Forrester GE, 2000, ECOLOGY, V81, P2416; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Frederick JL, 1997, B MAR SCI, V61, P399; Govindarajulu P, 2005, ECOL APPL, V15, P2161, DOI 10.1890/05-0486; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Gutowsky LFG, 2011, HYDROBIOLOGIA, V671, P27, DOI 10.1007/s10750-011-0701-9; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.1890/0012-9658(2002)083[1490:PRHCAC]2.0.CO;2; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hixon MA, 2012, ECOL MONOGR, V82, P467, DOI 10.1890/11-1525.1; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; Jones G.P., 1991, P294; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; KIRKPATRICK M, 1984, ECOLOGY, V65, P1874, DOI 10.2307/1937785; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; O'Neal SL, 2011, T AM FISH SOC, V140, P623, DOI 10.1080/00028487.2011.585577; Osenberg CW, 2002, ECOL LETT, V5, P715, DOI 10.1046/j.1461-0248.2002.00377.x; Overholtzer-McLeod KL, 2006, ECOLOGY, V87, P1017, DOI 10.1890/0012-9658(2006)87[1017:COPRSF]2.0.CO;2; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Raby GD, 2010, ENVIRON BIOL FISH, V89, P143, DOI 10.1007/s10641-010-9705-y; Reiskind MH, 2010, BIOL INVASIONS, V12, P2319, DOI 10.1007/s10530-009-9646-6; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Steele MA, 2005, P NATL ACAD SCI USA, V102, P13513, DOI 10.1073/pnas.0504306102; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x	41	39	41	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66995	10.1371/journal.pone.0066995	http://dx.doi.org/10.1371/journal.pone.0066995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825604	Green Published, gold			2022-12-25	WOS:000321223000057
J	Ferriere, F; Habauzit, D; Pakdel, F; Saligaut, C; Flouriot, G				Ferriere, Francois; Habauzit, Denis; Pakdel, Farzad; Saligaut, Christian; Flouriot, Gilles			Unliganded Estrogen Receptor Alpha Promotes PC12 Survival during Serum Starvation	PLOS ONE			English	Article							BREAST-CANCER; ER-ALPHA; IN-VIVO; ACTIVATION; CELLS; SRC; PHOSPHORYLATION; APOPTOSIS; BETA; DIFFERENTIATION	Many studies have reported proliferative, differentiating or protective effects of estradiol, notably through estrogen receptor alpha (ER alpha). On the contrary, the ligand-independent action of ERa is currently poorly documented notably in cell protection. The stable transfection of wild type, substituted or truncated form of ER alpha in PC12 cells (ER alpha negative cell line) lead the specific study of its ligand-independent action. Hence, we demonstrate here that, in the absence of E-2, the expression of ER alpha prevents cells from apoptosis induced by serum deprivation. This protection is not due to an ERE-mediated transcription and does not require either AF-1 or AF-2 transactivation functions. It is afforded to the Y537 residue of ERa and activation of c-Src/Stat3 signaling pathway.	[Ferriere, Francois; Habauzit, Denis; Pakdel, Farzad; Saligaut, Christian; Flouriot, Gilles] Univ Rennes 1, INSERM, U1085, Transcript Environm & Canc Grp,IRSET, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Ferriere, F (corresponding author), Univ Rennes 1, INSERM, U1085, Transcript Environm & Canc Grp,IRSET, Rennes, France.	francois.ferriere@univ-rennes1.fr	Pakdel, Farzad/K-1700-2015; saligaut, christian/K-3360-2015; Flouriot, Gilles/K-1833-2015; Ferriere, François/K-1817-2015; Habauzit, Denis/K-1779-2015	Pakdel, Farzad/0000-0002-3067-3156; Flouriot, Gilles/0000-0001-6250-4173; Ferriere, François/0000-0002-9190-2397; Habauzit, Denis/0000-0001-8101-3839	Agence National de la Recherche [NEED: CES 2008-011]; CRITT-Sante Bretagne [08007968]; INERIS [NEMO: 189]; CNRS; University of Rennes I	Agence National de la Recherche(French National Research Agency (ANR)); CRITT-Sante Bretagne; INERIS; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes I	This work was supported by grants from Agence National de la Recherche (http://www.agence-nationale-recherche.fr/; project NEED: CES 2008-011), CRITT-Sante Bretagne (http://www.critt-sante.fr/; contract: 08007968) and INERIS (http://www.ineris.fr/; project NEMO: 189). The authors also thank the CNRS and the University of Rennes I to support their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal MC, 2008, P NATL ACAD SCI USA, V105, P2433, DOI 10.1073/pnas.0712029105; ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Brendel A, 2013, RESTOR NEUROL NEUROS, V31, P199, DOI 10.3233/RNN-120272; Cardamone MD, 2009, P NATL ACAD SCI USA, V106, P7420, DOI 10.1073/pnas.0903033106; CASTORIA G, 1993, BIOCHEMISTRY-US, V32, P1740, DOI 10.1021/bi00058a007; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; FROISSARD P, 1994, NEUROCHEM INT, V24, P485, DOI 10.1016/0197-0186(94)90096-5; Gollapudi L, 1999, J NEUROSCI RES, V56, P99, DOI 10.1002/(SICI)1097-4547(19990401)56:1<99::AID-JNR13>3.0.CO;2-G; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Habauzit D, 2011, J TOXICOL ENV HEAL B, V14, P300, DOI 10.1080/10937404.2011.578554; Ju H, 2000, BIOCHEM J, V351, P257, DOI 10.1042/0264-6021:3510257; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Merot Y, 2005, J MOL ENDOCRINOL, V35, P257, DOI 10.1677/jme.1.01826; Merot Y, 2009, ENDOCRINOLOGY, V150, P200, DOI 10.1210/en.2008-0449; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oka M, 2009, J BIOL CHEM, V284, P30416, DOI 10.1074/jbc.M109.001073; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sun XG, 2010, FEBS J, V277, P4789, DOI 10.1111/j.1742-4658.2010.07884.x; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Wade CNB, 2003, ENDOCRINOLOGY, V144, P832, DOI 10.1210/en.2002-220899; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427	47	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e69081	10.1371/journal.pone.0069081	http://dx.doi.org/10.1371/journal.pone.0069081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825704	Green Published, gold			2022-12-25	WOS:000321223000132
J	Poisson, A; Ballanger, B; Metereau, E; Redoute, J; Comte, JC; Bernard, HG; Vidailhet, M; Broussolle, E; Thobois, S				Poisson, Alice; Ballanger, Benedicte; Metereau, Elise; Redoute, Jerome; Comte, Jean-Christophe; Bernard, Helene Gervais; Vidailhet, Marie; Broussolle, Emmanuel; Thobois, Stephane			A Functional Magnetic Resonance Imaging Study of Pathophysiological Changes Responsible for Mirror Movements in Parkinson's Disease	PLOS ONE			English	Article							INHIBITORY CONTROL; PREFRONTAL CORTEX; LATERAL PREMOTOR; DEFAULT MODE; NETWORK	Mirror movements correspond to involuntary movements observed in the limb contralateral to the one performing voluntary movement. They can be observed in Parkinson's disease (PD) but their pathophysiology remains unclear. The present study aims at identifying their neural correlates in PD using functional magnetic resonance imaging. Ten control subjects and 14-off drug patients with asymmetrical right-sided PD were included (8 with left-sided mirror movements during right-hand movements, and 6 without mirror movements). Between-group comparisons of BOLD signal were performed during right-hand movements and at rest (p<0.005 uncorrected). The comparison between PD patients with and without mirror movements showed that mirror movements were associated with an overactivation of the insula, precuneus/posterior cingulate cortex bilaterally and of the left inferior frontal cortex and with a deactivation of the right dorsolateral prefrontal cortex, medial prefrontal cortex, and pre-supplementary motor area and occipital cortex. These data suggest that mirror movements in Parkinson's disease are promoted by: 1- a deactivation of the non-mirroring inhibitory network (dorsolateral prefrontal cortex, pre-supplementary motor area); 2- an overactivation of prokinetic areas (notably the insula). The concomitant overactivation of a proactive inhibitory network (including the posterior cingulate cortex and precuneus) could reflect a compensatory inhibition of mirror movements.	[Poisson, Alice; Ballanger, Benedicte; Metereau, Elise; Bernard, Helene Gervais; Broussolle, Emmanuel; Thobois, Stephane] Univ Lyon, Face Med Lyon Sud Charles Merieux, Lyon, France; [Poisson, Alice; Ballanger, Benedicte; Metereau, Elise; Broussolle, Emmanuel; Thobois, Stephane] Ctr Neurosci Cognit, CNRS, UMR5229, Bron, France; [Poisson, Alice; Bernard, Helene Gervais; Broussolle, Emmanuel; Thobois, Stephane] Hospices Civils Lyon, Hosp Neurolog Pierre Wertheimer, Serv Neurol C, Lyon, France; [Ballanger, Benedicte; Metereau, Elise; Redoute, Jerome; Comte, Jean-Christophe; Bernard, Helene Gervais] CERMEP Imagerie Vivant, Lyon, France; [Vidailhet, Marie] CRICM, Fed Nurol, UMR S UPMC INSERM 975, Paris, France; Hop La Pitie Salpetriere, CNRS, UMR 7225, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Thobois, S (corresponding author), Univ Lyon, Face Med Lyon Sud Charles Merieux, Lyon, France.	stephane.thobois@chu-lyon.fr	Thobois, Stephane/H-5083-2017; Broussolle, Emmanuel/H-1592-2017; Ballanger, Benedicte/H-4446-2017; REDOUTE, Jerome/GRR-6921-2022; Metereau, Elise/G-9660-2017	Broussolle, Emmanuel/0000-0002-0410-9519; Ballanger, Benedicte/0000-0002-1901-3501; REDOUTE, Jerome/0000-0002-3741-1546; Metereau, Elise/0000-0001-6868-315X	Association France Parkinson; Societe Francaise de Neurologie	Association France Parkinson; Societe Francaise de Neurologie	This study was funded by a grant from the Association France Parkinson. A. Poisson was supported by a grant from the Societe Francaise de Neurologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Boulinguez P, 2009, CLIN NEUROPHYSIOL, V120, P730, DOI 10.1016/j.clinph.2009.02.167; BRINKMAN C, 1984, J NEUROSCI, V4, P918; CHAN JL, 1988, NEUROLOGY, V38, P59, DOI 10.1212/WNL.38.1.59; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cincotta M, 2006, MOVEMENT DISORD, V21, P1461, DOI 10.1002/mds.20972; Cincotta M, 2006, MOVEMENT DISORD, V21, P1019, DOI 10.1002/mds.20850; Cox Benjamin C, 2012, Tremor Other Hyperkinet Mov (N Y), V2, DOI 10.7916/D8VQ31DZ; Depienne C, 2012, AM J HUM GENET, V90, P301, DOI 10.1016/j.ajhg.2011.12.002; Espay AJ, 2006, J NEUROL NEUROSUR PS, V77, P1194, DOI 10.1136/jnnp.2005.086892; Espay AJ, 2005, J NEUROL NEUROSUR PS, V76, P1355, DOI 10.1136/jnnp.2005.062950; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; GarciaLarrea L, 1996, CORTEX, V32, P679, DOI 10.1016/S0010-9452(96)80038-4; Giovannelli F, 2006, EXP BRAIN RES, V175, P633, DOI 10.1007/s00221-006-0581-9; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Jahanshahi M, 1998, BRAIN, V121, P1533, DOI 10.1093/brain/121.8.1533; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Li JY, 2007, MOVEMENT DISORD, V22, P813, DOI 10.1002/mds.21386; Mayston MJ, 1997, BRAIN, V120, P1199, DOI 10.1093/brain/120.7.1199; Mayston MJ, 1999, ANN NEUROL, V45, P583, DOI 10.1002/1531-8249(199905)45:5<583::AID-ANA6>3.0.CO;2-W; Ottaviani D, 2008, MOVEMENT DISORD, V23, P253, DOI 10.1002/mds.21825; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Thobois S, 2006, CLIN THER, V28, P1, DOI 10.1016/j.clinthera.2005.12.003; Thobois S, 2000, NEUROREPORT, V11, P785, DOI 10.1097/00001756-200003200-00026; Vidal JS, 2003, J NEUROL NEUROSUR PS, V74, P1352, DOI 10.1136/jnnp.74.9.1352; WOODS BT, 1978, NEUROLOGY, V28, P1152, DOI 10.1212/WNL.28.11.1152	33	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66910	10.1371/journal.pone.0066910	http://dx.doi.org/10.1371/journal.pone.0066910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825583	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000040
J	Pirisinu, L; Nonno, R; Esposito, E; Benestad, SL; Gambetti, P; Agrimi, U; Zou, WQ				Pirisinu, Laura; Nonno, Romolo; Esposito, Elena; Benestad, Sylvie L.; Gambetti, Pierluigi; Agrimi, Umberto; Zou, Wen-Quan			Small Ruminant Nor98 Prions Share Biochemical Features with Human Gerstmann-Straussler-Scheinker Disease and Variably Protease-Sensitive Prionopathy	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; ATYPICAL SCRAPIE; PHENOTYPIC VARIABILITY; MONOCLONAL-ANTIBODIES; CLASSICAL SCRAPIE; STRAIN VARIATION; AMYLOID PROTEIN; SHEEP SCRAPIE; PRP	Prion diseases are classically characterized by the accumulation of pathological prion protein (PrPSc) with the protease resistant C-terminal fragment (PrPres) of 27-30 kDa. However, in both humans and animals, prion diseases with atypical biochemical features, characterized by PK-resistant PrP internal fragments (PrPres) cleaved at both the N and C termini, have been described. In this study we performed a detailed comparison of the biochemical features of PrPSc from atypical prion diseases including human Gerstmann-Straussler-Scheinker disease (GSS) and variably protease-sensitive prionopathy (VPSPr) and in small ruminant Nor98 or atypical scrapie. The kinetics of PrPres production and its cleavage sites after PK digestion were analyzed, along with the PrPSc conformational stability, using a new method able to characterize both protease- resistant and protease-sensitive PrPSc components. All these PrPSc types shared common and distinctive biochemical features compared to PrPSc from classical prion diseases such as sporadic Creutzfeldt-Jakob disease and scrapie. Notwithstanding, distinct biochemical signatures based on PrPres cleavage sites and PrPSc conformational stability were identified in GSS A117V, GSS F198S, GSS P102L and VPSPr, which allowed their specific identification. Importantly, the biochemical properties of PrPSc from Nor98 and GSS P102L largely overlapped, but were distinct from the other human prions investigated. Finally, our study paves the way towards more refined comparative approaches to the characterization of prions at the animal-human interface.	[Pirisinu, Laura; Nonno, Romolo; Esposito, Elena; Agrimi, Umberto] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Benestad, Sylvie L.] Norwegian Vet Inst, Oslo, Norway; [Gambetti, Pierluigi; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Dept Pathol, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA	Istituto Superiore di Sanita (ISS); Norwegian Veterinary Institute; Case Western Reserve University	Pirisinu, L (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	laura.pirisinu@iss.it; wenquan.zou@case.edu	Agrimi, Umberto/C-9956-2015; NONNO, ROMOLO/C-8323-2015; PIRISINU, LAURA/C-8993-2015; Zou, Wenquan/ABF-2875-2020; Zou, Wenquan/GWQ-3489-2022	Agrimi, Umberto/0000-0001-7828-0186; NONNO, ROMOLO/0000-0001-7556-1564; PIRISINU, LAURA/0000-0002-6548-8225; 	Italian Ministry of Health [RF-2009-1474624]; European Union (Neuroprion Network of Excellence) [CT-2004-506579]; National Institutes of Health (NIH) [NS062787]; NIH [AG-08012, AG-14359]; Alliance BioSecure; Center for Disease Control and Prevention [UR8/CCU515004]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359, P50AG008012] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); European Union (Neuroprion Network of Excellence)(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance BioSecure; Center for Disease Control and Prevention; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Italian Ministry of Health (RF-2009-1474624); the European Union (Neuroprion Network of Excellence CT-2004-506579); the National Institutes of Health (NIH) NS062787, NIH AG-08012, AG-14359; Alliance BioSecure, as well as the Center for Disease Control and Prevention Contract UR8/CCU515004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arsac JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007300; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; BAKER HF, 1990, BRAIN, V113, P1891, DOI 10.1093/brain/113.6.1891; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Choi YP, 2010, J VIROL, V84, P12030, DOI 10.1128/JVI.01057-10; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Colussi S, 2008, J GEN VIROL, V89, P3173, DOI 10.1099/vir.0.2008/004150-0; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; European Commission D-GfHaC Directorate G-Veterinary and International Affairs Unit G4-Food Alert System and Training, 2011, REP MON TEST RUM PRE; Everest SJ, 2006, J GEN VIROL, V87, P471, DOI 10.1099/vir.0.81539-0; Fediaevsky A, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-9; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gambetti P, 2011, J MOL NEUROSCI, V45, P422, DOI 10.1007/s12031-011-9543-1; Gielbert A, 2009, J MASS SPECTROM, V44, P384, DOI 10.1002/jms.1516; Gotte DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027510; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; Griffiths PC, 2010, J GEN VIROL, V91, P2132, DOI 10.1099/vir.0.018986-0; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kittelberger R, 2010, J VET DIAGN INVEST, V22, P863, DOI 10.1177/104063871002200604; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Loiacono CM, 2009, J VET DIAGN INVEST, V21, P454, DOI 10.1177/104063870902100406; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Mazza M, 2010, RES VET SCI, V88, P478, DOI 10.1016/j.rvsc.2009.11.015; McIntyre KM, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-13; Migliore S, 2012, J GEN VIROL, V93, P450, DOI 10.1099/vir.0.035469-0; Miller MB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002128; Mitchell GB, 2010, J VET DIAGN INVEST, V22, P408, DOI 10.1177/104063871002200310; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Muramoto T, 2000, NEUROSCI LETT, V288, P179, DOI 10.1016/S0304-3940(00)01232-5; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; O'Rourke KI, 1998, J CLIN MICROBIOL, V36, P1750; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Piccardo P, 1996, J NEUROPATH EXP NEUR, V55, P1157, DOI 10.1097/00005072-199611000-00007; Piccardo P, 2001, AM J PATHOL, V158, P2201, DOI 10.1016/S0002-9440(10)64692-5; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Pirisinu L, 2011, EMERG INFECT DIS, V17, P695, DOI 10.3201/eid1704.101215; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Tang Y, 2012, J IMMUNOL METHODS, V380, P30, DOI 10.1016/j.jim.2012.03.004; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tranulis MA, 2011, TOP CURR CHEM, V305, P23, DOI 10.1007/128_2011_161; Vulin J, 2011, EMERG INFECT DIS, V17, P55, DOI 10.3201/eid1701.100891; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Wemheuer WM, 2009, AM J PATHOL, V175, P2566, DOI 10.2353/ajpath.2009.090623; Xiao XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058786; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	85	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66405	10.1371/journal.pone.0066405	http://dx.doi.org/10.1371/journal.pone.0066405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826096	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400018
J	Okada, K; Venezia, JH; Matchin, W; Saberi, K; Hickok, G				Okada, Kayoko; Venezia, Jonathan H.; Matchin, William; Saberi, Kourosh; Hickok, Gregory			An fMRI Study of Audiovisual Speech Perception Reveals Multisensory Interactions in Auditory Cortex	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; VISUAL SPEECH; INTEGRATION; FACES; ACTIVATION; VOICES	Research on the neural basis of speech-reading implicates a network of auditory language regions involving inferior frontal cortex, premotor cortex and sites along superior temporal cortex. In audiovisual speech studies, neural activity is consistently reported in posterior superior temporal Sulcus (pSTS) and this site has been implicated in multimodal integration. Traditionally, multisensory interactions are considered high-level processing that engages heteromodal association cortices (such as STS). Recent work, however, challenges this notion and suggests that multisensory interactions may occur in low-level unimodal sensory cortices. While previous audiovisual speech studies demonstrate that high-level multisensory interactions occur in pSTS, what remains unclear is how early in the processing hierarchy these multisensory interactions may occur. The goal of the present fMRI experiment is to investigate how visual speech can influence activity in auditory cortex above and beyond its response to auditory speech. In an audiovisual speech experiment, subjects were presented with auditory speech with and without congruent visual input. Holding the auditory stimulus constant across the experiment, we investigated how the addition of visual speech influences activity in auditory cortex. We demonstrate that congruent visual speech increases the activity in auditory cortex.	[Okada, Kayoko; Venezia, Jonathan H.; Matchin, William; Saberi, Kourosh; Hickok, Gregory] Univ Calif Irvine, Dept Cognit Sci, Ctr Cognit Neurosci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hickok, G (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Ctr Cognit Neurosci, Irvine, CA 92717 USA.	greg.hickok@uci.edu	Saberi, Kourosh/GXG-0944-2022; Venezia, Jonathan/AAD-1296-2019	Matchin, William/0000-0002-2530-8429	National Institutes of Health [DC003681]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009659, R01DC003681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was funded by National Institutes of Health (DC003681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer ET, 2007, J SPEECH LANG HEAR R, V50, P1157, DOI 10.1044/1092-4388(2007/080); Balk MH, 2010, NEUROREPORT, V21, P822, DOI 10.1097/WNR.0b013e32833d138f; Beauchamp MS, 2010, J NEUROSCI, V30, P2414, DOI 10.1523/JNEUROSCI.4865-09.2010; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bernstein LE, 2002, NEUROREPORT, V13, P311, DOI 10.1097/00001756-200203040-00013; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Falchier A, 2002, J NEUROSCI, V22, P5749; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Hertrich I, 2011, J COGNITIVE NEUROSCI, V23, P221, DOI 10.1162/jocn.2010.21421; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Joassin F, 2011, CORTEX, V47, P367, DOI 10.1016/j.cortex.2010.03.003; Joassin F, 2011, NEUROIMAGE, V54, P1654, DOI 10.1016/j.neuroimage.2010.08.073; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; MacSweeney A, 2000, NEUROREPORT, V11, pCOVER3; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mottonen R, 2004, NEUROSCI LETT, V363, P112, DOI 10.1016/j.neulet.2004.03.076; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Nath AR, 2011, J NEUROSCI, V31, P1704, DOI 10.1523/JNEUROSCI.4853-10.2011; Okada K, 2009, NEUROSCI LETT, V452, P219, DOI 10.1016/j.neulet.2009.01.060; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; Strelnikov K, 2009, SCAND J PSYCHOL, V50, P437, DOI 10.1111/j.1467-9450.2009.00741.x; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Szycik GR, 2008, BRAIN RES, V1220, P142, DOI 10.1016/j.brainres.2007.08.027; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4	44	36	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e68959	10.1371/journal.pone.0068959	http://dx.doi.org/10.1371/journal.pone.0068959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805332	gold, Green Published			2022-12-25	WOS:000320846500161
J	Huibers, RP; Loonen, AEHM; Gao, DL; Van den Ackerveken, G; Visser, RGF; Bai, YL				Huibers, Robin P.; Loonen, Annelies E. H. M.; Gao, Dongli; Van den Ackerveken, Guido; Visser, Richard G. F.; Bai, Yuling			Powdery Mildew Resistance in Tomato by Impairment of SlPMR4 and SlDMR1	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DISEASE RESISTANCE; ARABIDOPSIS MUTANTS; TARGETED MUTAGENESIS; GENE; PLANTS; PATHOGENESIS; MUTATION	Genetic dissection of disease susceptibility in Arabidopsis to powdery and downy mildew has identified multiple susceptibility (S) genes whose impairment results in disease resistance. Although several of these S-genes have been cloned and characterized in more detail it is unknown to which degree their function in disease susceptibility is conserved among different plant species. Moreover, it is unclear whether impairment of such genes has potential in disease resistance breeding due to possible fitness costs associated with impaired alleles. Here we show that the Arabidopsis PMR4 and DMR1, genes encoding a callose synthase and homoserine kinase respectively, have functional orthologs in tomato with respect to their S-gene function. Silencing of both genes using RNAi resulted in resistance to the tomato powdery mildew fungus Oidium neolycopersici. Resistance to O. neolycopersici by SlDMR1 silencing was associated with severely reduced plant growth whereas SlPMR4 silencing was not. SlPMR4 is therefore a suitable candidate gene as target for mutagenesis to obtain alleles that can be deployed in disease resistance breeding of tomato.	[Huibers, Robin P.; Loonen, Annelies E. H. M.; Gao, Dongli; Visser, Richard G. F.; Bai, Yuling] Univ Wageningen & Res Ctr, Lab Plant Breeding, Wageningen, Netherlands; [Van den Ackerveken, Guido] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Bai, YL (corresponding author), Univ Wageningen & Res Ctr, Lab Plant Breeding, Wageningen, Netherlands.	Bai.Yuling@wur.nl	Visser, Richard GF/B-3423-2012; Van den Ackerveken, Guido/B-8568-2011	Visser, Richard GF/0000-0002-0213-4016; Van den Ackerveken, Guido/0000-0002-0183-8978				Bai YL, 2005, MOL PLANT MICROBE IN, V18, P354, DOI 10.1094/MPMI-18-0354; Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Gollner K, 2008, NEW PHYTOL, V177, P725, DOI 10.1111/j.1469-8137.2007.02339.x; GREENBERG JT, 1993, PLANT J, V4, P327, DOI 10.1046/j.1365-313X.1993.04020327.x; Heilersig HJB, 2006, PLANT MOL BIOL, V60, P647, DOI 10.1007/s11103-005-5280-6; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; Lyngkjaer MF, 2000, AGRONOMIE, V20, P745, DOI 10.1051/agro:2000173; Lyznik LA, 2012, METHODS MOL BIOL, V847, P399, DOI 10.1007/978-1-61779-558-9_32; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pavan S, 2011, THEOR APPL GENET, V123, P1425, DOI 10.1007/s00122-011-1677-6; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stuttmann J, 2011, PLANT CELL, V23, P2788, DOI 10.1105/tpc.111.087684; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107	29	59	63	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67467	10.1371/journal.pone.0067467	http://dx.doi.org/10.1371/journal.pone.0067467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818978	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800135
J	Maekawa, R; Sato, S; Yamagata, Y; Asada, H; Tamura, I; Lee, L; Okada, M; Tamura, H; Takaki, E; Nakai, A; Sugino, N				Maekawa, Ryo; Sato, Shun; Yamagata, Yoshiaki; Asada, Hiromi; Tamura, Isao; Lee, Lifa; Okada, Maki; Tamura, Hiroshi; Takaki, Eiichi; Nakai, Akira; Sugino, Norihiro			Genome-Wide DNA Methylation Analysis Reveals a Potential Mechanism for the Pathogenesis and Development of Uterine Leiomyomas	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; GLUTATHIONE-S-TRANSFERASE; GENE-EXPRESSION; X-CHROMOSOME; EPIGENETIC REGULATION; RISK-FACTORS; INACTIVE-X; FIBROIDS; IRS-1	Background: The pathogenesis of uterine leiomyomas, the most common benign tumor in women, remains unclear. Since acquired factors such as obesity, hypertension and early menarche place women at greater risk for uterine leiomyomas, uterine leiomyomas may be associated with epigenetic abnormalities that are caused by unfavorable environmental exposures. Principal Findings: Profiles of genome-wide DNA methylation and mRNA expression were investigated in leiomyomas and in myometrium with and without leiomyomas. Profiles of DNA methylation and mRNA expression in the myometrium with and without leiomyomas were quite similar while those in leiomyomas were distinct. We identified 120 genes whose DNA methylation and mRNA expression patterns differed between leiomyomas and the adjacent myometrium. The biological relevance of the aberrantly methylated and expressed genes was cancer process, including IRS1 that is related to transformation, and collagen-related genes such as COL4A1, COL4A2 and COL6A3. We also detected 22 target genes of estrogen receptor (ER) alpha, including apoptosis-related genes, that have aberrant DNA methylation in the promoter, suggesting that the aberrant epigenetic regulation of ER alpha-target genes contributes to the aberrant response to estrogen. Conclusions: Aberrant DNA methylation and its related transcriptional aberration were associated with cancer processes, which may represent a critical initial mechanism that triggers transformation of a single tumor stem cell that will eventually develop into a monoclonal leiomyoma tumor. The aberrant epigenetic regulation of ER alpha-target genes also may contribute to the aberrant response to estrogen, which is involved in the development of uterine leiomyomas after menarche.	[Maekawa, Ryo; Sato, Shun; Yamagata, Yoshiaki; Asada, Hiromi; Tamura, Isao; Lee, Lifa; Okada, Maki; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan; [Takaki, Eiichi; Nakai, Akira] Yamaguchi Univ, Dept Biochem & Mol Biol, Grad Sch Med, Ube, Yamaguchi 755, Japan	Yamaguchi University; Yamaguchi University	Sugino, N (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan.	sugino@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X	Japan Society for the Promotion of Science KAKENHI [23791846, 23890140, 24592471]; Ministry of Education, Science, and Culture, Japan [24791704]; Grants-in-Aid for Scientific Research [24791704] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant Number 23791846, 23890140, 24592471, and 24791704 for Scientific Research from the Ministry of Education, Science, and Culture, Japan (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 2008, MOL HUM REPROD, V14, P539, DOI 10.1093/molehr/gan045; Bajekal N, 2000, HUM REPROD UPDATE, V6, P614, DOI 10.1093/humupd/6.6.614; Bell A, 2011, CANCER-AM CANCER SOC, V117, P2898, DOI 10.1002/cncr.25818; Bernard D, 2010, AGING-US, V2, P317, DOI 10.18632/aging.100153; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cesarone G, 2006, J CELL BIOCHEM, V98, P440, DOI 10.1002/jcb.20817; Chiaffarino F, 1999, OBSTET GYNECOL, V94, P395, DOI 10.1016/S0029-7844(99)00305-1; Claus R, 2012, INT J CANCER, V131, pE138, DOI 10.1002/ijc.26429; DAMBROSIO C, 1995, CELL GROWTH DIFFER, V6, P557; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Esposito DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036190; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Faerstein E, 2001, AM J EPIDEMIOL, V153, P11, DOI 10.1093/aje/153.1.11; Faerstein E, 2001, AM J EPIDEMIOL, V153, P1, DOI 10.1093/aje/153.1.1; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Gilden M, 2012, FERTIL STERIL; Greathouse KL, 2012, MOL CANCER RES, V10, P546, DOI 10.1158/1541-7786.MCR-11-0605; Hitchler MJ, 2006, EPIGENETICS-US, V1, P163, DOI 10.4161/epi.1.4.3401; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Iwatani M, 2006, STEM CELLS, V24, P2549, DOI 10.1634/stemcells.2005-0427; Kawakami T, 2004, ONCOGENE, V23, P6163, DOI 10.1038/sj.onc.1207808; Kearns PR, 2003, BRIT J HAEMATOL, V120, P80, DOI 10.1046/j.1365-2141.2003.04039.x; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Maekawa R, 2011, J REPROD DEVELOP, V57, P604, DOI 10.1262/jrd.11-035A; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Missaoui N, 2011, PATHOL RES PRACT, V207, P37, DOI 10.1016/j.prp.2010.11.001; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Navarro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033284; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reiss K, 2012, J CELL PHYSIOL, V227, P2992, DOI 10.1002/jcp.24019; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Sirchia SM, 2005, CANCER RES, V65, P2139, DOI 10.1158/0008-5472.CAN-04-3465; Skubitz KM, 2003, CANCER, V98, P1029, DOI 10.1002/cncr.11586; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Sun M, 2001, CANCER RES, V61, P5985; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Vanharanta S, 2005, ONCOGENE, V24, P6545, DOI 10.1038/sj.onc.1208784; Weston G, 2003, MOL HUM REPROD, V9, P541, DOI 10.1093/molehr/gag066; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wu Q, 2004, BIOL REPROD, V70, P1790, DOI 10.1095/biolreprod.103.025387; Yamagata Y, 2009, MOL HUM REPROD, V15, P259, DOI 10.1093/molehr/gap010; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005	56	71	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66632	10.1371/journal.pone.0066632	http://dx.doi.org/10.1371/journal.pone.0066632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818951	gold, Green Submitted, Green Published			2022-12-25	WOS:000322342800087
J	Cassels, S; Manhart, L; Jenness, SM; Morris, M				Cassels, Susan; Manhart, Lisa; Jenness, Samuel M.; Morris, Martina			Short-term Mobility and Increased Partnership Concurrency among Men in Zimbabwe	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV-INFECTION; RESIDENTIAL-MOBILITY; MIGRATION; RISK; MIGRANT; SPREAD; POPULATION; BEHAVIOR; DISPARITIES	Background:Migration has long been understood as an underlying factor for HIV transmission, and sexual partner concurrency has been increasingly studied as an important component of HIV transmission dynamics. However, less work has examined the role of short-term mobility in sexual partner concurrency using a network approach. Short-term mobility may be a risk for HIV for the migrant's partner as well either through the partner's risk behaviors while the migrant is away, such as the partner having additional partners, or via exposure to the return migrant. Methods: Using data from the 2010-11 Zimbabwe Demographic and Health Survey, weighted generalized linear regression models were used to investigate the associations between short-term mobility and partnership concurrency at the individual and partnership levels. Results: At the individual level, we find strong evidence of an association between short-term mobility and concurrency. Men who traveled were more likely to have concurrent partnerships compared to men who did not travel and the relationship was non-linear: each trip was associated with a 2% higher probability of concurrency, with a diminishing risk at 60 trips (p<0.001). At the partnership level, short-term mobility by the male only or both partners was associated with male concurrency. Couples in which the female only traveled exhibited less male concurrency. Conclusions: Short-term mobility has the ability to impact population-level transmission dynamics by facilitating partnership concurrency and thus onward HIV transmission. Short-term migrants may be an important population to target for HIV testing, treatment, or social and behavioral interventions to prevent the spread of HIV.	[Cassels, Susan; Manhart, Lisa; Jenness, Samuel M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cassels, Susan] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cassels, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	scassels@uw.edu	Morris, Martina/I-7510-2012		NICHD [R00 HD057533, 5R24HD042828]; UW Center for AIDS Research SPRC [P30 AI027757]; UW Center for Studies in Demography and Ecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UW Center for AIDS Research SPRC; UW Center for Studies in Demography and Ecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the NICHD (R00 HD057533) and the UW Center for AIDS Research SPRC (P30 AI027757). Computing support was provided by a NICHD research infrastructure grant (5R24HD042828), to the UW Center for Studies in Demography and Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ASM, 2004, CLIN INFECT DIS, V39, P533, DOI 10.1086/422721; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anglewicz Philip, 2012, Demography, V49, P239, DOI 10.1007/s13524-011-0072-x; [Anonymous], 2007, ZIMB DEM HLTH SURV 2; Bailey JA, 2011, ARCH SEX BEHAV, V40, P951, DOI 10.1007/s10508-010-9633-0; Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Carnegie NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043048; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Feliciano C, 2005, INT MIGR REV, V39, P841, DOI 10.1111/j.1747-7379.2005.tb00291.x; Gasper J, 2010, SOC SCI RES, V39, P459, DOI 10.1016/j.ssresearch.2009.08.009; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Greif MJ, 2011, HEALTH PLACE, V17, P86, DOI 10.1016/j.healthplace.2010.08.019; Haynie DL, 2006, SOCIOL QUART, V47, P693, DOI 10.1111/j.1533-8525.2006.00063.x; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Kretzschmar M, 2010, AIDS, V24, P313, DOI 10.1097/QAD.0b013e328333eb9d; Kwena ZA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054523; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Lee D, 2007, AM J DRUG ALCOHOL AB, V33, P799, DOI 10.1080/00952990701653727; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M., 2012, 19 INT AIDS C WASH D; Morris M, 2010, 18 INT AIDS C VIENN; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Mundandi C, 2006, TROP MED INT HEALTH, V11, P705, DOI 10.1111/j.1365-3156.2006.01614.x; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Sambisa W, 2006, RURAL SOCIOL, V71, P183, DOI 10.1526/003601106777789684; Thomas KJA, 2012, DEMOGRAPHY, V49, P477, DOI 10.1007/s13524-012-0091-2; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Walker PT, 2008, SEX TRANSM INFECT, V84, pII42, DOI 10.1136/sti.2008.029975; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	46	21	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66342	10.1371/journal.pone.0066342	http://dx.doi.org/10.1371/journal.pone.0066342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23824635	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400090
J	Gao, H; Meng, J; Xu, MJ; Zhang, S; Ghose, B; Liu, J; Yao, P; Yan, H; Wang, D; Liu, LG				Gao, Hui; Meng, Jie; Xu, Mengjing; Zhang, Shun; Ghose, Bishwajit; Liu, Jun; Yao, Ping; Yan, Hong; Wang, Di; Liu, Liegang			Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population	PLOS ONE			English	Article							GRADE CHRONIC INFLAMMATION; HEAT-SHOCK PROTEINS; INSULIN-RESISTANCE; SYNDROME PCOS; OXIDATIVE STRESS; LEAN WOMEN; HSP70; EXPRESSION; MARKERS; HEALTH	Background: Polycystic ovary syndrome (PCOS) represents the most common cause of anovulatory infertility and affects 6-15% of women of reproductive age. However, the underlying etiology is still poorly understood. In this study, we attempted to examine the association between circulating heat shock protein 70 (Hsp70) concentrations and PCOS in a non-obese Chinese population. Methods and Results: Human peripheral blood from 52 patients with PCOS and 57 healthy controls, matched for age and BMI, were analyzed. Women with PCOS were found to have significantly higher fasting insulin (FI) levels, as well as Insulin resistance index (HOMA-IR) (P < 0.05). Identically, markers of oxidative stress (malondialdehyde (MDA), 8-Hydroxy-desoxyguanosine (8-OHdG), Nitric oxide (NO)) and inflammation (tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP)) were markedly increased when compared to controls (P < 0.05). Elevated serum Hsp70 was positively correlated with IR, oxidative stress and inflammation in PCOS, even after adjustment for age, BMI and gynecologic inflammation (GI). The receiver-operating characteristic curve (ROC) analysis yielded notably different discriminative value for PCOS, with or without an addition of Hsp70 (areas under the curves were 0.884 (95% CI 0.822-0.946) vs. 0.822 (95% CI 0.744-0.900); P for difference = 0.015). Conclusions and Significance: Increased serum Hsp70 levels are associated with the combination of IR, oxidative stress and low-grade chronic inflammation in PCOS individuals, which provides supportive evidence that Hsp70 plays a key role in the pathogenesis of PCOS. More consequent studies were warranted to confirm the clinical utility of circulating Hsp70, especially in diagnosis and prognosis of PCOS and its long-term health cost.	[Gao, Hui; Xu, Mengjing; Ghose, Bishwajit; Liu, Jun; Yao, Ping; Wang, Di; Liu, Liegang] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Peoples R China; [Gao, Hui; Xu, Mengjing; Zhang, Shun; Ghose, Bishwajit; Liu, Jun; Yao, Ping; Yan, Hong; Wang, Di; Liu, Liegang] Huazhong Univ Sci & Technol, MOE Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Di] Xiangyang Food & Drug Adm, Xiangyang, Peoples R China; [Meng, Jie] Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, D (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Peoples R China.	wad1983@126.com; lgliu@mails.tjmu.edu.cn	Ghose, Bishwajit/L-8479-2015; Zhang, Shun/AHD-3782-2022	Ghose, Bishwajit/0000-0003-4461-3821; 	National Science and Technology Support Program of China [2012BAI02B02]; National Natural Science Foundation of China [81202210]	National Science and Technology Support Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science and Technology Support Program of China (2012BAI02B02) and National Natural Science Foundation of China (No. 81202210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Bironaite D, 2013, J CELL BIOCH; Black MH, 2013, J NUTR, V143, P479, DOI 10.3945/jn.112.170449; Bozdag G, 2010, EXPERT REV OBSTET GY, V5, P67, DOI [10.1586/eog.09.73, DOI 10.1586/E0G.09.73]; Chae JI, 2013, INT J CARDIOL, V165, P341, DOI 10.1016/j.ijcard.2012.07.013; Chittenden BG, 2009, REPROD BIOMED ONLINE, V19, P398, DOI 10.1016/S1472-6483(10)60175-7; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gambineri A, 2012, DIABETES, V61, P2369, DOI 10.2337/db11-1360; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Gonzalez F, 2009, METABOLISM, V58, P954, DOI 10.1016/j.metabol.2009.02.022; JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Karadeniz M, 2008, EXP CLIN ENDOCR DIAB, V116, P231, DOI 10.1055/s-2007-992154; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Kurucz I, 2002, DIABETES, V51, P1102, DOI 10.2337/diabetes.51.4.1102; Lavie L, 2010, J SLEEP RES, V19, P139, DOI 10.1111/j.1365-2869.2009.00789.x; Liu Jin, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P187; Malyshev I., 2013, IMMUNITY TUMORS AGIN, V6, P113, DOI [10.1111/j.1365- 2702.2009.02945.x, DOI 10.1111/J.1365-2702.2009.02945.X]; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Marucci A, 2009, J MOL MED, V87, P139, DOI 10.1007/s00109-008-0429-9; McCarty MF, 2006, MED HYPOTHESES, V66, P527, DOI 10.1016/j.mehy.2004.08.033; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Molvarec A, 2010, CELL STRESS CHAPERON, V15, P237, DOI 10.1007/s12192-009-0146-5; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Murri M, 2013, HUM REPROD UPDATE, V19, P268, DOI 10.1093/humupd/dms059; Nakhjavani M, 2012, GENE, V498, P107, DOI 10.1016/j.gene.2012.01.085; Nakhjavani M, 2010, CELL STRESS CHAPERON, V15, P959, DOI 10.1007/s12192-010-0204-z; Narayansingh RM, 2004, CAN J PHYSIOL PHARM, V82, P363, DOI [10.1139/y04-032, 10.1139/Y04-032]; Nestler JE, 1997, J CLIN ENDOCR METAB, V82, P4075, DOI 10.1210/jc.82.12.4075; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Shumak SL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b954; Tarkun I, 2004, J CLIN ENDOCR METAB, V89, P5592, DOI 10.1210/jc.2004-0751; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Teede HJ, 2010, FERTIL STERIL, V93, P184, DOI 10.1016/j.fertnstert.2008.09.034; Terry DF, 2004, ANN NY ACAD SCI, V1019, P502, DOI 10.1196/annals.1297.092; Vince RV, 2010, AMINO ACIDS, V38, P1423, DOI 10.1007/s00726-009-0354-4; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Wijeyaratne CN, 2011, HUM REPROD, V26, P202, DOI 10.1093/humrep/deq310; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Zhang XM, 2010, CELL STRESS CHAPERON, V15, P675, DOI 10.1007/s12192-010-0180-3; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	50	19	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67727	10.1371/journal.pone.0067727	http://dx.doi.org/10.1371/journal.pone.0067727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825680	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400192
J	Hunsicker, ME; Ciannelli, L; Bailey, KM; Zador, S; Stige, LC				Hunsicker, Mary E.; Ciannelli, Lorenzo; Bailey, Kevin M.; Zador, Stephani; Stige, Leif Christian			Climate and Demography Dictate the Strength of Predator-Prey Overlap in a Subarctic Marine Ecosystem	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; EASTERN BERING-SEA; FUTURE CLIMATE; RECRUITMENT; SHIFTS; DISTRIBUTIONS; CANNIBALISM; TEMPERATURE; ABUNDANCE; SURVIVAL	There is growing evidence that climate and anthropogenic influences on marine ecosystems are largely manifested by changes in species spatial dynamics. However, less is known about how shifts in species distributions might alter predator-prey overlap and the dynamics of prey populations. We developed a general approach to quantify species spatial overlap and identify the biotic and abiotic variables that dictate the strength of overlap. We used this method to test the hypothesis that population abundance and temperature have a synergistic effect on the spatial overlap of arrowtooth flounder (predator) and juvenile Alaska walleye pollock (prey, age-1) in the eastern Bering Sea. Our analyses indicate that (1) flounder abundance and temperature are key variables dictating the strength of flounder and pollock overlap, (2) changes in the magnitude of overlap may be largely driven by density-dependent habitat selection of flounder, and (3) species overlap is negatively correlated to juvenile pollock recruitment when flounder biomass is high. Overall, our findings suggest that continued increases in flounder abundance coupled with the predicted long-term warming of ocean temperatures could have important implications for the predator-prey dynamics of arrowtooth flounder and juvenile pollock. The approach used in this study is valuable for identifying potential consequences of climate variability and exploitation on species spatial dynamics and interactions in many marine ecosystems.	[Hunsicker, Mary E.; Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Bailey, Kevin M.; Zador, Stephani] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Stige, Leif Christian] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Oslo	Hunsicker, ME (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	hunsicker@nceas.ucsb.edu	Stige, Leif Christian/P-6806-2015	Stige, Leif Christian/0000-0002-6808-1383	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; Research Council of Norway	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; Research Council of Norway(Research Council of Norway)	The National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) (http://cameo.noaa.gov/) program funded MEH, LC, and KMB for this work and the Research Council of Norway provided support for LCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E, 2008, AFSC181 NOAA NMFS US; [Anonymous], 2004, NMFSFSPO65 NOAA US D; Armistead CE, 1993, AFSC7 NOAA NMFS US D; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Bailey KM, 2012, MAR ECOL PROG SER, V452, P205, DOI 10.3354/meps09614; BAILEY KM, 1989, MAR ECOL PROG SER, V53, P205, DOI 10.3354/meps053205; Bailey KM, 2000, MAR ECOL PROG SER, V198, P215, DOI 10.3354/meps198215; Boldt JL, 2012, FISH B-NOAA, V110, P293; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Ciannelli L, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P143; Ciannelli L, 2005, MAR ECOL PROG SER, V291, P227, DOI 10.3354/meps291227; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Duffy-Anderson JT, 2003, BIG FISH BANG, P381; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; HOLLOWED AB, 1992, ICES MAR SC, V195, P433; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Ianelli J.N., 2011, STOCK ASSESSMENT FIS; Kotwicki S, 2005, FISH B-NOAA, V103, P574; Mueter FJ, 2006, PROG OCEANOGR, V68, P152, DOI 10.1016/j.pocean.2006.02.012; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Spencer PD, 2008, FISH OCEANOGR, V17, P396, DOI 10.1111/j.1365-2419.2008.00486.x; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Swain DP, 2006, FISH OCEANOGR, V15, P166, DOI 10.1111/j.1365-2419.2006.00357.x; Wang MY, 2012, DEEP-SEA RES PT II, V65-70, P46, DOI 10.1016/j.dsr2.2012.02.022; Wespestad VG, 2000, ICES J MAR SCI, V57, P272, DOI 10.1006/jmsc.2000.0640; Wilderbuer T.K., 2010, STOCK ASSESSMENT FIS; Wilderbuer TK, 2002, STOCK ASSESSMENT FIS; WILLIAMSON CE, 1993, ECOLOGY, V74, P320, DOI 10.2307/1939295; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wyllie-Echeverria T, 1998, FISH OCEANOGR, V7, P159, DOI 10.1046/j.1365-2419.1998.00058.x; Zador S, 2011, MAR ECOL PROG SER, V438, P229, DOI 10.3354/meps09316	46	39	39	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66025	10.1371/journal.pone.0066025	http://dx.doi.org/10.1371/journal.pone.0066025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824707	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400047
J	Kalhori, V; Kemppainen, K; Asghar, MY; Bergelin, N; Jaakkola, P; Tornquist, K				Kalhori, Veronica; Kemppainen, Kati; Asghar, Muhammad Yasir; Bergelin, Nina; Jaakkola, Panu; Tornquist, Kid			Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1 alpha in Thyroid Follicular Carcinoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROTEIN-COUPLED RECEPTOR; P70 S6 KINASE; SPHINGOSINE 1-PHOSPHATE; FACTOR 1-ALPHA; HIF-ALPHA; PHOSPHORYLATION; EXPRESSION; ACTIVATION; EIF4E	Sphingosine-1-phosphate (S1P) is a bioactive lipid, which regulates several cancer-related processes including migration and angiogenesis. We have previously shown S1P to induce migration of follicular ML-1 thyroid cancer cells. Hypoxia-induced factor-1 (HIF-1) is an oxygen-sensitive transcription factor, which adapts cells to hypoxic conditions through increased survival, motility and angiogenesis. Due to these properties and its increased expression in response to intratumoral hypoxia, HIF-1 is considered a significant regulator of tumor biology. We found S1P to increase expression of the regulatory HIF-1 alpha subunit in normoxic ML-1 cells. S1P also increased HIF-1 activity and expression of HIF-1 target genes. Importantly, inhibition or knockdown of HIF-1 alpha attenuated the S1P-induced migration of ML-1 cells. S1P-induced HIF-1 alpha expression was mediated by S1P receptor 3 (S1P(3)), G(i) proteins and their downstream effectors MEK, PI3K, mTOR and PKC beta I. Half-life measurements with cycloheximide indicated that S1P treatment stabilized the HIF-1 alpha protein. On the other hand, S1P activated translational regulators eIF-4E and p70S6K, which are known to control HIF-1 alpha synthesis. In conclusion, we have identified S1P as a non-hypoxic regulator of HIF-1 activity in thyroid cancer cells, studied the signaling involved in S1P-induced HIF-1 alpha expression and shown S1P-induced migration to be mediated by HIF-1.	[Kalhori, Veronica; Kemppainen, Kati; Asghar, Muhammad Yasir; Bergelin, Nina; Tornquist, Kid] Abo Akad Univ, Dept Biosci, Turku, Finland; [Kalhori, Veronica; Bergelin, Nina; Tornquist, Kid] Minerva Fdn Inst, Helsinki, Finland; [Jaakkola, Panu] Turku Ctr Biotechnol, Turku, Finland	Abo Akademi University; University of Turku	Tornquist, K (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	ktornqvi@abo.fi	Jaakkola, Panu M/B-4355-2012; Asghar, Muhammad Yasir/AAX-4895-2020	Asghar, Muhammad Yasir/0000-0002-1935-8462; Jaakkola, Panu/0000-0002-2365-4985; Kemppainen, Kati/0000-0003-3785-2269	Sigrid Juselius Foundation; Liv och Halsa Foundation; Academy of Finland; Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); cancer research funds; Magnus Ehrnrooth's Foundationand; Suomen Kulttuurirahasto Foundation; Stiftelsens for Abo Akademi forskningsinstitute; K. Albin Johanssos stiftelse; Receptor Research Program (Abo Akademi University); Receptor Research Program (University of Turku)	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa Foundation; Academy of Finland(Academy of Finland); Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); cancer research funds; Magnus Ehrnrooth's Foundationand; Suomen Kulttuurirahasto Foundation; Stiftelsens for Abo Akademi forskningsinstitute; K. Albin Johanssos stiftelse; Receptor Research Program (Abo Akademi University); Receptor Research Program (University of Turku)	The study was supported in part by the Sigrid Juselius Foundation, the Liv och Halsa Foundation, The Academy of Finland, the Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University), by cancer research funds donated to Abo Akademi University, by the Magnus Ehrnrooth's Foundationand, by the Suomen Kulttuurirahasto Foundation, the Stiftelsens for Abo Akademi forskningsinstitute, K. Albin Johanssos stiftelse and the Receptor Research Program (Abo Akademi University and the University of Turku), which are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Balthasar S, 2008, ENDOCR-RELAT CANCER, V15, P521, DOI 10.1677/ERC-07-0253; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Bergelin N, 2009, ENDOCRINOLOGY, V150, P2055, DOI 10.1210/en.2008-0625; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Burrows N, 2010, ENDOCR-RELAT CANCER, V17, P61, DOI 10.1677/ERC-08-0251; Chae SS, 2004, DEV BIOL, V268, P441, DOI 10.1016/j.ydbio.2004.01.001; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goodfellow IG, 2008, INT J BIOCHEM CELL B, V40, P2675, DOI 10.1016/j.biocel.2007.10.023; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Herr B, 2009, BLOOD, V114, P2140, DOI 10.1182/blood-2009-01-201889; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim BS, 2011, BIOCHEM BIOPH RES CO, V413, P189, DOI 10.1016/j.bbrc.2011.08.055; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Koide Y, 2002, J MED CHEM, V45, P4629, DOI 10.1021/jm020080c; Lauzier MC, 2007, ENDOCRINOLOGY, V148, P4023, DOI 10.1210/en.2007-0285; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Michaud MD, 2009, ARTERIOSCL THROM VAS, V29, P902, DOI 10.1161/ATVBAHA.109.185280; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Schwalm S, 2008, BIOCHEM BIOPH RES CO, V368, P1020, DOI 10.1016/j.bbrc.2008.01.132; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Silva RLA, 2008, CELL CYCLE, V7, P553, DOI 10.4161/cc.7.5.5486; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	49	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66189	10.1371/journal.pone.0066189	http://dx.doi.org/10.1371/journal.pone.0066189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824493	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400065
J	Lu, P; Xia, HC; Gao, L; Pan, Y; Wang, Y; Cheng, X; Lu, HG; Lin, F; Chen, L; Yao, Q; Liu, XY; Tang, Q; Chen, KP				Lu, Peng; Xia, Hengchuan; Gao, Lu; Pan, Ye; Wang, Yong; Cheng, Xin; Lu, Honggang; Lin, Feng; Chen, Liang; Yao, Qin; Liu, Xiaoyong; Tang, Qi; Chen, Keping			V-ATPase Is Involved in Silkworm Defense Response against Bombyx mori Nucleopolyhedrovirus	PLOS ONE			English	Article							H+-ATPASE; ANTIVIRAL ACTIVITY; BACULOVIRUS; MEMBRANE; CELLS; GENE; LOCALIZATION; RESISTANCE; PHYSIOLOGY; SUBUNIT	Silkworms are usually susceptible to the infection of Bombyx mori (B. mori) nucleopolyhedrovirus (BmNPV), which can cause significant economic loss. However, some silkworm strains are identified to be highly resistant to BmNPV. To explore the silkworm genes involved in this resistance in the present study, we performed comparative real-time PCR, ATPase assay, over-expression and sub-cellular localization experiments. We found that when inoculated with BmNPV both the expression and activity of V-ATPase were significantly up-regulated in the midgut column cells (not the goblet cells) of BmNPV-resistant strains (NB and BC8), the main sites for the first step of BmNPV invasion, but not in those of a BmNPV-susceptible strain 306. Furthermore, this up-regulation mainly took place during the first 24 hours post inoculation (hpi), the essential period required for establishment of virus infection, and then was down-regulated to normal levels. Amazingly, transient overexpression of V-ATPase c subunit in BmNPV-infected silkworm cells could significantly inhibit BmNPV proliferation. To our knowledge this is the first report demonstrating clearly that V-ATPase is indeed involved in the defense response against BmNPV. Our data further suggests that prompt and potent regulation of V-ATPase may be essential for execution of this response, which may enable fast acidification of endosomes and/or lysosomes to render them competent for degradation of invading viruses.	[Lu, Peng; Wang, Yong; Cheng, Xin; Chen, Liang; Tang, Qi; Chen, Keping] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Lu, Peng; Xia, Hengchuan; Lu, Honggang; Yao, Qin; Liu, Xiaoyong; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Gao, Lu] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Pan, Ye] Jiangsu Univ, Lab Anim Res Ctr, Zhenjiang, Jiangsu, Peoples R China; [Cheng, Xin] Jiangxi Agr Univ, Nanchang Key Lab Appl Fermentat Technol, Nanchang, Peoples R China; [Lin, Feng] Zhejiang Inst Freshwater Fisheries, Huzhou, Zhejiang, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University; Jiangxi Agricultural University	Chen, KP (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China.	kpchen@ujs.edu.cn	Xia, hengchuan/GQB-2955-2022; Xia, Hengchuan/AAB-1301-2020; cheng, xin/AAN-2326-2020	Xia, hengchuan/0000-0002-5701-6092; Chen, Liang/0000-0001-7371-3130	National basic Research Program of China "973" [2012CB114604]; National Natural Science Foundation of China [31101673, 31272507]; Postgraduate Research and Innovation Project of Jiangsu Province [CXLX12-0671]	National basic Research Program of China "973"(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Innovation Project of Jiangsu Province	This work was supported by the National basic Research Program of China "973" under Grant No. 2012CB114604, the National Natural Science Foundation of China (No. 31101673, No. 31272507) and Postgraduate Research and Innovation Project of Jiangsu Province (No. CXLX12-0671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2008, INSECT BIOCHEM MOLEC, V38, P853, DOI 10.1016/j.ibmb.2008.06.004; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Chen HQ, 2007, FEBS LETT, V581, P5836, DOI 10.1016/j.febslet.2007.11.059; Chen K.P., 1991, ACTA SERICOL SIN, V17, P45; Du J, 2006, J CELL SCI, V119, P2542, DOI 10.1242/jcs.02983; Elandalloussi LM, 2005, MOL BIOCHEM PARASIT, V141, P49, DOI 10.1016/j.molbiopara.2005.02.001; Forgac M, 1999, J BIOENERG BIOMEMBR, V31, P57, DOI 10.1023/A:1005496530380; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HARVEY WR, 1992, J EXP BIOL, V172, P1; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Lee KS, 2005, INSECT BIOCHEM MOLEC, V35, P73, DOI 10.1016/j.ibmb.2004.09.008; LEIKINA E, 1992, FEBS LETT, V304, P221, DOI 10.1016/0014-5793(92)80623-O; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; LuPeng, 2007, International Journal of Industrial Entomology, V15, P115; Maeda S, 1989, GENE TRANSFER VECTOR, P167; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Selot R, 2007, BIOSCI BIOTECH BIOCH, V71, P200, DOI 10.1271/bbb.60450; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMMERS MD, 1978, VIROLOGY, V84, P390, DOI 10.1016/0042-6822(78)90257-X; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Watanabe H, 2002, CURR SCI INDIA, V83, P439; Weng XH, 2003, J EXP BIOL, V206, P2211, DOI 10.1242/jeb.00385; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang HJ, 2009, Z NATURFORSCH C, V64, P899; Yao Q, 2003, J APPL ENTOMOL, V127, P134, DOI 10.1046/j.1439-0418.2003.00741.x; Zhao GL, 2008, GENE EXPR PATTERNS, V8, P254, DOI 10.1016/j.gep.2007.12.006	36	19	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e64962	10.1371/journal.pone.0064962	http://dx.doi.org/10.1371/journal.pone.0064962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823190	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400003
J	Wang, WJ; He, HS; Spetich, MA; Shifley, SR; Thompson, FR; Fraser, JS				Wang, Wen J.; He, Hong S.; Spetich, Martin A.; Shifley, Stephen R.; Thompson, Frank R., III; Fraser, Jacob S.			Modeling the Effects of Harvest Alternatives on Mitigating Oak Decline in a Central Hardwood Forest Landscape	PLOS ONE			English	Article							SPECIES COMPOSITION; MORTALITY; ARKANSAS; INDEX	Oak decline is a process induced by complex interactions of predisposing factors, inciting factors, and contributing factors operating at tree, stand, and landscape scales. It has greatly altered species composition and stand structure in affected areas. Thinning, clearcutting, and group selection are widely adopted harvest alternatives for reducing forest vulnerability to oak decline by removing susceptible species and declining trees. However, the long-term, landscape-scale effects of these different harvest alternatives are not well studied because of the limited availability of experimental data. In this study, we applied a forest landscape model in combination with field studies to evaluate the effects of the three harvest alternatives on mitigating oak decline in a Central Hardwood Forest landscape. Results showed that the potential oak decline in high risk sites decreased strongly in the next five decades irrespective of harvest alternatives. This is because oak decline is a natural process and forest succession (e.g., high tree mortality resulting from intense competition) would eventually lead to the decrease in oak decline in this area. However, forest harvesting did play a role in mitigating oak decline and the effectiveness varied among the three harvest alternatives. The group selection and clearcutting alternatives were most effective in mitigating oak decline in the short and medium terms, respectively. The long-term effects of the three harvest alternatives on mitigating oak decline became less discernible as the role of succession increased. The thinning alternative had the highest biomass retention over time, followed by the group selection and clearcutting alternatives. The group selection alternative that balanced treatment effects and retaining biomass was the most viable alternative for managing oak decline. Insights from this study may be useful in developing effective and informed forest harvesting plans for managing oak decline.	[Wang, Wen J.; He, Hong S.; Fraser, Jacob S.] Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA; [Spetich, Martin A.] US Forest Serv, USDA, Arkansas Forestry Sci Lab, Southern Res Stn, Hot Spring, AR USA; [Shifley, Stephen R.; Thompson, Frank R., III] US Forest Serv, USDA, No Res Stn, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	He, HS (corresponding author), Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA.	heh@missouri.edu		Fraser, Jacob/0000-0002-4960-3713; He, Hong S./0000-0002-3983-2512	U.S Forest Service South Central Research Station; University of Missouri GIS Mission Enhancement Program	U.S Forest Service South Central Research Station; University of Missouri GIS Mission Enhancement Program	This research was funded by the U.S Forest Service South Central Research Station, and the University of Missouri GIS Mission Enhancement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns R.M., 1990, USDA FOREST SERVICE, V2; Burrill EA, 1999, CAN J FOREST RES, V29, P347, DOI 10.1139/cjfr-29-3-347; Chapman RA, 2006, FOREST ECOL MANAG, V236, P85, DOI 10.1016/j.foreco.2006.08.341; Clatterbuck WK, 2005, PROFESSIONAL HARDWOO; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Dijak William, 2013, Computational Ecology and Software, V3, P17; Dwyer JP, 2007, NORTH J APPL FOR, V24, P123, DOI 10.1093/njaf/24.2.123; Fan ZF, 2008, FOREST ECOL MANAG, V255, P2297, DOI 10.1016/j.foreco.2007.12.041; Fan ZF, 2011, NORTH J APPL FOR, V28, P19, DOI 10.1093/njaf/28.1.19; Foti T. L., 2004, General Technical Report - Southern Research Station, USDA Forest Service, P21; Fraser JS, 2013, CANADIAN J IN PRESS; Heitzman E, 2003, SOUTH J APPL FOR, V27, P264, DOI 10.1093/sjaf/27.4.264; Heitzman E, 2007, SOUTH J APPL FOR, V31, P17, DOI 10.1093/sjaf/31.1.17; Hulting DJ, 2006, THESIS U MISSOURI; Johnson P. S., 2009, The ecology and silviculture of oaks, DOI 10.1079/9781845934743.0000; Kabrick J. M., 2007, General Technical Report - Southern Research Station, USDA Forest Service, P181; KABRICK JM, 2004, P 14 CENTR HARDW FOR, P27; Kabrick JM, 2008, FOREST ECOL MANAG, V255, P1409, DOI 10.1016/j.foreco.2007.10.054; Kessler Jr KJ, 1992, NC362 USDA FOR SERV; Loewenstein EF, 2000, CAN J FOREST RES, V30, P1060, DOI 10.1139/cjfr-30-7-1060; Luo YQ, 2011, ECOL APPL, V21, P1429; Manion P. D., 1991, Tree disease concepts.; Manion P.D., 1992, FOREST DECLINE CONCE; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Oak S, 1996, ANN SCI FOREST, V53, P721, DOI 10.1051/forest:19960248; Oak SW, 2004, P UPL OAK EC S HIST, P217; Oliver C.D., 1996, FOREST STAND DYNAMIC; Poole E. A., 2006, General Technical Report - Southern Research Station, USDA Forest Service, P428; Reineke LH, 1933, J AGRIC RES, V46, P0627; Revised and resource management plan Ozark-ST. Francis National forests, 2005, USDA MAN B, VR8-MB 125A; Shifley SR, 2006, FOREST ECOL MANAG, V229, P16, DOI 10.1016/j.foreco.2006.03.033; Spetich M. A., 2004, P UPL OAK EC S HIST, P3; Spetich MA, 2004, P 14 CENTR HARDW FOR, P21; Spetich MA, 2008, FOREST ECOL MANAG, V254, P454, DOI 10.1016/j.foreco.2007.09.087; Starkey D. A., 2004, General Technical Report - Southern Research Station, USDA Forest Service, P217; Wang WJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00040.1; Ward JS, 2005, NORTH J APPL FOR, V22, P59, DOI 10.1093/njaf/22.1.59; Welker SL, 2008, FOREST SCI, V54, P8; Woodall CW, 2011, NRSGTR88 US FOR SERV; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107	40	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66713	10.1371/journal.pone.0066713	http://dx.doi.org/10.1371/journal.pone.0066713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825560	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400153
J	Sun, Y; Liu, PY; Scarlett, CJ; Malyukova, A; Liu, B; Marshall, GM; MacKenzie, KL; Biankin, AV; Liu, T				Sun, Y.; Liu, P. Y.; Scarlett, C. J.; Malyukova, A.; Liu, B.; Marshall, G. M.; MacKenzie, K. L.; Biankin, A. V.; Liu, T.			Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc	ONCOGENE			English	Article						N-Myc; neuroblastoma; histone deacetylase 5	EMBRYONIC STEM-CELLS; C-MYC; MUSCLE DIFFERENTIATION; GENOMIC TARGETS; PROTEIN; REPRESSION; HDAC5; TRANSCRIPTION; EXPRESSION; INHIBITORS	The N-Myc oncoprotein induces neuroblastoma, which arises from undifferentiated neuroblasts in the sympathetic nervous system, by modulating gene and protein expression and consequently causing cell differentiation block and cell proliferation. The class Ila histone deacetylase 5 (HDAC5) represses gene transcription, and blocks myoblast, osteoblast and leukemia cell differentiation. Here we showed that N-Myc upregulated HDAC5 expression in neuroblastoma cells. Conversely, HDAC5 repressed the ubiquitin-protein ligase NEDD4 gene expression, increased Aurora A gene expression and consequently upregulated N-Myc protein expression. Genome-wide gene expression analysis and protein co-immunoprecipitation assays revealed that HDAC5 and N-Myc repressed the expression of a common subset of genes by forming a protein complex, whereas HDAC5 and the class III HDAC SIRT2 independently repressed the expression of another common subset of genes without forming a protein complex. Moreover, HDAC5 blocked differentiation and induced proliferation in neuroblastoma cells. Taken together, our data identify HDAC5 as a novel co-factor in N-Myc oncogenesis, and provide the evidence for the potential application of HDAC5 inhibitors in the therapy of N-Myc-induced neuroblastoma and potentially other c-Myc-induced malignancies.	[Sun, Y.; Liu, P. Y.; Malyukova, A.; Liu, B.; Marshall, G. M.; MacKenzie, K. L.; Liu, T.] Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia; [Scarlett, C. J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Scarlett, C. J.; Biankin, A. V.] Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW, Australia; [Liu, B.] Kids Canc Alliance, Randwick, NSW, Australia; [Marshall, G. M.] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia; [Biankin, A. V.] Bankstown Hosp, Dept Surg, Bankstown, NSW, Australia; [Biankin, A. V.] Univ New S Wales, Fac Med, South Western Sydney Clin Sch, Liverpool, NSW, Australia; [Liu, T.] Univ New S Wales, UNSW Med, Sch Womens & Childrens Hlth, Randwick, NSW, Australia	Children's Cancer Institute; University of Newcastle; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Liu, T (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW 2052, Australia.	tliu@unsw.edu.au	Mackenzie, Karen/F-1310-2011; Liu, Tao/A-3922-2015; MacKenzie, Karen/N-5849-2019	Scarlett, Christopher/0000-0002-4140-7785; Biankin, Andrew/0000-0002-0362-5597; MacKenzie, Karen/0000-0003-2996-1617; Liu, Tao/0000-0001-6244-7316	National Health and Medical Research Council [1006002]; Cancer Council NSW project grant; ARC Future Fellowship; Cancer Institute New South Wales Fellowships; Cancer Research UK [17263] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW project grant(Cancer Council New South Wales); ARC Future Fellowship(Australian Research Council); Cancer Institute New South Wales Fellowships; Cancer Research UK(Cancer Research UK)	We thank Dr Eric Olsen for the HDAC5 expression constructs. This work was supported by a National Health and Medical Research Council project grant 1006002 (T Liu and CJ Scarlett) and a Cancer Council NSW project grant. T Liu is a recipient of an ARC Future Fellowship, AV Biankin and CJ Scarlett are recipients of Cancer Institute New South Wales Fellowships. Children's Cancer Institute Australia is affiliated with University of New South Wales and Sydney Children's Hospital.	Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Huang EY, 2000, GENE DEV, V14, P45; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kao HY, 2000, GENE DEV, V14, P55; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Manji SSM, 2006, J NEUROSCI RES, V83, P181, DOI 10.1002/jnr.20721; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Peixoto P, 2012, CELL DEATH DIFFER, V19, P1239, DOI 10.1038/cdd.2012.3; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Silvagno F, 2002, FEBS LETT, V532, P153, DOI 10.1016/S0014-5793(02)03667-0; SUMMERHILL EM, 1987, MOL BRAIN RES, V2, P99, DOI 10.1016/0169-328X(87)90002-7; Tee AEL, 2010, J BIOL CHEM, V285, P3561, DOI 10.1074/jbc.M109.053041; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Watamoto K, 2003, ONCOGENE, V22, P9176, DOI 10.1038/sj.onc.1206902; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	38	27	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					2987	2994		10.1038/onc.2013.253	http://dx.doi.org/10.1038/onc.2013.253			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23812427				2022-12-25	WOS:000337232200005
J	Vargas, TR; Boudoukha, S; Simon, A; Souidi, M; Cuvellier, S; Pinna, G; Polesskaya, A				Vargas, T. Rivera; Boudoukha, S.; Simon, A.; Souidi, M.; Cuvellier, S.; Pinna, G.; Polesskaya, A.			Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization	ONCOGENE			English	Article						IMP-3; IGF2BP3; cyclins D1,D3 and G1; HNRNPM; post-transcriptional regulation	RNA-BINDING-PROTEIN; ACTIN MESSENGER-RNA; UNFAVORABLE PROGNOSIS; 3 IGF2BP3; TRANSLATION; EXPRESSION; ZBP1; TRANSCRIPTION; RADIATION; SURVIVAL	RNA-binding proteins of the IMP family (insulin-like growth factor 2 (IGF2) mRNA-binding proteins 1-3) are important post-transcriptional regulators of gene expression. Multiple studies have linked high expression of IMP proteins, and especially of IMP-3, to an unfavorable prognosis in numerous types of cancer. The specific importance of IMP-3 for cancer transformation remains poorly understood. We here show that all three IMPs can directly bind the mRNAs of cyclins D1, D3 and G1 (CCND1, D3 and G1) in vivo and in vitro, and yet only IMP-3 regulates the expression of these cyclins in a significant manner in six human cancer cell lines of different origins. In the absence of IMP-3, the levels of CCND1, D3 and G1 proteins fall dramatically, and the cells accumulate in the G1 phase of the cell cycle, leading to almost complete proliferation arrest. Our results show that, compared with IMP-1 and IMP2, IMP-3 is enriched in the nucleus, where it binds the transcripts of CCND1, D3 and G1. The nuclear localization of IMP-3 depends on its protein partner HNRNPM and is indispensable for the post-transcriptional regulation of expression of the cyclins. Cytoplasmic retention of IMP-3 and HNRNPM in human cancer cells leads to significant drop in proliferation. In conclusion, a nuclear IMP-3-HNRNPM complex is important for the efficient synthesis of CCND1, D3 and G1 and for the proliferation of human cancer cells.	[Vargas, T. Rivera; Boudoukha, S.; Simon, A.; Cuvellier, S.; Pinna, G.; Polesskaya, A.] CNR, FRE 3377, Gif Sur Yvette, France; [Vargas, T. Rivera; Boudoukha, S.; Simon, A.; Souidi, M.; Pinna, G.; Polesskaya, A.] Univ Paris 11, FRE 3377, Gif Sur Yvette, France; [Vargas, T. Rivera; Boudoukha, S.; Simon, A.; Souidi, M.; Pinna, G.; Polesskaya, A.] CEA, FRE 3377, Gif Sur Yvette, France; [Boudoukha, S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Cuvellier, S.] Inserm, Inst Cochin, Dept Genet & Dev, U1016, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Polesskaya, A (corresponding author), CEA Saclay, CNRS, IBiTeC S, SBIGeM,FRE 3377, Bat 144,P 65, F-91191 Gif Sur Yvette, France.	anna.polesskaya@cea.fr	SOUIDI, Mouloud/ABI-1444-2020	PINNA, Guillaume/0000-0001-7841-7250	Association Francais contre les Myopathies; Fondation ARC pour la Recherche sur le Cancer	Association Francais contre les Myopathies(Association Francaise contre les Myopathies); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	We thank Drs Annick Harel-Bellan and Linda L Pritchard for critical reading of the manuscript, Drs Jan Christianssen and Finn C Nielsen for the kind gifts of antibodies and for helpful discussions, Dr Yuh Min Chook for the kind gift of the M9M plasmid, and Dr Antoinette Lemoine for the HCC cell lines. This work was supported by a grant from the Association Francais contre les Myopathies to AP and from Fondation ARC pour la Recherche sur le Cancer to TRV.	Bell JL, 2012, CELL MOL LIFE SCI; Boudoukha S, 2010, MOL CELL BIOL, V30, P5710, DOI 10.1128/MCB.00665-10; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Liao BS, 2011, J BIOL CHEM, V286, P31145, DOI 10.1074/jbc.M111.263913; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lochhead P, 2012, EUR J CANCER, V48, P3405, DOI 10.1016/j.ejca.2012.06.021; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nielsen J, 2003, BIOCHEM J, V376, P383, DOI 10.1042/BJ20030943; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Yisraeli JK, 2005, BIOL CELL, V97, P87	28	33	33	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2866	2875		10.1038/onc.2013.252	http://dx.doi.org/10.1038/onc.2013.252			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23812426				2022-12-25	WOS:000337231800006
J	Austin, KM; Nguyen, N; Javid, G; Covic, L; Kuliopulos, A				Austin, Karyn M.; Nga Nguyen; Javid, Golrokh; Covic, Lidija; Kuliopulos, Athan			Noncanonical Matrix Metalloprotease-1-Protease-activated Receptor-1 Signaling Triggers Vascular Smooth Muscle Cell Dedifferentiation and Arterial Stenosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; BREAST-CANCER CELLS; CORONARY ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CONTRACTILE PHENOTYPE; BALLOON ANGIOPLASTY; METALLOPROTEINASES; RESTENOSIS; INHIBITION; EXPRESSION	Vascular injury that results in proliferation and dedifferentiation of vascular smooth muscle cells (SMCs) is an important contributor to restenosis following percutaneous coronary interventions or plaque rupture. Protease-activated receptor-1 (PAR1) has been shown to play a role in vascular repair processes; however, little is known regarding its function or the relative roles of the upstream proteases thrombin and matrix metalloprotease-1 (MMP-1) in triggering PAR1-mediated arterial restenosis. The goal of this study was to determine whether noncanonical MMP-1 signaling through PAR1 would contribute to aberrant vascular repair processes in models of arterial injury. A mouse carotid arterial wire injury model was used for studies of neointima hyperplasia and arterial stenosis. The mice were treated post-injury for 21 days with a small molecule inhibitor of MMP-1 or a direct thrombin inhibitor and compared with vehicle control. Intimal and medial hyperplasia was significantly inhibited by 2.8-fold after daily treatment with the small molecule MMP-1 inhibitor, an effect that was lost in PAR1-deficient mice. Conversely, chronic inhibition of thrombin showed no benefit in suppressing the development of arterial stenosis. Thrombin-PAR1 signaling resulted in a supercontractile, differentiated phenotype in SMCs. Noncanonical MMP-1-PAR1 signaling resulted in the opposite effect and led to a dedifferentiated phenotype via a different G protein pathway. MMP-1-PAR1 significantly stimulated hyperplasia and migration of SMCs, and resulted in down-regulation of SMC contractile genes. These studies provide a new mechanism for the development of vascular intimal hyperplasia and suggest a novel therapeutic strategy to suppress restenosis by targeting noncanonical MMP-1-PAR1 signaling in vascular SMCs.	[Austin, Karyn M.; Nga Nguyen; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Hemostasis & Thrombosis Lab, Mol Oncol Res Inst,Tufts Med Ctr,Program Genet,Sa, Boston, MA 02111 USA; [Austin, Karyn M.; Nga Nguyen; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Austin, Karyn M.; Nga Nguyen; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Javid, Golrokh] Tufts Univ, Dept Pathol, Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Hemostasis & Thrombosis Lab, Mol Oncol Res Inst,Tufts Med Ctr,Program Genet,Sa, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu			National Institutes of Health [F30 HL108590, P50 HL110789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL108590, P50HL110789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants F30 HL108590 (to K. M. A.) and P50 HL110789 (to A. K.).	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Burchenal JEB, 1998, AM J CARDIOL, V82, P511, DOI 10.1016/S0002-9149(98)00371-3; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; de Smet BJGL, 2000, CIRCULATION, V101, P2962, DOI 10.1161/01.CIR.101.25.2962; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Eckart Robert E, 2004, J Interv Cardiol, V17, P27, DOI 10.1111/j.1540-8183.2004.00289.x; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gaubatz JW, 2010, ARTERIOSCL THROM VAS, V30, P1034, DOI 10.1161/ATVBAHA.109.195370; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Gurbel PA, 2011, EXPERT OPIN INV DRUG, V20, P1445, DOI 10.1517/13543784.2011.606809; Hatziapostolou M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002006; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Jaffre F, 2012, CIRCULATION, V125, P2993, DOI 10.1161/CIRCULATIONAHA.111.066787; Kamath L, 2001, CANCER RES, V61, P5933; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Lehrke M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-50; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Navarese EP, 2011, INT J CARDIOL, V152, P387, DOI 10.1016/j.ijcard.2011.08.024; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2008, ARTERIOSCL THROM VAS, V28, P1416, DOI 10.1161/ATVBAHA.108.168930; Pearce E, 2005, CIRC RES, V97, P1070, DOI 10.1161/01.RES.0000189302.03303.11; Peeters W, 2011, EUR HEART J, V32, P2314, DOI 10.1093/eurheartj/ehq517; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Pfaffen S, 2010, EUR J NUCL MED MOL I, V37, P1559, DOI 10.1007/s00259-010-1446-9; Pfaffen S, 2010, EXP CELL RES, V316, P836, DOI 10.1016/j.yexcr.2009.11.004; Preisack MB, 1997, Z KARDIOL, V86, P581, DOI 10.1007/s003920050097; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Smyth SS, 2002, AM HEART J, V144, P577, DOI 10.1067/mhj.2002.123569; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Wu YW, 2008, J FORMOS MED ASSOC, V107, P93, DOI 10.1016/S0929-6646(08)60015-7; Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28, DOI 10.1161/01.ATV.16.1.28; Zhang JS, 2008, CIRCULATION, V118, P1953, DOI 10.1161/CIRCULATIONAHA.108.789743; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918	50	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23105	23115		10.1074/jbc.M113.467019	http://dx.doi.org/10.1074/jbc.M113.467019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814055	Green Published, hybrid			2022-12-25	WOS:000330598200018
J	Chou, CH; Lai, SL; Chen, CN; Lee, PH; Peng, FC; Kuo, ML; Lai, HS				Chou, Chia-Hung; Lai, Shuo-Lun; Chen, Chiung-Nien; Lee, Po-Huang; Peng, Fu-Chuo; Kuo, Min-Liang; Lai, Hong-Shiee			IL-6 Regulates Mcl-(1L) Expression through the JAK/PI3K/Akt/CREB Signaling Pathway in Hepatocytes: Implication of an Anti-Apoptotic Role during Liver Regeneration	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; MURINE LIVER; CELLS; MCL-1; INTERLEUKIN-6; DAMAGE; RATS; PROLIFERATION; INVOLVEMENT; ACTIVATION	Aims: To investigate the role and the regulation of the long variant of myeloid cell leukemia-1 protein (Mcl-1(L)) during liver regeneration. Background: Liver regeneration is an important phenomenon after liver injury. The rat partial hepatectomy (PH) model was used to characterize liver regeneration and Mcl-1(L) expression after PH. Methods: Male Wistar rats were subjected to 70% PH. The expression of mcl-1(L) mRNA was determined by quantitative RTPCR, and protein levels were analyzed by Western blot analysis and immunohistochemistry during liver regeneration. Functional evaluations of Mcl-1(L) were tested using chemical inhibition (flavopiridol), genetic inhibition (siRNA) of Mcl-1(L) production, and by assaying for annexin V levels and DNA ladder formation. Serum IL-6 levels were determined by enzyme immunoassays; signal transduction of IL-6-regulated Mcl-1(L) expression was verified by chemical inhibitors and decoy double-stranded oligodeoxynucleotides. Results: High levels of Mcl-1(L) were observed in remnant tissue at 4 h after PH. Administration of flavopiridol decreased Mcl-1(L) accumulation and also inhibited liver regeneration. IL-6 administration promoted the accumulation of Mcl-1(L) in rat hepatocytes, an effect that was impaired by siRNA treatments that reduced Mcl-1(L) production. Chemical inhibition and decoy oligonucleotide competition demonstrated that IL-6-induced Mcl-1(L) production required signaling mediated by JAK kinase, phosphoinositide 3-kinase (PI3K), and cAMP response-element-binding (CREB) proteins. Conclusion: Mcl-1(L) is an anti-apoptotic protein induced during liver regeneration after PH in rats. The expression of Mcl-1(L) is induced by IL-6 through the JAK/PI3K/Akt/CREB signaling pathway. Chemotherapy drugs that depend on Mcl-1(L)-or IL-6-related signaling should be considered carefully before use in patients undergoing hepatectomy for malignant tumor resection.	[Chou, Chia-Hung; Lai, Shuo-Lun; Chen, Chiung-Nien; Lee, Po-Huang; Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chou, Chia-Hung; Lai, Shuo-Lun; Chen, Chiung-Nien; Lee, Po-Huang; Lai, Hong-Shiee] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chou, Chia-Hung; Peng, Fu-Chuo; Kuo, Min-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Lai, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	hslai@ntu.edu.tw		Lai, Hong-Shiee/0000-0002-7958-2183; Lai, Shuo-Lun/0000-0002-2480-4252; PENG, FU-CHUO/0000-0003-4385-8499; KUO, MIN-LIANG/0000-0002-7139-0144; CHEN, CHIUNG-NIEN/0000-0003-1192-5220; LEE, PO-HUANG/0000-0001-5831-035X	Taiwan National Science Council [NSC 96-2314-B-002-079-MY3, NSC 100-2314-B-002-019-MY3]; National Taiwan University Hospital [NTUH100-S1491]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by Taiwan National Science Council grants NSC 96-2314-B-002-079-MY3 and NSC 100-2314-B-002-019-MY3, and National Taiwan University Hospital Grant NTUH100-S1491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; [Anonymous], 2005, J BIOL CHEM; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Blechacz BRA, 2009, HEPATOLOGY, V50, P1861, DOI 10.1002/hep.23214; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Drucker C, 2010, J AUTOIMMUN, V34, P29, DOI 10.1016/j.jaut.2009.08.003; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Galun E, 2000, FASEB J, V14, P1979, DOI 10.1096/fj.99-0913com; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Hamada T, 2007, AM J PATHOL, V171, P872, DOI 10.2353/ajpath.2007.060972; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; Ikeda O, 2009, J SURG RES, V152, P218, DOI 10.1016/j.jss.2008.02.059; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jackson RS, 2012, NEOPLASIA, V14, P656, DOI 10.1593/neo.12640; Kawasaki T, 2010, J HEPATOL, V53, P648, DOI 10.1016/j.jhep.2010.04.021; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Lai HS, 2009, AM SURGEON, V75, P49; Liu LM, 2010, EUR J CLIN INVEST, V40, P127, DOI 10.1111/j.1365-2362.2009.02235.x; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Palve VC, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-135; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Schleimer K, 2008, J SURG RES, V149, P250, DOI 10.1016/j.jss.2008.01.021; Sudo K, 2008, BBA-MOL BASIS DIS, V1782, P671, DOI 10.1016/j.bbadis.2008.09.010; Suh HN, 2008, CELL PHYSIOL BIOCHEM, V22, P673, DOI 10.1159/000185551; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Togo S, 2004, J HEPATOL, V40, P464, DOI 10.1016/j.jhep.2003.11.005; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Volkmann X, 2008, HEPATOLOGY, V47, P1624, DOI 10.1002/hep.22237; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Yamashita T, 2010, CANCER RES, V70, P4687, DOI 10.1158/0008-5472.CAN-09-4210; Zang Y, 2012, CLIN CANCER RES, V18, P5639, DOI 10.1158/1078-0432.CCR-12-1213; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	37	28	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66268	10.1371/journal.pone.0066268	http://dx.doi.org/10.1371/journal.pone.0066268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825534	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000013
J	den Bakker, HC; Desjardins, CA; Griggs, AD; Peters, JE; Zeng, QD; Young, SK; Kodira, CD; Yandava, C; Hepburn, TA; Haas, BJ; Birren, BW; Wiedmann, M				den Bakker, Henk C.; Desjardins, Christopher A.; Griggs, Allison D.; Peters, Joseph E.; Zeng, Qiandong; Young, Sarah K.; Kodira, Chinnappa D.; Yandava, Chandri; Hepburn, Theresa A.; Haas, Brian J.; Birren, Bruce W.; Wiedmann, Martin			Evolutionary Dynamics of the Accessory Genome of Listeria monocytogenes	PLOS ONE			English	Article							TEICHOIC-ACID GLYCOSYLATION; SEROTYPE 4B; SURFACE-ANTIGENS; SEQUENCE; GENES; ALIGNMENT; IDENTIFICATION; STRAINS; GTCA; ANNOTATION	Listeria monocytogenes, a foodborne bacterial pathogen, is comprised of four phylogenetic lineages that vary with regard to their serotypes and distribution among sources. In order to characterize lineage-specific genomic diversity within L. monocytogenes, we sequenced the genomes of eight strains from several lineages and serotypes, and characterized the accessory genome, which was hypothesized to contribute to phenotypic differences across lineages. The eight L. monocytogenes genomes sequenced range in size from 2.85-3.14 Mb, encode 2,822-3,187 genes, and include the first publicly available sequenced representatives of serotypes 1/2c, 3a and 4c. Mapping of the distribution of accessory genes revealed two distinct regions of the L. monocytogenes chromosome: an accessory-rich region in the first 65 degrees adjacent to the origin of replication and a more stable region in the remaining 295 degrees. This pattern of genome organization is distinct from that of related bacteria Staphylococcus aureus and Bacillus cereus. The accessory genome of all lineages is enriched for cell surface-related genes and phosphotransferase systems, and transcriptional regulators, highlighting the selective pressures faced by contemporary strains from their hosts, other microbes, and their environment. Phylogenetic analysis of O-antigen genes and gene clusters predicts that serotype 4 was ancestral in L. monocytogenes and serotype 1/2 associated gene clusters were putatively introduced through horizontal gene transfer in the ancestral population of L. monocytogenes lineage I and II.	[den Bakker, Henk C.; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Cornell University; Cornell University	den Bakker, HC (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	hcd5@cornell.edu	Peters, Joseph/P-7130-2019; Wiedmann, Martin/A-9683-2008; Bakker, Henk den/AAF-8282-2020; Zeng, Qiandong/AAF-3305-2019; den Bakker, Henk/A-8136-2010	Peters, Joseph/0000-0001-8309-3297; Wiedmann, Martin/0000-0002-4168-5662; Desjardins, Christopher/0000-0002-3160-4734; den Bakker, Henk/0000-0002-4086-1580	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200900018C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bille J, 1996, INT J FOOD MICROBIOL, V32, P251, DOI 10.1016/S0168-1605(96)01140-3; BORODOVSKY M, 1993, BIOSYSTEMS, V30, P161, DOI 10.1016/0303-2647(93)90068-N; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cheng Y, 2008, APPL ENVIRON MICROB, V74, P1653, DOI 10.1128/AEM.01773-07; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; den Bakker HC, 2012, APPL ENVIRON MICROB, V78, P1876, DOI 10.1128/AEM.06969-11; den Bakker HC, 2010, APPL ENVIRON MICROB, V76, P6085, DOI 10.1128/AEM.00447-10; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Doyon JP, 2011, BRIEF BIOINFORM, V12, P392, DOI 10.1093/bib/bbr045; Dunn KA, 2009, MOL BIOL EVOL, V26, P2605, DOI 10.1093/molbev/msp176; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Faith N, 2009, FOODBORNE PATHOG DIS, V6, P39, DOI 10.1089/fpd.2008.0154; FIEDLER F, 1988, INFECTION, V16, pS92, DOI 10.1007/BF01639729; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Glaser P, 2001, SCIENCE, V294, P849; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hain T, 2006, J BIOTECHNOL, V126, P37, DOI 10.1016/j.jbiotec.2006.03.047; Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06; Holder JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002219; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Janssen PJ, 2001, NUCLEIC ACIDS RES, V29, P4395, DOI 10.1093/nar/29.21.4395; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAMISANGO K, 1983, J BIOCHEM-TOKYO, V93, P1401, DOI 10.1093/oxfordjournals.jbchem.a134275; Kjos M, 2010, J BACTERIOL, V192, P5906, DOI 10.1128/JB.00777-10; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lan Z, 2000, J BACTERIOL, V182, P6161, DOI 10.1128/JB.182.21.6161-6168.2000; Lazarevic V, 2002, MICROBIOL-SGM, V148, P815, DOI 10.1099/00221287-148-3-815; Lei XH, 2001, J BACTERIOL, V183, P1133, DOI 10.1128/JB.183.4.1133-1139.2001; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Orsi RH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-233; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; Seeliger H.P.R., 1979, METHOD MICROBIOL, V13, P31, DOI [10.1016/S0580-9517(08)70372-6, DOI 10.1016/S0580-9517(08)70372-6]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steele CL, 2011, J BACTERIOL, V193, P3679, DOI 10.1128/JB.05236-11; Steinweg C, 2010, J BACTERIOL, V192, P1473, DOI 10.1128/JB.01415-09; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thiel A, 2012, PLOS GENET, V8, P564, DOI 10.1371/journal.pgen.1002672; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486; UCHIKAWA KI, 1986, J BACTERIOL, V168, P115, DOI 10.1128/jb.168.1.115-122.1986; Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang CM, 2003, J BACTERIOL, V185, P5573, DOI 10.1128/JB.185.18.5573-5584.2003	75	47	48	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67511	10.1371/journal.pone.0067511	http://dx.doi.org/10.1371/journal.pone.0067511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825666	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000106
J	Negri, A; Oliveri, C; Sforzini, S; Mignione, F; Viarengo, A; Banni, M				Negri, Alessandro; Oliveri, Catherina; Sforzini, Susanna; Mignione, Flavio; Viarengo, Aldo; Banni, Mohamed			Transcriptional Response of the Mussel Mytilus galloprovincialis (Lam.) following Exposure to Heat Stress and Copper	PLOS ONE			English	Article							REAL-TIME PCR; CLIMATE-CHANGE; OXIDATIVE STRESS; MEMBRANE INTEGRITY; EXPRESSION; SHOCK; TEMPERATURE; PROTEIN; CELLS; WATER	Global warming is a major factor that may affect biological organization, especially in marine ecosystems and in coastal areas that are particularly subject to anthropogenic pollution. We evaluated the effects of simultaneous changes in temperature and copper concentrations on lysosomal membrane stability (N-acetyl-hexosaminidase activity) and malondialdehyde accumulation (MDA) in the gill of the blue mussel Mytilus galloprovincialis (Lam.). Temperature and copper exerted additive effects on lysosomal membrane stability, exacerbating the toxic effects of metal cations present in non-physiological concentrations. Mussel lysosomal membrane stability is known to be positively related to scope for growth, indicating possible effects of increasing temperature on mussel populations in metal-polluted areas. To clarify the molecular response to environmental stressors, we used a cDNA microarray with 1,673 sequences to measure the relative transcript abundances in the gills of mussels exposed to copper (40 mu g/L) and a temperature gradient (16 degrees C, 20 degrees C, and 24 degrees C). In animals exposed only to heat stress, hierarchical clustering of the microarray data revealed three main clusters, which were largely dominated by down-regulation of translation-related differentially expressed genes, drastic up-regulation of protein folding related genes, and genes involved in chitin metabolism. The response of mussels exposed to copper at 24 degrees C was characterized by an opposite pattern of the genes involved in translation, most of which were up-regulated, as well as the down-regulation of genes encoding heat shock proteins and "microtubule-based movement" proteins. Our data provide novel information on the transcriptomic modulations in mussels facing temperature increases and high copper concentrations; these data highlight the risk of marine life exposed to toxic chemicals in the presence of temperature increases due to climate change.	[Negri, Alessandro; Oliveri, Catherina; Sforzini, Susanna; Mignione, Flavio; Viarengo, Aldo; Banni, Mohamed] Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy; [Banni, Mohamed] ISA, Lab Biochem & Environm Toxicol, Chott Mariem, Sousse, Tunisia	University of Eastern Piedmont Amedeo Avogadro; Universite de Tunis-El-Manar; Institut Salah Azaiez	Banni, M (corresponding author), Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy.	m_banni@yahoo.fr	Banni, Mohamed/M-2144-2014	Banni, Mohamed/0000-0001-9764-0343; Sforzini, Susanna/0000-0002-7310-7605; Viarengo, Aldo/0000-0002-1557-6526	Theme 6 of the EC seventh framework program through the Marine Ecosystem Evolution in a Changing Environment (MEECE) Collaborative Project [212085]	Theme 6 of the EC seventh framework program through the Marine Ecosystem Evolution in a Changing Environment (MEECE) Collaborative Project	This work was funded by Theme 6 of the EC seventh framework program through the Marine Ecosystem Evolution in a Changing Environment (MEECE, No 212085) Collaborative Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Allen JI, 2004, MAR ENVIRON RES, V58, P227, DOI 10.1016/j.marenvres.2004.03.119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bado-Nilles A, 2013, ENVIRON SCI POLLUT R, V20, P2692, DOI 10.1007/s11356-012-1410-2; Baines SB, 2008, ENVIRON SCI TECHNOL, V42, P3277, DOI 10.1021/es702336q; Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; BAYNE BL, 1979, PHILOS T ROY SOC B, V286, P563, DOI 10.1098/rstb.1979.0046; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Cevik U, 2008, J HAZARD MATER, V160, P396, DOI 10.1016/j.jhazmat.2008.03.010; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Colaco A, 2006, CHEMOSPHERE, V65, P2260, DOI 10.1016/j.chemosphere.2006.05.034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; Crowe TP, 2004, J APPL ECOL, V41, P114, DOI 10.1111/j.1365-2664.2004.00882.x; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Dondero F, 2006, AQUAT TOXICOL, V78, pS13, DOI 10.1016/j.aquatox.2006.02.025; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Elliott JA, 2012, WATER RES, V46, P1364, DOI 10.1016/j.watres.2011.12.018; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gomes EC, 2011, EUR J APPL PHYSIOL, V111, P2089, DOI 10.1007/s00421-011-1839-x; Handy RD, 2003, COMP BIOCHEM PHYS A, V135, P25, DOI 10.1016/S1095-6433(03)00018-7; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kamel N, 2012, ARCH ENVIRON CON TOX, V63, P534, DOI 10.1007/s00244-012-9790-3; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; McVeigh A, 2004, MAR ENVIRON RES, V58, P821, DOI 10.1016/j.marenvres.2004.03.099; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mokany K, 2010, TRENDS ECOL EVOL, V25, P550, DOI 10.1016/j.tree.2010.06.014; MOORE MN, 1976, CELL TISSUE RES, V175, P279; Morillo J, 2008, ECOTOX ENVIRON SAFE, V71, P851, DOI 10.1016/j.ecoenv.2008.01.016; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pytharopoulou S, 2011, AQUAT TOXICOL, V105, P157, DOI 10.1016/j.aquatox.2011.06.007; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Silvestre F, 2010, SCI TOTAL ENVIRON, V408, P3176, DOI 10.1016/j.scitotenv.2010.04.005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Verlecar XN, 2007, CHEM-BIOL INTERACT, V167, P219, DOI 10.1016/j.cbi.2007.01.018; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; VIARENGO A, 1980, COMP BIOCHEM PHYS C, V67, P215, DOI 10.1016/0306-4492(80)90021-0; Vicente-Martorell JJ, 2009, J HAZARD MATER, V162, P823, DOI 10.1016/j.jhazmat.2008.05.106; Yao CL, 2012, J EXP BIOL, V215, P4267, DOI 10.1242/jeb.073577	53	62	62	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66802	10.1371/journal.pone.0066802	http://dx.doi.org/10.1371/journal.pone.0066802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825565	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000027
J	Jacobson, A; Bell, F; Lejarcegui, N; Mitchell, C; Frenkel, L; Horton, H				Jacobson, Amanda; Bell, Frank; Lejarcegui, Nicholas; Mitchell, Caroline; Frenkel, Lisa; Horton, Helen			Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; REPLICATION IN-VITRO; UMBILICAL-CORD BLOOD; DENDRITIC CELLS; HIV-1 INFECTION; INDIVIDUALS; EXPRESSION; TRANSPLANTATION; DISEASE	Background: Neonatal Natural Killer (NK) cells show functional impairment and expansion of a CD56 negative population of uncertain significance. Methods: NK cells were isolated from cord blood and from adult donors. NK subpopulations were identified as positive or negative for the expression of CD56 and characterized for expression of granzyme B and surface markers by multi-parameter flow cytometry. Cell function was assessed by viral suppression and cytokine production using autologous lymphocytes infected with HIV. Activating (NKp30, NKp46) and inhibitory (Siglec-7) markers in healthy infants and adults were compared with viremic HIV-infected adults. Results: Cord blood contained increased frequencies of CD56 negative (CD56neg) NK cells with reduced expression of granzyme B and reduced production of IFNc and the CC-class chemokines RANTES, MIP1 alpha and MIP1 beta upon stimulation. Both CD56pos and CD56neg NK subpopulations showed impaired viral suppression in cord blood, with impairment most marked in the CD56neg subset. CD56neg NK cells from cord blood and HIV-infected adults shared decreased inhibitory and activating receptor expression when compared with CD56pos cells. Conclusions: CD56neg NK cells are increased in number in normal infants and these effectors show reduced anti-viral activity. Like the expanded CD56neg population described in HIV-infected adults, these NK cells demonstrate functional impairments which may reflect inadequate development or activation.	[Jacobson, Amanda; Bell, Frank; Lejarcegui, Nicholas; Horton, Helen] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Bell, Frank; Frenkel, Lisa] Seattle Childrens Hosp, Seattle, WA USA; [Bell, Frank; Frenkel, Lisa] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mitchell, Caroline; Horton, Helen] Univ Washington, Dept Med, Seattle, WA USA; [Mitchell, Caroline] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Frenkel, Lisa] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Frenkel, Lisa; Horton, Helen] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horton, H (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	Helen.horton@seattlebiomed.org		Frenkel, Lisa M/0000-0001-9566-8959; Bell, Frank/0000-0001-7281-516X	National Institutes of Health (NIH) [R01 AI100018, P30 AI027757]; University of Washington Center for AIDS Research (CFAR); NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NCCAM); Seattle Biomedical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100018, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Seattle Biomedical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by R01 AI100018 from the National Institutes of Health (NIH), the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM) and startup funds awarded to H. Horton by Seattle Biomedical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1996, AIDS, V10, P143, DOI 10.1097/00002030-199602000-00003; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2011, TRENDS IMMUNOL, V32, P219, DOI 10.1016/j.it.2011.02.003; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Bernstein HB, 2004, AIDS RES HUM RETROV, V20, P1189, DOI 10.1089/aid.2004.20.1189; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Bonaparte MI, 2003, AIDS, V17, P487, DOI 10.1097/00002030-200303070-00003; BRADSTOCK KF, 1993, IMMUNOL CELL BIOL, V71, P535, DOI 10.1038/icb.1993.59; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; De Angelis C, 2011, ACTA HAEMATOL-BASEL, V126, P13, DOI 10.1159/000323661; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Dominguez E, 1998, IMMUNOLOGY, V94, P109; GADDY J, 1995, J INTERF CYTOK RES, V15, P527, DOI 10.1089/jir.1995.15.527; Gaddy J, 1997, CELL IMMUNOL, V180, P132, DOI 10.1006/cimm.1997.1175; Gonzalez VD, 2008, CLIN IMMUNOL, V128, P46, DOI 10.1016/j.clim.2008.03.521; Gonzalez VD, 2009, J IMMUNOL, V183, P6612, DOI 10.4049/jimmunol.0901437; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Guilmot A, 2011, J INNATE IMMUN, V3, P280, DOI 10.1159/000323934; Hermann E, 2006, PEDIATR RES, V60, P38, DOI 10.1203/01.pdr.0000220335.05588.ea; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu E, 2001, BRIT J HAEMATOL, V113, P240, DOI 10.1046/j.1365-2141.2001.02720.x; Lu X, 2008, EUR J HAEMATOL, P81; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Zarife MAS, 2009, J MED VIROL, V81, P49, DOI 10.1002/jmv.21340; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; Verneris MR, 2009, BRIT J HAEMATOL, V147, P185, DOI 10.1111/j.1365-2141.2009.07768.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang YY, 2007, CELL MOL IMMUNOL, V4, P377; Wiesmayr S, 2012, EUR J IMMUNOL, V42, P541, DOI 10.1002/eji.201141832; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zucchini N, 2008, EXPERT REV ANTI-INFE, V6, P867, DOI 10.1586/14787210.6.6.867	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67700	10.1371/journal.pone.0067700	http://dx.doi.org/10.1371/journal.pone.0067700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805324	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500152
J	Riesco, MF; Robles, V				Riesco, Marta F.; Robles, Vanesa			Cryopreservation Causes Genetic and Epigenetic Changes in Zebrafish Genital Ridges	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; PRIMORDIAL GERM-CELLS; DNA-DAMAGE; RAINBOW-TROUT; EXPRESSION; MODEL; PCR; DEADENYLATION; ASSOCIATION; PATTERNS	Cryopreservation is an important tool routinely employed in Assisted Reproduction Technologies (ARTs) and germplasm banking. For several years, the assessment of global DNA fragmentation seemed to be enough to ensure the integrity of genetic material. However, cryopreservation can produce molecular alterations in key genes and transcripts undetectable by traditional assays, such modifications could interfere with normal embryo development. We used zebrafish as a model to study the effect of cryopreservation on key transcripts and genes. We employed an optimized cryopreservation protocol for genital ridges (GRs) containing primordial germ cells (PGCs) considered one of the best cell sources for gene banking. Our results indicated that cryopreservation produced a decrease in most of the zebrafish studied transcripts (cxcr4b, pou5f1, vasa and sox2) and upregulation of heat shock proteins (hsp70, hsp90). The observed downregulation could not always be explained by promoter hypermethylation (only the vasa promoter underwent clear hypermethylation). To corroborate this, we used human spermatozoa (transcriptionally inactive cells) obtaining a reduction in some transcripts (eIF2S1, and LHCGR). Our results also demonstrated that this effect was caused by freezing/thawing rather than exposure to cryoprotectants (CPAs). Finally, we employed real-time PCR (qPCR) technology to quantify the number of lesions produced by cryopreservation in the studied zebrafish genes, observing very different vulnerability to damage among them. All these data suggest that molecular alterations caused by cryopreservation should be studied in detail in order to ensure the total safety of the technique.	[Robles, Vanesa] Univ Leon, INDEGSAL, E-24071 Leon, Spain; Univ Leon, E-24071 Leon, Spain	Universidad de Leon; Universidad de Leon	Robles, V (corresponding author), Univ Leon, INDEGSAL, E-24071 Leon, Spain.	v.robles@unileon.es	Riesco, Marta/O-9766-2014; rodriguez, vanesa robles/N-7508-2015	Riesco, Marta/0000-0002-3655-6401; rodriguez, vanesa robles/0000-0002-7917-7700	Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion [MICINN AGL2009-06994]; Ramon y Cajal program [RYC-2008-02339]; Junta de Castilla y Leon [E-24-2009-0036681]; Fondo Social Europeo	Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion; Ramon y Cajal program(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by the Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion (MICINN AGL2009-06994), Ramon y Cajal program (RYC-2008-02339), Junta de Castilla y Leon (E-24-2009-0036681) and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Al-Khtib M, 2011, FERTIL STERIL, V95, P1955, DOI 10.1016/j.fertnstert.2011.02.029; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bermejo R, 2012, TRENDS CELL BIOL, V22, P465, DOI 10.1016/j.tcb.2012.05.007; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Dodd A, 2000, HUM MOL GENET, V9, P2443, DOI 10.1093/hmg/9.16.2443; Flores E, 2011, THERIOGENOLOGY, V76, P1450, DOI 10.1016/j.theriogenology.2011.05.039; Garcia-Herrero S, 2011, REPROD BIOMED ONLINE, V22, P25, DOI 10.1016/j.rbmo.2010.09.013; Goto-Kazeto R, 2010, INT J DEV BIOL, V54, P1487, DOI 10.1387/ijdb.092914rg; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Hu Yu, 2012, Yichuan, V34, P1097, DOI 10.3724/SP.J.1005.2012.01097; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; Jeske M, 2011, EMBO J, V30, P90, DOI 10.1038/emboj.2010.283; Kobayashi T, 2004, MOL REPROD DEV, V67, P91, DOI 10.1002/mrd.20003; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Li YJ, 2012, J GENET GENOMICS, V39, P521, DOI 10.1016/j.jgg.2012.07.006; Lim D, 2009, HUM REPROD, V24, P741, DOI 10.1093/humrep/den406; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Liu WY, 2010, FASEB J, V24, P2641, DOI 10.1096/fj.09-148403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzilli F, 1995, Acta Eur Fertil, V26, P145; Mimeault M, 2013, DRUG DISCOV TODAY, V18, P128, DOI 10.1016/j.drudis.2012.08.002; Miyake A, 2006, INT J DEV BIOL, V50, P619, DOI 10.1387/ijdb.062172am; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; OSTERMEIER GC, 2004, NATURE, V13, P429; Patterson Kate, 2011, J Vis Exp, DOI 10.3791/3170; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Riesco MF, 2012, J APPL ICHTHYOL, V28, P925, DOI 10.1111/jai.12089; Riesco MF, 2012, THERIOGENOLOGY, V77, P122, DOI 10.1016/j.theriogenology.2011.07.024; Robles V, 2011, ZEBRAFISH, V8, P57, DOI 10.1089/zeb.2010.0684; Robles V, 2009, ZEBRAFISH, V6, P281, DOI 10.1089/zeb.2009.0592; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Sanchez-Sanchez AV, 2011, INT J BIOL SCI, V7, P410, DOI 10.7150/ijbs.7.410; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Sorensen AL, 2010, STEM CELLS DEV, V19, P1257, DOI 10.1089/scd.2009.0309; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Thomson LK, 2009, HUM REPROD, V24, P2061, DOI 10.1093/humrep/dep214; Trapphoff T, 2010, HUM REPROD, V25, P3025, DOI 10.1093/humrep/deq278; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Watkins SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044018; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiao JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038742; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Zilli L, 2003, CRYOBIOLOGY, V47, P227, DOI 10.1016/j.cryobiol.2003.10.002	56	63	66	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67614	10.1371/journal.pone.0067614	http://dx.doi.org/10.1371/journal.pone.0067614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805321	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500149
J	Bavarva, JH; Tae, H; Settlage, RE; Garner, HR				Bavarva, Jasmin H.; Tae, Hongseok; Settlage, Robert E.; Garner, Harold R.			Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study	PLOS ONE			English	Article							BREAST-CANCER; RNA-SEQ; MESSENGER-RNA; TUMOR-GROWTH; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; CARCINOMA-CELLS; PASSIVE SMOKING; KAPPA-B; EXPRESSION	Nicotine is a known risk factor for cancer development and has been shown to alter gene expression in cells and tissue upon exposure. We used Illumina (R) Next Generation Sequencing (NGS) technology to gain unbiased biological insight into the transcriptome of normal epithelial cells (MCF-10A) to nicotine exposure. We generated expression data from 54,699 transcripts using triplicates of control and nicotine stressed cells. As a result, we identified 138 differentially expressed transcripts, including 39 uncharacterized genes. Additionally, 173 transcripts that are primarily associated with DNA replication, recombination, and repair showed evidence for alternative splicing. We discovered the greatest nicotine stress response by HPCAL4 (up-regulated by 4.71 fold) and NPAS3 (down-regulated by -2.73 fold); both are genes that have not been previously implicated in nicotine exposure but are linked to cancer. We also discovered significant down-regulation (-2.3 fold) and alternative splicing of NEAT1 (lncRNA) that may have an important, yet undiscovered regulatory role. Gene ontology analysis revealed nicotine exposure influenced genes involved in cellular and metabolic processes. This study reveals previously unknown consequences of nicotine stress on the transcriptome of normal breast epithelial cells and provides insight into the underlying biological influence of nicotine on normal cells, marking the foundation for future studies.	[Bavarva, Jasmin H.; Tae, Hongseok; Settlage, Robert E.; Garner, Harold R.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Garner, HR (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	garner@vbi.vt.edu			Medical Informatics and Systems Division director's fund at Virginia Bioinformatics Institute	Medical Informatics and Systems Division director's fund at Virginia Bioinformatics Institute	This work was supported by the Medical Informatics and Systems Division director's fund at Virginia Bioinformatics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 1998, HUM PATHOL, V29, P155, DOI 10.1016/S0046-8177(98)90226-X; Barr J, 2007, MOL CELL BIOCHEM, V297, P93, DOI 10.1007/s11010-006-9333-1; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bieche I, 2001, ONCOGENE, V20, P6955, DOI 10.1038/sj.onc.1204739; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Disher K, 2007, GENOME, V50, P946, DOI 10.1139/G07-074; Dunckley T, 2006, BRAIN RES, V1116, P39, DOI 10.1016/j.brainres.2006.07.111; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Gilon M, 2008, DIFFERENTIATION, V76, P518, DOI 10.1111/j.1432-0436.2007.00246.x; Gomez-Pina V, 2012, J LEUKOCYTE BIOL, V91, P933, DOI 10.1189/jlb.0711340; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Henderson LJ, 2005, BRIT J CANCER, V92, P1553, DOI 10.1038/sj.bjc.6602452; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Kalra R, 2004, CLIN DIAGN LAB IMMUN, V11, P563, DOI 10.1128/CDLI.11.3.563-568.2004; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Li YG, 2012, FEBS J, V279, P2247, DOI 10.1111/j.1742-4658.2012.08607.x; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; LINDELL G, 1993, SCAND J GASTROENTERO, V28, P487, DOI 10.3109/00365529309098254; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McKiernan E, 2011, TUMOR BIOL, V32, P441, DOI 10.1007/s13277-010-0137-2; Midorikawa Y, 2004, CANCER RES, V64, P7263, DOI 10.1158/0008-5472.CAN-04-1275; Moreira F, 2011, AM J PATHOL, V179, P462, DOI 10.1016/j.ajpath.2011.03.044; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Nishioka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018619; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Talvensaari-Mattila A, 2001, BREAST CANCER RES TR, V65, P55, DOI 10.1023/A:1006458601568; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang YS, 2012, BOSNIAN J BASIC MED, V12, P94; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; ZBINDEN G, 1981, ARCH TOXICOL, V47, P77, DOI 10.1007/BF00332351; Zhang SL, 2001, PHYSIOL GENOMICS, V5, P187, DOI 10.1152/physiolgenomics.2001.5.4.187; Zong Y, 2009, WORLD J GASTROENTERO, V15, P2500, DOI 10.3748/wjg.15.2500	46	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67252	10.1371/journal.pone.0067252	http://dx.doi.org/10.1371/journal.pone.0067252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825647	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400181
J	Charnley, M; Anderegg, F; Holtackers, R; Textor, M; Meraldi, P				Charnley, Mirren; Anderegg, Fabian; Holtackers, Rene; Textor, Marcus; Meraldi, Patrick			Effect of Cell Shape and Dimensionality on Spindle Orientation and Mitotic Timing	PLOS ONE			English	Article							CONTACT GUIDED CELLS; CENTROSOME SEPARATION; PROTEIN ADSORPTION; OXIDE SURFACES; SINGLE CELLS; PTK2 CELLS; DIVISION; ACTIN; MITOSIS; MYOSIN	The formation and orientation of the mitotic spindle is a critical feature of mitosis. The morphology of the cell and the spatial distribution and composition of the cells' adhesive microenvironment all contribute to dictate the position of the spindle. However, the impact of the dimensionality of the cells' microenvironment has rarely been studied. In this study we present the use of a microwell platform, where the internal surfaces of the individual wells are coated with fibronectin, enabling the three-dimensional presentation of adhesive ligands to single cells cultured within the microwells. This platform was used to assess the effect of dimensionality and cell shape in a controlled microenvironment. Single HeLa cells cultured in circular microwells exhibited greater tilting of the mitotic spindle, in comparison to cells cultured in square microwells. This correlated with an increase in the time required to align the chromosomes at the metaphase plate due to prolonged activation of the spindle checkpoint in an actin dependent process. The comparison to 2D square patterns revealed that the dimensionality of cell adhesions alone affected both mitotic timings and spindle orientation; in particular the role of actin varied according to the dimensionality of the cells' microenvironment. Together, our data revealed that cell shape and the dimensionality of the cells' adhesive environment impacted on both the orientation of the mitotic spindle and progression through mitosis.	[Charnley, Mirren; Anderegg, Fabian; Textor, Marcus] ETH, Lab Surface Sci & Technol, Zurich, Switzerland; [Holtackers, Rene; Meraldi, Patrick] ETH, Inst Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Charnley, M (corresponding author), Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Microphoton, Hawthorn, Vic 3122, Australia.	mcharnley@swin.edu.au	Meraldi, Patrick/D-6190-2013	Charnley, Mirren/0000-0003-3845-9290; Meraldi, Patrick/0000-0001-9742-8756	Swiss National Science Foundation (SNSF) [CR23I2_125290/1]; Competence Centre for Materials Science and Technoloy (CCMX); National Centers for Competence in Research (NCCR) [03]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Competence Centre for Materials Science and Technoloy (CCMX); National Centers for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	The authors thank the Swiss National Science Foundation (SNSF; www.snf.ch; grant number CR23I2_125290/1), the Competence Centre for Materials Science and Technoloy (CCMX; www.ccmx.ch), and the National Centers for Competence in Research (NCCR; www.nccr.ch; Nano-P5, project 03) for their financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN JE, 1980, J CELL SCI, V43, P177; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Charnley M, 2012, INTEGR BIOL-UK, V4, P1059, DOI 10.1039/c2ib20111a; Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Concha ML, 1998, DEVELOPMENT, V125, P983; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d; Hakanson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040141; Haraguchi T, 1997, GENES CELLS, V2, P369, DOI 10.1046/j.1365-2443.1997.1280326.x; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m; Khodjakov A, 2010, NAT CELL BIOL, V12, P919, DOI 10.1038/ncb1010-919; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Krzysiek-Maczka G, 2008, FOLIA BIOL-KRAKOW, V56, P13, DOI 10.3409/fb56_1-2.13-19; Krzysiek-Maczka G, 2010, FOLIA BIOL-KRAKOW, V58, P21, DOI 10.3409/fb58_1-2.21-27; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ochsner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009445; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Russell SM, 2008, IMMUNOL CELL BIOL, V86, P423, DOI 10.1038/icb.2008.24; SANGER JM, 1989, CELL MOTIL CYTOSKEL, V14, P201, DOI 10.1002/cm.970140207; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; Vasiliev JM, 2004, P NATL ACAD SCI USA, V101, P12526, DOI 10.1073/pnas.0404723101; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3; Zhao L, 2011, J BIOMECH, V44, P2388, DOI 10.1016/j.jbiomech.2011.06.033	58	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66918	10.1371/journal.pone.0066918	http://dx.doi.org/10.1371/journal.pone.0066918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825020	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400168
J	Faller, KME; Medway, DJ; Aksentijevic, D; Sebag-Montefiore, L; Schneider, JE; Lygate, CA; Neubauer, S				Faller, Kiterie M. E.; Medway, Debra J.; Aksentijevic, Dunja; Sebag-Montefiore, Liam; Schneider, Juergen E.; Lygate, Craig A.; Neubauer, Stefan			Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse Heart	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ADENINE-NUCLEOTIDES; DIASTOLIC FUNCTION; FAILURE PATIENTS; RAT-LIVER; METABOLISM; ISCHEMIA; RECOVERY; MICE; ATP	Background: Reduced levels of creatine and total adenine nucleotides (sum of ATP, ADP and AMP) are hallmarks of chronic heart failure and restoring these pools is predicted to be beneficial by maintaining the diseased heart in a more favourable energy state. Ribose supplementation is thought to support both salvage and re-synthesis of adenine nucleotides by bypassing the rate-limiting step. We therefore tested whether ribose would be beneficial in chronic heart failure in control mice and in mice with elevated myocardial creatine due to overexpression of the creatine transporter (CrT-OE). Methods and Results: Four groups were studied: sham; myocardial infarction (MI); MI+ribose; MI+CrT-OE+ribose. In a pilot study, ribose given in drinking water was bioavailable, resulting in a two-fold increase in myocardial ribose-5-phosphate levels. However, 8 weeks post-surgery, total adenine nucleotide (TAN) pool was decreased to a similar amount (8-14%) in all infarcted groups irrespective of the treatment received. All infarcted groups also presented with a similar and substantial degree of left ventricular (LV) dysfunction (3-fold reduction in ejection fraction) and LV hypertrophy (32-47% increased mass). Ejection fraction closely correlated with infarct size independently of treatment (r(2) = 0.63, p<0.0001), but did not correlate with myocardial creatine or TAN levels. Conclusion: Elevating myocardial ribose and creatine levels failed to maintain TAN pool or improve post-infarction LV remodeling and function. This suggests that ribose is not rate-limiting for purine nucleotide biosynthesis in the chronically failing mouse heart and that alternative strategies to preserve TAN pool should be investigated.	[Lygate, Craig A.] Univ Oxford, Radcliffe Dept Med, British Heart Fdn Ctr Res Excellence, Div Cardiovasc Med, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Lygate, CA (corresponding author), Univ Oxford, Radcliffe Dept Med, British Heart Fdn Ctr Res Excellence, Div Cardiovasc Med, Oxford, England.	clygate@well.ox.ac.uk	Lygate, Craig/AAO-4731-2020	Lygate, Craig/0000-0001-6079-0284; Neubauer, Stefan/0000-0001-9017-5645; Aksentijevic, Dunja/0000-0002-8480-6727; Faller, Kiterie ME/0000-0002-4525-7059	British Heart Foundation (BHF) [FS/07/065, RG/10/002/28187, FS11/50/29038]; BHF Centre of Research Excellence, Oxford [RE/08/004]; Wellcome Trust [090532/Z/09/Z]; British Heart Foundation [RG/10/002/28187, FS/11/50/29038] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10005] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Centre of Research Excellence, Oxford; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the British Heart Foundation (BHF, Grants FS/07/065 and RG/10/002/28187, FS11/50/29038) http://www.bhf.org.uk. Additional funding for the Visualsonics ultrasound system was provided by the BHF Centre of Research Excellence, Oxford (RE/08/004). The research centre where this work was conducted is funded by a Wellcome Trust Core Award (090532/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caretti A, 2010, CELL PHYSIOL BIOCHEM, V26, P831, DOI 10.1159/000323992; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; KIM YA, 1992, AM J PHYSIOL, V262, pE344, DOI 10.1152/ajpendo.1992.262.3.E344; KING MT, 1990, ANAL BIOCHEM, V187, P179, DOI 10.1016/0003-2697(90)90438-F; Lamberts RR, 2007, AM J PHYSIOL-HEART C, V293, pH1869, DOI 10.1152/ajpheart.00294.2007; LORTET S, 1989, CARDIOVASC RES, V23, P702, DOI 10.1093/cvr/23.8.702; Lygate C, 2006, DRUG DISCOV TODAY DI, V3, P283, DOI 10.1016/j.ddmod.2006.10.002; Lygate CA, 2007, J MOL CELL CARDIOL, V42, P1129, DOI 10.1016/j.yjmcc.2007.03.899; Lygate CA, 2012, CARDIOVASC RES, V96, P466, DOI 10.1093/cvr/cvs272; MacCarter D, 2009, INT J CARDIOL, V137, P79, DOI 10.1016/j.ijcard.2008.05.025; MAUSER M, 1985, CIRC RES, V56, P220, DOI 10.1161/01.RES.56.2.220; NEUBAUER S, 1995, J CLIN INVEST, V95, P1092, DOI 10.1172/JCI117756; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Omran H, 2003, EUR J HEART FAIL, V5, P615, DOI 10.1016/S1388-9842(03)00060-6; Perkowski D, 2007, J CARDIAC SURG, V22, P370, DOI 10.1111/j.1540-8191.2007.00427.x; PLIML W, 1992, LANCET, V340, P507, DOI 10.1016/0140-6736(92)91709-H; Sawada SG, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-5; Schneider JE, 2004, MAGNET RESON MED, V52, P1029, DOI 10.1002/mrm.20257; Shen WQ, 1999, CIRCULATION, V100, P2113, DOI 10.1161/01.CIR.100.20.2113; Sonoda T, 1998, BBA-PROTEIN STRUCT M, V1387, P32, DOI 10.1016/S0167-4838(98)00106-X; Starling RC, 1998, MOL CELL BIOCHEM, V180, P171, DOI 10.1023/A:1006876031121; STCYR JA, 1989, J SURG RES, V46, P157, DOI 10.1016/0022-4804(89)90220-5; ten Hove M, 2005, CIRCULATION, V111, P2477, DOI 10.1161/01.CIR.0000165147.99592.01; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; ZIMMER HG, 1989, BASIC RES CARDIOL, V84, P332, DOI 10.1007/BF01907981; ZIMMER HG, 1980, SCIENCE, V207, P319, DOI 10.1126/science.7350664; ZIMMER HG, 1983, SCIENCE, V220, P81, DOI 10.1126/science.6402820; ZIMMER HG, 1984, J MOL CELL CARDIOL, V16, P863, DOI 10.1016/S0022-2828(84)80010-3; ZIMMER HG, 1973, CIRC RES, V32, P635, DOI 10.1161/01.RES.32.5.635	32	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66461	10.1371/journal.pone.0066461	http://dx.doi.org/10.1371/journal.pone.0066461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823183	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000320576400111
J	Gaberman, E; Pinzur, L; Levdansky, L; Tsirlin, M; Netzer, N; Aberman, Z; Gorodetsky, R				Gaberman, Elena; Pinzur, Lena; Levdansky, Lilia; Tsirlin, Maria; Netzer, Nir; Aberman, Zami; Gorodetsky, Raphael			Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TOTAL-BODY IRRADIATION; HEMATOPOIETIC STEM; IMMUNE MODULATION; PROGENITOR CELLS; DOSE-RATE; RADIOBIOLOGICAL BASIS; COLLAGEN SCAFFOLDS; REPAIR; PROTECTION	Exposure to high lethal dose of ionizing radiation results in acute radiation syndrome with deleterious systemic effects to different organs. A primary target is the highly sensitive bone marrow and the hematopoietic system. In the current study C3H/HeN mice were total body irradiated by 7.7 Gy. Twenty four hrs and 5 days after irradiation 2610 6 cells from different preparations of human derived 3D expanded adherent placental stromal cells (PLX) were injected intramuscularly. Treatment with batches consisting of pure maternal cell preparations (PLX-Mat) increased the survival of the irradiated mice from similar to 27% to 68% (P < 0.001), while cell preparations with a mixture of maternal and fetal derived cells (PLX-RAD) increased the survival to similar to 98% (P < 0.0001). The dose modifying factor of this treatment for both 50% and 37% survival (DMF50 and DMF37) was similar to 1.23. Initiation of the more effective treatment with PLX-RAD injection could be delayed for up to 48 hrs after irradiation with similar effect. A delayed treatment by 72 hrs had lower, but still significantly effect (p < 0.05). A faster recovery of the BM and improved reconstitution of all blood cell lineages in the PLX-RAD treated mice during the follow-up explains the increased survival of the cells treated irradiated mice. The number of CD45+/SCA1+ hematopoietic progenitor cells within the fast recovering population of nucleated BM cells in the irradiated mice was also elevated in the PLX-RAD treated mice. Our study suggests that IM treatment with PLX-RAD cells may serve as a highly effective "off the shelf" therapy to treat BM failure following total body exposure to high doses of radiation. The results suggest that similar treatments may be beneficial also for clinical conditions associated with severe BM aplasia and pancytopenia.	[Gaberman, Elena; Levdansky, Lilia; Tsirlin, Maria; Gorodetsky, Raphael] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Pinzur, Lena; Netzer, Nir; Aberman, Zami] Pluristem Therapeut Inc, Haifa, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Gorodetsky, R (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel.	rafi@hadassah.org.il	, Rafi/GPW-8563-2022		Pluristem Therapeutic	Pluristem Therapeutic	The major funding by Pluristem Therapeutic enabled the execution of this scientific project, without compromising its scientific unbiased value. The funding company participated in the study design, but the data collection and analysis as well as preparation of the manuscript for publication was done by the academic researcher according to academic standards. The role of the author from Pluristem Therapeutics (LP and NN) who participated in the study was associated with the supply and examination of the GMP controlled cultivation and careful examination of or relevant cells that they supplied for the study, in disclosing and supplying part of the reagents and media needed for the research project, in advising the Hadassah's team and helping in the setup of experimental protocols based on their specific vast relevant experience. ZA from Pluristem Therapeutics is included as an author as he had a major role in envisioning and in the instigation of the research project. These authors were consulted on technical issues related to the current manuscript. The major funding by Pluristem Therapeutic enabled the execution of this scientific project, without compromising its scientific unbiased value. The funding company contributed to the study design, but the planning of the experiments, the data collection and analysis, as well as preparation of the manuscript for publication was done by the academic researcher guided by unbiased academic standards.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Andersson KG, 2008, RADIAT PROT DOSIM, V131, P297, DOI 10.1093/rpd/ncn173; Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Awwad Hassan K, 2005, J Egypt Natl Canc Inst, V17, P221; Baker JE, 2011, ANTIOXID REDOX SIGN, V15, P1945, DOI 10.1089/ars.2010.3742; Barria E, 2004, STEM CELLS DEV, V13, P548, DOI 10.1089/scd.2004.13.548; Barrilleaux BL, 2009, TISSUE ENG PT A, V15, P2335, DOI 10.1089/ten.tea.2008.0434; Basile LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030434; Bifari F, 2008, TRANSFUS MED HEMOTH, V35, P194, DOI 10.1159/000128968; BISTROVIC M, 1984, PHYS MED BIOL, V29, P895, DOI 10.1088/0031-9155/29/7/014; BLEEHEN NM, 1984, RECENT RES CANCER, V92, P65; Brizel DM, 2007, J CLIN ONCOL, V25, P4084, DOI 10.1200/JCO.2007.11.5816; Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Chiesa C, 2011, Q J NUCL MED MOL IM, V55, P168; Chung Jin Kwon, 2011, Korean J Ophthalmol, V25, P268, DOI 10.3341/kjo.2011.25.4.268; Clarke D, 1996, CYTOKINE, V8, P717, DOI 10.1006/cyto.1996.0095; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; ELKIND MM, 1970, BIOPHYS J, V10, P237, DOI 10.1016/S0006-3495(70)86296-8; English K, 2011, J CELL BIOCHEM, V112, P1963, DOI 10.1002/jcb.23119; Feinendegen LE, 2007, EXP HEMATOL, V35, P37, DOI 10.1016/j.exphem.2007.01.011; Fischer-Valuck BW, 2010, BIOTECHNOL LETT, V32, P19, DOI 10.1007/s10529-009-0110-6; Gao ZM, 2012, CYTOTHERAPY, V14, P267, DOI 10.3109/14653249.2011.616194; GORODETSKY R, 1990, INT J RADIAT ONCOL, V18, P1077, DOI 10.1016/0360-3016(90)90443-N; Gratwohl A, 1998, BLOOD, V92, P765; Guinan EC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003126; Hagby Moti, 2009, J Emerg Trauma Shock, V2, P117, DOI 10.4103/0974-2700.50747; Hopewell JW, 2003, INT J RADIAT BIOL, V79, P513, DOI 10.1080/09553000310001600907; Hu KX, 2010, BRIT J RADIOL, V83, P52, DOI 10.1259/bjr/61042310; Isern Joan, 2011, Curr Osteoporos Rep, V9, P210, DOI 10.1007/s11914-011-0075-y; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; KIMURA H, 1990, EUR J IMMUNOL, V20, P1927, DOI 10.1002/eji.1830200909; KINNAMON KE, 1980, RADIAT RES, V82, P215, DOI 10.2307/3575250; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; KRUEGER WWO, 1978, OTOLARYNG HEAD NECK, V86, P804, DOI 10.1177/019459987808600527; Kulkarni S, 2010, RADIAT RES, V173, P738, DOI 10.1667/RR1824.1; KUNA P, 1983, NEOPLASMA, V30, P349; Lange C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014486; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; Meineke V., 2005, BR J RADIOL S, P196, DOI DOI 10.1259/BJR/25654769; MENDIONDO OA, 1982, ACTA RADIOL ONCOL, V21, P319, DOI 10.3109/02841868209134022; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Need JT, 2006, MIL MED, V171, P698, DOI 10.7205/MILMED.171.8.698; Neves H, 2012, DEV BIOL, V361, P208, DOI 10.1016/j.ydbio.2011.10.022; Oya N, 2006, INT J HEMATOL, V83, P86, DOI 10.1532/IJH97.05046; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Prather WR, 2008, EXPERT OPIN BIOL TH, V8, P1241, DOI [10.1517/14712598.8.8.1241, 10.1517/14712598.8.8.1241 ]; Prather WR, 2009, CYTOTHERAPY, V11, P427, DOI 10.1080/14653240902849762; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Raaijmakers MHGP, 2012, INT J HEMATOL, V95, P17, DOI 10.1007/s12185-011-1001-x; Rabbani ZN, 2007, FREE RADICAL RES, V41, P1273, DOI 10.1080/10715760701689550; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024072; Santucci MA, 1997, ACTA HAEMATOL-BASEL, V97, P90; Schaniel C, 2009, ANN NY ACAD SCI, V1176, P26, DOI 10.1111/j.1749-6632.2009.04608.x; Schlosser S, 2012, MICROVASC RES, V83, P267, DOI 10.1016/j.mvr.2012.02.011; Shim S, 2013, EXP HEMATOL, V41, P346, DOI 10.1016/j.exphem.2013.01.002; Singh VK, 2012, RADIAT RES, V177, P781, DOI 10.1667/RR2894.1; Sioud M, 2011, INT J ONCOL, V38, P385, DOI 10.3892/ijo.2010.869; SONG CW, 1981, INT J RADIAT ONCOL, V7, P1695, DOI 10.1016/0360-3016(81)90195-4; TAMAYO E, 1994, STEM CELLS, V12, P304, DOI 10.1002/stem.5530120306; THIERRY D., 2005, BR J RADIOL S, V27, P175, DOI DOI 10.1259/BJR/90209767; TILL JE, 1964, ANN NY ACAD SCI, V114, P115; Tonn T, 2008, TRANSFUS MED HEMOTH, V35, P269, DOI 10.1159/000147276; UTLEY JF, 1976, INT J RADIAT ONCOL, V1, P699, DOI 10.1016/0360-3016(76)90152-8; VANDYK J, 1983, INT J RADIAT ONCOL, V9, P1913, DOI 10.1016/0360-3016(83)90362-0; WEICHSELBAUM RR, 1983, INT J RADIAT ONCOL, V9, P91, DOI 10.1016/0360-3016(83)90215-8; Wheldon TE, 1997, BRIT J RADIOL, V70, P1204, DOI 10.1259/bjr.70.840.9505837; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Yang Xiaodong, 2012, Adv Hematol, V2012, P142530, DOI 10.1155/2012/142530; Yuan T, 2011, J BIOMED MATER RES A, V98A, P332, DOI 10.1002/jbm.a.33121; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	82	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66549	10.1371/journal.pone.0066549	http://dx.doi.org/10.1371/journal.pone.0066549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823334	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400125
J	Lee, CF; Ullevig, S; Kim, HS; Asmis, R				Lee, Chi Fung; Ullevig, Sarah; Kim, Hong Seok; Asmis, Reto			Regulation of Monocyte Adhesion and Migration by Nox4	PLOS ONE			English	Article							REDOX REGULATION; MITOCHONDRIAL DYSFUNCTION; GLUTATHIONE-REDUCTASE; TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; HUMAN MACROPHAGES; CELL-MIGRATION; BETA-ACTIN; KINASE; SUPEROXIDE	We showed that metabolic disorders promote thiol oxidative stress in monocytes, priming monocytes for accelerated chemokine-induced recruitment, and accumulation at sites of vascular injury and the progression of atherosclerosis. The aim of this study was to identify both the source of reactive oxygen species (ROS) responsible for thiol oxidation in primed and dysfunctional monocytes and the molecular mechanisms through which ROS accelerate the migration and recruitment of monocyte-derived macrophages. We found that Nox4, a recently identified NADPH oxidase in monocytes and macrophages, localized to focal adhesions and the actin cytoskeleton, and associated with phospho-FAK, paxillin, and actin, implicating Nox4 in the regulation of monocyte adhesion and migration. We also identified Nox4 as a new, metabolic stress-inducible source of ROS that controls actin S-glutathionylation and turnover in monocytes and macrophages, providing a novel mechanistic link between Nox4-derived H2O2 and monocyte adhesion and migration. Actin associated with Nox4 was S-glutathionylated, and Nox4 association with actin was enhanced in metabolically-stressed monocytes. Metabolic stress induced Nox4 and accelerated monocyte adhesion and chemotaxis in a Nox4-dependent mechanism. In conclusion, our data suggest that monocytic Nox4 is a central regulator of actin dynamics, and induction of Nox4 is the rate-limiting step in metabolic stress-induced monocyte priming and dysfunction associated with accelerated atherosclerosis and the progression of atherosclerotic plaques.	[Lee, Chi Fung; Ullevig, Sarah; Asmis, Reto] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Sch Hlth Profess, San Antonio, TX 78229 USA; [Kim, Hong Seok; Asmis, Reto] Univ Texas Hlth Sci Ctr San Antonio, Dept Clin Lab Sci, Sch Hlth Profess, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Asmis, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Sch Hlth Profess, San Antonio, TX 78229 USA.	asmis@uthscsa.edu	Asmis, Reto/W-1344-2019	Lee, Chi Fung/0000-0002-5395-6925; Ullevig, Sarah/0000-0001-5322-2801	American Heart Association (AHA) Southwest Affiliate Predoctoral Fellowship [10PRE3460002]; NIH [HL-70963]; AHA [0855011F]; UTHSCSA [NIH-NCI P30 CA54174, NIH-NIA P30 AG013319, NIH-NIA P01AG19316]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319] Funding Source: NIH RePORTER	American Heart Association (AHA) Southwest Affiliate Predoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); UTHSCSA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to C.F.L. from the American Heart Association (AHA) Southwest Affiliate Predoctoral Fellowship 10PRE3460002, and R.A. from the NIH HL-70963 and the AHA 0855011F. Confocal images were acquired in the Core Optical Imaging Facility, which is supported by UTHSCSA, NIH-NCI P30 CA54174 (San Antonio Cancer Institute), NIH-NIA P30 AG013319 (Nathan Shock Center) and (NIH-NIA P01AG19316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Chaubey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054869; CHEN K, 2009, ANTIOXID REDOX SIGNA; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; GUZIK TJ, 2009, ANTIOXID REDOX SIGNA; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Johansson Magnus, 2007, BMC Biochemistry, V8, P26, DOI 10.1186/1471-2091-8-26; Kanda M, 2006, J BIOL CHEM, V281, P28518, DOI 10.1074/jbc.M604359200; Kim HS, 2012, P NATL ACAD SCI USA, V109, pE2803, DOI 10.1073/pnas.1212596109; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; QIAO M, 2009, ARTERIOSCLER THROMB; Qiao M, 2007, ARTERIOSCL THROM VAS, V27, P1375, DOI 10.1161/ATVBAHA.107.142109; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Taddei ML, 2007, ANTIOXID REDOX SIGN, V9, P469, DOI 10.1089/ars.2006.1392; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang YM, 2006, FREE RADICAL BIO MED, V41, P775, DOI 10.1016/j.freeradbiomed.2006.05.029; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Wintergerst ES, 1998, HISTOCHEM CELL BIOL, V110, P231, DOI 10.1007/s004180050285; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09	60	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66964	10.1371/journal.pone.0066964	http://dx.doi.org/10.1371/journal.pone.0066964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825596	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400172
J	Rauner, G; Leviav, A; Mavor, E; Barash, I				Rauner, Gat; Leviav, Amos; Mavor, Eliezer; Barash, Itamar			Development of Foreign Mammary Epithelial Morphology in the Stroma of Immunodeficient Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; ATHYMIC NUDE-MICE; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; STEROID-RECEPTORS; GLAND DEVELOPMENT; CANCER-CELLS; STEM-CELLS; FAT-PADS	Systemic growth and branching stimuli, and appropriate interactions with the host stroma are essential for the development of foreign epithelia in the mammary gland of immunodeficient mice. These factors were manipulated to promote and investigate the generation of representative bovine epithelial morphology in the transplanted mouse mammary stroma. The bovine mammary epithelium is unique in its commitment to rapid proliferation and high rate of differentiation. Its morphological organization within a fibrotic stroma resembles that of the human breast, and differs significantly from the rudimentary ductal network that penetrates a fatty stroma in mice. Transplantation of bovine mammary epithelial cells into the cleared mammary fat pad of NOD-SCID mice led to continuous growth of epithelial structures. Multilayered hollow spheres developed within fibrotic areas, but in contrast to mice, no epithelial organization was formed between adipocytes. The multilayered spheres shared characteristics with the heifer gland's epithelium, including lumen size, cell proliferation, cytokeratin orientation, estrogen/progesterone receptor expression and localization, and milk protein synthesis. However, they did not extend into the mouse fat pad via ductal morphology. Pre-transplantation of fibroblasts increased the number of spheres, but did not promote extension of bovine morphology. The bovine cells preserved their fate and rarely participated in chimeric mouse-bovine outgrowths. Nevertheless, a single case of terminal ductal lobuloalveolar unit (TDLU) development was recorded in mice treated with estrogen and progesterone, implying the feasibility of this representative bovine morphology's development. In vitro extension of these studies revealed paracrine inhibition of bovine epithelial mammosphere development by adipocytes, which was also generalized to breast epithelial mammosphere formation. The rescue of mammosphere development by fibroblast growth factor administration evidences an active equilibrium between inhibitory and supportive effects exerted by the adipose and fibrotic regions of the stroma, respectively, which determines the development of foreign epithelium.	[Rauner, Gat; Barash, Itamar] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Rauner, Gat] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Jerusalem, Israel; [Leviav, Amos] Kaplan Med Ctr, Dept Plast Surg, Rehovot, Israel; [Mavor, Eliezer] Kaplan Med Ctr, Dept Surg, Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center	Barash, I (corresponding author), Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel.	itamar.barash@mail.huji.ac.il			Israeli Ministry of Agriculture (Biotechnology and Animal Science); Israel Dairy Board and the Israel Science Foundation; Israel Academy of Sciences [289/11]	Israeli Ministry of Agriculture (Biotechnology and Animal Science); Israel Dairy Board and the Israel Science Foundation; Israel Academy of Sciences	This study was supported by the Chief Scientist, Israeli Ministry of Agriculture (Biotechnology and Animal Science), the Israel Dairy Board and the Israel Science Foundation, Israel Academy of Sciences, contract no. 289/11 to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Athie F, 1996, J DAIRY SCI, V79, P220, DOI 10.3168/jds.S0022-0302(96)76354-3; BANISACCHI T, 1987, ACTA ANAT, V129, P1, DOI 10.1159/000146368; BARASH I, 1993, TRANSGENIC RES, V2, P266, DOI 10.1007/BF01968839; BARASH I, 1995, MOL CELL BIOCHEM, V144, P175, DOI 10.1007/BF00944397; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; BEAMER PD, 1983, VET PATHOL, V20, P509, DOI 10.1177/030098588302000418; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2012, STEM CELLS DEV, V21, P948, DOI 10.1089/scd.2011.0148; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Bruno RD, 2012, SEMIN CELL DEV BIOL, V23, P591, DOI 10.1016/j.semcdb.2012.03.007; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Capuco AV, 2012, ANIMAL, V6, P382, DOI 10.1017/S1751731111002369; Capuco AV, 2005, J MAMMARY GLAND BIOL, V10, P5, DOI 10.1007/s10911-005-2536-3; Capuco AV, 2002, TISSUE CELL, V34, P143, DOI 10.1016/S0040-8166(02)00024-1; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; COLEMANKRNACIK S, 1994, MOL ENDOCRINOL, V8, P218, DOI 10.1210/me.8.2.218; Connor EE, 2007, J DAIRY SCI, V90, pE55, DOI 10.3168/jds.2006-466; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; DEOME KB, 1959, CANCER RES, V19, P515; Dillon C, 2004, J MAMMARY GLAND BIOL, V9, P207, DOI 10.1023/B:JOMG.0000037163.56461.1e; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Hovey RC, 1999, J MAMMARY GLAND BIOL, V4, P53, DOI 10.1023/A:1018704603426; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; JOHNSTON PG, 1992, CANCER RES, V52, P6860; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; KORDON EC, 1995, DEV BIOL, V168, P47, DOI 10.1006/dbio.1995.1060; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Maple RL, 1998, DOMEST ANIM ENDOCRIN, V15, P489, DOI 10.1016/S0739-7240(98)00037-X; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; MCFADDEN TB, 1993, PROC NEW ZEAL SOC AN, V53, P143; Motta M, 2007, MOL CELL ENDOCRINOL, V263, P149, DOI 10.1016/j.mce.2006.09.010; Mroue Rana, 2013, Methods Mol Biol, V945, P221, DOI 10.1007/978-1-62703-125-7_14; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Parmar H, 2002, ENDOCRINOLOGY, V143, P4886, DOI 10.1210/en.2002-220570; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Piantoni P, 2010, BIOINFORM BIOL INSIG, V4, P85; Pond AC, 2013, STEM CELLS, V31, P178, DOI 10.1002/stem.1266; POVEY RC, 1969, PATHOL VET, V6, P502, DOI 10.1177/030098586900600603; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Rauner G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030113; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Rosenfield Sonia M, 2013, Cells, V2, P43, DOI 10.3390/cells2010043; Rowson AR, 2012, SEMIN CELL DEV BIOL, V23, P557, DOI 10.1016/j.semcdb.2012.03.018; RUDLAND PS, 1989, J HISTOCHEM CYTOCHEM, V37, P1087, DOI 10.1177/37.7.2471725; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4; SHEFFIELD LG, 1988, INT J CANCER, V41, P713, DOI 10.1002/ijc.2910410513; SHEFFIELD LG, 1986, J DAIRY SCI, V69, P1141, DOI 10.3168/jds.S0022-0302(86)80513-6; SHEFFIELD LG, 1988, J DAIRY SCI, V71, P2855, DOI 10.3168/jds.S0022-0302(88)79881-1; Silva LFP, 2008, J DAIRY SCI, V91, P3034, DOI 10.3168/jds.2007-0761; Silva LFP, 2002, J DAIRY SCI, V85, P3277, DOI 10.3168/jds.S0022-0302(02)74416-0; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; SUD SC, 1968, J DAIRY SCI, V51, P210, DOI 10.3168/jds.S0022-0302(68)86954-1; Visvader JE, 2010, COLD SPRING HARB PER, P3; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Wilson CL, 2006, ENDOCR-RELAT CANCER, V13, P617, DOI 10.1677/erc.1.01165; WOODWARD TL, 1993, J ENDOCRINOL, V136, P149, DOI 10.1677/joe.0.1360149; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yamaji D, 2007, JPN J VET RES, V54, P183; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	81	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68637	10.1371/journal.pone.0068637	http://dx.doi.org/10.1371/journal.pone.0068637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825700	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400199
J	Tourniaire, F; Romier-Crouzet, B; Lee, JH; Marcotorchino, J; Gouranton, E; Salles, J; Malezet, C; Astier, J; Darmon, P; Blouin, E; Walrand, S; Ye, JP; Landrier, JF				Tourniaire, Franck; Romier-Crouzet, Beatrice; Lee, Jong Han; Marcotorchino, Julie; Gouranton, Erwan; Salles, Jerome; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Blouin, Eric; Walrand, Stephane; Ye, Jianping; Landrier, Jean-Francois			Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated by NF-kappa B	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; UP-REGULATION; OBESITY; INFLAMMATION; ACCUMULATION; ADIPOCYTES; METABOLISM	Immune cell infiltration of expanding adipose tissue during obesity and its role in insulin resistance has been described and involves chemokines. However, studies so far have focused on a single chemokine or its receptor (especially CCL2 and CCL5) whereas redundant functions of chemokines have been described. The objective of this work was to explore the expression of chemokines in inflamed adipose tissue in obesity. Human and mouse adipocytes were analyzed for expression of chemokines in response to inflammatory signal (TNF-alpha) using microarrays and gene set enrichment analysis. Gene expression was verified by qRT-PCR. Chemokine protein was determined in culture medium with ELISA. Chemokine expression was investigated in human subcutaneous adipose tissue biopsies and mechanism of chemokine expression was investigated using chemical inhibitors and cellular and animal transgenic models. Chemokine encoding genes were the most responsive genes in TNF-alpha treated human and mouse adipocytes. mRNA and protein of 34 chemokine genes were induced in a dose-dependent manner in the culture system. Furthermore, expression of those chemokines was elevated in human obese adipose tissue. Finally, chemokine expression was reduced by NF-kappa B inactivation and elevated by NF-kappa B activation. Our data indicate that besides CCL2 and CCL5, numerous other chemokines such as CCL19 are expressed by adipocytes under obesity-associated chronic inflammation. Their expression is regulated predominantly by NF-kappa B. Those chemokines could be involved in the initiation of infiltration of leukocytes into obese adipose tissue.	[Tourniaire, Franck; Romier-Crouzet, Beatrice; Marcotorchino, Julie; Gouranton, Erwan; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Landrier, Jean-Francois] INRA, UMR 1260, Marseille, France; [Tourniaire, Franck; Romier-Crouzet, Beatrice; Marcotorchino, Julie; Gouranton, Erwan; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Landrier, Jean-Francois] INSERM, UMR Nutr Obes & Risque Thrombot 1062, F-13258 Marseille, France; [Tourniaire, Franck; Romier-Crouzet, Beatrice; Marcotorchino, Julie; Gouranton, Erwan; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Landrier, Jean-Francois] Univ Aix Marseille, Fac Med, Marseille, France; [Lee, Jong Han; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Salles, Jerome; Walrand, Stephane] Ctr Rech INRA Clermont Ferrand Theix, UMR INRA Unite Nutr Humaine 1019, St Genes Champanelle, France; [Blouin, Eric] Lab Labcatal, Montrouge, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; INRAE	Landrier, JF (corresponding author), INRA, UMR 1260, Marseille, France.	jean-francois.landrier@univ-amu.fr	Ye, Jianping/N-1998-2017; Landrier, Jean-Francois/AAH-2757-2019; Tourniaire, Franck/K-9131-2017	Ye, Jianping/0000-0003-3875-365X; Landrier, Jean-Francois/0000-0002-8690-8014; Tourniaire, Franck/0000-0002-6394-7045; Darmon, Patrice/0000-0003-1726-2296; Walrand, Stephane/0000-0002-4349-3664; Salles, Jerome/0000-0002-1787-5802	NIH [DK068036, DK085495]; INRA; INSERM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085495, R01DK068036, R56DK068036] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INRA; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was partially supported by NIH grant (DK068036 and DK085495) to JY, and funding from INRA and INSERM to JFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Foster MT, 2010, PHYSIOL BEHAV, V101, P282, DOI 10.1016/j.physbeh.2010.05.014; Gouranton E, 2011, J NUTR BIOCHEM, V22, P642, DOI 10.1016/j.jnutbio.2010.04.016; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Landrier JF, 2008, FREE RADICAL RES, V42, P523, DOI 10.1080/10715760802098859; Landrier JF, 2010, J NUTR BIOCHEM, V21, P1207, DOI 10.1016/j.jnutbio.2009.10.008; Landrier JF, 2009, ENDOCRINOLOGY, V150, P5318, DOI 10.1210/en.2009-0506; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Nikolajczyk BS, 2011, GENES IMMUN, V12, P239, DOI 10.1038/gene.2011.14; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Tsigos C, 1999, METABOLISM, V48, P1332, DOI 10.1016/S0026-0495(99)90277-9; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229	44	94	97	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66515	10.1371/journal.pone.0066515	http://dx.doi.org/10.1371/journal.pone.0066515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824685	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400120
J	Wang, YX; Marshall, KL; Baba, Y; Gerling, GJ; Lumpkin, EA				Wang, Yuxiang; Marshall, Kara L.; Baba, Yoshichika; Gerling, Gregory J.; Lumpkin, Ellen A.			Hyperelastic Material Properties of Mouse Skin under Compression	PLOS ONE			English	Article							AGE-RELATED-CHANGES; MECHANICAL-PROPERTIES; THICKNESS; POPULATIONS; PATTERNS	The skin is a dynamic organ whose complex material properties are capable of withstanding continuous mechanical stress while accommodating insults and organism growth. Moreover, synchronized hair cycles, comprising waves of hair growth, regression and rest, are accompanied by dramatic fluctuations in skin thickness in mice. Whether such structural changes alter skin mechanics is unknown. Mouse models are extensively used to study skin biology and pathophysiology, including aging, UV-induced skin damage and somatosensory signaling. As the skin serves a pivotal role in the transfer function from sensory stimuli to neuronal signaling, we sought to define the mechanical properties of mouse skin over a range of normal physiological states. Skin thickness, stiffness and modulus were quantitatively surveyed in adult, female mice (Mus musculus). These measures were analyzed under uniaxial compression, which is relevant for touch reception and compression injuries, rather than tension, which is typically used to analyze skin mechanics. Compression tests were performed with 105 full-thickness, freshly isolated specimens from the hairy skin of the hind limb. Physiological variables included body weight, hair-cycle stage, maturity level, skin site and individual animal differences. Skin thickness and stiffness were dominated by hair-cycle stage at young (6-10 weeks) and intermediate (13-19 weeks) adult ages but by body weight in mature mice (26-34 weeks). Interestingly, stiffness varied inversely with thickness so that hyperelastic modulus was consistent across hair-cycle stages and body weights. By contrast, the mechanics of hairy skin differs markedly with anatomical location. In particular, skin containing fascial structures such as nerves and blood vessels showed significantly greater modulus than adjacent sites. Collectively, this systematic survey indicates that, although its structure changes dramatically throughout adult life, mouse skin at a given location maintains a constant elastic modulus to compression throughout normal physiological stages.	[Wang, Yuxiang; Gerling, Gregory J.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA; [Marshall, Kara L.; Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Lumpkin, Ellen A.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	University of Virginia; Columbia University; Columbia University	Gerling, GJ (corresponding author), Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA.	gregory-gerling@virginia.edu; eal2166@columbia.edu		Lumpkin, Ellen/0000-0002-1166-3374	National Institutes of Neurological Disorders and Stroke through the CRCNS program [NINDS R01NS073119]; Columbia University Skin Disease Research Center Tissue Culture and Histology and Advanced Imaging Cores [NIAMS P30AR044535]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073119] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke through the CRCNS program; Columbia University Skin Disease Research Center Tissue Culture and Histology and Advanced Imaging Cores; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Neurological Disorders and Stroke through the CRCNS program (NINDS R01NS073119 to EAL and GJG). Histology was performed with support from the Columbia University Skin Disease Research Center Tissue Culture and Histology and Advanced Imaging Cores (NIAMS P30AR044535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NINDS: http://www.ninds.nih.gov NIAMS:http://www.niams.nih.gov.	Ananthaswamy HN, 1997, NAT MED, V3, P510, DOI 10.1038/nm0597-510; Battaglia TC, 2005, J DERMATOL SCI, V39, P192, DOI 10.1016/j.jdermsci.2005.07.002; Crichton ML, 2013, BIOMATERIALS, V34, P2087, DOI 10.1016/j.biomaterials.2012.11.035; Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012; DALY CH, 1982, J INVEST DERMATOL, V79, pS17, DOI 10.1111/1523-1747.ep12544620; DALY CH, 1979, J INVEST DERMATOL, V73, P84, DOI 10.1111/1523-1747.ep12532770; ESCOFFIER C, 1989, J INVEST DERMATOL, V93, P353, DOI 10.1111/1523-1747.ep12280259; Eshel H, 2001, ANN BIOMED ENG, V29, P164, DOI 10.1114/1.1349697; FOSTER CA, 1987, ANAT REC, V218, P355, DOI 10.1002/ar.1092180317; Holzapfel G., 2000, NONLINEAR SOLID MECH; Kang GZ, 2011, J MECH BEHAV BIOMED, V4, P498, DOI 10.1016/j.jmbbm.2010.12.015; Kent RW, 2009, J BIOMECH, V42, P1656, DOI 10.1016/j.jbiomech.2009.04.027; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Krueger N, 2011, SKIN RES TECHNOL, V17, P141, DOI 10.1111/j.1600-0846.2010.00486.x; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; LANIR Y, 1974, J BIOMECH, V7, P171, DOI 10.1016/0021-9290(74)90058-X; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Martin PG., 2000, PROPERTIES HUMAN SKI; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; OOMENS CWJ, 1987, J BIOMECH, V20, P877, DOI 10.1016/0021-9290(87)90147-3; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2009, INT J DEV BIOL, V53, P857, DOI 10.1387/ijdb.072564mp; Serrat MA, 2007, CONNECT TISSUE RES, V48, P19, DOI 10.1080/03008200601021373; Smalls LK, 2006, SKIN RES TECHNOL, V12, P43, DOI 10.1111/j.0909-725X.2006.00135.x; Wang Y, 2013, IEEE INT WORKS INFOR, P49, DOI 10.1109/WIFS.2013.6707793; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; WHITTON JT, 1973, HEALTH PHYS, V24, P1, DOI 10.1097/00004032-197301000-00001; Wolnicka-Glubisz A, 2013, EXP DERMATOL, V22, P226, DOI 10.1111/exd.12100; Wu JZ, 2003, BIO-MED MATER ENG, V13, P373; Zaidi Z, 2010, DERMATOLOGY IN CLINICAL PRACTICE, P1, DOI 10.1007/978-1-84882-862-9_1; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	33	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67439	10.1371/journal.pone.0067439	http://dx.doi.org/10.1371/journal.pone.0067439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825661	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400185
J	Xu, H; Belkacemi, L; Jog, M; Parrent, A; Hebb, MO				Xu, Hu; Belkacemi, Louiza; Jog, Mandar; Parrent, Andrew; Hebb, Matthew O.			Neurotrophic factor expression in expandable cell populations from brain samples in living patients with Parkinson's disease	FASEB JOURNAL			English	Article						neurodegeneration; transplantation	MESENCHYMAL STEM-CELLS; ADULT HUMAN BRAIN; SUBCORTICAL WHITE-MATTER; NEURODEGENERATIVE DISEASES; EXTRACELLULAR-MATRIX; MULTIPLE-SCLEROSIS; PROGENITOR CELLS; NERVOUS-SYSTEM; GENE-TRANSFER; GLIAL-CELLS	Cell-based therapies offer promise for patients with Parkinson's disease (PD); however, durable and effective transplantation substrates need to be defined. This study characterized the feasibility and growth properties of primary cultures established from small-volume brain biopsies taken during deep brain stimulation (DBS) surgery in patients with PD. The lineage and expression of neurotrophic factors with known beneficial actions in PD-affected brain circuitry were also evaluated. Nineteen patients with PD undergoing DBS surgery consented to brain biopsies prior to electrode implantation. Cultures from these samples exhibited exponential and plateau phases of growth and were readily expanded throughout multiple passages. There was robust expression of progenitor markers and the unexpected colocalization of neural and mesenchymal proteins. The oligodendrocyte transcription factor, Olig1, and the myelin-specific sphingolipid, galactocerebroside, were coexpressed with each of glial-derived neurotrophic factor, brain-derived neurotrophic factor, and cerebral dopamine neurotrophic factor. Fluorescence-activated cell sorting demonstrated homogeneous expression of both nestin and Olig1 throughout the expanded cultures. Cells remained viable after a year in cryostorage. These findings confirm the feasibility of small brain biopsies as an expandable source of autologous cell substrate in living patients and demonstrate the complex phenotype of these cells, with implications for therapeutic application in PD and other neurological diseases. Xu, H., Belkacemi, L., Jog, M., Parrent, A., Hebb. M. O. Neurotrophic factor expression in expandable cell populations from brain samples in living patients with Parkinson's disease.	[Xu, Hu; Belkacemi, Louiza; Jog, Mandar; Parrent, Andrew; Hebb, Matthew O.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 5A5, Canada	Western University (University of Western Ontario)	Hebb, MO (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci Neurosurg, 339 Windermere Rd,C7-134, London, ON N6A 5A5, Canada.	mhebb@uwo.ca			Michael J. Fox Foundation for Parkinson's Research	Michael J. Fox Foundation for Parkinson's Research	The authors thank Drs. Marco and Vania Prado for their generous provision of technical resources. This work was supported by The Michael J. Fox Foundation for Parkinson's Research.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bernstein JJ, 1996, INT J DEV NEUROSCI, V14, P681, DOI 10.1016/0736-5748(95)00096-8; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brunet JF, 2002, LAB INVEST, V82, P809, DOI 10.1097/01.LAB.0000017166.26718.BB; Dass B, 2006, NEUROLOGY, V66, pS89, DOI 10.1212/WNL.66.10_suppl_4.S89; Defer GL, 1996, BRAIN, V119, P41, DOI 10.1093/brain/119.1.41; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Glavaski-Joksimovic A, 2010, J NEUROSCI RES, V88, P2669, DOI 10.1002/jnr.22435; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Hayashi T, 2013, J CLIN INVEST, V123, P272, DOI 10.1172/JCI62516; Hickey P, 2013, EXPERT OPIN BIOL TH, V13, P137, DOI 10.1517/14712598.2013.754420; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kells AP, 2012, NEUROBIOL DIS, V48, P228, DOI 10.1016/j.nbd.2011.10.004; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; L'Episcopo F, 2010, CNS NEUROL DISORD-DR, V9, P349, DOI 10.2174/187152710791292639; Lescaudron L, 2012, CURR MED CHEM, V19, P6018; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Ma YL, 2010, J NUCL MED, V51, P7, DOI 10.2967/jnumed.109.066811; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; MAPSTONE TB, 1992, PEDIATR NEUROSURG, V17, P169, DOI 10.1159/000120590; Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365; Mendez I, 2002, J NEUROSURG, V96, P589, DOI 10.3171/jns.2002.96.3.0589; Moloney TC, 2010, BRAIN RES, V1359, P33, DOI 10.1016/j.brainres.2010.08.040; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; NORTON WT, 1988, GLIA, V1, P403, DOI 10.1002/glia.440010608; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI [10.1056/NEJMct1208070, 10.1056/NEJMc1214078]; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Othman A, 2011, GLIA, V59, P914, DOI 10.1002/glia.21163; PERZELOVA A, 1993, GLIA, V7, P237, DOI 10.1002/glia.440070307; Perzelova A, 2007, BIOLOGIA, V62, P633, DOI 10.2478/s11756-007-0123-3; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; Ren LQ, 2000, MOL PHARMACOL, V58, P1303, DOI 10.1124/mol.58.6.1303; Roessler R., 2012, STEM CELL REV, DOI 10.1007/s12015-012-9369-4; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Ruozi B, 2012, INT REV NEUROBIOL, V102, P207, DOI 10.1016/B978-0-12-386986-9.00009-0; RUTKA JT, 1986, LAB INVEST, V55, P71; Sadan O, 2009, EXPERT OPIN BIOL TH, V9, P1487, DOI 10.1517/14712590903321439; Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; ZHANG ET, 1990, J ANAT, V170, P111; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	61	12	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4157	4168		10.1096/fj.12-226555	http://dx.doi.org/10.1096/fj.12-226555			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825231				2022-12-25	WOS:000329747100027
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			Phosphatidylglycerol Directs Binding and Inhibitory Action of EIIA(Glc) Protein on the Maltose Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PHOSPHOTRANSFERASE SYSTEM; PHOSPHORYL TRANSFER COMPLEX; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CASSETTE TRANSPORTER; INDUCER EXCLUSION; SUGAR-TRANSPORT; GLYCEROL KINASE; ATP; MEMBRANE	The signal-transducing protein EIIA(Glc) belongs to the phosphoenolpyruvate carbohydrate phosphotransferase system. In its dephosphorylated state, EIIA(Glc) is a negative regulator for several permeases, including the maltose transporter MalFGK(2). How EIIA(Glc) is targeted to the membrane, how it interacts with the transporter, and how it inhibits sugar uptake remain obscure. We show here that acidic phospholipids together with the N-terminal tail of EIIA(Glc) are essential for the high affinity binding of the protein to the transporter. Using protein docking prediction and chemical cross-linking, we demonstrate that EIIA(Glc) binds to the MalK dimer, interacting with both the nucleotide-binding and the C-terminal regulatory domains. Dissection of the ATPase cycle reveals that EIIA(Glc) does not affect the binding of ATP but rather inhibits the capacity of MalK to cleave ATP. We propose a mechanism of maltose transport inhibition by this central amphitropic regulatory protein.	[Bao, Huan; Duong, Franck] Univ British Columbia, Fac Med, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Fac Med, Inst Life Sci, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Bao, Huan/0000-0002-4301-4627; Duong Van Hoa, Franck/0000-0001-7328-6124	Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair II award	Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair II award	This work was supported by an infrastructure grant from the Canadian Foundation for Innovation and operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).; The recipient of a Canada Research Chair II award. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Life Sciences Institute, Faculty of Medicine, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia V6T1Z3, Canada. Tel.: 604-822-5975; Fax: 604-822-522; E-mail: fduong@mail.ubc.ca.	Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bluschke B, 2006, J BIOL CHEM, V281, P12833, DOI 10.1074/jbc.M512646200; Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 1996, J BIOL CHEM, V271, P4858; DEAN DA, 1990, J BIOL CHEM, V265, P21005; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; MISKO TP, 1987, J BIOL CHEM, V262, P16261; NOVOTNY MJ, 1985, J BACTERIOL, V162, P810, DOI 10.1128/JB.162.2.810-816.1985; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Poolman B, 2005, METHOD ENZYMOL, V400, P429, DOI 10.1016/S0076-6879(05)00025-X; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Richet E, 2012, MOL MICROBIOL, V85, P632, DOI 10.1111/j.1365-2958.2012.08137.x; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Sondej M, 2000, BIOCHEMISTRY-US, V39, P2931, DOI 10.1021/bi9919596; VANDERVLAG J, 1994, J BACTERIOL, V176, P3518, DOI 10.1128/JB.176.12.3518-3526.1994; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Wang GS, 2003, PROTEIN SCI, V12, P1087, DOI 10.1110/ps.0301503; Wang GS, 2000, J BIOL CHEM, V275, P39811, DOI 10.1074/jbc.C000709200; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382	31	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23666	23674		10.1074/jbc.M113.489567	http://dx.doi.org/10.1074/jbc.M113.489567			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821551	Green Published, hybrid			2022-12-25	WOS:000330611400006
J	Matsumoto, Y; Zhang, Q; Akita, K; Nakada, H; Hamamura, K; Tsuchida, A; Okajima, T; Furukawa, K; Urano, T; Furukawa, K				Matsumoto, Yasuyuki; Zhang, Qing; Akita, Kaoru; Nakada, Hiroshi; Hamamura, Kazunori; Tsuchida, Akiko; Okajima, Tetsuya; Furukawa, Keiko; Urano, Takeshi; Furukawa, Koichi			Trimeric Tn Antigen on Syndecan 1 Produced by ppGalNAc-T13 Enhances Cancer Metastasis via a Complex Formation with Integrin alpha 5 beta 1 and Matrix Metalloproteinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; LEWIS LUNG-CANCER; CELL-GROWTH; O-GLYCOSYLATION; GANGLIOSIDE GM1; IN-VIVO; ADHESION; RECEPTOR; ANTIBODY; MICRODOMAINS	We demonstrated previously that ppGalNAc-T13 (T13), identified as an up-regulated gene with increased metastasis in a DNA microarray, generated trimeric Tn (tTn) antigen (GalNAc alpha 1-Ser/Thr)(3) on Syndecan 1 in highly metastatic sublines of Lewis lung cancer. However, it is not known how tTn antigen regulates cancer metastasis. Here, we analyzed the roles of tTn antigen in cancer properties. tTn antigen on Syndecan 1 increased cell adhesion to fibronectin in an integrin-dependent manner. Furthermore, cell adhesion to fibronectin induced phosphorylation of focal adhesion kinase and paxillin in T13-transfectant cells. In the search of Syndecan 1-interacting molecules, it was demonstrated that tTn antigen-carrying Syndecan 1 interacted with integrin alpha 5 beta 1 and matrix metalloproteinase 9 and that these molecules shifted to a glycolipid-enriched microdomain/rafts along with increased metastatic potential in T13-transfectant cells. We also identified a tTn substitution site on Syndecan 1, demonstrating that tTn on Syndecan 1 is essential for the interaction with integrin alpha 5 beta 1 as well as for the reaction with mAb MLS128. These data suggest that high expression of the ppGalNAc-T13 gene generates tTn antigen on Syndecan 1 under reduced expression of GM1, leading to enhanced invasion and metastasis via the formation of a molecular complex consisting of integrin alpha 5 beta 1, Syndecan 1, and MMP-9 in the glycolipid-enriched microdomain/rafts.	[Matsumoto, Yasuyuki; Zhang, Qing; Hamamura, Kazunori; Tsuchida, Akiko; Okajima, Tetsuya; Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan; [Akita, Kaoru; Nakada, Hiroshi] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Tsuchida, Akiko] Noguchi Inst, Itabashi Ku, Tokyo 1730003, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan; [Urano, Takeshi] Shimane Univ, Dept Biochem, Sch Med, Izumo, Shimane 6938501, Japan	Nagoya University; Kyoto Sangyo University; Chubu University; Shimane University	Furukawa, K (corresponding author), 65 Tsurumai,Showa Ku, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X; Hamamura, Kazunori/0000-0002-8143-338X	Ministry of Education, Culture, Sports, and Technology of Japan [21390076, 24390078, 23590371, 23110008]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Ministry of Education, Culture, Sports, and Technology of Japan Grants-in-Aid for Scientific Research 21390076, 24390078, and 23590371 and by Ministry of Education, Culture, Sports, and Technology of Japan Grant-in-Aid for Scientific Research on Innovative Areas 23110008.	Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berois N, 2006, CLIN CHEM, V52, P1701, DOI 10.1373/clinchem.2006.067975; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; CHEN QM, 1994, J BIOL CHEM, V269, P26602; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GIANCOTTI FG, 1994, BBA-REV CANCER, V1198, P47, DOI 10.1016/0304-419X(94)90005-1; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kannagi R, 2004, GLYCOCONJUGATE J, V20, P353; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Li M, 2010, J BIOSCIENCES, V35, P665, DOI 10.1007/s12038-010-0073-8; Matsumoto Y, 2012, BIOCHEM BIOPH RES CO, V419, P7, DOI 10.1016/j.bbrc.2012.01.086; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; Meng XL, 2012, CANCER METAST REV, V31, P247, DOI 10.1007/s10555-011-9342-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Morita N, 2009, BIOSCI TRENDS, V3, P32; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Musselli C, 2002, INT J CANCER, V97, P660, DOI 10.1002/ijc.10081; Noujaim AA, 2001, CANCER BIOTHER RADIO, V16, P187, DOI 10.1089/10849780152389384; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Zhang Q, 2006, J BIOL CHEM, V281, P18145, DOI 10.1074/jbc.M512566200; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	39	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24264	24276		10.1074/jbc.M113.455006	http://dx.doi.org/10.1074/jbc.M113.455006			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814067	hybrid, Green Published			2022-12-25	WOS:000330611400063
J	Subramanian, P; Locatelli-Hoops, S; Kenealey, J; DesJardin, J; Notari, L; Becerra, SP				Subramanian, Preeti; Locatelli-Hoops, Silvia; Kenealey, Jason; DesJardin, Jacqueline; Notari, Luigi; Becerra, S. Patricia			Pigment Epithelium-derived Factor (PEDF) Prevents Retinal Cell Death via PEDF Receptor (PEDF-R) IDENTIFICATION OF A FUNCTIONAL LIGAND BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; POLYUNSATURATED FATTY-ACIDS; CEREBELLAR GRANULE CELLS; DOCOSAHEXAENOIC ACID; OXIDATIVE STRESS; NEUROPROTECTIN D1; PROSTATE-CANCER; FAMILY-MEMBERS; GENE-TRANSFER; IN-VITRO	The extracellular pigment epithelium-derived factor (PEDF) displays retina survival activity by interacting with receptor proteins on cell surfaces. We have previously reported that PEDF binds and stimulates PEDF receptor (PEDF-R), a transmembrane phospholipase. However, the PEDF binding site of PEDF-R and its involvement in survival activity have not been identified. The purpose of this work is to identify a biologically relevant ligand-binding site on PEDF-R. PEDF bound the PEDF-R ectodomain L4 (Leu(159)-Met(325)) with affinity similar to the full-length PEDF-R (Met(1)-Leu(504)). Binding assays using synthetic peptides spanning L4 showed that PEDF selectively bound E5b (Ile(193)-Leu(232)) and P1 (Thr(210)-Leu(249)) peptides. Recombinant C-terminal truncated PEDF-R4 (Met(1)-Leu(232)) and internally truncated PEDF-R and PEDF-R4 (Delta His(203)-Leu(232)) retained phospholipase activity of the full-length PEDF-R. However, PEDF-R polypeptides without the His(203)-Leu(232) region lost the PEDF affinity that stimulated their enzymatic activity. Cell surface labeling showed that PEDF-R is present in the plasma membranes of retina cells. Using siRNA to selectively knock down PEDF-R in retina cells, we demonstrated that PEDF-R is essential for PEDF-mediated cell survival and antiapoptotic activities. Furthermore, preincubation of PEDF with P1 and E5b peptides blocked the PEDF.PEDF-R-mediated retina cell survival activity, implying that peptide binding to PEDF excluded ligand-receptor interactions on the cell surface. Our findings establish that PEDF-R is required for the survival and antiapoptotic effects of PEDF on retina cells and has determinants for PEDF binding within its L4 ectodomain that are critical for enzymatic stimulation.	[Subramanian, Preeti; Locatelli-Hoops, Silvia; Kenealey, Jason; DesJardin, Jacqueline; Notari, Luigi; Becerra, S. Patricia] NEI, Sect Prot Struct & Funct, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Becerra, SP (corresponding author), NEI, NIH, Bldg 6,Rm 134,6 Ctr Dr, Bethesda, MD 20892 USA.	becerrap@nei.nih.gov		, Preeti/0000-0002-6062-6158; DesJardin, Jacqueline/0000-0002-6632-8995	National Institutes of Health, NEI, Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000306] Funding Source: NIH RePORTER	National Institutes of Health, NEI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, NEI, Intramural Research Program.	Abassi YA, 2004, J IMMUNOL METHODS, V292, P195, DOI 10.1016/j.jim.2004.06.022; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DeCoster MA, 1999, J NEUROSCI RES, V56, P604; Deshpande M, 2012, INT J ONCOL, V41, P219, DOI 10.3892/ijo.2012.1431; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Etschmaier K, 2011, J NEUROCHEM, V119, P1016, DOI 10.1111/j.1471-4159.2011.07498.x; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Goetzl EJ, 2004, J CELL BIOCHEM, V92, P867, DOI 10.1002/jcb.20186; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Hirsch J, 2011, CYTOKINE, V55, P202, DOI 10.1016/j.cyto.2011.04.010; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jimenez-Atienzar M, 2003, LIPIDS, V38, P677, DOI 10.1007/s11745-003-1114-9; Kim HY, 2001, J MOL NEUROSCI, V16, P223, DOI 10.1385/JMN:16:2-3:223; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Ladhani O, 2011, NEOPLASIA, V13, P633, DOI 10.1593/neo.11446; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Miyazaki M, 2011, HUM GENE THER, V22, P559, DOI 10.1089/hum.2010.132; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Notari L, 2005, INVEST OPHTH VIS SCI, V46, P2736, DOI 10.1167/iovs.04-1489; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Notari L, 2010, FEBS J, V277, P2192, DOI 10.1111/j.1742-4658.2010.07641.x; Ogata N, 2001, CURR EYE RES, V22, P245, DOI 10.1076/ceyr.22.4.245.5506; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Rotstein NP, 1997, J NEUROCHEM, V69, P504; Rotstein NP, 2003, INVEST OPHTH VIS SCI, V44, P2252, DOI 10.1167/iovs.02-0901; Sanchez A, 2012, NEUROSCI RES, V72, P1, DOI 10.1016/j.neures.2011.09.003; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Stratikos E, 1996, PROTEIN SCI, V5, P2575, DOI 10.1002/pro.5560051220; Subramanian P, 2010, ADV EXP MED BIOL, V664, P29, DOI 10.1007/978-1-4419-1399-9_4; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; Tanimoto Seiji, 2006, Hiroshima Journal of Medical Sciences, V55, P109; Taniwaki T, 1997, J NEUROCHEM, V68, P26; Unterlauft JD, 2012, NEUROCHEM RES, V37, P1524, DOI 10.1007/s11064-012-0747-8; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	64	54	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23928	23942		10.1074/jbc.M113.487884	http://dx.doi.org/10.1074/jbc.M113.487884			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818523	Green Published, hybrid			2022-12-25	WOS:000330611400032
J	Huang, T; Cai, YD				Huang, Tao; Cai, Yu-Dong			An Information-Theoretic Machine Learning Approach to Expression QTL Analysis	PLOS ONE			English	Article							INTERACTION NETWORKS; STATISTICAL-METHODS; MUTUAL INFORMATION; FEATURE-SELECTION; GENE-REGULATION; PREDICTION; MOUSE	Expression Quantitative Trait Locus (eQTL) analysis is a powerful tool to study the biological mechanisms linking the genotype with gene expression. Such analyses can identify genomic locations where genotypic variants influence the expression of genes, both in close proximity to the variant (cis-eQTL), and on other chromosomes (trans-eQTL). Many traditional eQTL methods are based on a linear regression model. In this study, we propose a novel method by which to identify eQTL associations with information theory and machine learning approaches. Mutual Information (MI) is used to describe the association between genetic marker and gene expression. MI can detect both linear and non-linear associations. What's more, it can capture the heterogeneity of the population. Advanced feature selection methods, Maximum Relevance Minimum Redundancy (mRMR) and Incremental Feature Selection (IFS), were applied to optimize the selection of the affected genes by the genetic marker. When we applied our method to a study of apoE-deficient mice, it was found that the cis-acting eQTLs are stronger than trans-acting eQTLs but there are more trans-acting eQTLs than cis-acting eQTLs. We compared our results (mRMR. eQTL) with R/qtl, and MatrixEQTL (modelLINEAR and modelANOVA). In female mice, 67.9% of mRMR. eQTL results can be confirmed by at least two other methods while only 14.4% of R/qtl result can be confirmed by at least two other methods. In male mice, 74.1% of mRMR. eQTL results can be confirmed by at least two other methods while only 18.2% of R/qtl result can be confirmed by at least two other methods. Our methods provide a new way to identify the association between genetic markers and gene expression. Our software is available from supporting information.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Shanghai University; Icahn School of Medicine at Mount Sinai	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101, 2011CB910200, 2010CB912702]; National Natural Science Foundation of China [90913009]; Chinese Academy of Sciences [KSCX2-EW-R-04]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101, 2011CB910200 and 2010CB912702), the National Natural Science Foundation of China (90913009), Research Program of the Chinese Academy of Sciences (KSCX2-EW-R-04) and the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916; Batina L, 2011, J CRYPTOL, V24, P269, DOI 10.1007/s00145-010-9084-8; Bhasin JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001435; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cai Y., 2011, AMINO ACIDS; CHAITIN GJ, 1975, J ACM, V22, P329, DOI 10.1145/321892.321894; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen M, 2007, GENETICS, V177, P761, DOI 10.1534/genetics.107.071407; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Geng HM, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-32; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Huang T, 2012, BIOCHIMIE; Huang T, 2011, PROTEIN CELL; Huang T., 2010, P 1 ACM INT C BIOINF, P502; Huang T, 2011, PROTEIN PEPT LETT; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, NEUROCOMPUTING, V74, P3677, DOI 10.1016/j.neucom.2011.07.019; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang Tao, 2011, International Journal of Computational Biology and Drug Design, V4, P5, DOI 10.1504/IJCBDD.2011.038654; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang Tao, 2010, BMC Res Notes, V3, P142, DOI 10.1186/1756-0500-3-142; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Kendziorski C, 2006, MAMM GENOME, V17, P509, DOI 10.1007/s00335-005-0189-6; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Kojadinovic I, 2005, APPL STOCH MOD DAT A; Kumar PTK, 2011, COMPUT BIOL MED, V41, P357, DOI 10.1016/j.compbiomed.2011.03.013; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038845; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thomas MC, 2006, ELEMENTS INFORM THEO; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; Zhang W, 2010, FRONTIERS COMPUTATIO	53	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67899	10.1371/journal.pone.0067899	http://dx.doi.org/10.1371/journal.pone.0067899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825689	Green Submitted, gold, Green Published			2022-12-25	WOS:000321223000123
J	Leong, HT; Ng, GYF; Leung, VYF; Fu, SN				Leong, Hio-Teng; Ng, Gabriel Yin-fat; Leung, Vivian Yee-fong; Fu, Siu Ngor			Quantitative Estimation of Muscle Shear Elastic Modulus of the Upper Trapezius with Supersonic Shear Imaging during Arm Positioning	PLOS ONE			English	Article							SHOULDER; ELASTOGRAPHY; PATTERNS	Pain and tenderness of the upper trapezius are the major complaints among people with chronic neck and shoulder disorders. Hyper-activation and increased muscle tension of the upper trapezius during arm elevation will cause imbalance of the scapular muscle force and contribute to neck and shoulder disorders. Assessing the elasticity of the upper trapezius in different arm positions is therefore important for identifying people at risk so as to give preventive programmes or for monitoring the effectiveness of the intervention programmes for these disorders. This study aimed to establish the reliability of supersonic shear imaging (SSI) in quantifying upper trapezius elasticity/shear elastic modulus and its ability to measure the modulation of muscle elasticity during arm elevation. Twenty-eight healthy adults (15 males, 13 females; mean age = 29.6 years) were recruited to participate in the study. In each participant, the shear elastic modulus of the upper trapezius while the arm was at rest and at 30 degrees abduction was measured by two operators and twice by operator 1 with a time interval between the measurements. The results showed excellent within-and between-session intra-operator (ICC = 0.87-0.97) and inter-observer (ICC = 0.78-0.83) reliability for the upper trapezius elasticity with the arm at rest and at 30 degrees abduction. An increase of 55.23% of shear elastic modulus from resting to 30 degrees abduction was observed. Our findings demonstrate the possibilities for using SSI to quantify muscle elasticity and its potential role in delineating the modulation of upper trapezius elasticity, which is essential for future studies to compare the differences in shear elastic modulus between normal elasticity and that of individuals with neck and shoulder disorders.	[Leong, Hio-Teng; Ng, Gabriel Yin-fat; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Leung, Vivian Yee-fong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Chinese University of Hong Kong; Prince of Wales Hospital	Fu, SN (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	rsamyfu@inet.polyu.edu.hk		FU, Amy/0000-0003-4405-015X; Leong, Hio Teng/0000-0003-4185-4814				Antony NT, 2010, J ELECTROMYOGR KINES, V20, P191, DOI 10.1016/j.jelekin.2009.04.010; Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Chen Q, 2007, ARCH PHYS MED REHAB, V88, P1658, DOI 10.1016/j.apmr.2007.07.020; Chester R, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-45; Cools AM, 2003, AM J SPORT MED, V31, P542, DOI 10.1177/03635465030310041101; Cram J, 1998, INTRO SURFACE ELECTR; Drakonaki EE, 2009, CLIN RADIOL, V64, P1196, DOI 10.1016/j.crad.2009.08.006; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623; Klauser AS, 2010, SEMIN MUSCULOSKEL R, V14, P323, DOI 10.1055/s-0030-1254521; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lin JJ, 2011, J ORTHOP RES, V29, P653, DOI 10.1002/jor.21300; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Lv FQ, 2012, ULTRASOUND MED BIOL, V38, P795, DOI 10.1016/j.ultrasmedbio.2012.01.010; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Strom V, 2009, PAIN, V144, P147, DOI 10.1016/j.pain.2009.04.002; Viir R, 2007, SCAND J WORK ENV HEA, P76; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004; Wu CH, 2011, RADIOLOGY, V259, P502, DOI 10.1148/radiol.11101665	26	41	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67199	10.1371/journal.pone.0067199	http://dx.doi.org/10.1371/journal.pone.0067199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825641	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000089
J	Ma, QQ; Pan, XH; Cai, GF; Yan, JH; Xu, Y; Ono-Kihara, M; Kihara, M				Ma, Qiaoqin; Pan, Xiaohong; Cai, Gaofeng; Yan, Jiezhe; Xu, Yun; Ono-Kihara, Masako; Kihara, Masahiro			The Characteristics of Heterosexual STD Clinic Attendees Who Practice Oral Sex in Zhejiang Province, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIV TRANSMISSION; RISK; BEHAVIORS; STIS	Background: The characteristics of heterosexual attendees who visit sexually transmitted disease (STD) clinics and practice oral sex have not been revealed in China. This information is important for the development of targeted STD prevention programmes for this population. Study Design: A self-administered questionnaire survey with a cross-sectional design was administered to consecutive attendees at four STD clinics in Zhejiang Province, China, between October and December in 2007. Demographic, psychosocial, and behavioural factors associated with oral sex over a lifetime were identified using univariate and multivariate analyses. Results: Of the 872 attendees, 6.9% engaged in oral sex over their lifetimes. Of the oral-sex group, 96.6% also engaged in vaginal sex. The correlates for oral sex over a lifetime as determined by the multivariate analysis were high income (odds ratio [OR] = 2.53, 95% confidence interval [CI] 1.39-4.59), high human immunodeficiency virus (HIV)-related knowledge (OR = 2.71, 95% CI 1.26-5.81), early sex initiation (OR = 2.42, 95% CI 1.37-4.27), multiple sexual partners (OR = 3.09, 95% CI 1.58-6.06), and sexually active in the previous 6 months (OR = 7.73, 95% CI 1.04-57.39). Conclusions: Though the prevalence of oral sex is low, the heterosexual STD clinic attendees practicing oral sex was found to have higher risks associated with STD/HIV transmission than those not. Behavioural and medical interventions conducted by clinicians in Chinese STD clinics should take into account the characteristics and related risks of those who practice oral sex.	[Ma, Qiaoqin; Pan, Xiaohong; Cai, Gaofeng; Yan, Jiezhe; Xu, Yun] Ctr Dis Control & Prevent Zhejiang Prov, Dept HIV STD Control, Hangzhou, Zhejiang, Peoples R China; [Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan	Kyoto University	Ma, QQ (corresponding author), Ctr Dis Control & Prevent Zhejiang Prov, Dept HIV STD Control, Hangzhou, Zhejiang, Peoples R China.	qiaoqinma@gamail.com			Zhejiang provincial center for disease prevention and control,China	Zhejiang provincial center for disease prevention and control,China	This research was supported by a grant from Zhejiang provincial center for disease prevention and control,China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 2005, SEX TRANSM DIS, V32, P710, DOI 10.1097/01.olq.0000175370.08709.72; Ballini A, 2012, J SEX MED, V9, P372, DOI 10.1111/j.1743-6109.2011.02515.x; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P966; Davis P, 1999, J SEX RES, V36, P135, DOI 10.1080/00224499909551978; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; Edwards S, 1998, SEX TRANSM INFECT, V74, P95, DOI 10.1136/sti.74.2.95; Gilbart VL, 2006, SEX TRANSM INFECT, V82, P15, DOI 10.1136/sti.2004.014191; Gindi RM, 2008, J ADOLESCENT HEALTH, V42, P307, DOI 10.1016/j.jadohealth.2007.09.015; Gong X, 2012, B STI PREVENTION CON, V26, P9; Harrison A, 2005, SEX TRANSM INFECT, V81, P259, DOI 10.1136/sti.2004.011486; Hawkins DA, 2001, SEX TRANSM INFECT, V77, P307, DOI 10.1136/sti.77.5.307; Hu Q, 2006, CHINESE J HLTH ED, V22, P647; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Ma QQ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-44; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; Mosher William D, 2005, Adv Data, P1; Ono-Kihara M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-106; Prinstein MJ, 2003, J PEDIATR PSYCHOL, V28, P243, DOI 10.1093/jpepsy/jsg012; Robinson EK, 1999, AIDS, V13, P737, DOI 10.1097/00002030-199904160-00021; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Teng F, 2011, B STI PREVENTION CON, V25, P1; Wong ML, 1999, AIDS, V13, P1981, DOI 10.1097/00002030-199910010-00024; Wu M, CHINA SEXUAL SCI, V3, P4; Xu J, 2007, DERMATOLOGY VENEREAL, Vl29, P54; Xu Yi, 2005, Zhonghua Yufang Yixue Zazhi, V39, P37; Zhang Bei-chuan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P32; Zhi H, 2001, WORLD J INFECT, V1, P255	29	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67092	10.1371/journal.pone.0067092	http://dx.doi.org/10.1371/journal.pone.0067092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825627	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000078
J	Oda, M; Oxley, D; Dean, W; Reik, W				Oda, Masaaki; Oxley, David; Dean, Wendy; Reik, Wolf			Regulation of Lineage Specific DNA Hypomethylation in Mouse Trophectoderm	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; METHYLATION; DNMT3A; EXPRESSION; METHYLTRANSFERASES; CHROMATIN; PROMOTER; UNDERMETHYLATION; TARGETS	Background: DNA methylation is reprogrammed during early embryogenesis by active and passive mechanisms in advance of the first differentiation event producing the embryonic and extraembryonic lineage cells which contribute to the future embryo proper and to the placenta respectively. Embryonic lineage cells re-acquire a highly methylated genome dependent on the DNA methyltransferases (DNMTs) Dnmt3a and Dnmt3b that are required for de novo methylation. By contrast, extraembryonic lineage cells remain globally hypomethylated but the mechanisms that underlie this hypomethylation remain unknown. Methodology/Principal Findings: We have employed an inducible system that supports differentiation between these two lineages and recapitulates the DNA methylation asymmetry generated in vivo. We find that in vitro down-regulation of Oct3/4 in ES cells recapitulates the decline in global DNA methylation associated with trophoblast. The de novo DNMTs Dnmt3a2 and Dnmt3b are down-regulated during trophoblast differentiation. Dnmt1, which is responsible for maintenance methylation, is expressed comparably in embryonic and trophoblast lineages, however importantly in trophoblast giant cells Dnmt1fails to be attracted to replication foci, thus allowing loss of DNA methylation while implicating a passive demethylation mechanism. Interestingly, Dnmt1 localization was restored by exogenous Np95/Uhrf1, a Dnmt1 chaperone required for Dnmt1-targeting to replication foci, yet DNA methylation levels remained low. Over-expression of de novo DNMTs also failed to increase DNA methylation in target sequences. Conclusions/Significance: We propose that induced trophoblast cells may have a mechanism to resist genome-wide increases of DNA methylation, thus reinforcing the genome-wide epigenetic distinctions between the embryonic and extraembryonic lineages in the mouse. This resistance may be based on transcription factors or on global differences in chromatin structure.	[Oda, Masaaki; Dean, Wendy; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge, England; [Oxley, David] Babraham Inst, Cambridge, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	wolf.reik@babraham.ac.uk	Dean, Wendy/GSE-3948-2022; Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Dean, Wendy/0000-0001-9441-5044	BBSRC [BB/H088071/1]; MRC [G0700760]; EU EpiGenesys; EU BLUEPRINT; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H334] Funding Source: researchfish; Medical Research Council [G0700760, G0700098] Funding Source: researchfish; BBSRC [BBS/E/B/0000H334] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU EpiGenesys; EU BLUEPRINT; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BBSRC; grant BB/H088071/1 (www.bbsrc.ac.uk), MRC; grant G0700760 (www.mrc.ac.uk), EU EpiGenesys; (www.epigenesys.eu), EU BLUEPRINT; Blueprint (www.blueprint-epigenome.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001764; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Lee HJ, 2011, STEM CELLS, V29, P1611, DOI 10.1002/stem.706; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	42	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68846	10.1371/journal.pone.0068846	http://dx.doi.org/10.1371/journal.pone.0068846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825703	Green Published, gold			2022-12-25	WOS:000321223000131
J	Piatkov, K; Graciet, E; Varshavsky, A				Piatkov, Konstantin; Graciet, Emmanuelle; Varshavsky, Alexander			Ubiquitin Reference Technique and Its Use in Ubiquitin-Lacking Prokaryotes	PLOS ONE			English	Article							N-END RULE; PROTEIN; PATHWAY; RESTRICTION; DISSECTION; PLASMIDS; SEQUENCE; CLONING; FUSION; SYSTEM	In a pulse-chase assay, the in vivo degradation of a protein is measured through a brief labeling of cells with, for example, a radioactive amino acid, followed by cessation of labeling and analysis of cell extracts prepared at different times afterward ("chase"), using immunoprecipitation, electrophoresis and autoradiography of a labeled protein of interest. A conventional pulse-chase assay is fraught with sources of data scatter, as the efficacy of labeling and immunoprecipitation can vary, and sample volumes can vary as well. The ubiquitin reference technique (URT), introduced in 1996, addresses these problems. In eukaryotes, a DNA-encoded linear fusion of ubiquitin to another protein is cleaved by deubiquitylases at the ubiquitin-protein junction. A URT assay uses a fusion in which the ubiquitin moiety is located between a downstream polypeptide (test protein) and an upstream polypeptide (a long-lived reference protein). The cotranslational cleavage of a URT fusion by deubiquitylases after the last residue of ubiquitin produces, at the initially equimolar ratio, a test protein with a desired N-terminal residue and a reference protein containing C-terminal ubiquitin moiety. In addition to being more accurate than pulse-chases without a reference, URT makes it possible to detect and measure the degradation of a test protein during the pulse (before the chase). Because prokaryotes, including Gram-negative bacteria such as, for example, Escherichia coli and Vibrio vulnificus, lack the ubiquitin system, the use of URT in such cells requires ectopic expression of a deubiquitylase. We describe designs and applications of plasmid vectors that coexpress, in bacteria, both a URT-type fusion and Ubp1, a deubiquitylase of the yeast Saccharomyces cerevisiae. This single-plasmid approach extends the accuracy-enhancing URT assay to studies of protein degradation in prokaryotes.	[Piatkov, Konstantin; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Graciet, Emmanuelle] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	California Institute of Technology; Trinity College Dublin	Piatkov, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	piatkov@caltech.edu; avarsh@caltech.edu		Graciet, Emmanuelle/0000-0003-3548-8213	National Institutes of Health [DK039520, GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by grants to AV from the National Institutes of Health (DK039520 and GM031530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 2010, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Catic A, 2007, EMBO J, V26, P3474, DOI 10.1038/sj.emboj.7601772; Davison J, 2002, BIOTECHNIQUES, V32, P386, DOI 10.2144/02322rv02; DAVISON J, 1987, GENE, V51, P275, DOI 10.1016/0378-1119(87)90316-7; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Dougan D. A., 2011, BIOCHIM BIOPHYS ACTA, V1823, P83; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; O'Sullivan LE, 2010, J MICROBIOL BIOTECHN, V20, P871, DOI 10.4014/jmb.0912.12017; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Piatkov KI, 2012, MOL CELL, V48, P926, DOI 10.1016/j.molcel.2012.10.012; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Thomas CM, 1989, PROMISCUOUS PLASMIDS; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200	39	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67952	10.1371/journal.pone.0067952	http://dx.doi.org/10.1371/journal.pone.0067952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825692	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000126
J	Roman de Mettelinge, T; Cambier, D; Calders, P; Van den Noortgate, N; Delbaere, K				Roman de Mettelinge, Tine; Cambier, Dirk; Calders, Patrick; Van den Noortgate, Nele; Delbaere, Kim			Understanding the Relationship between Type 2 Diabetes Mellitus and Falls in Older Adults: A Prospective Cohort Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RISK-FACTORS; GAIT VARIABILITY; PEOPLE; DYSFUNCTION; STRENGTH; RELIABILITY; PREVENTION; PREDICTOR; HEALTH	Background: Older adults with type 2 Diabetes Mellitus are at increased risk of falling. The current study aims to identify risk factors that mediate the relationship between diabetes and falls. Methods: 199 older adults (104 with diabetes and 95 healthy controls) underwent a medical screening. Gait (GAITRite (R)), balance (AccuGait (R) force plate), grip strength (Jamar (R)), and cognitive status (Mini-Mental State Examination and Clock Drawing Test) were assessed. Falls were prospectively recorded during a 12-month follow-up period using monthly calendars. Results: Compared to controls, diabetes participants scored worse on all physical and cognitive measures. Sixty-four participants (42 diabetes vs. 22 controls) reported at least one injurious fall or two non-injurious falls ("fallers"). Univariate logistic regression identified diabetes as a risk factor for future falls (Odds Ratio 2.25, 95%CI 1.21-4.15, p = 0.010). Stepwise multiple regressions defined diabetes and poor balance as independent risk factors for falling. Taking more medications, slower walking speed, shorter stride length and poor cognitive performance were mediators that reduced the Odds Ratio of the relationship between diabetes and faller status relationship the most followed by reduced grip strength and increased stride length variability. Conclusions: Diabetes is a major risk factor for falling, even after controlling for poor balance. Taking more medications, poorer walking performance and reduced cognitive functioning were mediators of the relationship between diabetes and falls. Tailored preventive programs including systematic medication reviews, specific balance exercises and cognitive training might be beneficial in reducing fall risk in older adults suffering from diabetes.	[Roman de Mettelinge, Tine; Cambier, Dirk; Calders, Patrick] Univ Ghent, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-9000 Ghent, Belgium; [Van den Noortgate, Nele] Ghent Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Ghent, Belgium; [Delbaere, Kim] Neurosci Res Australia, Falls & Balance Res Grp, Sydney, NSW, Australia	Ghent University; Ghent University; Ghent University Hospital; Neuroscience Research Australia	Roman de Mettelinge, T (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-9000 Ghent, Belgium.	Tine.RomandeMettelinge@Ugent.be	Roman de Mettelinge, Tine/ABC-6840-2020; Delbaere, Kim/D-6370-2011	Roman de Mettelinge, Tine/0000-0001-5338-0463; Delbaere, Kim/0000-0002-5655-0234	Special Research Fund, Bijzonder Onderzoeks Fonds (BOF), of the Ghent University [05v00608]	Special Research Fund, Bijzonder Onderzoeks Fonds (BOF), of the Ghent University	This study was funded by Special Research Fund, Bijzonder Onderzoeks Fonds (BOF), of the Ghent University (05v00608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2010, OTOL NEUROTOL; Allet L, 2008, DIABETES-METAB RES, V24, P173, DOI 10.1002/dmrr.809; Allet L, 2010, DIABETOLOGIA, V53, P458, DOI 10.1007/s00125-009-1592-4; Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; Bonnet C, 2009, J MOTOR BEHAV, V41, P172, DOI 10.3200/JMBR.41.2.172-192; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Delbaere K, 2012, AGE AGEING, V41, P404, DOI 10.1093/ageing/afs004; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Fess E. E., 1992, GRIP STRENGTH; Foley AL, 2012, AGE AGEING, V41, P35, DOI 10.1093/ageing/afr125; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeland KN, 2012, ANN PHARMACOTHER, V46, P1188, DOI 10.1345/aph.1Q689; Garrow AP, 2006, DIABETES-METAB RES, V22, P411, DOI 10.1002/dmrr.657; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Holtzer R, 2012, J AM GERIATR SOC, V60, P2093, DOI 10.1111/j.1532-5415.2012.04193.x; Kwan MMS, 2012, AGE AGEING, V41, P606, DOI 10.1093/ageing/afs065; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Lim JY, 2012, PM&R, V4, P945, DOI 10.1016/j.pmrj.2012.07.005; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157, DOI 10.1093/gerona/60.9.1157; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Reijmer YD, 2011, DIABETES-METAB RES, V27, P195, DOI 10.1002/dmrr.1163; Reijmer YD, 2010, DIABETES-METAB RES, V26, P507, DOI 10.1002/dmrr.1112; Richardson JK, 1996, POSTGRAD MED, V99, P161, DOI 10.1080/00325481.1996.11946142; Salonen L, 2012, CURR GERONTOL GERIAT, V2012; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Strotmeyer ES, 2005, ARCH INTERN MED, V165, P1612, DOI 10.1001/archinte.165.14.1612; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; THALMANN B, 2002, BRAIN AGING, V2, P36, DOI DOI 10.1093/AGEING/AFU157; Tiedemann A, 2005, GERONTOLOGY, V51, P390, DOI 10.1159/000088703; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	39	68	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67055	10.1371/journal.pone.0067055	http://dx.doi.org/10.1371/journal.pone.0067055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825617	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000069
J	Sinkko, H; Lukkari, K; Sihvonen, LM; Sivonen, K; Leivuori, M; Rantanen, M; Paulin, L; Lyra, C				Sinkko, Hanna; Lukkari, Kaarina; Sihvonen, Leila M.; Sivonen, Kaarina; Leivuori, Mirja; Rantanen, Matias; Paulin, Lars; Lyra, Christina			Bacteria Contribute to Sediment Nutrient Release and Reflect Progressed Eutrophication-Driven Hypoxia in an Organic-Rich Continental Sea	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CHLOROFLEXI SUBPHYLUM-I; BALTIC SEA; MARINE-SEDIMENTS; SP-NOV.; GEN. NOV.; DISSOLVED SUBSTANCES; COMMUNITY STRUCTURE; PHYLUM CHLOROFLEXI; CHEMICAL CHARACTER	In the sedimental organic matter of eutrophic continental seas, such as the largest dead zone in the world, the Baltic Sea, bacteria may directly participate in nutrient release by mineralizing organic matter or indirectly by altering the sediment's ability to retain nutrients. Here, we present a case study of a hypoxic sea, which receives riverine nutrient loading and in which microbe-mediated vicious cycles of nutrients prevail. We showed that bacterial communities changed along the horizontal loading and vertical mineralization gradients in the Gulf of Finland of the Baltic Sea, using multivariate statistics of terminal restriction fragments and sediment chemical, spatial and other properties of the sampling sites. The change was mainly explained by concentrations of organic carbon, nitrogen and phosphorus, which showed strong positive correlation with Flavobacteria, Sphingobacteria, Alphaproteobacteria and Gammaproteobacteria. These bacteria predominated in the most organic-rich coastal surface sediments overlain by oxic bottom water, whereas sulphate-reducing bacteria, particularly the genus Desulfobacula, prevailed in the reduced organic-rich surface sediments in the open sea. They correlated positively with organic nitrogen and phosphorus, as well as manganese oxides. These relationships suggest that the bacterial groups participated in the aerobic and anaerobic degradation of organic matter and contributed to nutrient cycling. The high abundance of sulphate reducers in the surficial sediment layers reflects the persistence of eutrophication-induced hypoxia causing ecosystem-level changes in the Baltic Sea. The sulphate reducers began to decrease below depths of 20 cm, where members of the family Anaerolineaceae (phylum Chloroflexi) increased, possibly taking part in terminal mineralization processes. Our study provides valuable information on how organic loading affects sediment bacterial community compositions, which consequently may maintain active nutrient recycling. This information is needed to improve our understanding on nutrient cycling in shallow seas where the dead zones are continuously spreading worldwide.	[Sinkko, Hanna; Sihvonen, Leila M.; Sivonen, Kaarina; Lyra, Christina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Lukkari, Kaarina] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Sihvonen, Leila M.] Natl Inst Hlth & Welf, Helsinki, Finland; [Leivuori, Mirja] Finnish Environm Inst, Reference Lab, Helsinki, Finland; [Rantanen, Matias; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; Finnish Environment Institute; Finland National Institute for Health & Welfare; Finnish Environment Institute; University of Helsinki	Sivonen, K (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi		Sivonen, Kaarina/0000-0002-2904-0458; Sinkko, Hanna/0000-0002-4003-0429	Maj and Tor Nessling Foundation [202441]; Centre of Excellence [53305, 118637]	Maj and Tor Nessling Foundation; Centre of Excellence	This work was supported by Maj and Tor Nessling Foundation, Baltic Sea Research Program (BIREME, 202441), the Centre of Excellence (53305, 118637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Arnosti C, 2004, MAR CHEM, V92, P263, DOI 10.1016/j.marchem.2004.06.030; Arnosti C, 2000, LIMNOL OCEANOGR, V45, P1112, DOI 10.4319/lo.2000.45.5.1112; Arnosti C, 2008, FEMS MICROBIOL ECOL, V66, P343, DOI 10.1111/j.1574-6941.2008.00587.x; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Beardsley C, 2011, FEMS MICROBIOL ECOL, V77, P134, DOI 10.1111/j.1574-6941.2011.01094.x; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; Bissett A, 2006, FEMS MICROBIOL ECOL, V55, P48, DOI 10.1111/j.1574-6941.2005.00012.x; Bissett A, 2008, AQUAT MICROB ECOL, V51, P31, DOI 10.3354/ame01174; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Carman R, 1998, VIE MILIEU, V48, P229; Choi JH, 2010, INT J SYST EVOL MICR, V60, P1488, DOI 10.1099/ijs.0.013557-0; Christensen KK, 1997, BIOGEOCHEMISTRY, V38, P149, DOI 10.1023/A:1005736930062; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 1997, ESTUAR COAST SHELF S, V45, P591, DOI 10.1006/ecss.1997.0246; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Edlund A, 2006, APPL ENVIRON MICROB, V72, P6800, DOI 10.1128/AEM.00971-06; GACHTER R, 1988, LIMNOL OCEANOGR, V33, P1542; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Helcom, 2004, BALT SEA ENV P, P93; Helcom, 1998, BALTIC SEA ENV P; Heyer J, 2000, ESTUAR COAST SHELF S, V51, P13, DOI 10.1006/ecss.2000.0616; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Ivanova EP, 2001, MICROBIOLOGY+, V70, P10, DOI 10.1023/A:1004876301036; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; JENSEN HS, 1993, HYDROBIOLOGIA, V253, P47, DOI 10.1007/BF00050721; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kindt R., 2005, WORLD; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kondo R, 2012, MICROBES ENVIRON, V27, P193, DOI 10.1264/jsme2.ME11278; KROM MD, 1981, GEOCHIM COSMOCHIM AC, V45, P207; Kuever J, 2001, INT J SYST EVOL MICR, V51, P171, DOI 10.1099/00207713-51-1-171; Kunihiro T, 2011, ISME J, V5, P1818, DOI 10.1038/ismej.2011.57; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Lukkari K, 2008, BIOGEOCHEMISTRY, V90, P171, DOI 10.1007/s10533-008-9243-2; Lukkari K, 2009, BIOGEOCHEMISTRY, V96, P25, DOI 10.1007/s10533-009-9343-7; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P433, DOI 10.4319/lom.2007.5.433; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P445, DOI 10.4319/lom.2007.5.445; Lukkari K, 2009, BIOGEOCHEMISTRY, V94, P141, DOI 10.1007/s10533-009-9315-y; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; Mortimer CH, 1942, J ECOL, V30, P147, DOI 10.2307/2256691; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Oksanen J., 2016, R PACKAG; Pallud C, 2006, GEOCHIM COSMOCHIM AC, V70, P1148, DOI 10.1016/j.gca.2005.11.002; Pimenov NV, 2012, MICROBIOLOGY+, V81, P79, DOI 10.1134/S0026261712010122; Pimenov NV, 2010, GEO-MAR LETT, V30, P439, DOI 10.1007/s00367-010-0200-4; Pitkanen H, 2001, AMBIO, V30, P195, DOI 10.1639/0044-7447(2001)030[0195:INFCDI]2.0.CO;2; R Development Core Team, 2011, R LANG ENV STAT COMP; Raber T, 1998, CURR MICROBIOL, V37, P172, DOI 10.1007/s002849900359; Rocker D, 2012, FEMS MICROBIOL ECOL, V80, P45, DOI 10.1111/j.1574-6941.2011.01269.x; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; SCHNITZER M, 1969, SOIL SCI SOC AM PRO, V33, P75, DOI 10.2136/sssaj1969.03615995003300010022x; Sinkko H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021555; Spiro TG, 2010, ACCOUNTS CHEM RES, V43, P2, DOI 10.1021/ar800232a; Steenbergh AK, 2011, LIMNOL OCEANOGR, V56, P2018, DOI 10.4319/lo.2011.56.6.2018; SUZUMURA M, 1995, GEOCHIM COSMOCHIM AC, V59, P1021, DOI 10.1016/0016-7037(95)00006-2; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Thiessen O, 2006, CONT SHELF RES, V26, P2469, DOI 10.1016/j.csr.2006.07.020; Urios L, 2008, INT J SYST EVOL MICR, V58, P1233, DOI 10.1099/ijs.0.65470-0; van der Zee C, 2001, J MAR RES, V59, P133, DOI 10.1357/002224001321237407; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whiticar MJ, 2002, MAR GEOL, V182, P29, DOI 10.1016/S0025-3227(01)00227-4; WINTERHALTER B, 1981, BALTIC SEA ELSEVIER, P00001; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yamada T, 2007, INT J SYST EVOL MICR, V57, P2299, DOI 10.1099/ijs.0.65098-0; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S	89	71	80	8	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67061	10.1371/journal.pone.0067061	http://dx.doi.org/10.1371/journal.pone.0067061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825619	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000071
J	Zan, JD; Heindl, JE; Liu, Y; Fuqua, C; Hill, RT				Zan, Jindong; Heindl, Jason E.; Liu, Yue; Fuqua, Clay; Hill, Russell T.			The CckA-ChpT-CtrA Phosphorelay System Is Regulated by Quorum Sensing and Controls Flagellar Motility in the Marine Sponge Symbiont Ruegeria sp KLH11	PLOS ONE			English	Article							GENE-TRANSFER AGENT; BACTERIAL-CELL-CYCLE; AGROBACTERIUM-TUMEFACIENS; TRANSCRIPTIONAL ACTIVATOR; HISTIDINE KINASE; MASTER REGULATOR; GENOME SEQUENCE; TI PLASMID; PROTEOBACTERIA; TRANSFORMATION	Bacteria respond to their environment via signal transduction pathways, often two-component type systems that function through phosphotransfer to control expression of specific genes. Phosphorelays are derived from two-component systems but are comprised of additional components. The essential cckA-chpT-ctrA phosphorelay in Caulobacter crescentus has been well studied and is important in orchestrating the cell cycle, polar development and flagellar biogenesis. Although cckA, chpT and ctrA homologues are widespread among the Alphaproteobacteria, relatively few is known about their function in the large and ecologically significant Roseobacter clade of the Rhodobacterales. In this study the cckA-chpT-ctrA system of the marine sponge symbiont Ruegeria sp. KLH11 was investigated. Our results reveal that the cckA, chpT and ctrA genes positively control flagellar biosynthesis. In contrast to C. crescentus, the cckA, chpT and ctrA genes in Ruegeria sp. KLH11 are non-essential and do not affect bacterial growth. Gene fusion and transcript analyses provide evidence for ctrA autoregulation and the control of motility-related genes. In KLH11, flagellar motility is controlled by the SsaRI system and acylhomoserine lactone (AHL) quorum sensing. SsaR and long chain AHLs are required for cckA, chpT and ctrA gene expression, providing a regulatory link between flagellar locomotion and population density in KLH11.	[Zan, Jindong; Liu, Yue; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Heindl, Jason E.; Fuqua, Clay] Indiana Univ, Dept Biol, Bloomington, IN USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Indiana University System; Indiana University Bloomington	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Hill, Russell/AAF-4190-2019; Liu, Yue/D-8816-2015	Hill, Russell/0000-0002-9832-1851; Heindl, Jason/0000-0003-3919-8045	National Science Foundation Microbial Interactions and Processes Program (MCB) [0703467, 6166]; BIO/IOS Program [IOS-0919728]; Ruth L. Kirschstein National Research Service [1 F32 GM100601-01A1]; Indiana University METACyt; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100601] Funding Source: NIH RePORTER	National Science Foundation Microbial Interactions and Processes Program (MCB); BIO/IOS Program; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University METACyt; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Science Foundation Microbial Interactions and Processes Program to CF (MCB #0703467, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 6166) and the BIO/IOS Program to RTH (#IOS-0919728, http://www.nsf.gov/bio/ios/about.jsp). This project was also supported by Ruth L. Kirschstein National Research Service Award 1 F32 GM100601-01A1 (JEH) and through a grant from the Indiana University METACyt program funded in part by a major endowment from the Lilly Foundation (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura R, 2002, J BIOL CHEM, V277, P15773, DOI 10.1074/jbc.M200109200; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Barnett MJ, 2001, J BACTERIOL, V183, P3204, DOI 10.1128/JB.183.10.3204-3210.2001; Belas R, 2009, J BACTERIOL, V191, P4502, DOI 10.1128/JB.00429-09; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bird TH, 2011, ARCH MICROBIOL, V193, P451, DOI 10.1007/s00203-011-0676-y; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Cheng ZH, 2011, MOL MICROBIOL, V82, P1217, DOI 10.1111/j.1365-2958.2011.07885.x; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gora KG, 2010, MOL CELL, V39, P455, DOI 10.1016/j.molcel.2010.06.024; Greene SE, 2012, J BACTERIOL, V194, P2973, DOI 10.1128/JB.00170-12; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kanbe M, 2007, J BACTERIOL, V189, P1083, DOI 10.1128/JB.01405-06; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056682; Klose KE, 1998, MOL MICROBIOL, V28, P501, DOI 10.1046/j.1365-2958.1998.00809.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Lang AS, 2000, P NATL ACAD SCI USA, V97, P859, DOI 10.1073/pnas.97.2.859; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Leung MM, 2010, CTRA GTAR 2 SYSTEMS; Leung MM, 2013, MICROBIOL-SGM, V159, P96, DOI 10.1099/mic.0.062349-0; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; MAYFIELD CI, 1977, CAN J MICROBIOL, V23, P1311, DOI 10.1139/m77-198; Mercer RG, 2012, FEMS MICROBIOL LETT, V331, P53, DOI 10.1111/j.1574-6968.2012.02553.x; Mercer RG, 2010, J BACTERIOL, V192, P2701, DOI 10.1128/JB.00160-10; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P1209, DOI 10.1128/AEM.02047-07; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schaefer AL, 2002, J BACTERIOL, V184, P6515, DOI 10.1128/JB.184.23.6515-6521.2002; Slightom RN, 2009, APPL ENVIRON MICROB, V75, P6027, DOI 10.1128/AEM.01508-09; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x; Zan JD, 2011, J BACTERIOL, V193, P5011, DOI 10.1128/JB.05556-11	50	27	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66346	10.1371/journal.pone.0066346	http://dx.doi.org/10.1371/journal.pone.0066346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825536	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000015
J	Kawano, Y; Neeley, S; Adachi, K; Nakai, H				Kawano, Yasuhiro; Neeley, Shane; Adachi, Kei; Nakai, Hiroyuki			An Experimental and Computational Evolution-Based Method to Study a Mode of Co-evolution of Overlapping Open Reading Frames in the AAV2 Viral Genome	PLOS ONE			English	Article							ASSEMBLY-ACTIVATING PROTEIN; GENE-THERAPY; ADENOASSOCIATED VIRUSES; DIRECTED EVOLUTION; IDENTIFICATION; PREDICTION; VECTORS; INFORMATION; HEMOPHILIA; SEQUENCES	Overlapping open reading frames (ORFs) in viral genomes undergo co-evolution; however, how individual amino acids coded by overlapping ORFs are structurally, functionally, and co-evolutionarily constrained remains difficult to address by conventional homologous sequence alignment approaches. We report here a new experimental and computational evolution-based methodology to address this question and report its preliminary application to elucidating a mode of co-evolution of the frame-shifted overlapping ORFs in the adeno-associated virus (AAV) serotype 2 viral genome. These ORFs encode both capsid VP protein and non-structural assembly-activating protein (AAP). To show proof of principle of the new method, we focused on the evolutionarily conserved QVKEVTQ and KSKRSRR motifs, a pair of overlapping heptapeptides in VP and AAP, respectively. In the new method, we first identified a large number of capsid-forming VP3 mutants and functionally competent AAP mutants of these motifs from mutant libraries by experimental directed evolution under no co-evolutionary constraints. We used Illumina sequencing to obtain a large dataset and then statistically assessed the viability of VP and AAP heptapeptide mutants. The obtained heptapeptide information was then integrated into an evolutionary algorithm, with which VP and AAP were co-evolved from random or native nucleotide sequences in silico. As a result, we demonstrate that these two heptapeptide motifs could exhibit high degeneracy if coded by separate nucleotide sequences, and elucidate how overlap-evoked co-evolutionary constraints play a role in making the VP and AAP heptapeptide sequences into the present shape. Specifically, we demonstrate that two valine (V) residues and beta-strand propensity in QVKEVTQ are structurally important, the strongly negative and hydrophilic nature of KSKRSRR is functionally important, and overlap-evoked co-evolution imposes strong constraints on serine (S) residues in KSKRSRR, despite high degeneracy of the motifs in the absence of co-evolutionary constraints.	[Kawano, Yasuhiro; Neeley, Shane; Adachi, Kei; Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97201 USA; [Kawano, Yasuhiro] Takara Bio Inc, Otsu, Shiga, Japan	Oregon Health & Science University; Takara Bio Inc.	Nakai, H (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97201 USA.	nakaih@ohsu.edu			Public Health Service grant [R01 DK078388]; Sponsored Research Fund from Takara Bio Inc; National Institutes of Health; Takara Bio Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078388] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Sponsored Research Fund from Takara Bio Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Public Health Service grant (R01 DK078388) and a Sponsored Research Fund from Takara Bio Inc, and in part by the National Institutes of Health through resources provided by the National Resource for Biomedical Supercomputing (P41 RR06009), which is part of the Pittsburgh Supercomputing Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following inerests: This project was in part supported by a sponsored research fund obtained from Takara Bio Inc. Co-author Yasuhiro Kawano is an employee of Takara Bio Inc. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Adachi Kei, 2010, Gene Ther Regul, V5, P31, DOI 10.1142/S1568558610000197; Baker J.E., P INT C GEN ALG THEI, P101; Bartel MA, 2012, GENE THER, V19, P694, DOI 10.1038/gt.2012.20; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruni R, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-48; Burton M, 1999, P NATL ACAD SCI USA, V96, P12725, DOI 10.1073/pnas.96.22.12725; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Firth AE, 2005, BIOINFORMATICS, V21, P282, DOI 10.1093/bioinformatics/bti007; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Kalinina OV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042468; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pavesi A, 2006, J GEN VIROL, V87, P1013, DOI 10.1099/vir.0.81375-0; Pavesi A, 1997, J MOL EVOL, V44, P625, DOI 10.1007/PL00006185; Pavesi A, 2000, J MOL EVOL, V50, P284, DOI 10.1007/s002399910033; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; Sabath N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-144; Sonntag F, 2011, J VIROL, V85, P12686, DOI 10.1128/JVI.05359-11; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yuen CM, 2007, NAT METHODS, V4, P995, DOI 10.1038/nmeth1207-995	40	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66211	10.1371/journal.pone.0066211	http://dx.doi.org/10.1371/journal.pone.0066211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826091	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400013
J	O'Neill, V; Asani, FF; Jeffery, TJ; Saccone, DS; Bornman, L				O'Neill, Vanessa; Asani, Furaha Florence; Jeffery, Tamsyn Jacki; Saccone, Donovan Sean; Bornman, Liza			Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; SKIN PIGMENTATION; COLORECTAL-CANCER; D DEFICIENCY; TUBERCULOSIS; POLYMORPHISM; SUPPLEMENTATION; DETERMINANTS; INFECTION; PROMOTER	Polymorphisms of the vitamin D receptor gene (VDR) have been associated inconsistently with various diseases, across populations of diverse origin. The T(f) allele of the functional SNP FokI, in exon 2 of VDR, results in a longer vitamin D receptor protein (VDR) isoform, proposed to be less active. Genetic association of VDR with disease is likely confounded by ethnicity and environmental factors such as plasma 25(OH)D-3 status. We hypothesized that VDR expression, VDR level and transactivation of target genes, CAMP and CYP24A1, depend on vitamin D, ethnicity and FokI genotype. Healthy volunteers participated in the study (African, n = 40 and White, n = 20). Plasma 25(OH)D-3 levels were quantified by LC-MS and monocytes cultured, with or without 1,25(OH)(2)D-3. Gene expression and protein level was quantified using qRT-PCR and flow cytometry, respectively. Mean plasma 25(OH)D-3 status was normal and not significantly different between ethnicities. Neither 25(OH)D-3 status nor 1,25(OH)(2)D-3 supplementation significantly influenced expression or level of VDR. Africans had significantly higher mean VDR protein levels (P<0.050), nonetheless transactivated less CAMP expression than Whites. Genotyping the FokI polymorphism by pyrosequencing together with HapMap data, showed a significantly higher (P<0.050) frequency of the CC genotype in Africans than in Whites. FokI genotype, however, did not influence VDR expression or VDR level, but influenced overall transactivation of CAMP and 1,25(OH)(2)D-3-elicited CYP24A1 induction; the latter, interacting with ethnicity. In conclusion, differential VDR expression relates to ethnicity, rather than 25(OH)D-3 status and FokI genotype. Instead, VDR transactivation of CAMP is influenced by FokI genotype and, together with ethnicity, influence 1,25(OH)(2)D-3-elicited CYP24A1 expression. Thus, the expression and role of VDR to transactivate target genes is determined not only by genetics, but also by ethnicity and environment involving complex interactions which may confound disease association.	[O'Neill, Vanessa; Asani, Furaha Florence; Jeffery, Tamsyn Jacki; Saccone, Donovan Sean; Bornman, Liza] Univ Johannesburg, Dept Biochem, Johannesburg, Gauteng, South Africa	University of Johannesburg	Bornman, L (corresponding author), Univ Johannesburg, Dept Biochem, Johannesburg, Gauteng, South Africa.	lizab@uj.ac.za		Meyer, Vanessa/0000-0002-1171-8195	National Research Foundation (NRF) [81774]; Cancer Association of South Africa (CANSA)	National Research Foundation (NRF); Cancer Association of South Africa (CANSA)	This study was supported by funding from the National Research Foundation (NRF, www.nrf.ac.za, Grant No 81774) and Cancer Association of South Africa (CANSA, www.cansa.org.za, Research Grant L. Bornman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Ashktorab H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025314; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Berry D, 2011, CURR OPIN NEPHROL HY, V20, P331, DOI 10.1097/MNH.0b013e328346d6ba; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Dawson-Hughes B, 2004, AM J CLIN NUTR, V80, p1763S, DOI 10.1093/ajcn/80.6.1763S; Dendrou Calliope A., 2009, Advances in Bioinformatics, V2009, P476106, DOI 10.1155/2009/476106; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hendrickson WK, 2011, J CLIN ONCOL, V29, P2378, DOI 10.1200/JCO.2010.30.9880; INTERNATIONAL H, 2013, INT, V15, P2013; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Luong KVQ, 2010, CRIT REV ONCOL HEMAT, V73, P192, DOI 10.1016/j.critrevonc.2009.04.008; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; LUI PT, 2006, SCIENCE, V311, P1770; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; MILNER J, 2008, BIOSOCIAL SURVEYS, P14; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Norman AW, 1998, AM J CLIN NUTR, V67, P1108, DOI 10.1093/ajcn/67.6.1108; OSWALD NC, 1946, THORAX, V1, P100, DOI 10.1136/thx.1.2.100; Parisi E, 2008, J STEROID BIOCHEM, V111, P87, DOI 10.1016/j.jsbmb.2008.05.001; Pettifor JM, 1996, S AFR MED J, V86, P1270; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; SUMETHKUL K, 2012, RHEUMATOL INT; THEIMMUNE S, EUR J IMMUNOL, V37, P395; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; VALDIVIELSO JM, CLIN CHIMICA ACTA, V371, P1; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; WHOGLOBAL TB, 2012, WHO GLOBAL TB REPORT, V2, P2013; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Wong HL, 2003, CARCINOGENESIS, V24, P1091, DOI 10.1093/carcin/bgg059; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	56	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67663	10.1371/journal.pone.0067663	http://dx.doi.org/10.1371/journal.pone.0067663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805323	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500151
J	Atteritano, M; Sorbara, S; Bagnato, G; Miceli, G; Sangari, D; Morgante, S; Visalli, E; Bagnato, G				Atteritano, Marco; Sorbara, Stefania; Bagnato, Gianluca; Miceli, Giovanni; Sangari, Donatella; Morgante, Salvatore; Visalli, Elisa; Bagnato, Gianfilippo			Bone Mineral Density, Bone Turnover Markers and Fractures in Patients with Systemic Sclerosis: A Case Control Study	PLOS ONE			English	Article							VITAMIN-D INTAKE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASES; INCREASED RISK; OSTEOPOROSIS; 25-HYDROXYVITAMIN-D; SCLERODERMA; HEALTH; WOMEN	Objective: The aim of our study was to elucidate the pathophysiology of systemic sclerosis-related osteoporosis and the prevalence of vertebral fragility fracture in postmenopausal women with systemic sclerosis (SSc). Methodology: Fifty-four postmenopausal women with scleroderma and 54 postmenopausal controls matched for age, BMI, and smoking habits were studied. BMD was measured by dual energy-x-ray absorptiometry at spine and femur, and by ultrasonography at calcaneus The markers of bone turnover included serum osteocalcin and urinary deoxypyridinoline. All subjects had a spine X-ray to ascertain the presence of vertebral fractures. Results: bone mineral density at lumbar spine (BMD 0.78 +/- 0.08 vs 0.88 +/- 0.07; p<0,001), femoral neck (BMD: 0.56 +/- 0.04 vs 0.72 +/- 0.07; p<0,001) and total femur (BMD: 0.57 +/- 0.04 vs 0.71 +/- 0.06; p<0,001) and ultrasound parameter at calcaneus (SI: 80.10 +/- 5.10 vs 94.80 +/- 6.10 p<0,001) were significantly lower in scleroderma compared with controls; bone turnover markers and parathyroid hormone level were significantly higher in scleroderma compared with controls, while serum of 25(OH)D3 was significantly lower. In scleroderma group the serum levels of 25(OH)D3 significantly correlated with PTH levels, BMD, stiffness index and bone turnover markers. One or more moderate or severe vertebral fractures were found in 13 patients with scleroderma, wherease in control group only one patient had a mild vertebral fracture. Conclusion: Our data shows, for the first time, that vertebral fractures are frequent in subjects with scleroderma, and suggest that lower levels of 25(OH)D3 may play a role in the risk of osteoporosis and vertebral fractures.	[Atteritano, Marco; Sorbara, Stefania; Bagnato, Gianluca; Miceli, Giovanni; Sangari, Donatella; Morgante, Salvatore; Visalli, Elisa; Bagnato, Gianfilippo] Univ Messina, Dept Internal Med, Messina, Italy	University of Messina	Atteritano, M (corresponding author), Univ Messina, Dept Internal Med, Messina, Italy.	matteritano@unime.it	Atteritano, Marco/AAL-9565-2020; Bagnato, Gianluca/D-5742-2018	Bagnato, Gianluca/0000-0002-7594-8520; visalli, elisa/0000-0002-8213-5528; Atteritano, Marco/0000-0001-9342-802X				Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Avouac J, 2012, ARTHRIT CARE RES, V64, P1871, DOI 10.1002/acr.21761; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Braun-Moscovici Y, 2008, J RHEUMATOL, V35, P2201, DOI 10.3899/jrheum.071171; Caramaschi P, 2010, CLIN RHEUMATOL, V29, P1419, DOI 10.1007/s10067-010-1478-3; Carbone L, 1999, RHEUMATOLOGY, V37, P1; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; Costenbader KH, 2008, ANN RHEUM DIS, V67, P530, DOI 10.1136/ard.2007.072736; Cutolo M, 2008, LUPUS, V17, P6, DOI 10.1177/0961203307085879; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; DIMUNNO O, 1995, CLIN RHEUMATOL, V14, P407, DOI 10.1007/BF02207673; Fredlani B, 2004, CLIN EXP RHEUMATOL, V22, P313; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gluer CC, 1997, J BONE MINER RES, V12, P1280, DOI 10.1359/jbmr.1997.12.8.1280; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; LAMONTAGNA G, 1991, CLIN RHEUMATOL, V10, P18, DOI 10.1007/BF02208027; Lee SC, 1997, BONE, V21, P119, DOI 10.1016/S8756-3282(97)00076-8; LEROY EC, 1988, J RHEUMATOL, V15, P202; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Morgan JW, 2000, ENDOCRINOLOGY, V141, P3225, DOI 10.1210/en.141.9.3225; Mouyis M, 2008, RHEUMATOLOGY, V47, P1348, DOI 10.1093/rheumatology/ken203; Neumann K, 2000, J RHEUMATOL, V27, P1822; Sampaio-Barros PD, 2005, CLIN EXP RHEUMATOL, V23, P180; Souza RBC, 2006, SCAND J RHEUMATOL, V35, P384, DOI 10.1080/03009740600704296; Szodoray P, 2008, SCAND J IMMUNOL, V68, P261, DOI 10.1111/j.1365-3083.2008.02127.x; Valentini G, 2003, CLIN EXP RHEUMATOL, V21, pS39; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Yuen SY, 2008, J RHEUMATOL, V35, P1073	32	50	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66991	10.1371/journal.pone.0066991	http://dx.doi.org/10.1371/journal.pone.0066991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818972	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800110
J	Li, C; Zhang, BY; Cressman, R; Tao, Y				Li, Cong; Zhang, Boyu; Cressman, Ross; Tao, Yi			Evolution of Cooperation in a Heterogeneous Graph: Fixation Probabilities under Weak Selection	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; SOCIAL DILEMMAS; NETWORKS; DIVERSITY; DYNAMICS	It has been shown that natural selection favors cooperation in a homogenous graph if the benefit-to-cost ratio exceeds the degree of the graph. However, most graphs related to interactions in real populations are heterogeneous, in which some individuals have many more neighbors than others. In this paper, we introduce a new state variable to measure the time evolution of cooperation in a heterogeneous graph. Based on the diffusion approximation, we find that the fixation probability of a single cooperator depends crucially on the number of its neighbors. Under weak selection, a cooperator with more neighbors has a larger probability of fixation in the population. We then investigate the average fixation probability of a randomly chosen cooperator. If a cooperator pays a cost for each of its neighbors (the so called fixed cost per game case), natural selection favors cooperation if the benefit-to-cost ratio is larger than the average degree. In contrast, if a cooperator pays a fixed cost and all its neighbors share the benefit (the fixed cost per individual case), cooperation is favored if the benefit-to-cost ratio is larger than the harmonic mean of the degree distribution. Moreover, increasing the graph heterogeneity will reduce the effect of natural selection.	[Li, Cong; Tao, Yi] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Boyu] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Cressman, Ross] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University; Wilfrid Laurier University	Zhang, BY (corresponding author), Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China.	zhangboyu5507@gmail.com; rcressman@wlu.ca		Li, Cong/0000-0002-7201-4140; Tao, Yi/0000-0002-0749-6614	NSFC of China [31270439]; NSERC of Canada	NSFC of China(National Natural Science Foundation of China (NSFC)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research received financial support from the NSFC 31270439 of China and from NSERC of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Axelord Robert, 1984, EVOLUTION COOPERATIO; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Devlin S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016107; Dorogotsev SN, 2003, EVOLUTION NETWORKS B; ERDOS P, 1960, B INT STATIST INST, V38, P343; Ewens W.J., 2004, MATH POPULATION GENE; Fu F, 2007, EUR PHYS J B, V56, P367, DOI 10.1140/epjb/e2007-00124-5; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Grujic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047718; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Konno T, 2011, J THEOR BIOL, V269, P224, DOI 10.1016/j.jtbi.2010.10.033; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nobari S., 2011, EDBT, P331, DOI DOI 10.1145/1951365.1951406; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Nowak Martin A., 2007, P7; Ohtsuki H, 2008, J THEOR BIOL, V251, P698, DOI 10.1016/j.jtbi.2008.01.005; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pinheiro FL, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073035; Pinheiro FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032114; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2010, INT J BIFURCAT CHAOS, V20, P849, DOI 10.1142/S0218127410026137; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Segbroeck SV, 2011, NEW J PHYS, V13, DOI DOI 10.1088/1367-2630/13/1/013007; Sherratt T. N., 2009, BIG QUESTIONS ECOLOG; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2009, PHYS REV E, V80; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Tanimoto J, 2010, PHYSICA A, V389, P2284, DOI 10.1016/j.physa.2010.01.033; Traulsen A, 2010, P NATL ACAD SCI USA, V91, P4877; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; WATTS D, 1999, SMALL WORLDS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026724; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	62	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66560	10.1371/journal.pone.0066560	http://dx.doi.org/10.1371/journal.pone.0066560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818942	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800078
J	Palkovits, M; Sebekova, K; Klenovics, KS; Kebis, A; Fazeli, G; Bahner, U; Heidland, A				Palkovits, Miklos; Sebekova, Katarina; Klenovics, Kristina Simon; Kebis, Anton; Fazeli, Gholamreza; Bahner, Udo; Heidland, August			Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; ATRIAL-NATRIURETIC-PEPTIDE; GLYCATION END-PRODUCTS; CHRONIC-RENAL-FAILURE; QUALITY-OF-LIFE; ASYMMETRIC DIMETHYLARGININE; SYMPATHETIC HYPERACTIVITY; COGNITIVE FUNCTION; ANGIOTENSIN-II; HEMODIALYSIS-PATIENTS	The effect of mild chronic renal failure (CRF) induced by 4/6-nephrectomy (4/6NX) on central neuronal activations was investigated by c-Fos immunohistochemistry staining and compared to sham-operated rats. In the 4/6 NX rats also the effect of the angiotensin receptor blocker, losartan, and the central sympatholyticum moxonidine was studied for two months. In serial brain sections Fos-immunoreactive neurons were localized and classified semiquantitatively. In 37 brain areas/nuclei several neurons with different functional properties were strongly affected in 4/6NX. It elicited a moderate to high Fos-activity in areas responsible for the monoaminergic innervation of the cerebral cortex, the limbic system, the thalamus and hypothalamus (e.g. noradrenergic neurons of the locus coeruleus, serotonergic neurons in dorsal raphe, histaminergic neurons in the tuberomamillary nucleus). Other monoaminergic cell groups (A5 noradrenaline, C1 adrenaline, medullary raphe serotonin neurons) and neurons in the hypothalamic paraventricular nucleus (innervating the sympathetic preganglionic neurons and affecting the peripheral sympathetic outflow) did not show Fos-activity. Stress-and painsensitive cortical/subcortical areas, neurons in the limbic system, the hypothalamus and the circumventricular organs were also affected by 4/6NX. Administration of losartan and more strongly moxonidine modulated most effects and particularly inhibited Fos-activity in locus coeruleus neurons. In conclusion, 4/6NX elicits high activity in central sympathetic, stress-and pain-related brain areas as well as in the limbic system, which can be ameliorated by losartan and particularly by moxonidine. These changes indicate a high sensitivity of CNS in initial stages of CKD which could be causative in clinical disturbances.	[Palkovits, Miklos] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, H-1085 Budapest, Hungary; [Palkovits, Miklos] Hungarian Acad Sci, Budapest, Hungary; [Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Klenovics, Kristina Simon] Comenius Univ, Fac Med, Inst Physiol, Bratislava, Slovakia; [Kebis, Anton] Slovak Med Univ, Slovak Ctr Organ Transplantat, Lab Organ Perfus, Bratislava, Slovakia; [Fazeli, Gholamreza] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Bahner, Udo; Heidland, August] KfH Kidney Ctr, Wurzburg, Germany; [Heidland, August] Univ Wurzburg, Dept Internal Med, D-97070 Wurzburg, Germany	Semmelweis University; Hungarian Academy of Sciences; Comenius University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences; Slovak Medical University Bratislava; University of Wurzburg; University of Wurzburg	Heidland, A (corresponding author), Univ Wurzburg, Dept Internal Med, D-97070 Wurzburg, Germany.	august.heidland@t-online.de	Palkovits, Miklos/F-2707-2013; Sebekova, Katarina/GSD-7056-2022; Sebekova, Katarina/H-4906-2016	Palkovits, Miklos/0000-0003-0578-0387; Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; Fazeli, Gholamreza/0000-0002-1367-1941	Slovak Academy of Sciences (CENDO) [II/2/2007]; Stiftung Zukunft Mensch	Slovak Academy of Sciences (CENDO); Stiftung Zukunft Mensch	This study was partially supported by a grant from Slovak Academy of Sciences (CENDO, No. II/2/2007, to KS), and from Stiftung Zukunft Mensch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBADIE C, 1992, NEUROSCIENCE, V48, P985, DOI 10.1016/0306-4522(92)90287-C; Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; Aguilera A, 2000, PERITON DIALYSIS INT, V20, P810; Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Amann K, 2000, J AM SOC NEPHROL, V11, P1469, DOI 10.1681/ASN.V1181469; Armstrong JE, 2010, PEDIATR NEPHROL, V25, P1497, DOI 10.1007/s00467-010-1529-7; Asif M, 2012, CURR ALZHEIMER RES; Augustyniak RA, 2006, AM J PHYSIOL-REG I, V290, pR726, DOI 10.1152/ajpregu.00768.2004; AVERILL DB, 1994, BRAIN RES, V665, P245, DOI 10.1016/0006-8993(94)91344-7; Barzilay JI, 2011, ARCH INTERN MED, V171, P142, DOI 10.1001/archinternmed.2010.502; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1901; Bomback AS, 2011, KIDNEY INT, V80, P803, DOI 10.1038/ki.2011.219; Bossola M, 2006, KIDNEY INT, V70, P417, DOI 10.1038/sj.ki.5001572; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Campese V M, 2000, J Renin Angiotensin Aldosterone Syst, V1, P202, DOI 10.3317/jraas.2000.026; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; CAMPESE VM, 1995, AM J KIDNEY DIS, V26, P861, DOI 10.1016/0272-6386(95)90456-5; Casper R C, 1998, Depress Anxiety, V8 Suppl 1, P96, DOI 10.1002/(SICI)1520-6394(1998)8:1+<96::AID-DA15>3.0.CO;2-4; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P919, DOI 10.2215/CJN.00820207; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Davison SN, 2005, ADV CHRONIC KIDNEY D, V12, P326, DOI 10.1016/j.ackd.2005.03.008; De Santo RM, 2010, J RENAL NUTR, V20, pS59, DOI 10.1053/j.jrn.2010.06.003; Elias MF, 2009, NEPHROL DIAL TRANSPL, V24, P2446, DOI 10.1093/ndt/gfp107; Ernsberger P, 2000, J CARDIOVASC PHARM, V35, pS27, DOI 10.1097/00005344-200000004-00005; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; GEIGER H, 1989, J CARDIOVASC PHARM, V13, pS20, DOI 10.1097/00005344-198905006-00007; GEIGER H, 1993, KIDNEY INT, V44, P24, DOI 10.1038/ki.1993.208; Gianaros PJ, 2012, HUM BRAIN MAPP, V33, P1700, DOI 10.1002/hbm.21315; Grassi G, 2011, CLIN J AM SOC NEPHRO, V6, P2620, DOI 10.2215/CJN.06970711; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Griep MI, 1997, NEPHROL DIAL TRANSPL, V12, P2093, DOI 10.1093/ndt/12.10.2093; Guasti L, 2002, J HYPERTENS, V20, P485, DOI 10.1097/00004872-200203000-00024; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Hebert MA, 2005, J NEUROCHEM, V95, P484, DOI 10.1111/j.1471-4159.2005.03386.x; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hirotsu C, 2011, BRAIN BEHAV IMMUN, V25, P416, DOI 10.1016/j.bbi.2010.10.021; Iliescu EA, 2004, NEPHROL DIAL TRANSPL, V19, P95, DOI 10.1093/ndt/gfg423; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; JELLINGER K, 1977, J NEURAL TRANSM, V41, P275, DOI 10.1007/BF01252022; JEPPSSON B, 1982, SURGERY, V92, P30; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Knopman DS, 2010, AM J EPIDEMIOL, V171, P287, DOI 10.1093/aje/kwp429; Konsman JP, 2005, EUR J NEUROSCI, V21, P2752, DOI 10.1111/j.1460-9568.2005.04102.x; Koomans HA, 2004, J AM SOC NEPHROL, V15, P524, DOI 10.1097/01.ASN.0000113320.57127.B9; Kotanko P, 2006, BLOOD PURIFICAT, V24, P95, DOI 10.1159/000089444; Krivosikova Z, 1999, PHYSIOL RES, V48, P429; Landis BN, 2011, KIDNEY INT, V80, P886, DOI 10.1038/ki.2011.189; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; Lux S, 2010, KIDNEY INT, V78, P794, DOI 10.1038/ki.2010.253; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORRISON AB, 1962, LAB INVEST, V11, P321; Muders F, 2001, PHARMACOL RES, V43, P251, DOI 10.1006/phrs.2000.0767; Mukaddam-Daher S, 2000, HYPERTENSION, V35, P1215, DOI 10.1161/01.HYP.35.6.1215; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Neil MJE, 2011, CURR CLIN PHARMACOL, V6, P280, DOI 10.2174/157488411798375886; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Niiya Y, 2006, BRAIN RES, V1108, P179, DOI 10.1016/j.brainres.2006.06.038; Orth SR, 2001, NEPHROL DIAL TRANSPL, V16, P67, DOI 10.1093/ndt/16.suppl_1.67; Palkovits M, 2009, NEUROSCIENCE, V159, P862, DOI 10.1016/j.neuroscience.2008.12.062; Parker KP, 2003, SLEEP MED REV, V7, P131, DOI 10.1053/smrv.2001.0240; Pikula A, 2009, STROKE, V40, P2959, DOI 10.1161/STROKEAHA.109.557116; Prichard BNC, 1999, J HYPERTENS, V17, pS41; Rabbani N, 2007, KIDNEY INT, V72, P1113, DOI 10.1038/sj.ki.5002513; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; Riezebos RK, 2010, NEPHROL DIAL TRANSPL, V25, P231, DOI 10.1093/ndt/gfp383; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; SCHMID G, 1978, AM J CLIN NUTR, V31, P1665, DOI 10.1093/ajcn/31.9.1665; Sebekova K, 1999, MINER ELECTROL METAB, V25, P380; Seifter JL, 2011, SEMIN NEUROL, V31, P139, DOI 10.1055/s-0031-1277984; Seliger SL, 2008, AM J NEPHROL, V28, P304, DOI 10.1159/000111386; Selley ML, 2003, NEUROBIOL AGING, V24, P903, DOI 10.1016/S0197-4580(03)00007-1; SIASSI F, 1977, AM J PHYSIOL, V232, pE526, DOI 10.1152/ajpendo.1977.232.5.E526; Sim JJ, 2009, CHEST, V135, P710, DOI 10.1378/chest.08-2248; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Spiegel BMR, 2008, CLIN J AM SOC NEPHRO, V3, P1759, DOI 10.2215/CJN.00820208; Stamp JA, 1999, NEUROSCIENCE, V94, P1313, DOI 10.1016/S0306-4522(99)00368-1; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Timofeeva E, 2001, J COMP NEUROL, V441, P71, DOI 10.1002/cne.1398; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Vanholder R, 2008, J AM SOC NEPHROL, V19, P1253, DOI 10.1681/ASN.2008040404; Wada M, 2008, J NEUROL SCI, V272, P36, DOI 10.1016/j.jns.2008.04.029; Weiner DE, 2009, AM J KIDNEY DIS, V53, P438, DOI 10.1053/j.ajkd.2008.08.022; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Ye SH, 1997, KIDNEY INT, V51, P722, DOI 10.1038/ki.1997.103; Ye SH, 2002, HYPERTENSION, V39, P1101, DOI 10.1161/01.HYP.0000018590.26853.C7; Yilmaz MI, 2010, NEPHROL DIAL TRANSPL, V25, P3250, DOI 10.1093/ndt/gfq159	96	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66543	10.1371/journal.pone.0066543	http://dx.doi.org/10.1371/journal.pone.0066543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818940	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800076
J	Parker, NH; Donninger, H; Birrer, MJ; Leaner, VD				Parker, Nina Holderness; Donninger, Howard; Birrer, Michael J.; Leaner, Virna D.			p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to Actin Organisation and Migration of Transformed Fibroblasts	PLOS ONE			English	Article							C-JUN ACTIVATION; CELL-MIGRATION; PROTEIN-KINASE; STRESS FIBERS; GROWTH-FACTOR; RAT-1A CELLS; EXPRESSION; CANCER; PROLIFERATION; TARGET	Activating Protein 1 (AP-1) plays a vital role in cell proliferation, differentiation and apoptosis. While de-regulation of AP-1 has been linked to many cancers, little is known regarding its downstream transcriptional targets that associate with cellular transformation. Previous studies identified PAK3, a serine/threonine kinase, as a potential AP-1 target gene. PAK3 has been implicated in a variety of pathological disorders and over-expression of other PAK-family members has been linked to cancer. In this study, we investigate AP-1 regulation of PAK3 expression and the role of PAK3 in cJun/AP-1-associated cellular transformation. Our results showed elevated PAK3 expression at both the mRNA and protein level in cJun-over-expressing Rat1a fibroblasts, as well as in transformed human fibroblasts. Elevated PAK3 expression in cJun/AP-1 over-expressing cells associated with a significant increase in PAK3 promoter activation. This increased promoter activity was lost when a single putative Jun binding site, which can bind AP-1 directly both in vitro and in vivo, was mutated. Further, inhibition of PAK3 using siRNA showed a regression in the cell morphology, migratory potential and actin organisation associated with AP-1 transformed cells. Our study is a first to describe a role for AP-1 in regulating PAK3 expression and suggest that PAK3 is an AP-1 target required for actin organization and migration observed in transformed cells.	[Parker, Nina Holderness; Leaner, Virna D.] Univ Cape Town, Div Med Biochem, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Donninger, Howard] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA; [Birrer, Michael J.] Harvard Univ, Massachusetts Gen Hosp, Gillette Ctr Gynecol Oncol, Gynecol Canc Res Program,Med Sch, Boston, MA 02115 USA	University of Cape Town; University of Louisville; Harvard University; Harvard Medical School; Massachusetts General Hospital	Leaner, VD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Gillette Ctr Gynecol Oncol, Gynecol Canc Res Program,Med Sch, Boston, MA 02115 USA.	Virna.Leaner@uct.ac.za	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660	University of Cape Town/Carnegie Corporation of New York Development Grants; Medical Research Council (SA)	University of Cape Town/Carnegie Corporation of New York Development Grants; Medical Research Council (SA)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by grants from the University of Cape Town/Carnegie Corporation of New York Development Grants, the Medical Research Council (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Baek SH, 2012, FEBS LETT, V586, P772, DOI 10.1016/j.febslet.2012.01.061; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Bamberger AM, 2001, J CANCER RES CLIN, V127, P545, DOI 10.1007/s004320100255; Berezikov E, 2004, GENOME RES, V14, P170; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cohen SB, 2001, ONCOGENE, V20, P141, DOI 10.1038/sj.onc.1204077; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Houghton SG, 2006, SURGERY, V139, P1, DOI 10.1016/j.surg.2005.02.010; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kinoshita I, 2003, ONCOGENE, V22, P2710, DOI 10.1038/sj.onc.1206371; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Liu RX, 2010, ENDOCRINE, V38, P38, DOI 10.1007/s12020-010-9324-6; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Maritz MF, 2011, BIOL CHEM, V392, P439, DOI 10.1515/BC.2011.036; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Neyns B, 1996, ONCOGENE, V12, P1247; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oya M, 2005, J UROLOGY, V174, P726, DOI 10.1097/01.ju.0000164656.99251.77; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rinehart-Kim J, 2000, INT J CANCER, V88, P180, DOI 10.1002/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H; Risse-Hackl G, 1998, ONCOGENE, V16, P3057, DOI 10.1038/sj.onc.1201845; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; Sells MA, 1998, J BIOL CHEM, V273, P18490, DOI 10.1074/jbc.273.29.18490; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; WATTS RG, 1995, MOL CARCINOGEN, V13, P27, DOI 10.1002/mc.2940130106; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866	46	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66892	10.1371/journal.pone.0066892	http://dx.doi.org/10.1371/journal.pone.0066892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818969	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800107
J	Zhang, M; Wei, J; Shan, H; Wang, H; Zhu, YH; Xue, JH; Lin, L; Yan, R				Zhang, Ming; Wei, Jin; Shan, Hu; Wang, Hao; Zhu, Yanhe; Xue, Jiahong; Lin, Lin; Yan, Rui			Calreticulin-STAT3 Signaling Pathway Modulates Mitochondrial Function in a Rat Model of Furazolidone-Induced Dilated Cardiomyopathy	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXYGEN SPECIES PRODUCTION; AVIAN MODEL; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; PROGNOSTIC VALUE; HEART-FAILURE; STAT3; CALCIUM; MICE	Background: Calreticulin is a Ca2+-binding chaperone of the endoplasmic reticulum which regulates the signal transducer and activator of transcription 3 (STAT3). The effects of the calreticulin-STAT3 signaling pathway on cardiac mitochondria and on the progress of dilated cardiomyopathy (DCM) are still unclear. Methods and Results: The DCM model was generated in rats by the daily oral administration of furazolidone. Echocardiographic and hemodynamic studies demonstrated enlarged LV dimensions and reduced systolic and diastolic functions at thirty weeks after the first furazolidone administration. Morphometric analysis showed significant myocardial degeneration, interstitial fibrosis, and mitochondrial swelling with fractured or dissolved cristae in the model group. Compared with the control group, the mitochondrial membrane potential (MMP) level of the freshly isolated cardiac mitochondria and the enzyme activities of cytochrome c oxidase and succinate dehydrogenase in the model group were significantly decreased (P<0.05). Real-time PCR and western-blot revealed the increased expression of calreticulin associated with decreased activity of STAT3 in the model group. When cultured neonatal rat cardiomyocytes were exposed to furazolidone, a dose-dependent decrease in cell viability and MMP, and the increase of apoptosis rate were observed. The mRNA and protein expression of CRT gradually increased with the increase of furazolidone concentration, associated with a gradual decrease of the STAT3 phosphorylation level both in the whole cell and mitochondrial fraction. When calreticulin was knocked down with siRNA in cardiomyocytes, these changes of cardiomyocytes and mitochondria induced by furazolidone were significantly attenuated. Conclusions: A rat model of DCM induced by furazolidone is successfully established. The calreticulin-STAT3 signaling pathway is involved in cardiac mitochondrial injury and the progress of furazolidone induced DCM.	[Zhang, Ming; Wei, Jin; Shan, Hu; Zhu, Yanhe; Xue, Jiahong; Lin, Lin; Yan, Rui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Xian 710049, Shaanxi, Peoples R China; [Wang, Hao] Wake Forest Univ, Sch Med, Dept Anesthesiol, Winston Salem, NC 27109 USA	Xi'an Jiaotong University; Wake Forest University	Wei, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Xian 710049, Shaanxi, Peoples R China.	weijindr@163.com		Wang, Hao/0000-0003-1537-661X	Science and Technology Projects of Shaanxi Province [2007K13-03]; National Natural Science Foundation of China [81170209, 81100210]	Science and Technology Projects of Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science and Technology Projects of Shaanxi Province (No. 2007K13-03 to J.W.), and grants from National Natural Science Foundation of China (No. 81170209 to J.W. and No. 81100210 to J.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Deisher T A, 1995, Am J Cardiovasc Pathol, V5, P79; Du XL, 2009, ONCOGENE, V28, P3714, DOI 10.1038/onc.2009.237; Dujardin KS, 1998, AM J CARDIOL, V82, P1071, DOI 10.1016/S0002-9149(98)00559-1; Goedel-Meinen L, 2001, AM J CARDIOL, V87, P809, DOI 10.1016/S0002-9149(00)01514-9; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; HAJJAR RJ, 1993, CARDIOVASC RES, V27, P2212, DOI 10.1093/cvr/27.12.2212; Hattori K, 2007, MOL GENET METAB, V91, P285, DOI 10.1016/j.ymgme.2007.02.003; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; JENSEN RA, 1984, J CARDIOVASC PHARM, V6, P186; Kim CS, 2000, J COMP PHYSIOL B, V170, P295, DOI 10.1007/s003600000103; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lee KS, 2011, CELL SIGNAL, V23, P1100, DOI 10.1016/j.cellsig.2011.01.006; Lim S, 2008, MOL CELLS, V25, P390; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Nozynski J, 2009, TRANSPL P, V41, P3171, DOI 10.1016/j.transproceed.2009.09.030; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; POWERS MD, 1983, POULTRY SCI, V62, P1850, DOI 10.3382/ps.0621850; Recchia FA, 2007, VET RES COMMUN, V31, P35, DOI 10.1007/s11259-007-0005-8; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu T, 2010, GERIATR GERONTOL INT, V10, pS70, DOI 10.1111/j.1447-0594.2010.00604.x; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Suzuki O, 2011, P JPN ACAD B-PHYS, V87, P550, DOI 10.2183/pjab.87.550; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Toyoda Y, 1998, J THORAC CARDIOV SUR, V115, P1367, DOI 10.1016/S0022-5223(98)70221-1; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wu YM, 2004, J MOL CELL CARDIOL, V37, P111, DOI 10.1016/j.yjmcc.2004.04.010; Yoo KJ, 2000, CIRCULATION, V102, P204; Yu HC, 2011, HEPATOLOGY, V54, P979, DOI 10.1002/hep.24469	41	19	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66779	10.1371/journal.pone.0066779	http://dx.doi.org/10.1371/journal.pone.0066779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818963	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800100
J	Beckmann, N; Schafferer, L; Schrettl, M; Binder, U; Talasz, H; Lindner, H; Haas, H				Beckmann, Nicola; Schafferer, Lukas; Schrettl, Markus; Binder, Ulrike; Talasz, Heribert; Lindner, Herbert; Haas, Hubertus			Characterization of the Link between Ornithine, Arginine, Polyamine and Siderophore Metabolism in Aspergillus fumigatus	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; IRON-METABOLISM; NIDULANS; BIOSYNTHESIS; VIRULENCE; GENE; PATHOGENICITY; ACTIVATION; DEFICIENT	The opportunistic fungal pathogen Aspergillus fumigatus produces siderophores for uptake and storage of iron, which is essential for its virulence. The main precursor of siderophore biosynthesis (SB), ornithine, can be produced from glutamate in the mitochondria or by cytosolic hydrolysis of ornithine-derived arginine. Here, we studied the impact of mitochondrial versus cytosolic ornithine biosynthesis on SB by comparison of the arginine auxotrophic mutants Delta argEF and Delta argB, which lack and possess mitochondrial ornithine production, respectively. Deficiency in argEF (encoding acetylglutamate kinase and acetylglutamyl-phosphate-reductase), but not argB (encoding ornithine transcarbamoyl transferase) decreased (i) the cellular ornithine content, (ii) extra-and intracellular SB, (iii) growth under harsh iron starvation, (iv) resistance to the ornithine decarboxylase inhibitor eflornithine, and (v) virulence in the Galleria mellonella larvae model. These lines of evidence indicate that SB is mainly fueled by mitochondrial rather than cytosolic ornithine production and underline the role of SB in virulence. Ornithine content and SB of Delta argB increased with declining arginine supplementation indicating feedback-inhibition of mitochondrial ornithine biosynthesis by arginine. In contrast to SB, the arginine and polyamine contents were only mildly affected in Delta argEF, indicating prioritization of the latter two ornithine-consuming pathways over SB. These data highlight the metabolic differences between the two arginine auxotrophic mutants DargEF and Delta argB and demonstrate that supplementation of an auxotrophic mutant does not restore the wild type metabolism at the molecular level, a fact to be considered when working with auxotrophic mutants. Moreover, cross pathway control-mediating CpcA was found to influence the ornithine pool as well as biosynthesis of siderophores and polyamines.	[Beckmann, Nicola; Schafferer, Lukas; Schrettl, Markus; Haas, Hubertus] Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria; [Binder, Ulrike] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Talasz, Heribert; Lindner, Herbert] Med Univ Innsbruck, Div Clin Biochem, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Haas, H (corresponding author), Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.	hubertus.haas@i-med.ac.at	Binder, Ulrike/AAN-8364-2021	Binder, Ulrike/0000-0002-2160-2903; Beckmann, Nicola/0000-0003-4010-4384	Austrian Science Foundation (FWF) [P21643-B11]; Tyrolian Science Foundation [UNI-0404/752]; Austrian Science Fund (FWF) [P 21643] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Tyrolian Science Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (FWF P21643-B11 to HH) and the Tyrolian Science Foundation (UNI-0404/752 to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P1848, DOI 10.1128/AAC.01504-09; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Blatzer M, 2011, FUNGAL GENET BIOL, V48, P1027, DOI 10.1016/j.fgb.2011.07.009; BOONCHIRD C, 1991, MOL GEN GENET, V226, P154, DOI 10.1007/BF00273599; Brock M, 2010, EUKARYOT CELL; Chamilos G, 2010, MED MYCOL, V48, P506, DOI 10.3109/13693780903225813; COHN MS, 1980, J BACTERIOL, V142, P791, DOI 10.1128/JB.142.3.791-799.1980; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Frederick RE, 2011, J AM CHEM SOC, V133, P12338, DOI 10.1021/ja203397s; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HILGER F, 1973, J GEN MICROBIOL, V75, P33, DOI 10.1099/00221287-75-1-33; HINDE RW, 1986, J BIOL CHEM, V261, P5848; Hu RH, 1997, BIOCHEM J, V328, P307, DOI 10.1042/bj3280307; Jadoun J, 2004, CURR GENET, V45, P235, DOI 10.1007/s00294-003-0480-6; Jin Y, 2002, MOL MICROBIOL, V46, P801, DOI 10.1046/j.1365-2958.2002.03201.x; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Klein RD, 1999, MICROBIOL-UK, V145, P301, DOI 10.1099/13500872-145-2-301; Krappmann S, 2004, MOL MICROBIOL, V52, P785, DOI 10.1111/j.1365-2958.2004.04015.x; MCDOUGALL KJ, 1977, A VAN LEEUW J MICROB, V43, P143, DOI 10.1007/BF00395669; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ramot Y, 2010, EXP DERMATOL, V19, P784, DOI 10.1111/j.1600-0625.2010.01111.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond-Bouchard I, 2012, EUKARYOT CELL, V11, P1333, DOI 10.1128/EC.00159-12; Sambrook J., 2002, MOL CLONING LAB MANU; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2010, PLOS PATHOG, V6, DOI DOI E1001124; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Wallner A, 2009, APPL ENVIRON MICROB, V75, P4194, DOI 10.1128/AEM.00479-09; WOLF EC, 1980, J BIOL CHEM, V255, P9189; WONGYAI S, 1989, J LIQ CHROMATOGR, V12, P2249	47	26	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67426	10.1371/journal.pone.0067426	http://dx.doi.org/10.1371/journal.pone.0067426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825660	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400184
J	Eichler, TW; Totland, C; Haugen, M; Qvale, TH; Mazengia, K; Storstein, A; Haukanes, BI; Vedeler, CA				Eichler, Tilo W.; Totland, Cecilie; Haugen, Mette; Qvale, Tor H.; Mazengia, Kibret; Storstein, Anette; Haukanes, Bjorn I.; Vedeler, Christian A.			CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration	PLOS ONE			English	Article							YO ANTIBODIES; DISORDERS; AVIDITY	Objective: Yo antibodies are associated with paraneoplastic cerebellar degeneration (PCD). We have characterized Yo sera by measuring CDR2 and CDR2L antibodies and the localization of their antigens. Methods: Forty-two Yo sera from patients with paraneoplastic neurological syndromes (PNS), 179 sera from ovarian and 114 sera from breast cancer patients without PNS and 100 blood donors were screened for CDR2 and CDR2L antibodies by radioactive immune assay (RIA). Fluorescence microscopy was also used to determine the presence of CDR2 or CDR2L antibodies by staining of HeLa cells transfected with CDR2 or CDR2L fused to green fluorescent protein (GFP). Confocal microscopy was further used to localize the CDR2 and CDR2L proteins. Results: RIA showed that 36 of the 42 Yo positive sera contained CDR2 and CDR2L antibodies whereas 6 sera contained only CDR2 antibodies. Five of the ovarian cancer patients had CDR2L antibodies and 4 of the breast cancer patients had either CDR2 or CDR2L antibodies. Only patients with both antibodies had PCD. RIA and staining of transfected cells showed similar results. Yo antibodies were not present in the 100 blood donors. Confocal microscopy showed that CDR2 and CDR2L were localized to the cytoplasm, whereas CDR2L was also present on the cell membrane. Interpretation: Yo sera usually contain CDR2 and CDR2L antibodies and both antibodies are associated with PCD. Since only CDR2L is localized to the cell membrane it is likely that CDR2L antibodies may be of primary pathogenic importance for the development of PCD.	[Eichler, Tilo W.; Totland, Cecilie; Qvale, Tor H.; Mazengia, Kibret; Vedeler, Christian A.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Haugen, Mette; Storstein, Anette; Vedeler, Christian A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Haukanes, Bjorn I.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Eichler, TW (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	tilo.eichler@helse-bergen.no		Haukanes, Bjorn Ivar/0000-0003-1559-3366	Western Norway Regional Health Authority (Helse Vest); University of Bergen	Western Norway Regional Health Authority (Helse Vest); University of Bergen	The Western Norway Regional Health Authority (Helse Vest) and the University of Bergen supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Bittins CM, 2010, CELL MOL NEUROBIOL, V30, P369, DOI 10.1007/s10571-009-9459-2; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Greenlee JE, 2010, J NEUROPATH EXP NEUR, V69, P997, DOI 10.1097/NEN.0b013e3181f0c82b; Hida C TTAHYT, 1994, ARCH NEUROL-CHICAGO, V51, P555; Monstad SE, 2006, CLIN EXP IMMUNOL, V144, P53, DOI 10.1111/j.1365-2249.2006.03031.x; Monstad SE, 2009, CANCER IMMUNOL IMMUN, V58, P1797, DOI 10.1007/s00262-009-0690-y; O'Donovan KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010045; Rossi CL, 1998, DIAGN MICR INFEC DIS, V30, P25, DOI 10.1016/S0732-8893(97)00194-6; Storstein A, 2009, ACTA NEUROL SCAND, V120, P64, DOI 10.1111/j.1600-0404.2008.01138.x; Storstein A, 2011, J NEUROIMMUNOL, V232, P166, DOI 10.1016/j.jneuroim.2010.10.009; Totland C, 2007, J NEUROIMMUNOL, V185, P162, DOI 10.1016/j.jneuroim.2007.01.016; Totland C, 2011, CANCER IMMUNOL IMMUN, V60, P283, DOI 10.1007/s00262-010-0943-9; Vincent A, 2008, NEUROL INDIA, V56, P305, DOI 10.4103/0028-3886.43449; Vincent A, 2010, CURR OPIN NEUROL, V23, P144, DOI 10.1097/WCO.0b013e32833735fe	16	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66002	10.1371/journal.pone.0066002	http://dx.doi.org/10.1371/journal.pone.0066002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823982	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400046
J	Ferraguti, M; Martinez-de La Puente, J; Munoz, J; Roiz, D; Ruiz, S; Soriguer, R; Figuerola, J				Ferraguti, Martina; Martinez-de la Puente, Josue; Munoz, Joaquin; Roiz, David; Ruiz, Santiago; Soriguer, Ramon; Figuerola, Jordi			Avian Plasmodium in Culex and Ochlerotatus Mosquitoes from Southern Spain: Effects of Season and Host-Feeding Source on Parasite Dynamics	PLOS ONE			English	Article							CYTOCHROME-B LINEAGES; WEST-NILE-VIRUS; MALARIA PARASITES; DIPTERA-CULICIDAE; BLOOD PARASITES; EVOLUTIONARY RELATIONSHIPS; VECTOR COMPETENCE; TRANSMISSION; HAEMOPROTEUS; ASSOCIATIONS	Haemosporidians, a group of vector-borne parasites that include Plasmodium, infect vertebrates including birds. Although mosquitoes are crucial elements in the transmission of avian malaria parasites, little is known of their ecology as vectors. We examined the presence of Plasmodium and Haemoproteus lineages in five mosquito species belonging to the genera Culex and Ochlerotatus to test for the effect of vector species, season and host-feeding source on the transmission dynamics of these pathogens. We analyzed 166 blood-fed individually and 5,579 unfed mosquitoes (grouped in 197 pools) from a locality in southern Spain. In all, 15 Plasmodium and two Haemoproteus lineages were identified on the basis of a fragment of 478 bp of the mitochondrial cytochrome b gene. Infection prevalence of blood parasites in unfed mosquitoes varied between species (range: 0-3.2%) and seasons. The feeding source was identified in 91 mosquitoes where 78% were identified as bird. We found that i) several Plasmodium lineages are shared among different Culex species and one Plasmodium lineage is shared between Culex and Ochlerotatus genera; ii) mosquitoes harboured Haemoproteus parasites; iii) pools of unfed females of mostly ornithophilic Culex species had a higher Plasmodium prevalence than the only mammophylic Culex species studied. However, the mammophylic Ochlerotatus caspius had in pool samples the greatest Plasmodium prevalence. This relative high prevalence may be determined by inter-specific differences in vector survival, susceptibility to infection but also the possibility that this species feeds on birds more frequently than previously thought. Finally, iv) infection rate of mosquitoes varies between seasons and reaches its maximum prevalence during autumn and minimum prevalence in spring.	[Ferraguti, Martina; Martinez-de la Puente, Josue; Munoz, Joaquin; Roiz, David; Figuerola, Jordi] CSIC, EBD, Dept Ecol Humedales, E-41080 Seville, Spain; [Ruiz, Santiago] Diputac Huelva, Serv Control Mosquitos, Huelva, Spain; [Soriguer, Ramon] CSIC, EBD, Dept Etol & Conservac Biodiversidad, E-41080 Seville, Spain; [Munoz, Joaquin] Univ Oklahoma, Biol Stn, Dept Biol, Kingston, OK USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Oklahoma System; University of Oklahoma - Norman	Ferraguti, M (corresponding author), CSIC, EBD, Dept Ecol Humedales, E-41080 Seville, Spain.	mferraguti@ebd.csic.es	la Puente, Josué Martínez-de/E-8597-2011; Roiz, David/F-2082-2011; Martinez-de la Puente, Josue/B-1648-2008; Ruíz, Santiago/HGU-6016-2022; Ferraguti, Martina/C-6109-2015; Figuerola, Jordi/B-7917-2008; ANGARITA, JOSUE MARTINEZ/AAL-9543-2021; Soriguer, Ramon/J-1494-2014; Munoz, Joaquin/B-9938-2009	la Puente, Josué Martínez-de/0000-0001-8055-4115; Roiz, David/0000-0002-5819-3648; Ferraguti, Martina/0000-0001-7481-4355; Figuerola, Jordi/0000-0002-4664-9011; ANGARITA, JOSUE MARTINEZ/0000-0001-5531-1920; Soriguer, Ramon/0000-0002-9165-7766; Munoz, Joaquin/0000-0003-3623-2439	Spanish Ministry of Science and Innovation [CGL2009-11445, CGL2012-30759]; Junta de Andalucia [P07-RNM-02511]; EU [FP7-261504]; LLP/Erasmus Student Placement Program of the UE; FPU program; Junta para la Ampliacion de Estud ios (CSIC); Fondo Social Europeo	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); EU(European Commission); LLP/Erasmus Student Placement Program of the UE; FPU program(Spanish Government); Junta para la Ampliacion de Estud ios (CSIC); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This study was partially funded by projects CGL2009-11445 and CGL2012-30759 from the Spanish Ministry of Science and Innovation, P07-RNM-02511 from Junta de Andalucia, and funded by EU grant FP7-261504 projects EuroWestnile and EDENext, and is catalogued by the EDENext Steering Committee as EDENext124 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. MF was first supported by a LLP/Erasmus Student Placement Program of the UE and later, by a grant from the FPU program. JMP is supported by the programme Junta para la Ampliacion de Estud ios (CSIC) co-financed by Fondo Social Europeo. Consejeria de Medio Ambiente, Junta de Andalucia gave permission for mosquito sampling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Gager AB, 2008, MOL ECOL, V17, P2552, DOI 10.1111/j.1365-294X.2008.03764.x; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harbach Ralph E., 1999, European Mosquito Bulletin, V4, P7; Hellgren O, 2008, MOL ECOL, V17, P1605, DOI 10.1111/j.1365-294X.2007.03680.x; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hughes T, 2010, J AM MOSQUITO CONTR, V26, P24, DOI 10.2987/09-5893.1; Hurford C, 2010, INTEGRATED MONITORIN, P325; Iezhova TA, 2011, J PARASITOL, V97, P682, DOI 10.1645/GE-2709.1; Inci A, 2012, VET PARASITOL, V188, P179, DOI 10.1016/j.vetpar.2012.02.012; Ishtiaq F, 2008, MOL ECOL, V17, P4545, DOI 10.1111/j.1365-294X.2008.03935.x; Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Kim KS, 2009, PARASITOL RES, V105, P1351, DOI 10.1007/s00436-009-1568-9; Kim KS, 2009, J MED ENTOMOL, V46, P1230, DOI 10.1603/033.046.0535; Kimura M, 2010, J PARASITOL, V96, P144, DOI 10.1645/GE-2060.1; Koella JC, 1999, MICROBES INFECT, V1, P303, DOI 10.1016/S1286-4579(99)80026-4; Komar Nicholas, 2003, Adv Virus Res, V61, P185; LaPointe DA, 2005, J PARASITOL, V91, P843, DOI 10.1645/GE-3431.1; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Martinez J, 2009, PARASITOLOGY, V136, P713, DOI 10.1017/S0031182009006118; Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109; Martinez-de la Puente J, 2012, J MED ENTOMOL, V49, P1419, DOI 10.1603/ME12081; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martinez-de la Puente J, 2010, ACTA OECOL, V36, P543, DOI 10.1016/j.actao.2010.07.008; Martinez-de la Puente J, 2009, J AVIAN BIOL, V40, P653, DOI 10.1111/j.1600-048X.2009.04726.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Perez-Tris J, 2005, TRENDS PARASITOL, V21, P209, DOI 10.1016/j.pt.2005.03.001; Perez-Tris J, 2005, PARASITOLOGY, V131, P15, DOI 10.1017/S003118200500733X; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; Schaffner F., 2001, MOSQUITOES EUROPE ID; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson J. N., 2005, INTERSPEC INTERACT; Tripet F, 2008, TRENDS PARASITOL, V24, P219, DOI 10.1016/j.pt.2008.02.008; Valkiunas G, 2005, TRENDS PARASITOL, V21, P357, DOI 10.1016/j.pt.2005.06.005; Valkiunas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2011, MOL ECOL, V20, P3084, DOI 10.1111/j.1365-294X.2011.05187.x; Ventim R, 2012, PARASITOL RES, V111, P637, DOI 10.1007/s00436-012-2880-3; Williams CJ, 2001, J AQUAT ANIM HEALTH, V13, P300, DOI 10.1577/1548-8667(2001)013&lt;0300:ACOMOS&gt;2.0.CO;2	66	55	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66237	10.1371/journal.pone.0066237	http://dx.doi.org/10.1371/journal.pone.0066237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823127	Green Published, gold			2022-12-25	WOS:000320576400071
J	Graf, D; Seifert, S; Jaudszus, A; Bub, A; Watzl, B				Graf, Daniela; Seifert, Stephanie; Jaudszus, Anke; Bub, Achim; Watzl, Bernhard			Anthocyanin-Rich Juice Lowers Serum Cholesterol, Leptin, and Resistin and Improves Plasma Fatty Acid Composition in Fischer Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; GLUCOSE-INTOLERANCE; BERRY ANTHOCYANINS; OBESITY; MICE; INFLAMMATION; RISK; OVERWEIGHT; HEALTH	Obesity and obesity-associated diseases e.g. cardiovascular diseases and type 2 diabetes are spread worldwide. Anthocyanins are supposed to have health-promoting properties, although convincing evidence is lacking. The aim of the present study was to investigate the effect of anthocyanins on several risk factors for obesity-associated diseases. Therefore, Fischer rats were fed anthocyanin-rich grape-bilberry juice or an anthocyanin-depleted control juice for 10 weeks. Intervention with anthocyanin-rich grape-bilberry juice reduced serum cholesterol and tended to decrease serum triglycerides. No effects were seen for serum non-esterified fatty acids, glucose, and insulin. Anthocyanin-rich grape-bilberry juice intervention reduced serum leptin and resistin, but showed no influence on serum adiponectin and secretion of adipokines from mesenteric adipose tissue. Furthermore, anthocyanin-rich grape-bilberry juice increased the proportion of polyunsaturated fatty acids and decreased the amount of saturated fatty acids in plasma. These results indicate that anthocyanins possess a preventive potential for obesity-associated diseases.	[Graf, Daniela; Seifert, Stephanie; Jaudszus, Anke; Bub, Achim; Watzl, Bernhard] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany		Watzl, B (corresponding author), Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany.	bernhard.watzl@mri.bund.de		Graf, Daniela/0000-0002-1746-1415	German Federal Ministry of Research and Education [0315379G]	German Federal Ministry of Research and Education	This study has been financially supported by the German Federal Ministry of Research and Education (0315379G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Espin JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014; Catalano KJ, 2010, DIABETES, V59, P1416, DOI 10.2337/db08-0675; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; di Giuseppe R, 2009, AM J CLIN NUTR, V89, P354, DOI 10.3945/ajcn.2008.26661; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Graf D, 2013, MOL NUTR FOOD RES, V57, P1753, DOI 10.1002/mnfr.201300022; Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013; Guo HH, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-10; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p; Karlsen A, 2010, EUR J NUTR, V49, P345, DOI 10.1007/s00394-010-0092-0; Lecerf JM, 2011, BRIT J NUTR, V106, P6, DOI 10.1017/S0007114511000237; Lehtonen HM, 2011, EUR J CLIN NUTR, V65, P394, DOI 10.1038/ejcn.2010.268; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Toufektsian MC, 2011, J NUTR, V141, P37, DOI 10.3945/jn.110.127225; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vafeiadou K, 2012, BRIT J NUTR, V107, P303, DOI 10.1017/S0007114511004764; Wang QQ, 2012, ATHEROSCLEROSIS, V221, P536, DOI 10.1016/j.atherosclerosis.2012.01.006; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002	36	52	52	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66690	10.1371/journal.pone.0066690	http://dx.doi.org/10.1371/journal.pone.0066690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825152	Green Published, gold			2022-12-25	WOS:000320576400148
J	Han, DW; Tapia, N; Arauzo-Bravo, MJ; Lim, KT; Kim, KP; Ko, K; Lee, HT; Scholer, HR				Han, Dong Wook; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Lim, Kyung Tae; Kim, Kee Pyo; Ko, Kinarm; Lee, Hoon Taek; Schoeler, Hans R.			Sox2 Level Is a Determinant of Cellular Reprogramming Potential	PLOS ONE			English	Article							NANOG; DIFFERENTIATION; PLURIPOTENCY; CELLS	Epiblast stem cells (EpiSCs) and embryonic stem cells (ESCs) differ in their in vivo differentiation potential. While ESCs form teratomas and efficiently contribute to the development of chimeras, EpiSCs form teratomas but very rarely chimeras. In contrast to their differentiation potential, the reprogramming potential of EpiSCs has not yet been investigated. Here we demonstrate that the epiblast-derived pluripotent stem cells EpiSCs and P19 embryonal carcinoma cells (ECCs) exhibit a lower reprogramming potential than ESCs and F9 ECCs. In addition, we show that the low reprogramming ability is due to the lower levels of Sox2 in epiblast-derived stem cells. Consistent with this observation, overexpression of Sox2 enhances reprogramming efficiency. In summary, these findings suggest that a low reprogramming potential is a general feature of epiblast-derived stem cells and that the Sox2 level is a determinant of the cellular reprogramming potential.	[Han, Dong Wook; Lim, Kyung Tae; Ko, Kinarm; Lee, Hoon Taek] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Han, Dong Wook; Ko, Kinarm] Konkuk Univ, Inst Funct Genom, Seoul, South Korea; [Tapia, Natalia; Arauzo-Bravo, Marcos J.; Kim, Kee Pyo; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Konkuk University; Konkuk University Medical Center; Konkuk University; Max Planck Society; University of Munster	Han, DW (corresponding author), Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea.	dwhan@konkuk.ac.kr	Marcos, Arauzo-Bravo/A-1706-2011; Lim, Kyungtae/GYU-3532-2022; , HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Lim, Kyungtae/0000-0001-6044-2191; , HS/0000-0003-2643-5136; Tapia, Natalia/0000-0003-0226-1952				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Do JT, 2009, J CELL SCI, V122, P4122, DOI 10.1242/jcs.056119; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67594	10.1371/journal.pone.0067594	http://dx.doi.org/10.1371/journal.pone.0067594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825671	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400189
J	Heine-Broring, RC; Winkels, RM; Botma, A; van Duijnhoven, FJB; Jung, AY; Kleibeuker, JH; Nagengast, FM; Vasen, HFA; Kampman, E				Heine-Broring, Renate C.; Winkels, Renate M.; Botma, Akke; van Duijnhoven, Franzel J. B.; Jung, Audrey Y.; Kleibeuker, Jan H.; Nagengast, Fokko M.; Vasen, Hans F. A.; Kampman, Ellen			Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study	PLOS ONE			English	Article							CANCER; VALIDITY; FAMILIES; VITAMIN; GENE; OMEGA-3-FATTY-ACIDS; QUESTIONNAIRE; POPULATION; PREVENTION; CARRIERS	Background and Aims: Individuals with Lynch syndrome have a high lifetime risk of developing colorectal tumors. In this prospective cohort study of individuals with Lynch syndrome, we examined associations between use of dietary supplements and occurrence of colorectal adenomas. Materials and Methods: Using data of 470 individuals with Lynch syndrome in a prospective cohort study, associations between dietary supplement use and colorectal adenoma risk were evaluated by calculating hazard ratios (HR) and 95% confidence intervals (CI) using cox regression models adjusted for age, sex, and number of colonoscopies during person time. Robust sandwich covariance estimation was used to account for dependency within families. Results: Of the 470 mismatch repair gene mutation carriers, 122 (26.0%) developed a colorectal adenoma during an overall median person time of 39.1 months. 40% of the study population used a dietary supplement. Use of any dietary supplement was not statistically significantly associated with colorectal adenoma risk (HR = 1.18; 95% CI 0.80-1.73). Multivitamin supplement use (HR = 1.15; 95% CI 0.72-1.84), vitamin C supplement use (HR = 1.57; 95% CI 0.93-2.63), calcium supplement use (HR = 0.69; 95% CI 0.25-1.92), and supplements containing fish oil (HR = 1.60; 95% CI 0.79-3.23) were also not associated with occurrence of colorectal adenomas. Conclusion: This prospective cohort study does not show inverse associations between dietary supplement use and occurrence of colorectal adenomas among individuals with Lynch syndrome. Further research is warranted to determine whether or not dietary supplement use is associated to colorectal adenoma and colorectal cancer risk in MMR gene mutation carriers.	[Heine-Broring, Renate C.; Winkels, Renate M.; Botma, Akke; van Duijnhoven, Franzel J. B.; Kampman, Ellen] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [van Duijnhoven, Franzel J. B.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Jung, Audrey Y.; Kampman, Ellen] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Kleibeuker, Jan H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol, Groningen, Netherlands; [Nagengast, Fokko M.] Radboud Univ Nijmegen, Dept Gastroenterol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vasen, Hans F. A.] Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands; [Kampman, Ellen] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kampman, E (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	Ellen.Kampman@wur.nl	Winkels, Renate M./AAB-2619-2019; Kampman, E./H-8057-2014; van Duijnhoven, Fränzel/GWC-0059-2022	Winkels, Renate M./0000-0002-0376-8811; Vasen, Hans/0000-0003-2682-2603; Jung, Audrey/0000-0003-0875-6673	Dutch Cancer Society [UW-2005-3275]; Wereld Kanker Onderzoek Fonds; World Cancer Research Fund International (WCRF International)	Dutch Cancer Society(KWF Kankerbestrijding); Wereld Kanker Onderzoek Fonds; World Cancer Research Fund International (WCRF International)	This work was financially supported by the Dutch Cancer Society (grant UW-2005-3275); Wereld Kanker Onderzoek Fonds (WCRF NL); and World Cancer Research Fund International (WCRF International). Websites: (http://dcs.kwfkankerbestrijding.nl/Pages/Home.aspx.) (http://www.wcrf.nl/). (http://www.wcrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2008, COL CANC FACTS FIG 2; [Anonymous], 2008, ERF DARMK LAND RICHT; Barrow E, 2008, CLIN GENET, V74, P233, DOI 10.1111/j.1399-0004.2008.01035.x; Bjelakovic G, 2006, ALIMENT PHARM THER, V24, P281, DOI 10.1111/j.1365-2036.2006.02970.x; BLOCK G, 1994, AM J CLIN NUTR, V59, p232S, DOI 10.1093/ajcn/59.1.232S; Botma A, 2011, GASTROENTEROLOGY; Botma A, 2013, CANCER-AM CANCER SOC, V119, P512, DOI 10.1002/cncr.27726; Botma A, 2010, J CLIN ONCOL, V28, P4346, DOI 10.1200/JCO.2010.28.0453; Calviello G, 2007, CURR MED CHEM, V14, P3059, DOI 10.2174/092986707782793934; Carroll C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-29; CATS A, 1995, JNCI-J NATL CANCER I, V87, P598, DOI 10.1093/jnci/87.8.598; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Diergaarde B, 2007, CLIN GASTROENTEROL H, V5, P736, DOI 10.1016/j.cgh.2007.02.019; Ervin RB, 1999, VITAL HLTH STAT, V11, p[i, 1]; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; Figueiredo JC, 2011, INT J CANCER, V129, P192, DOI 10.1002/ijc.25872; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Kempers MJE, 2011, LANCET ONCOL, V12, P49, DOI 10.1016/S1470-2045(10)70265-5; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; McGinnis JM, 2007, AM J CLIN NUTR, V85, p257S; Neugut AI, 1996, CANCER-AM CANCER SOC, V78, P723, DOI 10.1002/(SICI)1097-0142(19960815)78:4<723::AID-CNCR5>3.0.CO;2-F; Papaioannou D, 2011, COLORECTAL DIS, V13, P1085, DOI 10.1111/j.1463-1318.2010.02289.x; Patterson RE, 1998, AM J EPIDEMIOL, V148, P643, DOI 10.1093/aje/148.7.643; POLS MA, 1995, INT J EPIDEMIOL, V24, P381, DOI 10.1093/ije/24.2.381; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Reddy BS, 2004, INT J CANCER, V112, P1, DOI 10.1002/ijc.20320; Rijcken FEM, 2002, GUT, V50, P382, DOI 10.1136/gut.50.3.382; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Satia-Abouta J, 2003, AM J EPIDEMIOL, V157, P944, DOI 10.1093/aje/kwg039; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Signaleringscommissie Kanker van KWF Kankerbestrijding, 2007, SIGN KANS KANK BEW C; van Rossum CTM., 2011, 3500500062011 NAT I; Vasen HFA, 2010, GASTROENTEROLOGY, V138, P2300, DOI 10.1053/j.gastro.2010.02.053; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Weingarten MA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003548.pub3	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66819	10.1371/journal.pone.0066819	http://dx.doi.org/10.1371/journal.pone.0066819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825568	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400161
J	Jia, W; Liu, R; Shi, JG; Wu, B; Dang, W; Du, Y; Zhou, Q; Wang, JH; Zhang, R				Jia, Wei; Liu, Rui; Shi, Jianguo; Wu, Bin; Dang, Wei; Du, Ying; Zhou, Qiong; Wang, Jianhua; Zhang, Rui			Differential Regulation of MAPK Phosphorylation in the Dorsal Hippocampus in Response to Prolonged Morphine Withdrawal-Induced Depressive-Like Symptoms in Mice	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; OPIATE WITHDRAWAL; MAJOR DEPRESSION; RAT-BRAIN; BEHAVIOR; EXPRESSION; NALOXONE; NEURONS; MKP-3; SANGUINARINE	Depression is one of the most frequent neuropsychiatric comorbidities associated with opiate addiction. Mitogen activated protein kinase (MAPK) and MAPK phosphatase (MKP) are involved in drug addiction and depression. However, the potential role of MAPK and MKP in depression caused by morphine withdrawal remains unclear. We utilized a mouse model of repeated morphine administration to examine the molecular mechanisms that contribute to prolonged withdrawal induced depressive-like behaviors. Depressive-like behaviors were significant at 1 week after withdrawal and worsened over time. Phospho-ERK (extracellular signal-regulated protein kinase) was decreased and MKP-1 was elevated in the hippocampus, and JNK (c-Jun N-terminal protein kinase), p38 (p38 protein kinase) and MKP-3 were unaffected. A pharmacological blockade of MKP-1 by intra-hippocampal sanguinarine (SA) infusion prevented the development of depressive-like behaviors and resulted in relatively normal levels of MKP-1 and phospho-ERK after withdrawal. Our findings support the association between hippocampal MAPK phosphorylation and prolonged morphine withdrawal-induced depression, and emphasize the MKP-1 as an negative regulator of the ERK phosphorylation that contributes to depression.	[Jia, Wei; Shi, Jianguo; Wu, Bin; Dang, Wei; Zhang, Rui] Xian Mental Hlth Ctr, Methadone Maintenance Treatment Clin, Xian, Peoples R China; [Liu, Rui; Wang, Jianhua] Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Peoples R China; [Du, Ying; Zhou, Qiong] Fourth Mil Med Univ, Dept Neurol, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, R (corresponding author), Xian Mental Hlth Ctr, Methadone Maintenance Treatment Clin, Xian, Peoples R China.	liurui761@126.com			National Natural Science Foundation of China [81200966]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81200966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1995, BEHAV NEUROSCI, V109, P91, DOI 10.1037/0735-7044.109.1.91; Berke JD, 2001, SCIENCE, V294; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Caille S, 1999, J PHARMACOL EXP THER, V290, P881; Canales JJ, 2007, EUR ARCH PSY CLIN N, V257, P261, DOI 10.1007/s00406-007-0730-6; Carroll BJ, 2004, AM J PSYCHIAT, V161, P1309, DOI 10.1176/appi.ajp.161.7.1309-a; Chen YC, 2012, NEUROSCI LETT, V506, P327, DOI 10.1016/j.neulet.2011.11.038; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Goeldner C, 2011, BIOL PSYCHIAT, V69, P236, DOI 10.1016/j.biopsych.2010.08.021; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; Haghparast A, 2011, BEHAV BRAIN RES, V220, P112, DOI 10.1016/j.bbr.2011.01.045; Heinzen EL, 2004, BRAIN RES, V1023, P175, DOI 10.1016/j.brainres.2004.07.015; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Le Duigou C, 2005, J PHYSIOL-LONDON, V569, P833, DOI 10.1113/jphysiol.2005.094599; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Li T, 2010, NEUROSCI LETT, V468, P348, DOI 10.1016/j.neulet.2009.11.030; Ligeza A, 2008, FEBS J, V275, P3836, DOI 10.1111/j.1742-4658.2008.06531.x; Liu QF, 2011, NEUROL RES, V33, P56, DOI 10.1179/016164110X12714125204236; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Nunes EV, 2006, ADDICTION, V101, P89, DOI 10.1111/j.1360-0443.2006.01585.x; Paxinos K.B.J., 2001, MOUSE BRAIN STEREOTA; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Rehni AK, 2013, NEUROPHARMACOLOGY; Rehni AK, 2011, BEHAV PHARMACOL, V22, P182, DOI 10.1097/FBP.0b013e328343d7a0; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shu SY, 2003, J NEUROSCI RES, V71, P609, DOI 10.1002/jnr.10545; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Sun WL, 2008, BRAIN RES, V1243, P1, DOI 10.1016/j.brainres.2008.09.016; Takaki M, 2001, J NEUROCHEM, V79, P679, DOI 10.1046/j.1471-4159.2001.00615.x; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Yu T, 2011, INT J NEUROPSYCHOPH, V14, P303, DOI 10.1017/S1461145710000945; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zimmerman M, 2000, AM J PSYCHIAT, V157, P1337, DOI 10.1176/appi.ajp.157.8.1337	48	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66111	10.1371/journal.pone.0066111	http://dx.doi.org/10.1371/journal.pone.0066111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823128	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400054
J	Kluk, MJ; Ashworth, T; Wang, HF; Knoechel, B; Mason, EF; Morgan, EA; Dorfman, D; Pinkus, G; Weigert, O; Hornick, JL; Chirieac, LR; Hirsch, M; Oh, DJ; South, AP; Leigh, IM; Pourreyron, C; Cassidy, AJ; DeAngelo, DJ; Weinstock, DM; Krop, IE; Dillon, D; Brock, JE; Lazar, AJF; Peto, M; Cho, RJ; Stoeck, A; Haines, BB; Sathayanrayanan, S; Rodig, S; Aster, JC				Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Knoechel, Birgit; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Weigert, Oliver; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E.; Dillon, Deborah; Brock, Jane E.; Lazar, Alexander J. F.; Peto, Myron; Cho, Raymond J.; Stoeck, Alexander; Haines, Brian B.; Sathayanrayanan, Sriram; Rodig, Scott; Aster, Jon C.			Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry	PLOS ONE			English	Article							GENE AMPLIFICATION; CODING GENOME; B-CLL; MUTATIONS; TUMOR; REVEALS; PATHWAY; OVEREXPRESSION; ANGIOGENESIS; MECHANISMS	Fixed, paraffin-embedded (FPE) tissues are a potentially rich resource for studying the role of NOTCH1 in cancer and other pathologies, but tests that reliably detect activated NOTCH1 (NICD1) in FPE samples have been lacking. Here, we bridge this gap by developing an immunohistochemical (IHC) stain that detects a neoepitope created by the proteolytic cleavage event that activates NOTCH1. Following validation using xenografted cancers and normal tissues with known patterns of NOTCH1 activation, we applied this test to tumors linked to dysregulated Notch signaling by mutational studies. As expected, frequent NICD1 staining was observed in T lymphoblastic leukemia/lymphoma, a tumor in which activating NOTCH1 mutations are common. However, when IHC was used to gauge NOTCH1 activation in other human cancers, several unexpected findings emerged. Among B cell tumors, NICD1 staining was much more frequent in chronic lymphocytic leukemia than would be predicted based on the frequency of NOTCH1 mutations, while mantle cell lymphoma and diffuse large B cell lymphoma showed no evidence of NOTCH1 activation. NICD1 was also detected in 38% of peripheral T cell lymphomas. Of interest, NICD1 staining in chronic lymphocytic leukemia cells and in angioimmunoblastic lymphoma was consistently more pronounced in lymph nodes than in surrounding soft tissues, implicating factors in the nodal microenvironment in NOTCH1 activation in these diseases. Among carcinomas, diffuse strong NICD1 staining was observed in 3.8% of cases of triple negative breast cancer (3 of 78 tumors), but was absent from 151 non-small cell lung carcinomas and 147 ovarian carcinomas. Frequent staining of normal endothelium was also observed; in line with this observation, strong NICD1 staining was also seen in 77% of angiosarcomas. These findings complement insights from genomic sequencing studies and suggest that IHC staining is a valuable experimental tool that may be useful in selection of patients for clinical trials.	[Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; Dillon, Deborah; Brock, Jane E.; Rodig, Scott; Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; Dillon, Deborah; Brock, Jane E.; Rodig, Scott; Aster, Jon C.] Harvard Univ, Sch Med, Boston, MA USA; [Knoechel, Birgit; Weigert, Oliver; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E.] Dana Farber Canc Inst, Dept Pediat Hematol, Boston, MA 02115 USA; [Knoechel, Birgit; Weigert, Oliver; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E.] Dana Farber Canc Inst, Dept Oncol & Med Oncol, Boston, MA 02115 USA; [South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Dundee DD1 9SY, Scotland; [South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Genet Core Serv Unit, Dundee DD1 9SY, Scotland; [Lazar, Alexander J. F.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Peto, Myron] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Cho, Raymond J.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Stoeck, Alexander; Haines, Brian B.; Sathayanrayanan, Sriram] Merck Oncol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Dundee; University of Dundee; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; University of California System; University of California San Francisco	Aster, JC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu	Lazar, Alexander J/A-3416-2008; Cho, Raymond/AAO-8125-2020; Pourreyron, Celine/AAE-7362-2020; Rodig, Scott/Y-3889-2019; Chirieac, Lucian R./AAD-2030-2019	Lazar, Alexander J/0000-0002-6395-4499; Cho, Raymond/0000-0001-6090-6603; Morgan, Elizabeth/0000-0001-5880-9337; Hornick, Jason/0000-0001-6475-8345; Cassidy, Andrew/0000-0003-4309-6981	NIH; Leukemia and Lymphoma Society; BWH Department of Pathology Robbins Award; Cancer Research UK [13044] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K08CA169865] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); BWH Department of Pathology Robbins Award; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the NIH and Leukemia and Lymphoma Society (JCA) and the BWH Department of Pathology Robbins Award (MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Balatti V, 2012, BLOOD, V119, P329, DOI 10.1182/blood-2011-10-386144; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bogusz AM, 2012, CLIN CANCER RES, V18, P6122, DOI 10.1158/1078-0432.CCR-12-0397; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Deangelo DJ, 2006, J CLIN ONCOL, V24, p357S; Del Giudice I, 2012, HAEMATOL-HEMATOL J, V97, P437, DOI 10.3324/haematol.2011.060129; Di Ianni M, 2009, BRIT J HAEMATOL, V146, P689, DOI 10.1111/j.1365-2141.2009.07816.x; Dill MT, 2012, GASTROENTEROLOGY, V142, P967, DOI 10.1053/j.gastro.2011.12.052; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kridel R, 2012, BLOOD, V119, P1963, DOI 10.1182/blood-2011-11-391474; Lahat G, 2010, ANN SURG, V251, P1098, DOI 10.1097/SLA.0b013e3181dbb75a; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Liu JF, 2009, GYNECOL ONCOL, V115, P401, DOI 10.1016/j.ygyno.2009.08.023; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Simmons MJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3321; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015; Yen WC, 2012, CLIN CANCER RES, V18, P5374, DOI 10.1158/1078-0432.CCR-12-0736	57	78	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67306	10.1371/journal.pone.0067306	http://dx.doi.org/10.1371/journal.pone.0067306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825651	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400182
J	Liu, S; Ma, CY; Ren, WD; Yang, J; Zhang, Y; Li, S; Cheng, YB				Liu, Shuang; Ma, Chunyan; Ren, Weidong; Yang, Jun; Zhang, Yan; Li, Sha; Cheng, Yanbin			Left Atrial Systolic and Diastolic Dysfunction in Patients with Chronic Constrictive Pericarditis: A Study Using Speckle Tracking and Conventional Echocardiography	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; TISSUE CHARACTERIZATION; MYOCARDIAL-INFARCTION; FILLING PRESSURES; PUMP FUNCTION; STRAIN-RATE; SIZE; FIBRILLATION; RELAXATION; RECOMMENDATIONS	Background: Left atrial (LA) function plays an important role in the maintenance of cardiac output, however, in patients with constrictive pericarditis (CP), whether pericardial restriction and adhesion can lead to LA dysfunction, and the characteristics of LA function remain unclear. The aim of the study is to compare the left atrial (LA) function of patients with CP to that of healthy study participants using speckle tracking echocardiography (STE) and conventional echocardiography. Methods and Results: Thirty patients with CP and 30 healthy volunteers (controls) were enrolled in the study. The underlying cause of CP was viral pericarditis in 24 (80%) patients and unknown in 6 (20%) patients. The LA maximum volume (Vmax), LA minimal volume (Vmin), and LA volume before atrial contraction (Vpre-a) were measured using biplane modified Simpson's method. The LA expansion index (LA reservoir function) was determined as follows: ([LAVmax - LAVmin]/LAVmin) x 100. The passive emptying index (LA conduit function) was calculated as follows: ([LAVmax - LAVpre-a]/LAVmax) x 100, and the active emptying index (booster pump function) was calculated as follows: ([LAVpre-a - LAVmin]/LAVpre-a) x 100. All the patients underwent two-dimensional STE. The LA global systolic strain (S), systolic strain rate (SrS), early diastolic strain rate (SrE) and late diastolic strain rate (SrA) were measured. The LA expansion index, passive emptying index, the active emptying index and the LA global S, SrS, SrE, SrA were found to be significantly lower in patients with CP than in the control participants (P < 0.001). LA function was correlated with the early diastolic velocity of the lateral mitral annulus (P < 0.05). Conclusions: Although left ventricular systolic function was preserved in patients with CP, the LA reservoir, conduit, and booster functions were impaired. Pericardial restriction and impairment of the LA myocardium may play an important role in the reduction of LA function in patients with CP.	[Liu, Shuang; Ren, Weidong] China Med Univ, Dept Ultrasound, Shengjing Hosp, Shenyang, Peoples R China; [Liu, Shuang; Ma, Chunyan; Yang, Jun; Zhang, Yan; Li, Sha; Cheng, Yanbin] China Med Univ, Dept Cardiovasc Funct, Affiliated Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University	Ren, WD (corresponding author), China Med Univ, Dept Ultrasound, Shengjing Hosp, Shenyang, Peoples R China.	renweidong01@yahoo.com.cn	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Antoni ML, 2011, J AM SOC ECHOCARDIOG, V24, P1126, DOI 10.1016/j.echo.2011.06.017; Anwar AM, 2007, HEART, V93, P1393, DOI 10.1136/hrt.2006.099366; Barbier P, 1999, CIRCULATION, V100, P427, DOI 10.1161/01.CIR.100.4.427; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bertini M, 2010, CIRC-CARDIOVASC IMAG, V3, P86, DOI 10.1161/CIRCIMAGING.109.882324; Blondheim DS, 2005, AM J CARDIOL, V96, P457, DOI 10.1016/j.amjcard.2005.03.101; Cameli M, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-6; D'Andrea A, 2008, BRIT J SPORT MED, V42, P696, DOI 10.1136/bjsm.2007.041210; Dernellis JM, 1996, J HUM HYPERTENS, V10, P789; Dernellis JM, 1998, AM J CARDIOL, V81, P1138, DOI 10.1016/S0002-9149(98)00134-9; Di Salvo G, 2009, EUR J ECHOCARDIOGR, V10, P256, DOI 10.1093/ejechocard/jen218; Dittrich HC, 1999, AM HEART J, V137, P494, DOI 10.1016/S0002-8703(99)70498-9; Gabrielli L, 2011, ECHOCARDIOGR-J CARD, V28, P1104, DOI 10.1111/j.1540-8175.2011.01518.x; Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705; Hiroyama N, 1982, J Cardiogr, V12, P415; Kizer JR, 2006, AM HEART J, V151, P412, DOI 10.1016/j.ahj.2005.04.031; Kosmala W, 2013, HEART, V99, P320, DOI 10.1136/heartjnl-2012-303329; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee HH, 2013, ULTRASOUND MED BIOL, V39, P54, DOI 10.1016/j.ultrasmedbio.2012.08.023; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; MATSUZAKI M, 1991, AM J CARDIOL, V67, P1121, DOI 10.1016/0002-9149(91)90876-M; Mizuno R, 2001, CARDIOLOGY, V96, P16, DOI 10.1159/000047381; Mondillo S, 2011, J AM SOC ECHOCARDIOG, V24, P898, DOI 10.1016/j.echo.2011.04.014; Morris DA, 2011, J AM SOC ECHOCARDIOG, V24, P651, DOI 10.1016/j.echo.2011.02.004; Nagueh SF, 1998, CIRCULATION, V98, P1644, DOI 10.1161/01.CIR.98.16.1644; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nikitin N P, 2003, Eur J Echocardiogr, V4, P36, DOI 10.1053/euje.2002.0611; Okamatsu K, 2009, J AM SOC ECHOCARDIOG, V22, P70, DOI 10.1016/j.echo.2008.11.006; Ommen SR, 2000, CIRCULATION, V102, P1788; Paraskevaidis IA, 2012, INT J CARDIOL, V157, P31, DOI 10.1016/j.ijcard.2010.11.007; PICANO E, 1990, CIRCULATION, V81, P58, DOI 10.1161/01.CIR.81.1.58; Qirko S, 1996, ARCH MAL COEUR VAISS, V89, P1003; Quinones MA, 2000, J AM COLL CARDIOL, V35, P1237, DOI 10.1016/S0735-1097(00)00511-8; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P29, DOI 10.1016/j.jcmg.2007.10.006; Spencer KT, 2001, HEART, V85, P272, DOI 10.1136/heart.85.3.272; Vianna-Pinton R, 2009, J AM SOC ECHOCARDIOG, V22, P299, DOI 10.1016/j.echo.2008.12.017; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051204; Yiu KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036115; Yu CM, 2007, J AM COLL CARDIOL, V49, P1903, DOI 10.1016/j.jacc.2007.01.078	41	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68718	10.1371/journal.pone.0068718	http://dx.doi.org/10.1371/journal.pone.0068718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825701	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400200
J	Mares, J; Hrouzek, P; Kana, R; Ventura, S; Strunecky, O; Komarek, J				Mares, Jan; Hrouzek, Pavel; Kana, Radek; Ventura, Stefano; Strunecky, Otakar; Komarek, Jiri			The Primitive Thylakoid-Less Cyanobacterium Gloeobacter Is a Common Rock-Dwelling Organism	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; VIOLACEUS PCC-7421; PHYLOGENETIC-RELATIONSHIPS; PHOTOSYSTEM-I; ORIGIN; PHYCOBILISOME; BIODIVERSITY; CAROTENOIDS; MEMBRANE; PROTEINS	Cyanobacteria are an ancient group of photosynthetic prokaryotes, which are significant in biogeochemical cycles. The most primitive among living cyanobacteria, Gloeobacter violaceus, shows a unique ancestral cell organization with a complete absence of inner membranes (thylakoids) and an uncommon structure of the photosynthetic apparatus. Numerous phylogenetic papers proved its basal position among all of the organisms and organelles capable of plant-like photosynthesis (i.e., cyanobacteria, chloroplasts of algae and plants). Hence, G. violaceus has become one of the key species in evolutionary study of photosynthetic life. It also numbers among the most widely used organisms in experimental photosynthesis research. Except for a few related culture isolates, there has been little data on the actual biology of Gloeobacter, being relegated to an "evolutionary curiosity'' with an enigmatic identity. Here we show that members of the genus Gloeobacter probably are common rock-dwelling cyanobacteria. On the basis of morphological, ultrastructural, pigment, and phylogenetic comparisons of available Gloeobacter strains, as well as on the basis of three new independent isolates and historical type specimen, we have produced strong evidence as to the close relationship of Gloeobacter to a long known rock-dwelling cyanobacterial morphospecies Aphanothece caldariorum. Our results bring new clues to solving the 40 year old puzzle of the true biological identity of Gloeobacter violaceus, a model organism with a high value in several biological disciplines. A probable broader distribution of Gloeobacter in common wet-rock habitats worldwide is suggested by our data, and its ecological meaning is discussed taking into consideration the background of cyanobacterial evolution. We provide observations of previously unknown genetic variability and phenotypic plasticity, which we expect to be utilized by experimental and evolutionary researchers worldwide.	[Mares, Jan; Strunecky, Otakar; Komarek, Jiri] Ctr Phycol, Inst Bot ASCR, Trebon, Czech Republic; [Mares, Jan; Komarek, Jiri] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Hrouzek, Pavel; Kana, Radek] ALGATECH, Dept Autotroph Microorganisms, Inst Microbiol ASCR, Trebon, Czech Republic; [Ventura, Stefano] CNR, ISE, Sesto Fiorentino, Italy; [Strunecky, Otakar] Univ South Bohemia, Fac Sci, Ctr Polar Ecol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); University of South Bohemia Ceske Budejovice	Mares, J (corresponding author), Ctr Phycol, Inst Bot ASCR, Trebon, Czech Republic.	mares@butbn.cas.cz	Strunecky, Otakar/H-1629-2014; Ventura, Stefano/A-4014-2009; Mareš, Jan/B-2395-2009; Komarek, Jiri/H-1597-2014; Kaňa, Radek/A-6434-2009; strunecky, otakar/M-2643-2019	Strunecky, Otakar/0000-0001-9735-4662; Ventura, Stefano/0000-0002-8134-3675; Mareš, Jan/0000-0002-5745-7023; Kaňa, Radek/0000-0001-5768-6902; Hrouzek, Pavel/0000-0002-2061-0266	long-term research development project [RVO 67985939]; Center for Algal Biotechnology Trebon - ALGATECH [CZ. 1.05/21.00/03.0110];  [GA JU 135/2010/P];  [GACR P506/12/1818]	long-term research development project; Center for Algal Biotechnology Trebon - ALGATECH; ; 	This study was supported as a long-term research development project no. RVO 67985939, by the grant no. GA JU 135/2010/P, GACR P506/12/1818 and by the Center for Algal Biotechnology Trebon - ALGATECH (CZ. 1.05/21.00/03.0110). The authors acknowledge MetaCentrum v.o. for providing supercomputing facilities under the research agreement MSM6383917201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ-COBELAS M, 1988, Acta Botanica Malacitana, V13, P53; Beck C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-56; Bernat G, 2012, PLANT CELL PHYSIOL, V53, P528, DOI 10.1093/pcp/pcs009; Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BRYANT DA, 1981, ARCH MICROBIOL, V129, P190, DOI 10.1007/BF00425249; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P7, DOI 10.1099/00207713-52-1-7; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; Cuzman OA, 2010, MICROB ECOL, V60, P81, DOI 10.1007/s00248-010-9672-z; Dreher C, 2010, J BIOENERG BIOMEMBR, V42, P517, DOI 10.1007/s10863-010-9279-6; FOSS P, 1986, PHYTOCHEMISTRY, V25, P1127, DOI 10.1016/S0031-9422(00)81568-X; GEITLER L., 1927, ARCH PROTISTENKD, V60, P440; GOLUBIC S, 1979, PRECAMBRIAN RES, V8, P201, DOI 10.1016/0301-9268(79)90029-9; GUGLIELMI G, 1981, ARCH MICROBIOL, V129, P181, DOI 10.1007/BF00425248; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P2510, DOI 10.1099/ijs.0.005678-0; Gutierrez-Cirlos EB, 2006, BBA-BIOENERGETICS, V1757, P130, DOI 10.1016/j.bbabio.2006.01.006; HALDA J., 2011, OPERA CORCONTICA, V48, P45; Hansgirg, 1892, ARCH NATURWISS LANDE, V8, P1; Hauer T, 2008, FOTTEA, V8, P129, DOI 10.5507/fot.2008.011; Herrero A., 2008, CYANOBACTERIA MOL BI; Hoffmann L, 2005, ARCH HYDROBIOL S, V117, P21; Inoue H, 2004, FEBS LETT, V578, P275, DOI 10.1016/j.febslet.2004.11.013; Johansen JR, 2007, SOUTHEAST NAT, V6, P99, DOI 10.1656/1528-7092(2007)6[99:NASRFG]2.0.CO;2; Kana R, 2009, BBA-BIOENERGETICS, V1787, P1170, DOI 10.1016/j.bbabio.2009.04.013; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Koksharova OA, 2010, MICROBIOLOGY+, V79, P721, DOI 10.1134/S0026261710060020; Komarek J., 1998, SUSSWASSER FLORA MIT, P548; Kondo K, 2007, PLANT PHYSIOL, V144, P1200, DOI 10.1104/pp.107.099267; Krogmann DW, 2007, PHOTOSYNTH RES, V93, P27, DOI 10.1007/s11120-007-9133-9; Lamprinou V, 2012, INT J SPELEOL, V41, P267, DOI 10.5038/1827-806X.41.2.12; Matula Jan, 2007, Polish Polar Research, V28, P283; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Mimuro M, 2010, PHOTOCHEM PHOTOBIOL, V86, P62, DOI 10.1111/j.1751-1097.2009.00619.x; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Seo PS, 2003, J GEN APPL MICROBIOL, V49, P191, DOI 10.2323/jgam.49.191; Singh Shiv Mohan, 2008, Acta Botanica Malacitana, V33, P17; Skinner Stephen, 2001, Telopea, V9, P573; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; StatSoft Inc, 2012, STAT DAT AN SOFTW SY; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Takaichi S, 2010, MICROBIOL-SGM, V156, P757, DOI 10.1099/mic.0.034249-0; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; UHER B, 2002, B SLOVENSKEJ BOT SPO, V24, P25; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Williamson A, 2011, PHOTOSYNTH RES, V107, P71, DOI 10.1007/s11120-010-9559-3; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yilmaz M, 2009, J PHYCOL, V45, P517, DOI 10.1111/j.1529-8817.2009.00651.x; Yokono M, 2008, BBA-BIOENERGETICS, V1777, P55, DOI 10.1016/j.bbabio.2007.11.001; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	62	61	62	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66323	10.1371/journal.pone.0066323	http://dx.doi.org/10.1371/journal.pone.0066323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823729	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400084
J	Mishra, V; Cline, R; Noel, P; Karlsson, J; Baty, CJ; Orlichenko, L; Patel, K; Trivedi, RN; Husain, SZ; Acharya, C; Durgampudi, C; Stolz, DB; Navina, S; Singh, VP				Mishra, Vivek; Cline, Rachel; Noel, Pawan; Karlsson, Jenny; Baty, Catherine J.; Orlichenko, Lidiya; Patel, Krutika; Trivedi, Ram Narayan; Husain, Sohail Z.; Acharya, Chathur; Durgampudi, Chandra; Stolz, Donna B.; Navina, Sarah; Singh, Vijay P.			Src Dependent Pancreatic Acinar Injury Can Be Initiated Independent of an Increase in Cytosolic Calcium	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; ZYMOGEN ACTIVATION; GASTROINTESTINAL HORMONES/NEUROTRANSMITTERS; TRYPSINOGEN ACTIVATION; GROWTH-FACTORS; CELL INJURY; CHOLECYSTOKININ; SECRETION; ASSOCIATION	Several deleterious intra-acinar phenomena are simultaneously triggered on initiating acute pancreatitis. These culminate in acinar injury or inflammatory mediator generation in vitro and parenchymal damage in vivo. Supraphysiologic caerulein is one such initiator which simultaneously activates numerous signaling pathways including non-receptor tyrosine kinases such as of the Src family. It also causes a sustained increase in cytosolic calcium-a player thought to be crucial in regulating deleterious phenomena. We have shown Src to be involved in caerulein induced actin remodeling, and caerulein induced changes in the Golgi and post-Golgi trafficking to be involved in trypsinogen activation, which initiates acinar cell injury. However, it remains unclear whether an increase in cytosolic calcium is necessary to initiate acinar injury or if injury can be initiated at basal cytosolic calcium levels by an alternate pathway. To study the interplay between tyrosine kinase signaling and calcium, we treated mouse pancreatic acinar cells with the tyrosine phosphatase inhibitor pervanadate. We studied the effect of the clinically used Src inhibitor Dasatinib (BMS-354825) on pervanadate or caerulein induced changes in Src activation, trypsinogen activation, cell injury, upstream cytosolic calcium, actin and Golgi morphology. Pervanadate, like supraphysiologic caerulein, induced Src activation, redistribution of the F-actin from its normal location in the sub-apical area to the basolateral areas, and caused antegrade fragmentation of the Golgi. These changes, like those induced by supraphysiologic caerulein, were associated with trypsinogen activation and acinar injury, all of which were prevented by Dasatinib. Interestingly, however, pervanadate did not cause an increase in cytosolic calcium, and the caerulein induced increase in cytosolic calcium was not affected by Dasatinib. These findings suggest that intra-acinar deleterious phenomena may be initiated independent of an increase in cytosolic calcium. Other players resulting in acinar injury along with the Src family of tyrosine kinases remain to be explored.	[Mishra, Vivek; Cline, Rachel; Noel, Pawan; Orlichenko, Lidiya; Patel, Krutika; Trivedi, Ram Narayan; Singh, Vijay P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Karlsson, Jenny; Baty, Catherine J.; Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Husain, Sohail Z.] Univ Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15260 USA; [Acharya, Chathur; Durgampudi, Chandra] Univ Pittsburgh, Med Ctr, Dept Med, Passavant, PA USA; [Navina, Sarah] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, VP (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	singhv2@upmc.edu	Patel, Krutika/AAA-1302-2022	Singh, Vijay/0000-0001-6611-1908; Husain, Sohail Z/0000-0003-3012-1308	National Pancreas Foundation (NPF) [PR110417]; Department of Army (DOA) [UL1 RR024153]; National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK092460]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093491, T32DK007017, R01DK092460] Funding Source: NIH RePORTER	National Pancreas Foundation (NPF); Department of Army (DOA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Pancreas Foundation (NPF) Research Award 2010 (Role of Src in Antegrade Golgi Expansion and Autophagic Acinar Cell Death) to V.P.S., Grant number PR110417 from the Department of Army (DOA) (V.P.S.), grant number UL1 RR024153 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research (S.N. and V.P.S.), and award number R01DK092460 (V.P.S.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; DUAN RD, 1994, AM J PHYSIOL, V267, pG401, DOI 10.1152/ajpgi.1994.267.3.G401; El Alaoui-Talibi Z, 1997, AM J PHYSL, V272, pH1615; Eley T, 2009, J CLIN PHARMACOL, V49, P700, DOI 10.1177/0091270009333854; Fischer L, 2007, AM J PHYSIOL-GASTR L, V292, pG875, DOI 10.1152/ajpgi.00558.2005; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gnoni A, 2011, CURR DRUG TARGETS, V12, P563, DOI 10.2174/138945011794751591; Gorelick F, 2008, J GASTROEN HEPATOL, V23, pS37, DOI 10.1111/j.1440-1746.2007.05282.x; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Han B, 2000, AM J PHYSIOL-CELL PH, V278, pC344, DOI 10.1152/ajpcell.2000.278.2.C344; Han B, 2001, AM J PHYSIOL-CELL PH, V280, pC465, DOI 10.1152/ajpcell.2001.280.3.C465; Hietaranta AJ, 2001, J BIOL CHEM, V276, P18742, DOI 10.1074/jbc.M009721200; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lynch G, 2004, PFLUG ARCH EUR J PHY, V447, P445, DOI 10.1007/s00424-003-1188-7; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Muili KA, 2012, AM J PHYSIOL-GASTR L, V302, pG898, DOI 10.1152/ajpgi.00545.2011; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Nozu F, 1999, AM J PHYSIOL-GASTR L, V276, pG915, DOI 10.1152/ajpgi.1999.276.4.G915; OKONSKI MS, 1993, PANCREAS, V8, P638, DOI 10.1097/00006676-199309000-00018; Orlichenko L, 2012, J BIOL CHEM, V287, P24284, DOI 10.1074/jbc.M111.328815; Orlichenko LS, 2010, AM J PHYSIOL-GASTR L, V299, pG867, DOI 10.1152/ajpgi.00177.2010; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Parker EM, 2000, PANCREAS, V21, P219, DOI 10.1097/00006676-200010000-00001; Petersen OH, 2006, TRENDS PHARMACOL SCI, V27, P113, DOI 10.1016/j.tips.2005.12.006; Redondo PC, 2003, BIOCHEM J, V370, P255, DOI 10.1042/BJ20021505; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; SALUJA AK, 1989, P NATL ACAD SCI USA, V86, P8968, DOI 10.1073/pnas.86.22.8968; Samuel I, 2006, J GASTROINTEST SURG, V10, P1376, DOI 10.1016/j.gassur.2006.09.003; Sancho V, 2012, BBA-MOL CELL RES, V1823, P1285, DOI 10.1016/j.bbamcr.2012.05.015; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; Singh VP, 2001, GASTROENTEROLOGY, V120, P1818, DOI 10.1053/gast.2001.24883; Tapia JA, 1999, J BIOL CHEM, V274, P31261, DOI 10.1074/jbc.274.44.31261; Thrower EC, 2009, PANCREAS, V38, P930, DOI 10.1097/MPA.0b013e3181b8476a; Torgerson RR, 1998, J CELL SCI, V111, P2911; Torgerson RR, 2000, J CELL PHYSIOL, V182, P438, DOI 10.1002/(SICI)1097-4652(200003)182:3<438::AID-JCP15>3.0.CO;2-N; Tsunoda Y, 2004, BIOCHEM BIOPH RES CO, V314, P916, DOI 10.1016/j.bbrc.2003.11.186; Waterford SD, 2005, J BIOL CHEM, V280, P5430, DOI 10.1074/jbc.M413513200; Weber H, 2005, BIOCHEM PHARMACOL, V70, P1241, DOI 10.1016/j.bcp.2005.06.028; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66471	10.1371/journal.pone.0066471	http://dx.doi.org/10.1371/journal.pone.0066471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824669	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000320576400114
J	Pavlidi, N; Dermauw, W; Rombauts, S; Chrisargiris, A; Van Leeuwen, T; Vontas, J				Pavlidi, Nena; Dermauw, Wannes; Rombauts, Stephane; Chrisargiris, Antonis; Van Leeuwen, Thomas; Vontas, John			Analysis of the Olive Fruit Fly Bactrocera oleae Transcriptome and Phylogenetic Classification of the Major Detoxification Gene Families	PLOS ONE			English	Article							RESISTANCE; ANNOTATION; ABC; ACETYLCHOLINESTERASE; IDENTIFICATION; EXPRESSION; ENZYMES	The olive fruit fly Bactrocera oleae has a unique ability to cope with olive flesh, and is the most destructive pest of olives worldwide. Its control has been largely based on the use of chemical insecticides, however, the selection of insecticide resistance against several insecticides has evolved. The study of detoxification mechanisms, which allow the olive fruit fly to defend against insecticides, and/or phytotoxins possibly present in the mesocarp, has been hampered by the lack of genomic information in this species. In the NCBI database less than 1,000 nucleotide sequences have been deposited, with less than 10 detoxification gene homologues in total. We used 454 pyrosequencing to produce, for the first time, a large transcriptome dataset for B. oleae. A total of 482,790 reads were assembled into 14,204 contigs. More than 60% of those contigs (8,630) were larger than 500 base pairs, and almost half of them matched with genes of the order of the Diptera. Analysis of the Gene Ontology (GO) distribution of unique contigs, suggests that, compared to other insects, the assembly is broadly representative for the B. oleae transcriptome. Furthermore, the transcriptome was found to contain 55 P450, 43 GST-, 15 CCE- and 18 ABC transporter-genes. Several of those detoxification genes, may putatively be involved in the ability of the olive fruit fly to deal with xenobiotics, such as plant phytotoxins and insecticides. In summary, our study has generated new data and genomic resources, which will substantially facilitate molecular studies in B. oleae, including elucidation of detoxification mechanisms of xenobiotic, as well as other important aspects of olive fruit fly biology.	[Pavlidi, Nena; Chrisargiris, Antonis; Vontas, John] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Dermauw, Wannes; Van Leeuwen, Thomas] Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium; [Rombauts, Stephane] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	University of Crete; Ghent University; Ghent University	Vontas, J (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	vontas@biology.uoc.gr	Rombauts, Stephane M/D-7640-2014; Vontas, John/X-5112-2018; Rombauts, Stephane/P-2420-2019; Van Leeuwen, Thomas/H-5036-2013; Dermauw, Wannes/H-1583-2015	Rombauts, Stephane M/0000-0002-3985-4981; Vontas, John/0000-0002-8704-2574; Rombauts, Stephane/0000-0002-3985-4981; Dermauw, Wannes/0000-0003-4612-8969; Van Leeuwen, Thomas/0000-0003-4651-830X; Chrysargyris, Antonios/0000-0002-1067-7977	'HRAKLEITOS II' project; Operational Programme 'Education and Life Long Learning'; European Social Found and National Resources; Greek Ministry of Rural Development and Food	'HRAKLEITOS II' project; Operational Programme 'Education and Life Long Learning'; European Social Found and National Resources; Greek Ministry of Rural Development and Food	Part of this research was supported by 'HRAKLEITOS II' project, Operational Programme 'Education and Life Long Learning', which is co-funded by the European Social Found and National Resources and by the Greek Ministry of Rural Development and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ant T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-51; Berenbaum MR, 2002, J CHEM ECOL, V28, P873, DOI 10.1023/A:1015260931034; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corrado G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-86; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dermauw W, 2012, P NATL ACAD SCI USA, V110, P393; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; HAGEN KS, 1966, NATURE, V209, P423, DOI 10.1038/209423a0; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Hsu JC, 2012, INSECT BIOCHEM MOLEC, V42, P806, DOI 10.1016/j.ibmb.2012.07.010; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kakani EG, 2008, INSECT BIOCHEM MOLEC, V38, P781, DOI 10.1016/j.ibmb.2008.05.004; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Snyder MJ, 1996, METHOD ENZYMOL, V272, P304, DOI 10.1016/S0076-6879(96)72036-0; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Vontas JG, 2002, INSECT MOL BIOL, V11, P329, DOI 10.1046/j.1365-2583.2002.00343.x; Vontas J, 2011, PESTIC BIOCHEM PHYS, V100, P199, DOI 10.1016/j.pestbp.2011.04.004	43	34	38	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66533	10.1371/journal.pone.0066533	http://dx.doi.org/10.1371/journal.pone.0066533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824998	Green Published, gold			2022-12-25	WOS:000320576400123
J	Vilhelmsson, A; Svensson, T; Meeuwisse, A				Vilhelmsson, Andreas; Svensson, Tommy; Meeuwisse, Anna			A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression	PLOS ONE			English	Article							ANTIDEPRESSANT; DISORDERS; SEROTONIN; IMPACT; DRUGS	Background:Starting in the 1960s, a broad-based patients' rights movement began to question doctors' paternalism and health care. According to scholars, these changes contributed to downplay the biomedical approach in favor of a more patient-oriented perspective. The Swedish non-profit organization Consumer Association for Medicines and Health (KILEN) has offered the possibility for consumers to report their perceptions and experiences from their use of medicines in order to strengthen consumer rights within the health care sector. Methodology: In this paper, qualitative content analysis was used to analyze 181 KILEN consumer reports of adverse events from antidepressant medications in order to explore patients' views of mental ill health symptoms and the doctor-patient interaction. Principal Findings: Overall, the KILEN stories contained negative experiences of the patients' medical encounters. Some reports indicated intense emotional outrage and strong feelings of abuse by the health care system. Many reports suggested that doctors and patients had very different accounts of the nature of the problems for which the patient was seeking help. Although patients sought help for problems like tiredness and sleeplessness (often with a personal crisis of some sort as a described cause), the treating doctor in most cases was exceptionally quick in both diagnosing depression and prescribing antidepressant treatment. When patients felt they were not being listened to, trust in the doctor was compromised. This was evident in the cases when the doctor tried to convince them to take part in medical treatment, sometimes by threatening to withdraw their sick-listing. Conclusions: Overall, this study suggests that the dynamics happening in the medical encounter may still be highly affected by a medical dominance, instead of a patient-oriented perspective. This may contribute to a questionable medicalization and/or pharmaceuticalization of depression.	[Vilhelmsson, Andreas] Nord Sch Publ Hlth, Gothenburg, Sweden; [Svensson, Tommy] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Meeuwisse, Anna] Lund Univ, Sch Social Work, Lund, Sweden	Linkoping University; Lund University	Vilhelmsson, A (corresponding author), Nord Sch Publ Hlth, Gothenburg, Sweden.	andreas.vilhelmsson@nhv.se	Vilhelmsson, Andreas/D-3879-2018	Vilhelmsson, Andreas/0000-0002-6635-8182	Stiftelsen Kempe-Carlgrenska Fonden; Lundgrenska Fonden; Stiftelsen Sigurd och Elsa Goljes Minne; Stiftelsen Lars Hiertas Minne; Elsa Lundberg och Greta Flerons; studier av lakemedelsbiverkan	Stiftelsen Kempe-Carlgrenska Fonden; Lundgrenska Fonden; Stiftelsen Sigurd och Elsa Goljes Minne; Stiftelsen Lars Hiertas Minne; Elsa Lundberg och Greta Flerons; studier av lakemedelsbiverkan	This study has received funding from Stiftelsen Kempe-Carlgrenska Fonden, Lundgrenska Fonden, Stiftelsen Sigurd och Elsa Goljes Minne, Stiftelsen Lars Hiertas Minne and Elsa Lundberg och Greta Flerons fond for studier av lakemedelsbiverkan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2010, SOCIOLOGY, V44, P603, DOI 10.1177/0038038510369368; Almasi EA, 2006, PLOS MED, V3, P284, DOI 10.1371/journal.pmed.0030145; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], 2018, QUAL PRIM HLTH CAR; Barry CA, 2001, SOC SCI MED, V53, P487, DOI 10.1016/S0277-9536(00)00351-8; Bayer R, 2007, PUBLIC HLTH ETHICS T, P3; Bowling A., 2014, RES METHODS HLTH INV; Broom DH, 1996, SOCIOL HEALTH ILL, V18, P357, DOI 10.1111/1467-9566.ep10934730; Bunton R, 1997, FOUCAULT HLTH MED, P118; Busfield J, 2006, SOCIOLOGY, V40, P297, DOI 10.1177/0038038506062034; Busfield J, 2011, MENTAL ILLNESS; COHEN CI, 1993, COMMUNITY MENT HLT J, V29, P509, DOI 10.1007/BF00754260; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233; Conrad P., 2007, MED SOC TRANSFORMATI; COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Cornford CS, 2007, FAM PRACT, V24, P358, DOI 10.1093/fampra/cmm032; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fox NJ, 2008, SOCIOL HEALTH ILL, V30, P856, DOI 10.1111/j.1467-9566.2008.01114.x; Frazzetto G, 2008, EMBO REP, V9, P605, DOI 10.1038/embor.2008.116; Freidson E, 2007, PROFESSIONAL DOMINAN; Freidson E., 1988, PROFESSION MED STUDY; Gilmore K A, 2000, Int J Health Care Qual Assur Inc Leadersh Health Serv, V13, P34, DOI 10.1108/09526860010311071; Golafshani N., 2003, QUAL REP, V8, P597, DOI [DOI 10.46743/2160-3715/2003.1870, 10.46743/2160-3715/2003.1870]; Goldacre B., 2012, BAD PHARM DRUG CO MI; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Healy D., 2004, CREATION PSYCHOPHARM; Healy D., 1997, ANTIDEPRESSANT ERA; Healy D, 2006, GLOBAL PHARM ETHICS, P61, DOI DOI 10.1215/9780822387916-003; Healy D., 2012, PHARMAGEDDON; Helman C.G., 2007, CULTURE HLTH ILLNESS; Horwitz A.V., 2002, CREATING MENTAL ILLN; Illich I., 1976, LIMITS MED MED NEMES; Karp DA, 2007, IS IT ME MY MEDS LIV; Kessing LV, 2005, PSYCHOL MED, V35, P1205, DOI 10.1017/S0033291705004605; Kirsch I., 2011, EMPERORS NEW DRUGS E; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Knudsen P, 2003, PHARM WORLD SCI, V25, P162, DOI 10.1023/A:1024897427249; Knudsen P, 2002, QUAL HEALTH RES, V12, P932, DOI 10.1177/104973202129120368; Kramer Peter D., 1993, LISTENING PROZAC PSY; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Law J, 2006, BIG PHARM BIGGEST DR; Leo J, 2008, SOCIETY, V45, P35, DOI 10.1007/s12115-007-9047-3; Lexchin J, 2006, CAN MED ASSOC J, V174, P191, DOI 10.1503/cmaj.050971; Lexchin J, 2001, CAN MED ASSOC J, V164, P1449; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; Lynoe N, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000246; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Metzl JM, 2007, LANCET, V369, P697, DOI 10.1016/S0140-6736(07)60317-1; Middleton H, 2011, BRIT J GEN PRACT, V61, P47, DOI 10.3399/bjgp11X548983; Mintzes B, 2002, BRIT MED J, V324, P908, DOI 10.1136/bmj.324.7342.908; Moncrieff J., 2009, MYTH CHEM CURE CRITI; Moncrieff J, 2008, SOC SCI MED, V66, P2346, DOI 10.1016/j.socscimed.2008.01.047; Mulinari S, 2012, J HIST NEUROSCI, V21, P366, DOI 10.1080/0964704X.2011.623917; Ogden J, 1999, BRIT J GEN PRACT, V49, P123; Ogden J, 2000, HTLH PSYCHOL TXB; Patton M.Q., 2014, QUALITATIVE RES EVAL, V4th ed.; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Prior L, 2005, MED WORK MED KNOWLED, P1; Prior L, 2005, MED WORK MED KNOWLED, P208; Rose N, 2007, LANCET, V369, P700, DOI 10.1016/S0140-6736(07)60319-5; Rose Nikolas S., 2007, POLITICS LIFE ITSELF; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Shorter E., 2009, PROZAC TROUBLED HIST; Spence D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3135; The National Board of Health and Welfare, 2006, ANTIDEPRESSIVE LAKEM; Thom DH, 1997, J FAM PRACTICE, V44, P169; Thomas RK, 2003, SOC HLTH SOCIOLOGY H; Thomas-MacLean R, 2004, HEALTH-LONDON, V8, P275, DOI 10.1177/1363459304043461; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Valenstein E., 2002, BLAMING BRAIN TRUTH; van Geffen ECG, 2007, EUR J CLIN PHARMACOL, V63, P1193, DOI 10.1007/s00228-007-0375-4; Vilhelmsson A, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-19; Vilhelmsson Andreas, 2011, BMC Clin Pharmacol, V11, P16, DOI 10.1186/1472-6904-11-16; Wessel M, 2013, EUR J PUBLIC HEALTH, V23, P230, DOI 10.1093/eurpub/cks030; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2002, SAF MED GUID DET REP; World Health Organization, 2004, PROM MENT HLTH CONC; ZOLA IK, 1972, SOCIOL REV, V20, P487, DOI 10.1111/j.1467-954X.1972.tb00220.x; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	84	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66338	10.1371/journal.pone.0066338	http://dx.doi.org/10.1371/journal.pone.0066338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823902	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400087
J	Castoldi, R; Ecker, V; Wiehle, L; Majety, M; Busl-Schuller, R; Asmussen, M; Nopora, A; Jucknischke, U; Osl, F; Kobold, S; Scheuer, W; Venturi, M; Klein, C; Niederfellner, G; Sustmann, C				Castoldi, R.; Ecker, V.; Wiehle, L.; Majety, M.; Busl-Schuller, R.; Asmussen, M.; Nopora, A.; Jucknischke, U.; Osl, F.; Kobold, S.; Scheuer, W.; Venturi, M.; Klein, C.; Niederfellner, G.; Sustmann, C.			A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity	ONCOGENE			English	Article						EGFR; Met; HGF; EGF; bispecific antibody	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; HEPATOCYTE GROWTH; LUNG-CANCER; C-MET; GEFITINIB RESISTANCE; ACQUIRED-RESISTANCE; SIGNALING NETWORKS; CARCINOMA CELLS; TARGETING MET	Simultaneous targeting of epidermal growth factor receptor (EGFR) and Met in cancer therapy is under pre-clinical and clinical evaluation. Here, we report the finding that treatment with EGFR inhibitors of various tumor cells, when stimulated with hepatocyte growth factor (HGF) and EGF, results in transient upregulation of phosphorylated AKT. Furthermore, EGFR inhibition in this setting stimulates a pro-invasive phenotype as assessed in Matrigel-based assays. Simultaneous treatment with AKT and EGFR inhibitors abrogates this invasive growth, hence functionally linking signaling and phenotype. This observation implies that during treatment of tumors a balanced ratio of EGFR and Met inhibition is required. To address this, we designed a bispecific antibody targeting EGFR and Met, which has the advantage of a fixed 2:1 stoichiometry. This bispecific antibody inhibits proliferation in tumor cell cultures and co-cultures with fibroblasts in an additive manner compared with treatment with both single agents. In addition, cell migration assays reveal a higher potency of the bispecific antibody in comparison with the antibodies' combination at low doses. We demonstrate that the bispecific antibody inhibits invasive growth, which is specifically observed with cetuximab. Finally, the bispecific antibody potently inhibits tumor growth in a non-small cell lung cancer xenograft model bearing a strong autocrine HGF-loop. Together, our findings strongly support a combination treatment of EGFR and Met inhibitors and further evaluation of resistance mechanisms to EGFR inhibition in the context of active Met signaling.	[Castoldi, R.; Ecker, V.; Wiehle, L.; Majety, M.; Busl-Schuller, R.; Asmussen, M.; Nopora, A.; Jucknischke, U.; Osl, F.; Scheuer, W.; Venturi, M.; Niederfellner, G.; Sustmann, C.] Roche Diagnost GmbH, Pharma Res & Early Dev pRED, D-82377 Penzberg, Germany; [Kobold, S.] Univ Munich, Dept Internal Med 4, Div Clin Pharmacol, Munich, Germany; [Klein, C.] Glycart AG, pRED, Schlieren, Switzerland	Roche Holding; University of Munich	Sustmann, C (corresponding author), Roche Diagnost GmbH, Pharma Res & Early Dev pRED, Nonnenwald 2, D-82377 Penzberg, Germany.	claudio.sustmann@roche.com	Klein, Christian/G-1336-2010	Klein, Christian/0000-0001-7594-7280; Wiehle, Laura/0000-0001-6081-3925; Kobold, Sebastian/0000-0002-5612-4673	Bayerisches Immuntherapie-Netzwerk (BayImmuNet)	Bayerisches Immuntherapie-Netzwerk (BayImmuNet)	S.K. is supported by the Bayerisches Immuntherapie-Netzwerk (BayImmuNet).	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Amit I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100195; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bonine-Summers AR, 2007, CANCER BIOL THER, V6, P561, DOI 10.4161/cbt.6.4.3851; Brehmer D, 2005, CANCER RES, V65, P379; Chhatwani Laveena, 2009, Proc Am Thorac Soc, V6, P194, DOI 10.1513/pats.200807-068LC; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Croasdale R, 2012, ARCH BIOCHEM BIOPHYS, V526, P206, DOI 10.1016/j.abb.2012.03.016; Dikmen E, 2006, EUR RESPIR J, V27, P73, DOI 10.1183/09031936.06.00148704; Dong JY, 2011, MABS-AUSTIN, V3, P273, DOI 10.4161/mabs.3.3.15188; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hammond DE, 2010, J PROTEOME RES, V9, P2734, DOI 10.1021/pr100145w; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Metz S, 2011, P NATL ACAD SCI USA, V108, P8194, DOI 10.1073/pnas.1018565108; Naito Y, 2012, CELL CYCLE, V11, P604, DOI 10.4161/cc.11.3.19114; Nedergaard MK, 2012, BIODRUGS, V26, P83, DOI 10.2165/11599760-000000000-00000; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Puri Neelu, 2008, J Carcinog, V7, P9; Reusch U, 2006, CLIN CANCER RES, V12, P183, DOI 10.1158/1078-0432.CCR-05-1855; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Serrels A, 2011, CELL ADHES MIGR, V5, P360, DOI 10.4161/cam.5.4.17290; Sugahara K, 1998, INTENS CARE MED, V24, P434, DOI 10.1007/s001340050592; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Takata M, 2012, CANCER BIOL THER, V13, P6; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uchiyama A, 1999, BRIT J CANCER, V81, P721, DOI 10.1038/sj.bjc.6690754; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang SY, 2011, ANTI-CANCER AGENT ME, V11, P993, DOI 10.2174/187152011797927661; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Yamada T, 2012, J THORAC ONCOL, V7, P272, DOI 10.1097/JTO.0b013e3182398e69; Yang SY, 2011, FRONT BIOSCI-LANDMRK, V16, P531, DOI 10.2741/3703; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yap TA, 2011, CURR DRUG TARGETS, V12, P2045; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898	47	43	53	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2013	32	50					5593	5601		10.1038/onc.2013.245	http://dx.doi.org/10.1038/onc.2013.245			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	272LF	23812422	hybrid, Green Published			2022-12-25	WOS:000328461400004
J	Mehrotra, S; Sharma, B; Joshi, S; Kroczynska, B; Majchrzak, B; Stein, BL; McMahon, B; Altman, JK; Licht, JD; Baker, DP; Eklund, EA; Wickrema, A; Verma, A; Fish, EN; Platanias, LC				Mehrotra, Swarna; Sharma, Bhumika; Joshi, Sonali; Kroczynska, Barbara; Majchrzak, Beata; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Baker, Darren P.; Eklund, Elizabeth A.; Wickrema, Amittha; Verma, Amit; Fish, Eleanor N.; Platanias, Leonidas C.			Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; POLYCYTHEMIA-VERA; PEGYLATED INTERFERON-ALPHA-2B; ESSENTIAL THROMBOCYTHEMIA; MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; MAMMALIAN TARGET; GENE-EXPRESSION; MESSENGER-RNA; ALPHA	The mechanisms of generation of the antineoplastic effects of interferons (IFNs) in malignant hematopoietic cells remain to be precisely defined. We examined the activation of type I IFN-dependent signaling pathways in malignant cells transformed by Jak2V617F, a critical pathogenic mutation in myeloproliferative neoplasms (MPNs). Our studies demonstrate that during engagement of the type I IFN receptor (IFNAR), there is activation of Jak-Stat pathways and also engagement of Mnk kinases. Activation of Mnk kinases is regulated by the Mek/Erk pathway and is required for the generation of IFN-induced growth inhibitory responses, but Mnk kinase activation does not modulate IFN-regulated Jak-Stat signals. We demonstrate that for type I IFNs to exert suppressive effects in malignant hematopoietic progenitors from patients with polycythemia vera, induction of Mnk kinase activity is required, as evidenced by studies involving pharmacological inhibition of Mnk or siRNA-mediated Mnk knockdown. Altogether, these findings provide evidence for key and essential roles of the Mnk kinase pathway in the generation of the antineoplastic effects of type I IFNs in Jak2V617F-dependent MPNs.	[Mehrotra, Swarna; Sharma, Bhumika; Joshi, Sonali; Kroczynska, Barbara; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Mehrotra, Swarna; Sharma, Bhumika; Joshi, Sonali; Kroczynska, Barbara; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Majchrzak, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Verma, Amit] Albert Einstein Coll Med, Div Hematol Oncol, Bronx, NY 10467 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Biogen; University of Chicago; Yeshiva University; Albert Einstein College of Medicine	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, Lurie 3-107,303 East Super, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Licht, Jonathan/L-4239-2019; mehrotra, swarna/F-2688-2015; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369	National Institutes of Health [CA155566, CA77816, CA161796]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA155566, R01CA161796, R01CA121192, P30CA060553, R01CA077816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA155566, CA77816, and CA161796 (to L. C. P.); by a Merit Review grant from the Department of Veterans Affairs (to L. C. P.). D. P. B. is an employee of Biogen Idec and an owner of Biogen Idec stock.	Altman JK, 2013, BLOOD, V121, P3675, DOI 10.1182/blood-2013-01-477216; Alvarado Y, 2003, CANCER CHEMOTH PHARM, V51, P81, DOI 10.1007/s00280-002-0533-4; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Gowin K, 2012, HAEMATOL-HEMATOL J, V97, P1570, DOI 10.3324/haematol.2011.061390; Hou JQ, 2012, ONCOTARGET, V3, P118; Ianotto JC, 2009, BRIT J HAEMATOL, V146, P223, DOI 10.1111/j.1365-2141.2009.07745.x; Indraccolo S, 2010, AUTOIMMUNITY, V43, P244, DOI 10.3109/08916930903510963; Inoue M, 2013, IMMUNOLOGY, V139, P11, DOI 10.1111/imm.12081; Joshi Sonali, 2015, BioMolecular Concepts, V6, P85, DOI 10.1515/bmc-2011-2000; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Karussis D, 2013, BIODRUGS, V27, P113, DOI 10.1007/s40259-013-0011-z; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Lamers MH, 2012, ANTIVIR THER, V17, P1029, DOI 10.3851/IMP2306; Langer C, 2005, HAEMATOLOGICA, V90, P1333; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lu M, 2010, EXP HEMATOL, V38, P472, DOI 10.1016/j.exphem.2010.03.005; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Panaretakis T, 2008, MOL BIOL CELL, V19, P41, DOI 10.1091/mbc.E07-04-0358; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Peschel C, 1996, LEUKEMIA LYMPHOMA, V22, P129, DOI 10.3109/10428199609074370; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Redig AJ, 2007, J INTERF CYTOK RES, V27, P623, DOI 10.1089/jir.2007.0007; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Samuelsson J, 2006, CANCER-AM CANCER SOC, V106, P2397, DOI 10.1002/cncr.21900; Scagnolari C, 2013, EXPERT OPIN BIOL TH, V13, P693, DOI 10.1517/14712598.2013.764409; Sharma B, 2012, J BIOL CHEM, V287, P42352, DOI 10.1074/jbc.M112.400721; Silver RT, 2011, BLOOD, V117, P6669, DOI 10.1182/blood-2010-11-320069; SILVER RT, 1988, LANCET, V2, P403; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stein BL, 2013, J INTERF CYTOK RES, V33, P145, DOI 10.1089/jir.2012.0120; Tai AW, 2009, J HEPATOL, V50, P412, DOI 10.1016/j.jhep.2008.11.010; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Verma A, 2002, LEUKEMIA LYMPHOMA, V43, P703, DOI 10.1080/10428190290016782; Xiong ZY, 2007, CLIN IMMUNOL, V122, P279, DOI 10.1016/j.clim.2006.10.006; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	65	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23814	23822		10.1074/jbc.M113.476192	http://dx.doi.org/10.1074/jbc.M113.476192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814052	Green Published, hybrid			2022-12-25	WOS:000330611400021
J	Cormier, A; Drubin, DG; Barnes, G				Cormier, Anthony; Drubin, David G.; Barnes, Georjana			Phosphorylation Regulates Kinase and Microtubule Binding Activities of the Budding Yeast Chromosomal Passenger Complex in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; SPINDLE ASSEMBLY CHECKPOINT; CELL-DIVISION; ESCHERICHIA-COLI; CLEAVAGE FURROW; INCENP BINDS; SURVIVIN; ACTIVATION; LOCALIZATION; SEGREGATION	The chromosomal passenger complex (CPC) is a key regulator of mitosis in eukaryotes. It comprises four essential and conserved proteins known in mammals/yeasts as Aurora B/Ipl1, INCENP/Sli15, Survivin/Bir1, and Borealin/Nbl1. These subunits act together in a highly controlled fashion. Regulation of Aurora B/Ipl1 kinase activity and localization is critical for CPC function. Although regulation of CPC localization and kinase activity in vivo has been investigated elsewhere, studies on the complete, four-subunit CPC and its basic biochemical properties are only beginning. Here we describe the biochemical characterization of purified and complete Saccharomyces cerevisiae four-subunit CPC. We determined the affinity of the CPC for microtubules and demonstrated that the binding of CPC to microtubules is primarily electrostatic in nature and depends on the acidic C-terminal tail (E-hook) of tubulin. Moreover, phosphorylation of INCENP/Sli15 on its microtubule binding region also negatively regulates CPC affinity for microtubules. Furthermore, we show that phosphorylation of INCENP/Sli15 is required for activation of the kinase Aurora B/Ipl1 and can occur in trans. Although phosphorylation of INCENP/Sli15 is essential for activation, we determined that a version of the CPC lacking the INCENP/Sli15 microtubule binding region (residues Glu-91 to Ile-631) is able to form an intact complex that retains microtubule binding activity. Thus, we conclude that this INCENP/Sli15 linker domain plays a largely regulatory function and is not essential for complex formation or microtubule binding.	[Cormier, Anthony; Drubin, David G.; Barnes, Georjana] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Barnes, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	gbarnes@berkeley.edu			National Institutes of Health [R01 GM47842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grant R01 GM47842 (to G.B.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Campbell CS, 2013, NATURE, V497, P118, DOI 10.1038/nature12057; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carmena M, 2008, BIOCHEM SOC T, V36, P367, DOI 10.1042/BST0360367; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Nakajima Y, 2009, MOL BIOL CELL, V20, P1772, DOI 10.1091/mbc.E08-10-1011; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Vader G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-10; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Woodruff JB, 2010, J CELL BIOL, V191, P795, DOI 10.1083/jcb.201006028; Yang J, 2009, BIOCHEM J, V417, P355, DOI 10.1042/BJ20081365; Zimmermann D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025473	33	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23203	23211		10.1074/jbc.M113.491480	http://dx.doi.org/10.1074/jbc.M113.491480			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814063	Green Published, hybrid			2022-12-25	WOS:000330598200027
J	Mitani, Y; Roberts, DB; Fatani, H; Weber, RS; Kies, MS; Lippman, SM; El-Naggar, AK				Mitani, Yoshitsugu; Roberts, Dianna B.; Fatani, Hanadi; Weber, Randal S.; Kies, Merrill S.; Lippman, Scott M.; El-Naggar, Adel K.			MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome	PLOS ONE			English	Article							BREAST-CANCER; C-MYB; EXPRESSION; GENES; CELL; CLUSTER; HEAD; NECK; FUSION; MICROARRAYS	Background: Salivary adenoid cystic carcinoma (ACC) is a rare relentlessly progressive malignant tumor. The molecular events associated with ACC tumorigenesis are poorly understood. Variable microRNAs (miRNA) have been correlated with tumorigenesis of several solid tumors but not in ACC. To investigate the association of miRNAs with the development and/or progression of ACC, we performed a comparative analysis of primary ACC specimens and matched normal samples and a pooled salivary gland standard and correlated the results with clinicopathologic factors and validated selected miRNAs in a separate set of 30 tumors. Methods: MiRNA array platform was used for the identification of target miRNAs and the data was subjected to informatics and statistical interrelations. The results were also collected with the MYB-NFIB fusion status and the clinicopathologic features. Results: Differentially dysregulated miRNAs in ACC were characterized in comparison to normal expression. No significant differences in miRNA expression were found between the MYB-NFIB fusion positive and -negative ACCs. Of the highly dysregulated miRNA in ACC, overexpression of the miR-17 and miR-20a were significantly associated with poor outcome in the screening and validation sets. Conclusion: Our study indicates that the upregulation of miR-17-92 may play a role in the biology of ACC and could be potentially targeted in future therapeutic studies.	[Mitani, Yoshitsugu; Fatani, Hanadi; El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Roberts, Dianna B.; Weber, Randal S.; El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Kies, Merrill S.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Lippman, Scott M.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	El-Naggar, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	anaggar@mdanderson.org	Mitani, Yoshitsugu/ABA-2736-2021	Mitani, Yoshitsugu/0000-0002-8661-4702	NIH National Institute of Dental and Craniofacial Research; NIH Office of Rare Diseases Research [U01DE019765]; Head and Neck SPORE program [P50 CA097007]; Kenneth D. Muller professorship; NCI [CA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA097007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER	NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH Office of Rare Diseases Research; Head and Neck SPORE program; Kenneth D. Muller professorship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study is supported in part by the NIH National Institute of Dental and Craniofacial Research and the NIH Office of Rare Diseases Research grant number U01DE019765, the Head and Neck SPORE program grant number P50 CA097007, The Kenneth D. Muller professorship and an NCI CA-16672 grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2011, CLIN CANCER RES, V17, P4772, DOI 10.1158/1078-0432.CCR-11-0242; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BATSAKIS JG, 1990, ANN OTO RHINOL LARYN, V99, P1007, DOI 10.1177/000348949009901215; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; CHOMETTE G, 1982, VIRCHOWS ARCH A, V395, P289, DOI 10.1007/BF00429355; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; El Naggar AK, 2005, WHO CLASSIFICATION T, P221; Fordice J, 1999, ARCH OTOLARYNGOL, V125, P149, DOI 10.1001/archotol.125.2.149; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Huang GX, 2012, CANCER RES, V72, P908, DOI 10.1158/0008-5472.CAN-11-1460; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mitani Y, 2011, CLIN CANCER RES, V17, P7003, DOI 10.1158/1078-0432.CCR-11-1870; Mitani Y, 2010, CLIN CANCER RES, V16, P4722, DOI 10.1158/1078-0432.CCR-10-0463; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rao PH, 2008, CLIN CANCER RES, V14, P5181, DOI 10.1158/1078-0432.CCR-08-0158; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; SPIRO RH, 1986, HEAD NECK SURG, V8, P177, DOI 10.1002/hed.2890080309; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tran N, 2010, HEAD NECK-J SCI SPEC, V32, P1099, DOI 10.1002/hed.21356; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ujifuku K, 2010, CANCER LETT, V296, P241, DOI 10.1016/j.canlet.2010.04.013; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298	55	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66778	10.1371/journal.pone.0066778	http://dx.doi.org/10.1371/journal.pone.0066778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825564	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000026
J	Ng, TFF; Kondov, NO; Hayashimoto, N; Uchida, R; Cha, Y; Beyer, AI; Wong, W; Pesavento, PA; Suemizu, H; Muench, MO; Delwart, E				Ng, Terry Fei Fan; Kondov, Nikola O.; Hayashimoto, Nobuhito; Uchida, Ritsuki; Cha, Yunhee; Beyer, Ashley I.; Wong, Walt; Pesavento, Patricia A.; Suemizu, Hiroshi; Muench, Marcus O.; Delwart, Eric			Identification of an Astrovirus Commonly Infecting Laboratory Mice in the US and Japan	PLOS ONE			English	Article							SCID-HU MOUSE; ENTERIC VIRUSES; IMMUNE-SYSTEM; HIV-INFECTION; CORD BLOOD; CELLS; ENGRAFTMENT; MODEL; TRANSPLANTATION; REPOPULATION	Mice (Mus musculus) are the most commonly used laboratory animals. Viral metagenomics on tissues of immunodeficient mice revealed sequences of a novel mammalian astrovirus. Using PCR, we screened mice from 4 breeders, 4 pharmaceutical companies, 14 research institutes and 30 universities in the US and Japan. Mice from one US breeder tested positive while none from Japanese breeders were positive for MuAstV. Mice in over half of the universities (19/30), institutes (7/14) and pharmaceutical animal facilities (2/4) investigated revealed the presence of MuAstV. Nine mice strains tested positive including both immunodeficient strains (NSG, NOD-SCID, NSG-3GS, C57BL6-Timp-3(-/-), and uPA-NOG) and immunocompetent strains (B6J, ICR, Bash2, BALB/c). Our data indicates that MuAstV has a wide geographical, institutional and host strain distribution. Comparison of the MuAstV RdRp sequences showed numerous mutations indicating ongoing viral divergence in different facilities. This study demonstrates the need for metagenomic screening of laboratory animals to identify adventitious infections that may affect experimental outcomes.	[Ng, Terry Fei Fan; Kondov, Nikola O.; Cha, Yunhee; Beyer, Ashley I.; Wong, Walt; Muench, Marcus O.; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Ng, Terry Fei Fan; Muench, Marcus O.; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hayashimoto, Nobuhito; Uchida, Ritsuki] Cent Inst Expt Anim, ICLAS Monitoring Ctr, Kawasaki, Kanagawa, Japan; [Pesavento, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Suemizu, Hiroshi] Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California Davis	Muench, MO (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.	mmuench@bloodsystems.org; edelwart@bloodsystems.org	Ng, Terry Fei Fan/H-5305-2019; Muench, Marcus O./C-5025-2009	Ng, Terry Fei Fan/0000-0002-4815-8697; Muench, Marcus O./0000-0001-8946-6605; Delwart, Eric/0000-0002-6296-4484	Blood Systems Inc.; National Institutes of Health [R01HL105770, P01DK088760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088760] Funding Source: NIH RePORTER	Blood Systems Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Blood Systems Inc., and grants from the National Institutes of Health: R01HL105770 (ED) and P01DK088760 (MOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani M, 2012, INVEST NEW DRUG, V30, P1331, DOI 10.1007/s10637-011-9692-7; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Baumans V., 2007, WELFARE LAB ANIMALS, P119; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cohen-Haguenauer O, 2006, P NATL ACAD SCI USA, V103, P2340, DOI 10.1073/pnas.0510613103; Coppo P, 2000, ANN HEMATOL, V79, P43, DOI 10.1007/s002770050008; Cunliffe NA, 2002, J MED VIROL, V67, P563, DOI 10.1002/jmv.10139; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007; Farkas T, 2012, VIRUS GENES, V45, P518, DOI 10.1007/s11262-012-0803-0; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Gray J, 2005, J MED VIROL, V23, P377; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawano N, 2005, LEUKEMIA, V19, P1384, DOI 10.1038/sj.leu.2403829; Lapenta C, 2005, INT IMMUNOL, V17, P469, DOI 10.1093/intimm/dxh226; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; MCCUNE J, 1991, ANNU REV IMMUNOL, V9, P399, DOI 10.1146/annurev.iy.09.040191.002151; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ng TFF, 2012, J VIROLOGY; Padalino MA, 2012, EUR J CARDIO-THORAC, V42, pE128, DOI 10.1093/ejcts/ezs462; Peters V, 2012, EXP CLIN ENDOCR DIAB, V120, P191, DOI 10.1055/s-0032-1304569; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoeberlein A, 2004, STEM CELLS DEV, V13, P677, DOI 10.1089/scd.2004.13.677; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12	44	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66937	10.1371/journal.pone.0066937	http://dx.doi.org/10.1371/journal.pone.0066937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825590	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000047
J	Salces-Ortiz, J; Gonzalez, C; Moreno-Sanchez, N; Calvo, JH; Perez-Guzman, MD; Serrano, MM				Salces-Ortiz, Judit; Gonzalez, Carmen; Moreno-Sanchez, Natalia; Calvo, Jorge H.; Dolores Perez-Guzman, M.; Serrano, Magdalena M.			Ovine HSP90AA1 Expression Rate Is Affected by Several SNPs at the Promoter under Both Basal and Heat Stress Conditions	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; SHOCK PROTEINS; SHEEP; POLYMORPHISMS; EVOLUTIONARY; LINEAGES; TRAITS; DNA	The aim of this work was to investigate the association between polymorphisms located at the HSP90AA1 ovine gene promoter and gene expression rate under different environmental conditions, using a mixed model approach. Blood samples from 120 unrelated rams of the Manchega sheep breed were collected at three time points differing in environmental conditions. Rams were selected on the basis of their genotype for the transversion G/C located 660 base pairs upstream the gene transcription initiation site. Animals were also genotyped for another set of 6 SNPs located at the gene promoter. Two SNPs, G/C-660 and A/G(-444), were associated with gene overexpression resulting from heat stress. The composed genotype CC-660-AG(-444) was the genotype having the highest expression rates with fold changes ranging from 2.2 to 3.0. The genotype AG(-522) showed the highest expression levels under control conditions with a fold change of 1.4. Under these conditions, the composed genotype CC-601-TT-524-AG(-522)-TT-468 is expected to be correlated with higher basal expression of the gene according to genotype frequencies and linkage disequilibrium values. Some putative transcription factors were predicted for binding sites where the SNPs considered are located. Since the expression rate of the gene under alternative environmental conditions seems to depend on the composed genotype of several SNPs located at its promoter, a cooperative regulation of the transcription of the HSP90AA1 gene could be hypothesized. Nevertheless epigenetic regulation mechanisms cannot be discarded.	[Salces-Ortiz, Judit; Gonzalez, Carmen; Moreno-Sanchez, Natalia; Serrano, Magdalena M.] Inst Nac Invest Agr & Alimentarias, Dpto Mejora Genet Anim, Madrid, Spain; [Calvo, Jorge H.] ARAID, Zaragoza, Spain; [Dolores Perez-Guzman, M.] CERSYRA, Valdepenas, Spain		Salces-Ortiz, J (corresponding author), Inst Nac Invest Agr & Alimentarias, Dpto Mejora Genet Anim, Madrid, Spain.	malena@inia.es	Serrano, Malena/GXH-8219-2022; Serrano, Magdalena M/R-5716-2017; Calvo, Jorge H/E-5240-2016	Serrano, Magdalena M/0000-0002-1621-3102; Calvo, Jorge H/0000-0001-9513-0219; Gonzalez Verdejo, Carmen/0000-0001-8757-9147; Salces-Ortiz, Judit/0000-0002-3572-4020	INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias) [RTA2009-00098-00-00]; FEDER (Fondo Europeo de Desarrollo Regional)	INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	RTA2009-00098-00-00 INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias) and FEDER (Fondo Europeo de Desarrollo Regional) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2009, J DAIRY SCI, V92, P5702, DOI 10.3168/jds.2008-1928; [Anonymous], 2006, SAS MIXED MODELS; Arceo ME, 2012, FRONTIERS GENETICS, V3; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Blau J, 1996, MOL CELL BIOL, V16, P2044; Bustin SA, 2009, GENET ENG BIOTECHN N, V29, P40; Charoensook R, 2012, TROP ANIM HEALTH PRO, V44, P921, DOI 10.1007/s11250-011-9989-8; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Curtis SE, 1983, ENV MANAGEMENT ANIMA; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fanger O, 1970, THERMAL COMFORT; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Favatier F, 1997, CELL STRESS CHAPERON, V2, P141, DOI 10.1379/1466-1268(1997)002<0141:VIHGEA>2.3.CO;2; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Finocchiaro R, 2005, J DAIRY SCI, V88, P1855, DOI 10.3168/jds.S0022-0302(05)72860-5; Fleige S, 2006, MOL ASPECTS MED, V27; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; KRONE PH, 1994, BIOCHEM BIOPH RES CO, V204, P746, DOI 10.1006/bbrc.1994.2522; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Lim A, 2012, VET MED INT; Maijala K., 1997, P13; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Marai I. F. M., 2008, TROPICAL SUBTROPICAL, V8, P209; Marai IFM, 2001, TROP ANIM HEALTH PRO, V33, P451, DOI 10.1023/A:1012772311177; Marcos-Carcavilla A, 2008, CELL STRESS CHAPERON, V13, P19, DOI 10.1007/s12192-007-0004-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P343, DOI 10.1007/s12192-009-0149-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; Mendelson KG, 1996, P NATL ACAD SCI USA, V93, P12908, DOI 10.1073/pnas.93.23.12908; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morton JM, 2007, J DAIRY SCI, V90, P2271, DOI 10.3168/jds.2006-574; Oner Y, 2012, LIVEST SCI, V150, P381, DOI 10.1016/j.livsci.2012.07.028; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramon M, 2012, EFFECT ENV TEMPERATU; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Sanchez JP, 2009, J DAIRY SCI, V92, P4035, DOI 10.3168/jds.2008-1626; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Serrano M, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-36; Sevi A, 2012, SMALL RUMINANT RES, V107, P1, DOI 10.1016/j.smallrumres.2012.07.012; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stephanou A, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/238601; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thepot D, 2000, DEVELOPMENT, V127, P143; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wadekar SA, 2001, MOL ENDOCRINOL, V15, P1396, DOI 10.1210/me.15.8.1396; Wood MA, 2009, BIOL REPROD, V80, P24, DOI 10.1095/biolreprod.108.070037; Yan B, 2002, BIOCHEM BIOPH RES CO, V291, P582, DOI 10.1006/bbrc.2002.6483	64	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66641	10.1371/journal.pone.0066641	http://dx.doi.org/10.1371/journal.pone.0066641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826107	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400027
J	Yeo, SY; Choi, S; Dien, V; Sow-Peh, YK; Qi, GG; Hatton, TA; Doyle, PS; Thio, BJR				Yeo, Siang Yee; Choi, Siwon; Dien, Vivian; Sow-Peh, Yoke Keow; Qi, Genggeng; Hatton, T. Alan; Doyle, Patrick S.; Thio, Beng Joo Reginald			Using Magnetically Responsive Tea Waste to Remove Lead in Waters under Environmentally Relevant Conditions	PLOS ONE			English	Article							FULLERENE C-60 NANOPARTICLES; LOW-COST ADSORBENT; HUMIC-ACID; ACTIVATED CARBON; HEAVY-METALS; THERMAL REGENERATION; SORPTION; AGGREGATION; ADSORPTION; STABILITY	We report the use of a simple yet highly effective magnetite-waste tea composite to remove lead(II) (Pb2+) ions from water. Magnetite-waste tea composites were dispersed in four different types of water-deionized (DI), artificial rainwater, artificial groundwater and artificial freshwater-that mimic actual environmental conditions. The water samples had varying initial concentrations (0.16-5.55 ppm) of Pb2+ ions and were mixed with the magnetite-waste tea composite for at least 24 hours to allow adsorption of the Pb2+ ions to reach equilibrium. The magnetite-waste tea composites were stable in all the water samples for at least 3 months and could be easily removed from the aqueous media via the use of permanent magnets. We detected no significant leaching of iron (Fe) ions into the water from the magnetite-waste tea composites. The percentage of Pb adsorbed onto the magnetite-waste tea composite ranged from similar to 70% to 100%; the composites were as effective as activated carbon (AC) in removing the Pb2+ ions from water, depending on the initial Pb concentration. Our prepared magnetite-waste tea composites show promise as a green, inexpensive and highly effective sorbent for removal of Pb in water under environmentally realistic conditions.	[Yeo, Siang Yee; Thio, Beng Joo Reginald] Singapore Univ Technol & Design, Singapore, Singapore; [Choi, Siwon; Hatton, T. Alan; Doyle, Patrick S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Dien, Vivian] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Sow-Peh, Yoke Keow] Hwa Chong Inst, High Sch, Dept Sci, Singapore, Singapore; [Qi, Genggeng] Cornell Univ, Kaust Cornell Ctr Energy & Sustainabil, Ithaca, NY USA	Singapore University of Technology & Design; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cornell University	Thio, BJR (corresponding author), Singapore Univ Technol & Design, Singapore, Singapore.	reginaldthio@sutd.edu.sg	Qi, Genggeng/D-5250-2009; Doyle, Patrick S/H-7031-2013	Qi, Genggeng/0000-0001-7968-0931; Doyle, Patrick S/0000-0003-2147-9172; Thio, Beng Joo/0000-0002-5157-2477	Singapore University of Technology and Design (SUTD) [SRG EPD 2012 022]; SUTD-MIT International Design Centre Research [IDG11200105/IDD11200109]; Singapore-MIT Alliance (SMA)	Singapore University of Technology and Design (SUTD); SUTD-MIT International Design Centre Research; Singapore-MIT Alliance (SMA)	This work was supported in part by the Singapore University of Technology and Design (SUTD) Start-Up Research Grant SRG EPD 2012 022 and the SUTD-MIT International Design Centre Research Grant IDG11200105/IDD11200109, together with financial support from the Singapore-MIT Alliance (SMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Halim SH, 2003, WATER RES, V37, P1678, DOI 10.1016/S0043-1354(02)00554-7; Adekunle I. M., 2007, ANN ENV SCI, V1, P23; Ahluwalia SS, 2005, ENG LIFE SCI, V5, P158, DOI 10.1002/elsc.200420066; Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016; Barancikova G, 2003, PLANT SOIL ENVIRON, V49, P565, DOI 10.17221/4195-PSE; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Chen KL, 2008, ENVIRON SCI TECHNOL, V42, P7607, DOI 10.1021/es8012062; Chen KL, 2007, J COLLOID INTERF SCI, V309, P126, DOI 10.1016/j.jcis.2007.01.074; Coles CA, 2006, ENG GEOL, V85, P26, DOI 10.1016/j.enggeo.2005.09.024; CORAPCIOGLU MO, 1987, WATER RES, V21, P1031, DOI 10.1016/0043-1354(87)90024-8; COSPER EM, 1993, DEV MAR BIO, V3, P667; Gobler CJ, 2001, MAR ECOL PROG SER, V209, P19, DOI 10.3354/meps209019; Hu GP, 2003, CHEMOSPHERE, V51, P747, DOI 10.1016/S0045-6535(03)00028-6; Jin CW, 2005, CHEMOSPHERE, V59, P1151, DOI 10.1016/j.chemosphere.2004.11.058; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Li W, 2008, IND CROP PROD, V28, P294, DOI 10.1016/j.indcrop.2008.03.007; Lin DH, 2007, J AGR FOOD CHEM, V55, P5718, DOI 10.1021/jf0707031; Liu N, 2009, J ENVIRON QUAL, V38, P2260, DOI 10.2134/jeq2009.0114; Makokha A.O., 2008, AFRICAN J ENV SCI TE, V2, P349; MORENOCASTILLA C, 1995, CARBON, V33, P1417, DOI 10.1016/0008-6223(95)00090-Z; Pyrzynska K, 2010, COLLOID SURFACE A, V362, P102, DOI 10.1016/j.colsurfa.2010.03.047; ROSEN JF, 1992, SCIENCE, V256, P294, DOI 10.1126/science.256.5055.294; Sabio E, 2004, CARBON, V42, P2285, DOI 10.1016/j.carbon.2004.05.007; Shen LF, 1999, LANGMUIR, V15, P447, DOI 10.1021/la9807661; STEVENSON F. J, 1994, HUMUS CHEM; STEVENSON FJ, 1976, SOIL SCI SOC AM J, V40, P665, DOI 10.2136/sssaj1976.03615995004000050021x; Suh SK, 2012, J AM CHEM SOC, V134, P7337, DOI 10.1021/ja209245v; TEE TW, 1988, ENVIRON TECHNOL LETT, V9, P1223, DOI 10.1080/09593338809384685; Thio BJR, 2012, ENVIRON SCI TECHNOL, V46, P6985, DOI 10.1021/es203596w; Thio BJR, 2011, J HAZARD MATER, V194, P53, DOI 10.1016/j.jhazmat.2011.07.070; von Smoluchowski M., 1903, B INT ACAD SCI CRACO, V3, P184; WHO, 2003, LEAD DRINK WAT BACKG; WHO, 2011, GUID DRINK WAT QUAL; Xuan SH, 2009, CHEM MATER, V21, P5079, DOI 10.1021/cm901618m; Yoon SH, 1998, WATER RES, V32, P2180, DOI 10.1016/S0043-1354(97)00416-8	36	13	13	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66648	10.1371/journal.pone.0066648	http://dx.doi.org/10.1371/journal.pone.0066648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818955	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800091
J	Zhou, YC; Ru, YF; Wang, CM; Wang, SL; Zhou, ZM; Zhang, YL				Zhou, Yuchuan; Ru, Yanfei; Wang, Chunmei; Wang, Shoulin; Zhou, Zuomin; Zhang, Yonglian			Tripeptidyl Peptidase II Regulates Sperm Function by Modulating Intracellular Ca2+ Stores via the Ryanodine Receptor	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERMATOZOA; ACROSOME REACTION; CAPACITATION; PROTEASOME; PROGESTERONE; INHIBITION; FERTILIZATION; PURIFICATION; DEGRADATION	Recent studies have identified Ca2+ stores in sperm cells; however, it is not clear whether these Ca2+ stores are functional and how they are mobilized. Here, in vitro and in vivo, we determined that tripeptidyl peptidase II antagonists strongly activated the cAMP/PKA signaling pathway that drives sperm capacitation-associated protein tyrosine phosphorylation. We demonstrated that in the absence of Ca2+, TPIII antagonists elevated the intracellular Ca2+ levels in sperm, resulting in a marked improvement in sperm movement, capacitation, acrosome reaction, and the in vitro fertilizing ability. This antagonist-induced release of intracellular Ca2+ could be blocked by the inhibitors of ryanodine receptors (RyRs) which are the main intracellular Ca2+ channels responsible for releasing stored Ca2+. Consistent with these results, indirect immunofluorescence assay using anti-RyR antibodies further validated the presence of RyR(3) in the acrosomal region of mature sperm. Thus, TPPII can regulate sperm maturation by modulating intracellular Ca2+ stores via the type 3 RyR.	[Zhou, Yuchuan; Ru, Yanfei; Wang, Chunmei; Zhang, Yonglian] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai, Peoples R China; [Wang, Shoulin] Nanjing Med Univ, Sch Publ Hlth, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhou, Zuomin] Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University; Nanjing Medical University	Zhang, YL (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai, Peoples R China.	ylzhang@sibcb.ac.cn	zhou, yuchuan/AAF-6202-2019		National Key Basic Research Program (973 Program) [2009CB941701]; National Natural Science Foundation of China [30930053, 31171115, 30971089]; Chinese Academy of Sciences Knowledge Creative Program [KSCX2-EW-R-07]	National Key Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Creative Program	This work was supported by grants from the National Key Basic Research Program (973 Program) (2009CB941701), the National Natural Science Foundation of China (30930053, 31171115 and 30971089), and the Chinese Academy of Sciences Knowledge Creative Program (No. KSCX2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; BALOW RM, 1983, J BIOL CHEM, V258, P1622; BALOW RM, 1986, J BIOL CHEM, V261, P2409; Bastian Y, 2010, REPRODUCTION, V140, P673, DOI 10.1530/REP-09-0545; Brewis Ian A, 2005, Hum Fertil (Camb), V8, P253, DOI 10.1080/14647270500420178; Chiarella P, 2004, J CELL SCI, V117, P4127, DOI 10.1242/jcs.01283; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Espino J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-11; FRASER LR, 1987, J REPROD FERTIL, V81, P77, DOI 10.1530/jrf.0.0810077; FRASER LR, 1990, J REPROD FERTIL, V88, P611, DOI 10.1530/jrf.0.0880611; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; HANDROW RR, 1989, J EXP ZOOL, V252, P174, DOI 10.1002/jez.1402520209; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Huai J, 2008, P NATL ACAD SCI USA, V105, P5177, DOI 10.1073/pnas.0801413105; HYNE RV, 1979, BIOL REPROD, V21, P1135, DOI 10.1095/biolreprod21.5.1135; Kawahara M, 2009, J IMMUNOL, V183, P6069, DOI 10.4049/jimmunol.0803564; KRAUSZ C, 1995, HUM REPROD, V10, P120, DOI 10.1093/humrep/10.1.120; MATSUMURA K, 1989, GAMETE RES, V23, P255, DOI 10.1002/mrd.1120230303; Mckay RM, 2007, EMBO REP, V8, P1183, DOI 10.1038/sj.embor.7401086; Morales P, 2003, HUM REPROD, V18, P1010, DOI 10.1093/humrep/deg111; Morales P, 2000, BIOL REPROD, V63, P635, DOI 10.1095/biolreprod63.2.635; Pasten C, 2005, MOL REPROD DEV, V71, P209, DOI 10.1002/mrd.20280; PILLAI MC, 1991, J EXP ZOOL, V258, P384, DOI 10.1002/jez.1402580314; Preta G, 2010, J ONCOL, V2010, DOI 10.1155/2010/128478; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Schonegge AM, 2012, STRUCTURE, V20, P593, DOI 10.1016/j.str.2012.01.025; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; THOMAS P, 1989, J REPROD FERTIL, V85, P241; TOMKINSON B, 1994, BIOCHEM J, V304, P517, DOI 10.1042/bj3040517; Trevino CL, 1998, ZYGOTE, V6, P159, DOI 10.1017/S0967199498000094; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wang EW, 2000, P NATL ACAD SCI USA, V97, P9990, DOI 10.1073/pnas.180328897; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; WILSON C, 1993, NEUROCHEM RES, V18, P743, DOI 10.1007/BF00966768; Yanagimachi R., 1994, P189; Zeng HT, 2003, J CELL SCI, V116, P1981, DOI 10.1242/jcs.00396; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66634	10.1371/journal.pone.0066634	http://dx.doi.org/10.1371/journal.pone.0066634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818952	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800088
J	Bailey, LC; Milov, DE; Kelleher, K; Kahn, MG; Del Beccaro, M; Yu, F; Richards, T; Forrest, CB				Bailey, L. Charles; Milov, David E.; Kelleher, Kelly; Kahn, Michael G.; Del Beccaro, Mark; Yu, Feliciano; Richards, Thomas; Forrest, Christopher B.			Multi-Institutional Sharing of Electronic Health Record Data to Assess Childhood Obesity	PLOS ONE			English	Article							PEDIATRIC OBESITY; CHILDREN; UNDERDIAGNOSIS; TECHNOLOGY; PREVALENCE; OVERWEIGHT; DISEASE	Objective: To evaluate the validity of multi-institutional electronic health record (EHR) data sharing for surveillance and study of childhood obesity. Methods: We conducted a non-concurrent cohort study of 528,340 children with outpatient visits to six pediatric academic medical centers during 2007-08, with sufficient data in the EHR for body mass index (BMI) assessment. EHR data were compared with data from the 2007-08 National Health and Nutrition Examination Survey (NHANES). Results: Among children 2-17 years, BMI was evaluable for 1,398,655 visits (56%). The EHR dataset contained over 6,000 BMI measurements per month of age up to 16 years, yielding precise estimates of BMI. In the EHR dataset, 18% of children were obese versus 18% in NHANES, while 35% were obese or overweight versus 34% in NHANES. BMI for an individual was highly reliable over time (intraclass correlation coefficient 0.90 for obese children and 0.97 for all children). Only 14% of visits with measured obesity (BMI >= 95%) had a diagnosis of obesity recorded, and only 20% of children with measured obesity had the diagnosis documented during the study period. Obese children had higher primary care (4.8 versus 4.0 visits, p<0.001) and specialty care (3.7 versus 2.7 visits, p<0.001) utilization than non-obese counterparts, and higher prevalence of diverse co-morbidities. The cohort size in the EHR dataset permitted detection of associations with rare diagnoses. Data sharing did not require investment of extensive institutional resources, yet yielded high data quality. Conclusions: Multi-institutional EHR data sharing is a promising, feasible, and valid approach for population health surveillance. It provides a valuable complement to more resource-intensive national surveys, particularly for iterative surveillance and quality improvement. Low rates of obesity diagnosis present a significant obstacle to surveillance and quality improvement for care of children with obesity.	[Bailey, L. Charles; Richards, Thomas; Forrest, Christopher B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bailey, L. Charles; Forrest, Christopher B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Milov, David E.] Nemours Childrens Hosp, Orlando, FL USA; [Kelleher, Kelly] Nationwide Childrens Hosp, Columbus, OH USA; [Kahn, Michael G.] Childrens Hosp Colorado, Aurora, CO USA; [Del Beccaro, Mark] Seattle Childrens Hosp, Seattle, WA USA; [Yu, Feliciano] St Louis Childrens Hosp, St Louis, MO 63178 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Hospital Colorado; Seattle Children's Hospital; St. Louis Children's Hospital; Washington University (WUSTL)	Bailey, LC (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	baileyc@email.chop.edu	Forrest, Christopher/CAF-1379-2022; Kelleher, Kelly/E-3361-2011	Forrest, Christopher/0000-0003-1252-068X; 	Agency for Healthcare Research and Quality (AHRQ) [U18 HS020508-01]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Work on this project was supported in part by grant U18 HS020508-01 from the Agency for Healthcare Research and Quality (AHRQ). The AHRQ had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2011, CURR OPIN ENDOCRINOL, V18, P23, DOI 10.1097/MED.0b013e3283424b37; Allscripts Corporation, 2011, ALLSCR; [Anonymous], MYSQL DAT MAN SYST; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; BARTKO JJ, 1976, PSYCHOL BULL, V83, P762, DOI 10.1037/0033-2909.83.5.762; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Borycki EM, 2011, STUD HEALTH TECHNOL, V166, P197, DOI 10.3233/978-1-60750-740-6-197; Centers for Disease Control and Prevention, 2011, SAS PROGR CDC GROWTH; Centers for Disease Prevention and Control, 2011, CUT OFFS DEF OUTL 20; Centers for Medicare and Medicaid Services, 2011, EL PROF MEAN US TABL; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Cerner Corporation, 2011, CERN MILL; Collins L, 2010, J PEDIAT HEMATOL ONC, V32, pE304, DOI 10.1097/MPH.0b013e3181ece2bb; Cook S, 2011, PEDIATR CLIN N AM, V58, P1363, DOI 10.1016/j.pcl.2011.09.003; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; Dolin RH, 2011, J AM MED INFORM ASSN, V18, P99, DOI 10.1136/jamia.2010.007864; Epic Systems Corporation, 2011, EPICARE EL MED REC; Etheredge LM, 2007, HEALTH AFFAIR, V26, pW107, DOI 10.1377/hlthaff.26.2.w107; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franks S, 2008, INT J OBESITY, V32, P1035, DOI 10.1038/ijo.2008.61; Grossman C, 2011, CLIN DATA BASIC STAP; Holve E, 2012, MED CARE, V50, pS11, DOI 10.1097/MLR.0b013e318258530f; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Hripcsak G, 2011, J BIOMED DISCOV COLL, V6, DOI 10.5210/disco.v6i0.3581; Huang RC, 2011, DIABETES CARE, V34, P1019, DOI 10.2337/dc10-1809; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kahn MG, 2012, MED CARE, V50, pS21, DOI 10.1097/MLR.0b013e318257dd67; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Koebnick C, 2012, J PEDIATR GASTR NUTR, V55, P328, DOI 10.1097/MPG.0b013e31824d256f; Lemay CA, 2003, J AM BOARD FAM PRACT, V16, P14, DOI 10.3122/jabfm.16.1.14; Lieu TA, 2011, CLIN MED RES, V9, P137, DOI 10.3121/cmr.2011.1025; Lim Choi Keung Sarah N, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P9; Lin MC, 2012, J BIOMED INFORM, V45, P658, DOI 10.1016/j.jbi.2012.01.008; Maxson ER, 2010, HEALTH AFFAIR, V29, P1671, DOI 10.1377/hlthaff.2010.0577; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; National Center for Health Statistics CfDCaP, 2012, INT CLASS DIS 9 REV; National Research Council, 2004, CHILDR HLTH NAT WEAL; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Patel AI, 2010, ACAD PEDIATR, V10, P405, DOI 10.1016/j.acap.2010.09.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rea S, 2012, J BIOMEDICAL INFORM; Ruser CB, 2005, J GEN INTERN MED, V20, P1139, DOI 10.1111/j.1525-1497.2005.0263.x; SAS Institute Inc, 2008, SAS SYST MICR WIND 9; Slutsky JR, 2007, HEALTH AFFAIR, V26, pW122, DOI 10.1377/hlthaff.26.2.w122; Tauman R, 2011, EXPERT REV RESP MED, V5, P425, DOI [10.1586/ERS.11.7, 10.1586/ers.11.7]; The Perl Foundation, 2010, PERL; Volovelsky O, 2011, INT J PEDIATR OBES, V6, P59, DOI 10.3109/17477166.2011.583661; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; Weiner JP, 2009, J HOPKINS ACG SYSTEM; Wen XZ, 2012, PEDIATRICS, V129, P823, DOI 10.1542/peds.2011-1833; Williams C, 2012, HEALTH AFFAIR, V31, P527, DOI 10.1377/hlthaff.2011.1314	54	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66192	10.1371/journal.pone.0066192	http://dx.doi.org/10.1371/journal.pone.0066192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823186	Green Published, gold			2022-12-25	WOS:000320576400066
J	Khumalo, T; Reusch, U; Knackmuss, S; Little, M; Veale, RB; Weiss, SFT				Khumalo, Thandokuhle; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Veale, Robin B.; Weiss, Stefan F. T.			Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18	PLOS ONE			English	Article							67-KDA LAMININ RECEPTOR; BINDING PROTEIN; DIFFERENTIAL EXPRESSION; PROSTATE-CANCER; PRION PROTEIN; CARCINOMA; IDENTIFICATION; LOCALIZATION; RELEASE; DISEASE	Adhesion and invasion have been identified as the two key components of metastasis. The 37 kDa/67 kDa laminin receptor (LRP/LR) is thought to enhance these two processes thus endorsing the progression of cancer. Here we report on LRP/LR and the metastatic potential of MDA-MB 231 breast and WHCO1 oesophageal cancer cells. Western blot analysis revealed a significant increase in total laminin receptor precursor (LRP) levels of breast and oesophageal cancer cells in comparison to non-invasive MCF-7 breast cancer cells, whereas LRP/LR cell surface levels in both cell lines were not significantly different to those of MCF-7 cells as analysed by flow cytometry. Incubation of breast and oesophageal cancer cells with the anti-LRP/LR specific antibody, IgG1-iS18, resulted in significant reduction in the adhesive potential of WHCO1 and MDA-MB 231 cells by 92% and 16%, respectively. Moreover, invasion was significantly impeded by 98% and 25% for WHCO1 and MDA-MB 231 cells, respectively. Pearson's correlation coefficients proved a positive correlation between total LRP/LR levels and invasive potential as well as between the adhesive and invasive potential of breast and oesophageal cancer cells. Our findings suggest that through interference of the LRP/LR-laminin-1 interaction, anti-LRP/LR specific antibody IgG1-iS18 may act as a possible alternative therapeutic tool for metastatic breast and oesophageal cancer treatment.	[Khumalo, Thandokuhle; Veale, Robin B.; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed Therapeut AG, Heidelberg, Baden Wuerttemb, Germany	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	stefan.weiss@wits.ac.za			National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	This work was supported by the National Research Foundation, the Republic of South Africa and the Medical Research Council, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Ardini E, 2002, CANCER RES, V62, P1321; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; BEY E, 1976, IN VITRO CELL DEV B, V12, P107; de Manzoni G, 1998, ONCOLOGY-BASEL, V55, P456, DOI 10.1159/000011895; Fontanini G, 1997, CLIN CANCER RES, V3, P227; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; LIOTTA LA, 1991, CANCER RES, V51, pS5054; McKenna DJ, 2001, EXP EYE RES, V73, P81, DOI 10.1006/exer.2001.1013; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Nadji M, 1999, CANCER-AM CANCER SOC, V85, P432, DOI 10.1002/(SICI)1097-0142(19990115)85:2<432::AID-CNCR22>3.0.CO;2-J; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Ozaki I, 1998, GUT, V43, P837, DOI 10.1136/gut.43.6.837; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Siziopikou KP, 2007, BREAST, V16, P104, DOI 10.1016/j.breast.2006.09.003; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; TURPEENNIEMIHUJANEN T, 1986, J BIOL CHEM, V261, P1883; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vana Karen, 2009, Infectious Disorders - Drug Targets, V9, P69; VANDENBRULE FA, 1994, EUR J CANCER, V30A, P1096, DOI 10.1016/0959-8049(94)90464-2; Waltregny D, 1997, JNCI-J NATL CANCER I, V89, P1224, DOI 10.1093/jnci/89.16.1224; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Zhou L, 2006, LARYNGOSCOPE, V116, P28, DOI 10.1097/01.mlg.0000184505.05662.b9; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66297	10.1371/journal.pone.0066297	http://dx.doi.org/10.1371/journal.pone.0066297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823499	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400079
J	Kim, JH; Song, HN; Austin, JL; Cheng, W				Kim, Jin H.; Song, Hanna; Austin, Jamie L.; Cheng, Wei			Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells	PLOS ONE			English	Article							FUSION INHIBITOR T-20; REPLICATION-COMPETENT; REVERSE-TRANSCRIPTASE; VPR ARRESTS; IN-VITRO; VIRIONS; GENE; EXPRESSION; LEVEL; DNA	The infectivity of retroviruses such as HIV-1 in plasma or cultured media is less than 0.1% in general, the mechanisms of which are not yet fully understood. One possible explanation among others is the potential presence of large numbers of defective virions in a virus pool, which limits the apparent infectivity of HIV virions. To test this hypothesis, we have varied the culture conditions used to generate single-cycle HIV-1 virions. Among these culture variables, virion harvest time, media change after transfection, and envelope plasmid input can all improve HIV-1 infectivity by reducing the number of defective virions. A harvest time of 18-24 hours post transfection as opposed to 48 hours, and a media change six hours post transfection both improve viral infectivity. An optimal quantity of envelope plasmid input during transfection was also found. Collectively, these conditions increased the infectivity of HIV-1 virions by sevenfold compared to normally reported values in TZM-bl indicator cell lines. These conditions also increased the infectivity of HIV-1 in CD4(+) T cells, suggesting that these conditions work by increasing the intrinsic infectivity of a virus pool. Nevertheless, these improvements on virion infectivity were marginal compared to the impact of host cells on HIV infection, which can decrease the apparent infectivity by 19-fold even for the most optimized viruses. These results suggest that the infectivity of HIV-1 virions can be optimized by reducing the number of defective virions; however, viral-cell interactions may pose a major barrier for HIV-1 infectivity.	[Kim, Jin H.; Song, Hanna; Austin, Jamie L.; Cheng, Wei] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cheng, W (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	chengwe@umich.edu			NIH [1DP2OD008693-01]; March of Dimes Foundation [5-FY10-490]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008693] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant 1DP2OD008693-01 to WC and also in part by Research Grant No. 5-FY10-490 to WC from the March of Dimes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; An WF, 2001, VIROLOGY, V286, P475, DOI 10.1006/viro.2001.1025; Berkhout B, 2006, FEBS LETT, V580, P2896, DOI 10.1016/j.febslet.2006.02.070; BERNIER R, 1995, J VIROL, V69, P291, DOI 10.1128/JVI.69.1.291-300.1995; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Cavrois Marielle, 2004, Methods Mol Biol, V263, P333; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Haim H, 2005, J VIROL, V79, P622, DOI 10.1128/JVI.79.1.622-625.2005; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; KONIG R, 1989, P NATL ACAD SCI USA, V86, P9188, DOI 10.1073/pnas.86.23.9188; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Kwon YJ, 2003, J VIROL, V77, P5712, DOI 10.1128/JVI.77.10.5712-5720.2003; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McMahon MA, 2009, CURR OPIN INFECT DIS, V22, P574, DOI 10.1097/QCO.0b013e328332c54d; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Montefiori DC, 2004, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Munk C, 2003, CURR PROTOC PHARM; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Padow M, 2003, J VIROL, V77, P11050, DOI 10.1128/JVI.77.20.11050-11059.2003; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Poon B, 2005, J VIROL, V79, P10210, DOI 10.1128/JVI.79.16.10210-10217.2005; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; RICHARDS KH, 2006, CURR PROTOC MICROBIO, pCH15; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004	64	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67170	10.1371/journal.pone.0067170	http://dx.doi.org/10.1371/journal.pone.0067170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825637	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400178
J	Luo, XC; Wang, SS; Zhang, J; Qian, DD; Wang, SM; Li, LL				Luo, Xiao-Chun; Wang, Shan-Shan; Zhang, Jie; Qian, Duo-Duo; Wang, Si-Min; Li, Lu-Lin			Effects of Early or Overexpression of the Autographa californica Multiple Nucleopolyhedrovirus orf94 (ODV-e25) on Virus Replication	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; OCCLUSION-DERIVED VIRUS; SPODOPTERA-FRUGIPERDA CELLS; MESSENGER-RNA INITIATION; IN-VITRO TRANSCRIPTION; EARLY GENES; BACULOVIRUS; PROTEIN; IDENTIFICATION; INSECT	odv-e25(e25) is one of the core genes of baculoviruses. To investigate how it functions in the replication cycle of a baculovirus, a number of Autographa californica multiple nucleopolyhedrovirus recombinants with e25 under control of the promoter of immediate early gene ie1, or the promoter of the very late hyperexpressed gene p10, were constructed using a bacmid system, and the effects of early expression or overexpression of e25 on replication of the virus were evaluated. Microscopy and titration assays demonstrated that bacmids with e25 under control of ie1 promoter were unable to produce budded viruses; and that the recombinant viruses with e25 under control of p10 promoter generated budded virus normally, but formation of occlusion bodies were dramatically reduced and delayed in the infected cells. Electron microscopy showed that there were no mature virions or intact nucleocapsids present in the cells transfected with a recombinant bacmid with e25 under control of ie1 promoter. Quantitative real-time PCR analysis demonstrated that alteration of the e25 promoter did not affect viral DNA synthesis. The reporter gene expression from the promoter of the major capsid protein gene vp39 was reduced 63% by early expression of e25. Confocal microscopy revealed that E25 was predominantly localized in nuclei by 24 hours post infection with wild-type virus, but it remained in the cytoplasm in the cells transfected with a recombinant bacmid with e25 under control of the ie1 promoter, suggesting that the transport of E25 into nuclei was regulated in a specific and strict time dependent manner.	[Luo, Xiao-Chun; Wang, Shan-Shan; Zhang, Jie; Qian, Duo-Duo; Wang, Si-Min; Li, Lu-Lin] Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China	Central China Normal University	Li, LL (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China.	lilulin@mail.ccnu.edu.cn	LULIN, LI/W-3785-2019		National Natural Science Foundation of China [31170145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Natural Science Foundation of China (31170145) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Beniya H, 1996, VIROLOGY, V216, P12, DOI 10.1006/viro.1996.0029; Beniya H, 1998, VIROLOGY, V240, P64, DOI 10.1006/viro.1997.8903; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1999, J VIROL, V73, P8559, DOI 10.1128/JVI.73.10.8559-8570.1999; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Braunagel SC, 2009, J VIROL, V83, P1280, DOI 10.1128/JVI.01661-08; CHAABIHI H, 1993, J VIROL, V67, P2664, DOI 10.1128/JVI.67.5.2664-2671.1993; Chen L, 2012, ARCH VIROL, V157, P617, DOI 10.1007/s00705-011-1211-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; GLOCKER B, 1992, J VIROL, V66, P3476, DOI 10.1128/JVI.66.6.3476-3484.1992; GLOCKER B, 1993, J VIROL, V67, P3771, DOI 10.1128/JVI.67.7.3771-3776.1993; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Hong T, 1997, P NATL ACAD SCI USA, V94, P4050, DOI 10.1073/pnas.94.8.4050; HOOPES RR, 1991, P NATL ACAD SCI USA, V88, P4513, DOI 10.1073/pnas.88.10.4513; Hou D, 2012, J VIROL, V67, P4566; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; King A.M., 2012, VIRUS TAXONOMY, V9; KOVACS GR, 1991, VIROLOGY, V185, P633, DOI 10.1016/0042-6822(91)90534-I; KUZIO J, 1984, VIROLOGY, V139, P414, DOI 10.1016/0042-6822(84)90388-X; Li LL, 1999, VIROLOGY, V255, P9, DOI 10.1006/viro.1998.9546; Li ZF, 2006, VIRUS GENES, V32, P13, DOI 10.1007/s11262-005-5840-5; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; RUSSELL RLQ, 1993, VIROLOGY, V195, P532, DOI 10.1006/viro.1993.1404; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Sambrook J, 2001, MOL CLONING LAB MANU; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; THIEM SM, 1989, J VIROL, V63, P2008, DOI 10.1128/JVI.63.5.2008-2018.1989; Vanarsdall AL, 2004, VIROLOGY, V326, P191, DOI 10.1016/j.virol.2004.06.003; VANLENT JWM, 1990, ARCH VIROL, V111, P103, DOI 10.1007/BF01310508; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Xu F, 2011, VIRUS RES, V158, P1, DOI 10.1016/j.virusres.2011.02.014; Yuan MJ, 2011, J VIROL, V85, P11664, DOI 10.1128/JVI.05275-11; Zhang JH, 2005, J GEN VIROL, V86, P1619, DOI 10.1099/vir.0.80930-0	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65635	10.1371/journal.pone.0065635	http://dx.doi.org/10.1371/journal.pone.0065635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825525	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400014
J	Schack, LM; Noack, S; Winkler, R; Wissmann, G; Behrens, P; Wellmann, M; Jagodzinski, M; Krettek, C; Hoffmann, A				Schaeck, Luisa M.; Noack, Sandra; Winkler, Ramona; Wissmann, Gesa; Behrens, Peter; Wellmann, Mathias; Jagodzinski, Michael; Krettek, Christian; Hoffmann, Andrea			The Phosphate Source Influences Gene Expression and Quality of Mineralization during In Vitro Osteogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; VASCULAR CALCIFICATION; OSTEOBLAST DIFFERENTIATION; INORGANIC-PHOSPHATE; OSTEOCALCIN; HYDROXYAPATITE; DEXAMETHASONE; OSTEOPONTIN; MECHANISM	For in vitro differentiation of bone marrow-derived mesenchymal stem cells/mesenchymal stromal cells into osteoblasts by 2-dimensional cell culture a variety of protocols have been used and evaluated in the past. Especially the external phosphate source used to induce mineralization varies considerably both in respect to chemical composition and concentration. In light of the recent findings that inorganic phosphate directs gene expression of genes crucial for bone development, the need for a standardized phosphate source in in vitro differentiation becomes apparent. We show that chemical composition (inorganic versus organic phosphate origin) and concentration of phosphate supplementation exert a severe impact on the results of gene expression for the genes commonly used as markers for osteoblast formation as well as on the composition of the mineral formed. Specifically, the intensity of gene expression does not necessarily correlate with a high quality mineralized matrix. Our study demonstrates advantages of using inorganic phosphate instead of beta-glycerophosphate and propose colorimetric quantification methods for calcium and phosphate ions as cost-and time-effective alternatives to X-ray diffraction and Fourier-transform infrared spectroscopy for determination of the calcium phosphate ratio and concentration of mineral matrix formed under in vitro-conditions. We critically discuss the different assays used to assess in vitro bone formation in respect to specificity and provide a detailed in vitro protocol that could help to avoid contradictory results due to variances in experimental design.	[Schaeck, Luisa M.; Noack, Sandra; Winkler, Ramona; Jagodzinski, Michael; Krettek, Christian; Hoffmann, Andrea] Hannover Med Sch, Trauma Dept, Hannover, Germany; [Wissmann, Gesa; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, D-30167 Hannover, Germany; [Wellmann, Mathias] Hannover Med Sch, Clin Orthoped Surg, Hannover, Germany	Hannover Medical School; Leibniz University Hannover; Hannover Medical School	Hoffmann, A (corresponding author), Hannover Med Sch, Trauma Dept, Hannover, Germany.	Hoffmann.Andrea@mh-hannover.de	Hoffmann, Andrea/AAG-4488-2020	Hoffmann, Andrea/0000-0003-2318-8985; Krettek, Christian/0000-0001-9807-0020; Gladitz, Luisa Marilena/0000-0002-6460-1644	German Research Foundation [SFB 599, Ho2058/4-1]; Studienstiftung des Deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes	AH acknowledges funding by the German Research Foundation (www.dfg.de) within SFB 599 and Ho2058/4-1. LMS was supported by a PhD fellowship from the Studienstiftung des Deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Ali AT, 2006, ANN CLIN BIOCHEM, V43, P207, DOI 10.1258/000456306776865179; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Benayahu D, 1997, BIOCHEM BIOPH RES CO, V231, P442, DOI 10.1006/bbrc.1997.6116; BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Boskey AL, 2008, CHEM REV, V108, P4716, DOI 10.1021/cr0782473; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; BOSKEY AL, 1989, J PHYS CHEM-US, V93, P1628, DOI 10.1021/j100341a086; CASSELLA JP, 1995, CALCIFIED TISSUE INT, V56, P118, DOI 10.1007/BF00296342; Chang PL, 2006, CONNECT TISSUE RES, V47, P67, DOI 10.1080/03008200600584074; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Foresta C, 2010, J CLIN ENDOCR METAB, V95, P3502, DOI 10.1210/jc.2009-2557; FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Ichikawa H, 2002, BRAIN RES, V958, P459, DOI 10.1016/S0006-8993(02)03701-0; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]; Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002; Lian J B, 1993, J Oral Implantol, V19, P95; Lian J B, 1995, Iowa Orthop J, V15, P118; Lynch MP, 1998, J CELL BIOCHEM, V68, P31; Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mori K, 1998, FEBS LETT, V433, P19, DOI 10.1016/S0014-5793(98)00870-9; Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112; Park KW, 2009, MOL CELL BIOL, V29, P3905, DOI 10.1128/MCB.00002-09; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; PUCHTLER H, 1978, HISTOCHEMISTRY, V56, P177, DOI 10.1007/BF00495978; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sotiropoulou PA, 2006, STEM CELLS, V24, P1409, DOI 10.1634/stemcells.2005-0654; Stich S, 2009, CELL TISSUE RES, V336, P225, DOI 10.1007/s00441-009-0768-z; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; TENENBAUM HC, 1982, CALCIFIED TISSUE INT, V34, P76, DOI 10.1007/BF02411212; THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929; Wolf G, 1996, NUTR REV, V54, P332, DOI 10.1111/j.1753-4887.1996.tb03798.x	50	42	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65943	10.1371/journal.pone.0065943	http://dx.doi.org/10.1371/journal.pone.0065943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823126	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400036
J	Zhao, DH; Lv, MT; Jiang, H; Cai, Y; Xu, DL; An, SQ				Zhao, Dehua; Lv, Meiting; Jiang, Hao; Cai, Ying; Xu, Delin; An, Shuqing			Spatio-Temporal Variability of Aquatic Vegetation in Taihu Lake over the Past 30 Years	PLOS ONE			English	Article							CLASSIFICATION TREE; WATER; IMAGERY; CHINA; MACROPHYTES; THRESHOLDS; ECOSYSTEMS; FEATURES; SHIFTS; NORTH	It is often difficult to track the spatio-temporal variability of vegetation distribution in lakes because of the technological limitations associated with mapping using traditional field surveys as well as the lack of a unified field survey protocol. Using a series of Landsat remote sensing images (i.e. MSS, TM and ETM+), we mapped the composition and distribution area of emergent, floating-leaf and submerged macrophytes in Taihu Lake, China, at approximate five-year intervals over the past 30 years in order to quantify the spatio-temporal dynamics of the aquatic vegetation. Our results indicated that the total area of aquatic vegetation increased from 187.5 km(2) in 1981 to 485.0 km(2) in 2005 and then suddenly decreased to 341.3 km(2) in 2010. Similarly, submerged vegetation increased from 127.0 km(2) in 1981 to 366.5 km(2) in 2005, and then decreased to 163.3 km(2). Floating-leaf vegetation increased continuously through the study period in both area occupied (12.9 km(2) in 1981 to 146.2 km(2) in 2010) and percentage of the total vegetation (6.88% in 1981 to 42.8% in 2010). In terms of spatial distribution, the aquatic vegetation in Taihu Lake has spread gradually from the East Bay to the surrounding areas. The proportion of vegetation in the East Bay relative to that in the entire lake has decreased continuously from 62.3% in 1981, to 31.1% in 2005 and then to 21.8% in 2010. Our findings have suggested that drastic changes have taken place over the past 30 years in the spatial pattern of aquatic vegetation as well as both its relative composition and the amount of area it occupies.	[Zhao, Dehua; Lv, Meiting; Jiang, Hao; Cai, Ying; Xu, Delin; An, Shuqing] Nanjing Univ, Dept Biol Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhao, DH (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China.	dhzhao@nju.edu.cn			National Natural Science Foundation of China [31000226]; Environmental Monitoring Research Foundation of Jiangsu Province [1014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Monitoring Research Foundation of Jiangsu Province	This research was supported by the National Natural Science Foundation of China (31000226) and Environmental Monitoring Research Foundation of Jiangsu Province (1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S.Q., 2009, LECT CHINAS ENV; Brisson J, 2009, SCI TOTAL ENVIRON, V407, P3923, DOI 10.1016/j.scitotenv.2008.05.047; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Deng Jian-cai, 2008, Huanjing Kexue, V29, P3382; [谷孝鸿 Gu Xiaohong], 2005, [生态学报, Acta Ecologica Sinica], V25, P1541; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Harma P, 2001, SCI TOTAL ENVIRON, V268, P107, DOI 10.1016/S0048-9697(00)00688-4; He Jun, 2008, Hupo Kexue, V20, P790; Hu WP, 2008, ECOL ENG, V34, P30, DOI 10.1016/j.ecoleng.2008.05.018; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jiang H, 2012, SENSORS-BASEL, V12, P12437, DOI 10.3390/s120912437; [金相灿 JIN Xiangcan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P21; Jin Xiangcan, 2007, Hupo Kexue, V19, P151; Kloiber SM, 2002, WATER RES, V36, P4330, DOI 10.1016/S0043-1354(02)00146-X; Le CF, 2009, REMOTE SENS ENVIRON, V113, P1175, DOI 10.1016/j.rse.2009.02.005; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; [刘伟龙 Liu Weilong], 2007, [生态学报, Acta Ecologica Sinica], V27, P159; [吕振霖 Lv Zhenlin], 2012, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V40, P123; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Qin B Q, 2004, PROCESS MECH ENV CHA; Qin BQ, 2009, ECOL ENG, V35, P1569, DOI 10.1016/j.ecoleng.2009.04.003; Qing BQ, 2009, J LAKE SCI, V21, P445; Rouse J., 1974, MONITORING VEGETATIO, V1, P309; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Wang Qian, 2010, Environmental Science & Technology (China), V33, P96; Wu GF, 2007, WATER RES, V41, P3271, DOI 10.1016/j.watres.2007.05.018; Wu Q. L., 2000, ACTA SCI CIRCUMST, V20, P275; Xie P, 2008, HIST DEV CYANOBACTER; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yang Guishan, 2010, Hupo Kexue, V22, P799; Yang M, 2008, SCIENCE, V319, P158, DOI 10.1126/science.319.5860.158a; [俞海桥 YU Hai-qiao], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1903; Zhao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044836; Zhao DH, 2012, J ENVIRON MANAGE, V95, P98, DOI 10.1016/j.jenvman.2011.10.007; Zhao DH, 2011, ADV WATER RESOUR, V34, P165, DOI 10.1016/j.advwatres.2010.08.010; Zimmer KD, 2009, ECOSYSTEMS, V12, P843, DOI 10.1007/s10021-009-9262-4	40	33	42	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66365	10.1371/journal.pone.0066365	http://dx.doi.org/10.1371/journal.pone.0066365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823189	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400093
J	Babayeva, S; Rocque, B; Aoudjit, L; Zilber, Y; Li, J; Baldwin, C; Kawachi, H; Takano, T; Torban, E				Babayeva, Sima; Rocque, Brittany; Aoudjit, Lamine; Zilber, Yulia; Li, Jane; Baldwin, Cindy; Kawachi, Hiroshi; Takano, Tomoko; Torban, Elena			Planar Cell Polarity Pathway Regulates Nephrin Endocytosis in Developing Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; POLYCYSTIC KIDNEY-DISEASE; SLIT DIAPHRAGM; EMBRYONIC-DEVELOPMENT; NEPHROTIC SYNDROME; BETA-ARRESTIN; E-CADHERIN; VANGL2; MORPHOGENESIS; TRAFFICKING	The noncanonical Wnt/planar cell polarity (PCP) pathway controls a variety of cell behaviors such as polarized protrusive cell activity, directional cell movement, and oriented cell division and is crucial for the normal development of many tissues. Mutations in the PCP genes cause malformation in multiple organs. Recently, the PCP pathway was shown to control endocytosis of PCP and non-PCP proteins necessary for cell shape remodeling and formation of specific junctional protein complexes. During formation of the renal glomerulus, the glomerular capillary becomes enveloped by highly specialized epithelial cells, podocytes, that display unique architecture and are connected via specialized cell-cell junctions (slit diaphragms) that restrict passage of protein into the urine; podocyte differentiation requires active remodeling of cytoskeleton and junctional protein complexes. We report here that in cultured human podocytes, activation of the PCP pathway significantly stimulates endocytosis of the core slit diaphragm protein, nephrin, via a clathrin/beta-arrestin-dependent endocytic route. In contrast, depletion of the PCP protein Vangl2 leads to an increase of nephrin at the cell surface; loss of Vangl2 functions in Looptail mice results in disturbed glomerular maturation. We propose that the PCP pathway contributes to podocyte development by regulating nephrin turnover during junctional remodeling as the cells differentiate.	[Babayeva, Sima; Rocque, Brittany; Aoudjit, Lamine; Zilber, Yulia; Li, Jane; Baldwin, Cindy; Takano, Tomoko; Torban, Elena] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Kawachi, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol, Niigata 9502181, Japan	McGill University; Niigata University	Torban, E (corresponding author), McGill Univ, Dept Med, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	elena.torban@mcgill.ca		Li, Jane/0000-0003-4988-4436	Research Institute-McGill University Health Center; Canadian Institute of Health Research [MOP-97759, MOP-102646]	Research Institute-McGill University Health Center; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by a Research Institute-McGill University Health Center graduate scholarship award.; Supported by Canadian Institute of Health Research Operating Grant MOP-97759.; Supported by Canadian Institute of Health Research Operating Grant MOP-102646.	Babayeva S, 2011, AM J PHYSIOL-RENAL, V300, pF549, DOI 10.1152/ajprenal.00566.2009; Belotti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046213; Carroll TJ, 2012, CURR TOP DEV BIOL, V101, P185, DOI 10.1016/B978-0-12-394592-1.00011-9; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Czachorowski M, 2009, BIOCHEMISTRY-US, V48, P8422, DOI 10.1021/bi900606y; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Heinonen KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019279; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Komiya Yuko, 2008, Organogenesis, V4, P68; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Luyten A, 2010, J AM SOC NEPHROL, V21, P1521, DOI 10.1681/ASN.2010010127; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Saburi S, 2012, DEVELOPMENT, V139, P1806, DOI 10.1242/dev.077461; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Strutt H, 2011, DEV CELL, V20, P511, DOI 10.1016/j.devcel.2011.03.018; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Torban E, 2012, CURR TOP DEV BIOL, V101, P237, DOI 10.1016/B978-0-12-394592-1.00005-3; Tossidou I, 2010, J BIOL CHEM, V285, P25285, DOI 10.1074/jbc.M109.087239; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang B, 2011, HUM MOL GENET, V20, P271, DOI 10.1093/hmg/ddq462; Warrington SJ, 2013, DEVELOPMENT, V140, P1045, DOI 10.1242/dev.088724; Williams BB, 2012, J CELL SCI, V125, P2141, DOI 10.1242/jcs.097964; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yates LL, 2010, HUM MOL GENET, V19, P4663, DOI 10.1093/hmg/ddq397; Ye X, 2011, DEVELOPMENT, V138, P1161, DOI 10.1242/dev.057620; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	57	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24035	24048		10.1074/jbc.M113.452904	http://dx.doi.org/10.1074/jbc.M113.452904			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824190	Green Published, hybrid			2022-12-25	WOS:000330611400041
J	Dimaki, M; Xouri, G; Symeonidou, IE; Sirinian, C; Nishitani, H; Taraviras, S; Lygerou, Z				Dimaki, Maria; Xouri, Georgia; Symeonidou, Ioanna-Eleni; Sirinian, Chaido; Nishitani, Hideo; Taraviras, Stavros; Lygerou, Zoi			Cell Cycle-dependent Subcellular Translocation of the Human DNA Licensing Inhibitor Geminin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR IMPORT; S-PHASE; REPLICATION; CDT1; REREPLICATION; EXPRESSION; E2F; CHROMATIN; PROTEIN; XENOPUS	Once per cell cycle replication is crucial for maintaining genome integrity. Geminin interacts with the licensing factor Cdt1 to prevent untimely replication and is controlled by APC/C-dependent cell cycle specific proteolysis during mitosis and in G(1). We show here that human geminin, when expressed in human cells in culture under a constitutive promoter, is excluded from the nucleus during part of the G(1) phase and at the transition from G(0) to G(1). The N-terminal 30 amino acids of geminin, which contain its destruction box, are essential for nuclear exclusion. In addition, 30 amino acids within the central domain of geminin are required for both nuclear exclusion and nuclear accumulation. Cdt1 overexpression targets geminin to the nucleus, while reducing Cdt1 levels by RNAi leads to the appearance of endogenous geminin in the cytoplasm. Our data propose a novel means of regulating the balance of Cdt1/geminin in human cells, at the level of the subcellular localization of geminin.	[Dimaki, Maria; Xouri, Georgia; Symeonidou, Ioanna-Eleni; Sirinian, Chaido; Lygerou, Zoi] Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece; [Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26500, Greece; [Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of Patras; University of Patras; University of Hyogo	Lygerou, Z (corresponding author), Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece.	lygerou@med.upatras.gr	Taraviras, Stavros/AAJ-4690-2020	Taraviras, Stavros/0000-0002-7455-647X; Nishitani, Hideo/0000-0001-5907-9380	Karatheodori Program (University of Patras); Association for International Cancer Research; European Research Council	Karatheodori Program (University of Patras); Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Karatheodori Program (University of Patras), the Association for International Cancer Research, and the European Research Council.	Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Boos A, 2006, BIOL CELL, V98, P363, DOI 10.1042/BC20060007; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Iliou MS, 2013, MECH AGEING DEV, V134, P10, DOI 10.1016/j.mad.2012.10.001; Kingsbury SR, 2005, EXP CELL RES, V309, P56, DOI 10.1016/j.yexcr.2005.05.027; Kulartz M, 2004, BIOCHEM BIOPH RES CO, V315, P1011, DOI 10.1016/j.bbrc.2004.01.164; Li A, 2004, CELL CYCLE, V3, P443; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Luo LF, 2007, MOL CELL BIOL, V27, P4737, DOI 10.1128/MCB.00123-07; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688; Pines J, 1996, BIOCHEM SOC T, V24, P15, DOI 10.1042/bst0240015; Roukos V, 2007, J BIOL CHEM, V282, P9346, DOI 10.1074/jbc.M611643200; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	42	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23953	23963		10.1074/jbc.M113.453092	http://dx.doi.org/10.1074/jbc.M113.453092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814078	Green Published, hybrid			2022-12-25	WOS:000330611400034
J	O'Donnell, AF; Huang, LQ; Thorner, J; Cyert, MS				O'Donnell, Allyson F.; Huang, Laiqiang; Thorner, Jeremy; Cyert, Martha S.			A Calcineurin-dependent Switch Controls the Trafficking Function of alpha-Arrestin Aly1/Art6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; CLATHRIN-MEDIATED ENDOCYTOSIS; SACCHAROMYCES-CEREVISIAE; BETA-ARRESTINS; IN-VIVO; INTRACELLULAR TRAFFICKING; INTERACTING PROTEIN; SIGNALING PATHWAY; UBIQUITIN; RECEPTOR	Proper regulation of plasma membrane protein endocytosis by external stimuli is required for cell growth and survival. In yeast, excess levels of certain nutrients induce endocytosis of the cognate permeases to prevent toxic accumulation of metabolites. The alpha-arrestins, a family of trafficking adaptors, stimulate ubiquitin-dependent and clathrin-mediated endocytosis by interacting with both a client permease and the ubiquitin ligase Rsp5. However, the molecular mechanisms that control alpha-arrestin function are not well understood. Here, we show that alpha-arrestin Aly1/Art6 is a phosphoprotein that specifically interacts with and is dephosphorylated by the Ca2+- and calmodulin-dependent phosphoprotein phosphatase calcineurin/PP2B. Dephosphorylation of Aly1 by calcineurin at a subset of phospho-sites is required for Aly1-mediated trafficking of the aspartic acid and glutamic acid transporter Dip5 to the vacuole, but it does not alter Rsp5 binding, ubiquitinylation, or stability of Aly1. In addition, dephosphorylation of Aly1 by calcineurin does not regulate the ability of Aly1 to promote the intracellular sorting of the general amino acid permease Gap1. These results suggest that phosphorylation of Aly1 inhibits its vacuolar trafficking function and, conversely, that dephosphorylation of Aly1 by calcineurin serves as a regulatory switch to promote Aly1-mediated trafficking to the vacuole.	[O'Donnell, Allyson F.; Huang, Laiqiang; Cyert, Martha S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [O'Donnell, Allyson F.; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [O'Donnell, Allyson F.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Stanford University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cyert, MS (corresponding author), Stanford Univ, Dept Biol, 337 Campus Dr West, Stanford, CA 94305 USA.	mcyert@stanford.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X; Cyert, Martha/0000-0003-3825-7437; O'Donnell, Allyson/0000-0003-0966-288X	National Institutes of Health [S10 RR025622-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We gratefully acknowledge Marko Kaksonen (EMBL, Heidelberg, Germany) for providing the MKY yeast strains prior to their publication; Sandra Lemmon (University of Miami, FL) for providing the anti-Bmh antibody; and colleagues Alexander Sorkin, Jeffrey Brodsky, and Adam Kwiatkowski (University of Pittsburgh) for use of reagents and equipment. We thank Catherine Baty and Jenny Karlsson at the Center for Biological Imaging for assistance with cell imaging. We thank Lori Kohlstaedt (supported by National Institutes of Health Grant S10 RR025622-01) and the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at the University of California, Berkeley, for generating and analyzing the MS data.	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Ausubel F. M., 1991, CURRENT PROTOCOLS MO; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BAUM P, 1978, P NATL ACAD SCI USA, V75, P4962, DOI 10.1073/pnas.75.10.4962; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; HARPER JW, 1993, CELL, V75, P805; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Hong MH, 2009, J NEUROCHEM, V108, P102, DOI 10.1111/j.1471-4159.2008.05740.x; James P, 1996, GENETICS, V144, P1425; Jee C, 2012, J MOL BIOL, V417, P165, DOI 10.1016/j.jmb.2012.01.012; Jiang B, 1999, J BIOL CHEM, V274, P18543, DOI 10.1074/jbc.274.26.18543; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kamble C, 2011, J BIOSCIENCES, V36, P79, DOI 10.1007/s12038-011-9018-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Luttrell LM, 2002, J CELL SCI, V115, P455; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Marion S, 2007, J BIOL CHEM, V282, P18937, DOI 10.1074/jbc.M700090200; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; O'Donnell AF, 2012, MOL CELL BIOL, V32, P4506, DOI 10.1128/MCB.01176-12; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pina FJ, 2011, EUKARYOT CELL, V10, P63, DOI 10.1128/EC.00241-10; Polo S, 2008, CELL, V135, P590, DOI 10.1016/j.cell.2008.10.032; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Roberg KJ, 1997, GENETICS, V147, P1569; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Sambrook J., 1989, MOL CLONING LAB MANU, p[153, 510]; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; SCHWANINGER M, 1993, N-S ARCH PHARMACOL, V348, P541; SIKORSKI RS, 1989, GENETICS, V122, P19; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stark C., 2010, DATABASE-OXFORD, V2010, DOI DOI 10.1093/DATABASE/BAP026; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vina-Vilaseca A, 2011, J BIOL CHEM, V286, P8697, DOI 10.1074/jbc.M110.186858; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Xue J, 2011, J BIOL CHEM, V286, P30295, DOI 10.1074/jbc.M111.273110; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	90	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24063	24080		10.1074/jbc.M113.478511	http://dx.doi.org/10.1074/jbc.M113.478511			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824189	Green Published, hybrid			2022-12-25	WOS:000330611400043
J	Lowther, KM; Uliasz, TF; Gotz, KR; Nikolaev, VO; Mehlmann, LM				Lowther, Katie M.; Uliasz, Tracy F.; Goetz, Konrad R.; Nikolaev, Viacheslav O.; Mehlmann, Lisa M.			Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and beta-arrestin-2 Overexpression in HEK293 Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; 3RD INTRACELLULAR LOOP; MEIOTIC ARREST; MOLECULAR-CLONING; BETA-ARRESTINS; ALPHA(2)-ADRENERGIC RECEPTORS; INDEPENDENT REGULATION; CAMP CONCENTRATIONS; ENDOCYTIC VESICLES; LAEVIS OOCYTES	G protein-coupled receptor 3 (GPR3) is a constitutively active receptor that maintains high 3'-5'-cyclic adenosine monophosphate (cAMP) levels required for meiotic arrest in oocytes and CNS function. Ligand-activated G protein-coupled receptors (GPCRs) signal at the cell surface and are silenced by phosphorylation and beta-arrestin recruitment upon endocytosis. Some GPCRs can also signal from endosomes following internalization. Little is known about the localization, signaling, and regulation of constitutively active GPCRs. We demonstrate herein that exogenously-expressed GPR3 localizes to the cell membrane and undergoes internalization in HEK293 cells. Inhibition of endocytosis increased cell surface-localized GPR3 and cAMP levels while overexpression of GPCR-Kinase 2 (GRK2) and beta-arrestin-2 decreased cell surface-localized GPR3 and cAMP levels. GRK2 by itself is sufficient to decrease cAMP production but both GRK2 and beta-arrestin-2 are required to decrease cell surface GPR3. GRK2 regulates GPR3 independently of its kinase activity since a kinase inactive GRK2-K220R mutant significantly decreased cAMP levels. However, GRK2-K220R and beta-arrestin-2 do not diminish cell surface GPR3, suggesting that phosphorylation is required to induce GPR3 internalization. To understand which residues are targeted for desensitization, we mutated potential phosphorylation sites in the third intracellular loop and C-terminus and examined the effect on cAMP and receptor surface localization. Mutation of residues in the third intracellular loop dramatically increased cAMP levels whereas mutation of residues in the C-terminus produced cAMP levels comparable to GPR3 wild type. Interestingly, both mutations significantly reduced cell surface expression of GPR3. These results demonstrate that GPR3 signals at the plasma membrane and can be silenced by GRK2/beta-arrestin overexpression. These results also strongly implicate the serine and/or threonine residues in the third intracellular loop in the regulation of GPR3 activity.	[Lowther, Katie M.; Uliasz, Tracy F.; Mehlmann, Lisa M.] Univ Connecticut Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Goetz, Konrad R.; Nikolaev, Viacheslav O.] Univ Gottingen, Med Ctr, Heart Res Ctr Gottingen, European Heart Res Inst Gottingen,Dept Cardiol &, D-37073 Gottingen, Lower Saxony, Germany	University of Connecticut; University of Gottingen	Mehlmann, LM (corresponding author), Univ Connecticut Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA.	lmehlman@neuron.uchc.edu	Nikolaev, Vyacheslav/AAT-7746-2020		National Institutes of Health [HD056366]; Deutsche Forschungsgemeinschaft [NI 1301/1-1]; University of Gottingen Medical Center "pro futura" grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Gottingen Medical Center "pro futura" grant	National Institutes of Health HD056366 to LMM, the Deutsche Forschungsgemeinschaft grant NI 1301/1-1 and the University of Gottingen Medical Center "pro futura" grant to VON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Deng J, 2008, MOL ENDOCRINOL, V22, P1853, DOI 10.1210/me.2008-0124; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DiLuigi A, 2008, BIOL REPROD, V78, P667, DOI 10.1095/biolreprod.107.066019; Droese J, 2004, BIOCHEM BIOPH RES CO, V322, P42, DOI 10.1016/j.bbrc.2004.07.076; Dupre DJ, 2007, CELL SIGNAL, V19, P481, DOI 10.1016/j.cellsig.2006.07.021; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; El-Jouni W, 2007, DEVELOPMENT, V134, P3307, DOI 10.1242/dev.005454; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Fernandez N, 2011, J BIOL CHEM, V286, P28697, DOI 10.1074/jbc.M111.269613; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Iancu RV, 2008, AM J PHYSIOL-CELL PH, V295, pC414, DOI 10.1152/ajpcell.00038.2008; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Kovanci E, 2008, FERTIL STERIL, V90, P1269, DOI 10.1016/j.fertnstert.2007.07.1373; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leurs R, 1998, TRENDS BIOCHEM SCI, V23, P418, DOI 10.1016/S0968-0004(98)01287-0; Lowther KM, 2011, REPRODUCTION, V141, P737, DOI 10.1530/REP-10-0461; MAENHAUT C, 1990, BIOCHEM BIOPH RES CO, V173, P1169, DOI 10.1016/S0006-291X(05)80909-X; Mehlmann LM, 1998, DEV BIOL, V203, P221, DOI 10.1006/dbio.1998.9051; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Mokros T, 2002, J BIOL CHEM, V277, P45122, DOI 10.1074/jbc.M208214200; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Padmanabhan S, 2009, FEBS LETT, V583, P107, DOI 10.1016/j.febslet.2008.11.033; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Prezeau L, 1999, J BIOL CHEM, V274, P13462, DOI 10.1074/jbc.274.19.13462; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Rios-Cardona D, 2008, DEV BIOL, V317, P380, DOI 10.1016/j.ydbio.2008.02.047; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ruiz-Medina J, 2011, NEUROPHARMACOLOGY, V61, P43, DOI 10.1016/j.neuropharm.2011.02.014; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; SONG ZH, 1994, FEBS LETT, V351, P375, DOI 10.1016/0014-5793(94)00888-4; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005922; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tourino C, 2012, BR J PHARM; Valverde O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004704; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wade SM, 1999, MOL PHARMACOL, V56, P1005, DOI 10.1124/mol.56.5.1005; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Yang CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038807; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhang BL, 2012, J ZHEJIANG UNIV-SC B, V13, P555, DOI 10.1631/jzus.B1100353; Zhou SR, 2010, REPROD BIOMED ONLINE, V20, P53, DOI 10.1016/j.rbmo.2009.10.013	68	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e65365	10.1371/journal.pone.0065365	http://dx.doi.org/10.1371/journal.pone.0065365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826079	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000003
J	Chan, BT; Abu Osman, NA; Lim, E; Chee, KH; Aziz, YFA; Al Abed, A; Lovell, NH; Dokos, S				Chan, Bee Ting; Abu Osman, Noor Azuan; Lim, Einly; Chee, Kok Han; Aziz, Yang Faridah Abdul; Al Abed, Amr; Lovell, Nigel H.; Dokos, Socrates			Sensitivity Analysis of Left Ventricle with Dilated Cardiomyopathy in Fluid Structure Simulation	PLOS ONE			English	Article							STRAIN-RATE; MYOCARDIAL-INFARCTION; WALL STRESS; DIASTOLIC FUNCTION; HEART-DISEASE; BLOOD-FLOW; DOPPLER; DYNAMICS; VORTEX; ECHOCARDIOGRAPHY	Dilated cardiomyopathy (DCM) is the most common myocardial disease. It not only leads to systolic dysfunction but also diastolic deficiency. We sought to investigate the effect of idiopathic and ischemic DCM on the intraventricular fluid dynamics and myocardial wall mechanics using a 2D axisymmetrical fluid structure interaction model. In addition, we also studied the individual effect of parameters related to DCM, i.e. peak E-wave velocity, end systolic volume, wall compliance and sphericity index on several important fluid dynamics and myocardial wall mechanics variables during ventricular filling. Intraventricular fluid dynamics and myocardial wall deformation are significantly impaired under DCM conditions, being demonstrated by low vortex intensity, low flow propagation velocity, low intraventricular pressure difference (IVPD) and strain rates, and high-end diastolic pressure and wall stress. Our sensitivity analysis results showed that flow propagation velocity substantially decreases with an increase in wall stiffness, and is relatively independent of preload at low-peak E-wave velocity. Early IVPD is mainly affected by the rate of change of the early filling velocity and end systolic volume which changes the ventriculo: annular ratio. Regional strain rate, on the other hand, is significantly correlated with regional stiffness, and therefore forms a useful indicator for myocardial regional ischemia. The sensitivity analysis results enhance our understanding of the mechanisms leading to clinically observable changes in patients with DCM.	[Chan, Bee Ting; Abu Osman, Noor Azuan; Lim, Einly] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Chee, Kok Han] Univ Malaya, Dept Med, Fac Med Bldg, Kuala Lumpur, Malaysia; [Aziz, Yang Faridah Abdul] Univ Malaya, Fac Med, Dept Biomed Imaging, Res Imaging Ctr, Kuala Lumpur, Malaysia; [Al Abed, Amr; Lovell, Nigel H.; Dokos, Socrates] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of New South Wales Sydney	Chan, BT (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	beetn_chan@yahoo.com	LIM, EINLY/B-8861-2010; Aziz, Yang Faridah Abdul/C-7945-2012; ABDUL AZIZ, YANG FARIDAH/C-1063-2010; Chan, Bee Ting/K-5202-2015; ABU OSMAN, NOOR AZUAN/B-9265-2010; Lovell, Nigel H/AGF-6679-2022; Chee, Kok Han/I-2138-2013	LIM, EINLY/0000-0003-2037-4213; Aziz, Yang Faridah Abdul/0000-0002-0869-1972; Chan, Bee Ting/0000-0002-6625-1430; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Lovell, Nigel H/0000-0003-1637-1079; Chee, Kok Han/0000-0002-4485-0504; Dokos, Socrates/0000-0002-7399-2712	University of Malaya/Ministry of Higher Education/High Impact Research (UM/MOHE/HIR) [D000014-16001]	University of Malaya/Ministry of Higher Education/High Impact Research (UM/MOHE/HIR)	This study was supported by University of Malaya/Ministry of Higher Education/High Impact Research (UM/MOHE/HIR) grant (Project number D000014-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alben S, 2011, INT J NONLIN MECH, V46, P586, DOI 10.1016/j.ijnonlinmec.2010.12.011; Baccani B, 2002, J BIOMECH, V35, P665, DOI 10.1016/S0021-9290(02)00005-2; Buakhamsri A, 2009, EUR HEART J, V30, P1213, DOI 10.1093/eurheartj/ehp084; Choi HF, 2010, J BIOMECH, V43, P1745, DOI 10.1016/j.jbiomech.2010.02.022; De Boeck BWL, 2005, EUR J HEART FAIL, V7, P19, DOI 10.1016/j.ejheart.2004.03.010; DOUGLAS PS, 1989, J AM COLL CARDIOL, V13, P311, DOI 10.1016/0735-1097(89)90504-4; Duan FX, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-8; Eriksson J, 2012, EUROPEAN HEART J CAR; FALK RH, 1992, AM HEART J, V123, P136, DOI 10.1016/0002-8703(92)90757-M; Firstenberg MS, 2000, J AM COLL CARDIOL, V36, P1942, DOI 10.1016/S0735-1097(00)00963-3; Firstenberg MS, 2001, CIRCULATION, V104, pI330; Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3; Garcia MJ, 1996, J AM COLL CARDIOL, V27, P108, DOI 10.1016/0735-1097(95)00434-3; Gjesdal O, 2008, CIRC-CARDIOVASC IMAG, V1, P189, DOI 10.1161/CIRCIMAGING.108.784900; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Hanc J, 2004, AM J PHYS, V72, P514, DOI 10.1119/1.1645282; HAYASHIDA W, 1990, CIRCULATION, V82, P2075, DOI 10.1161/01.CIR.82.6.2075; Hong GR, 2008, JACC-CARDIOVASC IMAG, V1, P705, DOI 10.1016/j.jcmg.2008.06.008; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Khalafvand SS, 2011, COMPUT METHOD BIOMEC, V14, P113, DOI 10.1080/10255842.2010.493515; Loerakker S, 2008, COMPUT METHOD BIOMEC, V11, P649, DOI 10.1080/10255840802469379; MacGowan GA, 1997, CIRCULATION, V96, P535; MAZE SS, 1989, J AM COLL CARDIOL, V13, P873, DOI 10.1016/0735-1097(89)90230-1; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Ogden R.W., 2004, COMPUTATIONAL MECH; OHNO M, 1994, CIRCULATION, V89, P2241, DOI 10.1161/01.CIR.89.5.2241; Park TH, 2006, AM J PHYSIOL-HEART C, V290, pH724, DOI 10.1152/ajpheart.00714.2005; PARODI O, 1993, CIRCULATION, V88, P509, DOI 10.1161/01.CIR.88.2.509; Pasipoularides A, 2003, AM J PHYSIOL-HEART C, V284, pH1064, DOI 10.1152/ajpheart.00804.2002; Pislaru C, 2004, CIRCULATION, V109, P2905, DOI 10.1161/01.CIR.0000129311.73402.EF; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; Stoylen A, 2001, J AM SOC ECHOCARDIOG, V14, P264, DOI 10.1067/mje.2001.110375; Tibayan FA, 2003, J HEART VALVE DIS, V12, P292; Tulner SAF, 2006, J THORAC CARDIOV SUR, V132, P610, DOI 10.1016/j.jtcvs.2005.12.016; Veress AI, 2005, J BIOMECHANICAL ENG, V127; Voigt JU, 2002, J AM SOC ECHOCARDIOG, V15, P13, DOI 10.1067/mje.2002.116536; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Watanabe H, 2004, JSME INT J C-MECH SY, V47, P1019, DOI 10.1299/jsmec.47.1019; Yotti R, 2005, CIRCULATION, V112, P2921, DOI 10.1161/CIRCULATIONAHA.105.561340; Zabalgoitia M, 2001, AM J CARDIOL, V88, P521, DOI 10.1016/S0002-9149(01)01730-1; Zeng S, 2009, ECHOCARDIOGR-J CARD, V26, P163, DOI 10.1111/j.1540-8175.2008.00797.x; Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054	46	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67097	10.1371/journal.pone.0067097	http://dx.doi.org/10.1371/journal.pone.0067097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825628	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000079
J	Fetterman, JL; Pompilius, M; Westbrook, DG; Uyeminami, D; Brown, J; Pinkerton, KE; Ballinger, SW				Fetterman, Jessica L.; Pompilius, Melissa; Westbrook, David G.; Uyeminami, Dale; Brown, Jamelle; Pinkerton, Kent E.; Ballinger, Scott W.			Developmental Exposure to Second-Hand Smoke Increases Adult Atherogenesis and Alters Mitochondrial DNA Copy Number and Deletions in apoE(-/-) Mice	PLOS ONE			English	Article							TOBACCO-SMOKE; OXIDATIVE STRESS; MATERNAL HYPERCHOLESTEROLEMIA; ATHEROSCLEROTIC LESIONS; VITAL-STATISTICS; PASSIVE SMOKING; CARBON-MONOXIDE; HEART-DISEASE; FREE-RADICALS; DAMAGE	Cardiovascular disease is a major cause of morbidity and mortality in the United States. While many studies have focused upon the effects of adult second-hand smoke exposure on cardiovascular disease development, disease development occurs over decades and is likely influenced by childhood exposure. The impacts of in utero versus neonatal second-hand smoke exposure on adult atherosclerotic disease development are not known. The objective of the current study was to determine the effects of in utero versus neonatal exposure to a low dose (1 mg/m(3) total suspended particulate) of second-hand smoke on adult atherosclerotic lesion development using the apolipoprotein E null mouse model. Consequently, apolipoprotein E null mice were exposed to either filtered air or second-hand smoke: (i) in utero from gestation days 1-19, or (ii) from birth until 3 weeks of age (neonatal). Subsequently, all animals were exposed to filtered air and sacrificed at 12-14 weeks of age. Oil red-O staining of whole aortas, measures of mitochondrial damage, and oxidative stress were performed. Results show that both in utero and neonatal second-hand smoke exposure significantly increased adult atherogenesis in mice compared to filtered air controls. These changes were associated with changes in aconitase and mitochondrial superoxide dismutase activities consistent with increased oxidative stress in the aorta, changes in mitochondrial DNA copy number and deletion levels. These studies show that in utero or neonatal exposure to second-hand smoke significantly influences adult atherosclerotic lesion development and results in significant alterations to the mitochondrion and its genome that may contribute to atherogenesis.	[Fetterman, Jessica L.; Pompilius, Melissa; Westbrook, David G.; Brown, Jamelle; Ballinger, Scott W.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Uyeminami, Dale; Pinkerton, Kent E.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Ballinger, Scott W.] Dept Pathol, Div Mol & Cellular Pathol, Birmingham, England	University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis	Ballinger, SW (corresponding author), Univ Alabama Birmingham, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.	sballing@uab.edu		Brown, Jamelle/0000-0002-2040-0488; Pompilius, Melissa/0000-0002-3006-7930; Fetterman, Jessica/0000-0002-9286-7538	National Institutes of Health (NIH) [HL77419, HL94518, P60 DK079626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL094518, R01HL077419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants HL77419 and HL94518 (SWB) and by the NIH funded Diabetes Research Training Center (P60 DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2006, CIRCULATION, V105, P1; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Ballinger SW, 1996, CANCER RES, V56, P5692; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Bouhours-Nouet N, 2005, AM J PHYSIOL-ENDOC M, V288, pE171, DOI 10.1152/ajpendo.00260.2003; Cakir Y, 2007, FREE RADICAL BIO MED, V43, P1279, DOI 10.1016/j.freeradbiomed.2007.07.015; Coffman JA, 2007, DEV BIOL, V308, P266, DOI 10.1016/j.ydbio.2007.05.042; Coffman JA, 2009, SEMIN CELL DEV BIOL, V20, P321, DOI 10.1016/j.semcdb.2009.02.002; Coffman JA, 2009, DEV BIOL, V330, P123, DOI 10.1016/j.ydbio.2009.03.017; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Freeman B A, 1995, Adv Pharmacol, V34, P45; Gairola CG, 2001, ATHEROSCLEROSIS, V156, P49, DOI 10.1016/S0021-9150(00)00621-3; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; GVOZDJAKOVA A, 1992, CARDIOLOGY, V81, P81, DOI 10.1159/000175780; GVOZDJAKOVA A, 1984, CARDIOVASC RES, V18, P229, DOI 10.1093/cvr/18.4.229; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Harrison CM, 2011, ENVIRON HEALTH PERSP, V119, P676, DOI 10.1289/ehp.1002857; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Heron M, 2010, PEDIATRICS, V125, P4, DOI 10.1542/peds.2009-2416; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; KJELDSEN K, 1974, CIRC RES, V34, P339, DOI 10.1161/01.RES.34.3.339; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Knudsen Thomas B, 2004, Birth Defects Res C Embryo Today, V72, P313, DOI 10.1002/bdrc.20028; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; MASSAELI H, 1995, CARDIOVASC RES, V29, P597; May-Panloup P, 2007, CURR TOP DEV BIOL, V77, P51, DOI 10.1016/S0070-2153(06)77003-X; McMahan CA, 2005, ARCH INTERN MED, V165, P883, DOI 10.1001/archinte.165.8.883; Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; THOMSEN HK, 1974, ARCH ENVIRON HEALTH, V29, P73, DOI 10.1080/00039896.1974.10666536; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Westbrook DG, 2010, CARDIOVASC TOXICOL, V10, P216, DOI 10.1007/s12012-010-9085-8; Witschi H, 1997, ANNU REV PHARMACOL, V37, P29, DOI 10.1146/annurev.pharmtox.37.1.29; Yang Z, 2004, CIRCULATION, V110, P3715, DOI 10.1161/01.CIR.0000149747.82157.01; Yang Z, 2007, MUTAT RES-FUND MOL M, V621, P61, DOI 10.1016/j.mrfmmm.2007.02.010; Yuan Hongwei, 2007, BMC Cardiovasc Disord, V7, P1, DOI 10.1186/1471-2261-7-1; Zieske AW, 2005, ATHEROSCLEROSIS, V180, P87, DOI 10.1016/j.atherosclerosis.2004.10.039; Zieske AW, 2002, PEDIATR PATHOL MOL M, V21, P213, DOI 10.1080/15227950252852104	53	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66835	10.1371/journal.pone.0066835	http://dx.doi.org/10.1371/journal.pone.0066835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825571	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000032
J	Jia, LL; Li, XD; Shao, C; Wei, LL; Li, ML; Guo, ZG; Liu, ZH; Gao, YH				Jia, Lulu; Li, Xundou; Shao, Chen; Wei, Lilong; Li, Menglin; Guo, Zhengguang; Liu, Zhihong; Gao, Youhe			Using an Isolated Rat Kidney Model to Identify Kidney Origin Proteins in Urine	PLOS ONE			English	Article							TARGETED PROTEOMICS; BIOMARKERS; ORTHOLOGS; PARALOGS	The use of targeted proteomics to identify urinary biomarkers of kidney disease in urine can avoid the interference of serum proteins. It may provide better sample throughput, higher sensitivity, and specificity. Knowing which urinary proteins to target is essential. By analyzing the urine from perfused isolated rat kidneys, 990 kidney origin proteins with human analogs were identified in urine. Of these proteins, 128 were not found in normal human urine and may become biomarkers with zero background. A total of 297 proteins were not found in normal human plasma. These proteins will not be influenced by other normal organs and will be kidney specific. The levels of 33 proteins increased during perfusion with an oxygen-deficient solution compared to those perfused with oxygen. The 75 proteins in the perfusion-driven urine have a significantly increased abundance ranking compared to their ranking in normal human urine. When compared with existing candidate biomarkers, over ninety percent of the kidney origin proteins in urine identified in this study have not been examined as candidate biomarkers of kidney diseases.	[Jia, Lulu; Li, Xundou; Shao, Chen; Wei, Lilong; Li, Menglin; Guo, Zhengguang; Gao, Youhe] Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Physiol & Pathophy, Beijing 100021, Peoples R China; [Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing 210008, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nanjing University	Gao, YH (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Physiol & Pathophy, Beijing 100021, Peoples R China.	gaoyouhe@pumc.edu.cn	meng, li/GVT-2063-2022	Liu, Zhi-Hong/0000-0001-6093-0726	National Basic Research Program of China [2012CB517606, 2013CB530805, 2011CB964901]; National High Technology Research and Development Program of China [2011AA020116]; Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT [IRT0909]; 111 Project [B08007]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (2012CB517606, 2013CB530805, 2011CB964901), the National High Technology Research and Development Program of China (2011AA020116), Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT (IRT0909), and 111 Project (B08007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; EPSTEIN FH, 1982, AM J PHYSIOL, V243, pF284, DOI 10.1152/ajprenal.1982.243.3.F284; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gutman S, 2006, NAT REV CANCER, V6, P565, DOI 10.1038/nrc1911; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Li QR, 2010, RAPID COMMUN MASS SP, V24, P823, DOI 10.1002/rcm.4441; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pan S, 2005, MOL CELL PROTEOMICS, V4, P182, DOI 10.1074/mcp.M400161-MCP200; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Poola NR, 2002, J PHARM PHARM SCI, V5, P135; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Saha S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-12; Shao C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010975; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Taft David R, 2004, Curr Drug Discov Technol, V1, P97, DOI 10.2174/1570163043484824; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Y, 2008, BIOCHEM BIOPH RES CO, V371, P385, DOI 10.1016/j.bbrc.2008.04.082; Wang Z, 2011, PROTEOMICS; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Ye Xiaoying, 2009, Briefings in Functional Genomics & Proteomics, V8, P126, DOI 10.1093/bfgp/eln050	30	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66911	10.1371/journal.pone.0066911	http://dx.doi.org/10.1371/journal.pone.0066911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825584	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000041
J	Praveen, BB; Mazilu, M; Marchington, RF; Herrington, CS; Riches, A; Dholakia, K				Praveen, Bavishna B.; Mazilu, Michael; Marchington, Robert F.; Herrington, C. Simon; Riches, Andrew; Dholakia, Kishan			Optimisation of Wavelength Modulated Raman Spectroscopy: Towards High Throughput Cell Screening	PLOS ONE			English	Article							FLUORESCENCE SUPPRESSION; SPECTRA; STRETCH	In the field of biomedicine, Raman spectroscopy is a powerful technique to discriminate between normal and cancerous cells. However the strong background signal from the sample and the instrumentation affects the efficiency of this discrimination technique. Wavelength Modulated Raman spectroscopy (WMRS) may suppress the background from the Raman spectra. In this study we demonstrate a systematic approach for optimizing the various parameters of WMRS to achieve a reduction in the acquisition time for potential applications such as higher throughput cell screening. The Signal to Noise Ratio (SNR) of the Raman bands depends on the modulation amplitude, time constant and total acquisition time. It was observed that the sampling rate does not influence the signal to noise ratio of the Raman bands if three or more wavelengths are sampled. With these optimised WMRS parameters, we increased the throughput in the binary classification of normal human urothelial cells and bladder cancer cells by reducing the total acquisition time to 6 s which is significantly lower in comparison to previous acquisition times required for the discrimination between similar cell types.	[Praveen, Bavishna B.; Mazilu, Michael; Marchington, Robert F.; Dholakia, Kishan] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews, Fife, Scotland; [Herrington, C. Simon; Riches, Andrew] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Herrington, C. Simon] Univ Dundee, Ninewells Hosp, Jacqui Wood Canc Ctr, Dundee, Scotland	University of St Andrews; University of St Andrews; University of Dundee	Praveen, BB (corresponding author), Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews, Fife, Scotland.	bb295@st-andrews.ac.uk	Herrington, C Simon/I-4895-2014; Mazilu, Michael/B-1852-2009; Herrington, C Simon/O-4688-2017; Marchington, Robert F/A-4863-2011	Herrington, C Simon/0000-0001-9177-8165; Mazilu, Michael/0000-0002-4758-3528; Herrington, C Simon/0000-0001-9177-8165; Dholakia, Kishan/0000-0001-6534-9009	CRUK/EPSRC/MRC/DoH (England) imaging Programme; Cancer Research UK [10329] Funding Source: researchfish	CRUK/EPSRC/MRC/DoH (England) imaging Programme; Cancer Research UK(Cancer Research UK)	The work was funded by CRUK/EPSRC/MRC/DoH (England) imaging Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLEY RF, 1974, APPL PHYS LETT, V25, P387, DOI 10.1063/1.1655519; BRADLEY MS, 1992, J PHYS CHEM-US, V96, P75, DOI 10.1021/j100180a017; BRADLEY MS, 1993, J PHYS CHEM-US, V97, P575, DOI 10.1021/j100105a009; Bridges TE, 2004, ANAL CHEM, V76, P576, DOI 10.1021/ac034969s; BRUCKNER S, 1984, CHEM PHYS LETT, V105, P218, DOI 10.1016/0009-2614(84)85654-7; Carey PR, 1999, J BIOL CHEM, V274, P26625, DOI 10.1074/jbc.274.38.26625; Chan J, 2008, LASER PHOTONICS REV, V2, P325, DOI 10.1002/lpor.200810012; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cormack IG, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2756311; De Luca AC, 2010, ANAL CHEM, V82, P738, DOI 10.1021/ac9026737; Dochow S, 2011, LAB CHIP, V11, P1484, DOI 10.1039/c0lc00612b; FUNFSCHILLING J, 1976, APPL SPECTROSC, V30, P443, DOI 10.1366/000370276774457128; GALEENER FL, 1977, CHEM PHYS LETT, V48, P7, DOI 10.1016/0009-2614(77)80201-7; Harvey TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2999609; HOCHMUTH RM, 1982, ANNU REV BIOPHYS BIO, V11, P43, DOI 10.1146/annurev.bb.11.060182.000355; Jess PRT, 2006, OPT EXPRESS, V14, P5779, DOI 10.1364/OE.14.005779; LEVIN KH, 1978, APPL PHYS LETT, V33, P817, DOI 10.1063/1.90539; MASTERS JRW, 1986, BRIT J CANCER, V54, P131, DOI 10.1038/bjc.1986.163; Matousek P, 1999, APPL SPECTROSC, V53, P1485, DOI 10.1366/0003702991945993; Mazilu M, 2010, OPT EXPRESS, V18, P11382, DOI 10.1364/OE.18.011382; McCain ST, 2008, OPT EXPRESS, V16, P10975, DOI 10.1364/OE.16.010975; Nijssen A, 2002, J INVEST DERMATOL, V119, P64, DOI 10.1046/j.1523-1747.2002.01807.x; Nijsssen A, 2009, J BIOPHOTONICS, V2, P29, DOI 10.1002/jbio.200810055; Praveen BB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077006; Rusciano G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424674; Rusciano G, 2007, ANAL CHEM, V79, P3708, DOI 10.1021/ac070050n	26	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67211	10.1371/journal.pone.0067211	http://dx.doi.org/10.1371/journal.pone.0067211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825643	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000091
J	Renz, AJ; Meyer, A; Kuraku, S				Renz, Adina J.; Meyer, Axel; Kuraku, Shigehiro			Revealing Less Derived Nature of Cartilaginous Fish Genomes with Their Evolutionary Time Scale Inferred with Nuclear Genes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; METABOLIC-RATE; CHONDRICHTHYES; SHARKS; GENERATION; ELASMOBRANCHS; PHYLOGENOMICS; HOLOCEPHALI; POSITION	Cartilaginous fishes, divided into Holocephali (chimaeras) and Elasmoblanchii (sharks, rays and skates), occupy a key phylogenetic position among extant vertebrates in reconstructing their evolutionary processes. Their accurate evolutionary time scale is indispensable for better understanding of the relationship between phenotypic and molecular evolution of cartilaginous fishes. However, our current knowledge on the time scale of cartilaginous fish evolution largely relies on estimates using mitochondrial DNA sequences. In this study, making the best use of the still partial, but large-scale sequencing data of cartilaginous fish species, we estimate the divergence times between the major cartilaginous fish lineages employing nuclear genes. By rigorous orthology assessment based on available genomic and transcriptomic sequence resources for cartilaginous fishes, we selected 20 protein-coding genes in the nuclear genome, spanning 2973 amino acid residues. Our analysis based on the Bayesian inference resulted in the mean divergence time of 421 Ma, the late Silurian, for the Holocephali-Elasmobranchii split, and 306 Ma, the late Carboniferous, for the split between sharks and rays/skates. By applying these results and other documented divergence times, we measured the relative evolutionary rate of the Hox A cluster sequences in the cartilaginous fish lineages, which resulted in a lower substitution rate with a factor of at least 2.4 in comparison to tetrapod lineages. The obtained time scale enables mapping phenotypic and molecular changes in a quantitative framework. It is of great interest to corroborate the less derived nature of cartilaginous fish at the molecular level as a genome-wide phenomenon.	[Renz, Adina J.; Meyer, Axel; Kuraku, Shigehiro] Univ Konstanz, Dept Biol, Chair Zool & Evolutionary Biol, Constance, Germany	University of Konstanz	Kuraku, S (corresponding author), RIKEN Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo, Japan.	shigehiro-kuraku@cdb.riken.jp	Meyer, Axel/C-9826-2009; Kuraku, Shigehiro/B-2801-2009	Meyer, Axel/0000-0002-0888-8193; Kuraku, Shigehiro/0000-0003-1464-8388	University of Konstanz; Deutsche Forschungsgemeinschaft (DFG) [KU2669/1-1]	University of Konstanz; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Young Scholar Fund of the University of Konstanz and the research grant (KU2669/1-1) from the Deutsche Forschungsgemeinschaft (DFG) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Arnason U, 2001, ZOOL SCR, V30, P249, DOI 10.1046/j.1463-6409.2001.00067.x; Aschliman NC, 2012, MOL PHYLOGENET EVOL, V63, P28, DOI 10.1016/j.ympev.2011.12.012; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Benton M, 2009, TIMETREE LIFE, P35; Bigelow H. B., 1954, Memoirs Sears Foundation for Marine Research, V1, P1; BIGELOW H. B., 1948, MEM SEARS FOUND MARINE RES [NEW HAVEN], V1, P1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Casane D, 2013, BIOESSAYS, V35, P332, DOI 10.1002/bies.201200145; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Compagno Leonard J.V., 2005, P4; Daubin V, 2001, Genome Inform, V12, P155; de Carvalho Marcelo R., 1996, P35, DOI 10.1016/B978-012670950-6/50004-7; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dessimoz C, 2011, BRIEF BIOINFORM, V12, P474, DOI 10.1093/bib/bbr038; Didier Dominique A, 1998, J Morphol, V236, P25, DOI 10.1002/(SICI)1097-4687(199804)236:1<25::AID-JMOR2>3.0.CO;2-N; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Grogan ED, 2004, CRC MAR BIOL SER, P3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Hedges S. Blair, 2009, P383; Heinicke Matthew P., 2009, P320; Iglesias SP, 2005, MOL PHYLOGENET EVOL, V34, P569, DOI 10.1016/j.ympev.2004.10.022; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Ivanov Alexander, 2005, Revista Brasileira de Paleontologia, V8, P127; Janvier P., 1996, EARLY VERTEBRATES; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; King BL, 2011, SCIENCE, V334, P1517, DOI 10.1126/science.1210912; Klug S, 2010, ZOOL SCR, V39, P37, DOI 10.1111/j.1463-6409.2009.00399.x; Kuraku S, 2010, INTEGR COMP BIOL, V50, P124, DOI 10.1093/icb/icq044; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li CH, 2012, MOL PHYLOGENET EVOL, V63, P365, DOI 10.1016/j.ympev.2012.01.013; Luer CA, 2007, ENVIRON BIOL FISH, V80, P239, DOI 10.1007/s10641-007-9219-4; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; MAISEY JG, 1984, ZOOL J LINN SOC-LOND, V82, P33, DOI 10.1111/j.1096-3642.1984.tb00534.x; MAISEY JG, 2004, MESOZOIC FISHES, V3, P17; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; Martin AP, 1999, MOL BIOL EVOL, V16, P996, DOI 10.1093/oxfordjournals.molbev.a026189; Miller HC, 2009, TRENDS GENET, V25, P13, DOI 10.1016/j.tig.2008.09.007; Mulley JF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-218; NELSON J S, 1976, P416; Parton A, 2003, COMP BIOCHEM PHYS D, V5, P199; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Shirai S., 1992, SQUALEAN PHYLOGENY N; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Wang JL, 2009, MOL BIOL EVOL, V26, P487, DOI 10.1093/molbev/msn278; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	68	22	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66400	10.1371/journal.pone.0066400	http://dx.doi.org/10.1371/journal.pone.0066400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825540	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000018
J	Rong, MQ; Duan, ZG; Chen, JL; Li, JL; Xiao, YC; Liang, SP				Rong, Mingqiang; Duan, Zhigui; Chen, Juliang; Li, Jianglin; Xiao, Yuchen; Liang, Songping			Native Pyroglutamation of Huwentoxin-IV: A Post-Translational Modification that Increases the Trapping Ability to the Sodium Channel	PLOS ONE			English	Article							CHINESE BIRD SPIDER; TARANTULA CHILOBRACHYS-JINGZHAO; II VOLTAGE SENSOR; D-AMINO-ACID; SELENOCOSMIA-HUWENA; VENOM; CONOTOXINS; PEPTIDE; INHIBITION; NEUROTOXIN	Huwentoxin-IV (HWTX-IV), a tetrodotoxin-sensitive (TTX-s) sodium channel antagonist, is found in the venom of the Chinese spider Ornithoctonus huwena. A naturally modified HWTX-IV (mHWTX-IV), having a molecular mass 18 Da lower than HWTX-IV, has also been isolated from the venom of the same spider. By a combination of enzymatic fragmentation and MS/MS de novo sequencing, mHWTX-IV has been shown to have the same amino acid sequence as that of HWTX-IV, except that the N-terminal glutamic acid replaced by pyroglutamic acid. mHWTX-IV inhibited tetrodotoxin-sensitive voltage-gated sodium channels of dorsal root ganglion neurons with an IC50 nearly equal to native HWTX-IV. mHWTX-IV showed the same activation and inactivation kinetics seen for native HWTX-IV. In contrast with HWTX-IV, which dissociates at moderate voltage depolarization voltages (+50 mV, 180000 ms), mHWTX-IV inhibition of TTX-sensitive sodium channels is not reversed by strong depolarization voltages (+200 mV, 500 ms). Recovery of Nav1.7current was voltage-dependent and was induced by extreme depolarization in the presence of HWTX-IV, but no obvious current was elicited after application of mHWTX-IV. Our data indicate that the N-terminal modification of HWTX-IV gives the peptide toxin a greater ability to trap the voltage sensor in the sodium channel. Loss of a negative charge, caused by cyclization at the N-terminus, is a possible reason why the modified toxin binds much stronger. To our knowledge, this is the first report of a pyroglutamic acid residue in a spider toxin; this modification seems to increase the trapping ability of the voltage sensor in the sodium channel.	[Rong, Mingqiang; Duan, Zhigui; Chen, Juliang; Li, Jianglin; Xiao, Yuchen; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Rong, Mingqiang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China	Hunan Normal University; Chinese Academy of Sciences; Kunming Institute of Zoology	Liang, SP (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	liangsp@hunnu.edu.cn			National 973 Project of China [2010CB529801, 2009BC526510]; Science Research Fund of the Hunan Provincial Education Department [10B049]; National Natural Science Foundation of China [31200590, 30900242, 3100047]; Hunan Education Department of Science and Technology Research Project [10C0961]	National 973 Project of China(National Basic Research Program of China); Science Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Education Department of Science and Technology Research Project	This work was supported by grants from the National 973 Project of China (2010CB529801, 2009BC526510), the Science Research Fund of the Hunan Provincial Education Department (10B049), the National Natural Science Foundation of China (31200590, 30900242), the National Natural Science Foundation of China (grant 3100047), the Hunan Education Department of Science and Technology Research Project (10C0961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2005, FEBS J, V272, P4178, DOI 10.1111/j.1742-4658.2005.04830.x; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Chen JJ, 2009, PEPTIDES, V30, P1042, DOI 10.1016/j.peptides.2009.02.018; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Craig AG, 1997, J BIOL CHEM, V272, P4689, DOI 10.1074/jbc.272.8.4689; Deng MC, 2009, NEUROPHARMACOLOGY, V57, P77, DOI 10.1016/j.neuropharm.2009.04.009; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Jakubowski JA, 2004, ANAL CHEM, V76, P6541, DOI 10.1021/ac0494376; Li ZH, 2006, J BIOL CHEM, V281, P8628, DOI 10.1074/jbc.M513542200; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Morty RE, 2006, BIOCHEM J, V394, P635, DOI 10.1042/BJ20051593; Nillni EA, 1999, ENDOCRINE, V10, P185, DOI 10.1007/BF02738618; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Rigby AC, 1999, P NATL ACAD SCI USA, V96, P5758, DOI 10.1073/pnas.96.10.5758; Rong MQ, 2011, FASEB J, V25, P3177, DOI 10.1096/fj.10-178848; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shu Q, 1999, J PEPT RES, V53, P486, DOI 10.1034/j.1399-3011.1999.00039.x; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Witt KA, 2001, PEPTIDES, V22, P2329, DOI 10.1016/S0196-9781(01)00537-X; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zhang PF, 2003, TOXICON, V42, P15, DOI 10.1016/S0041-0101(03)00095-3	36	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65984	10.1371/journal.pone.0065984	http://dx.doi.org/10.1371/journal.pone.0065984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826086	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400008
J	Ji, BH; Wang, X; Pinto-Duarte, A; Kim, M; Caldwell, S; Young, JW; Behrens, MM; Sejnowski, TJ; Geyer, MA; Zhou, XJ				Ji, Baohu; Wang, Xin; Pinto-Duarte, Antonio; Kim, Minjung; Caldwell, Sorana; Young, Jared W.; Behrens, Margarita M.; Sejnowski, Terrence J.; Geyer, Mark A.; Zhou, Xianjin			Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia	PLOS ONE			English	Article							NMDA-RECEPTOR ENCEPHALITIS; TRANSCRIPTION FACTOR SP4; PREFRONTAL CORTEX; FREQUENCY OSCILLATIONS; PREPULSE INHIBITION; BIPOLAR DISORDER; MESSENGER-RNA; EXPRESSION; DEFICITS; NEURONS	It has been well established that schizophrenia patients display impaired NMDA receptor (NMDAR) functions as well as exacerbation of symptoms in response to NMDAR antagonists. Abnormal NMDAR signaling presumably contributes to cognitive deficits which substantially contribute to functional disability in schizophrenia. Establishing a mouse genetic model will help investigate molecular mechanisms of hypoglutmatergic neurotransmission in schizophrenia. Here, we examined the responses of Sp4 hypomorphic mice to NMDAR antagonists in electroencephalography and various behavioral paradigms. Sp4 hypomorphic mice, previously reported to have reduced NMDAR1 expression and LTP deficit in hippocampal CA1, displayed increased sensitivity and prolonged responses to NMDAR antagonists. Molecular studies demonstrated reduced expression of glutamic acid decarboxylase 67 (GAD67) in both cortex and hippocampus, consistent with abnormal gamma oscillations in Sp4 hypomorphic mice. On the other hand, human SP4 gene was reported to be deleted in schizophrenia. Several human genetic studies suggested the association of SP4 gene with schizophrenia and other psychiatric disorders. Therefore, elucidation of the Sp4 molecular pathway in Sp4 hypomorphic mice may provide novel insights to our understanding of abnormal NMDAR signaling in schizophrenia.	[Ji, Baohu; Kim, Minjung; Caldwell, Sorana; Young, Jared W.; Geyer, Mark A.; Zhou, Xianjin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Wang, Xin; Pinto-Duarte, Antonio; Behrens, Margarita M.; Sejnowski, Terrence J.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Wang, Xin; Pinto-Duarte, Antonio; Behrens, Margarita M.; Sejnowski, Terrence J.] Howard Hughes Med Inst, La Jolla, CA USA; [Caldwell, Sorana; Young, Jared W.; Geyer, Mark A.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Pinto-Duarte, Antonio] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Pinto-Duarte, Antonio] Univ Lisbon, Inst Mol Med, Neurosci Unit, P-1699 Lisbon, Portugal	University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Universidade de Lisboa; Universidade de Lisboa	Zhou, XJ (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	xzhou@ucsd.edu	Behrens, M. Margarita/K-2576-2014; Young, Jared W/G-9601-2012; Sejnowski, Terrence/AAV-5558-2021; Ji, Baohu/D-2281-2014; Pinto-Duarte, Antonio/B-6392-2008	Pinto-Duarte, Antonio/0000-0002-2215-7653	Howard Hughes Medical Institute; Life Sciences Research Foundation Pfizer Fellowship; NARSAD Young Investigator Grant; Calouste Gulbenkian Foundation Fellowship; Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center;  [R01MH073991];  [MH091407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073991, R01MH091407] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Life Sciences Research Foundation Pfizer Fellowship; NARSAD Young Investigator Grant(NARSAD); Calouste Gulbenkian Foundation Fellowship; Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study is supported by R01MH073991 (XZ), MH091407 (MMB), and Howard Hughes Medical Institute (TJS), the Life Sciences Research Foundation Pfizer Fellowship (XW), the NARSAD Young Investigator Grant (XW), the Calouste Gulbenkian Foundation Fellowship (APD), and the Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 1998, J NEUROSCI, V18, P5545, DOI 10.1523/JNEUROSCI.18-14-05545.1998; Bakshi VP, 1999, J PHARMACOL EXP THER, V288, P643; BANBURY, 1997, NEURON, V19, P755; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brody SA, 2003, PSYCHOPHARMACOLOGY, V169, P240, DOI 10.1007/s00213-003-1421-2; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2011, MOL PSYCHIAT; Curley AA, 2011, AM J PSYCHIAT, V168, P921, DOI 10.1176/appi.ajp.2011.11010052; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Holcomb HH, 2005, NEUROPSYCHOPHARMACOL, V30, P2275, DOI 10.1038/sj.npp.1300824; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hunt MJ, 2006, BIOL PSYCHIAT, V60, P1206, DOI 10.1016/j.biopsych.2006.01.020; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Nicolas MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021814; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; Kim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032043; Knowles JA, 2009, MOL PSYCHIAT; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Law AJ, 2001, NEUROREPORT, V12, P2971, DOI 10.1097/00001756-200109170-00043; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Razoux F, 2007, NEUROPSYCHOPHARMACOL, V32, P719, DOI 10.1038/sj.npp.1301057; Risbrough VB, 2006, NEUROPSYCHOPHARMACOL, V31, P2349, DOI 10.1038/sj.npp.1301161; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Shi J., 2010, MOL PSYCHIAT; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tanaka S, 2012, BEHAV BRAIN RES, V233, P55, DOI 10.1016/j.bbr.2012.04.045; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Weickert C.S., 2012, MOL PSYCHIAT; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196	51	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66327	10.1371/journal.pone.0066327	http://dx.doi.org/10.1371/journal.pone.0066327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823008	Green Published, gold			2022-12-25	WOS:000320576400085
J	Jia, HP; Wang, CY; Wang, GB; Qu, L; Chen, WB; Chan, Q; Zhao, B				Jia, Haipeng; Wang, Cuiyan; Wang, Guangbin; Qu, Lei; Chen, Weibo; Chan, Queenie; Zhao, Bin			Impact of 3.0 T Cardiac MR Imaging Using Dual-Source Parallel Radiofrequency Transmission with Patient-Adaptive B1 Shimming	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; RF TRANSMISSION; BODY; PRECESSION; HEART; COIL	Objectives: To prospectively evaluate the impact of 3.0 T Cardiac MR imaging using dual-source parallel radiofrequency (RF) transmission with patient-adaptive B1 shimming compared with single-source RF transmission in the RF homogeneity, image contrast and image quality. Methods: The study was approved by the local institutional review board, and all subjects provided written informed consent. Fourteen healthy volunteers were examined at 3.0 T MR, with both the conventional single-source and the new dual-source RF transmission. B1 calibrations (RF shimming) of the heart region were performed to acquire a percent of the prescribed flip angle (FA) of B1 maps, which were used for quantitative assessment of RF homogeneity. Contrast ratios (CRs) between ventricular blood pool and septum were calculated on balanced-turbo field echo (B-TFE) cine images. The off-resonance artifacts of cine images were blindly assessed by two radiologists according to a 4-point grading-scale. Results: A significantly lower mean coefficients of variance of the achieved FA with dual-source revealed better RF homogeneity compared to single-source (P = 0.0094). Dual-source RF shimming significantly increased the CRs (P<0.05) and reduced the off-resonance artifacts of B-TFE cine images (P<0.05). Inter-observer agreement for the off-resonance artifacts of B-TFE cine images was good to excellent (k >0.65). Conclusions: Dual-source parallel RF transmission significantly improves the RF homogeneity, increases image contrast and reduces image artifacts of cardiac B-TFE images compared to single-source mode. This may be of value in reducing the observer-dependence of cardiac MR images and enhancing diagnostic confidence for clinical practice using CMR at 3.0 T.	[Jia, Haipeng; Wang, Cuiyan; Wang, Guangbin; Qu, Lei; Zhao, Bin] Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Peoples R China; [Chen, Weibo; Chan, Queenie] Philips Ltd China, MR Res Collaborat, Shanghai, Peoples R China	Shandong University; Philips	Zhao, B (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Peoples R China.	cjr.zhaobin@vip.163.com	jia, haipeng/ABB-2498-2020	Jia, Haipeng/0000-0003-0186-5703	Provincial Natural Science Foundation of Shandong [ZR2012HM042]	Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This study was supported by Provincial Natural Science Foundation of Shandong (ZR2012HM042); http://www.sdnsf.gov.cn/portal/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhausen J, 2001, RADIOLOGY, V219, P264, DOI 10.1148/radiology.219.1.r01ap12264; Caudron J, 2011, EUR RADIOL, V21, P2111, DOI 10.1007/s00330-011-2152-0; Childs AS, 2013, MAGN RESON MATER PHY, V26, P401, DOI 10.1007/s10334-012-0360-5; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Franklin KM, 2008, J MAGN RESON IMAGING, V27, P1443, DOI 10.1002/jmri.21164; Hussain S, 2011, J CARDIOVASC MAGN S1, V13, pO10; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; Krishnamurthy R, 2011, P 19 ANN M ISMRM MON; Kubach MR, 2009, PHYS MED BIOL, V54, pN467, DOI 10.1088/0031-9155/54/20/N01; Kuhl CK, 2008, RADIOLOGY, V246, P675, DOI 10.1148/radiol.2463060881; Lee VS, 2007, RADIOLOGY, V244, P692, DOI 10.1148/radiol.2443060582; Mihara H, 1998, MAGN RESON MATER PHY, V7, P115; Mueller A, 2012, RADIOLOGY, V263, P77, DOI 10.1148/radiol.11110347; Nelles M, 2010, RADIOLOGY, V257, P743, DOI 10.1148/radiol.10092146; Oshinski JN, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-55; Plein S, 2001, J MAGN RESON IMAGING, V14, P230, DOI 10.1002/jmri.1178; Ridgway JP, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-71; Saremi F, 2008, RADIOGRAPHICS, V28, P1161, DOI 10.1148/rg.284065718; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Setsompop K, 2006, MAGN RESON MED, V56, P1163, DOI 10.1002/mrm.21042; Vernickel P, 2007, MAGN RESON MED, V58, P381, DOI 10.1002/mrm.21294; Weisser-Thomas J, 2010, J CARDIOVASC MAGN S1, pO72; Wieben O, 2008, EUR J RADIOL, V65, P15, DOI 10.1016/j.ejrad.2007.10.022; Willinek WA, 2007, EUR RADIOL, V17, P618, DOI 10.1007/s00330-006-0406-z; Willinek WA, 2010, RADIOLOGY, V256, P966, DOI 10.1148/radiol.10092127; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; Wong KKL, 2009, J MECH MED BIOL, V9, P1, DOI 10.1142/S0219519409002894; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005688; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Zhai Z, 2007, MR involving high speed coil mode switching between I-channel linear, Q-channel linear, quadrature and anti-quadrature modes, Patent No. [WO2007/124246, 2007124246]	30	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66946	10.1371/journal.pone.0066946	http://dx.doi.org/10.1371/journal.pone.0066946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825592	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400170
J	Najumudeen, AK; Kohnke, M; Solman, M; Alexandrov, K; Abankwa, D				Najumudeen, Arafath Kaja; Kohnke, Monika; Solman, Maja; Alexandrov, Kirill; Abankwa, Daniel			Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins	PLOS ONE			English	Article							H-RAS; PLASMA-MEMBRANE; METHIONINE AMINOPEPTIDASE; CANCER-THERAPY; IN-VIVO; MYRISTOYLTRANSFERASE; NANOCLUSTERS; TRANSFORMATION; SEQUENCE; PALMITOYLATION	Hundreds of eukaryotic signaling proteins require myristoylation to functionally associate with intracellular membranes. N-myristoyl transferases (NMT) responsible for this modification are established drug targets in cancer and infectious diseases. Here we describe NANOMS (NANOclustering and Myristoylation Sensors), biosensors that exploit the FRET resulting from plasma membrane nanoclustering of myristoylated membrane targeting sequences of G alpha(12), Yes- or Src-kinases fused to fluorescent proteins. When expressed in mammalian cells, NANOMS report on loss of membrane anchorage due to chemical or genetic inhibition of myristoylation e. g. by blocking NMT and methionine-aminopeptidase (Met-AP). We used Yes-NANOMS to assess inhibitors of NMT and a cherry-picked compound library of putative Met-AP inhibitors. Thus we successfully confirmed the activity of DDD85646 and fumagillin in our cellular assay. The developed assay is unique in its ability to identify modulators of signaling protein nanoclustering, and is amenable to high throughput screening for chemical or genetic inhibitors of functional membrane anchorage of myristoylated proteins in mammalian cells.	[Najumudeen, Arafath Kaja; Solman, Maja; Abankwa, Daniel] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland; [Kohnke, Monika; Alexandrov, Kirill; Abankwa, Daniel] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Abo Akademi University; University of Turku; University of Queensland	Alexandrov, K (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	k.alexandrov@uq.edu.au; daniel.abankwa@btk.fi	Najumudeen, Arafath/AAH-2250-2020; Alexandrov, Kirill/A-5830-2013	Najumudeen, Arafath/0000-0002-3764-5721; Alexandrov, Kirill/0000-0002-0957-6511; Abankwa, Daniel/0000-0003-2769-0745	National Health and Medical Research Council, Australia [569652]; ARC, Australia [DP1094080]; Academy of Finland fellowship [252381]; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration [268271]; graduate school, National Doctoral Programme in Informational and Structural Biology (ISB); Cancer Foundation Finland sr [100073] Funding Source: researchfish	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC, Australia(Australian Research Council); Academy of Finland fellowship; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration(European Commission); graduate school, National Doctoral Programme in Informational and Structural Biology (ISB); Cancer Foundation Finland sr	This work was supported National Health and Medical Research Council grant 569652 (Australia), ARC grant DP1094080 (Australia) (www.nhmrc.gov. au/www.arc.gov.au/). Additional support was provided by the Academy of Finland fellowship grant (252381), the Sigrid Juselius Foundation, the Cancer Society of Finland and the Marie-Curie Reintegration Grant to DA (268271). AKN is grateful for support by the graduate school, National Doctoral Programme in Informational and Structural Biology (ISB) (http://web.abo.fi/isb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bhandarkar SS, 2008, CLIN CANCER RES, V14, P5743, DOI 10.1158/1078-0432.CCR-08-0405; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Draper JM, 2009, MOL MEMBR BIOL, V26, P5, DOI 10.1080/09687680802683839; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Goncalves V, 2012, ANAL BIOCHEM, V421, P342, DOI 10.1016/j.ab.2011.10.013; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harrington JM, 2010, J BIOL CHEM, V285, P28659, DOI 10.1074/jbc.M110.151886; Hedberg C, 2011, ANGEW CHEM INT EDIT, V50, P9832, DOI 10.1002/anie.201102965; Hu X, 2007, CHEM BIOL, V14, P764, DOI 10.1016/j.chembiol.2007.05.010; Hu XY, 2006, P NATL ACAD SCI USA, V103, P18148, DOI 10.1073/pnas.0608389103; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kinder FR, 2001, J MED CHEM, V44, P3692; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Li ZL, 2012, J AM CHEM SOC, V134, P17278, DOI 10.1021/ja307716z; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rampoldi F, 2012, J LIPID RES, V53, P2459, DOI 10.1194/jlr.D026997; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; ROCQUE WJ, 1993, J BIOL CHEM, V268, P9964; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Selvakumar P, 2007, PROG LIPID RES, V46, P1, DOI 10.1016/j.plipres.2006.05.002; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Thale Z, 2001, J ORG CHEM, V66, P1733, DOI 10.1021/jo001380+; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wedegaertner PB, 1998, BIOL SIGNAL RECEPT, V7, P125; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	58	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66425	10.1371/journal.pone.0066425	http://dx.doi.org/10.1371/journal.pone.0066425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824448	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400108
J	Nakaya, T; Ishiguro, K; Belzil, C; Rietsch, AM; Yu, QY; Mizuno, S; Bronson, RT; Geng, Y; Nguyen, MD; Akashi, K; Sicinski, P; Nakatani, Y				Nakaya, Takeo; Ishiguro, Kei-ichiro; Belzil, Camille; Rietsch, Anna M.; Yu, Qunyan; Mizuno, Shin-ichi; Bronson, Roderick T.; Geng, Yan; Minh Dang Nguyen; Akashi, Koichi; Sicinski, Piotr; Nakatani, Yoshihiro			p600 Plays Essential Roles in Fetal Development	PLOS ONE			English	Article							END RULE PATHWAY; FOCAL ADHESION KINASE; AUXIN TRANSPORT; PROTEIN; IDENTIFICATION; GENES	p600 is a multifunctional protein implicated in cytoskeletal organization, integrin-mediated survival signaling, calcium-calmodulin signaling and the N-end rule pathway of ubiquitin-proteasome-mediated proteolysis. While push, the Drosophila counterpart of p600, is dispensable for development up to adult stage, the role of p600 has not been studied during mouse development. Here we generated p600 knockout mice to investigate the in vivo functions of p600. Interestingly, we found that homozygous deletion of p600 results in lethality between embryonic days 11.5 and 13.5 with severe defects in both embryo and placenta. Since p600 is required for placental development, we performed conditional disruption of p600, which deletes selectively p600 in the embryo but not in the placenta. The conditional mutant embryos survive longer than knockout embryos but ultimately die before embryonic day 14.5. The mutant embryos display severe cardiac problems characterized by ventricular septal defects and thin ventricular walls. These anomalies are associated with reduced activation of FAK and decreased expression of MEF2, which is regulated by FAK and plays a crucial role in cardiac development. Moreover, we observed pleiotropic defects in the liver and brain. In sum, our study sheds light on the essential roles of p600 in fetal development.	[Nakaya, Takeo; Ishiguro, Kei-ichiro; Rietsch, Anna M.; Yu, Qunyan; Geng, Yan; Sicinski, Piotr; Nakatani, Yoshihiro] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Nakaya, Takeo; Ishiguro, Kei-ichiro; Rietsch, Anna M.; Yu, Qunyan; Mizuno, Shin-ichi; Geng, Yan; Akashi, Koichi; Sicinski, Piotr; Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA USA; [Nakaya, Takeo] Tokyo Med Univ, Translat Res Unit, Shinjuku Ku, Tokyo 1608402, Japan; [Nakaya, Takeo] Tokyo Med Univ, Dept Mol Pathol, Shinjuku Ku, Tokyo 1608402, Japan; [Ishiguro, Kei-ichiro] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Belzil, Camille; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mizuno, Shin-ichi; Akashi, Koichi] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Mizuno, Shin-ichi; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Bronson, Roderick T.] Harvard Univ, Sch Med, Dana Farber Harvard Canc Ctr, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tokyo Medical University; Tokyo Medical University; University of Tokyo; University of Calgary; Harvard University; Dana-Farber Cancer Institute; Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	yoshihiro_nakatani@dfci.harvard.edu	Ishiguro, Kei-ichiro/K-3340-2019	Ishiguro, Kei-ichiro/0000-0002-7515-1511	National Institutes of Health [R01CA138866, R01CA108950]; Uehara foundation; Japan Society for the Promotion of Science; AIHS; NATIONAL CANCER INSTITUTE [R01CA138866, R01CA108950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AIHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants (R01CA138866 to YN and R01CA108950 to PS). TN was supported by Uehara foundation fellowship for research abroad. KI was supported by Japan Society for the Promotion of Science fellowship for research abroad, the Grant-in-Aid for Scientific Research on Priority Areas, a Grant in-Aid for Scientific Research on Innovative Areas and Grant in-Aid for Young Scientists. CB was supported by an AIHS doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Richards S, 1996, GENETICS, V142, P1215; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sakai H, 2011, ANN SURG ONCOL, V18, P2057, DOI 10.1245/s10434-010-1523-0; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sekelsky JJ, 1999, GENETICS, V152, P529; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sun GF, 2002, BBA-MOL BASIS DIS, V1588, P241, DOI 10.1016/S0925-4439(02)00171-0; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Webb S, 1998, CIRC RES, V82, P645, DOI 10.1161/01.RES.82.6.645; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66269	10.1371/journal.pone.0066269	http://dx.doi.org/10.1371/journal.pone.0066269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824717	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400075
J	Shigeta, K; Hayashida, T; Hoshino, Y; Okabayashi, K; Endo, T; Ishii, Y; Hasegawa, H; Kitagawa, Y				Shigeta, Kohei; Hayashida, Tetsu; Hoshino, Yoshinori; Okabayashi, Koji; Endo, Takashi; Ishii, Yoshiyuki; Hasegawa, Hirotoshi; Kitagawa, Yuko			Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells	PLOS ONE			English	Article							GENE COPY NUMBER; EGFR EXPRESSION; MONOCLONAL-ANTIBODIES; PLUS IRINOTECAN; RAS MUTATIONS; THERAPY; CHEMOTHERAPY; PROGNOSIS; ADENOCARCINOMA; ACTIVATION	Cetuximab is a chimeric mouse-human monoclonal antibody that targets the human epidermal growth factor receptor (EGFR). However, EGFR expression determined by immunohistochemistry does not predict clinical outcomes of colorectal cancer (CRC) patients treated with cetuximab. Therefore, we evaluated the correlation between EGFR levels detected by cetuximab and drug sensitivities of CRC cell lines (Caco-2, WiDR, SW480, and HCT116) and the A431 epidermoid carcinoma cell line. We used flow cytometry (FCM) to detect EGFR-binding of biotinylated cetuximab on the cell surface. Subcloned cell lines showing the highest and lowest EGFR expression levels were chosen for further study. Cytotoxic assays were used to determine differential responses to cetuximab. Xenograft models treated with cetuximab intraperitoneally to assess sensitivity to cetuximab. Strong responses to cetuximab were specifically exhibited by subcloned cells with high EGFR expression levels. Furthermore, cetuximab inhibited the growth of tumors in xenograft models with high or low EGFR expression levels by 35% and 10%-20%, respectively. We conclude that detection of EGFR expression by cetuximab promises to provide a novel, sensitive, and specific method for predicting the sensitivity of CRC to cetuximab.	[Shigeta, Kohei; Hayashida, Tetsu; Hoshino, Yoshinori; Okabayashi, Koji; Endo, Takashi; Ishii, Yoshiyuki; Hasegawa, Hirotoshi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan	Keio University	Hayashida, T (corresponding author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan.	tetsu@z7.keio.jp	Shigeta, Kohei/H-3451-2019	Shigeta, Kohei/0000-0003-1596-4200	Japanese Ministry of Education, Culture, Sports, Science and Technology [23791559, 23791499, 25293292]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research ( B) (#23791559 K.S., #23791499 T.H. and #25293292 Y.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 1999, J CLIN PATHOL, V52, P75, DOI 10.1136/jcp.52.1.75; Aerts HJWL, 2009, J NUCL MED, V50, P123, DOI 10.2967/jnumed.108.054312; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Boughdady I S, 1992, Surg Oncol, V1, P275, DOI 10.1016/0960-7404(92)90088-3; Castillo L, 2004, ANN ONCOL, V15, P1007, DOI 10.1093/annonc/mdh257; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Hebbar M, 2006, ANTI-CANCER DRUG, V17, P855, DOI 10.1097/01.cad.0000217425.44584.9f; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Matsuo Teppei, 2011, BMC Res Notes, V4, P140, DOI 10.1186/1756-0500-4-140; Mellstedt H, 2003, DRUG TODAY, V39, P1; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Scartozzi M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-303; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wierzbicki R, 2011, INVEST NEW DRUG, V29, P167, DOI 10.1007/s10637-009-9341-6; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zlobec I, 2007, BRIT J CANCER, V96, P793, DOI 10.1038/sj.bjc.6603619	40	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66302	10.1371/journal.pone.0066302	http://dx.doi.org/10.1371/journal.pone.0066302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824671	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400080
J	Sun, JF; Huang, Y; Huang, HQ; Liang, P; Wang, XY; Mao, Q; Men, JT; Chen, WJ; Deng, CH; Zhou, CH; Lv, XL; Zhou, JJ; Zhang, F; Li, R; Tian, YL; Lei, HL; Liang, C; Hu, XC; Xu, J; Li, XR; XinbingYu				Sun, Jiufeng; Huang, Yan; Huang, Huaiqiu; Liang, Pei; Wang, Xiaoyun; Mao, Qiang; Men, Jingtao; Chen, Wenjun; Deng, Chuanhuan; Zhou, Chenhui; Lv, Xiaoli; Zhou, Juanjuan; Zhang, Fan; Li, Ran; Tian, Yanli; Lei, Huali; Liang, Chi; Hu, Xuchu; Xu, Jin; Li, Xuerong; XinbingYu			Low Divergence of Clonorchis sinensis in China Based on Multilocus Analysis	PLOS ONE			English	Article							PARAGONIMUS-WESTERMANI; DNA; OPISTHORCHIASIS	Clonorchis sinensis, an ancient parasite that infects a number of piscivorous mammals, attracts significant public health interest due to zoonotic exposure risks in Asia. The available studies are insufficient to reflect the prevalence, geographic distribution, and intraspecific genetic diversity of C. sinensis in endemic areas. Here, a multilocus analysis based on eight genes (ITS1, act, tub, ef-1 alpha, cox1, cox3, nad4 and nad5 [4.986 kb]) was employed to explore the intra-species genetic construction of C. sinensis in China. Two hundred and fifty-six C. sinensis isolates were obtained from environmental reservoirs from 17 provinces of China. A total of 254 recognized Multilocus Types (MSTs) showed high diversity among these isolates using multilocus analysis. The comparison analysis of nuclear and mitochondrial phylogeny supports separate clusters in a nuclear dendrogram. Genetic differentiation analysis of three clusters (A, B, and C) showed low divergence within populations. Most isolates from clusters B and C are geographically limited to central China, while cluster A is extraordinarily genetically diverse. Further genetic analyses between different geographic distributions, water bodies and hosts support the low population divergence. The latter haplotype analyses were consistent with the phylogenetic and genetic differentiation results. A recombination network based on concatenated sequences showed a concentrated linkage recombination population in cox1, cox3, nad4 and nad5, with spatial structuring in ITS1. Coupled with the history record and archaeological evidence of C. sinensis infection in mummified desiccated feces, these data point to an ancient origin of C. sinensis in China. In conclusion, we present a likely phylogenetic structure of the C. sinensis population in mainland China, highlighting its possible tendency for biogeographic expansion. Meanwhile, ITS1 was found to be an effective marker for tracking C. sinensis infection worldwide. Thus, the present study improves our understanding of the global epidemiology and evolution of C. sinensis.	[Sun, Jiufeng] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Sun, Jiufeng; Huang, Yan; Liang, Pei; Wang, Xiaoyun; Mao, Qiang; Men, Jingtao; Chen, Wenjun; Deng, Chuanhuan; Zhou, Chenhui; Lv, Xiaoli; Zhou, Juanjuan; Zhang, Fan; Li, Ran; Tian, Yanli; Lei, Huali; Liang, Chi; Hu, Xuchu; Xu, Jin; Li, Xuerong; XinbingYu] Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jiufeng; Huang, Yan; Liang, Pei; Wang, Xiaoyun; Mao, Qiang; Men, Jingtao; Chen, Wenjun; Deng, Chuanhuan; Zhou, Chenhui; Lv, Xiaoli; Zhou, Juanjuan; Zhang, Fan; Li, Ran; Tian, Yanli; Lei, Huali; Liang, Chi; Hu, Xuchu; Xu, Jin; Li, Xuerong; XinbingYu] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Huaiqiu] Sun Yat Sen Univ, Dept Dermatol & Venereol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, XR (corresponding author), Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	xuerongli@hotmail.com; yuhxteam@163.com	Wang, Xiaoyun/F-1212-2015; sun, Jiufeng/CAG-6546-2022	sun, jiufeng/0000-0003-1047-929X; liang, pei/0000-0003-1674-8745; huaiqiu, HUANG/0000-0002-6320-8031	National S & T Major Program [2008ZX10004-011, 2012ZX10004-220]; National Key Basic Research and Development Project of China (973 project) [2010CB530000]; China Postdoctoral Science Foundation [20110490952]	National S & T Major Program; National Key Basic Research and Development Project of China (973 project)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the National S & T Major Program (Grant No. 2008ZX10004-011; 2012ZX10004-220), National Key Basic Research and Development Project of China (973 project; No. 2010CB530000) and China Postdoctoral Science Foundation (No. 20110490952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blair D, 1997, MOL BIOCHEM PARASIT, V85, P259, DOI 10.1016/S0166-6851(96)02827-7; Blair D, 1997, PARASITOLOGY, V115, P411, DOI 10.1017/S0031182097001534; BOWLES J, 1994, AM J TROP MED HYG, V50, P33, DOI 10.4269/ajtmh.1994.50.1.TM0500010033; BOWLES J, 1995, MOL PHYLOGENET EVOL, V4, P103, DOI 10.1006/mpev.1995.1011; Chen XQ, 1993, CHIN J ZOONOSIS S, V9, P36; Choi BI, 2004, CLIN MICROBIOL REV, V17, P540, DOI 10.1128/CMR.17.3.540-552.2004; CHOI DW, 1984, ARZNEIMITTELFORSCH, V34-2, P1145; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1985, GENETICS, V111, P147; Iwagami M, 2000, J HELMINTHOL, V74, P315; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Lai DH, 2008, ACTA TROP, V107, P213, DOI 10.1016/j.actatropica.2008.05.003; Lee Soo-Ung, 2004, Korean Journal of Parasitology, V42, P145, DOI 10.3347/kjp.2004.42.3.145; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu GH, J HELMINTHOL, P1; Liu WQ, 2007, ACTA TROP, V101, P91, DOI 10.1016/j.actatropica.2006.08.010; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Morgan JAT, 1998, INT J PARASITOL, V28, P493, DOI 10.1016/S0020-7519(97)00204-X; Nei M, 1987, MOL EVOLUTIONARY GEN; Pan B, 2000, ANN B SOC PARASITOL, V22, P85; Park G M, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P12; Park Gab-Man, 2000, Korean Journal of Parasitology, V38, P201, DOI 10.3347/kjp.2000.38.3.201; Park Gab-Man, 2000, Korean Journal of Parasitology, V38, P45, DOI 10.3347/kjp.2000.38.1.45; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sithiathaworn P, 2009, MANSONS TROPICAL DIS, P1461; Sithithaworn P, 2003, ACTA TROP, V88, P187, DOI 10.1016/j.actatropica.2003.02.001; Stauffer WM, 2004, J TRAVEL MED, V11, P157; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatonova YV, 2012, PARASITOL INT, V61, P664, DOI 10.1016/j.parint.2012.07.005; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Wang XY, 2009, PARASITOL RES, V106, P15, DOI 10.1007/s00436-009-1622-7; Wang YZ, 1983, HUMAN PARASITOLOGY, P451; Wei DX, 1980, J WUHAN MED COLL, V9, P1; Wu De, 2002, Journal of Tropical Medicine (Guangzhou), V2, P277; Yossepowitch O, 2004, EMERG INFECT DIS, V10, P2122, DOI 10.3201/eid1012.040410; Zou H, 1994, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V12, P294	42	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67006	10.1371/journal.pone.0067006	http://dx.doi.org/10.1371/journal.pone.0067006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825605	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400174
J	Wang, Z; Li, P; Xu, QH; Xu, J; Li, XQ; Zhang, XF; Ma, QY; Wu, Z				Wang, Zheng; Li, Pei; Xu, Qinhong; Xu, Jun; Li, Xuqi; Zhang, Xufeng; Ma, Qingyong; Wu, Zheng			Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell	PLOS ONE			English	Article							PHASE-I TRIAL; CD40 LIGAND; LOW-AVIDITY; E-CADHERIN; ANTIGENS; PEPTIDE; AGONIST	Hepatocellular carcinoma is one of the most common malignant neoplasms in the world and is the main cause of death in patients with liver cirrhosis. Surgical intervention is not suitable for majority of hepatocellular carcinoma. Investigation of the effective targeting to the tumor cells is essential for both primary tumors and metastases. Tumor specific cytotoxic T lymphocytes (CTL) have been considered to be the attractive vehicles for delivering therapeutic agents toward various tumor diseases. This study was to explore the distribution pattern of CTL carrying the lentiviral vectors with the characteristic of adenoviral E1 gene under the control of the cell activation-dependent CD40 ligand promoter (Lenti/hCD40L/E1AB). Following transduction with adenoviral vectors containing chimeric type 5 and type 35 fiber proteins (Ad5/35-TRAIL), these CTLs produced infectious virus when exposed to HepG2 cells. We assessed the therapeutic ability of CTLs using MTT, Western blot and colony formation assay. The novel CTL harboring Lenti/hCD40L/E1AB and Ad5/35-TRAIL caused proliferation inhibition and significant apoptosis in hepatocellular carcinoma cell lines. Thus, the novel CTL may be useful for the development of gene therapy approaches to hepatocellular carcinoma.	[Wang, Zheng; Li, Pei; Xu, Qinhong; Xu, Jun; Li, Xuqi; Zhang, Xufeng; Ma, Qingyong; Wu, Zheng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Wu, Z (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China.	wuzheng@126.com	zhang, xian/GYA-0290-2022; Li, Xuqi/B-3090-2014; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022	Li, Xuqi/0000-0002-2497-020X; 	National Nature Science Foundation of China [81071877]; Fundamental Research Funds for the Central University in Xi'an Jiaotong University [2011-05]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University in Xi'an Jiaotong University	The work was supported by National Nature Science Foundation of China (No. 81071877) and the Fundamental Research Funds for the Central University in Xi'an Jiaotong University (No. 2011-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger F, 2001, GENE THER, V8, P687, DOI 10.1038/sj.gt.3301455; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Clark HP, 2005, RADIOGRAPHICS, V25, pS3, DOI 10.1148/rg.25si055507; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; FELTKAMP MCW, 1995, EUR J IMMUNOL, V25, P2638, DOI 10.1002/eji.1830250935; Gao W, 2003, GENE THER, V10, P1941, DOI 10.1038/sj.gt.3302097; Hou YF, 2008, J IMMUNOL, V180, P1526, DOI 10.4049/jimmunol.180.3.1526; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KAST WM, 1989, CELL, V59, P603, DOI 10.1016/0092-8674(89)90006-8; Kazansky DB, 2007, ADV EXP MED BIOL, V601, P133; KNUTH A, 1989, P NATL ACAD SCI USA, V86, P2804, DOI 10.1073/pnas.86.8.2804; Lindgren H, 2001, J IMMUNOL, V166, P4578, DOI 10.4049/jimmunol.166.7.4578; McMahan RH, 2007, SEMIN CANCER BIOL, V17, P317, DOI 10.1016/j.semcancer.2007.06.006; Osada T, 1996, HEPATOLOGY, V24, P1460, DOI 10.1002/hep.510240627; Overwijk WW, 2001, TRENDS IMMUNOL, V22, P5, DOI 10.1016/S1471-4906(00)01793-2; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Segerman A, 2000, J VIROL, V74, P1457, DOI 10.1128/JVI.74.3.1457-1467.2000; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Visonneau S, 2000, CLIN CANCER RES, V6, P1744; Wolchok JD, 2002, J CLIN ONCOL, V20, P3176, DOI 10.1200/JCO.2002.20.14.3176; Yotnda P, 2001, GENE THER, V8, P930, DOI 10.1038/sj.gt.3301488; Zaremba S, 1997, CANCER RES, V57, P4570; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	28	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66659	10.1371/journal.pone.0066659	http://dx.doi.org/10.1371/journal.pone.0066659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825554	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400143
J	Zhao, XW; Wu, HY; Lu, HR; Li, GD; Huang, QS				Zhao, Xiaowei; Wu, Hongyu; Lu, Hairong; Li, Guodong; Huang, Qingshan			LAMP: A Database Linking Antimicrobial Peptides	PLOS ONE			English	Article							DEFENSE PEPTIDES; STRATEGIES; DISCOVERY; SEQUENCES; DESIGN; TOOL	The frequent emergence of drug-resistant bacteria has created an urgent demand for new antimicrobial agents. Traditional methods of novel antibiotic development are almost obsolete. Antimicrobial peptides (AMPs) are now regarded as a potential solution to revive the traditional methods of antibiotic development, although, until now, many AMPs have failed in clinical trials. A comprehensive database of AMPs with information about their antimicrobial activity and cytotoxicity will help promote the process of finding novel AMPs with improved antimicrobial activity and reduced cytotoxicity and eventually accelerate the speed of translating the discovery of new AMPs into clinical or preclinical trials. LAMP, a database linking AMPs, serves as a tool to aid the discovery and design of AMPs as new antimicrobial agents. The current version of LAMP has 5,547 entries, comprising 3,904 natural AMPs and 1,643 synthetic peptides. The database can be queried using either simply keywords or combinatorial conditions searches. Equipped with the detailed antimicrobial activity and cytotoxicity data, the cross-linking and top similar AMPs functions implemented in LAMP will help enhance our current understanding of AMPs and this may speed up the development of new AMPs for medical applications. LAMP is freely available at: http://biotechlab.fudan.edu.cn/database/lamp.	[Zhao, Xiaowei; Lu, Hairong; Huang, Qingshan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Xiaowei] Shanghai High Tech Bioengn Co Ltd, Shanghai, Peoples R China; [Wu, Hongyu; Lu, Hairong; Li, Guodong; Huang, Qingshan] Shanghai High Tech United Biotechnol R&D Co Ltd, Shanghai, Peoples R China	Fudan University	Huang, QS (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	qshuang@fudan.edu.cn			Shanghai Science and Technology Innovation Action Plan of China [12DE1940500]; 'Yangtze River Delta' joint scientific and technological project of China [10495810600]; SHUB	Shanghai Science and Technology Innovation Action Plan of China; 'Yangtze River Delta' joint scientific and technological project of China; SHUB	This work was supported in part by the Shanghai Science and Technology Innovation Action Plan (2012) of China (Grant 12DE1940500) and the 'Yangtze River Delta' joint scientific and technological project of China (Grant 10495810600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Shanghai High-Tech Bioengineering Co., Ltd (SHB) and Shanghai High-Tech United Bio-Technological R&D Co. Ltd (SHUB) are independent member companies of Yingtai Group, which is dedicated to researching, producing and selling products related to bio-disinfectant. Xiaowei Zhao is affiliated SHB and currently major in Master of Engineering at the State Key Laboratory of Genetic Engineering (SKLGE) at Fudan University. The program of Master of Engineering in China set two mentors from University and Industry respectively. Her two mentors are Guodong Li and Qingshan Huang, from SHUB and SKLGE separately. Hongyu Wu is affiliated SHUB as a paid employee. Hairong Lu is affiliated SHUB as a paid employee and currently major in Genetics as a PhD student at SKLGE. Guodong Li is the CTO at SHUB. Qingshan Huang is affiliated Fudan University and as a paid consultant at SHUB. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Gueguen Y, 2006, DEV COMP IMMUNOL, V30, P283, DOI 10.1016/j.dci.2005.04.003; Guo-Dong L, 2012, J MICROBIOLOGY, V2012; Hammami R, 2010, DRUG DISCOV TODAY, V15, P540, DOI 10.1016/j.drudis.2010.05.002; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jiang ZQ, 2011, CHEM BIOL DRUG DES, V77, P225, DOI 10.1111/j.1747-0285.2011.01086.x; Li YF, 2008, FEMS MICROBIOL LETT, V289, P126, DOI 10.1111/j.1574-6968.2008.01357.x; Novkovic M, 2012, BIOINFORMATICS, V28, P1406, DOI 10.1093/bioinformatics/bts141; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Seebah S, 2007, NUCLEIC ACIDS RES, V35, pD265, DOI 10.1093/nar/gkl866; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Wade D, 2002, PROTEIN PEPTIDE LETT, V9, P53, DOI 10.2174/0929866023408986; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Wu HY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-54; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	31	187	199	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66557	10.1371/journal.pone.0066557	http://dx.doi.org/10.1371/journal.pone.0066557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825543	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400129
J	Ghosh-Choudhury, N; Mandal, CC; Das, F; Ganapathy, S; Ahuja, S; Choudhury, GG				Ghosh-Choudhury, Nandini; Mandal, Chandi C.; Das, Falguni; Ganapathy, Suthakar; Ahuja, Seema; Choudhury, Goutam Ghosh			c-Abl-dependent Molecular Circuitry Involving Smad5 and Phosphatidylinositol 3-Kinase Regulates Bone Morphogenetic Protein-2-induced Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; BMP-2 GENE-TRANSCRIPTION; TGF-BETA; TYROSINE KINASE; OSTEOBLAST DIFFERENTIATION; SIGNAL-TRANSDUCTION; IMATINIB MESYLATE; CELL-DIFFERENTIATION; PRECURSOR CELLS	Skeletal remodeling consists of timely formation and resorption of bone by osteoblasts and osteoclasts in a quantitative manner. Patients with chronic myeloid leukemia receiving inhibitors of c-Abl tyrosine kinase often show reduced bone remodeling due to impaired osteoblast and osteoclast function. BMP-2 plays a significant role in bone generation and resorption by contributing to the formation of mature osteoblasts and osteoclasts. The effects of c-Abl on BMP-2-induced bone remodeling and the underlying mechanisms are not well studied. Using a pharmacological inhibitor and expression of a dominant negative mutant of c-Abl, we show an essential role of this tyrosine kinase in the development of bone nodules containing mature osteoblasts and formation of multinucleated osteoclasts in response to BMP-2. Calvarial osteoblasts prepared from c-Abl null mice showed the absolute requirement of this tyrosine kinase in maturation of osteoblasts and osteoclasts. Activation of phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling by BMP-2 leads to osteoblast differentiation. Remarkably, inhibition of c-Abl significantly suppressed BMP-2-stimulated PI 3-kinase activity and its downstream Akt phosphorylation. Interestingly, c-Abl regulated BMP-2-induced osteoclastogenic CSF-1 expression. More importantly, we identified the requirements of c-Abl in BMP-2 autoregulation and the expressions of alkaline phosphatase and osterix that are necessary for osteoblast differentiation. c-Abl contributed to BMP receptor-specific Smad-dependent transcription of CSF-1, osterix, and BMP-2. Finally, c-Abl associates with BMP receptor IA and regulates phosphorylation of Smad in response to BMP-2. We propose that activation of c-Abl is an important step, which induces into two signaling pathways involving noncanonical PI 3-kinase and canonical Smads to integrate BMP-2-induced osteogenesis.	[Ghosh-Choudhury, Nandini; Ahuja, Seema; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi C.; Ganapathy, Suthakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Das, Falguni; Ahuja, Seema; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ghosh-Choudhury, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.	choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 AR52425, RO1 DK50190]; Veterans Affairs Merit Review grant; CTRC P30 Cancer Center Support Grant [CA 054174]; Veterans Affairs Merit Review grants; Cancer Prevention Research Institute of Texas; Veterans Affairs Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grant(US Department of Veterans Affairs); CTRC P30 Cancer Center Support Grant; Veterans Affairs Merit Review grants(US Department of Veterans Affairs); Cancer Prevention Research Institute of Texas; Veterans Affairs Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR52425 (to N. G. C.) and RO1 DK50190 (to G. G. C.). This work was also supported by Veterans Affairs Merit Review grant and CTRC P30 Cancer Center Support Grant CA 054174 (to N. G. C.) and in part by Veterans Affairs Merit Review grants (to G. G. C.).; Recipient of a fellowship from the Cancer Prevention Research Institute of Texas.; Recipient of Veterans Affairs Senior Research Career Scientist Award.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Allington TM, 2011, CELLS TISSUES ORGANS, V193, P98, DOI 10.1159/000320163; Antoku S, 2008, J CELL SCI, V121, P3071, DOI 10.1242/jcs.031575; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Atfi A, 2005, EMBO REP, V6, P985, DOI 10.1038/sj.embor.7400501; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen S, 2009, AM J PHYSIOL-HEART C, V297, pH533, DOI 10.1152/ajpheart.00237.2009; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Ghosh-Choudhury NG, 2003, J BIOL CHEM, V278, P21998, DOI 10.1074/jbc.M302277200; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; GhoshChoudhury N, 1997, BIOCHEM BIOPH RES CO, V231, P196, DOI 10.1006/bbrc.1996.5962; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jain SK, 1996, BLOOD, V88, P1542; Kaplan MS, 2003, J GERONTOL A-BIOL, V58, P1018; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Kua HY, 2012, NAT CELL BIOL, V14, P727, DOI 10.1038/ncb2528; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nurmio M, 2011, TOXICOL APPL PHARM, V254, P267, DOI 10.1016/j.taap.2011.04.019; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Rastogi MV, 2012, PEDIATR BLOOD CANCER, V59, P840, DOI 10.1002/pbc.24121; Ren SY, 2005, EXP HEMATOL, V33, P1222, DOI 10.1016/j.exphem.2005.06.030; Sattler M, 1996, ONCOGENE, V12, P839; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8; Tokonzaba E, 2006, CHEM BIOL DRUG DES, V67, P230, DOI 10.1111/j.1747-0285.2006.00361.x; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhao Jean J, 2006, Sci STKE, V2006, ppe52, DOI 10.1126/stke.3652006pe52	78	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24503	24517		10.1074/jbc.M113.455733	http://dx.doi.org/10.1074/jbc.M113.455733			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23821550	Green Published, hybrid			2022-12-25	WOS:000330612300019
J	Kurz, S; Jin, CS; Hykollari, A; Gregorich, D; Giomarelli, B; Vasta, GR; Wilson, IBH; Paschinger, K				Kurz, Simone; Jin, Chunsheng; Hykollari, Alba; Gregorich, Daniel; Giomarelli, Barbara; Vasta, Gerardo R.; Wilson, Iain B. H.; Paschinger, Katharina			Hemocytes and Plasma of the Eastern Oyster (Crassostrea virginica) Display a Diverse Repertoire of Sulfated and Blood Group A-modified N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PERKINSUS-MARINUS; MASS-SPECTROMETRIC ANALYSIS; SNAIL BIOMPHALARIA-GLABRATA; LINKED CARBOHYDRATE CHAINS; SCHISTOSOMA-MANSONI; TRICHOMONAS-VAGINALIS; OLIGOSACCHARIDES; BINDING; HEMOCYANIN; FUCOSE	The eastern oyster (Crassostrea virginica) has become a useful model system for glycan-dependent host-parasite interactions due to the hijacking of the oyster galectin CvGal1 for host entry by the protozoan parasite Perkinsus marinus, the causative agent of Dermo disease. In this study, we examined the N-glycans of both the hemocytes, which via CvGal1 are the target of the parasite, and the plasma of the oyster. In combination with HPLC fractionation, exoglycosidase digestion, and fragmentation of the glycans, mass spectrometry revealed that the major N-glycans of plasma are simple hybrid structures, sometimes methylated and core alpha 1,6-fucosylated, with terminal alpha 1,3-linked galactose; a remarkable high degree of sulfation of such glycans was observed. Hemocytes express a larger range of glycans, including core-difucosylated paucimannosidic forms, whereas bi- and triantennary glycans were found in both sources, including structures carrying sulfated and methylated variants of the histo-blood group A epitope. The primary features of the oyster whole hemocyte N-glycome were also found in dominin, the major plasma glycoprotein, which had also been identified as a CvGal1 glycoprotein ligand associated with hemocytes. The occurrence of terminal blood group moieties on oyster dominin and on hemocyte surfaces can account in part for their affinity for the endogenous CvGal1.	[Kurz, Simone; Hykollari, Alba; Gregorich, Daniel; Wilson, Iain B. H.; Paschinger, Katharina] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; [Jin, Chunsheng] Univ Gothenburg, Inst Biomed, Dept Med Biochem, SE-40530 Gothenburg, Sweden; [Giomarelli, Barbara; Vasta, Gerardo R.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21202 USA; [Giomarelli, Barbara; Vasta, Gerardo R.] Inst Marine & Environm Technol, Baltimore, MD 21202 USA	University of Natural Resources & Life Sciences, Vienna; University of Gothenburg; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Wilson, Iain/B-3326-2009; Kurz, Simone/J-2390-2018	Wilson, Iain/0000-0001-8996-1518; Kurz, Simone/0000-0003-2062-2512; Paschinger, Katharina/0000-0002-3594-7136	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P21946]; Schrodinger Scholarship [J3160]; National Science Foundation [IOS-0822257, IOS-1063729]; Forderung der Wissenschaftlichen Forschung [W1224]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 21946] Funding Source: researchfish; Direct For Biological Sciences [1050518, 1063729] Funding Source: National Science Foundation	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Schrodinger Scholarship; National Science Foundation(National Science Foundation (NSF)); Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant P21946 (to K. P.), Schrodinger Scholarship J3160 (to C. J.), and Grants IOS-0822257 and IOS-1063729 from the National Science Foundation (to G. R. V.).; Supported by the Forderung der Wissenschaftlichen Forschung-funded Doctoral Programme "Biomolecular Technology of Proteins" Grant W1224.	Akilov OE, 2007, J LEUKOCYTE BIOL, V81, P1188, DOI 10.1189/jlb.0706439; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Chu FLE, 1997, DIS AQUAT ORGAN, V28, P61, DOI 10.3354/dao028061; Dame Richard, 2002, Aquatic Ecology, V36, P51, DOI 10.1023/A:1013354807515; Demeure K, 2007, ANAL CHEM, V79, P8678, DOI 10.1021/ac070849z; Dolashka-Angelova P, 2003, BIOCHEM J, V374, P185, DOI 10.1042/BJ20030291; Feng CG, 2013, J BIOL CHEM, V288, P24394, DOI 10.1074/jbc.M113.476531; Gauthier JD, 2004, J PARASITOL, V90, P446, DOI 10.1645/GE-3269; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Gielens C, 2005, BIOCHEM BIOPH RES CO, V331, P562, DOI 10.1016/j.bbrc.2005.03.217; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Harvey DJ, 2005, RAPID COMMUN MASS SP, V19, P287, DOI 10.1002/rcm.1761; Hykollari A, 2013, J PROTEOME RES, V12, P1173, DOI 10.1021/pr300806b; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Itoh N, 2011, COMP BIOCHEM PHYS B, V158, P9, DOI 10.1016/j.cbpb.2010.06.006; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; Lehr T, 2007, GLYCOBIOLOGY, V17, P82, DOI 10.1093/glycob/cwl048; Lehr T, 2010, EXP PARASITOL, V126, P592, DOI 10.1016/j.exppara.2010.06.031; Lin Z, 2011, BIOCHEMISTRY-US, V50, P6340, DOI 10.1021/bi200343h; Lommerse JPM, 1997, EUR J BIOCHEM, V249, P195, DOI 10.1111/j.1432-1033.1997.00195.x; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Natsuka S, 2006, J BIOCHEM, V140, P87, DOI 10.1093/jb/mvj131; Neville DCA, 2009, J PROTEOME RES, V8, P681, DOI 10.1021/pr800704t; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Oliver JL, 1999, J INVERTEBR PATHOL, V74, P173, DOI 10.1006/jipa.1999.4879; Paschinger K, 2012, INT J PARASITOL, V42, P279, DOI 10.1016/j.ijpara.2012.01.002; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Poulin R, 2008, OIKOS, V117, P331, DOI 10.1111/j.2007.0030-1299.16435.x; PUANGLARP N, 1995, EUR J BIOCHEM, V232, P873; Reece SE, 2009, EVOL APPL, V2, P11, DOI 10.1111/j.1752-4571.2008.00060.x; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schott EJ, 2003, MOL BIOCHEM PARASIT, V126, P81, DOI 10.1016/S0166-6851(02)00271-2; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Scotti PD, 2007, NEW ZEAL J MAR FRESH, V41, P91, DOI 10.1080/00288330709509898; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takakura D, 2008, MAR BIOTECHNOL, V10, P290, DOI 10.1007/s10126-007-9063-8; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Tian P, 2008, J FOOD PROTECT, V71, P1696, DOI 10.4315/0362-028X-71.8.1696; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5165; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; van der Vlist M, 2011, CURR OPIN HIV AIDS, V6, P348, DOI 10.1097/COH.0b013e328349a2d1; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; Vasta G. R., 2008, ANIMAL LECTINS; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Velkova L, 2011, GLYCOCONJUGATE J, V28, P385, DOI 10.1007/s10719-011-9337-2; Wenzel T, 2006, RAPID COMMUN MASS SP, V20, P785, DOI 10.1002/rcm.2378; Wright AC, 2002, MOL BIOCHEM PARASIT, V123, P73, DOI 10.1016/S0166-6851(02)00090-7; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Yoshino TP, 2008, GENE, V411, P46, DOI 10.1016/j.gene.2008.01.003; Yoshino TP, 2013, EXP PARASITOL, V133, P28, DOI 10.1016/j.exppara.2012.10.002; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153	62	37	37	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24410	24428		10.1074/jbc.M113.478933	http://dx.doi.org/10.1074/jbc.M113.478933			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824194	hybrid, Green Published			2022-12-25	WOS:000330612300012
J	Ambigapathy, G; Zheng, ZQ; Li, W; Keifer, J				Ambigapathy, Ganesh; Zheng, Zhaoqing; Li, Wei; Keifer, Joyce			Identification of a Functionally Distinct Truncated BDNF mRNA Splice Variant and Protein in Trachemys scripta elegans	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SYNAPTIC DELIVERY; TRANSCRIPTION; ACQUISITION; TRAFFICKING; BOUTONS; GENES	Brain-derived neurotrophic factor (BDNF) has a diverse functional role and complex pattern of gene expression. Alternative splicing of mRNA transcripts leads to further diversity of mRNAs and protein isoforms. Here, we describe the regulation of BDNF mRNA transcripts in an in vitro model of eyeblink classical conditioning and a unique transcript that forms a functionally distinct truncated BDNF protein isoform. Nine different mRNA transcripts from the BDNF gene of the pond turtle Trachemys scripta elegans (tBDNF) are selectively regulated during classical conditioning: exon I mRNA transcripts show no change, exon II transcripts are downregulated, while exon III transcripts are upregulated. One unique transcript that codes from exon II, tBDNF2a, contains a 40 base pair deletion in the protein coding exon that generates a truncated tBDNF protein. The truncated transcript and protein are expressed in the naive untrained state and are fully repressed during conditioning when full-length mature tBDNF is expressed, thereby having an alternate pattern of expression in conditioning. Truncated BDNF is not restricted to turtles as a truncated mRNA splice variant has been described for the human BDNF gene. Further studies are required to determine the ubiquity of truncated BDNF alternative splice variants across species and the mechanisms of regulation and function of this newly recognized BDNF protein.	[Ambigapathy, Ganesh; Zheng, Zhaoqing; Li, Wei; Keifer, Joyce] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Neurosci Grp, Vermillion, SD 57069 USA	University of South Dakota	Keifer, J (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Neurosci Grp, Vermillion, SD 57069 USA.	jkeifer@usd.edu		Keifer, Joyce/0000-0002-5900-0414	NIH INBRE; NIH [NS051187]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051187] Funding Source: NIH RePORTER	NIH INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Callegari was supported by the NIH INBRE Program. This study was supported by NIH Grant NS051187 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ambigapathy G, 2012, IDENTIFICATION NOVEL; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Branciamore S, 2010, P NATL ACAD SCI USA, V107, P15485, DOI 10.1073/pnas.1010506107; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; Keifer J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00009; Keifer J, 2009, J NEUROSCI, V29, P14956, DOI 10.1523/JNEUROSCI.3649-09.2009; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li W, 2008, NEUROSCIENCE, V155, P686, DOI 10.1016/j.neuroscience.2008.06.043; Li W, 2012, NEUROSCIENCE, V203, P50, DOI 10.1016/j.neuroscience.2011.12.015; Li W, 2011, J NEUROSCI, V31, P8441, DOI 10.1523/JNEUROSCI.6343-10.2011; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Mauk MD, 2004, LEARN MEMORY, V11, P566, DOI 10.1101/lm.83504; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yu Y, 2009, BRAIN RES, V1269, P1, DOI 10.1016/j.brainres.2009.01.071; Zheng ZQ, 2012, J NEUROPHYSIOL, V108, P101, DOI 10.1152/jn.01097.2011; Zheng ZQ, 2009, J NEUROPHYSIOL, V101, P2539, DOI 10.1152/jn.91282.2008	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67141	10.1371/journal.pone.0067141	http://dx.doi.org/10.1371/journal.pone.0067141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825634	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000084
J	Jimenez-Diaz, MB; Viera, S; Ibanez, J; Mulet, T; Magan-Marchal, N; Garuti, H; Gomez, V; Cortes-Gil, L; Martinez, A; Ferrer, S; Fraile, MT; Calderon, F; Fernandez, E; Shultz, LD; Leroy, D; Wilson, DM; Garcia-Bustos, JF; Gamo, FJ; Angulo-Barturen, I				Belen Jimenez-Diaz, Maria; Viera, Sara; Ibanez, Javier; Mulet, Teresa; Magan-Marchal, Noemi; Garuti, Helen; Gomez, Vanessa; Cortes-Gil, Lorena; Martinez, Antonio; Ferrer, Santiago; Teresa Fraile, Maria; Calderon, Felix; Fernandez, Esther; Shultz, Leonard D.; Leroy, Didier; Wilson, David M.; Francisco Garcia-Bustos, Jose; Javier Gamo, Francisco; Angulo-Barturen, Inigo			A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery	PLOS ONE			English	Article							FALCIPARUM-MALARIA; CYCLOPROPYL CARBOXAMIDES; ARTEMISININ RESISTANCE; PLASMODIUM-BERGHEI; STARTING POINTS; AZITHROMYCIN; CANDIDATE; EFFICACY; MODELS	The emergence of resistance to available antimalarials requires the urgent development of new medicines. The recent disclosure of several thousand compounds active in vitro against the erythrocyte stage of Plasmodium falciparum has been a major breakthrough, though converting these hits into new medicines challenges current strategies. A new in vivo screening concept was evaluated as a strategy to increase the speed and efficiency of drug discovery projects in malaria. The new in vivo screening concept was developed based on human disease parameters, i.e. parasitemia in the peripheral blood of patients on hospital admission and parasite reduction ratio (PRR), which were allometrically down-scaled into P. berghei-infected mice. Mice with an initial parasitemia (P-0) of 1.5% were treated orally for two consecutive days and parasitemia measured 24 h after the second dose. The assay was optimized for detection of compounds able to stop parasite replication (PRR = 1) or induce parasite clearance (PRR >1) with statistical power >99% using only two mice per experimental group. In the P. berghei in vivo screening assay, the PRR of a set of eleven antimalarials with different mechanisms of action correlated with human-equivalent data. Subsequently, 590 compounds from the Tres Cantos Antimalarial Set with activity in vitro against P. falciparum were tested at 50 mg/kg (orally) in an assay format that allowed the evaluation of hundreds of compounds per month. The rate of compounds with detectable efficacy was 11.2% and about one third of active compounds showed in vivo efficacy comparable with the most potent antimalarials used clinically. High-throughput, high-content in vivo screening could rapidly select new compounds, dramatically speeding up the discovery of new antimalarial medicines. A global multilateral collaborative project aimed at screening the significant chemical diversity within the antimalarial in vitro hits described in the literature is a feasible task.	[Belen Jimenez-Diaz, Maria; Viera, Sara; Ibanez, Javier; Mulet, Teresa; Magan-Marchal, Noemi; Garuti, Helen; Gomez, Vanessa; Cortes-Gil, Lorena; Martinez, Antonio; Ferrer, Santiago; Teresa Fraile, Maria; Calderon, Felix; Fernandez, Esther; Wilson, David M.; Francisco Garcia-Bustos, Jose; Javier Gamo, Francisco; Angulo-Barturen, Inigo] GlaxoSmithKline, Tres Cantos, Spain; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	GlaxoSmithKline; Jackson Laboratory	Angulo-Barturen, I (corresponding author), GlaxoSmithKline, Tres Cantos Med Dev Campus, Tres Cantos, Spain.	inigo.x.angulo@gsk.com	Ferrer-Bazaga, Santiago/AAA-7749-2021	Ferrer-Bazaga, Santiago/0000-0002-6672-551X; Garcia-Bustos, Jose/0000-0002-6310-796X; Ibanez, Javier/0000-0001-6215-6332	Medicines for Malaria Venture; GlaxoSmithKline, Diseases of the Developing World, Tres Cantos Medicines Development Campus	Medicines for Malaria Venture; GlaxoSmithKline, Diseases of the Developing World, Tres Cantos Medicines Development Campus	The study was funded in part under a Miniportfolio Agreement between the Medicines for Malaria Venture and GlaxoSmithKline, Diseases of the Developing World, Tres Cantos Medicines Development Campus. The funders had no role on study design, data collection and analysis.	Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; ANDERSEN SL, 1995, AM J TROP MED HYG, V52, P159, DOI 10.4269/ajtmh.1995.52.159; Angulo-Barturen Inigo, 2013, Drug Discov Today Technol, V10, pe351, DOI 10.1016/j.ddtec.2012.07.003; Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Anvikar AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-97; Apte SH, 2011, INT J PARASITOL, V41, P1285, DOI 10.1016/j.ijpara.2011.07.010; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Barker RH, 2011, ANTIMICROB AGENTS CH, V55, P2612, DOI 10.1128/AAC.01714-10; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Calderon F, 2012, ACS MED CHEM LETT, V3, P373, DOI 10.1021/ml300008j; Calderon F, 2011, ACS MED CHEM LETT, V2, P741, DOI 10.1021/ml200135p; Cao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006894; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Empfield JR, 2010, IDRUGS, V13, P869; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; GINGRAS BA, 1993, AM J TROP MED HYG, V49, P101, DOI 10.4269/ajtmh.1993.49.101; Gleeson MP, 2011, CURR TOP MED CHEM, V11, P358; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hou T, 2008, EXPERT OPIN DRUG MET, V4, P759, DOI 10.1517/17425255.4.6.759 ; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; KINNAMON KE, 1975, AM J TROP MED HYG, V24, P174, DOI 10.4269/ajtmh.1975.24.174; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Madden JC, 2012, REGUL TOXICOL PHARM, V63, P140, DOI 10.1016/j.yrtph.2012.03.010; Mahmood I., 2005, INTERSPECIES PHARMAC; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MMV, 2008, COMP PROGR CRIT; MMV, 2010, NEW MED MAL CONTR ER; Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11; Nilsen A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005029; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Ockenhouse Christian F, 2005, Mil Med, V170, P12; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Peters W, 1999, HDB ANIMAL MODELS IN, P757; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P2395, DOI 10.1128/AAC.44.9.2395-2398.2000; Ricklefs RE, 2010, SCIENCE, V329, P226, DOI 10.1126/science.1188954; Rueda L, 2011, ACS MED CHEM LETT, V2, P840, DOI 10.1021/ml2001517; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Sanz LM, 2011, ANTIMICROB AGENTS CH, V55, P5740, DOI 10.1128/AAC.05188-11; Slater LB, 2005, B HIST MED, V79, P261, DOI 10.1353/bhm.2005.0092; Tamimi NAM, 2009, NEPHRON CLIN PRACT, V113, pC125, DOI 10.1159/000232592; Thompson PE, 1972, ANTIMALARIAL AGENTS; van Eijk AM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006688.pub2; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2020, REP ANT DRUG EFF RES; Yeramian P, 2005, J INFECT DIS, V192, P319, DOI 10.1086/430928	61	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66967	10.1371/journal.pone.0066967	http://dx.doi.org/10.1371/journal.pone.0066967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825598	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000052
J	Eraso, P; Portillo, F; Mazon, MJ				Eraso, Pilar; Portillo, Francisco; Mazon, Maria J.			Characterization of Two Second-Site Mutations Preventing Wild Type Protein Aggregation Caused by a Dominant Negative PMA1 Mutant	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; ER QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PHOSPHORYLATION DOMAIN; SURFACE TRANSPORT; MISFOLDED MUTANTS; RAFT ASSOCIATION; LETHAL MUTATIONS; BINDING-SITE	The correct biogenesis and localization of Pma1 at the plasma membrane is essential for yeast growth. A subset of PMA1 mutations behave as dominant negative because they produce aberrantly folded proteins that form protein aggregates, which in turn provoke the aggregation of the wild type protein. One approach to understand this dominant negative effect is to identify second-site mutations able to suppress the dominant lethal phenotype caused by those mutant alleles. We isolated and characterized two intragenic second-site suppressors of the PMA1-D378T dominant negative mutation. We present here the analysis of these new mutations that are located along the amino-terminal half of the protein and include a missense mutation, L151F, and an in-frame 12bp deletion that eliminates four residues from Cys409 to Ala412. The results show that the suppressor mutations disrupt the interaction between the mutant and wild type enzymes, and this enables the wild type Pma1 to reach the plasma membrane.	[Eraso, Pilar; Portillo, Francisco] Univ Autonoma Madrid, Dept Bioquim, Consejo Super Invest Cient, Madrid, Spain; [Eraso, Pilar; Portillo, Francisco; Mazon, Maria J.] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Mazon, MJ (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid, Spain.	mjmazon@iib.uam.es	Mazmela, Pilar Eraso/E-9248-2016; Calpena, María Jesús Mazón/E-9168-2016	Mazmela, Pilar Eraso/0000-0002-6928-3219; Calpena, María Jesús Mazón/0000-0003-4151-4051; Portillo Perez, Francisco/0000-0003-4922-346X	Spanish Ministerio de Ciencia e Innovacion [BFU2008-04285]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion Grant BFU2008-04285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Almeida WI, 2006, BBA-BIOMEMBRANES, V1758, P1768, DOI 10.1016/j.bbamem.2006.08.018; Ambesi A, 2000, J EXP BIOL, V203, P155; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bukrinsky JT, 2001, FEBS LETT, V494, P6, DOI 10.1016/S0014-5793(01)02301-8; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; dExaerde AD, 1996, YEAST, V12, P907; ERASO P, 1987, FEBS LETT, V224, P193, DOI 10.1016/0014-5793(87)80446-5; Eraso P, 2011, MOL MICROBIOL, V79, P1339, DOI 10.1111/j.1365-2958.2010.07528.x; Eraso P, 2010, TRAFFIC, V11, P37, DOI 10.1111/j.1600-0854.2009.01005.x; Ferreira T, 2002, J BIOL CHEM, V277, P21027, DOI 10.1074/jbc.M112281200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HARRIS SL, 1994, P NATL ACAD SCI USA, V91, P10531, DOI 10.1073/pnas.91.22.10531; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Maldonado AM, 1998, GENETICS, V150, P11; MALDONADO AM, 1995, J BIOL CHEM, V270, P8655, DOI 10.1074/jbc.270.15.8655; Mason AB, 2006, J BIOL CHEM, V281, P23887, DOI 10.1074/jbc.M601818200; Mazon MJ, 2007, MOL MICROBIOL, V63, P1069, DOI 10.1111/j.1365-2958.2006.05580.x; MONK BC, 1994, J BIOENERG BIOMEMBR, V26, P101, DOI 10.1007/BF00763222; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; Pagant S, 2010, J BIOL CHEM, V285, P36304, DOI 10.1074/jbc.M110.142760; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Petrov VV, 1997, J BIOL CHEM, V272, P1688, DOI 10.1074/jbc.272.3.1688; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SERRANO R, 1993, EUR J BIOCHEM, V212, P737, DOI 10.1111/j.1432-1033.1993.tb17712.x; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R, 1991, MOL CELLULAR BIOL YE, P523; SetoYoung D, 1996, J BIOL CHEM, V271, P581, DOI 10.1074/jbc.271.1.581; SIKORSKI RS, 1989, GENETICS, V122, P19; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67080	10.1371/journal.pone.0067080	http://dx.doi.org/10.1371/journal.pone.0067080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825623	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000075
J	Fang, YF; Zhong, LK; Lin, MH; Zhou, XL; Jing, H; Ying, MD; Luo, PH; Yang, B; He, QJ				Fang, Yanfen; Zhong, Like; Lin, Meihua; Zhou, Xinglu; Jing, Hui; Ying, Meidan; Luo, Peihua; Yang, Bo; He, Qiaojun			MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; PHOSPHORYLATION; INHIBITORS; THERAPY; TRANSCRIPTION; PATHWAYS; CELLS; RAF	Dasatinib (BMS-354825) is a FDA-approved multitargeted kinase inhibitor of BCR/ABL and Src kinases. It is now used in the treatment of chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapies, including imatinib. Here we report a novel effect of dasatinib on inducing the differentiation of acute myeloid leukemia (AML) cells through MEK/ERK-dependent activation of signal transducer and activator of transcription 1 (STAT1). We found that dasatinib could induce the differentiation of AML cells as demonstrated by the expression of differentiation marker CD11b, G0/G1 phase arrest and decreased ratio of nucleus to cytoplasm. Of note, dasatinib induced robust phosphorylation of STAT1 both at Tyr701 and Ser727 as well as the redistribution of STAT1 from the cytoplasm to the nucleus, thus leading to the transcription of STAT1-targeted genes. Knocking down STAT1 expression by shRNA significantly attenuated dasatinib-induced differentiation, indicating an important role of STAT1 in myeloid maturation. We further found that dasatinib-induced activation of STAT1 was regulated by the MEK/ERK kinases. The phosporylation of MEK and ERK occurred rapidly upon dasatinib treatment and increased progressively as differentiation was induced. MEK inhibitors PD98059 and U0216 not only inhibited the phosphorylation of STAT1, but also abrogated dasatinib-induced myeloid differentiation, suggesting that MEK/ERK dependent phosphorylation of STAT1 might be indispensable for the differentiating effect of dasatinib in AML cells. Taken together, our study suggests that STAT1 is an important mediator in dasatinib-induced differentiation of AML cells, whose activation requires the activation of MEK/ERK cascades.	[Fang, Yanfen; Zhong, Like; Lin, Meihua; Zhou, Xinglu; Jing, Hui; Ying, Meidan; Luo, Peihua; Yang, Bo; He, Qiaojun] Zhejiang Univ, Sch Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Zhejiang, Peoples R China; [Fang, Yanfen] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Zhejiang University; University of Michigan System; University of Michigan	Yang, B (corresponding author), Zhejiang Univ, Sch Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Zhejiang, Peoples R China.	yang924@zju.edu.cn; qiaojunhe@zju.edu.cn	Jing, Hui/GXM-4109-2022; Jing, Hui/AAL-7810-2020	Jing, Hui/0000-0002-8389-8252; Jing, Hui/0000-0002-2129-7937	Zhejiang Provincial Program for the Cultivation of High-Level Innovative Heath Talents; Natural Science Foundation of Zhejiang Province [Y12H310029]; Research Foundation of Education Bureau of Zhejiang Province [Y201121007]; Science Foundation of Chinese University	Zhejiang Provincial Program for the Cultivation of High-Level Innovative Heath Talents; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Research Foundation of Education Bureau of Zhejiang Province; Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Zhejiang Provincial Program for the Cultivation of High-Level Innovative Heath Talents, Natural Science Foundation of Zhejiang Province (number Y12H310029), Research Foundation of Education Bureau of Zhejiang Province (Y201121007), and Science Foundation of Chinese University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Chevalier N, 2010, LEUKEMIA, V24, P1779, DOI 10.1038/leu.2010.151; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Dimberg A, 2000, BLOOD, V96, P2870; Fang YF, 2011, MOL CARCINOGEN, V50, P24, DOI 10.1002/mc.20687; Fang YF, 2010, CANCER BIOL THER, V10, P1158, DOI 10.4161/cbt.10.11.13556; Fey A, 2004, APPL ENVIRON MICROB, V70, P3618, DOI 10.1128/aem.70.6.3618-3623.2004; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Gu ZM, 2011, FEBS LETT, V585, P375, DOI 10.1016/j.febslet.2010.12.021; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Johnson DE, 2008, ADV ENZYME REGUL, V48, P98, DOI 10.1016/j.advenzreg.2007.11.002; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1198, DOI 10.1002/pbc.21368; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lainey E, 2011, BIOCHEM PHARMACOL, V82, P1457, DOI 10.1016/j.bcp.2011.05.011; Li SW, 2011, J GEN VIROL, V92, P1127, DOI 10.1099/vir.0.028936-0; Luo PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027298; Miranda MB, 2008, LEUKEMIA, V22, P1624, DOI 10.1038/leu.2008.28; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Rivieccio MA, 2005, J IMMUNOL, V174, P3719, DOI 10.4049/jimmunol.174.6.3719; Rosenzweig SA, 2012, BIOCHEM PHARMACOL, V83, P1041, DOI 10.1016/j.bcp.2011.12.025; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schuringa JJ, 2000, BLOOD, V95, P3765, DOI 10.1182/blood.V95.12.3765; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Sullivan C, 2010, BIOCHEM PHARMACOL, V80, P584, DOI 10.1016/j.bcp.2010.05.001; Vera J, 2011, PROG BIOPHYS MOL BIO, V106, P426, DOI 10.1016/j.pbiomolbio.2011.06.013; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Zhang YG, 2004, CARCINOGENESIS, V25, P1165, DOI 10.1093/carcin/bgh115	42	27	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66915	10.1371/journal.pone.0066915	http://dx.doi.org/10.1371/journal.pone.0066915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825585	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000042
J	Zamora, L; Fernandez-Garayzabal, JF; Sanchez-Porro, C; Palacios, MA; Moore, ERB; Dominguez, L; Ventosa, A; Vela, AI				Zamora, Leydis; Fernandez-Garayzabal, Jose F.; Sanchez-Porro, Cristina; Angel Palacios, Mari; Moore, Edward R. B.; Dominguez, Lucas; Ventosa, Antonio; Vela, Ana I.			Flavobacterium plurextorum sp nov Isolated from Farmed Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							EMENDED DESCRIPTION; LIPID-COMPOSITION; FAMILY	Five strains (1126-1H-08(T), 51B-09, 986-08, 1084B-08 and 424-08) were isolated from diseased rainbow trout. Cells were Gram-negative rods, 0.7 mu m wide and 3 mu m long, non-endospore-forming, catalase and oxidase positive. Colonies were circular, yellow-pigmented, smooth and entire on TGE agar after 72 hours incubation at 25 degrees C. They grew in a temperature range between 15 degrees C to 30 degrees C, but they did not grow at 37 degrees Cor 42 degrees C. Based on 16S rRNA gene sequence analysis, the isolates belonged to the genus Flavobacterium. Strain 1126-1H-08(T) exhibited the highest levels of similarity with Flavobacterium oncorhynchi CECT 7678(T) and Flavobacterium pectinovorum DSM 6368(T) (98.5% and 97.9% sequence similarity, respectively). DNA-DNA hybridization values were 87 to 99% among the five isolates and ranged from 21 to 48% between strain 1126-1H-08(T), selected as a representative isolate, and the type strains of Flavobacterium oncorhynchi CECT 7678(T) and other phylogenetic related Flavobacterium species. The DNA G+C content of strain 1126-1H-08(T) was 33.2 mol%. The predominant respiratory quinone was MK-6 and the major fatty acids were iso-C-15:0 and C-15:0. These data were similar to those reported for Flavobacterium species. Several physiological and biochemical tests differentiated the novel bacterial strains from related Flavobacterium species. Phylogenetic, genetic and phenotypic data indicate that these strains represent a new species of the genus Flavobacterium, for which the name Flavobacterium plurextorum sp. nov. was proposed. The type strain is 1126-1H-08(T) (=CECT 7844(T) = CCUG 60112(T)).	[Zamora, Leydis; Fernandez-Garayzabal, Jose F.; Dominguez, Lucas; Vela, Ana I.] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, E-28040 Madrid, Spain; [Fernandez-Garayzabal, Jose F.; Vela, Ana I.] Univ Complutense, Fac Vet, Dept Sanidad Anim, E-28040 Madrid, Spain; [Angel Palacios, Mari] Piszolla SL, Salamanca, Spain; [Sanchez-Porro, Cristina; Ventosa, Antonio] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Moore, Edward R. B.] Univ Gothenburg, CCUG, Gothenburg, Sweden; [Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden	Complutense University of Madrid; Complutense University of Madrid; University of Sevilla; University of Gothenburg; University of Gothenburg	Fernandez-Garayzabal, JF (corresponding author), Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, E-28040 Madrid, Spain.	garayzab@vet.ucm.es	Vela, Ana I/K-8015-2014; Ventosa, Antonio/K-8239-2017; Zamora Morales, Leydis/F-4790-2016; Rodríguez, Lucas Domínguez/B-9668-2014; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Sanchez, Cristina/K-8027-2017; studies, IT VISAVET Account for bibliometric/C-3115-2014	Vela, Ana I/0000-0001-5004-3103; Ventosa, Antonio/0000-0002-7573-0556; Zamora Morales, Leydis/0000-0003-4068-0584; Rodríguez, Lucas Domínguez/0000-0001-8843-0010; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Sanchez, Cristina/0000-0002-1834-1239; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Moore, Edward/0000-0001-7693-924X	Spanish Office for Science and Technology (CDETI); Spanish Ministry of Science and Innovation [CGL2010-19303]; Junta de Andalucia [P10-CVI-6226]; Vastra Gotaland Region [VGFOUREG-30781, 83080, 157801]	Spanish Office for Science and Technology (CDETI); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Vastra Gotaland Region	This work was funded by projects CENIT 2007-2010 (ACUISOST) of the Spanish Office for Science and Technology (CDETI), CGL2010-19303 of the Spanish Ministry of Science and Innovation and P10-CVI-6226 from the Junta de Andalucia. ERBM was supported by funding of Vastra Gotaland Region projects VGFOUREG-30781, 83080 and 157801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bernardet J.-F., 2006, PROKARYOTES, P481, DOI [10.1007/0-387-30747-8_17, DOI 10.1007/0-387-30747-8_17]; Bernardet J-F, 2006, PROKARYOTES HDB BIOL, V7, P455, DOI [DOI 10.1007/0-387-30747-8_16, DOI 10.1007/0-387-30747-8]; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; Bowman JP, 1996, INT J SYST BACTERIOL, V46, P841, DOI 10.1099/00207713-46-4-841; Chen WM, 2013, INT J SYST EVOL MICR, V63, P827, DOI 10.1099/ijs.0.041178-0; Chen YC, 2008, J FISH DIS, V31, P765, DOI 10.1111/j.1365-2761.2008.00950.x; DELEY J, 1970, ANTON VAN LEE J M S, V36, P461, DOI 10.1007/BF02069048; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Flemming L, 2007, RES MICROBIOL, V158, P18, DOI 10.1016/j.resmic.2006.09.001; Georgiadis MP, 2001, PREV VET MED, V48, P287, DOI 10.1016/S0167-5877(00)00202-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ilardi P, 2008, B EUR ASSOC FISH PAT, V28, P176; Johnson John L., 1994, P655; Kampfer P, 2012, INT J SYST EVOL MICR, V62, P1402, DOI 10.1099/ijs.0.033431-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lim CS, 2011, INT J SYST EVOL MICR, V61, P2734, DOI 10.1099/ijs.0.028563-0; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rasmussen S. W., 2002, SEQTOOLS SOFTWARE PA; Roberts R.J., 2012, FISH PATHOL, P339, DOI [10.1111/j.1751-0813.2002.tb14791.x, DOI 10.1111/J.1751-0813.2002.TB14791.X, DOI 10.1002/9781118222942.CH8]; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASSER M, 2001, 101 MIDI INC; Sheu SY, 2013, INT J SYST EVOL MICR, V63, P2239, DOI 10.1099/ijs.0.046425-0; Sheu SY, 2011, INT J SYST EVOL MICR, V61, P1402, DOI 10.1099/ijs.0.025403-0; Smibert Robert M., 1994, P607; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Starliper C. E., 2012, FISH DIS DISORDERS, V3, P606; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TINDALL BJ, 1990, FEMS MICROBIOL LETT, V66, P199; TINDALL BJ, 1990, SYST APPL MICROBIOL, V13, P128, DOI 10.1016/S0723-2020(11)80158-X; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Xu MS, 2011, INT J SYST EVOL MICR, V61, P20, DOI 10.1099/ijs.0.014126-0; Yoon JH, 2011, INT J SYST EVOL MICR, V61, P81, DOI 10.1099/ijs.0.017582-0; Zamora L, 2012, SYST APPL MICROBIOL, V35, P86, DOI 10.1016/j.syapm.2011.11.007	38	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67741	10.1371/journal.pone.0067741	http://dx.doi.org/10.1371/journal.pone.0067741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825681	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000321223000115
J	Wang, PH; Lee, TH; Ismail, W; Tsai, CY; Lin, CW; Tsai, YW; Chiang, YR				Wang, Po-Hsiang; Lee, Tzong-Huei; Ismail, Wael; Tsai, Ching-Yen; Lin, Ching-Wen; Tsai, Yu-Wen; Chiang, Yin-Ru			An Oxygenase-Independent Cholesterol Catabolic Pathway Operates under Oxic Conditions	PLOS ONE			English	Article							SIDE-CHAIN DEGRADATION; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; STEROLIBACTERIUM-DENITRIFICANS; MICROBIAL TRANSFORMATION; MYCOBACTERIUM-TUBERCULOSIS; ANAEROBIC DEGRADATION; AROMATIC-COMPOUNDS; STEROID OXIDATION; GENE-CLUSTER; SP-NOV.	Cholesterol is one of the most ubiquitous compounds in nature. The 9,10-seco-pathway for the aerobic degradation of cholesterol was established thirty years ago. This pathway is characterized by the extensive use of oxygen and oxygenases for substrate activation and ring fission. The classical pathway was the only catabolic pathway adopted by all studies on cholesterol-degrading bacteria. Sterolibacterium denitrificans can degrade cholesterol regardless of the presence of oxygen. Here, we aerobically grew the model organism with C-13-labeled cholesterol, and substrate consumption and intermediate production were monitored over time. Based on the detected C-13-labeled intermediates, this study proposes an alternative cholesterol catabolic pathway. This alternative pathway differs from the classical 9,10-seco-pathway in numerous important aspects. First, substrate activation proceeds through anaerobic C-25 hydroxylation and subsequent isomerization to form 26-hydroxycholest-4-en-3-one. Second, after the side chain degradation, the resulting androgen intermediate is activated by adding water to the C-1/C-2 double bond. Third, the cleavage of the core ring structure starts at the A-ring via a hydrolytic mechanism. The O-18-incorporation experiments confirmed that water is the sole oxygen donor in this catabolic pathway.	[Wang, Po-Hsiang; Tsai, Ching-Yen; Lin, Ching-Wen; Tsai, Yu-Wen; Chiang, Yin-Ru] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lee, Tzong-Huei] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Ismail, Wael] Arabian Gulf Univ, Coll Grad Studies, Biotechnol Program, Manama, Bahrain	Academia Sinica - Taiwan; Taipei Medical University; Arabian Gulf University	Chiang, YR (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	yinru915@gate.sinica.edu.tw	Chiang, Yin-Ru/L-7727-2019; Ismail, Wael/X-5336-2019	Chiang, Yin-Ru/0000-0001-6899-3166; Lee, Tzong-Huei/0000-0001-8036-7563; Ahmed Ismail El Moslimany, Wael/0000-0002-3027-928X	National Science Council [NSC 100-2311-B-182-005-MY3]; Chang-Gung Memorial Hospital of Taiwan [CMRPD1A0072]; Genomics Research Center, Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Chang-Gung Memorial Hospital of Taiwan; Genomics Research Center, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This study was funded by the National Science Council (NSC 100-2311-B-182-005-MY3) and Chang-Gung Memorial Hospital (CMRPD1A0072) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Small Molecule Metabolomics Core Facility sponsored by the Institute of Plant and Microbial Biology, Academia Sinica for UPLCMS analyses. NMR analysis was performed by the NMR Laboratory sponsored by the Genomics Research Center, Academia Sinica, Taiwan.	ARIMA K, 1969, AGR BIOL CHEM TOKYO, V33, P1636, DOI 10.1080/00021369.1969.10859516; Brodkorb D, 2010, J BIOL CHEM, V285, P30436, DOI 10.1074/jbc.M109.084244; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Dermer J, 2012, J BIOL CHEM, V287, P36905, DOI 10.1074/jbc.M112.407304; Doukyu N, 2009, APPL MICROBIOL BIOT, V83, P825, DOI 10.1007/s00253-009-2059-8; Drzyzga O, 2011, APPL ENVIRON MICROB, V77, P4802, DOI 10.1128/AEM.05149-11; Fahrbach M, 2006, INT J SYST EVOL MICR, V56, P1547, DOI 10.1099/ijs.0.63672-0; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; Horinouchi M, 2012, J STEROID BIOCHEM, V129, P4, DOI 10.1016/j.jsbmb.2010.10.008; Hylemon PB, 1998, FEMS MICROBIOL REV, V22, P475, DOI 10.1111/j.1574-6976.1998.tb00382.x; Ismail W., 2011, J BIOREMED BIODEGR S, DOI [10.4172/2155-6199, DOI 10.4172/2155-6199]; Ismail W, 2012, APPL ENVIRON MICROB, V78, P5043, DOI 10.1128/AEM.00633-12; JOHNSON DF, 1963, SCIENCE, V140, P198, DOI 10.1126/science.140.3563.198; KIESLICH K, 1985, J BASIC MICROB, V25, P461, DOI 10.1002/jobm.3620250713; KOCHHAR SP, 1983, PROG LIPID RES, V22, P161, DOI 10.1016/0163-7827(83)90008-5; Leu YL, 2011, J BACTERIOL, V193, P4447, DOI 10.1128/JB.00331-11; NAGASAWA M, 1970, AGR BIOL CHEM TOKYO, V34, P838, DOI 10.1080/00021369.1970.10859703; NAGASAWA M, 1969, AGR BIOL CHEM TOKYO, V33, P1644; OWEN RW, 1983, J LIPID RES, V24, P1500; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Petrusma M, 2009, APPL ENVIRON MICROB, V75, P5300, DOI 10.1128/AEM.00066-09; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; SIH CJ, 1967, J AM CHEM SOC, V89, P1957, DOI 10.1021/ja00984a039; SIH CJ, 1968, BIOCHEMISTRY-US, V7, P808, DOI 10.1021/bi00842a039; SIH CJ, 1965, J AM CHEM SOC, V87, P1386, DOI 10.1021/ja01084a043; SIH CJ, 1966, J BIOL CHEM, V241, P540; Sih CJ, 1965, J AM CHEM SOC, V87, P1385, DOI [10.1021/ja01084a042, DOI 10.1021/JA01084A042]; Tak J. D., 1942, ANTON LEEUW INT J G, V8, P32, DOI DOI 10.1007/BF02272764; Tarlera S, 2003, INT J SYST EVOL MICR, V53, P1085, DOI 10.1099/ijs.0.02039-0; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Wang PH, 2013, J LIPID RES, V54, P1493, DOI 10.1194/jlr.M034223; Weete JD, 1989, ADV LIPID RES, V23, P484; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Whitmarsh J. M., 1964, BIOCHEM J, V90, P23	44	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66675	10.1371/journal.pone.0066675	http://dx.doi.org/10.1371/journal.pone.0066675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826110	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400030
J	Goldeck, D; Larbi, A; Pellicano, M; Alam, I; Zerr, I; Schmidt, C; Fulop, T; Pawelec, G				Goldeck, David; Larbi, Anis; Pellicano, Mariavaleria; Alam, Iftikhar; Zerr, Inga; Schmidt, Christian; Fulop, Tamas; Pawelec, Graham			Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; T-CELLS; AMYLOID-BETA; TRANSENDOTHELIAL MIGRATION; TRANSPORTER EXPRESSION; FUNCTIONAL EXPRESSION; ACCUMULATION; RECRUITMENT; MACROPHAGES	Although primarily a neurological complaint, systemic inflammation is present in Alzheimer's Disease, with higher than normal levels of proinflammatory cytokines and chemokines in the periphery as well as the brain. A gradient of these factors may enhance recruitment of activated immune cells into the brain via chemotaxis. Here, we investigated the phenotypes of circulating immune cells in AD patients with multi-colour flow cytometry to determine whether their expression of chemokine receptors is consistent with this hypothesis. In this study, we confirmed our previously reported data on the shift of early-to late-differentiated CD4+ T-cells in AD patients. The percentage of cells expressing CD25, a marker of acute T-cell activation, was higher in patients than in age-matched controls, and percentages of CCR6+ cells were elevated. This chemokine receptor is primarily expressed on pro-inflammatory memory cells and Th17 cells. The proportion of cells expressing CCR4 (expressed on Th2 cells) and CCR5 (Th1 cells and dendritic cells) was also greater in patients, and was more pronounced on CD4+ than CD8+ T-cells. These findings allow a more detailed insight into the systemic immune status of patients with Alzheimer's disease and suggest possible novel targets for immune therapy.	[Goldeck, David; Pellicano, Mariavaleria; Alam, Iftikhar; Pawelec, Graham] Univ Tubingen, Med Res Ctr, Tubingen Ageing & Tumour Immunol Grp, Tubingen, Germany; [Larbi, Anis] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore, Singapore; [Alam, Iftikhar] Abdul Wali Khan Univ, Mardan, Pakistan; [Zerr, Inga; Schmidt, Christian] Univ Gottingen, Univ Med Sch, Dept Neurol, Clin Dementia Ctr, D-37073 Gottingen, Germany; [Fulop, Tamas] Univ Sherbrooke, Res Ctr Aging, Fac Med, Immunol Program,Geriatr Div, Sherbrooke, PQ J1K 2R1, Canada	Eberhard Karls University of Tubingen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Abdul Wali Khan University; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sherbrooke	Goldeck, D (corresponding author), Univ Tubingen, Med Res Ctr, Tubingen Ageing & Tumour Immunol Grp, Tubingen, Germany.	david.goldeck@medizin.uni-tuebingen.de	Larbi, Anis/ABE-5868-2020; Pawelec, Graham/H-2713-2019	Pawelec, Graham/0000-0002-3600-0163; alam, iftikhar/0000-0002-9014-4002	Tubingen University Medical School Fortune Program [1732-0-0]; Deutsche Forschungsgemeinschaft (Graduate School) [GK 794, PA 361-14/1]; Canadian Institutes of Health Research (CIHR) [106634]; Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia [KNDD-2, 2012-2015, 01GI1010C]	Tubingen University Medical School Fortune Program; Deutsche Forschungsgemeinschaft (Graduate School)(German Research Foundation (DFG)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia	This work was supported by the Tubingen University Medical School Fortune Program (grant no. 1732-0-0), the Deutsche Forschungsgemeinschaft (Graduate School GK 794; PA 361-14/1), and grants from the Canadian Institutes of Health Research (CIHR, grant No. 106634). The recruitment of clinical study patients was supported by a Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia (KNDD-2, 2012-2015, determinants for disease progression in AD, grant No. 01GI1010C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM I, 2012, AGE; Alam I, 2012, J IMMUNOASS IMMUNOCH, V33, P128, DOI 10.1080/15321819.2011.604370; Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Alter A, 2003, J IMMUNOL, V170, P4497, DOI 10.4049/jimmunol.170.9.4497; Buffa S, 2011, J NEUROIMMUNOL, V242, P52; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Correa JD, 2011, ARQ NEURO-PSIQUIAT, V69, P455, DOI 10.1590/S0004-282X2011000400009; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Glass WG, 2003, J VIROL, V77, P191, DOI 10.1128/JVI.77.1.191-198.2003; Kovac A, 2009, J ALZHEIMERS DIS, V18, P897, DOI 10.3233/JAD-2009-1197; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Lee KS, 2009, DEMENT GERIATR COGN, V28, P281, DOI 10.1159/000245156; Lee YK, 2009, NEUROBIOL LEARN MEM, V92, P356, DOI 10.1016/j.nlm.2009.04.003; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Man SM, 2007, NEUROBIOL AGING, V28, P485, DOI 10.1016/j.neurobiolaging.2006.02.013; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P98, DOI 10.1097/NEN.0b013e3181c8ad2f; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Subramanian S, 2010, J ALZHEIMERS DIS, V22, P619, DOI 10.3233/JAD-2010-100852; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66664	10.1371/journal.pone.0066664	http://dx.doi.org/10.1371/journal.pone.0066664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824053	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400144
J	Jakobsen, MR; Cashin, K; Roche, M; Sterjovski, J; Ellett, A; Borm, K; Flynn, J; Erikstrup, C; Gouillou, M; Gray, LR; Saksena, NK; Wang, B; Purcell, DFJ; Kallestrup, P; Zinyama-Gutsire, R; Gomo, E; Ullum, H; Ostergaard, L; Lee, B; Ramsland, PA; Churchill, MJ; Gorry, PR				Jakobsen, Martin R.; Cashin, Kieran; Roche, Michael; Sterjovski, Jasminka; Ellett, Anne; Borm, Katharina; Flynn, Jacqueline; Erikstrup, Christian; Gouillou, Maelenn; Gray, Lachlan R.; Saksena, Nitin K.; Wang, Bin; Purcell, Damian F. J.; Kallestrup, Per; Zinyama-Gutsire, Rutendo; Gomo, Exnevia; Ullum, Henrik; Ostergaard, Lars; Lee, Benhur; Ramsland, Paul A.; Churchill, Melissa J.; Gorry, Paul R.			Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naive Subjects with Progressive HIV-1 Subtype C Infection	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; CORECEPTOR USAGE; MACROPHAGE TROPISM; FUNCTIONAL-ANALYSIS; LYMPHOID-TISSUES; RURAL ZIMBABWE; VIRUS; GP120; CD4; ENTRY	HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-HIV infection. Nor do we completely understand the molecular determinants of coreceptor switching by C-HIV variants. Here, we characterized a panel of HIV-1 envelope glycoproteins (Envs) (n = 300) cloned sequentially from plasma of 21 antiretroviral therapy (ART)-naive subjects who experienced progression from chronic to advanced stages of C-HIV infection, and show that CXCR4-using C-HIV variants emerged in only one individual. Mutagenesis studies and structural models suggest that the evolution of R5 to X4 variants in this subject principally involved acquisition of an "Ile-Gly'' insertion in the gp120 V3 loop and replacement of the V3 "Gly-Pro-Gly'' crown with a "Gly-Arg-Gly'' motif, but that the accumulation of additional gp120 "scaffold'' mutations was required for these V3 loop changes to confer functional effects. In this context, either of the V3 loop changes could confer possible transitional R5X4 phenotypes, but when present together they completely abolished CCR5 usage and conferred the X4 phenotype. Our results show that the emergence of CXCR4-using strains is rare in this cohort of untreated individuals with advanced C-HIV infection. In the subject where X4 variants did emerge, alterations in the gp120 V3 loop were necessary but not sufficient to confer CXCR4 usage.	[Jakobsen, Martin R.; Cashin, Kieran; Roche, Michael; Sterjovski, Jasminka; Ellett, Anne; Borm, Katharina; Flynn, Jacqueline; Gray, Lachlan R.; Churchill, Melissa J.; Gorry, Paul R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Ramsland, Paul A.] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Gouillou, Maelenn] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Jakobsen, Martin R.; Ostergaard, Lars] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark; [Erikstrup, Christian] Aarhus Univ, Dept Clin Immunol, Aarhus, Denmark; [Ramsland, Paul A.] Univ Melbourne, Dept Surg, Austin Hlth, Melbourne, Vic 3010, Australia; [Cashin, Kieran; Purcell, Damian F. J.; Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Gray, Lachlan R.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Churchill, Melissa J.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Churchill, Melissa J.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gorry, Paul R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Saksena, Nitin K.; Wang, Bin] Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW, Australia; [Kallestrup, Per; Ullum, Henrik] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Zinyama-Gutsire, Rutendo; Gomo, Exnevia] Natl Inst Hlth Res, Harare, Zimbabwe	Burnet Institute; Burnet Institute; Burnet Institute; Aarhus University; Aarhus University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University; Monash University; Monash University; Monash University; Monash University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Sydney; Westmead Institute for Medical Research; Rigshospitalet; University of Copenhagen	Gorry, PR (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	gorry@burnet.edu.au	Lee, Benhur/A-8554-2016; Kallestrup, Per/AAA-8313-2022; Ostergaard, Lars/AAA-3020-2020	Lee, Benhur/0000-0003-0760-1709; Kallestrup, Per/0000-0001-6041-4510; Ostergaard, Lars/0000-0003-2459-0511; Gomo, Exnevia/0000-0003-0891-6251; Ostergaard, Lars/0000-0002-7619-605X; Flynn, Jacqueline/0000-0002-3822-294X; , Martin/0000-0001-8847-9201; Ramsland, Paul/0000-0002-2107-2738; Sterjovski, Jasminka/0000-0002-2471-3000; Churchill, Melissa/0000-0001-5510-7954; Erikstrup, Christian/0000-0001-6551-6647; Gray, Lachlan/0000-0002-9894-1049; Ullum, Henrik/0000-0001-7306-9058; Roche, Michael/0000-0001-8819-0096	Australian National Health and Medical Research Council [543133, 1022066]; Alfred Benzon foundation of Denmark; Aase foundation of Denmark; Ejner Danielsens foundation of Denmark; University of Melbourne Postgraduate Research Scholarship; Victorian International Research Scholarship; Australian National Health and Medical Research Council (NHMRC); Australian NHMRC Level 2 Biomedical Career Development Award; Australian Research Council Future Fellowship [FT2]; Sir Zelman Cowen Fellowship Fund, Burnet Institute	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alfred Benzon foundation of Denmark; Aase foundation of Denmark; Ejner Danielsens foundation of Denmark; University of Melbourne Postgraduate Research Scholarship(University of Melbourne); Victorian International Research Scholarship; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Level 2 Biomedical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Sir Zelman Cowen Fellowship Fund, Burnet Institute	This study was supported by grants from the Australian National Health and Medical Research Council to PRG and MJC (543133 & 1022066). MRJ was supported by grants from the Alfred Benzon and Aase and Ejner Danielsens foundations of Denmark. KC is supported by a University of Melbourne Postgraduate Research Scholarship. KB is supported by a Victorian International Research Scholarship. LRG is the recipient of an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Training Fellowship. PAR is the Sir Zelman Cowen Senior Research Fellow (Sir Zelman Cowen Fellowship Fund, Burnet Institute). PRG was the recipient of an Australian NHMRC Level 2 Biomedical Career Development Award, and is presently supported by an Australian Research Council Future Fellowship (FT2). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bjorndal A, 1997, J VIROL, V71, P7478; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Coetzer M, 2011, JAIDS-J ACQ IMM DEF, V56, P9, DOI 10.1097/QAI.0b013e3181f63906; Connell BJ, 2008, AIDS, V22, P896, DOI 10.1097/QAD.0b013e3282f57f7a; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Creery D, 2006, VIRAL IMMUNOL, V19, P409, DOI 10.1089/vim.2006.19.409; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Erikstrup C, 2008, AM J TROP MED HYG, V79, P331; Erikstrup C, 2007, JAIDS-J ACQ IMM DEF, V44, P478, DOI 10.1097/QAI.0b013e318032bbcd; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gray L, 2006, J VIROL, V80, P3684, DOI 10.1128/JVI.80.7.3684-3691.2006; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Gray L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-42; Gray L, 2009, J VIROL, V83, P5430, DOI 10.1128/JVI.02648-08; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-52; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Jakobsen MR, 2010, FUTURE VIROL, V5, P219, DOI 10.2217/FVL.09.77; Johnston ER, 2003, J VIROL, V77, P7682, DOI 10.1128/JVI.77.13.7682-7688.2003; Kallestrup P, 2005, J INFECT DIS, V191, P1311, DOI 10.1086/428907; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lin NH, 2012, VIROLOGY, V433, P296, DOI 10.1016/j.virol.2012.08.013; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michler K, 2008, AIDS RES HUM RETROV, V24, P743, DOI 10.1089/aid.2007.0304; Nedellec R, 2009, J VIROL, V83, P8353, DOI 10.1128/JVI.00780-09; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Roche M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-89; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salimi H, 2013, J LEUKOCYTE BIOL, V93, P113, DOI 10.1189/jlb.0612308; Secor WE, 2007, CURR OPIN INFECT DIS, V20, P519, DOI 10.1097/QCO.0b013e3282e9ac03; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Sterjovski J, 2011, VIROLOGY, V410, P418, DOI 10.1016/j.virol.2010.12.010; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; *UNAIDS, 2008, 2008 REP GLOB AIDS E; van Rensburg EJ, 2002, AIDS, V16, P2479, DOI [10.1097/00002030-200212060-00015, 10.1097/01.aids.0000042582.93174.df]; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhang H, 2010, VIROLOGY, V407, P68, DOI 10.1016/j.virol.2010.07.047	67	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65950	10.1371/journal.pone.0065950	http://dx.doi.org/10.1371/journal.pone.0065950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824043	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400038
J	Karlep, L; Reintamm, T; Kelve, M				Karlep, Liisi; Reintamm, Tonu; Kelve, Merike			Intragenomic Profiling Using Multicopy Genes: The rDNA Internal Transcribed Spacer Sequences of the Freshwater Sponge Ephydatia fluviatilis	PLOS ONE			English	Article							VERTICAL TRANSMISSION; CELL-ADHESION; DNA; EVOLUTION; PORIFERA; MUTATION; GENOME; RANGE	Multicopy genes, like ribosomal RNA genes (rDNA), are widely used to describe and distinguish individuals. Despite concerted evolution that homogenizes a large number of rDNA gene copies, the presence of different gene variants within a genome has been reported. Characterization of an organism by defining every single variant of tens to thousands of rDNA repeat units present in a eukaryotic genome would be quite unreasonable. Here we provide an alternative approach for the characterization of a set of internal transcribed spacer sequences found within every rDNA repeat unit by implementing direct sequencing methodology. The prominent allelic variants and their relative amounts characterizing an individual can be described by a single sequencing electropherogram of the mixed amplicon containing the variants present within the genome. We propose a method for rational analysis of heterogeneity of multicopy genes by compiling a profile based on quantification of different sequence variants of the internal transcribed spacers of the freshwater sponge Ephydatia fluviatilis as an example. In addition to using conventional substitution analysis, we have developed a mathematical method, the proportion model method, to quantify the relative amounts of allelic variants of different length using data from direct sequencing of the heterogeneous amplicon. This method is based on determining the expected signal intensity values (corresponding to peak heights from the sequencing electropherogram) by sequencing clones from the same or highly similar amplicon and comparing hypothesized combinations against the values obtained by direct sequencing of the heterogeneous amplicon. This method allowed to differentiate between all specimens analysed.	[Karlep, Liisi; Reintamm, Tonu; Kelve, Merike] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Tallinn University of Technology	Kelve, M (corresponding author), Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia.	merike.kelve@ttu.ee			Estonian Ministry of Education and Research [0140108]; Estonian Science Foundation [9185]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This work was supported by the Estonian Ministry of Education and Research (Grant No. 0140108) and the Estonian Science Foundation (Grant No. 9185) (www.etis.ee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amos CI, 2000, AM J HUM GENET, V66, P1689, DOI 10.1086/302894; Andreakis N, 2012, ZOOL J LINN SOC-LOND, V166, P225, DOI 10.1111/j.1096-3642.2012.00848.x; Applied Biosystems, 1998, AUT DNA SEQ CHEM GUI; Blanquer A, 2011, MOL BIOL EVOL, V28, P2435, DOI 10.1093/molbev/msr096; BOND C, 1992, J EXP ZOOL, V263, P284, DOI 10.1002/jez.1402630308; Buckler ES, 1997, GENETICS, V145, P821; BUSCEMA M, 1980, ROUX ARCH DEV BIOL, V188, P45, DOI 10.1007/BF00848609; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Costa R, 2013, MICROB ECOL, V65, P232, DOI 10.1007/s00248-012-0102-2; CURTIS ASG, 1971, J EMBRYOL EXP MORPH, V26, P295; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Fernandez-Busquets X, 1999, MICROSC RES TECHNIQ, V44, P204, DOI 10.1002/(SICI)1097-0029(19990215)44:4<204::AID-JEMT2>3.0.CO;2-I; Funayama N, 2005, DEV GROWTH DIFFER, V47, P243; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gigliarelli L, 2008, HYDROBIOLOGIA, V605, P265, DOI 10.1007/s10750-008-9327-y; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Ishijima J, 2008, ZOOL SCI, V25, P480, DOI 10.2108/zsj.25.480; Itskovich V, 2008, J MOL EVOL, V67, P608, DOI 10.1007/s00239-008-9158-5; Lee OO, 2009, APPL ENVIRON MICROB, V75, P6147, DOI 10.1128/AEM.00023-09; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lopp A, 2007, FUND APPL LIMNOL, V168, P93, DOI 10.1127/1863-9135/2007/0168-0093; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; Rasmont R, 1961, ANN SOC ROY ZOOL BEL, V91, P147; RUTHMANN A, 1965, Q J MICROSC SCI, V106, P99; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simpson TL, 1984, CELL BIOL SPONGES, P662; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; van de Vyver G., 1970, Annls Embryol. Morphogen., V3, P251; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; Wilkening S, 2005, BIOTECHNIQUES, V39, P853, DOI 10.2144/000112027; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; [No title captured]	40	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66601	10.1371/journal.pone.0066601	http://dx.doi.org/10.1371/journal.pone.0066601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825547	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400134
J	Zager, RA; Johnson, ACM; Becker, K				Zager, Richard A.; Johnson, Ali C. M.; Becker, Kirsten			Renal Cortical Lactate Dehydrogenase: A Useful, Accurate, Quantitative Marker of In Vivo Tubular Injury and Acute Renal Failure	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; HEME OXYGENASE-1; MORTALITY; EXPRESSION; NEPHROTOXICITY; MECHANISMS; INFARCTION; INCREASES; OUTCOMES; DEATH	Studies of experimental acute kidney injury (AKI) are critically dependent on having precise methods for assessing the extent of tubular cell death. However, the most widely used techniques either provide indirect assessments (e.g., BUN, creatinine), suffer from the need for semi-quantitative grading (renal histology), or reflect the status of residual viable, not the number of lost, renal tubular cells (e.g., NGAL content). Lactate dehydrogenase (LDH) release is a highly reliable test for assessing degrees of in vitro cell death. However, its utility as an in vivo AKI marker has not been defined. Towards this end, CD-1 mice were subjected to graded renal ischemia (0, 15, 22, 30, 40, or 60 min) or to nephrotoxic (glycerol; maleate) AKI. Sham operated mice, or mice with AKI in the absence of acute tubular necrosis (ureteral obstruction; endotoxemia), served as negative controls. Renal cortical LDH or NGAL levels were assayed 2 or 24 hrs later. Ischemic, glycerol, and maleate-induced AKI were each associated with striking, steep, inverse correlations (r, -0.89) between renal injury severity and renal LDH content. With severe AKI, >65% LDH declines were observed. Corresponding prompt plasma and urinary LDH increases were observed. These observations, coupled with the maintenance of normal cortical LDH mRNA levels, indicated the renal LDH efflux, not decreased LDH synthesis, caused the falling cortical LDH levels. Renal LDH content was well maintained with sham surgery, ureteral obstruction or endotoxemic AKI. In contrast to LDH, renal cortical NGAL levels did not correlate with AKI severity. In sum, the above results indicate that renal cortical LDH assay is a highly accurate quantitative technique for gauging the extent of experimental acute ischemic and toxic renal injury. That it avoids the limitations of more traditional AKI markers implies great potential utility in experimental studies that require precise quantitation of tubule cell death.	[Zager, Richard A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Zager, Richard A.; Johnson, Ali C. M.; Becker, Kirsten] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Zager, RA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	dzager@fhcrc.org			National Institutes of Health [DK-38432, DK083310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (DK-38432; DK083310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Huang CC, 2007, AM J EMERG MED, V25, P164, DOI 10.1016/j.ajem.2006.06.010; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Liu NN, 2000, GENE, V241, P175, DOI 10.1016/S0378-1119(99)00439-4; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2013, AM J PHYSIOL-RENAL, V304, pF317, DOI 10.1152/ajprenal.00606.2012; Rudnick MR, 1997, SEMIN NEPHROL, V17, P15; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Seta F, 2006, AM J PATHOL, V169, P1612, DOI 10.2353/ajpath.2006.060555; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WEINBERG JM, 1994, J AM SOC NEPHROL, V5, P1314; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zager RA, 2002, AM J KIDNEY DIS, V40, P90, DOI 10.1053/ajkd.2002.33917; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; ZAGER RA, 1989, LAB INVEST, V61, P290; Zager RA, 2008, KIDNEY INT, V74, P674, DOI 10.1038/ki.2008.251; Zager RA, 2008, AM J PHYSIOL-RENAL, V294, pF187, DOI 10.1152/ajprenal.00434.2007; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zager RA, 2009, AM J PHYSIOL-RENAL, V296, pF362, DOI 10.1152/ajprenal.90645.2008	25	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66776	10.1371/journal.pone.0066776	http://dx.doi.org/10.1371/journal.pone.0066776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825563	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400158
J	Jung, J; Sethi, A; Gaiotto, T; Han, JJ; Jeoh, T; Gnanakaran, S; Goodwin, PM				Jung, Jaemyeong; Sethi, Anurag; Gaiotto, Tiziano; Han, Jason J.; Jeoh, Tina; Gnanakaran, Sandrasegaram; Goodwin, Peter M.			Binding and Movement of Individual Cel7A Cellobiohydrolases on Crystalline Cellulose Surfaces Revealed by Single-molecule Fluorescence Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLULASES; ENZYMATIC-HYDROLYSIS; 1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE; LIMITED PROTEOLYSIS; SUBSTRATE; ENZYMES; DOMAIN; ADSORPTION; KINETICS; PROBES	The efficient catalytic conversion of biomass to bioenergy would meet a large portion of energy requirements in the near future. A crucial step in this process is the enzyme-catalyzed hydrolysis of cellulose to glucose that is then converted into fuel such as ethanol by fermentation. Here we use single-molecule fluorescence imaging to directly monitor the movement of individual Cel7A cellobiohydrolases from Trichoderma reesei (TrCel7A) on the surface of insoluble cellulose fibrils to elucidate molecular level details of cellulase activity. The motion of multiple, individual TrCel7A cellobiohydrolases was simultaneously recorded with similar to 15-nm spatial resolution. Time-resolved localization microscopy provides insights on the activity of TrCel7A on cellulose and informs on nonproductive binding and diffusion. Wemeasured single-molecule residency time distributions of TrCel7A bound to cellulose both in the presence of and absence of cellobiose the major product and a potent inhibitor of Cel7A activity. Combining these results with a kinetic model of TrCel7A binding provides microscopic insight into interactions between TrCel7A and the cellulose substrate.	[Jung, Jaemyeong; Han, Jason J.; Goodwin, Peter M.] Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87544 USA; [Sethi, Anurag; Gnanakaran, Sandrasegaram] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Gaiotto, Tiziano] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA; [Jeoh, Tina] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Davis	Goodwin, PM (corresponding author), Los Alamos Natl Lab, Mail Stop K771, Los Alamos, NM 87545 USA.	pmg@lanl.gov		Jeoh, Tina/0000-0002-0727-4237; Gnanakaran, S/0000-0002-9368-3044	Los Alamos National Laboratory Directed Research and Development Exploratory Research Grant [20100129ER]; U.S. Department of Energy [DE-AC52-06NA25396]; Div Of Chem, Bioeng, Env, & Transp Sys [1055518] Funding Source: National Science Foundation	Los Alamos National Laboratory Directed Research and Development Exploratory Research Grant(United States Department of Energy (DOE)Los Alamos National Laboratory); U.S. Department of Energy(United States Department of Energy (DOE)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by Los Alamos National Laboratory Directed Research and Development Exploratory Research Grant 20100129ER and U.S. Department of Energy Contract DE-AC52-06NA25396. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science.	[Anonymous], 2006, DEC 2005 WORKSH; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; CHANZY H, 1984, FEBS LETT, V172, P193, DOI 10.1016/0014-5793(84)81124-2; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; CHERNOGLAZOV VM, 1989, ANAL BIOCHEM, V179, P186, DOI 10.1016/0003-2697(89)90222-4; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Helbert W, 2003, BIOMACROMOLECULES, V4, P481, DOI 10.1021/bm020076i; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2002, BIOTECHNOL PROGR, V18, P760, DOI 10.1021/bp0200402; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lavenson DM, 2011, CELLULOSE, V18, P1543, DOI 10.1007/s10570-011-9588-x; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Medve J, 1998, J CHROMATOGR A, V808, P153, DOI 10.1016/S0021-9673(98)00132-0; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Sangseethong K, 1998, CARBOHYD RES, V314, P245, DOI 10.1016/S0008-6215(98)00294-8; Santa-Maria M, 2010, BIOMACROMOLECULES, V11, P2000, DOI 10.1021/bm100366h; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	35	32	32	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24164	24172		10.1074/jbc.M113.455758	http://dx.doi.org/10.1074/jbc.M113.455758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818525	Green Published, hybrid			2022-12-25	WOS:000330611400055
J	Lu, YX; Denlinger, DL; Xu, WH				Lu, Yu-Xuan; Denlinger, David L.; Xu, Wei-Hua			Polycomb Repressive Complex 2 (PRC2) Protein ESC Regulates Insect Developmental Timing by Mediating H3K27me3 and Activating Prothoracicotropic Hormone Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; ELEGANS LIFE-SPAN; COTTON BOLLWORM; DIAPAUSE; CHROMATIN; ENHANCER; DISTINCT; BINDING	The decision made by insects to develop into adults or halt development (enter diapause and prolong lifespan) is commonly based on environmental signals that provide reliable predictors of future seasons of adversity. For example, the short day lengths of early autumn accurately foretell the advent of winter, but little is known about the molecular mechanisms that preside over the hormonal events dictating whether the insect proceeds with development or enters diapause. In Helicoverpa armigera we show that day length affects H3K27me3 by affecting polycomb repressive complex 2 (PRC2) protein extra sex comb (ESC) and regulates the prothoracicotropic hormone (PTTH) gene, thus directly influencing developmental timing. ESC expression in brains of developing (nondiapause) pupae is higher than in brains from diapausing pupae. High ESC expression is localized in two pairs of PTTH neurosecretory cells, and H3K27me3 recruits on the PTTH promoter. Double strand ESC and PRC2 inhibitor (DzNep) treatment in vitro show that ESC triggers PTTH promoter activity, which in turn depends on PRC2 methyltransferase activity. Injection of DzNep into pupae programmed for development reduces the H3K27me3 mark and PTTH gene expression, thereby delaying development. Although ESC is best known as a transcriptional repressor, our results show that ESC prompts development and metamorphosis. We believe this is the first report showing that the PRC2 complex functions as an activator and that a low level of H3K27me3 can prolong lifespan (i.e. induce diapause) by controlling PTTH gene expression in insects.	[Lu, Yu-Xuan; Xu, Wei-Hua] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China; [Denlinger, David L.] Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA; [Denlinger, David L.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	Sun Yat Sen University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Denlinger, DL (corresponding author), Ohio State Univ, Dept Entomol, 318 West 12th Ave, Columbus, OH 43210 USA.	denlinger.1@osu.edu; xuweihua@mail.sysu.edu.cn	Lu, Yu-Xuan/GYU-8582-2022; Lu, Yu-Xuan/AHE-5003-2022	Lu, Yu-Xuan/0000-0001-6751-5250; Xu, wei-hua/0000-0003-1696-3330	Natural Scientific Foundation of China [31230066]; National Basic Research Program of China, Ministry of Science and Technology [2012CB114101]; United States Department of Agriculture National Institute of Food and Agriculture Grant [2011-67013-30199]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China, Ministry of Science and Technology; United States Department of Agriculture National Institute of Food and Agriculture Grant	This work was supported by Natural Scientific Foundation of China Grant-in-aid 31230066, National Basic Research Program of China, Ministry of Science and Technology Grant 2012CB114101 (to W.-H. X.), and United States Department of Agriculture National Institute of Food and Agriculture Grant 2011-67013-30199 (D. L. D.).	Bao B, 2011, INSECT BIOCHEM MOLEC, V41, P670, DOI 10.1016/j.ibmb.2011.04.009; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Denlinger DL., 2004, COMP MOL INSECT SCI, V3, P615; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Hou CL, 2007, CHINESE SCI BULL, V52, P2095, DOI 10.1007/s11434-007-0310-1; Hu Patrick J, 2007, WormBook, P1; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Ohtsuka K, 2011, INSECT BIOCHEM MOLEC, V41, P356, DOI 10.1016/j.ibmb.2011.02.002; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; PHILLIPS JR, 1966, ANN ENTOMOL SOC AM, V59, P154, DOI 10.1093/aesa/59.1.154; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tian R, 2013, J INSECT PHYSIOL, V59, P588, DOI 10.1016/j.jinsphys.2013.03.006; Tie F, 2005, BIOCHEM BIOPH RES CO, V332, P622, DOI 10.1016/j.bbrc.2005.04.157; Tie F, 1998, DEVELOPMENT, V125, P3483; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Wei ZJ, 2011, MOL BIOL REP, V38, P1121, DOI 10.1007/s11033-010-0209-9; Wei ZJ, 2005, J INSECT PHYSIOL, V51, P691, DOI 10.1016/j.jinsphys.2005.03.005; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Q, 2012, J PROTEOME RES, V11, P1042, DOI 10.1021/pr200796a; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003273	43	27	31	5	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23554	23564		10.1074/jbc.M113.482497	http://dx.doi.org/10.1074/jbc.M113.482497			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814061	Green Published, hybrid			2022-12-25	WOS:000330598200059
J	Chen, Y; Yang, L; Ding, YF; Zhang, SY; He, T; Mao, FL; Zhang, CY; Zhang, HN; Huo, CX; Liu, PS				Chen, Yong; Yang, Li; Ding, Yunfeng; Zhang, Shuyan; He, Tong; Mao, Fenglou; Zhang, Congyan; Zhang, Huina; Huo, Chaoxing; Liu, Pingsheng			Tracing Evolutionary Footprints to Identify Novel Gene Functional Linkages	PLOS ONE			English	Article							LIPID DROPLETS; COMPARATIVE GENOMICS; IDENTIFICATION; PROTEIN; FUSION; SNARE; ANNOTATION; CHROMOSOME; INSIGHTS; DNA	Systematic determination of gene function is an essential step in fully understanding the precise contribution of each gene for the proper execution of molecular functions in the cell. Gene functional linkage is defined as to describe the relationship of a group of genes with similar functions. With thousands of genomes sequenced, there arises a great opportunity to utilize gene evolutionary information to identify gene functional linkages. To this end, we established a computational method (called TRACE) to trace gene footprints through a gene functional network constructed from 341 prokaryotic genomes. TRACE performance was validated and successfully tested to predict enzyme functions as well as components of pathway. A so far undescribed chromosome partitioning-like protein ro03654 of an oleaginous bacteria Rhodococcus sp. RHA1 (RHA1) was predicted and verified experimentally with its deletion mutant showing growth inhibition compared to RHA1 wild type. In addition, four proteins were predicted to act as prokaryotic SNARE-like proteins, and two of them were shown to be localized at the plasma membrane. Thus, we believe that TRACE is an effective new method to infer prokaryotic gene functional linkages by tracing evolutionary events.	[Chen, Yong; Yang, Li; Ding, Yunfeng; Zhang, Shuyan; Zhang, Congyan; Zhang, Huina; Huo, Chaoxing; Liu, Pingsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Yang, Li; Zhang, Congyan; Huo, Chaoxing] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Tong] Cent Univ Finance & Econ, Sch Appl Math, Beijing, Peoples R China; [Mao, Fenglou] Univ Georgia, Inst Bioinformat, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central University of Finance & Economics; University System of Georgia; University of Georgia	Chen, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	yongchen@tsinghua.edu.cn; pliu@ibp.ac.cn	Zhang, Congyan/HHC-8442-2022; Zhang, Hui/HHN-8494-2022		Ministry of Science and Technology of China [2009CB919000, 2011CBA00906]; National Natural Science Foundation of China [30971431, 31100068, 61273228]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China (2009CB919000, 2011CBA00906), and the National Natural Science Foundation of China (30971431, 31100068, 61273228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brouwer RW, 2008, BRIEF BIOINFORM; Chen Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S1; Chuang LY, 2010, BIOINFORMATICS, V26, P3127, DOI 10.1093/bioinformatics/btq601; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; DEAZEVEDO JA, 1994, EUR J OPER RES, V73, P188, DOI 10.1016/0377-2217(94)90162-7; Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Egan AN, 2010, SYST BIOL, V59, P534, DOI 10.1093/sysbio/syq041; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Ghosh SK, 2006, ANNU REV BIOCHEM, V75, P211, DOI 10.1146/annurev.biochem.75.101304.124037; Hernandez MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-600; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karimpour-Fard A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-397; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kuroda Makoto, 2004, Methods Mol Biol, V266, P29; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Moscoso M, 1997, J MOL BIOL, V268, P840, DOI 10.1006/jmbi.1997.1012; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Pejaver VR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S2; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Powell BC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-31; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Ta HX, 2011, BIOINFORMATICS, V27, P700, DOI 10.1093/bioinformatics/btq705; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-80; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yang Y, 2010, BIOINFORMATICS, V26, P22, DOI 10.1093/bioinformatics/btp613; Yelton AP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002230	54	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66817	10.1371/journal.pone.0066817	http://dx.doi.org/10.1371/journal.pone.0066817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825567	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000029
J	Desestret, V; Riou, A; Chauveau, F; Cho, TH; Devillard, E; Marinescu, M; Ferrera, R; Rey, C; Chanal, M; Angoulvant, D; Honnorat, J; Nighoghossian, N; Berthezene, Y; Nataf, S; Wiart, M				Desestret, Virginie; Riou, Adrien; Chauveau, Fabien; Cho, Tae-Hee; Devillard, Emilie; Marinescu, Marilena; Ferrera, Rene; Rey, Catherine; Chanal, Marie; Angoulvant, Denis; Honnorat, Jerome; Nighoghossian, Norbert; Berthezene, Yves; Nataf, Serge; Wiart, Marlene			In Vitro and In Vivo Models of Cerebral Ischemia Show Discrepancy in Therapeutic Effects of M2 Macrophages	PLOS ONE			English	Article							CELLS; POLARIZATION; STROKE; ACTIVATION; EXPRESSION; MICROGLIA; MECHANISM; DYNAMICS; INJURY	The inflammatory response following ischemic stroke is dominated by innate immune cells: resident microglia and blood-derived macrophages. The ambivalent role of these cells in stroke outcome might be explained in part by the acquisition of distinct functional phenotypes: classically (M1) and alternatively activated (M2) macrophages. To shed light on the crosstalk between hypoxic neurons and macrophages, an in vitro model was set up in which bone marrow-derived macrophages were co-cultured with hippocampal slices subjected to oxygen and glucose deprivation. The results showed that macrophages provided potent protection against neuron cell loss through a paracrine mechanism, and that they expressed M2-type alternative polarization. These findings raised the possibility of using bone marrow-derived M2 macrophages in cellular therapy for stroke. Therefore, 2 million M2 macrophages (or vehicle) were intravenously administered during the subacute stage of ischemia (D4) in a model of transient middle cerebral artery occlusion. Functional neuroscores and magnetic resonance imaging endpoints (infarct volumes, blood-brain barrier integrity, phagocytic activity assessed by iron oxide uptake) were longitudinally monitored for 2 weeks. This cell-based treatment did not significantly improve any outcome measure compared with vehicle, suggesting that this strategy is not relevant to stroke therapy.	[Desestret, Virginie; Riou, Adrien; Chauveau, Fabien; Cho, Tae-Hee; Marinescu, Marilena; Nighoghossian, Norbert; Berthezene, Yves; Wiart, Marlene] CREATIS, INSA Lyon, INSERM, CNRS,UMR 5220, Lyon, France; [Desestret, Virginie; Cho, Tae-Hee; Angoulvant, Denis; Honnorat, Jerome; Nighoghossian, Norbert; Berthezene, Yves; Nataf, Serge] Lyon Univ Hosp, Hosp Civils Lyon, Lyon, France; [Desestret, Virginie; Cho, Tae-Hee; Ferrera, Rene; Angoulvant, Denis; Honnorat, Jerome; Nighoghossian, Norbert; Berthezene, Yves; Nataf, Serge] Univ Lyon, Lyon, France; [Devillard, Emilie; Honnorat, Jerome; Nataf, Serge] CRNL, INSERM, U1028, CNRS,UMR 5292, Lyon, France; [Ferrera, Rene; Angoulvant, Denis] INSERM, U886, F-69008 Lyon, France; [Rey, Catherine] ProfilXpert, Univ INSERM US7, UMS CNRS 3453, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm)	Wiart, M (corresponding author), CREATIS, INSA Lyon, INSERM, CNRS,UMR 5220, Lyon, France.	marlene.wiart@creatis.insa-lyon.fr	Cho, Tae-Hee/I-5491-2014; Chauveau, Fabien/I-9722-2014; Honnorat, jerome/G-6394-2017; Angoulvant, Denis/Q-9743-2019; Chauveau, Fabien/T-4295-2019; Wiart, Marlene/K-3839-2014; Cho, Tae-Hee/GOJ-9942-2022; Nighoghossian, Norbert/H-7492-2014; Desestret, Virginie/H-9056-2017; Berthezene, yves/I-5689-2014	Cho, Tae-Hee/0000-0001-8677-2447; Chauveau, Fabien/0000-0002-4177-741X; Honnorat, jerome/0000-0002-4721-5952; Angoulvant, Denis/0000-0003-0788-8092; Chauveau, Fabien/0000-0002-4177-741X; Wiart, Marlene/0000-0003-0326-7002; 	ANR; Fondation pour la Recherche pour le Cerveau (FRC); Rhone-Alpes Region [11]	ANR(French National Research Agency (ANR)); Fondation pour la Recherche pour le Cerveau (FRC); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes)	This work was supported by the ANR "INFLAM" and a grant from the Fondation pour la Recherche pour le Cerveau (FRC). AR was supported by a grant from the Rhone-Alpes Region (Cluster 11). MRI experiments were performed on the "Animage" platform of Centre d'Exploration et de Recherche Medicale par Emission de Positons (CERMEP) -Imagerie du Vivant, Lyon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUMONT M, 2009, J CEREB BLOOD FLOW M, V8, P8; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Hicks A, 2009, CELL STEM CELL, V5, P139, DOI 10.1016/j.stem.2009.07.009; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Riou A, 2013, NMR BIOMED, V26, P115, DOI 10.1002/nbm.2826; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Wagner DC, 2012, NEUROIMAGE, V61, P780, DOI 10.1016/j.neuroimage.2012.04.023; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863	29	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67063	10.1371/journal.pone.0067063	http://dx.doi.org/10.1371/journal.pone.0067063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825621	gold, Green Published			2022-12-25	WOS:000321223000073
J	Hu, XJ; Zhao, DZ; Strotmann, A				Hu, Xiaojun; Zhao, Dangzhi; Strotmann, Andreas			Mapping Molecular Association Networks of Nervous System Diseases via Large-Scale Analysis of Published Research	PLOS ONE			English	Article							PARKINSONS-DISEASE; INFORMATION-SCIENCE; PROTEIN; MEDICINE; AUTHOR; GENOTYPE	Network medicine has been applied successfully to elicit the structure of large-scale molecular interaction networks. Its main proponents have claimed that this approach to integrative medical investigation should make it possible to identify functional modules of interacting molecular biological units as well as interactions themselves. This paper takes a significant step in this direction. Based on a large-scale analysis of the nervous system molecular medicine literature, this study analyzes and visualizes the complex structure of associations between diseases on the one hand and all types of molecular substances on the other. From this analysis it then identifies functional co-association groups consisting of several types of molecular substances, each consisting of substances that exhibit a pattern of frequent co-association with similar diseases. These groups in turn exhibit interlinking in a complex pattern, suggesting that such complex interactions between functional molecular modules may play a role in disease etiology. We find that the patterns exhibited by the networks of disease - molecular substance associations studied here correspond well to a number of recently published research results, and that the groups of molecular substances identified by statistical analysis of these networks do appear to be interesting groups of molecular substances that are interconnected in identifiable and interpretable ways. Our results not only demonstrate that networks are a convenient framework to analyze and visualize large-scale, complex relationships among molecular networks and diseases, but may also provide a conceptual basis for bridging gaps in experimental and theoretical knowledge.	[Hu, Xiaojun] Zhejiang Univ, Sch Med, Med Informat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Dangzhi] Univ Alberta, Sch Lib & Informat Studies, Edmonton, AB, Canada; [Strotmann, Andreas] GESIS Leibniz Inst Social Sci, Cologne, Germany	Zhejiang University; University of Alberta; Leibniz Institut fur Sozialwissenschaften (GESIS)	Hu, XJ (corresponding author), Zhejiang Univ, Sch Med, Med Informat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	xihu@zju.edi.cn	Strotmann, Andreas/P-5891-2017	Strotmann, Andreas/0000-0002-0679-6498				Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; ALS, 2012, STRUCT 3 MEMBR TRANS; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barbosa-Silva A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-435; Batagelj V., 2003, PAJEK ANAL VISUALIZA; Brown DR, 2000, BIOCHEM J, V352, P511, DOI 10.1042/0264-6021:3520511; Chava KR, 2012, BLOOD, V119, P308, DOI 10.1182/blood-2011-02-339473; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Cohen S, 2008, SCIENCE, V320, P1172, DOI 10.1126/science.1159146; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; DAVIDOFF F, 1995, BRIT MED J, V310, P1085, DOI 10.1136/bmj.310.6987.1085; Dias N, 2002, MOL CANCER THER, V1, P347; Farmer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041750; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hair J.F., 1998, PEARSON LOND, V5th; Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Isserlin R, 2007, PROTEOM CLIN APPL, V1, P1156, DOI 10.1002/prca.200700146; Komotar RJ, 2011, NEUROSURGERY, V68, pN14, DOI 10.1227/01.neu.0000398206.71573.50; Larner AJ, 2009, J ALZHEIMERS DIS, V17, P259, DOI 10.3233/JAD-2009-1042; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Margineanu DG, 2012, EPILEPSY RES, V98, P104, DOI 10.1016/j.eplepsyres.2011.10.006; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Mueller Wolf C, 2009, Recent Results Cancer Res, V171, P217, DOI 10.1007/978-3-540-31206-2_13; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Olanow CW, 2011, MOVEMENT DISORD, V26, P1056, DOI 10.1002/mds.23767; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Poston KL, 2012, NEUROLOGY, V78, P1237, DOI 10.1212/WNL.0b013e318250d7fd; Riemenschneider MJ, 2010, TARGET ONCOL, V5, P161, DOI 10.1007/s11523-010-0153-6; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Sakoguchi Tetsuhiko, 2012, Hiroshima Journal of Medical Sciences, V61, P1; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wolk DA, 2010, P NATL ACAD SCI USA, V107, P10256, DOI 10.1073/pnas.1001412107; Yates D, 2012, NAT REV NEUROSCI, V13, P290, DOI [10.1038/nrn3235, 10.1038/nrn3248, 10.1038/nrd3731]; Zhao DZ, 2008, J AM SOC INF SCI TEC, V59, P2070, DOI 10.1002/asi.20910; Zhao DZ, 2008, J INFORMETR, V2, P229, DOI 10.1016/j.joi.2008.05.004; Zhao DZ, 2008, J AM SOC INF SCI TEC, V59, P916, DOI 10.1002/asi.20799; Zhao DZ, 2011, J AM SOC INF SCI TEC, V62, P654, DOI 10.1002/asi.21495; Zhao ZM, 2012, CHEM BIODIVERS, V9, P841, DOI 10.1002/cbdv.201100396; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	48	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67121	10.1371/journal.pone.0067121	http://dx.doi.org/10.1371/journal.pone.0067121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825632	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000082
J	Olsen, KS; Fenton, C; Froyland, L; Waaseth, M; Paulssen, RH; Lund, E				Olsen, Karina Standahl; Fenton, Christopher; Froyland, Livar; Waaseth, Marit; Paulssen, Ruth H.; Lund, Eiliv			Plasma Fatty Acid Ratios Affect Blood Gene Expression Profiles - A Cross-Sectional Study of the Norwegian Women and Cancer Post-Genome Cohort	PLOS ONE			English	Article							GROWTH-FACTOR; CARDIOVASCULAR-DISEASE; RISK; N-3; AUTOPHAGY; FISH; EPIDEMIOLOGY; MODULATION; RECEPTOR; MIR-296	High blood concentrations of n-6 fatty acids (FAs) relative to n-3 FAs may lead to a "physiological switch" towards permanent low-grade inflammation, potentially influencing the onset of cardiovascular and inflammatory diseases, as well as cancer. To explore the potential effects of FA ratios prior to disease onset, we measured blood gene expression profiles and plasma FA ratios (linoleic acid/alpha-linolenic acid, LA/ALA; arachidonic acid/eicosapentaenoic acid, AA/EPA; and total n-6/n-3) in a cross-section of middle-aged Norwegian women (n = 227). After arranging samples from the highest values to the lowest for all three FA ratios (LA/ALA, AA/EPA and total n-6/n-3), the highest and lowest deciles of samples were compared. Differences in gene expression profiles were assessed by single-gene and pathway-level analyses. The LA/ALA ratio had the largest impact on gene expression profiles, with 135 differentially expressed genes, followed by the total n-6/n-3 ratio (125 genes) and the AA/EPA ratio (72 genes). All FA ratios were associated with genes related to immune processes, with a tendency for increased pro-inflammatory signaling in the highest FA ratio deciles. Lipid metabolism related to peroxisome proliferator-activated receptor gamma (PPAR gamma) signaling was modified, with possible implications for foam cell formation and development of cardiovascular diseases. We identified higher expression levels of several autophagy marker genes, mainly in the lowest LA/ALA decile. This finding may point to the regulation of autophagy as a novel aspect of FA biology which warrants further study. Lastly, all FA ratios were associated with gene sets that included targets of specific microRNAs, and gene sets containing common promoter motifs that did not match any known transcription factors. We conclude that plasma FA ratios are associated with differences in blood gene expression profiles in this free-living population, and that affected genes and pathways may influence the onset and progression of disease.	[Olsen, Karina Standahl; Lund, Eiliv] Univ Tromso, Dept Community Med, Tromso, Norway; [Fenton, Christopher; Paulssen, Ruth H.] Univ Tromso, Dept Clin Med, Tromso, Norway; [Froyland, Livar] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Waaseth, Marit] Univ Tromso, Dept Pharm, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Olsen, KS (corresponding author), Univ Tromso, Dept Community Med, Tromso, Norway.	karina.s.olsen@uit.no	Waaseth, Marit/W-6711-2019	Waaseth, Marit/0000-0002-1318-3972; Lund, Eiliv/0000-0002-8071-8711	Norwegian Research Council; University of Tromso	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Tromso	The study was funded by grants from the Norwegian Research Council and the University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2012, PROG LIPID RES, V51, P63, DOI 10.1016/j.plipres.2011.11.005; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Ambring A, 2006, AM J CLIN NUTR, V83, P575, DOI 10.1093/ajcn.83.3.575; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouwens M, 2009, AM J CLIN NUTR AJCN, V2009, P28586; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Brustad M, 2004, EUR J CLIN NUTR, V58, P128, DOI 10.1038/sj.ejcn.1601759; Burdge GC, 2006, BRIT J NUTR, V96, P489, DOI 10.1079/BJN20061877; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Cazzola M, 2011, EUR RESPIR J, V38, P42, DOI 10.1183/09031936.00140310; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; de Aloysio D, 1999, ATHEROSCLEROSIS, V147, P147, DOI 10.1016/S0021-9150(99)00315-9; Dumeaux V, 2008, BIOMARK MED, V2, P11, DOI 10.2217/17520363.2.1.11; Dumeaux V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1859; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Goodstine SL, 2003, J NUTR, V133, P1409; Griffin BA, 2008, CURR OPIN LIPIDOL, V19, P57, DOI 10.1097/MOL.0b013e3282f2e2a8; GUEBREEGZIABHER F, 2007, EUR J CLIN NUTR; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Juhn YJ, 2012, ALLERGY ASTHMA IMMUN, V4, P122, DOI 10.4168/aair.2012.4.3.122; Kalogeropoulos N, 2010, CLIN CHIM ACTA, V411, P584, DOI 10.1016/j.cca.2010.01.023; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; Mauldin JP, 2008, CIRCULATION, V117, P2785, DOI 10.1161/CIRCULATIONAHA.107.741314; Myhrstad MCW, 2011, INFLAMM RES, V60, P309, DOI 10.1007/s00011-010-0302-5; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Rovito D, 2013, J CELL PHYSIOL, V228, P1314, DOI 10.1002/jcp.24288; Sebastiani G, 2011, DIABETES-METAB RES, V27, P862, DOI 10.1002/dmrr.1262; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Waaseth Marit, 2008, BMC Womens Health, V8, P1, DOI 10.1186/1472-6874-8-1; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wan JB, 2010, ARTERIOSCL THROM VAS, V30, P2487, DOI 10.1161/ATVBAHA.110.210054; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Welch AA, 2002, PUBLIC HEALTH NUTR, V5, P1273, DOI 10.1079/PHN2002404; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005	53	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67270	10.1371/journal.pone.0067270	http://dx.doi.org/10.1371/journal.pone.0067270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825649	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000094
J	Sun, J; Zhao, Y; Hu, JH				Sun, Jun; Zhao, Yi; Hu, Jinhong			Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice	PLOS ONE			English	Article							SUPPRESSES CONSTITUTIVE ACTIVATION; CYTOKINE GENE-EXPRESSION; TOPICAL IMMUNOMODULATOR; INTERLEUKIN-17 FAMILY; SKIN INFLAMMATION; 5-PERCENT CREAM; DOUBLE-BLIND; T-CELLS; KAPPA-B; KERATINOCYTES	Curcumin, a selective phosphorylase kinase inhibitor, is a naturally occurring phytochemical present in turmeric. Curcumin has been confirmed to have anti-inflammatory properties in addition to the ability to decrease the expression of pro-inflammatory cytokines in keratinocytes. The interleukin-23 (IL-23)/IL-17A cytokine axis plays a critical role in the pathogenesis of psoriasis. Here, we report that topical use of a curcumin gel formulation strongly inhibited imiquimod (IMQ)-induced psoriasis-like inflammation, the development of which was based on the IL-23/IL-17A axis. IMQ-induced epidermal hyperplasia and inflammation in BALB/c mouse ear was significantly inhibited following curcumin treatment. Real-time PCR showed that mRNA levels of IL-17A, IL-17F, IL-22, IL-1 beta, IL-6 and TNF-alpha cytokines were decreased significantly by curcumin in ear skin, an effect similar to that of clobetasol. In addition, we found that curcumin may enhance the proliferation of epidermis gamma delta T cells but inhibit dermal gamma delta T cell proliferation. We inferred that curcumin was capable of impacting the IL-23/IL-17A axis by inhibiting IL-1 beta/IL-6 and then indirectly down-regulating IL-17A/IL-22 production. In conclusion, curcumin can relieve the IMQ-induced psoriasis-like inflammation in a mouse model, similar to the effects of clobetasol. Therefore, we have every reason to expect that curcumin will be used in the treatment of psoriasis in the future.	[Sun, Jun; Zhao, Yi; Hu, Jinhong] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China	Naval Medical University	Hu, JH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	tudou_2000@yahoo.com.cn			National Natural Science Foundation of China [30873128]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported financially by Grant 30873128 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Beutner Karl R., 1997, American Journal of Medicine, V102, P9; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cho JW, 2007, INT J MOL MED, V19, P469; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Farahani SS, 2010, PATHOL RES PRACT, V206, P151, DOI 10.1016/j.prp.2009.10.006; Fujisawa H, 1996, J INTERF CYTOK RES, V16, P555, DOI 10.1089/jir.1996.16.555; Geisse JK, 2002, J AM ACAD DERMATOL, V47, P390, DOI 10.1067/mjd.2002.126215; Hidaka H, 2002, CANCER-AM CANCER SOC, V95, P1206, DOI 10.1002/cncr.10812; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KONO T, 1994, LYMPHOKINE CYTOK RES, V13, P71; Leverkus M, 1997, EXP CELL RES, V232, P255, DOI 10.1006/excr.1997.3514; Mahaisavariya P, 2000, INT J DERMATOL, V39, P274, DOI 10.1046/j.1365-4362.2000.00908.x; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Szeimies RM, 2004, J AM ACAD DERMATOL, V51, P547, DOI 10.1016/j.jaad.2004.02.022; Tsuruta D, 2009, RECENT PATENTS INFLA, V3, P40, DOI 10.2174/187221309787158399; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	38	118	124	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67078	10.1371/journal.pone.0067078	http://dx.doi.org/10.1371/journal.pone.0067078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825622	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000074
J	Tong, JF; Sydorskyy, Y; St-Germain, JR; Taylor, P; Tsao, MS; Moran, MF				Tong, Jiefei; Sydorskyy, Yaroslav; St-Germain, Jonathan R.; Taylor, Paul; Tsao, Ming S.; Moran, Michael F.			Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SIGNAL-TRANSDUCTION; PHOSPHORYLATION DYNAMICS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; ERBB RECEPTORS; PROTEIN GRB2; HUMAN CANCER; ENDOCYTOSIS; DOMAIN	The ANKS1A gene product, also known as Odin, was first identified as a tyrosine-phosphorylated component of the epidermal growth factor receptor network. Here we show that Odin functions as an effector of EGFR recycling. In EGF-stimulated HEK293 cells tyrosine phosphorylation of Odin was induced prior to EGFR internalization and independent of EGFR-to-ERK signaling. Over-expression of Odin increased EGF-induced EGFR trafficking to recycling endosomes and recycling back to the cell surface, and decreased trafficking to lysosomes and degradation. Conversely, Odin knockdown in both HEK293 and the non-small cell lung carcinoma line RVH6849, which expresses roughly 10-fold more EGF receptors than HEK293, caused decreased EGFR recycling and accelerated trafficking to the lysosome and degradation. By governing the endocytic fate of internalized receptors, Odin may provide a layer of regulation that enables cells to contend with receptor cell densities and ligand concentration gradients that are physiologically and pathologically highly variable.	[Tong, Jiefei; Sydorskyy, Yaroslav; St-Germain, Jonathan R.; Taylor, Paul; Moran, Michael F.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [St-Germain, Jonathan R.; Moran, Michael F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Tsao, Ming S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Tsao, Ming S.] Univ Toronto, Toronto, ON, Canada; [Tsao, Ming S.; Moran, Michael F.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Moran, MF (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	m.moran@utoronto.ca	Tsao, Ming Sound/AFQ-7332-2022; Moran, Michael/GYD-3631-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; 	Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This research was supported by the Canadian Institutes of Health Research, and Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Emaduddin Muhammad, 2008, Cell Commun Signal, V6, P7, DOI 10.1186/1478-811X-6-7; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Imamura H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-232; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kajiho H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030575; Kharchenko MV, 2007, CELL BIOL INT, V31, P349, DOI 10.1016/j.cellbi.2007.01.020; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Kristiansen TZ, 2004, DNA RES, V11, P285; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mercurio FA, 2012, BIOCHEMISTRY-US, V51, P2136, DOI 10.1021/bi300141h; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pandey A, 2002, ONCOGENE, V21, P8029, DOI 10.1038/sj.onc.1205988; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shin J, 2007, MOL CELL BIOL, V27, P8113, DOI 10.1128/MCB.00794-07; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; STEIN BS, 1984, J BIOL CHEM, V259, P4762; STOVER DR, 2004, CLIN PROTEOM, V1, P69; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tong J, 2008, J PROTEOME RES, V7, P1067, DOI 10.1021/pr7006363; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; WILLINGHAM MC, 1983, EXP CELL RES, V146, P163, DOI 10.1016/0014-4827(83)90334-8; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Woodman P, 2009, BIOCHEM SOC T, V37, P146, DOI 10.1042/BST0370146; Wu SL, 2006, MOL CELL PROTEOMICS, V5, P1610, DOI 10.1074/mcp.M600105-MCP200; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhong J, 2011, J PROTEOMICS, V74, P294, DOI 10.1016/j.jprot.2010.11.006; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	59	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e64817	10.1371/journal.pone.0064817	http://dx.doi.org/10.1371/journal.pone.0064817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825523	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000003
J	Li, YY; Zhang, RN; Xiang, HY; Abouelnasr, H; Li, DW; Yu, JL; McBeath, JH; Han, CG				Li, Yuan-Yuan; Zhang, Ru-Nan; Xiang, Hai-Ying; Abouelnasr, Hesham; Li, Da-Wei; Yu, Jia-Lin; McBeath, Jenifer Huang; Han, Cheng-Gui			Discovery and Characterization of a Novel Carlavirus Infecting Potatoes in China	PLOS ONE			English	Article							NUCLEIC-ACID-BINDING; ROUGH-DWARF-VIRUS; PROTEIN; SUPPRESSORS; INDUCTION; STRAINS	A new carlavirus, tentatively named Potato virus H (PVH), was found on potato plants with mild symptoms in Hohhot, Inner Mongolia Autonomous Region, China. PVH was confirmed by genome sequencing, serological reactions, electron microscopy, and host index assays. The PVH particles were filamentous and slightly curved, with a modal length of 570 nm. Complete RNA genomic sequences of two isolates of PVH were determined using reverse transcription-PCR (RT-PCR) and the 5' rapid amplification of cDNA ends (5' RACE) method. Sequence analysis revealed that PVH had the typical genomic organization of members of the genus Carlavirus, with a positive-sense single-stranded genome of 8410 nt. It shared coat protein (CP) and replicase amino acid sequence identities of 17.9-56.7% with those of reported carlaviruses. Phylogenetic analyses based on the protein-coding sequences of replicase and CP showed that PVH formed a distinct branch, which was related only distantly to other carlaviruses. Western blotting assays showed that PVH was not related serologically to other potato carlaviruses (Potato virus S, Potato virus M, and Potato latent virus). PVH systemically infected Nicotiana glutinosa but not Nicotiana tabacum, Nicotiana benthamiana, or Chenopodium quinoa, which is in contrast with the other potato carlaviruses. These results support the classification of PVH as a novel species in the genus Carlavirus. Preliminary results also indicated that a cysteine-rich protein encoded by the smallest ORF located in the 3' proximal region of the genome suppressed local RNA silencing and enhanced the pathogenicity of the recombinant PVX.	[Li, Yuan-Yuan; Zhang, Ru-Nan; Xiang, Hai-Ying; Abouelnasr, Hesham; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Yuan-Yuan; Zhang, Ru-Nan; Xiang, Hai-Ying; Abouelnasr, Hesham; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [McBeath, Jenifer Huang] Univ Alaska Fairbanks, Plant Pathol & Biotechnol Lab, Agr & Forestry Expt Stn, Fairbanks, AK USA	China Agricultural University; China Agricultural University; University of Alaska System; University of Alaska Fairbanks	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hanchenggui@cau.edu.cn	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; LI, YUANYUAN/0000-0001-8615-4374; ABOUELNASR, hesham/0000-0003-2386-8809	National Natural Science Foundation of China [31071663]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by the National Natural Science Foundation of China (31071663) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [白艳菊 BAI Yanju], 2007, [东北农业大学学报, Journal of Northeast Agricultural University], V38, P733; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; BODE O, 1971, Potato Research, V14, P119, DOI 10.1007/BF02361820; Brattey C, 2002, PLANT PATHOL, V51, P495, DOI 10.1046/j.1365-3059.2002.00729.x; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; DEBRUYN MPO, 1951, P C POTATO VIRUS DIS, P83; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Flatken S, 2008, ARCH VIROL, V153, P1385, DOI 10.1007/s00705-008-0127-5; Goth RW, 1999, PLANT DIS, V83, P751, DOI 10.1094/PDIS.1999.83.8.751; GRAMSTAT A, 1990, FEBS LETT, V276, P34, DOI 10.1016/0014-5793(90)80500-I; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARPER S, 1999, CURRENT PROTOCOLS PR; Hen CG, 2000, PLANT DIS, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; Huang Ping, 2009, Guizhou Agricultural Sciences, P88; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; KOONIN EV, 1991, VIROLOGY, V181, P395, DOI 10.1016/0042-6822(91)90512-A; KOSTIW M, 1975, Potato Research, V18, P641, DOI 10.1007/BF02365690; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; [刘洪义 LIU Hongyi], 2006, [东北农业大学学报, Journal of Northeast Agricultural University], V37, P307; Loebenstein G., 2001, VIRUS VIRUS LIKE DIS; Lukhovilskaya NI, 2005, MOL BIOL+, V39, P896; Lukhovitskaya NI, 2009, J GEN VIROL, V90, P723, DOI 10.1099/vir.0.005025-0; LUKHOVITSKAYA NI, 2013, PLANT CELL; MACKINNON JP, 1974, CAN J BOT, V52, P461, DOI 10.1139/b74-060; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Massa GA, 2006, ARCH VIROL, V151, P1243, DOI 10.1007/s00705-006-0760-9; Matousek J, 2009, VIRUS RES, V146, P81, DOI 10.1016/j.virusres.2009.09.003; Nie XZ, 2008, J VIROL METHODS, V149, P209, DOI 10.1016/j.jviromet.2008.02.004; Nisbet C, 2006, PLANT PATHOL, V55, P803, DOI 10.1111/j.1365-3059.2006.01448.x; Nyalugwe EP, 2012, PLANT DIS, V96, P43, DOI 10.1094/PDIS-04-11-0305; Pfeffer S, 2002, J VIROL, V76, P6815, DOI 10.1128/JVI.76.13.6815-6824.2002; ROGER ACJ, 2009, VIRUS DIS PLANTS GRA; Salazar LF, 1996, POTATO VIRUSES THEIR; SCHULTZ E, 1923, AGR RES, V25, P393; Senshu H, 2011, J VIROL, V85, P10269, DOI 10.1128/JVI.05273-11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAVANTZIS SM, 1983, PHYTOPATHOLOGY, V73, P190, DOI 10.1094/Phyto-73-190; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Vreugdenhil D., 2007, POTATO BIOL BIOTECHN; Wang BA, 2011, CROP PROT, V30, P1117, DOI 10.1016/j.cropro.2011.04.001; Wang X.M, 2005, CHIN POTATO J, V19, P285; WETTER C, 1960, POTATO RES, V3, P158; Xiang HY, 2011, ARCH VIROL, V156, P2251, DOI 10.1007/s00705-011-1091-z; Zhang W., 2010, HEILONGJIANG AGR SCI, V4, P71; Zhong TingTing, 2008, Southwest China Journal of Agricultural Sciences, V21, P96; [周巧梅 ZHOU Qiaomei], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P39	51	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e69255	10.1371/journal.pone.0069255	http://dx.doi.org/10.1371/journal.pone.0069255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805334	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500163
J	Lagache, L; Leger, JB; Daudin, JJ; Petit, RJ; Vacher, C				Lagache, Lelia; Leger, Jean-Benoist; Daudin, Jean-Jacques; Petit, Remy J.; Vacher, Corinne			Putting the Biological Species Concept to the Test: Using Mating Networks to Delimit Species	PLOS ONE			English	Article							HYBRIDIZATION; INTROGRESSION; MODEL; INDIVIDUALS; RECOGNITION; DIRECTION	Although interfertility is the key criterion upon which Mayr's biological species concept is based, it has never been applied directly to delimit species under natural conditions. Our study fills this gap. We used the interfertility criterion to delimit two closely related oak species in a forest stand by analyzing the network of natural mating events between individuals. The results reveal two groups of interfertile individuals connected by only few mating events. These two groups were largely congruent with those determined using other criteria (morphological similarity, genotypic similarity and individual relatedness). Our study, therefore, shows that the analysis of mating networks is an effective method to delimit species based on the interfertility criterion, provided that adequate network data can be assembled. Our study also shows that although species boundaries are highly congruent across methods of species delimitation, they are not exactly the same. Most of the differences stem from assignment of individuals to an intermediate category. The discrepancies between methods may reflect a biological reality. Indeed, the interfertility criterion is an environment-dependant criterion as species abundances typically affect rates of hybridization under natural conditions. Thus, the methods of species delimitation based on the interfertility criterion are expected to give results slightly different from those based on environment-independent criteria (such as the genotypic similarity criteria). However, whatever the criterion chosen, the challenge we face when delimiting species is to summarize continuous but non-uniform variations in biological diversity. The grade of membership model that we use in this study appears as an appropriate tool.	[Lagache, Lelia; Petit, Remy J.; Vacher, Corinne] INRA, BIOGECO, UMR1202, Cestas, France; [Lagache, Lelia; Petit, Remy J.; Vacher, Corinne] Univ Bordeaux, BIOGECO, UMR 1202, Talence, France; [Leger, Jean-Benoist; Daudin, Jean-Jacques] INRA, MIA, UMR 518, Paris, France; [Leger, Jean-Benoist; Daudin, Jean-Jacques] AgroParisTech, MIA, UMR 518, Paris, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Vacher, C (corresponding author), INRA, BIOGECO, UMR1202, Cestas, France.	corinne.vacher@pierroton.inra.fr	Vacher, Corinne/Q-3182-2019; Vacher, Corinne/ABG-8163-2020; Petit, Rémy/A-8842-2008; Daudin, Jean-Jacques/A-8582-2008; Vacher, Corinne/J-1777-2012; Petit, Remy/AAD-9078-2019	Vacher, Corinne/0000-0003-3023-6113; Petit, Rémy/0000-0002-4809-1453; Vacher, Corinne/0000-0003-3023-6113; 	LinkTree project (ANR BIODIVERSA); EU Network of Excellence EvolTree; INRA (CJS); Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227];  [ANR-10-EQPX-16 XYLOFOREST]	LinkTree project (ANR BIODIVERSA)(French National Research Agency (ANR)); EU Network of Excellence EvolTree; INRA (CJS); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER; 	Funding was provided by the LinkTree project (ANR BIODIVERSA), by the EU Network of Excellence EvolTree, by ANR-10-EQPX-16 XYLOFOREST and by the INRA (CJS grant). The genotyping was funded by grants from the Conseil Regional d'Aquitaine no20030304002FA, no20040305003FA and from the European Union, FEDER no2003227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilieri R, 1996, EVOLUTION, V50, P900, DOI 10.1111/j.1558-5646.1996.tb03898.x; Bacilieri R, 1996, ANN SCI FOREST, V53, P79, DOI 10.1051/forest:19960106; Batagelj V., 1998, PAJEK PROGRAM LARGE; Coyne JA, 2004, SPECIATION, V37; Daudin JJ, 2010, BIOMETRICS, V66, P1043, DOI 10.1111/j.1541-0420.2009.01378.x; de Meeus T, 2003, TRENDS PARASITOL, V19, P425, DOI 10.1016/S1471-4922(03)00195-8; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; de Queiroz K, 1998, GEN LINEAGE CONCEPT; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dettman JR, 2003, EVOLUTION, V57, P2721; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Field DL, 2008, J ECOL, V96, P1198, DOI 10.1111/j.1365-2745.2008.01434.x; Focke WO, 1881, PFLANZENMISCHLINGE; Fortuna MA, 2008, ECOL LETT, V11, P490, DOI 10.1111/j.1461-0248.2008.01167.x; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FROST DR, 1990, HERPETOLOGICA, V46, P87; Guichoux E, 2013, MOL ECOL, V22, P450, DOI 10.1111/mec.12125; Guichoux E, 2011, MOL ECOL RESOUR, V11, P578, DOI 10.1111/j.1755-0998.2011.02983.x; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; HIBBETT DS, 1995, MYCOLOGIA, V87, P618, DOI 10.2307/3760806; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Lagache L, 2013, MOL ECOL, V22, P423, DOI 10.1111/mec.12121; Legendre G, 1984, ECOLOGIE NUMERIQUE; Leger J-B, 2013, STAT COMPUT IN PRESS; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Lepais O, 2011, EVOLUTION, V65, P156, DOI 10.1111/j.1558-5646.2010.01101.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Marcussen T, 2011, PLANT SYST EVOL, V291, P183, DOI 10.1007/s00606-010-0377-z; Mariadassou M, 2010, ANN APPL STAT, V4, P715, DOI 10.1214/10-AOAS361; Marin J, 2010, ZOOL SCR, V39, P591, DOI 10.1111/j.1463-6409.2010.00450.x; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; Mayr E., 1942, SYSTEMATICS ORIGIN S; MISHLER BD, 1985, BRYOLOGIST, V88, P207, DOI 10.2307/3243030; Moalic Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-33; Nelson G., 1981, SYSTEMATICS BIOGEORA; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noor MAF, 2002, TRENDS ECOL EVOL, V17, P153, DOI 10.1016/S0169-5347(02)02452-7; Orr HA, 2001, J EVOLUTION BIOL, V14, P870, DOI 10.1046/j.1420-9101.2001.00340.x; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Shennan SJ., 2009, INNOVATIONS CULTURAL, P53; Simpson G.G., 1961, PRINCIPLES ANIMAL TA; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; SOKAL RR, 1970, AM NAT, V104, P127, DOI 10.1086/282646; Streiff R, 1998, GENET SEL EVOL, V30, pS137, DOI 10.1051/gse:19980708; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809	55	7	7	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68267	10.1371/journal.pone.0068267	http://dx.doi.org/10.1371/journal.pone.0068267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818990	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800147
J	Stenrod, M; Klemsdal, SS; Norli, HR; Eklo, OM				Stenrod, Marianne; Klemsdal, Sonja S.; Norli, Hans Ragnar; Eklo, Ole Martin			Effects of Picoxystrobin and 4-n-Nonylphenol on Soil Microbial Community Structure and Respiration Activity	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; 4-NONYLPHENOL; NONYLPHENOL; DEGRADATION; DIVERSITY; TOXICITY; FUNGI	There is widespread use of chemical amendments to meet the demands for increased productivity in agriculture. Potentially toxic compounds, single or in mixtures, are added to the soil medium on a regular basis, while the ecotoxicological risk assessment procedures mainly follow a chemical by chemical approach. Picoxystrobin is a fungicide that has caused concern due to studies showing potentially detrimental effects to soil fauna (earthworms), while negative effects on soil microbial activities (nitrification, respiration) are shown to be transient. Potential mixture situations with nonylphenol, a chemical frequently occurring as a contaminant in sewage sludge used for land application, infer a need to explore whether these chemicals in mixture could alter the potential effects of picoxystrobin on the soil microflora. The main objective of this study was to assess the effects of picoxystrobin and nonylphenol, as single chemicals and mixtures, on soil microbial community structure and respiration activity in an agricultural sandy loam. Effects of the chemicals were assessed through measurements of soil microbial respiration activity and soil bacterial and fungal community structure fingerprints, together with a degradation study of the chemicals, through a 70 d incubation period. Picoxystrobin caused a decrease in the respiration activity, while 4-n-nonylphenol caused an increase in respiration activity concurring with a rapid degradation of the substance. Community structure fingerprints were also affected, but these results could not be directly interpreted in terms of positive or negative effects, and were indicated to be transient. Treatment with the chemicals in mixture caused less evident changes and indicated antagonistic effects between the chemicals in soil. In conclusion, the results imply that the application of the fungicide picoxystrobin and nonylphenol from sewage sludge application to agricultural soil in environmentally relevant concentrations, as single chemicals or in mixture, will not cause irreversible effects on soil microbial respiration and community structure.	[Stenrod, Marianne; Klemsdal, Sonja S.; Norli, Hans Ragnar; Eklo, Ole Martin] Bioforsk, Norwegian Inst Agr & Environm Res, As, Norway	Bioforsk	Stenrod, M (corresponding author), Bioforsk, Norwegian Inst Agr & Environm Res, As, Norway.	marianne.stenrod@bioforsk.no			Norwegian Research Council [186901/i30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was performed as part of the strategic institute programme 'Bioavailability and biological effects of chemicals - Novel tools in risk assessment of mixtures in agricultural and contaminated soil' funded by the Norwegian Research Council, project number 186901/i30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken JT, 2011, SOIL SCI SOC AM J, V75, P102, DOI 10.2136/sssaj2008.0088; ALEXANDER M, 1995, ENVIRON SCI TECHNOL, V29, P2713, DOI 10.1021/es00011a003; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; BCPC, 2011, EPESTICIDE MAN V5 2; Bending GD, 2007, CHEMOSPHERE, V69, P82, DOI 10.1016/j.chemosphere.2007.04.042; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Chaussod R., 1986, SCI SOL, V2, P201; Coleman DC, 2008, SOIL BIOL BIOCHEM, V40, P271, DOI 10.1016/j.soilbio.2007.08.005; Corvini PFX, 2006, APPL MICROBIOL BIOT, V72, P223, DOI 10.1007/s00253-006-0476-5; Defra, 2010, DEV GUID IMPL AG SOI; EC, 2003, SANCO101962003FINAL; [EFSA PPR] European Food Safety Authority Plant Protection Products and Their Residues Panel, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen AB, 2008, TEMANORD2008530; Hesselsoe M, 2001, ENVIRON SCI TECHNOL, V35, P3695, DOI 10.1021/es010024l; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; JRC, 2001, ORG CONT SEW SLUDG A; Kollmann A, 2003, J ENVIRON QUAL, V32, P1269, DOI 10.2134/jeq2003.1269; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Loewe S., 1927, J MOL MED, V6, P1077, DOI DOI 10.1007/BF01890305; Macdonald CA, 2011, SOIL BIOL BIOCHEM, V43, P932, DOI 10.1016/j.soilbio.2011.01.004; Norwegian Food Safety Autority, 2005, VURD PLANT AC PRIM P; Norwegian Scientific Committee for Food Safety, 2009, RISK ASS CONT SEW SL; OECD, 2000, TEST 216 SOIL MICROO, DOI [10.1787/9789264070226-en., DOI 10.1787/9789264070226-EN]; OECD, 2000, TEST 217 SOIL MICROO, DOI [10.1787/9789264070240-en, DOI 10.1787/9789264070240-EN]; Oksanen J., 2017, R PACKAGE VERSION 26; Ovreas L, 1998, MICROB ECOL, V36, P303, DOI 10.1007/s002489900117; R Core Team, 2012, R LANG ENV STAT COMP; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shan J, 2011, ENVIRON SCI TECHNOL, V45, P8283, DOI 10.1021/es200224c; Singh BK, 2008, ENVIRON MICROBIOL, V10, P534, DOI 10.1111/j.1462-2920.2007.01474.x; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; Topp E, 2000, ENVIRON TOXICOL CHEM, V19, P313, DOI [10.1002/etc.5620190210, 10.1897/1551-5028(2000)019&lt;0313:RMOTED&gt;2.3.CO;2]; Venables W.N., 2002, MODERN APPL STAT S; White T., 1990, PCR PROTOCOLS GUIDE, P315; Winding A, 2005, ECOTOX ENVIRON SAFE, V62, P230, DOI 10.1016/j.ecoenv.2005.03.026; Wu LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020611	40	11	14	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66989	10.1371/journal.pone.0066989	http://dx.doi.org/10.1371/journal.pone.0066989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818971	gold, Green Submitted, Green Published			2022-12-25	WOS:000322342800109
J	Zhang, D; Zhou, B; Li, Y; Wang, MJ; Wang, C; Zhou, ZG; Sun, XF				Zhang, Dan; Zhou, Bin; Li, Yuan; Wang, Mojin; Wang, Cun; Zhou, Zongguang; Sun, Xiaofeng			Polymorphisms of Glucose-Regulated Protein 78 and Risk of Colorectal Cancer: A Case-Control Study in Southwest China	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; ER CHAPERONE; PROMOTER POLYMORPHISM; STRESS INDUCTION; GRP78; EXPRESSION; OVEREXPRESSION; ASSOCIATION; HSPA5; GENE	Glucose-regulated protein 78 (GRP78), an endoplasmic reticulum chaperone, up-regulation serves as an efficient mechanism to promote malignant transformation of colorectal cancer (CRC) and protect CRC cells against apoptosis. Recently, the analysis of GRP78 polymorphisms has already determined that GRP78 rs391957 polymorphism could predict clinical outcome in CRC patients. Thus, we tested whether GRP78 polymorphisms are related to the risk of CRC. In this study, we detected two GRP78 polymorphisms (rs391957 (C>T) and rs430397 (G>A)) in 414 CRC cases and 502 hospital-based cancer-free healthy controls in Southwest China using a polymerase chain reaction-restriction fragment length polymorphism technique. Compared with the CC genotype, carriers of CT and TT genotypes of rs391957 polymorphism had higher risks of CRC (odds ratio (OR) = 1.39, 95% confidence interval (CI) = 1.06-1.83 for CT genotype and OR = 2.10, 95% CI = 1.06-4.14 for TT genotype, respectively). In CRC cases, the variant T allele was significantly associated with tumor invasion stage (P = 0.030), but not with status of lymph nodes metastasis (P = 0.052). Compared with the GG genotype, carriers of GA and AA genotypes of rs430397 polymorphism had higher risks of CRC (OR = 1.63, 95% CI = 1.23-2.15 for GA genotype and OR = 2.92, 95% CI = 1.23-6.94 for AA genotype, respectively). The rs430397 polymorphism was not associated with the clinicopathological characteristics of CRC. These data provide the first evidence that GRP78 rs391957 and rs430397 polymorphisms could serve as markers to predict the risk of CRC.	[Zhang, Dan; Wang, Mojin; Wang, Cun; Zhou, Zongguang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhang, Dan; Zhou, Bin; Li, Yuan; Wang, Mojin; Wang, Cun; Zhou, Zongguang] Sichuan Univ, West China Hosp, Lab Digest Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Sun, Xiaofeng] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden	Sichuan University; Sichuan University; Linkoping University	Zhou, ZG (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	zhou767@163.com	Wang, Cun/C-5600-2015	, Zongguang/0000-0002-7616-1199	Outstanding Doctoral Dissertation Foundation of Ministry of Education of China [2007B66]	Outstanding Doctoral Dissertation Foundation of Ministry of Education of China	This research was supported by grants from Outstanding Doctoral Dissertation Foundation of Ministry of Education of China (No. 2007B66). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Houlston RS, 2001, GASTROENTEROLOGY, V121, P282, DOI 10.1053/gast.2001.26265; Hsu WC, 2008, J NEURAL TRANSM, V115, P1537, DOI 10.1007/s00702-008-0117-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kakiuchi C, 2005, BIOCHEM BIOPH RES CO, V336, P1136, DOI 10.1016/j.bbrc.2005.08.248; Kemp Z, 2004, HUM MOL GENET, V13, pR177, DOI 10.1093/hmg/ddh247; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee H P, 1987, Ann Acad Med Singap, V16, P397; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Maekelae R, 2008, CLIN BIOCHEM, V41, P532, DOI 10.1016/j.clinbiochem.2008.01.017; Merrick DT, 2012, CHEST, V141, P1377, DOI 10.1378/chest.11-2662; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Uramoto H, 2005, LUNG CANCER, V49, P55, DOI 10.1016/j.lungcan.2004.12.011; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang MJ, 2009, ONCOLOGY-BASEL, V76, P199, DOI 10.1159/000201572; Winder T, 2011, ANN ONCOL, V22, P2431, DOI 10.1093/annonc/mdq771; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063; Zhu X, 2013, CARCINOGENESIS; Zhu X, 2012, CHEST, V141, P1466, DOI 10.1378/chest.11-0469; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66791	10.1371/journal.pone.0066791	http://dx.doi.org/10.1371/journal.pone.0066791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818965	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800102
J	Hua, RH; Liu, LK; Chen, ZS; Li, YN; Bu, ZG				Hua, Rong-Hong; Liu, Li-Ke; Chen, Zhen-Shi; Li, Ye-Nan; Bu, Zhi-Gao			Comprehensive Mapping Antigenic Epitopes of NS1 Protein of Japanese Encephalitis Virus with Monoclonal Antibodies	PLOS ONE			English	Article							WEST-NILE-VIRUS; RECOMBINANT VACCINIA VIRUS; LINKED-IMMUNOSORBENT-ASSAY; CROSS-REACTIVE EPITOPES; B-CELL EPITOPES; NONSTRUCTURAL-1 PROTEIN; PROTECTIVE IMMUNITY; ENVELOPE; MICE; IDENTIFICATION	Japanese encephalitis virus (JEV) non-structural protein 1 (NS1) contributes to virus replication and elicits protective immune responses during infection. JEV NS1-specific antibody responses could be a target in the differential diagnosis of different flavivirus infections. However, the epitopes on JEV NS1 are poorly characterized. The present study describes the full mapping of linear B-cell epitopes in JEV NS1. We generated eleven NS1-specific monoclonal antibodies from mice immunized with recombinant NS1. For epitope mapping of monoclonal antibodies, a set of 51 partially-overlapping peptides covering the entire NS1 protein were expressed with a GST-tag and then screened using monoclonal antibodies. Through enzyme-linked immunosorbent assay (ELISA), five linear epitope-containing peptides were identified. By sequentially removing amino acid residues from the carboxy and amino terminal of peptides, the minimal units of the five linear epitopes were identified and confirmed using monoclonal antibodies. Five linear epitopes are located in amino acids residues (5)AIDITRK(11), (RDELNVL78)-R-72, (251)KSKHNRREGY(260), (269)DENGIVLD(276), and (DETTLVRS348)-D-341. Furthermore, it was found that the epitopes are highly conserved among JEV strains through sequence alignment. Notably, none of the homologous regions on NS1 proteins from other flaviviruses reacted with the MAbs when they were tested for cross-reactivity, and all five epitope peptides were not recognized by sera against West Nile virus or Dengue virus. These novel virus-specific linear B-cell epitopes of JEV NS1 would benefit the development of new vaccines and diagnostic assays.	[Hua, Rong-Hong; Liu, Li-Ke; Chen, Zhen-Shi; Li, Ye-Nan; Bu, Zhi-Gao] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Hua, RH (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China.	huaronghong@163.com		Hua, Rong-Hong/0000-0001-7034-5766	Special Fund for Agro-scientific Research in the Public Interest of China [201203082]; Basic Scientific Research Fund of Central Research Academies and Institutes [ZGKJ201106, 1610302013011]	Special Fund for Agro-scientific Research in the Public Interest of China; Basic Scientific Research Fund of Central Research Academies and Institutes	This work was supported by grants from the Special Fund for Agro-scientific Research in the Public Interest of China (201203082) and the Basic Scientific Research Fund of Central Research Academies and Institutes (ZGKJ201106, 1610302013011). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin SE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-45; Wang B, 2009, VIRUS RES, V141, P90, DOI 10.1016/j.virusres.2009.01.004; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Hall RA, 2001, ANN NY ACAD SCI, V951, P153; HALL RA, 1990, J GEN VIROL, V71, P2923, DOI 10.1099/0022-1317-71-12-2923; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072; Khoretonenko MV, 2003, IMMUNOL LETT, V90, P161, DOI 10.1016/j.imlet.2003.09.002; KIMURAKURODA J, 1986, J GEN VIROL, V67, P2663, DOI 10.1099/0022-1317-67-12-2663; Kitai Y, 2007, CLIN VACCINE IMMUNOL, V14, P1024, DOI 10.1128/CVI.00051-07; Kitai Y, 2011, J VIROL METHODS, V171, P123, DOI 10.1016/j.jviromet.2010.10.012; Konishi E, 2004, J CLIN MICROBIOL, V42, P5087, DOI 10.1128/JCM.42.11.5087-5093.2004; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8; Lee TH, 2012, J GEN VIROL, V93, P20, DOI 10.1099/vir.0.036640-0; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Lindahl J, 2012, TROP ANIM HEALTH PRO, V44, P239, DOI 10.1007/s11250-011-0005-0; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998; Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; Shu PY, 2004, J CLIN MICROBIOL, V42, P2489, DOI 10.1128/JCM.42.6.2489-2494.2004; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Sun EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031434; Thakare J. P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P801; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510	36	21	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67553	10.1371/journal.pone.0067553	http://dx.doi.org/10.1371/journal.pone.0067553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825668	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400187
J	Sims-Lucas, S; Schaefer, C; Bushnell, D; Ho, J; Logar, A; Prochownik, E; Gittes, G; Bates, CM				Sims-Lucas, Sunder; Schaefer, Caitlin; Bushnell, Daniel; Ho, Jacqueline; Logar, Alison; Prochownik, Edward; Gittes, George; Bates, Carlton M.			Endothelial Progenitors Exist within the Kidney and Lung Mesenchyme	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEIN; PHENOTYPIC HETEROGENEITY; VASCULOGENIC MIMICRY; CELLS; MECHANISMS; ORIGIN	The renal endothelium has been debated as arising from resident hemangioblast precursors that transdifferentiate from the nephrogenic mesenchyme (vasculogenesis) and/or from invading vessels (angiogenesis). While the Foxd1-positive renal cortical stroma has been shown to differentiate into cells that support the vasculature in the kidney (including vascular smooth muscle and pericytes) it has not been considered as a source of endothelial cell progenitors. In addition, it is unclear if Foxd1-positive mesenchymal cells in other organs such as the lung have the potential to form endothelium. This study examines the potential for Foxd1-positive cells of the kidney and lung to give rise to endothelial progenitors. We utilized immunofluorescence (IF) and fluorescence-activated cell sorting (FACS) to co-label Foxd1-expressing cells (including permanently lineage-tagged cells) with endothelial markers in embryonic and postnatal mice. We also cultured FACsorted Foxd1-positive cells, performed in vitro endothelial cell tubulogenesis assays and examined for endocytosis of acetylated low-density lipoprotein (Ac-LDL), a functional assay for endothelial cells. Immunofluorescence and FACS revealed that a subset of Foxd1-positive cells from kidney and lung co-expressed endothelial cell markers throughout embryogenesis. In vitro, cultured embryonic Foxd1-positive cells were able to differentiate into tubular networks that expressed endothelial cell markers and were able to endocytose Ac-LDL. IF and FACS in both the kidney and lung revealed that lineage-tagged Foxd1-positive cells gave rise to a significant portion of the endothelium in postnatal mice. In the kidney, the stromal-derived cells gave rise to a portion of the peritubular capillary endothelium, but not of the glomerular or large vessel endothelium. These findings reveal the heterogeneity of endothelial cell lineages; moreover, Foxd1-positive mesenchymal cells of the developing kidney and lung are a source of endothelial progenitors that are likely critical to patterning the vasculature.	[Sims-Lucas, Sunder; Schaefer, Caitlin; Bushnell, Daniel; Ho, Jacqueline; Logar, Alison; Prochownik, Edward; Gittes, George; Bates, Carlton M.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Sims-Lucas, Sunder; Schaefer, Caitlin; Bushnell, Daniel; Ho, Jacqueline; Bates, Carlton M.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Nephrol,Dept Pediat, Pittsburgh, PA USA; [Prochownik, Edward] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Sect Hematol Oncol, Pittsburgh, PA USA; [Prochownik, Edward] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Prochownik, Edward] Univ Pittsburgh, Ctr Comprehens Canc, Pittsburgh, PA USA; [Gittes, George] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Gen & Thorac Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sims-Lucas, S (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Rangos Res Ctr, Pittsburgh, PA 15213 USA.	simslucass@upmc.edu; batescm@upmc.edu	Ho, Jackie/AAP-1531-2021	Ho, Jackie/0000-0001-7115-1381; Sims-Lucas, Sunder/0000-0003-1908-4809	American Heart Association postdoctoral fellowship [11POST7330002]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096996, R00DK087922] Funding Source: NIH RePORTER	American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SSL was supported by an American Heart Association postdoctoral fellowship (11POST7330002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 1998, KIDNEY INT, V54, pS7, DOI 10.1046/j.1523-1755.1998.06702.x; Aird WC, 2006, CIRC RES, V98, P159, DOI 10.1161/01.RES.0000204553.32549.a7; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; ESKILD W, 1987, SCAND J GASTROENTERO, V22, P1263, DOI 10.3109/00365528708996474; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hyink DP, 1996, AM J PHYSIOL-RENAL, V270, pF886, DOI 10.1152/ajprenal.1996.270.5.F886; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Lancrin C, 2010, J MOL MED, V88, P167, DOI 10.1007/s00109-009-0554-0; Lopez MLSS, 2011, J AM SOC NEPHROL, V22, P2156, DOI 10.1681/ASN.2011080818; Lopez MLSS, 2001, AM J PHYSIOL-RENAL, V281, pF345, DOI 10.1152/ajprenal.2001.281.2.F345; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Robert B, 1998, AM J PHYSIOL-RENAL, V275, pF164, DOI 10.1152/ajprenal.1998.275.1.F164; Sajithlal GB, 2010, INT J CANCER, V127, P2268, DOI 10.1002/ijc.25251; Schnapp L, 2012, AC LUNG INJ AJRCCM C; Shah SR, 2011, DEV BIOL, V349, P342, DOI 10.1016/j.ydbio.2010.10.033; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034	20	47	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65993	10.1371/journal.pone.0065993	http://dx.doi.org/10.1371/journal.pone.0065993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823180	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000320576400045
J	Xie, T; Sun, C; Uslu, K; Auth, RD; Fang, H; Ouyang, WM; Frucht, DM				Xie, Tao; Sun, Chen; Uslu, Kadriye; Auth, Roger D.; Fang, Hui; Ouyang, Weiming; Frucht, David M.			A New Murine Model for Gastrointestinal Anthrax Infection	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; BACILLUS-ANTHRACIS; LETHAL TOXIN; PATHOLOGY; HISTOPATHOLOGY; SUSCEPTIBILITY; DISSEMINATION	The scientific community has been restricted by the lack of a practical and informative animal model of gastrointestinal infection with vegetative Bacillus anthracis. We herein report the development of a murine model of gastrointestinal anthrax infection by gavage of vegetative Sterne strain of Bacillus anthracis into the complement-deficient A/J mouse strain. Mice infected in this manner developed lethal infections in a dose-dependent manner and died 30 h-5 d following gavage. Histological findings were consistent with penetration and growth of the bacilli within the intestinal villi, with subsequent dissemination into major organs including the spleen, liver, kidney and lung. Blood cultures confirmed anthrax bacteremia in all moribund animals, with approximately 1/3 showing co-infection with commensal enteric organisms. However, no evidence of immune activation was observed during infection. Time-course experiments revealed early compromise of the intestinal epithelium, characterized by villus blunting and ulceration in the ileum and jejunum. A decrease in body temperature was most predictive of near-term lethality. Antibiotic treatment of infected animals 24 h following high-dose bacterial gavage protected all animals, demonstrating the utility of this animal model in evaluating potential therapeutics.	[Xie, Tao; Sun, Chen; Uslu, Kadriye; Auth, Roger D.; Fang, Hui; Ouyang, Weiming; Frucht, David M.] US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Frucht, DM (corresponding author), US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	david.frucht@fda.hhs.gov			Federal Drug Administration Medical Countermeasures Initiative	Federal Drug Administration Medical Countermeasures Initiative	This project was supported by the Federal Drug Administration Medical Countermeasures Initiative. No external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEBY JC, 1955, J GEN MICROBIOL, V12, P526, DOI 10.1099/00221287-12-3-526; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; DRUETT HA, 1953, J HYG-CAMBRIDGE, V51, P359, DOI 10.1017/S0022172400015795; Duong S, 2006, INT J EXP PATHOL, V87, P131, DOI 10.1111/j.0959-9673.2006.00473.x; Fang H, 2010, J IMMUNOL, V185, P5463, DOI 10.4049/jimmunol.1002471; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; LINCOLN RE, 1965, J INFECT DIS, V115, P481, DOI 10.1093/infdis/115.5.481; Lovchik JA, 2012, INFECT IMMUN, V80, P2414, DOI 10.1128/IAI.06340-11; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Plaut RD, 2012, INFECT IMMUN, V80, P3189, DOI 10.1128/IAI.00515-12; Popov SG, 2012, MICROBES INFECT; Sun C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033583; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WHO, 2008, ANTHRAX HUMANS ANIMA; YOUNG GA, 1946, J INFECT DIS, V79, P233, DOI 10.1093/infdis/79.3.233; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66943	10.1371/journal.pone.0066943	http://dx.doi.org/10.1371/journal.pone.0066943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825096	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400169
J	Aguer, C; Fiehn, O; Seifert, EL; Bezaire, V; Meissen, JK; Daniels, A; Scott, K; Renaud, JM; Padilla, M; Bickel, DR; Dysart, M; Adams, SH; Harper, ME				Aguer, Celine; Fiehn, Oliver; Seifert, Erin L.; Bezaire, Veronic; Meissen, John K.; Daniels, Amanda; Scott, Kyle; Renaud, Jean-Marc; Padilla, Marta; Bickel, David R.; Dysart, Michael; Adams, Sean H.; Harper, Mary-Ellen			Muscle uncoupling protein 3 overexpression mimics endurance training and reduces circulating biomarkers of incomplete beta-oxidation	FASEB JOURNAL			English	Article						fatty acid oxidation; acylcarnitines; oxidative stress; exercise mimetic; mitochondria	OXYGEN SPECIES PRODUCTION; FATTY-ACID OXIDATION; MOUSE SKELETAL-MUSCLE; INSULIN-RESISTANCE; SUPEROXIDE-DISMUTASE; CARNITINE ACETYLTRANSFERASE; CELL-FREE; EXERCISE; MITOCHONDRIA; INCREASES	Exercise substantially improves metabolic health, making the elicited mechanisms important targets for novel therapeutic strategies. Uncoupling protein 3 (UCP3) is a mitochondrial inner membrane protein highly selectively expressed in skeletal muscle. Here we report that moderate UCP3 overexpression (roughly 3-fold) in muscles of UCP3 transgenic (UCP3 Tg) mice acts as an exercise mimetic in many ways. UCP3 overexpression increased spontaneous activity (approximate to 40%) and energy expenditure (approximate to 5-10%) and decreased oxidative stress (approximate to 15-20%), similar to exercise training in wild-type (WT) mice. The increase in complete fatty acid oxidation (FAO; approximate to 30% for WT and approximate to 70% for UCP3 Tg) and energy expenditure (approximate to 8% for WT and 15% for UCP3 Tg) in response to endurance training was higher in UCP3 Tg than in WT mice, showing an additive effect of UCP3 and endurance training on these two parameters. Moreover, increases in circulating short-chain acylcarnitines in response to acute exercise in untrained WT mice were absent with training or in UCP3 Tg mice. UCP3 overexpression had the same effect as training in decreasing long-chain acylcarnitines. Outcomes coincided with a reduction in muscle carnitine acetyltransferase activity that catalyzes the formation of acylcarnitines. Overall, results are consistent with the conclusions that circulating acylcarnitines could be used as a marker of incomplete muscle FAO and that UCP3 is a potential target for the treatment of prevalent metabolic diseases in which muscle FAO is affected.Aguer, C., Fiehn, O., Seifert, E. L., Bezaire, V., Meissen, J. K., Daniels, A., Scott, K., Renaud, J.-M., Padilla, M., Bickel, D. R., Dysart, M., Adams, S. H., Harper, M.-E. Muscle uncoupling protein 3 overexpression mimics endurance training and reduces circulating biomarkers of incomplete beta-oxidation.	[Aguer, Celine; Seifert, Erin L.; Daniels, Amanda; Padilla, Marta; Bickel, David R.; Dysart, Michael; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Scott, Kyle; Renaud, Jean-Marc] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Padilla, Marta; Bickel, David R.; Harper, Mary-Ellen] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Fiehn, Oliver; Meissen, John K.] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Fiehn, Oliver; Meissen, John K.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Adams, Sean H.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Bezaire, Veronic] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); Carleton University	Harper, ME (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	sean.h.adams@ars.usda.gov; mharper@uottawa.ca	Aguer, Celine/U-7848-2019; Bickel, David/ABF-7206-2021; ADAMS, SEAN/N-9262-2018	Aguer, Celine/0000-0001-8828-8472; Bickel, David/0000-0002-9623-3946; ADAMS, SEAN/0000-0002-9515-2319; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism and Diabetes grant); U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant [R01DK078328-01]; U.S. Department of Agriculture-Agricultural Research Service Intramural Projects [5306-51530-016-00D, 5306-51530-019-00]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism and Diabetes grant); U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant; U.S. Department of Agriculture-Agricultural Research Service Intramural Projects; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Linda Jut for muscle fiber typing, Mahmoud Salkhordeh, Jian Xuan, Jaehoon Kim, Mine Palazoglu, Massud Atta, Kristie Cloos, and Wan Tan for their excellent technical assistance, Trina Knotts (Mouse Metabolomic Phenotyping Center, University of California, Davis, CA, USA) for ANCOVA analyses, and Dolors Serra (University of Barcelona, Barcelona, Spain) for her generous gift of anti-CrAT antibody. This work was supported by the Canadian Institutes of Health Research (Institute of Nutrition, Metabolism and Diabetes grant to M.E.H.), U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK078328-01 (to S.H.A., M.E.H., and O.F.), and U.S. Department of Agriculture-Agricultural Research Service Intramural Projects 5306-51530-016-00D and 5306-51530-019-00 (to S.H.A.). C.A., O.F., S.H.A., and M.-E.H. conceived the experiments; CA., O.F., E.L.S., V.B., S.H.A., and M.-E.H. designed the experiments; C.A., E.L.S., V.B., J.K.M., A.D., K.S., and M.D. performed experiments; C.A., O.F., E.L.S., V.B., J.K.M., A.D., K.S., J.-M.R., M.P., D.R.B., and M.D. analyzed data; C.A. wrote the article; and V.B., E.L.S., S.H.A., and M.-E.H. edited the article. The authors declare no conflicts of interest.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Baillet L, 2000, J BIOL CHEM, V275, P36766, DOI 10.1074/jbc.M008265200; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bickel DR, 2013, STAT APPL GENET MOL, V12, P529, DOI 10.1515/sagmb-2013-0003; BICKEL DR, 2004, STAT APPL GENET MOL, V3; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Cifelli C, 2007, J PHYSIOL-LONDON, V582, P843, DOI 10.1113/jphysiol.2007.130955; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; Pimenta AD, 2007, EUR J APPL PHYSIOL, V102, P119, DOI 10.1007/s00421-007-0542-4; Dekany M, 2006, INT J SPORTS MED, V27, P112, DOI 10.1055/s-2005-865634; Di Meo S, 2001, BIOL SIGNAL RECEPT, V10, P125; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B., 2010, LARGE SCALE INFERENC; Efron B., 2011, LOCFDR COMPUTES LOCA; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Estey C, 2012, EXP GERONTOL, V47, P361, DOI 10.1016/j.exger.2012.02.008; Gerrits MF, 2010, J LIPID RES, V51, P2394, DOI 10.1194/jlr.P005298; GLATZ JFC, 1984, BIOCHIM BIOPHYS ACTA, V794, P454, DOI 10.1016/0005-2760(84)90012-2; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hitomi Y, 2008, REDOX REP, V13, P213, DOI 10.1179/135100008X308894; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jaudzems K, 2009, J ENZYM INHIB MED CH, V24, P1269, DOI 10.3109/14756360902829527; JONES RE, 1981, BIOCHIM BIOPHYS ACTA, V666, P120, DOI 10.1016/0005-2760(81)90097-7; JORGENSEN TG, 1976, SCAND J CLIN LAB INV, V36, P771, DOI 10.3109/00365517609081936; Kim JK, 2002, METABOLISM, V51, P460, DOI 10.1053/meta.2002.31326; Kitzmann M, 2011, BBA-MOL BASIS DIS, V1812, P423, DOI 10.1016/j.bbadis.2010.12.007; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, BIOCHEM J, V437, P301, DOI 10.1042/BJ20110571; Majerczak J, 2010, J PHYSIOL PHARMACOL, V61, P743; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Padilla M, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1807; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Steinberg J, 2002, RESP PHYSIOL NEUROBI, V130, P189, DOI 10.1016/S0034-5687(02)00002-6; Thyfault JP, 2010, AM J PHYSIOL-REG I, V299, pR926, DOI 10.1152/ajpregu.00093.2010; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4	55	38	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4213	4225		10.1096/fj.13-234302	http://dx.doi.org/10.1096/fj.13-234302			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825224	Green Published			2022-12-25	WOS:000329747100032
J	Farrell, JJ; Sampath, R; Ecker, DJ; Bonomo, RA				Farrell, John J.; Sampath, Rangarajan; Ecker, David J.; Bonomo, Robert A.			"Salvage Microbiology": Detection of Bacteria Directly from Clinical Specimens following Initiation of Antimicrobial Treatment	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; RAPID IDENTIFICATION; PCR; MENINGITIS; PATHOGENS; DIAGNOSIS	Background: PCR coupled with electrospray ionization mass spectrometry (ESI-MS) is a diagnostic approach that has demonstrated the capacity to detect pathogenic organisms from culture negative clinical samples after antibiotic treatment has been initiated. [1] We describe the application of PCR/ESI-MS for detection of bacteria in original patient specimens that were obtained after administration of antibiotic treatment in an open investigation analysis. Methods: We prospectively identified cases of suspected bacterial infection in which cultures were not obtained until after the initiation of antimicrobial treatment. PCR/ESI-MS was performed on 76 clinical specimens that were submitted for conventional microbiology testing from 47 patients receiving antimicrobial treatment. Findings: In our series, 72% (55/76) of cultures obtained following initiation of antimicrobial treatment were non-diagnostic (45 negative cultures; and 10 respiratory specimens with normal flora (5), yeast (4), or coagulase-negative staphylococcus (1)). PCR/ESR-MS detected organisms in 83% (39/47) of cases and 76% (58/76) of the specimens. Bacterial pathogens were detected by PCR/ESI-MS in 60% (27/45) of the specimens in which cultures were negative. Notably, in two cases of relapse of prosthetic knee infections in patients on chronic suppressive antibiotics, the previous organism was not recovered in tissue cultures taken during extraction of the infected knee prostheses, but was detected by PCR/ESI-MS. Conclusion: Molecular methods that rely on nucleic acid amplification may offer a unique advantage in the detection of pathogens collected after initiation of antimicrobial treatment and may provide an opportunity to target antimicrobial therapy and "salvage" both individual treatment regimens as well as, in select cases, institutional antimicrobial stewardship efforts.	[Farrell, John J.] Univ Illinois, Sch Med, Dept Med, Peoria, IL USA; [Sampath, Rangarajan; Ecker, David J.] Ibis Biosci, Carlsbad, CA USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Microbiol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH USA	University of Illinois System; University of Illinois Peoria; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Farrell, JJ (corresponding author), Univ Illinois, Sch Med, Dept Med, Peoria, IL USA.	jjf@uic.edu		Ecker, David/0000-0003-4350-9037	Veterans Affairs Merit Review Program; National Institutes of Health [AI072219-05, AI063517-07]; Geriatric Research Education and Clinical Center VISN 10; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072219, R01AI063517] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Program(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geriatric Research Education and Clinical Center VISN 10; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Veterans Affairs Merit Review Program, the National Institutes of Health (Grant AI072219-05 and AI063517-07), and the Geriatric Research Education and Clinical Center VISN 10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Bhatia NS, 2012, J CLIN MICROBIOL, V50, P4160, DOI 10.1128/JCM.01296-12; Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Fitch MT, 2007, LANCET INFECT DIS, V7, P191, DOI 10.1016/S1473-3099(07)70050-6; Houck PM, 2002, ARCH INTERN MED, V162, P843, DOI 10.1001/archinte.162.7.843-a; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; McGarvey R N, 1993, QRB Qual Rev Bull, V19, P124; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Puskarich MA, 2011, CRIT CARE MED, V39, P2066, DOI 10.1097/CCM.0b013e31821e87ab; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008	11	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66349	10.1371/journal.pone.0066349	http://dx.doi.org/10.1371/journal.pone.0066349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825537	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000016
J	Mulherkar, S; Liu, F; Chen, Q; Narayanan, A; Couvillon, AD; Shine, HD; Tolias, KF				Mulherkar, Shalaka; Liu, Feng; Chen, Qin; Narayanan, Anjana; Couvillon, Anthony D.; Shine, H. David; Tolias, Kimberley F.			The Small GTPase RhoA Is Required for Proper Locomotor Circuit Assembly	PLOS ONE			English	Article							GROWTH CONE COLLAPSE; SPINAL-CORD; AXON GUIDANCE; CORTICOSPINAL TRACT; IN-VIVO; EPHA4; RECEPTORS; KINASE; ORGANIZATION; PLASTICITY	The assembly of neuronal circuits during development requires the precise navigation of axons, which is controlled by attractive and repulsive guidance cues. In the developing spinal cord, ephrinB3 functions as a short-range repulsive cue that prevents EphA4 receptor-expressing corticospinal tract and spinal interneuron axons from crossing the midline, ensuring proper formation of locomotor circuits. Here we report that the small GTPase RhoA, a key regulator of cytoskeletal dynamics, is also required for ephrinB3/EphA4-dependent locomotor circuit formation. Deletion of RhoA from neural progenitor cells results in mice that exhibit a rabbit-like hopping gait, which phenocopies mice lacking ephrinB3 or EphA4. Consistent with this locomotor defect, we found that corticospinal tract axons and spinal interneuron projections from RhoA-deficient mice aberrantly cross the spinal cord midline. Furthermore, we determined that loss of RhoA blocks ephrinB3-induced growth cone collapse of cortical axons and disrupts ephrinB3 expression at the spinal cord midline. Collectively, our results demonstrate that RhoA is essential for the ephrinB3/EphA4-dependent assembly of cortical and spinal motor circuits that control normal locomotor behavior.	[Mulherkar, Shalaka; Liu, Feng; Chen, Qin; Shine, H. David; Tolias, Kimberley F.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chen, Qin; Shine, H. David] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Narayanan, Anjana] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Shine, H. David] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Couvillon, Anthony D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tolias, KF (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.			Tolias, Kimberley/0000-0002-2092-920X	NINDS NIH HHS [R01 NS062829] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062829] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Chen Q, 2008, EXP NEUROL, V209, P497, DOI 10.1016/j.expneurol.2007.11.025; Chen Q, 2006, J NEUROTRAUM, V23, P1254, DOI 10.1089/neu.2006.23.1254; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Imondi R, 2000, DEVELOPMENT, V127, P1397; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Leslie JR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00067; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038	36	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67015	10.1371/journal.pone.0067015	http://dx.doi.org/10.1371/journal.pone.0067015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825607	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000059
J	Ribeiro, E; Ganzinelli, M; Andreis, D; Bertoni, R; Giardini, R; Fox, SB; Broggini, M; Bottini, A; Zanoni, V; Bazzola, L; Foroni, C; Generali, D; Damia, G				Ribeiro, Enilze; Ganzinelli, Monica; Andreis, Daniele; Bertoni, Ramona; Giardini, Roberto; Fox, Stephen B.; Broggini, Massimo; Bottini, Alberto; Zanoni, Vanessa; Bazzola, Letizia; Foroni, Chiara; Generali, Daniele; Damia, Giovanna			Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL LUNG-CANCER; THERAPEUTIC STRATEGIES; POLY(ADP-RIBOSE) POLYMERASE; SUBTYPES; CHEMOTHERAPY; SENSITIVITY; PHENOTYPE; DEFECTS; ERCC1	DNA repair is a key determinant in the cellular response to therapy and tumor repair status could play an important role in tailoring patient therapy. Our goal was to evaluate the mRNA of 13 genes involved in different DNA repair pathways (base excision, nucleotide excision, homologous recombination, and Fanconi anemia) in paraffin embedded samples of triple negative breast cancer (TNBC) compared to luminal A breast cancer (LABC). Most of the genes involved in nucleotide excision repair and Fanconi Anemia pathways, and CHK1 gene were significantly less expressed in TNBC than in LABC. PARP1 levels were higher in TNBC than in LABC. In univariate analysis high level of FANCA correlated with an increased overall survival and event free survival in TNBC; however multivariate analyses using Cox regression did not confirm FANCA as independent prognostic factor. These data support the evidence that TNBCs compared to LABCs harbour DNA repair defects.	[Ribeiro, Enilze] UFPR, Dept Genet, Lab Citogenet Humana & Oncogenet, Curitiba, Parana, Brazil; [Ganzinelli, Monica; Broggini, Massimo; Damia, Giovanna] IRCCS Ist Ric Farmacol Mario Negri, Mol Pharmacol Lab, Milan, Italy; [Andreis, Daniele; Bottini, Alberto; Zanoni, Vanessa; Bazzola, Letizia; Foroni, Chiara; Generali, Daniele] AO Ist Ospitalieri Cremona, UO Multidisciplinare Patol Mammaria, Lab Oncol Mol Senol, Cremona, Italy; [Bertoni, Ramona; Giardini, Roberto] AO Ist Ospitalieri Cremona, UO Anat Patol, Cremona, Italy; [Fox, Stephen B.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Universidade Federal do Parana; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Peter Maccallum Cancer Center	Generali, D (corresponding author), AO Ist Ospitalieri Cremona, UO Multidisciplinare Patol Mammaria, Lab Oncol Mol Senol, Cremona, Italy.	daniele.generali@gmail.com; giovanna.damia@marionegri.it	broggini, massimo/AAA-6460-2020; Andreis, Daniele/J-8333-2016; damia, giovanna/AAB-1428-2020; Ganzinelli, Monica/K-4548-2016; Ribeiro, Enilze MSF/K-7319-2012; Fox, Stephen/G-9719-2016	Andreis, Daniele/0000-0001-6686-5662; damia, giovanna/0000-0001-9749-434X; Ganzinelli, Monica/0000-0002-0526-0835; GENERALI, DANIELE/0000-0003-2480-3855; BROGGINI, MASSIMO/0000-0002-8138-9358; Fox, Stephen/0000-0002-7648-8896	Italian Association for Cancer Research (AIRC); Associazione Ricerca in Campo Oncologico (ARCO); Victorian Breast Cancer Research Consortium of Australia	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Ricerca in Campo Oncologico (ARCO); Victorian Breast Cancer Research Consortium of Australia	The work was supported by the Italian Association for Cancer Research (AIRC), Associazione Ricerca in Campo Oncologico (ARCO) and the Victorian Breast Cancer Research Consortium of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BM, 2010, CLIN CANCER RES, V16, P5796, DOI 10.1158/1078-0432.CCR-10-0292; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Carrassa L, 2011, CELL CYCLE, V10, P2121, DOI 10.4161/cc.10.13.16398; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Damia G, 2010, CURR DRUG TARGETS, V11, P1317, DOI 10.2174/1389450111007011317; Damia G, 1996, INT J CANCER, V66, P779, DOI 10.1002/(SICI)1097-0215(19960611)66:6<779::AID-IJC12>3.0.CO;2-Z; Damia G, 2007, EUR J CANCER, V43, P1791, DOI 10.1016/j.ejca.2007.05.003; de Bruin PC, 2011, MOD PATHOL; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dienstmann R, 2011, CANCER J, V17, P114, DOI 10.1097/PPO.0b013e318212f844; Domagala P, 2011, BREAST CANCER RES TR, V127, P861, DOI 10.1007/s10549-011-1441-2; Friboulet L, 2011, CLIN CANCER RES, V17, P5562, DOI 10.1158/1078-0432.CCR-11-0790; Fumagalli C, 2012, BREAST CANC RES TREA; Generali D, 2009, J CLIN ONCOL, V27, P227, DOI 10.1200/JCO.2007.13.7083; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Kaplan HG, 2008, BREAST J, V14, P456, DOI 10.1111/j.1524-4741.2008.00622.x; Karihtala P, 2012, BRIT J CANCER, V106, P344, DOI 10.1038/bjc.2011.518; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Latimer JJ, 2010, P NATL ACAD SCI USA, V107, P21725, DOI 10.1073/pnas.0914772107; Lips EH, 2011, ANN ONCOL, V22, P870, DOI 10.1093/annonc/mdq468; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P303, DOI 10.1007/s12282-008-0042-3; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rhee JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-307; Rothschild SI, 2011, CURR OPIN ONCOL, V23, P150, DOI 10.1097/CCO.0b013e328341ee38; Rowe BP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2566; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Wang Shu, 2009, Gan To Kagaku Ryoho, V36, P255; Weigman VJ, 2011, BREAST CANC RES TREA; Willers H, 2009, MOL CANCER RES, V7, P1304, DOI 10.1158/1541-7786.MCR-09-0149; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192	56	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66243	10.1371/journal.pone.0066243	http://dx.doi.org/10.1371/journal.pone.0066243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825533	Green Published, gold			2022-12-25	WOS:000321223000012
J	Woodell, A; Coughlin, B; Kunchithapautham, K; Casey, S; Williamson, T; Ferrell, WD; Atkinson, C; Jones, BW; Rohrer, B				Woodell, Alex; Coughlin, Beth; Kunchithapautham, Kannan; Casey, Sarah; Williamson, Tucker; Ferrell, W. Drew; Atkinson, Carl; Jones, Bryan W.; Rohrer, Baerbel			Alternative Complement Pathway Deficiency Ameliorates Chronic Smoke-Induced Functional and Morphological Ocular Injury	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; FACTOR-H POLYMORPHISM; CAUSES OXIDATIVE DAMAGE; MACULAR DEGENERATION; CIGARETTE-SMOKE; BRUCHS MEMBRANE; FACTOR-B; CHOROIDAL NEOVASCULARIZATION; MITOCHONDRIAL DYSFUNCTION	Background: Age-related macular degeneration (AMD), a complex disease involving genetic variants and environmental insults, is among the leading causes of blindness in Western populations. Genetic and histologic evidence implicate the complement system in AMD pathogenesis; and smoking is the major environmental risk factor associated with increased disease risk. Although previous studies have demonstrated that cigarette smoke exposure (CE) causes retinal pigment epithelium (RPE) defects in mice, and smoking leads to complement activation in patients, it is unknown whether complement activation is causative in the development of CE pathology; and if so, which complement pathway is required. Methods: Mice were exposed to cigarette smoke or clean, filtered air for 6 months. The effects of CE were analyzed in wildtype (WT) mice or mice without a functional complement alternative pathway (AP; CFB-/-) using molecular, histological, electrophysiological, and behavioral outcomes. Results: CE in WT mice exhibited a significant reduction in function of both rods and cones as determined by electroretinography and contrast sensitivity measurements, concomitant with a thinning of the nuclear layers as measured by SD-OCT imaging and histology. Gene expression analyses suggested that alterations in both photoreceptors and RPE/choroid might contribute to the observed loss of function, and visualization of complement C3d deposition implies the RPE/Bruch's membrane (BrM) complex as the target of AP activity. RPE/BrM alterations include an increase in mitochondrial size concomitant with an apical shift in mitochondrial distribution within the RPE and a thickening of BrM. CFB-/- mice were protected from developing these CE-mediated alterations. Conclusions: Taken together, these findings provide clear evidence that ocular pathology generated in CE mice is dependent on complement activation and requires the AP. Identifying animal models with RPE/BrM damage and verifying which aspects of pathology are dependent upon complement activation is essential for developing novel complement-based treatment approaches for the treatment of AMD.	[Woodell, Alex; Rohrer, Baerbel] Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA; [Coughlin, Beth; Kunchithapautham, Kannan; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Casey, Sarah; Williamson, Tucker; Atkinson, Carl] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Ferrell, W. Drew; Jones, Bryan W.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA; [Rohrer, Baerbel] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rohrer, B (corresponding author), Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA.	rohrer@musc.edu		Jones, Bryan/0000-0001-5527-6643	Department for Veterans Affairs [RX000444]; Research to Prevent Blindness (RPB), New York, NY; Foundation Fighting Blindness, Columbia, MD; NIH NHLBI [RO1 091944]; NIH [C06RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091944] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	Department for Veterans Affairs(US Department of Veterans Affairs); Research to Prevent Blindness (RPB), New York, NY(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness, Columbia, MD; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by a Department for Veterans Affairs merit award RX000444 (BR), unrestricted grant to MUSC from Research to Prevent Blindness (RPB), New York, NY and Foundation Fighting Blindness, Columbia, MD, and NIH NHLBI RO1 091944 (CA). Animal studies were conducted in a facility constructed with support from the NIH (C06RR015455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Atkinson C, 2010, J IMMUNOL, V185, P7007, DOI 10.4049/jimmunol.1001504; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; BROWN B, 1986, OPHTHAL PHYSL OPT, V6, P81, DOI 10.1111/j.1475-1313.1986.tb00704.x; BROWN B, 1986, AM J OPTOM PHYS OPT, V63, P450; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Bruno Richard S, 2006, Pathophysiology, V13, P143, DOI 10.1016/j.pathophys.2006.05.003; Burke JM, 2009, INVEST OPHTH VIS SCI, V50, P1940, DOI 10.1167/iovs.08-2671; Cankova Z, 2011, EXP EYE RES, V93, P947, DOI 10.1016/j.exer.2011.10.016; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; CHEN JC, 1992, INVEST OPHTH VIS SCI, V33, P334; CHOW CK, 1986, J AM COLL NUTR, V5, P305; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; CRONIN VB, 1990, BIOCHEM SOC T, V18, P256, DOI 10.1042/bst0180256; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; Droz I, 2008, BRIT J OPHTHALMOL, V92, P513, DOI 10.1136/bjo.2007.127811; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Freund KB, 2010, RETINA-J RET VIT DIS, V30, P1333, DOI 10.1097/IAE.0b013e3181e7976b; FRIEDMAN E, 1995, OPHTHALMOLOGY, V102, P640, DOI 10.1016/S0161-6420(95)30974-8; Friedman E, 2004, BRIT J OPHTHALMOL, V88, P161, DOI 10.1136/bjo.2003.036277; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harboe M, 2006, CLIN EXP IMMUNOL, V144, P512, DOI 10.1111/j.1365-2249.2006.03072.x; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; He Y, 2010, ADV EXP MED BIOL, V664, P165, DOI 10.1007/978-1-4419-1399-9_20; Hecker LA, 2010, ADV EXP MED BIOL, V703, P49, DOI 10.1007/978-1-4419-5635-4_4; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; Huang JD, 2007, EXP EYE RES, V85, P202, DOI 10.1016/j.exer.2007.03.011; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jia LH, 2007, INVEST OPHTH VIS SCI, V48, P339, DOI 10.1167/iovs.06-0248; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033; Liu CH, 2012, APPL IMMUNOHISTOCHEM; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Lois N, 2008, BRIT J OPHTHALMOL, V92, P1304, DOI 10.1136/bjo.2008.141168; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Mantel I, 2013, OPHTHALMIC GENET; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Marshall J., 1998, RETINAL PIGMENT EPIT, P669; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P1310, DOI 10.1167/iovs.05-1292; Panda K, 1999, FREE RADICAL BIO MED, V27, P1064, DOI 10.1016/S0891-5849(99)00154-9; Pappuru RR, 2011, INVEST OPHTH VIS SCI, V52, P6743, DOI 10.1167/iovs.10-6723; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Sanai M, 2011, AFR J BIOTECHNOL, V10, P19211, DOI 10.5897/AJB11.254; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P586, DOI 10.1167/iovs.08-2514; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Stoppelkamp S, 2010, J NEUROSCI METH, V194, P132, DOI 10.1016/j.jneumeth.2010.10.008; TATE DJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P963, DOI 10.1001/archopht.1993.01090070083023; Thomas BB, 2010, NEUROSCI LETT, V479, P92, DOI 10.1016/j.neulet.2010.05.031; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yin W, 2008, THROMB RES, V122, P221, DOI 10.1016/j.thromres.2007.11.005; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; ZHU BQ, 1995, AM HEART J, V130, P1270, DOI 10.1016/0002-8703(95)90154-X	93	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67894	10.1371/journal.pone.0067894	http://dx.doi.org/10.1371/journal.pone.0067894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825688	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000122
J	Lim, J; Thompson, J; May, RC; Hotchin, NA; Caron, E				Lim, Jenson; Thompson, Jo; May, Robin C.; Hotchin, Neil A.; Caron, Emmanuelle			Regulator of G-Protein Signalling-14 (RGS14) Regulates the Activation of alpha M beta 2 Integrin during Phagocytosis	PLOS ONE			English	Article							NEURITE OUTGROWTH; ADHESION; TALIN; RAP1; RAS; BINDING; GTPASE; DISRUPTION; KINDLIN-3; EFFECTOR	Integrin-mediated phagocytosis, an important physiological activity undertaken by professional phagocytes, requires bidirectional signalling to/from alpha M beta 2 integrin and involves Rap1 and Rho GTPases. The action of Rap1 and the cytoskeletal protein talin in activating alpha M beta 2 integrins, in a RIAM-independent manner, has been previously shown to be critical during phagocytosis in mammalian phagocytes. However, the events downstream of Rap1 are not clearly understood. Our data demonstrate that one potential Rap1 effector, Regulator of G-Protein Signalling-14 (RGS14), is involved in activating alpha M beta 2. Exogenous expression of RGS14 in COS-7 cells expressing alpha M beta 2 results in increased binding of C3bi-opsonised sheep red blood cells. Consistent with this, knock-down of RGS14 in J774.A1 macrophages results in decreased association with C3bi-opsonised sheep red blood cells. Regulation of alpha M beta 2 function occurs through the R333 residue of the RGS14 Ras/Rap binding domain (RBD) and the F754 residue of beta 2, residues previously shown to be involved in binding of H-Ras and talin1 head binding prior to alpha M beta 2 activation, respectively. Surprisingly, overexpression of talin2 or RAPL had no effect on alpha M beta 2 regulation. Our results establish for the first time a role for RGS14 in the mechanism of Rap1/talin1 activation of alpha M beta 2 during phagocytosis.	[Lim, Jenson; May, Robin C.; Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lim, Jenson] NanoTher Ltd, Newcastle Under Lyme, Staffs, England; [Thompson, Jo] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol, London, England; [Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	University of Birmingham; University of Exeter; Imperial College London; Imperial College London	Lim, J (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	Limj@adf.bham.ac.uk	May, Robin Charles/ABA-9266-2021	May, Robin Charles/0000-0001-5364-1838; Hotchin, Neil/0000-0002-1844-7607	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Cancer Research United Kingdom; MRC [MR/J008176/1] Funding Source: UKRI; Medical Research Council [MR/J008176/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Wellcome Trust, Biotechnology and Biological Sciences Research Council and Cancer Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Debrand E, 2009, FEBS J, V276, P1610, DOI 10.1111/j.1742-4658.2009.06893.x; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2011, IMMUNITY, V34, P24, DOI 10.1016/j.immuni.2010.12.010; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Lim J, 2011, BIOCHEM J, V437, P461, DOI 10.1042/BJ20101666; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; Mechai N, 2005, J NEUROSCI RES, V82, P753, DOI 10.1002/jnr.20693; Medrano-Fernandez I, 2013, CELL MOL LIFE SCI, V70, P2395, DOI 10.1007/s00018-013-1268-6; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Self AJ, 2001, J CELL SCI, V114, P1357; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; Xue ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056911; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao PS, 2013, J CELL BIOCHEM, V114, P1414, DOI 10.1002/jcb.24483	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e69163	10.1371/journal.pone.0069163	http://dx.doi.org/10.1371/journal.pone.0069163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805333	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500162
J	Nordfeldt, S; Angarne-Lindberg, T; Nordwall, M; Ekberg, J; Bertero, C				Nordfeldt, Sam; Angarne-Lindberg, Teresia; Nordwall, Maria; Ekberg, Joakim; Bertero, Carina			As Facts and Chats Go Online, What Is Important for Adolescents with Type 1 Diabetes?	PLOS ONE			English	Article							DAWN YOUTH; CARE; INTERNET; COMPLICATIONS; MANAGEMENT; ATTITUDES; PERSPECTIVE; USABILITY; EDUCATION; CHILDREN	Background: Continued refinement of resources for patient information, education and support is needed. Considering the rapid development of new communication practices, the perspectives of young people themselves warrant more attention using a wide research focus. The purpose of this study was to understand information-seeking behaviours, Internet use and social networking online in adolescents with type 1 diabetes (T1DM). This applied to their everyday life, including the context of diabetes and their experiences and need of contact with T1DM peers. Methodology/Principal Findings: Twenty-four adolescents aged 10-17 years with T1DM were recruited from a county hospital in the south-east of Sweden. Qualitative data were obtained using eight focus groups, wherein each participant engaged in a 60-90 minute video/audio-recorded session. The focus group data were transcribed and analysed using qualitative content analysis. Some demographic and medical information was also collected. The three main categories that were identified; Aspects of Security, Updating, and Plainness and their sub-categories gave significant information about how to enhance information retrieval and peer contacts related to T1DM. Regarding the persons' information-seeking behaviour, Internet use, and use of social media some differences could be identified depending on gender and age. Conclusions/Significance: Sensitivity and adaptation to users' needs and expectations seem crucial in the development of future online resources for adolescents with T1DM. To start with, this could mean applying a wider range of already existing information and communication technologies. Health practitioners need to focus on the areas of security of information and communication, frequency of updating, and simplicity of design-less is more.	[Nordfeldt, Sam; Angarne-Lindberg, Teresia] Linkoping Univ, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden; [Nordfeldt, Sam] Linkoping Univ, Dept Med & Hlth Sci, Ctr Med Technol Assessment, Linkoping, Sweden; [Nordwall, Maria] Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden; [Nordwall, Maria] Vrinnevi Hosp, Paediat Clin, Linkoping, Sweden; [Ekberg, Joakim] Univ Skovde, Sch Life Sci, Publ Hlth Unit, Skovde, Sweden; [Bertero, Carina] Linkoping Univ, Dept Med & Hlth Sci, Div Nursing Sci, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; University of Skovde; Linkoping University	Nordfeldt, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden.	sam.nordfeldt@liu.se	Berterö, Carina/H-8659-2019	Berterö, Carina/0000-0003-1588-135X	Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden; County Council of Ostergotland, Sweden	Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden; County Council of Ostergotland, Sweden	This study was supported by the Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden and the County Council of Ostergotland, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstoot HJ, 2009, PEDIATR DIABETES, V10, P21, DOI 10.1111/j.1399-5448.2009.00611.x; Aanstoot HJ, 2009, PEDIATR DIABETES, V10, P15, DOI 10.1111/j.1399-5448.2009.00610.x; Brink SJ, 2002, J PEDIATR ENDOCR MET, V15, P1113; Carroll AE, 2011, DIABETES EDUCATOR, V37, P59, DOI 10.1177/0145721710387163; Couch Robert, 2008, Evid Rep Technol Assess (Full Rep), P1; Ekberg J, 2010, J MED SYST, V34, P107, DOI 10.1007/s10916-008-9222-0; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Findahl O., 2010, SVENSKARNA INTERNET; Flicker S, 2004, J MED INTERNET RES, V6, P77, DOI 10.2196/jmir.6.3.e32; Gentles Stephen James, 2010, J Med Internet Res, V12, pe22, DOI 10.2196/jmir.1390; Hanberger L, 2006, DIABETES RES CLIN PR, V72, P197, DOI 10.1016/j.diabres.2005.10.009; Hanberger L, 2008, DIABETES CARE, V31, P927, DOI 10.2337/dc07-1863; Hansen DL, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.4.e25; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kerr C, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e13; Kreuger RA, 1998, ANAL REPORTING FOCUS; Krippendorff K., 2004, CONTENT ANAL INTRO I, V2nd ed; Lenhart A, 2010, SOCIAL MEDIA MOBILE; Lowe P, 2005, J TELEMED TELECARE, V11, P59, DOI 10.1258/1357633054461840; Ludvigsson J, 2001, DIABETES NUTR METAB, V14, P292; Martenson EK, 2009, NURS SCI QUART, V22, P281, DOI 10.1177/0894318409338681; Martenson EK, 2009, INT J NURS PRACT, V15, P185, DOI 10.1111/j.1440-172X.2009.01743.x; Mayring P., 2000, QUALITATIVE CONTENT; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Nordfeldt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062096; Nordfeldt S, 2012, J MED INTERNET RES, V14, P279, DOI 10.2196/jmir.1987; Nordfeldt S, 2012, FUTURE INTERNET, V4, P514, DOI 10.3390/fi4020514; Nordfeldt S, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1267; Nordqvist C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1152; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Nordwall M, 2009, PEDIATR DIABETES, V10, P168, DOI 10.1111/j.1399-5448.2008.00472.x; Pak R, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1220; Peyrot M, 2009, PEDIATR DIABETES, V10, P37, DOI 10.1111/j.1399-5448.2009.00612.x; Powell J, 2009, J TELEMED TELECARE, V15, P150, DOI 10.1258/jtt.2009.003014; Ravert RD, 2004, DIABETES EDUCATOR, V30, P827, DOI 10.1177/014572170403000518; Ritterband LM, 2009, ANN BEHAV MED, V38, P18, DOI 10.1007/s12160-009-9133-4; Stinson J, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1349; Swift PGF, 2009, PEDIATR DIABETES, V10, P51, DOI 10.1111/j.1399-5448.2009.00570.x; Valaitis RK, 2005, HEALTH PROMOT PRACT, V6, P464, DOI 10.1177/1524839904263897; Verhoeven Fenne, 2010, J Diabetes Sci Technol, V4, P666; Verhoeven F, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e37; Wysocki T, 2011, DIABETES CARE, V34, P1701, DOI 10.2337/dc11-0577; Zrebiec JF, 2005, DIABETES EDUCATOR, V31, P825, DOI 10.1177/0145721705282162; Zrebiec JF, 2005, DIABETES ED, V31, P36, DOI DOI 10.1177/0145721705282162	44	13	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67659	10.1371/journal.pone.0067659	http://dx.doi.org/10.1371/journal.pone.0067659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805322	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500150
J	Jutras, BL; Chenail, AM; Rowland, CL; Carroll, D; Miller, MC; Bykowski, T; Stevenson, B				Jutras, Brandon L.; Chenail, Alicia M.; Rowland, Christi L.; Carroll, Dustin; Miller, M. Clarke; Bykowski, Tomasz; Stevenson, Brian			Eubacterial SpoVG Homologs Constitute a New Family of Site-Specific DNA-Binding Proteins	PLOS ONE			English	Article							BORRELIA-BURGDORFERI EBFC; LYME-DISEASE SPIROCHETE; BACILLUS-SUBTILIS; SPORULATION GENE; SIGMA-FACTOR; MOLECULAR CHARACTERIZATION; ANTIGENIC VARIATION; CLONED GENE; EXPRESSION; CAPSULE	A site-specific DNA-binding protein was purified from Borrelia burgdorferi cytoplasmic extracts, and determined to be a member of the highly conserved SpoVG family. This is the first time a function has been attributed to any of these ubiquitous bacterial proteins. Further investigations into SpoVG orthologues indicated that the Staphylococcus aureus protein also binds DNA, but interacts preferentially with a distinct nucleic acid sequence. Site-directed mutagenesis and domain swapping between the S. aureus and B. burgdorferi proteins identified that a 6-residue stretch of the SpoVG alpha-helix contributes to DNA sequence specificity. Two additional, highly conserved amino acid residues on an adjacent beta-sheet are essential for DNA-binding, apparently by contacts with the DNA phosphate backbone. Results of these studies thus identified a novel family of bacterial DNA-binding proteins, developed a model of SpoVG-DNA interactions, and provide direction for future functional studies on these wide-spread proteins.	[Jutras, Brandon L.; Chenail, Alicia M.; Bykowski, Tomasz; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA; [Rowland, Christi L.] Univ Kentucky, Coll Med, Dept Agr Sci, Lexington, KY USA; [Carroll, Dustin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY USA; [Miller, M. Clarke] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Louisville	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA.	brian.stevenson@uky.edu	Miller, M. Clarke/C-9483-2011	Miller, M. Clarke/0000-0002-9877-6581; Jutras, Brandon/0000-0002-7989-1031	National Research Fund for Tick-Borne Diseases	National Research Fund for Tick-Borne Diseases	This work was supported by a grant from the National Research Fund for Tick-Borne Diseases to B. Stevenson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb K, 2004, J BACTERIOL, V186, P2745, DOI 10.1128/JB.186.9.2745-2756.2004; Babb K, 2006, J BACTERIOL, V188, P4331, DOI 10.1128/JB.00005-06; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Burns LH, 2010, NUCLEIC ACIDS RES, V38, P5443, DOI 10.1093/nar/gkq284; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Cocchiaro JL, 2006, MOL MICROBIOL, V59, P948, DOI 10.1111/j.1365-2958.2005.04978.x; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FURBASS R, 1991, MOL GEN GENET, V225, P347; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOHNSON WC, 1983, NATURE, V302, P800, DOI 10.1038/302800a0; Jutras BL, 2012, CURR PROTOCOLS MICRO; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Kim HH, 2010, ARCH PHARM RES, V33, P1285, DOI 10.1007/s12272-010-0820-2; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Luong TT, 2006, MICROBIOL-SGM, V152, P3123, DOI 10.1099/mic.0.29177-0; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; MARGOLIS PS, 1993, J BACTERIOL, V175, P528, DOI 10.1128/JB.175.2.528-540.1993; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Norris SJ, 2006, MOL MICROBIOL, V60, P1319, DOI 10.1111/j.1365-2958.2006.05204.x; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Perez AR, 2006, J BACTERIOL, V188, P1159, DOI 10.1128/JB.188.3.1159-1164.2006; Perez AR, 2000, J BACTERIOL, V182, P1096, DOI 10.1128/JB.182.4.1096-1108.2000; RESNEKOV O, 1995, J BACTERIOL, V177, P5628, DOI 10.1128/jb.177.19.5628-5635.1995; Riley SP, 2009, NUCLEIC ACIDS RES, V37, P1973, DOI 10.1093/nar/gkp027; ROBERTSON JB, 1989, P NATL ACAD SCI USA, V86, P8457, DOI 10.1073/pnas.86.21.8457; ROSENBLUH A, 1981, J BACTERIOL, V148, P341, DOI 10.1128/JB.148.1.341-351.1981; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Schulthess B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-17; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; SEGALL J, 1977, CELL, V11, P751, DOI 10.1016/0092-8674(77)90289-6; Walia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057792; WILLEMS A, 1995, INT J SYST BACTERIOL, V45, P832, DOI 10.1099/00207713-45-4-832; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; ZUBER P, 1983, CELL, V35, P275, DOI 10.1016/0092-8674(83)90230-1; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	51	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66683	10.1371/journal.pone.0066683	http://dx.doi.org/10.1371/journal.pone.0066683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818957	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800094
J	Temerozo, JR; Joaquim, R; Regis, EG; Savino, W; Bou-Habib, DC				Temerozo, Jairo R.; Joaquim, Rafael; Regis, Eduardo G.; Savino, Wilson; Bou-Habib, Dumith Chequer			Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-COUPLED RECEPTORS; NITRIC-OXIDE PRODUCTION; NECROSIS-FACTOR-ALPHA; ADENYLATE-CYCLASE; CHEMOKINE PRODUCTION; IN-VITRO; T-CELLS	It is well established that host factors can modulate HIV-1 replication in macrophages, critical cells in the pathogenesis of HIV-1 infection due to their ability to continuously produce virus. The neuropeptides VIP and PACAP induce well-characterized effects on macrophages through binding to the G protein-coupled receptors VPAC1, VPAC2 and PAC1, but their influence on HIV-1 production by these cells has not been established. Here, we describe that VIP and PACAP reduce macrophage production of HIV-1, acting in a synergistic or additive manner to decrease viral growth. Using receptor antagonists, we detected that the HIV-1 inhibition promoted by VIP is dependent on its ligation to VPAC1/2, whereas PACAP decreases HIV-1 growth via activation of the VPAC1/2 and PAC1 receptors. Specific agonists of VPAC2 or PAC1 decrease macrophage production of HIV-1, whereas sole activation of VPAC1 enhances viral growth. However, the combination of specific agonists mimicking the receptor preference of the natural neuropeptides reproduces the ability of VIP and PACAP to increase macrophage resistance to HIV-1 replication. VIP and PACAP up-regulated macrophage secretion of the beta-chemokines CCL3 and CCL5 and the cytokine IL-10, whose neutralization reversed the neuropeptide-induced inhibition of HIV-1 replication. Our results suggest that VIP and PACAP and the receptors VPAC2 and PAC1 could be used as targets for developing alternative therapeutic strategies for HIV-1 infection.	[Temerozo, Jairo R.; Regis, Eduardo G.; Savino, Wilson; Bou-Habib, Dumith Chequer] Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil; [Joaquim, Rafael] Cent Hosp Maputo, Microbiol Lab, Maputo, Mozambique	Fundacao Oswaldo Cruz	Bou-Habib, DC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.	dumith@ioc.fiocruz.br	Temerozo, Jairo R/K-4894-2012; Bou-Habib, Dumith/GPP-1624-2022	Temerozo, Jairo R/0000-0002-8092-2149; Bou-Habib, Dumith/0000-0003-0552-9045	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475958/2011-0]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj) [E-26/102755/2008]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant # 475958/2011-0) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj; grant # E-26/102755/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2011, CURR PHARM DESIGN, V17, P1025, DOI 10.2174/138161211795589364; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Andreani G, 2012, CURR OPIN HIV AIDS, V7, P276, DOI 10.1097/COH.0b013e32835211e9; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bokaei PB, 2007, VIROLOGY, V362, P38, DOI 10.1016/j.virol.2006.12.012; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; Branch DR, 2002, AIDS, V16, P309, DOI 10.1097/00002030-200202150-00001; Brenneman DE, 2002, NEUROPEPTIDES, V36, P271, DOI 10.1016/S0143-4179(02)00045-8; Brenneman DE, 1999, BRAIN RES, V838, P27, DOI 10.1016/S0006-8993(99)01644-3; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Chorny A, 2006, ANN NY ACAD SCI, V1088, P187, DOI 10.1196/annals.1366.004; Dejda A, 2005, PHARMACOL REP, V57, P307; Delgado M, 1999, ANN NY ACAD SCI, V897, P401, DOI 10.1111/j.1749-6632.1999.tb07909.x; Delgado M, 2004, FASEB J, V18, P1453, DOI 10.1096/fj.04-1548fje; Delgado M, 2001, Arch Physiol Biochem, V109, P377; Delgado M, 1999, J NEUROIMMUNOL, V96, P167, DOI 10.1016/S0165-5728(99)00023-5; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Garzino-Demo A, 2000, IMMUNOL REV, V177, P79, DOI 10.1034/j.1600-065X.2000.17711.x; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gonzalez-Rey E, 2008, BRAIN BEHAV IMMUN, V22, P35, DOI 10.1016/j.bbi.2007.07.004; Gonzalez-Rey E, 2007, CURR PHARM DESIGN, V13, P1113, DOI 10.2174/138161207780618966; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Kim WK, 2000, J NEUROSCI, V20, P3622, DOI 10.1523/JNEUROSCI.20-10-03622.2000; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Langer I, 2007, BIOCHEM SOC T, V35, P724, DOI 10.1042/BST0350724; Larocca L, 2007, INT IMMUNOPHARMACOL, V7, P1343, DOI 10.1016/j.intimp.2007.05.017; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MONTANER LJ, 1994, J GEN VIROL, V75, P3393, DOI 10.1099/0022-1317-75-12-3393; Naif HM, 1996, AIDS RES HUM RETROV, V12, P1237, DOI 10.1089/aid.1996.12.1237; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Pozo D, 2007, PEPTIDES, V28, P1833, DOI 10.1016/j.peptides.2007.04.008; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Sanchez A, 2009, NEUROPEPTIDES, V43, P315, DOI 10.1016/j.npep.2009.05.002; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Souza TML, 2011, BLOOD, V117, P2944, DOI 10.1182/blood-2010-05-287193; WEISSMAN D, 1994, AIDS RES HUM RETROV, V10, P1199, DOI 10.1089/aid.1994.10.1199	47	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67701	10.1371/journal.pone.0067701	http://dx.doi.org/10.1371/journal.pone.0067701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818986	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800143
J	Capozzi, A; Vincentini, O; Gizzi, P; Porzia, A; Longo, A; Felli, C; Mattei, V; Mainiero, F; Silano, M; Sorice, M; Misasi, R				Capozzi, Antonella; Vincentini, Olimpia; Gizzi, Pietro; Porzia, Alessandra; Longo, Agostina; Felli, Cristina; Mattei, Vincenzo; Mainiero, Fabrizio; Silano, Marco; Sorice, Maurizio; Misasi, Roberta			Modulatory Effect of Gliadin Peptide 10-mer on Epithelial Intestinal CACO-2 Cell Inflammatory Response	PLOS ONE			English	Article							CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; DIETARY GLUTEN; ACTIVATION; THERAPY; CHALLENGE; SECRETION; MUCOSA; IL-8	Celiac Disease (CD) is a chronic inflammatory enteropathy, triggered in genetically susceptible individuals by dietary gluten. Gluten is able to elicit proliferation of specific T cells and secretion of inflammatory cytokines in the small intestine. In this study we investigated the possibility that p10-mer, a decapeptide from durum wheat (QQPQDAVQPF), which was previously shown to prevent the activation of celiac peripheral lymphocytes, may exert an inhibitory effect on peptic-tryptic digested gliadin (PT-Gly)-stimulated intestinal carcinoma CACO-2 cells. In these cells, incubated with PT-Gly or p31-43 alpha-gliadin derived peptide in the presence or in the absence of p10-mer, IRAK1 activation and NF-kB, ERK1/2 and p38 MAPK phosphorylation were measured by immunoblotting, Cyclooxigenase 2 (COX-2) activity by PGE-2 release assay, and production of cytokines in the cell supernatants by ELISA. Our results showed that pre-treatment of CACO-2 cells with p10-mer significantly inhibited IRAK1 activation and NF-kB, ERK1/2 and p38 MAPK phosphorylation, as well as COX-2 activity (i.e. PGE-2 release) and production of the IL-6 and IL-8 pro-inflammatory cytokines, induced by gliadin peptides. These findings demonstrate the inhibitory effect of the p10-mer peptide on inflammatory response in CACO-2 cells. The results of the present study show that this p10-mer peptide can modulate "in vitro" the inflammatory response induced by gliadin peptides, allowing to move towards new therapeutic strategies. Turning off the inflammatory response, may in fact represent a key target in the immunotherapy of celiac disease.	[Capozzi, Antonella; Gizzi, Pietro; Porzia, Alessandra; Longo, Agostina; Mainiero, Fabrizio; Sorice, Maurizio; Misasi, Roberta] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Vincentini, Olimpia; Felli, Cristina; Silano, Marco] Ist Super Sanita, Unit Human Nutr & Hlth, I-00161 Rome, Italy; [Mattei, Vincenzo] Univ La Sapienza, Expt Med & Environm Pathol Lab, Rieti, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome	Misasi, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	roberta.misasi@uniromal.it	Sorice, Maurizio/Q-5079-2019; Silano, Marco/AAC-9792-2022; Mattei, Vincenzo/AAQ-3667-2020; vincentini, olimpia/N-3332-2019; Sousa, Maria/HCI-9642-2022; Felli, Cristina/I-9795-2014; VINCENTINI, OLIMPIA/B-3837-2015; porzia, alessandra/AAA-7753-2020; Silano, Marco/B-3835-2015	Mattei, Vincenzo/0000-0003-4677-088X; vincentini, olimpia/0000-0002-4137-4135; Felli, Cristina/0000-0002-5253-0367; VINCENTINI, OLIMPIA/0000-0002-4137-4135; Silano, Marco/0000-0002-7051-3405; Sorice, Maurizio/0000-0003-3534-1502; Mainiero, Fabrizio/0000-0002-7136-9839; porzia, alessandra/0000-0002-7545-3018	University La Sapienza School of Medicine	University La Sapienza School of Medicine	This work has been supported by grants from the University La Sapienza School of Medicine (to RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Camarca A, 2009, J IMMUNOL, V182, P4158, DOI 10.4049/jimmunol.0803181; Chow WL, 2008, BRIT J NUTR, V99, P449, DOI 10.1017/S0007114507812062; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; De Vita P, 2012, J CEREAL SCI, V55, P234, DOI 10.1016/j.jcs.2011.12.006; DeVincenzi M, 1997, TOXICOLOGY, V120, P207, DOI 10.1016/S0300-483X(97)00060-7; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hall RP, 2007, J INVEST DERMATOL, V127, P2158, DOI 10.1038/sj.jid.5700929; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; Kelly CP, 2013, ALIMENT PHARM THER, V37, P252, DOI 10.1111/apt.12147; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; LAVO B, 1990, GASTROENTEROLOGY, V99, P703, DOI 10.1016/0016-5085(90)90958-4; Lerner A, 2010, AUTOIMMUN REV, V9, P144, DOI 10.1016/j.autrev.2009.05.002; Londei M, 2005, MOL IMMUNOL, V42, P913, DOI 10.1016/j.molimm.2004.12.005; Maiuri L, 2005, GASTROENTEROLOGY, V129, P1400, DOI 10.1053/j.gastro.2005.07.054; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Martin-Venegas R, 2006, J LIPID RES, V47, P1416, DOI 10.1194/jlr.M500564-JLR200; Morisi G, 1979, PEDIATR RES, V131, P255; Pardin C, 2008, J ORG CHEM, V73, P5766, DOI 10.1021/jo8004843; Pinier M, 2009, GASTROENTEROLOGY, V136, P288, DOI 10.1053/j.gastro.2008.09.016; Salvati VM, 2005, GUT, V54, P46, DOI 10.1136/gut.2003.023150; Siegel M, 2007, BIOORGAN MED CHEM, V15, P6253, DOI 10.1016/j.bmc.2007.06.020; Silano M, 2008, AM J CLIN NUTR, V87, P415, DOI 10.1093/ajcn/87.2.415; Silano M, 2007, PEDIATR RES, V61, P67, DOI 10.1203/01.pdr.0000250173.88049.79; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Vincentini O, 2011, CLIN NUTR, V30, P541, DOI 10.1016/j.clnu.2011.02.007	34	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66561	10.1371/journal.pone.0066561	http://dx.doi.org/10.1371/journal.pone.0066561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823806	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400130
J	Sun, RX; Kittichotirat, W; Wang, J; Jan, M; Chen, WZ; Asikainen, S; Bumgarner, R; Chen, C				Sun, Ruoxing; Kittichotirat, Weerayuth; Wang, Justin; Jan, Minnie; Chen, Weizhen; Asikainen, Sirkka; Bumgarner, Roger; Chen, Casey			Genomic Stability of Aggregatibacter actinomycetemcomitans during Persistent Oral Infection in Human	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HELICOBACTER-PYLORI; PSEUDOMONAS-AERUGINOSA; INTRAFAMILIAL TRANSMISSION; PERIODONTAL PATHOGENS; SUBGINGIVAL PLAQUE; SEROTYPES; EVOLUTION; ANTIGEN; HYBRIDIZATION	The genome of periodontal pathogen Aggregatibacter actinomycetemcomitans exhibits substantial variations in gene content among unrelated strains primarily due to the presence or absence of genomic islands. This study examined the genomic stability of A. actinomycetemcomitans during its persistent infection in the same host. Four pairs of A. actinomycetemcomitans strains, each pair isolated from an individual over time (0-10 years), were examined for their gains/losses of genes by whole genome sequencing, comparative genomic hybridization by microarray and PCR analysis. Possible effects due to genomic changes were further assessed by comparative transcriptome analysis using microarrays. The results showed that each pair of strains was clonally identical based on phylogenetic analysis of 150 core genes. A novel 24.1-Kb plasmid found in strain S23A was apparently lost in the sibling strain I23C. A 353-bp inversion affecting two essential genes of the serotype-specific gene cluster was found in the serotype antigen-nonexpressing strain I23C, while the same gene cluster was intact in the serotype-expressing sibling strain S23A. A 2,293-bp deletion affecting a gene encoding oxaloacetate decarboxylase and its neighbor region was found in strain SCC2302 but not in the sibling strain AAS4a. However, no evidence of gains or losses of genomic islands was found in the paired strains. Transcriptome profiles showed little or no difference in the paired strains. In conclusion, the genome of A. actinomycetemcomitans appears to be relatively stable during short-term infection. Several types of genomic changes were observed in the paired strains of A. actinomycetemcomitans recovered from the same subjects, including a mutation in serotype-specific gene cluster that may allow the bacteria to evade host immune response.	[Sun, Ruoxing; Wang, Justin; Jan, Minnie; Chen, Weizhen; Chen, Casey] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA; [Kittichotirat, Weerayuth; Bumgarner, Roger] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Kittichotirat, Weerayuth] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand; [Asikainen, Sirkka] Umea Univ, Dept Oral Microbiol, Umea, Sweden	University of Southern California; University of Washington; University of Washington Seattle; King Mongkuts University of Technology Thonburi; Umea University	Chen, C (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA.	ccchen@usc.edu	Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger E/K-3531-2015; Jan, Minnie/ABC-3695-2021	Bumgarner, Roger E/0000-0002-8168-6985; Kittichotirat, Weerayuth/0000-0001-8397-633X	National Institutes of Health [RO1 DE012212]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was supported by National Institutes of Health grant RO1 DE012212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALALUUSUA S, 1991, J PERIODONTOL, V62, P207, DOI 10.1902/jop.1991.62.3.207; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Asikainen S, 1997, J AM DENT ASSOC, V128, P1263, DOI 10.14219/jada.archive.1997.0403; ASIKAINEN S, 1991, J PERIODONTOL, V62, P203, DOI 10.1902/jop.1991.62.3.203; Asikainen S, 1999, PERIODONTOL 2000, V20, P65, DOI 10.1111/j.1600-0757.1999.tb00158.x; Asikainen S, 1996, ORAL MICROBIOL IMMUN, V11, P387, DOI 10.1111/j.1399-302X.1996.tb00200.x; ASIKAINEN S, 1995, ORAL MICROBIOL IMMUN, V10, P65, DOI 10.1111/j.1399-302X.1995.tb00120.x; Asikainen S, 1997, CLIN INFECT DIS, V25, pS227, DOI 10.1086/516211; ASIKAINEN S, 1991, ORAL MICROBIOL IMMUN, V6, P115, DOI 10.1111/j.1399-302X.1991.tb00462.x; Chen C, 2010, MOL ORAL MICROBIOL, V25, P207, DOI 10.1111/j.2041-1014.2010.00567.x; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Di Bonaventura MP, 2009, J BACTERIOL, V191, P4693, DOI 10.1128/JB.00447-09; Dogan B, 2008, J PERIODONTOL, V79, P307, DOI [10.1902/jop.2008.070270, 10.1902/jop.2008.070270 ]; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujise O, 2008, ORAL MICROBIOL IMMUN, V23, P226, DOI 10.1111/j.1399-302X.2007.00416.x; Fujise O, 2004, ORAL MICROBIOL IMMUN, V19, P340, DOI 10.1111/j.1399-302x.2004.00157.x; Gu K, 1998, ORAL MICROBIOL IMMUN, V13, P150, DOI 10.1111/j.1399-302X.1998.tb00726.x; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; Huang Y, 2013, MOL ORAL MICROBIOL, V28, P1, DOI 10.1111/omi.12005; Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Kanasi E, 2010, J DENT RES, V89, P292, DOI 10.1177/0022034509358865; Karched M, 2007, J MICROBIOL METH, V68, P46, DOI 10.1016/j.mimet.2006.06.004; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kiewitz C, 2000, MICROBIOL-UK, V146, P2365, DOI 10.1099/00221287-146-10-2365; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Maughan H, 2009, J BACTERIOL, V191, P428, DOI 10.1128/JB.01234-08; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; NOVAK KF, 1994, PLASMID, V31, P31, DOI 10.1006/plas.1994.1004; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PAGE RC, 1991, INFECT IMMUN, V59, P3451, DOI 10.1128/IAI.59.10.3451-3462.1991; Paju S, 1998, J CLIN MICROBIOL, V36, P2019, DOI 10.1128/JCM.36.7.2019-2022.1998; Patra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043370; Rylev M, 2008, J CLIN PERIODONTOL, V35, P346, DOI 10.1111/j.1600-051X.2008.01280.x; SAARELA M, 1992, ORAL MICROBIOL IMMUN, V7, P277, DOI 10.1111/j.1399-302X.1992.tb00588.x; SAARELA M, 1993, ORAL MICROBIOL IMMUN, V8, P349, DOI 10.1111/j.1399-302X.1993.tb00610.x; Saarela MH, 1999, J PERIODONTOL, V70, P504, DOI 10.1902/jop.1999.70.5.504; Silva IN, 2011, MICROBIOL-SGM, V157, P3124, DOI 10.1099/mic.0.050989-0; Smeets LC, 2002, TRENDS MICROBIOL, V10, P159, DOI 10.1016/S0966-842X(02)02314-4; Takada K, 2010, MOL ORAL MICROBIOL, V25, P200, DOI 10.1111/j.2041-1014.2010.00572.x; Yakoob J, 2000, APMIS, V108, P482, DOI 10.1034/j.1600-0463.2000.d01-86.x; Yoshida Y, 1998, INFECT IMMUN, V66, P107, DOI 10.1128/IAI.66.1.107-114.1998	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66472	10.1371/journal.pone.0066472	http://dx.doi.org/10.1371/journal.pone.0066472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824402	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400115
J	Zhao, DX; Zhang, XF; Chen, DS; Zhang, YK; Hong, XY				Zhao, Dong-Xiao; Zhang, Xiang-Fei; Chen, Da-Song; Zhang, Yan-Kai; Hong, Xiao-Yue			Wolbachia-Host Interactions: Host Mating Patterns Affect Wolbachia Density Dynamics	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; INDUCED HYBRID BREAKDOWN; CYTOPLASMIC INCOMPATIBILITY; ENDOSYMBIONT WOLBACHIA; TETRANYCHUS-URTICAE; DROSOPHILA; INFECTION; MOSQUITO; FITNESS; MITOCHONDRIAL	Wolbachia are maternally inherited intracellular bacteria that infect a wide range of arthropods and cause an array of effects on host reproduction, fitness and mating behavior. Although our understanding of the Wolbachia-associated effects on hosts is rapidly expanding, our knowledge of the host factors that mediate Wolbachia dynamics is rudimentary. Here, we explore the interactions between Wolbachia and its host, the two-spotted spider mite Tetranychus urticae Koch. Our results indicate that Wolbachia induces strong cytoplasmic incompatibility (CI), increases host fecundity, but has no effects on the longevity of females and the mating competitiveness of males in T. urticae. Most importantly, host mating pattern was found to affect Wolbachia density dynamics during host aging. Mating of an uninfected mite of either sex with an infected mite attenuates the Wolbachia density in the infected mite. According to the results of Wolbachia localization, this finding may be associated with the tropism of Wolbachia for the reproductive tissue in adult spider mites. Our findings describe a new interaction between Wolbachia and their hosts.	[Zhao, Dong-Xiao; Zhang, Xiang-Fei; Chen, Da-Song; Zhang, Yan-Kai; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020		Science and Technology Program of the National Public Welfare Professional Fund, Ministry of Agriculture of China [201103020]; National Basic Science Program of China (973 program) [2009CB119202]; National Natural Science Foundation of China [31172131]	Science and Technology Program of the National Public Welfare Professional Fund, Ministry of Agriculture of China; National Basic Science Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Grant-in-Aid from the Science and Technology Program of the National Public Welfare Professional Fund (number 201103020) from the Ministry of Agriculture of China (www.moa.gov.cn), a Grant-in-Aid from the National Basic Science Program of China (973 program, number 2009CB119202)(www.most.gov.cn), and a Grant-in-Aid for Scientific Research (number 31172131) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Bordenstein SR, 2003, GENETICS, V164, P223; Breeuwer JAJ, 1997, HEREDITY, V79, P41, DOI 10.1038/hdy.1997.121; Calvitti M, 2009, MED VET ENTOMOL, V23, P132, DOI 10.1111/j.1365-2915.2008.00791.x; Carrington LB, 2010, P ROY SOC B-BIOL SCI, V277, P2059, DOI 10.1098/rspb.2010.0166; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Cone W.W., 1985, P243; Corsaro D, 1999, CRIT REV MICROBIOL, V25, P39, DOI 10.1080/10408419991299167; De Crespigny FEC, 2006, J EVOLUTION BIOL, V19, P1964, DOI 10.1111/j.1420-9101.2006.01143.x; de Crespigny FEC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1229, DOI 10.1007/s00265-007-0353-y; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koukou K, 2006, EVOLUTION, V60, P87, DOI 10.1111/j.0014-3820.2006.tb01084.x; Lu MH, 2012, EXP APPL ACAROL, V58, P207, DOI 10.1007/s10493-012-9578-1; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Mouton L, 2005, HEREDITY, V94, P187, DOI 10.1038/sj.hdy.6800596; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; Perrot-Minnot MJ, 2002, J EVOLUTION BIOL, V15, P808, DOI 10.1046/j.1420-9101.2002.00446.x; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Snook RR, 2000, GENETICS, V155, P167; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vala F, 2000, P ROY SOC B-BIOL SCI, V267, P1931, DOI 10.1098/rspb.2000.1232; Vala F, 2003, EXP APPL ACAROL, V29, P253, DOI 10.1023/A:1025810414956; Vala F, 2003, EXP APPL ACAROL, V29, P1, DOI 10.1023/A:1024279831966; Vavre F, 2000, EVOLUTION, V54, P191, DOI 10.1111/j.0014-3820.2000.tb00019.x; Veneti Z, 2003, GENETICS, V164, P545; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xie L, 2006, ZOOTAXA, P33, DOI 10.11646/zootaxa.1165.1.2; Xie RR, 2011, APPL ENTOMOL ZOOL, V46, P95, DOI 10.1007/s13355-010-0014-x; Zhao DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054964; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhu LY, 2012, CURR MICROBIOL, V65, P516, DOI 10.1007/s00284-012-0190-8; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	54	25	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66373	10.1371/journal.pone.0066373	http://dx.doi.org/10.1371/journal.pone.0066373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823081	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400096
J	Sferruzzi-Perri, AN; Vaughan, OR; Haro, M; Cooper, WN; Musial, B; Charalambous, M; Pestana, D; Ayyar, S; Ferguson-Smith, AC; Burton, GJ; Constancia, M; Fowden, AL				Sferruzzi-Perri, Amanda N.; Vaughan, Owen R.; Haro, Maria; Cooper, Wendy N.; Musial, Barbara; Charalambous, Marika; Pestana, Diogo; Ayyar, Shruti; Ferguson-Smith, Anne C.; Burton, Graham J.; Constancia, Miguel; Fowden, Abigail L.			An obesogenic diet during mouse pregnancy modifies maternal nutrient partitioning and the fetal growth trajectory	FASEB JOURNAL			English	Article						resource allocation; developmental programming; metabolic signaling pathways; imprintome; placental phenotype	DIFFUSIONAL EXCHANGE CHARACTERISTICS; HIGH-FAT DIET; PLACENTAL PHENOTYPE; SIGNALING PATHWAYS; DOWN-REGULATION; GENE; UNDERNUTRITION; RESTRICTION; ADAPTATIONS; EXPRESSION	In developed societies, high-sugar and high-fat (HSHF) diets are now the norm and are increasing the rates of maternal obesity during pregnancy. In pregnant rodents, these diets lead to cardiovascular and metabolic dysfunction in their adult offspring, but the intrauterine mechanisms involved remain unknown. This study shows that, relative to standard chow, HSHF feeding throughout mouse pregnancy increases maternal adiposity (+30%, P<0.05) and reduces fetoplacental growth at d 16 (-10%, P<0.001). At d 19, however, HSHF diet group pup weight had normalized, despite the HSHF diet group placenta remaining small and morphologically compromised. This altered fetal growth trajectory was associated with enhanced placental glucose and amino acid transfer (+35%, P<0.001) and expression of their transporters (+40%, P<0.024). HSHF feeding also up-regulated placental expression of fatty acid transporter protein, metabolic signaling pathways (phosphoinositol 3-kinase and mitogen-activated protein kinase), and several growth regulatory imprinted genes (Igf2, Dlk1, Snrpn, Grb10, and H19) independently of changes in DNA methylation. Obesogenic diets during pregnancy, therefore, alter maternal nutrient partitioning, partly through changes in the placental phenotype, which helps to meet fetal nutrient demands for growth near term. However, by altering provision of specific nutrients, dietary-induced placental adaptations have important roles in programming development with health implications for the offspring in later life.Sferruzzi-Perri, A. N., Vaughan, O. R., Haro, M., Cooper, W. N., Musial, B., Charalambous, M., Pestana, D., Ayyar, S., Ferguson-Smith, A. C., Burton, G. J., Constancia, M., Fowden, A. L. An obesogenic diet during mouse pregnancy modifies maternal nutrient partitioning and the fetal growth trajectory.	[Sferruzzi-Perri, Amanda N.; Vaughan, Owen R.; Musial, Barbara; Charalambous, Marika; Ayyar, Shruti; Burton, Graham J.; Constancia, Miguel; Fowden, Abigail L.] Univ Cambridge, Ctr Trophoblast Res, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Haro, Maria; Cooper, Wendy N.; Pestana, Diogo; Ferguson-Smith, Anne C.; Constancia, Miguel] Cambridege Biomed Res Ctr, Metab Res Labs, Dept Obstet & Gynaecol, Cambridge, England; [Haro, Maria; Cooper, Wendy N.; Pestana, Diogo; Ferguson-Smith, Anne C.; Constancia, Miguel] Cambridege Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Sferruzzi-Perri, AN (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	ans48@cam.ac.uk	Constancia, Miguel/F-6654-2013	Constancia, Miguel/0000-0002-8976-1679; Sferruzzi-Perri, Amanda/0000-0002-4931-4233; Ferguson-Smith, Anne/0000-0002-7608-5894; Pestana, Diogo/0000-0001-6332-7914; Charalambous, Marika/0000-0002-1684-5783	UK Biotechnology and Biological Sciences Research Council; Centre for Trophoblast Research (CTR); C.J. Martin Overseas Biomedical Fellowship from the Australian National Health and Medical Research Council; Next Generation Fellowship from the CTR; CTR; Medical Research Council; BBSRC [BB/I014594/1] Funding Source: UKRI; MRC [G0600717, MR/J001597/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C513626/1, BB/I014594/1] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish; Medical Research Council [G0600717, G0600717B, MR/J001597/1, MC_UU_12012/5/B] Funding Source: researchfish; Wellcome Trust [095606/Z/11/Z] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Trophoblast Research (CTR); C.J. Martin Overseas Biomedical Fellowship from the Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Next Generation Fellowship from the CTR; CTR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Nuala Daw, Chris Cardinal, and Wendy Cassidy for technical help. This work was supported by the UK Biotechnology and Biological Sciences Research Council and the Centre for Trophoblast Research (CTR). A.N.S.-P. received a C.J. Martin Overseas Biomedical Fellowship from the Australian National Health and Medical Research Council and a Next Generation Fellowship from the CTR. O.R.V. received a Ph.D. studentship from CTR. B.M. received a Ph.D. studentship from the Medical Research Council.	Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Angiolini E, 2011, FASEB J, V25, P1737, DOI 10.1096/fj.10-175273; Appelbe OK, 2013, MECH DEVELOP, V130, P143, DOI 10.1016/j.mod.2012.09.010; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Charalambous M, 2012, CELL METAB, V15, P209, DOI 10.1016/j.cmet.2012.01.006; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Coan PM, 2008, J PHYSIOL-LONDON, V586, P5023, DOI 10.1113/jphysiol.2008.157313; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2011, J PHYSIOL-LONDON, V589, P3659, DOI 10.1113/jphysiol.2011.208629; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Ivanova E, 2012, EPIGENETICS-US, V7, P1200, DOI 10.4161/epi.22141; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Jansson T, 2012, PLACENTA, V33, pE23, DOI 10.1016/j.placenta.2012.05.010; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Lin Y, 2011, BRIT J NUTR, V106, P510, DOI 10.1017/S0007114511000614; Ma Y, 2011, PLACENTA, V32, P255, DOI 10.1016/j.placenta.2011.01.007; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Petry CJ, 2011, EXP DIABETES RES, DOI 10.1155/2011/171376; Petry CJ, 2010, DIABETES, V59, P282, DOI 10.2337/db09-0757; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rasmussen T, 2009, DIABETES CARE, V32, P1904, DOI 10.2337/dc09-0663; Redmer DA, 2009, REPRODUCTION, V137, P749, DOI 10.1530/REP-08-0516; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schieve L A, 1998, Matern Child Health J, V2, P111, DOI 10.1023/A:1022992823185; Sferruzzi-Perri AN, 2011, ENDOCRINOLOGY, V152, P3202, DOI 10.1210/en.2011-0240; Sferruzzi-Perri AN, 2009, BIOL REPROD, V81, P207, DOI 10.1095/biolreprod.108.073312; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Swan G, 2004, P NUTR SOC, V63, P505, DOI 10.1079/PNS2004381; Thorsdottir I, 2002, OBSTET GYNECOL, V99, P799, DOI 10.1016/S0029-7844(02)01946-4; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wallace JM, 2004, BIOL REPROD, V71, P1055, DOI 10.1095/biolreprod.104.030965; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Zhu MJ, 2007, PLACENTA, V28, P1192, DOI 10.1016/j.placenta.2007.05.004; Zhu MJ, 2009, PLACENTA, V30, P405, DOI 10.1016/j.placenta.2009.02.001; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	57	104	104	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3928	3937		10.1096/fj.13-234823	http://dx.doi.org/10.1096/fj.13-234823			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825226				2022-12-25	WOS:000329747100008
J	Layer, JH; Weil, PA				Layer, Justin H.; Weil, P. Anthony			Direct TFIIA-TFIID Protein Contacts Drive Budding Yeast Ribosomal Protein Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; CORE PROMOTER DNA; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; IN-VIVO; CRYSTAL-STRUCTURE; ACTIVATED TRANSCRIPTION; TFIIA/TBP/DNA COMPLEX; FUNCTIONAL-ANALYSIS	We have previously shown that yeast TFIID provides coactivator function on the promoters of ribosomal protein-encoding genes (RPGs) by making direct contact with the transactivator repressor activator protein 1 (Rap1). Further, our structural studies of assemblies generated with purified Rap1, TFIID, and TFIIA on RPG enhancer-promoter DNA indicate that Rap1-TFIID interaction induces dramatic conformational rearrangements of enhancer-promoter DNA and TFIID-bound TFIIA. These data indicate a previously unknown yet critical role for yeast TFIIA in the integration of activator-TFIID contacts with promoter conformation and downstream preinitiation complex formation and/or function. Here we describe the use of systematic mutagenesis to define how specific TFIIA contacts contribute to these processes. We have verified that TFIIA is required for RPG transcription in vivo and in vitro, consistent with the existence of a critical Rap1-TFIIA-TFIID interaction network. We also identified essential points of contact for TFIIA and Rap1 within the Rap1 binding domain of the Taf4 subunit of TFIID. These data suggest a mechanism for how interactions between TFIID, TFIIA, and Rap1 contribute to the high rate of transcription initiation seen on RPGs in vivo.	[Layer, Justin H.; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			National Institutes of Health [GM52461]; NCI, National Institutes of Health, Cancer Center Support Grant [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052461, R56GM052461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52461 (to P. A. W.). RNA-Seq analyses were supported in part by NCI, National Institutes of Health, Cancer Center Support Grant P30 CA068485, utilizing the Genome Sciences Shared Resource.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bai Y, 1997, MOL CELL BIOL, V17, P3081, DOI 10.1128/MCB.17.6.3081; Banik U, 2001, J BIOL CHEM, V276, P49100, DOI 10.1074/jbc.M109246200; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belinchon NM, 2004, FEMS YEAST RES, V4, P751, DOI 10.1016/j.femsyr.2004.02.004; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Emami KH, 1997, GENE DEV, V11, P3007, DOI 10.1101/gad.11.22.3007; Fribourg S, 2001, J MOL BIOL, V306, P363, DOI 10.1006/jmbi.2000.4376; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kraemer SM, 2001, MOL CELL BIOL, V21, P1737, DOI 10.1128/MCB.21.5.1737-1746.2001; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu Q, 1999, MOL CELL BIOL, V19, P8673; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murakami K, 2013, J BIOL CHEM, V288, P6325, DOI 10.1074/jbc.M112.433623; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; Reese JC, 2003, METHOD ENZYMOL, V370, P415; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Robinson MM, 2005, MOL CELL BIOL, V25, P945, DOI 10.1128/MCB.25.3.945-957.2005; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; SIKORSKI RS, 1989, GENETICS, V122, P19; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; VANDYKE MW, 1989, MOL CELL BIOL, V9, P342, DOI 10.1128/MCB.9.1.342; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; Zhang HS, 2008, J BIOL CHEM, V283, P27360, DOI 10.1074/jbc.M803831200; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005	93	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23273	23294		10.1074/jbc.M113.486829	http://dx.doi.org/10.1074/jbc.M113.486829			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814059	Green Published, hybrid			2022-12-25	WOS:000330598200034
J	Sakuraba, J; Shintani, T; Tani, S; Noda, M				Sakuraba, Juichi; Shintani, Takafumi; Tani, Sachiko; Noda, Masaharu			Substrate Specificity of R3 Receptor-like Protein-tyrosine Phosphatase Subfamily toward Receptor Protein-tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PC12 CELLS; NEURITE OUTGROWTH; TRAPPING SYSTEM; EPH RECEPTORS; DIFFERENTIATION; ROLES; PHOSPHORYLATION; CD148; IDENTIFICATION	Receptor-like protein-tyrosine phosphatases (RPTPs) are involved in various aspects of cellular functions, such as proliferation, differentiation, survival, migration, and metabolism. A small number of RPTPs have been reported to regulate activities of some cellular proteins including receptor protein-tyrosine kinases (RPTKs). However, our understanding about the roles of individual RPTPs in the regulation of RPTKs is still limited. The R3 RPTP subfamily reportedly plays pivotal roles in the development of several tissues including the vascular and nervous systems. Here, we examined enzyme-substrate relationships between the four R3 RPTP subfamily members and 21 RPTK members selected from 14 RPTK subfamilies by using a mammalian two-hybrid system with substrate-trapping RPTP mutants. Among the 84 RPTP-RPTK combinations conceivable, we detected 30 positive interactions: 25 of the enzyme-substrate relationships were novel. We randomly chose several RPTKs assumed to be substrates for R3 RPTPs, and validated the results of this screen by in vitro dephosphorylation assays, and by cell-based assays involving overexpression and knockdown experiments. Because their functional relationships were verified without exception, it is probable that the RPTKs identified as potential substrates are actually physiological substrates for the R3 RPTPs. Interestingly, some RPTKs were recognized as substrates by all R3 members, but others were recognized by only one or a few members. The enzyme-substrate relationships identified in the present study will shed light on physiological roles of the R3 RPTP subfamily.	[Sakuraba, Juichi; Shintani, Takafumi; Tani, Sachiko; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Sakuraba, Juichi; Shintani, Takafumi; Tani, Sachiko; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Shintani, Takafumi/0000-0002-6165-2307	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chen ZY, 2001, NEUROSCIENCE, V104, P593, DOI 10.1016/S0306-4522(01)00093-8; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Flanagan JG, 1997, CELL, V90, P403; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Gatto G, 2013, J NEUROSCI, V33, P5399, DOI 10.1523/JNEUROSCI.4707-12.2013; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; Gonzalez-Brito MR, 2009, MOL CELL NEUROSCI, V42, P458, DOI 10.1016/j.mcn.2009.09.009; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Keane MM, 1996, CANCER RES, V56, P4236; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; SANO M, 1992, J NEUROCHEM, V58, P837, DOI 10.1111/j.1471-4159.1992.tb09333.x; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Xu YR, 2012, NEOPLASIA, V14, P1015, DOI 10.1593/neo.12870	42	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23421	23431		10.1074/jbc.M113.458489	http://dx.doi.org/10.1074/jbc.M113.458489			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814054	hybrid, Green Published			2022-12-25	WOS:000330598200045
J	Alam, MM; Khurshid, A; Shaukat, S; Suleman, RM; Sharif, S; Angez, M; Malik, SA; Ahmed, TM; Aamir, UB; Naeem, M; Zaidi, SSZ				Alam, Muhammad Masroor; Khurshid, Adnan; Shaukat, Shahzad; Suleman, Rana Muhammad; Sharif, Salmaan; Angez, Mehar; Malik, Salman Akbar; Ahmed, Tahir Masood; Aamir, Uzma Bashir; Naeem, Muhammad; Zaidi, Syed Sohail Zahoor			Epidemiology and Genetic Diversity of Rotavirus Strains in Children with Acute Gastroenteritis in Lahore, Pakistan	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; POLYMERASE-CHAIN-REACTION; UNITED-STATES; VIRAL GASTROENTERITIS; VACCINE-INTRODUCTION; DIARRHEAL DISEASE; SEROTYPE G9; VP7; SURVEILLANCE; EFFICACY	Pakistan harbors high disease burden of gastro-enteric infections with majority of these caused by rotavirus. Unfortunately, lack of proper surveillance programs and laboratory facilities have resulted in scarcity of available data on rotavirus associated disease burden and epidemiological information in the country. We investigated 1306 stool samples collected over two years (2008-2009) from hospitalized children under 5 years of age for the presence of rotavirus strains and its genotypic diversity in Lahore. The prevalence rate during 2008 and 2009 was found to be 34% (n = 447 out of 1306). No significant difference was found between different age groups positive for rotavirus (p>0.05). A subset of EIA positive samples was further screened for rotavirus RNA through RT-PCR and 44 (49.43%) samples, out of total 89 EIA positive samples, were found positive. G and P type prevalence was found as follows: G1P [4] = 3(6.81%); G1P [6] = 9(20.45%); G1P [8] = 1(2.27%); G2P [4] = 21(47.72%); G2P [8] = 1(2.27%); G9P [4] = 1(2.27%); G9P [6] = 1(2.27%) and G9P [8] = 7(15.90%). Phylogenetic analysis revealed that the VP7 and VP4 sequences clustered closely with the previously detected strains in the country as well as Belgian rotaviruses. Antigenic characterization was performed by analyzing major epitopes in the immunodominant VP7 and VP4 gene segments. Although the neutralization conferring motifs were found variable between the Pakistani strains and the two recommended vaccines strains (Rotarix (TM) and RotaTeq (TM)), we validate the use of rotavirus vaccine in Pakistan based on the proven and recognized vaccine efficacy across the globe. Our findings constitute the first report on rotavirus' genotype diversity, their phylogenetic relatedness and epidemiology during the pre-vaccination era in Lahore, Pakistan and support the immediate introduction of rotavirus vaccine in the routine immunization program of the country.	[Alam, Muhammad Masroor; Naeem, Muhammad] Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan; [Khurshid, Adnan; Shaukat, Shahzad; Suleman, Rana Muhammad; Sharif, Salmaan; Angez, Mehar; Aamir, Uzma Bashir; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Malik, Salman Akbar] Quaid I Azam Univ, Dept Biochem, Islamabad, Pakistan; [Ahmed, Tahir Masood] Childrens Hosp Lahore, Dept Pediat, Lahore, Pakistan	Quaid I Azam University; Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Shaukat, Shahzad/HHZ-1088-2022; Zaidi, Syed Sohail Zahoor/F-7432-2015; Angez, Mehar/J-3792-2015; Naeem, Muhammad/F-4869-2011	Naeem, Muhammad/0000-0002-3894-3085				Alam MM, 2009, VIRUS RES, V144, P280, DOI 10.1016/j.virusres.2009.03.015; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1255; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; ANSARI SA, 1991, REV INFECT DIS, V13, P448; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; Bishop RF, 2001, J CLIN MICROBIOL, V39, P1085, DOI 10.1128/JCM.39.3.1085-1091.2001; Bishop RF, 1996, ARCH VIROL, P119; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Clark HF, 2004, J CLIN MICROBIOL, V42, P1434, DOI 10.1128/JCM.42.4.1434-1438.2004; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; Das S, 2003, J CLIN MICROBIOL, V41, P2760, DOI 10.1128/JCM.41.6.2760-2762.2003; Dennehy PH, 2005, INFECT DIS CLIN N AM, V19, P585, DOI 10.1016/j.idc.2005.05.003; DUTTA SR, 1990, INT J EPIDEMIOL, V19, P722, DOI 10.1093/ije/19.3.722; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Giaquinto C, 2011, HUM VACCINES, V7, P734, DOI 10.4161/hv.7.7.15511; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; HIEBER JP, 1978, AM J DIS CHILD, V132, P853, DOI 10.1001/archpedi.1978.02120340029004; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024; Iturriza-Gomara M, 2000, J MED VIROL, V61, P510, DOI 10.1002/1096-9071(200008)61:4&lt;510::AID-JMV15&gt;3.0.CO;2-Q; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Jin Q, 1996, ARCH VIROL, V141, P2057, DOI 10.1007/BF01718215; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; KONNO T, 1983, J INFECT DIS, V147, P125, DOI 10.1093/infdis/147.1.125; Koopmans M, 1999, ACTA PAEDIATR, V88, P14, DOI 10.1111/j.1651-2227.1999.tb14320.x; Laird AR, 2003, J CLIN MICROBIOL, V41, P3100, DOI 10.1128/JCM.41.7.3100-3111.2003; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Logan C, 2006, J CLIN MICROBIOL, V44, P3189, DOI 10.1128/JCM.00915-06; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; McIver CJ, 2001, PATHOLOGY, V33, P353, DOI 10.1080/00313020120062983; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Monnier N, 2006, J VIROL, V80, P1513, DOI 10.1128/JVI.80.3.1513-1523.2006; Nakagomi T, 2005, J INFECT DIS, V192, pS106, DOI 10.1086/431503; Nishio O, 2000, PEDIATR INT, V42, P425, DOI 10.1046/j.1442-200x.2000.01256.x; Oka T, 2000, MICROBIOL IMMUNOL, V44, P957, DOI 10.1111/j.1348-0421.2000.tb02590.x; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel MM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001330; Phan TG, 2007, J VIROL, V81, P4645, DOI 10.1128/JVI.02342-06; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Rahman M, 2005, J CLIN MICROBIOL, V43, P3208, DOI 10.1128/JCM.43.7.3208-3212.2005; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Soares-Weiser K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; WEN LY, 1995, MICROBIOL IMMUNOL, V39, P911, DOI 10.1111/j.1348-0421.1995.tb03277.x; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	67	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67998	10.1371/journal.pone.0067998	http://dx.doi.org/10.1371/journal.pone.0067998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825693	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000127
J	Ramsing, BGU; Arpi, M; Andersen, EA; Knabe, N; Mogensen, D; Buhl, D; Westh, H; Ostergaard, C				Ramsing, Benedicte Grenness Utke; Arpi, Magnus; Andersen, Erik Arthur; Knabe, Niels; Mogensen, Dorthe; Buhl, Dorte; Westh, Henrik; Ostergaard, Christian			First Outbreak with MRSA in a Danish Neonatal Intensive Care Unit: Risk Factors and Control Procedures	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NOSOCOMIAL TRANSMISSION; STAPHYLOCLOCCUS-AUREUS; INFECTION; COLONIZATION; INFANTS; SURVEILLANCE; CARRIAGE; NURSERY	Introduction: The purpose of the study was to describe demographic and clinical characteristics and outbreak handling of a large methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a neonatal intensive care unit (NICU) in Denmark June 25th-August 8th 2008, and to identify risk factors for MRSA transmission. Methods: Data were collected retrospectively from medical records and the Danish Neobase database. All MRSA isolates obtained from neonates, relatives and NICU health care workers (HCW) as well as environmental cultures were typed. Results: During the 46 day outbreak period, 102 neonates were admitted to the two neonatal wards. Ninety-nine neonates were subsequently sampled, and 32 neonates (32%) from 25 families were colonized with MRSA (spa-type t127, SCCmec V, PVL negative). Thirteen family members from 11 of those families (44%) and two of 161 HCWs (1%) were colonized with the same MRSA. No one was infected. Five environmental cultures were MRSA positive. In a multiple logistic regression analysis, nasal Continuous Positive Airway Pressure (nCPAP) treatment (p = 0.006) and Caesarean section (p = 0.016) were independent risk factors for MRSA acquisition, whereas days of exposure to MRSA was a risk factors in the unadjusted analysis (p = 0.04). Conclusions: MRSA transmission occurs with high frequency in the NICU during hospitalization with unidentified MRSA neonates. Caesarean section and nCPAP treatment were identified as risk factors for MRSA colonization. The MRSA outbreak was controlled through infection control procedures.	[Ramsing, Benedicte Grenness Utke; Andersen, Erik Arthur; Knabe, Niels] Copenhagen Univ Hosp, Dept Pediat, Glostrup, Denmark; [Arpi, Magnus; Mogensen, Dorthe; Buhl, Dorte; Ostergaard, Christian] Copenhagen Univ Hosp, Dept Clin Microbiol, Herlev, Denmark; [Westh, Henrik; Ostergaard, Christian] Copenhagen Univ Hosp, MRSA Knowledge Ctr, Dept Clin Microbiol, Hvidovre, Denmark; [Westh, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Ramsing, BGU (corresponding author), Copenhagen Univ Hosp, Dept Pediat, Glostrup, Denmark.	benedicte.ramsing@gmail.com		Westh, Henrik/0000-0001-5681-647X				Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Babazono A, 2008, ACTA MED OKAYAMA, V62, P261; Bartels MD, 2008, J HOSP INFECT, V70, P35, DOI 10.1016/j.jhin.2008.05.018; Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; Carey AJ, 2010, J PERINATOL, V30, P135, DOI 10.1038/jp.2009.119; Chapman AK, 2012, J PERINATOL, V32, P4, DOI 10.1038/jp.2011.148; David MD, 2006, J HOSP INFECT, V64, P244, DOI 10.1016/j.jhin.2006.06.022; Gerber SI, 2006, INFECT CONT HOSP EP, V27, P139, DOI 10.1086/501216; Gould IM, 2009, EPIDEMIOL INFECT, V137, P1242, DOI 10.1017/S0950268809002234; Gregory ML, 2009, PEDIATRICS, V123, pE790, DOI 10.1542/peds.2008-1526; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hayakawa T, 2000, PEDIATR INT, V42, P67, DOI 10.1046/j.1442-200x.2000.01177.x; Heinrich N, 2011, EUR J CLIN MICROBIOL, V30, P909, DOI 10.1007/s10096-011-1175-4; Hetem DJ, 2012, J ANTIMICROB CHEMOTH, V67, P1775, DOI 10.1093/jac/dks125; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Khoury J, 2005, INFECT CONT HOSP EP, V26, P616, DOI 10.1086/502590; Laing IA, 2009, ARCH DIS CHILD-FETAL, V94, pF307, DOI 10.1136/adc.2008.151290; Lebon A, 2010, J CLIN MICROBIOL, V48, P960, DOI 10.1128/JCM.01799-09; Lin Yu-Chen, 2007, Journal of Microbiology Immunology and Infection, V40, P325; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Maraqa NF, 2011, AM J INFECT CONTROL, V39, P35, DOI 10.1016/j.ajic.2010.07.013; McDonald JR, 2007, PEDIATR INFECT DIS J, V26, P678, DOI 10.1097/INF.0b013e3180616ce4; Milstone AM, 2010, INFECT CONT HOSP EP, V31, P766, DOI 10.1086/653615; Milstone AM, 2010, INFECT CONT HOSP EP, V31, P558, DOI 10.1086/652449; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nambiar Sumathi, 2003, Pediatr Crit Care Med, V4, P220, DOI 10.1097/01.PCC.0000059736.20597.75; Otter JA, 2007, J HOSP INFECT, V67, P232, DOI 10.1016/j.jhin.2007.07.024; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Pinter DM, 2009, AM J PERINAT, V26, P145, DOI 10.1055/s-0028-1095179; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Sakaki H, 2009, AM J INFECT CONTROL, V37, P580, DOI 10.1016/j.ajic.2009.02.008; Sax H, 2006, J HOSP INFECT, V63, P93, DOI 10.1016/j.jhin.2005.11.016; Stein M, 2006, PEDIATR INFECT DIS J, V25, P557, DOI 10.1097/01.inf.0000219407.31195.44	35	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66904	10.1371/journal.pone.0066904	http://dx.doi.org/10.1371/journal.pone.0066904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825581	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000039
J	Shan, D; Sun, JP; Yakusik, A; Chen, ZD; Yuan, JH; Li, T; Fu, J; Khoshnood, K; Yang, X; Wei, M; Duan, S; Bulterys, M; Sante, M; Ye, RH; Xiang, LF; Yang, YC				Shan, Duo; Sun, Jiangping; Yakusik, Anna; Chen, Zhongdan; Yuan, Jianhua; Li, Tao; Fu, Jeannia; Khoshnood, Kaveh; Yang, Xing; Wei, Mei; Duan, Song; Bulterys, Marc; Sante, Michael; Ye, Runhua; Xiang, Lifen; Yang, Yuecheng			Total HIV/AIDS Expenditures in Dehong Prefecture, Yunnan Province in 2010: The First Systematic Evaluation of Both Health and Non-Health Related HIV/AIDS Expenditures in China	PLOS ONE			English	Article							AREA	Objective: We assessed HIV/AIDS expenditures in Dehong Prefecture, Yunnan Province, one of the highest prevalence regions in China, and describe funding sources and spending for different categories of HIV-related interventions and at-risk populations. Methods: 2010 HIV/AIDS expenditures in Dehong Prefecture were evaluated based on UNAIDS' National AIDS Spending Assessment methodology. Results: Nearly 93% of total expenditures for HIV/AIDS was contributed by public sources. Of total expenditures, 52.7% was allocated to treatment and care, 24.5% to program management and administration and 19.8% to prevention. Spending on treatment and care was primarily allocated to the treatment of opportunistic infections. Most (40.4%) prevention spending was concentrated on most-at-risk populations, injection drug users (IDUs), sex workers, and men who have sex with men (MSM), with 5.5% allocated to voluntary counseling and testing. Prevention funding allocated for MSM, partners of people living with HIV and prisoners and other confined populations was low compared to the disproportionate burden of HIV/AIDS in these populations. Overall, people living with HIV accounted for 57.57% of total expenditures, while most-at-risk populations accounted for only 7.99%. Conclusions: Our study demonstrated the applicability of NASA for tracking and assessing HIV expenditure in the context of China, it proved to be a useful tool in understanding national HIV/AIDS response from financial aspect, and to assess the extent to which HIV expenditure matches epidemic patterns. Limited funding for primary prevention and prevention for MSM, prisoners and partners of people living with HIV, signal that resource allocation to these key areas must be strengthened. Comprehensive analyses of regional and national funding strategies are needed to inform more equitable, effective and cost-effective HIV/AIDS resource allocation.	[Shan, Duo; Sun, Jiangping; Sante, Michael] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Yakusik, Anna] UNAIDS Belarus Off, Minsk, BELARUS; [Chen, Zhongdan] UNAIDS China Off, Beijing, Peoples R China; [Yuan, Jianhua; Li, Tao] Beijing Informat & Control Inst, Beijing, Peoples R China; [Fu, Jeannia; Khoshnood, Kaveh] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Yang, Xing; Wei, Mei] Dehong Prefecture Hlth Bur, Dehong, Yunnan, Peoples R China; [Duan, Song; Ye, Runhua; Xiang, Lifen; Yang, Yuecheng] Dehong Prefecture Ctr Dis Control & Prevent, Dehong, Yunnan, Peoples R China; [Bulterys, Marc] Global AIDS Program China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Yale University	Sun, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	jpsun@chinaaids.cn	Khoshnood, Kaveh/AAX-1402-2020; Yakusik, Anna/ABF-3984-2021	Khoshnood, Kaveh/0000-0003-2795-0447; Yakusik, Anna/0000-0001-7105-9120	UNAIDS; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	UNAIDS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from UNAIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 27 CHIN INT INF CTR, P5; Aran-Matero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022373; Botswana National AIDS Coordinating Agency (NACA) Joint United Nations Program on AIDS (UNAIDS), 2007, BOTSW NAT AIDS SPEND; Council State AIDS Working Committee Office Disease Control Bureau of Ministry of Health National Center for Disease Prevention and Control, 2011, HIV AIDS PREV CONTR, P26; Country Coordinating Mechanism/National AIDS Council, 2006, ZAMB COORD MECH COUN; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Han MJ, 2010, INT J EPIDEMIOL, V39, pII47, DOI 10.1093/ije/dyq212; International Health Policy Program National Economics and Social Development Board Office of Prime Ministers, 2007, THAIL NAT AIDS SPEND; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; National Coordination Committeeto Combat HIV/AIDS Tuberculosis and Malaria in The Republic of Tajikistan Ministry of Health of The Republic of Tajikistan, 2011, TAJ NAT AIDS SPEND A; National HIV and AIDS/STI/TB Council, 2008, ZAMB NAT AIDS SPEND; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sun JP, 2010, INT J EPIDEMIOL, V39, pII14, DOI 10.1093/ije/dyq208; UNAIDS, 2009, NAT AIDS SPEND ASS N; UNAIDS, 2009, ZAMB NAT AIDS SPEND; Who UNAIDS UNICEF, 2013, UN ACC SCAL PRIOR HI, V8; Wu ZY, 2011, B WORLD HEALTH ORGAN, V89, P227, DOI 10.2471/BLT.10.082552; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	18	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68006	10.1371/journal.pone.0068006	http://dx.doi.org/10.1371/journal.pone.0068006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825694	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000128
J	Zhang, XW; Tian, WX; Cai, XZ; Wang, XF; Dang, WQ; Tang, H; Cao, H; Wang, L; Chen, TM				Zhang, Xiwen; Tian, Wenxia; Cai, Xiaozhong; Wang, Xiaofei; Dang, Weiqi; Tang, Hao; Cao, Hong; Wang, Lin; Chen, Tingmei			Hydrazinocurcumin Encapsuled Nanoparticles "Re-Educate" Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							MOLECULAR TARGETS; PROGRESSION; CURCUMIN; POLARIZATION; POPULATION; INHIBITION; APOPTOSIS; CELLS	Tumor-associated macrophages (TAMs) are essential cellular components within tumor microenvironment (TME). TAMs are educated by TME to transform to M2 polarized population, showing a M2-like phenotype, IL-10(high), IL-12(low), TGF-beta(high). STAT3 signaling triggers crosstalk between tumor cells and TAMs, and is crucial for the regulation of malignant progression. In our study, legumain-targeting liposomal nanoparticles (NPs) encapsulating HC were employed to suppress STAT3 activity and "re-educate" TAMs, and to investigate the effects of suppression of tumor progression in vivo. The results showed that TAMs treated by HC encapsuled NPs could switch to M1-like phenotype, IL-10(low), IL-12(high), TGF-beta(low), and the "re-educated" macrophages (M1-like macrophages) considerably demonstrated opposite effect of M2-like macrophages, especially the induction of 4T1 cells migration and invasion in vitro, and suppression of tumor growth, angiogenesis and metastasis in vivo. These data indicated that inhibition of STAT3 activity of TAMs by HC-NPs was able to reverse their phenotype and could regulate their crosstalk between tumor cells and TAMs in order to suppress tumor progression.	[Zhang, Xiwen; Tian, Wenxia; Cai, Xiaozhong; Wang, Xiaofei; Dang, Weiqi; Tang, Hao; Cao, Hong; Wang, Lin; Chen, Tingmei] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China	Chongqing Medical University	Chen, TM (corresponding author), Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.	chentingmei@sohu.com	Tian, Wenxi/M-4316-2016	Tian, Wenxi/0000-0001-6815-6974; Chen, Tingmei/0000-0003-4250-674X	National Natural Science Foundation of China [81272544, 30971131]; Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University	This work was supported by a grant from National Natural Science Foundation of China (No. 81272544, 30971131) and was supported in part by Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alas S, 2003, CLIN CANCER RES, V9, P316; Allavena P, 2005, CANCER RES, V65, P2964, DOI 10.1158/0008-5472.CAN-04-4037; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chiang CS, 2008, INT IMMUNOL, V20, P215, DOI 10.1093/intimm/dxm137; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; JOHN C, 2006, CELL, V124, P263, DOI DOI 10.1016/J.CELL.2006.01.007.PUBMED:16439202; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Liao D, 2011, CANCER RES, V71, P5688, DOI 10.1158/0008-5472.CAN-11-1264; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Niu GL, 2001, CANCER RES, V61, P3276; Rathore R, 2008, J PHARMACEUT BIOMED, V46, P374, DOI 10.1016/j.jpba.2007.09.019; Robinson SC, 2003, CANCER RES, V63, P8360; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Wang XF, 2012, INT J ONCOL, V40, P1189, DOI 10.3892/ijo.2011.1298; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	28	98	108	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65896	10.1371/journal.pone.0065896	http://dx.doi.org/10.1371/journal.pone.0065896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825527	Green Published, gold			2022-12-25	WOS:000321223000006
J	Lim, CB; Prele, CM; Cheah, HM; Cheng, YY; Klebe, S; Reid, G; Watkins, DN; Baltic, S; Thompson, PJ; Mutsaers, SE				Lim, Chuan Bian; Prele, Cecilia M.; Cheah, Hui Min; Cheng, Yuen Yee; Klebe, Sonja; Reid, Glen; Watkins, D. Neil; Baltic, Svetlana; Thompson, Philip J.; Mutsaers, Steven E.			Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma	PLOS ONE			English	Article							BASAL-CELL CARCINOMAS; PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; HUMAN HOMOLOG; PTCH GENE; ODONTOGENIC KERATOCYSTS; SOMATIC MUTATIONS; PATCHED GENE; PLEURAL MESOTHELIOMA; MISSENSE MUTATIONS	Background: The Hedgehog (HH) signaling pathway is critical for embryonic development and adult homeostasis. Recent studies have identified regulatory roles for this pathway in certain cancers with mutations in the HH pathway genes. The extent to which mutations of the HH pathway genes are involved in the pathogenesis of malignant mesothelioma (MMe) is unknown. Methodology/Principal Findings: Real-time PCR analysis of HH pathway genes PTCH1, GLI1 and GLI2 were performed on 7 human MMe cell lines. Exon sequencing of 13 HH pathway genes was also performed in cell lines and human MMe tumors. In silico programs were used to predict the likelihood that an amino-acid substitution would have a functional effect. GLI1, GLI2 and PTCH1 were highly expressed in MMe cells, indicative of active HH signaling. PTCH1, SMO and SUFU mutations were found in 2 of 11 MMe cell lines examined. A non-synonymous missense SUFU mutation (p.T411M) was identified in LO68 cells. In silico characterization of the SUFU mutant suggested that the p.T411M mutation might alter protein function. However, we were unable to demonstrate any functional effect of this mutation on Gli activity. Deletion of exons of the PTCH1 gene was found in JU77 cells, resulting in loss of one of two extracellular loops implicated in HH ligand binding and the intracellular C-terminal domain. A 3-bp insertion (69_70insCTG) in SMO, predicting an additional leucine residue in the signal peptide segment of SMO protein was also identified in LO68 cells and a MMe tumour. Conclusions/Significance: We identified the first novel mutations in PTCH1, SUFU and SMO associated with MMe. Although HH pathway mutations are relatively rare in MMe, these data suggest a possible role for dysfunctional HH pathway in the pathogenesis of a subgroup of MMe and help rationalize the exploration of HH pathway inhibitors for MMe therapy.	[Lim, Chuan Bian; Prele, Cecilia M.; Cheah, Hui Min; Baltic, Svetlana; Thompson, Philip J.; Mutsaers, Steven E.] Univ Western Australia, Sch Med & Pharmacol, Lung Inst Western Australia, Crawley, WA, Australia; [Lim, Chuan Bian; Prele, Cecilia M.; Cheah, Hui Min; Baltic, Svetlana; Thompson, Philip J.; Mutsaers, Steven E.] Univ Western Australia, Sch Med & Pharmacol, Dept Med, Ctr Asthma Allergy & Resp Res, Crawley, WA, Australia; [Prele, Cecilia M.; Mutsaers, Steven E.] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Crawley, WA, Australia; [Prele, Cecilia M.; Mutsaers, Steven E.] Univ Western Australia, Western Australian Inst Med Res, Crawley, WA, Australia; [Cheng, Yuen Yee; Reid, Glen] Univ Sydney, ADRI, Sydney, NSW 2006, Australia; [Klebe, Sonja] SA Pathol, Dept Anat Pathol, Adelaide, SA, Australia; [Klebe, Sonja] Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Watkins, D. Neil] Monash Univ, Monash Inst Med Res, Ctr Canc Res, Melbourne, Vic 3004, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Sydney; SA Pathology; Flinders Medical Centre; Flinders University South Australia; Monash University	Mutsaers, SE (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Lung Inst Western Australia, Crawley, WA, Australia.	steven.mutsaers@uwa.edu.au	Cheng, Yuen Yee/G-4406-2016; Cheng, Yuen/AAU-2402-2020; Prele, Cecilia/H-5664-2014; CHeah, Hui Min/AAU-3478-2020; Baltic, Svetlana/C-2313-2014	Cheng, Yuen Yee/0000-0001-7060-0624; Prele, Cecilia/0000-0002-9014-263X; Klebe, Sonja/0000-0002-8976-4714; Baltic, Svetlana/0000-0002-3428-940X; Cheah, Hui Min/0000-0003-1292-4561; Reid, Glen/0000-0001-6465-5223	National Health and Medical Research Council, Australia [572676]; Mesothelioma Applied Research Foundation, USA	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Mesothelioma Applied Research Foundation, USA	This study was supported by grants from the National Health and Medical Research Council, Australia (Project ID number 572676) and the Mesothelioma Applied Research Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asplund A, 2005, BRIT J DERMATOL, V152, P868, DOI 10.1111/j.1365-2133.2005.06464.x; Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang-Claude J, 2003, INT J CANCER, V103, P779, DOI 10.1002/ijc.10889; Chen M, 2010, CANCER PREV RES, V3, P1235, DOI 10.1158/1940-6207.CAPR-10-0035; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Couve-Privat S, 2002, CANCER RES, V62, P7186; Evans T, 2000, HUM MUTAT, V16, P43, DOI 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.3.CO;2-Z; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Hafner C, 2007, HUM PATHOL, V38, P1496, DOI 10.1016/j.humpath.2007.02.015; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Holloway AJ, 2006, CLIN CANCER RES, V12, P5129, DOI 10.1158/1078-0432.CCR-06-1027; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kagawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018638; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kao SCH, 2011, PATHOLOGY, V43, P128, DOI 10.1097/PAT.0b013e328342016c; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lee Y, 2003, CANCER RES, V63, P5428; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057346; Liboutet M, 2006, J INVEST DERMATOL, V126, P1510, DOI 10.1038/sj.jid.5700263; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; McGarvey TW, 1998, ONCOGENE, V17, P1167, DOI 10.1038/sj.onc.1202045; Michimukai E, 2001, IN VITRO CELL DEV-AN, V37, P459; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Musk AW, 2011, EUR RESPIR J, V38, P1420, DOI 10.1183/09031936.00000811; Musk AW, 2004, LUNG CANCER, V45, pS21, DOI 10.1016/j.lungcan.2004.04.010; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ohki K, 2004, INT J ORAL MAX SURG, V33, P584, DOI 10.1016/j.ijom.2004.01.013; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Ping XL, 2001, J INVEST DERMATOL, V116, P614, DOI 10.1046/j.1523-1747.2001.01301.x; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; Putoux A, NAT GENET, V43, P601; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Reifenberger J, 1998, CANCER RES, V58, P1798; Robinson BWS, 2002, MESOTHELIOMA, Vxiii; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slade I, 2011, FAM CANCER, V10, P337, DOI 10.1007/s10689-010-9411-0; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Song YL, 2006, TUMOR BIOL, V27, P175, DOI 10.1159/000093054; Stone DM, 1999, J CELL SCI, V112, P4437; Sun LS, 2008, J DENT RES, V87, P575, DOI 10.1177/154405910808700616; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vorechovsky I, 1997, CANCER RES, V57, P4677; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054415; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1997, CANCER RES, V57, P2369; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Zaphiropoulos PG, 1999, CANCER RES, V59, P787	76	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66685	10.1371/journal.pone.0066685	http://dx.doi.org/10.1371/journal.pone.0066685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826113	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400033
J	Cheng, J; Guggino, W				Cheng, Jie; Guggino, William			Ubiquitination and Degradation of CFTR by the E3 Ubiquitin Ligase MARCH2 through Its Association with Adaptor Proteins CAL and STX6	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS GENE; PDZ DOMAIN; DOWN-REGULATION; QUALITY-CONTROL; PROTEASOMAL DEGRADATION; PLASMA-MEMBRANE; CLASS-I	Golgi-localized cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand (CAL) and syntaxin 6 (STX6) regulate the abundance of mature, post-ER CFTR by forming a CAL/STX6/CFTR complex (CAL complex) that promotes CFTR degradation in lysosomes. However, the molecular mechanism underlying this degradation is unknown. Here we investigated the interaction of a Golgi-localized, membrane-associated RING-CH E3 ubiquitin ligase, MARCH2, with the CAL complex and the consequent binding, ubiquitination, and degradation of mature CFTR. We found that MARCH2 not only co-immunoprecipitated and co-localized with CAL and STX6, but its binding to CAL was also enhanced by STX6, suggesting a synergistic interaction. In vivo ubiquitination assays demonstrated the ubiquitination of CFTR by MARCH2, and overexpression of MARCH2, like that of CAL and STX6, led to a dose-dependent degradation of mature CFTR that was blocked by bafilomycin A1 treatment. A catalytically dead MARCH2 RING mutant was unable to promote CFTR degradation. In addition, MARCH2 had no effect on a CFTR mutant lacking the PDZ motif, suggesting that binding to the PDZ domain of CAL is required for MARCH2-mediated degradation of CFTR. Indeed, silencing of endogenous CAL ablated the effect of MARCH2 on CFTR. Consistent with its Golgi localization, MARCH2 had no effect on ER-localized Delta F508-CFTR. Finally, siRNA-mediated silencing of endogenous MARCH2 in the CF epithelial cell line CFBE-CFTR increased the abundance of mature CFTR. Taken together, these data suggest that the recruitment of the E3 ubiquitin ligase MARCH2 to the CAL complex and subsequent ubiquitination of CFTR are responsible for the CAL-mediated lysosomal degradation of mature CFTR.	[Cheng, Jie; Guggino, William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Guggino, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu			NIDDK [PO1 DK072084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIDDK (PO1 DK072084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher JF, 2011, ACTA CRYSTALLOGR F, V67, P600, DOI 10.1107/S1744309111009985; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; CUTTING GR, 1993, J BIOENERG BIOMEMBR, V25, P7, DOI 10.1007/BF00768062; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Ito H, 2006, BIOCHEM J, V397, P389, DOI 10.1042/BJ20052015; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	50	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68001	10.1371/journal.pone.0068001	http://dx.doi.org/10.1371/journal.pone.0068001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818989	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800146
J	Lai, LJ; Hsu, WH; Wu, AM; Wu, JH				Lai, Li-Ju; Hsu, Wei-Hsiu; Wu, Albert M.; Wu, June H.			Ocular Injury by Transient Formaldehyde Exposure in a Rabbit Eye Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CORNEAL EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; OCCUPATIONAL-EXPOSURE; FIBROBLASTS DERIVE; SIGNALING PATHWAYS; UV-IRRADIATION; APOPTOSIS; IRRITATION; FIBROSIS	Formaldehyde (FA) is frequently used in sterilizing surgical instruments and materials. Exposure to FA is highly concerned for eye tissues. Rabbit corneal epithelial cells were examined for changes after FA exposure. Our results showed that cell survival decreased 7 days after transient 3 min exposure to more than 100 ppm FA by trypan blue staining while MTT assay detected significant decrease at 20 ppm at 24 hours observation. The decrease of cell survival rate was concentration (up to 600 ppm)- and observation time (1-7 day)- dependent. The cell number decreased after 100 ppm FA exposure for more than 10 min at 7-day observation. The FA treated cells showed increased apoptosis/necrosis and cell cycle accumulation at sub G1 phase as well as mitochondria clustering around nucleus. The in vivo rabbit eye exposure for tear production by Schirmer's test revealed that the FA-induced overproduction of tear also exhibited observation time (1-10 day)- and FA concentration (20-300 ppm for 5 min exposure)- dependent. Activated extracellular signal-regulated kinase (pERK2) in cornea explants by western blotting was reduced and increased c-Jun amino - terminal kinase (JNK) activation (pJNK) in cornea and conjunctiva was evident at 2 month after exposure to 50-200 ppm FA for 5 min. In conclusion, injury to the eye with transient exposure of up to 100 ppm FA for 3 min decreased corneal cell survival while a more sensitive MTT test detected the cell decrease at 20 ppm FA exposure. Morphology changes can be observed even at 5 ppm FA exposure for 3 min at 7 days after. The FA exposure also increased apoptotic/necrotic cells and sub-G1 phase in cell cycle. Long term effect (2 months after exposure) on the eye tissues even after the removal of FA can be observed with persistent JNK activation in cornea and conjunctiva.	[Lai, Li-Ju] Chang Gang Mem Hosp, Dept Ophthalmol, Chiayi, Taiwan; [Lai, Li-Ju; Hsu, Wei-Hsiu] Chang Gang Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Wu, Albert M.] Chang Gang Univ, Coll Med, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Wu, June H.] Chang Gang Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Wu, JH (corresponding author), Chang Gang Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan.	jhwu@mail.cgu.edu.tw		Hsu, Wei-Hsiu/0000-0003-4831-8467	Chang Gung Memorial Hospital, Taiwan [CMRPG670401]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The work is suported by grant CMRPG670401 of Chang Gung Memorial Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Costa S, 2011, J TOXICOL ENV HEAL A, V74, P1040, DOI 10.1080/15287394.2011.582293; Duong A, 2011, MUTAT RES-REV MUTAT, V728, P118, DOI 10.1016/j.mrrev.2011.07.003; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Horwath-Winter J, 2003, ARCH OPHTHALMOL-CHIC, V121, P1364, DOI 10.1001/archopht.121.10.1364; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jester JV, 2001, TOXICOL IN VITRO, V15, P115, DOI 10.1016/S0887-2333(00)00065-5; Kawakita T, 2005, AM J PATHOL, V167, P381, DOI 10.1016/S0002-9440(10)62983-5; Kawashima M, 2007, ARCH OPHTHALMOL-CHIC, V125, P1337, DOI 10.1001/archopht.125.10.1337; Kim KH, 2011, J ENVIRON SCI HEAL C, V29, P277, DOI 10.1080/10590501.2011.629972; Lanigan RS, 2001, INT J TOXICOL, V20, P53; Lazenby V, 2012, CHEMOSPHERE, V88, P966, DOI 10.1016/j.chemosphere.2012.03.029; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; Matsuoka T, 2010, J TOXICOL SCI, V35, P721, DOI 10.2131/jts.35.721; Maurer JK, 2001, TOXICOL PATHOL, V29, P187, DOI 10.1080/019262301317052468; Mirabelli MC, 2011, OCCUP ENVIRON MED, V68, P375, DOI 10.1136/oem.2010.059352; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Pratt GC, 2012, RISK ANAL, V32, P96, DOI 10.1111/j.1539-6924.2011.01640.x; Saika S, 2008, PROG RETIN EYE RES, V27, P177, DOI 10.1016/j.preteyeres.2007.12.002; Shimmura Shigeto, 2002, Curr Opin Ophthalmol, V13, P213, DOI 10.1097/00055735-200208000-00004; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tang XQ, 2011, CLIN EXP PHARMACOL P, V38, P208, DOI 10.1111/j.1440-1681.2011.05485.x; Ushio H, 1999, TOXICOL LETT, V105, P17, DOI 10.1016/S0378-4274(98)00379-8; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; YAN MH, 1994, NATURE, V372, P798; YAN MH, 1994, J BIOL CHEM, V269, P19067; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang LP, 2010, ENVIRON MOL MUTAGEN, V51, P181, DOI 10.1002/em.20534	33	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66649	10.1371/journal.pone.0066649	http://dx.doi.org/10.1371/journal.pone.0066649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818956	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800092
J	DeSouza, DD; Moayedi, M; Chen, DQ; Davis, KD; Hodaie, M				DeSouza, Danielle D.; Moayedi, Massieh; Chen, David Q.; Davis, Karen D.; Hodaie, Mojgan			Sensorimotor and Pain Modulation Brain Abnormalities in Trigeminal Neuralgia: A Paroxysmal, Sensory-Triggered Neuropathic Pain	PLOS ONE			English	Article							GRAY-MATTER; HEMISPHERIC LATERALIZATION; CORTEX; MECHANISMS; PLASTICITY; THICKNESS; ROBUST; MODEL	Objective: Idiopathic trigeminal neuralgia (TN) is characterized by paroxysms of severe facial pain but without the major sensory loss that commonly accompanies neuropathic pain. Since neurovascular compression of the trigeminal nerve root entry zone does not fully explain the pathogenesis of TN, we determined whether there were brain gray matter abnormalities in a cohort of idiopathic TN patients. We used structural MRI to test the hypothesis that TN is associated with altered gray matter (GM) in brain areas involved in the sensory and affective aspects of pain, pain modulation, and motor function. We further determined the contribution of long-term TN on GM plasticity. Methods: Cortical thickness and subcortical GM volume were measured from high-resolution 3T T1-weighted MRI scans in 24 patients with right-sided TN and 24 healthy control participants. Results: TN patients had increased GM volume in the sensory thalamus, amygdala, periaqueductal gray, and basal ganglia (putamen, caudate, nucleus accumbens) compared to healthy controls. The patients also had greater cortical thickness in the contralateral primary somatosensory cortex and frontal pole compared to controls. In contrast, patients had thinner cortex in the pregenual anterior cingulate cortex, the insula and the orbitofrontal cortex. No relationship was observed between GM abnormalities and TN pain duration. Conclusions: TN is associated with GM abnormalities in areas involved in pain perception, pain modulation and motor function. These findings may reflect increased nociceptive input to the brain, an impaired descending modulation system that does not adequately inhibit pain, and increased motor output to control facial movements to limit pain attacks.	[DeSouza, Danielle D.; Moayedi, Massieh; Chen, David Q.; Davis, Karen D.] Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [DeSouza, Danielle D.; Moayedi, Massieh; Chen, David Q.; Davis, Karen D.; Hodaie, Mojgan] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Davis, Karen D.; Hodaie, Mojgan] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Davis, Karen D.; Hodaie, Mojgan] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Hodaie, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	mojgan.hodaie@uhn.on.ca	DeSouza, Danielle/J-9821-2019	DeSouza, Danielle/0000-0001-6861-5691; Moayedi, Massieh/0000-0002-7324-2540; Chen, David Qixiang/0000-0001-6407-8024	PSI Foundation; Canadian Institutes of Health Research Strategic Training Fellowship [TGF-53877]; University of Toronto/Purdue Pharma OGSST award	PSI Foundation; Canadian Institutes of Health Research Strategic Training Fellowship(Canadian Institutes of Health Research (CIHR)); University of Toronto/Purdue Pharma OGSST award	This work was supported by the PSI Foundation, the Canadian Institutes of Health Research Strategic Training Fellowship, TGF-53877, and the University of Toronto/Purdue Pharma OGSST award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Borsook D, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-34; CALVIN WH, 1977, PAIN, V3, P147, DOI 10.1016/0304-3959(77)90078-1; Coghill RC, 2001, J NEUROPHYSIOL, V85, P2602, DOI 10.1152/jn.2001.85.6.2602; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Daskalakis ZJ, 2012, J NEUROIMMUNE PHARM; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FROMM GH, 1981, NEUROLOGY, V31, P683, DOI 10.1212/WNL.31.6.683; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Ji GC, 2009, J NEUROPHYSIOL, V102, P2253, DOI 10.1152/jn.00166.2009; Knight YE, 2001, NEUROSCIENCE, V106, P793, DOI 10.1016/S0306-4522(01)00303-7; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Miller JP, 2009, J NEUROSURG, V110, P627, DOI 10.3171/2008.6.17620; Moayedi M, 2012, J NEUROIMMUNE PHARM; Moayedi M, 2012, BRAIN RES, V1456, P82, DOI 10.1016/j.brainres.2012.03.040; Moayedi M, 2011, J NEUROSCI, V31, P12396, DOI 10.1523/JNEUROSCI.3103-11.2011; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Nurmikko TJ, 2001, BRIT J ANAESTH, V87, P117, DOI 10.1093/bja/87.1.117; Peck CC, 2008, AUST DENT J, V53, P201, DOI 10.1111/j.1834-7819.2008.00050.x; RAPPAPORT ZH, 1994, PAIN, V56, P127, DOI 10.1016/0304-3959(94)90086-8; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Schweinhardt P, 2010, J CLIN INVEST, V120, P3788, DOI 10.1172/JCI43498; Siccoli MM, 2006, LANCET NEUROL, V5, P257, DOI 10.1016/S1474-4422(06)70375-1; Siddiqui MN, 2003, HOSP PHYS, V39, P64; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sinay VJ, 2003, CEPHALALGIA, V23, P541, DOI 10.1046/j.1468-2982.2003.00581.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taylor KS, 2009, BRAIN, V132, P3122, DOI 10.1093/brain/awp231; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Zald D. H., 2006, ORBITOFRONTAL CORTEX; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	54	85	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66340	10.1371/journal.pone.0066340	http://dx.doi.org/10.1371/journal.pone.0066340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823184	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400089
J	Ehya, F; Monavarfeshani, A; Fard, EM; Farsad, LK; Nekouei, MK; Mardi, M; Salekdeh, GH				Ehya, Farveh; Monavarfeshani, Aboozar; Fard, Ehsan Mohseni; Farsad, Laleh Karimi; Nekouei, Mojtaba Khayam; Mardi, Mohsen; Salekdeh, Ghasem Hosseini			Phytoplasma-Responsive microRNAs Modulate Hormonal, Nutritional, and Stress Signalling Pathways in Mexican Lime Trees	PLOS ONE			English	Article							WITCHES-BROOM DISEASE; ABIOTIC STRESS; ARABIDOPSIS; GENES; EXPRESSION; AUXIN; IDENTIFICATION; PROLIFERATION; TRANSDUCTION; DEFICIENCY	Background: Witches' broom disease of Mexican lime (Citrus aurantifolia L.), which is associated to the phytoplasma 'Candidatus Phytoplasma aurantifolia', is a devastating disease that results in significant economic losses. Plants adapt to biotic stresses by regulating gene expression at the transcriptional and post-transcriptional levels. MicroRNAs (miRNAs) are a recently identified family of molecules that regulate plant responses to environmental stresses through post-transcriptional gene silencing. Methods: Using a high-throughput approach to sequence small RNAs, we compared the expression profiles of miRNAs in healthy Mexican lime trees and in plants infected with 'Ca. P. aurantifolia'. Results: Our results demonstrated the involvement of different miRNAs in the response of Mexican lime trees to infection by 'Ca. P. aurantifolia'. We identified miRNA families that are expressed differentially upon infection with phytoplasmas. Most of the miRNAs had variants with small sequence variations (isomiRs), which are expressed differentially in response to pathogen infection. Conclusions: It is likely that the miRNAs that are expressed differentially in healthy and phytoplasma-infected Mexican lime trees are involved in coordinating the regulation of hormonal, nutritional, and stress signalling pathways, and the complex interactions between them. Future research to elucidate the roles of these miRNAs should improve our understanding of the level of diversity of specific plant responses to phytoplasmas.	[Ehya, Farveh; Monavarfeshani, Aboozar; Fard, Ehsan Mohseni; Farsad, Laleh Karimi; Nekouei, Mojtaba Khayam; Mardi, Mohsen; Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Genom, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Tehran, Iran; [Salekdeh, Ghasem Hosseini] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR)	Mardi, M (corresponding author), Agr Biotechnol Res Inst Iran, Dept Genom, Tehran, Iran.	Mardi@abrii.ac.ir; h_salekdeh@abrii.ac.ir	Salekdeh, Ghasem Hosseini/E-4198-2012; Mardi, Mohsen/M-5829-2017; Monavarfeshani, Aboozar/ABI-4689-2020	Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Mardi, Mohsen/0000-0002-4718-7701; Monavarfeshani, Aboozar/0000-0001-8906-5115	Iranian Witches' Broom Disease of Lime Network (IWBDLN); Agricultural Biotechnology Research Institute of Iran	Iranian Witches' Broom Disease of Lime Network (IWBDLN); Agricultural Biotechnology Research Institute of Iran	The work was supported by grants from the Iranian Witches' Broom Disease of Lime Network (IWBDLN) and Agricultural Biotechnology Research Institute of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Blumwald E, 1998, TRENDS PLANT SCI, V3, P342, DOI 10.1016/S1360-1385(98)01289-8; BOVE J, 1988, P INT ORG CITR VIR, V10, P307; Bove J, 1993, WITCHES BROOM DIS LI, P342; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; DUNLAP JR, 1989, PLANT PHYSIOL, V90, P197, DOI 10.1104/pp.90.1.197; Feshani AM, 2012, GENE, V493, P253, DOI 10.1016/j.gene.2011.11.024; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lang QL, 2011, J ZHEJIANG UNIV-SC B, V12, P116, DOI 10.1631/jzus.B1000278; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu Lei, 2008, Yichuan, V30, P1265, DOI 10.3724/SP.J.1005.2008.01265; Mardi M, 2011, B INSECTOL, V64, pS205; Meng YJ, 2010, PLANT SIGNAL BEHAV, V5, P252, DOI 10.4161/psb.5.3.10549; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Musetti R, 2005, EUR J PLANT PATHOL, V112, P53, DOI 10.1007/s10658-004-8233-z; Musetti R, 2004, PHYTOPATHOLOGY, V94, P203, DOI 10.1094/PHYTO.2004.94.2.203; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Sanchez-Rojo S, 2011, AM J POTATO RES, V88, P175, DOI 10.1007/s12230-010-9175-y; Shikata M, 2012, PLANTA, V236, P1027, DOI 10.1007/s00425-012-1649-3; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhao Y, 2009, INT J SYST EVOL MICR, V59, P2582, DOI 10.1099/ijs.0.010249-0; ZREIK L, 1995, INT J SYST BACTERIOL, V45, P449, DOI 10.1099/00207713-45-3-449	54	42	43	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66372	10.1371/journal.pone.0066372	http://dx.doi.org/10.1371/journal.pone.0066372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824690	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400095
J	Jin, H; Xiong, YY; Sun, J; Zhang, Y; Huang, F; Zhou, HS; Fan, ZP; Xu, D; Wei, YQ; Dai, M; Feng, R; Liu, QF				Jin, Hua; Xiong, Yiying; Sun, Jing; Zhang, Yu; Huang, Fen; Zhou, Hongsheng; Fan, Zhiping; Xu, Dan; Wei, Yongqiang; Dai, Min; Feng, Ru; Liu, Qifa			Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; CHRONIC MYELOGENOUS LEUKEMIA; DONOR LYMPHOCYTE INFUSIONS; VERSUS-HOST-DISEASE; COMPLETE MOLECULAR REMISSION; PATIENTS RECEIVING IMATINIB; FOLLOW-UP; MESYLATE DISCONTINUATION; KINASE INHIBITORS; INTERFERON-ALPHA	Imatinib can induce complete molecular remission (CMR) in relapse chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation, but it is indefinite whether imatinib is required to maintain CMR. We retrospectively reviewed 37 relapse CML post-transplants treated with imatinib (n = 20) or donor lymphocyte infusion (DLI) (n = 17). The rate of CMR was 85% and 76.47% (P = 0.509) and treatment-related mortality was 0% and 29.4% (P = 0.019), respectively, in imatinib and DLI groups. Fifteen patients obtaining CMR voluntarily ceased imatinib, and did not experience relapse. The 8-year overall survival (OS) after relapse was 85% 68% and 40.3 +/- 12.1% (P = 0.017), and disease-free survival (DFS) after relapse was 85%+/- 68% and 40.3 +/- 12.1% (P = 0.011), respectively, in imatinib and DLI groups. Imatinib resulted in higher OS and DFS than that of DLI in relapse CML. Imatinib maintenance might not be required for patients with relapse CML post-transplants after they achieved full donor chimerism and CMR.	[Jin, Hua; Xiong, Yiying; Sun, Jing; Zhang, Yu; Huang, Fen; Zhou, Hongsheng; Fan, Zhiping; Xu, Dan; Wei, Yongqiang; Dai, Min; Feng, Ru; Liu, Qifa] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Feng, R (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	ruth1626@hotmail.com; liuqifa628@163.com	DAI, M/GPS-8291-2022		National Natural Science Foundation of China [81000231, 81270647, 30971300]; National Public Health Grand Research Foundation of China [201202017]; Technology Plan of Guangdong Province of China [2009A030200007]; Science and Technology Project of Guangdong Province of China [2011J4300104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation of China; Technology Plan of Guangdong Province of China; Science and Technology Project of Guangdong Province of China	The study was supported by grants from the National Natural Science Foundation of China (No. 81000231, No. 81270647, and No. 30971300), the National Public Health Grand Research Foundation of China (No. 201202017) the Technology Plan of Guangdong Province of China (No. 2009A030200007) and the Science and Technology Project of Guangdong Province of China (No. 2011J4300104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Breccia M, 2012, LEUKEMIA RES, V36, P1498, DOI 10.1016/j.leukres.2012.09.006; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Dazzi F, 2000, BLOOD, V96, P2712; Dazzi F, 2007, BEST PRACT RES CL HA, V20, P311, DOI 10.1016/j.beha.2006.10.002; Deangelo DJ, 2004, CLIN CANCER RES, V10, P5065, DOI 10.1158/1078-0432.CCR-03-0580; Deenik W, 2010, HAEMATOL-HEMATOL J, V95, P914, DOI 10.3324/haematol.2009.016766; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fernandez HF, 2009, CANCER CONTROL, V16, P153, DOI 10.1177/107327480901600207; Forrest DL, 2009, LEUKEMIA RES, V33, P271, DOI 10.1016/j.leukres.2008.07.015; Goh HG, 2009, LEUKEMIA LYMPHOMA, V50, P944, DOI 10.1080/10428190902926973; Goldman JM, 2008, BONE MARROW TRANSPL, V42, pS11, DOI 10.1038/bmt.2008.105; Guglielmi C, 2002, BLOOD, V100, P397, DOI 10.1182/blood.V100.2.397; HERTENSTEIN B, 1993, TRANSPLANTATION, V56, P1114, DOI 10.1097/00007890-199311000-00013; Hess G, 2005, J CLIN ONCOL, V23, P7583, DOI 10.1200/JCO.2005.01.3110; Higano CS, 1997, BLOOD, V90, P2549, DOI 10.1182/blood.V90.7.2549.2549_2549_2554; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Igarashi Tetsuyuki, 2012, Rinsho Ketsueki, V53, P215; Jabbour E, 2007, CANCER-AM CANCER SOC, V109, P2171, DOI 10.1002/cncr.22661; Kantarjian HM, 2002, BLOOD, V100, P1590, DOI 10.1182/blood.V100.5.1590.h81702001590_1590_1595; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Lipka DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040853; Liu QF, 2011, ANN HEMATOL, V90, P331, DOI 10.1007/s00277-010-1081-3; Liu QF, 2009, BIOL BLOOD MARROW TR, V15, P1376, DOI 10.1016/j.bbmt.2009.06.017; Luo Y, 2011, LEUKEMIA RES, V35, P1307, DOI 10.1016/j.leukres.2011.01.001; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Martinez C, 2005, BONE MARROW TRANSPL, V36, P301, DOI 10.1038/sj.bmt.1705063; Merante S, 2005, HAEMATOLOGICA, V90, P979; Olavarria E, 2003, LEUKEMIA, V17, P1707, DOI 10.1038/sj.leu.2403068; Olavarria E, 2007, BLOOD, V110, P4614, DOI 10.1182/blood-2007-04-082990; Olivieri J, 2011, THESCIENTIFICWORLDJO, V11, P1908, DOI 10.1100/2011/924954; Palandri F, 2007, BONE MARROW TRANSPL, V39, P189, DOI 10.1038/sj.bmt.1705554; PORTER DL, 1994, NEW ENGL J MED, V330, P100, DOI 10.1056/NEJM199401133300204; Raiola AM, 2003, BONE MARROW TRANSPL, V31, P687, DOI 10.1038/sj.bmt.1703883; Ringden O, 2009, BLOOD, V113, P3110, DOI 10.1182/blood-2008-07-163212; Robin M, 2005, LEUKEMIA, V19, P1613, DOI 10.1038/sj.leu.2403821; Roman J, 2000, HAEMATOLOGICA, V85, P1072; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Savani BN, 2005, BONE MARROW TRANSPL, V36, P1009, DOI 10.1038/sj.bmt.1705167; Sekhri A, 2009, LEUKEMIA RES, V33, P1291, DOI 10.1016/j.leukres.2009.03.010; Shah Neil P, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS31; Steegmann JL, 1999, BONE MARROW TRANSPL, V23, P483, DOI 10.1038/sj.bmt.1701607; Takahashi N, 2012, HAEMATOL-HEMATOL J, V97, P903, DOI 10.3324/haematol.2011.056853; Ullmann Andrew J., 2003, Keio Journal of Medicine, V52, P182; Wang HW, 2005, BLOOD, V105, P1135, DOI 10.1182/blood-2004-01-0027; Weisdorf DJ, 2002, BLOOD, V99, P1971, DOI 10.1182/blood.V99.6.1971; Weisser M, 2006, HAEMATOLOGICA, V91, P663; Wright MP, 2010, BIOL BLOOD MARROW TR, V16, P639, DOI 10.1016/j.bbmt.2009.11.026; Xuan L, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-46; Yhim HY, 2012, LEUKEMIA RES, V36, P689, DOI 10.1016/j.leukres.2012.02.011	52	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65981	10.1371/journal.pone.0065981	http://dx.doi.org/10.1371/journal.pone.0065981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823695	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400042
J	Skubisz, MM; Brown, JK; Tong, S; Kaitu'u-Lino, T; Horne, AW				Skubisz, Monika M.; Brown, Jeremy K.; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha; Horne, Andrew W.			Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MARKER; MIC-1; MISCARRIAGE	Background: Ectopic pregnancy (EP) occurs in 1-2% of pregnancies, but is over-represented as a leading cause of maternal death in early pregnancy. It remains a challenge to diagnose early and accurately. Women often present in early pregnancy with a `pregnancy of unknown location' (PUL) and the diagnosis and exclusion of EP is difficult due to a lack of reliable biomarkers. A serum biomarker able to clearly distinguish between EP and other pregnancy outcomes would greatly assist clinicians in diagnosing and safely managing PULs. This study evaluates the ability of maternal serum macrophage inhibitory cytokine-1 (MIC-1) levels to differentiate between EP and other pregnancy outcomes in women with a PUL. Methods: Sera were collected from 120 women with a PUL at first clinical presentation and assayed for MIC-1 by ELISA. Results were classified according to ultimate pregnancy outcome and the discriminatory ability of MIC-1 to diagnose EP was assessed. Results: Serum MIC-1 levels were lower in women with histologically confirmed (definite) EP (dEP) (median 552 ng/mL; interquartile range (IQR) 414-693 ng/mL) compared to women with definite viable intra-uterine pregnancies (dVIUPs) (722 ng/mL; IQR 412-1122 ng/mL), and higher when compared to women with definite non-viable intra-uterine pregnancies (dNVIUPs) (465 ng/mL; IQR 341-675 ng/mL). MIC-1 levels were significantly higher in women with dEP compared to women whose PULs resolved without medical intervention (srPUL) (401 ng/mL; IQR 315-475 ng/mL) (p<0.003). There were no women with an ectopic pregnancy where serum MIC-1>1000 ng/mL. Conclusion: Serum MIC-1 levels in PUL were not able to categorically diagnose EP, however, MIC-1 could distinguish women with an EP that required medical intervention and those women whose PULs spontaneously resolved. A single serum MIC-1 measurement also excluded EP at levels above 1000 ng/mL. MIC-1 may play a role in the development of a combined assay of biomarkers for the diagnosis of EP.	[Skubisz, Monika M.; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha] Univ Melbourne, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia; [Skubisz, Monika M.] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Brown, Jeremy K.; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Melbourne; Monash University; University of Edinburgh	Skubisz, MM (corresponding author), Univ Melbourne, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia.	monika.skubisz@monash.edu		Horne, Andrew/0000-0002-9656-493X; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586	Australian National Health and Medical Research Council [1008276, 606611]; United Kingdom Medical Research Council [MRC G0802808]; MRC [G1002033, G0802808] Funding Source: UKRI; Medical Research Council [G0802808, G1002033] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Australian National Health and Medical Research Council (# 1008276; # 606611) and by the United Kingdom Medical Research Council (MRC G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Creanga AA, 2011, OBSTET GYNECOL, V117, P837, DOI 10.1097/AOG.0b013e3182113c10; Daniel Y, 1999, FERTIL STERIL, V72, P1013, DOI 10.1016/S0015-0282(99)00417-3; Daponte A, 2005, HUM REPROD, V20, P3163, DOI 10.1093/humrep/dei218; Daponte A, 2011, J CLIN ENDOCR METAB, V96, pE1444, DOI 10.1210/jc.2011-0037; Felemban A, 2002, HUM REPROD, V17, P490, DOI 10.1093/humrep/17.2.490; Horne AW, 2011, J CLIN ENDOCR METAB, V96, pE104, DOI 10.1210/jc.2010-1403; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Kirk E, 2009, BEST PRACT RES CL OB, V23, P493, DOI 10.1016/j.bpobgyn.2009.01.008; Lewis Ge, 2007, SAVING MOTHERS LIVES; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Rausch ME, 2012, CLIN OBSTET GYNECOL, V55, P418, DOI 10.1097/GRF.0b013e31825109f6; Rausch ME, 2011, OBSTET GYNECOL, V117, P573, DOI 10.1097/AOG.0b013e31820b3c61; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66339	10.1371/journal.pone.0066339	http://dx.doi.org/10.1371/journal.pone.0066339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824055	gold, Green Published			2022-12-25	WOS:000320576400088
J	Zhou, W; Quan, JH; Lee, YH; Shin, DW; Cha, GH				Zhou, Wei; Quan, Juan-Hua; Lee, Young-Ha; Shin, Dae-Whan; Cha, Guang-Ho			Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway	PLOS ONE			English	Article							FACTOR-KAPPA-B; OCULAR TOXOPLASMOSIS; REACTIVE OXYGEN; PROTEIN-KINASE; INHIBITION; CELLS; ROS; LOCALIZATION; INJURY	Toxoplasma gondii results in ocular toxoplasmosis characterized by chorioretinitis with inflammation and necrosis of the neuroretina, pigment epithelium, and choroid. After invasion, T. gondii replicates in host cells before cell lysis, which releases the parasites to invade neighboring cells to repeat the life cycle and establish a chronic retinal infection. The mechanism by which T. gondii avoids innate immune defense, however, is unknown. Therefore, we determined whether PI3K/Akt signaling pathway activation by T. gondii is essential for subversion of host immunity and parasite proliferation. T. gondii infection or excretory/secretory protein (ESP) treatment of the human retinal pigment epithelium cell line ARPE-19 induced Akt phosphorylation, and PI3K inhibitors effectively reduced T. gondii proliferation in host cells. Furthermore, T. gondii reduced intracellular reactive oxygen species (ROS) while activating the PI3K/Akt signaling pathway. While searching for the main source of these ROS, we found that NADPH oxidase 4 (Nox4) was prominently expressed in ARPE-19 cells, and this expression was significantly reduced by T. gondii infection or ESP treatment along with decreased ROS levels. In addition, artificial reduction of host Nox4 levels with specific siRNA increased replication of intracellular T. gondii compared to controls. Interestingly, these T. gondii-induced effects were reversed by PI3K inhibitors, suggesting that activation of the PI3K/Akt signaling pathway is important for suppression of both Nox4 expression and ROS levels by T. gondii infection. These findings demonstrate that manipulation of the host PI3K/Akt signaling pathway and Nox4 gene expression is a novel mechanism involved in T. gondii survival and proliferation.	[Zhou, Wei; Quan, Juan-Hua; Lee, Young-Ha; Shin, Dae-Whan; Cha, Guang-Ho] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea; [Quan, Juan-Hua] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China	Chungnam National University; Guangdong Medical University	Cha, GH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea.	gcha@cnu.ac.kr		Cha, Guang-Ho/0000-0003-2639-1727	Basic Science Research Program through the National Research Foundation of Korea; Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [A100876-1102-0000100]; Ministry of Education, Science, and Technology [2007-0054932, 2009-0068747, 2011-0006228, 2011-0023501]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2007-0054932, 2009-0068747, 2011-0006228, 2011-0023501) and Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (A100876-1102-0000100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aline F, 2002, INFECT IMMUN, V70, P2368, DOI 10.1128/IAI.70.5.2368-2374.2002; Allen LAH, 2005, J IMMUNOL, V174, P3658, DOI 10.4049/jimmunol.174.6.3658; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Coppens I, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002277; da Silva CV, 2009, BIOCHEM BIOPH RES CO, V378, P656, DOI 10.1016/j.bbrc.2008.11.108; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Garcia-Garcia JC, 2009, INFECT IMMUN, V77, P2385, DOI 10.1128/IAI.00023-09; GRITZ DC, 1991, CURR EYE RES, V10, P927, DOI 10.3109/02713689109020328; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; JABS DA, 1990, INT OPHTHALMOL CLIN, V30, P264, DOI 10.1097/00004397-199030040-00009; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim L, 2006, J CELL SCI, V119, P2119, DOI 10.1242/jcs.02934; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lee H, 2010, INT J BIOL MACROMOL, V47, P104, DOI 10.1016/j.ijbiomac.2010.05.014; Lin MQ, 2007, CELL MICROBIOL, V9, P861, DOI 10.1111/j.1462-5822.2006.00835.x; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; MacLaren A, 2004, VET PARASITOL, V125, P301, DOI 10.1016/j.vetpar.2004.07.006; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; MCMENAMIN PG, 1986, EXP EYE RES, V43, P529, DOI 10.1016/S0014-4835(86)80021-5; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P248, DOI 10.1001/archopht.1976.03910030120009; PERKINS ES, 1973, BRIT J OPHTHALMOL, V57, P1, DOI 10.1136/bjo.57.1.1; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Qian JQ, 2011, J CELL BIOCHEM, V112, P2480, DOI 10.1002/jcb.23173; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Shrestha SP, 2006, INT J PARASITOL, V36, P433, DOI 10.1016/j.ijpara.2006.01.006; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P49, DOI 10.3347/kjp.2001.39.1.49; Streilein JW, 1996, INVEST OPHTH VIS SCI, V37, P413; TABBARA KF, 1974, ARCH OPHTHALMOL-CHIC, V92, P244; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Vallochi AL, 2002, SCAND J IMMUNOL, V55, P324, DOI 10.1046/j.1365-3083.2002.01052.x; Wang YB, 2010, MOL BIOCHEM PARASIT, V173, P142, DOI 10.1016/j.molbiopara.2010.05.020; Wang YB, 2010, J BIOL CHEM, V285, P15611, DOI 10.1074/jbc.M109.095778; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361	47	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66306	10.1371/journal.pone.0066306	http://dx.doi.org/10.1371/journal.pone.0066306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824914	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400081
J	Lu, H; Hu, L; Yu, L; Wang, X; Urvalek, AM; Li, T; Shen, C; Mukherjee, D; Lahiri, SK; Wason, MS; Zhao, J				Lu, H.; Hu, L.; Yu, L.; Wang, X.; Urvalek, A. M.; Li, T.; Shen, C.; Mukherjee, D.; Lahiri, S. K.; Wason, M. S.; Zhao, J.			KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer	ONCOGENE			English	Article						KLF8; FAK; MMP14; beta-catenin/TCF1; metastasis; breast cancer	FOCAL ADHESION KINASE; KRUPPEL-LIKE FACTOR-8; E-CADHERIN; 1-MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE-1; BETA-CATENIN/TCF4 COMPLEX; MESENCHYMAL TRANSITION; TUMOR-CELLS; TRANSCRIPTION; MT1-MMP	Kruppel-like factor 8 (KLF8) regulates critical gene transcription associated with cancer. The underlying mechanisms, however, remain largely unidentified. We have recently demonstrated that KLF8 expression enhances the activity but not expression of matrix metalloproteinase-2 (MMP2), the target substrate of MMP14. Here, we report a novel KLF8 to MMP14 signaling that promotes human breast cancer invasion and metastasis. Using cell lines for inducible expression and knockdown of KLF8, we demonstrate that KLF8 promotes MMP14 expression at the transcriptional level. Knocking down KLF8 expression inhibited the breast cancer cell invasion both in vitro and in vivo as well as the lung metastasis in mice, which could be rescued by ectopic expression of MMP14. Promoter reporter assays and oligonucleotide and chromatin immunoprecipitations determined that KLF8 activates the human MMP14 gene promoter by both directly acting on the promoter and indirectly via promoting the nuclear translocation of beta-catenin, the expression of T-cell factor-1 (TCF1) and subsequent activation of the promoter by the beta-catenin/TCF1 complex. Inhibition of focal adhesion kinase (FAK) using pharmacological inhibitor, RNA interference or knockout showed that the cell surface presentation of active MMP14 downstream of KLF8 depends on FAK expression and activity. Taken together, this work identified novel signaling mechanisms by which KLF8 and FAK work together to promote the extracellular activity of MMP14 critical for breast cancer metastasis.	[Lu, H.; Hu, L.; Yu, L.; Wang, X.; Urvalek, A. M.; Li, T.; Shen, C.; Mukherjee, D.; Lahiri, S. K.; Wason, M. S.; Zhao, J.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Zhao, J (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	Jihe.Zhao@ucf.edu	Lahiri, Satadru/J-3483-2019; Li, Tianshu/L-6426-2014	Li, Tianshu/0000-0002-9972-4644	NCI [CA132977]; Susan G Komen for Cure breast cancer foundation [KG090444, KG080616]; NATIONAL CANCER INSTITUTE [R01CA132977] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen for Cure breast cancer foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate Dr Jouko Lohi of University of Helsinki for kindly providing the human MMP14 gene promoter reporter vectors. This work was supported by grants from NCI (CA132977) and Susan G Komen for Cure breast cancer foundation (KG090444 and KG080616) to JZ.	Afsar NA, 2012, EUR J CLIN PHARMACOL, V68, P389, DOI 10.1007/s00228-011-1134-0; Ara T, 2000, CANCER LETT, V157, P115, DOI 10.1016/S0304-3835(00)00494-8; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Cristofanilli M, 2006, SEMIN ONCOL, V33, pS9, DOI 10.1053/j.seminoncol.2006.03.016; Dwivedi DJ, 2006, AM J PATHOL, V168, P69, DOI 10.2353/ajpath.2006.041089; Lahiri SK, 2012, AM J TRANSL RES, V4, P357; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Lu H, 2014, ONCOGENE, V33, P10, DOI 10.1038/onc.2012.545; Lu H, 2012, J BIOL CHEM, V287, P43720, DOI 10.1074/jbc.M112.418053; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	32	43	47	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2909	2917		10.1038/onc.2013.247	http://dx.doi.org/10.1038/onc.2013.247			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23812425	Green Accepted			2022-12-25	WOS:000337231800010
J	Schlam, D; Bohdanowicz, M; Chatilialoglu, A; Steinberg, BE; Ueyama, T; Du, GW; Grinstein, S; Fairn, GD				Schlam, Daniel; Bohdanowicz, Michal; Chatilialoglu, Alexandros; Steinberg, Benjamin E.; Ueyama, Takehiko; Du, Guangwei; Grinstein, Sergio; Fairn, Gregory D.			Diacylglycerol Kinases Terminate Diacylglycerol Signaling during the Respiratory Burst Leading to Heterogeneous Phagosomal NADPH Oxidase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; PROTEIN-KINASE; PLASMA-MEMBRANE; GAMMA; PHOSPHORYLATION; P47(PHOX); DYNAMICS; BINDING; SYSTEM; METABOLISM	It is commonly assumed that all phagosomes have identical molecular composition. This assumption has remained largely unchallenged due to a paucity of methods to distinguish individual phagosomes. We devised an assay that extends the utility of nitro blue tetrazolium for detection and quantification of NAPDH oxidase (NOX) activity in individual phagosomes. Implementation of this assay revealed that in murine macrophages there is heterogeneity in the ability of individual phagosomes to generate superoxide, both between and within cells. To elucidate the molecular basis of the variability in NOX activation, we employed genetically encoded fluorescent biosensors to evaluate the uniformity in the distribution of phospholipid mediators of the oxidative response. Despite variability in superoxide generation, the distribution of phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-phosphate, and phosphatidic acid was nearly identical in all phagosomes. In contrast, diacylglycerol (DAG) was not generated uniformly across the phagosomal population, varying in a manner that directly mirrored superoxide production. Modulation of DAG levels suggested that NOX activation is precluded when phagosomes fail to reach a critical DAG concentration. In particular, forced expression of diacylglycerol kinase beta abrogated DAG accumulation at the phagosome, leading to impaired respiratory burst. Conversely, pharmacological inhibition of DAG kinases or expression of an inactive diacylglycerol kinase beta mutant increased the proportion of DAG-positive phagosomes, concomitantly potentiating phagosomal NOX activity. Our data suggest that diacylglycerol kinases limit the extent of NADPH oxidase activation, curtailing the production of potentially harmful reactive oxygen species. The resulting heterogeneity in phagosome responsiveness could enable the survival of a fraction of invading microorganisms.	[Schlam, Daniel; Bohdanowicz, Michal; Chatilialoglu, Alexandros; Steinberg, Benjamin E.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Schlam, Daniel; Bohdanowicz, Michal; Grinstein, Sergio] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Ueyama, Takehiko] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Fairn, Gregory D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Fairn, Gregory D.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Kobe University; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Fairn, GD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 209 Victoria St, Toronto, ON M5B 1W8, Canada.	fairng@smh.ca		Fairn, Greg/0000-0001-6508-168X; Du, Guangwei/0000-0003-4193-6975	Cystic Fibrosis Canada; Canadian Institutes for Health Research [MOP7075, MOP93634]; St. Michael's Hospital New Investigator Fund; Canadian Institutes of Health Research	Cystic Fibrosis Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); St. Michael's Hospital New Investigator Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Cystic Fibrosis Canada, Canadian Institutes for Health Research Grants MOP7075 and MOP93634, and St. Michael's Hospital New Investigator Fund (to G. D. F.).; Supported by an M.D./Ph.D. scholarship from the Canadian Institutes of Health Research.	Afzal M, 2003, BIOCHEM BIOPH RES CO, V304, P619, DOI 10.1016/S0006-291X(03)00641-7; Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563; BAEHNER RL, 1968, NEW ENGL J MED, V278, P971, DOI 10.1056/NEJM196805022781801; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Check J, 2010, MOL IMMUNOL, V47, P756, DOI 10.1016/j.molimm.2009.10.012; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; DIGREGORIO KA, 1987, AM J PHYSIOL, V252, pC677, DOI 10.1152/ajpcell.1987.252.6.C677; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Flannagan RS, 2010, METHODS MOL BIOL, V591, P121, DOI 10.1007/978-1-60761-404-3_7; Goebel WS, 2002, J PEDIAT HEMATOL ONC, V24, P787, DOI 10.1097/00043426-200212000-00026; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; He R, 2004, J IMMUNOL, V173, P7462, DOI 10.4049/jimmunol.173.12.7462; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; PERRY DK, 1992, J IMMUNOL, V149, P2749; QUALLIOTINEMANN D, 1993, J BIOL CHEM, V268, P23843; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shindo M, 2003, J BIOL CHEM, V278, P18448, DOI 10.1074/jbc.M300400200; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; TYAGI SR, 1992, INFECT IMMUN, V60, P2481, DOI 10.1128/IAI.60.6.2481-2487.1992; Ueyama T, 2004, J IMMUNOL, V173, P4582, DOI 10.4049/jimmunol.173.7.4582; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wattenberg BW, 2007, SCI STKE, pe43; WHITE JR, 1989, AGENTS ACTIONS, V27, P410, DOI 10.1007/BF01972837; Yaffe MB, 2002, STRUCTURE, V10, P1288, DOI 10.1016/S0969-2126(02)00860-2; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P19332, DOI 10.1073/pnas.1008248107; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612	48	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23090	23104		10.1074/jbc.M113.457606	http://dx.doi.org/10.1074/jbc.M113.457606			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814057	Green Published, hybrid			2022-12-25	WOS:000330598200017
J	Snitker, S; Xie, KM; Ryan, KA; Yu, DZ; Shuldiner, AR; Mitchell, BD; Gong, DW				Snitker, Soren; Xie, Keming; Ryan, Kathleen A.; Yu, Daozhan; Shuldiner, Alan R.; Mitchell, Braxton D.; Gong, Da-Wei			Correlation of Circulating MMP-9 with White Blood Cell Count in Humans: Effect of Smoking	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; OBSTRUCTIVE PULMONARY-DISEASE; LEFT-VENTRICULAR MEASURES; MATRIX METALLOPROTEINASES; METABOLIC SYNDROME; EXTRACELLULAR-MATRIX; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; INFLAMMATORY MARKERS; SERUM MMP-9	Background: Matrix metalloproteinase-9 (MMP-9) is an emerging biomarker for several disease conditions, where white blood cell (WBC) count is also elevated. In this study, we examined the relationship between MMP-9 and WBC levels in apparently healthy smoking and non-smoking human subjects. Methods: We conducted a cross-sectional study to assess the relationship of serum MMP-9 with WBC in 383 men and 356 women. Next, we divided the male population (women do not smoke in this population) into three groups: never (n = 243), current (n = 76) and former (n = 64) smokers and compared the group differences in MMP-9 and WBC levels and their correlations within each group. Results: Circulating MMP-9 and WBC count are significantly correlated in men (R-2 = 0.13, p<0.001) and women (R-2 = 0.19, p<0.001). After stratification by smoking status, MMP-9 level was significantly higher in current smokers (mean 6 SE; 663.3 +/- 43.4 ng/ml), compared to never (529.7 +/- 20.6) and former smokers (568 +/- 39.3). WBC count was changed in a similar pattern. Meanwhile, the relationship became stronger in current smokers with increased correlation coefficient of r = 0.45 or R-2 = 0.21 (p<0.001) and steeper slope of beta = 1.16 +/- 0.30 (p<0.001) in current smokers, compared to r = 0.26 or R-2 = 0.07 (p<0.001) and beta = 0.34 +/- 0.10 (p<0.001) in never smokers. Conclusions: WBC count accounts for 13% and 19% of MMP-9 variance in men and women, respectively. In non-smoking men, WBC count accounts for 7% of MMP-9 variance, but in smoking subjects, it accounts for up to 21% of MMP-9 variance. Thus, we have discovered a previously unrecognized correlation between the circulating MMP-9 and WBC levels in humans.	[Snitker, Soren; Xie, Keming; Ryan, Kathleen A.; Yu, Daozhan; Shuldiner, Alan R.; Mitchell, Braxton D.; Gong, Da-Wei] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Xie, Keming] Soochow Univ, Coll Med, Dept Pathophysiol, Suzhou, Peoples R China; [Shuldiner, Alan R.; Gong, Da-Wei] Baltimore Vet Affairs Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Soochow University - China; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Gong, DW (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	dgong@medicine.umaryland.edu	Gong, Dawei/AAB-4283-2020; Mitchell, Braxton/CAF-0876-2022	Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	Maryland Clinical Nutrition Research Unit [DK072488]; Baltimore Diabetes Research and Training Center from the National Institutes of Health [U01 HL072512, U01GM074518]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER	Maryland Clinical Nutrition Research Unit; Baltimore Diabetes Research and Training Center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was partially supported by grants from Maryland Clinical Nutrition Research Unit (DK072488), the Baltimore Diabetes Research and Training Center, U01 HL072512, and U01GM074518 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Arunachalam G, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-34; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Batlle M, 2007, TRANSPL P, V39, P2344, DOI 10.1016/j.transproceed.2007.06.046; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bolton C E, 2009, Chron Respir Dis, V6, P81, DOI 10.1177/1479972309103131; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Busti C, 2010, INTERN EMERG MED, V5, P13, DOI 10.1007/s11739-009-0283-y; Chambaut-Guerin AM, 2000, J NEUROCHEM, V74, P508, DOI 10.1046/j.1471-4159.2000.740508.x; Dogan A, 2008, CORONARY ARTERY DIS, V19, P559, DOI 10.1097/MCA.0b013e3283109079; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Fang L, 2010, CLIN SCI, V119, P175, DOI 10.1042/CS20100011; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Genersch E, 2000, J CELL SCI, V113, P4319; Giannelli G, 2004, CLIN EXP RHEUMATOL, V22, P335; Goncalves FM, 2009, CLIN CHIM ACTA, V403, P173, DOI 10.1016/j.cca.2009.02.013; Grodin JL, 2011, VASC MED, V16, P339, DOI 10.1177/1358863X11422110; Gruber BL, 1996, CLIN IMMUNOL IMMUNOP, V78, P161, DOI 10.1006/clin.1996.0025; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Hansson J, 2009, EUR J CARDIOV PREV R, V16, P297, DOI 10.1097/HJR.0b013e3283213108; Hwang JJ, 2009, ATHEROSCLEROSIS, V204, P293, DOI 10.1016/j.atherosclerosis.2008.08.019; Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Jouneau S, 2011, RESPIROLOGY, V16, P705, DOI 10.1111/j.1440-1843.2011.01960.x; Kato R, 2005, AM J CARDIOL, V95, P90, DOI 10.1016/j.amjcard.2004.08.066; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; KOOLWIJK P, 1995, J RHEUMATOL, V22, P385; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Li XM, 1999, VET IMMUNOL IMMUNOP, V67, P247, DOI 10.1016/S0165-2427(98)00228-1; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Lim HS, 2008, J INTERN MED, V263, P620, DOI 10.1111/j.1365-2796.2008.01937.x; Muzzio ML, 2009, ARCH MED RES, V40, P48, DOI 10.1016/j.arcmed.2008.10.011; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; Oda E, 2009, INTERNAL MED, V48, P1127, DOI 10.2169/internalmedicine.48.2138; Odagiri K, 2011, INTERNAL MED, V50, P2491, DOI 10.2169/internalmedicine.50.5877; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Overbeek SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055612; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Roberts CK, 2006, J APPL PHYSIOL, V100, P1657, DOI 10.1152/japplphysiol.01292.2005; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Rydlova M, 2008, ANTICANCER RES, V28, P1389; Sands MF, 2012, IMMUNOL INVEST, V41, P87, DOI 10.3109/08820139.2011.584600; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Takagi Hisato, 2009, Interact Cardiovasc Thorac Surg, V9, P437, DOI 10.1510/icvts.2009.208835; Velthove KJ, 2009, BIOMARKERS, V14, P523, DOI 10.3109/13547500903150763; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Welsh P, 2008, QJM-INT J MED, V101, P785, DOI 10.1093/qjmed/hcn088; Wu YW, 2008, J FORMOS MED ASSOC, V107, P93, DOI 10.1016/S0929-6646(08)60015-7; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; ZYSSET T, 1985, HEPATOLOGY, V5, P531, DOI 10.1002/hep.1840050402	57	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66277	10.1371/journal.pone.0066277	http://dx.doi.org/10.1371/journal.pone.0066277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825535	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000014
J	Hoobler, EK; Rai, G; Warrilow, AGS; Perry, SC; Smyrniotis, CJ; Jadhav, A; Simeonov, A; Parker, JE; Kelly, DE; Maloney, DJ; Kelly, SL; Holman, TR				Hoobler, Eric K.; Rai, Ganesha; Warrilow, Andrew G. S.; Perry, Steven C.; Smyrniotis, Christopher J.; Jadhav, Ajit; Simeonov, Anton; Parker, Josie E.; Kelly, Diane E.; Maloney, David J.; Kelly, S. L.; Holman, Theodore R.			Discovery of a Novel Dual Fungal CYP51/Human 5-Lipoxygenase Inhibitor: Implications for Anti-Fungal Therapy	PLOS ONE			English	Article							MONOXIDE-BINDING PIGMENT; SELECTIVE INHIBITORS; CANDIDA-ALBICANS; PHENYLENEDIAMINE DERIVATIVES; NORDIHYDROGUAIARETIC ACID; SEBORRHEIC DERMATITIS; LIVER MICROSOMES; ACCURATE DOCKING; WHOLE-BLOOD; LIPOXYGENASE	We report the discovery of a novel dual inhibitor targeting fungal sterol 14 alpha-demethylase (CYP51 or Erg11) and human 5-lipoxygenase (5-LOX) with improved potency against 5-LOX due to its reduction of the iron center by its phenylenediamine core. A series of potent 5-LOX inhibitors containing a phenylenediamine core, were synthesized that exhibit nanomolar potency and >30-fold selectivity against the LOX paralogs, platelet-type 12-human lipoxygenase, reticulocyte 15-human lipoxygenase type-1, and epithelial 15-human lipoxygenase type-2, and >100-fold selectivity against ovine cyclooxygenase-1 and human cyclooxygnease-2. The phenylenediamine core was then translated into the structure of ketoconazole, a highly effective anti-fungal medication for seborrheic dermatitis, to generate a novel compound, ketaminazole. Ketaminazole was found to be a potent dual inhibitor against human 5-LOX (IC50 = 700 nM) and CYP51 (IC50 = 43 nM) in vitro. It was tested in whole blood and found to down-regulate LTB4 synthesis, displaying 45% inhibition at 10 mu M. In addition, ketaminazole selectively inhibited yeast CYP51 relative to human CYP51 by 17-fold, which is greater selectivity than that of ketoconazole and could confer a therapeutic advantage. This novel dual anti-fungal/anti-inflammatory inhibitor could potentially have therapeutic uses against fungal infections that have an anti-inflammatory component.	[Hoobler, Eric K.; Perry, Steven C.; Smyrniotis, Christopher J.; Holman, Theodore R.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rai, Ganesha; Jadhav, Ajit; Simeonov, Anton; Maloney, David J.] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Warrilow, Andrew G. S.; Parker, Josie E.; Kelly, Diane E.; Kelly, S. L.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales	University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Swansea University	Maloney, DJ (corresponding author), NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	maloneyd@mail.nih.gov; s.l.kelly@swansea.ac.uk; holman@ucsc.edu		Parker, Josie/0000-0002-3855-4194; Perry, Steven/0000-0003-4428-5338; Warrilow, Andrew/0000-0003-0183-8334; Jadhav, Ajit/0000-0001-7955-1451	National Institutes of Health [GM56062, S10-RR20939]; Welsh Government (SLK); ERDF, via the Beacon project; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056062, R01GM056062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welsh Government (SLK); ERDF, via the Beacon project; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM56062 (TRH) S10-RR20939 (UCSC MS Equipment grant), the Welsh Government (SLK) and the ERDF, via the Beacon project (SLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; BEETENS JR, 1986, BIOCHEM PHARMACOL, V35, P883, DOI 10.1016/0006-2952(86)90072-9; BELL RL, 1992, INT J IMMUNOPHARMACO, V14, P505, DOI 10.1016/0192-0561(92)90182-K; Borgers M, 2007, CUTIS, V80, P359; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Deschamps JD, 2007, BIOORGAN MED CHEM, V15, P6900, DOI 10.1016/j.bmc.2007.08.015; Ducharme Y, 2010, ACS MED CHEM LETT, V1, P170, DOI 10.1021/ml100029k; Estabrook RW., 1972, METHODS PHARM, Vvol 2, P303; Faergemann J, 2000, Am J Clin Dermatol, V1, P75, DOI 10.2165/00128071-200001020-00001; Faergemann J, 2007, EXPERT OPIN PHARMACO, V8, P1365, DOI 10.1517/14656566.8.9.1365; FALGUEYRET JP, 1993, BIOCHEM PHARMACOL, V45, P978, DOI 10.1016/0006-2952(93)90185-Y; FOGH J, 1992, J PHARMACOL TOXICOL, V28, P185, DOI 10.1016/1056-8719(92)90002-I; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hutchinson JH, 2009, J MED CHEM, V52, P5803, DOI 10.1021/jm900945d; Ito S, 2005, J ORG CHEM, V70, P2285, DOI 10.1021/jo048489s; Itoh T, 2004, TETRAHEDRON, V60, P6649, DOI 10.1016/j.tet.2004.05.096; Jefcoate C R, 1978, Methods Enzymol, V52, P258; JEFCOATE CR, 1969, BIOCHEMISTRY-US, V8, P3455, DOI 10.1021/bi00836a049; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Kenyon V, 2011, J MED CHEM, V54, P5485, DOI 10.1021/jm2005089; Koeberle A, 2008, J MED CHEM, V51, P8068, DOI 10.1021/jm801085s; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Lo HY, 2010, BIOORG MED CHEM LETT, V20, P6379, DOI 10.1016/j.bmcl.2010.09.095; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; Masferrer JL, J PHARM EXP THER, V334, P294; McGill KA, 1996, LANCET, V348, P519, DOI 10.1016/S0140-6736(95)12297-4; MCMILLAN RM, 1992, TRENDS PHARMACOL SCI, V13, P323, DOI 10.1016/0165-6147(92)90100-K; MUSSER JH, 1992, J MED CHEM, V35, P2501, DOI 10.1021/jm00092a001; NELSON MJ, 1994, BIOCHEMISTRY-US, V33, P4966, DOI 10.1021/bi00182a027; OByrne PM, 1997, ANN INTERN MED, V127, P472, DOI 10.7326/0003-4819-127-6-199709150-00009; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pergola C, 2010, EXPERT OPIN THER PAT, V20, P355, DOI 10.1517/13543771003602012; Pham C, 1998, BIOCHEMISTRY-US, V37, P17952, DOI 10.1021/bi981989t; Radmark OP, 2000, AM J RESP CRIT CARE, V161, pS11, DOI 10.1164/ajrccm.161.supplement_1.ltta-3; Rai G, 2010, J MED CHEM, V53, P7392, DOI 10.1021/jm1008852; Robert NY, 1999, EUR J MED CHEM, V34, P671; Robinson SJ, 2009, J NAT PROD, V72, P1857, DOI 10.1021/np900465e; Rubin P, 2007, PROSTAG OTH LIPID M, V83, P188, DOI 10.1016/j.prostaglandins.2007.01.005; Sakurai H, 2005, J ORG CHEM, V70, P2754, DOI 10.1021/jo048324j; Scheinfeld N, 2008, DRUG TODAY, V44, P369, DOI 10.1358/dot.2008.44.5.1216598; Segraves EN, 2003, BIOCHEMISTRY-US, V42, P5236, DOI 10.1021/bi0273462; SPAETHE SM, 1992, BIOCHEM PHARMACOL, V43, P377, DOI 10.1016/0006-2952(92)90302-Y; Steel HC, 2007, CLIN EXP IMMUNOL, V150, P144, DOI 10.1111/j.1365-2249.2007.03470.x; Stewart AO, 1997, J MED CHEM, V40, P1955, DOI 10.1021/jm9700474; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Vasquez-Martinez Y, 2007, BIOORGAN MED CHEM, V15, P7408, DOI 10.1016/j.bmc.2007.07.036; VENKATESWARLU K, 1995, FEMS MICROBIOL LETT, V131, P337, DOI 10.1111/j.1574-6968.1995.tb07797.x; VOUROS P, 1969, ORG MASS SPECTROM, V2, P375, DOI 10.1002/oms.1210020406; WALENGA RW, 1980, LIFE SCI, V27, P1047, DOI 10.1016/0024-3205(80)90028-4; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Whitman S, 2002, J MED CHEM, V45, P2659, DOI 10.1021/jm0201262; Zouboulis CC, 2005, DERMATOLOGY, V210, P36, DOI 10.1159/000081481	61	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65928	10.1371/journal.pone.0065928	http://dx.doi.org/10.1371/journal.pone.0065928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826084	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400006
J	Almunia, C; Bretaudeau, M; Held, G; Babon, A; Marchetti, C; Castelli, FA; Menez, A; Maillere, B; Gillet, D				Almunia, Christine; Bretaudeau, Marie; Held, Gerhard; Babon, Aurelie; Marchetti, Charles; Castelli, Florence Anne; Menez, Andre; Maillere, Bernard; Gillet, Daniel			Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1	PLOS ONE			English	Article							CROSS-PRESENTATION; EXOGENOUS ANTIGENS; IMMUNE-RESPONSES; SIPULEUCEL-T; PROTEIN; EPITOPE; VACCINATION; COMPLEX; IMMUNOTHERAPY; PROTEASOMES	Bee venom phospholipase A2 (bvPLA2) is a small, 15kDa enzyme which hydrolyses many phospholipids through interfacial binding. The mutated bvPLA2H34Q (bvPLA2m), in which histidine-34 is replaced by glutamine, is not catalytically active. This protein has been shown to be a suitable membrane anchor and has been suggested as a suitable tumor-antigen vector for the development of novel dendritic cell-based vaccines. To confirm this feature, in this study the fusion protein PNY, composed of NY-ESO-1(NY(s)) fused to the C-terminus of bvPLA2m, was engineered. bvPLA2m enhanced the binding of NY(s) to the membrane of human monocyte-derived dendritic cells (DCs) and, once taken up by the cells, the antigen fused to the vector was directed to both MHC I and MHC II peptide-loading compartments. bvPLA2m was shown to increase the cross-presentation of the NY(s)-derived, restricted HLA-A*02 peptide, NY-ESO-1(157-165)(NY157-165), at the T1 cell surface. DCs loaded with the fusion protein induced cross-priming of NY(s)-specific CD8 + T-cells with greater efficiency than DCs loaded with NY( s). Sixty-five percent of these NY(s)-specific CD8+ T-cell lines could also be activated with the DCs pulsed with the peptide, NY157-165. Of these CD8+ T-cell lines, two were able to recognize the human melanoma cell line, SK-MEL-37, in a context of HLA-A*02. Only a small number of bvPLA2m CD8+ T-cell lines were induced, indicating the low immunogenicity of the protein. It was concluded that bvPLA2m can be used as a membrane-binding vector to promote MHC class II peptide presentation and MHC class I peptide cross-presentation. Such a system can, therefore, be tested for the preparation of cell-based vaccines.	[Almunia, Christine; Babon, Aurelie; Castelli, Florence Anne; Menez, Andre; Maillere, Bernard; Gillet, Daniel] Commissariat Energie Atom & Energies Alternat, Serv Ingn Mol Prot, Inst Biol & Technol Saclay, Gif Sur Yvette, France; [Held, Gerhard] Univ Klin Saarlandes, Med Klin 1, Homburg, Germany; [Almunia, Christine; Bretaudeau, Marie; Marchetti, Charles] Commissariat Energie Atom & Energies Alternat, Serv Biochim & Toxicol Nucl, Inst Biol Environm & Biotechnol, Bagnols Sur Ceze, France; [Menez, Andre] Museum Natl Hist Nat, F-75231 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Universitatsklinikum des Saarlandes; CEA; Museum National d'Histoire Naturelle (MNHN)	Almunia, C (corresponding author), Commissariat Energie Atom & Energies Alternat, Serv Ingn Mol Prot, Inst Biol & Technol Saclay, Gif Sur Yvette, France.	christine.almunia@cea.fr	Gillet, Daniel/C-5592-2008	Gillet, Daniel/0000-0003-0477-3599	CEA; Association pour la Recherche sur le Cancer [5876]	CEA(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the CEA and grant #5876 from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Annand RR, 1996, BIOCHEMISTRY-US, V35, P4591, DOI 10.1021/bi9528412; Babon A, 2005, FEBS LETT, V579, P1658, DOI 10.1016/j.febslet.2005.02.019; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beinart Garth, 2005, Clin Prostate Cancer, V4, P55, DOI 10.3816/CGC.2005.n.013; Bioley G, 2009, J IMMUNOTHER, V32, P161, DOI 10.1097/CJI.0b013e31819302f6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buhot C, 2004, PROTEIN SCI, V13, P2970, DOI 10.1110/ps.04885404; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chen YT, 1997, CYTOGENET CELL GENET, V79, P237, DOI 10.1159/000134734; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; den Brok MHMGM, 2005, EXPERT REV VACCINES, V4, P699, DOI 10.1586/14760584.4.5.699; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Held G, 2004, EUR J IMMUNOL, V34, P2919, DOI 10.1002/eji.200425297; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; ILLINGER D, 1991, BIOL CELL, V73, P131, DOI 10.1016/0248-4900(91)90095-5; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kreer Christoph, 2011, Front Immunol, V2, P87, DOI 10.3389/fimmu.2011.00087; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Luckey CJ, 1998, J IMMUNOL, V161, P112; MAILLERE B, 1995, TOXICON, V33, P475, DOI 10.1016/0041-0101(94)00186-C; Mandic M, 2005, J IMMUNOL, V174, P1751, DOI 10.4049/jimmunol.174.3.1751; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Palucka AK, 2008, J IMMUNOTHER, V31, P793, DOI 10.1097/CJI.0b013e31818403bc; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; ROCK KL, 1993, J IMMUNOL, V150, P438; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x; Tavallaie M, 2004, FEBS LETT, V572, P299, DOI 10.1016/j.febslet.2004.06.094; Villunger A, 1999, NAT MED, V5, P874, DOI 10.1038/11311; Yewdell JW, 2001, J CELL SCI, V114, P845; Zarei S, 2009, BLOOD, V113, P6658, DOI 10.1182/blood-2008-06-161075; Zarour HM, 2000, P NATL ACAD SCI USA, V97, P400, DOI 10.1073/pnas.97.1.400; Zeng G, 2006, J IMMUNOL, V177, P3582, DOI 10.4049/jimmunol.177.6.3582	44	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67645	10.1371/journal.pone.0067645	http://dx.doi.org/10.1371/journal.pone.0067645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825678	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400191
J	Bottermann, K; Reinartz, M; Barsoum, M; Kotter, S; Godecke, A				Bottermann, Katharina; Reinartz, Michael; Barsoum, Marian; Koetter, Sebastian; Goedecke, Axel			Systematic Analysis Reveals Elongation Factor 2 and alpha-Enolase as Novel Interaction Partners of AKT2	PLOS ONE			English	Article							PROTEIN-KINASE-B; GLUCOSE-HOMEOSTASIS; MASS-SPECTROMETRY; CELL-CULTURE; CANCER-CELLS; AMINO-ACIDS; PHOSPHORYLATION; INSULIN; COMPLEXES; MICE	AKT2 is one of the three isoforms of the protein kinase AKT being involved in the modulation of cellular metabolism. Since protein-protein interactions are one possibility to convey specificity in signal transduction, we performed AKT2-protein interaction analysis to elucidate their relevance for AKT2-dependent cellular functions. We identified heat shock protein 90 kDa (HSP90), Cdc37, heat shock protein 70 kDa (HSP70), 78 kDa glucose regulated protein (GRP78), tubulin, GAPDH, alpha-enolase and elongation factor 2 (EF2) as AKT2-interacting proteins by a combination of tandem affinity purification and mass spectrometry in HEK293T cells. Quantitative MS-analysis using stable isotope labeling by amino acids in cell culture (SILAC) revealed that only HSP90 and Cdc37 interact stably with AKT2, whereas the other proteins interact with low affinity with AKT2. The interactions of AKT2 with a-enolase and EF2 were further analyzed in order to uncover the functional relevance of these newly discovered binding partners. Despite the interaction of AKT2 and alpha-enolase, which was additionally validated by proximity ligation assay (PLA), no significant impact of AKT on alpha-enolase activity was detected in activity measurements. AKT stimulation via insulin and/or inhibition with the ATP-competitive inhibitor CCT128930 did not alter enzymatic activity of alpha-enolase. Interestingly, the direct interaction of AKT2 and EF2 was found to be dynamically regulated in embryonic rat cardiomyocytes. Treatment with the PI3-kinase inhibitor LY294002 before stimulation with several hormones stabilized the complex, whereas stimulation alone led to complex dissociation which was analyzed in situ with PLA. Taken together, these findings point to new aspects of AKT2-mediated signal transduction in protein synthesis and glucose metabolism.	[Bottermann, Katharina; Reinartz, Michael; Barsoum, Marian; Koetter, Sebastian; Goedecke, Axel] Univ Dusseldorf, Dept Cardiovasc Physiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Godecke, A (corresponding author), Univ Dusseldorf, Dept Cardiovasc Physiol, D-40225 Dusseldorf, Germany.	axel.goedecke@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft (DFG) [SFB612, TPA5, GRK1089]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG) SFB612, TPA5 to AG. KB and MB were supported by stipends for medical doctoral students and PhD students via the DFG funded GRK1089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Baba T, 2010, FEBS LETT, V584, P2796, DOI 10.1016/j.febslet.2010.05.015; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Drummond A., 2011, GENEIOUS V5 5; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Everett AD, 2001, AM J PHYSIOL-HEART C, V281, pH161, DOI 10.1152/ajpheart.2001.281.1.H161; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horman S, 2003, J BIOL CHEM, V278, P41970, DOI 10.1074/jbc.M302403200; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Li YF, 2011, BIOTECHNOL LETT, V33, P1487, DOI 10.1007/s10529-011-0592-x; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oeljeklaus S, 2012, J PROTEOME RES, V11, P2567, DOI 10.1021/pr3000333; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pfaffenbach KT, 2012, J CELL PHYSIOL, V227, P3803, DOI 10.1002/jcp.24090; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tuana BS, 2004, J BIOL; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weser S, 2006, J BIOCHEM BIOPH METH, V68, P189, DOI 10.1016/j.jbbm.2006.06.002; Yamagishi N, 2012, BIOCHEM BIOPH RES CO, V417, P364, DOI 10.1016/j.bbrc.2011.11.118; Yap TA, 2011, MOL CANCER THER, V10, P360, DOI 10.1158/1535-7163.MCT-10-0760; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	58	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66045	10.1371/journal.pone.0066045	http://dx.doi.org/10.1371/journal.pone.0066045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823123	Green Published, gold			2022-12-25	WOS:000320576400049
J	Chang, SH; Pollack, LM; Colditz, GA				Chang, Su-Hsin; Pollack, Lisa M.; Colditz, Graham A.			Life Years Lost Associated with Obesity-Related Diseases for US Non-Smoking Adults	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST-HIP RATIO; PROSPECTIVE COHORT; MORTALITY; OVERWEIGHT; WEIGHT; UNDERWEIGHT; HETEROGENEITY; CONSEQUENCES; EXPECTANCY	The objectives of this paper are to predict life years lost associated with obesity-related diseases (ORDs) for U.S. non-smoking adults, and to examine the relationship between those ORDs and mortality. Data from the National Health Interview Survey, 1997-2000, were used. We employed mixed proportional hazard models to estimate the association between those ORDs and mortality and used simulations to project life years lost associated with the ORDs. We found that obesity-attributable comorbidities are associated with large decreases in life years and increases in mortality rates. The life years lost associated with ORDs is more marked for younger adults than older adults, for blacks than whites, for males than females, and for the more obese than the less obese. Using U. S. non-smoking adults aged 40 to 49 years as an example to illustrate percentage of the life years lost associated with ORDs, we found that the mean life years lost associated with ORDs for U. S. non-smoking black males aged 40 to 49 years with a body mass index above 40 kg/m(2) was 5.43 years, which translates to a 7.5% reduction in total life years. White males of the same age range and same degree of obesity lost 5.23 life years on average - a 6.8% reduction in total life years, followed by black females (5.04 years, a 6.5% reduction in life years), and white females (4.7 years, a 5.8% reduction in life years). Overall, ORDs increased chances of dying and lessened life years by 0.2 to 11.7 years depending on gender, race, BMI classification, and age.	[Chang, Su-Hsin; Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Pollack, Lisa M.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Chang, SH (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA.	changsh@wudosis.wustl.edu	Chang, Su-Hsin/Q-8556-2019; Colditz, Graham/A-3963-2009	Chang, Su-Hsin/0000-0001-5872-9556; Colditz, Graham/0000-0002-7307-0291	Foundation for Barnes-Jewish Hospital; American Cancer Society Clinical Research Professorship;  [U54 CA 155496]; NATIONAL CANCER INSTITUTE [U54CA155496, KM1CA156708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	Foundation for Barnes-Jewish Hospital; American Cancer Society Clinical Research Professorship(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding from the Foundation for Barnes-Jewish Hospital and U54 CA 155496 supported this research. G. Colditz is supported by an American Cancer Society Clinical Research Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbring JH, 2007, BIOMETRIKA, V94, P87, DOI 10.1093/biomet/asm013; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Anderson R N, 1999, Natl Vital Stat Rep, V47, P1; Anderson RH, 2001, CARDIOL YOUNG, V11, P1, DOI 10.1017/S1047951100012348; [Anonymous], 2000, Vital Health Stat 2, P1; Arias E, 2002, NATL VITAL STAT REP, V51, P1; Arias Elizabeth, 2008, Natl Vital Stat Rep, V57, P1; Baio G., 2011, STAT METHODS MED RES, DOI 0962280211419832; Beasley JW, 2003, JAMA-J AM MED ASSOC, V289, P1777, DOI 10.1001/jama.289.14.1777-a; Beason T, 2012, ENERG BALANCE CANCER, V5, P71, DOI 10.1007/978-1-4614-2403-1_4; BOTMAN SL, 1995, STAT MED, V14, P669, DOI 10.1002/sim.4780140523; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cai LM, 2010, MED CARE, V48, P510, DOI 10.1097/MLR.0b013e3181dbdb20; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cawley J., 2011, J HLTH EC; Centers for Disease Control and Prevention, 2010, NAT HLTH INT SUR NHI; Centers for Disease Control and Prevention National Health Interview Survey, NAT HLTH INT SURV PR; Chang SH, 2011, MATURITAS, V69, P230, DOI 10.1016/j.maturitas.2011.04.007; COX DR, 1972, J R STAT SOC B, V34, P187; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Durazo-Arvizu R, 1997, J AM STAT ASSOC, V92, P1312, DOI 10.2307/2965401; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Efron B, 1993, INTRO BOOTSTRAP, pxvi; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; HECKMAN JJ, 1984, J ECONOMETRICS, V24, P63, DOI 10.1016/0304-4076(84)90075-7; Hens N, 2006, STAT MED, V25, P2502, DOI 10.1002/sim.2559; Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Lancaster T, 1997, ECONOMETRIC ANAL TRA, VXII; Leyland AH, 2010, INT J OBES LOND; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Padwal R, 2011, APPL PHYSL NUTR META; Paolini JBM, 2010, CRIT CARE MED, V38, P1308, DOI 10.1097/CCM.0b013e3181d8cd8b; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Price GM, 2006, AM J CLIN NUTR, V84, P449; Rao J. N. K., 1992, SURV METHODOL, V18, P209; RAO JNK, 1988, J AM STAT ASSOC, V83, P231, DOI 10.2307/2288945; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Rosner F, 2010, ISR MED ASSOC J, V12, P47; Sakata S, 2002, QUASIMAXIMUM LIKELIH; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019; Strickler HD, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; Van den Berg G. J., 2001, HDB ECONOMETRICS, V5, P3381, DOI DOI 10.1016/S1573-4412(01)05008-5; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787	61	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66550	10.1371/journal.pone.0066550	http://dx.doi.org/10.1371/journal.pone.0066550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823705	Green Published, gold			2022-12-25	WOS:000320576400126
J	Gong, HL; Shi, Y; Zhou, L; Wu, CP; Cao, PY; Tao, L; Xu, C; Hou, DS; Wang, YZ				Gong, Hong-Li; Shi, Yi; Zhou, Liang; Wu, Chun-Ping; Cao, Peng-Yu; Tao, Lei; Xu, Chen; Hou, Dong-Sheng; Wang, Yue-Zhu			The Composition of Microbiome in Larynx and the Throat Biodiversity between Laryngeal Squamous Cell Carcinoma Patients and Control Population	PLOS ONE			English	Article							DIVERSITY; GUT; INFECTIONS; NUTRITION; COMMENSAL	The throat is an ecological assemblage involved human cells and microbiota, and the colonizing bacteria are important factors in balancing this environment. However, this bacterial community profile has thus been poorly investigated. The purpose of this study was to investigate the microbial biology of the larynx and to analyze the throat biodiversity in laryngeal carcinoma patients compared to a control population in a case-control study. Barcoded pyrosequencing analysis of the 16S rRNA gene was used. We collected tissue samples from 29 patients with laryngeal carcinoma and 31 control patients with vocal cord polyps. The findings of high-quality sequence datasets revealed 218 genera from 13 phyla in the laryngeal mucosa. The predominant communities of phyla in the larynx were Firmicutes (54%), Fusobacteria (17%), Bacteroidetes (15%), Proteobacteria (11%), and Actinobacteria (3%). The leading genera were Streptococcus (36%), Fusobacterium (15%), Prevotella (12%), Neisseria (6%), and Gemella (4%). The throat bacterial compositions were highly different between laryngeal carcinoma subjects and control population (p = 0.006). The abundance of the 26 genera was significantly different between the laryngeal cancer and control groups by metastats analysis (p < 0.05). Fifteen genera may be associated with laryngeal carcinoma by partial least squares discriminant analysis (p < 0.001). In summary, this study revealed the microbiota profiles in laryngeal mucosa from tissue specimens. The compositions of bacteria community in throat were different between laryngeal cancer patients and controls, and probably were related with this carcinoma. The disruption of this bio-ecological niche might be a risk factor for laryngeal carcinoma.	[Gong, Hong-Li; Zhou, Liang; Wu, Chun-Ping; Cao, Peng-Yu; Tao, Lei] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China; [Shi, Yi] Fudan Univ, Dept Clin Lab, Shanghai Pudong Hosp, Pudong Med Ctr, Shanghai 200433, Peoples R China; [Xu, Chen; Hou, Dong-Sheng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China; [Wang, Yue-Zhu] Chinese Natl Human Genome Sequencing Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Shi, Y (corresponding author), Fudan Univ, Dept Clin Lab, Shanghai Pudong Hosp, Pudong Med Ctr, Shanghai 200433, Peoples R China.	yishi750@163.com; zhoulent@126.com	Zhou, Liang/AAJ-4024-2020		National Natural Science Foundation of China [81001203]; Academic Leaders Training Program of Pudong Health Bureau of Shanghai [PWRd2012-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Leaders Training Program of Pudong Health Bureau of Shanghai	This work was supported by National Natural Science Foundation of China, No. 81001203, and was funded by the Academic Leaders Training Program of Pudong Health Bureau of Shanghai (Grant No. PWRd2012-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; El-Sharif A, 2012, FUTURE MICROBIOL, V7, P1423, DOI [10.2217/fmb.12.125, 10.2217/FMB.12.125]; Gale N, 2009, HISTOPATHOLOGY, V54, P639, DOI 10.1111/j.1365-2559.2008.03111.x; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Gong HL, 2012, CLIN TRANSL ONCOL, V14, P905, DOI 10.1007/s12094-012-0879-y; Hand D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053115; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; James WPT, 2012, NUTR REV, V70, pS87, DOI 10.1111/j.1753-4887.2012.00497.x; Kahrstrom CT, 2012, NAT REV MICROBIOL, V10, DOI 10.1038/nrmicro2878; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelly D, 2012, NUTR REV, V70, pS18, DOI 10.1111/j.1753-4887.2012.00498.x; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peyyala R, 2013, J DENT RES; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rudolph E, 2011, EUR ARCH OTO-RHINO-L, V268, P165, DOI 10.1007/s00405-010-1395-8; Santos AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028088; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siqueira JF, 2008, J ENDODONT, V34, P1457, DOI 10.1016/j.joen.2008.08.037; Sobin LH, 2002, INT UN CANC UICC TNM; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tirandaz H, 2013, MED HYPOTHESES, V80, P675, DOI 10.1016/j.mehy.2013.01.024; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Walker A, 2007, NAT REV MICROBIOL, V5, P572, DOI 10.1038/nrmicro1720; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Widdicombe J, 2004, DRUG AGING, V21, P243, DOI 10.2165/00002512-200421040-00003; Yamanaka W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042806; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhuo XL, 2008, ARCH MED RES, V39, P625, DOI 10.1016/j.arcmed.2008.04.008	49	55	56	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66476	10.1371/journal.pone.0066476	http://dx.doi.org/10.1371/journal.pone.0066476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824228	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400116
J	Kalliokoski, S; Sulic, AM; Korponay-Szabo, IR; Szondy, Z; Frias, R; Perez, MA; Martucciello, S; Roivainen, A; Pelliniemi, LJ; Esposito, C; Griffin, M; Sblattero, D; Maki, M; Kaukinen, K; Lindfors, K; Caja, S				Kalliokoski, Suvi; Sulic, Ana-Marija; Korponay-Szabo, Ilma R.; Szondy, Zsuzsa; Frias, Rafael; Perez, Mileidys Alea; Martucciello, Stefania; Roivainen, Anne; Pelliniemi, Lauri J.; Esposito, Carla; Griffin, Martin; Sblattero, Daniele; Maki, Markku; Kaukinen, Katri; Lindfors, Katri; Caja, Sergio			Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; NEOVASCULARIZATION; ERYTHROPOIETIN; GROWTH	A characteristic feature of celiac disease is the presence of circulating autoantibodies targeted against transglutaminase 2 (TG2), reputed to have a function in angiogenesis. In this study we investigated whether TG2-specific autoantibodies derived from celiac patients inhibit angiogenesis in both ex vivo and in vivo models and sought to clarify the mechanism behind this phenomenon. We used the ex vivo murine aorta-ring and the in vivo mouse matrigel-plug assays to address aforementioned issues. We found angiogenesis to be impaired as a result of celiac disease antibody supplementation in both systems. Our results also showed the dynamics of endothelial cells was affected in the presence of celiac antibodies. In the in vivo angiogenesis assays, the vessels formed were able to transport blood despite impairment of functionality after treatment with celiac autoantibodies, as revealed by positron emission tomography. We conclude that celiac autoantibodies inhibit angiogenesis ex vivo and in vivo and impair vascular functionality. Our data suggest that the anti-angiogenic mechanism of the celiac disease-specific autoantibodies involves extracellular TG2 and inhibited endothelial cell mobility.	[Kalliokoski, Suvi; Sulic, Ana-Marija; Korponay-Szabo, Ilma R.; Martucciello, Stefania; Maki, Markku; Lindfors, Katri; Caja, Sergio] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Kalliokoski, Suvi; Sulic, Ana-Marija; Korponay-Szabo, Ilma R.; Martucciello, Stefania; Maki, Markku; Lindfors, Katri; Caja, Sergio] Tampere Univ Hosp, Tampere, Finland; [Korponay-Szabo, Ilma R.] Heim Pal Childrens Hosp, Celiac Dis Ctr, Budapest, Hungary; [Korponay-Szabo, Ilma R.] Univ Debrecen, Dept Paediat, Med & Hlth Sci Ctr, Debrecen, Hungary; [Szondy, Zsuzsa] Univ Debrecen, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, Debrecen, Hungary; [Frias, Rafael] Univ Turku, Cent Anim Lab, Turku, Finland; [Perez, Mileidys Alea; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Martucciello, Stefania; Esposito, Carla] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Roivainen, Anne] Turku Univ Hosp, Turku PET Ctr, FIN-20520 Turku, Finland; [Roivainen, Anne] Univ Turku, Turku, Finland; [Roivainen, Anne] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Pelliniemi, Lauri J.] Univ Turku, Lab Electron Microscopy, Turku, Finland; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Kaukinen, Katri] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kaukinen, Katri] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere, Finland; [Kaukinen, Katri] Seinajoki Cent Hosp, Dept Med, Seinajoki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Debrecen; University of Debrecen; University of Turku; Aston University; University of Salerno; University of Turku; University of Turku; University of Turku; University of Turku; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital	Caja, S (corresponding author), Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	sergio.caja@uta.fi	Korponay-Szabó, Ilma/AFK-1690-2022; Korponay-Szabó, Ilma/AAF-9048-2022; Frías, Rafael/AAE-5664-2020; Caja, Sergio/H-5947-2015	Griffin, Martin/0000-0003-3824-306X; Kalliokoski, Suvi/0000-0003-2934-3077; Roivainen, Anne/0000-0002-4006-7977; MARTUCCIELLO, STEFANIA/0000-0002-3720-1442; Caja, Sergio/0000-0003-2662-3145; Caja Galan, Sergio/0000-0002-5161-880X; Sblattero, Daniele/0000-0003-4309-242X	Academy of Finland; Sigrid Juselius Foundation; Pediatric Research Foundation; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital [9P033, 9P020]; Finnish Coeliac Society; Elna Kaarina Savolainen's fund; Hungarian Scientific Research Fund [OTKA K101788]; European Commission [PIA-GA-2010-251506, PERG08-GA-2010-277049]; University of Turku; Turku University Hospital; Abo Akademi University; EC Marie Curie Research Training Network [MRTN-CT-20010-289964]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pediatric Research Foundation; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Finnish Coeliac Society; Elna Kaarina Savolainen's fund; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Turku; Turku University Hospital; Abo Akademi University; EC Marie Curie Research Training Network(European Commission)	This work was supported by grants to Celiac Disease Study Group from the Academy of Finland, the Sigrid Juselius Foundation, the Pediatric Research Foundation, the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (grants 9P033 and 9P020), the Research Fund of the Finnish Coeliac Society, Elna Kaarina Savolainen's fund allocated for the development of cancer treatment, the Hungarian Scientific Research Fund (OTKA K101788), and the European Commission (contract numbers PIA-GA-2010-251506 and PERG08-GA-2010-277049). PET studies were conducted within the Finnish Center of Excellence in Molecular Imaging in Cardiovascular and Metabolic Research supported by the Academy of Finland, the University of Turku, Turku University Hospital, and Abo Akademi University. This work was supported by EC Marie Curie Research Training Network (MRTN-CT-20010-289964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alkim C, 2012, LIBYAN J MED, V7, DOI 10.3402/ljm.v7i0.8942; Caja S, 2010, SCAND J GASTROENTERO, V45, P421, DOI 10.3109/00365520903540822; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng XW, 2011, HYPERTENSION, V57, P981, DOI 10.1161/HYPERTENSIONAHA.110.168385; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Figg WD, 2008, ANGIOGENESIS INTEGRA, P55; FROJDMAN K, 1992, DIFFERENTIATION, V50, P113, DOI 10.1111/j.1432-0436.1992.tb00492.x; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Jones RA, 2006, CELL DEATH DIFFER, V13, P1442, DOI 10.1038/sj.cdd.4401816; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Myrsky E, 2009, SCAND J GASTROENTERO, V44, P162, DOI 10.1080/00365520802400875; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Pagonopoulou O, 2008, IN VIVO, V22, P587; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Rubio-Tapia A, 2012, MAYO CLIN PROC, V87, P732, DOI 10.1016/j.mayocp.2012.06.003; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; SMITH KA, 1988, BRIT J CANCER, V57, P247, DOI 10.1038/bjc.1988.54; [No title captured]	30	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65887	10.1371/journal.pone.0065887	http://dx.doi.org/10.1371/journal.pone.0065887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824706	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400029
J	Ku, C; Chung, WC; Chen, LL; Kuo, CH				Ku, Chuan; Chung, Wan-Chia; Chen, Ling-Ling; Kuo, Chih-Horng			The Complete Plastid Genome Sequence of Madagascar Periwinkle Catharanthus roseus (L.) G. Don: Plastid Genome Evolution, Molecular Marker Identification, and Phylogenetic Implications in Asterids	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; TRANSFER-RNA; HIGHER-PLANTS; GENES; GENERATION; DNA; MICROSATELLITES; DIVERSIFICATION; ANGIOSPERM; AMBORELLA	The Madagascar periwinkle (Catharanthus roseus in the family Apocynaceae) is an important medicinal plant and is the source of several widely marketed chemotherapeutic drugs. It is also commonly grown for its ornamental values and, due to ease of infection and distinctiveness of symptoms, is often used as the host for studies on phytoplasmas, an important group of uncultivated plant pathogens. To gain insights into the characteristics of apocynaceous plastid genomes (plastomes), we used a reference-assisted approach to assemble the complete plastome of C. roseus, which could be applied to other C. roseus-related studies. The C. roseus plastome is the second completely sequenced plastome in the asterid order Gentianales. We performed comparative analyses with two other representative sequences in the same order, including the complete plastome of Coffea arabica (from the basal Gentianales family Rubiaceae) and the nearly complete plastome of Asclepias syriaca (Apocynaceae). The results demonstrated considerable variations in gene content and plastome organization within Apocynaceae, including the presence/absence of three essential genes (i.e., accD, clpP, and ycf1) and large size changes in non-coding regions (e. g., rps2-rpoC2 and IRb-ndhF). To find plastome markers of potential utility for Catharanthus breeding and phylogenetic analyses, we identified 41 C. roseus-specific simple sequence repeats. Furthermore, five intergenic regions with high divergence between C. roseus and three other euasterids I taxa were identified as candidate markers. To resolve the euasterids I interordinal relationships, 82 plastome genes were used for phylogenetic inference. With the addition of representatives from Apocynaceae and sampling of most other asterid orders, a sister relationship between Gentianales and Solanales is supported.	[Ku, Chuan; Chung, Wan-Chia; Chen, Ling-Ling; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Mol & Biol Agr Sci Program, Taiwan Int Grad Program, Taipei, Taiwan; [Kuo, Chih-Horng] Acad Sinica, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Kuo, CH (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Chen, Ling-Ling/AAY-3547-2021; Ku, Chuan/N-3093-2013; Kuo, Chih-Horng/E-2045-2013	Ku, Chuan/0000-0001-6414-4423; Kuo, Chih-Horng/0000-0002-2857-0529	National Science Council of Taiwan [NSC 99-2313-B-001-006-MY2]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	Funding for this work was provided by research grants from the National Science Council of Taiwan (NSC 99-2313-B-001-006-MY2) and Academia Sinica to CHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2001, ANN MO BOT GARD, V88, P163, DOI 10.2307/2666224; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backlund M, 2000, AM J BOT, V87, P1029, DOI 10.2307/2657003; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Contin A, 1998, FEBS LETT, V434, P413, DOI 10.1016/S0014-5793(98)01022-9; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hatch SB, 2004, MUTAT RES-FUND MOL M, V545, P117, DOI 10.1016/j.mrfmmm.2003.09.015; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Kim SW, 2007, BIOTECHNOL BIOPROC E, V12, P646, DOI 10.1007/BF02931081; Kim SW, 2009, J PLANT BIOL, V52, P462, DOI 10.1007/s12374-009-9059-1; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcone C, 1997, EUR J FOREST PATHOL, V27, P347; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; MORENO PRH, 1993, PLANT CELL REP, V12, P702, DOI 10.1007/BF00233423; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Pribylova Jaroslava, 2013, Methods Mol Biol, V938, P41, DOI 10.1007/978-1-62703-089-2_4; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roepke J, 2010, P NATL ACAD SCI USA, V107, P15287, DOI 10.1073/pnas.0911451107; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simoes AO, 2007, ANN MO BOT GARD, V94, P268, DOI 10.3417/0026-6493(2007)94[268:PASOTR]2.0.CO;2; Soltis DE, 2004, AM J BOT, V91, P997, DOI 10.3732/ajb.91.6.997; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; THURSTON MI, 2005, MSATFINDER DETECTION; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Winkworth RC, 2008, TAXON, V57, P53, DOI 10.2307/25065948; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	68	42	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68518	10.1371/journal.pone.0068518	http://dx.doi.org/10.1371/journal.pone.0068518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825699	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400198
J	Sahu, U; Sidhar, H; Ghate, PS; Advirao, GM; Raghavan, SC; Giri, RK				Sahu, Upasana; Sidhar, Himakshi; Ghate, Pankaj S.; Advirao, Gopal M.; Raghavan, Sathees C.; Giri, Ranjit K.			A Novel Anticancer Agent, 8-Methoxypyrimido[4 ',5 ': 4,5]thieno(2,3-b) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and Independent Apoptotic Pathways	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; DNA-DAMAGE; CANCER-CELLS; IONIZING-RADIATION; SIGNALING PATHWAYS; DRUG ELLIPTICINE; THP-1 MONOCYTES; STRAND BREAKS; CYTOCHROME-C; CYCLE ARREST	Neuroblastoma is the most common cancer in infants and fourth most common cancer in children. Despite recent advances in cancer treatments, the prognosis of stage-IV neuroblastoma patients continues to be dismal which warrant new pharmacotherapy. A novel tetracyclic condensed quinoline compound, 8-methoxypyrimido [4 ',5 ': 4,5] thieno(2,3-b) quinoline-4(3H)-one (MPTQ) is a structural analogue of an anticancer drug ellipticine and has been reported to posses anticancer property. Study on MPTQ on neuroblastoma cells is very limited and mechanisms related to its cytotoxicity on neuroblastoma cells are completely unknown. Here, we evaluated the anticancer property of MPTQ on mouse neuro 2a and human SH-SY5Y neuroblastoma cells and investigated the mechanisms underlying MPTQ-mediated neuro 2a cell death. MPTQ-mediated neuro 2a and SH-SY5Y cell deaths were found to be dose and time dependent. Moreover, MPTQ induced cell death reached approximately 99.8% and 90% in neuro 2a and SH-SY5Y cells respectively. Nuclear oligonucleosomal DNA fragmentation and Terminal dUTP Nick End Labelling assays indicated MPTQ-mediated neuro 2a cell death involved apoptosis. MPTQ-mediated apoptosis is associated with increased phosphorylation of p53 at Ser15 and Ser20 which correlates with the hyperphosphorylation of Ataxia-Telangiectasia mutated protein (ATM). Immunocytochemical analysis demonstrated the increased level of Bax protein in MPTQ treated neuro 2a cells. MPTQ-mediated apoptosis is also associated with increased activation of caspase-9, -3 and -7 but not caspase-2 and -8. Furthermore, increased level of caspase-3 and cleaved Poly ( ADP Ribose) polymerase were observed in the nucleus of MPTQ treated neuro 2a cells, suggesting the involvement of caspase-dependent intrinsic but not extrinsic apoptotic pathway. Increased nuclear translocation of apoptosis inducing factor suggests additional involvement of caspase-independent apoptosis pathway in MPTQ treated neuro 2a cells. Collectively, MPTQ-induced neuro 2a cell death is mediated by ATM and p53 activation, and Bax-mediated activation of caspase-dependent and caspase-independent mitochondrial apoptosis pathways.	[Sahu, Upasana; Sidhar, Himakshi; Ghate, Pankaj S.; Giri, Ranjit K.] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India; [Advirao, Gopal M.] Kuvempu Univ, Dept Biochem, Davanagere, Karnataka, India; [Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Kuvempu University; Indian Institute of Science (IISC) - Bangalore	Giri, RK (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India.	ranjit@nbrc.ac.in	Advirao, Gopal M/ABD-1766-2020	Sahu, Upasana/0000-0003-2473-9312	National Brain Research Centre, Manesar, Haryana, India [BT/PR10721/Med/30/105/2008, 102/IFD/SAN/758/2007-08]; Department of Biotechnology, New Delhi, India; UGC; CSIR Fellowship, New Delhi, India	National Brain Research Centre, Manesar, Haryana, India; Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); UGC(University Grants Commission, India); CSIR Fellowship, New Delhi, India	This study was supported by core funding of National Brain Research Centre, Manesar, Haryana, India and partly by grants (No. BT/PR10721/Med/30/105/2008 and 102/IFD/SAN/758/2007-08) from Department of Biotechnology, New Delhi, India to RKG. HS and PSG are supported by UGC and CSIR Fellowship, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; AUCLAIR C, 1987, ARCH BIOCHEM BIOPHYS, V259, P1, DOI 10.1016/0003-9861(87)90463-2; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bansal D, 2008, INDIAN PEDIATR, V45, P135; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brossard J, 1996, BRIT MED BULL, V52, P787; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Chong MJ, 2000, P NATL ACAD SCI USA, V97, P889, DOI 10.1073/pnas.97.2.889; Chu CM, 2011, BRIT J RADIOL, V84, P81, DOI 10.1259/bjr/31861984; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; David R, 1989, Radiographics, V9, P859; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dong Z, 1997, AM J PATHOL, V151, P1205; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P14998, DOI 10.1074/jbc.270.25.14998; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Giri RK, 2004, J NEUROCHEM, V91, P1199, DOI 10.1111/j.1471-4159.2004.02800.x; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; GOODWIN S, 1959, J AM CHEM SOC, V81, P1903, DOI 10.1021/ja01517a031; Gopal M, 2004, INDIAN J MED RES, V119, P198; Gopal M, 2002, P INDIAN AS-CHEM SCI, V114, P687; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kuo PL, 2005, ANTI-CANCER DRUG, V16, P789, DOI 10.1097/01.cad.0000171768.36317.93; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Maity R, 2010, J CELL BIOCHEM, V109, P933, DOI 10.1002/jcb.22469; Malik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018116; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Nichols NM, 2008, CURR PROTOC MOL BIOL, V84; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Poljakova J, 2009, BIOCHEM PHARMACOL, V77, P1466, DOI 10.1016/j.bcp.2009.01.021; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Prochazka P, 2012, CANCER SCI, V103, P334, DOI 10.1111/j.1349-7006.2011.02137.x; RAJ TT, 1988, J CHEM RES, V50, P537; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schor NF, 2009, PHARMACOL THERAPEUT, V122, P44, DOI 10.1016/j.pharmthera.2009.01.001; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P873, DOI 10.1007/s10637-010-9436-0; Sharma S, 2013, MOL CARCINOGEN, V52, P413, DOI 10.1002/mc.21867; SHAW PJ, 1992, MED PEDIATR ONCOL, V20, P149, DOI 10.1002/mpo.2950200211; Shiloh Y, 2003, CELL CYCLE, V2, P116, DOI 10.4161/cc.2.2.342; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; Sottile F, 2012, ONCOTARGET, V3, P535; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; Stiborova M, 2012, BIOMED PAP, V156, P115, DOI 10.5507/bp.2012.043; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wu Y, 2012, INT J NANOMED, V7, P3221, DOI 10.2147/IJN.S31858; WYLLIE AH, 1993, BRIT J CANCER, V67, P205, DOI 10.1038/bjc.1993.40; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhang JH, 2002, TRENDS CELL BIOL, V12, P84, DOI 10.1016/S0962-8924(01)02206-1; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	82	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66430	10.1371/journal.pone.0066430	http://dx.doi.org/10.1371/journal.pone.0066430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824039	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000320576400109
J	Wuriyanghan, H; Falk, BW				Wuriyanghan, Hada; Falk, Bryce W.			RNA Interference towards the Potato Psyllid, Bactericera cockerelli, Is Induced in Plants Infected with Recombinant Tobacco mosaic virus (TMV)	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENE KNOCKDOWN; EXPRESSION; RESISTANCE; TOMATO; VECTOR; SYSTEM; HOST	The potato/tomato psyllid, Bactericera cockerelli (B. cockerelli), is an important plant pest and the vector of the phloem-limited bacterium Candidatus Liberibacter psyllaurous (solanacearum), which is associated with the zebra chip disease of potatoes. Previously, we reported induction of RNA interference effects in B. cockerelli via in vitro-prepared dsRNA/siRNAs after intrathoracic injection, and after feeding of artificial diets containing these effector RNAs. In order to deliver RNAi effectors via plant hosts and to rapidly identify effective target sequences in plant-feeding B. cockerelli, here we developed a plant virus vector-based in planta system for evaluating candidate sequences. We show that recombinant Tobacco mosaic virus (TMV) containing B. cockerelli sequences can efficiently infect and generate small interfering RNAs in tomato (Solanum lycopersicum), tomatillo (Physalis philadelphica) and tobacco (Nicotiana tabacum) plants, and more importantly delivery of interfering sequences via TMV induces RNAi effects, as measured by actin and V-ATPase mRNA reductions, in B. cockerelli feeding on these plants. RNAi effects were primarily detected in the B. cockerelli guts. In contrast to our results with TMV, recombinant Potato virus X (PVX) and Tobacco rattle virus (TRV) did not give robust infections in all plants and did not induce detectable RNAi effects in B. cockerelli. The greatest RNA interference effects were observed when B. cockerelli nymphs were allowed to feed on leaf discs collected from inoculated or lower expanded leaves from corresponding TMV-infected plants. Tomatillo plants infected with recombinant TMV containing B. cockerelli actin or V-ATPase sequences also showed phenotypic effects resulting in decreased B. cockerelli progeny production as compared to plants infected by recombinant TMV containing GFP. These results showed that RNAi effects can be achieved in plants against the phloem feeder, B. cockerelli, and the TMV-plant system will provide a faster and more convenient method for screening of suitable RNAi target sequences in planta.	[Wuriyanghan, Hada; Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Wuriyanghan, Hada] Inner Mongolia Univ, Life Sci Coll, Hohhot, Inner Mongolia, Peoples R China	University of California System; University of California Davis; Inner Mongolia University	Falk, BW (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bwfalk@ucdavis.edu		Yan, Zhiyong/0000-0001-8253-0694	Florida Citrus Research and Development Foundation (FDACS) [NAS ID 122]; University of California	Florida Citrus Research and Development Foundation (FDACS); University of California(University of California System)	This work was funded in part by a grant from the Florida Citrus Research and Development Foundation (FDACS Contract Number NAS ID 122) and the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; CHAPMAN S, 1992, PLANT J, V2, P549; Ding SW, 2011, CURR OPIN VIROL, V1, P533, DOI 10.1016/j.coviro.2011.10.028; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; PALUKAITIS P, 1983, VIROLOGY, V131, P533, DOI 10.1016/0042-6822(83)90518-4; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Rosa C, 2012, PEST MANAG SCI; Roy G, 2006, PHYTOPATHOLOGY, V96, P819, DOI 10.1094/PHYTO-96-0819; Stewart LR, 2009, VIROLOGY, V388, P212, DOI 10.1016/j.virol.2009.03.016; Tomilov AA, 2008, PLANT J, V56, P389, DOI 10.1111/j.1365-313X.2008.03613.x; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Valentine TA, 2007, PLANT BIOTECHNOL J, V5, P827, DOI 10.1111/j.1467-7652.2007.00289.x; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yin CT, 2011, MOL PLANT MICROBE IN, V24, P554, DOI 10.1094/MPMI-10-10-0229; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	42	57	63	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66050	10.1371/journal.pone.0066050	http://dx.doi.org/10.1371/journal.pone.0066050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824081	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400050
J	Zheng, Y; Xu, ZY; Zhu, QY; Liu, JF; Qian, J; You, HZ; Gu, Y; Hao, CM; Jiao, Z; Ding, F				Zheng, Yin; Xu, Zhongye; Zhu, Qiuyu; Liu, Junfeng; Qian, Jing; You, Huaizhou; Gu, Yong; Hao, Chuanming; Jiao, Zheng; Ding, Feng			Citrate Pharmacokinetics in Critically IllPatients with Acute Kidney Injury	PLOS ONE			English	Article							CONTINUOUS RENAL REPLACEMENT; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; SYSTEMIC HEPARIN ANTICOAGULATION; REGIONAL CITRATE; HEMODIALYSIS; THERAPY; BLOOD; METABOLISM	Introduction: Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy (CRRT) for critically ill patients. The risk of citrate toxicity is a primary concern during the prolonged process. The aim of this study was to assess the pharmacokinetics of citrate in critically ill patients with AKI, and used the kinetic parameters to predict the risk of citrate accumulation in this population group undergoing continuous veno-venous hemofiltration (CVVH) with RCA. Methods: Critically ill patients with AKI (n = 12) and healthy volunteers (n = 12) were investigated during infusing comparative dosage of citrate. Serial blood samples were taken before, during 120 min and up to 120 min after infusion. Citrate pharmacokinetics were calculated and compared between groups. Then the estimated kinetic parameters were applied to the citrate kinetic equation for validation in other ten patients' CVVH sessions with citrate anticoagulation. Results: Total body clearance of citrate was similar in critically ill patients with AKI and healthy volunteers (648.04 +/- 347.00 L/min versus 686.64 +/- 353.60 L/min; P = 0.624). Basal and peak citrate concentrations were similar in both groups (p = 0.423 and 0.247, respectively). The predicted citrate curve showed excellent fit to the measurements. Conclusions: Citrate clearance is not impaired in critically ill patients with AKI in the absence of severe liver dysfunction. Citrate pharmacokinetic data can provide a basis for the clinical use of predicting the risk of citrate accumulation.	[Zheng, Yin; Xu, Zhongye; Zhu, Qiuyu; Liu, Junfeng; Qian, Jing; You, Huaizhou; Gu, Yong; Hao, Chuanming; Ding, Feng] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Jiao, Zheng] Fudan Univ, Clin Pharm Lab, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Jiao, Z (corresponding author), Fudan Univ, Clin Pharm Lab, Huashan Hosp, Shanghai 200433, Peoples R China.	zjiao@fudan.edu.cn; dingfeng@fudan.edu.cn	Jiao, Zheng/H-7596-2014	Jiao, Zheng/0000-0001-7999-7162	National Natural Science Foundation of China [81270850, 81070609]; Science and Technology Commission of Shanghai Municipality [09411961500, 11441901401]; Board of Health of Shanghai Municipality [20124Y126]; Scientific Research foundation of Huashan Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Board of Health of Shanghai Municipality; Scientific Research foundation of Huashan Hospital	This study was supported, in part, by grants from the National Natural Science Foundation of China (No: 81270850, 81070609), the Science and Technology Commission of Shanghai Municipality (No: 09411961500,11441901401) (to FD), the Board of Health of Shanghai Municipality (20124Y126) (to JL), and the Scientific Research foundation of Huashan Hospital (to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsner R, 1997, WIEN KLIN WOCHENSCHR, V109, P123; Bagshaw SM, 2005, J CRIT CARE, V20, P155, DOI 10.1016/j.jcrc.2005.01.001; Bauer E, 2005, AM J KIDNEY DIS, V46, P903, DOI 10.1053/j.ajkd.2005.07.041; Bohler J, 1999, KIDNEY INT, V56, pS24; Chow S. C., 2003, SAMPLE SIZE CALCULAT; Dhondt A, 2000, NEPHRON, V85, P334, DOI 10.1159/000045683; Durao MS, 2008, CRIT CARE MED, V36, P3024, DOI 10.1097/CCM.0b013e31818b9100; Hofbauer R, 1999, KIDNEY INT, V56, P1578, DOI 10.1046/j.1523-1755.1999.00671.x; Kozik-Jaromin J, 2009, NEPHROL DIAL TRANSPL, V24, P2244, DOI 10.1093/ndt/gfp017; Kramer L, 2003, CRIT CARE MED, V31, P2450, DOI 10.1097/01.CCM.0000084871.76568.E6; Kutsogiannis DJ, 2005, KIDNEY INT, V67, P2361, DOI 10.1111/j.1523-1755.2005.00342.x; Mariano F, 2011, NEPHROL DIAL TRANSPL, V26, P3882, DOI 10.1093/ndt/gfr106; Meier-Kriesche HU, 2001, CRIT CARE MED, V29, P748, DOI 10.1097/00003246-200104000-00010; Monchi M, 2004, INTENS CARE MED, V30, P260, DOI 10.1007/s00134-003-2047-x; Morgera S, 2009, CRIT CARE MED, V37, P2018, DOI 10.1097/CCM.0b013e3181a00a92; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WEXLER IB, 1949, J CLIN INVEST, V28, P474, DOI 10.1172/JCI102093; WHITFIELD LR, 1981, THROMB RES, V21, P681, DOI 10.1016/0049-3848(81)90270-X; Wu MY, 2012, AM J KIDNEY DIS, V59, P810, DOI 10.1053/j.ajkd.2011.11.030; Yee J, 2007, J AM SOC NEPHROL, V18, p455A	21	18	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65992	10.1371/journal.pone.0065992	http://dx.doi.org/10.1371/journal.pone.0065992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824037	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400044
J	Stockebrand, M; Sauter, K; Neu, A; Isbrandt, D; Choe, CU				Stockebrand, Malte; Sauter, Kathrin; Neu, Axel; Isbrandt, Dirk; Choe, Chi-un			Differential regulation of AMPK activation in leptin- and creatine-deficient mice	FASEB JOURNAL			English	Article						AGAT; AICAR; ob; ob; skeletal muscle; white adipose tissue	PROTEIN-KINASE; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; BODY-WEIGHT; FATTY-ACID; INSULIN; TISSUE; MOUSE; AICAR	AMP-activated protein kinase (AMPK) is a key sensor and regulator of energy homeostasis. Previously, we demonstrated that intracellular energy depletion by l-arginine:glycine amidinotransferase (AGAT) deficiency resulted in AMPK activation and protected from metabolic syndrome. In the present study, we show tissue-specific leptin dependence of AMPK activation by energy depletion. We investigated leptin-dependent AMPK regulation in AGAT- and leptin-deficient (d/d ob/ob) mice. Like ob/ob mice, but unlike d/d mice, d/d ob/ob mice were obese and glucose intolerant. Therefore, leptin is a prerequisite for resistance to metabolic syndrome in AGAT-deficient mice. Quantitative Western blots revealed a 4-fold increase in AMPK activation in skeletal muscle of d/d ob/ob mice (P<0.001). However, AMPK activation was absent in white adipose tissue (WAT) and liver. Compared with blood glucose levels in ob/ob mice, fasting levels were still reduced and therefore did not show leptin dependence (wild-type, 79.4 +/- 3.9 mg/dl; d/d, 68.4 +/- 3.2 mg/dl; P<0.05). In ob/ob mice and wild-type mice, 5-aminoimidazole-4-carboxamide-1--d-ribofuranoside (AICAR), in combination with leptin, augmented glucose tolerance compared with AICAR alone, whereas no improvement was found under conditions of high-fat-diet feeding. These findings reveal a previously unknown synergistic AMPK activation by leptin and intracellular energy depletion, suggesting that AMPK activation can be therapeutically effective in metabolic syndrome only if leptin sensitivity is preserved.Stockebrand, M., Sauter, K., Neu, A., Isbrandt, D., Choe, C. Differential regulation of AMPK activation in leptin- and creatine-deficient mice.	[Stockebrand, Malte; Sauter, Kathrin; Neu, Axel; Isbrandt, Dirk; Choe, Chi-un] Univ Med Ctr Hamburg Eppendorf, D-20251 Hamburg, Germany; [Choe, Chi-un] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, D-20251 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Choe, CU (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Falkenried 94, D-20251 Hamburg, Germany.	cchoe@uke.de		Neu, Axel/0000-0001-7045-7194; Isbrandt, Dirk/0000-0002-4720-1016	Else Kroner Memorial Stipendium from the Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft (DFG) [CH872/1-1, IS63/3-1, IS63/3-2]	Else Kroner Memorial Stipendium from the Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank H. Voss, I. Heinsohn, and U. Wolters for expert animal care; S. Schillemeit for expert technical assistance; M. Schweizer, C. Raithore, and S. Fehr for help with histology; T. Streichert for blood chemistry (University Medical Center Hamburg-Eppendorf); D. Clausen for help with Fig. 7; and the reviewer, whose valuable comments helped to improve the paper. This work was supported by an Else Kroner Memorial Stipendium from the Else Kroner-Fresenius-Stiftung (C.U.C.) and the Deutsche Forschungsgemeinschaft (DFG; CH872/1-1 to C.U.C., A.N., and D.I., and IS63/3-1 and IS63/3-2 to D.I.).	Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; BERLET HH, 1976, BIOCHIM BIOPHYS ACTA, V437, P166, DOI 10.1016/0304-4165(76)90358-5; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Choe CU, 2013, HUM MOL GENET, V22, P110, DOI 10.1093/hmg/dds407; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Ipsiroglu OS, 2001, LIFE SCI, V69, P1805, DOI 10.1016/S0024-3205(01)01268-1; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Mackintosh JA, 2003, PROTEOMICS, V3, P2273, DOI 10.1002/pmic.200300578; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyamoto L., 2012, J BIOL CHEM; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nabuurs CI, 2013, J PHYSIOL-LONDON, V591, P571, DOI 10.1113/jphysiol.2012.241760; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Rasband W., 2006, IMAGEJ; Schmidt A, 2004, HUM MOL GENET, V13, P905, DOI 10.1093/hmg/ddh112; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Tanaka T, 2005, DIABETES, V54, P2365, DOI 10.2337/diabetes.54.8.2365; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	32	16	18	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4147	4156		10.1096/fj.12-225136	http://dx.doi.org/10.1096/fj.12-225136			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825223				2022-12-25	WOS:000329747100026
J	Gallos, LK; Potiguar, FQ; Andrade, JS; Makse, HA				Gallos, Lazaros K.; Potiguar, Fabricio Q.; Andrade, Jose S., Jr.; Makse, Hernan A.			IMDB Network Revisited: Unveiling Fractal and Modular Properties from a Typical Small-World Network	PLOS ONE			English	Article							COMPLEX; SPREAD	We study a subset of the movie collaboration network, http://www.imdb.com, where only adult movies are included. We show that there are many benefits in using such a network, which can serve as a prototype for studying social interactions. We find that the strength of links, i.e., how many times two actors have collaborated with each other, is an important factor that can significantly influence the network topology. We see that when we link all actors in the same movie with each other, the network becomes small-world, lacking a proper modular structure. On the other hand, by imposing a threshold on the minimum number of links two actors should have to be in our studied subset, the network topology becomes naturally fractal. This occurs due to a large number of meaningless links, namely, links connecting actors that did not actually interact. We focus our analysis on the fractal and modular properties of this resulting network, and show that the renormalization group analysis can characterize the self-similar structure of these networks.	[Gallos, Lazaros K.; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Potiguar, Fabricio Q.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Andrade, Jose S., Jr.] Fed Univ Para, ICEN, Fac Fis, BR-66059 Belem, Para, Brazil; Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Universidade Federal do Para; Universidade Federal do Ceara	Makse, HA (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.	hmakse@lev.ccny.cuny.edu	Andrade, José S/C-5451-2013; Potiguar, Fabricio Q./AAL-2329-2020	Andrade, José S/0000-0002-5571-7610; Potiguar, Fabricio Q./0000-0002-4922-9151; Gallos, Lazaros/0000-0002-2713-7934	CNPq; CAPES; FUNCAP; FUNCAP/Cnpq Pronex grant; National Institute of Science and Technology for Complex Systems in Brazil	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); FUNCAP/Cnpq Pronex grant; National Institute of Science and Technology for Complex Systems in Brazil	The authors acknowledge support from Brazilian agencies CNPq, CAPES, and FUNCAP, the FUNCAP/Cnpq Pronex grant, and the National Institute of Science and Technology for Complex Systems in Brazil for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 2012, AIRP COUNC INT ANN W; [Anonymous], 2012, INTERNET MAPPING PRO; [Anonymous], 2012, DATABASE INTERACTING; [Anonymous], 2009, INTERNET MOVIE DATAB; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERNARD HR, 1988, ETHNOLOGY, V27, P155, DOI 10.2307/3773626; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Davis GF, 1997, AM J SOCIOL, V103, P1, DOI 10.1086/231170; Fararo T, 1964, STUDY BIASED FRIENDS; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Galvao V, 2010, P NATL ACAD SCI USA, V107, P5750, DOI 10.1073/pnas.0914748107; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rozenfeld HD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.025701; SATTENSPIEL L, 1988, MATH BIOSCI, V90, P341, DOI 10.1016/0025-5564(88)90074-0; Song CM, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/03/P03006; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; VANRAAN AFJ, 1990, NATURE, V347, P626, DOI 10.1038/347626a0; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	30	21	24	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66443	10.1371/journal.pone.0066443	http://dx.doi.org/10.1371/journal.pone.0066443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826098	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400020
J	Goldsworthy, M; Absalom, NL; Schroter, D; Matthews, HC; Bogani, D; Moir, L; Long, A; Church, C; Hugill, A; Anstee, QM; Goldin, R; Thursz, M; Hollfelder, F; Cox, RD				Goldsworthy, Michelle; Absalom, Nathan L.; Schroeter, David; Matthews, Helen C.; Bogani, Debora; Moir, Lee; Long, Anna; Church, Christopher; Hugill, Alison; Anstee, Quentin M.; Goldin, Rob; Thursz, Mark; Hollfelder, Florian; Cox, Roger D.			Mutations in Mll2, an H3K4 Methyltransferase, Result in Insulin Resistance and Impaired Glucose Tolerance in Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FATTY LIVER-DISEASE; TYPE-2 DIABETES RISK; SUSCEPTIBILITY LOCI; PANCREATIC-ISLETS; GENETIC-VARIANTS; BETA-CELLS; MOUSE; EXPRESSION; SECRETION	We employed a random mutagenesis approach to identify novel monogenic determinants of type 2 diabetes. Here we show that haplo-insufficiency of the histone methyltransferase myeloid-lineage leukemia (Mll2/Wbp7) gene causes type 2 diabetes in the mouse. We have shown that mice heterozygous for two separate mutations in the SET domain of Mll2 or heterozygous Mll2 knockout mice were hyperglycaemic, hyperinsulinaemic and developed non-alcoholic fatty liver disease. Consistent with previous Mll2 knockout studies, mice homozygous for either ENU mutation (or compound heterozygotes) died during embryonic development at 9.5-14.5 days post coitum. Heterozygous deletion of Mll2 induced in the adult mouse results in a normal phenotype suggesting that changes in chromatin methylation during development result in the adult phenotype. Mll2 has been shown to regulate a small subset of genes, a number of which Neurod1, Enpp1, Slc27a2, and Plcxd1 are downregulated in adult mutant mice. Our results demonstrate that histone H3K4 methyltransferase Mll2 is a component of the genetic regulation necessary for glucose homeostasis, resulting in a specific disease pattern linking chromatin modification with causes and progression of type 2 diabetes, providing a basis for its further understanding at the molecular level.	[Goldsworthy, Michelle; Absalom, Nathan L.; Matthews, Helen C.; Bogani, Debora; Moir, Lee; Long, Anna; Church, Christopher; Hugill, Alison; Anstee, Quentin M.; Cox, Roger D.] MRC Harwell, Diabet Grp, Oxford, England; [Schroeter, David; Hollfelder, Florian] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Matthews, Helen C.; Thursz, Mark] Univ London Imperial Coll Sci Technol & Med, Acad Dept Med, London, England; [Anstee, Quentin M.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goldin, Rob] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England	MRC Harwell; University of Cambridge; Imperial College London; Newcastle University - UK; Imperial College London	Goldsworthy, M (corresponding author), MRC Harwell, Diabet Grp, Harwell Sci & Innovat Campus, Oxford, England.	m.goldsworthy@har.mrc.ac.uk	Anstee, Quentin M./L-2981-2013	Anstee, Quentin M./0000-0002-9518-0088; Cox, Roger/0000-0001-7170-5014; Moir, Lee/0000-0003-4829-3597; Thursz, Mark/0000-0002-8218-192X; Hollfelder, Florian/0000-0002-1367-6312; Goldin, Robert/0000-0001-5184-4519; Goldsworthy, Michelle/0000-0003-1354-7737	Higher Education Funding Council for England (HEFCE); Wellcome Trust Research Training Fellowship (OXION); Diabetes UK [BDA:RD07/0003447]; Medical Research Council [G84/6233, MC_U142661184] Funding Source: researchfish; National Institute for Health Research [CL-2007-21-007] Funding Source: researchfish; MRC [G84/6233, MC_U142661184] Funding Source: UKRI	Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust Research Training Fellowship (OXION); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	QMA is the recipient of a Clinical Senior Lectureship Award from the Higher Education Funding Council for England (HEFCE). NLA was supported by a Wellcome Trust Research Training Fellowship (OXION) and by a Diabetes UK grant BDA:RD07/0003447. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2011, BBA-MOL BASIS DIS, V1812, P1557, DOI 10.1016/j.bbadis.2011.07.017; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Ghanaat-Pour H, 2007, J MOL ENDOCRINOL, V39, P135, DOI 10.1677/JME-07-0002; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Goldsworthy M, 2008, DIABETES, V57, P2234, DOI 10.2337/db07-0337; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679; Toye AA, 2004, DIABETES, V53, P1577, DOI 10.2337/diabetes.53.6.1577; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	51	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e61870	10.1371/journal.pone.0061870	http://dx.doi.org/10.1371/journal.pone.0061870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826075	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400001
J	Guha, M; Castellanos-Rizaldos, E; Makrigiorgos, GM				Guha, Minakshi; Castellanos-Rizaldos, Elena; Makrigiorgos, G. Mike			DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR-RECEPTOR; REAL-TIME PCR; COLD-PCR; ACQUIRED-RESISTANCE; GENE-MUTATIONS; GEFITINIB; ERLOTINIB; IDENTIFICATION; ENRICHMENT	Non-small cell lung cancer (NSCLC) patients treated with small molecule EGFR inhibitors, such as gefitinib, frequently develop drug resistance due to the presence of secondary mutations like the T790M mutation on EGFR exon 20. These mutations may originate from small subclonal populations in the primary tumor that become dominant later on during treatment. In order to detect these low-level DNA variations in the primary tumor or to monitor their progress in plasma, it is important to apply reliable and sensitive mutation detection methods. Here, we combine two recently developed methodologies, Differential Strand Separation at Critical Temperature (DISSECT), with peptide nucleic acid-locked nucleic acid (PNA-LNA) polymerase chain reaction (PCR) for the detection of T790M EGFR mutation. DISSECT pre-enriches low-abundance T790M EGFR mutations from target DNA prior to implementing PNA-LNA PCR, a method that can detect 1 mutant allele in a background of 100-1000 wild type alleles. The combination of DISSECT and PNA-LNA PCR enables the detection of 1 mutant allele in a background of 10,000 wild type alleles. The combined DISSECT-PNA-LNA PCR methodology is amenable to adaptation for the sensitive detection of additional emerging resistance mutations in cancer.	[Guha, Minakshi; Castellanos-Rizaldos, Elena; Makrigiorgos, G. Mike] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div DNA Repair & Genome Stabil,Dept Radiat Oncol, Boston, MA 02115 USA; [Makrigiorgos, G. Mike] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Div Med Phys & Biophys,Dept Radiat Oncol,Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Makrigiorgos, GM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div DNA Repair & Genome Stabil,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	mmakrigiorgos@lroc.harvard.edu	Makrigiorgos, Mike/AFC-4575-2022		Innovative Molecular Analysis Technologies Program of National Cancer Institute [CA-111994]	Innovative Molecular Analysis Technologies Program of National Cancer Institute	This work was supported in part by grant CA-111994 of the Innovative Molecular Analysis Technologies Program of National Cancer Institute. The contents of this manuscript do not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Li J, 2011, CLIN CHEM, V57, P770, DOI 10.1373/clinchem.2010.157784; Li J, 2009, HUM MUTAT, V30, P1583, DOI 10.1002/humu.21112; Li J, 2009, CLIN CHEM, V55, P748, DOI 10.1373/clinchem.2008.113381; Li J, 2009, BIOCHEM SOC T, V37, P427, DOI 10.1042/BST0370427; Makrigiorgos GM, 2012, NUCL ACIDS RES; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Miyazawa H, 2008, CANCER SCI, V99, P595, DOI 10.1111/j.1349-7006.2007.00706.x; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nielsen P E, 1999, Curr Issues Mol Biol, V1, P89; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; TADA M, 1993, CANCER RES, V53, P2472	22	29	36	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67782	10.1371/journal.pone.0067782	http://dx.doi.org/10.1371/journal.pone.0067782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805327	gold, Green Submitted, Green Published			2022-12-25	WOS:000320846500155
J	Kumari, K; Muthamilarasan, M; Misra, G; Gupta, S; Subramanian, A; Parida, SK; Chattopadhyay, D; Prasad, M				Kumari, Kajal; Muthamilarasan, Mehanathan; Misra, Gopal; Gupta, Sarika; Subramanian, Alagesan; Parida, Swarup Kumar; Chattopadhyay, Debasis; Prasad, Manoj			Development of eSSR-Markers in Setaria italica and Their Applicability in Studying Genetic Diversity, Cross-Transferability and Comparative Mapping in Millet and Non-Millet Species	PLOS ONE			English	Article							EST-SSR MARKERS; PERIWINKLE CATHARANTHUS-ROSEUS; GENOMIC MICROSATELLITE MARKERS; FOXTAIL MILLET; GENOTYPING APPLICATIONS; PHYLOGENETIC ANALYSIS; MEDICAGO-TRUNCATULA; LOLIUM-PERENNE; GRASS MODEL; SEQUENCE	Foxtail millet (Setaria italica L.) is a tractable experimental model crop for studying functional genomics of millets and bioenergy grasses. But the limited availability of genomic resources, particularly expressed sequence-based genic markers is significantly impeding its genetic improvement. Considering this, we attempted to develop EST-derived-SSR (eSSR) markers and utilize them in germplasm characterization, cross-genera transferability and in silico comparative mapping. From 66,027 foxtail millet EST sequences 24,828 non-redundant ESTs were deduced, representing similar to 16 Mb, which revealed 534 (similar to 2%) eSSRs in 495 SSR containing ESTs at a frequency of 1/30 kb. A total of 447 pp were successfully designed, of which 327 were mapped physically onto nine chromosomes. About 106 selected primer pairs representing the foxtail millet genome showed high-level of cross-genera amplification at an average of similar to 88% in eight millets and four non-millet species. Broad range of genetic diversity (0.02-0.65) obtained in constructed phylogenetic tree using 40 eSSR markers demonstrated its utility in germplasm characterizations and phylogenetics. Comparative mapping of physically mapped eSSR markers showed considerable proportion of sequence-based orthology and syntenic relationship between foxtail millet chromosomes and sorghum (similar to 68%), maize (similar to 61%) and rice (similar to 42%) chromosomes. Synteny analysis of eSSRs of foxtail millet, rice, maize and sorghum suggested the nested chromosome fusion frequently observed in grass genomes. Thus, for the first time we had generated large-scale eSSR markers in foxtail millet and demonstrated their utility in germplasm characterization, transferability, phylogenetics and comparative mapping studies in millets and bioenergy grass species.	[Kumari, Kajal; Muthamilarasan, Mehanathan; Misra, Gopal; Gupta, Sarika; Parida, Swarup Kumar; Chattopadhyay, Debasis; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India; [Subramanian, Alagesan] Tamil Nadu Agr Univ, Coimbatore 641003, Tamil Nadu, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Tamil Nadu Agricultural University	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	Alagesan, Subramanian/AAO-2343-2020; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017	Alagesan, Subramanian/0000-0002-7992-1384; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Chattopadhyay, Debasis/0000-0002-5754-4987	National Institute of Plant Genome Research (NIPGR), New Delhi, India; University Grants Commission, New Delhi	National Institute of Plant Genome Research (NIPGR), New Delhi, India; University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by the core grant of National Institute of Plant Genome Research (NIPGR), New Delhi, India. MM acknowledges the award of Junior Research Fellowship from University Grants Commission, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gupta PK, 2002, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, P9; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2013, PLANT BREEDING, V132, P496, DOI 10.1111/j.1439-0523.2012.01983.x; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; MAROOF MAS, 1994, P NATL ACAD SCI USA, V91, P5466, DOI 10.1073/pnas.91.12.5466; Mishra RK, 2011, PLANT OMICS, V4, P154; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Roldan-Ruiz I, 2001, THEOR APPL GENET, V103, P1138, DOI 10.1007/s001220100571; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Shokeen B, 2007, PLANT SCI, V172, P441, DOI 10.1016/j.plantsci.2006.10.010; Siles MM, 2001, CROP SCI, V41, P1408, DOI 10.2135/cropsci2001.4151408x; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Soto-Cerda BJ, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue2-fulltext-6; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WANG CB, 2006, CHINESE SCI BULL, V51, P316; Xie WG, 2010, BIOCHEM SYST ECOL, V38, P740, DOI 10.1016/j.bse.2010.06.009; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316	56	80	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67742	10.1371/journal.pone.0067742	http://dx.doi.org/10.1371/journal.pone.0067742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805325	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500153
J	Vanhomwegen, J; Berthet, N; Mazuet, C; Guigon, G; Vallaeys, T; Stamboliyska, R; Dubois, P; Kennedy, GC; Cole, ST; Caro, V; Manuguerra, JC; Popoff, MR				Vanhomwegen, Jessica; Berthet, Nicolas; Mazuet, Christelle; Guigon, Ghislaine; Vallaeys, Tatiana; Stamboliyska, Rayna; Dubois, Philippe; Kennedy, Giulia C.; Cole, Stewart T.; Caro, Valerie; Manuguerra, Jean-Claude; Popoff, Michel-Robert			Application of High-Density DNA Resequencing Microarray for Detection and Characterization of Botulinum Neurotoxin-Producing Clostridia	PLOS ONE			English	Article							FOOD-BORNE BOTULISM; FOODBORNE BOTULISM; A STRAINS; GENETIC-CHARACTERIZATION; TOXIN; IDENTIFICATION; OUTBREAKS; SEQUENCE; DIFFERENTIATION; DIAGNOSTICS	Background: Clostridium botulinum and related clostridia express extremely potent toxins known as botulinum neurotoxins (BoNTs) that cause severe, potentially lethal intoxications in humans. These BoNT-producing bacteria are categorized in seven major toxinotypes (A through G) and several subtypes. The high diversity in nucleotide sequence and genetic organization of the gene cluster encoding the BoNT components poses a great challenge for the screening and characterization of BoNT-producing strains. Methodology/Principal Findings: In the present study, we designed and evaluated the performances of a resequencing microarray (RMA), the PathogenId v2.0, combined with an automated data approach for the simultaneous detection and characterization of BoNT-producing clostridia. The unique design of the PathogenID v2.0 array allows the simultaneous detection and characterization of 48 sequences targeting the BoNT gene cluster components. This approach allowed successful identification and typing of representative strains of the different toxinotypes and subtypes, as well as the neurotoxin-producing C. botulinum strain in a naturally contaminated food sample. Moreover, the method allowed fine characterization of the different neurotoxin gene cluster components of all studied strains, including genomic regions exhibiting up to 24.65% divergence with the sequences tiled on the arrays. Conclusions/Significance: The severity of the disease demands rapid and accurate means for performing risk assessments of BoNT-producing clostridia and for tracing potentials sources of contamination in outbreak situations. The RMA approach constitutes an essential higher echelon component in a diagnostics and surveillance pipeline. In addition, it is an important asset to characterise potential outbreak related strains, but also environment isolates, in order to obtain a better picture of the molecular epidemiology of BoNT-producing clostridia.	[Vanhomwegen, Jessica; Dubois, Philippe; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Berthet, Nicolas; Guigon, Ghislaine; Caro, Valerie] Inst Pasteur, Paris, France; [Berthet, Nicolas] CNRS, UMR3569, Paris, France; [Mazuet, Christelle; Popoff, Michel-Robert] Inst Pasteur, Anaerob Bacteria & Toxins Unit, Paris, France; [Vallaeys, Tatiana] Univ Montpellier 2, CNRS, CC093, Ecosyst Lagunaires UMR5119, Montpellier, France; [Stamboliyska, Rayna] Univ Munich LMU, Dept Biol 2, Planegg Martinsried, Germany; [Kennedy, Giulia C.] Veracyte Inc, Dept Res & Dev, San Francisco, CA USA; [Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Munich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Vanhomwegen, J (corresponding author), Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France.	jvhomweg@pasteur.fr	Vallaeys, Tatiana/AAE-5508-2019; Berthet, Nicolas/J-9373-2012; Popoff, Michel/O-7719-2016; Mazuet, Christelle/O-7731-2016	Popoff, Michel/0000-0001-9305-8989; Mazuet, Christelle/0000-0001-7619-9050; Dubois, Philippe/0000-0003-1534-1564	U.S. National Institute of Allergy and Infectious Diseases, National Institute of Health [UC1 AI062613]; "Programme Transversal de Recherche'' (DEVA) [246]; Institut Pasteur (Paris, France); Fondation Total-Institut Pasteur; Elisabeth Taub award from the Academie Nationale de Medecine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062613] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases, National Institute of Health; "Programme Transversal de Recherche'' (DEVA); Institut Pasteur (Paris, France); Fondation Total-Institut Pasteur; Elisabeth Taub award from the Academie Nationale de Medecine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This program was supported by grant UC1 AI062613 (to GC Kennedy) from the U.S. National Institute of Allergy and Infectious Diseases, National Institute of Health; by the "Programme Transversal de Recherche'' (DEVA No. 246), financed by the Institut Pasteur (Paris, France), sponsorship by the Fondation Total-Institut Pasteur and the Elisabeth Taub award from the Academie Nationale de Medecine. The funders had no role in study design, data analysis or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Bouzid M, 2010, PARASITOLOGY, V137, P27, DOI 10.1017/S0031182009991132; Browning LM, 2011, EUROSURVEILLANCE, V16, P11; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; BRUGGEMANN H, 2011, CLOSTRIDIUM BOTULINU, P185; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Corless CE, 2008, J MOL DIAGN, V10, P265, DOI 10.2353/jmoldx.2008.070152; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; Daminelli P, 2011, NEW MICROBIOL, V34, P287; Date K, 2011, J FOOD PROTECT, V74, P2090, DOI 10.4315/0362-028X.JFP-11-128; Davignon L, 2005, J CLIN MICROBIOL, V43, P5690, DOI 10.1128/JCM.43.11.5690-5695.2005; Dineen SS, 2003, CURR MICROBIOL, V46, P345, DOI 10.1007/s00284-002-3851-1; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; Fach P, 2011, INT J FOOD MICROBIOL, V145, pS145, DOI 10.1016/j.ijfoodmicro.2010.04.006; Fach P, 2009, J APPL MICROBIOL, V107, P465, DOI 10.1111/j.1365-2672.2009.04215.x; Fillo S, 2011, J CLIN MICROBIOL, V49, P4252, DOI 10.1128/JCM.05396-11; Franciosa G, 2004, APPL ENVIRON MICROB, V70, P7192, DOI 10.1128/AEM.70.12.7192-7199.2004; Franciosa G, 2006, FEMS MICROBIOL LETT, V261, P88, DOI 10.1111/j.1574-6968.2006.00331.x; Gadkar V, 2005, J MICROBIOL METH, V63, P157, DOI 10.1016/j.mimet.2005.03.009; Han T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-217; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; HUTSON RA, 1993, ANTON LEEUW INT J G, V64, P273, DOI 10.1007/BF00873087; Hutson RA, 1996, J BIOL CHEM, V271, P10786, DOI 10.1074/jbc.271.18.10786; Jalava K, 2011, EUROSURVEILLANCE, V16, P8; Kirma N, 2004, FEMS MICROBIOL LETT, V231, P159, DOI 10.1016/S0378-1097(03)00911-X; Lai Lung-Shiang, 2011, Acta Neurol Taiwan, V20, P138; Leclair D, 2006, J CLIN MICROBIOL, V44, P1635, DOI 10.1128/JCM.44.5.1635-1644.2006; Leski TA, 2011, APPL ENVIRON MICROB, V77, P4285, DOI 10.1128/AEM.00021-11; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Lin Baochuan, 2009, V529, P231, DOI 10.1007/978-1-59745-538-1_15; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Lindstrom M, 2009, APPL ENVIRON MICROB, V75, P2643, DOI 10.1128/AEM.02557-08; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; Oriot C, 2011, CLIN TOXICOL, V49, P752, DOI 10.3109/15563650.2011.606222; Pandya GA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015950., DOI 10.1371/J0URNAL.P0NE.0015950]; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Pingeon JM, 2011, EUROSURVEILLANCE, V16, P5; Pourshaban M, 2002, FEMS MICROBIOL LETT, V214, P119, DOI 10.1016/S0378-1097(02)00849-2; Raphael BH, 2008, APPL ENVIRON MICROB, V74, P4390, DOI 10.1128/AEM.00260-08; Raphael BH, 2010, MOL CELL PROBE, V24, P146, DOI 10.1016/j.mcp.2009.12.003; Santos-Buelga JA, 1998, CURR MICROBIOL, V37, P312, DOI 10.1007/s002849900384; Sasaki Y, 2001, INT J SYST EVOL MICR, V51, P901, DOI 10.1099/00207713-51-3-901; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Takeda M, 2005, AVIAN DIS, V49, P376, DOI 10.1637/7347-022305R1.1; Therre H., 1999, EURO SURVEILL, V4, P2; Umeda K, 2010, MICROBIOL IMMUNOL, V54, P308, DOI 10.1111/j.1348-0421.2010.00213.x; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Villar RG, 2006, INFECT DIS CLIN N AM, V20, P313, DOI 10.1016/j.idc.2006.02.003; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	59	12	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67510	10.1371/journal.pone.0067510	http://dx.doi.org/10.1371/journal.pone.0067510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818983	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800140
J	Arora, N; Sachdev, B; Gupta, R; Vimala, Y; Bhatnagar, RK				Arora, Naresh; Sachdev, Bindiya; Gupta, Rani; Vimala, Y.; Bhatnagar, Raj K.			Characterization of a Chitin-Binding Protein from Bacillus thuringiensis HD-1	PLOS ONE			English	Article							CRY1AC TOXIN; RESIDUES; MODULE; GENE	Strains of Bacillus thuringiensis produce insecticidal proteins. These strains have been isolated from diverse ecological niches, such as soil, phylloplane, insect cadavers and grain dust. To effectively propagate, these strains produce a range of molecules that facilitate its multiplication in a competing environment. In this report, we have examined synthesis of a chitin-binding protein and evaluated its effect on fungi encountered in environment and its interaction with insecticidal proteins synthesized by B. thuringiensis. The gene encoding chitin-binding protein has been cloned and expressed. The purified protein has been demonstrated to interact with Cry insecticidal protein, Cry1Ac by Circular Dichrosim spectroscopy (CD) and in vitro pull down assays. The chitin-binding protein potentiates insecticidal activity of bacillar insecticidal protein, Cry1Ac. Further, chitin-binding protein was fungistatic against several soil fungi. The chitin binding protein is expressed in spore mother cell and deposited along with insecticidal protein, Cry1Ac. It interacts with Cry1Ac to potentiate its insecticidal activity and facilitate propagation of Bacillus strain in environment by inhibiting growth of certain fungi.	[Arora, Naresh; Sachdev, Bindiya; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Gupta, Rani] Univ Delhi, Dept Microbiol, New Delhi, India; [Vimala, Y.] Ch Charan Singh Univ, Dept Bot, Meerut, Uttar Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Chaudhary Charan Singh University	Bhatnagar, RK (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	raj@icgeb.res.in	Sachdev, Bindiya/AAR-7156-2020	Arora, Naresh/0000-0003-2131-735X	"International Center for Genetic Engineering and Biotechnology'' (ICGEB), New Delhi, India	"International Center for Genetic Engineering and Biotechnology'' (ICGEB), New Delhi, India	This work was supported by research grant of "International Center for Genetic Engineering and Biotechnology'' (ICGEB), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2008, INT J PEPT RES THER, V14, P21, DOI 10.1007/s10989-007-9095-y; Ahmad T, 2003, BIOCHEM BIOPH RES CO, V310, P188, DOI 10.1016/j.bbrc.2003.08.136; Arora N, 2003, BIOCHEM BIOPH RES CO, V307, P620, DOI 10.1016/S0006-291X(03)01228-2; CHARNEY J, 1947, J BIOL CHEM, V171, P501; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; HJELMELAND K, 1982, COMP BIOCHEM PHYS B, V71, P557, DOI 10.1016/0305-0491(82)90462-X; Lee MK, 1999, APPL ENVIRON MICROB, V65, P4513; Liu Y, 2002, ANTIMICROB AGENTS CH, V46, P1455, DOI 10.1128/AAC.46.5.1455-1461.2002; Mishra RN, 2002, BIOTECHNIQUES, V33, P830, DOI 10.2144/02334st07; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Neeraja C, 2010, CRIT REV BIOTECHNOL, V30, P231, DOI 10.3109/07388551.2010.487258; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Pena G, 2006, APPL ENVIRON MICROB, V72, P353, DOI 10.1128/AEM.72.1.353-360.2006; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Purushotham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036714; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; SHARPE ES, 1975, APPL MICROBIOL, V30, P1052, DOI 10.1128/AEM.30.6.1052-1053.1975; SHIMAHARA K, 1988, METHOD ENZYMOL, V161, P417; SPURLINO JC, 1992, J MOL BIOL, V226, P15, DOI 10.1016/0022-2836(92)90119-5; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; WU D, 1991, FEMS MICROBIOL LETT, V81, P31, DOI 10.1016/0378-1097(91)90466-N	30	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66603	10.1371/journal.pone.0066603	http://dx.doi.org/10.1371/journal.pone.0066603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824872	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400136
J	Lau, NM; Green, PHR; Taylor, AK; Hellberg, D; Ajamian, M; Tan, CZ; Kosofsky, BE; Higgins, JJ; Rajadhyaksha, AM; Alaedini, A				Lau, Nga M.; Green, Peter H. R.; Taylor, Annette K.; Hellberg, Dan; Ajamian, Mary; Tan, Caroline Z.; Kosofsky, Barry E.; Higgins, Joseph J.; Rajadhyaksha, Anjali M.; Alaedini, Armin			Markers of Celiac Disease and Gluten Sensitivity in Children with Autism	PLOS ONE			English	Article							IMMUNE-RESPONSE; SPECTRUM DISORDERS; GLIADIN; SCHIZOPHRENIA; PATHOGENESIS; AUTOIMMUNE; ANTIBODIES; SERUM; LINK	Objective: Gastrointestinal symptoms are a common feature in children with autism, drawing attention to a potential association with celiac disease or gluten sensitivity. However, studies to date regarding the immune response to gluten in autism and its association with celiac disease have been inconsistent. The aim of this study was to assess immune reactivity to gluten in pediatric patients diagnosed with autism according to strict criteria and to evaluate the potential link between autism and celiac disease. Methods: Study participants included children (with or without gastrointestinal symptoms) diagnosed with autism according to both the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview, Revised (ADIR) (n = 37), their unaffected siblings (n = 27), and age-matched healthy controls (n = 76). Serum specimens were tested for antibodies to native gliadin, deamidated gliadin, and transglutaminase 2 (TG2). Affected children were genotyped for celiac disease associated HLA-DQ2 and -DQ8 alleles. Results: Children with autism had significantly higher levels of IgG antibody to gliadin compared with unrelated healthy controls (p<0.01). The IgG levels were also higher compared to the unaffected siblings, but did not reach statistical significance. The IgG anti-gliadin antibody response was significantly greater in the autistic children with gastrointestinal symptoms in comparison to those without them (p<0.01). There was no difference in IgA response to gliadin across groups. The levels of celiac disease-specific serologic markers, i.e., antibodies to deamidated gliadin and TG2, did not differ between patients and controls. An association between increased anti-gliadin antibody and presence of HLA-DQ2 and/or -DQ8 was not observed. Conclusions: A subset of children with autism displays increased immune reactivity to gluten, the mechanism of which appears to be distinct from that in celiac disease. The increased anti-gliadin antibody response and its association with GI symptoms points to a potential mechanism involving immunologic and/or intestinal permeability abnormalities in affected children.	[Lau, Nga M.; Green, Peter H. R.; Ajamian, Mary; Tan, Caroline Z.; Alaedini, Armin] Columbia Univ, Dept Med, New York, NY 10027 USA; [Lau, Nga M.; Green, Peter H. R.; Ajamian, Mary; Tan, Caroline Z.; Alaedini, Armin] Columbia Univ, Celiac Dis Ctr, New York, NY USA; [Taylor, Annette K.] LabCorp, Kimball Genet, Denver, CO USA; [Hellberg, Dan] Uppsala Univ, Clin Res Ctr, Falun, Sweden; [Kosofsky, Barry E.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Kosofsky, Barry E.; Higgins, Joseph J.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Alaedini, Armin] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University; Uppsala University; Cornell University; Cornell University; Columbia University	Alaedini, A (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	aa819@columbia.edu		Ajamian, Mary/0000-0001-5819-7078	Department of Defense [W81XWH 10-1-0887]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a grant from the Department of Defense, award number W81XWH 10-1-0887, to Armin Alaedini (PI). The sponsor of the study had no role in the study design, collection, analysis, interpretation of data, writing of the report, or the decision to submit the paper for publication.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Alaedini A, 2008, AUTOIMMUNITY, V41, P19, DOI 10.1080/08916930701619219; Alaedini A, 2007, J IMMUNOL, V178, P6590, DOI 10.4049/jimmunol.178.10.6590; Aldrimer M, 2012, SCAND J CLIN LAB INV, V72, P326, DOI 10.3109/00365513.2012.667571; Barcia G, 2008, J AUTISM DEV DISORD, V38, P407, DOI 10.1007/s10803-007-0480-3; Batista IC, 2012, ARQ NEURO-PSIQUIAT, V70, P28, DOI 10.1590/S0004-282X2012000100007; Briani C, 2008, AUTOIMMUN REV, V7, P644, DOI 10.1016/j.autrev.2008.05.006; Brown AC, 2011, EXPERT REV GASTROENT, V5, P465, DOI [10.1586/egh.11.46, 10.1586/EGH.11.46]; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; DEufemia P, 1996, ACTA PAEDIATR, V85, P1076, DOI 10.1111/j.1651-2227.1996.tb14220.x; DOHAN FC, 1969, MENT HYG, V53, P525; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; Elder JH, 2008, NUTR CLIN PRACT, V23, P583, DOI 10.1177/0884533608326061; Frye RE, 2012, MOL PSYCHIAT; Goines P, 2011, BRAIN BEHAV IMMUN, V25, P514, DOI 10.1016/j.bbi.2010.11.017; GOODWIN MS, 1969, MENT HYG, V53, P550; Jabri B, 2005, IMMUNOL REV, V206, P219, DOI 10.1111/j.0105-2896.2005.00294.x; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Lundin Knut E A, 2012, Gastrointest Endosc Clin N Am, V22, P723, DOI 10.1016/j.giec.2012.07.006; MCCARTHY DM, 1979, LANCET, V2, P877; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pavone L, 1997, BIOL PSYCHIAT, V42, P72, DOI 10.1016/S0006-3223(97)00267-9; Qiao SW, 2012, SEMIN IMMUNOPATHOL, V34, P523, DOI 10.1007/s00281-012-0314-z; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; Schwertz E, 2004, CLIN CHEM, V50, P2370, DOI 10.1373/clinchem.2004.036111; Valicenti-McDermott MD, 2008, PEDIATR NEUROL, V39, P392, DOI 10.1016/j.pediatrneurol.2008.07.019; van Eckert R, 2006, J CEREAL SCI, V43, P331, DOI 10.1016/j.jcs.2005.12.009; Vojdani A, 2004, NUTR NEUROSCI, V7, P151, DOI 10.1080/10284150400004155; Wang LW, 2011, J DEV BEHAV PEDIATR, V32, P351, DOI 10.1097/DBP.0b013e31821bd06a; Zhang BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-80	32	73	76	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66155	10.1371/journal.pone.0066155	http://dx.doi.org/10.1371/journal.pone.0066155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823064	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400059
J	Maher, RL; Morrical, SW				Maher, Robyn L.; Morrical, Scott W.			Coordinated Binding of Single-Stranded and Double-Stranded DNA by UvsX Recombinase	PLOS ONE			English	Article							ESCHERICHIA-COLI RECA; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE-T4 UVSX; HUMAN RAD51; SACCHAROMYCES-CEREVISIAE; MEDIATOR PROTEIN; ATP HYDROLYSIS; DYNAMICS; REPLICATION; BREAKS	Homologous recombination is important for the error-free repair of DNA double-strand breaks and for replication fork restart. Recombinases of the RecA/Rad51 family perform the central catalytic role in this process. UvsX recombinase is the RecA/Rad51 ortholog of bacteriophage T4. UvsX and other recombinases form presynaptic filaments on ssDNA that are activated to search for homology in dsDNA and to perform DNA strand exchange. To effectively initiate recombination, UvsX must find and bind to ssDNA within an excess of dsDNA. Here we examine the binding of UvsX to ssDNA and dsDNA in the presence and absence of nucleotide cofactor, ATP. We also examine how the binding of one DNA substrate is affected by simultaneous binding of the other to determine how UvsX might selectively assemble on ssDNA. We show that the two DNA binding sites of UvsX are regulated by the nucleotide cofactor ATP and are coordinated with each other such that in the presence of ssDNA, dsDNA binding is significantly reduced and correlated with its homology to the ssDNA bound to the enzyme. UvsX has high affinity for dsDNA in the absence of ssDNA, which may allow for sequestration of the enzyme in an inactive form prior to ssDNA generation.	[Maher, Robyn L.; Morrical, Scott W.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Morrical, SW (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA.	smorrica@uvm.edu			National Institutes of Health research [R01GM48847]; American Cancer Society [PF-09-254-01-DMC]	National Institutes of Health research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	This work was supported by National Institutes of Health research grant no. R01GM48847 to SWM and by American Cancer Society postdoctoral fellowship no. PF-09-254-01-DMC to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5; Ando RA, 1998, J MOL BIOL, V283, P785, DOI 10.1006/jmbi.1998.2124; Bar-Ziv R, 2001, P NATL ACAD SCI USA, V98, P9068, DOI 10.1073/pnas.151242898; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Eisen JA, 1995, J MOL EVOL, V41, P1105; Farb JN, 2009, J MOL BIOL, V385, P393, DOI 10.1016/j.jmb.2008.11.003; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; Gajewski S, 2011, J MOL BIOL, V405, P65, DOI 10.1016/j.jmb.2010.10.004; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; GRIFFITH J, 1985, J BIOL CHEM, V260, P4484; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KODADEK T, 1990, J BIOL CHEM, V265, P20966; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; Liu J, 2006, BIOCHEMISTRY-US, V45, P5493, DOI 10.1021/bi0525167; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; LLOYD AT, 1993, J MOL EVOL, V37, P399; Maher RL, 2011, J CELL BIOCH; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mishra G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031930; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sweezy MA, 1997, J MOL BIOL, V266, P927, DOI 10.1006/jmbi.1996.0829; Xu H, 2010, NUCLEIC ACIDS RES, V38, P4821, DOI 10.1093/nar/gkq219; Yang SX, 2001, J MOL BIOL, V312, P999, DOI 10.1006/jmbi.2001.5025; YONESAKI T, 1985, EMBO J, V4, P3321, DOI 10.1002/j.1460-2075.1985.tb04083.x; YU X, 1993, J MOL BIOL, V232, P1, DOI 10.1006/jmbi.1993.1363; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	41	9	10	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66654	10.1371/journal.pone.0066654	http://dx.doi.org/10.1371/journal.pone.0066654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824136	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400141
J	Perez-Montarelo, D; Fernandez, A; Barragan, C; Noguera, JL; Folch, JM; Rodriguez, MC; Ovilo, C; Silio, L; Fernandez, AI				Perez-Montarelo, Dafne; Fernandez, Almudena; Barragan, Carmen; Noguera, Jose L.; Folch, Josep M.; Carmen Rodriguez, M.; Ovilo, Cristina; Silio, Luis; Fernandez, Ana I.			Transcriptional Characterization of Porcine Leptin and Leptin Receptor Genes	PLOS ONE			English	Article							RT-PCR; RELATIVE QUANTIFICATION; EARLY-PREGNANCY; MESSENGER-RNA; FAT TISSUE; LONG FORM; EXPRESSION; LOCALIZATION; PROMOTER; ISOFORMS	The leptin (LEP) and its receptor (LEPR) regulate food intake and energy balance through hypothalamic signaling. However, the LEP-LEPR axis seems to be more complex and its expression regulation has not been well described. In pigs, LEP and LEPR genes have been widely studied due to their relevance. Previous studies reported significant effects of SNPs located in both genes on growth and fatness traits. The aim of this study was to determine the expression profiles of LEP and LEPR across hypothalamic, adipose, hepatic and muscle tissues in Iberian x Landrace backcrossed pigs and to analyze the effects of gene variants on transcript abundance. To our knowledge, non porcine LEPR isoforms have been described rather than LEPRb. A short porcine LEPR isoform (LEPRa), that encodes a protein lacking the intracellular residues responsible of signal transduction, has been identified for the first time. The LEPRb isoform was only quantifiable in hypothalamus while LEPRa appeared widely expressed across tissues, but at higher levels in liver, suggesting that both isoforms would develop different roles. The unique LEP transcript showed expression in backfat and muscle. The effects of gene variants on transcript expression revealed interesting results. The LEPRc. 1987C> T polymorphism showed opposite effects on LEPRb and LEPRa hypothalamic expression. In addition, one out of the 16 polymorphisms identified in the LEPR promoter region revealed high differential expression in hepatic LEPRa. These results suggest a LEPR isoform-specific regulation at tissue level. Conversely, non-differential expression of LEP conditional on the analyzed polymorphisms could be detected, indicating that its regulation is likely affected by other mechanisms rather than gene sequence variants. The present study has allowed a transcriptional characterization of LEP and LEPR isoforms on a range of tissues. Their expression patterns seem to indicate that both molecules develop peripheral roles apart from their known hypothalamic signal transduction function.	[Perez-Montarelo, Dafne; Fernandez, Almudena; Barragan, Carmen; Carmen Rodriguez, M.; Ovilo, Cristina; Silio, Luis; Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Mejora Genet Anim, Madrid, Spain; [Noguera, Jose L.] Inst Recerca Tecnol Agroalimentaries, Lleida, Spain; [Folch, Josep M.] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliments, Bellaterra, Spain; [Folch, Josep M.] Ctr Recerca Agrigen, Bellaterra, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Perez-Montarelo, D (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Mejora Genet Anim, Madrid, Spain.	dafne.perez@inia.es	Fernández, Ana Isabel/J-3265-2012; Silio, Luis/R-6439-2019; Muñoz, Almudena Fernández/AAB-4608-2019; Ovilo, Cristina/N-9931-2014; Folch, Josep M/I-4738-2015	Fernández, Ana Isabel/0000-0002-1509-5191; Muñoz, Almudena Fernández/0000-0002-4495-9366; Ovilo, Cristina/0000-0002-5738-8435; Folch, Josep M/0000-0003-3689-1303	Ministerio de Ciencia e Innovacion (MICINN) [AGL2008-04818-C03, AGL2011-29821-C02-02]; Spanish Ministerio de Ciencia e Innovacion [BES-2009-025417]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by Ministerio de Ciencia e Innovacion (MICINN) projects AGL2008-04818-C03 and AGL2011-29821-C02-02. D. Perez-Montarelo was funded by a Formacion de Personal Investigador (FPI) PhD grant from the Spanish Ministerio de Ciencia e Innovacion (BES-2009-025417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bacart J, 2010, FEBS LETT, V584, P2213, DOI 10.1016/j.febslet.2010.03.033; Barb CR, 2001, DOMEST ANIM ENDOCRIN, V21, P297, DOI 10.1016/S0739-7240(01)00123-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogacka I, 2006, J PHYSIOL PHARMACOL, V57, P479; Brown DE, 2012, J DAIRY SCI, V95, P6384, DOI 10.3168/jds.2012-5593; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Cumin F, 1996, INT J OBESITY, V20, P1120; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Galve A, 2012, LIVEST SCI, V145, P145, DOI 10.1016/j.livsci.2012.01.010; Garibotto G, 1998, BIOCHEM BIOPH RES CO, V247, P504, DOI 10.1006/bbrc.1998.8819; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; Hu XX, 2001, CHINESE SCI BULL, V46, P396, DOI 10.1007/BF03183273; Jensen MD, 1999, AM J CLIN NUTR, V69, P18; Kaminski T, 2006, J PHYSIOL PHARMACOL, V57, P95; Kin JH, 2008, C INT SOC AN GEN 200; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu DJ, 2011, MOL BIOL REP, V38, P2051, DOI 10.1007/s11033-010-0330-9; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Manavella PA, 2007, BIOCHEM BIOPH RES CO, V360, P621, DOI 10.1016/j.bbrc.2007.06.088; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Meyer C, 1997, AM J PHYSIOL-ENDOC M, V273, pE903, DOI 10.1152/ajpendo.1997.273.5.E903; Munoz G, 2011, MEAT SCI, V88, P169, DOI 10.1016/j.meatsci.2010.12.018; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Oczkowicz M, 2010, DOMEST ANIM ENDOCRIN, V40, P147; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2000, MAMM GENOME, V11, P344, DOI 10.1007/s003350010065; Ovilo C, 2010, MAMM GENOME, V21, P583, DOI 10.1007/s00335-010-9307-1; Perez-Montarelo D, 2012, ANIM GENET, V43, P805, DOI 10.1111/j.1365-2052.2012.02338.x; Pinson J, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-25; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rezamand P, 2012, J DAIRY SCI, V95, P7097, DOI 10.3168/jds.2012-5613; Rodriguez MC, 2010, P 9 WORLD C GEN APPL; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Stachowiak M, 2007, BIOCHEM GENET, V45, P245, DOI 10.1007/s10528-006-9070-x; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stenger C, 2010, FASEB J, V24, P4218, DOI 10.1096/fj.10-160440; Svobodova K, 2008, J APPL GENET, V49, P263, DOI 10.1007/BF03195623; Switonski M, 2010, J APPL GENET, V51, P153, DOI 10.1007/BF03195724; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wrann CD, 2012, ADIPOCYTE, V1, P168, DOI 10.4161/adip.20574; Wylie ARG, 2011, ANIMAL, V5, P246, DOI 10.1017/S1751731110001540; Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940; Zeng JB, 1997, AM J PHYSIOL-ENDOC M, V273, pE1102, DOI 10.1152/ajpendo.1997.273.6.E1102	59	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66398	10.1371/journal.pone.0066398	http://dx.doi.org/10.1371/journal.pone.0066398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824082	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400103
J	Sykes, A; Edwards, MR; Macintyre, J; del Rosario, A; Gielen, V; Haas, J; Kon, OM; McHale, M; Johnston, SL				Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Kon, Onn Min; McHale, Mark; Johnston, Sebastian L.			TLR3, TLR4 and TLRs7-9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; BRONCHIAL EPITHELIAL-CELLS; MONONUCLEAR-CELLS; RHINOVIRUS; INFECTION; DEFICIENT; RESPONSES; CHILDREN; AGONISTS; ALPHA	Defective Rhinovirus induced interferon-beta and interferon-lambda production has been reported in bronchial epithelial cells from asthmatics but the mechanisms of defective interferon induction in asthma are unknown. Virus infection can induce interferon through Toll like Receptors (TLR) 3, TLR7 and TLR8. The role of these TLRs in interferon induction in asthma is unclear. This objective of this study was to measure the type I and III interferon response to TLR in bronchial epithelial cells and peripheral blood cells from atopic asthmatics and non-atopic non-asthmatics. Bronchial epithelial cells and peripheral blood mononuclear cells from atopic asthmatic and non-atopic non-asthmatic subjects were stimulated with agonists to TLR3, TLR4 & TLRs7-9 and type I and III interferon and pro-inflammatory cytokine, interleukin(IL)-6 and IL-8, responses assessed. mRNA expression was analysed by qPCR. Interferon proteins were analysed by ELISA. Pro-inflammatory cytokines were induced by each TLR ligand in both cell types. Ligands to TLR3 and TLR7/8, but not other TLRs, induced interferon-beta and interferon-lambda in bronchial epithelial cells. The ligand to TLR7/8, but not those to other TLRs, induced only type I interferons in peripheral blood mononuclear cells. No difference was observed in TLR induced interferon or pro-inflammatory cytokine production between asthmatic and non-asthmatic subjects from either cell type. TLR3 and TLR7/8,, stimulation induced interferon in bronchial epithelial cells and peripheral blood mononuclear cells. Interferon induction to TLR agonists was not observed to be different in asthmatics and non-asthmatics.	[Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] MRC, London, England; [Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, London, England; [Sykes, Annemarie; Macintyre, Jonathan; del Rosario, Ajerico; Kon, Onn Min; Johnston, Sebastian L.] Imperial Coll Healthcare NHS Trust, London, England; [McHale, Mark] AstraZeneca R&D Charnwood, Resp & Inflammat Res Area, Loughborough, Leics, England	Imperial College London; University of London; King's College London; Imperial College London; Imperial College London; AstraZeneca	Sykes, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	annemarie.sykes@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012	Johnston, Sebastian Lennox/0000-0003-3009-9200; Edwards, Michael Robert/0000-0001-6837-0532; Kon, Onn Min/0000-0003-2647-4688	Medical Research Council (MRC) [G0601236, 100758]; MRC Clinical Research Fellowship; British Lung Foundation [P06/3]; Wellcome Trust [083567/Z/07/Z]; Asthma UK [05/067, 08/048]; Asthma UK Fellowship [RF07/04]; Asthma UK Clinical Chair [CH11SJ]; ERC [233015]; AstraZeneca; National Institute of Health Research Biomedical Research Centre and Clinical Lecturer funding schemes; Medical Research Council [G0601236, G0700552, G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [RF07/04, MRC-Asthma UK Centre] Funding Source: researchfish; MRC [G0601236, G0700552] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Asthma UK Fellowship; Asthma UK Clinical Chair; ERC(European Research Council (ERC)European Commission); AstraZeneca(AstraZeneca); National Institute of Health Research Biomedical Research Centre and Clinical Lecturer funding schemes; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (MRC project grant G0601236 and Centre grant 100758, and a MRC Clinical Research Fellowship (to AS)), the British Lung Foundation (Grant P06/3), the Wellcome Trust (Grant 083567/Z/07/Z for the Centre for Respiratory Infection), Asthma UK (grants 05/067 and 08/048), an Asthma UK Fellowship RF07/04 (to MRE), the Asthma UK Clinical Chair (CH11SJ to SLJ), ERC FP7 Advanced grant 233015 (to SLJ), AstraZeneca and the National Institute of Health Research Biomedical Research Centre and Clinical Lecturer funding schemes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Biscione GL, 2004, EUR RESPIR J, V24, P745, DOI 10.1183/09031936.04.00049004; Bufe A, 2002, INT ARCH ALLERGY IMM, V127, P82, DOI 10.1159/000048173; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Gehlhar K, 2006, CLIN EXP ALLERGY, V36, P331, DOI 10.1111/j.1365-2222.2006.02450.x; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Iikura K, 2011, INT ARCH ALLERGY IMM, V155, P27, DOI 10.1159/000327262; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Klemets P, 2010, THORAX, V65, P698, DOI 10.1136/thx.2009.132670; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Montville DJ, 2012, J ALLERGY CLIN IMMUN; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Pilishvili T, 2010, PEDIATRICS, V126, pE9, DOI 10.1542/peds.2009-2150; Roponen M, 2010, EUR RESPIR J, V35, P64, DOI 10.1183/09031936.00172008; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; Vissers M, 2012, EUR J IMMUNOL; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	32	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65921	10.1371/journal.pone.0065921	http://dx.doi.org/10.1371/journal.pone.0065921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824215	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400032
J	Fan, GF; Lin, G; Lucito, R; Tonks, NK				Fan, Gaofeng; Lin, Guang; Lucito, Robert; Tonks, Nicholas K.			Protein-tyrosine Phosphatase 1B Antagonized Signaling by Insulin-like Growth Factor-1 Receptor and Kinase BRK/PTK6 in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; THERAPEUTIC TARGET; BRK; EXPRESSION; ACTIVATION; PATHWAY; IDENTIFICATION; INHIBITION; CARCINOMA	Ovarian cancer, which is the leading cause of death from gynecological malignancies, is a heterogeneous disease known to be associated with disruption of multiple signaling pathways. Nevertheless, little is known regarding the role of protein phosphatases in the signaling events that underlie the disease; such knowledge will be essential to gain a complete understanding of the etiology of the disease and how to treat it. We have demonstrated that protein-tyrosine phosphatase 1B (PTP1B) was underexpressed in a panel of ovarian carcinoma-derived cell lines, compared with immortalized human ovarian surface epithelial cell lines. Stable restoration of PTP1B in those cancer cell lines substantially decreased cell migration and invasion, as well as proliferation and anchorage-independent survival. Mechanistically, the pro-survival IGF-1R signaling pathway was attenuated upon ectopic expression of PTP1B. This was due to dephosphorylation by PTP1B of IGF-1R beta-subunit and BRK/PTK6, an SRC-like protein-tyrosine kinase that physically and functionally interacts with the IGF-1R beta-subunit. Restoration of PTP1B expression led to enhanced activation of BAD, one of the major pro-death members of the BCL-2 family, which triggered cell death through apoptosis. Conversely, inhibition of PTP1B with a small molecular inhibitor, MSI-1436, increased proliferation and migration of immortalized HOSE cell lines. These data reveal an important role for PTP1B as a negative regulator of BRK and IGF-1R beta signaling in ovarian cancer cells.	[Fan, Gaofeng; Lin, Guang; Lucito, Robert; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	Tonks@cshl.edu	Lucito, Robert/AID-7159-2022; Fan, Gaofeng/H-2996-2013	Fan, Gaofeng/0000-0002-6729-2867	National Institutes of Health [CA53840, GM55989]; STARR Foundation; Department of Defense Congressional funds; Cold Spring Harbor Laboratory Cancer Centre [CA45508]; Gladowsky Breast Cancer Foundation; Hansen Foundation; Irving Hansen Foundation; Islip Breast Cancer Coalition; Fannie Rippel Foundation; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [P30CA045508, R37CA053840, R01CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STARR Foundation; Department of Defense Congressional funds(United States Department of Defense); Cold Spring Harbor Laboratory Cancer Centre; Gladowsky Breast Cancer Foundation; Hansen Foundation; Irving Hansen Foundation; Islip Breast Cancer Coalition; Fannie Rippel Foundation; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53840 and GM55989 (to N. K. T.). This work was also supported by a grant from the STARR Foundation, Department of Defense Congressional funds (to R. L. and N. K. T.), Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508, and from The Gladowsky Breast Cancer Foundation, Hansen Foundation, Irving Hansen Foundation, Islip Breast Cancer Coalition, Fannie Rippel Foundation, Robertson Research Fund, and the Masthead Cove Yacht Club Carol Marcincuk Fund.	Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Bruchim I, 2013, EXPERT OPIN THER TAR, V17, P307, DOI 10.1517/14728222.2013.749863; Buckley DA, 2002, J CLIN PATHOL-MOL PA, V55, P46, DOI 10.1136/mp.55.1.46; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kang SA, 2010, J BIOL CHEM, V285, P26013, DOI 10.1074/jbc.M109.088971; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Locatelli A, 2012, HORM CANCER-US, V3, P14, DOI 10.1007/s12672-011-0097-z; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; Mabuchi S, 2011, CURR MED CHEM, V18, P2960, DOI 10.2174/092986711796150450; Mhawech-Fauceglia P., 2012, PATHOL RES INT, V2012; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Ostrander JH, 2010, CURR OPIN PHARMACOL, V10, P662, DOI 10.1016/j.coph.2010.08.007; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Szkandera J, 2013, INT J MOL SCI, V14, P1179, DOI 10.3390/ijms14011179; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Tupper J, 2011, ARCH DERMATOL RES, V303, P293, DOI 10.1007/s00403-010-1118-4; Wittman M, 2005, J MED CHEM, V48, P5639, DOI 10.1021/jm050392q; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	54	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24923	24934		10.1074/jbc.M113.482737	http://dx.doi.org/10.1074/jbc.M113.482737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23814047	hybrid, Green Published			2022-12-25	WOS:000330612300056
J	Raedts, J; Lundgren, M; Kengen, SWM; Li, JP; van der Oost, J				Raedts, John; Lundgren, Magnus; Kengen, Serve W. M.; Li, Jin-Ping; van der Oost, John			A Novel Bacterial Enzyme with D-Glucuronyl C5-epimerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-IDURONIC ACID; HEPARAN-SULFATE; HEPARIN/HEPARAN SULFATE; ESCHERICHIA-COLI; BIOSYNTHESIS; POLYSACCHARIDE; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES; PURIFICATION; DATABASE	Glycosaminoglycans are biologically active polysaccharides that are found ubiquitously in the animal kingdom. The biosynthesis of these complex polysaccharides involves complicated reactions that turn the simple glycosaminoglycan backbone into highly heterogeneous structures. One of the modification reactions is the epimerization of D-glucuronic acid to its C5-epimer L-iduronic acid, which is essential for the function of heparan sulfate. Although L-iduronic acid residues have been shown to exist in polysaccharides of some prokaryotes, there has been no experimental evidence for the existence of a prokaryotic D-glucuronyl C5-epimerase. This work for the first time reports on the identification of a bacterial enzyme with D-glucuronyl C5-epimerase activity. A gene of the marine bacterium Bermanella marisrubri sp. RED65 encodes a protein (RED65_08024) of 448 amino acids that has an overall 37% homology to the human D-glucuronic acid C5-epimerase. Alignment of this peptide with the human and mouse sequences revealed a 60% similarity at the carboxyl terminus. The recombinant protein expressed in Escherichia coli showed epimerization activity toward substrates generated from heparin and the E. coli K5 capsular polysaccharide, thereby providing the first evidence for bacterial D-glucuronyl C5-epimerase activity. These findings may eventually be used for modification of mammalian glycosaminoglycans.	[Raedts, John; Kengen, Serve W. M.; van der Oost, John] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Lundgren, Magnus] Uppsala Univ, Dept Cell & Mol Biol, S-75123 Uppsala, Sweden; [Li, Jin-Ping] Uppsala Univ, Dept Med Biochem, S-75123 Uppsala, Sweden	Wageningen University & Research; Uppsala University; Uppsala University	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem, S-75123 Uppsala, Sweden.	jin-ping.li@imbim.uu.se; john.vanderoost@wur.nl	van+der+Oost, John/Y-2548-2019	Kengen, Serve/0000-0001-6139-8946	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program; Swedish Research Council [K2012-67X-21128-04-4]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was carried out in close collaboration with MSD Oss (formerly NV Organon/Schering Plough) and was supported by The Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program and Swedish Research Council Grant K2012-67X-21128-04-4.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aono E, 2010, MOL BIOSYST, V6, P1216, DOI 10.1039/c000396d; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; CAMPBELL P, 1983, ANAL BIOCHEM, V131, P146, DOI 10.1016/0003-2697(83)90146-X; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Chung JY, 1998, FEMS MICROBIOL LETT, V166, P289, DOI 10.1111/j.1574-6968.1998.tb13903.x; Clarke BR, 1999, J BACTERIOL, V181, P2279, DOI 10.1128/JB.181.7.2279-2285.1999; CONRAD HE, 1980, BIOCHEM J, V191, P355, DOI 10.1042/bj1910355; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Hanniffy OM, 1998, CARBOHYD RES, V307, P291, DOI 10.1016/S0008-6215(97)10108-2; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Li JP, 2010, PROG MOL BIOL TRANSL, V93, P59, DOI 10.1016/S1877-1173(10)93004-4; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Perepelov AV, 2008, CARBOHYD RES, V343, P571, DOI 10.1016/j.carres.2007.10.013; Pinhassi J, 2009, INT J SYST EVOL MICR, V59, P373, DOI 10.1099/ijs.0.002113-0; Raedts J, 2011, GLYCOCONJUGATE J, V28, P57, DOI 10.1007/s10719-011-9324-7; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; VUILLARD L, 1995, BIOCHEM J, V305, P337, DOI 10.1042/bj3050337; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WHITFIELD DM, 1991, ANAL BIOCHEM, V194, P259, DOI 10.1016/0003-2697(91)90228-L; WIELAND F, 1986, FEBS LETT, V195, P77, DOI 10.1016/0014-5793(86)80134-X; Zhang YL, 2002, INFECT IMMUN, V70, P2326, DOI 10.1128/IAI.70.5.2326-2335.2002	32	13	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24332	24339		10.1074/jbc.M113.476440	http://dx.doi.org/10.1074/jbc.M113.476440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824188	Green Published, hybrid			2022-12-25	WOS:000330612300005
J	Gingras, AR; Puzon-McLaughlin, W; Ginsberg, MH				Gingras, Alexandre R.; Puzon-McLaughlin, Wilma; Ginsberg, Mark H.			The Structure of the Ternary Complex of Krev Interaction Trapped 1 (KRIT1) Bound to Both the Rap1 GTPase and the Heart of Glass (HEG1) Cytoplasmic Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATION; EFFECTOR INTERACTION; CONCENTRIC GROWTH; RAS BINDING; ASSOCIATION; DOMAINS	Loss of function mutation in Krev interaction trapped 1 (KRIT1) causes autosomal dominant familial cerebral cavernous malformations and disrupts cardiovascular development. The biological function of KRIT1 requires that its FERM (band 4.1, ezrin, radixin, moesin) domain physically interact with both the small GTPase Rap1 and the cytoplasmic tail of the Heart of glass (HEG1) membrane anchor. In this study, we show that the KRIT1 FERM domain can bind both Rap1 and HEG1 simultaneously, and we solved the crystal structure of the KRIT1-Rap1-HEG1 ternary complex. Rap1 binds on the surface of the F1 and F2 subdomains, in an interaction that leaves its Switch II region accessible to other potential effectors. HEG1 binds in a hydrophobic pocket at the KRIT1 F1 and F3 interface, and there is no overlap with the Rap1-binding site. Indeed, the affinity of KRIT1 or the KRIT1-Rap1 complex for HEG1 is comparable (K-d = 1.2 and 0.96 mu M, respectively) showing that there is no competition between the two sites. Furthermore, analysis of this structure revealed a specific ionic interaction between the F2 lobe of KRIT1 and Rap1 that could explain the remarkable Rap1 specificity of KRIT1. This structural insight enabled design of KRIT1(K570I), a mutant that binds Rap1 with 8-fold lower affinity and exhibits increased binding to HRas. These data show that HEG1 can recruit the Rap1-KRIT complex to the plasma membrane where Rap1's Switch II region remains accessible and reveals an important determinant of KRIT1's specificity for Rap1.	[Gingras, Alexandre R.; Puzon-McLaughlin, Wilma; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gingras, AR (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	agingras@ucsd.edu	Gingras, Alexandre R/E-1867-2011	Gingras, Alexandre R/0000-0002-5373-0176	National Institutes of Health [HL106489, GM094663]; American Heart Association [12SDG11610043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL106489 and GM094663 (to M. H. G.). This work was also supported by American Heart Association Scientist Development Grant 12SDG11610043 (to A. R. G.).	Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Collaborative Computational Project No. 4, 1994, ACTA CRYSTALLOGR D, V66, P125; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Kabsch W., 2010, J APPL CRYSTALLOGR, V26, P795; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Liquori CL, 2007, AM J HUM GENET, V80, P69, DOI 10.1086/510439; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mably JD, 2006, DEVELOPMENT, V133, P3139, DOI 10.1242/dev.02469; Mayer Chad L, 2009, BMC Res Notes, V2, P135, DOI 10.1186/1756-0500-2-135; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Wong JH, 2000, NEUROSURGERY, V46, P1454, DOI 10.1097/00006123-200006000-00027	32	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23639	23649		10.1074/jbc.M113.462911	http://dx.doi.org/10.1074/jbc.M113.462911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814056	Green Published, hybrid			2022-12-25	WOS:000330611400003
J	Xie, LW; Collins, JF				Xie, Liwei; Collins, James F.			Transcription Factors Sp1 and Hif2 alpha Mediate Induction of the Copper-transporting ATPase (Atp7a) Gene in Intestinal Epithelial Cells during Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; IRON-DEPRIVATION; RAT DUODENUM; MITHRAMYCIN; PROMOTER; BINDING; DEFICIENCY; EXPRESSION; ALPHA; MICE	Genes with G/C-rich promoters were up-regulated in the duodenal epithelium of iron-deficient rats including those encoding iron (e. g. Dmt1 and Dcytb) and copper (e. g. Atp7a and Mt1) metabolism-related proteins. It was shown previously that an intestinal copper transporter (Atp7a) was co-regulated with iron transport-related genes by a hypoxia-inducible transcription factor, Hif2 alpha. In the current study, we sought to test the role of Sp1 in transcriptional regulation of Atp7a expression during iron deprivation/hypoxia. Initial studies in IEC-6 cells showed that mithramycin, an Sp1 inhibitor, reduced expression of Atp7a and iron transport-related genes (Dmt1, Dcytb, and Fpn1) and blocked their induction by CoCl2, a hypoxia mimetic. Consistent with this, overexpression of Sp1 increased endogenous Atp7a mRNA and protein expression and stimulated Atp7a, Dmt1, and Dcytb promoter activity. Site-directed mutagenesis and functional analysis of a basal Atp7a promoter construct revealed four functional Sp1 binding sites that were necessary for Hif2 alpha-mediated induction of promoter activity. Furthermore, chromatin immunoprecipitation (ChIP) assays confirmed that Sp1 specifically interacts with the Atp7a promoter in IEC-6 cells and in rat duodenal enterocytes. This investigation has thus revealed a novel aspect of Atp7a gene regulation in which Sp1 may be necessary for the HIF-mediated induction of gene transcription during iron deficiency/hypoxia. Understanding regulation of Atp7a expression may help further clarify the physiological role of copper in the maintenance of iron homeostasis. Furthermore, this Sp1/Hif2 alpha regulatory mechanism may have broader implications for understanding the genetic response of the intestinal epithelium to maintain whole-body iron homeostasis during states of deficiency.	[Xie, Liwei; Collins, James F.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, 572 Newell Dr,FSN Bldg 441, Gainesville, FL 32611 USA.	jfcollins@ufl.edu			National Institutes of Health [1R01-DK074867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-DK074867 (to J.F.C.).	Adrian GS, 1996, J GERONTOL A-BIOL, V51, pB66, DOI 10.1093/gerona/51A.1.B66; Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Collins JF, 2009, AM J PHYSIOL-GASTR L, V297, pG695, DOI 10.1152/ajpgi.00203.2009; Collins JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-420; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Fuqua BK, 2012, J TRACE ELEM MED BIO, V26, P115, DOI 10.1016/j.jtemb.2012.03.015; Gulec S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066010; Hu ZH, 2010, AM J PHYSIOL-CELL PH, V299, pC930, DOI 10.1152/ajpcell.00238.2010; Jiang LL, 2011, AM J PHYSIOL-GASTR L, V301, pG877, DOI 10.1152/ajpgi.00261.2011; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaler S G, 1994, Adv Pediatr, V41, P263; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mura C, 2004, FASEB J, V18, P1922, DOI 10.1096/fj.04-2520fje; NAVEH Y, 1981, PEDIATRICS, V68, P397; Prohaska JR, 2006, COMP BIOCHEM PHYS B, V143, P360, DOI 10.1016/j.cbpb.2005.12.010; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Ravia JJ, 2005, J BIOL CHEM, V280, P36221, DOI 10.1074/jbc.M506727200; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; Rohlff C, 1998, INT J ONCOL, V12, P383; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SCHNEDL W, 1977, HUM GENET, V36, P299, DOI 10.1007/BF00446280; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tsuji Y, 1998, J BIOL CHEM, V273, P2984, DOI 10.1074/jbc.273.5.2984; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wada T, 2006, BIOL PHARM BULL, V29, P49, DOI 10.1248/bpb.29.49; WARD DC, 1965, SCIENCE, V149, P1259, DOI 10.1126/science.149.3689.1259; Xie LW, 2013, AM J PHYSIOL-CELL PH, V304, pC257, DOI 10.1152/ajpcell.00336.2012; Xie LW, 2011, AM J PHYSIOL-CELL PH, V300, pC1298, DOI 10.1152/ajpcell.00023.2011; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Yuan Y, 2001, BIOCHEM BIOPH RES CO, V288, P849, DOI 10.1006/bbrc.2001.5835	43	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23943	23952		10.1074/jbc.M113.489500	http://dx.doi.org/10.1074/jbc.M113.489500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814049	hybrid, Green Published			2022-12-25	WOS:000330611400033
J	Bueno, D; Palacios-Gimenez, OM; Cabral-de-Mello, DC				Bueno, Danilo; Palacios-Gimenez, Octavio Manuel; Cabral-de-Mello, Diogo Cavalcanti			Chromosomal Mapping of Repetitive DNAs in the Grasshopper Abracris flavolineata Reveal Possible Ancestry of the B Chromosome and H3 Histone Spreading	PLOS ONE			English	Article							PROCHILODUS-LINEATUS CHARACIFORMES; MYRMELEOTETTIX-MACULATUS THUNB; EXTRACHROMOSOMAL CIRCULAR DNA; REPEATED GENOMIC SEQUENCES; NUCLEAR-RNA GENES; 5S RIBOSOMAL DNA; EVOLUTIONARY DYNAMICS; A-CHROMOSOME; EYPREPOCNEMIS-PLORANS; ASTYANAX-SCABRIPINNIS	Supernumerary chromosomes (B chromosomes) occur in approximately 15% of eukaryote species. Although these chromosomes have been extensively studied, knowledge concerning their specific molecular composition is lacking in most cases. The accumulation of repetitive DNAs is one remarkable characteristic of B chromosomes, and the occurrence of distinct types of multigene families, satellite DNAs and some transposable elements have been reported. Here, we describe the organization of repetitive DNAs in the A complement and B chromosome system in the grasshopper species Abracris flavolineata using classical cytogenetic techniques and FISH analysis using probes for five multigene families, telomeric repeats and repetitive C(0)t-1 DNA fractions. The 18S rRNA and H3 histone multigene families are highly variable and well distributed in A. flavolineata chromosomes, which contrasts with the conservation of U snRNA genes and less variable distribution of 5S rDNA sequences. The H3 histone gene was an extensively distributed with clusters occurring in all chromosomes. Repetitive DNAs were concentrated in C-positive regions, including the pericentromeric region and small chromosomal arms, with some occurrence in C-negative regions, but abundance was low in the B chromosome. Finally, the first demonstration of the U2 snRNA gene in B chromosomes in A. flavolineata may shed light on its possible origin. These results provide new information regarding chromosomal variability for repetitive DNAs in grasshoppers and the specific molecular composition of B chromosomes.	[Bueno, Danilo; Palacios-Gimenez, Octavio Manuel; Cabral-de-Mello, Diogo Cavalcanti] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Biol, Rio Claro, SP, Brazil	Universidade Estadual Paulista	Cabral-de-Mello, DC (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Biol, Rio Claro, SP, Brazil.	mellodc@rc.unesp.br	Bueno, Danilo/J-6154-2018; Cabral-de-Mello, Diogo C/F-5328-2010; Bueno, Danilo/GLT-0793-2022; Cabral-de-Mello, Diogo Cavalcanti/E-7656-2012	Bueno, Danilo/0000-0002-8788-9695; Bueno, Danilo/0000-0002-8788-9695; Cabral-de-Mello, Diogo Cavalcanti/0000-0002-4721-2655	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2011/19481-3, 2011/18028-3]; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [475308/2011-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (2011/19481-3, 2011/18028-3), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (475308/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoni RF, 2006, GENETICA, V127, P277, DOI 10.1007/s10709-005-4846-1; Barzotti R, 2003, CHROMOSOME RES, V11, P365, DOI 10.1023/A:1024048108918; Bidau CJ, 2004, CYTOGENET GENOME RES, V106, P295, DOI 10.1159/000079302; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bugrov AG, 2004, CYTOGENET GENOME RES, V106, P284, DOI 10.1159/000079300; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Cabral-de-Mello DC, 2012, CHROMOSOME RES, V20, P279, DOI 10.1007/s10577-011-9271-y; Cabral-De-Mello DC, 2011, CYTOGENET GENOME RES, V132, P89, DOI 10.1159/000317476; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabral-de-Mello DC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-88; Cabral-de-Mello DC, 2011, GENETICA, V139, P921, DOI 10.1007/s10709-011-9596-7; Cabral-de-Mello DC, 2011, GENETICA, V139, P315, DOI 10.1007/s10709-011-9551-7; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 2003, CHROMOSOME RES, V11, P375, DOI 10.1023/A:1024127525756; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Castillo E.R.D., 2011, REV CIENC TECNOL, V16, P31; CELLA DM, 1991, REV BRAS GENET, V14, P315; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen S, 2008, PLANT J, V53, P1027, DOI 10.1111/j.1365-313X.2007.03394.x; Cohen S, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-11; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; CONFALONIERI VA, 1986, GENETICA, V68, P87, DOI 10.1007/BF02424404; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; Ferreira IA, 2008, MICRON, V39, P411, DOI 10.1016/j.micron.2007.02.010; GALLAGHER A, 1973, CHROMOSOMA, V40, P167; Grieco ML, 2000, HEREDITY, V84, P639, DOI 10.1046/j.1365-2540.2000.00688.x; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; Hewitt G.M., 1979, Animal Cytogenetics, V3, P1; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; JOHN B, 1965, CHROMOSOMA, V16, P548, DOI 10.1007/BF00326973; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; Jones RN, 2008, CYTOGENET GENOME RES, V120, P265, DOI 10.1159/000121076; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Jones RN, 1993, FRONT PLANT SCI, P81; LONG EO, 1980, J MOL BIOL, V138, P873, DOI 10.1016/0022-2836(80)90070-4; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Loreto V, 2008, CHROMOSOME RES, V16, P233, DOI 10.1007/s10577-007-1188-0; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Merlo MA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-201; Mestriner CA, 2000, HEREDITY, V85, P1, DOI 10.1046/j.1365-2540.2000.00702.x; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Oliveira NL, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-24; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Pelliccia F, 2001, GENOME, V44, P331, DOI 10.1139/gen-44-3-331; PENDAS AM, 1994, CHROMOSOMA, V103, P147, DOI 10.1007/BF00352324; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Rubtsov NB, 2004, CYTOGENET GENOME RES, V106, P289, DOI 10.1159/000079301; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; Ruiz-Ruano FJ, 2011, CYTOGENET GENOME RES, V134, P120, DOI 10.1159/000324690; Sambrook J, 2001, MOL CLONING LAB MANU; SCHUBERT I, 1984, PLANT SYST EVOL, V144, P291, DOI 10.1007/BF00984139; SCHWEIZER D, 1983, CHROMOSOMA, V88, P227, DOI 10.1007/BF00285625; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Teruel M, 2011, CYTOGENET GENOME RES, V132, P94, DOI 10.1159/000319621; Teruel M, 2009, CYTOGENET GENOME RES, V125, P286, DOI 10.1159/000235935; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOMA, V118, P291, DOI 10.1007/s00412-008-0197-x; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; Ubeda-Manzanaro M, 2010, GENETICA, V138, P787, DOI 10.1007/s10709-010-9460-1; Vicari MR, 2011, GENETICA, V139, P1073, DOI 10.1007/s10709-011-9611-z; VILARDI JC, 1986, MENDELIANA, V7, P125; Voltolin TA, 2010, GENETICA, V138, P1133, DOI 10.1007/s10709-010-9502-8; Wilson E, 1907, SCIENCE, V26, P870, DOI [10.1126/science.26.677.870-a, DOI 10.1126/SCIENCE.26.660.258]; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Zhang LL, 2007, GENETICA, V130, P193, DOI 10.1007/s10709-006-9006-8; Zwick MS, 1997, GENOME, V40, P138, DOI 10.1139/g97-020	77	78	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66532	10.1371/journal.pone.0066532	http://dx.doi.org/10.1371/journal.pone.0066532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826099	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000005
J	Kolahdooz, F; Spearing, K; Sharma, S				Kolahdooz, Fariba; Spearing, Kerry; Sharma, Sangita			Dietary Adequacies among South African Adults in Rural KwaZulu-Natal	PLOS ONE			English	Article							NUTRITION TRANSITION; OBESITY; FOOD; ZINC; DEFICIENCY; CARBOHYDRATE; POPULATION; COUNTRIES; IRON	Background: Food quality, determined by micronutrient content, is a stronger determinant of nutritional status than food quantity. Health concerns resulting from the co-existence of over-nutrition and under-nutrition in low income populations in South Africa have been fully recognized in the last two decades. This study aimed to further investigate dietary adequacy amongst adults in rural KwaZulu-Natal, by determining daily energy and nutrient intakes, and identifying the degree of satisfaction of dietary requirements. Methods: Cross-sectional study assessing dietary adequacy from 24-hour dietary recalls of randomly selected 136 adults in Empangeni, KwaZulu-Natal, South Africa. Results: Results are presented for men (n = 52) and women (n = 84) 19-50 and >50 years old. Mean energy intake was greatest in women >50 years (2852 kcal/day) and exceeded Dietary Reference Intake's for both men and women, regardless of age. Mean daily energy intake from carbohydrates was 69% for men and 67% for women, above the Dietary Reference Intake range of 45-65%. Sodium was also consumed in excess, and the Dietary Reference Intakes of vitamins A, B12, C, D, and E, calcium, zinc and pantothenic acid were not met by the majority of the population. Conclusion: Despite mandatory fortification of staple South African foods, micronutrient inadequacies are evident among adults in rural South African communities. Given the excess caloric intake and the rising prevalence of obesity and other non-communicable diseases in South Africa, a focus on diet quality may be a more effective approach to influence micronutrient status than a focus on diet quantity.	[Kolahdooz, Fariba; Spearing, Kerry; Sharma, Sangita] Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada	University of Alberta	Sharma, S (corresponding author), Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada.	gita.sharma@ualberta.ca		Sharma, Sangita/0000-0002-4995-0010	Aboriginal and Global Health Research Group, Department of Medicine, University of Alberta	Aboriginal and Global Health Research Group, Department of Medicine, University of Alberta	Funding was provided by the Aboriginal and Global Health Research Group, Department of Medicine, University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; ALLEN LH, 1993, NUTR REV, V51, P255, DOI 10.1111/j.1753-4887.1993.tb03117.x; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Buyken AE, 2010, AM J CLIN NUTR, V92, P634, DOI 10.3945/ajcn.2010.29390; Campbell NC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/860954; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Gautam S, 2011, INT J FOOD SCI NUTR, V62, P826, DOI 10.3109/09637486.2011.584861; Hattingh Z, 2008, W INDIAN MED J, V57, P431; Hunt JR, 2002, NUTR REV, V60, P127, DOI 10.1301/00296640260093788; Institute of Medicine of the National Academies, 2005, DIET REF INT EN CARB; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Labadarios D, 2005, PUBLIC HEALTH NUTR, V8, P533, DOI 10.1079/PHN2005816; MacIntyre UE, 2002, NUTR RES, V22, P239, DOI 10.1016/S0271-5317(01)00392-X; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Merchant AT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-2; Mocchegiani E, 2013, AGE, V35, P839, DOI 10.1007/s11357-011-9377-3; Mohan S, 2009, CLIN SCI, V117, P1, DOI 10.1042/CS20080207; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Muscogiuri G, 2012, NUTR METAB CARDIOVAS, V22, P81, DOI 10.1016/j.numecd.2011.11.001; Neumann CG, 2003, J NUTR, V133, p3941S, DOI 10.1093/jn/133.11.3941S; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prasad AS, 2009, J AM COLL NUTR, V28, P257, DOI 10.1080/07315724.2009.10719780; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Prentice A, 2009, CLIN REV BONE MINER, V7, P94, DOI 10.1007/s12018-009-9038-6; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Sanchez-Castillo CP, 2005, SODIUM SALT INTAKE H; Sharma S, 2011, P NUTR SOC, V70, P232, DOI 10.1017/S0029665110004775; Shikany JM, 2010, NUTRITION, V26, P641, DOI 10.1016/j.nut.2009.08.014; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; South African Medical Research Council, 2012, SAFOODS S AFR FOOD D; Spearing K, 2013, J HUM NUTR DIET, V26, P222, DOI 10.1111/jhn.12001; Statistics South Africa, 2011, STATS BRIEF 2010; Statistics South Africa, 2011, MID YEAR POP EST; Steyn NP, 2008, PUBLIC HEALTH NUTR, V11, P307, DOI 10.1017/S136898000700033X; Temple NJ, 2011, NUTRITION, V27, P55, DOI 10.1016/j.nut.2009.12.004; Tremblay A, 2011, J AM COLL NUTR, V30, p449S, DOI 10.1080/07315724.2011.10719989; Venti CA, 2002, J NUTR, V132, P1050, DOI 10.1093/jn/132.5.1050; Wolmarans P., 2010, CONDENSED FOOD COMPO; World Health Organization, 2011, WHO GLOB INF DAT SAV; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144	42	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67184	10.1371/journal.pone.0067184	http://dx.doi.org/10.1371/journal.pone.0067184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825639	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000087
J	Almeida-Souza, L; Asselbergh, B; De Winter, V; Goethals, S; Timmerman, V; Janssens, S				Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent; Janssens, Sophie			HSPB1 Facilitates the Formation of Non-Centrosomal Microtubules	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GAMMA-TUBULIN COMPLEXES; MARIE-TOOTH NEUROPATHY; PROTEASOMAL DEGRADATION; ACTIN POLYMERIZATION; IN-VITRO; F-ACTIN; HSP27; NUCLEATION; CELLS	The remodeling capacity of microtubules (MT) is essential for their proper function. In mammals, MTs are predominantly formed at the centrosome, but can also originate from non-centrosomal sites, a process that is still poorly understood. We here show that the small heat shock protein HSPB1 plays a role in the control of non-centrosomal MT formation. The HSPB1 expression level regulates the balance between centrosomal and non-centrosomal MTs. The HSPB1 protein can be detected specifically at sites of de novo forming non-centrosomal MTs, while it is absent from the centrosomes. In addition, we show that HSPB1 binds preferentially to the lattice of newly formed MTs in vitro, suggesting that its function occurs by stabilizing MT seeds. Our findings open new avenues for the understanding of the role of HSPB1 in the development, maintenance and protection of cells with specialized non-centrosomal MT arrays.	[Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent; Janssens, Sophie] VIB, Dept Mol Genet, Antwerp, Belgium; [Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent; Janssens, Sophie] Univ Antwerp, B-2020 Antwerp, Belgium; [Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Janssens, Sophie] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, GROUP ID Consortium, B-9000 Ghent, Belgium; [Janssens, Sophie] VIB, Dept Mol Biomed Res, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Ghent University; Flanders Institute for Biotechnology (VIB)	Timmerman, V (corresponding author), VIB, Dept Mol Genet, Antwerp, Belgium.	vincent.timmerman@molgen.vib-ua.be; sophie.janssens@dmbr.vib-ugent.be	Almeida-Souza, Leonardo/C-3437-2011; Timmerman, Vincent/O-7283-2019; Janssens, Sophie/HHN-1756-2022	Almeida-Souza, Leonardo/0000-0002-7169-1238; Timmerman, Vincent/0000-0002-2162-0933; Asselbergh, Bob/0000-0003-2784-2470	University of Antwerp; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth (GSKE); "Association Belge contre les Maladies Neuromusculaires'' (ABMM); American Muscular Dystrophy Association (MDA); Hercules foundation	University of Antwerp; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth (GSKE); "Association Belge contre les Maladies Neuromusculaires'' (ABMM); American Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Hercules foundation	This work was supported in part by the special research fund and the Methusalem program of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth (GSKE), the "Association Belge contre les Maladies Neuromusculaires'' (ABMM), the American Muscular Dystrophy Association (MDA). We thank the Hercules foundation providing funding for the transmission electron and spinning disk microscopes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Barron DM, 2003, ANAL BIOCHEM, V315, P49, DOI 10.1016/S0003-2697(02)00691-7; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Brown DD, 2007, GENESIS, V45, P667, DOI 10.1002/dvg.20340; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen L, 2012, P NATL ACAD SCI USA, V109, P11842, DOI 10.1073/pnas.1121180109; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Ferns G, 2006, INT J EXP PATHOL, V87, P253, DOI 10.1111/j.1365-2613.2006.00484.x; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HUOT J, 1991, CANCER RES, V51, P5245; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Komarova YA, 2002, J CELL SCI, V115, P3527; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Macurek L, 2008, BIOCHEM J, V416, P421, DOI 10.1042/BJ20080909; Mehlen P, 1999, CELL DEATH DIFFER, V6, P227, DOI 10.1038/sj.cdd.4400483; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; MIRON T, 1988, J MUSCLE RES CELL M, V9, P91; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Pivovarova AV, 2007, FEBS J, V274, P5937, DOI 10.1111/j.1742-4658.2007.06117.x; Pivovarova AV, 2005, BIOCHEM BIOPH RES CO, V331, P1548, DOI 10.1016/j.bbrc.2005.04.077; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Salmon P., 2006, CURR PROTOC NEUROSCI; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Xiao JJ, 2010, PHARMACOLOGY, V85, P301, DOI 10.1159/000292948	56	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66541	10.1371/journal.pone.0066541	http://dx.doi.org/10.1371/journal.pone.0066541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826100	Green Published, gold			2022-12-25	WOS:000321738400021
J	Bond, WS; Akinfenwa, PY; Perlaky, L; Hurwitz, MY; Hurwitz, RL; Chevez-Barrios, P				Bond, Wesley S.; Akinfenwa, Patricia Y.; Perlaky, Laszlo; Hurwitz, Mary Y.; Hurwitz, Richard L.; Chevez-Barrios, Patricia			Tumorspheres but Not Adherent Cells Derived from Retinoblastoma Tumors Are of Malignant Origin	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; GENE; IDENTIFICATION; EXPRESSION; LINES; MISIDENTIFICATION; PRECURSORS; CULTURE; BRAIN	Verification that cell lines used for cancer research are derived from malignant cells in primary tumors is imperative to avoid invalidation of study results. Retinoblastoma is a childhood ocular tumor that develops from loss of functional retinoblastoma protein (pRb) as a result of genetic or epigenetic changes that affect both alleles of the RB1 gene. These patients contain unique identifiable genetic signatures specifically present in malignant cells. Primary cultures derived from retinoblastoma tumors can be established as non-adherent tumorspheres when grown in defined media or as attached monolayers when grown in serum-containing media. While the RB1 genotypes of tumorspheres match those of the primary tumor, adherent cultures have the germline RB1 genotype. Tumorspheres derived from pRb-negative tumors do not express pRb and express the neuroendocrine tumor markers synaptophysin and microtubule-associated protein 2 (MAP2). Adherent cells are synaptophysin-negative and express pRb, the epithelial cell marker cytokeratin that is expressed in the retinal pigmented epithelium and the vascular endothelial cell marker CD34. While tumorspheres are of malignant origin, our results cast doubt on the assumption that adherent tumor-derived cultures are always valid in vitro models of malignant cells and emphasize the need for validation of primary tumor cultures.	[Bond, Wesley S.; Akinfenwa, Patricia Y.; Hurwitz, Richard L.; Chevez-Barrios, Patricia] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bond, Wesley S.; Akinfenwa, Patricia Y.; Perlaky, Laszlo; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Bond, Wesley S.; Akinfenwa, Patricia Y.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Ctr Cell & Gene Therapy, Houston, TX USA; [Bond, Wesley S.; Akinfenwa, Patricia Y.; Perlaky, Laszlo; Hurwitz, Mary Y.; Hurwitz, Richard L.] Texas Childrens Canc & Hematol Cts, Houston, TX USA; [Chevez-Barrios, Patricia] Methodist Hosp, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Hurwitz, Richard L.; Chevez-Barrios, Patricia] Retinoblastoma Ctr Houston, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	Chevez-Barrios, P (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA.	pchevez-barrios@tmhs.org			Retina Research Foundation; Golfers Against Cancer; National Institutes of Health grant [T32 EY007001-37]; NATIONAL EYE INSTITUTE [T32EY007001] Funding Source: NIH RePORTER	Retina Research Foundation; Golfers Against Cancer; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Retina Research Foundation (RLH), Golfers Against Cancer (RLH) and National Institutes of Health grant T32 EY007001-37 (PYA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond WS, 2011, JOVE-J VIS EXP, DOI 10.3791/2644; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; FINA L, 1990, BLOOD, V75, P2417; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GOULD VE, 1987, AM J PATHOL, V126, P243; HERMAN MM, 1989, AM J PATHOL, V134, P115; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; HURWITZ RL, 1990, J CLIN INVEST, V85, P1872, DOI 10.1172/JCI114648; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; McCallum HM, 1996, BREAST CANCER RES TR, V39, P247, DOI 10.1007/BF01806153; Nardone RM, 2008, BIOTECHNIQUES, V45, P221, DOI 10.2144/000112925; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Singh SK, 2003, CANCER RES, V63, P5821; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; Wadhwa L, 2012, INVEST OPHTH VIS SCI, V53, P3454, DOI 10.1167/iovs.12-9549; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880	29	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e63519	10.1371/journal.pone.0063519	http://dx.doi.org/10.1371/journal.pone.0063519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826078	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400002
J	Dias, IHK; Chapple, ILC; Milward, M; Grant, MM; Hill, E; Brown, J; Griffiths, HR				Dias, Irundika H. K.; Chapple, Ian L. C.; Milward, Mike; Grant, Melissa M.; Hill, Eric; Brown, James; Griffiths, Helen R.			Sulforaphane Restores Cellular Glutathione Levels and Reduces Chronic Periodontitis Neutrophil Hyperactivity In Vitro	PLOS ONE			English	Article							LIPID RAFTS; RESPIRATORY BURST; REACTIVE OXYGEN; DNA-BINDING; REDOX; NRF2; CELLS; ACTIVATION; SPHINGOMYELINASE; MODEL	The production of high levels of reactive oxygen species by neutrophils is associated with the local and systemic destructive phenotype found in the chronic inflammatory disease periodontitis. In the present study, we investigated the ability of sulforaphane (SFN) to restore cellular glutathione levels and reduce the hyperactivity of circulating neutrophils associated with chronic periodontitis. Using differentiated HL60 cells as a neutrophil model, here we show that generation of extracellular O-2 center dot - by the nicotinamide adenine dinucleotide (NADPH) oxidase complex is increased by intracellular glutathione depletion. This may be attributed to the upregulation of thiol regulated acid sphingomyelinase driven lipid raft formation. Intracellular glutathione was also lower in primary neutrophils from periodontitis patients and, consistent with our previous findings, patients neutrophils were hyper-reactive to stimuli. The activity of nuclear factor erythroid-2-related factor 2 (Nrf2), a master regulator of the antioxidant response, is impaired in circulating neutrophils from chronic periodontitis patients. Although patients' neutrophils exhibit a low reduced glutathione (GSH)/oxidised glutathione (GSSG) ratio and a higher total Nrf2 level, the DNA-binding activity of nuclear Nrf2 remained unchanged relative to healthy controls and had reduced expression of glutamate cysteine ligase catalytic (GCLC), and modifier (GCLM) subunit mRNAs, compared to periodontally healthy subjects neutrophils. Pre-treatment with SFN increased expression of GCLC and GCM, improved intracellular GSH/GSSG ratios and reduced agonist-activated extracellular O-2 center dot - production in both dHL60 and primary neutrophils from patients with periodontitis and controls. These findings suggest that a deficiency in Nrf2-dependent pathways may underpin susceptibility to hyper-reactivity in circulating primary neutrophils during chronic periodontitis.	[Dias, Irundika H. K.; Hill, Eric; Brown, James; Griffiths, Helen R.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Chapple, Ian L. C.; Milward, Mike; Grant, Melissa M.] Univ Birmingham, Coll Med & Dent Sci, Sch Dent, Birmingham, W Midlands, England	Aston University; University of Birmingham	Griffiths, HR (corresponding author), Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.	h.r.griffiths@aston.ac.uk	Griffiths, Helen R./E-3453-2013; Grant, Melissa/A-5590-2010; Dias, Irundika H.K./AAC-3838-2019; Brown, James E/A-7503-2012; Chapple, Iain L C/T-2986-2017	Griffiths, Helen R./0000-0002-2666-2147; Grant, Melissa/0000-0003-1154-7266; Chapple, Iain L C/0000-0003-2697-7082; Hill, Eric/0000-0002-9419-1500; Dias, Irundika/0000-0002-6620-8221	Dunhill Medical Trust [R92/1108]; COST [CM1001, BM1203]	Dunhill Medical Trust(Dunhill Medical Trust); COST(European Cooperation in Science and Technology (COST))	IHKD gratefully acknowledges funding from the Dunhill Medical Trust (R92/1108). HRG gratefully acknowledges funding by COST CM1001 and COST BM1203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EM, 2011, J CLIN PERIODONTOL, V38, P894, DOI 10.1111/j.1600-051X.2011.01764.x; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Chapple ILC, 2012, J CLIN PERIODONTOL, V39, P62, DOI 10.1111/j.1600-051X.2011.01793.x; Chapple IL., 2013, J CLIN PERIODONTOL, V40, pS106; Chapple ILC, 2002, J CLIN PATHOL-MOL PA, V55, P367; Cui WP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/821936; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; Dias IHK, 2008, INFECT IMMUN, V76, P317, DOI 10.1128/IAI.00618-07; Dias IHK, 2011, J CLIN PERIODONTOL, V38, P1, DOI 10.1111/j.1600-051X.2010.01628.x; Evans WE, 2003, J ANDROL, V24, P812; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P1604, DOI 10.1016/j.jaci.2011.03.031; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Go YM, 2010, METHOD ENZYMOL, V474, P165, DOI 10.1016/S0076-6879(10)74010-6; Grant MM, 2010, J CLIN PERIODONTOL, V37, P17, DOI 10.1111/j.1600-051X.2009.01504.x; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Griffiths HR, 2005, REDOX REP, V10, P273, DOI 10.1179/135100005X83680; Griffiths HR, 2000, FREE RADICAL RES, V33, pS47; Guerra BA, 2012, DIABETES RES CLIN PR, V98, P108, DOI 10.1016/j.diabres.2012.07.004; Guichard C, 2005, J BIOL CHEM, V280, P37021, DOI 10.1074/jbc.M506594200; Hancock John T., 2008, V476, P1, DOI 10.1007/978-1-59745-129-1_1; Hancock JT, 2003, ANN NY ACAD SCI, V1010, P446, DOI 10.1196/annals.1299.081; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jacob C, 2002, INT IMMUNOPHARMACOL, V2, P1647, DOI 10.1016/S1567-5769(02)00141-8; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Li PL, 2007, ANTIOXID REDOX SIGN, V9, P1457, DOI 10.1089/ars.2007.1667; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Matthews JB, 2007, CLIN EXP IMMUNOL, V147, P255, DOI 10.1111/j.1365-2249.2006.03276.x; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Panjamurthy K, 2005, CELL MOL BIOL LETT, V10, P255; Petri S, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878030; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Seckin S, 1997, PHARMACOL RES, V36, P55, DOI 10.1006/phrs.1997.0204; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Soeda S, 2004, NEUROCHEM INT, V45, P619, DOI 10.1016/j.neuint.2004.04.001; Starrett W, 2011, J IMMUNOTOXICOL, V8, P150, DOI 10.3109/1547691X.2011.558529; Sun XY, 2011, TOXICOL APPL PHARM, V255, P9, DOI 10.1016/j.taap.2011.05.011; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tonetti MS, 2013, J CLIN PERIODONTOL, V40; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	51	53	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66407	10.1371/journal.pone.0066407	http://dx.doi.org/10.1371/journal.pone.0066407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826097	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000321738400019
J	Zuo, ZT; Wang, R; Zhuo, Y; Xue, R; St Lawrence, KS; Wang, DJJ				Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong; St Lawrence, Keith S.; Wang, Danny J. J.			Turbo-FLASH Based Arterial Spin Labeled Perfusion MRI at 7 T	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; NOISE RATIO; HIGH-FIELD; MODEL; QUANTIFICATION; RELAXATION; EFFICIENCY; COIL	Motivations of arterial spin labeling (ASL) at ultrahigh magnetic fields include prolonged blood T-1 and greater signal-to-noise ratio (SNR). However, increased B-0 and B-1 inhomogeneities and increased specific absorption ratio (SAR) challenge practical ASL implementations. In this study, Turbo-FLASH (Fast Low Angle Shot) based pulsed and pseudo-continuous ASL sequences were performed at 7T, by taking advantage of the relatively low SAR and short TE of Turbo-FLASH that minimizes susceptibility artifacts. Consistent with theoretical predictions, the experimental data showed that Turbo-FLASH based ASL yielded approximately 4 times SNR gain at 7T compared to 3T. High quality perfusion images were obtained with an in-plane spatial resolution of 0.85x1.7 mm(2). A further functional MRI study of motor cortex activation precisely located the primary motor cortex to the precentral gyrus, with the same high spatial resolution. Finally, functional connectivity between left and right motor cortices as well as supplemental motor area were demonstrated using resting state perfusion images. Turbo-FLASH based ASL is a promising approach for perfusion imaging at 7T, which could provide novel approaches to high spatiotemporal resolution fMRI and to investigate the functional connectivity of brain networks at ultrahigh field.	[Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong; Wang, Danny J. J.] Univ Calif Los Angeles, Beijing Joint Ctr Adv Brain Imaging, Beijing, Peoples R China; [Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong; Wang, Danny J. J.] Univ Calif Los Angeles, Beijing Joint Ctr Adv Brain Imaging, Los Angeles, CA USA; [St Lawrence, Keith S.] Lawson Hlth Res Inst, London, ON, Canada; [Wang, Danny J. J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of California System; University of California Los Angeles; Western University (University of Western Ontario); University of California System; University of California Los Angeles	Zuo, ZT (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	ztzuo@bcslab.ibp.ac.cn	Wang, Danny JJ/O-2482-2018; St. Lawrence, Keith/B-5726-2015	Wang, Danny JJ/0000-0002-0840-7062; St Lawrence, Keith/0000-0001-8022-8205	Ministry of Science and Technology of China [2012CB825500, 2010IM030800]; National Nature Science Foundation of China [91132302, 90820307]; United States National Institutes of Health [R01-MH080892, R01-NS081077, R01-EB014922]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Ministry of Science and Technology of China grants (2012CB825500, 2010IM030800), National Nature Science Foundation of China grants (91132302, 90820307), and United States National Institutes of Health grants R01-MH080892, R01-NS081077 and R01-EB014922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Bauer WR, 1996, MAGNET RESON MED, V35, P43, DOI 10.1002/mrm.1910350107; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cho ZH, 2010, NEUROIMAGE, V49, P2134, DOI 10.1016/j.neuroimage.2009.11.002; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Detre JA, 2000, MED RAD DIA IMG, P47; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dixon JE, 2013, EUR J RADIOL, V82, P719, DOI 10.1016/j.ejrad.2011.09.023; Duhamel G, 2011, P ISMRM 19 ANN M MON, P371; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gardener AG, 2009, MAGN RESON MED, V61, P874, DOI 10.1002/mrm.21796; Golay X, 2005, MAGNET RESON MED, V53, P15, DOI 10.1002/mrm.20338; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; Jahng GH, 2007, MED PHYS, V34, P4519, DOI 10.1118/1.2795675; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kjolby BF, 2006, MAGN RESON MED, V56, P187, DOI 10.1002/mrm.20920; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Lee J, 2010, P NATL ACAD SCI USA, V107, P5130, DOI 10.1073/pnas.0910222107; Luh WM, 2013, MAGN RESON MED, V69, P402, DOI 10.1002/mrm.24266; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Pfeuffer J, 2002, MAGNET RESON MED, V47, P903, DOI 10.1002/mrm.10154; Rane SD, 2013, MAGN RESON IMAGING, V31, P477, DOI 10.1016/j.mri.2012.08.008; Raoult H, 2011, NEUROIMAGE, V58, P157, DOI 10.1016/j.neuroimage.2011.06.011; Sodickson DK, 1999, MAGN RESON MED, V41, P1009, DOI 10.1002/(SICI)1522-2594(199905)41:5<1009::AID-MRM21>3.0.CO;2-4; Lawrence KS, 2012, MAGN RESON MED, V67, P1275, DOI 10.1002/mrm.23104; Talagala SL, 2004, MAGNET RESON MED, V52, P131, DOI 10.1002/mrm.20124; Teeuwisse WM, 2010, P ISMRM 18 ANN M STO; Teeuwisse WM, 2010, INT J IMAG SYST TECH, V20, P62, DOI 10.1002/ima.20218; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wong EC, 2000, MED RAD DIA IMG, P63; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Wong EC, 2006, MAGN RESON MED, V55, P1334, DOI 10.1002/mrm.20906; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Wu WC, 2009, IEEE T MED IMAGING, V28, P703, DOI 10.1109/TMI.2008.2012020; Ziener CH, 2007, J MAGN RESON, V184, P169, DOI 10.1016/j.jmr.2006.09.018; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	43	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66612	10.1371/journal.pone.0066612	http://dx.doi.org/10.1371/journal.pone.0066612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818950	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800086
J	Caldwell, W; McInnis, OA; McQuaid, RJ; Liu, G; Stead, JD; Anisman, H; Hayley, S				Caldwell, Warren; McInnis, Opal A.; McQuaid, Robyn J.; Liu, Gele; Stead, John D.; Anisman, Hymie; Hayley, Shawn			The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms	PLOS ONE			English	Article							MAJOR DEPRESSION; LIFE STRESS; RISK-FACTOR; BDNF; VARIANT; ASSOCIATION; INVENTORY; SUSCEPTIBILITY; VULNERABILITY; RUMINATION	Disturbances of brain derived neurotrophic factor (BDNF) signalling have been implicated in the evolution of depression, which likely arises, in part, as a result of diminished synaptic plasticity. Predictably, given stressor involvement in depression, BDNF is affected by recent stressors as well as stressors such as neglect experienced in early life. The effects of early life maltreatment in altering BDNF signalling may be particularly apparent among those individuals with specific BDNF polymorphisms. We examined whether polymorphisms of the Val66Met genotype might be influential in moderating how early-life events play out with respect to later coping styles, cognitive flexibility and depressive features. Among male and female undergraduate students (N = 124), childhood neglect was highly related to subsequent depressive symptoms. This outcome was moderated by the BDNF polymorphism in the sense that depressive symptoms appeared higher in Met carriers who reported low levels of neglect than in those with the Val/Val allele. However, under conditions of high neglect depressive symptoms only increased in the Val/Val individuals. In effect, the Met polymorphism was associated with depressive features, but did not interact with early life neglect in predicting later depressive features. It was further observed that among the Val/Val individuals, the relationship between neglect and depression was mediated by emotion-focused styles and diminished perceived control, whereas this mediation was not apparent in Met carriers. In contrast to the more typical view regarding this polymorphism, the data are consistent with the perspective that in the presence of synaptic plasticity presumably associated with the Val/Val genotype, neglect allows for the emergence of specific appraisal and coping styles, which are tied to depression. In the case of the reduced degree of neuroplasticity expected in the Met carriers, early life adverse experiences are not tied to coping styles, and hence less likely to be translated into depressive states.	[Caldwell, Warren; McInnis, Opal A.; McQuaid, Robyn J.; Liu, Gele; Stead, John D.; Anisman, Hymie; Hayley, Shawn] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Hayley, S (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	shawn_hayley@carleton.ca	Stead, John/X-8500-2018; McQuaid, Robyn/ABB-4143-2021	Stead, John/0000-0002-5726-6809; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Barker-Collo Suzanne, 2003, Trauma Violence Abuse, V4, P95, DOI 10.1177/1524838002250760; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beevers CG, 2009, EMOTION, V9, P579, DOI 10.1037/a0016189; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Brougham RR, 2009, CURR PSYCHOL, V28, P85, DOI 10.1007/s12144-009-9047-0; Buchmann AF, 2012, EUR NEUROPS IN PRESS; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Channon S, 1996, J AFFECT DISORDERS, V39, P107, DOI 10.1016/0165-0327(96)00027-4; Chen L, 2008, AM J MED GENET B, V147B, P814, DOI 10.1002/ajmg.b.30686; Demare D, 1996, APA TOR CAN; Dennis JP, 2010, COGNITIVE THER RES, V34, P241, DOI 10.1007/s10608-009-9276-4; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1; Espejo EP, 2012, J ABNORM CHILD PSYCH, V40, P303, DOI 10.1007/s10802-011-9552-0; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Grabe HJ, 2012, PROG NEURO-PSYCHOPH, V36, P264, DOI 10.1016/j.pnpbp.2011.09.010; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hilt LM, 2007, NEUROSCI LETT, V429, P12, DOI 10.1016/j.neulet.2007.09.053; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Karlovic D, 2013, J PSYCHIATR RES, V47, P162, DOI 10.1016/j.jpsychires.2012.09.017; Kato T, 2012, J COUNS PSYCHOL, V59, P262, DOI 10.1037/a0027770; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kelly O, 2007, DEPRESS ANXIETY, V24, P233, DOI 10.1002/da.20236; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Lavebratt C, 2010, J AFFECT DISORDERS, V125, P249, DOI 10.1016/j.jad.2010.02.113; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matheson K, 2003, STRESS, V6, P223, DOI 10.1080/10253890310001594487; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; Meyer SE, 2001, DEV PSYCHOPATHOL, V13, P565, DOI 10.1017/S095457940100308X; Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015; Nolen-Hoeksema S., 1998, MOTIVATION SELF REGU, P237, DOI DOI 10.1017/CBO9780511527869; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Okamoto T, 2008, PROG NEURO-PSYCHOPH, V32, P1185, DOI 10.1016/j.pnpbp.2008.02.009; Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Ravindran AV, 2002, J AFFECT DISORDERS, V71, P121, DOI 10.1016/S0165-0327(01)00389-5; Roelofs J, 2009, EUR CHILD ADOLES PSY, V18, P635, DOI 10.1007/s00787-009-0026-7; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Schmidt HD, 2010, NEUROPSYCHOPHARMACOL, V35, P2378, DOI 10.1038/npp.2010.114; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; STANTON AL, 1994, J PERS SOC PSYCHOL, V66, P350, DOI 10.1037/0022-3514.66.2.350; STANTON AL, 1999, COPING PSYCHOL WHAT; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Thompson M, 2011, J PSYCHIATR NEUROSCI, V36, P195, DOI 10.1503/jpn.100048; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wolkowitz OM, 2011, PROG NEURO-PSYCHOPH, V35, P1623, DOI 10.1016/j.pnpbp.2011.06.013; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zou YF, 2010, EUR NEUROPSYCHOPHARM, V20, P535, DOI 10.1016/j.euroneuro.2009.12.005	64	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65547	10.1371/journal.pone.0065547	http://dx.doi.org/10.1371/journal.pone.0065547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824678	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400009
J	da Silva, MV; Figueiredo, AA; Machado, JR; Castellano, LC; Alexandre, PBD; Oliveira, RF; Faria, GEL; Pereira, SAL; Rodrigues, DBR; Rodrigues, V				da Silva, Marcos Vinicius; Figueiredo, Amanda A.; Machado, Juliana R.; Castellano, Lucio C.; Alexandre, Patricia B. D.; Oliveira, Rafael F.; Faria, Gladstone E. L.; Pereira, Sanivia A. L.; Rodrigues, Denise B. R.; Rodrigues, Virmondes, Jr.			T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INTERFERON-GAMMA RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; IMMUNE-RESPONSES; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; LUNG INFLAMMATION; LT-ALPHA; TGF-BETA	Background: Th1 cytokines are essential for the control of M. tuberculosis infection. The role of IL-10 in tuberculosis is controversial and there is an increasing body of evidence suggesting that the relationship between Th1 cytokines and IL-10 is not as antagonistic as it was first believed, and that these cytokines may complement each other in infectious diseases. Methods: The present study evaluated the activating capacity of CD4+ and CD8+ T cell repertoire in response to antigen stimulation through the expression of CD69 using Flow Cytometry, as well as the functionality of PBMCs by determining the cytokine profile in patients with active tuberculosis and in clinically cured patients after in vitro stimulation using ELISA. Treated patients were subdivided according to time after clinical cure (<12 months or >12 months post-treatment). Results: We observed that T cell activation was higher in TB-treated patients, especially CD8+ T cell activation in TB-Treated >1 year. Th1 cytokines were significantly higher in TB-Treated, and the levels of IFN-gamma and TNF-alpha increased continuously after clinical cure. Moreover, IL-10 production was significantly higher in cured patients and it was also enhanced in cured patients over time after treatment. Th17, Th2 and Th22 cytokines showed no statistically significant differences between Healthy Donors, Active-TB and TB-Treated. Conclusions: This study describes a scenario in which potentiation of CD4+ and CD8+ T cell activation and increased Th1 cytokine production are associated with the clinical cure of tuberculosis in the absence of significant changes in Th2 cytokine production and is accompanied by increased production of IL-10. In contrast to other infections with intracellular microorganisms, this response occurs later after the end of treatment.	[da Silva, Marcos Vinicius; Figueiredo, Amanda A.; Machado, Juliana R.; Oliveira, Rafael F.; Faria, Gladstone E. L.; Rodrigues, Virmondes, Jr.] Triangulo Mineiro Fed Univ, Dept Biol Sci, Immunol Lab, Uberaba, MG, Brazil; [Castellano, Lucio C.] Univ Fed Paraiba, Dept Tech Sch Hlth, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Pereira, Sanivia A. L.; Rodrigues, Denise B. R.] Univ Uberaba, Lab Biopathol & Mol Biol, Uberaba, MG, Brazil; [Alexandre, Patricia B. D.] Uberaba Municipal Dept Hlth, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal da Paraiba; Universidade de Uberaba (Uniube)	Rodrigues, V (corresponding author), Triangulo Mineiro Fed Univ, Dept Biol Sci, Immunol Lab, Uberaba, MG, Brazil.	vrodrigues@mednet.com.br	Silva, Marcos Vinicius/AAY-1986-2020; Machado, Juliana/AAY-1978-2020; Castellano, Lucio/D-8887-2015	Silva, Marcos Vinicius/0000-0002-2966-7621; Machado, Juliana/0000-0002-8673-7788; Castellano, Lucio/0000-0003-0851-5298; Rodrigues Jr, Virmondes/0000-0001-8706-4223	CAPES; Programa de Apoio a Planos de Reestruturacao e Expansao das Universidades Federais (Reuni); CNPq; FAPEMIG	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio a Planos de Reestruturacao e Expansao das Universidades Federais (Reuni); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by CAPES, Programa de Apoio a Planos de Reestruturacao e Expansao das Universidades Federais (Reuni), CNPq, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Avgustin B, 2005, CLIN DIAGN LAB IMMUN, V12, P101, DOI 10.1128/CDLI.12.1.101-106.2005; Baker KS, 1999, BONE MARROW TRANSPL, V23, P1123, DOI 10.1038/sj.bmt.1701780; Bean AGD, 1999, J IMMUNOL, V162, P3504; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; *BRAZ MIN HEALTH, 2013, TUBERCULOSIS CONF CA; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; Capo C, 1996, INFECT IMMUN, V64, P4143, DOI 10.1128/IAI.64.10.4143-4147.1996; Casanova JL, 2001, SWISS MED WKLY, V131, P445; Castellano LR, 2009, HUM IMMUNOL, V70, P383, DOI 10.1016/j.humimm.2009.01.007; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; De Miranda SS, 2012, REV MED CHILE, V140, P1022, DOI 10.4067/S0034-98872012000800008; Deckert M, 2001, INFECT IMMUN, V69, P4561, DOI 10.1128/IAI.69.7.4561-4571.2001; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Esnault S, 1996, CLIN EXP IMMUNOL, V103, P111, DOI 10.1046/j.1365-2249.1996.00911.x; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Harris J, 2009, VET IMMUNOL IMMUNOP, V128, P37, DOI 10.1016/j.vetimm.2008.10.293; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Hunter CA, 1997, J IMMUNOL, V158, P3311; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jason J, 2000, J INFECT DIS, V182, P474, DOI 10.1086/315740; Jason J, 2001, CLIN DIAGN LAB IMMUN, V8, P1097, DOI 10.1128/CDLI.8.6.1097-1103.2001; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kruisbeek A. M., 2004, CURR PROTOC IMMUNOL; Lee JS, 2002, CLIN EXP IMMUNOL, V128, P516, DOI 10.1046/j.1365-2249.2002.01858.x; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Lin YG, 1996, INFECT IMMUN, V64, P1351, DOI 10.1128/IAI.64.4.1351-1356.1996; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Murray PJ, 1997, J IMMUNOL, V158, P315; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; Pereira CB, 2004, MICROBES INFECT, V6, P25, DOI 10.1016/j.micinf.2003.10.007; Petit-Bertron AF, 2003, J LEUKOCYTE BIOL, V73, P145, DOI 10.1189/jlb.0802388; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Sharma S, 2004, IMMUNOL CELL BIOL, V82, P377, DOI 10.1111/j.0818-9641.2004.01245.x; Smith SM, 2002, TUBERCULOSIS, V82, P7, DOI 10.1054/tube.2001.0317; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Tapaninen P, 2010, INT J TUBERC LUNG D, V14, P347; TESTI R, 1989, J IMMUNOL, V143, P1123; Vankayalapati R, 2003, CLIN INFECT DIS, V36, P24, DOI 10.1086/344903; Walker D, 2002, CLIN DIAGN LAB IMMUN, V9, P1049, DOI 10.1128/CDLI.9.5.1049-1056.2002; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	72	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65492	10.1371/journal.pone.0065492	http://dx.doi.org/10.1371/journal.pone.0065492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824716	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400007
J	Faircloth, BC; Sorenson, L; Santini, F; Alfaro, ME				Faircloth, Brant C.; Sorenson, Laurie; Santini, Francesco; Alfaro, Michael E.			A Phylogenomic Perspective on the Radiation of Ray-Finned Fishes Based upon Targeted Sequencing of Ultraconserved Elements (UCEs)	PLOS ONE			English	Article							SPECIES TREES; SISTER-GROUP; EVOLUTION; GENOME; ALGORITHMS; RESOLUTION; MARKERS	Ray-finned fishes constitute the dominant radiation of vertebrates with over 32,000 species. Although molecular phylogenetics has begun to disentangle major evolutionary relationships within this vast section of the Tree of Life, there is no widely available approach for efficiently collecting phylogenomic data within fishes, leaving much of the enormous potential of massively parallel sequencing technologies for resolving major radiations in ray-finned fishes unrealized. Here, we provide a genomic perspective on longstanding questions regarding the diversification of major groups of ray-finned fishes through targeted enrichment of ultraconserved nuclear DNA elements (UCEs) and their flanking sequence. Our workflow efficiently and economically generates data sets that are orders of magnitude larger than those produced by traditional approaches and is well-suited to working with museum specimens. Analysis of the UCE data set recovers a well-supported phylogeny at both shallow and deep time-scales that supports a monophyletic relationship between Amia and Lepisosteus (Holostei) and reveals elopomorphs and then osteoglossomorphs to be the earliest diverging teleost lineages. Our approach additionally reveals that sequence capture of UCE regions and their flanking sequence offers enormous potential for resolving phylogenetic relationships within ray-finned fishes.	[Faircloth, Brant C.; Sorenson, Laurie; Santini, Francesco; Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Alfaro, ME (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	michaelalfaro@ucla.edu	Faircloth, Brant C/Y-3978-2019; Alfaro, Michael/Q-2113-2017	Alfaro, Michael/0000-0002-8898-8230; Faircloth, Brant/0000-0002-1943-0217	National Science Foundation [DEB-6861953, DEB-6701648, DEB-1242260]; Amazon Web Services education; Direct For Biological Sciences [0918748] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Amazon Web Services education; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation grants DEB-6861953 and DEB-6701648 (to MEA) and DEB-1242260 (to BCF) provided partial support for this work. Funds from an Amazon Web Services education grant (to BCF) supported computational portions of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; Arratia G, 2010, REV BIOL MAR OCEANOG, V45, P635, DOI 10.4067/S0718-19572010000400009; Arratia Gloria, 2004, P279; Bayzid MS, 2012, J COMPUT BIOL, V19, P591, DOI 10.1089/cmb.2012.0037; Broughton Richard E., 2010, P61; Castillo-Ramirez S, 2010, ESTIMATING SPECIES T; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; de Pinna Mario C.C., 1996, P147; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Grande L, 2010, COPEIA, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris R. S., 2007, THESIS PENNSYLVANIA; He S, 2012, INTEGRATING MULTIORI, V2; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Meynard CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036443; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson G, 1969, B AM MUS NAT HIST, V141, P465; Nylander J, 2004, MRAIC PL EVOLUTIONAR; Olsen PE., 1984, J VERTEBR PALEONTOL, V4, P481, DOI [10.1080/02724634.1984.10012024, DOI 10.1080/02724634.1984.10012024]; PATTERSON C, 1977, Bulletin of the American Museum of Natural History, V158, P83; Patterson C., 1973, INTERRELATIONSHIPS F, P207; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santini F, 2012, 12100120 ARXIV; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Smith WL, 2006, J HERED, V97, P206, DOI 10.1093/jhered/esj034; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Zaragueta-Bagils R, 2002, CR BIOL, V325, P1191, DOI 10.1016/S1631-0691(02)01535-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	191	194	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65923	10.1371/journal.pone.0065923	http://dx.doi.org/10.1371/journal.pone.0065923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824177	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400033
J	Rieg, AD; Rossaint, R; Verjans, E; Maihofer, NA; Uhlig, S; Martin, C				Rieg, Annette D.; Rossaint, Rolf; Verjans, Eva; Maihoefer, Nina A.; Uhlig, Stefan; Martin, Christian			Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of K-ATP-Channels, cAMP and cGMP	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; POTASSIUM CHANNELS; SMOOTH-MUSCLE; PHYSIOLOGICAL ROLES; VASODILATING MECHANISMS; INDIVIDUAL AIRWAYS; HYPERTENSION; ACTIVATION; RECEPTOR; METHACHOLINE	Introduction: Levosimendan is approved for left heart failure and is also used in right heart failure to reduce right ventricular afterload. Despite the fact that pulmonary arteries (PAs) and pulmonary veins (PVs) contribute to cardiac load, their responses to levosimendan are largely unknown. Materials and Methods: Levosimendan-induced vasorelaxation of PAs and PVs was studied in precision-cut lung slices from guinea pigs by videomicroscopy; baseline luminal area was defined as 100%. Intracellular cAMP- and cGMP-levels were measured by ELISA and NO end products were determined by the Griess reaction. Results: Levosimendan relaxed control PVs (116%) and those pre-constricted with an endothelin(A)-receptor agonist (119%). PAs were only relaxed if pre-constricted (115%). Inhibition of K-ATP-channels (glibenclamide), adenyl cyclase (SQ 22536) and protein kinase G (KT 5823) largely attenuated the levosimendan-induced relaxation in control PVs, as well as in pre-constricted PAs and PVs. Inhibition of BKCa2+-channels (iberiotoxin) and K-v-channels (4-aminopyridine) only contributed to the relaxant effect of levosimendan in pre-constricted PAs. In both PAs and PVs, levosimendan increased intracellular cAMP- and cGMP-levels, whereas NO end products remained unchanged. Notably, basal NO-levels were higher in PVs. The K-ATP-channel activator levcromakalim relaxed PAs dependent on cAMP/PKA/PKG and increased cAMP-levels in PAs. Discussion: Levosimendan initiates complex and divergent signaling pathways in PAs and PVs. Levosimendan relaxes PAs and PVs primarily via KATP-channels and cAMP/cGMP; in PAs, BKCa2+- and K-v-channels are also involved. Our findings with levcromakalim do further suggest that in PAs the activation of KATP-channels leads to the production of cAMP/PKA/PKG. In conclusion, these results suggest that levosimendan might reduce right ventricular afterload by relaxation of PAs as well as pulmonary hydrostatic pressure and pulmonary edema by relaxation of PVs.	[Rieg, Annette D.; Verjans, Eva; Maihoefer, Nina A.; Uhlig, Stefan; Martin, Christian] Rhenish Westphalian Tech Univ, Med Fac Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Rieg, Annette D.; Rossaint, Rolf] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Anesthesiol, Aachen, Germany; [Verjans, Eva] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Pediat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Rieg, AD (corresponding author), Rhenish Westphalian Tech Univ, Med Fac Aachen, Inst Pharmacol & Toxicol, Aachen, Germany.	arieg@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280	START-program of the Medical Faculty Aachen, RWTH Aachen	START-program of the Medical Faculty Aachen, RWTH Aachen	This work was supported by the START-program of the Medical Faculty Aachen, RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bina S, 1998, EUR J PHARMACOL, V351, P253, DOI 10.1016/S0014-2999(98)00307-0; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; Bowman P, 1999, J PHARMACOL EXP THER, V288, P316; Cavusoglu Y, 2009, J CARDIOVASC MED, V10, P503, DOI 10.2459/JCM.0b013e32832aa873; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Chong TJ, 2007, PEPTIDES, V28, P2036, DOI 10.1016/j.peptides.2007.07.018; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; DANDURAND RJ, 1993, J APPL PHYSIOL, V75, P364, DOI 10.1152/jappl.1993.75.1.364; De Witt BJ, 2002, ANESTH ANALG, V94, P1427; Evans AM, 2011, CURR OPIN ANESTHESIO, V24, P13, DOI 10.1097/ACO.0b013e3283421201; Forrest P, 2009, ANAESTH INTENS CARE, V37, P370, DOI 10.1177/0310057X0903700314; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; Gruhn N, 1998, J CARDIOVASC PHARM, V31, P741, DOI 10.1097/00005344-199805000-00013; Hou YL, 2003, J BIOL CHEM, V278, P16706, DOI 10.1074/jbc.M300045200; Hourani SMO, 2001, BRIT J PHARMACOL, V133, P833, DOI 10.1038/sj.bjp.0704140; JIANG H, 1992, J BIOL CHEM, V267, P1015; Kleber FX, 2009, J CLIN PHARMACOL, V49, P109, DOI 10.1177/0091270008325150; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Kostic TS, 2002, J BIOL CHEM, V277, P16412, DOI 10.1074/jbc.M112439200; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Landoni G, 2012, CRIT CARE MED, V40, P634, DOI 10.1097/CCM.0b013e318232962a; Leather HA, 2003, CRIT CARE MED, V31, P2339, DOI 10.1097/01.CCM.0000084844.95073.C0; Lubomirov LT, 2006, BIOFIZIKA+, V51, P773; Martin C, 1996, EUR RESPIR J, V9, P2479, DOI 10.1183/09031936.96.09122479; Michelakis ED, 2001, AM J PHYSIOL-LUNG C, V280, pL1138, DOI 10.1152/ajplung.2001.280.6.L1138; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nijhawan N, 1999, J CARDIOVASC PHARM, V34, P219, DOI 10.1097/00005344-199908000-00007; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Park Won Sun, 2010, Journal of Smooth Muscle Research, V46, P89; Pataricza J, 2003, CARDIOVASC DRUG THER, V17, P115, DOI 10.1023/A:1025331617233; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Poelzl G, 2008, HERZ, V33, P368, DOI 10.1007/s00059-008-3051-2; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Revermann M, 2011, INTENS CARE MED, V37, P1368, DOI 10.1007/s00134-011-2254-9; Rieg AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029698; Rossi P, 2008, INTENS CARE MED, V34, P873, DOI 10.1007/s00134-007-0980-9; Schleputz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047344; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Shi WB, 1998, BRIT J PHARMACOL, V123, P1525, DOI 10.1038/sj.bjp.0701759; Usta C, 2006, EUR J CARDIO-THORAC, V30, P329, DOI 10.1016/j.ejcts.2006.05.019; Yildiz O, 2006, ANN THORAC SURG, V81, P1715, DOI 10.1016/j.athoracsur.2005.12.057; Yildiz O, 2007, J PHARMACOL SCI, V104, P1, DOI 10.1254/jphs.CP0060010; Yokoshiki H, 2003, CARDIOVASC DRUG THER, V17, P111, DOI 10.1023/A:1025379400395	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66195	10.1371/journal.pone.0066195	http://dx.doi.org/10.1371/journal.pone.0066195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824760	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400067
J	Sriwai, W; Mahavadi, S; Al-Shboul, O; Grider, JR; Murthy, KS				Sriwai, Wimolpak; Mahavadi, Sunila; Al-Shboul, Othman; Grider, John R.; Murthy, Karnam S.			Distinctive G Protein-Dependent Signaling by Protease-Activated Receptor 2 (PAR2) in Smooth Muscle: Feedback Inhibition of RhoA by cAMP-Independent PKA	PLOS ONE			English	Article							MYOSIN PHOSPHATASE; MYENTERIC NEURONS; MOLECULAR-CLONING; EPITHELIAL-CELLS; IN-VIVO; PHOSPHORYLATION; CONTRACTION; RELAXATION; EXPRESSION; THROMBIN	We examined expression of protease-activated receptors 2 (PAR2) and characterized their signaling pathways in rabbit gastric muscle cells. The PAR2 activating peptide SLIGRL (PAR2-AP) stimulated G(q), G(13), G(i1), PI hydrolysis, and Rho kinase activity, and inhibited cAMP formation. Stimulation of PI hydrolysis was partly inhibited in cells expressing PAR2 siRNA, Ga-q or Ga-i minigene and in cells treated with pertussis toxin, and augmented by expression of dominant negative regulator of G protein signaling (RGS4(N88S)). Stimulation of Rho kinase activity was abolished by PAR-2 or Ga-13 siRNA, and by Ga-13 minigene. PAR2-AP induced a biphasic contraction; initial contraction was selectively blocked by the inhibitor of PI hydrolysis (U73122) or MLC kinase (ML-9), whereas sustained contraction was selectively blocked by the Rho kinase inhibitor (Y27632). PAR2-AP induced phosphorylation of MLC20, MYPT1 but not CPI-17. PAR2-AP also caused a decrease in the association of NF-kappa B and PKA catalytic subunit: the effect of PAR2-AP was blocked by PAR2 siRNA or phosphorylation-deficient RhoA (RhoA(S188A)). PAR2-AP-induced degradation of IkBa and activation of NF-kappa B were abolished by the blockade of RhoA activity by Clostridium botulinum C3 exoenzyme suggesting RhoA-dependent activation of NF-kappa B. PAR2-AP- stimulated Rho kinase activity was significantly augmented by the inhibitors of PKA (myristoylated PKI), IKK2 (IKKIV) or NF-kappa B (MG132), and in cells expressing dominant negative mutants of IKK (IKK(K44A), IkBa (IkBa (S32A/S36A)) or RhoA(S188A), suggesting feedback inhibition of Rho kinase activity via PKA derived from NF-kappa B pathway. PAR2-AP induced phosphorylation of RhoA and the phosphorylation was attenuated in cells expressing phosphorylation-deficient RhoA(S188A). Our results identified signaling pathways activated by PAR2 to mediate smooth muscle contraction and a novel pathway for feedback inhibition of PAR2-stimulated RhoA. The pathway involves activation of the NF-kappa B to release catalytic subunit of PKA from its binding to IkBa and phosphorylation of RhoA at Ser(188).	[Sriwai, Wimolpak; Mahavadi, Sunila; Al-Shboul, Othman; Grider, John R.; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA	Virginia Commonwealth University	Murthy, KS (corresponding author), Virginia Commonwealth Univ, Dept Physiol, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA.	skarnam@vcu.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK28300, DK15564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants (DK28300 and DK15564 to KSM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Bohm SK, 1996, BIOCHEM J, V314, P1009; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Cocks TM, 1999, GASTROENTEROLOGY, V116, P586, DOI 10.1016/S0016-5085(99)70180-0; Corvera CU, 1999, J PHYSIOL-LONDON, V517, P741, DOI 10.1111/j.1469-7793.1999.0741s.x; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; de Godoy MAF, 2011, TRENDS PHARMACOL SCI, V32, P384, DOI 10.1016/j.tips.2011.03.005; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Gao CY, 2002, GASTROENTEROLOGY, V123, P1554, DOI 10.1053/gast.2002.36581; Garrido R, 2002, J NEUROCHEM, V83, P556, DOI 10.1046/j.1471-4159.2002.01119.x; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Kawabata A, 2008, BRIT J PHARMACOL, V153, pS230, DOI 10.1038/sj.bjp.0707491; Kawabata A, 2001, BRIT J PHARMACOL, V133, P1213, DOI 10.1038/sj.bjp.0704211; Kawabata A, 1999, BRIT J PHARMACOL, V128, P865, DOI 10.1038/sj.bjp.0702755; Kawabata A, 2003, NIPPON YAKURIGAKU ZA, V121, P411; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; Mule F, 2002, BRIT J PHARMACOL, V136, P367, DOI 10.1038/sj.bjp.0704746; MURTHY KS, 1991, AM J PHYSIOL, V261, pG945, DOI 10.1152/ajpgi.1991.261.6.G945; Murthy KS, 1996, MOL PHARMACOL, V50, P870; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; Nishikawa H, 2002, EUR J PHARMACOL, V447, P87, DOI 10.1016/S0014-2999(02)01892-7; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; OKAMOTO T, 1992, FEBS LETT, V305, P125, DOI 10.1016/0014-5793(92)80878-K; Profirovic J, 2005, J BIOL CHEM, V280, P32866, DOI 10.1074/jbc.M501361200; Salinthone S, 2004, AM J PHYSIOL-GASTR L, V287, pG627, DOI 10.1152/ajpgi.00462.2003; Schmidlin F, 2001, AM J RESP CRIT CARE, V164, P1276, DOI 10.1164/ajrccm.164.7.2101157; Shea-Donohue T, 2010, NEUROGASTROENT MOTIL, V22, P1138, DOI 10.1111/j.1365-2982.2010.01557.x; Shi XZ, 2005, AM J PHYSIOL-GASTR L, V289, pG274, DOI 10.1152/ajpgi.00512.2004; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Singer CA, 2004, BIOESSAYS, V26, P646, DOI 10.1002/bies.20041; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhou HP, 2004, AM J PHYSIOL-CELL PH, V286, pC1130, DOI 10.1152/ajpcell.00429.2003	43	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66743	10.1371/journal.pone.0066743	http://dx.doi.org/10.1371/journal.pone.0066743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825105	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400156
J	Sun, HL; Zhang, SH; Zhong, K; Xu, ZH; Feng, B; Yu, J; Fang, Q; Wang, S; Wu, DC; Zhang, JM; Chen, Z				Sun, Hong-Liu; Zhang, Shi-Hong; Zhong, Kai; Xu, Zheng-Hao; Feng, Bo; Yu, Jie; Fang, Qi; Wang, Shuang; Wu, Deng-Chang; Zhang, Jian-Min; Chen, Zhong			A Transient Upregulation of Glutamine Synthetase in the Dentate Gyrus Is Involved in Epileptogenesis Induced by Amygdala Kindling in the Rat	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; TEMPORAL-LOBE EPILEPSY; THERAPEUTIC TIME-WINDOW; SPRAGUE-DAWLEY RATS; EPILEPTIFORM ACTIVITY; EXTRACELLULAR GLUTAMATE; SEIZURE DEVELOPMENT; MODEL; HIPPOCAMPUS; SUSCEPTIBILITY	Reduction of glutamine synthetase (GS) function is closely related to established epilepsy, but little is known regarding its role in epileptogenesis. The present study aimed to elucidate the functional changes of GS in the brain and its involvement in epileptogenesis using the amygdala kindling model of epilepsy induced by daily electrical stimulation of basolateral amygdala in rats. Both expression and activity of GS in the ipsilateral dentate gyrus (DG) were upregulated when kindled seizures progressed to stage 4. A single dose of L-methionine sulfoximine (MSO, in 2 mu l), a selective GS inhibitor, was administered into the ipsilateral DG on the third day following the first stage 3 seizure (just before GS was upregulated). It was found that low doses of MSO (5 or 10 mu g) significantly and dose-dependently reduced the severity of and susceptibility to evoked seizures, whereas MSO at a high dose (20 mu g) aggravated kindled seizures. In animals that seizure acquisition had been successfully suppressed with 10 mu g MSO, GS upregulation reoccurred when seizures re-progressed to stage 4 and re-administration of 10 mu g MSO consistently reduced the seizures. GLN at a dose of 1.5 mu g abolished the alleviative effect of 10 mu g MSO and deleterious effect of 20 mu g MSO on kindled seizures. Moreover, appropriate artificial microRNA interference (1 and 1.5x10(6) TU/2 mu l) of GS expression in the ipsilateral DG also inhibited seizure progression. In addition, a transient increase of GS expression and activity in the cortex was also observed during epileptogenesis evoked by pentylenetetrazole kindling. These results strongly suggest that a transient and region-specific upregulation of GS function occurs when epilepsy develops into a certain stage and eventually promotes the process of epileptogenesis. Inhibition of GS to an adequate degree and at an appropriate timing may be a potential therapeutic approach to interrupting epileptogenesis.	[Sun, Hong-Liu; Zhang, Shi-Hong; Zhong, Kai; Xu, Zheng-Hao; Feng, Bo; Yu, Jie; Fang, Qi; Wu, Deng-Chang; Chen, Zhong] Zhejiang Univ, Sch Med, Dept Pharmacol,Coll Pharmaceut Sci, Key Lab Med Neurobiol,Minist Hlth China,Zhejiang, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Shuang; Zhang, Jian-Min; Chen, Zhong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Epilepsy Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hong-Liu] Binzhou Med Univ, Dept Pharmacol, Yantai, Peoples R China	Zhejiang University; Zhejiang University; Binzhou Medical University	Chen, Z (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol,Coll Pharmaceut Sci, Key Lab Med Neurobiol,Minist Hlth China,Zhejiang, Hangzhou 310003, Zhejiang, Peoples R China.	chenzhong@zju.edu.cn		Xu, Zhenghao/0000-0003-0033-525X	National Natural Science Foundation of China [81030061, 81273506, 81221003, 81173042, 81202516, 81273492]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (81030061, 81273506, 81221003, 81173042, 81202516, 81273492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarpour B, 2012, NEUROSCI BULL, V28, P729, DOI 10.1007/s12264-012-1279-6; Amaral David G., 1995, P443; Bacci A, 2002, J NEUROPHYSIOL, V88, P2302, DOI 10.1152/jn.00665.2001; Bidmon HJ, 2008, EPILEPSIA, V49, P1733, DOI 10.1111/j.1528-1167.2008.01642.x; Broman J, 2000, HAND CHEM N, V18, P1; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; DURING MJ, 1993, LANCET, V341, P1607; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Gorg B, 2007, FEBS LETT, V581, P84, DOI 10.1016/j.febslet.2006.11.081; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; HEINEMANN U, 1992, EPILEPSY RES, P273; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Hu WW, 2012, CNS NEUROSCI THER, V18, P683, DOI 10.1111/j.1755-5949.2012.00356.x; Itoh K, 2009, NEUROSCIENCE, V159, P735, DOI 10.1016/j.neuroscience.2008.12.040; Kang TC, 2006, GLIA, V54, P258, DOI 10.1002/glia.20380; LEPPIK IE, 1992, EPILEPSY RES, P7; LOTHMAN EW, 1987, EPILEPSY RES, V1, P313, DOI 10.1016/0920-1211(87)90055-6; LOTHMAN EW, 1992, EPILEPSY RES, P301; Olney J W, 1986, Adv Neurol, V44, P857; OLNEY JW, 1978, KAINIC ACID TOOL NEU, P37; Perez EL, 2012, NEUROBIOL DIS, V47, P331, DOI 10.1016/j.nbd.2012.05.010; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; STRINGER JL, 1992, NEUROSCIENCE, V46, P309, DOI 10.1016/0306-4522(92)90053-5; Tani H, 2007, NEUROBIOL DIS, V25, P230, DOI 10.1016/j.nbd.2006.08.025; UEDA Y, 1995, EPILEPSY RES, V20, P213, DOI 10.1016/0920-1211(94)00081-7; van Gassen KLI, 2009, GENES BRAIN BEHAV, V8, P290, DOI 10.1111/j.1601-183X.2008.00471.x; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; Wang S, 2008, NEUROBIOL DIS, V29, P52, DOI 10.1016/j.nbd.2007.07.027; WILLIAMSON A, 1994, CLIN NEUROSCI, V2, P47; Wu DC, 2008, NEUROBIOL DIS, V32, P151, DOI 10.1016/j.nbd.2008.07.002; Wu DC, 2008, NEUROBIOL DIS, V31, P74, DOI 10.1016/j.nbd.2008.03.007; Xu ZH, 2010, EPILEPSIA, V51, P1861, DOI 10.1111/j.1528-1167.2010.02663.x; Yang LX, 2006, NEUROSCIENCE, V138, P1089, DOI 10.1016/j.neuroscience.2005.12.006; Zhang LS, 2003, PHARMACOLOGY, V69, P27, DOI 10.1159/000071263; Zhang SH, 2009, NEUROSCI LETT, V455, P51, DOI 10.1016/j.neulet.2009.03.041; Zhong K, 2012, NEUROBIOL DIS, V48, P20, DOI 10.1016/j.nbd.2012.05.011	41	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66885	10.1371/journal.pone.0066885	http://dx.doi.org/10.1371/journal.pone.0066885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825580	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400166
J	Yakunina, N; Tae, WS; Lee, KU; Kim, SS; Nam, EC				Yakunina, Natalia; Tae, Woo Suk; Lee, Kang Uk; Kim, Sam Soo; Nam, Eui-Cheol			Spatiotemporal Segregation of Neural Response to Auditory Stimulation: An fMRI Study Using Independent Component Analysis and Frequency-Domain Analysis	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; TIME-SERIES; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; MAGNETIC-RESONANCE; NEGATIVE BOLD; WORKING-MEMORY; VISUAL-CORTEX	Although auditory processing has been widely studied with conventional parametric methods, there have been a limited number of independent component analysis (ICA) applications in this area. The purpose of this study was to examine spatiotemporal behavior of brain networks in response to passive auditory stimulation using ICA. Continuous broadband noise was presented binaurally to 19 subjects with normal hearing. ICA was performed to segregate spatial networks, which were subsequently classified according to their temporal relation to the stimulus using power spectrum analysis. Classification of separated networks resulted in 3 stimulus-activated, 9 stimulus-deactivated, 2 stimulus-neutral (stimulus-dependent but not correlated with the stimulation timing), and 2 stimulus-unrelated (fluctuations that did not follow the stimulus cycles) components. As a result of such classification, spatiotemporal subdivisions were observed in a number of cortical structures, namely auditory, cingulate, and sensorimotor cortices, where parts of the same cortical network responded to the stimulus with different temporal patterns. The majority of the classified networks seemed to comprise subparts of the known resting-state networks (RSNs); however, they displayed different temporal behavior in response to the auditory stimulus, indicating stimulus-dependent temporal segregation of RSNs. Only one of nine deactivated networks coincided with the "classic'' default-mode network, suggesting the existence of a stimulus-dependent default-mode network, different from that commonly accepted.	[Yakunina, Natalia; Nam, Eui-Cheol] Kangwon Natl Univ, Sch Med, Dept Otolaryngol, Chunchon, South Korea; [Yakunina, Natalia; Tae, Woo Suk; Lee, Kang Uk; Kim, Sam Soo; Nam, Eui-Cheol] Kangwon Natl Univ, Sch Med, Neurosci Res Inst, Chunchon, South Korea; [Lee, Kang Uk] Kangwon Natl Univ, Sch Med, Dept Psychiat, Chunchon, South Korea; [Kim, Sam Soo] Kangwon Natl Univ, Sch Med, Dept Radiol, Chunchon, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Nam, EC (corresponding author), Kangwon Natl Univ, Sch Med, Dept Otolaryngol, Chunchon, South Korea.	birdynec@kangwon.ac.kr			National Research Foundation (NRF) of Korea; Ministry of Education, Science, and Technology [2011-0006602]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science, and Technology (2011-0006602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CC, 2010, AM J GERIAT PSYCHIAT, V18, P897, DOI 10.1097/JGP.0b013e3181e9b9d9; Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Ardekani BA, 1999, IEEE T MED IMAGING, V18, P101, DOI 10.1109/42.759109; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Bassim MK, 2003, HEARING RES, V182, P140, DOI 10.1016/S0378-5955(03)00190-4; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bergomi Margherita, 1991, Public Health Reviews, V19, P263; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Calhoun VD, 2005, NEUROIMAGE, V25, P527, DOI 10.1016/j.neuroimage.2004.12.012; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD., 2004, GROUP ICA FMRI TOOLB; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Formisano E, 2002, NEUROCOMPUTING, V49, P241, DOI 10.1016/S0925-2312(02)00517-9; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fraser LM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-91; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; FUJII K, 1990, AM J PHYSIOL, V258, pH1829, DOI 10.1152/ajpheart.1990.258.6.H1829; Gaab N, 2008, HUM BRAIN MAPP, V29, P858, DOI 10.1002/hbm.20578; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gawryluk JR, 2011, NEUROIMAGE, V54, P10, DOI 10.1016/j.neuroimage.2010.07.028; Goldstein, 1996, Int Tinnitus J, V2, P83; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Harms MP, 2003, HUM BRAIN MAPP, V20, P168, DOI 10.1002/hbm.10136; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Huang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044062; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Langers DRM, 2011, BRAIN CONNECT, V1, P233, DOI 10.1089/brain.2011.0023; Langers DRM, 2011, NEUROIMAGE, V55, P1617, DOI 10.1016/j.neuroimage.2011.01.019; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; McKeown MJ, 2000, NEUROIMAGE, V11, P24, DOI 10.1006/nimg.1999.0518; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Moritz CH, 2003, HUM BRAIN MAPP, V18, P111, DOI 10.1002/hbm.10081; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Munoz-Lopez MM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00129; Nam EC, 2008, MAGN RESON IMAGING, V26, P715, DOI 10.1016/j.mri.2008.01.020; Nir Y, 2008, NAT NEUROSCI, V11, P523, DOI 10.1038/nn0508-523; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 1998, HUM BRAIN MAPP, V6, P283, DOI 10.1002/(SICI)1097-0193(1998)6:4<283::AID-HBM7>3.0.CO;2-#; Rimol LM, 2006, NEUROIMAGE, V30, P554, DOI 10.1016/j.neuroimage.2005.10.021; Rimol LM, 2005, NEUROIMAGE, V26, P1059, DOI 10.1016/j.neuroimage.2005.03.028; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; SAWADA Y, 1993, EUR J APPL PHYSIOL O, V67, P367, DOI 10.1007/BF00357637; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Shechter B, 2006, HEARING RES, V221, P91, DOI 10.1016/j.heares.2006.08.002; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Sigalovsky IS, 2006, HEARING RES, V215, P67, DOI 10.1016/j.heares.2006.03.002; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; Talavage TM, 1999, HUM BRAIN MAPP, V7, P79, DOI 10.1002/(SICI)1097-0193(1999)7:2<79::AID-HBM1>3.0.CO;2-R; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vercammen A, 2012, J PSYCHIATR NEUROSCI, V37, P379, DOI 10.1503/jpn.110088; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Weber B, 2002, NEUROIMAGE, V16, P993, DOI 10.1006/nimg.2002.1104; Willich SN, 2006, EUR HEART J, V27, P276, DOI 10.1093/eurheartj/ehi658; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Windischberger C, 2002, MAGN RESON IMAGING, V20, P575, DOI 10.1016/S0730-725X(02)00563-5; Xie G, 2012, NEUROIMAGE, V63, P245, DOI 10.1016/j.neuroimage.2012.06.057; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; YUKIE M, 1995, NEUROSCI RES, V22, P179, DOI 10.1016/0168-0102(95)00888-1; Zeng WM, 2009, NEUROIMAGE, V46, P1041, DOI 10.1016/j.neuroimage.2009.02.048	98	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66424	10.1371/journal.pone.0066424	http://dx.doi.org/10.1371/journal.pone.0066424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823501	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400107
J	Zhang, X; Jia, HY; Liu, F; Pan, LP; Xing, AY; Gu, SX; Du, BP; Sun, Q; Wei, RR; Zhang, ZD				Zhang, Xia; Jia, Hongyan; Liu, Fei; Pan, Liping; Xing, Aiying; Gu, Shuxiang; Du, Boping; Sun, Qi; Wei, Rongrong; Zhang, Zongde			Prevalence and Risk Factors for Latent Tuberculosis Infection among Health Care Workers in China: A Cross-Sectional Study	PLOS ONE			English	Article							WHOLE-BLOOD; TB; DIAGNOSIS; DISEASE	Background: Health care workers (HCWs) are at risk of latent tuberculosis infection (LTBI). In China, tuberculosis (TB) is a major public health problem, but the prevalence of LTBI in HCWs especially in the hospital for pulmonary diseases has not been assessed enough. The aim of this study was to determine the prevalence and putative risk factors of LTBI among HCWs in a chest hospital and a TB research institute in China. Methodology/Principal Findings: A cross-sectional study was conducted among HCWs in China in 2012. LTBI was assessed by T-SPOT. TB, and information on HCWs was collected using a standardised questionnaire. Risk factors for LTBI were analyzed by univariate and multivariate regression. The overall prevalence of LTBI among HCWs was 33.6%. Analyzed by job category, the highest prevalence was found among laboratory staff (43.4%). In the different workplaces, the proportion of LTBI was significantly higher among the high risk workplaces (37.4%) compared to the low risk workplaces. The duration of employment had a significant impact on the prevalence of LTBI. Positive T-SPOT. TB test results accounted for 17.6%, 16.8%, 23.5%, 41.8% and 41.6% in groups of <= 2, 3-5, 6-10, 11-20, and > 20 working years respectively. In multivariate analysis, job categories (Laboratory staff [2.76 (95% CI: 1.36; 5.60)], technician staff [2.02 (95% CI: 1.12; 3.64)]); working duration as a HCW for 11 to 20 years [3.57 (95% CI: 1.46; 8.71)], and 20 years above [3.41 (95% CI: 1.28; 9.11)]; and the history of household TB contact [2.47 (95% CI: 1.15; 5.33)] were associated with increased risk of LTBI. Conclusions/Significance: Prevalence of LTBI estimated by T-SPOT. TB is high among Chinese HCWs and working duration, job category and the history of household TB contact were associated with increased risk. These data highlight adequate infection control measures should be undertaken.	[Zhang, Xia; Jia, Hongyan; Liu, Fei; Pan, Liping; Xing, Aiying; Gu, Shuxiang; Du, Boping; Sun, Qi; Wei, Rongrong; Zhang, Zongde] Capital Med Univ, Beijing Chest Hosp, Beijing Key Lab Drug Resistance TB Res, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing Key Lab Drug Resistance TB Res, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.	zzd417@163.com			National Science and Technology Major Project of China [2012ZX10003002]	National Science and Technology Major Project of China	This work was supported by the National Science and Technology Major Project of China (2012ZX10003002) http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Borroto S, 2011, INT J TUBERC LUNG D, V15, P1510, DOI 10.5588/ijtld.10.0333; de Vries G, 2006, EUR RESPIR J, V28, P1216, DOI 10.1183/09031936.06.00039906; Demkow U, 2008, J PHYSIOL PHARMACOL, V59, P209; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Girardi E, 2009, EURO SURVEIL, V14; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Hirama T, 2011, J HOSP INFECT, V77, P257, DOI 10.1016/j.jhin.2010.11.012; Hosoglu S, 2005, AM J INFECT CONTROL, V33, P23, DOI 10.1016/j.ajic.2004.07.013; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Qi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032103; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Sawanyawisuth Kittisak, 2009, J Occup Med Toxicol, V4, P20, DOI 10.1186/1745-6673-4-20; Schablon A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-107; Schablon Anja, 2009, J Occup Med Toxicol, V4, P1, DOI 10.1186/1745-6673-4-1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	32	38	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66412	10.1371/journal.pone.0066412	http://dx.doi.org/10.1371/journal.pone.0066412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823871	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400105
J	Cai, XQ; Yu, HQ; Ruan, ZX; Yang, LL; Bai, JS; Qiu, DY; Jian, ZH; Xiao, YQ; Yang, JY; Le, TH; Zhu, XQ				Cai, Xian-Quan; Yu, Hai-Qiong; Ruan, Zhou-Xi; Yang, Lei-Liang; Bai, Jian-Shan; Qiu, De-Yi; Jian, Zhi-Hua; Xiao, Yi-Qian; Yang, Jie-Yang; Thanh Hoa Le; Zhu, Xing-Quan			Rapid Detection and Simultaneous Genotyping of Cronobacter spp. (formerly Enterobacter sakazakii) in Powdered Infant Formula Using Real-time PCR and High Resolution Melting (HRM) Analysis	PLOS ONE			English	Article							DUBLINENSIS SP-NOV; IDENTIFICATION; STRAINS; GENUS; PROPOSAL; ASSAY	Cronobacter spp. is an emerging pathogen that causes meningitis, sepsis, bacteremia, and necrotizing enterocolitis in neonates and children. The present study developed an assay integrating real-time PCR and high resolution melting (HRM) analysis targeting the OmpA gene for the specific detection and rapid identification of Cronobacter spp. (formerly Enterobacter sakazakii) in powdered infant formula. Eleven Cronobacter field isolates and 25 reference strains were examined using one pair of primers, having the accuracy of 100% in reference to conventional methods. The assay was proved to be highly sensitive with a detection limit of 10(2) CFU/ml without pre-enrichment, and highly concordant (100%) when compared with ISO-IDF 22964 in 89 actual samples. The method performed for Cronobacter spp. detection was less than 24 h, drastically shortened, compared to several days using standard culturing method, it is probe-free and reduces a risk of PCR carryover. Moreover, all Cronobacter strains examined in this study were genotyped into two species according to their HRM profiles. The established method should provide a molecular tool for direct detection and simultaneous genotyping of Cronobacter spp. in powdered infant formula.	[Cai, Xian-Quan; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Cai, Xian-Quan; Yang, Lei-Liang; Qiu, De-Yi; Jian, Zhi-Hua; Xiao, Yi-Qian; Yang, Jie-Yang] Zhongshan Entry Exit Inspect & Quarantine Bur, Ctr Tech, Zhongshan, Guangdong, Peoples R China; [Yu, Hai-Qiong] Guangdong Entry Exit Inspect & Quarantine Bur, Ctr Tech, Guangzhou, Guangdong, Peoples R China; [Ruan, Zhou-Xi] Shenzhen Entry Exit Inspect & Quarantine Bur, Anim & Plant Inspect & Quarantine Tech Ctr, Shenzhen, Guangdong, Peoples R China; [Yang, Jie-Yang] Guangzhou Airport Entry Exit Inspect & Quarantine, Guangzhou, Guangdong, Peoples R China; [Thanh Hoa Le] Vietnam Acad Sci & Technol, Dept Immunol, Inst Biotechnol, Hanoi, Vietnam	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Vietnam Academy of Science & Technology (VAST)	Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	xingquanzhu1@hotmail.com	Le, Thanh/GRY-4094-2022	LE, THANH HOA/0000-0003-3841-368X	Science & Technology Program of Zhongshan [20123A299]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; Science & Technology Program of The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China [2008IK007]	Science & Technology Program of Zhongshan; Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups); Science & Technology Program of The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China	This work was supported by The Science & Technology Program of Zhongshan (Grant No. 20123A299) to XQC, The Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006) to XQZ, and the Science & Technology Program of The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (Grant No. 2008IK007) to HQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359; Douarre PE, 2012, J MICROBIOL METH, V88, P172, DOI 10.1016/j.mimet.2011.10.009; Druggan P, 2009, INT J FOOD MICROBIOL, V136, P169, DOI 10.1016/j.ijfoodmicro.2009.09.008; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Gori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030199; Hoque A, 2010, INT J FOOD MICROBIOL, V142, P375, DOI 10.1016/j.ijfoodmicro.2010.07.019; Hunter CJ, 2008, SURG INFECT, V9, P533, DOI 10.1089/sur.2008.006; International Organization for Standardization, 2006, 22964 ISOIDF; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Jaradat ZW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-225; Jin DZ, 2012, FEMS MICROBIOL LETT, V330, P72, DOI 10.1111/j.1574-6968.2012.02535.x; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Kandhai MC, 2010, FOOD CONTROL, V21, P1127, DOI 10.1016/j.foodcont.2010.01.007; Lehner A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-43; Liu X, 2012, WORLD J MICROB BIOT, V28, P1013, DOI 10.1007/s11274-011-0899-8; Liu Y, 2006, J MICROBIOL METH, V65, P21, DOI 10.1016/j.mimet.2005.06.007; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164; Nair MKM, 2006, APPL ENVIRON MICROB, V72, P2539, DOI 10.1128/AEM.72.4.2539-2546.2006; Ngui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041996; O'Brien S, 2009, LETT APPL MICROBIOL, V48, P536, DOI 10.1111/j.1472-765X.2009.02562.x; Seo KH, 2005, J FOOD PROTECT, V68, P59, DOI 10.4315/0362-028X-68.1.59; Stoop B, 2009, INT J FOOD MICROBIOL, V136, P165, DOI 10.1016/j.ijfoodmicro.2009.04.023; Strydom A, 2012, CURR MICROBIOL, V64, P251, DOI 10.1007/s00284-011-0061-8; Strydom A, 2011, FOOD MICROBIOL, V28, P1472, DOI 10.1016/j.fm.2011.08.015; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Terragno R, 2009, INT J FOOD MICROBIOL, V136, P193, DOI 10.1016/j.ijfoodmicro.2009.10.013; Turcovsky I, 2011, ANTON LEEUW INT J G, V99, P257, DOI 10.1007/s10482-010-9484-7; World Health Organization, 2007, GUID SAF PREP STOR H; Ye Y, 2010, J DAIRY SCI, V93, P2315, DOI 10.3168/jds.2009-2662; Zeinzinger J, 2012, APPL ENVIRON MICROB, V78, P3352, DOI 10.1128/AEM.07668-11	33	30	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67082	10.1371/journal.pone.0067082	http://dx.doi.org/10.1371/journal.pone.0067082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825624	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000076
J	Heister, D; Diwakar, M; Nichols, S; Robb, A; Angeles, AM; Tal, O; Harrington, DL; Song, T; Lee, RR; Huang, MX				Heister, David; Diwakar, Mithun; Nichols, Sharon; Robb, Ashley; Angeles, Anne Marie; Tal, Omer; Harrington, Deborah L.; Song, Tao; Lee, Roland R.; Huang, Mingxiong			Resting-State Neuronal Oscillatory Correlates of Working Memory Performance	PLOS ONE			English	Article							SIGNAL SPACE SEPARATION; INDIVIDUAL-DIFFERENCES; FUNCTIONAL CONNECTIVITY; PRINCIPAL COMPONENT; EEG DIFFERENCES; ATTENTION; ALPHA; TASK; NETWORK; AROUSAL	Purpose: Working memory (WM) represents the brain's ability to maintain information in a readily available state for short periods of time. This study examines the resting-state cortical activity patterns that are most associated with performance on a difficult working-memory task. Methods: Magnetoencephalographic (MEG) band-passed (delta/theta (1-7 Hz), alpha (8-13 Hz), beta (14-30 Hz)) and sensor based regional power was collected in a population of adult men (18-28 yrs, n = 24) in both an eyes-closed and eyes-open resting state. The normalized power within each resting state condition as well as the normalized change in power between eyes closed and open (zECO) were correlated with performance on a WM task. The regional and band-limited measures that were most associated with performance were then combined using singular value decomposition (SVD) to determine the degree to which zECO power was associated with performance on the three-back verbal WM task. Results: Changes in power from eyes closed to open revealed a significant decrease in power in all band-widths that was most pronounced in the posterior brain regions (delta/theta band). zECO right posterior frontal and parietal cortex delta/theta power were found to be inversely correlated with three-back working memory performance. The SVD evaluation of the most correlated zECO metrics then provided a singular measure that was highly correlated with three-back performance (r = 20.73, p<0.0001). Conclusion: Our results indicate that there is an association between WM performance and changes in resting-state power (right posterior frontal and parietal delta/theta power). Moreover, an SVD of the most associated zECO measures produces a composite resting-state metric of regional neural oscillatory power that has an improved association with WM performance. To our knowledge, this is the first investigation that has found that changes in resting state electromagnetic neural patterns are highly associated with verbal working memory performance.	[Heister, David; Diwakar, Mithun; Tal, Omer; Harrington, Deborah L.; Lee, Roland R.; Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Nichols, Sharon; Song, Tao] Univ Calif San Diego, San Diego, CA 92103 USA; [Robb, Ashley; Angeles, Anne Marie; Harrington, Deborah L.; Lee, Roland R.; Huang, Mingxiong] Vet Affairs San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Robb, Ashley; Angeles, Anne Marie; Harrington, Deborah L.; Lee, Roland R.; Huang, Mingxiong] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Heister, D (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	dheister@ucsd.edu		Harrington, Deborah/0000-0001-9658-9080	National Institutes of Health-The National Institute of Biomedical Imaging and Bioengineering [T32 EB005970]; Department of Veterans Affairs; National Football League; McDonnell Foundation via the Brain Trauma Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health-The National Institute of Biomedical Imaging and Bioengineering; Department of Veterans Affairs(US Department of Veterans Affairs); National Football League; McDonnell Foundation via the Brain Trauma Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health-The National Institute of Biomedical Imaging and Bioengineering T32 EB005970 (DH). Merit Review Grants from the Department of Veterans Affairs (two for MX Huang, one for RR Lee), National Football League (MX Huang and RR Lee), and McDonnell Foundation via the Brain Trauma Foundation (PI: J Ghajar, site PIs: RR Lee and MX Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These supporting sources do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arruda JE, 2009, APPL PSYCHOPHYS BIOF, V34, P7, DOI 10.1007/s10484-008-9071-0; Arruda JE, 1999, INT J PSYCHOPHYSIOL, V32, P119, DOI 10.1016/S0167-8760(99)00006-9; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barry RJ, 2005, J PSYCHOPHYSIOL, V19, P91, DOI 10.1027/0269-8803.19.2.91; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P402, DOI 10.1016/S1388-2457(03)00343-2; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Clark CR, 2004, INT J PSYCHOPHYSIOL, V53, P1, DOI 10.1016/j.ijpsycho.2003.12.011; Cohen D., 2002, P 13 INT C BIOMAGNET, P919; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; del Rio D, 2012, INT J PSYCHOPHYSIOL, V86, P160, DOI 10.1016/j.ijpsycho.2012.08.011; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Foucher JR, 2004, NEUROIMAGE, V22, P688, DOI 10.1016/j.neuroimage.2004.01.048; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Goldman-Rakic PS, 1995, CELL, V14, P477; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Klimesch W, 1999, INTELLIGENCE, V27, P347, DOI 10.1016/S0160-2896(99)00027-6; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Levy F, 2001, CURR DRUG TARGETS, V2, P347, DOI 10.2174/1389450013348155; Macmillan N. A., 2005, DETECTION THEORY USE; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; Makeig S, 1995, NEUROREPORT, V7, P213, DOI 10.1097/00001756-199512000-00051; Makeig S, 2000, CAN J EXP PSYCHOL, V54, P266, DOI 10.1037/h0087346; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; O'Hearn K, 2008, DEV PSYCHOPATHOL, V20, P1103, DOI 10.1017/S0954579408000527; Perin B, 2010, BRAIN COGNITION, V72, P271, DOI 10.1016/j.bandc.2009.09.010; Petersen S. E., 2012, ANN REV NEUROSCIENCE, DOI 10.1146/annurev-neuro062111-150525; Pyka M, 2013, HUM BRAIN MAPP, V34, P3010, DOI 10.1002/hbm.22121; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Sala-Llonch R, 2011, CORTEX, P1; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Sturm W, 2006, EXP BRAIN RES, V171, P16, DOI 10.1007/s00221-005-0253-1; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; VaezMousavi SM, 2009, PHYSIOL BEHAV, V98, P326, DOI 10.1016/j.physbeh.2009.06.007; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Zou Q, 2012, HUMAN BRAIN IN PRESS	49	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66820	10.1371/journal.pone.0066820	http://dx.doi.org/10.1371/journal.pone.0066820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825569	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000030
J	Ma, JB; Zhang, MR; Xiao, XL; You, JJ; Wang, JR; Wang, T; Yao, YN; Tian, CY				Ma, Jinbiao; Zhang, Meiru; Xiao, Xinlong; You, Jinjin; Wang, Junru; Wang, Tao; Yao, Yinan; Tian, Changyan			Global Transcriptome Profiling of Salicornia europaea L. Shoots under NaCl Treatment	PLOS ONE			English	Article							CONFERRED SALT TOLERANCE; SALINITY TOLERANCE; ARABIDOPSIS-THALIANA; REGULATES EXPRESSION; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; NA+/H+ ANTIPORTER; SEED-GERMINATION; STRESS RESPONSES; ION ACCUMULATION	Background: Soil salinity is a major abiotic stress that limits agriculture productivity worldwide. Salicornia europaea is well adapted to extreme saline environments with more than 1,000 mM NaCl in the soil, so it could serve as an important model species for studying halophilic mechanisms in euhalophytes. To obtain insights into the molecular basis of salt tolerance, we present here the first extensive transcriptome analysis of this species using the Illumina HiSeq (TM) 2000. Principal Findings: A total of 41 and 39 million clean reads from the salt-treated (Se200S) and salt-free (SeCKS) tissues of S. europaea shoots were obtained, and de novo assembly produced 97,865 and 101,751 unigenes, respectively. Upon further assembly with EST data from both Se200S and SeCKS, 109,712 high-quality non-redundant unigenes were generated with a mean unigene size of 639 bp. Additionally, a total of 3,979 differentially expressed genes (DEGs) were detected between the Se200S and SeCKS libraries, with 348 unigenes solely expressed in Se200S and 460 unigenes solely expressed in SeCKS. Furthermore, we identified a large number of genes that are involved in ion homeostasis and osmotic adjustment, including cation transporters and proteins for the synthesis of low-molecular compounds. All unigenes were functionally annotated within the COG, GO and KEGG pathways, and 10 genes were validated by qRT-PCR. Conclusion: Our data contains the extensive sequencing and gene-annotation analysis of S. europaea. This genetic knowledge will be very useful for future studies on the molecular adaptation to abiotic stress in euhalophytes and will facilitate the genetic manipulation of other economically important crops.	[Ma, Jinbiao; Zhang, Meiru; Xiao, Xinlong; You, Jinjin; Wang, Junru; Yao, Yinan; Tian, Changyan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhang, Meiru; Xiao, Xinlong; Wang, Junru] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Tao] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xinjiang University	Yao, YN (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.	yaoya@ms.xjb.ac.cn; tiancy@ms.xjb.ac.cn	Xiao, Xinlong/I-6330-2012		programme of 100 Distinguished Young Scientists in the Chinese Academy of Sciences; Natural Science Foundation in China [31270660]; Youth Science Foundation of Xinjiang Uygur Autonomous Region of China [2011211B47]; Open Fund of the State Key Laboratory of Crop Stress Biology for Arid Areas [CSBAA2011-04]; Doctor Western [XBBS 201201]	programme of 100 Distinguished Young Scientists in the Chinese Academy of Sciences; Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Xinjiang Uygur Autonomous Region of China; Open Fund of the State Key Laboratory of Crop Stress Biology for Arid Areas; Doctor Western	This work was supported by the programme of 100 Distinguished Young Scientists in the Chinese Academy of Sciences, Natural Science Foundation in China (Grant No. 31270660), the Youth Science Foundation of Xinjiang Uygur Autonomous Region of China (Grant No. 2011211B47), the Open Fund of the State Key Laboratory of Crop Stress Biology for Arid Areas (CSBAA2011-04), and the Doctor Western-funded Projects of Chinese Academy of Sciences (XBBS 201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaleh M, 2009, BIOL PLANTARUM, V53, P243, DOI 10.1007/s10535-009-0046-7; Aghaleh M, 2011, ACTA PHYSIOL PLANT, V33, P1261, DOI 10.1007/s11738-010-0656-x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Ardie SW, 2009, J EXP BOT, V60, P3491, DOI 10.1093/jxb/erp184; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Barkla BJ, 2011, PLANT CELL MONOGR, V19, P457, DOI 10.1007/978-3-642-13431-9_21; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Chen SH, 2007, DNA SEQUENCE, V18, P61, DOI 10.1080/10425170601108555; Chen XY, 2011, PLANT CELL PHYSIOL, V52, P909, DOI 10.1093/pcp/pcr043; Chinnusamy Viswanathan, 2006, Genet Eng (N Y), V27, P141, DOI 10.1007/0-387-25856-6_9; Cockburn W, 1996, J EXP BOT, V47, P647, DOI 10.1093/jxb/47.5.647; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; FOYER C, 1991, PLANT PHYSIOL, V97, P863, DOI 10.1104/pp.97.3.863; Fukuda A, 1998, PLANT CELL PHYSIOL, V39, P196, DOI 10.1093/oxfordjournals.pcp.a029357; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YH, 2012, ACTA PHYSIOL PLANT, V34, P1287, DOI 10.1007/s11738-012-0925-y; Halfter Ursula, 1999, Plant Biology (Rockville), V1999, P123; Han HP, 2008, BIOTECHNOL LETT, V30, P1501, DOI 10.1007/s10529-008-9705-6; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kachout SS, 2012, J SCI FOOD AGR, V92, P336, DOI 10.1002/jsfa.4581; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kore-eda S, 2004, GENE, V341, P83, DOI 10.1016/j.gene.2004.06.037; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Li HT, 2009, BIOCHEM BIOPH RES CO, V382, P637, DOI 10.1016/j.bbrc.2009.03.091; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Lv SL, 2012, ACTA PHYSIOL PLANT, V34, P503, DOI 10.1007/s11738-011-0847-0; Lv SL, 2012, PLANT PHYSIOL BIOCH, V51, P47, DOI 10.1016/j.plaphy.2011.10.015; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; Moghaieb REA, 2004, PLANT SCI, V166, P1345, DOI 10.1016/j.plantsci.2004.01.016; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozawa T, 2007, SOIL SCI PLANT NUTR, V53, P12, DOI 10.1111/j.1747-0765.2007.00098.x; Pardo JM, 1998, P NATL ACAD SCI USA, V95, P9681, DOI 10.1073/pnas.95.16.9681; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; RIEHL TE, 1982, OECOLOGIA, V54, P193, DOI 10.1007/BF00378392; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Sokhansanj A, 2006, RUSS J PLANT PHYSL+, V53, P110, DOI 10.1134/S1021443706010146; Su H, 2003, PLANT MOL BIOL, V52, P967, DOI 10.1023/A:1025445612244; Subramanyam K, 2012, PLANTA, V236, P1909, DOI 10.1007/s00425-012-1733-8; Subramanyam K, 2011, PLANT CELL TISS ORG, V105, P181, DOI 10.1007/s11240-010-9850-1; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Taji T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-115; Torabi S, 2011, IN VITRO CELL DEV-PL, V47, P734, DOI 10.1007/s11627-011-9371-6; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Ueda A, 2001, PLANT CELL PHYSIOL, V42, P1282, DOI 10.1093/pcp/pce166; Ungar IA, 1996, AM J BOT, V83, P604, DOI 10.2307/2445919; Ushakova SA, 2005, ADV SPACE RES-SERIES, V36, P1349, DOI 10.1016/j.asr.2004.09.017; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Waditee R, 2002, J BIOL CHEM, V277, P18373, DOI 10.1074/jbc.M112012200; Wang DY, 2012, PLANT PHYSIOL BIOCH, V51, P53, DOI 10.1016/j.plaphy.2011.10.009; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; Winicov I, 1999, PLANT PHYSIOL, V120, P473, DOI 10.1104/pp.120.2.473; Wu S, 2010, ISOLATION CHOLINE MO; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang XL, 2011, AFR J BIOTECHNOL, V10, P16452, DOI 10.5897/AJB11.1092; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang JS, 1999, THEOR APPL GENET, V99, P1006, DOI 10.1007/s001220051408; Zhou SF, 2008, BIOTECHNOL LETT, V30, P369, DOI 10.1007/s10529-007-9548-6; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	73	28	34	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65877	10.1371/journal.pone.0065877	http://dx.doi.org/10.1371/journal.pone.0065877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825526	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000005
J	Zhong, XC; Zhang, H; Zhao, Y; Sun, QW; Hu, YF; Peng, H; Zhou, DX				Zhong, Xiaochao; Zhang, Hua; Zhao, Yu; Sun, Qianwen; Hu, Yongfeng; Peng, Hai; Zhou, Dao-Xiu			The Rice NAD(+)-Dependent Histone Deacetylase OsSRT1 Targets Preferentially to Stress- and Metabolism-Related Genes and Transposable Elements	PLOS ONE			English	Article							EXPRESSION; ACETYLATION; ARABIDOPSIS; SIRT6	Histone acetylation/deacetylation is an important chromatin modification for epigenetic regulation of gene expression. Silent information regulation2 (Sir2)-related sirtuins are nicotinamide-adenine dinucleotide (NAD(+))-dependent histone deacetylases (HDAC). The mammalian sirtuin family comprises 7 members (SIRT1-7) that act in different cellular compartments to regulate metabolism and aging. The rice genome contains only two Sir2-related genes: OsSRT1 (or SRT701) and OsSRT2 (orSRT702). OsSRT1 is closely related to the mammalian SIRT6, while OsSRT2 is homologous to SIRT4. Previous work has shown that OsSRT1 is required for the safeguard against genome instability and cell damage in rice plant. In this work we investigated the role of OsSRT1 on genome-wide acetylation of histone H3 lysine 9 (H3K9ac) and studied the genome-wide binding targets of OsSRT1. The study reveals that OsSRT1 binds to loci with relatively low levels of H3K9ac and directly regulates H3K9ac and expression of many genes that are related to stress and metabolism, indicating that OsSRT1 is an important site-specific histone deacetylase for gene regulation in rice. In addition, OsSRT1 is found to also target to several families of transposable elements, suggesting that OsSRT1 is directly involved in transposable element repression.	[Zhong, Xiaochao; Zhang, Hua; Zhao, Yu; Sun, Qianwen] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hu, Yongfeng; Zhou, Dao-Xiu] Univ Paris 11, Inst Biol Plantes, Orsay, France; [Peng, Hai] Jianghan Univ, Inst Interdisciplinary Sci, Res Inst, Wuhan, Peoples R China	Huazhong Agricultural University; UDICE-French Research Universities; Universite Paris Saclay; Jianghan University	Zhou, DX (corresponding author), Univ Paris 11, Inst Biol Plantes, Orsay, France.	dao-xiu.zhou@u-psud.fr		Zhou, Dao-Xiu/0000-0002-1540-0598	Chinese Ministry of Science and Technology "863" project [2012AA10A303]; Fundamental Research Funds for the Central Universities [2011PY051, 2012ZYTS057]; French Agence Nationale de la Recherche (ANR) program Blanc (NERDPATH)	Chinese Ministry of Science and Technology "863" project(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); French Agence Nationale de la Recherche (ANR) program Blanc (NERDPATH)(French National Research Agency (ANR))	This work was supported by the Chinese Ministry of Science and Technology "863" project (2012AA10A303); the Fundamental Research Funds for the Central Universities ("2011PY051" and "2012ZYTS057"); and the French Agence Nationale de la Recherche (ANR) program Blanc (NERDPATH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chung PJ, 2009, FEBS LETT, V583, P2249, DOI 10.1016/j.febslet.2009.06.003; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Earley KW, 2007, PLANT J, V52, P615, DOI 10.1111/j.1365-313X.2007.03264.x; Greiss S, 2009, MOL CELLS, V28, P407, DOI 10.1007/s10059-009-0169-x; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu YF, 2012, P NATL ACAD SCI USA, V109, P5773, DOI 10.1073/pnas.1203148109; Hu YF, 2009, BIOCHEM BIOPH RES CO, V388, P266, DOI 10.1016/j.bbrc.2009.07.162; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	20	31	37	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66807	10.1371/journal.pone.0066807	http://dx.doi.org/10.1371/journal.pone.0066807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825566	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000028
J	Lasko, TA; Denny, JC; Levy, MA				Lasko, Thomas A.; Denny, Joshua C.; Levy, Mia A.			Computational Phenotype Discovery Using Unsupervised Feature Learning over Noisy, Sparse, and Irregular Clinical Data	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; RISK STRATIFICATION; HEART-FAILURE; MODELS; REGULARIZATION; TIME	Inferring precise phenotypic patterns from population-scale clinical data is a core computational task in the development of precision, personalized medicine. The traditional approach uses supervised learning, in which an expert designates which patterns to look for (by specifying the learning task and the class labels), and where to look for them (by specifying the input variables). While appropriate for individual tasks, this approach scales poorly and misses the patterns that we don't think to look for. Unsupervised feature learning overcomes these limitations by identifying patterns (or features) that collectively form a compact and expressive representation of the source data, with no need for expert input or labeled examples. Its rising popularity is driven by new deep learning methods, which have produced high-profile successes on difficult standardized problems of object recognition in images. Here we introduce its use for phenotype discovery in clinical data. This use is challenging because the largest source of clinical data - Electronic Medical Records - typically contains noisy, sparse, and irregularly timed observations, rendering them poor substrates for deep learning methods. Our approach couples dirty clinical data to deep learning architecture via longitudinal probability densities inferred using Gaussian process regression. From episodic, longitudinal sequences of serum uric acid measurements in 4368 individuals we produced continuous phenotypic features that suggest multiple population subtypes, and that accurately distinguished (0.97 AUC) the uric-acid signatures of gout vs. acute leukemia despite not being optimized for the task. The unsupervised features were as accurate as gold-standard features engineered by an expert with complete knowledge of the domain, the classification task, and the class labels. Our findings demonstrate the potential for achieving computational phenotype discovery at population scale. We expect such data-driven phenotypes to expose unknown disease variants and subtypes and to provide rich targets for genetic association studies.	[Lasko, Thomas A.; Denny, Joshua C.; Levy, Mia A.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Denny, Joshua C.; Levy, Mia A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Levy, Mia A.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lasko, TA (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	tom.lasko@vanderbilt.edu	Denny, Josh/AAL-3359-2021	Denny, Josh/0000-0002-3049-7332	Edward Mallinckrodt, Jr. Foundation; Vanderbilt University Medical Center; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	Edward Mallinckrodt, Jr. Foundation; Vanderbilt University Medical Center; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded in part by a grant from the Edward Mallinckrodt, Jr. Foundation, and Vanderbilt University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lario B, 2011, QJM-INT J MED, V104, P1015, DOI 10.1093/qjmed/hcr159; Arel I, 2010, IEEE COMPUT INTELL M, V5, P13, DOI 10.1109/MCI.2010.938364; Batal I, 2011, IEEE INT C BIOINFORM, P358, DOI 10.1109/BIBM.2011.39; Bengio Y., 2007, LARGE SCALE KERNEL M; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bengio Yoshua, 2012, P ICML WORKSH UNS TR, P17, DOI DOI 10.1109/83.902291; Bishop C.M., 2006, PATTERN RECOGNITION; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Conway Mike, 2011, AMIA Annu Symp Proc, V2011, P274; Cover TM, 1991, ELEMENTS INFORM THEO; De Keulenaer GW, 2011, CIRCULATION, V123, P1996, DOI 10.1161/CIRCULATIONAHA.110.981431; De Keulenaer GW, 2009, CIRCULATION, V119, P3044, DOI 10.1161/CIRCULATIONAHA.109.870006; Dean BB, 2009, MED CARE RES REV, V66, P611, DOI 10.1177/1077558709332440; Denny JC, 2009, J AM MED INFORM ASSN, V16, P806, DOI 10.1197/jamia.M3037; DIETTERICH TG, 1981, ARTIF INTELL, V16, P257, DOI 10.1016/0004-3702(81)90002-3; Fawcett TE, 1992, P 9 INT C MACH LEARN, P144; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Gramacy RB, 2008, J AM STAT ASSOC, V103, P1119, DOI 10.1198/016214508000000689; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Klompas M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002626; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Le Q., 2012, P INT C MACH LEARN; Lee H., 2008, ADV NEURAL INFORM PR; Lee H, 2009, NIPS 2009 WORKSH DEE; Lee H, 2011, COMMUN ACM, V54, P95, DOI 10.1145/2001269.2001295; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; MacKay D. J. C., 1998, Neural Networks and Machine Learning. Proceedings, P133; MacKay D. J. C., 2003, INFORM THEORY INFERE; Markovitch S, 2002, MACH LEARN, V49, P59, DOI 10.1023/A:1014046307775; Matheny ME, 2010, MED DECIS MAKING, V30, P639, DOI 10.1177/0272989X10364246; Moskovitch Robert, 2009, AMIA Annu Symp Proc, V2009, P452; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Ng A, 2011, UFLDL TUTORIAL; Ngiam J., 2011, P 28 INT C INT C MAC, P265; Ngiam J., 2011, P INT C MACH LEARN; Noren GN, 2010, DATA MIN KNOWL DISC, V20, P361, DOI 10.1007/s10618-009-0152-3; O'Sullivan F., 1986, STAT SCI, V1, P502, DOI DOI 10.1214/ss/1177013525; Paciorek C.J., 2004, ADV NEURAL INFORM PR; Poggio Tomaso, 2003, NOTICES AM MATH SOC, V50, P537; R Core Team, 2012, R LANG ENV STAT COMP; Raina R, 2007, 24 ANN INT C MACH LE, V227, P759, DOI [10.1145/1273496.1273592, DOI 10.1145/1273496.1273592]; Rasmussen C. E., 2011, GPML TOOLBOX VERSION; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Saria S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001304; Schmidt AM, 2003, J R STAT SOC B, V65, P743, DOI 10.1111/1467-9868.00413; Stacey M, 2007, ARTIF INTELL MED, V39, P1, DOI 10.1016/j.artmed.2006.08.002; Syed Z, 2011, J MACH LEARN RES, V12, P999; Tikhonov A., 1977, SOLUTION ILL POSED P; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang F., 2012, P 18 ACM SIGKDD INT, P453, DOI DOI 10.1145/2339530.2339605; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wilcox WD, 1996, J PEDIATR-US, V128, P731, DOI 10.1016/S0022-3476(96)70322-0; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	63	162	165	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66341	10.1371/journal.pone.0066341	http://dx.doi.org/10.1371/journal.pone.0066341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826094	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400016
J	Nydam, ML; Netuschil, N; Sanders, E; Langenbacher, A; Lewis, DD; Taketa, DA; Marimuthu, A; Gracey, AY; De Tomaso, AW				Nydam, Marie L.; Netuschil, Nikolai; Sanders, Erin; Langenbacher, Adam; Lewis, Daniel D.; Taketa, Daryl A.; Marimuthu, Arumugapradeep; Gracey, Andrew Y.; De Tomaso, Anthony W.			The Candidate Histocompatibility Locus of a Basal Chordate Encodes Two Highly Polymorphic Proteins	PLOS ONE			English	Article							PROTOCHORDATE ALLORECOGNITION; EVOLUTION; GENE; REJECTION; GENOME; FESTER	The basal chordate Botryllus schlosseri undergoes a natural transplantation reaction governed by a single, highly polymorphic locus called the fuhc. Our initial characterization of this locus suggested it encoded a single gene alternatively spliced into two transcripts: a 555 amino acid-secreted form containing the first half of the gene, and a full-length, 1008 amino acid transmembrane form, with polymorphisms throughout the ectodomain determining outcome. We have now found that the locus encodes two highly polymorphic genes which are separated by a 227 bp intergenic region: first, the secreted form as previously described, and a second gene encoding a 531 amino acid membrane-bound gene containing three extracellular immunoglobulin domains. While northern blotting revealed only these two mRNAs, both PCR and mRNA-seq detect a single capped and polyadenylated transcript that encodes processed forms of both genes linked by the intergenic region, as well as other transcripts in which exons of the two genes are spliced together. These results might suggest that the two genes are expressed as an operon, during which both genes are co-transcribed and then trans-spliced into two separate messages. This type of transcriptional regulation has been described in tunicates previously; however, the membrane-bound gene does not encode a typical Splice Leader (SL) sequence at the 59 terminus that usually accompanies trans-splicing. Thus, the presence of stable transcripts encoding both genes may suggest a novel mechanism of regulation, or conversely may be rare but stable transcripts in which the two mRNAs are linked due to a small amount of read-through by RNA polymerase. Both genes are highly polymorphic and co-expressed on tissues involved in histocompatibility. In addition, polymorphisms on both genes correlate with outcome, although we have found a case in which it appears that the secreted form may be major allorecognition determinant.	[Nydam, Marie L.; Netuschil, Nikolai; Sanders, Erin; Langenbacher, Adam; Lewis, Daniel D.; Taketa, Daryl A.; Marimuthu, Arumugapradeep; De Tomaso, Anthony W.] Univ Calif Santa Barbara, Dept MCD Biol, Santa Barbara, CA 93106 USA; [Gracey, Andrew Y.] Univ So Calif, Dept Marine Environm Biol, Los Angeles, CA USA	University of California System; University of California Santa Barbara; University of Southern California	De Tomaso, AW (corresponding author), Univ Calif Santa Barbara, Dept MCD Biol, Santa Barbara, CA 93106 USA.	detomaso@lifesci.ucsb.edu		Sanders, Erin/0000-0003-2312-6346	National Institutes of Health [NIH R01 AI041588, NIH R01 AG037966, NSF IOS-08421387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by the National Institutes of Health grants NIH R01 AI041588, NIH R01 AG037966, and NSF IOS-08421387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Blumenthal Thomas, 2012, WormBook, P1, DOI 10.1895/wormbook.1.5.2; Brown FD, 2009, DEVELOPMENT, V136, P3485, DOI 10.1242/dev.037754; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; De Tomaso AW, 2006, TRENDS GENET, V22, P485, DOI 10.1016/j.tig.2006.07.001; De Tomaso AW, 2009, DIS MODEL MECH, V2, P440, DOI 10.1242/dmm.001156; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Gasparini F, 2011, DEV GENES EVOL, V220, P329, DOI 10.1007/s00427-011-0351-y; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Matsumoto J, 2010, GENOME RES, V20, P636, DOI 10.1101/gr.100271.109; McKitrick TR, 2011, IMMUNITY, V34, P616, DOI 10.1016/j.immuni.2011.01.019; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nydam ML, 2013, DEV COMP IMMUNOL, V41, P128, DOI 10.1016/j.dci.2013.03.004; Nydam ML, 2013, EVOLUTION, V67, P487, DOI 10.1111/j.1558-5646.2012.01787.x; Nydam ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-249; Nydam ML, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00079; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rinkevich B, 2012, DEV COMP IMMUNOL, V36, P718, DOI 10.1016/j.dci.2011.10.015; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; Sabbadin A, 1962, ATTI ACCAD NAZ LINCE, V32; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCOFIELD VL, 1983, BIOL BULL, V165, P733, DOI 10.2307/1541475; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65980	10.1371/journal.pone.0065980	http://dx.doi.org/10.1371/journal.pone.0065980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826085	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400007
J	Kashima, S; Inoue, K; Matsumoto, M; Akimoto, K				Kashima, Saori; Inoue, Kazuo; Matsumoto, Masatoshi; Akimoto, Kimihiko			Do Non-Glycaemic Markers Add Value to Plasma Glucose and Hemoglobin A1c in Predicting Diabetes? Yuport Health Checkup Center Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMPAIRED FASTING GLUCOSE; MIDDLE-AGED JAPANESE; BLOOD-CELL COUNT; SERUM URIC-ACID; LIVER-ENZYMES; METABOLIC SYNDROME; RISK-FACTORS; DIAGNOSTIC-CRITERIA; ALCOHOL-CONSUMPTION	Background: Many markers have been indicated as predictors of type 2 diabetes. However, the question of whether or not non-glycaemic (blood) biomarkers and non-blood biomarkers have a predictive additive utility when combined with glycaemic (blood) biomarkers is unknown. The study aim is to assess this additive utility in a large Japanese population. Methods: We used data from a retrospective cohort study conducted from 1998 to 2002 for the baseline and 2002 to 2006 for follow-up, inclusive of 5,142 men (mean age of 51.9 years) and 4,847 women (54.1 years) at baseline. The cumulative incidence of diabetes [defined either as a fasting plasma glucose (FPG) >= 7.00 mmol/l or as clinically diagnosed diabetes] was measured. In addition to glycaemic biomarkers [FPG and hemoglobin A1c (HbA1c)], we examined the clinical usefulness of adding non-glycaemic biomarkers and non-blood biomarkers, using sensitivity and specificity, and the area under the curve (AUC) of the receiver operating characteristics. Results: The AUCs to predict diabetes were 0.874 and 0.924 for FPG, 0.793 and 0.822 for HbA1c, in men and women, respectively. Glycaemic biomarkers were the best and second-best for diabetes prediction among the markers. All non-glycaemic markers (except uric acid in men and creatinine in both sexes) predicted diabetes. Among these biomarkers, the highest AUC in the single-marker analysis was 0.656 for alanine aminotransferase (ALT) in men and 0.740 for body mass index in women. The AUC of the combined markers of FPG and HbA1c was 0.895 in men and 0.938 in women, which were marginally increased to 0.904 and 0.940 when adding ALT, respectively. Conclusions: AUC increments were marginal when adding non-glycaemic biomarkers and non-blood biomarkers to the classic model based on FPG and HbA1c. For the prediction of diabetes, FPG and HbA1c are sufficient and the other markers may not be needed in clinical practice.	[Kashima, Saori] Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Hiroshima University; Teikyo University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Hiroshima, Japan.	saori_ksm@ybb.ne.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303				Chou PS, 1998, DIABETES CARE, V21, P1183, DOI 10.2337/diacare.21.7.1183; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000869; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinneen SF, 1998, DIABETES CARE, V21, P1408, DOI 10.2337/diacare.21.9.1408; Doi Y, 2007, OBESITY, V15, P1841, DOI 10.1038/oby.2007.218; Dotevall A, 2004, DIABETIC MED, V21, P615, DOI 10.1111/j.1464-5491.2004.01189.x; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-S301, 10.2337/dc09-9033]; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garrido-Sanchez L, 2008, EUR J CLIN INVEST, V38, P615, DOI 10.1111/j.1365-2362.2008.01988.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Inoue K, 2012, DIABETIC MED, V29, P1327; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kuzuya T, 1999, J JPN DIAB SOC, V42, P385; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; NAGI DK, 1995, DIABETOLOGIA, V38, P187, DOI 10.1007/s001250050269; Nakanishi N, 2002, DIABETOLOGIA, V45, P42, DOI 10.1007/s125-002-8243-1; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Onat A, 2007, CIRC J, V71, P1463, DOI 10.1253/circj.71.1463; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; Sato KK, 2008, DIABETES CARE, V31, P1230, DOI 10.2337/dc07-2184; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Sattar N, 2012, DIABETIC MED, V29, P5, DOI 10.1111/j.1464-5491.2011.03480.x; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wang WY, 2011, DIABETES CARE, V34, P363, DOI 10.2337/dc10-1680; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Wilson PWF, 2011, DIABETES RES CLIN PR, V92, P124, DOI 10.1016/j.diabres.2010.12.024; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	46	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66899	10.1371/journal.pone.0066899	http://dx.doi.org/10.1371/journal.pone.0066899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818970	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800108
J	Liu, Y; Zhang, YB; Liu, TK; Gui, JF				Liu, Ying; Zhang, Yi-Bing; Liu, Ting-Kai; Gui, Jian-Fang			Lineage-Specific Expansion of IFIT Gene Family: An Insight into Coevolution with IFN Gene Family	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; INNATE IMMUNE-RESPONSE; CARP CARASSIUS-AURATUS; ANTIVIRAL RESPONSE; INDUCIBLE PROTEIN; MESSENGER-RNA; I IFNS; FISH	In mammals, IFIT (Interferon [IFN]-induced proteins with Tetratricopeptide Repeat [TPR] motifs) family genes are involved in many cellular and viral processes, which are tightly related to mammalian IFN response. However, little is known about non-mammalian IFIT genes. In the present study, IFIT genes are identified in the genome databases from the jawed vertebrates including the cartilaginous elephant shark but not from non-vertebrates such as lancelet, sea squirt and acorn worm, suggesting that IFIT gene family originates from a vertebrate ancestor about 450 million years ago. IFIT family genes show conserved gene structure and gene arrangements. Phylogenetic analyses reveal that this gene family has expanded through lineage-specific and species-specific gene duplication. Interestingly, IFN gene family seem to share a common ancestor and a similar evolutionary mechanism; the function link of IFIT genes to IFN response is present early since the origin of both gene families, as evidenced by the finding that zebrafish IFIT genes are upregulated by fish IFNs, poly(I:C) and two transcription factors IRF3/IRF7, likely via the IFN-stimulated response elements (ISRE) within the promoters of vertebrate IFIT family genes. These coevolution features creates functional association of both family genes to fulfill a common biological process, which is likely selected by viral infection during evolution of vertebrates. Our results are helpful for understanding of evolution of vertebrate IFN system.	[Liu, Ying; Zhang, Yi-Bing; Liu, Ting-Kai; Gui, Jian-Fang] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhang, YB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	ybzhang@ihb.ac.cn; jfgui@ihb.ac.cn	Liu, Ying/A-7127-2019; Liu, Ting-Kai/B-1880-2013	Liu, Ying/0000-0002-6419-1980; Liu, Ting-Kai/0000-0003-2708-0779	973 National Basic Research Program of China [2010CB126303]; National Natural Science Foundation of China [31272690, 31172435]	973 National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from 973 National Basic Research Program of China (2010CB126303), and National Natural Science Foundation of China (31272690, 31172435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; BANDYOPADHYAY SK, 1995, J BIOL CHEM, V270, P19624, DOI 10.1074/jbc.270.33.19624; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLUYSSEN HAR, 1994, GENOMICS, V24, P137, DOI 10.1006/geno.1994.1591; Chang MX, 2009, IMMUNOGENETICS, V61, P315, DOI 10.1007/s00251-009-0366-y; CHEBATH J, 1983, NUCLEIC ACIDS RES, V11, P1213, DOI 10.1093/nar/11.5.1213; Chen M.R., 1985, J FISHERIES CHINA, V9, P121; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liu TK, 2011, J VIROL, V85, P12769, DOI 10.1128/JVI.05849-11; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Shi J, 2012, FISH SHELLFISH IMMUN, V33, P258, DOI 10.1016/j.fsi.2012.05.014; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Sun BJ, 2009, DEV COMP IMMUNOL, V33, P547, DOI 10.1016/j.dci.2008.10.001; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATHELET MG, 1987, EUR J BIOCHEM, V169, P313, DOI 10.1111/j.1432-1033.1987.tb13614.x; Woelk CH, 2007, GENE, V397, P38, DOI 10.1016/j.gene.2007.03.018; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yu FF, 2010, MOL IMMUNOL, V47, P2330, DOI 10.1016/j.molimm.2010.05.282; Zhang YB, 2004, GENE, V325, P43, DOI 10.1016/j.gene.2003.09.039; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	54	32	36	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66859	10.1371/journal.pone.0066859	http://dx.doi.org/10.1371/journal.pone.0066859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818968	gold, Green Submitted, Green Published			2022-12-25	WOS:000322342800106
J	Odegaard, AO; Choh, AC; Nahhas, RW; Towne, B; Czerwinski, SA; Demerath, EW				Odegaard, Andrew O.; Choh, Audrey C.; Nahhas, Ramzi W.; Towne, Bradford; Czerwinski, Stefan A.; Demerath, Ellen W.			Systematic Examination of Infant Size and Growth Metrics as Risk Factors for Overweight in Young Adulthood	PLOS ONE			English	Article							WEIGHT-GAIN; RAPID GROWTH; OBESITY; CHILDHOOD; COHORT; LIFE	Objective: To systematically examine infant size and growth, according to the 2006 WHO infant growth standards, as risk factors for overweight status in young adulthood in a historical cohort. Specifically, to assess: Whether accounting for length (weight-for-length) provides a different picture of risk than weight-for-age, intervals of rapid growth in both weight-for-age and weight-for-length metrics, and what particular target ages for infant size and intervals of rapid growth associate most strongly with overweight as a young adult. Patients/Methods: Data analysis of 422 appropriate for gestational age white singleton infants enrolled in the Fels Longitudinal Study. Odds ratios (OR) for overweight and obesity in young adulthood (age 20-29) were calculated using logistic regression models for the metrics at each target age (0, 1, 3, 6, 9, 12, 18, 24 months) comparing >= 85th v. <85th percentile, as well as rapid growth (Delta >= 0.67 Z-score) through target age intervals. Models accounted for both maternal and paternal BMI. Results: Infants >= 85th percentile of weight-for-age at each target age (except 3 months) had a greater odds of being overweight as a young adult. After accounting for length (weight-for-length) this association was limited to 12, and 18 months. Rapid weight-for-age growth was infrequently associated with overweight as a young adult. Rapid weight-for-length growth from 0 to 24 months, 1 to 6, 9, 12, 18, and 24 months and from 3 to 9, 12, 18, and 24 months was strongly associated with overweight status as a young adult. Conclusions: The WHO weight-for-length metric associates differently with risk of being overweight as a young adult compared to weight-for-age. Intervals of rapid weight-for-length growth ranging from months (0-24), (1-12, 18, and 24) and (3-9, and 12) displayed the largest OR for being overweight as a young adult.	[Odegaard, Andrew O.; Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Choh, Audrey C.; Nahhas, Ramzi W.; Towne, Bradford; Czerwinski, Stefan A.] Wright State Univ, Boonshoft Sch Med, Lifespan Hlth Res Ctr, Dayton, OH 45435 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Wright State University Dayton	Odegaard, AO (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	Odeg0025@umn.edu	Nahhas, Ramzi W./AAT-4729-2021	Demerath, Ellen/0000-0002-4585-4064	NIH/NICHD [R01 HD053685, R01 HD012252]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012252] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053685] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NIH/NICHD grants R01 HD053685 and R01 HD012252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronne LJ, 2009, AM J MED, V122, pS24, DOI 10.1016/j.amjmed.2009.01.005; Baird J, 2005, BMJ, V331; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Mei Z, 2011, CLIN PEDIAT PHILA; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; ROCHE AF, 1992, MATURATION BODY COMP; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; van Dommelen P, 2004, TWIN RES, V7, P607, DOI 10.1375/1369052042663805; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854	22	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66994	10.1371/journal.pone.0066994	http://dx.doi.org/10.1371/journal.pone.0066994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818973	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800111
J	Zuo, X; Dong, DY; Sun, M; Xie, HQ; Kang, YJ				Zuo, Xiao; Dong, Daoyin; Sun, Miao; Xie, Huiqi; Kang, Y. James			Homocysteine Restricts Copper Availability Leading to Suppression of Cytochrome C Oxidase Activity in Phenylephrine-Treated Cardiomyocytes	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; HYPERTROPHIC CARDIOMYOPATHY; PRESSURE-OVERLOAD; 2.8 ANGSTROM; DEFICIENCY; MUTATIONS; SCO1; SUBUNITS; COX17; GENE	Cardiomyocyte hypertrophy induced by phenylephrine (PE) is accompanied by suppression of cytochrome c oxidase (CCO) activity, and copper (Cu) supplementation restores CCO activity and reverses the hypertrophy. The present study was aimed to understand the mechanism of PE-induced decrease in CCO activity. Primary cultures of neonatal rat cardiomyocytes were treated with PE at a final concentration of l00 mu M in cultures for 72 h to induce cell hypertrophy. The CCO activity was determined by enzymatic assay and changes in CCO subunit COX-IV as well as copper chaperones for CCO (COX17, SCO2, and COX11) were determined by Western blotting. PE treatment increased both intracellular and extracellular homocysteine concentrations and decreased intracellular Cu concentrations. Studies in vitro found that homocysteine and Cu form complexes. Inhibition of the intracellular homocysteine synthesis in the PE-treated cardiomyocytes prevented the increase in the extracellular homocysteine concentration, retained the intracellular Cu concentration, and preserved the CCO activity. PE treatment decreased protein concentrations of the COX-IV, and the Cu chaperones COX17, COX11, and SCO2. These PE effects were prevented by either inhibition of the intracellular homocysteine synthesis or Cu supplementation. Therefore, PE-induced elevation of homocysteine restricts Cu availability through its interaction with Cu and suppression of Cu chaperones, leading to the decrease in CCO enzyme activity.	[Zuo, Xiao; Dong, Daoyin; Sun, Miao; Xie, Huiqi; Kang, Y. James] Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Kang, Y. James] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Sichuan University; University of Louisville	Kang, YJ (corresponding author), Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yjkang01@louisville.edu	Dong, Daoyin/D-6014-2016	Dong, Daoyin/0000-0003-0544-8341	National Science Foundation of China (NSFC) [81230004]; US National Institutes of Health [HL-63760]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by the National Science Foundation of China grant (NSFC grant 81230004 to YJK) and US National Institutes of Health grant (HL-63760 to YJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova MD, 2003, J INORG BIOCHEM, V95, P321, DOI 10.1016/S0162-0134(03)00133-8; Carrasco-Pozo C, 2006, EXP BIOL MED, V231, P1569, DOI 10.1177/153537020623100918; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; DALLMAN PR, 1967, J CLIN INVEST, V46, P1819, DOI 10.1172/JCI105672; Das J, 2004, MOL BIOL EVOL, V21, P1572, DOI 10.1093/molbev/msh161; Emsley AM, 1999, BRIT J PHARMACOL, V126, P1034, DOI 10.1038/sj.bjp.0702374; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Garcia AJ, 2002, J CHROMATOGR B, V779, P359, DOI 10.1016/S1570-0232(02)00401-4; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Hoffmann P, 1995, CARDIOVASC RES, V30, P889, DOI 10.1016/S0008-6363(95)00133-6; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huttemann M, 2012, MITOCHONDRION, V12, P294, DOI 10.1016/j.mito.2011.11.002; Hughes WM, 2008, CARDIOVASC TOXICOL, V8, P137, DOI 10.1007/s12012-008-9021-3; Jeremy JY, 2002, ANN THORAC SURG, V74, P1553, DOI 10.1016/S0003-4975(02)03807-9; Jiang YC, 2007, J EXP MED, V204, P657, DOI 10.1084/jem.20061943; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; LIAO ZM, 1995, COMP BIOCHEM PHYS B, V111, P61, DOI 10.1016/0305-0491(94)00226-K; Lu YM, 2009, MOL PHARMACOL, V75, P101, DOI 10.1124/mol.108.050716; Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, pH575, DOI 10.1152/ajpheart.00619.2002; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mansoor MA, 2000, CLIN CHEM, V46, P385; Medeiros DM, 1997, COMP BIOCHEM PHYS A, V117, P77, DOI 10.1016/S0300-9629(96)00365-9; OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; Shukla N, 2007, ANN THORAC SURG, V84, P43, DOI 10.1016/j.athoracsur.2007.03.087; Siddiqui RA, 2004, J CELL BIOCHEM, V92, P1141, DOI 10.1002/jcb.20135; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Streck EL, 2003, BBA-MOL BASIS DIS, V1637, P187, DOI 10.1016/S0925-4439(03)00019-X; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; Valnot I, 2000, AM J HUM GENET, V67, P1104; ZEVIANI M, 1986, ARCH NEUROL-CHICAGO, V43, P1198, DOI 10.1001/archneur.1986.00520110084025; Zuo XA, 2010, CARDIOVASC TOXICOL, V10, P208, DOI 10.1007/s12012-010-9080-0	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67549	10.1371/journal.pone.0067549	http://dx.doi.org/10.1371/journal.pone.0067549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818984	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800141
J	Armstrong, CL; Marquardt, D; Dies, H; Kucerka, N; Yamani, Z; Harroun, TA; Katsaras, J; Shi, AC; Rheinstadter, MC				Armstrong, Clare L.; Marquardt, Drew; Dies, Hannah; Kucerka, Norbert; Yamani, Zahra; Harroun, Thad A.; Katsaras, John; Shi, An-Chang; Rheinstaedter, Maikel C.			The Observation of Highly Ordered Domains in Membranes with Cholesterol	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PHASE DPPC BILAYERS; X-RAY-SCATTERING; LIPID-BILAYERS; MOLECULAR SIMULATION; COLLECTIVE DYNAMICS; MAXIMUM SOLUBILITY; MODEL MEMBRANES; CELL BIOLOGY; RAFTS	Rafts, or functional domains, are transient nano- or mesoscopic structures in the exoplasmic leaflet of the plasma membrane, and are thought to be essential for many cellular processes. Using neutron diffraction and computer modelling, we present evidence for the existence of highly ordered lipid domains in the cholesterol-rich (32.5 mol%) liquid-ordered (l(o)) phase of dipalmitoylphosphatidylcholine membranes. The liquid ordered phase in one-component lipid membranes has previously been thought to be a homogeneous phase. The presence of highly ordered lipid domains embedded in a disordered lipid matrix implies non-uniform distribution of cholesterol between the two phases. The experimental results are in excellent agreement with recent computer simulations of DPPC/cholesterol complexes [Meinhardt, Vink and Schmid (2013). Proc Natl Acad Sci USA 110(12): 4476-4481], which reported the existence of nanometer size l(o) domains in a liquid disordered lipid environment.	[Armstrong, Clare L.; Dies, Hannah; Shi, An-Chang; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Marquardt, Drew; Harroun, Thad A.] Brock Univ, Dept Phys, St Catharines, ON L2S 3A1, Canada; [Marquardt, Drew; Kucerka, Norbert; Yamani, Zahra; Katsaras, John; Rheinstaedter, Maikel C.] Natl Res Council Canada, Canadian Neutron Beam Ctr, Chalk River, ON, Canada; [Katsaras, John] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN USA; [Katsaras, John] Oak Ridge Natl Lab, Joint Inst Neutron Sci, Oak Ridge, TN USA	McMaster University; Brock University; Atomic Energy of Canada Limited; National Research Council Canada; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Armstrong, CL (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	armstc5@mcmaster.ca; rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Harroun, Thad/AAG-3322-2020; yamani, zahra/AAU-4048-2021; Katsaras, John/K-4525-2018; yamani, zahra/B-7892-2012; Kucerka, Norbert/Q-7476-2016; Bacon, Hannah/AAQ-9604-2021; Harroun, Thad/C-6491-2009; Shi, An-Chang/A-2910-2008	Rheinstadter, Maikel C/0000-0002-0558-7475; Harroun, Thad/0000-0001-9816-2590; Kucerka, Norbert/0000-0002-1075-6640; Harroun, Thad/0000-0001-9816-2590; Shi, An-Chang/0000-0003-1379-7162; Marquardt, Drew/0000-0001-6848-2497; yamani, zahra/0000-0001-8445-4656; Bacon, Hannah/0000-0002-2772-141X; Katsaras, John/0000-0002-8937-4177	Natural Sciences and Engineering Research Council of Canada; National Research Council; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Oak Ridge National Laboratory's Laboratory Directed Research and Development program; Early Researcher Award from the Province of Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Oak Ridge National Laboratory's Laboratory Directed Research and Development program; Early Researcher Award from the Province of Ontario	This research was funded by the Natural Sciences and Engineering Research Council of Canada, the National Research Council, the Canada Foundation for Innovation, and the Ontario Ministry of Economic Development and Innovation. JK is partially supported by Oak Ridge National Laboratory's Laboratory Directed Research and Development program. MCR is the recipient of an Early Researcher Award from the Province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Andoh Y, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4704740; Apajalahti T, 2010, FARADAY DISCUSS, V144, P411, DOI 10.1039/b901487j; Armstrong CL, 2012, SOFT MATTER, V8, P4687, DOI 10.1039/c2sm07158d; Armstrong CL, 2012, EUR BIOPHYS J BIOPHY, V41, P901, DOI 10.1007/s00249-012-0826-4; Armstrong CL, 2011, PROTEIN PEPTIDE LETT, V18, P344; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bruning B, 2010, EUR PHYS J E, V31, P419, DOI 10.1140/epje/i2010-10574-6; Bruning B, 2009, SOFT MATTER, V5, P3340, DOI 10.1039/b901389j; Canadian Neutron Beam Centre, SPECTR INF; Casuso I, 2010, BIOPHYS J, V99, pL47, DOI 10.1016/j.bpj.2010.07.028; Dai J, 2010, J PHYS CHEM B, V114, P840, DOI 10.1021/jp909061h; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; de Meyer FJM, 2010, BIOPHYS J, V99, P3629, DOI 10.1016/j.bpj.2010.09.030; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; de Meyer FJM, 2008, BIOPHYS J, V95, P1851, DOI 10.1529/biophysj.107.124164; Edholm O, 2005, BIOPHYS J, V89, P1827, DOI 10.1529/biophysj.105.064329; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ehrig J, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045019; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Hall A, 2010, J PHYS CHEM B, V114, P7797, DOI 10.1021/jp912175d; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Holzwarth U, 2011, NAT NANOTECHNOL, V6, P534, DOI 10.1038/nnano.2011.145; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; KAISER H, 1983, PHYS REV LETT, V50, P560, DOI 10.1103/PhysRevLett.50.560; Katsaras J, 1997, PHYS REV E, V55, P3751, DOI 10.1103/PhysRevE.55.3751; Katsaras J, 2000, PHYS REV E, V61, P5668, DOI 10.1103/PhysRevE.61.5668; KATSARAS J, 1995, BIOCHEMISTRY-US, V34, P4684, DOI 10.1021/bi00014a023; Kaye MD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.050907; Kraus W, 1996, J APPL CRYSTALLOGR, V29, P301, DOI 10.1107/S0021889895014920; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Kucerka N, 2006, BIOPHYS J, V90, pL83, DOI 10.1529/biophysj.106.086017; Lenne PF, 2009, SOFT MATTER, V5, P2841, DOI 10.1039/b822956b; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; M'Baye G, 2008, BIOPHYS J, V95, P1217, DOI 10.1529/biophysj.107.127480; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P688, DOI 10.1016/j.bbamem.2009.12.027; McIntosh TJ, 2003, BIOPHYS J, V85, P1656, DOI 10.1016/S0006-3495(03)74595-0; Meinhardt S, 2013, P NATL ACAD SCI USA, V110, P4476, DOI 10.1073/pnas.1221075110; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Mills TT, 2008, BIOPHYS J, V95, P682, DOI 10.1529/biophysj.107.127910; Mills TT, 2009, GEN PHYSIOL BIOPHYS, V28, P126, DOI 10.4149/gpb_2009_02_126; Murtola T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238102; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; RAGHUNATHAN VA, 1995, PHYS REV LETT, V74, P4456, DOI 10.1103/PhysRevLett.74.4456; RAUCH H, 1993, FOUND PHYS, V23, P7, DOI 10.1007/BF01883988; Rheinstadter MC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011907; Rheinstadter MC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108107; Rheinstadter MC, 2004, PHYSICA B, V350, P136, DOI 10.1016/j.physb.2004.04.060; Rheinstadter MC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128104; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Scherrer P., 1918, S AFR J SCI, V2, P98; Shirane G, 2002, NEUTRON SCATTERING T; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SZABO G, 1974, NATURE, V252, P47, DOI 10.1038/252047a0; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Watkins EB, 2011, P NATL ACAD SCI USA, V108, P6975, DOI 10.1073/pnas.1014579108; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zheludev A, 2009, RESLIB	79	92	92	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66162	10.1371/journal.pone.0066162	http://dx.doi.org/10.1371/journal.pone.0066162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823623	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400060
J	Baumann, H; Doherty, O				Baumann, Hannes; Doherty, Owen			Decadal Changes in the World's Coastal Latitudinal Temperature Gradients	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; COUNTERGRADIENT VARIATION; CONTRASTING PATTERNS; GEOGRAPHIC-VARIATION; MARINE GASTROPOD; RANGE SHIFTS; GROWTH-RATE; VARIABILITY; IMPACTS	Most of the world's living marine resources inhabit coastal environments, where average thermal conditions change predictably with latitude. These coastal latitudinal temperature gradients (CLTG) coincide with important ecological clines,e.g., in marine species diversity or adaptive genetic variations, but how tightly thermal and ecological gradients are linked remains unclear. A first step is to consistently characterize the world's CLTGs. We extracted coastal cells from a global 1 degrees x 1 degrees dataset of weekly sea surface temperatures (SST, 1982-2012) to quantify spatial and temporal variability of the world's 11 major CLTGs. Gradient strength, i.e., the slope of the linear mean-SST/latitude relationship, varied 3-fold between the steepest (North-American Atlantic and Asian Pacific gradients: -0.91 degrees C and -0.68 degrees C lat(-1), respectively) and weakest CLTGs (African Indian Ocean and the South- and North-American Pacific gradients: -0.28, -0.29, -0.32 degrees C lat(-1), respectively). Analyzing CLTG strength by year revealed that seven gradients have weakened by 3-10% over the past three decades due to increased warming at high compared to low latitudes. Almost the entire South- American Pacific gradient (6-47 degrees S), however, has considerably cooled over the study period (-0.3 to -1.7 degrees C, 31 years), and the substantial weakening of the North-American Atlantic gradient (-10%) was due to warming at high latitudes (42-60 degrees N, +0.8 to +1.6 degrees C, 31 years) and significant mid-latitude cooling ( Florida to Cape Hatteras 26-35 degrees N, -0.5 to -2.2 degrees C, 31 years). Average SST trends rarely resulted from uniform shifts throughout the year; instead individual seasonal warming or cooling patterns elicited the observed changes in annual means. This is consistent with our finding of increased seasonality (i.e., summer-winter SST amplitude) in three quarters of all coastal cells (331 of 433). Our study highlights the regionally variable footprint of global climate change, while emphasizing ecological implications of changing CLTGs, which are likely driving observed spatial and temporal clines in coastal marine life.	[Baumann, Hannes] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Doherty, Owen] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego; Scripps Institution of Oceanography	Baumann, H (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	hannes.baumann@stonybrook.edu	Baumann, Hannes/D-1435-2010	Baumann, Hannes/0000-0002-4039-4230				[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BAKUN A, 1991, J PHYS OCEANOGR, V21, P1815, DOI 10.1175/1520-0485(1991)021<1815:TSCOWS>2.0.CO;2; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Baumann H, 2012, COPEIA, P341, DOI 10.1643/CG-10-189; Baumann H, 2011, P ROY SOC B-BIOL SCI, V278, P2265, DOI 10.1098/rspb.2010.2479; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Beninger PG, 2012, J EXP MAR BIOL ECOL, V426, P97, DOI 10.1016/j.jembe.2012.05.020; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Brown JJ, 1998, T AM FISH SOC, V127, P598, DOI 10.1577/1548-8659(1998)127<0598:VILGRA>2.0.CO;2; Bryden HL, 2005, J OCEANOGR, V61, P479, DOI 10.1007/s10872-005-0057-8; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dengler M., 2006, GEOPHYS RES LETT, P33; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ezer T, 2013, J GEOPHYS RES-OCEANS, V118, P685, DOI 10.1002/jgrc.20091; Folland CK, 1990, CLIMATE CHANGE: THE IPCC SCIENTIFIC ASSESSMENT, P195; Gomez-Gesteira M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004315; Goreau T.J., 2005, WORLD RESOURCE REV, V17, P350; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Jonassen TM, 2000, J FISH BIOL, V56, P279, DOI 10.1111/j.1095-8649.2000.tb02106.x; Jordan D. S., 1891, Proceedings of the United States National Museum, Vxiv, P107; Lemos RT, 2004, INT J CLIMATOL, V24, P511, DOI 10.1002/joc.1009; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; McDowall RM, 2008, J BIOGEOGR, V35, P501, DOI 10.1111/j.1365-2699.2007.01823.x; Munch SB, 2003, EVOLUTION, V57, P2119, DOI 10.1554/02-711; Munch SB, 2003, ECOLOGY, V84, P2168, DOI 10.1890/02-0137; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; NOAA, 2012, EARTH SYST RES LAB N; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; PALTRIDGE G, 1981, MON WEATHER REV, V109, P2427, DOI 10.1175/1520-0493(1981)109<2427:CIGSTF>2.0.CO;2; Pardo PC, 2011, CLIM RES, V48, P231, DOI 10.3354/cr00989; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parsons KE, 1997, EVOLUTION, V51, P784, DOI 10.1111/j.1558-5646.1997.tb03661.x; PAULY D, 1980, J CONSEIL, V39, P175; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Portner H.-O., 2022, SUMMARY POLICYMAKERS; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rossby T, 1996, REV GEOPHYS, V34, P463, DOI 10.1029/96RG02214; Roughan M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001833; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Salinas S, 2012, ECOL LETT, V15, P159, DOI 10.1111/j.1461-0248.2011.01721.x; Sanford E, 2006, ECOLOGY, V87, P2882, DOI 10.1890/0012-9658(2006)87[2882:LTGFAT]2.0.CO;2; Santos F, 2012, CONT SHELF RES, V47, P1, DOI 10.1016/j.csr.2012.07.023; Santos F, 2011, CONT SHELF RES, V31, P2012, DOI 10.1016/j.csr.2011.10.005; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; SCHROEDER EH, 1966, B MAR SCI, V16, P302; Schultz ET, 1996, FUNCT ECOL, V10, P366, DOI 10.2307/2390285; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Strong AE, 2000, GEOPHYS RES LETT, V27, P1667, DOI 10.1029/1999GL002392; ter Hofstede R, 2010, MAR ECOL PROG SER, V414, P1, DOI 10.3354/meps08753; Yasuhara M, 2012, ECOL LETT, V15, P1174, DOI 10.1111/j.1461-0248.2012.01828.x; Zacherl D, 2003, J BIOGEOGR, V30, P913, DOI 10.1046/j.1365-2699.2003.00899.x	68	39	39	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67596	10.1371/journal.pone.0067596	http://dx.doi.org/10.1371/journal.pone.0067596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825672	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400190
J	Cheung, V; Bouralexis, S; Gillespie, MT				Cheung, Vanessa; Bouralexis, Steve; Gillespie, Matthew T.			PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAIL	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; AGONISTIC MONOCLONAL-ANTIBODY; RECEPTOR-SELECTIVE MUTANTS; PARATHYROID-HORMONE; INDUCED APOPTOSIS; BONE DESTRUCTION; APO-2 LIGAND; IN-VITRO; GROWTH; LOCALIZATION	Parathyroid hormone-related protein (PTHrP) is a key component in breast development and breast tumour biology. PTHrP has been discovered as a causative agent of hypercalcaemia of malignancy and is also one of the main factors implicated in breast cancer mediated osteolysis. Clinical studies have determined that PTHrP expression by primary breast cancers was an independent predictor of improved prognosis. Furthermore, PTHrP has been demonstrated to cause tumour cell death both in vitro and in vivo. Apo2L/TRAIL is a promising new anti-cancer agent, due to its ability to selectively induce apoptosis in cancer cells whilst sparing most normal cells. However, some cancer cells are resistant to Apo2L/TRAIL-induced apoptosis thus limiting its therapeutic efficacy. The effects of PTHrP on cell death signalling pathways initiated by Apo2L/TRAIL were investigated in breast cancer cells. Expression of PTHrP in Apo2L/TRAIL resistant cell line MCF-7 sensitised these cells to Apo2L/TRAIL-induced apoptosis. The actions of PTHrP resulted from intracellular effects, since exogenous treatment of PTHrP had no effect on Apo2L/TRAIL-induced apoptosis. Apo2L/TRAIL-induced apoptosis in PTHrP expressing cells occurred through the activation of caspase-10 resulting in caspase-9 activation and induction of apoptosis through the effector caspases, caspase-6 and -7. PTHrP increased cell surface expression of Apo2L/TRAIL death receptors, TRAIL-R1 and TRAIL-R2. Antagonistic antibodies against the death receptors demonstrated that Apo2L/TRAIL mediated its apoptotic signals through activation of the TRAIL-R2 in PTHrP expressing breast cancer cells. These studies reveal a novel role for PTHrP with Apo2L/TRAIL that maybe important for future diagnosis and treatment of breast cancer.	[Cheung, Vanessa; Bouralexis, Steve; Gillespie, Matthew T.] Prince Henrys Inst, Bone Joint & Canc Unit, Melbourne, Vic, Australia; [Gillespie, Matthew T.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Monash University	Gillespie, MT (corresponding author), Prince Henrys Inst, Bone Joint & Canc Unit, Melbourne, Vic, Australia.	matthew.gillespie@princehenrys.org		Gillespie, Matthew/0000-0001-6543-8909	National Health and Medical Research Council, Australia [345401, GNT448338]; Cancer Council Victoria and National Breast Cancer Research Foundation; Victorian Government Operational Infrastructure Support Program	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria and National Breast Cancer Research Foundation(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government Operational Infrastructure Support Program	This work was supported by a Program Grant (345401, M.T.G.) and Scholarship GNT448338 (V.C.) of the National Health and Medical Research Council, Australia, Project Grants from the Cancer Council Victoria and National Breast Cancer Research Foundation, and the Victorian Government Operational Infrastructure Support Program. PHI data audit # 13-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; BOUIZAR Z, 1993, CANCER RES, V53, P5076; BUNDRED NJ, 1992, EUR J CANCER, V28A, P690, DOI 10.1016/S0959-8049(05)80127-3; Butler LM, 2006, INT J CANCER, V119, P944, DOI 10.1002/ijc.21939; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Falzon M, 2000, ENDOCRINOLOGY, V141, P1882, DOI 10.1210/en.141.5.1882; Foley J, 2001, DEVELOPMENT, V128, P513; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Henderson MA, 2001, JNCI-J NATL CANCER I, V93, P234, DOI 10.1093/jnci/93.3.234; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Labrinidis A, 2009, CLIN CANCER RES, V15, P1998, DOI 10.1158/1078-0432.CCR-08-2444; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Lam MHC, 1999, J BIOL CHEM, V274, P18559, DOI 10.1074/jbc.274.26.18559; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Luparello C, 2001, J BONE MINER RES, V16, P2173, DOI 10.1359/jbmr.2001.16.12.2173; Luparello C, 2007, BREAST CANC RES TREA; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Marini P, 2006, ONCOGENE, V25, P5145, DOI 10.1038/sj.onc.1209516; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Martin TJ, 2000, ENDOCR-RELAT CANCER, V7, P271, DOI 10.1677/erc.0.0070271; MOSELEY JM, 1995, CRIT REV CL LAB SCI, V32, P299, DOI 10.3109/10408369509084687; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Okoumassoun LE, 2007, J CELL PHYSIOL, V212, P591, DOI 10.1002/jcp.21055; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; POWELL GJ, 1991, CANCER RES, V51, P3059; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Singh TR, 2003, CANCER RES, V63, P5390; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Thai L, 2006, CANCER RES, V66, P5363, DOI 10.1158/0008-5472.CAN-05-4386; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Winter MC, 2009, CURR OPIN ONCOL, V21, P499, DOI 10.1097/CCO.0b013e328331c794; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; WYSOLMERSKI JJ, 1995, DEVELOPMENT, V121, P3539; Ye YM, 2001, REGUL PEPTIDES, V99, P169, DOI 10.1016/S0167-0115(01)00248-8	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66343	10.1371/journal.pone.0066343	http://dx.doi.org/10.1371/journal.pone.0066343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822995	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400091
J	Dottorini, T; Palladino, P; Senin, N; Persampieri, T; Spaccapelo, R; Crisanti, A				Dottorini, Tania; Palladino, Pietro; Senin, Nicola; Persampieri, Tania; Spaccapelo, Roberta; Crisanti, Andrea			CluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data	PLOS ONE			English	Article							REED-STERNBERG CELLS; ACCESSORY-GLAND GENES; B-CELL; IMMUNOGLOBULIN TRANSCRIPTION; NEIGHBORING GENES; BINDING SITES; MICE LACKING; GENOME; CLUSTERS; HODGKIN	The full understanding of the mechanisms underlying transcriptional regulatory networks requires unravelling of complex causal relationships. Genome high-throughput technologies produce a huge amount of information pertaining gene expression and regulation; however, the complexity of the available data is often overwhelming and tools are needed to extract and organize the relevant information. This work starts from the assumption that the observation of co-occurrent events (in particular co-localization, co-expression and co-regulation) may provide a powerful starting point to begin unravelling transcriptional regulatory networks. Co-expressed genes often imply shared functional pathways; co-expressed and functionally related genes are often co-localized, too; moreover, co-expressed and co-localized genes are also potential targets for co-regulation; finally, co-regulation seems more frequent for genes mapped to proximal chromosome regions. Despite the recognized importance of analysing co-occurrent events, no bioinformatics solution allowing the simultaneous analysis of co-expression, co-localization and co-regulation is currently available. Our work resulted in developing and valuating CluGene, a software providing tools to analyze multiple types of co-occurrences within a single interactive environment allowing the interactive investigation of combined co-expression, co-localization and co-regulation of genes. The use of CluGene will enhance the power of testing hypothesis and experimental approaches aimed at unravelling transcriptional regulatory networks. The software is freely available at http://bioinfolab.unipg.it/.	[Dottorini, Tania; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London, England; [Palladino, Pietro; Persampieri, Tania; Spaccapelo, Roberta; Crisanti, Andrea] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Senin, Nicola] Univ Perugia, Dept Ind Engn, I-06100 Perugia, Italy	Imperial College London; University of Perugia; University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London, England.	acrs@imperial.ac.uk	senin, nicola/B-5292-2016	senin, nicola/0000-0002-9556-0363; Spaccapelo, Roberta/0000-0003-2100-6172; Dottorini, Tania/0000-0001-7733-906X; Crisanti, Andrea/0000-0002-2406-4426	European Union [PIEF-GA-2010-273268]; acronym Vectrap [218164]; acronym FIGHTMAL	European Union(European Commission); acronym Vectrap; acronym FIGHTMAL	This work was supported by the European Union, [PIEF-GA-2010-273268], acronym Vectrap and [218164], acronym FIGHTMAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Browne P, 2003, AM J CLIN PATHOL, V120, P767, DOI 10.1309/YCH8DWUFFQBKGPVB; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dai Z, 2011, NUCL ACIDS RES; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Dottorini T, 2013, FASEB J, V27, P86, DOI 10.1096/fj.12-219444; Dottorini T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-34; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ester M., 1996, KDD, V96, P226; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Flenghi L, 1996, AM J PATHOL, V148, P1543; Foss HD, 1999, BLOOD, V94, P3108, DOI 10.1182/blood.V94.9.3108.421a21_3108_3113; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Hamada T, 1998, BRIT J HAEMATOL, V102, P691; Hamerly G, 2002, ALTERNATIVES K MEANS; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; He X, 2005, J COMPUT BIOL, V12, P638, DOI 10.1089/cmb.2005.12.638; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Janga SC, 2008, P NATL ACAD SCI USA, V105, P15761, DOI 10.1073/pnas.0806317105; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence JG, 2002, CELL, V110, P407, DOI 10.1016/S0092-8674(02)00900-5; Li Q, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-7; Ling X, 2009, BIOINFORMATICS, V25, P571, DOI 10.1093/bioinformatics/btp027; Luc N, 2003, COMPUT BIOL CHEM, V27, P59, DOI 10.1016/S1476-9271(02)00097-X; Magnusson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021572; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; McCune RC, 2006, MODERN PATHOL, V19, P1010, DOI 10.1038/modpathol.3800622; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Re D, 2001, CANCER RES, V61, P2080; Saez AI, 2002, MODERN PATHOL, V15, P211, DOI 10.1038/modpathol.3880518; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Starczynowski DT, 2007, ONCOGENE, V26, P2685, DOI 10.1038/sj.onc.1210089; Stein H, 2001, BLOOD, V97, P496, DOI 10.1182/blood.V97.2.496; STORMO GD, 1990, METHOD ENZYMOL, V183, P211; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Theil J, 2001, BLOOD, V97, P3191, DOI 10.1182/blood.V97.10.3191; Thieblemont C, 2004, BLOOD, V103, P2727, DOI 10.1182/blood-2003-06-2160; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Torlakovic E, 2001, AM J PATHOL, V159, P1807, DOI 10.1016/S0002-9440(10)63027-1; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wasserman WW, 2003, NATURWISSENSCHAFTEN, V90, P156, DOI 10.1007/s00114-003-0409-4; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104	74	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66196	10.1371/journal.pone.0066196	http://dx.doi.org/10.1371/journal.pone.0066196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823315	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400068
J	Foltz, JL; Makumbi, I; Sejvar, JJ; Malimbo, M; Ndyomugyenyi, R; Atai-Omoruto, AD; Alexander, LN; Abang, B; Melstrom, P; Kakooza, AM; Olara, D; Downing, RG; Nutman, TB; Dowell, SF; Lwamafa, DKW				Foltz, Jennifer L.; Makumbi, Issa; Sejvar, James J.; Malimbo, Mugagga; Ndyomugyenyi, Richard; Atai-Omoruto, Anne Deborah; Alexander, Lorraine N.; Abang, Betty; Melstrom, Paul; Kakooza, Angelina M.; Olara, Dennis; Downing, Robert G.; Nutman, Thomas B.; Dowell, Scott F.; Lwamafa, D. K. W.			An Epidemiologic Investigation of Potential Risk Factors for Nodding Syndrome in Kitgum District, Uganda	PLOS ONE			English	Article							CLINICAL CLASSIFICATION; ONCHOCERCA-VOLVULUS; EPILEPSY	Introduction: Nodding Syndrome (NS), an unexplained illness characterized by spells of head bobbing, has been reported in Sudan and Tanzania, perhaps as early as 1962. Hypothesized causes include sorghum consumption, measles, and onchocerciasis infection. In 2009, a couple thousand cases were reportedly in Northern Uganda. Methods: In December 2009, we identified cases in Kitgum District. The case definition included persons who were previously developmentally normal who had nodding. Cases, further defined as 5- to 15-years-old with an additional neurological deficit, were matched to village controls to assess risk factors and test biological specimens. Logistic regression models were used to evaluate associations. Results: Surveillance identified 224 cases; most (95%) were 5-15-years-old (range = 2-27). Cases were reported in Uganda since 1997. The overall prevalence was 12 cases per 1,000 (range by parish = 0.6-46). The case-control investigation (n = 49 case/village control pairs) showed no association between NS and previously reported measles; sorghum was consumed by most subjects. Positive onchocerciasis serology [age-adjusted odds ratio (AOR(1)) = 14.4 (2.7, 78.3)], exposure to munitions [AOR(1)= 13.9 (1.4, 135.3)], and consumption of crushed roots [AOR(1)= 5.4 (1.3, 22.1)] were more likely in cases. Vitamin B6 deficiency was present in the majority of cases (84%) and controls (75%). Conclusion: NS appears to be increasing in Uganda since 2000 with 2009 parish prevalence as high as 46 cases per 1,000 5 to 15-year old children. Our results found no supporting evidence for many proposed NS risk factors, revealed association with onchocerciasis, which for the first time was examined with serologic testing, and raised nutritional deficiencies and toxic exposures as possible etiologies.	[Foltz, Jennifer L.] Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Atlanta, GA 30333 USA; [Makumbi, Issa; Malimbo, Mugagga; Ndyomugyenyi, Richard; Atai-Omoruto, Anne Deborah; Lwamafa, D. K. W.] Uganda Minist Hlth, Kampala, Uganda; [Sejvar, James J.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Alexander, Lorraine N.; Abang, Betty; Olara, Dennis; Downing, Robert G.] Centers Dis Control & Prevent Uganda, Div Global HIV AIDS, Entebbe, Uganda; [Melstrom, Paul] Ctr Dis Control & Prevent, Div Environm Hazards & Hlth Effects, Atlanta, GA USA; [Kakooza, Angelina M.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Nutman, Thomas B.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Dowell, Scott F.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Makerere University; National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Foltz, JL (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Atlanta, GA 30333 USA.	jfoltz@cdc.gov			CDC; WHO; MoH Uganda for public health investigations; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000439, ZIAAI000512] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); WHO(World Health Organization); MoH Uganda for public health investigations; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The investigation was supported with resources available from CDC, WHO, and MoH Uganda for public health investigations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALLJILEK LM, 1965, ACTA PSYCHIAT SCAND, V41, P57, DOI 10.1111/j.1600-0447.1965.tb04970.x; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; [Anonymous], 2010, 2008 UGANDA FOOD CON; Bauernfeind J, 1978, HUMAN VITAMIN B6 REQ; Baxter P, 2001, DEV MED CHILD NEUROL, V43, P416, DOI 10.1017/S0012162201000779; BEG MA, 1995, PARASITOLOGY, V111, P111, DOI 10.1017/S0031182000064660; Burbelo PD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000438; COURSIN DB, 1954, JAMA-J AM MED ASSOC, V154, P406, DOI 10.1001/jama.1954.02940390030009; Food and Nutrition Board, 1998, DIET REF INT THIAM R, P150; GERRITS C, 1983, LANCET, V1, P358; GRABOW JD, 1969, AM J CLIN NUTR, V22, P1429; Kaiser C, 2000, B SOC PATHOL EXOT, V93, P255; Kaiser C, 2009, EPILEPSIA, V50, P2325, DOI 10.1111/j.1528-1167.2009.02280.x; Konig R, 2010, PARASITOLOGY, V137, P1559, DOI 10.1017/S0031182010000338; KRETSCH MJ, 1991, AM J CLIN NUTR, V53, P1266, DOI 10.1093/ajcn/53.5.1266; Lacey M, 2003, LANCET NEUROL, V2, P714, DOI 10.1016/S1474-4422(03)00599-4; Nyungura JL, 2010, SO SUDAN MED J, V4, P3; Pearlman Eric, 2007, Chem Immunol Allergy, V92, P254, DOI 10.1159/000099276; Pion SDS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000461; Prost A., 1978, Medecine Tropicale, V38, P519; Reik Lul, 2012, Morbidity and Mortality Weekly Report, V61, P52; Rybak ME, 2004, ANAL BIOCHEM, V333, P336, DOI 10.1016/j.ab.2004.06.036; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Tumwine JK, 2012, AFR HEALTH SCI, V12, P242, DOI 10.4314/ahs.v12i3.1; van der Waals FW, 1983, NEUROEPIDEMIOLOGY, V2, P35, DOI DOI 10.1159/000110508; Winkler AS, 2010, TROP DOCT, V40, P173, DOI 10.1258/td.2010.090373; Winkler AS, 2008, EPILEPSIA, V49, P2008, DOI 10.1111/j.1528-1167.2008.01671.x	27	73	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66419	10.1371/journal.pone.0066419	http://dx.doi.org/10.1371/journal.pone.0066419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823012	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400106
J	Larsen, MH; Albrechtsen, A; Thorner, LW; Werge, T; Hansen, T; Gether, U; Haastrup, E; Ullum, H				Larsen, Margit Horup; Albrechtsen, Anders; Thorner, Lise Wegner; Werge, Thomas; Hansen, Thomas; Gether, Ulrik; Haastrup, Eva; Ullum, Henrik			Genome-Wide Association Study of Genetic Variants in LPS-Stimulated IL-6, IL-8, IL-10, IL-1ra and TNF-alpha Cytokine Response in a Danish Cohort	PLOS ONE			English	Article								Background: Cytokine response plays a vital role in various human lipopolysaccharide (LPS) infectious and inflammatory diseases. This study aimed to find genetic variants that might affect the levels of LPS-induced interleukin (IL)-6, IL-8, IL-10, IL-1ra and tumor necrosis factor (TNF)-alpha cytokine production. Methods: We performed an initial genome-wide association study using Affymetrix Human Mapping 500 K GeneChip (R) to screen 130 healthy individuals of Danish descent. The levels of IL-6, IL-8, IL-10, IL-1r alpha and TNF-alpha in 24-hour LPS-stimulated whole blood samples were compared within different genotypes. The 152 most significant SNPs were replicated using Illumina Golden Gate (R) GeneChip in an independent cohort of 186 Danish individuals. Next, 9 of the most statistical significant SNPs were replicated using PCR-based genotyping in an independent cohort of 400 Danish individuals. All results were analyzed in a combined study among the 716 Danish individuals. Results: Only one marker of the 500 K Gene Chip in the discovery study showed a significant association with LPS-induced IL-1ra cytokine levels after Bonferroni correction (P, 10 27). However, this SNP was not associated with the IL-1ra cytokine levels in the replication dataset. No SNPs reached genome-wide significance for the five cytokine levels in the combined analysis of all three stages. Conclusions: The associations between the genetic variants and the LPS-induced IL-6, IL-8, IL-10, IL-1ra and TNF-alpha cytokine levels were not significant in the meta-analysis. This present study does not support a strong genetic effect of LPS-stimulated cytokine production; however, the potential for type II errors should be considered.	[Larsen, Margit Horup; Thorner, Lise Wegner; Haastrup, Eva; Ullum, Henrik] Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark; [Albrechtsen, Anders] Univ Copenhagen, Ctr Bioinformat, Copenhagen, Denmark; [Werge, Thomas; Hansen, Thomas] Copenhagen Univ Hosp, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Roskilde, Denmark; [Gether, Ulrik] Univ Copenhagen, Mol Neuropharmacol & Genet Lab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Larsen, MH (corresponding author), Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark.	margit.anita.hoerup.larsen@regionh.dk	Hansen, Thomas Folkmann/O-5965-2014; Albrechtsen, Anders/K-4281-2013; Hansen, Thomas/GWZ-2858-2022	Hansen, Thomas Folkmann/0000-0001-6703-7762; Albrechtsen, Anders/0000-0001-7306-031X; Thorner, Lise Wegner/0000-0003-4391-4956; Ullum, Henrik/0000-0001-7306-9058; Gether, Ulrik/0000-0002-0020-3807	Copenhagen University Hospital, Rigshospitalet; Center for Pharmacogenomics Copenhagen University; Villum Fonden [00007171] Funding Source: researchfish	Copenhagen University Hospital, Rigshospitalet; Center for Pharmacogenomics Copenhagen University; Villum Fonden(Villum Fonden)	This study was supported by grants from the Copenhagen University Hospital, Rigshospitalet; Center for Pharmacogenomics Copenhagen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; Huang H, 2012, IMMUNOGENETICS, V64, P351; Martin TR, 1997, AM J RESP CRIT CARE, V155, P937, DOI 10.1164/ajrccm.155.3.9117029; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006	5	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66262	10.1371/journal.pone.0066262	http://dx.doi.org/10.1371/journal.pone.0066262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823136	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400074
J	Rai, S; Mahapatra, B; Sircar, S; Raj, PY; Venkatesh, S; Shaukat, M; Rewari, BB				Rai, Sandeep; Mahapatra, Bidhubhusan; Sircar, Subhashish; Raj, Pinnamaneni Yujwal; Venkatesh, Srinivasan; Shaukat, Mohammed; Rewari, Bharat Bhusan			Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; MORTALITY; ADULTS; CARE; OUTCOMES; PREDICTORS; RETENTION; BARRIERS; FAILURE; PROGRAM	Introduction: Research in India has extensively examined the factors associated with non-adherence to antiretroviral therapy (ART) with limited focus on examining the relationship between adherence to ART regimen and survival status of HIV infected patients. This study examines the effect of optimal adherence to ART on survival status of HIV infected patients attending ART centers in Jharkhand, India. Materials and Methods: Data from a cohort of 239 HIV infected individuals who were initiated ART in 2007 were compiled from medical records retrospectively for 36 months. Socio-demographic characteristics, CD4 T cell count, presence of opportunistic infections at the time of ART initiation and ART regimen intake and survival status was collected periodically. Optimal adherence was assessed using pill count methods; patients who took <95% of the specified regimens were identified as non-adherent. Cox-proportional hazard model was used to determine the relative hazards of mortality. Results: More than three-fourths of the patients were male, on an average 34 year old and median CD4 T cell count was 118 cells/cmm at the time of ART registration. About 57% of the patients registered for ART were found to be adherent to ART. A total of 104 patients died in 358.5 patient-years of observation resulting in a mortality rate of 29 per 100 patient-years (95% confidence interval (CI): 23.9-35.2) and median survival time of 6.5 months (CI: 2.7-10.9). The mortality rate was higher among patients who were non-adherent to ART (64.5, CI: 50.5-82.4) than who were adherent (15.4, CI: 11.3-21.0). The risk of mortality was fourfold higher among individuals who were non-adherent to ART than who were adherent (Adjusted hazard ratio: 3.9, CI: 2.6-6.0). Conclusion: Adherence to ART is associated with a higher chance of survival of HIV infected patients, ascertaining the need for interventions to improve the ART adherence and early initiation of ART.	[Rai, Sandeep; Sircar, Subhashish] Jharkhand & Bihar State AIDS Control Soc, Ranchi, Bihar, India; [Mahapatra, Bidhubhusan] Populat Council, HIV & AIDS Program, New Delhi, India; [Raj, Pinnamaneni Yujwal; Venkatesh, Srinivasan; Shaukat, Mohammed; Rewari, Bharat Bhusan] Govt India, Natl AIDS Control Org, Dept AIDS Control, Minist Hlth & Family Welf, New Delhi, India		Mahapatra, B (corresponding author), Populat Council, HIV & AIDS Program, New Delhi, India.	bbmahapatra@popcouncil.org	RAJ, PROFESSORDES/AAA-1007-2020; Mahapatra, Bidhubhusan/M-1411-2019; Rai, Dr Sandeep/AAX-3363-2021	RAJ, PROFESSORDES/0000-0002-4050-4778; Mahapatra, Bidhubhusan/0000-0003-0240-7026; 	Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative	Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative(Bill & Melinda Gates FoundationGates Foundation India)	This paper was written as part of the Knowledge Network project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan. We are also thankful to the national AIDS control organization (NACO) and Jharkhand state AIDS control society (JSACS) for providing the necessary approval to use of the patients medical records. The views expressed in this publication are those of the authors and do not necessarily reflect those of the NACO and JSACS.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Arrivillaga M, 2009, REV PANAM SALUD PUBL, V26, P502, DOI 10.1590/S1020-49892009001200005; Bachani D, 2010, NATL MED J INDIA, V23, P7; Batavia AS, 2010, AIDS BEHAV, V14, P794, DOI 10.1007/s10461-009-9663-6; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chan KCW, 2002, AIDS, V16, P1693, DOI 10.1097/00002030-200208160-00020; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Ghate M, 2011, INDIAN J MED RES, V133, P414; Gonzalez MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-605; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Joglekar N, 2011, INDIAN J MED RES, V134, P954, DOI 10.4103/0971-5916.92642; Kumarasamy N, 2005, CLIN INFECT DIS, V41, P1525, DOI 10.1086/497267; Kunutsor S, 2010, JAIDS-J ACQ IMM DEF, V55, P221, DOI 10.1097/QAI.0b013e3181e255ec; Lal Vivek, 2010, Indian J Public Health, V54, P179, DOI 10.4103/0019-557X.77256; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Minzi O M S, 2008, Tanzan J Health Res, V10, P84; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; National AIDS Control Organisation (NACO), 2011, NAT AIDS CONTR PROGR; Rajasekaran S, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000279706.24428.78; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Sahay S, 2011, INDIAN J MED RES, V134, P835, DOI 10.4103/0971-5916.92629; Sogarwal Ruchi, 2009, J Indian Med Assoc, V107, P276; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Teja Vijay Dharma, 2007, Indian J Med Sci, V61, P555; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Wagner JH, 2001, J CLIN EPIDEMIOL, V54, pS91, DOI 10.1016/S0895-4356(01)00450-4; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	36	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66860	10.1371/journal.pone.0066860	http://dx.doi.org/10.1371/journal.pone.0066860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825577	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400162
J	Sheehy, SH; Spencer, AJ; Douglas, AD; Sim, BKL; Longley, RJ; Edwards, NJ; Poulton, ID; Kimani, D; Williams, AR; Anagnostou, NA; Roberts, R; Kerridge, S; Voysey, M; James, ER; Billingsley, PF; Gunasekera, A; Lawrie, AM; Hoffman, SL; Hill, AVS				Sheehy, Susanne H.; Spencer, Alexandra J.; Douglas, Alexander D.; Sim, B. Kim Lee; Longley, Rhea J.; Edwards, Nick J.; Poulton, Ian D.; Kimani, Domtila; Williams, Andrew R.; Anagnostou, Nicholas A.; Roberts, Rachel; Kerridge, Simon; Voysey, Merryn; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Lawrie, Alison M.; Hoffman, Stephen L.; Hill, Adrian V. S.			Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe	PLOS ONE			English	Article							BLOOD-STAGE ANTIGEN; T-CELLS RECOGNIZE; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; SPOROZOITE VACCINE; CHALLENGE; PROTECTION; EPITOPES; SURFACE; CANDIDATE	Background: Controlled human malaria infection (CHMI) studies have become a routine tool to evaluate efficacy of candidate anti-malarial drugs and vaccines. To date, CHMI trials have mostly been conducted using the bite of infected mosquitoes, restricting the number of trial sites that can perform CHMI studies. Aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) provide a potentially more accurate, reproducible and practical alternative, allowing a known number of sporozoites to be administered simply by injection. Methodology: We sought to assess the infectivity of PfSPZ Challenge administered in different dosing regimens to malaria-naive healthy adults (n = 18). Six participants received 2,500 sporozoites intradermally (ID), six received 2,500 sporozoites intramuscularly (IM) and six received 25,000 sporozoites IM. Findings: Five out of six participants receiving 2,500 sporozoites ID, 3/6 participants receiving 2,500 sporozoites IM and 6/6 participants receiving 25,000 sporozoites IM were successfully infected. The median time to diagnosis was 13.2, 17.8 and 12.7 days for 2,500 sporozoites ID, 2,500 sporozoites IM and 25,000 sporozoites IM respectively (Kaplan Meier method; p = 0.024 log rank test). Conclusions: 2,500 sporozoites ID and 25,000 sporozoites IM have similar infectivities. Given the dose response in infectivity seen with IM administration, further work should evaluate increasing doses of PfSPZ Challenge IM to identify a dosing regimen that reliably infects 100% of participants.	[Sheehy, Susanne H.; Poulton, Ian D.; Anagnostou, Nicholas A.; Roberts, Rachel; Kerridge, Simon; Lawrie, Alison M.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Sheehy, Susanne H.; Spencer, Alexandra J.; Douglas, Alexander D.; Longley, Rhea J.; Edwards, Nick J.; Williams, Andrew R.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford, England; [Sim, B. Kim Lee; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Kimani, Domtila] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Voysey, Merryn] Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford; Sanaria Inc.; Kenya Medical Research Institute; University of Oxford	Sheehy, SH (corresponding author), Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England.	susanne.sheehy@ndm.ox.ac.uk	Williams, Andrew R/A-3057-2013; Longley, Rhea J/C-9573-2018; Spencer, Alexandra/AAE-6494-2019; Douglas, Alexander/E-7040-2012	Williams, Andrew R/0000-0002-8231-282X; Longley, Rhea J/0000-0002-4510-5602; Spencer, Alexandra/0000-0001-7958-6961; Douglas, Alexander/0000-0002-5410-7562; Hodgson, Susanne/0000-0002-0895-3442; Edwards, Nick/0000-0002-7030-7839; Voysey, Merryn/0000-0001-6324-6559	United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre [A91301]; Wellcome Trust [084113/Z/07/Z, 089455/2/09/Z, 45488/Z/05, 097940/Z/11/Z]; National Institute of Allergy and Infectious Disease [R44AI058375]; National Institute for Health Research Academic Clinical Fellow; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI058375] Funding Source: NIH RePORTER	United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Health Research Academic Clinical Fellow; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre (http://www.oxfordbrc.org/) [A91301 Adult Vaccine], and the Wellcome Trust (http://www.wellcome.ac.uk/) [084113/Z/07/Z]. Funding for manufacture, quality control release and stability studies of Sanaria's PfSPZ Challenge was provided by the National Institute of Allergy and Infectious Disease (http://www.niaid.nih.gov) [R44AI058375] 'Universal Attenuated Malaria Sporozoite Vaccine and Challenge System.' SHS holds a Wellcome Trust research training fellowship (097940/Z/11/Z). ADD recently held a Wellcome Trust research training fellowship (089455/2/09/Z) and is currently an National Institute for Health Research Academic Clinical Fellow. AVSH holds a Wellcome Trust Principal Research Fellowship (45488/Z/05) and is a Jenner Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2000, INFECT IMMUN, V68, P227, DOI 10.1128/IAI.68.1.227-232.2000; BEIER JC, 1991, MED VET ENTOMOL, V5, P71, DOI 10.1111/j.1365-2915.1991.tb00523.x; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; CASPERS P, 1991, MOL BIOCHEM PARASIT, V47, P143, DOI 10.1016/0166-6851(91)90173-4; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-168; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Douglas AD, 2013, J INFECT DIS; Elias SC, 2012, MOL THER; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; FIDOCK DA, 1994, MOL BIOCHEM PARASIT, V64, P219, DOI 10.1016/0166-6851(94)00012-3; Flanagan KL, 2003, AM J TROP MED HYG, V68, P421, DOI 10.4269/ajtmh.2003.68.421; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOPE IA, 1984, NATURE, V308, P191, DOI 10.1038/308191a0; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; MOELANS IIMD, 1991, MOL BIOCHEM PARASIT, V45, P193, DOI 10.1016/0166-6851(91)90086-L; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; Moxon R, 2005, MICROBIAL CHALLENGE; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Perlaza BL, 2008, EUR J IMMUNOL, V38, P2610, DOI 10.1002/eji.200738055; Ploemen I. H., 2012, VACCINE; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Roestenberg M, 2012, AM J TROP MED HYG; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Sauzet JP, 2001, INFECT IMMUN, V69, P1202, DOI 10.1128/IAI.69.2.1202-1206.2001; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; Vignali M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-211; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; WIZEL B, 1995, J IMMUNOL, V155, P766	52	67	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65960	10.1371/journal.pone.0065960	http://dx.doi.org/10.1371/journal.pone.0065960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823332	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400040
J	Tang, XY; Oishi, K; Faria, AV; Hillis, AE; Albert, MS; Mori, S; Miller, MI				Tang, Xiaoying; Oishi, Kenichi; Faria, Andreia V.; Hillis, Argye E.; Albert, Marilyn S.; Mori, Susumu; Miller, Michael I.			Bayesian Parameter Estimation and Segmentation in the Multi-Atlas Random Orbit Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; IMAGE SEGMENTATION; WHITE-MATTER; HUMAN BRAIN; MR-IMAGES; ANATOMICAL STRUCTURES; PROBABILISTIC ATLAS; SHAPE MODEL; HIPPOCAMPAL; FRAMEWORK	This paper examines the multiple atlas random diffeomorphic orbit model in Computational Anatomy (CA) for parameter estimation and segmentation of subcortical and ventricular neuroanatomy in magnetic resonance imagery. We assume that there exist multiple magnetic resonance image (MRI) atlases, each atlas containing a collection of locally-defined charts in the brain generated via manual delineation of the structures of interest. We focus on maximum a posteriori estimation of high dimensional segmentations of MR within the class of generative models representing the observed MRI as a conditionally Gaussian random field, conditioned on the atlas charts and the diffeomorphic change of coordinates of each chart that generates it. The charts and their diffeomorphic correspondences are unknown and viewed as latent or hidden variables. We demonstrate that the expectation-maximization (EM) algorithm arises naturally, yielding the likelihood-fusion equation which the a posteriori estimator of the segmentation labels maximizes. The likelihoods being fused are modeled as conditionally Gaussian random fields with mean fields a function of each atlas chart under its diffeomorphic change of coordinates onto the target. The conditional-mean in the EM algorithm specifies the convex weights with which the chartspecific likelihoods are fused. The multiple atlases with the associated convex weights imply that the posterior distribution is a multi-modal representation of the measured MRI. Segmentation results for subcortical and ventricular structures of subjects, within populations of demented subjects, are demonstrated, including the use of multiple atlases across multiple diseased groups.	[Tang, Xiaoying; Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD 21218 USA; [Oishi, Kenichi; Faria, Andreia V.; Mori, Susumu] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Hillis, Argye E.; Albert, Marilyn S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Cognit Sci, Baltimore, MD USA; [Albert, Marilyn S.] Johns Hopkins Alzheimers Dis Res Ctr, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Miller, MI (corresponding author), Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD 21218 USA.	mim@cis.jhu.edu	Oishi, Kenichi/H-1371-2013	Oishi, Kenichi/0000-0002-1200-8611	National Institutes of Health (NIH) [RO1AG020012]; NIBIB/NIH [R01 DC011317, R01 EB000975, P41 EB015909, R01 EB008171, R01 HD065955, R21AG033774, U01 AG033655, R03EB04357]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065955] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017638, P41EB015909, R03EB014357, R01EB000975, R01EB008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033774, U01AG033655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011317, R01DC003681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is partially supported by National Institutes of Health (NIH) RO1AG020012, R03EB04357 from NIBIB/NIH, R01 DC011317, R01 EB000975, P41 EB015909, R01 EB008171, R01 HD065955, R21AG033774, and U01 AG033655. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Allassonniere S, 2007, J R STAT SOC B, V69, P3; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Asman AJ, 2012, IEEE T MED IMAGING, V31, P1326, DOI 10.1109/TMI.2012.2190992; Awate SP, 2007, LECT NOTES COMPUT SC, V4584, P296; Baillard C, 2000, LECT NOTES COMPUT SC, V1935, P236; Baillard C, 2001, MED IMAGE ANAL, V5, P185, DOI 10.1016/S1361-8415(01)00039-1; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; BAJCSY R, 1989, COMPUT VISION GRAPH, V46, P1, DOI 10.1016/S0734-189X(89)80014-3; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Boothby W. M., 1986, INTRO DIFFERENTIABLE; Carmichael OT, 2005, NEUROIMAGE, V27, P979, DOI 10.1016/j.neuroimage.2005.05.005; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Christensen GE, 1997, IEEE T MED IMAGING, V16, P864, DOI 10.1109/42.650882; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; COOTES TF, 1994, IMAGE VISION COMPUT, V12, P355, DOI 10.1016/0262-8856(94)90060-4; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Crum WR, 2001, NEUROIMAGE, V13, P847, DOI 10.1006/nimg.2001.0744; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drury HA, 1996, J COGNITIVE NEUROSCI, V8, P1, DOI 10.1162/jocn.1996.8.1.1; Dubes R. C., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P808, DOI 10.1109/ICPR.1990.118221; Dupuis P, 1998, Q APPL MATH, V56, P587, DOI 10.1090/qam/1632326; Duta N, 1998, IEEE T MED IMAGING, V17, P1049, DOI 10.1109/42.746716; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Glaunes J, 2005, SURFACE MATCHING VIA, V3565, P1; Grenander U, 1998, Q APPL MATH, V56, P617, DOI 10.1090/qam/1668732; Grenander U., 1993, GEN PATTERN THEORY; Haller JW, 1997, RADIOLOGY, V202, P504, DOI 10.1148/radiology.202.2.9015081; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Han X, 2003, IEEE T PATTERN ANAL, V25, P755, DOI 10.1109/TPAMI.2003.1201824; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Hogan RE, 2000, RADIOLOGY, V216, P291, DOI 10.1148/radiology.216.1.r00jl41291; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kittler J, 2003, IEEE T PATTERN ANAL, V25, P110, DOI 10.1109/TPAMI.2003.1159950; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Ma J, 2008, NEUROIMAGE, V42, P252, DOI 10.1016/j.neuroimage.2008.03.056; Ma J, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/974957; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Miller MI, 2006, J MATH IMAGING VIS, V24, P209, DOI 10.1007/s10851-005-3624-0; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; Miller MI, 2002, ANNU REV BIOMED ENG, V4, P375, DOI 10.1146/annurev.bioeng.4.092101.125733; Miller MI, 2001, INT J COMPUT VISION, V41, P61, DOI 10.1023/A:1011161132514; Mitchell SC, 2001, IEEE T MED IMAGING, V20, P415, DOI 10.1109/42.925294; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Paragios N, 2003, IEEE T MED IMAGING, V22, P773, DOI 10.1109/TMI.2003.814785; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Priebe CE, 2006, COMPUT STAT DATA AN, V50, P551, DOI 10.1016/j.csda.2004.09.003; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Shen DG, 2001, IEEE T MED IMAGING, V20, P257, DOI 10.1109/42.921475; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang Xu, 2012, Microcomputer Information, P123; Trouve A, 1995, INFINITE DI IN PRESS; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P924, DOI 10.1109/TMI.2002.803121; van Rikxoort EM, 2010, MED IMAGE ANAL, V14, P39, DOI 10.1016/j.media.2009.10.001; VANCAMPENHOUT JM, 1981, IEEE T INFORM THEORY, V27, P483, DOI 10.1109/TIT.1981.1056374; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Warfield S, 1999, BRAIN WARPING, V4, P67; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yang J, 2004, MED IMAGE ANAL, V8, P285, DOI 10.1016/j.media.2004.06.008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	89	111	113	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65591	10.1371/journal.pone.0065591	http://dx.doi.org/10.1371/journal.pone.0065591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824159	gold, Green Published			2022-12-25	WOS:000320576400012
J	Van Horn, DJ; Van Horn, ML; Barrett, JE; Gooseff, MN; Altrichter, AE; Geyer, KM; Zeglin, LH; Takacs-Vesbach, CD				Van Horn, David J.; Van Horn, M. Lee; Barrett, John E.; Gooseff, Michael N.; Altrichter, Adam E.; Geyer, Kevin M.; Zeglin, Lydia H.; Takacs-Vesbach, Cristina D.			Factors Controlling Soil Microbial Biomass and Bacterial Diversity and Community Composition in a Cold Desert Ecosystem: Role of Geographic Scale	PLOS ONE			English	Article							MCMURDO DRY VALLEYS; WRIGHT VALLEY; TAYLOR VALLEY; FUNGAL COMMUNITIES; GLOBAL PATTERNS; VICTORIA LAND; BIODIVERSITY; CLASSIFICATION; BIOGEOCHEMISTRY; GEOMORPHOLOGY	Understanding controls over the distribution of soil bacteria is a fundamental step toward describing soil ecosystems, understanding their functional capabilities, and predicting their responses to environmental change. This study investigated the controls on the biomass, species richness, and community structure and composition of soil bacterial communities in the McMurdo Dry Valleys, Antarctica, at local and regional scales. The goals of the study were to describe the relationships between abiotic characteristics and soil bacteria in this unique, microbially dominated environment, and to test the scale dependence of these relationships in a low complexity ecosystem. Samples were collected from dry mineral soils associated with snow patches, which are a significant source of water in this desert environment, at six sites located in the major basins of the Taylor and Wright Valleys. Samples were analyzed for a suite of characteristics including soil moisture, pH, electrical conductivity, soil organic matter, major nutrients and ions, microbial biomass, 16 S rRNA gene richness, and bacterial community structure and composition. Snow patches created local biogeochemical gradients while inter-basin comparisons encompassed landscape scale gradients enabling comparisons of microbial controls at two distinct spatial scales. At the organic carbon rich, mesic, low elevation sites Acidobacteria and Actinobacteria were prevalent, while Firmicutes and Proteobacteria were dominant at the high elevation, low moisture and biomass sites. Microbial parameters were significantly related with soil water content and edaphic characteristics including soil pH, organic matter, and sulfate. However, the magnitude and even the direction of these relationships varied across basins and the application of mixed effects models revealed evidence of significant contextual effects at local and regional scales. The results highlight the importance of the geographic scale of sampling when determining the controls on soil microbial community characteristics.	[Van Horn, David J.; Takacs-Vesbach, Cristina D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Van Horn, M. Lee] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Barrett, John E.; Altrichter, Adam E.; Geyer, Kevin M.] Virginia Technol Inst, Dept Biol Sci, Blacksburg, VA USA; [Gooseff, Michael N.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Zeglin, Lydia H.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	University of New Mexico; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oregon State University	Takacs-Vesbach, CD (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	cvesbach@unm.edu	Barrett, John/D-5851-2016; Gooseff, Michael N/N-6087-2015	Barrett, John/0000-0002-7610-0505; Gooseff, Michael N/0000-0003-4322-8315; Geyer, Kevin/0000-0002-5218-2745; Altrichter, Adam/0000-0002-8201-0346	NSF [0838879]; McMurdo LTER, NSF [1115245]; Office of Polar Programs (OPP) [0838850] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); McMurdo LTER, NSF; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by NSF OPP grant 0838879 to JEB, MNG, and CTV. Additional support was provided by the McMurdo LTER, NSF grant 1115245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Aislabie JM, 2008, GEODERMA, V144, P9, DOI 10.1016/j.geoderma.2007.10.006; Aislabie JM, 2006, SOIL BIOL BIOCHEM, V38, P3041, DOI 10.1016/j.soilbio.2006.02.018; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Babalola OO, 2009, ENVIRON MICROBIOL, V11, P566, DOI 10.1111/j.1462-2920.2008.01809.x; Bamforth SS, 2005, POLAR BIOL, V28, P756, DOI 10.1007/s00300-005-0006-4; Barrett JE, 2004, ECOLOGY, V85, P3105, DOI 10.1890/03-0213; Bockheim JG, 2008, ARCT ANTARCT ALP RES, V40, P279, DOI 10.1657/1523-0430(06-057)[BOCKHEIM]2.0.CO;2; Bockheim JG, 1997, SOIL SCI SOC AM J, V61, P224, DOI 10.2136/sssaj1997.03615995006100010031x; Burkins MB, 2001, GLOB CHANGE BIOL, V7, P113, DOI 10.1046/j.1365-2486.2001.00393.x; Burkins MB, 2000, ECOLOGY, V81, P2377, DOI 10.1890/0012-9658(2000)081[2377:OADOSO]2.0.CO;2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Clow GD, 1988, J CLIMATE, V1, P715, DOI 10.1175/1520-0442(1988)001<0715:COAPSR>2.0.CO;2; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Dequiedt S, 2009, ENV MICROBIOL REP, V1, P251, DOI 10.1111/j.1758-2229.2009.00040.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon JC, 2005, GEOMORPHOLOGY, V67, P127, DOI 10.1016/j.geomorph.2004.07.009; Doran PT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002045; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elberling B, 2006, SOIL BIOL BIOCHEM, V38, P3095, DOI 10.1016/j.soilbio.2005.12.011; Fell JW, 2006, SOIL BIOL BIOCHEM, V38, P3107, DOI 10.1016/j.soilbio.2006.01.014; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fountain AG, 2010, INT J CLIMATOL, V30, P633, DOI 10.1002/joc.1933; Freckman DW, 1998, ANTARCT RES SER, V72, P323; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; GIOVANNONI SJ, 1990, APPL ENVIRON MICROB, V56, P2572, DOI 10.1128/AEM.56.8.2572-2575.1990; Gooseff MN, 2003, ARCT ANTARCT ALP RES, V35, P91, DOI 10.1657/1523-0430(2003)035[0091:SPIOSB]2.0.CO;2; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hall BL, 2005, GEOMORPHOLOGY, V64, P25, DOI 10.1016/j.geomorph.2004.05.002; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; McLeod M, 2008, GEODERMA, V144, P93, DOI 10.1016/j.geoderma.2007.10.017; McLeod M, 2009, ANTARCT SCI, V21, P355, DOI 10.1017/S0954102009001965; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Moorhead DL, 2007, ECOSYSTEMS, V10, P86, DOI 10.1007/s10021-006-9005-8; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Niederberger TD, 2008, ENVIRON MICROBIOL, V10, P1713, DOI 10.1111/j.1462-2920.2008.01593.x; Oksanen J., 2017, R PACKAGE VERSION 26; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Poage MA, 2008, ARCT ANTARCT ALP RES, V40, P119, DOI 10.1657/1523-0430(06-051)[POAGE]2.0.CO;2; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Porazinska DL, 2004, ARCT ANTARCT ALP RES, V36, P84, DOI 10.1657/1523-0430(2004)036[0084:TBABOC]2.0.CO;2; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Smith JJ, 2006, MICROB ECOL, V51, P413, DOI 10.1007/s00248-006-9022-3; Smith JL, 2010, ANTARCT SCI, V22, P673, DOI 10.1017/S0954102010000763; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; Szekely AJ, 2013, ISME J, V7, P61, DOI 10.1038/ismej.2012.80; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Tiao G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1645; Treonis AM, 1999, ECOSYSTEMS, V2, P482, DOI 10.1007/s100219900096; Ugolini FC, 2008, GEODERMA, V144, P1, DOI 10.1016/j.geoderma.2007.10.005; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Wood SA, 2008, ISME J, V2, P308, DOI 10.1038/ismej.2007.104; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7; Zeglin LH, 2009, ECOSYSTEMS, V12, P562, DOI 10.1007/s10021-009-9242-8	81	74	75	1	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66103	10.1371/journal.pone.0066103	http://dx.doi.org/10.1371/journal.pone.0066103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824063	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400053
J	Li, D; Beisswenger, C; Herr, C; Schmid, RM; Gallo, RL; Han, G; Zakharkina, T; Bals, R				Li, D.; Beisswenger, C.; Herr, C.; Schmid, R. M.; Gallo, R. L.; Han, G.; Zakharkina, T.; Bals, R.			Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth	ONCOGENE			English	Article						lung cancer; cathelicidin; antimicrobial peptide; inflammation; macrophage	HOST-DEFENSE; PROTEIN HCAP18/LL-37; HUMAN KERATINOCYTES; LL-37; CANCER; GENE; RECEPTOR; MURINE; SKIN; PROLIFERATION	Antimicrobial peptides, such as the cathelicidin LL-37/hCAP-18 and its mouse homolog cathelicidin-related antimicrobial peptide ( CRAMP), are important effectors of the innate immune system with direct anti-bacterial activity. Cathelicidin is possibly involved in the regulation of tumor cell growth. The aim of this study was to characterize the role of cathelicidin expressed in non-tumorous cells in a preclinical mouse model of tumor growth. Wild-type and CRAMP-deficient animals were exposed to cigarette smoke ( CS) and Lewis lung carcinoma cells were injected to initiate the growth of tumors in the lung. CS exposure significantly increased the proliferation of lung tumors in wild-type mice, but not in CRAMP-deficient mice. CS exposure induced the recruitment of myeloid cell into tumor tissue in a CRAMP-dependent manner. Mice lacking RelA/p65 specifically in myeloid cells showed impaired recruitment of CRAMP-positive cells into the lung. In vitro studies with human cells showed that LL-37/hCAP-18 in macrophages is induced by soluble factors derived from cancer cells. Taken together, these data indicate that cathelicidin expressed from myeloid cells promotes CS-induced lung tumor growth by further recruitment of inflammatory cells. The regulation of cathelicidin expression involves myeloid p65/RelA and soluble factor from tumor cells.	[Li, D.; Beisswenger, C.; Herr, C.; Han, G.; Zakharkina, T.; Bals, R.] Saarland Univ Hosp, Dept Internal Med 5, D-66421 Homburg, Germany; [Schmid, R. M.] Tech Univ Munich, Dept Internal Med 2, D-80290 Munich, Germany; [Gallo, R. L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA	Universitatsklinikum des Saarlandes; Technical University of Munich; University of California System; University of California San Diego	Bals, R (corresponding author), Saarland Univ Hosp, Dept Internal Med 5, D-66421 Homburg, Germany.	robert.bals@uks.eu	Herr, Christian/AAH-5291-2021; Beisswenger, Christoph/GRO-6580-2022; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Herr, Christian/0000-0001-9422-6569	Deutsche Forschungsgemeinschaft (DFG) [1641/12]; Federal Ministry of Education and Research (FKZ ) [01GI0881-0888]; LOEWE-Schwerpunkt 'Tumor and Inflammation' of the state of Hesse	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (FKZ )(Federal Ministry of Education & Research (BMBF)); LOEWE-Schwerpunkt 'Tumor and Inflammation' of the state of Hesse	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG Ba 1641/12), the Federal Ministry of Education and Research (FKZ 01GI0881-0888) and the LOEWE-Schwerpunkt 'Tumor and Inflammation' of the state of Hesse (to RB). We thank Thomas Damm, Andreas Kamyschnikow and Anja Honecker for excellent technical support.	Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Buchau AS, 2010, J IMMUNOL, V184, P369, DOI 10.4049/jimmunol.0902110; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Coffelt SB, 2008, INT J CANCER, V122, P1030, DOI 10.1002/ijc.23186; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Golec M, 2009, ANN AGR ENV MED, V16, P289; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Heilborn JD, 2005, INT J CANCER, V114, P713, DOI 10.1002/ijc.20795; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Heilborn JD, 2010, EXP DERMATOL, V19, P332, DOI 10.1111/j.1600-0625.2009.00997.x; Hensel JA, 2011, PROSTATE, V71, P659, DOI 10.1002/pros.21282; Hess C, 2010, EUR RESPIR J, V35, P343, DOI 10.1183/09031936.00196408; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Li D, 2014, ONCOGENE, V33, P1239, DOI 10.1038/onc.2013.75; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Muehleisen B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003759; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Niyonsaba Francois, 2003, Current Drug Targets - Inflammation and Allergy, V2, P224, DOI 10.2174/1568010033484115; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Okumura K, 2004, CANCER LETT, V212, P185, DOI 10.1016/j.canlet.2004.04.006; Papi A, 2004, THORAX, V59, P679, DOI 10.1136/thx.2003.018291; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weber G, 2005, J INVEST DERMATOL, V124, P1080, DOI 10.1111/j.0022-202X.2005.23687.x; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	54	35	43	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2709	2716		10.1038/onc.2013.248	http://dx.doi.org/10.1038/onc.2013.248			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23812430				2022-12-25	WOS:000337231700004
J	van der Kooi-Pol, MM; Sadabad, MS; Duipmans, JC; Sabat, AJ; Stobernack, T; Omansen, TF; Westerhout-Pluister, GN; Jonkman, MF; Harmsen, HJM; van Dijl, JM				van der Kooi-Pol, Magdalena M.; Sadabad, Mehdi Sadaghian; Duipmans, Jose C.; Sabat, Artur J.; Stobernack, Tim; Omansen, Till F.; Westerhout-Pluister, Gerlinde N.; Jonkman, Marcel F.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten			Topography of Distinct Staphylococcus aureus Types in Chronic Wounds of Patients with Epidermolysis Bullosa	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; NASAL CARRIAGE; DIVERSITY	The opportunistic pathogen Staphylococcus aureus is known to interfere with wound healing and represents a significant risk factor for wound infections and invasive disease. It is generally assumed that one individual is predominantly colonized by one S. aureus type. Nevertheless, patients with the genetic blistering disease epidermolysis bullosa (EB) often carry multiple S. aureus types. We therefore investigated whether different S. aureus types are present in individual wounds of EB patients and, if so, how they are spatially distributed. The staphylococcal topography in chronic wounds was mapped by replica-plating of used bandages and subsequent typing of S. aureus isolates. Individual chronic wounds of five patients contained up to six different S. aureus types. Unexpectedly, distinct S. aureus types formed micro-colonies that were located in close proximity and sometimes even overlapped. While some adjacent S. aureus isolates were closely related, others belonged to distinct molecular complexes. We conclude that the general assumption that one individual is predominantly colonized by one type of S. aureus does not apply to chronic wounds of EB patients. We consider this observation important, not only for EB patients, but also for other patients with chronic wounds in view of the potential risk for severe staphylococcal infections.	[van der Kooi-Pol, Magdalena M.; Sadabad, Mehdi Sadaghian; Sabat, Artur J.; Stobernack, Tim; Omansen, Till F.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [van der Kooi-Pol, Magdalena M.; Sadabad, Mehdi Sadaghian; Duipmans, Jose C.; Sabat, Artur J.; Stobernack, Tim; Omansen, Till F.; Jonkman, Marcel F.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Duipmans, Jose C.; Jonkman, Marcel F.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Westerhout-Pluister, Gerlinde N.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands	University of Groningen; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment	van Dijl, JM (corresponding author), Univ Groningen, Dept Med Microbiol, Groningen, Netherlands.	M.van.Dijl01@umcg.nl		Omansen, Till Frederik/0000-0003-0645-9683	Commission of the European Union [LSHG-CT-2006-037469]; Top Institute Pharma [T4-213]; Dutch Butterfly Child Foundation	Commission of the European Union(European Commission); Top Institute Pharma; Dutch Butterfly Child Foundation	This work was supported by the Commission of the European Union (grant LSHG-CT-2006-037469), the Top Institute Pharma (project T4-213), and the Dutch Butterfly Child Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Coen PG, 2006, J THEOR BIOL, V240, P98, DOI 10.1016/j.jtbi.2005.08.031; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Friedrich A W, 2008, Euro Surveill, V13; Glasner C, 2013, INT J MED MICROBIOL, V303, P124, DOI 10.1016/j.ijmm.2013.02.015; Glasner C, 2013, INT J MED MICROBIOL, V303, P70, DOI 10.1016/j.ijmm.2012.12.005; Goerke C, 2007, ENVIRON MICROBIOL, V9, P3134, DOI 10.1111/j.1462-2920.2007.01423.x; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallin M, 2007, J CLIN MICROBIOL, V45, P127, DOI 10.1128/JCM.01866-06; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Jansen GJ, 2000, J CLIN MICROBIOL, V38, P814, DOI 10.1128/JCM.38.2.814-817.2000; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Lomholt H, 2005, J INVEST DERMATOL, V125, P977, DOI 10.1111/j.0022-202X.2005.23916.x; Madsen SM, 1996, APMIS, V104, P895, DOI 10.1111/j.1699-0463.1996.tb04955.x; Mongkolrattanothai K, 2011, J MED MICROBIOL, V60, P317, DOI 10.1099/jmm.0.025841-0; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Sabat AJ, 2012, J CLIN MICROBIOL, V50, P2255, DOI 10.1128/JCM.00056-12; van der Kooi-Pol MM, 2013, J INVEST DERMATOL, V133, P847, DOI 10.1038/jid.2012.347; van der Kooi-Pol MM, 2012, EXP DERMATOL, V21, P463, DOI 10.1111/j.1600-0625.2012.01502.x; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966	23	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67272	10.1371/journal.pone.0067272	http://dx.doi.org/10.1371/journal.pone.0067272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825650	Green Published, gold			2022-12-25	WOS:000321223000095
J	Zhang, Y; Whitfield-Gabrieli, S; Christodoulou, JA; Gabrieli, JDE				Zhang, Ying; Whitfield-Gabrieli, Susan; Christodoulou, Joanna A.; Gabrieli, John D. E.			Atypical Balance between Occipital and Fronto-Parietal Activation for Visual Shape Extraction in Dyslexia	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; TOP-DOWN; DIRECTED ATTENTION; CYTOARCHITECTONIC AREAS; VISUOSPATIAL ATTENTION; DEVELOPMENTAL DYSLEXIA; CONTRAST SENSITIVITY; PERCEPTION DEFICITS; NEURAL MECHANISMS; BRAIN ACTIVITY	Reading requires the extraction of letter shapes from a complex background of text, and an impairment in visual shape extraction would cause difficulty in reading. To investigate the neural mechanisms of visual shape extraction in dyslexia, we used functional magnetic resonance imaging (fMRI) to examine brain activation while adults with or without dyslexia responded to the change of an arrow's direction in a complex, relative to a simple, visual background. In comparison to adults with typical reading ability, adults with dyslexia exhibited opposite patterns of atypical activation: decreased activation in occipital visual areas associated with visual perception, and increased activation in frontal and parietal regions associated with visual attention. These findings indicate that dyslexia involves atypical brain organization for fundamental processes of visual shape extraction even when reading is not involved. Overengagement in higher-order association cortices, required to compensate for underengagment in lower-order visual cortices, may result in competition for top-down attentional resources helpful for fluent reading.	[Zhang, Ying; Whitfield-Gabrieli, Susan; Christodoulou, Joanna A.; Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Zhang, Ying] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, Y (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	yzhang00@mit.edu	Gabrieli, John/AAJ-2869-2020; Christodoulou, Joanna/AFV-2648-2022	Christodoulou, Joanna/0000-0001-8167-8021	Ellison Medical Foundation; MIT; Martin Richmond Memorial Fund; NIH [UL1RR025758, F32EY014750-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY014750] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); MIT; Martin Richmond Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Ellison Medical Foundation; MIT Class of 1976 Funds for Dyslexia Research; Bard and Julie Richmond through the Martin Richmond Memorial Fund; and NIH grants UL1RR025758 and F32EY014750-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitay S, 2002, BRAIN, V125, P2272, DOI 10.1093/brain/awf231; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; [Anonymous], 2002, READING WRITING INTE, DOI DOI 10.1023/A:1013872422108; Barnard N, 1998, OPTOMETRY VISION SCI, V75, P62, DOI 10.1097/00006324-199801000-00026; Beattie RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027893; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brown JM, 2009, PROG BRAIN RES, V176, P47, DOI 10.1016/S0079-6123(09)17604-5; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Callaway EM, 2005, J PHYSIOL-LONDON, V566, P13, DOI 10.1113/jphysiol.2005.088047; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Cieslik EC, 2010, J NEUROPHYSIOL, V104, P1472, DOI 10.1152/jn.00261.2010; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; Conlon EG, 2012, NEUROPSYCHOLOGIA, V50, P1672, DOI 10.1016/j.neuropsychologia.2012.03.023; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Demb JB, 1998, J NEUROSCI, V18, P6939; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; Dole M, 2012, NEUROPSYCHOLOGIA, V50, P1543, DOI 10.1016/j.neuropsychologia.2012.03.007; Durrwachter U, 2010, ANN DYSLEXIA, V60, P86, DOI 10.1007/s11881-010-0034-9; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; EVANS BJW, 1994, VISION RES, V34, P1913, DOI 10.1016/0042-6989(94)90315-8; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Facoetti A, 2003, COGNITIVE BRAIN RES, V16, P185, DOI 10.1016/S0926-6410(02)00270-7; Facoetti A, 2001, EXP BRAIN RES, V138, P46, DOI 10.1007/s002210100700; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Gaab N, 2007, RESTOR NEUROL NEUROS, V25, P295; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Glantz SA, 1992, PRIMER BIOSTATISTICS, P309; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Iles J, 2000, Dyslexia, V6, P163, DOI 10.1002/1099-0909(200007/09)6:3<163::AID-DYS150>3.0.CO;2-U; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kaufman A. S., 1997, KAUFMAN BRIEF INTELL; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Lobier M, 2011, CORTEX; LOVEGROVE W, 1982, NEUROPSYCHOLOGIA, V20, P309, DOI 10.1016/0028-3932(82)90105-1; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; Marinus E, 2010, CORTEX, V46, P1259, DOI 10.1016/j.cortex.2010.06.005; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; McMains SA, 2007, J NEUROPHYSIOL, V98, P2110, DOI 10.1152/jn.00538.2007; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Moores E, 2011, NEUROPSYCHOLOGIA, V49, P3881, DOI 10.1016/j.neuropsychologia.2011.10.005; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Oleksiak A, 2011, BRAIN RES REV, V67, P56, DOI 10.1016/j.brainresrev.2010.11.002; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Reynolds M, 2006, J EXP PSYCHOL HUMAN, V32, P1303, DOI 10.1037/0096-1523.32.6.1303; Reynolds MG, 2011, Q J EXP PSYCHOL, V64, P2405, DOI 10.1080/17470218.2011.614352; Roach NW, 2008, VISION RES, V48, P193, DOI 10.1016/j.visres.2007.11.001; Roach NW, 2004, PSYCHOL SCI, V15, P650, DOI 10.1111/j.0956-7976.2004.00735.x; Rottschy C, 2007, HUM BRAIN MAPP, V28, P1045, DOI 10.1002/hbm.20348; RUMSEY JM, 1992, JAMA-J AM MED ASSOC, V268, P912, DOI 10.1001/jama.268.7.912; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Skottun BC, 2000, VISION RES, V40, P111, DOI 10.1016/S0042-6989(99)00170-4; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Szlyk JP, 2009, INVEST OPHTH VIS SCI, V50, P4487, DOI 10.1167/iovs.08-2258; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Torgesen Wagner, 1999, COMPREHENSIVE TEST P; Twomey T, 2011, NEUROIMAGE, V55, P1242, DOI 10.1016/j.neuroimage.2011.01.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Ingelghem M, 2001, NEUROREPORT, V12, P3603, DOI 10.1097/00001756-200111160-00046; Vidyasagar TR, 1999, NEUROREPORT, V10, P1283, DOI 10.1097/00001756-199904260-00024; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Waldie KE, 2010, NEUROPSYCHOLOGIA, V48, P3650, DOI 10.1016/j.neuropsychologia.2010.08.023; Walker KMM, 2006, BRAIN RES, V1124, P126, DOI 10.1016/j.brainres.2006.09.080; Wechsler D., 1999, WECHSLER ABBREVIATED; Wilms M, 2005, ANAT EMBRYOL, V210, P485, DOI 10.1007/s00429-005-0064-y; Wilms M, 2010, NEUROIMAGE, V49, P1171, DOI 10.1016/j.neuroimage.2009.09.063; Woodcock R.W., 2011, WOODCOCK READING MAS; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	106	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67331	10.1371/journal.pone.0067331	http://dx.doi.org/10.1371/journal.pone.0067331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825653	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000096
J	Boys, CA; Robinson, W; Baumgartner, LJ; Rampano, B; Lowry, M				Boys, Craig A.; Robinson, Wayne; Baumgartner, Lee J.; Rampano, Ben; Lowry, Michael			Influence of Approach Velocity and Mesh Size on the Entrainment and Contact of a Lowland River Fish Assemblage at a Screened Irrigation Pump	PLOS ONE			English	Article							PHYSIOLOGICAL STRESS RESPONSES; SWIMMING PERFORMANCE; CLOSE ENCOUNTERS; 2-VECTOR FLOWS; CHINOOK SALMON; DELTA SMELT; BEHAVIOR; DIVERSIONS; MANAGEMENT; LARVAE	Fish screens can help prevent the entrainment or injury of fish at irrigation diversions, but only when designed appropriately. Design criteria cannot simply be transferred between sites or pump systems and need to be developed using an evidence-based approach with the needs of local species in mind. Laboratory testing is typically used to quantify fish responses at intake screens, but often limits the number of species that can studied and creates artificial conditions not directly applicable to screens in the wild. In this study a field-based approach was used to assess the appropriateness of different screen design attributes for the protection of a lowland river fish assemblage at an experimental irrigation pump. Direct netting of entrained fish was used along with sonar technology to quantify the probability of screen contact for a Murray-Darling Basin (Australia) fish species. Two approach velocities (0.1 and 0.5 m. sec(-1)) and different sizes of woven mesh (5, 10 and 20 mm) were evaluated. Smaller fish (< 150 mm) in the assemblage were significantly more susceptible to entrainment and screen contact, especially at higher approach velocities. Mesh size appeared to have little impact on screen contact and entrainment, suggesting that approach velocity rather than mesh size is likely to be the primary consideration when developing screens. Until the effects of screen contacts on injury and survival of these species are better understood, it is recommended that approach velocities not exceed 0.1 m. sec(-1) when the desire is to protect the largest range of species and size classes for lowland river fish assemblages in the Murray-Darling Basin. The field method tested proved to be a useful approach that could compliment laboratory studies to refine fish screen design and facilitate field validation.	[Boys, Craig A.; Rampano, Ben; Lowry, Michael] Fisheries NSW, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia; [Robinson, Wayne; Baumgartner, Lee J.] Fisheries NSW, Narrandera Fisheries Ctr, Narrandera, NSW, Australia; [Robinson, Wayne] Charles Sturt Univ, Thurgoona, NSW, Australia	NSW Department of Primary Industries; Charles Sturt University	Boys, CA (corresponding author), Fisheries NSW, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia.	craig.boys@dpi.nsw.gov.au	Baumgartner, Lee/P-2035-2015; Boys, Craig/AAW-8829-2021	Baumgartner, Lee/0000-0002-1237-5163; ROBINSON, WAYNE/0000-0002-8793-7466	Murray-Darling Basin Authority (through the Native Fish Strategy Initiative); Cooperative Research Centre for Cotton Communities and Catchments; Namoi Catchment Management Authority; New South Wales Department of Primary Industries	Murray-Darling Basin Authority (through the Native Fish Strategy Initiative); Cooperative Research Centre for Cotton Communities and Catchments(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Namoi Catchment Management Authority; New South Wales Department of Primary Industries	The Murray-Darling Basin Authority (through the Native Fish Strategy Initiative), Cooperative Research Centre for Cotton Communities and Catchments, Namoi Catchment Management Authority and New South Wales Department of Primary Industries jointly funded this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran E, 2001, FLOODS FLOODPLAINS F, P920; BARROS J. J. C., 2008, SEA HUME DAM RESTORI, P1; Baumgartner L, 2007, FISHERIES FINAL REPO; Baumgartner LJ, 2009, FISHERIES MANAG ECOL, V16, P429, DOI 10.1111/j.1365-2400.2009.00693.x; Baumgartner L.J., 2006, FISHERIES FINAL REPO, V84N5W; Baumgartner Lee J., 2012, Ecological Management & Restoration, V13, P135, DOI 10.1111/j.1442-8903.2012.00655.x; Belcher EO, 1999, OCEANS '99 MTS/IEEE : RIDING THE CREST INTO THE 21ST CENTURY, VOLS 1-3, P1495, DOI 10.1109/OCEANS.1999.800215; Boswell KM, 2008, N AM J FISH MANAGE, V28, P799, DOI 10.1577/M07-116.1; Boys CA, 2013, FISHERIES MANAG ECOL, V20, P362, DOI 10.1111/fme.12026; CDFG, 2000, FISH SCREEN CRIT; Cech JJM, 2006, CEC5002006117; Danley ML, 2002, N AM J FISH MANAGE, V22, P1241, DOI 10.1577/1548-8675(2002)022<1241:SPAPSR>2.0.CO;2; Downes B.J., 2002, MONITORING ECOLOGICA; Galbraith H, 2005, 1 CA COMPR ASS SECR; Gilligan DM, 2003, NSW FISHERIES FINAL, V50; Godinho AL, 2009, RIVER RES APPL, V25, P702, DOI 10.1002/rra.1180; Higginbottom I., 2008, HYDROACOUSTIC DATA P, P40; Humphries P, 2000, REGUL RIVER, V16, P421, DOI 10.1002/1099-1646(200009/10)16:5<421::AID-RRR594>3.0.CO;2-4; Humphries P, 2002, FRESHWATER BIOL, V47, P1307, DOI 10.1046/j.1365-2427.2002.00871.x; Jamieson D, 2005, FISH SCREENING GOOD; JONES DR, 1974, J FISH RES BOARD CAN, V31, P1641, DOI 10.1139/f74-206; King Alison J., 2007, Ecological Management & Restoration, V8, P32, DOI 10.1111/j.1442-8903.2007.00329.x; Kingsford RT, 2000, AUSTRAL ECOL, V25, P109, DOI 10.1111/j.1442-9993.2000.tb00012.x; Koehn John D., 2012, Endangered Species Research, V16, P165, DOI 10.3354/esr00398; Larinier M, 2008, HYDROBIOLOGIA, V609, P97, DOI 10.1007/s10750-008-9398-9; Lintermans M., 2007, FISHES MURRAY DARLIN; Lintermans M., 2004, DOWNSTR MOV FISH MUR; McMichael GA, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:CFSPTP]2.0.CO;2; Moursund RA, 2003, ICES J MAR SCI, V60, P678, DOI 10.1016/S1054-3139(03)00036-5; Moyle PB, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:UA]2.0.CO;2; MOYLE PB, 1990, CONSERV BIOL, V4, P275, DOI 10.1111/j.1523-1739.1990.tb00289.x; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:POMFSA>2.0.CO;2; Neter J., 1996, APPL LINEAR STAT MOD; NMFS, 1997, JUV FISH SCREEN CRIT; NSW DPI, 2007, END EC COMM LOWL DAR; Peake S, 2004, N AM J FISH MANAGE, V24, P390, DOI 10.1577/M02-010.1; Prince E. E., 1923, T AM FISH SOC, V52, P157; Puckridge JT, 1998, MAR FRESHWATER RES, V49, P55, DOI 10.1071/MF94161; Rose BP, 2008, N AM J FISH MANAGE, V28, P1702, DOI 10.1577/M07-073.1; Rosegrant M. W., 2002, 14 IFPRI; Sound Metrics, 2009, DUAL FREQ ID SON DID; Swanson C, 2005, T AM FISH SOC, V134, P1111, DOI 10.1577/T04-121.1; Swanson C, 1998, J EXP BIOL, V201, P333; Swanson C, 2004, T AM FISH SOC, V133, P265, DOI 10.1577/03-068; Thoms M., 2004, The Darling, P350; Tiffan KF, 2004, N AM J FISH MANAGE, V24, P1421, DOI 10.1577/1548-8675(2004)24<1421:IFCSRI>2.0.CO;2; Turnpenny WH, 1998, UK GUIDE INTAKE FISH; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; WALKER KF, 1985, HYDROBIOLOGIA, V125, P111, DOI 10.1007/BF00045929; Wood S., 2000, PILOT ANAL GLOBAL EC; Young PS, 2010, T AM FISH SOC, V139, P713, DOI 10.1577/T09-029.1; Zar JH., 2010, BIOSTAT ANAL; Zydlewski GB, 2002, N AM J FISH MANAGE, V22, P1276, DOI 10.1577/1548-8675(2002)022<1276:ROBTFT>2.0.CO;2	53	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67026	10.1371/journal.pone.0067026	http://dx.doi.org/10.1371/journal.pone.0067026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818975	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800114
J	Chong, G; Kimyon, O; Manefield, M				Chong, Grace; Kimyon, Oender; Manefield, Mike			Quorum Sensing Signal Synthesis May Represent a Selective Advantage Independent of Its Role in Regulation of Bioluminescence in Vibrio fischeri	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; LUMINESCENCE; POPULATIONS; COOPERATION; MUTAGENESIS; INDUCTION; DIFFUSION; BIOFILMS; FITNESS	The evolution of biological signalling systems and apparently altruistic or cooperative traits in diverse organisms has required selection against the subversive tendencies of self-interested biological entities. The bacterial signalling and response system known as quorum sensing or Acylated Homoserine Lactone (AHL) mediated gene expression is thought to have evolved through kin selection. In this in vitro study on the model quorum sensing bioluminescent marine symbiont Vibrio fischeri, competition and long-term sub culturing experiments suggest that selection for AHL synthesis (encoded by the AHL synthase gene luxI) is independent of the quorum sensing regulated phenotype (bioluminescence encoded by luxCDABE). Whilst results support the hypothesis that signal response (AHL binding and transcriptional activation encoded by the luxR gene) is maintained through indirect fitness benefits (kin selection), signal synthesis is maintained in the V. fischeri genome over evolutionary time through direct fitness benefits at the individual level from an unknown function.	[Chong, Grace; Kimyon, Oender; Manefield, Mike] UNSW, CMB, Sch Biotechnol & Biomol Sci BABS, Sydney, NSW, Australia	University of New South Wales Sydney	Manefield, M (corresponding author), UNSW, CMB, Sch Biotechnol & Biomol Sci BABS, Sydney, NSW, Australia.	manefield@unsw.edu.au	Kimyon, Onder/J-8852-2014	Kimyon, Onder/0000-0001-9222-7672	Centre for Marine Bio-Innovation; Environmental Biotechnology Cooperative Research Centre; Australian Research Council Future Fellowship [FT100100078]	Centre for Marine Bio-Innovation; Environmental Biotechnology Cooperative Research Centre; Australian Research Council Future Fellowship(Australian Research Council)	This work was partially supported by grants from the Centre for Marine Bio-Innovation, the Environmental Biotechnology Cooperative Research Centre and an Australian Research Council Future Fellowship (FT100100078) awarded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Bose JL, 2011, APPL ENVIRON MICROB, V77, P2445, DOI 10.1128/AEM.02643-10; Brookfield JEY, 1998, EVOLUTION, V52, P1263, DOI 10.1111/j.1558-5646.1998.tb02007.x; Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Heurlier K, 2006, INT J MED MICROBIOL, V296, P93, DOI 10.1016/j.ijmm.2006.01.043; KUO A, 1994, J BACTERIOL, V176, P7558, DOI 10.1128/JB.176.24.7558-7565.1994; Manefield M, 2007, PHILOS T R SOC B, V362, P1235, DOI 10.1098/rstb.2007.2048; Miyashiro T, 2012, MOL MICROBIOL, V84, P795, DOI 10.1111/j.1365-2958.2012.08065.x; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Rumbaugh KP, 2012, P ROY SOC B-BIOL SCI, V279, P3584, DOI 10.1098/rspb.2012.0843; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schuster BM, 2010, SYMBIOSIS, V51, P85, DOI 10.1007/s13199-010-0074-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Szathmary E, 1995, MAJOR TRANSITIONS EV; Trott AE, 2001, J BACTERIOL, V183, P387, DOI 10.1128/JB.183.1.387-392.2001; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; Visick KL, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P119; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904	38	11	13	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67443	10.1371/journal.pone.0067443	http://dx.doi.org/10.1371/journal.pone.0067443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825662	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400186
J	de Vienne, DM; Giraud, T; Gouyon, PH				de Vienne, Damien M.; Giraud, Tatiana; Gouyon, Pierre-Henri			Lineage Selection and the Maintenance of Sex	PLOS ONE			English	Article							SPECIES SELECTION; PLURALIST APPROACH; EVOLUTION; COMPETITION; SPECIATION; RECOMBINATION; REPRODUCTION; POPULATIONS; PATTERNS; SYSTEMS	Sex predominates in eukaryotes, despite its short-term disadvantage when compared to asexuality. Myriad models have suggested that short-term advantages of sex may be sufficient to counterbalance its twofold costs. However, despite decades of experimental work seeking such evidence, no evolutionary mechanism has yet achieved broad recognition as explanation for the maintenance of sex. We explore here, through lineage-selection models, the conditions favouring the maintenance of sex. In the first model, we allowed the rate of transition to asexuality to evolve, to determine whether lineage selection favoured species with the strongest constraints preventing the loss of sex. In the second model, we simulated more explicitly the mechanisms underlying the higher extinction rates of asexual lineages than of their sexual counterparts. We linked extinction rates to the ecological and/ or genetic features of lineages, thereby providing a formalisation of the only figure included in Darwin's "The origin of species". Our results reinforce the view that the long-term advantages of sex and lineage selection may provide the most satisfactory explanations for the maintenance of sex in eukaryotes, which is still poorly recognized, and provide figures and a simulation website for training and educational purposes. Short-term benefits may play a role, but it is also essential to take into account the selection of lineages for a thorough understanding of the maintenance of sex.	[de Vienne, Damien M.] CRG, Bionformat & Genom Programme, Barcelona, Spain; [de Vienne, Damien M.] Univ Pompeu Fabra, Bionformat & Genom Programme, Barcelona, Spain; [Giraud, Tatiana] CNRS, UMR 8079, F-91405 Orsay, France; [Giraud, Tatiana] Univ Paris 11, Orsay, France; [Gouyon, Pierre-Henri] Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 7205, Paris, France	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	de Vienne, DM (corresponding author), CRG, Bionformat & Genom Programme, Barcelona, Spain.	damien.de-vienne@crg.es	Gouyon, Pierre-Henri/A-9603-2013	de Vienne, Damien/0000-0001-9532-5251; Giraud, Tatiana/0000-0002-2685-6478	FungiSex [ANR-09-0064-01]; Chaire Modelisation Mathematique et Biodiversite (MMB) of Veolia Environnement-Ecole Polytechnique-Museum national d'Histoire naturelle-Fondation X	FungiSex; Chaire Modelisation Mathematique et Biodiversite (MMB) of Veolia Environnement-Ecole Polytechnique-Museum national d'Histoire naturelle-Fondation X	TG received funding from the FungiSex ANR-09-0064-01 grant (http://urgi.versailles.inra.fr/Projects/FungiSex). DDV received a postdoctoral grant from the Chaire Modelisation Mathematique et Biodiversite (MMB) of Veolia Environnement-Ecole Polytechnique-Museum national d'Histoire naturelle-Fondation X (http://www.cmap.polytechnique.fr/chaire-mmb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen Duur K., 2007, P527; Agnarsson I, 2006, EVOLUTION, V60, P2342; Barton NH, 2010, PHILOS T R SOC B, V365, P2559, DOI 10.1098/rstb.2010.0106; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Becerra M, 1999, EVOL ECOL RES, V1, P567; Bell G., 1982, MASTERPIECE NATURE E; Bruggeman J, 2004, FUNGAL GENET BIOL, V41, P181, DOI 10.1016/j.fgb.2003.10.007; Burt A, 2000, EVOLUTION, V54, P337; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Darwin C, 1859, ORIGINS SPECIES MEAN; Davy A, 1988, PLANT POPULATION ECO; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Fisher R.A., 1930, GENETICAL THEORY NAT; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Getz WM, 2001, ANN ZOOL FENN, V38, P315; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; GLIDDON CJ, 1989, TRENDS ECOL EVOL, V4, P204, DOI 10.1016/0169-5347(89)90074-8; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Gouyon PH, 1999, J EVOLUTION BIOL, V12, P1029; Gray MM, 2001, CAN J FISH AQUAT SCI, V58, P1313, DOI 10.1139/cjfas-58-7-1313; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Janko K, 2008, EVOLUTION, V62, P1264, DOI 10.1111/j.1558-5646.2008.00359.x; Johnson MTJ, 2011, EVOLUTION, V65, P3230, DOI 10.1111/j.1558-5646.2011.01378.x; Jokela J, 1997, EVOLUTION, V51, P1120, DOI 10.1111/j.1558-5646.1997.tb03959.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Kono T, 2006, CYTOGENET GENOME RES, V113, P31, DOI 10.1159/000090812; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lopez-Villacencio M, 2013, J EVOL BIOL IN PRESS; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maynard Smith J., 1971, GROUP SELECTION, P163; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Normark BB, 2003, ANNU REV ENTOMOL, V48, P397, DOI 10.1146/annurev.ento.48.091801.112703; NUNNEY L, 1989, EVOLUTION, V43, P245, DOI 10.1111/j.1558-5646.1989.tb04225.x; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Rice WR, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P75, DOI 10.1007/978-90-481-2770-2_5; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Rispe C, 1998, J EVOLUTION BIOL, V11, P685, DOI 10.1007/s000360050113; Schwander T, 2009, MOL ECOL, V18, P28, DOI 10.1111/j.1365-294X.2008.03992.x; Silliker ME, 1997, CURR GENET, V32, P281, DOI 10.1007/s002940050278; SLATKIN M, 1981, PALEOBIOLOGY, V7, P421, DOI 10.1017/S0094837300025471; SMITH JM, 1978, EVOLUTION SEX; STANLEY SM, 1975, SCIENCE, V190, P382, DOI 10.1126/science.1179215; Stireman JO, 2005, J EVOLUTION BIOL, V18, P325, DOI 10.1111/j.1420-9101.2004.00850.x; Tagg N, 2005, BIOL J LINN SOC, V85, P111, DOI 10.1111/j.1095-8312.2005.00475.x; Templeton A.R., 1982, P75; van Diepeningen AD, 2008, ASPERGILLUS IN THE GENOMIC ERA, P133; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Wilson CG, 2011, BIOL J LINN SOC, V104, P564, DOI 10.1111/j.1095-8312.2011.01737.x; Zhang XS, 2007, EVOLUTION, V61, P1532, DOI 10.1111/j.1558-5646.2007.00147.x	53	22	22	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66906	10.1371/journal.pone.0066906	http://dx.doi.org/10.1371/journal.pone.0066906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825582	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400167
J	Ding, R; Chen, XM; Wu, D; Wei, RB; Hong, Q; Shi, SZ; Yin, Z; Ma, LL; Xie, YS				Ding, Rui; Chen, Xiangmei; Wu, Di; Wei, Ribao; Hong, Quan; Shi, Suozhu; Yin, Zhong; Ma, Linlin; Xie, Yuansheng			Effects of Aging on Kidney Graft Function, Oxidative Stress and Gene Expression after Kidney Transplantation	PLOS ONE			English	Article							RECIPIENT AGE DIFFERENCE; SENESCENCE; APOPTOSIS; BIOMARKER; PROTEINS; SIRTUINS; SURVIVAL; OUTCOMES; IMPACT; VIRUS	Conflicting results have been reported regarding the effects of donor age, recipient age and donor-recipient age difference on short-and long-term outcomes after kidney transplantation. The aim of this study was to evaluate the effects of recipient age on graft function, oxidative stress, and gene expression after renal transplantation. Fifty male Fischer 344 rats [25 young (Y, 4 months), 25 senior (S, 16 months)] were randomized to 6 groups: 2 sham groups (Y and S, n = 5 in each group) and 4 renal transplant groups[young-to-young (Y-Y), young-to-senior (Y-S), senior-to-young (S-Y), senior-to-senior (S-S), (n = 10 in each group)]. The left kidneys were transplanted from donor to recipient. After 12 weeks, systematic blood pressure, graft weight, graft function, histology and oxidative stress were measured. Microarray analysis and quantitative real-time PCR confirmation were performed to study gene expression in the grafts. There were no differences in renal graft function between young and senior kidney cross-transplantation. Transplanted kidneys showed no significant differences in glomerulosclerosis index compared to non-transplanted kidneys but had significantly different tubulointerstitium scores compared to age-matched controls. Senior rats had lower SOD activity and higher MDA content than young rats. SOD activity was significantly lower and MDA content significantly higher in the Y-S group than in the Y-Y group. There were 548 transcript differences between senior and young kidneys with 36 upregulated and 512 downregulated transcripts. There were 492 transcript differences between Y-S and Y-Y groups with 127 upregulated and 365 downregulated transcripts. There were 1244 transcript differences between the S-Y and S-S groups with 680 upregulated and 574 downregulated transcripts. Oxidative stress and gene expression profile was significantly different in the Y-S compared to the S-Y group. The identified differences were mainly in the MAPK and insulin signal pathways, making these potential targets for therapeutic intervention.	[Ding, Rui; Chen, Xiangmei; Wu, Di; Wei, Ribao; Hong, Quan; Shi, Suozhu; Yin, Zhong; Ma, Linlin; Xie, Yuansheng] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Nephrol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chen, XM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Nephrol, Beijing, Peoples R China.	xmchen301@126.com			National Natural Sciences Foundation of China [30901573, 81102673]; National Basic Research Program of China [2011CB944000]; Major State Basic Research Development Program of China [2013CB530800]; Nursery Foundation of PLA General Hospital [0712]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Major State Basic Research Development Program of China(National Basic Research Program of China); Nursery Foundation of PLA General Hospital	This work was supported by grants from the National Natural Sciences Foundation of China (30901573), National Basic Research Program of China (No. 2011CB944000), the Major State Basic Research Development Program of China (No. 2013CB530800), National Natural Sciences Foundation of China (No. 81102673), and the Nursery Foundation of PLA General Hospital (No. 0712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak MI, 1998, J MOL CELL CARDIOL, V30, P661, DOI 10.1006/jmcc.1997.0633; Barouki R, 2006, M S-MED SCI, V22, P266, DOI 10.1051/medsci/2006223266; Basar H, 1999, TRANSPLANTATION, V67, P1191, DOI 10.1097/00007890-199904270-00019; Bowie AG, 2008, BIOCHEM SOC T, V36, P449, DOI 10.1042/BST0360449; Brouard S, 2011, TRANSPLANTATION, V91, P691, DOI 10.1097/TP.0b013e31820c4559; D'Souza T, 2009, J GERONTOL A-BIOL, V64, P1146, DOI 10.1093/gerona/glp118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONNELLY P, 1991, TRANSPLANT INT, V4, P88, DOI 10.1007/BF00336403; Esseghir S, 2006, J PATHOL, V210, P420, DOI 10.1002/path.2071; Fan PY, 2010, AM J TRANSPLANT, V10, P1090, DOI 10.1111/j.1600-6143.2009.03009.x; Ferrari P, 2011, NEPHROL DIAL TRANSPL, V26, P702, DOI 10.1093/ndt/gfq383; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1; Gong ZW, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/320482; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jassal S V, 1997, Geriatr Nephrol Urol, V7, P157, DOI 10.1023/A:1008246129084; Kainz A, 2007, TRANSPLANTATION, V83, P1048, DOI 10.1097/01.tp.0000259960.56786.ec; Keith DS, 2004, J AM SOC NEPHROL, V15, P1086, DOI 10.1097/01.ASN.0000119572.02053.F2; Kolodziej S, 2004, AM J TRANSPLANT, V4, P428; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; La Manna G, 2011, AM J NEPHROL, V34, P496, DOI 10.1159/000329320; Lane N, 2003, J THEOR BIOL, V225, P531, DOI 10.1016/S0022-5193(03)00304-7; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim WH, 2013, TRANSPLANTATION, V95, P106, DOI 10.1097/TP.0b013e318277b2be; Lim WH, 2010, NEPHROL DIAL TRANSPL, V25, P3082, DOI 10.1093/ndt/gfq127; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994; MCLIGEYO SO, 1993, E AFR MED J, V70, P3; Nikolich-Zugich J, 2005, J EXP MED, V201, P837, DOI 10.1084/jem.20050341; Pascher Andreas, 2004, Ann Transplant, V9, P72; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao X, 2005, J GERONTOL A-BIOL, V60, P830, DOI 10.1093/gerona/60.7.830; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; REAVEN GM, 1988, DIABETES METAB REV, V4, P639, DOI 10.1002/dmr.5610040703; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Tullius SG, 1998, KIDNEY INT, V53, P465, DOI 10.1046/j.1523-1755.1998.00757.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Waiser J, 2000, NEPHROL DIAL TRANSPL, V15, P696, DOI 10.1093/ndt/15.5.696; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang XJ, 2006, J AM SOC NEPHROL, V17, P1532, DOI 10.1681/ASN.2005070776; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	51	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65613	10.1371/journal.pone.0065613	http://dx.doi.org/10.1371/journal.pone.0065613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824036	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400013
J	Shanks, RMQ; Davra, VR; Romanowski, EG; Brothers, KM; Stella, NA; Godboley, D; Kadouri, DE				Shanks, Robert M. Q.; Davra, Viral R.; Romanowski, Eric G.; Brothers, Kimberly M.; Stella, Nicholas A.; Godboley, Dipti; Kadouri, Daniel E.			An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; GALLERIA-MELLONELLA; STAPHYLOCOCCUS-AUREUS; MICAVIBRIO-AERUGINOSAVORUS; CONTACT-LENS; MODEL; HOST; CIPROFLOXACIN; BIOFILMS; THERAPY	Ocular infections are a leading cause of vision loss. It has been previously suggested that predatory prokaryotes might be used as live antibiotics to control infections. In this study, Pseudomonas aeruginosa and Serratia marcescens ocular isolates were exposed to the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. All tested S. marcescens isolates were susceptible to predation by B. bacteriovorus strains 109J and HD100. Seven of the 10 P. aeruginosa isolates were susceptible to predation by B. bacteriovorus 109J with 80% being attacked by M. aeruginosavorus. All of the 19 tested isolates were found to be sensitive to at least one predator. To further investigate the effect of the predators on eukaryotic cells, human corneal-limbal epithelial (HCLE) cells were exposed to high concentrations of the predators. Cytotoxicity assays demonstrated that predatory bacteria do not damage ocular surface cells in vitro whereas the P. aeruginosa used as a positive control was highly toxic. Furthermore, no increase in the production of the proinflammatory cytokines IL-8 and TNF-alpha was measured in HCLE cells after exposure to the predators. Finally, injection of high concentration of predatory bacteria into the hemocoel of Galleria mellonella, an established model system used to study microbial pathogenesis, did not result in any measurable negative effect to the host. Our results suggest that predatory bacteria could be considered in the near future as a safe topical bio-control agent to treat ocular infections.	[Shanks, Robert M. Q.; Romanowski, Eric G.; Brothers, Kimberly M.; Stella, Nicholas A.] Univ Pittsburgh, Dept Ophthalmol, Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Davra, Viral R.; Godboley, Dipti; Kadouri, Daniel E.] Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kadouri, DE (corresponding author), Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA.	kadourde@umdnj.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Brothers, Kimberly/0000-0003-2055-9760	Department of the ARMY USAMRAA [W81XWH-12-2-0067]; UMDNJ departmental start-up fund; National Institutes of Health (NIH) [AI085570]; Research to Prevent Blindness Career Development award; NIH [EY08098]; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER	Department of the ARMY USAMRAA; UMDNJ departmental start-up fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development award(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Department of the ARMY USAMRAA #W81XWH-12-2-0067 and by UMDNJ departmental start-up fund to DEK and RMQS was supported by National Institutes of Health (NIH) grant AI085570 and a Research to Prevent Blindness Career Development award. The authors thank the NIH EY08098 grant sponsored hybridoma module for providing HCLE cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejko M, 2009, COMP BIOCHEM PHYS B, V152, P118, DOI 10.1016/j.cbpb.2008.10.008; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Boileau MJ, 2011, CAN J VET RES, V75, P285; Das S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1182, DOI 10.1001/archopht.125.9.1182; Dashiff A, 2011, MOL ORAL MICROBIOL, V26, P19, DOI 10.1111/j.2041-1014.2010.00592.x; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Dubovskiy IM, 2008, J INVERTEBR PATHOL, V98, P360, DOI 10.1016/j.jip.2008.03.011; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; FRATAMICO PM, 1995, J FOOD PROTECT, V58, P160, DOI 10.4315/0362-028X-58.2.160; Fratamico PM, 1996, J FOOD SAFETY, V16, P161, DOI 10.1111/j.1745-4565.1996.tb00157.x; Fukuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047742; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gorski A, 2009, OPHTHALMOLOGICA, V223, P162, DOI 10.1159/000193293; Hazlett LD, 2005, OCUL IMMUNOL INFLAMM, V13, P133, DOI 10.1080/09273940490912362; Hume E, 2004, Arch Soc Esp Oftalmol, V79, P475; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kowalski RP, 2001, OPHTHALMOLOGY, V108, P1826, DOI 10.1016/S0161-6420(01)00724-2; LAMBINA V A, 1983, Mikrobiologiya, V52, P777; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; Lu F, 2010, LETT APPL MICROBIOL, V51, P625, DOI 10.1111/j.1472-765X.2010.02943.x; Markelova NY, 2010, INT J HYG ENVIR HEAL, V213, P428, DOI 10.1016/j.ijheh.2010.08.004; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; NAKAMURA M, 1972, AM J CLIN NUTR, V25, P1441; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Ramirez JC, 2012, INVEST OPHTH VIS SCI, V53, P448, DOI 10.1167/iovs.11-8999; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rhee MK, 2004, AM J OPHTHALMOL, V138, P226, DOI 10.1016/j.ajo.2004.03.016; Rogosky AM, 2006, CURR MICROBIOL, V52, P81, DOI 10.1007/s00284-005-0038-6; Santos TMA, 2011, AM J VET RES, V72, P1079, DOI 10.2460/ajvr.72.8.1079; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Van Essche M, 2011, MOL ORAL MICROBIOL, V26, P52, DOI 10.1111/j.2041-1014.2010.00595.x; Van Essche M, 2009, J DENT RES, V88, P182, DOI 10.1177/0022034508329693; Varaprasathan G, 2004, CORNEA, V23, P360, DOI 10.1097/00003226-200405000-00009; VERKLOVA Z S, 1973, Gigiena i Sanitariya, V38, P10; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wingard JB, 2011, ANTIMICROB AGENTS CH, V55, P3788, DOI 10.1128/AAC.01828-10; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150	47	58	59	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66723	10.1371/journal.pone.0066723	http://dx.doi.org/10.1371/journal.pone.0066723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824756	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400154
J	Jensen, DD; Godfrey, CB; Niklas, C; Canals, M; Kocan, M; Poole, DP; Murphy, JE; Alemi, F; Cottrell, GS; Korbmacher, C; Lambert, NA; Bunnett, NW; Corvera, CU				Jensen, Dane D.; Godfrey, Cody B.; Niklas, Christian; Canals, Meritxell; Kocan, Martina; Poole, Daniel P.; Murphy, Jane E.; Alemi, Farzad; Cottrell, Graeme S.; Korbmacher, Christoph; Lambert, Nevin A.; Bunnett, Nigel W.; Corvera, Carlos U.			The Bile Acid Receptor TGR5 Does Not Interact with beta-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MU-OPIOID RECEPTOR; RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT ENDOCYTOSIS; ACTIVATED RECEPTOR-2; KINASE ACTIVATION; EGF RECEPTOR; GPBAR1 TGR5	TGR5 is a G protein-coupled receptor that mediates bile acid (BA) effects on energy balance, inflammation, digestion, and sensation. The mechanisms and spatiotemporal control of TGR5 signaling are poorly understood. We investigated TGR5 signaling and trafficking in transfected HEK293 cells and colonocytes (NCM460) that endogenously express TGR5. BAs (deoxycholic acid (DCA), taurolithocholic acid) and the selective agonists oleanolic acid and 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N, 5-dimethylisoxazole-4-carboxamide stimulated cAMP formation but did not induce TGR5 endocytosis or recruitment of beta-arrestins, as assessed by confocal microscopy. DCA, taurolithocholic acid, and oleanolic acid did not stimulate TGR5 association with beta-arrestin 1/2 or G protein-coupled receptor kinase (GRK) 2/5/6, as determined by bioluminescence resonance energy transfer. 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N, 5-dimethylisoxazole-4-carboxamide stimulated a low level of TGR5 interaction with beta-arrestin 2 and GRK2. DCA induced cAMP formation at the plasma membrane and cytosol, as determined using exchange factor directly regulated by cAMP (Epac2)-based reporters, but cAMP signals did not desensitize. AG1478, an inhibitor of epidermal growth factor receptor tyrosine kinase, the metalloprotease inhibitor batimastat, and methyl-beta-cyclodextrin and filipin, which block lipid raft formation, prevented DCA stimulation of ERK1/2. Bioluminescence resonance energy transfer analysis revealed TGR5 and EGFR interactions that were blocked by disruption of lipid rafts. DCA stimulated TGR5 redistribution to plasma membrane microdomains, as localized by immunogold electron microscopy. Thus, TGR5 does not interact with beta-arrestins, desensitize, or traffic to endosomes. TGR5 signals from plasma membrane rafts that facilitate EGFR interaction and transactivation. An understanding of the spatiotemporal control of TGR5 signaling provides insights into the actions of BAs and therapeutic TGR5 agonists/antagonists.	[Jensen, Dane D.; Niklas, Christian; Canals, Meritxell; Kocan, Martina; Poole, Daniel P.; Bunnett, Nigel W.] Monash Inst Pharma Sci, Parkville, Vic 3052, Australia; [Godfrey, Cody B.; Murphy, Jane E.; Alemi, Farzad; Corvera, Carlos U.] Univ Calif San Francisco, Dept Surg, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Niklas, Christian; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Cottrell, Graeme S.] Univ Reading, Dept Pharm & Pharmacol, Reading Sch Pharm, Reading RG6 6UB, Berks, England; [Lambert, Nevin A.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Erlangen Nuremberg; University of Reading; University System of Georgia; Augusta University	Bunnett, NW (corresponding author), Monash Inst Pharma Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu; carlos.corvera@ucsfmedctr.org	Poole, Daniel/AET-6645-2022	Poole, Daniel/0000-0002-6168-8422; Niklas, Christian/0000-0002-8887-0996; Kocan, Martina/0000-0003-3468-6197; Jensen, Dane D./0000-0001-6540-2375; Cottrell, Graeme/0000-0001-9098-7627; Bunnett, Nigel W./0000-0003-3367-0644; Canals, Meritxell/0000-0002-7942-5006	National Institutes of Health from NIDDK [P30-DK026743]; Northern California Institute for Research and Education; Veterans Health Administration; National Health and Medical Research Council (NHMRC) [63303, 103188]; Monash University; NHMRC [454858]; British Heart Foundation [FS/08/017/25027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Northern California Institute for Research and Education; Veterans Health Administration(US Department of Veterans Affairs); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30-DK026743 from NIDDK (to C. U. C.). This work was also supported by the Northern California Institute for Research and Education, the Veterans Health Administration, National Health and Medical Research Council (NHMRC) Grants 63303 and 103188, and Monash University (to N. W. B.); by NHMRC Grant 454858 (to D. P. P.); and by British Heart Foundation Grant FS/08/017/25027 (to G. S. C.).	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Alemi F, 2013, GASTROENTEROLOGY, V144, P145, DOI 10.1053/j.gastro.2012.09.055; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Evans KA, 2009, J MED CHEM, V52, P7962, DOI 10.1021/jm901434t; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2011, DIGEST DIS, V29, P45, DOI 10.1159/000324127; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kocan M, 2010, FRONT ENDOCRINOL, V1, P12; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lavoie B, 2010, J PHYSIOL-LONDON, V588, P3295, DOI 10.1113/jphysiol.2010.192146; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Olivares-Reyes JA, 2005, MOL PHARMACOL, V68, P356, DOI 10.1124/mol.104.010637; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pols TWH, 2011, DIGEST DIS, V29, P37, DOI 10.1159/000324126; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Savage EE, 2013, BIOTECHNIQUES, V54, P217, DOI 10.2144/000114013; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yang JI, 2007, BIOCHEM BIOPH RES CO, V361, P156, DOI 10.1016/j.bbrc.2007.07.001; Yasuda H, 2007, BIOCHEM BIOPH RES CO, V354, P154, DOI 10.1016/j.bbrc.2006.12.168; Yin X, 2008, MOL PHARMACOL, V74, P1223, DOI 10.1124/mol.108.048504	62	70	70	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22942	22960		10.1074/jbc.M113.455774	http://dx.doi.org/10.1074/jbc.M113.455774			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23818521	Green Published, hybrid			2022-12-25	WOS:000330598200006
J	Prie, D; Forand, A; Francoz, C; Elie, C; Cohen, I; Courbebaisse, M; Eladari, D; Lebrec, D; Durand, F; Friedlander, G				Prie, Dominique; Forand, Anne; Francoz, Claire; Elie, Caroline; Cohen, Isabelle; Courbebaisse, Marie; Eladari, Dominique; Lebrec, Didier; Durand, Francois; Friedlander, Gerard			Plasma Fibroblast Growth Factor 23 Concentration Is Increased and Predicts Mortality in Patients on the Liver-Transplant Waiting List	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM SODIUM; MELD SCORE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; DIETARY PHOSPHATE; GENE-EXPRESSION; FGF-23; FGF23; MODEL; CIRRHOSIS	High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic heart failure. We checked if FGF23 concentration could be modified in patients with end stage liver disease (ESLD) and predict mortality. We measured plasma FGF23 in 200 patients with ESLD registered on a liver transplant waiting list between January 2005 and October 2008. We found that median plasma FGF23 concentration was above normal values in 63% of the patients. Increased FGF23 concentration was not explained by its classical determinants: hyperphosphataemia, increased calcitriol concentration or decreased renal function. FGF23 concentration correlated with the MELD score, serum sodium concentration, and GFR. Forty-six patients died before being transplanted and 135 underwent liver transplantation. We analyzed the prognostic value of FGF23 levels. Mortality was significantly associated with FGF23 levels, the MELD score, serum sodium concentration and glomerular filtration rate. On multivariate analyses only FGF23 concentration was associated with mortality. FGF23 levels were independent of the cause of the liver disease. To determine if the damaged liver can produce FGF23 we measured plasma FGF23 concentration and liver FGF23 mRNA expression in control and diethyl-nitrosamine (DEN)-treated mice. FGF23 plasma levels increased with the apparition of liver lesions in DEN-treated mice and that FGF23 mRNA expression, which was undetectable in the liver of control mice, markedly increased with the development of liver lesions. The correlation between FGF23 plasma concentration and FGF23 mRNA expression in DEN-treated mice suggests that FGF23 production by the liver accounts for the increased plasma FGF23 concentration. In conclusion chronic liver lesions can induce expression of FGF23 mRNA leading to increased FGF23 concentration, which is associated with a higher mortality in patients on a liver-transplant waiting list. In these patients FGF23 concentration was the best predictor of mortality.	[Prie, Dominique; Courbebaisse, Marie] Univ Paris 05, INSERM, Hop Necker Enfants Malad, AP HP,Fac Med,U845, Paris, France; [Forand, Anne; Cohen, Isabelle] INSERM, U845, Paris, France; [Francoz, Claire; Lebrec, Didier; Durand, Francois] Hop Beaujon, INSERM, AP HP, Unite Soins Intensifs,Serv Hepatol, Clichy, France; [Elie, Caroline] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Biostat & Informat Med,Fac Med,EA 4472, Paris, France; [Eladari, Dominique] Univ Paris 05, INSERM, Hop Europe Georges Pompidou, AP HP,Fac Med,INSERM,UMRS 872,Serv Explorat Fonct, Paris, France; [Friedlander, Gerard] Univ Paris 05, INSERM, Hop Europe Georges Pompidou, AP HP,Fac Med,Serv Explorat Fonct & Radio Isotope, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prie, D (corresponding author), Univ Paris 05, INSERM, Hop Necker Enfants Malad, AP HP,Fac Med,U845, Paris, France.	dominique.prie@inserm.fr		Forand, Anne/0000-0003-4970-2372; Durand, Francois/0000-0002-0357-1090; Friedlander, Gerard/0000-0002-6854-4261; Eladari, Dominique/0000-0003-1067-0844; Francoz, Claire/0000-0001-7391-8507	INSERM; Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche [ANR-07-PHYSIO-017-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from INSERM, Universite Paris Descartes, Association Laboratoire de Recherches Physiologiques, and l'Agence Nationale pour la Recherche (ANR-07-PHYSIO-017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Arnlov J, 2012, KIDNEY INT; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Biggins SW, 2005, HEPATOLOGY, V41, P32, DOI 10.1002/hep.20517; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; COX DR, 1972, J R STAT SOC B, V34, P187; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Gotthardt D, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-72; Gruson D, 2012, PEPTIDES, V37, P258, DOI 10.1016/j.peptides.2012.08.003; Gupta A, 2004, J CLIN ENDOCR METAB, V89, P4489, DOI 10.1210/jc.2004-0724; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; JinNo K, 1997, J GASTROENTEROL, V32, P119; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Lang PO, 2012, OSTEOPOROS INT; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londono MC, 2007, GUT, V56, P1283, DOI 10.1136/gut.2006.102764; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; NAGASAKI T, 1991, HEPATOLOGY, V13, P6, DOI 10.1002/hep.1840130103; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Northup PG, 2005, ANN SURG, V242, P244, DOI 10.1097/01.sla.0000171327.29262.e0; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Plischke M, 2011, EUROPEAN J CLIN INVE; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Raimann A, 2013, CONNECT TISSUE RES, V54, P108, DOI 10.3109/03008207.2012.753879; Ruf AE, 2005, LIVER TRANSPLANT, V11, P336, DOI 10.1002/lt.20329; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Seiler S, 2011, EUROPEAN HEART J; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Uematsu S, 2005, J GASTROEN HEPATOL, V20, P583, DOI 10.1111/j.1440-1746.2005.03726.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Yamazaki Y, 2008, J BONE MINER RES, V23, P1509, DOI 10.1359/JBMR.080417; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	56	39	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66182	10.1371/journal.pone.0066182	http://dx.doi.org/10.1371/journal.pone.0066182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825530	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000009
J	Stefos, GC; Soppa, U; Dierssen, M; Becker, W				Stefos, Georgios C.; Soppa, Ulf; Dierssen, Mara; Becker, Walter			NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; DOWN-SYNDROME; GENE-EXPRESSION; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; HUMAN HOMOLOG; KINASE; MINIBRAIN; ROLES	Background: Plasminogen activator inhibitor 1 (PAI-1) is a key regulator of the plasminogen activation system. Although several lines of evidence support a significant role of PAI-1 in the brain, the regulation of its expression in neurons is poorly understood. In the present study we tested the hypothesis that NGF induces the upregulation of PAI-1 via the calcineurin/nuclear factor of activated T cells (NFAT) pathway and analysed whether the overexpression of the Down syndrome-related proteins DYRK1A and RCAN1 modulated the effect of NGF on PAI-1 expression. Results: NGF upregulated PAI-1 mRNA levels in primary mouse hippocampal neurons cultured for 3 days in vitro and in the rat pheochromocytoma cell line PC12. Reporter gene assays revealed that NGF activated the calcineurin/NFAT pathway in PC12 cells. Induction of PAI-1 by NGF was sensitive to the calcineurin inhibitor FK506 and the specific inhibition of NFAT activation by the cell permeable VIVIT peptide. Activation of calcineurin/NFAT signalling through other stimuli resulted in a much weaker induction of PAI-1 expression, suggesting that other NGF-induced pathways are involved in PAI-1 upregulation. Overexpression of either DYRK1A or RCAN1 negatively regulated NFAT-dependent transcriptional activity and reduced the upregulation of PAI-1 levels by NGF. Conclusion: The present results show that the calcineurin/NFAT pathway mediates the upregulation of PAI-1 by NGF. The negative effect of DYRK1A and RCAN1 overexpression on NGF signal transduction in neural cells may contribute to the altered neurodevelopment and brain function in Down syndrome.	[Stefos, Georgios C.; Soppa, Ulf; Becker, Walter] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany; [Stefos, Georgios C.; Dierssen, Mara] Pompeu Fabra Univ, Ctr Genom Regulat, Syst Biol Programme, Barcelona, Spain; [Stefos, Georgios C.; Dierssen, Mara] Ctr Invest Biomed Red Enfermedades Raras, Barcelona, Spain	RWTH Aachen University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Stefos, GC (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany.	stegi121@yahoo.gr	Becker, Walter/B-8889-2008; Dierssen, Mara/G-3552-2015	Becker, Walter/0000-0002-0347-4768; Dierssen, Mara/0000-0003-0853-6865; Stefos, Georgios/0000-0001-7832-6965	Alexander von Humboldt Stiftung, Germany; Jerome Lejeune Foundation, France; Spanish Ministry of Science and Innovation [SAF2010-16427]; European Union [PS09102673]; Friedrich-Naumann-Foundation, Germany	Alexander von Humboldt Stiftung, Germany(Alexander von Humboldt Foundation); Jerome Lejeune Foundation, France; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Friedrich-Naumann-Foundation, Germany	This work was supported by grants from the Alexander von Humboldt Stiftung, Germany (GCS), the Jerome Lejeune Foundation, France (WB), the Spanish Ministry of Science and Innovation SAF2010-16427 (MD), the European Union CureFXS ERare- FIS PS09102673 (MD) and the Friedrich-Naumann-Foundation, Germany (US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukawa H, 2009, MOL VIS, V15, P451; Ahamed J, 2004, J IMMUNOL, V172, P6961, DOI 10.4049/jimmunol.172.11.6961; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BANKER G, 1998, CULTURING NERVE CELL; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de la Luna S, 2006, TRENDS MOL MED, V12, P451, DOI 10.1016/j.molmed.2006.08.001; Dierssen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017010; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Goldberg HJ, 2002, J BIOL CHEM, V277, P33833, DOI 10.1074/jbc.M112331200; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Harslund J, 2007, AM J PHYSIOL-REG I, V293, pR1630, DOI 10.1152/ajpregu.00380.2007; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hopkins WE, 2000, AM J CARDIOL, V85, P784, DOI 10.1016/S0002-9149(99)00864-4; Jankun J, 2009, POL ARCH MED WEWN, V119, P410, DOI 10.20452/pamw.729; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Lee MH, 2010, J LIPID RES, V51, P2619, DOI 10.1194/jlr.M003988; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Lopez S, 1999, THROMB HAEMOSTASIS, V81, P415, DOI 10.1055/s-0037-1614488; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Minneman KP, 2000, J NEUROCHEM, V74, P2392, DOI 10.1046/j.1471-4159.2000.0742392.x; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nguyen T, 2009, J BIOL CHEM, V284, P18816, DOI 10.1074/jbc.M109.015719; Nico B, 2008, MICROVASC RES, V75, P135, DOI 10.1016/j.mvr.2007.07.004; Pandey M, 2005, FASEB J, V19, P1317, DOI 10.1096/fj.04-3459fje; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Papadopoulos C, 2011, J BIOL CHEM, V286, P5494, DOI 10.1074/jbc.M110.157909; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Peiretti F, 1996, BLOOD, V87, P162; Prasai P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-90; Rahmani Z, 1998, BIOCHEM BIOPH RES CO, V253, P514, DOI 10.1006/bbrc.1998.9803; Ren S, 2000, AM J PHYSIOL-ENDOC M, V278, pE656, DOI 10.1152/ajpendo.2000.278.4.E656; Ryeom S, 2009, J CRANIOFAC SURG, V20, P595, DOI 10.1097/SCS.0b013e3181927f47; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Shin SY, 2011, J CELL SCI, V124, P82, DOI 10.1242/jcs.076034; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Soeda S, 2006, NEUROSCIENCE, V141, P101, DOI 10.1016/j.neuroscience.2006.03.026; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Takahashi H, 2000, NEUROREPORT, V11, P1111, DOI 10.1097/00001756-200004070-00040; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vician L, 1997, J NEUROSCI RES, V50, P32, DOI 10.1002/(SICI)1097-4547(19971001)50:1<32::AID-JNR4>3.0.CO;2-M; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Yeh CC, 2009, ARTHRITIS RHEUM-US, V60, P2350, DOI 10.1002/art.24680; Zhao J, 2008, CELL RES, V18, P803, DOI 10.1038/cr.2008.89	72	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67470	10.1371/journal.pone.0067470	http://dx.doi.org/10.1371/journal.pone.0067470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825664	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000104
J	Wu, LP; Li, YC; Zhao, JL; Zheng, C; Chen, JH; Hong, J; Lin, JX; Li, J; Li, J; Ji, KT; Lin, JF				Wu Lian-Pin; Li Yue-Chun; Zhao Jing-Lin; Zheng Cheng; Chen Jun-Hua; Hong Jun; Lin Jia-Xuan; Li Jin; Li Jia; Ji Kang-Ting; Lin Jia-Feng			Catheter Ablation of Idiopathic Premature Ventricular Contractions and Ventricular Tachycardias Originating from Right Ventricular Septum	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC CHARACTERISTICS	Background: Idiopathic premature ventricular contractions (PVCs) and ventricular tachycardias (IVTs) originating from the subtricuspid septum and near the His bundle have been reported. However, little is known about the prevalence, distribution, electrocardiographic characteristics and the efficacy of radiofrequency catheter ablation (RFCA) for the ventricular arrhythmias arising from the right ventricular (RV) septum. This study aimed to investigate electrocardiographic characteristics and effects of RFCA for patients with symptomatic PVCs/IVTs, originating from the different portions of the RV septum. Methodology/Principal Findings: Characteristics of body surface electrocardiogram and electrophysiologic recordings were analyzed in 29 patients with symptomatic PVCs/IVTs originating from the RV septum. Among 581 patients with PVCs/IVTs, the incidence of ventricular arrhythmias originating from the RV septum was 5%. Twenty (69%) had PVCs/IVTs from the septal portion of the tricuspid valvular RV region (3 from superoseptum, 15 from midseptum, 2 from inferoseptum), and 9 (31%) from the septal portion of the basal RV (1 from superoseptum, 4 from midseptum, 4 from inferoseptum). There were different characteristics of ECG of PVCs/VT originating from the different portions of the RV septum. Twenty-seven of 29 patients with PVCs/IVTs arising from the RV septum were successfully ablated (93.1% acute success). Conclusions/Significance: ECG characteristics of PVCs/VTs originating from the different portions of the RV septum are different, and can help regionalize the origin of these arrhythmias. The septal portion of the tricuspid valvular RV region was the preferential site of origin. RFCA was effective and safe for the PVCs/IVTs arising from the RV septum.	[Wu Lian-Pin; Li Yue-Chun; Zhao Jing-Lin; Zheng Cheng; Chen Jun-Hua; Hong Jun; Lin Jia-Xuan; Li Jin; Li Jia; Ji Kang-Ting; Lin Jia-Feng] Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China	Wenzhou Medical University	Lin, JF (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China.	linjiafeng_wzmcfey@163.com			Wenzhou Municipal Science and Technology Commission [Y2008086]; Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association, China [2011ZYC-A27]	Wenzhou Municipal Science and Technology Commission; Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association, China	This study is supported by Wenzhou Municipal Science and Technology Commission (Grant No. Y2008086) and Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association (Grant No. 2011ZYC-A27), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan V, 2006, HEART RHYTHM, V3, P1132, DOI 10.1016/j.hrthm.2006.06.024; Ceresnak SR, 2012, J ELECTROCARDIOL, V45, P385, DOI 10.1016/j.jelectrocard.2012.03.009; COGGINS DL, 1994, J AM COLL CARDIOL, V23, P1333, DOI 10.1016/0735-1097(94)90375-1; Li YC, 2013, INT J CARDIOL, V167, P2673, DOI 10.1016/j.ijcard.2012.06.119; Navarrete A, 2008, EUROPACE, V10, P1343, DOI 10.1093/europace/eun239; Satish OS, 2005, EUROPACE, V7, P348, DOI 10.1016/j.eupc.2005.02.122; Tada H, 2007, HEART RHYTHM, V4, P7, DOI 10.1016/j.hrthm.2006.09.025; Tsai CF, 1997, INT J CARDIOL, V62, P143, DOI 10.1016/S0167-5273(97)00198-8; Van Herendael H, 2011, HEART RHYTHM, V8, P511, DOI 10.1016/j.hrthm.2010.11.044; Yamauchi Y, 2005, J CARDIOVASC ELECTR, V16, P1041, DOI 10.1111/j.1540-8167.2005.40787.x; Yue-Chun Li, 2012, BMC Cardiovasc Disord, V12, P32, DOI 10.1186/1471-2261-12-32	11	8	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67038	10.1371/journal.pone.0067038	http://dx.doi.org/10.1371/journal.pone.0067038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825610	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000062
J	Yoon, Y; Yoon, J; Jang, MY; Na, Y; Ko, Y; Choi, JH; Seok, SH				Yoon, Yina; Yoon, Jihye; Jang, Man-Young; Na, Yirang; Ko, Youngho; Choi, Jae-Hoon; Seok, Seung Hyeok			High Cholesterol Diet Induces IL-1 beta Expression in Adult but Not Larval Zebrafish	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; ZINC-FINGER NUCLEASES; MOUSE MODELS; HYPERCHOLESTEROLEMIC ZEBRAFISH; LIPID-ACCUMULATION; TNF-ALPHA; ATHEROSCLEROSIS; DISEASE; INTERLEUKIN-1-BETA; TALENS	Recently, it has been demonstrated that high cholesterol diet induced hypercholesterolemia and vascular lipid oxidation and accumulation in zebrafish larvae, suggesting that zebrafish is a new promising atherosclerosis model in addition to mouse models. However, up to date, there was no report regarding inflammatory cytokine expression during the lipid accumulation in zebrafish larva and adult fish. In this study, we first demonstrated the expression levels of IL-1 beta and TNF-alpha in high cholesterol diet (HCD)-fed zebrafish larvae, and found that although HCD induced vascular lipid accumulation, the cytokine expressions in the larvae were not changed by HCD. Furthermore, there was no significant difference in leukocyte accumulation in vessels between control and HCD fed group. But prolonged HCD induced IL-1 beta expression in spleen and liver compared to those of control zebrafish, and produced very early stage of fatty streak lesion in dorsal aorta of 19 week HCD-fed zebrafish. These results indicate that HCD induced hypercholesterolemia and atherosclerotic changes in zebrafish are very early stage, and suggest the necessity of the generation of mutant zebrafish having a disruption in a lipid metabolism-related gene leading to severe hypercholesterolemia and advanced atherosclerosis.	[Yoon, Yina; Na, Yirang; Ko, Youngho; Seok, Seung Hyeok] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Yoon, Yina; Na, Yirang; Ko, Youngho; Seok, Seung Hyeok] Seoul Natl Univ, Coll Med, Inst Endem Dis, Seoul, South Korea; [Yoon, Jihye; Jang, Man-Young; Choi, Jae-Hoon] Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea; [Yoon, Jihye; Jang, Man-Young; Choi, Jae-Hoon] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hanyang University	Choi, JH (corresponding author), Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea.	jchoi75@hanyang.ac.kr; lamseok@snu.ac.kr	Choi, Jae-Hoon/R-6224-2016; Seok, Seung Hyeok/J-3279-2012	Choi, Jae-Hoon/0000-0002-5265-3463; Seok, Seung Hyeok/0000-0002-4315-0688	Ministry of Education, Science and Technology, Korea [2011-0005843]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, South Korea [2011-0013669]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was funded by the Ministry of Education, Science and Technology, Korea (2011-0005843) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, South Korea (2011-0013669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestrom P, 2006, TRENDS BIOTECHNOL, V24, P15, DOI 10.1016/j.tibtech.2005.11.004; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fang LH, 2011, J CLIN INVEST, V121, P4861, DOI 10.1172/JCI57755; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lei L, 2009, J LIPID RES, V50, P1057, DOI 10.1194/jlr.M800484-JLR200; Lewis JD, 2005, CANCER RES, V65, P2938, DOI 10.1158/0008-5472.CAN-04-2874; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Ozeren A, 2003, MEDIAT INFLAMM, V12, P361, DOI 10.1080/09629350310001633360; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schonbeck U, 2002, CIRCULATION, V106, P2888, DOI 10.1161/01.CIR.0000043029.52803.7B; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	28	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66970	10.1371/journal.pone.0066970	http://dx.doi.org/10.1371/journal.pone.0066970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825600	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000054
J	Zheng, ZJ; Hong, L; Huang, XD; Yang, PR; Li, J; Ding, Y; Yao, RE; Geng, J; Shen, YN; Shen, YP; Fu, QH; Yu, YG				Zheng, Zhaojing; Hong, Li; Huang, Xiaodong; Yang, Peirong; Li, Juan; Ding, Yu; Yao, Ru-en; Geng, Juan; Shen, Yongnian; Shen, Yiping; Fu, Qihua; Yu, Yongguo			Screening for Coding Variants in FTO and SH2B1 Genes in Chinese Patients with Obesity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; CHILDHOOD OBESITY; FAT MASS; RNA; PREVALENCE; OVERWEIGHT; SUBSTRATE; DELETIONS; CHILDREN	Objective: To investigate potential functional variants in FTO and SH2B1 genes among Chinese children with obesity. Methods: Sanger sequencing of PCR products of all FTO and SH2B1 exons and their flanking regions were performed in 338 Chinese Han children with obesity and 221 age- and sex-matched lean controls. Results: A total of seven and five rare non-synonymous variants were identified in FTO and SH2B1, respectively. The overall frequencies of FTO and SH2B1 rare non-synonymous variants were similar in obese and lean children (2.37% and 0.90% vs. 1.81% and 1.36%, P>0.05). However, four out of the seven variants in FTO were novel and all were unique to obese children (p>0.05). None of the novel variants was consistently being predicted to be deleterious. Four out of five variants in SH2B1 were novel and one was unique to obese children (p>0.05). One variant (L293R) that was consistently being predicted as deleterious in SH2B1 gene was unique to lean control. While rare missense mutations were more frequently detected in girls from obesity as well as lean control than boys, the difference was not statistically significant. In addition, it's shown that the prevalence of rare missense mutations of FTO as well as SH2B1 was similar across different ethnic groups. Conclusion: The rare missense mutations of FTO and SH2B1 did not confer risks of obesity in Chinese Han children in our cohort.	[Zheng, Zhaojing; Yao, Ru-en; Geng, Juan; Shen, Yiping; Fu, Qihua] Shanghai Jiao Tong Univ, Dept Lab Med, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Hong, Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Nutr, Shanghai 200030, Peoples R China; [Huang, Xiaodong; Yang, Peirong; Li, Juan; Ding, Yu; Shen, Yongnian; Yu, Yongguo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Internal Med, Shanghai 200030, Peoples R China; [Shen, Yiping] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Boston Children's Hospital	Fu, QH (corresponding author), Shanghai Jiao Tong Univ, Dept Lab Med, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China.	qfu@shsmu.edu.cn; yuyongguo@shsmu.edu.cn	Fu, Qihua/AAW-9989-2020	yu, yongguo/0000-0002-4472-0910	Project HOPE "The Abbott Fund Institute of Nutrition Science" [AFINS-HOPE-2013-05]; Shanghai Jiaotong University Cross Biomedical Engineering [YG-2011-MS28]; National Natural Science Foundation of China [81000346]; Shanghai Science & Technology Commission Major Project [11dz1950300]	Project HOPE "The Abbott Fund Institute of Nutrition Science"; Shanghai Jiaotong University Cross Biomedical Engineering; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Commission Major Project	This work was supported by Project HOPE "The Abbott Fund Institute of Nutrition Science (AFINS-HOPE-2013-05, to YGY)", the other is Shanghai Jiaotong University Cross Biomedical Engineering (YG-2011-MS28, to YGY). This study is further supported by grant from the National Natural Science Foundation of China (No. 81000346, to YGY), and grant from Shanghai Science & Technology Commission Major Project (No. 11dz1950300, to YGY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Deliard S, 2013, OBESITY, V21, P159, DOI 10.1002/oby.20147; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sallman Almen M, 2012, INT J OBESITY, DOI [10.1038/ijo.2012.57, DOI 10.1038/IJ0.2012.57.[]; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang H, 2011, PROTECTING PRIVACY IN CHINA: A RESEARCH ON CHINAS PRIVACY STANDARDS AND THE POSSIBILITY OF ESTABLISHING THE RIGHT TO PRIVACY AND THE INFORMATION PRIVACY PROTECTION LEGISLATION IN MODERN CHINA, P1, DOI 10.1007/978-3-642-21750-0_1; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	38	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67039	10.1371/journal.pone.0067039	http://dx.doi.org/10.1371/journal.pone.0067039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825611	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000063
J	Fiers, M; Lognay, G; Fauconnier, ML; Jijakli, MH				Fiers, Marie; Lognay, Georges; Fauconnier, Marie-Laure; Jijakli, M. Haiassam			Volatile Compound-Mediated Interactions between Barley and Pathogenic Fungi in the Soil	PLOS ONE			English	Article							GAS CHROMATOGRAPHY-OLFACTOMETRY; ORGANIC-COMPOUNDS VOCS; AROMA COMPOUNDS; RETENTION INDEXES; ACTIVE COMPOUNDS; PLANT VOLATILES; CROWN ROT; IDENTIFICATION; FLAVOR; BIOSYNTHESIS	Plants are able to interact with their environment by emitting volatile organic compounds. We investigated the volatile interactions that take place below ground between barley roots and two pathogenic fungi, Cochliobolus sativus and Fusarium culmorum. The volatile molecules emitted by each fungus, by non-infected barley roots and by barley roots infected with one of the fungi or the two of them were extracted by head-space solid phase micro extraction and analyzed by gas chromatography mass spectrometry. The effect of fungal volatiles on barley growth and the effect of barley root volatiles on fungal growth were assessed by cultivating both organisms in a shared atmosphere without any physical contact. The results show that volatile organic compounds, especially terpenes, are newly emitted during the interaction between fungi and barley roots. The volatile molecules released by non-infected barley roots did not significantly affect fungal growth, whereas the volatile molecules released by pathogenic fungi decreased the length of barley roots by 19 to 21.5% and the surface of aerial parts by 15%. The spectrum of the volatiles released by infected barley roots had no significant effect on F. culmorum growth, but decreased C. sativus growth by 13 to 17%. This paper identifies the volatile organic compounds emitted by two pathogenic fungi and shows that pathogenic fungi can modify volatile emission by infected plants. Our results open promising perspectives concerning the biological control of edaphic diseases.	[Fiers, Marie; Jijakli, M. Haiassam] Univ Liege, Gembloux Agrobio Tech GxABT, Phytopathol Unit, Gembloux, Belgium; [Lognay, Georges] Univ Liege, Gembloux Agrobio Tech GxABT, Analyt Chem Lab, Gembloux, Belgium; [Fauconnier, Marie-Laure] Univ Liege, Gembloux Agrobio Tech GxABT, Gen & Organ Chem Unit, Gembloux, Belgium	University of Liege; University of Liege; University of Liege	Fauconnier, ML (corresponding author), Univ Liege, Gembloux Agrobio Tech GxABT, Gen & Organ Chem Unit, Gembloux, Belgium.	Marie-Laure.Fauconnier@ulg.ac.be	Fauconnier, Marie-Laure/AAB-9807-2020	Fauconnier, Marie-Laure/0000-0002-2027-3896	University of Liege - Gembloux Agro-Bio Tech	University of Liege - Gembloux Agro-Bio Tech	This study was financially supported by the University of Liege - Gembloux Agro-Bio Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa LCA, 2009, MOLECULES, V14, P160, DOI 10.3390/molecules14010160; BERGER RG, 1989, Z LEBENSM UNTERS FOR, V188, P122, DOI 10.1007/BF01042735; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Bianchi F, 2007, J SEP SCI, V30, P563, DOI 10.1002/jssc.200600393; BINDER RG, 1990, J AGR FOOD CHEM, V38, P1053, DOI 10.1021/jf00094a030; Blom D, 2011, ENVIRON MICROBIOL, V13, P3047, DOI 10.1111/j.1462-2920.2011.02582.x; Carrapiso AI, 2002, J AGR FOOD CHEM, V50, P6453, DOI 10.1021/jf025526c; Cavalli JF, 2003, FLAVOUR FRAG J, V18, P532, DOI 10.1002/ffj.1263; Choi HS, 2003, J AGR FOOD CHEM, V51, P2687, DOI 10.1021/jf021069o; CHUNG TY, 1993, J AGR FOOD CHEM, V41, P1693, DOI 10.1021/jf00034a033; Claeson AS, 2007, J ENVIRON MONITOR, V9, P240, DOI 10.1039/b614766f; Cullere L, 2004, J AGR FOOD CHEM, V52, P1653, DOI 10.1021/jf0350820; DASTUR J. F., 1942, Indian Journal of Agricultural Science, V12, P731; DAVIES NW, 1990, J CHROMATOGR, V503, P1, DOI 10.1016/S0021-9673(01)81487-4; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Ferreira V, 2001, J AGR FOOD CHEM, V49, P4818, DOI 10.1021/jf010283u; FISCHER KH, 1987, LEBENSM WISS TECHNOL, V20, P233; Fukami K, 2002, J AGR FOOD CHEM, V50, P5412, DOI 10.1021/jf020405y; Garbeva P, 2011, SOIL BIOL BIOCHEM, V43, P469, DOI 10.1016/j.soilbio.2010.11.020; Hamm S, 2004, J SEP SCI, V27, P235, DOI 10.1002/jssc.200301611; Hayata Y, 2003, J AGR FOOD CHEM, V51, P3415, DOI 10.1021/jf0209950; Hiltpold I, 2011, PLANT CELL ENVIRON, V34, P1; Hognadottir A, 2003, J CHROMATOGR A, V998, P201, DOI 10.1016/S0021-9673(03)00524-7; Jelen H, 1997, J MICROBIOL METH, V31, P45, DOI 10.1016/S0167-7012(97)00088-2; Jennings W., 1980, QUALITATIVE ANAL FLA; Jerkovic I, 2003, PHYTOCHEMISTRY, V63, P109, DOI 10.1016/S0031-9422(02)00706-9; Jurjevic Z, 2008, PHYTOPATHOL MEDITERR, V47, P266; Karimi S, 2001, J NAT PROD, V64, P406, DOI 10.1021/np000550a; Kumar J, 2002, MOL PLANT PATHOL, V3, P185, DOI 10.1046/j.1364-3703.2002.00120.x; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Lodewyk MW, 2008, J ORG CHEM, V73, P6570, DOI 10.1021/jo800868r; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Maeztu L, 2001, J AGR FOOD CHEM, V49, P5437, DOI 10.1021/jf0107959; Mahmood U, 2004, PHYTOCHEMISTRY, V65, P2163, DOI 10.1016/j.phytochem.2004.04.003; Mancini E, 2009, MOLECULES, V14, P4725, DOI 10.3390/molecules14114725; Mathre DE, 2003, PLANT HLTH PROGR, DOI [10.1094/PHP-2003-0819-01-DG, DOI 10.1094/PHP-2003-0819-01-DG]; Matysik S, 2009, CHEMOSPHERE, V76, P114, DOI 10.1016/j.chemosphere.2009.02.010; MELLON JE, 1979, PLANT PHYSIOL, V64, P406, DOI 10.1104/pp.64.3.406; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Murray GM, 2010, AUSTRALAS PLANT PATH, V39, P85, DOI 10.1071/AP09064; OKUDA M, 1967, PLANTA, V72, P289; Pennarun AL, 2002, J SCI FOOD AGR, V82, P1652, DOI 10.1002/jsfa.1236; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; PIENING LJ, 1976, CAN J PLANT SCI, V56, P419, DOI 10.4141/cjps76-070; PIERS E, 1977, CAN J CHEM, V55, P1039, DOI 10.1139/v77-145; Piesik D, 2013, J APPL ENTOMOL, V137, P296, DOI 10.1111/j.1439-0418.2012.01742.x; Piesik D, 2011, J PLANT PHYSIOL, V168, P878, DOI 10.1016/j.jplph.2010.11.010; PIRY J, 1995, FOOD CHEM, V54, P73, DOI 10.1016/0308-8146(95)92665-7; Priestap HA, 2003, PHYTOCHEMISTRY, V63, P221, DOI 10.1016/S0031-9422(02)00751-3; Rasmann S, 2008, OIKOS, V117, P362, DOI 10.1111/j.2007.0030-1299.16204.x; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Rose LJ, 2000, CURR MICROBIOL, V41, P206, DOI 10.1007/s002840010120; Ruther J, 2000, J CHROMATOGR A, V890, P313, DOI 10.1016/S0021-9673(00)00618-X; RYCHLIK M, 1998, COMPILATION ODOR THR, P63; Sanz C, 2001, J AGR FOOD CHEM, V49, P1364, DOI 10.1021/jf001100r; Schmelz EA, 2011, P NATL ACAD SCI USA, V108, P5455, DOI 10.1073/pnas.1014714108; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; Semighini CP, 2008, FEMS MICROBIOL LETT, V279, P259, DOI 10.1111/j.1574-6968.2007.01042.x; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Ulrich D, 1997, Z LEBENSM UNTERS F A, V205, P218, DOI 10.1007/s002170050154; Umano K, 2000, J AGR FOOD CHEM, V48, P3463, DOI 10.1021/jf0001738; Umano K, 2002, J AGR FOOD CHEM, V50, P5355, DOI 10.1021/jf0203951; Valim MF, 2003, J AGR FOOD CHEM, V51, P1010, DOI 10.1021/jf025738+; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Varming C, 2004, J AGR FOOD CHEM, V52, P1647, DOI 10.1021/jf035133t; Wagacha JM, 2007, CROP PROT, V26, P877, DOI 10.1016/j.cropro.2006.09.003; Weckerle B, 2001, FLAVOUR FRAG J, V16, P360, DOI 10.1002/ffj.1012; Wenda-Piesik A, 2010, INT J PEST MANAGE, V56, P377, DOI 10.1080/09670874.2010.505668; Wheatley RE, 2002, ANTON LEEUW INT J G, V81, P357, DOI 10.1023/A:1020592802234; Wiese MV, 1977, COMPENDIUM WHEAT DIS, p[xii, 106]; WONG JM, 1988, J AGR FOOD CHEM, V36, P123, DOI 10.1021/jf00079a032; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	78	41	44	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66805	10.1371/journal.pone.0066805	http://dx.doi.org/10.1371/journal.pone.0066805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818966	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800103
J	Adams, AC; Halstead, CA; Hansen, BC; Irizarry, AR; Martin, JA; Myers, SR; Reynolds, VL; Smith, HW; Wroblewski, VJ; Kharitonenkov, A				Adams, Andrew C.; Halstead, Carolyn A.; Hansen, Barbara C.; Irizarry, Armando R.; Martin, Jennifer A.; Myers, Sharon R.; Reynolds, Vincent L.; Smith, Holly W.; Wroblewski, Victor J.; Kharitonenkov, Alexei			LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys	PLOS ONE			English	Article							INSULIN SENSITIVITY; ENERGY-EXPENDITURE; GROWTH; FGF-21	Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that represents a promising target for the treatment of several metabolic diseases. Administration of recombinant wild type FGF21 to diabetic animals leads to a dramatic improvement in glycaemia and ameliorates other systemic measures of metabolic health. Here we report the pharmacologic outcomes observed in non-human primates upon administration of a recently described FGF21 analogue, LY2405319 (LY). Diabetic rhesus monkeys were treated subcutaneously with LY once daily for a period of seven weeks. The doses of LY used were 3, 9 and 50 mg/kg each delivered in an escalating fashion with washout measurements taken at 2, 4, 6 and 8 weeks following the final LY dose. LY therapy led to a dramatic and rapid lowering of several important metabolic parameters including glucose, body weight, insulin, cholesterol and triglyceride levels at all doses tested. In addition, we observed favorable changes in circulating profiles of adipokines, with increased adiponectin and reduced leptin indicative of direct FGF21 action on adipose tissue. Importantly, and for the first time we show that FGF21 based therapy has metabolic efficacy in an animal with late stage diabetes. While the glycemic efficacy of LY in this animal was partially attenuated its lipid lowering effect was fully preserved suggesting that FGF21 may be a viable treatment option even in patients with advanced disease progression. These findings support continued exploration of the FGF21 pathway for the treatment of metabolic disease.	[Adams, Andrew C.; Halstead, Carolyn A.; Irizarry, Armando R.; Martin, Jennifer A.; Myers, Sharon R.; Reynolds, Vincent L.; Smith, Holly W.; Wroblewski, Victor J.; Kharitonenkov, Alexei] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Hansen, Barbara C.] Univ S Florida, Ctr Preclin Res, Tampa, FL USA	Eli Lilly; State University System of Florida; University of South Florida	Kharitonenkov, A (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	a.kharch@lilly.com	Hansen, Barbara C/J-8723-2012	Hansen, Barbara C/0000-0001-9646-3525	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	The study was funded by Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Gimeno RE, 2012, MOL METABOLISM, P1; Hansen Barbara C, 2012, Methods Mol Biol, V933, P177, DOI 10.1007/978-1-62703-068-7_11; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2012, PLOS ONE; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Moller DE, 2012, CELL METAB, V15, P19, DOI 10.1016/j.cmet.2011.10.012; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Tharakan G, 2011, TRENDS PHARMACOL SCI, V32, P8, DOI 10.1016/j.tips.2010.10.003; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Warner A, 2012, J NEUROENDOCRINOL; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	23	128	138	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65763	10.1371/journal.pone.0065763	http://dx.doi.org/10.1371/journal.pone.0065763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823755	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400021
J	Ho, EL; Ronquillo, R; Altmeppen, H; Spudich, SS; Price, RW; Sinclair, E				Ho, Emily L.; Ronquillo, Rollie; Altmeppen, Hermann; Spudich, Serena S.; Price, Richard W.; Sinclair, Elizabeth			Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIPLE-SCLEROSIS PATIENTS; CENTRAL-NERVOUS-SYSTEM; CD8(+) T-CELLS; ANTIRETROVIRAL THERAPY; HIV-1 INFECTION; PERIPHERAL-BLOOD; VIRAL LOAD; NEUROCOGNITIVE DISORDERS; TREATMENT INTERRUPTION	In order to characterize the cellular composition of cerebrospinal fluid (CSF) in a healthy state and in the setting of chronic pleocytosis associated with HIV-1 (HIV) infection, multi-parameter flow cytometry was used to identify and quantitate cellular phenotypes in CSF derived from HIV-uninfected healthy controls and HIV-infected subjects across a spectrum of disease and treatment. CD4+ T cells were the most frequent CSF population and the CD4:CD8 ratio was significantly increased in the CSF compared to blood (p = 0.0232), suggesting preferential trafficking of CD4+ over CD8+ T cells to this compartment. In contrast, in HIV-infection, CD8+ T cells were the major cellular component of the CSF and were markedly increased compared to HIV-uninfected subjects (p<0.001). As with peripheral blood, the CSF CD4:CD8 ratio was reversed in HIV-infected subjects compared to HIV-uninfected subjects. Monocytes, B cells and NK cells were rare in the CSF in both groups, although absolute counts of CSF NK cells and B cells were significantly increased in HIV-infected subjects (p<0.05). Our studies show that T cells are the major cellular component of the CSF in HIV-infected and uninfected subjects. The CSF pleocytosis characteristic of HIV infection involves all lymphocyte subsets we measured, except for CD4+ T cells, but is comprised primarily of CD8+ T cells. The reduced proportion of CD4+ T cells in the CSF may reflect both HIV-related peripheral loss and changes in trafficking patterns in response to HIV infection in the central nervous system.	[Ho, Emily L.] Univ Washington, Harborview Med Ctr, Dept Neurol, Seattle, WA 98104 USA; [Ronquillo, Rollie] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Altmeppen, Hermann] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Spudich, Serena S.] Yale Univ, Dept Neurol, New Haven, CT USA; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Sinclair, Elizabeth] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Rush University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sinclair, E (corresponding author), Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.	esinclair@sfgh.ucsf.edu	Ho, Emily Lin/AAR-4815-2021	Altmeppen, Hermann/0000-0001-9439-6533	American Academy of Neurology Clinical Research Training Fellowship; National Institutes of Health (UCSF-GIVI Center for AIDS Research) [R01 MH62701, R01 NS37660, R01 NS43103, K23 MH074466, P30AI027763]; NCRR UCSF-CTSI [UL1RR024131]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	American Academy of Neurology Clinical Research Training Fellowship; National Institutes of Health (UCSF-GIVI Center for AIDS Research); NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the subjects who volunteered for these studies, the staff of the San Francisco General Hospital (SFGH)/University of California-San Francisco (UCSF) General Clinical Research Center, the GIVI/UCSF CFAR Immunology Core and the AIDS Research Institute-UCSF Laboratory of Clinical Virology for their invaluable help. E.L.H. was a recipient of the American Academy of Neurology Clinical Research Training Fellowship.; This study was funded by grants from the National Institutes of Health: R01 MH62701; R01 NS37660; R01 NS43103; K23 MH074466; P30AI027763 (UCSF-GIVI Center for AIDS Research); UL1RR024131 (NCRR UCSF-CTSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Cepok S, 2003, ARCH NEUROL-CHICAGO, V60, P849, DOI 10.1001/archneur.60.6.849; Cepok S, 2007, ANN NEUROL, V62, P458, DOI 10.1002/ana.21195; Cepok S, 2006, J NEUROIMMUNOL, V180, P33, DOI 10.1016/j.jneuroim.2006.06.031; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; de Graaf MT, 2011, CYTOM PART B-CLIN CY, V80B, P271, DOI 10.1002/cyto.b.20603; de Graaf MT, 2011, CYTOM PART B-CLIN CY, V80B, P43, DOI 10.1002/cyto.b.20542; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Garcia F, 1999, AIDS, V13, P1491, DOI 10.1097/00002030-199908200-00008; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gregoire C, 2008, EUR J IMMUNOL, V38, P2076, DOI 10.1002/eji.200838550; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; HOLLANDER H, 1987, AM J MED, V83, P813, DOI 10.1016/0002-9343(87)90635-8; KATZ RL, 1989, ACTA CYTOL, V33, P233; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; MARGOLICK JB, 1988, J NEUROIMMUNOL, V20, P73, DOI 10.1016/0165-5728(88)90116-6; Marra CM, 2004, NEUROLOGY, V63, P85, DOI 10.1212/01.WNL.0000131902.69113.34; MARSHALL DW, 1988, ARCH NEUROL-CHICAGO, V45, P954, DOI 10.1001/archneur.1988.00520330032007; Maxeiner HG, 2009, BRAIN BEHAV IMMUN, V23, P134, DOI 10.1016/j.bbi.2008.08.003; MCARTHUR JC, 1988, ANN NEUROL, V23, pS34, DOI 10.1002/ana.410230712; MCARTHUR JH, 1988, NURS CLIN N AM, V23, P823; Morris L, 1998, J INFECT DIS, V177, P473, DOI 10.1086/517379; Neuenburg JK, 2005, JAIDS-J ACQ IMM DEF, V39, P16, DOI 10.1097/01.qai.0000155036.03004.a0; Neuenburg JK, 2005, AIDS, V19, P1351, DOI 10.1097/01.aids.0000181008.39514.ee; Neuenburg JK, 2004, JAIDS-J ACQ IMM DEF, V37, P1237, DOI 10.1097/01.qai.0000136733.09275.fa; NORONHA A, 1985, ANN NEUROL, V18, P722, DOI 10.1002/ana.410180617; Okuda Y, 2005, J NEUROL SCI, V235, P11, DOI 10.1016/j.jns.2005.02.013; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Price RW, 2004, J NEUROVIROL, V10, P44, DOI 10.1080/jnv.10.s1.44.51; Price RW, 2001, AIDS, V15, P1251, DOI 10.1097/00002030-200107060-00006; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; SCOLOZZI R, 1992, J NEUROL SCI, V108, P93, DOI 10.1016/0022-510X(92)90193-O; Shacklett BL, 2004, J INFECT DIS, V189, P2202, DOI 10.1086/421244; Sinclair E, 2008, JAIDS-J ACQ IMM DEF, V47, P544, DOI 10.1097/QAI.0b013e318162754f; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Spudich S, 2006, J INFECT DIS, V194, P1686, DOI 10.1086/508750; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Svenningsson A, 1995, J NEUROIMMUNOL, V63, P39, DOI 10.1016/0165-5728(95)00126-3; TRAUGOTT U, 1978, J NEUROL, V219, P185, DOI 10.1007/BF00314534; VANWIELINK G, 1990, NEUROLOGY, V40, P816, DOI 10.1212/WNL.40.5.816	46	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66188	10.1371/journal.pone.0066188	http://dx.doi.org/10.1371/journal.pone.0066188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822975	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400064
J	Liu, M; Wang, JH; Jiang, B; Sun, DL; Wu, L; Yang, SS; Wang, YY; Li, XY; He, Y				Liu, Miao; Wang, Jianhua; Jiang, Bin; Sun, Dongling; Wu, Lei; Yang, Shanshan; Wang, Yiyan; Li, Xiaoying; He, Yao			Increasing Prevalence of Metabolic Syndrome in a Chinese Elderly Population: 2001-2010	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METAANALYSIS; RISK; TRENDS; DETERMINANTS; CHOLESTEROL; OBESITY; ADULTS; HEALTH; DIET	Objective: The information on the changes of prevalence of MetS in China is limited. Our objective was to assess a 10-year's change of the prevalence of MetS in a Chinese elderly population between 2001 and 2010. Methods: We conducted two cross-sectional surveys in a representative sample of elderly population aged 60 to 95 years in Beijing in 2001 and 2010 respectively. MetS was defined according to the 2009 harmonizing definition. Results: A total of 2,334 participants (943 male, 1,391 female) in 2001 and 2,102 participants (848 male, 1,254 female) in 2010 completed the survey. The prevalence of MetS was 50.4% (95% CI: 48.4%-52.4%) in 2001 and 58.1% (95% CI: 56.0%-60.2%) in 2010. The absolute change of prevalence of MetS was 7.7% over the 10-year's period (p<0.001). The syndrome was more common in female than male in both survey years. Among the five components, hypertriglyceridemia and low HDL-C had increased most, with an increase of 14.8% (from 29.4% to 44.2%) and 9.9% (from 28.3% to 38.2%) respectively. The adjusted ORs of MetS for CHD, stroke and CVD were 1.67(95% CI: 1.39-1.99), 1.50(95% CI: 1.19-1.88) and 1.70(95% CI: 1.43-2.01) respectively in 2001, and were 1.74(95% CI: 1.40-2.17), 1.25(95% CI: 0.95-1.63) and 1.52(95% CI: 1.25-1.86) respectively in 2010. Conclusion: The prevalence of MetS is high and increasing rapidly in this Chinese elderly population. Participants with Mets and its individual components are at significantly elevated ORs for CVD. Urgent public health actions are needed to control MetS and its components, especially for dislipidemia.	[Liu, Miao; Wang, Jianhua; Sun, Dongling; Wu, Lei; Yang, Shanshan; Wang, Yiyan; He, Yao] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China; [Liu, Miao; Wang, Jianhua; Wu, Lei; Yang, Shanshan; Wang, Yiyan; He, Yao] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [Jiang, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Chinese Tradit Med & Acupuncture, Beijing, Peoples R China; [Li, Xiaoying] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China.	yhe301@sina.com	刘, 淼/X-1216-2019	Liu, Miao/0000-0002-7975-6702; He, Yao/0000-0001-6205-7895	National Natural Science Foundation of China [81072355]; Beijing Municipal Science and Technology Commission [D121100004912003]; National Public Benefit Research Foundation by the Ministry of Health of China [201002011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Public Benefit Research Foundation by the Ministry of Health of China	This study is supported by research grants from the National Natural Science Foundation of China (81072355), Beijing Municipal Science and Technology Commission (D121100004912003) and National Public Benefit Research Foundation by the Ministry of Health of China (201002011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036936; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hu G, 2008, J CLIN ENDOCR METAB, V93, P832, DOI 10.1210/jc.2007-1883; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lorenzo C, 2005, DIABETES CARE, V28, P2480, DOI 10.2337/diacare.28.10.2480; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Villegas R, 2009, METAB SYNDR RELAT D, V7, P37, DOI 10.1089/met.2008.0042; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wu ZS, 2001, CIRCULATION, V103, P462; Zhao J, 2011, J ENDOCRINOL INVEST, V34, P444, DOI [10.1007/BF03346711, 10.3275/7482]	21	52	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66233	10.1371/journal.pone.0066233	http://dx.doi.org/10.1371/journal.pone.0066233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824753	gold, Green Published			2022-12-25	WOS:000320576400070
J	Ordonez, C; Moreno-Murciano, P; Hernandez, M; Di Caudo, C; Carril-Mundinano, I; Vazquez, N; Garcia-Verdugo, JM; Sanchez-Pernaute, R; Luquin, MR				Ordonez, Cristina; Moreno-Murciano, Paz; Hernandez, Maria; Di Caudo, Carla; Carril-Mundinano, Inaki; Vazquez, Nerea; Manuel Garcia-Verdugo, Jose; Sanchez-Pernaute, Rosario; Luquin, Maria-Rosario			Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; NEWLY GENERATED NEURONS; MAMMALIAN SPINAL-CORD; SUBVENTRICULAR ZONE; STEM-CELLS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; EXPRESSION DEFINES; ADULT HIPPOCAMPUS; NEUROGENESIS	existence of endogenous neural progenitors in the nigrostriatal system could represent a powerful tool for restorative therapies in Parkinson's disease. Sox-2 is a transcription factor expressed in pluripotent and adult stem cells, including neural progenitors. In the adult brain Sox-2 is expressed in the neurogenic niches. There is also widespread expression of Sox-2 in other brain regions, although the neurogenic potential outside the niches is uncertain. Here, we analyzed the presence of Sox-2(+) cells in the adult primate (Macaca fascicularis) brain in naive animals (N = 3) and in animals exposed to systemic administration of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine to render them parkinsonian (N = 8). Animals received bromodeoxyuridine (100 mg/kg once a day during five consecutive days) to label proliferating cells and their progeny. Using confocal and electron microscopy we analyzed the Sox-2(+) cell population in the nigrostriatal system and investigated changes in the number, proliferation and neurogenic potential of Sox-2(+) cells, in control conditions and at two time points after MPTP administration. We found Sox-2(+) cells with self-renewal capacity in both the striatum and the substantia nigra. Importantly, only in the striatum Sox-2(+) was expressed in some calretinin(+) neurons. MPTP administration led to an increase in the proliferation of striatal Sox-2(+) cells and to an acute, concomitant decrease in the percentage of Sox-2(+)/calretinin(+) neurons, which recovered by 18 months. Given their potential capacity to differentiate into neurons and their responsiveness to dopamine neurotoxic insults, striatal Sox-2(+) cells represent good candidates to harness endogenous repair mechanisms for regenerative approaches in Parkinson's disease.	[Ordonez, Cristina; Hernandez, Maria; Di Caudo, Carla; Carril-Mundinano, Inaki; Luquin, Maria-Rosario] Univ Navarra Clin, Ctr Invest Med Aplicada, Div Neurosci, Lab Regenerat Therapy, Pamplona, Spain; [Ordonez, Cristina; Moreno-Murciano, Paz; Hernandez, Maria; Di Caudo, Carla; Carril-Mundinano, Inaki; Luquin, Maria-Rosario] Univ Navarra Clin, Dept Neurol, Pamplona, Spain; [Moreno-Murciano, Paz] CIBERNED, Ctr Invest Principe Felipe, Lab Cellular Morphol, Valencia, Spain; [Vazquez, Nerea; Sanchez-Pernaute, Rosario] Fdn Inbiomed, Lab Stem Cells & Neural Repair, San Sebastian, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, CIBERNED, Inst Cavanilles, Lab Comparat Neurobiol, Paterna, Spain	University of Navarra; University of Navarra; CIBERNED; Prince Felipe Research Center; CIBERNED; University of Valencia	Sanchez-Pernaute, R (corresponding author), Fdn Inbiomed, Lab Stem Cells & Neural Repair, San Sebastian, Spain.	rpernaute@inbiomed.org; rluquin@unav.es	Luquin, M R/T-5546-2017; Sanchez-Pernaute, Rosario/ABD-8661-2021; Moreno-Murciano, Paz/D-7871-2018; Sanchez-Pernaute, Rosario/AAZ-9566-2021; García-Verdugo, José Manuel/L-8421-2017	Luquin, M R/0000-0002-5594-1794; Sanchez-Pernaute, Rosario/0000-0003-1144-9025; García-Verdugo, José Manuel/0000-0001-9872-6499; Mundinano, Inaki-Carril/0000-0003-1063-7550	Foundation Kutxa Obra; UTE-project/Foundation for Applied Medical Research (F.I.M.A.); Spanish Ministry of Science and Innovation; European Social Fund	Foundation Kutxa Obra; UTE-project/Foundation for Applied Medical Research (F.I.M.A.); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund(European Social Fund (ESF))	This study was supported by funding from Foundation Kutxa Obra social to RSP for a collaborative network to advance translational stem cell research for neurodegenerative disorders (Inbiomed, CIMA, UV), PD research network and by the UTE-project/Foundation for Applied Medical Research (F.I.M.A.) to MRL. CO and I-CM were supported by a Torres Quevedo grant awarded by the Spanish Ministry of Science and Innovation, and by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2011, NEUROBIOL AGING, V32, P140, DOI 10.1016/j.neurobiolaging.2008.12.011; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bankiewicz KS, 2001, CURR PROTOC NEUROSCI; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Betarbet R, 1997, J NEUROSCI, V17, P6761; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; Bjorklund A, 2010, PROG BRAIN RES, V184, P265, DOI 10.1016/S0079-6123(10)84014-2; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Ganz J, 2011, EXPERT REV NEUROTHER, V11, P1325, DOI [10.1586/ERN.11.74, 10.1586/ern.11.74]; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Jiang M, 1997, NEUROSCIENCE, V81, P1137, DOI 10.1016/S0306-4522(97)00231-5; Kato T, 1999, NEUROREPORT, V10, P2769, DOI 10.1097/00001756-199909090-00013; Kay JN, 2000, DEV NEUROSCI-BASEL, V22, P56, DOI 10.1159/000017427; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Komitova M, 2005, EUR J NEUROSCI, V21, P2397, DOI 10.1111/j.1460-9568.2005.04072.x; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lie DC, 2002, J NEUROSCI, V22, P6639; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025088; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mao LM, 2001, DEV BRAIN RES, V131, P57, DOI 10.1016/S0165-3806(01)00260-7; Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036; Merlo S, 2011, NEUROPHARMACOLOGY, V60, P892, DOI 10.1016/j.neuropharm.2011.01.026; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Ngwenya LB, 2006, J COMP NEUROL, V498, P204, DOI 10.1002/cne.21045; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parent A, 1996, NEUROSCI RES, V25, P309; Politis M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-80; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sirerol-Piquer MS, 2012, MICRON, V43, P589, DOI 10.1016/j.micron.2011.10.008; San Sebastian W, 2007, BRAIN, V130, P1306, DOI 10.1093/brain/awm061; Shi SR, 2006, J HISTOCHEM CYTOCHEM, V54, P739, DOI 10.1369/jhc.5B6851.2006; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; Tonchev AB, 2006, NEUROSCIENCE, V139, P1355, DOI 10.1016/j.neuroscience.2006.01.053; Ulfig N, 2002, ADV ANAT EMBRYOL CEL, V165, P1; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Weiss S, 1996, J NEUROSCI, V16, P7599; Yang ZG, 2008, J COMP NEUROL, V511, P19, DOI 10.1002/cne.21819; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	61	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66377	10.1371/journal.pone.0066377	http://dx.doi.org/10.1371/journal.pone.0066377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824751	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400097
J	Wong, SZH; Ching, BY; Chng, YR; Wong, WP; Chew, SF; Ip, YK				Wong, Samuel Z. H.; Ching, Biyun; Chng, You R.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Ascorbic Acid Biosynthesis and Brackish Water Acclimation in the Euryhaline Freshwater White-Rimmed Stingray, Himantura signifer	PLOS ONE			English	Article							GAMMA-LACTONE OXIDASE; L-GULONOLACTONE-OXIDASE; DIETARY VITAMIN-C; KEY ENZYME; BIOLOGICAL SYNTHESIS; ANIMAL-TISSUES; GLUTATHIONE; FISH; STRESS; EXPRESSION	L-gulono-gamma-lactone oxidase (Gulo) catalyzes the last step of ascorbic acid biosynthesis, which occurs in the kidney of elasmobranchs. This study aimed to clone and sequence gulonolactone oxidase (gulo) from the kidney of the euryhaline freshwater stingray, Himantura signifer, and to determine the effects of acclimation from freshwater to brackish water (salinity 20) on its renal gulo mRNA expression and Gulo activity. We also examined the effects of brackish water acclimation on concentrations of ascorbate, dehydroascorbate and ascorbate + dehydroascorbate in the kidney, brain and gill. The complete cDNA coding sequence of gulo from the kidney of H. signifer contained 1323 bp coding for 440 amino acids. The expression of gulo was kidney-specific, and renal gulo expression decreased significantly by 67% and 50% in fish acclimated to brackish water for 1 day and 6 days, respectively. There was also a significant decrease in renal Gulo activity after 6 days of acclimation to brackish water. Hence, brackish water acclimation led to a decrease in the ascorbic acid synthetic capacity in the kidney of H. signifer. However, there were significant increases in concentrations of ascorbate and ascorbate + dehydroascorbate in the gills (after 1 or 6 days), and a significant increase in the concentration of ascorbate and a significant decrease in the concentration of dehydroascorbate in the brain (after 1 day) of fish acclimated to brackish water. Taken together, our results indicate that H. signifer might experience greater salinity-induced oxidative stress in freshwater than in brackish water, possibly related to its short history of freshwater invasion. These results also suggest for the first time a possible relationship between the successful invasion of the freshwater environment by some euryhaline marine elasmobranchs and the ability of these elasmobranchs to increase the capacity of ascorbic acid synthesis in response to hyposalinity stress.	[Wong, Samuel Z. H.; Ching, Biyun; Chng, You R.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	Singapore Ministry of Education [R154-000-470-112]; Singapore Ministry of Defence [R-347-000-188-232]	Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Defence(Ministry of Defence, Singapore)	This study was supported in part by the Singapore Ministry of Education through grant R154-000-470-112 and the Singapore Ministry of Defence through grant R-347-000-188-232 to Y. K. Ip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1997, J CLIN INVEST, V100, P2842, DOI 10.1172/JCI119832; Ballantyne JS, 2010, J COMP PHYSIOL B, V180, P475, DOI 10.1007/s00360-010-0447-0; BISBY RH, 1995, ARCH BIOCHEM BIOPHYS, V317, P170, DOI 10.1006/abbi.1995.1150; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BODANNES RS, 1979, FEBS LETT, V105, P195, DOI 10.1016/0014-5793(79)80609-2; Braun L, 1999, FEBS LETT, V463, P345, DOI 10.1016/S0014-5793(99)01649-X; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CHATTERJEE IB, 1960, BIOCHEM J, V74, P193, DOI 10.1042/bj0740193; CHATTERJEE IB, 1960, BIOCHEM J, V76, P279, DOI 10.1042/bj0760279; Chew SF, 2006, J EXP BIOL, V209, P484, DOI 10.1242/jeb.02002; Ching BY, 2009, AQUAT TOXICOL, V95, P203, DOI 10.1016/j.aquatox.2009.09.004; Cho YS, 2007, COMP BIOCHEM PHYS B, V147, P178, DOI 10.1016/j.cbpb.2007.01.001; Choi CY, 2008, COMP BIOCHEM PHYS A, V149, P330, DOI 10.1016/j.cbpa.2008.01.013; COHEN G, 1994, ANN NY ACAD SCI, V738, P8; DABROWSKA H, 1990, MAGNESIUM TRACE ELEM, V9, P101; DABROWSKI K, 1990, BIOL CHEM H-S, V371, P207, DOI 10.1515/bchm3.1990.371.1.207; DABROWSKI K, 1990, J COMP PHYSIOL B, V160, P549; DAVIES MB, 1991, VITAMIN C ITS CHEM B, V154; Drouin G, 2011, CURR GENOMICS, V12, P371, DOI 10.2174/138920211796429736; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fornai F, 1999, NEUROSCIENCE, V94, P937, DOI 10.1016/S0306-4522(99)00349-8; Fracalossi DM, 2001, AQUACULTURE, V192, P321, DOI 10.1016/S0044-8486(00)00455-5; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gong X, 2011, FISHERIES SCI, V77, P547, DOI 10.1007/s12562-011-0370-7; GUPTA R, 2001, THESIS TU DENMARK; Gupta R., 2003, PAC S BIOCOMPUT, V7, P310; Gupta R, 2004, PREDICTION N GLYCOSY; Ha MN, 2004, GENOMICS, V83, P482, DOI 10.1016/j.ygeno.2003.08.018; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HORIO F, 1993, J NUTR, V123, P2075; Horio F, 1997, BIOSCI BIOTECH BIOCH, V61, P109, DOI 10.1271/bbb.61.109; Jenner AM, 2002, ARTERIOSCL THROM VAS, V22, P574, DOI 10.1161/01.ATV.0000013785.03265.5C; KIUCHI K, 1982, BIOCHEMISTRY-US, V21, P5076, DOI 10.1021/bi00263a035; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; KOSHIZAKA T, 1988, J BIOL CHEM, V263, P1619; Liu Y, 2007, AQUACULTURE, V265, P351, DOI 10.1016/j.aquaculture.2007.02.010; Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1670, DOI 10.1016/j.biocel.2005.02.024; MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Martinez-Alvarez RM, 2002, J EXP BIOL, V205, P3699; MEISTER A, 1994, J BIOL CHEM, V269, P9397; Moreau R, 1999, AQUACULTURE, V180, P359, DOI 10.1016/S0044-8486(99)00211-2; Moreau R, 2003, FREE RADICAL BIO MED, V34, P1326, DOI 10.1016/S0891-5849(03)00148-5; Nam YK, 2002, AQUACULTURE, V209, P271, DOI 10.1016/S0044-8486(01)00731-1; Nandi A, 1997, FREE RADICAL BIO MED, V22, P1047, DOI 10.1016/S0891-5849(96)00491-1; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; NISHIKIMI M, 1991, AM J CLIN NUTR, V54, pS1203, DOI 10.1093/ajcn/54.6.1203s; OTAKE T, 1999, REPORT STUDIES ADAPT, P79; Otake Tsuguo, 2005, Coastal Marine Science, V29, P147; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Papp G, 1999, J APPL ICHTHYOL, V15, P258; Ramos-Vasconcelos GR, 2003, J EXP BIOL, V206, P675, DOI 10.1242/jeb.00124; Ren T, 2005, J WORLD AQUACULT SOC, V36, P437, DOI 10.1111/j.1749-7345.2005.tb00391.x; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Roche H, 1996, MAR ENVIRON RES, V41, P27, DOI 10.1016/0141-1136(95)00015-1; ROSE RC, 1993, BRAIN RES, V628, P49, DOI 10.1016/0006-8993(93)90936-H; Sarma K, 2013, AQUACULT INT, V21, P183, DOI 10.1007/s10499-012-9544-2; SATO P, 1976, BIOCHEM BIOPH RES CO, V71, P293, DOI 10.1016/0006-291X(76)90281-3; Sezaki K, 1999, FISHERIES SCI, V65, P563, DOI 10.2331/fishsci.65.563; Tam WL, 2003, J EXP BIOL, V206, P2931, DOI 10.1242/jeb.00510; TSAO CS, 1989, LIFE SCI, V45, P1553, DOI 10.1016/0024-3205(89)90421-9; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wang XJ, 2003, AQUACULTURE, V215, P203, DOI 10.1016/S0044-8486(02)00042-X; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Zhou XQ, 2005, AQUACULT NUTR, V11, P169, DOI 10.1111/j.1365-2095.2005.00343.x; Zhou XQ, 2003, COMP BIOCHEM PHYS A, V135, P263, DOI 10.1016/S1095-6433(03)00066-7	71	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66691	10.1371/journal.pone.0066691	http://dx.doi.org/10.1371/journal.pone.0066691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825042	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400149
J	Xu, B; Chotewutmontri, S; Wolf, S; Klos, U; Schmitz, M; Durst, M; Schwarz, E				Xu, Bo; Chotewutmontri, Sasithorn; Wolf, Stephan; Klos, Ursula; Schmitz, Martina; Duerst, Matthias; Schwarz, Elisabeth			Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas	PLOS ONE			English	Article							CELLULAR FUSION TRANSCRIPTS; VIRAL INTEGRATION; TYPE-16 DNA; INTRAEPITHELIAL NEOPLASIA; READ ALIGNMENT; E6 VARIANTS; MYC LOCUS; E2 GENE; CANCER; SEQUENCES	Cervical cancer is caused by high-risk human papillomaviruses (HPV), in more than half of the worldwide cases by HPV16. Viral DNA integration into the host genome is a frequent mutation in cervical carcinogenesis. Because integration occurs into different genomic locations, it creates unique viral-cellular DNA junctions in every single case. This singularity complicates the precise identification of HPV integration sites enormously. We report here the development of a novel multiplex strategy for sequence determination of HPV16 DNA integration sites. It includes DNA fragmentation and adapter tagging, PCR enrichment of the HPV16 early region, Illumina next-generation sequencing, data processing, and validation of candidate integration sites by junction-PCR. This strategy was performed with 51 cervical cancer samples (47 primary tumors and 4 cell lines). Altogether 75 HPV16 integration sites (3'-junctions) were identified and assigned to the individual samples. By comparing the DNA junctions with the presence of viral oncogene fusion transcripts, 44 tumors could be classified into four groups: Tumors with one transcriptionally active HPV16 integrate (n = 12), tumors with transcribed and silent DNA junctions (n = 8), tumors carrying episomal HPV16 DNA (n = 10), and tumors with one to six DNA junctions, but without fusion transcripts (n = 14). The 39-breakpoints of integrated HPV16 DNA show a statistically significant (p<0.05) preferential distribution within the early region segment upstream of the major splice acceptor underscoring the importance of deregulated viral oncogene expression for carcinogenesis. Half of the mapped HPV16 integration sites target cellular genes pointing to a direct influence of HPV integration on host genes (insertional mutagenesis). In summary, the multiplex strategy for HPV16 integration site determination worked very efficiently. It will open new avenues for comprehensive mapping of HPV integration sites and for the possible use of HPV integration sites as individualized biomarkers after cancer treatment of patients for the early diagnosis of residual and recurrent disease.	[Xu, Bo; Chotewutmontri, Sasithorn; Klos, Ursula; Schwarz, Elisabeth] DKFZ, Res Program Infect & Canc, Heidelberg, Germany; [Wolf, Stephan] DKFZ, Genom & Prote Core Facil, Heidelberg, Germany; [Schmitz, Martina; Duerst, Matthias] Jena Univ Hosp, Dept Gynecol, Jena, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Friedrich Schiller University of Jena	Schwarz, E (corresponding author), DKFZ, Res Program Infect & Canc, Heidelberg, Germany.	e.schwarz@dkfz.de			BMBF/HGF-Canceropole Grand-Est (BMBF) [01KX0908]; Deutsche Forschungsgemeinschaft [DR780/3-1]	BMBF/HGF-Canceropole Grand-Est (BMBF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from BMBF/HGF-Canceropole Grand-Est (BMBF grant number 01KX0908; www.bmbf.de) granted to ES, and in part by funds of the Deutsche Forschungsgemeinschaft (DR780/3-1; www dfg.de) granted to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Badaracco G, 2002, J MED VIROL, V67, P574, DOI 10.1002/jmv.10141; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Bechtold V, 2003, J VIROL, V77, P2021, DOI 10.1128/JVI.77.3.2021-2028.2003; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Campitelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043393; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; Casas L, 1999, INT J CANCER, V83, P449, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;449::AID-IJC3&gt;3.0.CO;2-0; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Corden SA, 1999, J CLIN PATHOL-MOL PA, V52, P275, DOI 10.1136/mp.52.5.275; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; COUTURIER J, 1991, J VIROL, V65, P4534, DOI 10.1128/JVI.65.8.4534-4538.1991; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; Einstein MH, 2002, CLIN CANCER RES, V8, P549; ELAWADY MK, 1987, VIROLOGY, V159, P389, DOI 10.1016/0042-6822(87)90478-8; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gadducci A, 2013, CRIT REV ONCOL HEMAT, V86, P104, DOI 10.1016/j.critrevonc.2012.09.003; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Klaes R, 1999, CANCER RES, V59, P6132; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; MINCHEVA A, 1987, MED MICROBIOL IMMUN, V176, P245, DOI 10.1007/bf00190531; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; POPESCU NC, 1989, CANCER GENET CYTOGEN, V42, P157, DOI 10.1016/0165-4608(89)90084-8; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; SMITS HL, 1991, VIROLOGY, V182, P870, DOI 10.1016/0042-6822(91)90632-L; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Swan DC, 2005, GYNECOL ONCOL, V96, P695, DOI 10.1016/j.ygyno.2004.11.045; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Thorland EC, 2000, CANCER RES, V60, P5916; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; WAGATSUMA M, 1990, J VIROL, V64, P813, DOI 10.1128/JVI.64.2.813-821.1990; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; YEE C, 1985, AM J PATHOL, V119, P361; Yu TX, 2005, CANCER GENET CYTOGEN, V158, P27, DOI 10.1016/j.cancergencyto.2004.08.021; Zehbe I, 1998, CANCER RES, V58, P829; Zhao X, 2012, NUCLEIC ACIDS RES, V40, pD1041, DOI 10.1093/nar/gkr1142; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	76	80	85	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66693	10.1371/journal.pone.0066693	http://dx.doi.org/10.1371/journal.pone.0066693			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824673	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400150
J	Hu, C; Liu, D; Zhang, Y; Lou, G; Huang, G; Chen, B; Shen, X; Gao, M; Gong, W; Zhou, P; Dai, S; Zeng, Y; He, F				Hu, C.; Liu, D.; Zhang, Y.; Lou, G.; Huang, G.; Chen, B.; Shen, X.; Gao, M.; Gong, W.; Zhou, P.; Dai, S.; Zeng, Y.; He, F.			LXR alpha-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells	ONCOGENE			English	Article						LXRs; FOXM1; cell proliferation; cell cycle; HCC	LIVER-X-RECEPTOR; FORKHEAD BOX M1B; PROSTATE-CANCER CELLS; TRANSCRIPTION FACTOR; BREAST-CANCER; NUCLEAR RECEPTORS; GENE-EXPRESSION; POOR-PROGNOSIS; TUMOR-GROWTH; TARGET GENE	Liver X receptors (LXRs), including LXR alpha and LXR beta isoforms, have important roles in the metabolic regulation of glucose, cholesterol and lipid. Moreover, activation of LXRs also represses the expression of cyclin D1 and cyclin B1, and thus suppresses the proliferation of multiple cancer cells, but the relevant mechanism is not well known. Forkhead box M1 ( FOXM1) is a proliferationspecific member of forkhead box family, which is highly expressed in proliferating normal cells and numerous cancer cells. FOXM1 directly activates transcription of cyclin D1 and cyclin B1, resulting in the enhancement of cell cycle progression and cell proliferation. However, it is unclear whether LXRs are involved in the regulation of FOXM1. In this study, we demonstrated that specific LXRs agonists downregulated expression of FOXM1, cyclin D1 and cyclin B1 in hepatocellular carcinoma ( HCC) cells, which led to cell cycle and cell proliferation arrest. Knockdown of FOXM1 significantly alleviated LXRs activation-mediated cell cycle arrest and cell growth suppression. Reporter assays showed that the activation of LXRs significantly reduced the transcriptional activity of FOXM1 promoter. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrated that LXRa but not LXRb could bind to an inverted repeat IR2(-52CCGTCAcgTGACCT- 39) in the promoter region of FOXM1 gene. Moreover, the xenograft tumor growth and the corresponding FOXM1 expression in nude mice were dramatically repressed by LXRs agonists. Taken together, we conclude that LXRa but not LXRb functions as a transcriptional repressor for FOXM1 expression. The pathway ` LXRa- FOXM1- cyclin D1/ cyclin B1' is a novel mechanism by which LXRs suppress the proliferation of HCC cells, suggesting that the pathway may be a novel target for HCC treatment.	[Hu, C.; Liu, D.; Zhang, Y.; Lou, G.; Huang, G.; Chen, B.; Shen, X.; Gao, M.; Gong, W.; Zhou, P.; Dai, S.; Zeng, Y.; He, F.] Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China; [Liu, D.] Daping Hosp, Depeartment State Key Lab Trauma Burns & Combined, Chongqing, Peoples R China; [Liu, D.] Inst Surg Res, Chongqing, Peoples R China	Army Medical University; Army Medical University	He, F (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, 30 Gaotanyan, Chongqing 400038, Peoples R China.	hefengtian06@aliyun.com	He, Feng/HHS-6457-2022; HUANG, GANG/AAO-5503-2020	He, Feng/0000-0002-1996-0744; 	National Natural Science Foundation of China [81273226, 81102276]; Key Project of the Natural Science Foundation of Chongqing [cstc2013jjB10015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Natural Science Foundation of Chongqing	This work was supported by the National Natural Science Foundation of China (nos. 81273226 and 81102276) and the Key Project of the Natural Science Foundation of Chongqing (no. cstc2013jjB10015).	Annicotte JS, 2004, ANAT REC PART A, V277A, P312, DOI 10.1002/ar.a.20015; Beaudet MJ, 2005, BIOCHEM J, V388, P407, DOI 10.1042/BJ20041556; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen H, 2012, J GENE MED, V14, P231, DOI 10.1002/jgm.2614; Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Kim KH, 2010, J LIPID RES, V51, P3425, DOI 10.1194/jlr.M007989; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Korver W, 1997, IMMUNOBIOLOGY, V198, P157, DOI 10.1016/S0171-2985(97)80036-8; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li YW, 2005, MOL CANCER THER, V4, P389; Littler DR, 2010, NUCLEIC ACIDS RES, V38, P4527, DOI 10.1093/nar/gkq194; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Pascual-Garcia M, 2011, J IMMUNOL, V186, P4656, DOI 10.4049/jimmunol.1000585; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Ratni H, 2010, CURR OPIN DRUG DISC, V13, P403; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Scoles DR, 2010, GYNECOL ONCOL, V116, P109, DOI 10.1016/j.ygyno.2009.09.034; Sun HC, 2011, ONCOL REP, V25, P1533, DOI 10.3892/or.2011.1230; Sun HC, 2011, CANCER LETT, V306, P214, DOI 10.1016/j.canlet.2011.03.009; Uddin S, 2011, AM J PATHOL, V178, P537, DOI 10.1016/j.ajpath.2010.10.020; Uno S, 2009, BIOCHEM PHARMACOL, V77, P186, DOI 10.1016/j.bcp.2008.10.007; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wu QF, 2010, ACTA PHARMACOL SIN, V31, P361, DOI 10.1038/aps.2010.4; Xia JT, 2012, PANCREAS, V41, P629, DOI 10.1097/MPA.0b013e31823bcef2; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	50	44	51	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2888	2897		10.1038/onc.2013.250	http://dx.doi.org/10.1038/onc.2013.250			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23812424				2022-12-25	WOS:000337231800008
J	Frankel, LK; Sallans, L; Bellamy, H; Goettert, JS; Limbach, PA; Bricker, TM				Frankel, Laurie K.; Sallans, Larry; Bellamy, Henry; Goettert, Jost S.; Limbach, Patrick A.; Bricker, Terry M.			Radiolytic Mapping of Solvent-Contact Surfaces in Photosystem II of Higher Plants EXPERIMENTAL IDENTIFICATION OF PUTATIVE WATER CHANNELS WITHIN THE PHOTOSYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CHOLESTEROL OXIDASE; MOLECULAR-DYNAMICS; STRUCTURAL-CHANGES; PSBQ PROTEIN; COMPLEX; ASSEMBLY/STABILITY; PHOTOAUTOTROPHY; ARABIDOPSIS	Photosystem II uses water as an enzymatic substrate. It has been hypothesized that this water is vectored to the active site for water oxidation via water channels that lead from the surface of the protein complex to the Mn4O5Ca metal cluster. The radiolysis of water by synchrotron radiation produces amino acid residue-modifying OH center dot and is a powerful technique to identify regions of proteins that are in contact with water. In this study, we have used this technique to oxidatively modify buried amino acid residues in higher plant Photosystem II membranes. Fourier transform ion cyclotron resonance mass spectrometry was then used to identify these oxidized amino acid residues that were located in several core Photosystem II subunits (D1, D2, CP43, and CP47). While, as expected, the majority of the identified oxidized residues (approximate to 75%) are located on the solvent-exposed surface of the complex, a number of buried residues on these proteins were also modified. These residues form groups which appear to lead from the surface of the complex to the Mn4O5Ca cluster. These residues may be in contact with putative water channels in the photosystem. These results are discussed within the context of a number of largely computational studies that have identified putative water channels in Photosystem II.	[Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA; [Sallans, Larry; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Rieveschl Labs Mass Spectrometry, Cincinnati, OH 45221 USA; [Bellamy, Henry; Goettert, Jost S.] Louisiana State Univ, J Bennett Johnston Sr Ctr Adv Microstruct & Devic, Baton Rouge, LA 70806 USA	Louisiana State University System; Louisiana State University; University of Cincinnati; Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu	Limbach, Patrick/A-9188-2009	Limbach, Patrick/0000-0003-1526-4546	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U. S. Department of Energy [DE-FG02-98ER20310]; National Institutes of Health [RR019900, GM58843]; State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058843, R56GM058843] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U. S. Department of Energy through Grant DE-FG02-98ER20310 (to T. M. B. and L. K. F.). Additional support was provided by National Institutes of Health Grants RR019900 and GM58843 (to P. A. L.) and the State of Louisiana (to H. B. and J. S. G.).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Barry BA, 2006, P NATL ACAD SCI USA, V103, P7288, DOI 10.1073/pnas.0600216103; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frankel LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058042; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; GHANOTAKIS DF, 1983, FEBS LETT, V153, P231, DOI 10.1016/0014-5793(83)80154-9; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Ho FM, 2012, BBA-BIOENERGETICS, V1817, P106, DOI 10.1016/j.bbabio.2011.04.009; Kallio JP, 2011, BIOCHEMISTRY-US, V50, P4396, DOI 10.1021/bi200486b; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Klauss A, 2012, BBA-BIOENERGETICS, V1817, P1196, DOI 10.1016/j.bbabio.2012.04.017; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; Liu RT, 2003, BIOCHEMISTRY-US, V42, P12447, DOI 10.1021/bi0352973; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; RABILLOUD T, 1995, ELECTROPHORESIS, V16, P1414, DOI 10.1002/elps.11501601234; Renzone Giovanni, 2007, Current Proteomics, V4, P1; Sagermann M, 2010, J STRUCT BIOL, V170, P32, DOI 10.1016/j.jsb.2010.01.012; Sun G, 2004, ELECTROPHORESIS, V25, P959, DOI 10.1002/elps.200305800; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Vassiliev S, 2010, BIOCHEMISTRY-US, V49, P1873, DOI 10.1021/bi901900s; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23565	23572		10.1074/jbc.M113.487033	http://dx.doi.org/10.1074/jbc.M113.487033			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814046	hybrid, Green Published			2022-12-25	WOS:000330598200060
J	Seok, S; Kanamaluru, D; Xiao, Z; Ryerson, D; Choi, SE; Suino-Powell, K; Xu, HE; Veenstra, TD; Kemper, JK				Seok, Sunmi; Kanamaluru, Deepthi; Xiao, Zhen; Ryerson, Daniel; Choi, Sung-E; Suino-Powell, Kelly; Xu, H. Eric; Veenstra, Timothy D.; Kemper, Jongsook Kim			Bile Acid Signal-induced Phosphorylation of Small Heterodimer Partner by Protein Kinase C zeta Is Critical for Epigenomic Regulation of Liver Metabolic Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-RECEPTOR-SHP; FARNESOID X RECEPTOR; OBESITY; REPRESSION; EXPRESSION; MICE; FXR; BIOSYNTHESIS; MICRORNA-34A; CHOLESTASIS	Bile acids (BAs) are recently recognized key signaling molecules that control integrative metabolism and energy expenditure. BAs activate multiple signaling pathways, including those of nuclear receptors, primarily farnesoid X receptor (FXR), membrane BA receptors, and FXR-induced FGF19 to regulate the fed-state metabolism. Small heterodimer partner (SHP) has been implicated as a key mediator of these BA signaling pathways by recruitment of chromatin modifying proteins, but the key question of how SHP transduces BA signaling into repressive histone modifications at liver metabolic genes remains unknown. Here we show that protein kinase C zeta (PKC zeta) is activated by BA or FGF19 and phosphorylates SHP at Thr-55 and that Thr-55 phosphorylation is critical for the epigenomic coordinator functions of SHP. PKC zeta is coimmunopreciptitated with SHP and both are recruited to SHP target genes after bile acid or FGF19 treatment. Activated phosphorylated PKC zeta and phosphorylated SHP are predominantly located in the nucleus after FGF19 treatment. Phosphorylation at Thr-55 is required for subsequent methylation at Arg-57, a naturally occurring mutation site in metabolic syndrome patients. Thr-55 phosphorylation increases interaction of SHP with chromatin modifiers and their occupancy at selective BA-responsive genes. This molecular cascade leads to repressive modifications of histones at metabolic target genes, and consequently, decreased BA pools and hepatic triglyceride levels. Remarkably, mutation of Thr-55 attenuates these SHP-mediated epigenomic and metabolic effects. This study identifies PKC zeta as a novel key upstream regulator of BA-regulated SHP function, revealing the role of Thr-55 phosphorylation in epigenomic regulation of liver metabolism.	[Seok, Sunmi; Kanamaluru, Deepthi; Ryerson, Daniel; Choi, Sung-E; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiao, Zhen; Veenstra, Timothy D.] SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Van Andel Institute	Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jongsook@illinois.edu	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK71662, DK66202, DK62777, DK95842]; National Institutes of Health NCI [HHSN261200800001E]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662, R01DK095842, R56DK062777, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK71662 (to H. E. X.), DK66202 (to H. E. X.), DK62777 (to J. K. K.), and DK95842 (to J. K. K.) and federal funds from National Institutes of Health NCI Contract HHSN261200800001E.	Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Connelly Sheila, 2004, Methods Mol Biol, V246, P37; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Frankenberg T, 2008, HEPATOLOGY, V48, P1896, DOI 10.1002/hep.22431; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee J, 2012, HEPATOLOGY, V56, P108, DOI 10.1002/hep.25609; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Mitro N, 2007, HEPATOLOGY, V46, P885, DOI 10.1002/hep.21819; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Smith Z, 2013, MOL CELL ENDOCRINOL, V368, P59, DOI 10.1016/j.mce.2012.04.008; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064	39	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23252	23263		10.1074/jbc.M113.452037	http://dx.doi.org/10.1074/jbc.M113.452037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23824184	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330598200032
J	Doyle, SR; Kasinadhuni, NRP; Chan, CK; Grant, WN				Doyle, Stephen R.; Kasinadhuni, Naga R. P.; Chan, Chee Kai; Grant, Warwick N.			Evidence of Evolutionary Constraints That Influences the Sequence Composition and Diversity of Mitochondrial Matrix Targeting Signals	PLOS ONE			English	Article							PROTEIN-IMPORT; PRECURSOR PROTEINS; PREPROTEIN IMPORT; INNER MEMBRANE; PRESEQUENCE; IDENTIFICATION; TRANSLOCATION; PREDICTION; PEPTIDES; CLEAVAGE	Mitochondrial targeting signals (MTSs) are responsible for trafficking nuclear encoded proteins to their final destination within mitochondria. These sequences are diverse, sharing little amino acid homology and vary significantly in length, and although the formation of a positively-charged amphiphilic alpha helix within the MTS is considered to be necessary and sufficient to mediate import, such a feature does not explain their diversity, nor how such diversity influences target sequence function, nor how such dissimilar signals interact with a single, evolutionarily conserved import mechanism. An in silico analysis of 296 N-terminal, matrix destined MTSs from Homo sapiens, Mus musculus, Saccharomyces cerevisiae, Arabidopsis thaliana, and Oryza sativa was undertaken to investigate relationships between MTSs, and/or, relationships between an individual targeting signal sequence and the protein that it imports. We present evidence that suggests MTS diversity is influenced in part by physiochemical and N-terminal characteristics of their mature sequences, and that some of these correlated characteristics are evolutionarily maintained across a number of taxa. Importantly, some of these associations begin to explain the variation in MTS length and composition.	[Doyle, Stephen R.; Kasinadhuni, Naga R. P.; Chan, Chee Kai; Grant, Warwick N.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	La Trobe University	Doyle, SR (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia.	s.doyle@latrobe.edu.au	Grant, Warwick/AAF-5854-2020; Doyle, Stephen/GRJ-3949-2022; Doyle, Stephen/AAS-8224-2021	Grant, Warwick/0000-0002-1187-5270; Doyle, Stephen/0000-0001-9167-7532; Doyle, Stephen/0000-0001-9167-7532; Kasinadhuni, Naga/0000-0001-6924-1476	La Trobe University	La Trobe University	SRD was supported by an Early Career Development Fellowship from La Trobe University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Braun HP, 1999, PLANTA, V209, P267, DOI 10.1007/s004250050632; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Emanuelsson O, 2001, METHOD CELL BIOL, V65, P175, DOI 10.1016/S0091-679X(01)65011-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Geissler A, 2001, MOL CELL BIOL, V21, P7097, DOI 10.1128/MCB.21.20.7097-7104.2001; Gonzalez-Halphen D, 2004, ANN NY ACAD SCI, V1019, P232, DOI 10.1196/annals.1297.039; Hammen PK, 2000, FEBS LETT, V468, P101, DOI 10.1016/S0014-5793(00)01160-1; HARTMANN C, 1991, NATURE, V352, P762, DOI 10.1038/352762b0; HARTMANN CM, 1991, BIOCHEM BIOPH RES CO, V174, P1232, DOI 10.1016/0006-291X(91)91553-O; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Huang SB, 2009, PLANT PHYSIOL, V150, P1272, DOI 10.1104/pp.109.137885; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; Lim JH, 2001, EMBO J, V20, P941, DOI 10.1093/emboj/20.5.941; Lister R, 2006, CURR BIOL, V16, pR197, DOI 10.1016/j.cub.2006.02.024; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Meier S, 2005, J BIOL CHEM, V280, P7777, DOI 10.1074/jbc.M412158200; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; Muto T, 2001, J MOL BIOL, V306, P137, DOI 10.1006/jmbi.2000.4397; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Schleiff E, 1999, FEBS LETT, V461, P9, DOI 10.1016/S0014-5793(99)01415-5; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Schwartz MP, 1999, J BIOL CHEM, V274, P12759, DOI 10.1074/jbc.274.18.12759; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; VERNER K, 1989, EMBO J, V8, P1491, DOI 10.1002/j.1460-2075.1989.tb03533.x; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Waltner M, 1996, J BIOL CHEM, V271, P21226, DOI 10.1074/jbc.271.35.21226; Werhahn W, 2003, PLANT PHYSIOL BIOCH, V41, P407, DOI 10.1016/S0981-9428(03)00047-0; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67938	10.1371/journal.pone.0067938	http://dx.doi.org/10.1371/journal.pone.0067938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825690	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000124
J	Wang, R; Hsu, HK; Blattler, A; Wang, YS; Lan, X; Wang, Y; Hsu, PY; Leu, YW; Huang, THM; Farnham, PJ; Jin, VX				Wang, Rui; Hsu, Hang-Kai; Blattler, Adam; Wang, Yisong; Lan, Xun; Wang, Yao; Hsu, Pei-Yin; Leu, Yu-Wei; Huang, Tim H. -M.; Farnham, Peggy J.; Jin, Victor X.			LOcating Non-Unique matched Tags (LONUT) to Improve the Detection of the Enriched Regions for ChIP-seq Data	PLOS ONE			English	Article							WEB APPLICATION TOOL; DNA BINDING-SITES; BREAST-CANCER; HUMAN GENOME; RNA-SEQ; HI-C; IDENTIFICATION; REVEALS; ALPHA; MODEL	One big limitation of computational tools for analyzing ChIP-seq data is that most of them ignore non-unique tags (NUTs) that match the human genome even though NUTs comprise up to 60% of all raw tags in ChIP-seq data. Effectively utilizing these NUTs would increase the sequencing depth and allow a more accurate detection of enriched binding sites, which in turn could lead to more precise and significant biological interpretations. In this study, we have developed a computational tool, LOcating Non-Unique matched Tags (LONUT), to improve the detection of enriched regions from ChIP-seq data. Our LONUT algorithm applies a linear and polynomial regression model to establish an empirical score (ES) formula by considering two influential factors, the distance of NUTs to peaks identified using uniquely matched tags (UMTs) and the enrichment score for those peaks resulting in each NUT being assigned to a unique location on the reference genome. The newly located tags from the set of NUTs are combined with the original UMTs to produce a final set of combined matched tags (CMTs). LONUT was tested on many different datasets representing three different characteristics of biological data types. The detected sites were validated using de novo motif discovery and ChIP-PCR. We demonstrate the specificity and accuracy of LONUT and show that our program not only improves the detection of binding sites for ChIP-seq, but also identifies additional binding sites.	[Wang, Rui] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Wang, Rui; Wang, Yisong; Lan, Xun; Wang, Yao; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Hsu, Hang-Kai; Hsu, Pei-Yin; Huang, Tim H. -M.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA; [Blattler, Adam; Farnham, Peggy J.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Blattler, Adam] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA; [Leu, Yu-Wei] Natl Chung Cheng Univ, Inst Mol Biol, Dept Life Sci, Human Epigen Ctr, Chiayi, Taiwan; [Leu, Yu-Wei] Natl Chung Cheng Univ, Inst Biomed Sci, Chiayi, Taiwan	Lanzhou University; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio; University of Southern California; University of California System; University of California Davis; National Chung Cheng University; National Chung Cheng University	Jin, VX (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Victor.Jin@osumc.edu		Lan, Xun/0000-0002-6523-046X; Farnham, Peggy/0000-0003-4469-7914; Blattler, Adam/0000-0002-4682-7201				Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonneville R, 2013, BIOINFORMATICS, V29, P22, DOI 10.1093/bioinformatics/bts639; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gu F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-170; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Narlikar L, 2012, METHODS MOL BIOL, V802, P305, DOI 10.1007/978-1-61779-400-1_20; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenfeld JA, 2009, EPIGENETICS-US, V4, P476, DOI 10.4161/epi.4.7.9809; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shen CY, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-67; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Wu J, 2011, BIOINFORMATICS, V27, P3010, DOI 10.1093/bioinformatics/btr508; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67788	10.1371/journal.pone.0067788	http://dx.doi.org/10.1371/journal.pone.0067788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825685	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000119
J	Zorko, DJ; Choong, K; Gilleland, J; Agar, B; Baker, S; Brennan, C; Pullenayegum, E				Zorko, David J.; Choong, Karen; Gilleland, Jonathan; Agar, Barbara; Baker, Shawn; Brennan, Cindy; Pullenayegum, Eleanor			Urgent Ultrasound Guided Hemodynamic Assessments by a Pediatric Medical Emergency Team: A Pilot Study	PLOS ONE			English	Article							CARDIAC-OUTPUT MONITOR; CLINICAL-PRACTICE PARAMETERS; SEPTIC SHOCK; CHILDREN; MANAGEMENT; SUPPORT; UPDATE	Purpose: To determine the feasibility of using the Ultrasound Cardiac Output Monitor (USCOM) as an adjunct during hemodynamic assessments by a pediatric medical emergency team (PMET). Methods: Pediatric in-patients at McMaster Children's Hospital aged under 18 years requiring urgent PMET consultation, were eligible. Patients with known cardiac outflow valve defects, Pediatric Critical Care Unit in-patients, and those in cardiorespiratory arrest, were excluded. The primary outcome was feasibility, and the ease of USCOM transport and application as assessed by a self-administered user questionnaire. Secondary outcomes included the quality of USCOM measurements, and agreement in clinical versus USCOM-derived assessments. Results: Forty-one patients from 85 eligible PMET consultations were enrolled between March and August 2011. A total of 55 USCOM assessments were performed on 36 of 41 (87.8%) participants. USCOM could not be completed in 5 (12.2%) participants due to patient agitation (n = 4) and emergent care (n = 1). USCOM was reported as easy to transport and apply by 97.4% and 94.7% of respondents respectively, not obstructive to patient care by 94.7%, and yielded timely measurements by 84.2% respondents. USCOM tracings were of good quality in 41 (75.9%) assessments. Agreement between clinical and USCOM-derived hemodynamic assessments by two independent raters was poor (Rater 1: kappa = 0.094; Rater 2: kappa = 0.146). Conclusion: USCOM can be applied by a PMET during urgent hemodynamic assessments in children. While USCOM has been validated in stable children, its role in guiding hemodynamic resuscitation and informing therapeutic goals in a hemodynamically unstable pediatric population requires further investigation.	[Zorko, David J.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Choong, Karen; Gilleland, Jonathan] McMaster Univ, Fac Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Choong, Karen; Gilleland, Jonathan; Agar, Barbara; Baker, Shawn; Brennan, Cindy] McMaster Univ, Fac Hlth Sci, Dept Crit Care, Hamilton, ON, Canada; [Pullenayegum, Eleanor] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Ottawa; McMaster University; McMaster University; McMaster University	Choong, K (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Pediat, Hamilton, ON, Canada.	choongk@mcmaster.ca	Zorko, David/AAA-3748-2021; Choong, Karen/ABB-7867-2021; Pullenayegum, Eleanor/AAT-1712-2020	Choong, Karen/0000-0002-4608-4508; Pullenayegum, Eleanor/0000-0003-4265-1330	USCOM Limited	USCOM Limited	With respect to funding received from USCOM Limited, the authors declare that USCOM Limited provided the ultrasound cardiac output monitory device on loan to McMaster University for the duration of this specific research project. The authors did not receive any other funding from USCOM Limited or other sources to support this study. USCOM Limited has no intellectual property of the design, execution, analysis, interpretation, and reporting of the results, or manuscript preparation for this study. As such, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arnold DM, 2009, CRIT CARE MED, V37, pS69, DOI 10.1097/CCM.0b013e3181920e33; Bonanno Fabrizio Giuseppe, 2011, J Emerg Trauma Shock, V4, P233, DOI 10.4103/0974-2700.82211; Brierley J, 2008, PEDIATRICS, V122, P752, DOI 10.1542/peds.2007-1979; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; Carcillo JA, 2009, PEDIATRICS, V124, P500, DOI 10.1542/peds.2008-1967; Cattermole GN, 2010, CRIT CARE MED, V38, P1875, DOI 10.1097/CCM.0b013e3181e8adee; Ceneviva G, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e19; Chand R, 2006, J CARDIOTHOR VASC AN, V20, P315, DOI 10.1053/j.jvca.2005.05.024; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dhanani S, 2011, PEDIATR ANESTH, V21, P858, DOI 10.1111/j.1460-9592.2010.03480.x; Duchateau FX, 2011, EUR J EMERG MED, V18, P357, DOI 10.1097/MEJ.0b013e32834777b6; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; He SR, 2012, EARLY HUM DEV, DOI [10.1016/j.bbr.2011.03.031, DOI 10.1016/J.BBR.2011.03.031]; Ho GYL, 2013, PEDIAT CRIT IN PRESS; Holmes CL, 2003, CLIN CHEST MED, V24, P775, DOI 10.1016/S0272-5231(03)00107-2; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Jain S, 2008, AM J SURG, V196, P961, DOI 10.1016/j.amjsurg.2008.07.039; Jenkins SD, 2010, CLIN NURSE SPEC, V24, P24, DOI 10.1097/NUR.0b013e3181c4abe9; Knirsch W, 2008, INTENS CARE MED, V34, P1060, DOI 10.1007/s00134-008-1030-y; Likes ML, 2010, J HEART LUNG TRANSPL, V29, pS172, DOI 10.1016/j.healun.2009.11.546; On Tang C, 2009, SCI S EM MED HONG KO; Oren-Grinberg A, 2010, INT ANESTHESIOL CLIN, V48, P57, DOI 10.1097/AIA.0b013e3181c3dc11; Phillips R., 2006, CRIT CARE, V10, pP343, DOI [10.1186/cc4690, DOI 10.1186/CC4690]; Rainer TH, 2013, ANESTH ANAL IN PRESS; Ranjit Suchitra, 2005, Pediatr Crit Care Med, V6, P412, DOI 10.1097/01.PCC.0000163676.75693.BF; Scherr K, 2012, AACN ADV CRIT CARE, V23, P32, DOI 10.1097/NCI.0b013e318240e2f9; Tan HL, 2005, BRIT J ANAESTH, V94, P287, DOI 10.1093/bja/aei054; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Tibby SM, 1997, ARCH DIS CHILD, V77, P516, DOI 10.1136/adc.77.6.516; USCOM Ltd, 2009, USCOM BAS TRAIN MOD; van Lelyveld-Haas LEM, 2008, EUR J ANAESTH, V25, P917, DOI 10.1017/S0265021508004882; Vincent JL, 2011, CRIT CARE, V15, DOI 10.1186/cc10291; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012	36	2	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66951	10.1371/journal.pone.0066951	http://dx.doi.org/10.1371/journal.pone.0066951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825593	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000049
J	Sheen, P; Couvin, D; Grandjean, L; Zimic, M; Dominguez, M; Luna, G; Gilman, RH; Rastogi, N; Moore, DAJ				Sheen, Patricia; Couvin, David; Grandjean, Louis; Zimic, Mirko; Dominguez, Maria; Luna, Giannina; Gilman, Robert H.; Rastogi, Nalin; Moore, David A. J.			Genetic Diversity of Mycobacterium tuberculosis in Peru and Exploration of Phylogenetic Associations with Drug Resistance	PLOS ONE			English	Article							SUSCEPTIBILITY ASSAY; EPIDEMIOLOGY; SPOLIGOTYPES	Background: There is limited available data on the strain diversity of M tuberculosis in Peru, though there may be interesting lessons to learn from a setting where multidrug resistant TB has emerged as a major problem despite an apparently well-functioning DOTS control programme. Methods: Spoligotyping was undertaken on 794 strains of M tuberculosis collected between 1999 and 2005 from 553 community-based patients and 241 hospital-based HIV co-infected patients with pulmonary tuberculosis in Lima, Peru. Phylogenetic and epidemiologic analyses permitted identification of clusters and exploration of spoligotype associations with drug resistance. Results: Mean patient age was 31.9 years, 63% were male and 30.4% were known to be HIV+. Rifampicin mono-resistance, isoniazid mono-resistance and multidrug resistance (MDR) were identified in 4.7%, 8.7% and 17.3% of strains respectively. Of 794 strains from 794 patients there were 149 different spoligotypes. Of these there were 27 strains (3.4%) with novel, unique orphan spoligotypes. 498 strains (62.7%) were clustered in the nine most common spoligotypes: 16.4% SIT 50 (clade H3), 12.3% SIT 53 (clade T1), 8.3% SIT 33 (LAM3), 7.4% SIT 42 (LAM9), 5.5% SIT 1 (Beijing), 3.9% SIT 47 (H1), 3.0% SIT 222 (clade unknown), 3.0% SIT1355 (LAM), and 2.8% SIT 92 (X3). Amongst HIV-negative community-based TB patients no associations were seen between drug resistance and specific spoligotypes; in contrast HIV-associated MDRTB, but not isoniazid or rifampicin mono-resistance, was associated with SIT42 and SIT53 strains. Conclusion: Two spoligotypes were associated with MDR particularly amongst patients with HIV. The MDR-HIV association was significantly reduced after controlling for SIT42 and SIT53 status; residual confounding may explain the remaining apparent association. These data are suggestive of a prolonged, clonal, hospital-based outbreak of MDR disease amongst HIV patients but do not support a hypothesis of strain-specific propensity for the acquisition of resistance-conferring mutations.	[Sheen, Patricia; Grandjean, Louis; Zimic, Mirko; Dominguez, Maria; Luna, Giannina; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lab Enfermedades Infecciosas, Lima, Peru; [Grandjean, Louis; Moore, David A. J.] Univ London London Sch Hyg & Trop Med, LSHTM TB Ctr, London WC1E 7HT, England; [Grandjean, Louis; Moore, David A. J.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Grandjean, Louis; Gilman, Robert H.; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Gilman, Robert H.; Moore, David A. J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moore, DAJ (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lab Enfermedades Infecciosas, Lima, Peru.	david.moore@lshtm.ac.uk	RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Grandjean, Louis/0000-0002-1457-8327; Couvin, David/0000-0002-7897-9023	Wellcome Trust Fellowships [064672/Z/01/Z, 078067/Z/05/Z]; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wellcome Trust Fellowships(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DAJM was supported by Wellcome Trust Fellowships (064672/Z/01/Z and 078067/Z/05/Z; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	12	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65873	10.1371/journal.pone.0065873	http://dx.doi.org/10.1371/journal.pone.0065873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826083	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000321738400005
J	Jung, TW; Choi, HY; Lee, SY; Hong, HC; Yang, SJ; Yoo, HJ; Youn, BS; Baik, SH; Choi, KM				Jung, Tae Woo; Choi, Hae Yoon; Lee, So Young; Hong, Ho Cheol; Yang, Sae Jeong; Yoo, Hye Jin; Youn, Byung-Soo; Baik, Sei Hyun; Choi, Kyung Mook			Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1 alpha Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; TARGET INFLAMMATION; KAPPA-B; BETA	Selenoprotein P (SeP) was recently identified as a hepatokine that induces insulin resistance (IR) in rodents and humans. Recent clinical trials have shown that salsalate, a prodrug of salicylate, significantly lowers blood glucose levels and increases adiponectin concentrations. We examined the effects of salsalate and full length-adiponectin (fAd) on the expression of SeP under hyperlipidemic conditions and explored their regulatory mechanism on SeP. In palmitate-treated HepG2 cells as well as high fat diet (HFD)-fed male Spraque Dawley (SD) rats and male db/db mice, SeP expression and its regulatory pathway, including AMPK-FOXO1 alpha, were evaluated after administration of salsalate and salicylate. Palmitate treatment significantly increased SeP expression and aggravated IR, while knock-down of SeP by siRNA restored these changes in HepG2 cells. Palmitate-induced SeP expression was inhibited by both salsalate and salicylate, which was mediated by AMPK activation, and was blocked by AMPK siRNA or an inhibitor of AMPK. Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift (EMSA) assay showed that salsalate suppressed SeP expression by AMPK-mediated phosphorylation of FOXO1 alpha. Moreover, fAd also reduced palmitate-induced SeP expression through the activation of AMPK, which results in improved IR. Both salsalate and salicylate treatment significantly improved glucose intolerance and insulin sensitivity, accompanied by reduced SeP mRNA and protein expression in HFD-fed rats and db/db mice, respectively. Taken together, we found that salsalate and adiponectin ameliorated palmitate-induced IR in hepatocytes via SeP inhibition through the AMPK-FOXO1 alpha pathway. The regulation of SeP might be a novel mechanism mediating the anti-diabetic effects of salsalate and adiponectin.	[Jung, Tae Woo; Choi, Hae Yoon; Lee, So Young; Hong, Ho Cheol; Yang, Sae Jeong; Yoo, Hye Jin; Baik, Sei Hyun; Choi, Kyung Mook] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Youn, Byung-Soo] AdipoGen Inc, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine)	Choi, KM (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	medica7@gmail.com	Choi, Kyung Mook/C-4195-2018	Choi, Kyung Mook/0000-0001-6175-0225	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012006363]; Ministry of Education and Human Resources Development, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education and Human Resources Development, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012006363) (by K.M.C.) and by the Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea. (by K.M.C. and S.H.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, INFLAMMATION, V32, P296, DOI 10.1007/s10753-009-9135-1; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Goldfine AB, 2011, CLIN CHEM, V57, P162, DOI 10.1373/clinchem.2010.148833; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hawley SA, 2012, SCIENCE; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Kim NH, 2012, DIABETES METAB J, V36, P268, DOI [10.4093/dmj.2012.36.4.268, 10.4093/dmj.2012.36.1.26]; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lesniewski LA, 2011, J GERONTOL A-BIOL, V66, P409, DOI 10.1093/gerona/glq233; MALOFF BL, 1986, DIABETOLOGIA, V29, P295, DOI 10.1007/BF00452066; Misu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034952; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	25	31	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66529	10.1371/journal.pone.0066529	http://dx.doi.org/10.1371/journal.pone.0066529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825542	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400122
J	Li, H; Jiang, WH; Zhang, Z; Xing, YR; Li, F				Li, Hang; Jiang, Weihua; Zhang, Zan; Xing, Yanru; Li, Fei			Transcriptome Analysis and Screening for Potential Target Genes for RNAi-Mediated Pest Control of the Beet Armyworm, Spodoptera exigua	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERENCE; LEPIDOPTERA; EXPRESSION; MANAGEMENT; NOCTUIDAE; MOTH	The beet armyworm, Spodoptera exigua (Hubner), is a serious pest worldwide that causes significant losses in crops. Unfortunately, genetic resources for the beet armyworm is extremely scarce. To improve these resources we sequenced the transcriptome of S. exigua representing all stages including eggs, 1st to 5th instar larvae, pupae, male and female adults using the Illumina Solexa platform. We assembled the transcriptome with Trinity that yielded 31,414 contigs. Of these contigs, 18,592 were annotated as protein coding genes by Blast searches against the NCBI nr database. It has been shown that knockdown of important insect genes by dsRNAs or siRNAs is a feasible mechanism to control insect pests. The first key step towards developing an efficient RNAi-mediated pest control technique is to find suitable target genes. To screen for effective target genes in the beet armyworm, we selected nine candidate genes. The sequences of these genes were amplified using the RACE strategy. Then, siRNAs were designed and chemically synthesized. We injected 2 mu l siRNA (2 mu g/mu l) into the 4th instar larvae to knock down the respective target genes. The mRNA abundance of target genes decreased to different levels (similar to 20-94.3%) after injection of siRNAs. Knockdown of eight genes including chitinase7, PGCP, chitinase1, ATPase, tubulin1, arf2, tubulin2 and arf1 caused a significantly high level of mortality compared to the negative control (P<0.05). About 80% of the surviving insects in the siRNA-treated group of five genes (PGCP, chitinase1, tubulin1, tubulin2 and helicase) showed retarded development. In chitinase1-siRNA and chitinase7-siRNA administered groups, 12.5% survivors exhibited "half-ecdysis''. In arf1-siRNA and arf2-siRNA groups, the body color of 15% became black 48 h after injections. In summary, the transcriptome could be a valuable genetic resource for identification of genes in S. exigua and this study provided putative targets for RNAi pest control.	[Li, Hang; Jiang, Weihua; Zhang, Zan; Xing, Yanru; Li, Fei] Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Li, Hang; Jiang, Weihua; Zhang, Zan; Xing, Yanru; Li, Fei] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Li, F (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	lifei@njau.edu.cn			National High Technology Research and Development Program ("863'' Program) of China [2012AA101505]; Basic Research Development Program of China (973 Program) [2012CB114100]; National Science Foundation of China [31171843]; Jiangsu Science Foundation for Distinguished Young Scholars [BK2012028]	National High Technology Research and Development Program ("863'' Program) of China(National High Technology Research and Development Program of China); Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Foundation for Distinguished Young Scholars	This work was in partial supported by the National High Technology Research and Development Program ("863'' Program, http://www.863.gov.cn) of China (2012AA101505), the Basic Research Development Program of China (973 Program, 2012CB114100, http://www.973.gov.cn/), the National Science Foundation of China (31171843, http://www.nsfc.gov.cn/) and the Jiangsu Science Foundation for Distinguished Young Scholars (BK2012028, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS EL, 1960, J ECON ENTOMOL, V53, P616, DOI 10.1093/jee/53.4.616; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; EAST DA, 1989, J ECON ENTOMOL, V82, P1367, DOI 10.1093/jee/82.5.1367; Gay H, 2012, AMBIX, V59, P88, DOI 10.1179/174582312X13345259995930; Gingras R, 1999, J BIOL CHEM, V274, P11742, DOI 10.1074/jbc.274.17.11742; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Taylor JE, 2008, CROP PROT, V27, P268, DOI 10.1016/j.cropro.2007.05.014; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Xiu WM, 2007, J CHEM ECOL, V33, P947, DOI 10.1007/s10886-007-9277-2; Xue XY, 2012, ADV INSECT PHYSIOL, V42, P73, DOI 10.1016/B978-0-12-387680-5.00003-3; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhao YY, 2011, INSECT MOL BIOL, V20, P97, DOI 10.1111/j.1365-2583.2010.01049.x; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	40	49	52	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65931	10.1371/journal.pone.0065931	http://dx.doi.org/10.1371/journal.pone.0065931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823756	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400034
J	Reetz, J; Genz, B; Meier, C; Kowtharapu, BS; Timm, F; Vollmar, B; Herchenroder, O; Abshagen, K; Putzer, BM				Reetz, Julia; Genz, Berit; Meier, Claudia; Kowtharapu, Bhavani S.; Timm, Franziska; Vollmar, Brigitte; Herchenroeder, Ottmar; Abshagen, Kerstin; Puetzer, Brigitte M.			Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo	PLOS ONE			English	Article							LIVER FIBROSIS; GENE DELIVERY; RECEPTOR EXPRESSION; UNDERGO APOPTOSIS; VECTORS; TROPISM; TOXICITY; BINDING; STRATEGIES; CIRRHOSIS	Hepatic stellate cells (HSCs) are known as initiator cells that induce liver fibrosis upon intoxication or other noxes. Deactivation of this ongoing remodeling process of liver parenchyma into fibrotic tissue induced by HSCs is an interesting goal to be achieved by targeted genetic modification of HSCs. The most widely applied approach in gene therapy is the utilization of specifically targeted vectors based on Adenovirus (Ad) serotype 5. To narrow down the otherwise ubiquitous tropism of parental Ad, two modifications are required: a) ablating the native tropism and b) redirecting the vector particles towards a specific entity solely present on the cells of interest. Therefore, we designed a peptide of the nerve growth factor (NGF(p)) with specific affinity for the p75 neurotrophin receptor (p75NTR) present on HSCs. Coupling of this NGF(p) to vector particles was done either via chemical conjugation using bifunctional polyethylene glycol (PEG) or, alternatively, by molecular bridging with a fusion protein specific for viral fiber knob and p75NTR. Both Ad vectors transmit the gene for the green fluorescent protein (GFP). GFP expression was monitored in vitro on primary murine HSCs as well as after systemic administration in mice with healthy and fibrotic livers using intravital fluorescence microscopy. Coupling of NGF(p) to Ad via S11 and/or PEGylation resulted in markedly reduced liver tropism and an enhanced adenoviral-mediated gene transfer to HSCs. Transduction efficiency of both specific Ads was uniformly higher in fibrotic livers, whereas Ad. GFP-S11-NGF(p) transduce activated HSCs better than Ad. GFP-PEG-NGF(p). These experiments contribute to the development of a targeted gene transfer system to specifically deliver antifibrotic compounds into activated HSCs by systemically applied adenoviral vector modified with NGF(p).	[Reetz, Julia; Meier, Claudia; Kowtharapu, Bhavani S.; Herchenroeder, Ottmar; Puetzer, Brigitte M.] Univ Rostock, Inst Expt Gene Therapy & Canc Res, Sch Med, D-18055 Rostock, Germany; [Genz, Berit; Timm, Franziska; Vollmar, Brigitte; Abshagen, Kerstin] Univ Rostock, Inst Expt Surg, Sch Med, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Abshagen, K (corresponding author), Univ Rostock, Inst Expt Surg, Sch Med, D-18055 Rostock, Germany.	kerstin.abshagen@uni-rostock.de	Genz, Berit/AAZ-4230-2020; Kowtharapu, Bhavani S./AAQ-7603-2020	Kowtharapu, Bhavani S./0000-0002-2336-5729	FORUN, University of Rostock [889036]; Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany [AB 453/1-1, PU 188/9-1]	FORUN, University of Rostock; Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany(German Research Foundation (DFG))	This work was supported by FORUN, University of Rostock (No. 889036) and by the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany (AB 453/1-1, PU 188/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Armendariz-Borunda J, 2011, J BIOSCI BIOENG, V112, P415, DOI 10.1016/j.jbiosc.2011.07.018; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beljaars L, 2002, FRONT BIOSCI-LANDMRK, V7, pE214, DOI 10.2741/beljaars; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; Curiel DT, 1999, ANN NY ACAD SCI, V886, P158, DOI 10.1111/j.1749-6632.1999.tb09409.x; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Douglas Joanne T, 2004, Methods Mol Biol, V246, P29; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Gonzalo T, 2007, J PHARMACOL EXP THER, V321, P856, DOI 10.1124/jpet.106.114496; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Haisma HJ, 2010, INT J PHARMACEUT, V391, P155, DOI 10.1016/j.ijpharm.2010.02.032; Haisma HJ, 2000, CANCER GENE THER, V7, P901, DOI 10.1038/sj.cgt.7700198; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kawakami Y, 2009, COLD SPRING HARB PRO, V2009; Kim PH, 2011, BIOMATERIALS, V32, P2314, DOI 10.1016/j.biomaterials.2010.10.031; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LOMENHOERTH C, 1995, J NEUROCHEM, V64, P1780; Lyle C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-148; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Myhre S, 2007, GENE THER, V14, P376, DOI 10.1038/sj.gt.3302875; Nettelbeck DM, 2004, INT J CANCER, V108, P136, DOI 10.1002/ijc.11563; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Ogawa S, 2010, HEPATOL RES, V40, P1128, DOI 10.1111/j.1872-034X.2010.00718.x; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Perez-Perez M, 2003, ANAT REC PART A, V270A, P117, DOI 10.1002/ar.a.10010; RAIVICH G, 1987, J COMP NEUROL, V256, P229, DOI 10.1002/cne.902560204; RAIVICH G, 1987, J NEUROCYTOL, V16, P689, DOI 10.1007/BF01637660; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Romanczuk H, 1999, HUM GENE THER, V10, P2615, DOI 10.1089/10430349950016654; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Schachtrup C, 2011, CELL CYCLE, V10, P1764, DOI 10.4161/cc.10.11.15828; Schmidt A, 2011, GENE THER, V18, P418, DOI 10.1038/gt.2010.165; Schmidt A, 2007, STEM CELLS, V25, P2910, DOI 10.1634/stemcells.2007-0238; Schoemaker MH, 2008, MOL PHARM, V5, P399, DOI 10.1021/mp700118p; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Vollmar B, 1998, HEPATOLOGY, V27, P1544, DOI 10.1002/hep.510270612; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wonganan P, 2010, VIRUSES-BASEL, V2, P468, DOI 10.3390/v2020468; Zhang XY, 2000, MICROVASC RES, V60, P232, DOI 10.1006/mvre.2000.2264	54	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67091	10.1371/journal.pone.0067091	http://dx.doi.org/10.1371/journal.pone.0067091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825626	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400175
J	Schee, K; Lorenz, S; Worren, MM; Gunther, CC; Holden, M; Hovig, E; Fodstad, O; Meza-Zepeda, LA; Flatmark, K				Schee, Kristina; Lorenz, Susanne; Worren, Merete Molton; Gunther, Clara-Cecilie; Holden, Marit; Hovig, Eivind; Fodstad, Oystein; Meza-Zepeda, Leonardo A.; Flatmark, Kjersti			Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer	PLOS ONE			English	Article							EXPRESSION; BIOMARKERS; TARGETS; KRAS; DIAGNOSIS; SURVIVAL; PCR	Colorectal cancer (CRC) is one of the leading causes of cancer related deaths and the search for prognostic biomarkers that might improve treatment decisions is warranted. MicroRNAs (miRNAs) are short non-coding RNA molecules involved in regulating gene expression and have been proposed as possible biomarkers in CRC. In order to characterize the miRNA transcriptome, a large cohort including 88 CRC tumors with long-term follow-up was deep sequenced. 523 mature miRNAs were expressed in our cohort, and they exhibited largely uniform expression patterns across tumor samples. Few associations were found between clinical parameters and miRNA expression, among them, low expression of miR-592 and high expression of miR-10b-5p and miR-615-3p were associated with tumors located in the right colon relative to the left colon and rectum. High expression of miR-615-3p was also associated with poorly differentiated tumors. No prognostic biomarker candidates for overall and metastasis-free survival were identified by applying the LASSO method in a Cox proportional hazards model or univariate Cox. Examination of the five most abundantly expressed miRNAs in the cohort (miR-10a-5p, miR-21-5p, miR-22-3p, miR-143-3p and miR-192-5p) revealed that their collective expression represented 54% of the detected miRNA sequences. Pathway analysis of the target genes regulated by the five most highly expressed miRNAs uncovered a significant number of genes involved in the CRC pathway, including APC, TGF beta and PI3K, thus suggesting that these miRNAs are relevant in CRC.	[Schee, Kristina; Lorenz, Susanne; Hovig, Eivind; Fodstad, Oystein; Meza-Zepeda, Leonardo A.; Flatmark, Kjersti] Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc Surg & Transplantat, Inst Canc Res,Dept Tumor Biol, Oslo, Norway; [Lorenz, Susanne; Meza-Zepeda, Leonardo A.] Univ Oslo, Inst Mol Biosci, Genom Core Facil, Oslo, Norway; [Worren, Merete Molton; Hovig, Eivind] Univ Oslo, Inst Informat, Oslo, Norway; [Gunther, Clara-Cecilie; Holden, Marit] Norwegian Comp Ctr, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Bioinformat Core Facil, Oslo, Norway; [Flatmark, Kjersti] Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc Surg & Transplantat, Dept Surg Gastroenterol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Flatmark, K (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc Surg & Transplantat, Inst Canc Res,Dept Tumor Biol, Oslo, Norway.	kjersti.flatmark-@rr-research.no	Hovig, Eivind/H-2474-2011; Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Hovig, Eivind/0000-0002-9103-1077; Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X	South-Eastern Norway Regional Health Authority; Norwegian Cancer Society	South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from South-Eastern Norway Regional Health Authority and from the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Flatmark K, 2011, BRIT J CANCER, V104, P1434, DOI 10.1038/bjc.2011.97; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Giovannucci E, 2003, J WOMEN HEALTH GEN-B, V12, P173, DOI 10.1089/154099903321576574; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Han L, 2007, CANCER BIOL THER, V6, P1284; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ju JF, 2010, BIOANALYSIS, V2, P901, DOI [10.4155/bio.10.45, 10.4155/BIO.10.45]; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lin MS, 2011, ONCOL REP, V25, P739, DOI 10.3892/or.2010.1112; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Migliore L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/792362; Mori Y, ENDOCR RELAT CANC, V18, P465; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mosakhani N, 2012, CANCER GENET-NY, V205, P545, DOI 10.1016/j.cancergen.2012.08.003; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Tang JT, 2009, MINI-REV MED CHEM, V9, P921, DOI 10.2174/138955709788681672; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Toth E, 2011, ROM J MORPHOL EMBRYO, V52, P767; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Vergoulis T., NUCL ACIDS RES, V40, pD222; Wu Y, 2012, GENE; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113	48	117	125	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66165	10.1371/journal.pone.0066165	http://dx.doi.org/10.1371/journal.pone.0066165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824282	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400062
J	Simkova, A; Civanova, K; Gettova, L; Gilles, A				Simkova, Andrea; Civanova, Kristina; Gettova, Lenka; Gilles, Andre			Genomic Porosity between Invasive Chondrostoma nasus and Endangered Endemic Parachondrostoma toxostoma (Cyprinidae): The Evolution of MHC IIB Genes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSSPECIES POLYMORPHISM; POPULATION-STRUCTURE; INTROGRESSIVE HYBRIDIZATION; SEXUAL SELECTION; CLASS-I; DIVERSITY; MICROSATELLITE; PATTERNS; LOCI	Two cyprinid species, Parachondrostoma toxostoma, an endemic threatened species, and Chondrostoma nasus, an invasive species, live in sympatry in southern France and form two sympatric zones where the presence of intergeneric hybrids is reported. To estimate the potential threat to endemic species linked to the introduction of invasive species, we focused on the DAB genes (functional MHC IIB genes) because of their adaptive significance and role in parasite resistance. More specifically, we investigated (1) the variability of MHC IIB genes, (2) the selection pattern shaping MHC polymorphism, and (3) the extent to which trans-species evolution and intergeneric hybridization affect MHC polymorphism. In sympatric areas, the native species has more diversified MHC IIB genes when compared to the invasive species, probably resulting from the different origins and dispersal of both species. A similar level of MHC polymorphism was found at population level in both species, suggesting similar mechanisms generating MHC diversity. In contrast, a higher number of DAB-like alleles per specimen were found in invasive species. Invasive species tended to express the alleles of two DAB lineages, whilst native species tended to express the alleles of only the DAB3 lineage. Hybrids have a pattern of MHC expression intermediate between both species. Whilst positive selection acting on peptide binding sites (PBS) was demonstrated in both species, a slightly higher number of positively selected sites were identified in C. nasus, which could result from parasite-mediated selection. Bayesian clustering analysis revealed a similar pattern of structuring for the genetic variation when using microsatellites or the MHC approach. We confirmed the importance of trans-species evolution for MHC polymorphism. In addition, we demonstrated bidirectional gene flow for MHC IIB genes in sympatric areas. The positive significant correlation between MHC and microsatellites suggests that demographic factors may contribute to MHC variation on a short time scale.	[Simkova, Andrea; Civanova, Kristina; Gettova, Lenka] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Gilles, Andre] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, UMR 7263, CNRS, Marseille, France	Masaryk University Brno; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Simkova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	simkova@sci.muni.cz	Civanova, Kristina/G-1182-2014; Simkova, Andrea/F-7636-2019	Civanova, Kristina/0000-0001-5690-3637; Simkova, Andrea/0000-0002-5995-6766	Czech Science Foundation [P505/10/1138]; European Centre of Excellence [P505/12/G112]	Czech Science Foundation(Grant Agency of the Czech Republic); European Centre of Excellence	This study (from 2010 to 2012) was funded by the Czech Science Foundation, Project No. P505/10/1138. A part of analyses performed in 2013 was funded by the Czech Science Foundation, European Centre of Excellence, Project No. P505/12/G112. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; Anderson EC, 2002, GENETICS, V160, P1217; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biedrzycka A, 2008, MOL ECOL, V17, P4801, DOI 10.1111/j.1365-294X.2008.03955.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Cohen S, 2002, MOL BIOL EVOL, V19, P1870, DOI 10.1093/oxfordjournals.molbev.a004011; Corse E, 2010, THESIS U PROVENCE MA; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Corse E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-26; Costedoat C, 2005, BIOL J LINN SOC, V85, P135, DOI 10.1111/j.1095-8312.2005.00478.x; Costedoat C, 2004, CYBIUM, V28, P51; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Dixon B, 1996, IMMUNOGENETICS, V44, P419, DOI 10.1007/s002510050148; Doherty P C, 1975, Nature, V256, P50; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Dubut Vincent, 2010, BMC Res Notes, V3, P135, DOI 10.1186/1756-0500-3-135; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Figueroa F, 2000, IMMUNOGENETICS, V51, P556, DOI 10.1007/s002510000181; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graser R, 1996, IMMUNOGENETICS, V44, P36, DOI 10.1007/BF02602655; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; HUGHES AL, 1992, NATURE, V355, P402, DOI 10.1038/355402b0; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JUKES T H, 1969, P21; KLEIN J, 1994, PHILOS T R SOC B, V346, P351, DOI 10.1098/rstb.1994.0152; KLEIN J, 1986, CRC CR REV IMMUNOL, V6, P295; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Longeri M, 2002, EUR J IMMUNOGENET, V29, P517, DOI 10.1046/j.1365-2370.2002.00356.x; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Marsden CD, 2009, J HERED, V100, pS54, DOI 10.1093/jhered/esp031; Mason RAB, 2011, CONSERV GENET, V12, P91, DOI 10.1007/s10592-009-9993-y; Meglecz E, 2011, BIOINFORMATICS, V27, P277, DOI 10.1093/bioinformatics/btq641; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Miller HC, 2010, MOL ECOL, V19, P3894, DOI 10.1111/j.1365-294X.2010.04771.x; Moutou KA, 2011, CONSERV GENET, V12, P1159, DOI 10.1007/s10592-011-0217-x; Nadachowska-Brzyska K, 2012, MOL ECOL, V21, P887, DOI 10.1111/j.1365-294X.2011.05347.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ottova E, 2005, FISH SHELLFISH IMMUN, V18, P199, DOI 10.1016/j.fsi.2004.07.004; Ottova E, 2007, BIOL J LINN SOC, V90, P525, DOI 10.1111/j.1095-8312.2007.00743.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Rakus KL, 2003, AQUAT LIVING RESOUR, V16, P432, DOI 10.1016/S0990-7440(03)00057-3; Rakus KL, 2009, AQUACULTURE, V288, P44, DOI 10.1016/j.aquaculture.2008.11.016; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Ricanova S, 2011, CONSERV GENET, V12, P1115, DOI 10.1007/s10592-011-0213-1; Sawyer S, 1999, GENECONV COMPUTER PA; Seifertova M, 2011, IMMUNOGENETICS, V63, P167, DOI 10.1007/s00251-010-0495-3; Simkova A, 2006, EVOL ECOL, V20, P465, DOI 10.1007/s10682-006-0014-z; Simkova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-200; Smith S, 2010, CONSERV GENET, V11, P269, DOI 10.1007/s10592-009-0029-4; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; vanErp SHM, 1996, IMMUNOGENETICS, V44, P192, DOI 10.1007/BF02602585; Wegner KM, 2012, MOL ECOL, V21, P779, DOI 10.1111/j.1365-294X.2011.05401.x; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395	74	8	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65883	10.1371/journal.pone.0065883	http://dx.doi.org/10.1371/journal.pone.0065883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824831	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400028
J	Tuladhar, AM; Snaphaan, L; Shumskaya, E; Rijpkema, M; Fernandez, G; Norris, DG; de Leeuw, FE				Tuladhar, Anil Man; Snaphaan, Liselore; Shumskaya, Elena; Rijpkema, Mark; Fernandez, Guillen; Norris, David G.; de Leeuw, Frank-Erik			Default Mode Network Connectivity in Stroke Patients	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; BRAIN; MEMORY; FMRI; FLUCTUATIONS; DEFICITS; LESIONS; MRI	The pathophysiology of episodic memory dysfunction after infarction is not completely understood. It has been suggested that infarctions located anywhere in the brain can induce widespread effects causing disruption of functional networks of the cortical regions. The default mode network, which includes the medial temporal lobe, is a functional network that is associated with episodic memory processing. We investigated whether the default mode network activity is reduced in stroke patients compared to healthy control subjects in the resting state condition. We assessed the whole brain network properties during resting state functional MRI in 21 control subjects and 20 'first-ever' stroke patients. Patients were scanned 9-12 weeks after stroke onset. Stroke lesions were located in various parts of the brain. Independent component analyses were conducted to identify the default mode network and to compare the group differences of the default mode network. Furthermore, region-of-interest based analysis was performed to explore the functional connectivity between the regions of the default mode network. Stroke patients performed significantly worse than control subjects on the delayed recall score on California verbal learning test. We found decreased functional connectivity in the left medial temporal lobe, posterior cingulate and medial prefrontal cortical areas within the default mode network and reduced functional connectivity between these regions in stroke patients compared with controls. There were no significant volumetric differences between the groups. These results demonstrate that connectivity within the default mode network is reduced in `first-ever' stroke patients compared to control subjects. This phenomenon might explain the occurrence of post-stroke cognitive dysfunction in stroke patients.	[Tuladhar, Anil Man; Snaphaan, Liselore; Fernandez, Guillen; Norris, David G.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Dept Neurol,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Tuladhar, Anil Man; Shumskaya, Elena; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Shumskaya, Elena] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 ED Nijmegen, Netherlands; [Norris, David G.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Norris, David G.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Duisburg Essen; University of Twente	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Dept Neurol,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands.	H.deLeeuw@neuro.umcn.nl	Tuladhar, Anil/G-8214-2016; de Leeuw, H.F./L-4479-2015; Fernandez, Guillen/B-3771-2009; Norris, David G/A-1937-2010; de Leeuw, Frank-Erik/E-4795-2012; Rijpkema, Mark/D-1974-2010	Tuladhar, Anil/0000-0002-4815-2834; Fernandez, Guillen/0000-0002-5522-0604; Norris, David G/0000-0002-3699-6917; Rijpkema, Mark/0000-0002-8495-4703	Dutch Brain foundation [H04-12]; Netherlands Organization for Scientific Research [40-00703-97-07197]	Dutch Brain foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Dr. De Leeuw received a personal fellowship from the Dutch Brain foundation (H04-12) and a clinical fellowship from the Netherlands Organization for Scientific Research (project number: 40-00703-97-07197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Damasio H, 1989, LESION ANAL NEUROPSY; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Jonghe J F, 1997, Tijdschr Gerontol Geriatr, V28, P224; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Delis DC., 2000, CALIFORNIA VERBAL LE; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; FOLSTEIN M, 1973, BIOL PSYCHIAT, V7, P147; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Lassalle-Lagadec S, 2012, RADIOLOGY, V264, P218, DOI 10.1148/radiol.12111718; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; MAHONEY F I, 1965, Md State Med J, V14, P61; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Pineiro R, 2002, STROKE, V33, P103, DOI 10.1161/hs0102.100482; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raj D, 2001, PHYS MED BIOL, V46, P3331, DOI 10.1088/0031-9155/46/12/318; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; Snaphaan L, 2009, BRAIN, V132, P1882, DOI 10.1093/brain/awp133; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; Tuladhar AM, 2010, NAT REV NEUROL, V6, P63, DOI 10.1038/nrneurol.2009.229; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Young MP, 2000, PHILOS T R SOC B, V355, P147, DOI 10.1098/rstb.2000.0555; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	69	74	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66556	10.1371/journal.pone.0066556	http://dx.doi.org/10.1371/journal.pone.0066556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824302	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400128
J	Steinke, K; Sachse, F; Ettischer, N; Strutz-Seebohm, N; Henrion, U; Rohrbeck, M; Klosowski, R; Wolters, D; Brunner, S; Franz, WM; Pott, L; Munoz, C; Kandolf, R; Schulze-Bahr, E; Lang, F; Klingel, K; Seebohm, G				Steinke, Katja; Sachse, Frank; Ettischer, Nicole; Strutz-Seebohm, Nathalie; Henrion, Ulrike; Rohrbeck, Matthias; Klosowski, Rafael; Wolters, Dirk; Brunner, Stefan; Franz, Wolfgang-Michael; Pott, Lutz; Munoz, Carlos; Kandolf, Reinhard; Schulze-Bahr, Eric; Lang, Florian; Klingel, Karin; Seebohm, Guiscard			Coxsackie virus B3 modulates cardiac ion channels	FASEB JOURNAL			English	Article						CVB3; trafficking; arrhythmias; myocarditis	RHINOVIRUS 3C PROTEASE; LONG-QT SYNDROME; TORSADE-DE-POINTES; VENTRICULAR-TACHYCARDIA; UNIDIRECTIONAL BLOCK; POTASSIUM CHANNELS; ANTIVIRAL ACTIVITY; VULNERABLE WINDOW; GENE-EXPRESSION; COMMON-CAUSE	Infections with coxsackieviruses of type B (CVBs), which are known to induce severe forms of acute and chronic myocarditis, are often accompanied by ventricular arrhythmias and sudden cardiac death. The mechanisms underlying the development of virus-induced, life-threatening arrhythmias, which are phenotypically similar to those observed in patients having functionally impaired cardiac ion channels, remain, however, enigmatic. In the present study, we show, for the first time, modulating time-dependent effects of CVB3 on the cardiac ion channels KCNQ1, hERG1, and Ca(v)1.2 in heterologous expression. Channel protein abundance in cellular plasma membrane and patterns of their subcellular distribution were altered in infected murine hearts. The antiviral compound AG7088 did not prevent these effects on channels. In silico analyses of infected human myocytes suggest pronounced alterations of electrical and calcium signaling and increased risk of arrhythmogenesis. These modifications are attenuated by the common Asian polymorphism KCNQ1 P448R, a genetic determinant preventing coxsackievirus-induced effects in vitro. This study provides a previously unknown explanation for the development of arrhythmias in enteroviral myocarditis, which will help to develop therapeutic strategies for arrhythmia treatment.Steinke, K., Sachse, F., Ettischer, N., Strutz-Seebohm, N., Henrion, U., Rohrbeck, M., Klosowski, R., Wolters, D., Brunner, S., Franz, W.-M., Pott, L., Munoz, C., Kandolf, R., Schulze-Bahr, E., Lang, F., Klingel, K., Seebohm, G. Coxsackievirus B3 modulates cardiac ion channels.	[Steinke, Katja; Strutz-Seebohm, Nathalie; Henrion, Ulrike; Rohrbeck, Matthias; Schulze-Bahr, Eric; Seebohm, Guiscard] Univ Hosp Munster, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Steinke, Katja; Brunner, Stefan] Ruhr Univ Bochum, Dept Biochem 1, Cat Channel Grp, Bochum, Germany; [Klosowski, Rafael; Wolters, Dirk] Ruhr Univ Bochum, Dept Analyt Chem, Bochum, Germany; [Pott, Lutz] Ruhr Univ Bochum, Dept Cellular Physiol, Bochum, Germany; [Sachse, Frank; Kandolf, Reinhard] Univ Utah, Nora Eccles Cardiovasc Res & Training Inst, Salt Lake City, UT USA; [Sachse, Frank; Kandolf, Reinhard] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Ettischer, Nicole; Klingel, Karin] Univ Hosp Tuebingen, Dept Mol Pathol, Tubingen, Germany; [Henrion, Ulrike; Munoz, Carlos; Lang, Florian] Univ Tubingen, Dept Physiol 1, Tubingen, Germany; [Franz, Wolfgang-Michael] Univ Munich, Dept Internal Med 1, Munich, Germany	University of Munster; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Munich	Seebohm, G (corresponding author), Inst Genet Herzerkrankungen IfGH, Abt Myozellulare Elektrophysiol, Albert Schweitzer Campus 1 Gebaude D3, D-48149 Munster, Germany.	guiscard.seebohm@ukmuenster.de		Sachse, Frank/0000-0003-4987-705X; Pott, Lutz/0000-0002-4000-4132	Deutsche Forschungsgemeinschaft [SE1077/3, SFB-TR19]; Interdisziplinares Zentrurn fur Klinische Forschung (IZKF) Minister [IZKF-Seel-012-13]; Federal Ministry of Education and Research [01EZ0817]; Research School of the Ruhr University Bochum; Richard A. and Nora Eccles Fund for Cardiovascular Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrurn fur Klinische Forschung (IZKF) Minister; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Research School of the Ruhr University Bochum; Richard A. and Nora Eccles Fund for Cardiovascular Research	The authors thank Ilaria Piccini for performing the qRT-PCR of endogenous SSGK1 transcripts and Stephanie Nolte and Sandra Bundschuh for technical assistance. This work was funded by the Deutsche Forschungsgemeinschaft (SE1077/3 to G.S. and K.K.; SFB-TR19 to KK, R.K., and F.L.), the Interdisziplinares Zentrurn fur Klinische Forschung (IZKF) Minister (IZKF-Seel-012-13), the Federal Ministry of Education and Research (01EZ0817 to K.K. and R.K.), the Research School of the Ruhr University Bochum, and the Richard A. and Nora Eccles Fund for Cardiovascular Research (to F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the German animal welfare act, which is based on the directive of the European parliament and of the council on the protection of animals used for scientific purposes. This study conforms to the Baden-Wuerttemberg State guidelines for animal welfare. The protocol was approved by the Committee on the Ethics of Animal Experiments of Baden-Wuerttemberg State authorities. All efforts were made to minimize suffering. The authors declare no conflicts of interest.	Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Badorff C, 2001, HEART, V86, P489, DOI 10.1136/heart.86.5.489; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Carthy CM, 1998, J VIROL, V72, P7669, DOI 10.1128/JVI.72.9.7669-7675.1998; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Collier JM, 2003, BIRTH DEFECTS RES A, V67, P488, DOI 10.1002/bdra.10073; Cunningham R, 2000, ANN EMERG MED, V35, P618, DOI 10.1016/S0196-0644(00)70037-0; Daley AJ, 1998, J PAEDIATR CHILD H, V34, P196, DOI 10.1046/j.1440-1754.1998.00176.x; Dragovich PS, 1998, J MED CHEM, V41, P2806, DOI 10.1021/jm980068d; Dutton JR, 2009, DEV DYNAM, V238, P1412, DOI 10.1002/dvdy.21932; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; KANDOLF R, 1987, P NATL ACAD SCI USA, V84, P6272, DOI 10.1073/pnas.84.17.6272; KANDOLF R, 1985, P NATL ACAD SCI USA, V82, P4818, DOI 10.1073/pnas.82.14.4818; Kessler A, 2000, DIABETOLOGIA, V43, P1518, DOI 10.1007/s001250051563; Klingel K, 1998, LAB INVEST, V78, P1227; Koo SH, 2006, BRIT J CLIN PHARMACO, V61, P301, DOI 10.1111/j.1365-2125.2005.02545.x; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Leonard EG, 2004, PEDIATR INFECT DIS J, V23, P665, DOI 10.1097/01.inf.0000132280.36984.a9; Leong Louis E.-C., 2002, P187; Levander OA, 1997, BIOL TRACE ELEM RES, V56, P5, DOI 10.1007/BF02778980; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; Mena I, 2000, VIROLOGY, V271, P276, DOI 10.1006/viro.2000.0332; MOSS AJ, 1982, MOD CONC CARDIOV DIS, V51, P85; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Patick AK, 1999, ANTIMICROB AGENTS CH, V43, P2444, DOI 10.1128/AAC.43.10.2444; Press W. H., 1992, ART SCI COMPUTING; Qu ZL, 2006, BIOPHYS J, V91, P793, DOI 10.1529/biophysj.106.080945; QUAN WL, 1990, CIRC RES, V66, P367, DOI 10.1161/01.RES.66.2.367; Sachse FB, 2008, ANN BIOMED ENG, V36, P41, DOI 10.1007/s10439-007-9405-8; Salerno F, 2011, INT J CARDIOL, V147, P468, DOI 10.1016/j.ijcard.2011.01.019; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; SARELI P, 1987, CLIN CARDIOL, V10, P361, DOI 10.1002/clc.4960100514; SATO Y, 1989, JPN HEART J, V30, P935; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Seebohm G, 2008, CIRC RES, V103, P1451, DOI 10.1161/CIRCRESAHA.108.177360; Shah SS, 1998, PEDIATR CARDIOL, V19, P185, DOI 10.1007/s002469900277; Sharma D, 2004, J MOL CELL CARDIOL, V37, P79, DOI 10.1016/j.yjmcc.2004.03.015; SHAW RM, 1995, J CARDIOVASC ELECTR, V6, P115, DOI 10.1111/j.1540-8167.1995.tb00763.x; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Strutz-Seebohm N, 2009, CHANNELS, V3, P88, DOI 10.4161/chan.3.2.8086; TAI YT, 1992, CARDIOLOGY, V80, P339, DOI 10.1159/000175023; Ten Tusscher KHWJ, 2006, PHYS MED BIOL, V51, P6141, DOI 10.1088/0031-9155/51/23/014; Terasaki F, 1990, Heart Vessels Suppl, V5, P45; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Wessely R, 1998, CIRCULATION, V98, P450, DOI 10.1161/01.CIR.98.5.450; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Wetzel U, 2003, HERZ, V28, P583, DOI 10.1007/s00059-003-2492-x; Witherell G, 2000, Curr Opin Investig Drugs, V1, P297; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C	59	18	19	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4108	4121		10.1096/fj.13-230193	http://dx.doi.org/10.1096/fj.13-230193			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825229				2022-12-25	WOS:000329747100023
J	Nemeth, BC; Wartmann, T; Halangk, W; Sahin-Toth, M				Nemeth, Balazs Csaba; Wartmann, Thomas; Halangk, Walter; Sahin-Toth, Miklos			Autoactivation of Mouse Trypsinogens Is Regulated by Chymotrypsin C via Cleavage of the Autolysis Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; POLYACRYLAMIDE-GELS; ZYMOGEN ACTIVATION; ESCHERICHIA-COLI; BOVINE TRYPSIN; EXPRESSION; PROTEINS; PURIFICATION; DEGRADATION	Chymotrypsin C (CTRC) is a proteolytic regulator of trypsinogen autoactivation in humans. CTRC cleavage of the trypsinogen activation peptide stimulates autoactivation, whereas cleavage of the calcium binding loop promotes trypsinogen degradation. Trypsinogen mutations that alter these regulatory cleavages lead to increased intrapancreatic trypsinogen activation and cause hereditary pancreatitis. The aim of this study was to characterize the regulation of autoactivation of mouse trypsinogens by mouse Ctrc. We found that the mouse pancreas expresses four trypsinogen isoforms to high levels, T7, T8, T9, and T20. Only the T7 activation peptide was cleaved by mouse Ctrc, causing negligible stimulation of autoactivation. Surprisingly, mouse Ctrc poorly cleaved the calcium binding loop in all mouse trypsinogens. In contrast, mouse Ctrc readily cleaved the Phe-150-Gly-151 peptide bond in the autolysis loop of T8 and T9 and inhibited autoactivation. Mouse chymotrypsin B also cleaved the same peptide bond but was 7-fold slower. T7 was less sensitive to chymotryptic regulation, which involved slow cleavage of the Leu-149-Ser-150 peptide bond in the autolysis loop. Modeling indicated steric proximity of the autolysis loop and the activation peptide in trypsinogen, suggesting the cleaved autolysis loop may directly interfere with activation. We conclude that autoactivation of mouse trypsinogens is under the control of mouse Ctrc with some notable differences from the human situation. Thus, cleavage of the trypsinogen activation peptide or the calcium binding loop by Ctrc is unimportant. Instead, inhibition of autoactivation via cleavage of the autolysis loop is the dominant mechanism that can mitigate intrapancreatic trypsinogen activation.	[Nemeth, Balazs Csaba; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Wartmann, Thomas; Halangk, Walter] Otto Von Guericke Univ, Dept Surg, Div Expt Surg, D-39120 Magdeburg, Germany	Boston University; Otto von Guericke University	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Nemeth, Balazs/0000-0001-5338-7577; Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01DK058088, R01DK082412, R01DK082412-S2, R01DK095753]; Deutsche Forschungsgemeinschaft [DFG HA2080/7-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095753, R01DK058088, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK058088, R01DK082412, R01DK082412-S2, and R01DK095753 (to M. S.-T.). This work was also supported by Grant DFG HA2080/7-1 from the Deutsche Forschungsgemeinschaft.	Archer H, 2006, GASTROENTEROLOGY, V131, P1844, DOI 10.1053/j.gastro.2006.09.049; Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Hayashi H, 2011, P NATL ACAD SCI USA, V108, P18766, DOI 10.1073/pnas.1116273108; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; LUTCKE H, 1989, NUCLEIC ACIDS RES, V17, P6736; MAROUX S, 1969, BIOCHIM BIOPHYS ACTA, V181, P59, DOI 10.1016/0005-2795(69)90227-X; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ohmura K, 1999, J BIOL CHEM, V274, P29426, DOI 10.1074/jbc.274.41.29426; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 1999, J BIOL CHEM, V274, P29699, DOI 10.1074/jbc.274.42.29699; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Selig L, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-30; SMITH RL, 1969, J BIOL CHEM, V244, P4704; STEVENSON BJ, 1986, NUCLEIC ACIDS RES, V14, P8307, DOI 10.1093/nar/14.21.8307; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Wang J, 2010, LAB INVEST, V90, P654, DOI 10.1038/labinvest.2010.44; WATANABE T, 1982, BIOCHIM BIOPHYS ACTA, V717, P439, DOI 10.1016/0304-4165(82)90285-9; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	34	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24049	24062		10.1074/jbc.M113.478800	http://dx.doi.org/10.1074/jbc.M113.478800			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814066	Green Published, hybrid			2022-12-25	WOS:000330611400042
J	Rodriguez, VB; Kidd, BA; Interlandi, G; Tchesnokova, V; Sokurenko, EV; Thomas, WE				Rodriguez, Victoria B.; Kidd, Brian A.; Interlandi, Gianluca; Tchesnokova, Veronika; Sokurenko, Evgeni V.; Thomas, Wendy E.			Allosteric Coupling in the Bacterial Adhesive Protein FimH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY-TRACT-INFECTION; UROPATHOGENIC ESCHERICHIA-COLI; TYPE-1 FIMBRIAL ADHESIN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; BOND; BINDING; FORCE; COLONIZATION; AFFINITY	The protein FimH is expressed by the majority of commensal and uropathogenic strains of Escherichia coli on the tips of type 1 fimbriae and mediates adhesion via a catch bond to its ligand mannose. Crystal structures of FimH show an allosteric conformational change, but it remains unclear whether all of the observed structural differences are part of the allosteric mechanism. Here we use the protein structural analysis tool Rosetta-Design combined with human insight to identify and synthesize 10 mutations in four regions that we predicted would stabilize one of the conformations of that region. The function of each variant was characterized by measuring binding to the ligand mannose, whereas the allosteric state was determined using a conformation-specific monoclonal antibody. These studies demonstrated that each region investigated was indeed part of the FimH allosteric mechanism. However, the studies strongly suggested that some regions were more tightly coupled to mannose binding and others to antibody binding. In addition, we identified many FimH variants that appear locked in the low affinity state. Knowledge of regulatory sites outside the active and effector sites as well as the ability to make FimH variants locked in the low affinity state may be crucial to the future development of novel antiadhesive and antimicrobial therapies using allosteric regulation to inhibit FimH.	[Rodriguez, Victoria B.; Kidd, Brian A.; Interlandi, Gianluca; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Tchesnokova, Veronika; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thomas, WE (corresponding author), Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA.	wendyt@u.washington.edu		Thomas, Wendy/0000-0001-8602-0819; Kidd, Brian/0000-0003-2110-1145	National Institutes of Health [1RO1 AI50940]; University of Washington [1RO1 AI50940]; National Science Foundation (NSF) [CBET-1132860]; Integrative Graduate Education and Research Traineeship Fellowship Award NSF [DGE-0504573]; University of Washington Initiatives Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); National Science Foundation (NSF)(National Science Foundation (NSF)); Integrative Graduate Education and Research Traineeship Fellowship Award NSF; University of Washington Initiatives Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 AI50940 and Molecular Biophysics Training Grant 1RO1 AI50940 (University of Washington; to B. A. K. and V. B. R.). This work was also supported by National Science Foundation (NSF) Grant CBET-1132860, Integrative Graduate Education and Research Traineeship Fellowship Award NSF #DGE-0504573 (to B. A. K.), and the University of Washington Initiatives Fund (to B. A. K.).	Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjornham O, 2010, BIOPHYS J, V99, P1331, DOI 10.1016/j.bpj.2010.06.003; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2002, PYMOL USERS MANUAL; Ding AM, 2010, APPL ENVIRON MICROB, V76, P1294, DOI 10.1128/AEM.02083-09; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Hartmann M, 2011, EUR J ORG CHEM, V2011, P3583, DOI 10.1002/ejoc.201100407; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kisiela DI, 2011, J BIOL CHEM, V286, P38136, DOI 10.1074/jbc.M111.237511; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Li ZJ, 2000, BIOTECHNOL PROGR, V16, P1086, DOI 10.1021/bp000117r; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Nilsson LM, 2008, STRUCTURE, V16, P1047, DOI 10.1016/j.str.2008.03.012; Nilsson LM, 2007, MOL MICROBIOL, V65, P1158, DOI 10.1111/j.1365-2958.2007.05858.x; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schito GC, 2009, INT J ANTIMICROB AG, V34, P407, DOI 10.1016/j.ijantimicag.2009.04.012; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; SOKURENKO EV, 1995, J BACTERIOL, V177, P3680, DOI 10.1128/jb.177.13.3680-3686.1995; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sokurenko EV, 2001, MOL MICROBIOL, V41, P675, DOI 10.1046/j.1365-2958.2001.02545.x; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas W, 2008, ANNU REV BIOMED ENG, V10, P39, DOI 10.1146/annurev.bioeng.10.061807.160427; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Whitfield M, 2010, BIOPHYS J, V99, P2470, DOI 10.1016/j.bpj.2010.08.045; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	55	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24128	24139		10.1074/jbc.M113.461376	http://dx.doi.org/10.1074/jbc.M113.461376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821547	Green Published, hybrid			2022-12-25	WOS:000330611400048
J	Zhang, Y; Teng, F; Luo, GZ; Wang, M; Tong, M; Zhao, XY; Wang, L; Wang, XJ; Zhou, Q				Zhang, Ying; Teng, Fei; Luo, Guan-Zheng; Wang, Meng; Tong, Man; Zhao, Xiaoyang; Wang, Liu; Wang, Xiu-Jie; Zhou, Qi			MicroRNA-323-3p Regulates the Activity of Polycomb Repressive Complex 2 (PRC2) via Targeting the mRNA of Embryonic Ectoderm Development (Eed) Gene in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3; METHYLATION; EZH2; DIFFERENTIATION; PLURIPOTENCY; ACTIVATION; PROTEIN; MARKS; TRANSLATION	PRC2 (Polycomb repressive complex 2) mediates epigenetic gene silencing by catalyzing the triple methylation of histone H3 Lys-27 (H3K27me3) to establish a repressive epigenetic state. PRC2 is involved in the regulation of many fundamental biological processes and is especially essential for embryonic stem cells. However, how the formation and function of PRC2 are regulated is largely unknown. Here, we show that a microRNA encoded by the imprinted Dlk1-Dio3 region of mouse chromosome 12, miR-323-3p, targets Eed (embryonic ectoderm development) mRNA, which encodes one of the core components of PRC2, the EED protein. Binding of miR-323-3p to Eed mRNA resulted in reduced EED protein abundance and cellular H3K27me3 levels, indicating decreased PRC2 activity. Such regulation seems to be conserved among mammals, at least between mice and humans. We demonstrate that induced pluripotent stem cells with varied developmental abilities had different miR-323-3p as well as EED and H3K27me3 levels, indicating that miR-323-3p may be involved in the regulation of stem cell pluripotency through affecting PRC2 activity. Mouse embryonic fibroblast cells had much higher miR-323-3p expression and nearly undetectable H3K27me3 levels. These findings identify miR-323-3p as a new regulator for PRC2 and provide a new approach for regulating PRC2 activity via microRNAs.	[Zhang, Ying; Teng, Fei; Zhao, Xiaoyang; Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Luo, Guan-Zheng; Wang, Meng; Tong, Man; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China; [Teng, Fei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China.	xjwang@genetics.ac.cn; qzhou@ioz.ac.cn	Wang, Xiu-Jie/L-1312-2019	ZHAO, Xiao-Yang/0000-0003-2544-8293	Ministry of Science and Technology of China [2011CBA01101]; Chinese Academy of Sciences [XDA01020101, XDA01020105]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by Grant 2011CBA01101 (to Q.Z. and X.-J.W.) from the Ministry of Science and Technology of China and by Strategic Priority Research Program Grants XDA01020101 (to Q.Z.) and XDA01020105 (to X.-J.W.) from the Chinese Academy of Sciences.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Faust C, 1998, DEVELOPMENT, V125, P4495; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lin SL, 2005, GENE, V356, P32, DOI 10.1016/j.gene.2005.04.036; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	37	7	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23659	23665		10.1074/jbc.M113.475608	http://dx.doi.org/10.1074/jbc.M113.475608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821546	Green Published, hybrid			2022-12-25	WOS:000330611400005
J	Hu, WX; Zhao, J; Pei, G				Hu, Wenxiang; Zhao, Jian; Pei, Gang			Activation of Aryl Hydrocarbon Receptor (AhR) by Tranilast, an Anti-allergy Drug, Promotes miR-302 Expression and Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; GENERATION; MOUSE; INDUCTION; MICRORNAS; FIBROBLASTS; INVOLVEMENT; TARGETS; GROWTH	MiR-302 has been shown to regulate pluripotency genes and help somatic cell reprogramming. Thus, promotion of endogenous miR-302 expression could be a desirable way to facilitate cell reprogramming. By using a luciferase reporter system of the miR-302 promoter, we screened and found that an anti-allergy drug, tranilast, could significantly promote miR-302 expression. Further experiments revealed that two aryl hydrocarbon receptor (AhR) binding motifs on the miR-302 promoter are critical and that activation of AhR is required for tranilast-induced miR-302 expression. Consistently, not only tranilast but other AhR agonists promoted miR-302 expression. Furthermore, the activation of AhR facilitated cell reprogramming in a miR-302-dependent way. These results elucidate that miR-302 expression can be regulated by AhR and thus provide a strategy for promoting somatic cell reprogramming by AhR ligands.	[Hu, Wenxiang; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Hu, Wenxiang; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, Shanghai 200031, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017; Zhao, Jian/E-2008-2019	Hu, Wenxiang/0000-0002-6754-5625; Zhao, Jian/0000-0002-8862-0591	Chinese Academy of Sciences [XDA01010302]; Ministry of Science and Technology [2011CB910202, 2009CB940903]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Chinese Academy of Sciences (XDA01010302) and the Ministry of Science and Technology (2011CB910202 and 2009CB940903).	Akahoshi E., 2006, ENV HLTH, V5, P1; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kang H, 2012, J BIOL CHEM, V287, P38656, DOI 10.1074/jbc.M112.390898; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lindsey S, 2012, STEM CELL REV REP, V8, P1223, DOI 10.1007/s12015-012-9384-5; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Liu HY, 2011, MOL BIOL REP, V38, P2155, DOI 10.1007/s11033-010-0343-4; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Muraro MJ, 2013, STEM CELLS, V31, P838, DOI 10.1002/stem.1340; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nukaya M, 2010, TOXICOL SCI, V118, P554, DOI 10.1093/toxsci/kfq305; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Reyes-Hernandez OD, 2010, BIOCHEM PHARMACOL, V80, P932, DOI 10.1016/j.bcp.2010.05.007; Rogosnitzky M, 2012, ANTICANCER RES, V32, P2471; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; SUZAWA H, 1992, JPN J PHARMACOL, V60, P85, DOI 10.1254/jjp.60.85; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313; Zhang ZH, 2013, STEM CELLS DEV, V22, P2268, DOI 10.1089/scd.2012.0650	58	32	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22972	22984		10.1074/jbc.M113.475624	http://dx.doi.org/10.1074/jbc.M113.475624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23821545	hybrid, Green Published			2022-12-25	WOS:000330598200008
J	Gay, L; Siol, M; Ronfort, J				Gay, Laurene; Siol, Mathieu; Ronfort, Joelle			Pedigree-Free Estimates of Heritability in the Wild: Promising Prospects for Selfing Populations	PLOS ONE			English	Article							QUANTITATIVE GENETIC-PARAMETERS; ESTIMATING VARIANCE-COMPONENTS; PAIRWISE RELATEDNESS; INBREEDING DEPRESSION; NATURAL-POPULATIONS; BREEDING VALUES; SPATIAL AUTOCORRELATION; INFERRED RELATEDNESS; RELATIONSHIP MATRIX; GENOMIC SELECTION	Estimating the genetic variance available for traits informs us about a population's ability to evolve in response to novel selective challenges. In selfing species, theory predicts a loss of genetic diversity that could lead to an evolutionary dead-end, but empirical support remains scarce. Genetic variability in a trait is estimated by correlating the phenotypic resemblance with the proportion of the genome that two relatives share identical by descent ('realized relatedness'). The latter is traditionally predicted from pedigrees (Phi(A): expected value) but can also be estimated using molecular markers (average number of alleles shared). Nevertheless, evolutionary biologists, unlike animal breeders, remain cautious about using marker-based relatedness coefficients to study complex phenotypic traits in populations. In this paper, we review published results comparing five different pedigree-free methods and use simulations to test individual-based models (hereafter called animal models) using marker-based relatedness coefficients, with a special focus on the influence of mating systems. Our literature review confirms that Ritland's regression method is unreliable, but suggests that animal models with marker-based estimates of relatedness and genomic selection are promising and that more testing is required. Our simulations show that using molecular markers instead of pedigrees in animal models seriously worsens the estimation of heritability in outcrossing populations, unless a very large number of loci is available. In selfing populations the results are less biased. More generally, populations with high identity disequilibrium (consanguineous or bottlenecked populations) could be propitious for using marker-based animal models, but are also more likely to deviate from the standard assumptions of quantitative genetics models (non-additive variance).	[Gay, Laurene; Siol, Mathieu; Ronfort, Joelle] UMR AGAP 1334, Montpellier, France; [Siol, Mathieu] UMR Agroecol 1347, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne	Gay, L (corresponding author), UMR AGAP 1334, Montpellier, France.	Laurene.Gay@supagro.inra.fr	Gay, Laurene/K-6644-2014		French Research Institute INRA	French Research Institute INRA	This work was funded by the French Research Institute INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2010, P ROY SOC B-BIOL SCI, V277, P2531, DOI 10.1098/rspb.2010.0196; Andrew RL, 2005, GENETICS, V171, P1989, DOI 10.1534/genetics.105.042952; Baird NA, 2008, PLOS ONE, V3; Barton NH, 2004, EVOLUTION, V58, P2111; Bessega C, 2009, AM J BOT, V96, P458, DOI 10.3732/ajb.0800074; Blonk RJW, 2010, GENETICS, V184, P213, DOI 10.1534/genetics.109.110536; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Bouvet JM, 2008, GENET RESOUR CROP EV, V55, P1291, DOI 10.1007/s10722-008-9328-8; Brookfield JFY, 2009, BIOL LETTERS, V5, P44, DOI 10.1098/rsbl.2008.0639; Bulmer MG, 1980, MATH THEORY QUANTITA; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; CHARLESWORTH D, 1995, EVOLUTION, V49, P911, DOI 10.2307/2410413; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; COCKERHAM CC, 1985, CROP SCI, V25, P483, DOI 10.2135/cropsci1985.0011183X002500030012x; COCKERHAM CC, 1983, THEOR POPUL BIOL, V23, P85, DOI 10.1016/0040-5809(83)90006-0; COCKERHAM CC, 1971, GENETICS, V69, P235; Coltman DW, 2005, MOL ECOL, V14, P2593, DOI 10.1111/j.1365-294X.2005.02600.x; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; DiBattista JD, 2009, EVOLUTION, V63, P1051, DOI 10.1111/j.1558-5646.2008.00605.x; Doran J. C., 1994, New Forests, V8, P155, DOI 10.1007/BF00028191; Duchesne P, 2002, MOL ECOL NOTES, V2, P191, DOI 10.1046/j.1471-8286.2002.00164.x; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frentiu FD, 2008, P R SOC B, V275, P639, DOI 10.1098/rspb.2007.1032; Garant D, 2005, MOL ECOL, V14, P1843, DOI 10.1111/j.1365-294X.2005.02561.x; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Gilmore AR, 2006, ASREML USER GUIDE RE; Glemin S, 2003, GENETICS, V165, P2193; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Goldringer I, 1997, HEREDITY, V79, P60, DOI 10.1038/hdy.1997.123; Guo S-W, 1998, HUM HERED, V46, P61; Hamrick JL, 1997, CROP SCI, V37, P26, DOI 10.2135/cropsci1997.0011183X003700010004x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; HARRIS DL, 1964, GENETICS, V50, P1319; Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733; HEATH DD, 1994, HEREDITY, V72, P146, DOI 10.1038/hdy.1994.21; HEDRICK PW, 1980, GENETICS, V94, P791; Henderson C. R, 1984, APPL LINEAR MODELS A; HILL WG, 1993, HEREDITY, V71, P652, DOI 10.1038/hdy.1993.190; Hill WG, 2012, CURR GENOMICS, V13, P196, DOI 10.2174/138920212800543110; Holland J. B., 2010, ESTIMATING INTERPRET, P9; Holland JB, 2010, EPISTASIS PLANT BREE, P27; HOULE D, 1992, GENETICS, V130, P195; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; Jarne P, 2006, EVOLUTION, V60, P1816; Jensen J, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-44; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kelly JK, 1999, EVOLUTION, V53, P336, DOI 10.1111/j.1558-5646.1999.tb03770.x; Kelly JK, 2000, J THEOR BIOL, V207, P37, DOI 10.1006/jtbi.2000.2154; Klaper R, 2001, J HERED, V92, P421, DOI 10.1093/jhered/92.5.421; Kruuk LEB, 2008, P ROY SOC B-BIOL SCI, V275, P593, DOI 10.1098/rspb.2007.1689; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; Kumar S, 2005, MOL BREEDING, V15, P55, DOI 10.1007/s11032-004-2059-4; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lee SH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-22; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Leroy G, 2012, ANIM GENET, V43, P309, DOI 10.1111/j.1365-2052.2011.02253.x; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M, 1999, GENETICS, V152, P1753; Lynch M., 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Milner JM, 2000, J EVOLUTION BIOL, V13, P804, DOI 10.1046/j.1420-9101.2000.00222.x; Mousseau TA, 1998, HEREDITY, V80, P218, DOI 10.1046/j.1365-2540.1998.00269.x; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Nordborg M, 1997, GENETICS, V146, P1185; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940; PEDERSON DG, 1969, AUST J BIOL SCI, V22, P117, DOI 10.1071/BI9690117; Pemberton JM, 2008, P ROY SOC B-BIOL SCI, V275, P613, DOI 10.1098/rspb.2007.1531; Peterson BK, 2012, PLOS ONE, P7; POLLAK E, 1987, GENETICS, V117, P353; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Reid JM, 2010, EVOLUTION, V64, P973, DOI 10.1111/j.1558-5646.2009.00865.x; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Ritland K, 2000, DETECTING INHERITANC; Rodriguez-Ramilo ST, 2007, CONSERV GENET, V8, P1189, DOI 10.1007/s10592-006-9273-z; Rolf MM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-24; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; Shaw RG, 1998, GENETICS, V150, P1649; Shikano T, 2008, J HERED, V99, P94, DOI 10.1093/jhered/esm105; Sillanpaa MJ, 2011, MOL ECOL, V20, P1324, DOI 10.1111/j.1365-294X.2011.05021.x; Smith BR, 2001, GENETICS, V158, P1329; Sorensen A, 2002, GENET SEL EVOL, V34, P1; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stopher KV, 2012, EVOLUTION, V66, P2411, DOI 10.1111/j.1558-5646.2012.01620.x; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Thomas SC, 2000, HEREDITY, V84, P427, DOI 10.1046/j.1365-2540.2000.00681.x; Thomas SC, 2000, GENETICS, V155, P1961; Thomas SC, 2002, J EVOLUTION BIOL, V15, P92, DOI 10.1046/j.1420-9101.2002.00372.x; Toro M, 2002, CONSERV GENET, V3, P309, DOI 10.1023/A:1019921131171; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; van Kleunen M, 2005, J HERED, V96, P368, DOI 10.1093/jhered/esi039; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Veerkamp RF, 2011, J DAIRY SCI, V94, P4189, DOI 10.3168/jds.2011-4223; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Villanueva B, 2005, J ANIM SCI, V83, P1747; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2009, GENETICA, V136, P351, DOI 10.1007/s10709-008-9301-7; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang JL, 2002, GENETICS, V160, P1203; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Wilson AJ, 2003, GENET RES, V81, P145, DOI 10.1017/S0016672302006055; Wright A J, 1985, SELECTION PARTIAL SE; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	134	17	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66983	10.1371/journal.pone.0066983	http://dx.doi.org/10.1371/journal.pone.0066983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825602	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000056
J	Heerwagen, MJR; Stewart, MS; de la Houssaye, BA; Janssen, RC; Friedman, JE				Heerwagen, Margaret J. R.; Stewart, Michael S.; de la Houssaye, Becky A.; Janssen, Rachel C.; Friedman, Jacob E.			Transgenic Increase in N-3/N-6 Fatty Acid Ratio Reduces Maternal Obesity-Associated Inflammation and Limits Adverse Developmental Programming in Mice	PLOS ONE			English	Article							BODY-MASS INDEX; ADIPOSE-TISSUE; INSULIN-RESISTANCE; EARLY-CHILDHOOD; LIPOPROTEIN-LIPASE; GROWTH RESTRICTION; GLUCOSE-TOLERANCE; FETAL-GROWTH; RISK-FACTORS; FAT-1 MOUSE	Maternal and pediatric obesity has risen dramatically over recent years, and is a known predictor of adverse long-term metabolic outcomes in offspring. However, which particular aspects of obese pregnancy promote such outcomes is less clear. While maternal obesity increases both maternal and placental inflammation, it is still unknown whether this is a dominant mechanism in fetal metabolic programming. In this study, we utilized the Fat-1 transgenic mouse to test whether increasing the maternal n-3/n-6 tissue fatty acid ratio could reduce the consequences of maternal obesity-associated inflammation and thereby mitigate downstream developmental programming. Eight-week-old WT or hemizygous Fat-1 C57BL/6J female mice were placed on a high-fat diet (HFD) or control diet (CD) for 8 weeks prior to mating with WT chowfed males. Only WT offspring from Fat-1 mothers were analyzed. WT-HFD mothers demonstrated increased markers of infiltrating adipose tissue macrophages (P<0.02), and a striking increase in 12 serum pro-inflammatory cytokines (P<0.05), while Fat1-HFD mothers remained similar to WT-CD mothers, despite equal weight gain. E18.5 Fetuses from WT-HFD mothers had larger placentas (P<0.02), as well as increased placenta and fetal liver TG deposition (P<0.01 and P<0.02, respectively) and increased placental LPL TG-hydrolase activity (P<0.02), which correlated with degree of maternal insulin resistance (r = 0.59, P<0.02). The placentas and fetal livers from Fat1-HFD mothers were protected from this excess placental growth and fetal-placental lipid deposition. Importantly, maternal protection from excess inflammation corresponded with improved metabolic outcomes in adult WT offspring. While the offspring from WT-HFD mothers weaned onto CD demonstrated increased weight gain (P<0.05), body and liver fat (P<0.05 and P<0.001, respectively), and whole body insulin resistance (P<0.05), these were prevented in WT offspring from Fat1-HFD mothers. Our results suggest that reducing excess maternal inflammation may be a promising target for preventing adverse fetal metabolic outcomes in pregnancies complicated by maternal obesity.	[Heerwagen, Margaret J. R.; Stewart, Michael S.; de la Houssaye, Becky A.; Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Pediat, Div Neonatol, Aurora, CO USA; [Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Friedman, JE (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Div Neonatol, Aurora, CO USA.	jed.friedman@ucdenver.edu			National Institutes of Health [DK-5R01DK062155]; Colorado Nutrition and Obesity Research (NORC) NIH [P30 DK048520]; American Heart Association [AHA-11PRE5020014]; Colorado Clinical Translational Science Institute [TL1-RR-025778]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R24DK090964, R01DK062155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition and Obesity Research (NORC) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Colorado Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support for this study from the National Institutes of Health DK-5R01DK062155, the Colorado Nutrition and Obesity Research (NORC) NIH P30 DK048520, the American Heart Association Predoctoral Fellowship AHA-11PRE5020014, and the Colorado Clinical Translational Science Institute T32 Grant TL1-RR-025778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamendi Ana, 2012, ISRN Endocrinol, V2012, P757913, DOI 10.5402/2012/757913; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Baranowski M, 2012, CYTOKINE, V59, P382, DOI 10.1016/j.cyto.2012.04.004; Barroso CS, 2012, CHILD OBES, V8, P449, DOI 10.1089/chi.2011.0094; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Bilal S, 2011, BBA-MOL BASIS DIS, V1812, P1164, DOI 10.1016/j.bbadis.2011.05.002; Birbilis M, 2013, EUR J CLIN NUTR, V67, P115, DOI 10.1038/ejcn.2012.176; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2012, J PEDIAT; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Cole BK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/851798; Cordero P, 2012, J ENDOCRINOL INVEST, V35, P981, DOI 10.1007/BF03346741; Crawford MA, 2000, AM J CLIN NUTR, V71, p275S, DOI 10.1093/ajcn/71.1.275S; Cunningham P, 2009, J NUTR, V139, P636, DOI 10.3945/jn.108.098608; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; DuBois BN, 2012, PLACENTA, V33, P1045, DOI 10.1016/j.placenta.2012.09.008; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Durnwald C, 2004, AM J OBSTET GYNECOL, V191, P804, DOI 10.1016/j.ajog.2003.11.033; ECKEL RH, 1995, INT J OBESITY, V19, pS16; Eckel RH, 1986, METHODS DIABETES RES, V2, P259; Ehrenthal DB, 2013, OBSTET GYNECOL, V121, P115, DOI [10.1097/AOG.0b013e318278f56a, http://10.1097/AOG.0b013e318278f56a]; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gil-Sanchez Alfonso, 2011, Frontiers in Genetics, V2, P57, DOI 10.3389/fgene.2011.00057; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; Hagopian K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012696; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jones ML, 2012, BIOL REPROD; Jungheim ES, 2011, BIOL REPROD, V85, P678, DOI 10.1095/biolreprod.111.092148; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kappen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038445; Kim EH, 2012, BIOCHEM PHARMACOL, V84, P1359, DOI 10.1016/j.bcp.2012.08.029; Krasnow SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1243, DOI 10.1152/ajpendo.00261.2011; Burgueno AL, 2013, J NUTR BIOCHEM, V24, P6, DOI 10.1016/j.jnutbio.2011.12.008; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026656; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Monk JM, 2012, J NUTR, V142, P117, DOI 10.3945/jn.111.147058; Moon RJ, 2013, J CLIN ENDOCR METAB, V98, P299, DOI 10.1210/jc.2012-2482; Mouralidarane A, 2013, HEPATOLOGY; Much D, 2013, EUR J CLIN NUTR, V67, P282, DOI 10.1038/ejcn.2013.2; Muhlhausler BS, 2011, PROSTAG LEUKOTR ESS, V85, P83, DOI 10.1016/j.plefa.2011.04.027; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Orr SK, 2010, NEUROCHEM RES, V35, P811, DOI 10.1007/s11064-010-0139-x; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Smith BK, 2010, APPL PHYSIOL NUTR ME, V35, P699, DOI 10.1139/H10-066; Strakovsky RS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094482; Torres-Rovira L, 2013, J STEROID BIOCHEM; Turdi S, 2012, J MOL CELL CARDIOL; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vonnahme KA, 2013, J ANIM SCI; Wadhwani NS, 2013, PROSTAG LEUKOTR ESS, V88, P235, DOI 10.1016/j.plefa.2012.12.002; Wallace JM, 2012, PLACENTA, V33, P611, DOI 10.1016/j.placenta.2012.05.006; Wallace JM, 2004, BIOL REPROD, V71, P1055, DOI 10.1095/biolreprod.104.030965; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Weylandt KH, 2008, BBA-MOL BASIS DIS, V1782, P634, DOI 10.1016/j.bbadis.2008.08.011; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhu MJ, 2010, PLACENTA, V31, P387, DOI 10.1016/j.placenta.2010.02.002	85	87	88	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67791	10.1371/journal.pone.0067791	http://dx.doi.org/10.1371/journal.pone.0067791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825686	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000120
J	Tzeng, ST; Tsai, MH; Chen, CL; Lee, JX; Jao, TM; Yu, SL; Yen, SJ; Yang, YC				Tzeng, Sheng-Tai; Tsai, Ming-Hong; Chen, Chi-Long; Lee, Jing-Xing; Jao, Tzu-Ming; Yu, Sung-Liang; Yen, Sou-Jhy; Yang, Ya-Chien			NDST4 Is a Novel Candidate Tumor Suppressor Gene at Chromosome 4q26 and Its Genetic Loss Predicts Adverse Prognosis in Colorectal Cancer	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MOLECULAR MARKERS; SULFOTRANSFERASE; CARCINOMA; DELETIONS; BIOSYNTHESIS; PATHOGENESIS; INSTABILITY; ISOZYMES; PATTERNS	Background: Genomic deletion at tumor suppressor loci is a common genetic aberration in human cancers. The study aimed to explore candidate tumor suppressor genes at chromosome 4q25-q28.2 and to delineate novel prognostic biomarkers associated with colorectal cancer (CRC). Methods: Deletion mapping of chromosome 4q25-q28.2 was conducted in 114 sporadic CRC by loss of heterozygosity study with 11 microsatellite markers. A novel candidate tumor suppressor gene, namely NDST4, was identified at 4q26. Gene expression of NDST4 was investigated in 52 pairs of primary CRC tissues by quantitative reverse transcription-polymerase chain reaction. Allelic loss of NDST4 gene was further determined in 174 colorectal carcinomas by loss of heterozygosity analysis, and then was assessed for clinical relevance. Results: One minimal deletion region was delineated between D4S2297 and D4S2303 loci at 4q26, where NDST4 was the only gene that had markedly been downregulated in CRC tumors. By laser capture microdissection, NDST4 RNA expression was demonstrated in colonic epithelial cells, but was undetectable in tumor cells. In total, 30 (57.7%) of 52 colorectal carcinomas showed a dramatic reduction in NDST4 gene expression compared with matched normal mucosae. The genetic loss of NDST4 was significantly associated with advanced pathological stage (P = 0.039) and poorer overall survival of patients (P = 0.036). Conclusions: NDST4 gene is a novel candidate tumor suppressor gene in human cancer, and the loss of its function might be involved in CRC progression. In addition, the loss of heterozygosity assay, which was established to determine the allelic loss of NDST4 gene, could be a cost-effective tool for providing a useful biomarker of adverse prognosis in CRC.	[Tzeng, Sheng-Tai; Lee, Jing-Xing; Jao, Tzu-Ming; Yu, Sung-Liang; Yang, Ya-Chien] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsai, Ming-Hong; Yen, Sou-Jhy] Cardinal Tien Hosp, Dept Surg, New Taipei City, Taiwan; [Tsai, Ming-Hong] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chen, Chi-Long] Taipei Municipal Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Taipei, Taiwan; [Yu, Sung-Liang; Yang, Ya-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; Cardinal Tien Hospital; Fu Jen Catholic University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Yang, YC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	ycyangntu@ntu.edu.tw	Jao, Tzu-Ming/GQB-1940-2022; Jao, Tzu-Ming/L-3490-2019	Jao, Tzu-Ming/0000-0003-2676-292X; YANG, YA-CHIEN/0000-0002-9981-210X; Tzeng, Sheng-Tai/0000-0002-0089-0512; YU, SUNG-LIANG/0000-0003-4535-9036	National Science Council, Executive Yuan [NSC99-2320-B-002-020-MY3]; Cardinal Tien Hospital [CTH-93-1-2A01]; National Health Research Institutes, Taiwan [NHRI-EX101-10136BI]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	The study was supported by grants from the National Science Council, Executive Yuan (NSC99-2320-B-002-020-MY3), the Cardinal Tien Hospital (CTH-93-1-2A01), and the National Health Research Institutes (NHRI-EX101-10136BI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Arai Y, 2010, GENE CHROMOSOME CANC, V49, P596, DOI 10.1002/gcc.20770; Arribas R, 1999, CLIN CANCER RES, V5, P3454; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bendardaf R, 2004, ANTICANCER RES, V24, P2519; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Duffy MJ, 2011, CANCER TREAT REV, V37, P151, DOI 10.1016/j.ctrv.2010.07.004; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Vega I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-24; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Harrison S, 2011, SURG-J R COLL SURG E, V9, P200, DOI 10.1016/j.surge.2011.01.011; Jones AM, 2007, J PATHOL, V213, P249, DOI 10.1002/path.2234; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurje G, 2007, CLIN COLORECTAL CANC, V6, P683, DOI 10.3816/CCC.2007.n.037; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Perea J, 2011, REV ESP ENFERM DIG, V103, P29, DOI 10.4321/s1130-01082011000100006; Raman Karthik, 2010, Curr Chem Biol, V4, P20; Raman K, 2011, FEBS LETT, V585, P3420, DOI 10.1016/j.febslet.2011.09.030; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sarrazin S, 2011, COLD SPRING HARB PER, P3; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Shivapurkar N, 2001, HUM PATHOL, V32, P169, DOI 10.1053/hupa.2001.21560; Singh RK, 2007, HUM GENET, V122, P71, DOI 10.1007/s00439-007-0375-6; Tsai MH, 2002, HEPATO-GASTROENTEROL, V49, P672; van Engeland M, 2011, J CLIN ONCOL, V29, P1382, DOI 10.1200/JCO.2010.28.2319; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67040	10.1371/journal.pone.0067040	http://dx.doi.org/10.1371/journal.pone.0067040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825612	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000064
J	Montgomery, P; Burton, JR; Sewell, RP; Spreckelsen, TF; Richardson, AJ				Montgomery, Paul; Burton, Jennifer R.; Sewell, Richard P.; Spreckelsen, Thees F.; Richardson, Alexandra J.			Low Blood Long Chain Omega-3 Fatty Acids in UK Children Are Associated with Poor Cognitive Performance and Behavior: A Cross-Sectional Analysis from the DOLAB Study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; FATTY-ACIDS; OMEGA-3 INDEX; SUPPLEMENTATION	Background: Omega-3 long-chain polyunsaturated fatty acids (LC-PUFA), especially DHA (docosahexaenonic acid) are essential for brain development and physical health. Low blood Omega-3 LC-PUFA have been reported in children with ADHD and related behavior/learning difficulties, as have benefits from dietary supplementation. Little is known, however, about blood fatty acid status in the general child population. We therefore investigated this in relation to age-standardized measures of behavior and cognition in a representative sample of children from mainstream schools. Participants: 493 schoolchildren aged 7-9 years from mainstream Oxfordshire schools, selected for below average reading performance in national assessments at age seven. Method: Whole blood fatty acids were obtained via fingerstick samples. Reading and working memory were assessed using the British Ability Scales (II). Behaviour (ADHD-type symptoms) was rated using the revised Conners' rating scales (long parent and teacher versions). Associations were examined and adjusted for relevant demographic variables. Results: DHA and eicosapentaenoic acid (EPA), accounted for only 1.9% and 0.55% respectively of total blood fatty acids, with DHA showing more individual variation. Controlling for sex and socio-economic status, lower DHA concentrations were associated with poorer reading ability (std. OLS coeff. = 0.09, p = <.042) and working memory performance (0.14, p = <.001). Lower DHA was also associated with higher levels of parent rated oppositional behavior and emotional lability (-0.175, p= <.0001 and -0.178, p = <.0001). Conclusions: In these healthy UK children with below average reading ability, concentrations of DHA and other Omega-3 LC-PUFA were low relative to adult cardiovascular health recommendations, and directly related to measures of cognition and behavior. These findings require confirmation, but suggest that the benefits from dietary supplementation with Omega-3 LC-PUFA found for ADHD, Dyspraxia, Dyslexia, and related conditions might extend to the general school population.	[Montgomery, Paul; Burton, Jennifer R.; Sewell, Richard P.; Spreckelsen, Thees F.; Richardson, Alexandra J.] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England	University of Oxford	Montgomery, P (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	paul.montgomery@spi.ox.ac.uk	Spreckelsen, Thees/L-9281-2019	Spreckelsen, Thees/0000-0002-5043-2077; Richardson, Alex/0000-0001-5650-4409; Montgomery, Paul/0000-0001-8008-1370	Martek Biosciences Inc.	Martek Biosciences Inc.	The study was funded by Martek Biosciences Inc. (http://www.lifesdha.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding for the trial was provided by Martek Biosciences Inc., who also provided product and placebo. JRB, TFS and RPS declare that no other competing interests exist. AJR and PM acts as an occasional paid consultant (lectures and advisory work) for companies and organisations involved in producing, selling, or promoting foods or supplements containing omega-3. None of these issues alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bailey-Hall E, 2008, LIPIDS, V43, P181, DOI 10.1007/s11745-007-3140-7; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; BURGESS JR, 2003, PHOSPHOLIPID SPECTRU, P511; Chen JR, 2004, J NUTR BIOCHEM, V15, P467, DOI 10.1016/j.jnutbio.2004.01.008; Conners C.K., 1997, CONNERSRATING SCALES; Cyhlarova E, 2007, EUR NEUROPSYCHOPHARM, V17, P116, DOI 10.1016/j.euroneuro.2006.07.003; Decsi T, 2011, AM J CLIN NUTR, V94, p1914S, DOI 10.3945/ajcn.110.000893; Department of Education, 2001, DFES5812001 DEP ED; Elliott C. D., 1997, TECHNICAL MANUAL BRI; Food Standards Agency, 2010, EAT WELL YOUR GUID H; Galli C, 2010, 9 C INT SOC STUD FAT; Glaser C, 2010, J PEDIATR-US, V157, P826, DOI 10.1016/j.jpeds.2010.05.001; Harris WS, 2011, AM J CLIN NUTR, V93, P907, DOI 10.3945/ajcn.111.014365; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hobbs G, 2010, BRIT EDUC RES J, V36, P673, DOI 10.1080/01411920903083111; Kirby A, 2010, RES DEV DISABIL, V31, P718, DOI 10.1016/j.ridd.2010.01.014; Marangoni F, 2004, ANAL BIOCHEM, V326, P267, DOI 10.1016/j.ab.2003.12.016; Mathias RA, 2011, BMC GENET, V12, DOI [10.1186/1471-2156-1112-1150, DOI 10.1186/1471-2156-1112-1150]; MORRISON WR, 1964, J LIPID RES, V5, P600; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, p958S, DOI 10.3945/ajcn.2008.26692F; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Richardson AJ, 2006, INT REV PSYCHIATR, V18, P155, DOI 10.1080/09540260600583031; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Sinn N, 2008, PROSTAG LEUKOTR ESS, V78, P311, DOI 10.1016/j.plefa.2008.04.004; Standards and Testing Agency, 2012, NAT CURR ASS ASS REP; STEVENS LJ, 1995, AM J CLIN NUTR, V62, P761, DOI 10.1093/ajcn/62.4.761	30	63	66	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66697	10.1371/journal.pone.0066697	http://dx.doi.org/10.1371/journal.pone.0066697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826114	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400034
J	Fonseca, CR; Coutinho, RM; Azevedo, F; Berbert, JM; Corso, G; Kraenkel, RA				Fonseca, Carlos Roberto; Coutinho, Renato M.; Azevedo, Franciane; Berbert, Juliana M.; Corso, Gilberto; Kraenkel, Roberto A.			Modeling Habitat Split: Landscape and Life History Traits Determine Amphibian Extinction Thresholds	PLOS ONE			English	Article							METAPOPULATION DYNAMICS; GLOBAL DECLINE; FRAGMENTATION; CONSERVATION; BIODIVERSITY; DISEASE; BRAZIL; POPULATIONS; FOREST; SIZE	Habitat split is a major force behind the worldwide decline of amphibian populations, causing community change in richness and species composition. In fragmented landscapes, natural remnants, the terrestrial habitat of the adults, are frequently separated from streams, the aquatic habitat of the larvae. An important question is how this landscape configuration affects population levels and if it can drive species to extinction locally. Here, we put forward the first theoretical model on habitat split which is particularly concerned on how split distance - the distance between the two required habitats - affects population size and persistence in isolated fragments. Our diffusive model shows that habitat split alone is able to generate extinction thresholds. Fragments occurring between the aquatic habitat and a given critical split distance are expected to hold viable populations, while fragments located farther away are expected to be unoccupied. Species with higher reproductive success and higher diffusion rate of post-metamorphic youngs are expected to have farther critical split distances. Furthermore, the model indicates that negative effects of habitat split are poorly compensated by positive effects of fragment size. The habitat split model improves our understanding about spatially structured populations and has relevant implications for landscape design for conservation. It puts on a firm theoretical basis the relation between habitat split and the decline of amphibian populations.	[Fonseca, Carlos Roberto] Univ Fed Rio Grande do Norte, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil; [Coutinho, Renato M.; Azevedo, Franciane; Berbert, Juliana M.; Kraenkel, Roberto A.] Univ Estadual Paulista, Inst Fis Teor, BR-01405 Sao Paulo, Brazil; [Corso, Gilberto] Univ Fed Rio Grande do Norte, Dept Biofis & Farmacol, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Estadual Paulista; Universidade Federal do Rio Grande do Norte	Fonseca, CR (corresponding author), Univ Fed Rio Grande do Norte, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil.	cfonseca@cb.ufrn.br	Fonseca, Carlos MMS/D-9744-2011; Corso, Gilberto/G-6160-2012; Kraenkel, Roberto A/B-5479-2010; Berbert, Juliana/AAG-1616-2021; Corso, Gilberto/AAE-9056-2021; Fonseca, Carlos Roberto/V-5869-2017; Coutinho, Renato M/H-9133-2017; Fonseca, Carlos Roberto/A-9273-2013	Fonseca, Carlos MMS/0000-0001-6559-7133; Corso, Gilberto/0000-0003-1748-4040; Kraenkel, Roberto A/0000-0001-5602-5184; Corso, Gilberto/0000-0003-1748-4040; Fonseca, Carlos Roberto/0000-0003-0292-0399; Coutinho, Renato M/0000-0002-2828-8558; Berbert, Juliana/0000-0003-2389-7837	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Internacional Center for Theoretical Physics - ICTP-SAIFR	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Internacional Center for Theoretical Physics - ICTP-SAIFR	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (CRF, GC, RAK), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (FA), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (RMC,JMB), and Internacional Center for Theoretical Physics - ICTP-SAIFR (RAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Ananthasubramaniam B, 2011, ECOLOGY, V92, P362, DOI 10.1890/09-2346.1; Artiles W, 2008, J MATH BIOL, V57, P521, DOI 10.1007/s00285-008-0174-2; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Cantrell RS, 1998, J MATH BIOL, V37, P491, DOI 10.1007/s002850050139; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fonseca CR, 2009, BIOL CONSERV, V142, P1209, DOI 10.1016/j.biocon.2009.02.017; Fonseca CR, 2008, SCIENCE, V320, DOI 10.1126/science.1155686; Gardner TA, 2007, BIOL CONSERV, V138, P166, DOI 10.1016/j.biocon.2007.04.017; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Glista DJ, 2008, HERPETOL CONSERV BIO, V3, P77; HADDAD CFB, 1997, BIODIVERSIDADE ESTAD, P15; Hale JM, 2013, CONSERV GENET, V14, P313, DOI 10.1007/s10592-012-0428-9; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; HANSKI I, 1994, BIOL CONSERV, V68, P167, DOI 10.1016/0006-3207(94)90348-4; Hanski I., 1999, METAPOPULATION ECOLO; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; HARRISON S, 1988, AM NAT, V132, P360, DOI 10.1086/284858; Harrison S, 2008, BIOL J LINN SOC, V42, P73; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; LAAN R, 1990, BIOL CONSERV, V54, P251, DOI 10.1016/0006-3207(90)90055-T; Lehtinen RM, 1999, WETLANDS, V19, P1, DOI 10.1007/BF03161728; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; LOMAN J, 1988, Memoranda Societatis pro Fauna et Flora Fennica, V64, P113; Lomolino MV, 2008, BIOL J LINN SOC, V28, P1; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; MAC ARTHUR ROBERT H., 1967; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Mittermeier RA, 2004, HOTSPOTS REVISITED; ORBACH R, 1986, SCIENCE, V231, P814, DOI 10.1126/science.231.4740.814; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Remsburg AJ, 2009, J N AM BENTHOL SOC, V28, P44, DOI 10.1899/08-004.1; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Smith MA, 2005, ECOGRAPHY, V28, P110; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WEDERKINCH E, 1988, Memoranda Societatis pro Fauna et Flora Fennica, V64, P101; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070	53	17	17	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66806	10.1371/journal.pone.0066806	http://dx.doi.org/10.1371/journal.pone.0066806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818967	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800104
J	Looyenga, BD; Resau, J; MacKeigan, JP				Looyenga, Brendan D.; Resau, James; MacKeigan, Jeffrey P.			Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway	PLOS ONE			English	Article							INDUCED SWEATING SYNDROME; ACID-INDUCED DIFFERENTIATION; NEURO-BLASTOMA CELLS; PARKINSONS-DISEASE; HUMAN NEUROBLASTOMA; OXIDATIVE STRESS; CNTF RECEPTOR; SH-SY5Y CELLS; MICE LACKING; IN-VIVO	Oxidative stress is an important cause of cellular toxicity in the central nervous system and contributes to the pathology associated with neurodegenerative disorders including Parkinson's disease. As such, elucidation of cellular mechanisms that enhance neuronal resistance to oxidative stress may provide new avenues for therapy. In this study we employed a simple two-state cellular model to identify genes that are associated with resistance to oxidative stress induced by 6-hydroxydopamine (6-OHDA). In this model, undifferentiated neuroblastoma cells display higher sensitivity to 6-OHDA than differentiated cells. By comparing the gene expression between these two states, we identified several genes whose expression is altered concomitant with changes in 6-OHDA sensitivity. This gene set includes cytokine receptor-like factor 1 (CRLF1), which is up-regulated during the differentiation process and has been previously implicated in neuroprotection. We show that the product of this gene is both necessary and sufficient for increased resistance to 6-OHDA in differentiated neuroblastoma cells, and that CRLF1 serves its protective role by a cell autonomous mechanism that is independent from its known role as a co-ligand for the ciliary neurotrophic factor receptor. These data provide an additional role for CRLF1 that could potentially explain its broad expression pattern and effects on cells lacking expression of this receptor.	[Looyenga, Brendan D.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA; [Resau, James] Van Andel Res Inst, Program Biospecimen Sci, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	Looyenga, BD (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA.	brendan.looyenga@vai.org		MacKeigan, Jeffrey/0000-0002-0198-5679; Looyenga, Brendan/0000-0002-0661-0956	Van Andel Research Institute	Van Andel Research Institute	This work was funded internally by the Van Andel Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BIEDLER JL, 1978, CANCER RES, V38, P3751; Burbulla LF, 2011, J NEUROL SCI, V306, P1, DOI 10.1016/j.jns.2011.04.005; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Choi HJ, 2005, NEUROCHEM INT, V46, P329, DOI 10.1016/j.neuint.2004.10.009; Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039; Collier TJ, 2003, ANN NY ACAD SCI, V991, P140; Crisponi L, 2007, AM J HUM GENET, V80, P971, DOI 10.1086/516843; Dagoneau N, 2007, AM J HUM GENET, V80, P966, DOI 10.1086/513608; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Dick FD, 2006, BRIT MED BULL, V79-80, P219, DOI 10.1093/bmb/ldl018; Elson GCA, 1998, J IMMUNOL, V161, P1371; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; Herholz J, 2011, EUR J HUM GENET, V19, P525, DOI 10.1038/ejhg.2010.253; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; Kort EJ, 2009, VET PATHOL, V46, P598, DOI 10.1354/vp.08-VP-0276-R-REV; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Miyazaki I, 2009, NEUROCHEM RES, V34, P698, DOI 10.1007/s11064-008-9843-1; Opacka-Juffry J, 1998, BRAIN RES, V810, P27, DOI 10.1016/S0006-8993(98)00866-X; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; PERUMAL AS, 1992, BRAIN RES BULL, V29, P699, DOI 10.1016/0361-9230(92)90142-K; ROSS RA, 1983, J NATL CANCER I, V71, P741; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirmenstein MA, 2005, TOXICOL IN VITRO, V19, P471, DOI 10.1016/j.tiv.2005.01.006; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; ZIGMOND MJ, 1989, MOL CHEM NEUROPATHOL, V10, P185, DOI 10.1007/BF03159728	45	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66548	10.1371/journal.pone.0066548	http://dx.doi.org/10.1371/journal.pone.0066548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818941	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800077
J	Blicher, A; Heimburg, T				Blicher, Andreas; Heimburg, Thomas			Voltage-Gated Lipid Ion Channels	PLOS ONE			English	Article							PHASE-TRANSITION TEMPERATURE; BILAYER-MEMBRANES; ELECTRICAL BREAKDOWN; MELTING TRANSITION; PHOSPHATIDIC-ACID; CERAMIDE CHANNELS; POTASSIUM CHANNEL; THERMODYNAMICS; CAPACITANCE; FLUCTUATIONS	Synthetic lipid membranes can display channel-like ion conduction events even in the absence of proteins. We show here that these events are voltage-gated with a quadratic voltage dependence as expected from electrostatic theory of capacitors. To this end, we recorded channel traces and current histograms in patch-experiments on lipid membranes. We derived a theoretical current-voltage relationship for pores in lipid membranes that describes the experimental data very well when assuming an asymmetric membrane. We determined the equilibrium constant between closed and open state and the open probability as a function of voltage. The voltage-dependence of the lipid pores is found comparable to that of protein channels. Lifetime distributions of open and closed events indicate that the channel open distribution does not follow exponential statistics but rather power law behavior for long open times.	[Blicher, Andreas; Heimburg, Thomas] Univ Copenhagen, Niels Bohr Inst, Membrane Biophys Grp, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Heimburg, T (corresponding author), Univ Copenhagen, Niels Bohr Inst, Membrane Biophys Grp, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	theimbu@nbi.dk	Heimburg, Thomas/AAA-7726-2022; Heimburg, Thomas R/I-5064-2014	Heimburg, Thomas R/0000-0003-4599-4582	University of Copenhagen; Villum foundation [VKR 022130]	University of Copenhagen; Villum foundation(Villum Fonden)	A.B. was supported by a grant from the University of Copenhagen. T.H. was supported by the Villum foundation (VKR 022130) - URL:http://veluxfoundations.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; ANTONOV VF, 1990, CHEM PHYS LIPIDS, V52, P251, DOI 10.1016/0009-3084(90)90121-7; Antonov VF, 2005, EUR BIOPHYS J BIOPHY, V34, P155, DOI 10.1007/s00249-004-0438-8; ANTONOV VF, 1980, NATURE, V283, P585, DOI 10.1038/283585a0; ANTONOV VF, 1985, BIOCHEM BIOPH RES CO, V133, P1098, DOI 10.1016/0006-291X(85)91249-5; Blicher A, 2011, THESIS U COPENHAGEN; Blicher A, 2009, BIOPHYS J, V96, P4581, DOI 10.1016/j.bpj.2009.01.062; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; CROWLEY JM, 1973, BIOPHYS J, V13, P711, DOI 10.1016/S0006-3495(73)86017-5; Ebel H, 2001, J PHYS CHEM B, V105, P7353, DOI 10.1021/jp010515s; Gallaher J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061925; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2; HANKE W, 1984, BIOELECTROCH BIOENER, V12, P329, DOI 10.1016/0302-4598(84)87013-0; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heimburg T, 2010, BIOPHYS CHEM, V150, P2, DOI 10.1016/j.bpc.2010.02.018; Heimburg T, 1998, BBA-BIOMEMBRANES, V1415, P147, DOI 10.1016/S0005-2736(98)00189-8; Heimburg T., 2007, THERMAL BIOPHYSICS M; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; KAUFMANN K, 1983, BIOPHYS CHEM, V18, P89, DOI 10.1016/0301-4622(83)85002-9; KAUFMANN K, 1983, NATURWISSENSCHAFTEN, V70, P147, DOI 10.1007/BF00401606; Kaufmann K., 1989, LIPID MEMBRANE; Laub KR, 2012, BIOCHIM BIOPHYS ACTA, V1818, P1; LIEBOVITCH LS, 1987, BIOPHYS J, V52, P979, DOI 10.1016/S0006-3495(87)83290-3; Liebovitch LS, 2001, METHODS, V24, P359, DOI 10.1006/meth.2001.1206; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Neumann E, 1999, BIOELECTROCH BIOENER, V48, P3, DOI 10.1016/S0302-4598(99)00008-2; Nielsen LK, 2000, NATURE, V404, P352, DOI 10.1038/35006162; Petrov A. G., 2002, BIOCHIM BIOPHYS ACTA, V1561, P1, DOI DOI 10.1016/S0304-4157(01)00007-7; Seeger HM, 2007, J PHYS CHEM B, V111, P13858, DOI 10.1021/jp075346b; Shao CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043513; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Stark JA, 2000, BIOPHYS J, V78, P662, DOI 10.1016/S0006-3495(00)76624-0; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; WHITE SH, 1973, BIOCHIM BIOPHYS ACTA, V323, P7, DOI 10.1016/0005-2736(73)90428-8; WINTERHALTER M, 1987, PHYS REV A, V36, P5874, DOI 10.1103/PhysRevA.36.5874; Wodzinska K, 2009, SOFT MATTER, V5, P3319, DOI 10.1039/b909877a; Wu D, 1995, CELLULAR NEUROPHYSIO; Wunderlich B, 2009, BIOPHYS J, V96, P4592, DOI 10.1016/j.bpj.2009.02.053; YAFUSO M, 1974, J MEMBRANE BIOL, V17, P201, DOI 10.1007/BF01870182; Yang J, 2000, J PHYS CHEM B, V104, P8097, DOI 10.1021/jp001403o	50	21	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65707	10.1371/journal.pone.0065707	http://dx.doi.org/10.1371/journal.pone.0065707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823188	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400019
J	Lemaitre, JF; Gaillard, JM				Lemaitre, Jean-Francois; Gaillard, Jean-Michel			Polyandry Has No Detectable Mortality Cost in Female Mammals	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SPERM COMPETITION; MATING SYSTEMS; PREDATION RISK; MATE CHOICE; LIFE-SPAN; EVOLUTION; PATTERNS; SURVIVAL; BENEFITS	In several taxonomic groups, females mate with several males during a single reproductive cycle. Although there is evidence that polyandry provides some benefits to females, it often involves mortality costs. However, empirical evidences of mortality costs of polyandry have so far been reported only in invertebrates. Whether polyandry has mortality costs in vertebrates is currently unknown. In the present study, we aimed to fill the gap by investigating the relationships between the level of polyandry (measured either by male relative testes mass or the percentage of multiple paternities) and female patterns of mortality across mammals. While we found that the two metrics of female mortality co-varied with pace of life, we did not find any evidence that polyandry leads to either decreased median lifespan or increased aging rate in mammals. We discuss such an absence of detectable mortality costs of polyandry in female mammals in light of recent advances in the study of mammalian reproductive biology and life-history tactics.	[Lemaitre, Jean-Francois] Univ Lyon, Lyon, France; Univ Lyon 1, F-69622 Villeurbanne, France; CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Lemaitre, JF (corresponding author), Univ Lyon, Lyon, France.	jeff.lemaitre@gmail.com		Gaillard, Jean-Michel/0000-0003-0174-8451	Fyssen Foundation	Fyssen Foundation	The funder is the Fyssen Foundation that provides grants for young researchers in Behavioural Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Anderson MJ, 2004, J REPROD IMMUNOL, V61, P31, DOI 10.1016/j.jri.2003.11.001; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birkhead TR, 1998, SPERM COMPETITION SE; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bro-Jorgensen J, 2011, EVOL BIOL, V38, P28, DOI 10.1007/s11692-010-9105-4; Cappozzo HL, 2008, NATURWISSENSCHAFTEN, V95, P625, DOI 10.1007/s00114-008-0363-2; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cothran RD, 2004, ANIM BEHAV, V68, P1133, DOI 10.1016/j.anbehav.2003.09.021; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; DEWSBURY DA, 1972, Q REV BIOL, V47, P1, DOI 10.1086/407097; Dixson AF, 1998, FOLIA PRIMATOL, V69, P300, DOI 10.1159/000021643; Eberhard WG, 1985, SEXUAL SELECTION ANI; Fischer K, 2007, ECOL ENTOMOL, V32, P674, DOI 10.1111/j.1365-2311.2007.00922.x; Fitzpatrick JL, 2012, EVOLUTION, V66, P3595, DOI 10.1111/j.1558-5646.2012.01713.x; Fortes P, 2011, PHYSIOL ENTOMOL, V36, P215, DOI 10.1111/j.1365-3032.2011.00786.x; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaillard JM, 2003, POPUL DEV REV, V29, P39; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 2005, AM NAT, V166, P119, DOI 10.1086/430330; GINSBERG JR, 1990, BEHAV ECOL SOCIOBIOL, V26, P427; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; HART BL, 1987, PHYSIOL BEHAV, V41, P321, DOI 10.1016/0031-9384(87)90395-7; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hastie T., 2006, GAM GEN ADDITIVE MOD; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 2003, EVOL BIOL, V33, P173; Hosken DJ, 2002, PHYSIOL ENTOMOL, V27, P87, DOI 10.1046/j.1365-3032.2002.00271.x; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kawagoe T, 2001, ECOL ENTOMOL, V26, P258, DOI 10.1046/j.1365-2311.2001.00326.x; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; King BH, 2010, BEHAVIOUR, V147, P85, DOI 10.1163/000579509X12483520922241; Klemme I, 2008, P ROY SOC B-BIOL SCI, V275, P1095, DOI 10.1098/rspb.2008.0038; Klemme I, 2010, BIOL LETTERS, V6, P24, DOI 10.1098/rsbl.2009.0500; KREMENTZ DG, 1989, OIKOS, V56, P203, DOI 10.2307/3565337; Lemaitre JF, 2009, J EVOLUTION BIOL, V22, P2215, DOI 10.1111/j.1420-9101.2009.01837.x; Lemaitre JF, 2013, BEHAV ECOL, V24, P421, DOI 10.1093/beheco/ars179; Lemaitre JF, 2012, BEHAV ECOL SOCIOBIOL, V66, P97, DOI 10.1007/s00265-011-1257-4; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Long TAF, 2005, J EVOLUTION BIOL, V18, P209; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; McNamara KB, 2008, BEHAV ECOL SOCIOBIOL, V62, P1433, DOI 10.1007/s00265-008-0573-9; Moorad JA, 2012, AGING CELL, V11, P940, DOI 10.1111/j.1474-9726.2012.00861.x; Nunn CL, 2003, ANIM BEHAV, V66, P37, DOI 10.1006/anbe.2003.2130; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2012, AGING CELL, V11, P178, DOI 10.1111/j.1474-9726.2011.00771.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; Reale D, 1996, CAN J ZOOL, V74, P1812, DOI 10.1139/z96-202; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; SILVA M, 1995, CRC HDB MAMMALIAN BO; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Stearns S.C., 1992, pi; Stockley P, 2004, J EVOLUTION BIOL, V17, P1048, DOI 10.1111/j.1420-9101.2004.00742.x; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; Stockley P, 2002, EVOL ECOL, V16, P123, DOI 10.1023/A:1016323511091; Thrall PH, 1997, AM NAT, V149, P485, DOI 10.1086/286001; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Wlasiuk G, 2010, EVOLUTION, V64, P2204, DOI 10.1111/j.1558-5646.2010.00989.x; WOOTTON JT, 1987, EVOLUTION, V41, P732, DOI 10.1111/j.1558-5646.1987.tb05849.x	82	11	11	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66670	10.1371/journal.pone.0066670	http://dx.doi.org/10.1371/journal.pone.0066670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825000	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400147
J	Omata, K; Hanakawa, T; Morimoto, M; Honda, M				Omata, Kei; Hanakawa, Takashi; Morimoto, Masako; Honda, Manabu			Spontaneous Slow Fluctuation of EEG Alpha Rhythm Reflects Activity in Deep-Brain Structures: A Simultaneous EEG-fMRI Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; CEREBROSPINAL-FLUID FLOW; EMPIRICAL MODE DECOMPOSITION; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; THALAMUS; RESPONSES; ARTIFACT; STIMULATION; SUPPRESSION	The emergence of the occipital alpha rhythm on brain electroencephalogram (EEG) is associated with brain activity in the cerebral neocortex and deep brain structures. To further understand the mechanisms of alpha rhythm power fluctuation, we performed simultaneous EEGs and functional magnetic resonance imaging recordings in human subjects during a resting state and explored the dynamic relationship between alpha power fluctuation and blood oxygenation level-dependent (BOLD) signals of the brain. Based on the frequency characteristics of the alpha power time series (APTS) during 20-minute EEG recordings, we divided the APTS into two components: fast fluctuation (0.04-0.167 Hz) and slow fluctuation (0-0.04 Hz). Analysis of the correlation between the MRI signal and each component revealed that the slow fluctuation component of alpha power was positively correlated with BOLD signal changes in the brain stem and the medial part of the thalamus and anterior cingulate cortex, while the fast fluctuation component was correlated with the lateral part of the thalamus and the anterior cingulate cortex, but not the brain stem. In summary, these data suggest that different subcortical structures contribute to slow and fast modulations of alpha spectra on brain EEG.	[Omata, Kei; Morimoto, Masako; Honda, Manabu] Natl Ctr Neurol & Psychiat, Dept Funct Brain Res, Natl Inst Neurosci, Tokyo, Japan; [Omata, Kei] Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Hanakawa, Takashi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Omata, Kei; Morimoto, Masako; Honda, Manabu] Japan Sci & Technol Agcy, CREST, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; Hamamatsu University School of Medicine; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Honda, M (corresponding author), Natl Ctr Neurol & Psychiat, Dept Funct Brain Res, Natl Inst Neurosci, Tokyo, Japan.	honda@ncnp.go.jp	HONDA, Manabu/AAO-1202-2020; Hanakawa, Takashi/AEU-7951-2022		Japan Science and Technology Agency, CREST; Health Labour Sciences Research Grant	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	This work was partly supported by Japan Science and Technology Agency, CREST (URL: http://www.jst.go.jp/kisoken/crest/en/research _area/ongoing/area02-1.html), a Grant-in-Aid for Scientific Research on Innovative Areas (Brain and Information Science on SHITSUKAN)(URL: http://shitsukan.jp/content/137, Number: C01-3) and a Health Labour Sciences Research Grant (URL: http://www.mhlw.go.jp/bunya/ kenkyuujigyou/hojokin-koubo20/07-03.html, Number: 33) to M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASU T, 1984, J PHYSIOL-LONDON, V351, P583, DOI 10.1113/jphysiol.1984.sp015264; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; ANDERSEN P, 1967, J PHYSIOL-LONDON, V192, P257, DOI 10.1113/jphysiol.1967.sp008299; Astolfi L, 2008, IEEE T NEUR SYS REH, V16, P522, DOI 10.1109/TNSRE.2008.2009784; Bear MF, 2007, NEUROSCIENCE EXPLORI, Vxxxviii, P857, DOI DOI 10.1093/BRAIN/AWM203; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bridwell DA, 2013, NEUROIMAGE, V69, P101, DOI 10.1016/j.neuroimage.2012.12.024; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; de Munck JC, 2007, NEUROIMAGE, V35, P1142, DOI 10.1016/j.neuroimage.2007.01.022; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; DiFrancesco MW, 2008, J CLIN NEUROPHYSIOL, V25, P255, DOI 10.1097/WNP.0b013e3181879d56; DUN NJ, 1984, J PHYSIOL-LONDON, V351, P61, DOI 10.1113/jphysiol.1984.sp015232; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frackowiak RSJ., 2003, HUMAN BRAIN FUNCTION; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grouiller F, 2007, NEUROIMAGE, V38, P124, DOI 10.1016/j.neuroimage.2007.07.025; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Henning S, 2006, BRAIN RES, V1073, P359, DOI 10.1016/j.brainres.2005.12.058; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Hsu MM, 1997, NEUROREPORT, V8, P2701, DOI 10.1097/00001756-199708180-00013; Hsu MM, 2000, CHINESE J PHYSIOL, V43, P81; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; KOBAYASHI H, 1970, J PHYSIOL-LONDON, V208, P353, DOI 10.1113/jphysiol.1970.sp009125; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Laufs H, 2008, NEUROIMAGE, V40, P515, DOI 10.1016/j.neuroimage.2007.11.039; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Libet B, 1992, CAN J PHYSIOL PHARM, V70, pS311; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Makeig S., 1996, ADV NEURAL INFORM PR, V8; Michelsen KA, 2008, PROG BRAIN RES, V172, P233, DOI 10.1016/S0079-6123(08)00912-6; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Naidich TP, 2009, DUVERNOYS ATLAS HUMA, Vxi, P876; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU, V4th ed, pxiv; Nikouline VV, 2000, NEUROSCI LETT, V294, P163, DOI 10.1016/S0304-3940(00)01562-7; Oohashi T, 2000, J NEUROPHYSIOL, V83, P3548, DOI 10.1152/jn.2000.83.6.3548; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Patel P, 1997, P INT SOC MAGN RES M, V3, P1653; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rechtschaffen A, 1986, MANUAL STANDARDIZED; Rilling G., 2003, IEEE EURASIP WORKSH, V3, P8; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Salek-Haddadi A, 2003, BRAIN RES REV, V43, P110, DOI 10.1016/S0165-0173(03)00193-0; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; SCHROTH G, 1992, NEURORADIOLOGY, V35, P1, DOI 10.1007/BF00588270; SCHROTH G, 1992, NEURORADIOLOGY, V35, P16, DOI 10.1007/BF00588272; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Tyvaert L, 2008, CLIN NEUROPHYSIOL, V119, P2762, DOI 10.1016/j.clinph.2008.07.284; Vecchiato G, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/643489; Vecchiato G, 2011, MED BIOL ENG COMPUT, V49, P579, DOI 10.1007/s11517-011-0747-x; WALLIS DI, 1988, BRIT J PHARMACOL, V93, P110, DOI 10.1111/j.1476-5381.1988.tb11411.x; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	71	31	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66869	10.1371/journal.pone.0066869	http://dx.doi.org/10.1371/journal.pone.0066869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824708	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400164
J	Solari, A; Giordano, A; Kasper, J; Drulovic, J; van Nunen, A; Vahter, L; Viala, F; Pietrolongo, E; Pugliatti, M; Antozzi, C; Radice, D; Kopke, S; Heesen, C				Solari, Alessandra; Giordano, Andrea; Kasper, Jurgen; Drulovic, Jelena; van Nunen, An; Vahter, Liina; Viala, Frederique; Pietrolongo, Erika; Pugliatti, Maura; Antozzi, Carlo; Radice, Davide; Koepke, Sascha; Heesen, Christoph		AutoMS Project	Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale	PLOS ONE			English	Article							TREATMENT DECISION-MAKING; PARTICIPATION; IMMUNOTHERAPY; WANT	Background: The Control Preference Scale (CPS) is the most frequently used measure of patients' preferred roles in treatment decisions. We revised the original CPS and developed a new computerized patient self-administered version (eCPS). We used the eCPS to assess role preferences, and their determinants, in Italian and German people with multiple sclerosis (MS). Methods: New cartoons were produced, based on MS health professional and patient input/feedback and previous findings, and pilot tested on 26 Italian and German MS patients. eCPS acceptability and reliability (weighted kappa statistic, wK) in comparison to the original tool, was determined in 92 MS patients who received both CPS versions in random order. Results: The new cartoons were well accepted and easily interpreted by patients, who reported they based their choices mainly on the text and considered the images of secondary importance. eCPS reliability was moderate (wK 0.53, 95% confidence interval [CI] 0.40-0.65) and similar to the test-retest reliability of face-to-face administration assessed in a previous publication (wK 0.65, 95% CI 0.45-0.81). Higher education (odds ratio [OR] 3.74, 95% CI 1.00-14.05) and German nationality (OR 10.30, 95% CI 3.10-34.15) were associated with preference for an active role in the logistic model. Conclusions: The newly devised eCPS was well received and considered easy to use by MS patients. Reliability was in line with that of the original version. Role preference appears affected by cultural characteristics and (borderline statistical significance) education.	[Solari, Alessandra; Giordano, Andrea] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Unit Neuroepidemiol, Milan, Italy; [Kasper, Jurgen] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Drulovic, Jelena] Univ Belgrade, Sch Med, Inst Neurol, Belgrade, Serbia; [van Nunen, An] Natl MS Ctr, Melsbroek, Belgium; [Vahter, Liina] West Tallinn Cent Hosp, Dept Neurol, Tallinn, Estonia; [Viala, Frederique] Purpan Univ Hosp, Dept Neurol, Toulouse, France; [Pietrolongo, Erika] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Pugliatti, Maura] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Antozzi, Carlo] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Dept Neuromuscular Dis, Milan, Italy; [Radice, Davide] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Koepke, Sascha] Med Univ Lubeck, Nursing Res Grp, Inst Social Med, D-23538 Lubeck, Germany; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Belgrade; CHU de Toulouse; G d'Annunzio University of Chieti-Pescara; University of Sassari; IRCCS European Institute of Oncology (IEO); University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Solari, A (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Antozzi, Carlo/AAB-8787-2019; Pugliatti, Maura/K-4071-2016; Giordano, Andrea/AAN-3738-2021; Radice, Davide/B-7462-2016; pietrolongo, erika/AAC-5694-2020; Solari, Alessandra/AAO-1741-2021	Antozzi, Carlo/0000-0001-9270-5224; Pugliatti, Maura/0000-0001-9396-8683; Giordano, Andrea/0000-0003-4466-9788; Radice, Davide/0000-0002-5075-1895; pietrolongo, erika/0000-0002-6311-5994; Solari, Alessandra/0000-0001-9930-7579	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]; German Hertie Foundation, AutoMS project; Novartis; Ritchter Gedeon; Bayer Schering; Biogen Idec; Merck Serono; Sanofi Aventis; Teva	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); German Hertie Foundation, AutoMS project; Novartis(Novartis); Ritchter Gedeon; Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Teva(Teva Pharmaceutical Industries)	This study was supported by grants from the Fondazione Italiana Sclerosi Multipla (FISM) (grant No. 2010/R/37) and by the German Hertie Foundation as part of the AutoMS project. The FISM also supported AG with a research fellowship. The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.; AS was a board member for Biogen Idec and Novartis, and has received speaker honoraria from Genzyme and Merck Serono. JD has received honoraria for consultancy from Bayer Healthcare Pharmaceuticals, and speker's fees from Novartis and Ritchter Gedeon. AL was a board member for Bayer Schering, Biogen Idec, and Merck Serono; she has received travel grants and honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva. MP has received speaker honoraria from Sanofi Aventis, and travel support from Biogen Idec, Merck-Serono, Novartis, Sanofi Aventis and Teva. CH has received financial support from Bayer Schering, Biogen Idec, Merck Serono and Teva. All other authors declare that they have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Berry DL, 2010, J MED INTERNET RES, V12, P109, DOI 10.2196/jmir.1576; Bruce JM, 2011, NAT REV NEUROL, V7, P421, DOI 10.1038/nrneurol.2011.106; Charles C, 2006, PATIENT EDUC COUNS, V63, P262, DOI 10.1016/j.pec.2006.06.018; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Davison B Joyce, 2007, Cancer Nurs, V30, pE7; Davison B Joyce, 2003, Oncol Nurs Forum, V30, P107, DOI 10.1188/03.ONF.107-114; Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x; Degner L F, 1997, Can J Nurs Res, V29, P21; European Commission, 2007, TOG HLTH STRAT APPR; Frosch DL, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-73; Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026; Hamann J, 2012, EUR J PUBLIC HEALTH, V22, P469, DOI 10.1093/eurpub/ckr112; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2011, J NEUROL SCI, V306, P192, DOI 10.1016/j.jns.2010.09.012; Hong F, 2011, UROL ONCOL, DOI [10.1016/j.uro-lonc.2011.10.004, DOI 10.1016/J.UR0-L0NC.2011.10.004]; HOSMER DW, 1989, APPL LOGISTIC REGRES; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kagawa-Singer M, 2006, J CANCER EDUC, V21, pS22, DOI 10.1207/s15430154jce2101s_6; Kasper J, 2008, EUR J NEUROL, V15, P1345, DOI 10.1111/j.1468-1331.2008.02313.x; Kasper J, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-60; Kremer H, 2008, MED DECIS MAKING, V28, P899, DOI 10.1177/0272989X08317014; Kryworuchko J, 2008, PATIENT EDUC COUNS, V73, P497, DOI 10.1016/j.pec.2008.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; LEVINSON W, 1994, JAMA-J AM MED ASSOC, V272, P1619, DOI 10.1001/jama.272.20.1619; Mansell D, 2000, ARCH INTERN MED, V160, P2991, DOI 10.1001/archinte.160.19.2991; Melbourne E, 2011, PATIENT EDUC COUNS, V83, P55, DOI 10.1016/j.pec.2010.04.019; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Pietrolongo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060721; Solari A, 2007, MULT SCLER J, V13, P763, DOI 10.1177/1352458506074689; Terry K, 1994, Med Econ, V71, ppassim; UK Department of Health, 2012, INV PAT PUBL HEALTHC; Wallberg B, 2000, ACTA ONCOL, V39, P467; Yadav V, 2012, CURR NEUROL NEUROSCI, V12, P489, DOI 10.1007/s11910-012-0295-2; Yennurajalingam S, 2013, J PAIN SYMPTOM MANAG, V46, P376, DOI 10.1016/j.jpainsymman.2012.08.015	36	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66127	10.1371/journal.pone.0066127	http://dx.doi.org/10.1371/journal.pone.0066127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823627	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400055
J	Leinster, DA; Colom, B; Whiteford, JR; Ennis, DP; Lockley, M; McNeish, IA; Aurrand-Lions, M; Chavakis, T; Imhof, BA; Balkwill, FR; Nourshargh, S				Leinster, David A.; Colom, Bartomeu; Whiteford, James R.; Ennis, Darren P.; Lockley, Michelle; McNeish, Iain A.; Aurrand-Lions, Michel; Chavakis, Triantafyllos; Imhof, Beat A.; Balkwill, Frances R.; Nourshargh, Sussan			Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer	FASEB JOURNAL			English	Article						pericytes; angiogenesis; vascular development; immune cell infiltrate	JAM-C; TRANSENDOTHELIAL MIGRATION; MOUSE MODEL; EXPRESSION; ANGIOGENESIS; METASTASIS; PERICYTES; NETWORK; GROWTH	Junctional adhesion molecule C (JAM-C) is a transmembrane protein with significant roles in regulation of endothelial cell (EC) functions, including immune cell recruitment and angiogenesis. As these responses are important in promoting tumor growth, the role of EC JAM-C in tumor development was investigated using the ID8 syngeneic model of ovarian cancer. Within 10-15 wk, intraperitoneally injected ID8 cells form multiple tumor deposits and ascites that resemble human high-grade serous ovarian cancer. Compared to wild-type mice, survival in this model was increased in EC JAM-C knockouts (KOs; 88 vs. 96 d, P=0.04) and reduced in EC JAM-C transgenics (88 vs. 78.5 d, P=0.03), mice deficient in or overexpressing EC JAM-C, respectively. While tumor growth was significantly reduced in EC JAM-C KOs (87% inhibition at 10 wk, P<0.0005), this was not associated with alterations in tumor vessel density or immune cell infiltration. However, tumor microvessels from EC JAM-C-deficient mice exhibited reduced pericyte coverage and increased vascular leakage, suggesting a role for EC JAM-C in the development of functional tumor vessels. These findings provide evidence for a role for EC JAM-C in tumor growth and aggressiveness as well as recruitment of pericytes to newly formed blood vessels in a model of ovarian cancer.Leinster, D. A., Colom, B., Whiteford, J. R., Ennis, D. P., Lockley, M., McNeish, I. A., Aurrand-Lions, M., Chavakis, T., Imhof, B. A., Balkwill, F. R., Nourshargh, S. Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer.	[Leinster, David A.; Colom, Bartomeu; Whiteford, James R.; Nourshargh, Sussan] Queen Mary Univ London, William Harvey Res Inst, London EC1M 6BQ, England; [Ennis, Darren P.; Lockley, Michelle; McNeish, Iain A.; Balkwill, Frances R.] Queen Mary Univ London, Barts Canc Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Aurrand-Lions, Michel] Aix Marseille Univ, Ctr Rech Cancerol Marseille, INSERM, Inst Paoli Calmettes,UMR 1068, Marseille, France; [Chavakis, Triantafyllos] Tech Univ Dresden, Dresden, Germany; [Imhof, Beat A.] Ctr Med Univ Geneva, Geneva, Switzerland	University of London; Queen Mary University London; University of London; Queen Mary University London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Technische Universitat Dresden; University of Geneva	Nourshargh, S (corresponding author), Queen Mary Univ London, Ctr Microvasc Res, William Harvey Res Inst, Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.	s.nourshargh@qmul.ac.uk	Aurrand-Lions, Michel/O-9953-2016; Chavakis, Triantafyllos/ABE-8845-2020; Colom, Bartomeu/AAA-7539-2019	Aurrand-Lions, Michel/0000-0002-8361-3034; Colom, Bartomeu/0000-0001-6256-6462; Whiteford, James/0000-0002-8967-7389; Balkwill, Frances/0000-0002-5587-9759; lockley, michelle/0000-0002-9281-5789; McNeish, Iain/0000-0002-9387-7586; Nourshargh, Sussan/0000-0001-5677-1806	Wellcome Trust [088407/Z/09/Z, 081172/Z/06/Z, 098291/Z/12/Z]; Deutsche Forschungsgemeinschaft; European Research Council; Arthritis Research-UK [19207]; MRC [G0501974] Funding Source: UKRI; Cancer Research UK [16354, 13034] Funding Source: researchfish; Medical Research Council [G0501974] Funding Source: researchfish; Versus Arthritis [19207] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Arthritis Research-UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	The present work was funded by the Wellcome Trust (project grant 088407/Z/09/Z, programme grant 081172/Z/06/Z, and senior investigator award 098291/Z/12/Z to S.N.). T.C. was funded by the Deutsche Forschungsgemeinschaft and the European Research Council. J.R.W. was funded by Arthritis Research-UK (grant 19207).	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Colom B, 2012, FASEB J, V26, P1064, DOI 10.1096/fj.11-196220; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Falcon BL, 2011, AM J PATHOL, V178, P2920, DOI 10.1016/j.ajpath.2011.02.019; Garson K, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-39; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Keiper T, 2005, FASEB J, V19, P2078, DOI 10.1096/fj.05-4196fje; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Murakami M, 2010, CANCER RES, V70, P1759, DOI 10.1158/0008-5472.CAN-09-1703; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; Ody C, 2007, LEUKEMIA, V21, P1285, DOI 10.1038/sj.leu.2404689; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Palmer G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2223; Rabquer BJ, 2010, J IMMUNOL, V185, P1777, DOI 10.4049/jimmunol.1000556; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Scheiermann C, 2009, ARTERIOSCL THROM VAS, V29, P1509, DOI 10.1161/ATVBAHA.109.187559; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Tenan M, 2010, GLIA, V58, P524, DOI 10.1002/glia.20941; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Vonlaufen A, 2006, J PATHOL, V209, P540, DOI 10.1002/path.2007; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zen K, 2004, MOL BIOL CELL, V15, P3926, DOI 10.1091/mbc.E04-04-0317	37	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4244	4253		10.1096/fj.13-230441	http://dx.doi.org/10.1096/fj.13-230441			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825230	Green Published			2022-12-25	WOS:000329747100034
J	Karmakar, S; Jin, YT; Nagaich, AK				Karmakar, Sudipan; Jin, Yetao; Nagaich, Akhilesh K.			Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) alpha and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ER alpha Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; STEROID-HORMONE RECEPTORS; FACTOR-KAPPA-B; GENE-EXPRESSION; DNA-BINDING; COACTIVATOR AIB1; MONOAMINE-OXIDASE; ZINC-FINGER; TUMOR-CELLS; CROSS-TALK	The role of glucocorticoids in the inhibition of estrogen (17-beta-estradiol (E2))-regulated estrogen receptor (ER)-positive breast cancer cell proliferation is well established. We and others have seen that synthetic glucocorticoid dexamethasone (Dex) antagonizes E2-stimulated endogenous ER alpha target gene expression. However, how glucocorticoids negatively regulate the ER alpha signaling pathway is still poorly understood. ChIP studies using ER alpha- and glucocorticoid receptor (GR)-positive MCF-7 cells revealed that GR occupies several ER alpha-binding regions (EBRs) in cells treated with E2 and Dex simultaneously. Interestingly, there was little or no GR loading to these regions when cells were treated with E2 or Dex alone. The E2+Dex-dependent GR recruitment is associated with the displacement of ER alpha and steroid receptor coactivator-3 from the target EBRs leading to the repression of ER alpha-mediated transcriptional activation. The recruitment of GR to EBRs requires assistance from ER alpha and FOXA1 and is facilitated by AP1 binding within the EBRs. The GR binding to EBRs is mediated via direct protein-protein interaction between the GR DNA-binding domain and ER alpha. Limited mutational analyses indicate that arginine 488 located within the C-terminal zinc finger domain of the GR DNA-binding domain plays a critical role in stabilizing this interaction. Together, the results of this study unravel a novel mechanism involved in glucocorticoid inhibition of ER alpha transcriptional activity and E2-mediated cell proliferation and thus establish a foundation for future exploitation of the GR signaling pathway in the treatment of ER-positive breast cancer.	[Karmakar, Sudipan; Jin, Yetao; Nagaich, Akhilesh K.] US FDA, CDER, OPS, Div Therapeut Prot,OBP, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Nagaich, AK (corresponding author), US FDA, CDER, OPS, Div Therapeut Prot,OBP, 29 Lincoln Dr, Bethesda, MD 20892 USA.	akhilesh.nagaich@fda.hhs.gov			Food and Drug Administration Commissioner's Fellowship	Food and Drug Administration Commissioner's Fellowship	This project was supported in part by a Food and Drug Administration Commissioner's Fellowship (to S. K.).	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Azorsa DO, 2001, BREAST CANCER RES TR, V70, P89, DOI 10.1023/A:1012972808558; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Biswas D. K., 2005, SCI STKE, V2005, ppe27; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Chen K, 2011, MOL PHARMACOL, V79, P308, DOI 10.1124/mol.110.067439; Coleman KM, 2003, J BIOL CHEM, V278, P12834, DOI 10.1074/jbc.M212312200; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; HALL RE, 1990, INT J CANCER, V46, P1081, DOI 10.1002/ijc.2910460622; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Karmakar S, 2010, MOL ENDOCRINOL, V24, P1187, DOI 10.1210/me.2009-0480; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P3782, DOI 10.1128/MCB.13.6.3782; Kim MJ, 2007, EMBO J, V26, P3075, DOI 10.1038/sj.emboj.7601755; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; LIPPMAN M, 1976, CANCER RES, V36, P4602; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ou XM, 2006, J BIOL CHEM, V281, P21512, DOI 10.1074/jbc.M600250200; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Safe S., 2001, VITAMINS HORMONES; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Sumikawa T, 2008, INT J ONCOL, V32, P683; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Vaidya JS, 2010, CURR PHARM DESIGN, V16, P3593; Volden PA, 2013, BRAIN BEHAV IMMUN, V30, pS26, DOI 10.1016/j.bbi.2012.10.022; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Yang LM, 1997, CANCER RES, V57, P4652; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Zhang CW, 2006, INT J ONCOL, V29, P1295; ZHOU F, 1989, MOL CELL ENDOCRINOL, V66, P189	72	82	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24020	24034		10.1074/jbc.M113.473819	http://dx.doi.org/10.1074/jbc.M113.473819			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814048	hybrid, Green Published			2022-12-25	WOS:000330611400040
J	Liu, JY; Stevens, PD; Eshleman, NE; Gao, TY				Liu, Jianyu; Stevens, Payton D.; Eshleman, Nichole E.; Gao, Tianyan			Protein Phosphatase PPM1G Regulates Protein Translation and Cell Growth by Dephosphorylating 4E Binding Protein 1 (4E-BP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; PHOSPHORYLATION; MTOR; PHLPP; S6K1; AKT; ACTIVATION; MECHANISMS; INITIATION; RAPAMYCIN	Protein translation initiation is a tightly controlled process responding to nutrient availability and mitogen stimulation. Serving as one of the most important negative regulators of protein translation, 4E binding protein 1 (4E-BP1) binds to translation initiation factor 4E and inhibits cap-dependent translation in a phosphorylation-dependent manner. Although it has been demonstrated previously that the phosphorylation of 4E-BP1 is controlled by mammalian target of rapamycin in the mammalian target of rapamycin complex 1, the mechanism underlying the dephosphorylation of 4E-BP1 remains elusive. Here, we report the identification of PPM1G as the phosphatase of 4E-BP1. A coimmunoprecipitation experiment reveals that PPM1G binds to 4E-BP1 in cells and that purified PPM1G dephosphorylates 4E-BP1 in vitro. Knockdown of PPM1G in 293E and colon cancer HCT116 cells results in an increase in the phosphorylation of 4E-BP1 at both the Thr-37/46 and Ser-65 sites. Furthermore, the time course of 4E-BP1 dephosphorylation induced by amino acid starvation or mammalian target of rapamycin inhibition is slowed down significantly in PPM1G knockdown cells. Functionally, the amount of 4E-BP1 bound to the cap-dependent translation initiation complex is decreased when the expression of PPM1G is depleted. As a result, the rate of cap-dependent translation, cell size, and protein content are increased in PPM1G knockdown cells. Taken together, our study has identified protein phosphatase PPM1G as a novel regulator of cap-dependent protein translation by negatively controlling the phosphorylation of 4E-BP1.	[Liu, Jianyu; Stevens, Payton D.; Gao, Tianyan] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Eshleman, Nichole E.] Univ Kentucky, Mansfield Univ, Lexington, KY 40536 USA; [Eshleman, Nichole E.] Univ Kentucky, Res Experiences Undergrad REU Program, Lexington, KY 40536 USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			National Institutes of Health [R01 CA133429-01A1]; American Cancer Society [RSG0822001TBE]; NATIONAL CANCER INSTITUTE [R01CA133429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA133429-01A1 (to T. G.). This work was also supported by American Cancer Society Grant RSG0822001TBE (to T.G.).	Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Fadden P, 1997, J BIOL CHEM, V272, P10240; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fraser CS, 2009, PROG MOL BIOL TRANSL, V90, P1, DOI 10.1016/S1877-1173(09)90001-1; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; Petri S, 2007, J CELL BIOL, V179, P451, DOI 10.1083/jcb.200704163; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	32	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23225	23233		10.1074/jbc.M113.492371	http://dx.doi.org/10.1074/jbc.M113.492371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814053	hybrid, Green Published			2022-12-25	WOS:000330598200029
J	Caproni, S; Muti, M; Principi, M; Ottaviano, P; Frondizi, D; Capocchi, G; Floridi, P; Rossi, A; Calabresi, P; Tambasco, N				Caproni, Stefano; Muti, Marco; Principi, Massimo; Ottaviano, Pierfausto; Frondizi, Domenico; Capocchi, Giuseppe; Floridi, Piero; Rossi, Aroldo; Calabresi, Paolo; Tambasco, Nicola			Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study	PLOS ONE			English	Article							BASAL GANGLIA; FINGER MOVEMENTS; CORTEX; ACTIVATION; FMRI; HAND; TASK; PET; REPRESENTATIONS; CEREBELLUM	Motor impairment is the most relevant clinical feature in Parkinson's disease (PD). Functional imaging studies on motor impairment in PD have revealed changes in the cortical motor circuits, with particular involvement of the fronto-striatal network. The aim of this study was to assess brain activations during the performance of three different motor exercises, characterized by progressive complexity, using a functional fMRI multiple block paradigm, in PD patients and matched control subjects. Unlike from single-task comparisons, multi-task comparisons between similar exercises allowed to analyse brain areas involved in motor complexity planning and execution. Our results showed that in the single-task comparisons the involvement of primary and secondary motor areas was observed, consistent with previous findings based on similar paradigms. Most notably, in the multi-task comparisons a greater activation of supplementary motor area and posterior parietal cortex in PD patients, compared with controls, was observed. Furthermore, PD patients, compared with controls, had a lower activation of the basal ganglia and limbic structures, presumably leading to the impairment in the higher levels of motor control, including complexity planning and execution. The findings suggest that in PD patients occur both compensatory mechanisms and loss of efficiency and provide further insight into the pathophysiological role of distinct cortical and subcortical areas in motor dysfunction.	[Caproni, Stefano; Rossi, Aroldo; Calabresi, Paolo; Tambasco, Nicola] Univ Perugia, Azienda Osped, Neurol Clin, I-06100 Perugia, Italy; [Muti, Marco] Azienda Osped Terni, Serv Fis Sanit, Terni, Italy; [Principi, Massimo; Ottaviano, Pierfausto] Azienda Osped Terni, Serv Neuroradiol, Terni, Italy; [Frondizi, Domenico; Capocchi, Giuseppe] Azienda Osped Terni, UO Neurol, Terni, Italy; [Floridi, Piero] Azienda Osped Perugia, Serv Neuroradiol, Perugia, Italy; [Calabresi, Paolo] Fdn S Lucia, IRCCS, Rome, Italy	University of Perugia; Azienda Ospedaliera di Perugia; University of Perugia; Azienda Ospedaliera di Perugia; IRCCS Santa Lucia	Tambasco, N (corresponding author), Univ Perugia, Azienda Osped, Neurol Clin, I-06100 Perugia, Italy.	n.tambasco@libero.it	Tambasco, Nicola/K-4788-2018; Caproni, Stefano/GSE-1880-2022; Calabresi, Paolo/G-8496-2011	Tambasco, Nicola/0000-0003-1497-4482; Calabresi, Paolo/0000-0003-0326-5509	Novartis; Lundbeck; Boheringer Ingelheim; Bayer Schering; Biogen; Boehringer Ingelheim; Eisai; Sanofi-Aventis; Sigma-Tau; UCB Pharma; Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS; Italian Minister of Health and Agenzia Italiana del Farmaco (AIFA)	Novartis(Novartis); Lundbeck(Lundbeck Corporation); Boheringer Ingelheim; Bayer Schering(Bayer AG); Biogen(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Sanofi-Aventis(Sanofi-Aventis); Sigma-Tau; UCB Pharma(UCB Pharma SA); Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS; Italian Minister of Health and Agenzia Italiana del Farmaco (AIFA)	Nicola Tambasco has received funding for travel and speaker from Novartis, Lundbeck and Boheringer Ingelheim; Paolo Calabresi receives research support from Bayer Schering, Biogen, Boehringer Ingelheim, Eisai, Novartis, Lundbeck, Sanofi-Aventis, Sigma-Tau, and UCB Pharma; and from Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS (European Community Grants SYNSCAFF and REPLACES), the Italian Minister of Health and Agenzia Italiana del Farmaco (AIFA); Stefano Caproni, Marco Muti, Massimo Principi, Pierfausto Ottaviano, Domenico Frondizi, Giuseppe Capocchi, Aroldo Rossi and Piero Floridi declare no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; Beltramello A, 1998, ITAL J NEUROL SCI, V19, P277, DOI 10.1007/BF00713853; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; BRINKMAN J, 1973, BRAIN, V96, P653, DOI 10.1093/brain/96.4.653; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Deiber MP, 1997, J NEUROPHYSIOL, V78, P977, DOI 10.1152/jn.1997.78.2.977; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Diciotti S, 2007, NEUROIMAGE, V38, P402, DOI 10.1016/j.neuroimage.2007.07.045; Eckert T, 2006, J NEUROL, V253, P199, DOI 10.1007/s00415-005-0956-z; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 2004, HUMAN BRAIN FUNCTION; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Furl N, 2011, J NEUROSCI, V31, P17572, DOI 10.1523/JNEUROSCI.4236-11.2011; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Harrington DL, 2000, J COGNITIVE NEUROSCI, V12, P56, DOI 10.1162/08989290051137602; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Holden A, 2006, PARKINSONISM RELAT D, V12, P73, DOI 10.1016/j.parkreldis.2005.11.001; Humberstone M, 1997, ANN NEUROL, V42, P632, DOI 10.1002/ana.410420414; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lausberg H, 1999, NEUROPSYCHOLOGIA, V37, P253, DOI 10.1016/S0028-3932(98)00079-7; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Macri MA, 2006, MAGN RESON IMAGING, V24, P419, DOI 10.1016/j.mri.2005.12.035; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Menon V, 1998, NEUROREPORT, V9, P1567, DOI 10.1097/00001756-199805110-00058; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; SALINAS E, 1995, J NEUROSCI, V15, P6461; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Scholz VH, 2000, BRAIN RES, V879, P204, DOI 10.1016/S0006-8993(00)02749-9; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Toyokura M, 2002, J NEUROIMAGING, V12, P172, DOI 10.1111/j.1552-6569.2002.tb00116.x; Ukmar M, 2006, RADIOL MED, V111, P104, DOI 10.1007/s11547-006-0011-x; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Weiss PH, 2006, HUM BRAIN MAPP, V27, P1004, DOI 10.1002/hbm.20239; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	53	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66834	10.1371/journal.pone.0066834	http://dx.doi.org/10.1371/journal.pone.0066834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825570	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000031
J	Li, Y; Sun, Y; Liu, FY; Sun, L; Li, J; Duan, SB; Liu, H; Peng, YM; Xiao, L; Liu, YP; Xi, YY; You, YH; Li, H; Wang, M; Wang, S; Hou, T				Li, Ying; Sun, Yan; Liu, Fuyou; Sun, Lin; Li, Jun; Duan, Shaobin; Liu, Hong; Peng, Youming; Xiao, Li; Liu, Yuping; Xi, Yiyun; You, Yanhua; Li, Hua; Wang, Min; Wang, Shuai; Hou, Tao			Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; DIABETIC-NEPHROPATHY; URETERAL OBSTRUCTION; SNAIL GENES; EXPRESSION; KIDNEY; CELLS; FIBROBLASTS	Epithelial-mesenchymal transition (EMT) is thought to contribute to the progression of renal tubulointerstitial fibrosis. Norcantharidin (NCTD) is a promising agent for inhibiting renal interstitial fibrosis. However, the molecular mechanisms of NCTD are unclear. In this study, a unilateral ureteral obstruction (UUO) rat model was established and treated with intraperitoneal NCTD (0.1 mg/kg/day). The UUO rats treated with NCTD showed a reduction in obstruction-induced upregulation of alpha-SMA and downregulation of E-cadherin in the rat kidney (P<0.05). Human renal proximal tubule cell lines (HK-2) stimulated with TGF-beta(1) were treated with different concentrations of NCTD. HK-2 cells stimulated by TGF-beta(1) in vitro led to downregulation of E-cadherin and increased de novo expression of alpha-SMA; co-treatment with NCTD attenuated all of these changes (P<0.05). NCTD reduced TGF-beta(1)-induced expression and phosphorylation of Smad2/3 and downregulated the expression of Snail1 (P<0.05). These results suggest that NCTD antagonizes tubular EMT by inhibiting the Smad pathway. NCTD may play a critical role in preserving the normal epithelial phenotype and modulating tubular EMT.	[Li, Ying; Liu, Fuyou; Sun, Lin; Li, Jun; Duan, Shaobin; Liu, Hong; Peng, Youming; Xiao, Li; Liu, Yuping; Xi, Yiyun; You, Yanhua; Li, Hua; Wang, Shuai; Hou, Tao] Cent S Univ, Xiangya Hosp 2, Div Nephrol, Changsha, Hunan, Peoples R China; [Sun, Yan] XinJiang Med Univ, Affiliated Hosp 1, Div Nephrol, Uramuq, Peoples R China; [Wang, Min] Cent S Univ, Xiangya Hosp 2, Dept Clin Lab, Changsha, Hunan, Peoples R China	Central South University; Xinjiang Medical University; Central South University	Li, Y (corresponding author), Cent S Univ, Xiangya Hosp 2, Div Nephrol, Changsha, Hunan, Peoples R China.	yachi20101213@gmail.com			National Natural Science Foundation of China [81100486]; Natural Science Foundation of Hunan Province of China [10JJ2011]; scientific project of the Research Center of Metabolic Syndrome in Central South University of China [DY-2008-02-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province of China(Natural Science Foundation of Hunan Province); scientific project of the Research Center of Metabolic Syndrome in Central South University of China	This study was supported by the National Natural Science Foundation of China (Grant No. 81100486), the Natural Science Foundation of Hunan Province of China (Grant No. 10JJ2011), and the scientific project of the Research Center of Metabolic Syndrome in Central South University of China (Grant No. DY-2008-02-03). The corresponding author and all the above grand funders played a role in designing and doing the experiment and writing the manuscript.	Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Boutet A, 2008, M S-MED SCI, V24, P238, DOI 10.1051/medsci/2008243238; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boutet A, 2007, CELL CYCLE, V6, P638, DOI 10.4161/cc.6.6.4022; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Galichon P, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-11; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li Y, 2012, MOL CELL BIOCHEM, V361, P79, DOI 10.1007/s11010-011-1091-z; Li Y, 2011, LAB INVEST, V91, P1706, DOI 10.1038/labinvest.2011.119; Li Y, 2011, CELL BIOL INT, V35, P1239, DOI 10.1042/CBI20100850; Li Y, 2011, RENAL FAILURE, V33, P233, DOI 10.3109/0886022X.2011.553305; Liu FY, 2008, AM J NEPHROL, V28, P465, DOI 10.1159/000112850; Liu FY, 2007, AM J NEPHROL, V27, P176, DOI 10.1159/000100518; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Ohnuki K, 2012, J NEPHROL, V25, P233, DOI 10.5301/JN.2011.8449; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Stewart SG, 2007, BIOORGAN MED CHEM, V15, P7301, DOI 10.1016/j.bmc.2007.08.028; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	39	23	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66356	10.1371/journal.pone.0066356	http://dx.doi.org/10.1371/journal.pone.0066356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825538	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000017
J	Okuyama, T; Isoe, Y; Hoki, M; Suehiro, Y; Yamagishi, G; Naruse, K; Kinoshita, M; Kamei, Y; Shimizu, A; Kubo, T; Takeuchi, H				Okuyama, Teruhiro; Isoe, Yasuko; Hoki, Masahito; Suehiro, Yuji; Yamagishi, Genki; Naruse, Kiyoshi; Kinoshita, Masato; Kamei, Yasuhiro; Shimizu, Atushi; Kubo, Takeo; Takeuchi, Hideaki			Controlled Cre/loxP Site-Specific Recombination in the Developing Brain in Medaka Fish, Oryzias latipes	PLOS ONE			English	Article							NEURAL STEM-CELLS; GENE INDUCTION; ADULT NEUROGENESIS; INFRARED-LASER; ZEBRAFISH; TELEOST; SYSTEM; DISSECTION; EXPRESSION; MARKER	Background: Genetic mosaic techniques have been used to visualize and/or genetically modify a neuronal subpopulation within complex neural circuits in various animals. Neural populations available for mosaic analysis, however, are limited in the vertebrate brain. Methodology/Principal Findings: To establish methodology to genetically manipulate neural circuits in medaka, we first created two transgenic (Tg) medaka lines, Tg (HSP:Cre) and Tg (HuC:loxP-DsRed-loxP-GFP). We confirmed medaka HuC promoter-derived expression of the reporter gene in juvenile medaka whole brain, and in neuronal precursor cells in the adult brain. We then demonstrated that stochastic recombination can be induced by micro-injection of Cre mRNA into Tg (HuC:loxP-DsRed-loxP-GFP) embryos at the 1-cell stage, which allowed us to visualize some subpopulations of GFP-positive cells in compartmentalized regions of the telencephalon in the adult medaka brain. This finding suggested that the distribution of clonally-related cells derived from single or a few progenitor cells was restricted to a compartmentalized region. Heat treatment of Tg(HSP:Cre x HuC:loxP-DsRed-loxP-GFP) embryos (0-1 day post fertilization [dpf]) in a thermalcycler (39 degrees C) led to Cre/loxP recombination in the whole brain. The recombination efficiency was notably low when using 2-3 dpf embyos compared with 0-1 dpf embryos, indicating the possibility of stage-dependent sensitivity of heat-inducible recombination. Finally, using an infrared laser-evoked gene operator (IR-LEGO) system, heat shock induced in a micro area in the developing brains led to visualization of clonally-related cells in both juvenile and adult medaka fish. Conclusions/Significance: We established a noninvasive method to control Cre/loxP site-specific recombination in the developing nervous system in medaka fish. This method will broaden the neural population available for mosaic analyses and allow for lineage tracing of the vertebrate nervous system in both juvenile and adult stages.	[Okuyama, Teruhiro; Isoe, Yasuko; Hoki, Masahito; Suehiro, Yuji; Yamagishi, Genki; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Okuyama, Teruhiro; Naruse, Kiyoshi; Kamei, Yasuhiro] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Suehiro, Yuji] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kinoshita, Masato] Kyoto Univ, Div Appl Biosci, Grad Sch Agr, Kyoto, Japan; [Shimizu, Atushi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Women's Medical University; Kyoto University; Keio University	Takeuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	takeuchi@biol.s.u-tokyo.ac.jp	Kamei, Yasuhiro/AAD-9281-2019; Takeuchi, Hideaki/W-6739-2018; KUBO, TAKEO/G-4951-2014; TAKEUCHI, HIDEAKI/G-4969-2014	Kamei, Yasuhiro/0000-0001-6382-1365; Takeuchi, Hideaki/0000-0001-6610-3895; Kubo, Takeo/0000-0002-5914-5269; Naruse, Kiyoshi/0000-0001-9185-3495	National Institute for Basic Biology Priority Collaborative Research Project [10-104]; Cell Science Research Foundation; Comprehensive Brain Science Network;  [23300115]; Grants-in-Aid for Scientific Research [23300115] Funding Source: KAKEN	National Institute for Basic Biology Priority Collaborative Research Project; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Comprehensive Brain Science Network; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institute for Basic Biology Priority Collaborative Research Project (10-104), a Grant-in-Aid for Scientific Research (B) 23300115, a Grant-in-Aid for a JSPS postdoctoral SPD fellowship (to T.O.), the Cell Science Research Foundation (to T.O.), and the Comprehensive Brain Science Network (to T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Fox DT, 2008, LINEAGE ANAL STEM CE; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hiratani I, 2001, DEV BIOL, V229, P456, DOI 10.1006/dbio.2000.9986; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Isoe Y, 2012, BIOCHEM BIOPH RES CO, V423, P627, DOI 10.1016/j.bbrc.2012.05.125; Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kao CF, 2012, COLD SPRING HARB PRO, V2012; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kobayashi K, 2013, GENESIS, V51, P59, DOI 10.1002/dvg.22348; Kuroyanagi Y, 2010, BRAIN RES, V1323, P33, DOI 10.1016/j.brainres.2010.01.045; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Nakazawa N, 2012, DEV DYNAM, V241, P965, DOI 10.1002/dvdy.23784; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Shimada A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2643; Shimizu A, 2013, TRANSGENIC RES, V22, P435, DOI 10.1007/s11248-012-9653-8; Suehiro Y, 2010, FEBS LETT, V584, P3545, DOI 10.1016/j.febslet.2010.06.047; Vopalensky P, 2010, BIOTECHNIQUES, V48, P235, DOI 10.2144/000113368; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; YASUMASU S, 1989, J BIOCHEM-TOKYO, V105, P204, DOI 10.1093/oxfordjournals.jbchem.a122640; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007	42	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66597	10.1371/journal.pone.0066597	http://dx.doi.org/10.1371/journal.pone.0066597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825546	gold, Green Submitted, Green Published			2022-12-25	WOS:000321223000021
J	Villalobos-Duno, H; San-Blas, G; Paulinkevicius, M; Sanchez-Martin, Y; Nino-Vega, G				Villalobos-Duno, Hector; San-Blas, Gioconda; Paulinkevicius, Maryan; Sanchez-Martin, Yolanda; Nino-Vega, Gustavo			Biochemical Characterization of Paracoccidioides brasiliensis alpha-1,3-Glucanase Agn1p, and Its Functionality by Heterologous Expression in Schizosaccharomyces pombe	PLOS ONE			English	Article							CELL-WALL ALPHA-1,3-GLUCAN; ALPHA-GLUCANASE AGN1P; HISTOPLASMA-CAPSULATUM; CRYPTOCOCCUS-NEOFORMANS; ANTITUMOR-ACTIVITY; GENE; PROTEINS; SEPARATION; ALPHA-(1,3)-GLUCAN; IDENTIFICATION	alpha-1,3-Glucan is present as the outermost layer of the cell wall in the pathogenic yeastlike (Y) form of Paracoccidioides brasiliensis. Based on experimental evidence, this polysaccharide has been proposed as a fungal virulence factor. To degrade alpha-1,3-glucan and allow remodeling of the cell wall, alpha-1,3-glucanase is required. Therefore, the study of this enzyme, its encoding gene, and regulatory mechanisms, might be of interest to understand the morphogenesis and virulence process in this fungus. A single gene, orthologous to other fungal alpha-1,3-glucanase genes, was identified in the Paracoccidioides genome, and labeled AGN1. Transcriptional levels of AGN1 and AGS1 (alpha-1,3-glucan synthase-encoding gene) increased sharply when the pathogenic Y phase was cultured in the presence of 5% horse serum, a reported booster for cell wall alpha-1,3-glucan synthesis in this fungus. To study the biochemical properties of P. brasiliensis Agn1p, the enzyme was heterologously overexpressed, purified, and its activity profile determined by means of the degradation of carboxymethyl alpha-1,3-glucan (SCMG, chemically modified from P. brasiliensis alpha-1,3-glucan), used as a soluble substrate for the enzymatic reaction. Inhibition assays, thin layer chromatography and enzymatic reactions with alternative substrates (dextran, starch, chitin, laminarin and cellulose), showed that Agn1p displays an endolytic cut pattern and high specificity for SCMG. Complementation of a Schizosaccharomyces pombe agn1 Delta strain with the P. brasiliensis AGN1 gene restored the wild type phenotype, indicating functionality of the gene, suggesting a possible role of Agn1p in the remodeling of P. brasiliensis Y phase cell wall. Based on amino acid sequence, P. brasiliensis Agn1p, groups within the family 71 of fungal glycoside hydrolases (GH-71), showing similar biochemical characteristics to other members of this family. Also based on amino acid sequence alignments, we propose a subdivision of fungal GH-71 into at least five groups, for which specific conserved sequences can be identified.	[Villalobos-Duno, Hector; San-Blas, Gioconda; Paulinkevicius, Maryan; Nino-Vega, Gustavo] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Caracas, Venezuela; [Sanchez-Martin, Yolanda] Univ Salamanca, Inst Biol Funct & Genom, E-37008 Salamanca, Spain; [Sanchez-Martin, Yolanda] Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain	Venezuelan Institute Science Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Salamanca	Nino-Vega, G (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Caracas, Venezuela.	gnino@ivic.gob.ve	Niño-Vega, Gustavo A/M-5333-2018; Sanchez, Yolanda/L-2847-2014; Niño-Vega, Gustavo/AAI-2621-2019	Niño-Vega, Gustavo A/0000-0003-3760-5620; Sanchez, Yolanda/0000-0002-7650-9319; Niño-Vega, Gustavo/0000-0003-3760-5620; Villalobos, Hector/0000-0003-4343-889X	Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy; FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela; IVIC, Caracas Venezuela	Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy; FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela; IVIC, Caracas Venezuela	This work was partially supported by Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy. HV-D was recipient of a Ph.D scholarship awarded by FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela. MP was recipiente of a MSc scholarship awarded by IVIC, Caracas Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao XF, 2001, CARBOHYD RES, V336, P127, DOI 10.1016/S0008-6215(01)00238-5; Barreto L, 2010, YEAST, V27, P293, DOI 10.1002/yea.1748; Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Bhushan R, 1997, BIOMED CHROMATOGR, V11, P59, DOI 10.1002/(SICI)1099-0801(199701)11:1<59::AID-BMC632>3.0.CO;2-Q; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bonfim SMRC, 2006, FEMS IMMUNOL MED MIC, V46, P269, DOI 10.1111/j.1574-695X.2005.00036.x; Calcagno AM, 1998, J CLIN MICROBIOL, V36, P1733, DOI 10.1128/JCM.36.6.1733-1736.1998; Castro ND, 2009, FEMS YEAST RES, V9, P103, DOI 10.1111/j.1567-1364.2008.00463.x; Santana LAD, 2012, MEM I OSWALDO CRUZ, V107, P310, DOI 10.1590/S0074-02762012000300004; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Dekker N, 2007, YEAST, V24, P279, DOI 10.1002/yea.1464; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Forsburg S. L., 2003, CURR PROTOC MOL BIOL, V64, P1316; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Francoise S, 2010, MED MYCOL, V48, P35, DOI 10.3109/13693780802713356; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; Garcia I, 2005, BIOL CELL, V97, P569; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Gonzalez A, 2005, INFECT IMMUN, V73, P2486, DOI 10.1128/IAI.73.4.2486-2495.2005; Grun CH, 2005, GLYCOBIOLOGY, V15, P245, DOI 10.1093/glycob/cwi002; Grun CH, 2006, FEBS LETT, V580, P3780, DOI 10.1016/j.febslet.2006.05.062; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HIRANO S, 1988, METHOD ENZYMOL, V161, P408; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Dantas SFIM, 2009, MICROBES INFECT, V11, P895, DOI 10.1016/j.micinf.2009.05.009; KIHO T, 1989, CARBOHYD RES, V189, P273, DOI 10.1016/0008-6215(89)84103-5; Kobayashi G., 1994, MOL BIOL PATHOGENIC, P489; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCMAHON JP, 1995, J CLIN INVEST, V96, P1010, DOI 10.1172/JCI118086; Meeuwsen PJA, 2000, J BIOSCI BIOENG, V89, P107, DOI 10.1016/S1389-1723(00)88062-7; Nino-Vega GA, 2000, MED MYCOL, V38, P31, DOI 10.1080/mmy.38.1.31.39; Nino-Vega GA, 2009, MYCOL RES, V113, P1091, DOI 10.1016/j.mycres.2009.07.005; Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; San-Blas G, 1998, MED MYCOL, V36, P75, DOI 10.1080/02681219880000131; San-Blas G, 2001, FUNGAL PATHOGENESIS, P205; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Sanz L, 2005, FEBS J, V272, P493, DOI 10.1111/j.1742-4658.2004.04491.x; SASAKI T, 1979, EUR J CANCER, V15, P211, DOI 10.1016/0014-2964(79)90062-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Suga M, 2005, YEAST, V22, P799, DOI 10.1002/yea.1247; Sugawara T, 2003, J ELECTRON MICROSC, V52, P237, DOI 10.1093/jmicro/52.2.237; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wiater A, 2011, POL J MICROBIOL, V60, P293, DOI 10.33073/pjm-2011-042; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	63	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66853	10.1371/journal.pone.0066853	http://dx.doi.org/10.1371/journal.pone.0066853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825576	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000037
J	Walker, DM; Mahfooz, N; Kemme, KA; Patel, VC; Spangler, M; Drew, ME				Walker, Dawn M.; Mahfooz, Najmus; Kemme, Katherine A.; Patel, Viral C.; Spangler, Maribeth; Drew, Mark E.			Plasmodium falciparum Erythrocytic Stage Parasites Require the Putative Autophagy Protein PfAtg7 for Normal Growth	PLOS ONE			English	Article							LOW-COMPLEXITY REGIONS; MALARIA PARASITES; DEGRADATION; MECHANISM; MACROAUTOPHAGY; INHIBITION; CYTOPLASM; YEAST; E1	Analysis of the Plasmodium falciparum genome reveals a limited number of putative autophagy genes, specifically the four genes involved in ATG8 lipidation, an essential step in formation of autophagosomes. In yeast, Atg8 lipidation requires the E1-type ligase Atg7, an E2-type ligase Atg3, and a cysteine protease Atg4. These four putative P. falciparum ATG (PfATG) genes are transcribed during the parasite's erythrocytic stages. PfAtg7 has relatively low identity and similarity to yeast Atg7 (14.7% and 32.2%, respectively), due primarily to long insertions typical of P. falciparum. Excluding the insertions the identity and similarity are higher (38.0% and 70.8%, respectively). This and the fact that key residues are conserved, including the catalytic cysteine and ATP binding domain, we hypothesize that PfAtg7 is the activating enzyme of PfAtg8. To assess the role of PfAtg7 we have generated two transgenic parasite lines. In one, the PfATG7 locus was modified to introduce a C-terminal hemagglutinin tag. Western blotting reveals two distinct protein species, one migrating near the predicted 150 kDa and one at approximately 65 kDa. The second transgenic line introduces an inducible degradation domain into the PfATG7 locus, allowing us to rapidly attenuate PfAtg7 protein levels. Corresponding species are also observed in this parasite line at approximately 200 kDa and 100 kDa. Upon PfATG7 attenuation parasites exhibit a slow growth phenotype indicating the essentiality of this putative enzyme for normal growth.	[Walker, Dawn M.; Mahfooz, Najmus; Kemme, Katherine A.; Patel, Viral C.; Spangler, Maribeth; Drew, Mark E.] Ohio State Univ, Dept Microbial Infect & Immun, Wexner Med Ctr, Columbus, OH 43210 USA; [Drew, Mark E.] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Drew, ME (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Wexner Med Ctr, Columbus, OH 43210 USA.	mark.drew@osumc.edu			Ohio State University program for Public Health Preparedness for Infectious Diseases; Howard Hughes Medical Institute Med into Grad program	Ohio State University program for Public Health Preparedness for Infectious Diseases; Howard Hughes Medical Institute Med into Grad program	MED is supported by The Ohio State University program for Public Health Preparedness for Infectious Diseases. DMW was supported by the Howard Hughes Medical Institute Med into Grad program for a portion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Balu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013282; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Caza TN, 2012, CLIN IMMUNOL, V144, P200, DOI 10.1016/j.clim.2012.07.001; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Eastwood MD, 2012, AUTOPHAGY, V9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Ikeda T, 2012, J PHARM SCI; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Liu C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-622; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rado-Trilla N, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-155; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sinai AP, 2012, TRENDS PARASITOL, V28, P358, DOI 10.1016/j.pt.2012.06.006; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	53	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67047	10.1371/journal.pone.0067047	http://dx.doi.org/10.1371/journal.pone.0067047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825614	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000066
J	Zhu, SJ; Wang, GH; Liu, B; Wang, YD				Zhu, Shijia; Wang, Guohua; Liu, Bo; Wang, Yadong			Modeling Exon Expression Using Histone Modifications	PLOS ONE			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; CODING REGIONS; ACTIVE GENES; STEM-CELLS; TRANSCRIPTION; ACETYLATION; METHYLATION; CHROMATIN; NETWORK	Histones undergo numerous covalent modifications that play important roles in regulating gene expression. Previous investigations have focused on the effects of histone modifications on gene promoters, whereas efforts to unravel their effects on transcribed regions have lagged behind. To elucidate the effects of histone modification on transcribed regions, we constructed a quantitative model, which we suggest can predict the variation of gene expression more faithfully than the model constructed on promoters. Moreover, motivated by the fact that exon spicing is functionally coupled to transcription, we also devised a quantitative model to predict alternative exon expression using histone modifications on exons. This model was found to be general across different exon types and even cell types. Furthermore, an interaction network linking histone modifications to alternative exon expression was constructed using partial correlations. The network indicated that gene expression and specific histone modifications (H3K36me3 and H4K20me1) could directly influence the exon expression, while other modifications could act in an additive way to account for the stability and robustness. In addition, our results suggest that combinations of histone modifications contribute to exon splicing in a redundant and cumulative fashion. To conclude, this study provides a better understanding of the effects of histone modifications on gene transcribed regions.	[Zhu, Shijia; Wang, Guohua; Liu, Bo; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Biomed Informat, Harbin 150006, Peoples R China	Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Biomed Informat, Harbin 150006, Peoples R China.	ydwang@hit.edu.cn	Zhu, Shijia/K-7404-2019; Wang, Guohua/GLR-7939-2022		China National 863 High-Tech Program [2012AA020404]; National Natural Science Foundation of China [60973078, 60901075, 61173085]; Natural Science Foundation of Heilongjiang Province of China [LC2009C35]; Special Research Foundation for technological Innovation Talents of Harbin [2011RFLXG011]	China National 863 High-Tech Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Special Research Foundation for technological Innovation Talents of Harbin	This work is supported by China National 863 High-Tech Program (2012AA020404), the National Natural Science Foundation of China (60973078, 60901075, 61173085), the Natural Science Foundation of Heilongjiang Province of China (LC2009C35) and the Special Research Foundation for technological Innovation Talents of Harbin (2011RFLXG011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Butte A J, 2000, Pac Symp Biocomput, P418; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; Cheng C, 2011, GENOME BIOL, V12; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Enroth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029911; Gabriel K, 1969, SYSTEMAT ZOOL, V18, P20; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim S, 2011, N KOREAN REV, V7, P3; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WASYLYK B, 1979, EUR J BIOCHEM, V98, P317, DOI 10.1111/j.1432-1033.1979.tb13191.x; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhao KJ, 2009, NUCL ACIDS RES, V37; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	72	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67448	10.1371/journal.pone.0067448	http://dx.doi.org/10.1371/journal.pone.0067448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825663	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000103
J	Del Fabbro, S; Nazzi, F				Del Fabbro, Simone; Nazzi, Francesco			From Chemistry to Behavior. Molecular Structure and Bioactivity of Repellents against Ixodes ricinus Ticks	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; OLFACTORY RECEPTORS; ANOPHELES-GAMBIAE; ESSENTIAL OILS; INSECT REPELLENTS; CRYSTAL-STRUCTURE; HALLERS ORGAN; DEET	Tick-borne zoonoses are considered as emerging diseases. Tick repellents represent an effective tool for reducing the risk of tick bite and pathogens transmission. Previous work demonstrated the repellent activity of the phenylpropanoid eugenol against Ixodes ricinus; here we investigate the relationship between molecular structure and repellency in a group of substances related to that compound. We report the biological activity of 18 compounds varying for the presence/number of several moieties, including hydroxyl and methoxy groups and carbon side-chain. Each compound was tested at different doses with a bioassay designed to measure repellency against individual tick nymphs. Both vapor pressure and chemical features of the tested compounds appeared to be related to repellency. In particular, the hydroxyl and methoxy groups as well as the side-chain on the benzene ring seem to play a role. These results are discussed in light of available data on chemical perception in ticks. In the course of the study new repellent compounds were identified; the biological activity of some of them (at least as effective as the "gold standard'' repellent DEET) appears to be very promising from a practical point of view.	[Del Fabbro, Simone; Nazzi, Francesco] Univ Udine, Dipartimento Sci Agrarie & Ambientali, I-33100 Udine, Italy	University of Udine	Del Fabbro, S (corresponding author), Univ Udine, Dipartimento Sci Agrarie & Ambientali, I-33100 Udine, Italy.	simone.delfabbro@uniud.it		NAZZI, Francesco/0000-0002-2085-7621; Del Fabbro, Simone/0000-0001-5347-1322	Universita degli Studi di Udine	Universita degli Studi di Udine	The work was financed by the Universita degli Studi di Udine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman A, 2001, EXP NEUROL, V172, P153, DOI 10.1006/exnr.2001.7807; Allan SA, 2010, ECOL CONT VECTOR-BOR, V2, P327; Benton R, 2009, ANN NY ACAD SCI, V1170, P478, DOI 10.1111/j.1749-6632.2009.03880.x; Bissinger BW, 2010, PESTIC BIOCHEM PHYS, V96, P63, DOI 10.1016/j.pestbp.2009.09.010; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00029; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Brown Heather A., 1998, Insect Science and its Application, V18, P9; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Carroll JF, 2005, MED VET ENTOMOL, V19, P101, DOI 10.1111/j.0269-283X.2005.00559.x; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Del Fabbro S, 2008, EXP APPL ACAROL, V45, P219, DOI 10.1007/s10493-008-9182-6; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; DOBROTVORSKII A K, 1989, Izvestiya Sibirskogo Otdeleniya Akademii Nauk SSSR Seriya Biologicheskikh Nauk, P62; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Donze G, 2004, J EXP BIOL, V207, P4283, DOI 10.1242/jeb.01241; Erler F, 2006, FITOTERAPIA, V77, P491, DOI 10.1016/j.fitote.2006.05.028; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Garcia-Domenech R, 2010, MOL DIVERS, V14, P321, DOI 10.1007/s11030-009-9179-z; Gbolade A. A., 2000, Journal of Tropical Medicinal Plants, V1, P146; Grenacher S, 2001, EXP APPL ACAROL, V25, P641, DOI 10.1023/A:1016145805759; Herrington JE, 2004, AM J PREV MED, V26, P135, DOI 10.1016/j.amepre.2003.10.010; Iason GR, 2012, ECOL REV, P1, DOI 10.1017/CBO9780511675751; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kim EH, 2003, J AGR FOOD CHEM, V51, P885, DOI 10.1021/jf0208278; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Koren G, 2003, CAN MED ASSOC J, V169, P209; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Leonovich SA, 2004, EXP APPL ACAROL, V32, P89, DOI 10.1023/B:APPA.0000018200.24760.78; MOORE WARREN, 1934, JOUR NEW YORK ENT SOC, V42, P185; Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009; MWANGI EN, 1995, EXP APPL ACAROL, V19, P11, DOI 10.1007/BF00051933; Nazzi F, 2010, TRENDS IN ACAROLOGY, P517, DOI 10.1007/978-90-481-9837-5_88; Paluch G, 2010, PEST MANAG SCI, V66, P925, DOI 10.1002/ps.1974; Paluch G, 2009, J AGR FOOD CHEM, V57, P7618, DOI 10.1021/jf900964e; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Peterson C., 2001, Pesticide Outlook, V12, P154, DOI 10.1039/b106296b; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Randolph S, 2006, INT J MED MICROBIOL, V296, P84, DOI 10.1016/j.ijmm.2005.12.008; Schoenig GP, 1999, TOXICOL SCI, V47, P99, DOI 10.1093/toxsci/47.1.99; Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2; Sfara V, 2011, J INSECT PHYSIOL, V57, P1431, DOI 10.1016/j.jinsphys.2011.07.009; Snyder JC, 2011, EXP APPL ACAROL, V55, P215, DOI 10.1007/s10493-011-9472-2; Soares SF, 2012, ACTA TROP, V124, P192, DOI 10.1016/j.actatropica.2012.08.007; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; STEULLET P, 1994, J COMP PHYSIOL A, V174, P27, DOI 10.1007/BF00192003; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Szabadics J, 2000, ACTA BIOL HUNG, V51, P265; Thorsell W, 2006, PHYTOMEDICINE, V13, P132, DOI 10.1016/j.phymed.2004.04.008; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Tunon H, 2006, FITOTERAPIA, V77, P257, DOI 10.1016/j.fitote.2006.02.009; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527; Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; Yang YC, 2003, J AGR FOOD CHEM, V51, P4884, DOI 10.1021/jf034225f; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011	67	11	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67832	10.1371/journal.pone.0067832	http://dx.doi.org/10.1371/journal.pone.0067832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805329	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500157
J	Cao, TT; Wang, YJ; Zhang, YQ				Cao, Ting-Ting; Wang, Yuan-Jing; Zhang, Yu-Qing			Effect of Strongly Alkaline Electrolyzed Water on Silk Degumming and the Physical Properties of the Fibroin Fiber	PLOS ONE			English	Article							SERICIN; PROTEIN; COCOON; SILKWORMS	Strongly alkaline electrolyzed water (SAEW) was prepared by electrolysis of tap water in a laboratory-made water electrolyzer. The pH of stored SAEW was stable for more than one month. The hardness of the electrolyzed water was 30% lower and the Na+ concentration was 18% higher than those of the tap water. Silkworm cocoon shells were boiled in pH 11.50 SAEW at a ratio of 1:40 similar to 80 (W/V) for 20 min and the sericin layers around the silk fibroin fibers were removed completely. The tensile properties and thermal decomposition temperature of a single filament of silk fibroin obtained by the SAEW method were almost the same as those for the fiber obtained by the neutral soap, and much higher than those for the fiber obtained by Na2CO3 degumming. The results demonstrate that SAEW is an environmentally friendly and pollution-free silk degumming agent that allows highly efficient, low cost recovery of sericin.	[Cao, Ting-Ting; Wang, Yuan-Jing; Zhang, Yu-Qing] Soochow Univ, Sch Biol & Basic Med Sci, Natl Engn Lab Modern Silk, Silk Biotechnol Lab, Suzhou, Peoples R China	Soochow University - China	Zhang, YQ (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Natl Engn Lab Modern Silk, Silk Biotechnol Lab, Suzhou, Peoples R China.	sericult@suda.edu.cn		Zhang, Yu-Qing/0000-0001-7670-386X	earmarked fund for China Agriculture Research System [CARS-22-ZJ0504]; Priority Academic Program Development of Jiangsu Higher Education Institutions	earmarked fund for China Agriculture Research System; Priority Academic Program Development of Jiangsu Higher Education Institutions	The authors gratefully acknowledge the earmarked fund (CARS-22-ZJ0504) for China Agriculture Research System and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ADV ENVIRON BIOL; Arami M, 2007, J APPL POLYM SCI, V106, P267, DOI 10.1002/app.26492; Capar G, 2008, J MEMBRANE SCI, V325, P920, DOI 10.1016/j.memsci.2008.09.020; Fabiani C, 1996, DESALINATION, V105, P1, DOI 10.1016/0011-9164(96)00050-1; Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006; Fujii T, 1996, Japan Patent, Patent No. [JP8143595A, 8143595]; GULRAJANI ML, 1992, J SOC DYERS COLOUR, V108, P79; Gulrajani ML., 1992, INDIAN J FIBRE TEXT, V17, P39; Hasegawa T, 2003, Japan Patent, Patent No. [JP2003165843A, 2003165843]; Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145; Khan MMR, 2010, BIORESOURCE TECHNOL, V101, P8439, DOI 10.1016/j.biortech.2010.05.100; Kim YD, 2002, KOREAN J SERIC SCI, V47, P36; Kitagawa J, 1998, Japan Patent, Patent No. [JP10029909A, 10029909]; Makoto H, 2005, Japan Patent, Patent No. [JP2005052066A, 2005052066]; Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026; MCCONLOGUE WA, 1952, J AM OIL CHEM SOC, V29, P526, DOI 10.1007/BF02632644; Ogawa A, 2004, J BIOSCI BIOENG, V98, P217; Sarovart S, 2003, REV ADV MATER SCI, V5, P193; Sasaki M, 2000, ONCOL REP, V7, P1049; Seo BK, 2001, Korea Patent, Patent No. [KR2001079066, 2001079066]; Sun W, 2012, SCI CHINA LIFE SCI, V55, P483, DOI 10.1007/s11427-012-4334-7; Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667; Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608; Wang HY, 2012, FOOD FUNCT, V3, P150, DOI 10.1039/c1fo10148j; Wang YJ, 2011, ADV MATER RES-SWITZ, V175-176, P158, DOI 10.4028/www.scientific.net/AMR.175-176.158; Zhang Y. Q., 2002, ACTA SERICOLOGICA SI, V28, P75; Zhang Y.Q., 2012, China Patent, Patent No. [CN 201210082082 X, 201210082082, 201210082082.X]; Zhang Y.Q., 2004, China Patent, Patent No. [CN 1477141 A, 1477141]; Zhang YQ, 2010, SCI CHINA LIFE SCI, V53, P1330, DOI 10.1007/s11427-010-4084-3; Zhaorigetu S, 2001, BIOSCI BIOTECH BIOCH, V65, P2181, DOI 10.1271/bbb.65.2181	30	46	49	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65654	10.1371/journal.pone.0065654	http://dx.doi.org/10.1371/journal.pone.0065654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824061	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400018
J	Convertino, M; Valverde, LJ				Convertino, Matteo; Valverde, L. James, Jr.			Portfolio Decision Analysis Framework for Value-Focused Ecosystem Management	PLOS ONE			English	Article							EVOLUTIONARY MULTIOBJECTIVE OPTIMIZATION; ENVIRONMENTAL-MANAGEMENT; EXTINCTION RISK; PARETO FRONT; LAND-USE; CONSERVATION; BIODIVERSITY; UNCERTAINTY; DESIGN; INVESTMENT	Management of natural resources in coastal ecosystems is a complex process that is made more challenging by the need for stakeholders to confront the prospect of sea level rise and a host of other environmental stressors. This situation is especially true for coastal military installations, where resource managers need to balance conflicting objectives of environmental conservation against military mission. The development of restoration plans will necessitate incorporating stakeholder preferences, and will, moreover, require compliance with applicable federal/state laws and regulations. To promote the efficient allocation of scarce resources in space and time, we develop a portfolio decision analytic (PDA) framework that integrates models yielding policy-dependent predictions for changes in land cover and species metapopulations in response to restoration plans, under different climate change scenarios. In a manner that is somewhat analogous to financial portfolios, infrastructure and natural resources are classified as human and natural assets requiring management. The predictions serve as inputs to a Multi Criteria Decision Analysis model (MCDA) that is used to measure the benefits of restoration plans, as well as to construct Pareto frontiers that represent optimal portfolio allocations of restoration actions and resources. Optimal plans allow managers to maintain or increase asset values by contrasting the overall degradation of the habitat and possible increased risk of species decline against the benefits of mission success. The optimal combination of restoration actions that emerge from the PDA framework allows decision-makers to achieve higher environmental benefits, with equal or lower costs, than those achievable by adopting the myopic prescriptions of the MCDA model. The analytic framework presented here is generalizable for the selection of optimal management plans in any ecosystem where human use of the environment conflicts with the needs of threatened and endangered species. The PDA approach demonstrates the advantages of integrated, top-down management, versus bottom-up management approaches.	[Convertino, Matteo] Univ Florida, Inst Food & Agr Sci, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Convertino, Matteo] Univ Florida, Florida Climate Inst, Gainesville, FL 32611 USA; [Valverde, L. James, Jr.] USA, Corps Engineers, Engineer Res & Dev Ctr, HQ, Washington, DC 20310 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Geospatial Research Laboratory (GRL)	Convertino, M (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	mconvertino@ufl.edu	Convertino, Matteo/ABD-5828-2021; Convertino, Matteo/J-1365-2016	Convertino, Matteo/0000-0001-7003-7587	Center Directed Research (ERDC/USACE CDR) Program; Strategic Environmental Research and Development Program (SERDP) [1699]	Center Directed Research (ERDC/USACE CDR) Program; Strategic Environmental Research and Development Program (SERDP)	Funding from the Center Directed Research (ERDC/USACE CDR) Program and Strategic Environmental Research and Development Program (SERDP) 1699 Program supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JCJH, 2008, ECOL SOC, V13; Aiello-Lammens ME, 2011, GLOBAL CHANGE BIOL, V17, P3644, DOI 10.1111/j.1365-2486.2011.02497.x; Akcakaya HR, 2011, FRONT ECOL ENVIRON, V9, P485, DOI 10.1890/11.WB.025; Akcakaya R, 2012, ECOLOGICAL MODELLING; Andersen MC, 2004, RISK ANAL, V24, P1231, DOI 10.1111/j.0272-4332.2004.00521.x; Ando AW, 2012, P NATL ACAD SCI USA, V109, P6484, DOI 10.1073/pnas.1114653109; Beale N., 2011, INDIVIDUAL VERSUS SY; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Chu-Agor ML, 2011, ECOLOGICAL ENG; Convertino M, 2011, ECOL COMPLEX, V8, P364, DOI 10.1016/j.ecocom.2011.07.007; Crowe KA, 2008, CLIMATIC CHANGE, V89, P355, DOI 10.1007/s10584-007-9373-x; Demers SA, 2012, J FISH WILDL MANAG, V3, P123, DOI 10.3996/062011-JFWM-036; Devireddy VK, 2007, ENVIRON MODELL SOFTW, V22, P5, DOI [10.1016/j.envsoft.2005.12.021, DOI 10.1016/J.ENVS0FT.2005.12.021]; Diwekar U, 2005, RESOUR CONSERV RECY, V44, P215, DOI 10.1016/j.resconrec.2005.01.007; Drechsler M, 2003, ECOL APPL, V13, P990, DOI 10.1890/1051-0761(2003)13[990:RMERFP]2.0.CO;2; Dunkel J, 2012, P NATL ACAD SCI USA, V109, pE2304, DOI 10.1073/pnas.1207485109; EAFB, 2012, EGL AIR FORC BAS FLO; EAFB Plan, 2005, EGL AFB SANT ROS ISL; Eberhart-Phillips L. J., 2012, THESIS HUMBOLDT STAT; Edwards SF, 2004, ECOL ECON, V49, P317, DOI 10.1016/j.ecolecon.2004.04.002; Enriquez-Andrade RR, 2004, ECOL ECON, V48, P303, DOI 10.1016/j.ecolecon.2003.09.009; FGDL Florida Geographic Data Library Documentation, 2009, FFWCC POTENTIAL HABI; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Greene R, 2011, GEOGR COMPASS, V5, P412, DOI 10.1111/j.1749-8198.2011.00431.x; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hildebrandt P, 2011, FOREST POLICY ECON, V13, P1, DOI 10.1016/j.forpol.2010.09.001; Hills J, 2009, MAR POLICY, V33, P887, DOI 10.1016/j.marpol.2009.04.017; Hoekstra J, 2012, P NATL ACAD SCI USA, V109, P6360, DOI 10.1073/pnas.1205114109; Huang B, 2008, INT J GEOGR INF SCI, V22, P507, DOI 10.1080/13658810701492365; IUCN, 2010, GUIDELINES USING IUC; Karvetski CW, 2011, IEEE T SYST MAN CY A, V41, P63, DOI 10.1109/TSMCA.2010.2055154; Kasprzyk JR, 2012, ENVIRON MODELL SOFTW, V34, P87, DOI 10.1016/j.envsoft.2011.04.003; Keisler JM, 2011, WILEY ENCY OPERATION, P2960; Kennedy MC, 2008, J APPL ECOL, V45, P181, DOI 10.1111/j.1365-2664.2007.01367.x; Kennedy MC, 2011, BIOSCIENCE, V61, P994, DOI 10.1525/bio.2011.61.12.9; Kim IY, 2005, STRUCT MULTIDISCIP O, V29, P149, DOI 10.1007/s00158-004-0465-1; Knoke T, 2011, ECOL ECON, V70, P1139, DOI 10.1016/j.ecolecon.2011.01.007; Koenen MT, 1996, J FIELD ORNITHOL, V67, P281; Kollat JB, 2007, ENVIRON MODELL SOFTW, V22, P1691, DOI 10.1016/j.envsoft.2007.02.001; Kotaich AA, 2011, DISTRIBUTION REPROD; Labiosa W. B., 2009, 20095181 US GEOL SUR; Leatherman S, 1989, NATL ASSESSMENT BEAC; Linkov I, 2012, SERDP FINAL REPORT I; Linkov I, 2012, MULTICRITERIA DECISI; Linkov I, 2011, SERDP VULN REP INT C; Linkov I, 2013, ENV MODELLING SOFTWA; Linkov I, 2006, INTEGR ENVIRON ASSES, V2, P92, DOI 10.1002/ieam.5630020116; Linkov I, 2012, RISK ANAL, V32, P374, DOI 10.1111/j.1539-6924.2011.01683.x; Lott CA, 2011, TNDOERE28 ERDC; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Macmillan WD, 1992, GEOGRAPHICAL ANAL, V24; Malczewski J, 2006, INT J GEOGR INF SYST, V20, P249; Marinoni O, 2011, ENVIRON MODELL SOFTW, V26, P18, DOI 10.1016/j.envsoft.2010.03.001; Martinez CJ, 2011, PLOS ONE, DOI [10.1371/journal.pone.0015683, DOI 10.1371/J0URNAL.P0NE.0015683]; MILLS WL, 1982, LAND ECON, V58, P33, DOI 10.2307/3146075; Moloney PD, 2011, NAT RESOUR MODEL, V24, P102, DOI 10.1111/j.1939-7445.2010.00084.x; Munoz-Carpena R, 2011, ECOLOGICAL MODELLING; Munoz-Carpena R, 2012, COASTLINE FRACTALITY; Munoz-Carpena R, 2011, INTEGRATED MODELING; Murley JF, 2002, EC FLORIDAS BEACHES; National Academy of Science, 2012, EC SERV CHART PATH S; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIlkey OH, 1998, J COASTAL RES, P127; Pruner R. A, 2010, THESIS U FLORIDA GAI; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Roberts SA, 2011, J GEOGR SYST, V13, P299, DOI 10.1007/s10109-010-0136-2; Salo A, 2011, INT SER OPER RES MAN, V162, P1, DOI 10.1007/978-1-4419-9943-6; Saltelli A., 2004, GLOBAL SENSITIVITY A, V1st; Schmitz OJ, 2006, BIODIVERSITY ECOSYST, V56, P12; Sethi SA, 2010, FISH FISH, V11, P341, DOI 10.1111/j.1467-2979.2010.00363.x; Smith K. V., 1996, ESTIMATING EC VALUES; Smith WD, 2010, J ENV MANAGEMENT, V91; Sundell RC, 1997, APPL PARK PLANNING J, V1, P100; Warne B, 2007, RECOVERY PLAN PACIFI, V1; Xiao NC, 2007, COMPUT ENVIRON URBAN, V31, P232, DOI 10.1016/j.compenvurbsys.2006.08.001; Yanmei Q, 2001, MAN SCI IND ENG MSIE; Zhou Q, 2012, RISK ANAL, V32, P1873, DOI 10.1111/j.1539-6924.2012.01870.x; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	80	44	44	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65056	10.1371/journal.pone.0065056	http://dx.doi.org/10.1371/journal.pone.0065056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823331	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400004
J	Fu, HX; Le, SM; Muniyappa, K; Yan, J				Fu, Hongxia; Le, Shimin; Muniyappa, Kalappa; Yan, Jie			Dynamics and Regulation of RecA Polymerization and De-Polymerization on Double-Stranded DNA	PLOS ONE			English	Article							SINGLE-MOLECULE; MAGNETIC TWEEZERS; S-DNA; PROTEIN; BINDING; FORCE; RECOMBINATION; FILAMENT	The RecA filament formed on double-stranded (ds) DNA is proposed to be a functional state analogous to that generated during the process of DNA strand exchange. RecA polymerization and de-polymerization on dsDNA is governed by multiple physiological factors. However, a comprehensive understanding of how these factors regulate the processes of polymerization and de-polymerization of RecA filament on dsDNA is still evolving. Here, we investigate the effects of temperature, pH, tensile force, and DNA ends (in particular ssDNA overhang) on the polymerization and de-polymerization dynamics of the E. coli RecA filament at a single-molecule level. Our results identified the optimal conditions that permitted spontaneous RecA nucleation and polymerization, as well as conditions that could maintain the stability of a preformed RecA filament. Further examination at a nano-meter spatial resolution, by stretching short DNA constructs, revealed a striking dynamic RecA polymerization and de-polymerization induced saw-tooth pattern in DNA extension fluctuation. In addition, we show that RecA does not polymerize on S-DNA, a recently identified novel base-paired elongated DNA structure that was previously proposed to be a possible binding substrate for RecA. Overall, our studies have helped to resolve several previous single-molecule studies that reported contradictory and inconsistent results on RecA nucleation, polymerization and stability. Furthermore, our findings also provide insights into the regulatory mechanisms of RecA filament formation and stability in vivo.	[Fu, Hongxia; Le, Shimin; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Fu, Hongxia; Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Muniyappa, Kalappa] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Yan, Jie] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Indian Institute of Science (IISC) - Bangalore; National University of Singapore	Yan, J (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore.	phyyj@nus.edu.sg	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291; Fu, Hongxia/0000-0002-6893-8260; Le, Shimin/0000-0003-2359-1897	National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore	National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore(National Research Foundation, Singapore)	This work was supported by the National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore (to J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bosaeus N, 2012, P NATL ACAD SCI USA, V109, P15179, DOI 10.1073/pnas.1213172109; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Cocco S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011910; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Feinstein E, 2011, NUCLEIC ACIDS RES, V39, P3781, DOI 10.1093/nar/gkr013; Fu HX, 2013, NUCLEIC ACIDS RES, V41, P924, DOI 10.1093/nar/gks1162; Fu HX, 2011, NUCLEIC ACIDS RES, V39, P3473, DOI 10.1093/nar/gkq1278; Fu HX, 2010, NUCLEIC ACIDS RES, V38, P5594, DOI 10.1093/nar/gkq309; Fulconis R, 2004, BIOPHYS J, V87, P2552, DOI 10.1529/biophysj.104.043059; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Hsu HF, 2011, BIOCHEMISTRY-US, V50, P8270, DOI 10.1021/bi200423t; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Mani A, 2010, NUCLEIC ACIDS RES, V38, P2036, DOI 10.1093/nar/gkp1177; Mazin AV, 1996, P NATL ACAD SCI USA, V93, P10673, DOI 10.1073/pnas.93.20.10673; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; van der Heijden T, 2005, NUCLEIC ACIDS RES, V33, P2099, DOI 10.1093/nar/gki512; Vaze MB, 1999, BIOCHEMISTRY-US, V38, P3175, DOI 10.1021/bi9819125; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905; Zhang XH, 2013, P NATL ACAD SCI USA, V110, P3865, DOI 10.1073/pnas.1213740110; Zhang XH, 2012, P NATL ACAD SCI USA, V109, P8103, DOI 10.1073/pnas.1109824109	31	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66712	10.1371/journal.pone.0066712	http://dx.doi.org/10.1371/journal.pone.0066712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825559	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000320576400152
J	Kapoula, Z; Gaertner, C; Yang, Q; Denise, P; Toupet, M				Kapoula, Zoi; Gaertner, Chrystal; Yang, Qing; Denise, Pierre; Toupet, Michel			Vergence and Standing Balance in Subjects with Idiopathic Bilateral Loss of Vestibular Function	PLOS ONE			English	Article							COMBINED EYE-MOVEMENTS; VESTIBULOOCULAR REFLEX; SUPERIOR COLLICULUS; POSTURAL CONTROL; SACCADES; CHILDREN; DISTANCE; PRIMATE; NEURONS; SIGNALS	There is a natural symbiosis between vergence and vestibular responses. Deficits in vergence can lead to vertigo, disequilibrium, and postural instability. This study examines both vergence eye movements in patients with idiopathic bilateral vestibular loss, and their standing balance in relation to vergence. Eleven patients participated in the study and 16 controls. Bilateral loss of vestibular function was objectified with many tests; only patients without significant response to caloric tests, to video head impulse tests and without vestibular evoked myogenic potentials were included in the study. Vergence testing (from 8 patients and 15 controls): A LED display with targets at 20, 40, and 100 cm along the median plane was used to elicit vergence eye movements, recorded with the IRIS device. Standing balance (11 patients and 16 controls): Four conditions were run, each lasting 1 min: fixation of a LED at 40 cm (convergence of 9 degrees), at 150 cm (convergence of 2.3 degrees); this last condition was repeated with eyes closed. Comparison of the eyes closed-eyes open conditions at 150 cm allowed evaluation of the Romberg Quotient. In the forth condition, two LEDS, at 20 and at 100 cm, were light on, one after the other for 1 sec, causing the eyes to converge then diverge. Standing balance was recorded with an accelerometer placed at the back near the center of mass (McRoberts, Dynaport). Results: Vergence: Relative to controls, convergence eye movements in patients showed significantly lower accuracy, lower mean velocity, and saccade intrusions of significantly higher amplitude. Balance: The normalized 90% area of body sway was significantly higher for patients than for controls for all conditions. Yet, similarly to controls, postural stability was better while fixating at near (sustained convergence) than at far, or while making active vergence movements. We argue that vestibular loss deteriorates convergence, but even deficient, convergence can be helpful for postural control.	[Kapoula, Zoi; Gaertner, Chrystal; Yang, Qing] Univ Paris 05, CNRS, Hop Europeen Georges Pompidou, Grp IRIS,Serv Ophthalmol,UMR 8194,Ctr Etud Sensor, F-75270 Paris, France; [Denise, Pierre] INSERM, U7075, Caen, France; [Toupet, Michel] Ctr Explorat Otoneurol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kapoula, Z (corresponding author), Univ Paris 05, CNRS, Hop Europeen Georges Pompidou, Grp IRIS,Serv Ophthalmol,UMR 8194,Ctr Etud Sensor, F-75270 Paris, France.	zoi.kapoula@egp.aphp.fr	Denise, Pierre/E-2174-2011	Denise, Pierre/0000-0002-9049-7692				Alkan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025866; Bucci MP, 2006, VISION RES, V46, P3594, DOI 10.1016/j.visres.2006.06.001; Bucci MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023125; Bucci MP, 2004, EXP BRAIN RES, V157, P286, DOI 10.1007/s00221-004-1842-0; Bucci MP, 2004, J NEUROL, V251, P204, DOI 10.1007/s00415-004-0304-8; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Coenen OJMD, 1998, THESIS U CALIFORNIA; Coubard OA, 2006, CEREB CORTEX, V16, P425, DOI 10.1093/cercor/bhi122; Erkelens CJ, 2000, VISION RES, V40, P2411, DOI 10.1016/S0042-6989(00)00120-6; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Erkelens CJ, 2001, VISION RES, V41, P3497, DOI 10.1016/S0042-6989(01)00004-9; Gaertner C, 2013, INVEST OPHTH VIS SCI, V54, P529, DOI 10.1167/iovs.12-10586; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115, DOI 10.1152/jn.1995.73.5.2115; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HAN Y, 1995, ACTA OPHTHALMOL SCAN, V73, P414; Jainta S, 2011, VISION RES, V51, P1845, DOI 10.1016/j.visres.2011.06.014; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; Kapoula Z, 2007, J NEUROL, V254, P1174, DOI 10.1007/s00415-006-0460-0; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Leigh, 2006, NEUROLOGY EYE MOVEME, P189; Liao K, 2008, NEUROLOGY, V70, P802, DOI 10.1212/01.wnl.0000304134.33380.1e; Liao K, 2010, RESTOR NEUROL NEUROS, V28, P91, DOI 10.3233/RNN-2010-0507; Lopez C, 2005, BIPUDIC CONTRUCLE PO; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mergner T, 2009, ANN NY ACAD SCI, V1164, P206, DOI 10.1111/j.1749-6632.2008.03722.x; Migliaccio AA, 2004, EXP BRAIN RES, V159, P92, DOI 10.1007/s00221-004-1936-8; Moschner C, 1999, BRAIN, V122, P2147, DOI 10.1093/brain/122.11.2147; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Ramat S, 2003, J NEUROPHYSIOL, V90, P887, DOI 10.1152/jn.01121.2002; Richter HO, 2004, EUR J NEUROSCI, V20, P2722, DOI 10.1111/j.1460-9568.2004.03743.x; Serra A, 2011, CURR OPIN NEUROL, V24, P32, DOI 10.1097/WCO.0b013e328341eebd; SNYDER LH, 1992, J NEUROPHYSIOL, V67, P861, DOI 10.1152/jn.1992.67.4.861; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; Takagi M, 2003, PROG BRAIN RES, V142, P19; Takagi M, 2001, INVEST OPHTH VIS SCI, V42, P1479; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; Tzelepi A, 2004, EXP BRAIN RES, V155, P439, DOI 10.1007/s00221-003-1741-9; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Walton MMG, 2003, J NEUROPHYSIOL, V90, P1124, DOI 10.1152/jn.00877.2002; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Yang Q, 2009, INVEST OPHTH VIS SCI, V50, P1145, DOI 10.1167/iovs.08-2474	46	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66652	10.1371/journal.pone.0066652	http://dx.doi.org/10.1371/journal.pone.0066652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825551	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400139
J	Monceau, K; Arca, M; Lepretre, L; Mougel, F; Bonnard, O; Silvain, JF; Maher, N; Arnold, G; Thiery, D				Monceau, Karine; Arca, Mariangela; Lepretre, Lisa; Mougel, Florence; Bonnard, Olivier; Silvain, Jean-Francois; Maher, Nevile; Arnold, Gerard; Thiery, Denis			Native Prey and Invasive Predator Patterns of Foraging Activity: The Case of the Yellow-Legged Hornet Predation at European Honeybee Hives	PLOS ONE			English	Article							VESPA-VELUTINA; LEPUS-CALIFORNICUS; CHEMICAL DEFENSE; CANIS-LATRANS; APIS-CERANA; WING DAMAGE; BEHAVIOR; WASP; CIRCUMVENTION; HYMENOPTERA	Contrary to native predators, which have co-evolved with their prey, alien predators often benefit from native prey naivete. Vespa velutina, a honeybee predator originating from Eastern China, was introduced into France just before 2004. The present study, based on video recordings of two beehives at an early stage of the invasion process, intends to analyse the alien hornet hunting behaviour on the native prey, Apis mellifera, and to understand the interaction between the activity of the predator and the prey during the day and the season. Chasing hornets spent most of their time hovering facing the hive, to catch flying honeybees returning to the hive. The predation pressure increased during the season confirming previous study based on predator trapping. The number of honeybee captures showed a maximum peak for an intermediate number of V. velutina, unrelated to honeybee activity, suggesting the occurrence of competition between hornets. The number of honeybees caught increased during midday hours while the number of hornets did not vary, suggesting an increase in their efficacy. These results suggest that the impact of V. velutina on honeybees is limited by its own biology and behaviour and did not match the pattern of activity of its prey. Also, it could have been advantageous during the invasion, limiting resource depletion and thus favouring colonisation. This lack of synchronization may also be beneficial for honeybee colonies by giving them an opportunity to increase their activity when the hornets are less effective.	[Monceau, Karine; Lepretre, Lisa; Bonnard, Olivier; Maher, Nevile; Thiery, Denis] INRA, UMR Sante & Agroecol Vignoble 1065, F-33883 Villenave Dornon, France; [Monceau, Karine; Lepretre, Lisa; Bonnard, Olivier; Maher, Nevile; Thiery, Denis] Univ Bordeaux, Bordeaux Sci Agro, ISVV, UMR Sante & Agroecol Vignoble 1065, Villenave Dornon, France; [Arca, Mariangela; Mougel, Florence; Silvain, Jean-Francois; Arnold, Gerard] CNRS, Lab Evolut Genomes & Speciat, UPR 9034, F-91198 Gif Sur Yvette, France; [Arca, Mariangela; Mougel, Florence; Silvain, Jean-Francois; Arnold, Gerard] Univ Paris 11, Orsay, France; [Arca, Mariangela; Mougel, Florence; Silvain, Jean-Francois; Arnold, Gerard] CNRS, Lab Evolut Genomes & Speciat, UPR 9034, Unite Rech IRD 072, F-91198 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay	Thiery, D (corresponding author), INRA, UMR Sante & Agroecol Vignoble 1065, F-33883 Villenave Dornon, France.	denis.thiery@bordeaux.inra.fr		Monceau, Karine/0000-0003-3786-1835	FranceAgriMer grant [797/2007-2010]; Fondation pour la Recherche sur la Biodiversite (Wasprey project); CNRS; IRD; INRA SPE department core budgets	FranceAgriMer grant; Fondation pour la Recherche sur la Biodiversite (Wasprey project); CNRS(Centre National de la Recherche Scientifique (CNRS)); IRD; INRA SPE department core budgets	This research project was funded by a FranceAgriMer grant # 797/2007-2010 and is a part of Labex COTE Continental To coastal Ecosystems. MA was also supported by a grant from the Fondation pour la Recherche sur la Biodiversite (Wasprey project). Financial support was also provided by CNRS, IRD and INRA SPE department core budgets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Arca M, 2012, THESIS U P M CURIE P; Arias-Del Razo I, 2011, J ARID ENVIRON, V75, P112, DOI 10.1016/j.jaridenv.2010.09.008; Arias-Del Razo I, 2012, CAN J ZOOL, V90, P683, DOI 10.1139/Z2012-036; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Baracchi D, 2010, ETHOL ECOL EVOL, V22, P281, DOI 10.1080/03949370.2010.502323; Beaton MJ, 1997, LIMNOL OCEANOGR, V42, P346, DOI 10.4319/lo.1997.42.2.0346; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Benjamini Y, 2001, ANN STAT, V29, P1165; BERENBAUM MR, 1992, J INSECT BEHAV, V5, P547, DOI 10.1007/BF01048003; Bourdeau PE, 2011, BIOL INVASIONS, V13, P2533, DOI 10.1007/s10530-011-0073-0; Bura VL, 2009, NATURWISSENSCHAFTEN, V96, P713, DOI 10.1007/s00114-009-0527-8; Calderone NW, 1998, APIDOLOGIE, V29, P127, DOI 10.1051/apido:19980108; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; D'Adamo P, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.10301; da Rocha AA, 2007, SOCIOBIOLOGY, V50, P813; de Castro MM, 2011, SOCIOBIOLOGY, V58, P133; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; Domenici P, 2008, CURR BIOL, V18, P1792, DOI 10.1016/j.cub.2008.09.062; Dukas R, 2011, ANIM BEHAV, V81, P635, DOI 10.1016/j.anbehav.2010.12.011; Edwards R, 1980, SOCIAL WASPS THEIR B; Eisner T, 2005, CHEMOECOLOGY, V15, P227, DOI 10.1007/s00049-005-0316-6; Eisner T, 1993, P NATL ACAD SCI USA, V90, P6716, DOI 10.1073/pnas.90.14.6716; Eisner T, 1998, P NATL ACAD SCI USA, V95, P1108, DOI 10.1073/pnas.95.3.1108; Eisner T, 2008, CHEMOECOLOGY, V18, P197, DOI 10.1007/s00049-008-0406-3; Feuerbacher E, 2003, J EXP BIOL, V206, P1855, DOI 10.1242/jeb.00347; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; GILLER PS, 1993, OIKOS, V67, P351, DOI 10.2307/3545482; Glaiim Murtadha K., 2009, Bulletin of the Iraq Natural History Museum, V10, P17; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Grant JB, 2007, J ANIM ECOL, V76, P439, DOI 10.1111/j.1365-2656.2007.01216.x; Haddaway NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032229; Hieber CS, 2002, BEHAV ECOL SOCIOBIOL, V53, P51, DOI 10.1007/s00265-002-0547-2; Higginson AD, 2004, ECOL ENTOMOL, V29, P52, DOI 10.1111/j.0307-6946.2004.00573.x; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Ishay JS, 2004, J ELECTRON MICROSC, V53, P623, DOI 10.1093/jmicro/dfh077; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; Koeniger N, 1996, APIDOLOGIE, V27, P341, DOI 10.1051/apido:19960502; KOTLER BP, 1994, OECOLOGIA, V100, P391, DOI 10.1007/BF00317860; Kotler BP, 2002, EVOL ECOL RES, V4, P495; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044350; Machado G, 2005, J CHEM ECOL, V31, P2519, DOI 10.1007/s10886-005-7611-0; Matsuura M., 1991, P232; Matsuura M, 1990, BIOL VESPINE WASPS; Miyatake T, 2004, P ROY SOC B-BIOL SCI, V271, P2293, DOI 10.1098/rspb.2004.2858; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Monceau K, 2013, APIDOLOGIE, V44, P209, DOI 10.1007/s13592-012-0172-7; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Perdereau E, 2011, BIOL INVASIONS, V13, P1457, DOI 10.1007/s10530-010-9906-5; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Plotkin M, 2010, NATURWISSENSCHAFTEN, V97, P1067, DOI 10.1007/s00114-010-0728-1; R Development Core Team, 2008, R LANG ENV STAT COMP; Rehage JS, 2009, ETHOLOGY, V115, P1046, DOI 10.1111/j.1439-0310.2009.01694.x; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rome Q, 2010, ATLAS BIODIVERSITY R, P11; Roy HE, 2011, BIOCONTROL, V56, P477, DOI 10.1007/s10526-011-9355-9; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schaber M, 2011, BIOL INVASIONS, V13, P2647, DOI 10.1007/s10530-011-9936-7; Short J, 2002, BIOL CONSERV, V103, P283, DOI 10.1016/S0006-3207(01)00139-2; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sileshi G, 2006, B ENTOMOL RES, V96, P479, DOI 10.1079/BER2006449; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Spradbery JP, 1973, WASPS ACCOUNT BIOL N; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, NATURWISSENSCHAFTEN, V100, P245, DOI 10.1007/s00114-013-1019-4; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; ter Hofstede HM, 2008, BEHAV ECOL SOCIOBIOL, V63, P217, DOI 10.1007/s00265-008-0652-y; Turner AM, 2006, ANIM BEHAV, V72, P1443, DOI 10.1016/j.anbehav.2006.05.010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volynchik S, 2008, PHOTOCHEM PHOTOBIOL, V84, P81, DOI 10.1111/j.1751-1097.2007.00198.x; Wilson EE, 2009, P NATL ACAD SCI USA, V106, P12809, DOI 10.1073/pnas.0902979106; ZARET TM, 1973, SCIENCE, V182, P449, DOI 10.1126/science.182.4111.449	79	51	54	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66492	10.1371/journal.pone.0066492	http://dx.doi.org/10.1371/journal.pone.0066492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823754	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400118
J	Sanchez-Catasus, CA; Cabrera-Gomez, J; Melian, WA; Benitez, JLG; Rojas, RR; Bayard, JB; Galan, L; Sanchez, RG; Fuentes, NP; Valdes-Sosa, P				Sanchez-Catasus, Carlos A.; Cabrera-Gomez, Jose; Almaguer Melian, William; Giroud Benitez, Jose Luis; Rodriguez Rojas, Rafael; Bosch Bayard, Jorge; Galan, Lidice; Galvizu Sanchez, Reinaldo; Pavon Fuentes, Nancy; Valdes-Sosa, Pedro			Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CLINICAL-COURSE; MATTER DAMAGE; MRI; AQUAPORIN-4; DEMYELINATION; PATHOGENESIS; DISTINCTION; MORPHOMETRY; IMPAIRMENT	Recent neuroimaging studies show that brain abnormalities in neuromyelitis optica (NMO) are more frequent than earlier described. Yet, more research considering multiple aspects of NMO is necessary to better understand these abnormalities. A clinical feature of relapsing NMO (RNMO) is that the incremental disability is attack-related. Therefore, association between the attack-related process and neuroimaging might be expected. On the other hand, the immunopathological analysis of NMO lesions has suggested that CNS microvasculature could be an early disease target, which could alter brain perfusion. Brain tissue volume changes accompanying perfusion alteration could also be expected throughout the attack-related process. The aim of this study was to investigate in RNMO patients, by voxel-based correlation analysis, the assumed associations between regional brain white (WMV) and grey matter volumes (GMV) and/or perfusion on one side, and the number of optic neuritis (ON) attacks, myelitis attacks and/or total attacks on the other side. For this purpose, high resolution T1-weighted MRI and perfusion SPECT imaging were obtained in 15 RNMO patients. The results showed negative regional correlations of WMV, GMV and perfusion with the number of ON attacks, involving important components of the visual system, which could be relevant for the comprehension of incremental visual disability in RNMO. We also found positive regional correlation of perfusion with the number of ON attacks, mostly overlapping the brain area where the WMV showed negative correlation. This provides evidence that brain microvasculature is an early disease target and suggests that perfusion alteration could be important in the development of brain structural abnormalities in RNMO.	[Sanchez-Catasus, Carlos A.; Cabrera-Gomez, Jose; Almaguer Melian, William; Rodriguez Rojas, Rafael; Galvizu Sanchez, Reinaldo; Pavon Fuentes, Nancy] Ctr Neurol Restorat, Havana, Cuba; [Giroud Benitez, Jose Luis] Salvador Allende Hosp, Havana, Cuba; [Sanchez-Catasus, Carlos A.; Bosch Bayard, Jorge; Galan, Lidice; Valdes-Sosa, Pedro] Cuban Neurosci Ctr, Havana, Cuba		Sanchez-Catasus, CA (corresponding author), Ctr Neurol Restorat, Havana, Cuba.	casanchezcatasus@gmail.com	Bosch-Bayard, Jorge F/L-3295-2015; Rodriguez-Rojas, Rafael/ABC-2361-2020; Valdes-Sosa, Pedro A./AFT-6873-2022; Rodriguez-Rojas, Rafael/B-2759-2017	Bosch-Bayard, Jorge F/0000-0001-7168-5551; Valdes-Sosa, Pedro A./0000-0001-5485-2661; Rodriguez-Rojas, Rafael/0000-0002-2903-199X; Sanchez Catasus, Carlos Alfredo/0000-0002-0411-2961	Center for Neurological Restoration; Cuban Neuroscience Center from Havana, Cuba	Center for Neurological Restoration; Cuban Neuroscience Center from Havana, Cuba	This study was supported by the Center for Neurological Restoration and the Cuban Neuroscience Center from Havana, Cuba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnett MH, 2012, CURR OPIN NEUROL, V25, P215, DOI 10.1097/WCO.0b013e3283533a3f; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; Cabrera-Gomez JA, 2012, EUR J NEUROL, V19, P812, DOI 10.1111/j.1468-1331.2011.03565.x; Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Kiebel SJ, 2004, HUMAN BRAIN FUNCTION, P725; Kim JE, 2011, J NEUROL SCI, V302, P43, DOI 10.1016/j.jns.2010.12.001; Kister I, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/398259; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Lu ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022766; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Pfueller CF, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/869814; Pfueller CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018019; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Popescu BFG, 2010, NEUROLOGY, V75, P2103, DOI 10.1212/WNL.0b013e318200d80c; Quarantelli M, 2004, J NUCL MED, V45, P192; Rizzo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050230; Rocca MA, 2004, NEUROIMAGE, V21, P1061, DOI 10.1016/j.neuroimage.2003.10.013; Rocca MA, 2004, NEUROLOGY, V62, P476, DOI 10.1212/01.WNL.0000106946.08741.41; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Simon JH, 2006, AM J NEURORADIOL, V27, P455; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Waschbisch Anne, 2011, Exp Transl Stroke Med, V3, P7, DOI 10.1186/2040-7378-3-7; Waters P, 2008, Int MS J, V15, P99; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wuerfel J, 2007, J NEUROL SCI, V259, P16, DOI 10.1016/j.jns.2007.02.011; Wuerfel JT, 2012, PLOS ONE, V6, DOI [10.1371/journal.pone.0036847, DOI 10.1371/J0URNAL.P0NE.0036847]; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075; Zhao DD, 2012, NEUROIMAGE, V59, P3173, DOI 10.1016/j.neuroimage.2011.11.022; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	55	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66271	10.1371/journal.pone.0066271	http://dx.doi.org/10.1371/journal.pone.0066271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824339	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400076
J	Xiong, YN; Zhang, M; Hong, Y; Wei, MM; Ai, DZ; Meng, PP; Han, YH; Fu, ZQ; Shi, YJ; Yang, JM; Lin, JJ				Xiong, Yanian; Zhang, Ming; Hong, Yang; Wei, Meimei; Ai, Dezhou; Meng, Peipei; Han, Yanhui; Fu, Zhiqiang; Shi, Yaojun; Yang, Jianmei; Lin, Jiaojiao			Characterization Analysis of Schistosoma japonicum Plasma Membrane Repair Relative Gene Myoferlin	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFECTION; MANSONI; PROTEIN; EXPRESSION; FUSION; MICE	Myoferlin is a member of the ferlin family of proteins, which are involved in plasma membrane repair, and has been identified as one of the tegument proteins of Schistosoma japonicum. The tegument proteins are potential candidates for vaccines and new drug targets. In this study, myoferlin of S. japonicum (SjMF) was cloned, expressed and characterized, the potential of SjMF recombinant protein (rSjMF) as a vaccine candidate was evaluated, and the effect of praziquantel on SjMF was detected by Real-time PCR. Immunofluorescence showed that this protein was mainly distributed on the surface of worms at different stages. Sequence analysis revealed that the SjMF open reading frame was conserved at all stages of the S. japonicum life cycle. And SjMF transcription was upregulated in 42-day-old worms, and was significantly higher in female worms. Western blotting revealed that rSjMF showed strong immunogenicity. The cytokine profile and IgG isotype analysis demonstrated that rSjMF plus ISA206 immunization induced a mixed T helper (Th)1/Th2 response. Purified rSjMF emulsified with ISA206 adjuvant significantly reduced worm burden from 21.8% to 23.21% and liver egg number from42.58% to 28.35%. Besides, SjMF transcription was downregulated when worms were exposed to low-dose praziquantel (PZQ) and upregulated when PZQ was degraded, accompanied by recovery of damaged tegument. When worms were exposed to high-dose PZQ, SjMF transcription was downregulated all the time and the damaged tegument did not recover. These findings indicated that SjMF is a potential vaccine against S. japonicum and provides the basis for further investigations into the biological function of SjMF.	[Xiong, Yanian; Zhang, Ming; Hong, Yang; Wei, Meimei; Ai, Dezhou; Meng, Peipei; Han, Yanhui; Fu, Zhiqiang; Shi, Yaojun; Yang, Jianmei; Lin, Jiaojiao] Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Shanghai Vet Res Inst,Minist Agr, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Lin, JJ (corresponding author), Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Shanghai Vet Res Inst,Minist Agr, Shanghai, Peoples R China.	JJlin@shvri.ac.cn			National Natural Science Foundation of China [31172315]; Agro-scientific Research in the Public Interest [200903036]; China Postdoctoral Science Foundation [2012M510630]; Science Technology and Development Foundation of Shanghai [12140902700]; State-level public welfare scientific research courtyard basic scientific research operation cost [2013JB18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science Technology and Development Foundation of Shanghai; State-level public welfare scientific research courtyard basic scientific research operation cost	This work was supported by the National Natural Science Foundation of China (no. 31172315), Agro-scientific Research in the Public Interest (200903036), China Postdoctoral Science Foundation (No. 2012M510630), Science Technology and Development Foundation of Shanghai (no. 12140902700) and State-level public welfare scientific research courtyard basic scientific research operation cost (2013JB18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caffrey CR, 2011, CURR OPIN INFECT DIS, V24, P410, DOI 10.1097/QCO.0b013e328349156f; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Carod AF, 2012, CURR NEUROL NEUROSCI, V5, P1420; COFFMAN RL, 1986, J IMMUNOL, V136, P949; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Demonbreun AR, 2010, J CELL SCI, V123, P2413, DOI 10.1242/jcs.065375; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HE YX, 1980, ACTA ZOOL SINICA, V26, P32; Hong Y, 2010, EXP PARASITOL, V126, P517, DOI 10.1016/j.exppara.2010.06.029; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Robinson JM, 2010, 4D ELECT MICROSCOPYI; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Xiao SH, 1996, ACTA PHARMACOL SIN, V17, P535	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66396	10.1371/journal.pone.0066396	http://dx.doi.org/10.1371/journal.pone.0066396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823740	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400102
J	Harmancey, R; Vasquez, HG; Guthrie, PH; Taegtmeyer, H				Harmancey, Romain; Vasquez, Hernan G.; Guthrie, Patrick H.; Taegtmeyer, Heinrich			Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart	FASEB JOURNAL			English	Article						high-sucrose diet; myocardial metabolism; type 2 diabetes; cardiac function; uncoupling proteins	ACUTE MYOCARDIAL-INFARCTION; ACTIVATED RECEPTOR-ALPHA; UNCOUPLING PROTEIN-3; DIABETES-MELLITUS; SKELETAL-MUSCLE; REPERFUSION; SUBSTRATE; ISCHEMIA; GLUCOSE; UCP3	Diabetic patients with acute myocardial infarction are more likely to die than nondiabetic patients. In the present study we examined the effect of insulin resistance on myocardial ischemia tolerance. Hearts of rats, rendered insulin resistant by high-sucrose feeding, were subjected to ischemia/reperfusion ex vivo. Cardiac power of control hearts from chow-fed rats recovered to 93%, while insulin-resistant hearts recovered only to 80% (P<0.001 vs. control). Unexpectedly, impaired contractile recovery did not result from an impairment of glucose oxidation (576 +/- 36 vs. 593 +/- 42 nmol/min/g dry weight; not significant), but from a failure to increase and to sustain oxidation of the long-chain fatty acid oleate on reperfusion (1878 +/- 56 vs. 2070 +/- 67 nmol/min/g dry weight; P<0.05). This phenomenon was due to a reduced ability to transport oleate into mitochondria and associated with a 38-58% decrease in the mitochondrial uncoupling protein 3 (UCP3) levels. Contractile function was rescued by replacing oleate with a medium-chain fatty acid or by restoring UCP3 levels with 24 h of food withdrawal. Lastly, the knockdown of UCP3 in rat L6 myocytes also decreased oleate oxidation by 13-18% following ischemia. Together the results expose UCP3 as a critical regulator of long-chain fatty acid oxidation in the stressed heart postischemia and identify octanoate as an intervention by which myocardial metabolism can be manipulated to improve function of the insulin-resistant heart.Harmancey, R., Vasquez, H. G., Guthrie, P. H., Taegtmeyer, H. Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart.	[Harmancey, Romain; Vasquez, Hernan G.; Guthrie, Patrick H.; Taegtmeyer, Heinrich] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Cardiol, Univ Texas Med Sch Houston, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Taegtmeyer, H (corresponding author), Univ Texas Med Sch Houston, 6431 Fannin,MSB 1-246, Houston, TX 77030 USA.	heinrich.taegtmeyer@uth.tmc.edu			U.S. National Institutes of Health (NIH) [R01-HL-061483]; NIH [P30 DK-079638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Roxy Tate for editorial assistance. This work was supported by U.S. National Institutes of Health (NIH) grant R01-HL-061483 to H.T. The Mouse Metabolism Core at the Baylor College of Medicine Diabetes Research Center (Houston, TX, USA) is supported by NIH grant P30 DK-079638.	Adel W, 2010, INT J ANGIOL, V19, pE78, DOI 10.1055/s-0031-1278373; Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boudina S, 2012, DIABETES, V61, P3260, DOI 10.2337/db12-0063; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Cook SA, 2010, EUR HEART J, V31, P100, DOI 10.1093/eurheartj/ehp396; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; Goodwin GW, 1998, AM J PHYSIOL-HEART C, V274, pH1239, DOI 10.1152/ajpheart.1998.274.4.H1239; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harjai KJ, 2003, AM J CARDIOL, V91, P1041, DOI 10.1016/S0002-9149(03)00145-0; Harmancey R, 2012, FASEB J, V26, P3118, DOI 10.1096/fj.12-208991; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Hidaka S, 1999, DIABETES, V48, P430, DOI 10.2337/diabetes.48.2.430; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Iozzo P, 2002, DIABETES, V51, P3020, DOI 10.2337/diabetes.51.10.3020; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Longnus SL, 2001, AM J PHYSIOL-HEART C, V281, pH1561, DOI 10.1152/ajpheart.2001.281.4.H1561; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mak KH, 2000, J AM COLL CARDIOL, V35, P563, DOI 10.1016/S0735-1097(99)00628-2; Marso SP, 2007, AM J CARDIOL, V100, P206, DOI 10.1016/j.amjcard.2007.02.080; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; MORROW RJ, 1973, P SOC EXP BIOL MED, V142, P223; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; SADDIK M, 1992, J BIOL CHEM, V267, P3825; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Schrauwen P, 2001, DIABETES, V50, P2870, DOI 10.2337/diabetes.50.12.2870; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Sena S, 2009, J MOL CELL CARDIOL, V46, P910, DOI 10.1016/j.yjmcc.2009.02.014; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com; Zhu Y, 2013, MOL ENDOCRINOL, V27, P172, DOI 10.1210/me.2012-1210	39	43	46	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3966	3978		10.1096/fj.13-234914	http://dx.doi.org/10.1096/fj.13-234914			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825227	Green Published			2022-12-25	WOS:000329747100012
J	Dai, YN; Chi, CB; Zhou, K; Cheng, W; Jiang, YL; Ren, YM; Ruan, K; Chen, YX; Zhou, CZ				Dai, Ya-Nan; Chi, Chang-Biao; Zhou, Kang; Cheng, Wang; Jiang, Yong-Liang; Ren, Yan-Min; Ruan, Ke; Chen, Yuxing; Zhou, Cong-Zhao			Structure and Catalytic Mechanism of Yeast 4-Amino-4-deoxychorismate Lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-AMINOBENZOIC ACID; ESCHERICHIA-COLI; AMINODEOXYCHORISMATE LYASE; COENZYME Q(10); GENE; BIOSYNTHESIS; SYNTHASE; PURIFICATION; EVOLUTION; ENCODES	Saccharomyces cerevisiae Abz2 is a pyridoxal 5'-phosphate (PLP)-dependent lyase that converts 4-amino-4-deoxychorismate (ADC) to para-aminobenzoate and pyruvate. To investigate the catalytic mechanism, we determined the 1.9 angstrom resolution crystal structure of Abz2 complexed with PLP, representing the first eukaryotic ADC lyase structure. Unlike Escherichia coli ADClyase, whose dimerization is critical to the formation of the active site, the overall structure of Abz2 displays as a monomer of two domains. At the interdomain cleft, a molecule of cofactor PLP forms a Schiff base with residue Lys-251. Computational simulations defined a basic clamp to orientate the substrate ADC in a proper pose, which was validated by site-directed mutageneses combined with enzymatic activity assays. Altogether, we propose a putative catalytic mechanism of a unique class of monomeric ADC lyases led by yeast Abz2.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014; Zhou, Kang/ABH-7206-2020; Ruan, Ke/N-1995-2013	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Zhou, Kang/0000-0002-3034-2808; Jiang, YongLiang/0000-0001-5441-4936; Ruan, Ke/0000-0001-9358-0451	Ministry of Science and Technology of China [2012CB911000]; National Natural Science Foundation of China [31170695]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Project 2012CB911000 and National Natural Science Foundation of China Grant 31170695.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basset GJC, 2004, PLANT J, V40, P453, DOI 10.1111/j.1365-313X.2004.02231.x; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Chang Z, 2001, MICROBIOL-SGM, V147, P2113, DOI 10.1099/00221287-147-8-2113; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; CRIADO LM, 1993, GENE, V126, P135, DOI 10.1016/0378-1119(93)90602-Y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EDMAN JC, 1993, YEAST, V9, P669, DOI 10.1002/yea.320090613; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; GREEN JM, 1991, J BIOL CHEM, V266, P12971; GREEN JM, 1992, J BACTERIOL, V174, P5317, DOI 10.1128/JB.174.16.5317-5323.1992; James TY, 2002, J BASIC MICROB, V42, P91, DOI 10.1002/1521-4028(200205)42:2<91::AID-JOBM91>3.0.CO;2-8; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2000, J BIOCHEM, V128, P29, DOI 10.1093/oxfordjournals.jbchem.a022727; NICHOLS BP, 1989, J BIOL CHEM, V264, P8597; O'Rourke PEF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024158; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Ortega RM, 1997, AM J CLIN NUTR, V66, P803; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2009, ACTA CRYSTALLOGR F, V65, P1234, DOI 10.1107/S1744309109050052; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Schadt HS, 2009, J AM CHEM SOC, V131, P3481, DOI 10.1021/ja809283u; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Triglia T, 1999, EXP PARASITOL, V92, P154, DOI 10.1006/expr.1999.4400; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; YE QZ, 1990, P NATL ACAD SCI USA, V87, P9391, DOI 10.1073/pnas.87.23.9391; Zhang YR, 2009, MICROBIOL-SGM, V155, P2450, DOI 10.1099/mic.0.026336-0	42	4	4	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22985	22992		10.1074/jbc.M113.480335	http://dx.doi.org/10.1074/jbc.M113.480335			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23818518	hybrid, Green Published			2022-12-25	WOS:000330598200009
J	Ingleby, FC; Hunt, J; Hosken, DJ				Ingleby, Fiona C.; Hunt, John; Hosken, David J.			Genotype-by-Environment Interactions for Female Mate Choice of Male Cuticular Hydrocarbons in Drosophila simulans	PLOS ONE			English	Article							SEXUAL SELECTION; CONDITION-DEPENDENCE; COURTSHIP BEHAVIOR; GENETIC VARIANCE; EVOLUTION; ATTRACTIVENESS; PREFERENCES; PLASTICITY; EXPRESSION; FITNESS	Recent research has highlighted the potential importance of environmental and genotype-by-environment (GxE) variation in sexual selection, but most studies have focussed on the expression of male sexual traits. Consequently, our understanding of genetic variation for plasticity in female mate choice is extremely poor. In this study we examine the genetics of female mate choice in Drosophila simulans using isolines reared across two post-eclosion temperatures. There was evidence for GxEs in female choosiness and preference, which suggests that the evolution of female mate choice behaviour could differ across environments. However, the ranked order of preferred males was consistent across females and environments, so the same males are favoured by mate choice in spite of GxEs. Our study highlights the importance of taking cross-environment perspectives in order to gain a more comprehensive understanding of the operation of sexual selection.	[Ingleby, Fiona C.; Hunt, John; Hosken, David J.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Tremough, Penryn, England; [Ingleby, Fiona C.] Univ Sussex, Brighton, E Sussex, England	University of Exeter; University of Sussex	Hosken, DJ (corresponding author), Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Cornwall Campus, Tremough, Penryn, England.	D.J.Hosken@exeter.ac.uk	Ingleby, Fiona C/C-4271-2014; Hunt, John/F-1279-2014	Hunt, John/0000-0002-4962-8750; Ingleby, Fiona/0000-0003-1800-2015	Association for the Study of Animal Behaviour; ESF; NERC; Royal Society; Natural Environment Research Council [NE/G005303/1] Funding Source: researchfish; NERC [NE/G005303/1] Funding Source: UKRI	Association for the Study of Animal Behaviour; ESF(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Association for the Study of Animal Behaviour (DJH), the ESF and NERC (DJH and JH), and a Royal Society Fellowship and Equipment grant (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arienti M, 2010, INTEGR ZOOL, V5, P272, DOI 10.1111/j.1749-4877.2010.00213.x; Avent TD, 2008, ANIM BEHAV, V75, P1413, DOI 10.1016/j.anbehav.2007.09.015; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; Barth M, 1997, ANIM BEHAV, V53, P25, DOI 10.1006/anbe.1996.0275; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Danielson-Francois AM, 2006, J EVOLUTION BIOL, V19, P532, DOI 10.1111/j.1420-9101.2005.01006.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Delcourt M, 2010, EVOLUTION, V64, P2758, DOI 10.1111/j.1558-5646.2010.01031.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P325, DOI 10.1017/CBO9780511711909.016; Gosden TP, 2011, J EVOLUTION BIOL, V24, P685, DOI 10.1111/j.1420-9101.2010.02205.x; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; Higginson AD, 2009, P ROY SOC B-BIOL SCI, V276, P1153, DOI 10.1098/rspb.2008.1592; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hosken DJ, 2011, CURR BIOL, V21, pR62, DOI 10.1016/j.cub.2010.11.053; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P311, DOI 10.1111/jeb.12045; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P94, DOI 10.1111/jeb.12030; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jia FY, 2000, EVOLUTION, V54, P953; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kokko H, 2008, GENETICA, V134, P55, DOI 10.1007/s10709-008-9249-7; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Lewandowski E, 2008, BIOL J LINN SOC, V94, P663, DOI 10.1111/j.1095-8312.2008.01021.x; Lynch M., 1998, GENETICS ANAL QUANTI; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Miller LK, 2005, EVOLUTION, V59, P2414; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Narraway C, 2010, J EVOLUTION BIOL, V23, P2550, DOI 10.1111/j.1420-9101.2010.02113.x; O'Donald P, 1979, GENETIC MODELS SEXUA; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Rodriguez RL, 2011, GENETICA, V139, P871, DOI 10.1007/s10709-011-9591-z; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Sharma MD, 2012, EVOLUTION, V106, P295; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Tolle AE, 2011, EVOLUTION, V65, P283, DOI 10.1111/j.1558-5646.2010.01123.x; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Zhou YH, 2011, EVOL ECOL, V25, P307, DOI 10.1007/s10682-010-9421-2	45	25	25	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67623	10.1371/journal.pone.0067623	http://dx.doi.org/10.1371/journal.pone.0067623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825675	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000111
J	Liu, XQ; Gao, RF; Chen, XM; Zhang, HL; Zheng, AS; Yang, DH; Ding, YB; Wang, YX; He, JL				Liu, Xueqing; Gao, Rufei; Chen, Xuemei; Zhang, Hailing; Zheng, Anshun; Yang, Dehui; Ding, Yubin; Wang, Yingxiong; He, Junlin			Possible Roles of mmu-miR-141 in the Endometrium of Mice in Early Pregnancy Following Embryo Implantation	PLOS ONE			English	Article							MAMMALIAN MICRORNAS; PTEN EXPRESSION; GENE-EXPRESSION; PROSTATE-CANCER; CARCINOMA; PROLIFERATION; APOPTOSIS; DECIDUALIZATION; POLYPLOIDY; PATTERNS	Objective: Embryo implantation is directly affected by genes related to uterine receptivity. Studies have demonstrated the important roles of miRNAs in the regulation of gene expression. Our early miRNA chip analyses revealed that the mmu-miR-141 expression in endometrial tissue is lower after embryo implantation than before it. However, the possible roles of miR-141 in embryo implantation have not yet been elucidated. Here, mmu-miR-141 was designed to detect the expression and role of miR-141 in the endometria of mice in early pregnancy following embryo implantation. Methods: Real-time PCR and in-situ hybridization were used to study mmu-miR-141 expression in mouse uterus. Cell proliferation was detected by tetrazolium dye (MTT) assay and flow cytometry. Real-time PCR and Western blot analysis were used to confirm the mRNA and protein levels of phosphatase and tensin homolog (PTEN) to determine whether it was the target gene of mmu-miR-141. Enhanced green fluorescent protein (EGFP) fluorescence reporter vector analysis was also performed. A functional study was performed by injecting mice uteri with mmu-miR-141 inhibitor or mimic vectors. Results: mmu-miR-141 expression was lower on day 6 (D6) than day 4 (D4) and could be increased by progesterone. Reduced mmu-miR-141 could decrease the proliferation activity of stromal cells and promote apoptosis. Upregulation of mmu-miR-141 inhibited PTEN protein expression but downregulation of mmu-miR-141 increased it, while the mRNA level remained unchanged. EGFP fluorescence reporter vector analysis showed that miR-141 targets the 39-untranslated region of the PTEN mRNA. In addition, when the physiological mmu-miR-141 level was altered on D2 by injecting with inhibitor or mimic, the embryo implantation sites were significantly decreased on D7. Conclusions: This study demonstrated that mmu-miR-141 might influence cell proliferation and apoptosis in the endometrium by negatively regulating PTEN expression, and could also influence the number of embryo implantation sites. mmu-miR-141 plays an essential role in embryo implantation.	[Liu, Xueqing; Gao, Rufei; Chen, Xuemei; Zhang, Hailing; Zheng, Anshun; Yang, Dehui; Ding, Yubin; Wang, Yingxiong; He, Junlin] Chongqing Med Univ, Sch Publ Hlth, Reprod Biol Lab, Chongqing, Peoples R China	Chongqing Medical University	He, JL (corresponding author), Chongqing Med Univ, Sch Publ Hlth, Reprod Biol Lab, Chongqing, Peoples R China.	hejunlin_11@aliyun.com			National Natural Science Foundation of China [31071278]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31071278) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Altmae S, 2012, REPROD SCI; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chegini N, 2002, J REPROD IMMUNOL, V56, P93, DOI 10.1016/S0165-0378(02)00043-8; Chen H, 2010, J INT MED RES, V38, P1801, DOI 10.1177/147323001003800527; Chen Xiao-Ling, 2008, Shengli Xuebao, V60, P119; Correia-da-Silva G, 2004, PLACENTA, V25, P538, DOI 10.1016/j.placenta.2003.11.007; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Fassan M, 2011, VIRCHOWS ARCH, V458, P413, DOI 10.1007/s00428-011-1046-5; Gao QL, 2009, J HUAZHONG U SCI-MED, V29, P59, DOI 10.1007/s11596-009-0112-6; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZZ, 2009, CHINESE J CELL BIOL, V31, P848; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Morales-Prieto DM, 2011, AM J REPROD IMMUNOL, V66, P57, DOI 10.1111/j.1600-0897.2011.01037.x; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Quenby S, 2007, REPROD BIOMED ONLINE, V14, P224, DOI 10.1016/S1472-6483(10)60791-2; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Veillette A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107136; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	38	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67382	10.1371/journal.pone.0067382	http://dx.doi.org/10.1371/journal.pone.0067382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825654	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000097
J	Muller, TA; Yu, KF; Hausinger, RP; Meek, K				Mueller, Tina A.; Yu, Kefei; Hausinger, Robert P.; Meek, Katheryn			ALKBH1 Is Dispensable for Abasic Site Cleavage during Base Excision Repair and Class Switch Recombination	PLOS ONE			English	Article							DNA-DAMAGE; OXIDATIVE DEMETHYLATION; LYASE ACTIVITY; AID; PROTEIN; GENE; ENDONUCLEASE; ACCUMULATION; DEAMINATION; DEFICIENT	Potential roles of the abasic site lyase activity associated with AlkB homolog 1 (ALKBH1) were assessed by studies focusing on the two cellular processes that create abasic sites as intermediates: base excision repair and class switch recombination. Alkbh1(-/-) pups (lacking exon 3) were born at a lower than expected frequency from heterozygous parents, suggesting a reduced survival rate and non-Mendelian inheritance, and they exhibited a gender bias in favor of males (70% males and 30% females). To study ALKBH1's potential involvement in DNA repair, fibroblasts were isolated from Alkbh1(-/-) mice, spontaneously immortalized and tested for resistance to DNA damaging agents. Alkbh1(-/-) and isogenic cells expressing hALKBH1 showed no difference in survival to the DNA damaging agents methyl-methionine sulfate or H2O2. This result indicates that ALKBH1 does not play a major role in the base excision repair pathway. To assess ALKBH1's role in class switch recombination, splenic B cells were isolated from Alkbh1(-/-) and Alkbh1(+/+) mice and subjected to switching from IgM to IgG1. No differences were found in IgG1 switching, suggesting that Alkbh1 is not involved in class switch recombination of the immunoglobulin heavy chain during B lymphocyte activation.	[Mueller, Tina A.; Yu, Kefei; Hausinger, Robert P.; Meek, Katheryn] Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Muller, TA (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	tmueller@msu.edu		Hausinger, Robert/0000-0002-3643-2054	National Institutes of Health [5R21AI79430-2, GM063582, AI048758]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079430, R01AI048758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063582, R01GM063584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (5R21AI79430-2 to T. A. M., GM063582 to R. P. H. and AI048758 to K. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Muller TA, 2010, DNA REPAIR, V9, P58, DOI 10.1016/j.dnarep.2009.10.011; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459; Ougland R, 2012, STEM CELLS; Pan Z, 2008, DEV DYN, V237; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Piersen CE, 2000, MUTAT RES-DNA REPAIR, V459, P43, DOI 10.1016/S0921-8777(99)00054-3; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; van Oers JMM, 2010, P NATL ACAD SCI USA, V107, P13384, DOI 10.1073/pnas.1008589107; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	44	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67403	10.1371/journal.pone.0067403	http://dx.doi.org/10.1371/journal.pone.0067403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825659	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000102
J	Na, R; Wu, YS; Xu, JF; Jiang, HW; Ding, Q				Na, Rong; Wu, Yishuo; Xu, Jianfeng; Jiang, Haowen; Ding, Qiang			Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population	PLOS ONE			English	Article							REFERENCE RANGES; CANCER INCIDENCE; TOTAL PSA; MEN; ESTABLISHMENT; TRENDS	Background: Age-specific prostate specific antigen (PSA) cutoffs for prostate biopsy have been widely used in the USA and European countries. However, the application of age-specific PSA remains poorly understood in China. Methods: Between 2003 and 2012, 1,848 men over the age of 40, underwent prostate biopsy for prostate cancer (PCa) at Huashan Hospital, Shanghai, China. Clinical information and blood samples were collected prior to biopsy for each patient. Men were divided into three age groups (<= 60, 61 to 80, and >80) for analyses. Digital rectal examination (DRE), transrectal ultrasound (prostate volume and nodule), total PSA (tPSA), and free PSA (fPSA) were also included in the analyses. Logistic regression was used to build the multi-variate model. Results: Serum tPSA levels were age-dependent (P = 0.008), while %fPSA (P = 0.051) and PSAD (P = 0.284) were age-independent. At a specificity of 80%, the sensitivities for predicting PCa were 83%, 71% and 68% with tPSA cutoff values of 19.0 ng/mL (age <= 60), 21.0 ng/mL (age 61-80), and 23.0 ng/mL (age >= 81). Also, sensitivities at the same tPSA levels were able to reach relatively high levels (70%-88%) for predicting high-grade PCa. Area (AUC) under the receive operating curves (ROCs) of tPSA, %fPSA, PSAD and multi-variate model were different in age groups. When predicting PCa, the AUC of tPSA, % fPSA, PSAD and multi-variate model were 0.90, 0.57, 0.93 and 0.87 respectively in men <= 60 yr; 0.82, 0.70, 0.88 and 0.86 respectively in men 61-80 yr; 0.79, 0.78, 0.87 and 0.88 respectively in men>80 yr. When predicting Gleason Score >= 7 or 8 PCa, there were no significant differences between AUCs of each variable. Conclusion: Age-specific PSA cutoff values for prostate biopsy should be considered in the Chinese population. Indications for prostate biopsies (tPSA, % fPSA and PSAD) should be considered based on age in the Chinese population.	[Na, Rong; Wu, Yishuo; Xu, Jianfeng; Jiang, Haowen; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Na, Rong; Wu, Yishuo; Xu, Jianfeng; Jiang, Haowen; Ding, Qiang] Fudan Univ, Urol Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Fudan University	Jiang, HW (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	haowenj@yahoo.com; qiangd.urol@gmail.com	Na, Rong/AAN-8655-2021	Na, Rong/0000-0001-7470-5108				Aus G, 2001, EUR UROL, V40, P97, DOI 10.1159/000049758; Carter HB, 2004, JNCI-J NATL CANCER I, V96, P557, DOI 10.1093/jnci/djh111; Draisma G, 2006, INT J CANCER, V119, P2366, DOI 10.1002/ijc.22158; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitzpatrick JM, 2009, BJU INT, V103, P578, DOI 10.1111/j.1464-410X.2009.08345.x; Galen R S, 1982, Clin Lab Med, V2, P685; Guan Meng, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P586; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalish LA, 1999, UROLOGY, V54, P1022, DOI 10.1016/S0090-4295(99)00349-0; Kao CH, 1997, ANTICANCER RES, V17, P1361; Lein M, 1998, BRIT J UROL, V82, P231; Liu ZY, 2009, ASIAN J ANDROL, V11, P100, DOI 10.1038/aja.2008.17; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; Na R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049914; O'Dowd GJ, 2000, UROLOGY, V55, P553, DOI 10.1016/S0090-4295(00)00447-7; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2; Orozco R, 1998, UROLOGY, V51, P186, DOI 10.1016/S0090-4295(97)00620-1; Park Jae, 2003, Clin Prostate Cancer, V2, P173, DOI 10.3816/CGC.2003.n.026; Partin AW, 1996, J UROLOGY, V155, P1336, DOI 10.1016/S0022-5347(01)66260-8; Presti JC, 2003, J UROLOGY, V169, P125, DOI 10.1016/S0022-5347(05)64051-7; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Veltri RW, 2002, UROLOGY, V60, P47, DOI 10.1016/S0090-4295(02)01695-3; Wolf JS, 2012, J UROLOGY, V188, P2454, DOI 10.1016/j.juro.2012.10.010; Ye DW, 2007, CHINA ONCOLOGY, V17, P4	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67585	10.1371/journal.pone.0067585	http://dx.doi.org/10.1371/journal.pone.0067585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825670	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000108
J	Sakai, H; Uchiyama, Y; Shin, D; Hayashi, MJ; Sadato, N				Sakai, Hiroyuki; Uchiyama, Yuji; Shin, Duk; Hayashi, Masamichi J.; Sadato, Norihiro			Neural Activity Changes Associated with Impulsive Responding in the Sustained Attention to Response Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEFAULT NETWORK; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; ERROR-DETECTION; WORKING-MEMORY; BRAIN; INHIBITION; MIND; PERFORMANCE	Humans can anticipate and prepare for uncertainties to achieve a goal. However, it is difficult to maintain this effort over a prolonged period of time. Inappropriate behavior is impulsively (or mindlessly) activated by an external trigger, which can result in serious consequences such as traffic crashes. Thus, we examined the neural mechanisms underlying such impulsive responding using functional magnetic resonance imaging (fMRI). Twenty-two participants performed a block-designed sustained attention to response task (SART), where each task block was composed of consecutive Go trials followed by a NoGo trial at the end. This task configuration enabled us to measure compromised preparation for NoGo trials during Go responses using reduced Go reaction times. Accordingly, parametric modulation analysis was conducted on fMRI data using block-based mean Go reaction times as an online marker of impulsive responding in the SART. We found that activity in the right dorsolateral prefrontal cortex (DLPFC) and the bilateral intraparietal sulcus (IPS) was positively modulated with mean Go reaction times. In addition, activity in the medial prefrontal cortex (MPFC) and the posterior cingulate cortex (PCC) was negatively modulated with mean Go reaction times, albeit statistically weakly. Taken together, spontaneously reduced activity in the right DLPFC and the IPS and spontaneously elevated activity in the MPFC and the PCC were associated with impulsive responding in the SART. These results suggest that such a spontaneous transition of brain activity pattern results in impulsive responding in monotonous situations, which in turn, might cause human errors in actual work environments.	[Sakai, Hiroyuki; Uchiyama, Yuji] Toyota Cent Res & Dev Labs Inc, Frontier Res Ctr, Nagakute, Aichi 48011, Japan; [Shin, Duk] Toyota Technol Inst, Precis & Intelligence Lab, Yokohama, Kanagawa, Japan; [Hayashi, Masamichi J.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Hayashi, Masamichi J.] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Hayashi, Masamichi J.] UCL, Inst Cognit Neurosci, London, England; [Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan	Toyota Central R&D Labs Inc; Toyota Technological Institute; University of Helsinki; Aalto University; University of London; University College London; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Sakai, H (corresponding author), Toyota Cent Res & Dev Labs Inc, Frontier Res Ctr, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	sakai@mosk.tytlabs.co.jp	Shin, Duk/G-9620-2011; Uchiyama, Yuji/GVS-0186-2022	Uchiyama, Yuji/0000-0003-1581-8668; Sadato, Norihiro/0000-0002-9786-3907; Hayashi, Masamichi/0000-0003-2631-5177	Toyota Central Research and Development Laboratories, Inc.; Brain Research at Aalto University; University of Helsinki Consortium Postdoctoral Program	Toyota Central Research and Development Laboratories, Inc.; Brain Research at Aalto University; University of Helsinki Consortium Postdoctoral Program	This work was performed under the financial support of Toyota Central Research and Development Laboratories, Inc., which is funded by its stockholding companies (http://www.tytlabs.co.jp/english/comp/outline02.html). The fourth author (MJH) was supported by Brain Research at Aalto University and University of Helsinki Consortium Postdoctoral Program. The funders had no role in the study design, data collection and analysis and the decision to publish.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Jaffard M, 2007, BRAIN RES, V1179, P106, DOI 10.1016/j.brainres.2007.08.032; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Larson KE, 1997, ACCIDENT ANAL PREV, V88, P29; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reason J, 1995, Qual Health Care, V4, P80, DOI 10.1136/qshc.4.2.80; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sakai H, 2011, ERGONOMICS, V54, P146, DOI 10.1080/00140139.2010.538724; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zandbelt BB, 2012, HUM BRAIN MAPP, V22, P1479; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	52	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67391	10.1371/journal.pone.0067391	http://dx.doi.org/10.1371/journal.pone.0067391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825657	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000321223000100
J	Zhu, LX; Yan, ZQ; Zhang, ZJ; Zhou, QM; Zhou, JC; Wakeland, EK; Fang, XD; Xuan, ZY; Shen, DX; Li, QZ				Zhu, Lingxiang; Yan, Zhongqiang; Zhang, Zhaojun; Zhou, Qiming; Zhou, Jinchun; Wakeland, Edward K.; Fang, Xiangdong; Xuan, Zhenyu; Shen, Dingxia; Li, Quan-Zhen			Complete Genome Analysis of Three Acinetobacter baumannii Clinical Isolates in China for Insight into the Diversification of Drug Resistance Elements	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; IMIPENEM-RESISTANCE; CARBAPENEM RESISTANCE; IV SECRETION; RNA GENES; MDR-TJ; SEQUENCE; STRAIN; EPIDEMIOLOGY; EXPRESSION	Background: The emergence and rapid spreading of multidrug-resistant Acinetobacter baumannii strains has become a major health threat worldwide. To better understand the genetic recombination related with the acquisition of drug-resistant elements during bacterial infection, we performed complete genome analysis on three newly isolated multidrug-resistant A. baumannii strains from Beijing using next-generation sequencing technology. Methodologies/Principal Findings: Whole genome comparison revealed that all 3 strains share some common drug resistant elements including carbapenem-resistant bla(OXA-23) and tetracycline (tet) resistance islands, but the genome structures are diversified among strains. Various genomic islands intersperse on the genome with transposons and insertions, reflecting the recombination flexibility during the acquisition of the resistant elements. The blood-isolated BJAB07104 and ascites-isolated BJAB0868 exhibit high similarity on their genome structure with most of the global clone II strains, suggesting these two strains belong to the dominant outbreak strains prevalent worldwide. A large resistance island (RI) of about 121-kb, carrying a cluster of resistance-related genes, was inserted into the ATPase gene on BJAB07104 and BJAB0868 genomes. A 78-kb insertion element carrying tra-locus and bla(OXA-23) island, can be either inserted into one of the tniB gene in the 121-kb RI on the chromosome, or transformed to conjugative plasmid in the two BJAB strains. The third strains of this study, BJAB0715, which was isolated from spinal fluid, exhibit much more divergence compared with above two strains. It harbors multiple drug-resistance elements including a truncated AbaR-22-like RI on its genome. One of the unique features of this strain is that it carries both bla(OXA-23) and bla(OXA-58) genes on its genome. Besides, an Acinetobacter lwoffii adeABC efflux element was found inserted into the ATPase position in BJAB0715. Conclusions: Our comparative analysis on currently completed Acinetobacter baumannii genomes revealed extensive and dynamic genome organizations, which may facilitate the bacteria to acquire drug-resistance elements into their genomes.	[Zhu, Lingxiang; Zhou, Jinchun; Wakeland, Edward K.; Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA; [Zhu, Lingxiang; Zhang, Zhaojun; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yan, Zhongqiang; Shen, Dingxia] Peoples Liberat Army, Gen Hosp, Dept Clin Microbiol, Beijing, Peoples R China; [Zhou, Qiming] Chinese Acad Sci, State Key Lab Mycol, Beijing, Peoples R China; [Xuan, Zhenyu] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Xuan, Zhenyu] Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75083 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Xuan, ZY (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA.	zxx091000@utdallas.edu; shengdx301@yahoo.com; quan.li@utsouthwestern.edu		Xuan, Zhenyu/0000-0001-9344-8493; zhou, qi ming/0000-0002-2892-6329	Capital Medical Development Research Fund, Beijing, China [2009-1023]; UT Dallas start-up fund for ZYX; National Institutes of Health [P50 CORT AR055503, R03 AR055778]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055503, R03AR055778] Funding Source: NIH RePORTER	Capital Medical Development Research Fund, Beijing, China; UT Dallas start-up fund for ZYX; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Capital Medical Development Research Fund, Beijing, China (No. 2009-1023), UT Dallas start-up fund for ZYX and National Institutes of Health grants P50 CORT AR055503, R03 AR055778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bogaerts P, 2006, J CLIN MICROBIOL, V44, P4189, DOI 10.1128/JCM.00796-06; Bou G, 2000, ANTIMICROB AGENTS CH, V44, P1556, DOI 10.1128/AAC.44.6.1556-1561.2000; Calhoun JH, 2008, CLIN ORTHOP RELAT R, V466, P1356, DOI 10.1007/s11999-008-0212-9; Carvalho KR, 2009, INT J ANTIMICROB AG, V34, P25, DOI 10.1016/j.ijantimicag.2008.12.009; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen Chang-Hua, 2006, Journal of Microbiology Immunology and Infection, V39, P372; Chen CC, 2011, J BACTERIOL, V193, P2361, DOI 10.1128/JB.00244-11; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Domingues S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002837; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P117, DOI 10.1111/j.1469-0691.2006.01596.x; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gao F, 2011, J BACTERIOL, V193, P2365, DOI 10.1128/JB.00226-11; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hamidian M, 2011, J ANTIMICROB CHEMOTH, V66, P2484, DOI 10.1093/jac/dkr356; Harrison E, 2012, TRENDS MICROBIOL, V20, P262, DOI 10.1016/j.tim.2012.04.003; Heritier C, 2006, CLIN MICROBIOL INFEC, V12, P123, DOI 10.1111/j.1469-0691.2005.01320.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou PF, 2012, CHEMOTHERAPY, V58, P152, DOI 10.1159/000335599; Huang H, 2012, J ANTIMICROB CHEMOTH, V67, P2825, DOI 10.1093/jac/dks327; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Lin MF, 2011, J MICROBIOL IMMUNOL, V44, P39, DOI 10.1016/j.jmii.2011.01.008; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Lopes BS, 2012, J MED MICROBIOL, V61, P1103, DOI 10.1099/jmm.0.044156-0; Lopez-Otsoa F, 2002, J CLIN MICROBIOL, V40, P4741, DOI 10.1128/JCM.40.12.4741-4743.2002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Martinez JL, 2002, CLIN MICROBIOL REV, V15, P647, DOI 10.1128/CMR.15.4.647-679.2002; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Sahl JW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-291; Sambrook J, 2001, MOL CLONING LAB MANU; SCAIFE W, 1995, J ANTIMICROB CHEMOTH, V36, P585, DOI 10.1093/jac/36.3.585; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Soares SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030848; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Standards NCfCL, 2003, APPROVED STANDARD M2; Stoeva T, 2008, CLIN MICROBIOL INFEC, V14, P723, DOI 10.1111/j.1469-0691.2008.02018.x; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; VILA J, 1995, ANTIMICROB AGENTS CH, V39, P1201, DOI 10.1128/AAC.39.5.1201; Vila J, 1997, J ANTIMICROB CHEMOTH, V39, P757, DOI 10.1093/jac/39.6.757; Yan ZQ, 2010, INT J ANTIMICROB AG, V35, P269, DOI 10.1016/j.ijantimicag.2009.10.016; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zhou H, 2007, J MED MICROBIOL, V56, P1076, DOI 10.1099/jmm.0.47206-0; Zhou H, 2011, ANTIMICROB AGENTS CH, V55, P4506, DOI 10.1128/AAC.01134-10	75	53	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66584	10.1371/journal.pone.0066584	http://dx.doi.org/10.1371/journal.pone.0066584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826102	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400023
J	Rivas-Pardo, JA; Herrera-Morande, A; Castro-Fernandez, V; Fernandez, FJ; Vega, MC; Guixe, V				Andres Rivas-Pardo, Jaime; Herrera-Morande, Alejandra; Castro-Fernandez, Victor; Fernandez, Francisco J.; Cristina Vega, M.; Guixe, Victoria			Crystal Structure, SAXS and Kinetic Mechanism of Hyperthermophilic ADP-Dependent Glucokinase from Thermococcus litoralis Reveal a Conserved Mechanism for Catalysis	PLOS ONE			English	Article							RAY SOLUTION SCATTERING; CATION-PI INTERACTIONS; INDUCED-FIT; CONFORMATIONAL SELECTION; ADENOSINE KINASE; BINDING; PROTEINS; ENZYME; SPECIFICITY; ARCHAEA	ADP-dependent glucokinases represent a unique family of kinases that belong to the ribokinase superfamily, being present mainly in hyperthermophilic archaea. For these enzymes there is no agreement about the magnitude of the structural transitions associated with ligand binding and whether they are meaningful to the function of the enzyme. We used the ADP-dependent glucokinase from Termococcus litoralis as a model to investigate the conformational changes observed in Xray crystallographic structures upon substrate binding and to compare them with those determined in solution in order to understand their interplay with the glucokinase function. Initial velocity studies indicate that catalysis follows a sequential ordered mechanism that correlates with the structural transitions experienced by the enzyme in solution and in the crystal state. The combined data allowed us to resolve the open-closed conformational transition that accounts for the complete reaction cycle and to identify the corresponding clusters of aminoacids residues responsible for it. These results provide molecular bases for a general mechanism conserved across the ADP-dependent kinase family.	[Andres Rivas-Pardo, Jaime; Herrera-Morande, Alejandra; Castro-Fernandez, Victor; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Herrera-Morande, Alejandra; Fernandez, Francisco J.; Cristina Vega, M.] CSIC, Ctr Invest Biol, Madrid, Spain	Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Vega, MC (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	cvega@cib.csic.es; vguixe@uchile.cl	Guixe, Victoria/I-1126-2013; Castro-Fernandez, Victor/K-9621-2018; Fernandez, Francisco J./C-3647-2011; Vega, M. Cristina/C-3640-2011	Guixe, Victoria/0000-0001-9643-1339; Castro-Fernandez, Victor/0000-0002-4309-6415; Herrera-Morande, Alejandra/0000-0002-4140-0743; Fernandez, Francisco J./0000-0002-5015-1849; Rivas Pardo, Andres/0000-0002-8304-3238; Vega, M. Cristina/0000-0003-0628-8378	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1110137]; Spanish Ministry of Science and Innovation [PET2008_0101, BIO2009-11184, BFU2010-22260-C02-02]; EC [279039]; LNLS (Laboratorio Nacional de Luz Sincrotron), Sao Paulo, Brazil; Departamento de Postgrado y Postitulo, Universidad de Chile; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; Universitat de Barcelona	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); LNLS (Laboratorio Nacional de Luz Sincrotron), Sao Paulo, Brazil; Departamento de Postgrado y Postitulo, Universidad de Chile; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; Universitat de Barcelona	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT grant 1110137 to V.G, Spanish Ministry of Science and Innovation grants PET2008_0101, BIO2009-11184 and BFU2010-22260-C02-02 and the EC project ComplexINC (Framework Programme 7 (FP7) under grant agreement no. 279039) to M.C.V. The SAXS measurements (SAXS1 and SAXS2 beamlines) were supported by LNLS (Laboratorio Nacional de Luz Sincrotron), Sao Paulo, Brazil, to V.G. and J.A.R-P. We also thank the Departamento de Postgrado y Postitulo, Universidad de Chile by the support given to J.A.R-P to accomplish the SAXS studies in Sao Paulo. J.A.R-P and V.C-F are PhD fellowship from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile. A.H-M. acknowledges the support of the PhD program in Molecular Biotechnology of the Universitat de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Cleland W. W, 1970, ENZYMES, V2, P1; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cornish-Bowden A, 2011, FUNDAMENTALS ENZYME; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dougherty DA, 2012, ACCOUNTS CHEM RES; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gromiha MM, 2002, PREP BIOCHEM BIOTECH, V32, P355, DOI 10.1081/PB-120015459; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kumar S, 2000, PROTEIN SCI, V9, P10; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; Minoux H, 1999, J AM CHEM SOC, V121, P10366, DOI 10.1021/ja990914p; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Reddy MCM, 2007, J BIOL CHEM, V282, P27334, DOI 10.1074/jbc.M703290200; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakuraba H, 2004, CHEM REC, V3, P281, DOI 10.1002/tcr.10066; Sakuraba H, 2002, J BIOSCI BIOENG, V93, P441, DOI 10.1263/jbb.93.441; Schumacher MA, 2000, J MOL BIOL, V296, P549, DOI 10.1006/jmbi.1999.3474; Sigrell JA, 1999, J MOL BIOL, V290, P1009, DOI 10.1006/jmbi.1999.2938; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Varga A, 2006, FEBS LETT, V580, P2698, DOI 10.1016/j.febslet.2006.04.024; Vertessy BG, 2011, BIOESSAYS, V33, P30, DOI 10.1002/bies.201000068; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Vondrasek J, 2009, J PHYS CHEM B, V113, P9041, DOI 10.1021/jp902377q; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813; Zhang Y, 2004, STRUCTURE, V12, P1809, DOI 10.1016/j.str.2004.07.020	48	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66687	10.1371/journal.pone.0066687	http://dx.doi.org/10.1371/journal.pone.0066687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818958	Green Submitted, gold, Green Published			2022-12-25	WOS:000322342800095
J	Lovati, AB; Drago, L; Monti, L; De Vecchi, E; Previdi, S; Banfi, G; Romano, CL				Lovati, Arianna B.; Drago, Lorenzo; Monti, Lorenzo; De Vecchi, Elena; Previdi, Sara; Banfi, Giuseppe; Romano, Carlo L.			Diabetic Mouse Model of Orthopaedic Implant-Related Staphylococcus Aureus Infection	PLOS ONE			English	Article							OSTEOMYELITIS; ARTHROPLASTY; MICE; VANCOMYCIN; BONE; HIP; HYDROXYAPATITE; EPIDEMIOLOGY; PATHOGENESIS; DEBRIDEMENT	Background: Periprosthetic bacterial infections represent one of the most challenging orthopaedic complications that often require implant removal and surgical debridement and carry high social and economical costs. Diabetes is one of the most relevant risk factors of implant-related infection and its clinical occurrence is growing worldwide. The aim of the present study was to test a model of implant-related infection in the diabetic mouse, with a view to allow further investigation on the relative efficacy of prevention and treatment options in diabetic and non-diabetic individuals. Methodology: A cohort of diabetic NOD/ShiLtJ mice was compared with non-diabetic CD1 mice as an in vivo model of S. aureus orthopaedic infection of bone and soft tissues after femur intramedullary pin implantation. We tested control and infected groups with 1 x 10(3) colony-forming units of S. aureus ATCC 25923 strain injected in the implant site. At 4 weeks post-inoculation, host response to infection, microbial biofilm formation, and bone damage were assessed by traditional diagnostic parameters (bacterial culture, C-reactive protein and white blood cell count), histological analysis and imaging techniques (micro computed tomography and scanning electron microscopy). Results: Unlike the controls and the CD1 mice, all the diabetic mice challenged with a single inoculum of S. aureus displayed severe osteomyelitic changes around the implant. Conclusions: Our findings demonstrate for the first time that the diabetic mouse can be successfully used in a model of orthopaedic implant-related infection. Furthermore, the same bacteria inoculum induced periprosthetic infection in all the diabetic mice but not in the controls. This animal model of implant-related infection in diabetes may be a useful tool to test in vivo treatments in diabetic and non-diabetic individuals.	[Lovati, Arianna B.] Grp Osped San Donato Fdn, Cell & Tissue Engn Lab, Milan, Italy; [Drago, Lorenzo; De Vecchi, Elena] IRCCS Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Drago, Lorenzo; Banfi, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Monti, Lorenzo; Romano, Carlo L.] IRCCS Galeazzi Orthopaed Inst, Dipartimento Chirurg Ricostrutt & Infez Osteoarti, Milan, Italy; [Previdi, Sara] Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Canc Cachexia AIRC Start Up, Milan, Italy; [Banfi, Giuseppe] IRCCS Galeazzi Orthopaed Inst, Lab Expt Biochem & Mol Biol, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Istituto Ortopedico Galeazzi; University of Milan; IRCCS Istituto Ortopedico Galeazzi; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Ortopedico Galeazzi	Lovati, AB (corresponding author), Grp Osped San Donato Fdn, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposandonato.it	Monti, Lorenzo/AAB-2967-2020; De Vecchi, Elena/B-8209-2017; Lovati, Arianna Barbara/J-8213-2016; ROMANO, CARLO LUCA/C-4310-2017; Banfi, Giuseppe/K-6585-2015	De Vecchi, Elena/0000-0001-9781-8607; Lovati, Arianna Barbara/0000-0002-5230-9718; ROMANO, CARLO LUCA/0000-0001-6726-0593; Lorenzo, Drago/0000-0002-5206-540X; Banfi, Giuseppe/0000-0001-9578-5338	Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was funded by the Italian Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035; Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp032966; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; BUTT WP, 1973, CLIN ORTHOP RELAT R, P20; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Deirmengian C, 2003, J ARTHROPLASTY, V18, P22, DOI 10.1016/S0883-5403(03)00288-2; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Facchiano F, 2002, AM J PATHOL, V161, P531, DOI 10.1016/S0002-9440(10)64209-5; Follak N, 2005, DIABETES-METAB RES, V21, P288, DOI 10.1002/dmrr.537; Fujimura S, 2009, J ORTHOP SCI, V14, P658, DOI 10.1007/s00776-009-1366-3; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; Giavaresi G, 2008, J ORTHOP RES, V26, P785, DOI 10.1002/jor.20543; Guglielmo BJ, 2000, CLIN INFECT DIS, V30, P205, DOI 10.1086/313620; Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506; Jamsen Esa, 2012, J Bone Joint Surg Am, V94, pe101, DOI 10.2106/JBJS.J.01935; Kaya M, 2012, OR SURG OR MED OR PA, V113, P340, DOI 10.1016/j.tripleo.2011.03.032; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Lankinen P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-41; Le Nga N, 2011, J Diabetes Sci Technol, V5, P605; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010; Liu ZD, 2007, ACTA ORTHOP, V78, P46, DOI 10.1080/17453670610013411; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; MARUYAMA T, 1988, DIABETES RES CLIN EX, V7, P93; Mazza A, 2000, J Chemother, V12 Suppl 3, P29; Parvizi Javad, 2010, Orthopedics, V33, P659, DOI 10.3928/01477447-20100722-42; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Pettersson US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022480; PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Romano CL, 2012, HIP INT, V22, pS46, DOI 10.5301/HIP.2012.9570; Romano Carlo Luca, 2011, Eur Orthop Traumatol, V1, P207; Romano CL, 2010, J ORTHOP TRAUMATOL, V11, P167, DOI 10.1007/s10195-010-0106-y; Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x; Sheagren JN, 1997, STAPHYLOCOCCI HUMAN, P565; Spatz M, 2003, CELL IMMUNOL, V221, P15, DOI 10.1016/S0008-8749(03)00043-1; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; TATER D, 1987, HORM METAB RES, V19, P642, DOI 10.1055/s-2007-1011899; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Veronelli A, 2004, DIABETES CARE, V27, P2501, DOI 10.2337/diacare.27.10.2501; Viens Nicholas A, 2012, J Surg Orthop Adv, V21, P253; Wu HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-172	59	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67628	10.1371/journal.pone.0067628	http://dx.doi.org/10.1371/journal.pone.0067628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818985	Green Submitted, gold, Green Published			2022-12-25	WOS:000322342800142
J	Trotta, N; Goldman, S; Legros, B; Baete, K; Van Laere, K; Van Bogaert, P; De Tiege, X				Trotta, Nicola; Goldman, Serge; Legros, Benjamin; Baete, Kristof; Van Laere, Koen; Van Bogaert, Patrick; De Tiege, Xavier			Changes in Functional Integration with the Non-Epileptic Temporal Lobe of Patients with Unilateral Mesiotemporal Epilepsy	PLOS ONE			English	Article							INTERICTAL GLUCOSE HYPOMETABOLISM; HIPPOCAMPAL SCLEROSIS; EMOTION RECOGNITION; DECISION-MAKING; FDG-PET; CONNECTIVITY; METABOLISM; MEMORY; BRAIN; LOBECTOMY	Purpose: To investigate epilepsy-induced changes in effective connectivity between the non-epileptic amygdalo-hippocampal complex (AHC) and the rest of the brain in patients with unilateral mesiotemporal lobe epilepsy (MTLE) associated with hippocampal sclerosis (HS). Methods: Thirty-three patients with unilateral MTLE associated with HS (20 females, mean age: 36 years, 19 left HS) and 33 adult controls matched for age and gender underwent F-18-Fluorodeoxyglucose positron emission tomography (FDG-PET). Right-HS patients' FDG-PET data were flipped to obtain a left-epileptic-focus-lateralized group of patients. Voxels of interest (VOI) were selected within the cytoarchitectonic probabilistic maps of the non-epileptic AHC (probability level = 100%, SPM8 Anatomy toolbox v1.7). Patients and controls were compared using VOI metabolic activity as covariate of interest to search for epilepsy-induced changes in the contribution of the non-epileptic AHC to the level of metabolic activity in other brain areas. Age, gender, duration of epilepsy, seizure type and frequency were used as covariates of no-interest for connectivity analyses. Key findings: Significant decrease in effective connectivity was found between the non-epileptic AHC and ventral prefrontal cortical areas bilaterally, as well as with the temporal pole and the posterior cingulate cortex contralateral to HS. Significant increase in connectivity was found between the non-epileptic AHC and midline structures, such as the anterior cingulate and dorsal medial prefrontal cortices, as well as the temporo-parietal junction bilaterally. Connectivity analyses also revealed a preserved positive connectivity between the non-epileptic and the epileptic AHC in the patients' group. Significance: This study evidences epilepsy-induced changes in connectivity between the non-epileptic AHC and some limbic and default mode network areas. These changes in connectivity probably account for emotional, cognitive and decision-making impairments frequently observed in MTLE patients. The preserved neurometabolic connectivity between the non-epileptic and the epileptic AHC in MTLE patients is pivotal to explain the epilepsy-induced changes found in this study.	[Trotta, Nicola; Goldman, Serge; Van Bogaert, Patrick; De Tiege, Xavier] Univ Libre Brussels, Hop Erasme, Lab Cartog Fonct Cerveau, Brussels, Belgium; [Trotta, Nicola; Goldman, Serge] Univ Libre Brussels, Hop Erasme, Dept Nucl Med, Brussels, Belgium; [Legros, Benjamin; Van Bogaert, Patrick] Univ Libre Brussels, Hop Erasme, Reference Ctr Refractory Epilepsy, Brussels, Belgium; [Baete, Kristof; Van Laere, Koen] UZ Leuven, Dept Nucl Med, Louvain, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven	Trotta, N (corresponding author), Univ Libre Brussels, Hop Erasme, Lab Cartog Fonct Cerveau, Brussels, Belgium.	ntrotta@ulb.ac.be	Baete, Kristof/AAI-6051-2021	Baete, Kristof/0000-0003-0113-1590; De Tiege, Xavier/0000-0003-0127-089X; Goldman, Serge/0000-0002-9917-8735	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium)	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS)	XDT is "clinicien-chercheur specialiste" at the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium, http://www.fnrs.be/). KVL is senior clinical researcher at the FWO (Fonds voor Wetenschappelijk Onderzoek, Belgium, http://www.fwo.be/). This study was supported by a research grant of the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Arnold S, 1996, NEUROLOGY, V46, P1422, DOI 10.1212/WNL.46.5.1422; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonatti E, 2009, EPILEPSY BEHAV, V14, P665, DOI 10.1016/j.yebeh.2009.02.015; Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x; Boucsein K, 2001, NEUROPSYCHOLOGIA, V39, P231, DOI 10.1016/S0028-3932(00)00117-2; Brix G, 1997, J NUCL MED, V38, P1614; Broicher SD, 2012, NEUROPSYCHOLOGIA, V50, P118, DOI 10.1016/j.neuropsychologia.2011.11.005; BRUEHL C, 1995, ANN NEUROL, V38, P414, DOI 10.1002/ana.410380311; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campo P, 2012, CEREB CORTEX, V22, P1225, DOI 10.1093/cercor/bhr201; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; De Tiege X, 2004, NEUROLOGY, V63, P853, DOI 10.1212/01.WNL.0000137015.04054.2C; Delazer M, 2010, NEUROPSYCHOLOGIA, V48, P194, DOI 10.1016/j.neuropsychologia.2009.08.025; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Getz K, 2002, AM J PSYCHIAT, V159, P644, DOI 10.1176/appi.ajp.159.4.644; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; HENRY TR, 1990, J CEREBR BLOOD F MET, V10, P748, DOI 10.1038/jcbfm.1990.128; Hermann B, 1995, J CLIN EXP NEUROPSYC, V17, P809, DOI 10.1080/01688639508402430; Iversen S., 2000, PRINCIPLES NEURAL SC, V4, P982; Jokeit H, 1997, BRAIN, V120, P2283, DOI 10.1093/brain/120.12.2283; Joo EY, 2005, BRAIN, V128, P1802, DOI 10.1093/brain/awh534; Juhasz H, 2011, NEUROIMAGING EPILEPS, P146; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Labudda K, 2009, NEUROPSYCHOLOGIA, V47, P50, DOI 10.1016/j.neuropsychologia.2008.08.014; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Ligot N, 2011, J CEREBR BLOOD F MET, V31, P41, DOI 10.1038/jcbfm.2010.186; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; McClelland S, 2006, EPILEPSIA, V47, P1337, DOI 10.1111/j.1528-1167.2006.00557.x; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Morgan VL, 2011, EPILEPSIA, V52, P1741, DOI 10.1111/j.1528-1167.2011.03196.x; Nelissen N, 2006, NEUROIMAGE, V32, P684, DOI 10.1016/j.neuroimage.2006.04.185; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU, P361; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Powell HWR, 2007, EPILEPSIA, V48, P1512, DOI 10.1111/j.1528-1167.2007.01053.x; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; Rubin E, 1995, NEUROLOGY, V45, P2212, DOI 10.1212/WNL.45.12.2212; Salzberg M, 2006, EPILEPSIA, V47, P2125, DOI 10.1111/j.1528-1167.2006.00860.x; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Schwartz TH, 2001, NAT MED, V7, P1063, DOI 10.1038/nm0901-1063; Shaw P, 2007, NEUROPSYCHOLOGIA, V45, P2783, DOI 10.1016/j.neuropsychologia.2007.04.020; SPERLING MR, 1990, EPILEPSIA, V31, P145, DOI 10.1111/j.1528-1167.1990.tb06299.x; Stephan KE, 2007, NEUROPSYCHOLOGIA, V45, P209, DOI 10.1016/j.neuropsychologia.2006.07.002; Takaya S, 2009, BRAIN, V132, P185, DOI 10.1093/brain/awn218; THEODORE WH, 1992, ANN NEUROL, V32, P789, DOI 10.1002/ana.410320613; Thivard L, 2005, NEUROIMAGE, V24, P841, DOI 10.1016/j.neuroimage.2004.10.001; Trotta N, 2011, EPILEPSIA, V52, P2003, DOI 10.1111/j.1528-1167.2011.03271.x; Van Bogaert P, 2000, NEUROIMAGE, V12, P129, DOI 10.1006/nimg.2000.0606; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042	62	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67053	10.1371/journal.pone.0067053	http://dx.doi.org/10.1371/journal.pone.0067053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818976	Green Published, gold			2022-12-25	WOS:000322342800115
J	Wang, Q; Wang, CY; Mu, CK; Wu, HF; Zhang, LB; Zhao, JM				Wang, Qing; Wang, Chunyan; Mu, Changkao; Wu, Huifeng; Zhang, Linbao; Zhao, Jianmin			A Novel C-Type Lysozyme from Mytilus galloprovincialis: Insight into Innate Immunity and Molecular Evolution of Invertebrate C-Type Lysozymes	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; EXPRESSION ANALYSIS; DROSOPHILA-MELANOGASTER; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; SHRIMP LYSOZYME; GENE-EXPRESSION; SALIVARY-GLANDS; LYTIC ACTIVITY; BOMBYX-MORI	A c-type lysozyme (named as MgCLYZ) gene was cloned from the mussel Mytilus galloprovincialis. Blast analysis indicated that MgCLYZ was a salivary c-type lysozyme which was mainly found in insects. The nucleotide sequence of MgCLYZ was predicted to encode a polypeptide of 154 amino acid residues with the signal peptide comprising the first 24 residues. The deduced mature peptide of MgCLYZ was of a calculated molecular weight of 14.4 kD and a theoretical isoelectric point (pI) of 8.08. Evolution analysis suggested that bivalve branch of the invertebrate c-type lysozymes phylogeny tree underwent positive selection during evolution. By quantitative real-time RT-PCR (qRT-PCR) analysis, MgCLYZ transcript was widely detected in all examined tissues and responded sensitively to bacterial challenge in hemocytes and hepatopancreas. The optimal temperature and pH of recombinant MgCLYZ (rMgCLYZ) were 20 degrees C and 4, respectively. The rMgCLYZ displayed lytic activities against Gram-positive bacteria including Micrococcus luteus and Staphyloccocus aureus, and Gram-negative bacteria including Vibrio anguillarum, Enterobacter cloacae, Pseudomonas putida, Proteus mirabilis and Bacillus aquimaris. These results suggest that MgCLYZ perhaps play an important role in innate immunity of M. galloprovincialis, and invertebrate c-type lysozymes might be under positive selection in a species-specific manner during evolution for undergoing adaptation to different environment and diverse pathogens.	[Wang, Qing; Wu, Huifeng; Zhang, Linbao; Zhao, Jianmin] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc & Ecol Remedia, Yantai, Peoples R China; [Wang, Chunyan; Mu, Changkao] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Ningbo University	Wu, HF (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc & Ecol Remedia, Yantai, Peoples R China.	hfwu@yic.ac.cn; jmzhao@yic.ac.cn	Wang, Qing/O-1991-2013; Wu, Huifeng/E-4886-2016	Wang, Qing/0000-0002-5180-5154; Wu, Huifeng/0000-0002-4042-8103	NSFC [31172388]; 100 Talents Program of the Chinese Academy of Sciences; Department of Science and Technology of Yantai City [2011067]	NSFC(National Natural Science Foundation of China (NSFC)); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Science and Technology of Yantai City(Department of Science & Technology (India))	This work was supported by grant from NSFC (31172388), the 100 Talents Program of the Chinese Academy of Sciences and the Department of Science and Technology of Yantai City (2011067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ABRAHAM EG, 1995, J INVERTEBR PATHOL, V65, P17, DOI 10.1006/jipa.1995.1003; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; de-la-Re-Vega E, 2006, FISH SHELLFISH IMMUN, V20, P405, DOI 10.1016/j.fsi.2005.06.005; Ding JF, 2011, FISH SHELLFISH IMMUN, V30, P163, DOI 10.1016/j.fsi.2010.10.008; Fujimoto S, 2001, COMP BIOCHEM PHYS B, V128, P709, DOI 10.1016/S1096-4959(00)00368-7; Fujita A, 2002, INSECT BIOCHEM MOLEC, V32, P1615, DOI 10.1016/S0965-1748(02)00100-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herreweghe J.M., 2012, J BIOSCIENCE, V37, P327; Hikima S, 2003, GENE, V316, P187, DOI 10.1016/S0378-1119(03)00761-3; Hultmark D, 1996, LYSOZYMES MODEL ENZY, V75, P87; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kaizu A, 2011, J BIOL CHEM, V286, P44344, DOI 10.1074/jbc.M111.292672; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; KYLSTEN P, 1992, MOL GEN GENET, V232, P335, DOI 10.1007/BF00266235; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lynn DJ, 2004, MOL BIOL EVOL, V21, P819, DOI 10.1093/molbev/msh084; MAENAKA K, 1994, J BIOL CHEM, V269, P7070; Mai WJ, 2010, FISH SHELLFISH IMMUN, V28, P727, DOI 10.1016/j.fsi.2010.01.002; Mai WJ, 2009, MOL BIOL REP, V36, P1587, DOI 10.1007/s11033-008-9355-8; Mai WJ, 2009, PROG NAT SCI-MATER, V19, P837, DOI 10.1016/j.pnsc.2008.10.008; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Moreira-Ferro CK, 1998, INSECT MOL BIOL, V7, P257, DOI 10.1111/j.1365-2583.1998.00067.x; MURAKI M, 1992, BIOCHEMISTRY-US, V31, P9212, DOI 10.1021/bi00153a014; NITTA K, 1987, FEBS LETT, V223, P405, DOI 10.1016/0014-5793(87)80328-9; Pan Bao-Ping, 2010, Oceanologia et Limnologia Sinica, V41, P901; PRAGER EM, 1996, LYSOZYMES MODEL ENZY, P323; Ren Q, 2009, J GENET GENOMICS, V36, P7, DOI 10.1016/S1673-8527(09)60002-3; Shen T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-39; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soderhall K, 1999, DEV COMP IMMUNOL, V23, P263; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Supungul P, 2010, FISH SHELLFISH IMMUN, V28, P490, DOI 10.1016/j.fsi.2010.01.003; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045148; Wang Q, 2010, AQUAT TOXICOL, V100, P321, DOI 10.1016/j.aquatox.2010.08.012; Wang WX, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1701; Wei SN, 2012, FISH SHELLFISH IMMUN, V33, P186, DOI 10.1016/j.fsi.2012.03.027; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye X, 2010, DEV COMP IMMUNOL, V34, P501, DOI 10.1016/j.dci.2009.12.009; Ye X, 2009, MOL BIOL REP, V36, P1239, DOI 10.1007/s11033-008-9303-7; Yu KH, 2002, DEV COMP IMMUNOL, V26, P707, DOI 10.1016/S0145-305X(02)00027-7; Yu LP, 2013, FISH SHELLFISH IMMUN, V34, P46, DOI 10.1016/j.fsi.2012.10.007; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zhu S, 2008, CELL MOL LIFE SCI, V65, P1285, DOI 10.1007/s00018-008-8070-x	55	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67469	10.1371/journal.pone.0067469	http://dx.doi.org/10.1371/journal.pone.0067469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818979	Green Published, gold			2022-12-25	WOS:000322342800136
J	Ekouevi, DK; Balestre, E; Coffie, PA; Minta, D; Messou, E; Sawadogo, A; Minga, A; Sow, PS; Bissagnene, E; Eholie, SP; Gottlieb, GS; Dabis, F				Ekouevi, Didier K.; Balestre, Eric; Coffie, Patrick A.; Minta, Daouda; Messou, Eugene; Sawadogo, Adrien; Minga, Albert; Sow, Papa Salif; Bissagnene, Emmanuel; Eholie, Serge P.; Gottlieb, Geoffrey S.; Dabis, Francois		IeDEA West Africa Collaboration	Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; IMMUNOLOGICAL RESPONSE; DRUG-RESISTANCE; INTERNATIONAL COLLABORATION; HIV-2-INFECTED INDIVIDUALS; TYPE-1 HIV-1; INFECTION; RALTEGRAVIR; DIFFERENTIATION; INHIBITORS	Background: HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for HIV-2 or HIV-1/HIV-2 dual infections. Because of these issues, we designed a West African collaborative cohort for HIV-2 infection within the framework of the International epidemiological Databases to Evaluate AIDS (IeDEA). Methods: We collected data on all HIV-2 and HIV-1/HIV-2 dually seropositive patients (both ARV-naive and starting ART) and followed-up in clinical centres in the IeDEA-WA network including a total of 13 clinics in five countries: Benin, Burkina-Faso Cote d'Ivoire, Mali, and Senegal, in the West Africa region. Results: Data was merged for 1,754 patients (56% female), including 1,021 HIV-2 infected patients (551 on ART) and 733 dually seropositive for both HIV-1 and HIV 2 (463 on ART). At ART initiation, the median age of HIV-2 patients was 45.3 years, IQR: (38.3-51.7) and 42.4 years, IQR (37.0-47.3) for dually seropositive patients (p = 0.048). Overall, 16.7% of HIV-2 patients on ART had an advanced clinical stage (WHO IV or CDC-C). The median CD4 count at the ART initiation is 166 cells/mm(3), IQR (83-247) among HIV-2 infected patients and 146 cells/mm(3), IQR (55-249) among dually seropositive patients. Overall, in ART-treated patients, the CD4 count increased 126 cells/mm(3) after 24 months on ART for HIV-2 patients and 169 cells/mm(3) for dually seropositive patients. Of 551 HIV-2 patients on ART, 5.8% died and 10.2% were lost to follow-up during the median time on ART of 2.4 years, IQR (0.7-4.3). Conclusions: This large multi-country study of HIV-2 and HIV-1/HIV-2 dual infection in West Africa suggests that routine clinical care is less than optimal and that management and treatment of HIV-2 could be further informed by ongoing studies and randomized clinical trials in this population.	[Ekouevi, Didier K.; Balestre, Eric; Dabis, Francois] Univ Bordeaux Segalen, ISPED, Ctr INSERM, U897,Epidemiol Biostat, Bordeaux, France; [Ekouevi, Didier K.; Coffie, Patrick A.; Messou, Eugene] Programme PACCI, Abidjan, Cote Ivoire; [Ekouevi, Didier K.] Univ Lome, Dept Sci Fondamentales & Sante Publ, Lome, Togo; [Coffie, Patrick A.; Messou, Eugene; Bissagnene, Emmanuel; Eholie, Serge P.] Univ Felix Houphouet Boigny, UFR Sci Med, Dept Dermatol & Infectiol, Abidjan, Cote Ivoire; [Minta, Daouda] Hop Point G, Ctr Prise Charge Personnes Vivant Avec VIH, Bamako, Mali; [Messou, Eugene] ACONDA CePReF Adultes, Abidjan, Cote Ivoire; [Sawadogo, Adrien] CHU Souro Sanou, Hop Jour, Bobo Dioulasso, Burkina Faso; [Minga, Albert] Projet PRIMO CI, Ctr Med Suivi Donneurs Sang, Abidjan, Cote Ivoire; [Sow, Papa Salif] CHU Fann, Serv Malad Infect & Trop, Dakar, Senegal; [Bissagnene, Emmanuel; Eholie, Serge P.] CHU Treichville, Serv Malad Infect & Trop, Dakar, Senegal; [Gottlieb, Geoffrey S.] Univ Washington, Dept Med, Seattle, WA USA; [Gottlieb, Geoffrey S.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ekouevi, DK (corresponding author), Univ Bordeaux Segalen, ISPED, Ctr INSERM, U897,Epidemiol Biostat, Bordeaux, France.	didier.ekouevi@gmail.com	Leroy, Valeriane/AAO-5175-2020; EKOUEVI, Didier K/E-7960-2014; Eholie, Serge/T-6008-2019; Leroy, Valeriane/F-8129-2013; Leroy, Valeriane/GQB-1102-2022; Adebamowo, Clement/C-8778-2011; Wejse, Christian/C-8468-2014; DABIS, FRANCOIS/S-9298-2019; Anglaret, Xavier/F-7333-2013; Ostergaard, Lars/AAA-3020-2020	Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Adebamowo, Clement/0000-0002-6571-2880; Wejse, Christian/0000-0002-2534-2942; DABIS, FRANCOIS/0000-0002-1614-8857; Ostergaard, Lars/0000-0003-2459-0511; Erikstrup, Christian/0000-0001-6551-6647; Eugen-Olsen, Jesper/0000-0002-4630-4275; Ostergaard, Lars/0000-0002-7619-605X; HEMA, Arsene/0000-0002-5279-643X; Fomsgaard, Anders/0000-0003-4304-0603; Anglaret, Xavier/0000-0003-3319-8423; Gottlieb, Geoffrey/0000-0002-5749-481X; Sodemann, Morten/0000-0001-8992-2500	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [5U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060466, U01AI069919] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The International epidemiological Database to Evaluate AIDS in West Africa (IeDEA West Africa) is supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no.5U01AI069919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; [Anonymous], 2010, PRISE CHARGE MED PER; Balestre E, 2012, AIDS, V26, P951, DOI 10.1097/QAD.0b013e3283528ad4; Benard A, 2011, CLIN INFECT DIS, V52, P1257, DOI 10.1093/cid/cir123; Burgard M, 2010, CLIN INFECT DIS, V51, P833, DOI 10.1086/656284; Chang M, 2012, J CLIN VIROL, V55, P128, DOI 10.1016/j.jcv.2012.06.024; CLAVEL F, 1987, NEW ENGL J MED, V316, P1180, DOI 10.1056/NEJM198705073161903; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; CLAVEL F, 1987, AIDS, V1, P135; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Damond F, 1998, J CLIN MICROBIOL, V36, P809, DOI 10.1128/JCM.36.3.809-811.1998; Damond F, 2011, J CLIN MICROBIOL, V49, P3491, DOI 10.1128/JCM.02389-10; Damond F, 2008, J CLIN MICROBIOL, V46, P2088, DOI 10.1128/JCM.00126-08; Damond F, 2008, AIDS, V22, P665, DOI 10.1097/QAD.0b013e3282f51203; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Drylewicz J, 2010, AIDS, V24, P1043, DOI 10.1097/QAD.0b013e3283377a06; Egger M, 2011, INT J EPIDEMIOL; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Gilbert PB, 2003, STAT MED, V22, P573, DOI 10.1002/sim.1342; Gilleece Y, 2010, HIV MED, V11, P611, DOI 10.1111/j.1468-1293.2010.00889.x; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Hawes SE, 2008, AIDS, V22, P2517, DOI 10.1097/QAD.0b013e328315cdbc; Heitzinger K, 2012, INT J STD AIDS, V23, P710, DOI 10.1258/ijsa.2012.011219; IMAI M, 1995, J CLIN MICROBIOL, V33, P1727, DOI 10.1128/JCM.33.7.1727-1729.1995; Jallow S, 2006, AIDS, V20, P1455, DOI 10.1097/01.aids.0000233582.64467.8e; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; Matheron S, 2008, AIDS, V22, P2073, DOI 10.1097/QAD.0b013e32830edd59; O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019; Parkin NT, 2004, ANTIVIR THER, V9, P3; PEETERS M, 1992, LANCET, V340, P339, DOI 10.1016/0140-6736(92)91407-Y; Peterson I, 2011, AIDS, V25, P2167, DOI 10.1097/QAD.0b013e32834c4adb; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Poveda E, 2005, AIDS REV, V7, P139; RESAPCI IMEA, 2011, WORKSH COH STUD HIV; RESAPSI IMEA, 2009, 4 WORKSH STRAT ANT T; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Rouet F, 2004, J CLIN MICROBIOL, V42, P4147, DOI 10.1128/JCM.42.9.4147-4153.2004; Smith RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045372; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; Torian LV, 2010, CLIN INFECT DIS, V51, P1334, DOI 10.1086/657117; Toro Carlos, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 13, P66, DOI 10.1157/13128783; van der Ende ME, 2003, AIDS, V17, pS55, DOI 10.1097/00002030-200317003-00008; van der Loeff MFS, 2003, AIDS, V17, P2389, DOI [10.1097/01.aids.0000076344.42412.05, 10.1097/00002030-200311070-00015]; van Tienen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029026; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039	51	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66135	10.1371/journal.pone.0066135	http://dx.doi.org/10.1371/journal.pone.0066135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V6C3A	23824279	gold, Green Published, Green Submitted			2022-12-25	WOS:000420153300001
J	Guo, WL; Chen, RG; Gong, ZH; Yin, YX; Li, DW				Guo, Wei-Li; Chen, Ru-Gang; Gong, Zhen-Hui; Yin, Yan-Xu; Li, Da-Wei			Suppression Subtractive Hybridization Analysis of Genes Regulated by Application of Exogenous Abscisic Acid in Pepper Plant (Capsicum annuum L.) Leaves under Chilling Stress	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MESSENGER-RNA; HIGH-SALINITY; STOMATAL CLOSURE; DROUGHT STRESS; GUARD-CELLS; SALT STRESS; COLD; EXPRESSION; RICE	Low temperature is one of the major factors limiting pepper (Capsicum annuum L.) production during winter and early spring in non-tropical regions. Application of exogenous abscisic acid (ABA) effectively alleviates the symptoms of chilling injury, such as wilting and formation of necrotic lesions on pepper leaves; however, the underlying molecular mechanism is not understood. The aim of this study was to identify genes that are differentially up-or downregulated in ABA-pretreated hot pepper seedlings incubated at 6 degrees C for 48 h, using a suppression subtractive hybridization (SSH) method. A total of 235 high-quality ESTs were isolated, clustered and assembled into a collection of 73 unigenes including 18 contigs and 55 singletons. A total of 37 unigenes (50.68%) showed similarities to genes with known functions in the non-redundant database; the other 36 unigenes (49.32%) showed low similarities or unknown functions. Gene ontology analysis revealed that the 37 unigenes could be classified into nine functional categories. The expression profiles of 18 selected genes were analyzed using quantitative RT-PCR; the expression levels of 10 of these genes were at least two-fold higher in the ABA-pretreated seedlings under chilling stress than water-pretreated (control) plants under chilling stress. In contrast, the other eight genes were downregulated in ABA-pretreated seedlings under chilling stress, with expression levels that were one-third or less of the levels observed in control seedlings under chilling stress. These results suggest that ABA can positively and negatively regulate genes in pepper plants under chilling stress.	[Guo, Wei-Li; Chen, Ru-Gang; Gong, Zhen-Hui; Yin, Yan-Xu; Li, Da-Wei] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Guo, Wei-Li; Chen, Ru-Gang; Gong, Zhen-Hui; Li, Da-Wei] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Gong, ZH (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	zhgong@nwsuaf.edu.cn			National Natural Science Foundation of China [31201615, 31272163]; "The Twelfth Five-Year'' Plan of National Science and Technology in Rural Areas [2011BAD12B03]; Natural Science Foundation of Shaanxi Province [2011JQ3010]; Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project [2012KTCL02-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "The Twelfth Five-Year'' Plan of National Science and Technology in Rural Areas(Chinese Academy of Sciences); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project	This work was supported by the National Natural Science Foundation of China (# 31201615, # 31272163), "The Twelfth Five-Year'' Plan of National Science and Technology in Rural Areas (# 2011BAD12B03), the Natural Science Foundation of Shaanxi Province (# 2011JQ3010) and the Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project (# 2012KTCL02-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaki M, 2012, PLANT CELL ENVIRON, V35, P281, DOI 10.1111/j.1365-3040.2011.02310.x; Assmann SM, 1999, PLANT PHYSIOL, V119, P809, DOI 10.1104/pp.119.3.809; Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; Bertin P, 1996, PLANT BREEDING, V115, P268, DOI 10.1111/j.1439-0523.1996.tb00915.x; BRAY EA, 1988, PLANT PHYSIOL, V88, P1210, DOI 10.1104/pp.88.4.1210; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Chak RKF, 2000, PLANTA, V210, P875, DOI 10.1007/s004250050692; Clement M, 2008, GENE, V426, P15, DOI 10.1016/j.gene.2008.08.016; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Faccioli P, 2001, PLANT BREEDING, V120, P497, DOI 10.1046/j.1439-0523.2001.00652.x; Di Mauro MF, 2012, PLANT SIGNAL BEHAV, V7, P188, DOI 10.4161/psb.18843; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gao M, 2012, PLANT PHYSIOL BIOCH, V58, P253, DOI 10.1016/j.plaphy.2012.07.009; Gulyani V, 2011, TREE GENET GENOMES, V7, P725, DOI 10.1007/s11295-011-0369-3; Guo WL, 2012, GENET MOL RES, V11, P4063, DOI 10.4238/2012.September.10.5; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; HANNAH MA, 2005, PLOS GENET; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hemming MN, 2011, PLANT SCI, V180, P447, DOI 10.1016/j.plantsci.2010.12.001; Hossain Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030425; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ignatova LK, 2011, PHOTOSYNTH RES, V110, P89, DOI 10.1007/s11120-011-9699-0; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Jiang WJ, 2012, HORTTECHNOLOGY, V22, P137, DOI 10.21273/HORTTECH.22.1.137; Kim TE, 2002, PHYSIOL PLANTARUM, V115, P370, DOI 10.1034/j.1399-3054.2002.1150306.x; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; Krause G. H., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P43; Kumar S, 2008, J AGRON CROP SCI, V194, P449, DOI 10.1111/j.1439-037X.2008.00335.x; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; LEE TM, 1993, PLANT CELL ENVIRON, V16, P481, DOI 10.1111/j.1365-3040.1993.tb00895.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu YJ, 2011, J PLANT PHYSIOL, V168, P853, DOI 10.1016/j.jplph.2010.09.020; LOIK ME, 1993, PLANT PHYSIOL, V103, P871, DOI 10.1104/pp.103.3.871; Ma XW, 2008, PLANT GROWTH REGUL, V56, P77, DOI 10.1007/s10725-008-9287-2; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Maraschin SDF, 2006, PHYSIOL PLANTARUM, V127, P535, DOI 10.1111/j.1399-3054.2006.00673.x; Mateos RM, 2009, PHYSIOL PLANTARUM, V135, P130, DOI 10.1111/j.1399-3054.2008.01179.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; MITTELHEUSER CJ, 1969, NATURE, V221, P281, DOI 10.1038/221281a0; Nguyen HT, 2009, PLANT PHYSIOL BIOCH, V47, P116, DOI 10.1016/j.plaphy.2008.10.010; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Paquis S, 2011, MOL BIOL REP, V38, P3327, DOI 10.1007/s11033-010-0438-y; Pawlowski TA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-48; PEREZPRAT E, 1992, PLANT PHYSIOL, V100, P1471, DOI 10.1104/pp.100.3.1471; Pressman E, 2006, PHYSIOL PLANTARUM, V126, P618, DOI 10.1111/j.1399-3054.2005.00623.x; Pushpanathan M, 2012, PROTEIN PEPTIDE LETT, V19, P1289, DOI 10.2174/092986612803521620; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Schiott M, 2005, PHYSIOL PLANTARUM, V124, P278, DOI 10.1111/j.1399-3054.2005.00512.x; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Smallwood M, 2002, PHILOS T R SOC B, V357, P831, DOI 10.1098/rstb.2002.1073; Tan X, 2009, AM J PHYSIOL-ENDOC M, V296, pE223, DOI 10.1152/ajpendo.90807.2008; Topuz A, 2007, J FOOD COMPOS ANAL, V20, P596, DOI 10.1016/j.jfca.2007.03.007; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Vij S, 2007, PLANT BIOTECHNOL J, V5, P361, DOI 10.1111/j.1467-7652.2007.00239.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; WIMMERS LE, 1992, P NATL ACAD SCI USA, V89, P9205, DOI 10.1073/pnas.89.19.9205; WRIGHT M, 1974, PLANTA, V120, P63, DOI 10.1007/BF00388271; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yang L, 2006, RUSS J PLANT PHYSL+, V53, P390, DOI 10.1134/S1021443706030150; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Yu S, 2007, BIOTECHNOL LETT, V29, P89, DOI 10.1007/s10529-006-9199-z; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhou BY, 2006, PLANT GROWTH REGUL, V48, P195, DOI 10.1007/s10725-006-0005-7; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	74	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66667	10.1371/journal.pone.0066667	http://dx.doi.org/10.1371/journal.pone.0066667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825555	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400145
J	Koepfli, C; Timinao, L; Antao, T; Barry, AE; Siba, P; Mueller, I; Felger, I				Koepfli, Cristian; Timinao, Lincoln; Antao, Tiago; Barry, Alyssa E.; Siba, Peter; Mueller, Ivo; Felger, Ingrid			A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; SULFADOXINE-PYRIMETHAMINE; GENETIC DIVERSITY; DRUG-RESISTANCE; SOLOMON-ISLANDS; MALARIA; FALCIPARUM; INFECTIONS; TRANSMISSION; CHLOROQUINE	Introduction: The importance of Plasmodium vivax in malaria elimination is increasingly being recognized, yet little is known about its population size and population genetic structure in the South Pacific, an area that is the focus of intensified malaria control. Methods: We have genotyped 13 microsatellite markers in 295 P. vivax isolates from four geographically distinct sites in Papua New Guinea (PNG) and one site from Solomon Islands, representing different transmission intensities. Results: Diversity was very high with expected heterozygosity values ranging from 0.62 to 0.98 for the different markers. Effective population size was high (12'872 to 19'533 per site). In PNG population structuring was limited with moderate levels of genetic differentiation. F-ST values (adjusted for high diversity of markers) were 0.14-0.15. Slightly higher levels were observed between PNG populations and Solomon Islands (F-ST = 0.16). Conclusions: Low levels of population structure despite geographical barriers to transmission are in sharp contrast to results from regions of low P. vivax endemicity. Prior to intensification of malaria control programs in the study area, parasite diversity and effective population size remained high.	[Koepfli, Cristian; Timinao, Lincoln; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Koepfli, Cristian; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Timinao, Lincoln; Siba, Peter] PNG Inst Med Res, Goroka, Papua N Guinea; [Antao, Tiago] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; [Koepfli, Cristian; Barry, Alyssa E.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia; [Barry, Alyssa E.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; PNG Institute Of Medical Research; University of Cambridge; Walter & Eliza Hall Institute; University of Melbourne; ISGlobal; CRESIB	Felger, I (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch	Koepfli, Cristian/H-8772-2019; Antao, Tiago/C-3615-2009	Koepfli, Cristian/0000-0002-9354-0414; Antao, Tiago/0000-0002-7269-5513; Barry, Alyssa/0000-0002-1189-2310; Felger, Ingrid/0000-0003-1255-2606	Swiss National Science Foundation [320030-125316/1, 310030-134889/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (www.snf.ch, grant numbers: 320030-125316/1, 310030-134889/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers MP, 1992, HUMAN BIOL PAPUA NEW, Vxiii; Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Antao T, 2011, EVOL APPL, V4, P144, DOI 10.1111/j.1752-4571.2010.00150.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Ballif M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-270; Barnadas C, 2011, ANTIMICROB AGENTS CH, V55, P4479, DOI 10.1128/AAC.01552-10; Beaumont MA, 1996, P ROY SOC LOND B BIO, V263, P8; Buckee CO, 2010, ADV EXP MED BIOL, V673, P112; Cammack N, 2011, SCIENCE, V333, P705, DOI 10.1126/science.1210875; De Castro MC, 2005, J ARCHAEOL SCI, V32, P4; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hunt P, 2005, MOL BIOCHEM PARASIT, V143, P173, DOI 10.1016/j.molbiopara.2005.05.014; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Iwagami M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-96; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; KOEPFLI C, 2008, J INFECT DIS; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mueller I, 2002, AM J TROP MED HYG, V67, P459, DOI 10.4269/ajtmh.2002.67.459; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Mueller Ivo, 2004, Papua New Guinea Medical Journal, V47, P159; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Susomboon P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-212; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WHO, 2011, WORLD MALARIA REPORT 2011, P1	53	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66041	10.1371/journal.pone.0066041	http://dx.doi.org/10.1371/journal.pone.0066041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823758	Green Published, Green Accepted, gold			2022-12-25	WOS:000320576400048
J	Li, ZQ				Li, Zhongqiu			Sex-Age Related Rumination Behavior of Pere David's Deer under Constraints of Feeding Habitat and Rainfall	PLOS ONE			English	Article							BODY-SIZE; PHYSICAL STRUCTURE; CHEWING BEHAVIOR; ACTIVITY BUDGETS; OVIS-CANADENSIS; RUMINANTS; FORAGE; CATTLE; TIME; DIGESTIBILITY	Extensive studies have been conducted on the rumination behavior of domestic herbivores. However, studies on wild animals are limited, particularly wild animals with specific ruminating parameters. In this study, Pere David's deer, a previously extirpated species, was observed to analyze the effects of sex-age, feeding habitat, and rainfall on rumination behavior in the Dafeng Nature Reserve, China. Rumination behavior was investigated based on four parameters: proportion of bedding time spent chewing, bolus processing time (s/bolus), chewing frequency (chews/bolus), and chewing rate (chews/s). Results showed that all three factors affect rumination behavior. The extent of their effects varied based on the four rumination parameters. Chewing rate and frequency decreased based on sex-age levels, i.e., from fawns to juvenile female, juvenile male, adult female, stag, and harem holder. Therefore, body size played a major role in shaping rumination behavior. Deer found in grasslands could chew faster compared with deer found in woodlands. This result might be caused by the effects of dietary composition and sunlight intensity. A deer spends a longer time ruminating while bedding during rainy days compared with rainless days to maximize energy and nutrition intake and compensate for the loss of feeding time during rainy days. Therefore, rumination behavior is plastic and is shaped by intrinsic and extrinsic factors.	Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Li, ZQ (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	lizq0314@gmail.com	Li, Zhong-qiu/A-1748-2011	Li, Zhong-qiu/0000-0003-2004-293X	National Natural Science Foundation of China [31000174, J1103512]; National Nature Reserve Remote Sense Investigation and Assessment [STSN-7]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Reserve Remote Sense Investigation and Assessment; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Financial support for this work was provided by the National Natural Science Foundation of China (numbers 31000174 and J1103512), National Nature Reserve Remote Sense Investigation and Assessment during 2000-2010 (number STSN-7) and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth JAW, 2012, AGR ECOSYST ENVIRON, V155, P105, DOI 10.1016/j.agee.2012.04.005; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BLACKSHAW JK, 1994, AUST J EXP AGR, V34, P285, DOI 10.1071/EA9940285; Blanchard P, 2005, J ZOOL, V265, P107, DOI 10.1017/S0952836904006077; Blanchard P, 2008, WILDLIFE BIOL, V14, P372, DOI 10.2981/0909-6396(2008)14[372:SVIRPO]2.0.CO;2; BUTRIS GY, 1987, GRASS FORAGE SCI, V42, P259, DOI 10.1111/j.1365-2494.1987.tb02114.x; Chumpawadee S, 2009, J ANIM VET ADV, V8, P2038; Das N, 1999, SMALL RUMINANT RES, V32, P129, DOI 10.1016/S0921-4488(98)00175-8; DEBOEVER JL, 1990, ANIM FEED SCI TECH, V27, P281, DOI 10.1016/0377-8401(90)90143-V; Ding Y, 2004, CHINESE MILU RES, P92; Ding Y, 2004, CHINESE MILU RES, P112; du Toit JT, 2005, OECOLOGIA, V143, P317, DOI 10.1007/s00442-004-1789-7; GORDON JG, 1970, J AGR SCI-CAMBRIDGE, V74, P291, DOI 10.1017/S0021859600022905; GRANT RJ, 1990, J DAIRY SCI, V73, P3158, DOI 10.3168/jds.S0022-0302(90)79005-4; GROSS JE, 1995, FUNCT ECOL, V9, P385, DOI 10.2307/2390001; Hamel S, 2008, ANIM BEHAV, V75, P217, DOI 10.1016/j.anbehav.2007.04.028; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jiang Z, 2011, MILU BIODIVERSITY DA, P75; Jiang ZG, 2000, WILDLIFE SOC B, V28, P681; Jiang Zhi-Gang, 2004, Acta Zoologica Sinica, V50, P706; Julien KC, 1996, ARCH ORAL BIOL, V41, P69, DOI 10.1016/0003-9969(95)00098-4; Li C, 2007, ZOO BIOL, V26, P461, DOI 10.1002/zoo.20132; Li CW, 2001, HORM BEHAV, V40, P518, DOI 10.1006/hbeh.2001.1711; Liang C, 1991, FOREST SCI, V27, P425; Mellado M, 2005, SMALL RUMINANT RES, V57, P105, DOI 10.1016/j.smallrumres.2004.03.009; MEYER RM, 1964, J DAIRY SCI, V47, P1339, DOI 10.3168/jds.S0022-0302(64)88915-3; Moquin P, 2010, ANIM BEHAV, V79, P1047, DOI 10.1016/j.anbehav.2010.01.020; Mysterud A, 1998, OECOLOGIA, V113, P442, DOI 10.1007/s004420050396; OAKES EJ, 1992, CAN J ZOOL, V70, P605, DOI 10.1139/z92-089; Oshiro S, 1996, SMALL RUMINANT RES, V22, P97, DOI 10.1016/S0921-4488(96)00886-3; Pelletier F, 2004, BEHAV ECOL SOCIOBIOL, V56, P546, DOI 10.1007/s00265-004-0820-7; Perez-Barberia FJ, 2008, OECOLOGIA, V157, P21, DOI 10.1007/s00442-008-1056-4; Perez-Barberia FJ, 1998, J ZOOL, V245, P307, DOI 10.1111/j.1469-7998.1998.tb00106.x; Perez-Barberia FJ, 1998, BIOL J LINN SOC, V63, P233, DOI 10.1111/j.1095-8312.1998.tb01516.x; SHIPLEY LA, 1994, AM NAT, V143, P1055, DOI 10.1086/285648; SPALINGER DE, 1986, CAN J ZOOL, V64, P312, DOI 10.1139/z86-051; THOMAS JW, 1961, J DAIRY SCI, V44, P1471, DOI 10.3168/jds.S0022-0302(61)89909-8; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WILSON JR, 1994, J AGR SCI, V122, P173, DOI 10.1017/S0021859600087347; Yu Changqing, 1996, Acta Theriologica Sinica, V16, P19; Yu S, 2011, MILU BIODIVERSITY DA, P18; Zeng Yan, 2004, Acta Theriologica Sinica, V24, P78; Zheng W, 2013, CURR ZOOL, V59, P265, DOI 10.1093/czoolo/59.2.265	43	7	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66261	10.1371/journal.pone.0066261	http://dx.doi.org/10.1371/journal.pone.0066261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823072	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400073
J	Mueller, JL; Harmany, ZT; Mito, JK; Kennedy, SA; Kim, Y; Dodd, L; Geradts, J; Kirsch, DG; Willett, RM; Brown, JQ; Ramanujam, N				Mueller, Jenna L.; Harmany, Zachary T.; Mito, Jeffrey K.; Kennedy, Stephanie A.; Kim, Yongbaek; Dodd, Leslie; Geradts, Joseph; Kirsch, David G.; Willett, Rebecca M.; Brown, J. Quincy; Ramanujam, Nimmi			Quantitative Segmentation of Fluorescence Microscopy Images of Heterogeneous Tissue: Application to the Detection of Residual Disease in Tumor Margins	PLOS ONE			English	Article							CELL-NUCLEI; AUTOMATIC SEGMENTATION; BREAST-CANCER; MOUSE MODEL; REPRESENTATIONS; DIAGNOSIS; THERAPY	Purpose: To develop a robust tool for quantitative in situ pathology that allows visualization of heterogeneous tissue morphology and segmentation and quantification of image features. Materials and Methods: Tissue excised from a genetically engineered mouse model of sarcoma was imaged using a subcellular resolution microendoscope after topical application of a fluorescent anatomical contrast agent: acriflavine. An algorithm based on sparse component analysis (SCA) and the circle transform (CT) was developed for image segmentation and quantification of distinct tissue types. The accuracy of our approach was quantified through simulations of tumor and muscle images. Specifically, tumor, muscle, and tumor+muscle tissue images were simulated because these tissue types were most commonly observed in sarcoma margins. Simulations were based on tissue characteristics observed in pathology slides. The potential clinical utility of our approach was evaluated by imaging excised margins and the tumor bed in a cohort of mice after surgical resection of sarcoma. Results: Simulation experiments revealed that SCA+CT achieved the lowest errors for larger nuclear sizes and for higher contrast ratios (nuclei intensity/background intensity). For imaging of tumor margins, SCA+CT effectively isolated nuclei from tumor, muscle, adipose, and tumor+muscle tissue types. Differences in density were correctly identified with SCA+CT in a cohort of ex vivo and in vivo images, thus illustrating the diagnostic potential of our approach. Conclusion: The combination of a subcellular-resolution microendoscope, acriflavine staining, and SCA+CT can be used to accurately isolate nuclei and quantify their density in anatomical images of heterogeneous tissue.	[Mueller, Jenna L.; Kennedy, Stephanie A.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Harmany, Zachary T.; Willett, Rebecca M.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Mito, Jeffrey K.; Kirsch, David G.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Lab Vet Clin Pathol, Seoul, South Korea; [Dodd, Leslie] Univ N Carolina, Sch Med, Dept Pathol, Chapel Hill, NC USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Kirsch, David G.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC USA; [Brown, J. Quincy] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Duke University; Duke University; Duke University; Seoul National University (SNU); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Tulane University	Mueller, JL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	jenna.mueller@duke.edu	Harmany, Zachary/AAN-6389-2021; Ramanujam, Nimmi/AAA-7575-2021; Brown, J. Quincy/F-6090-2012	Harmany, Zachary/0000-0002-5871-1783; Ramanujam, Nimmi/0000-0001-7319-8415; 	Department of Defense (DOD) [W81XWH-09-1-0410]; Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE [R21CA159936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the Department of Defense (DOD) Grant Number W81XWH-09-1-0410 and a Damon Runyon-Rachleff Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Bigio IJ, 2000, J BIOMED OPT, V5, P221, DOI 10.1117/1.429990; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Bunyak F, 2011, ADV EXP MED BIOL, V696, P413, DOI 10.1007/978-1-4419-7046-6_41; Candes EJ, 2004, COMMUN PUR APPL MATH, V57, P219, DOI 10.1002/cpa.10116; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Clark AL, 2004, J BIOMED OPT, V9, P1271, DOI 10.1117/1.1805558; Clark AL, 2003, CLIN CANCER RES, V9, P4714; Cohen C, 1996, HUM PATHOL, V27, P482, DOI 10.1016/S0046-8177(96)90091-X; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Drezek RA, 2003, CANCER-AM CANCER SOC, V98, P2015, DOI 10.1002/cncr.11678; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Eng J, 2006, ROC ANAL WEB BASED C; FERGUSON LR, 1991, MUTAT RES, V258, P123, DOI 10.1016/0165-1110(91)90006-H; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Figueiredo MAT, 2010, IEEE T IMAGE PROCESS, V19, P3133, DOI 10.1109/TIP.2010.2053941; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Gonzalez R. C., 2007, DIGITAL IMAGING PROC; Haka AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247154; Harmany Z, 2011, P SPIE, V8138; Harmany ZT, 2012, IEEE T IMAGE PROCESS, V21, P1084, DOI 10.1109/TIP.2011.2168410; Karen JK, 2009, BRIT J DERMATOL, V160, P1242, DOI 10.1111/j.1365-2133.2009.09141.x; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Ko B, 2009, J DIGIT IMAGING, V22, P259, DOI 10.1007/s10278-008-9129-9; Korde VR, 2009, ANAL QUANT CYTOL, V31, P83; Korzynska A, 2007, PATTERN ANAL APPL, V10, P301, DOI 10.1007/s10044-007-0069-7; Krolenko SA, 2006, CELL BIOL INT, V30, P933, DOI 10.1016/j.cellbi.2006.06.017; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Millot C, 2000, HISTOL HISTOPATHOL, V15, P1185, DOI 10.14670/HH-15.1185; Mito JK, 2012, CANCER-AM CANCER SOC, V118, P5320, DOI 10.1002/cncr.27458; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Muldoon TJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3406386; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Nyirenda N, 2011, BREAST CANCER RES TR, V126, P345, DOI 10.1007/s10549-010-0914-z; Pisters PWT, 1996, J CLIN ONCOL, V14, P859, DOI 10.1200/JCO.1996.14.3.859; Sabolch A, 2012, AM J CLIN ONCOL-CANC, V35, P151, DOI 10.1097/COC.0b013e318209cd72; SADOSKI C, 1993, J SURG ONCOL, V52, P223, DOI 10.1002/jso.2930520405; SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Starck JL, 2005, IEEE T IMAGE PROCESS, V14, P1570, DOI 10.1109/TIP.2005.852206; Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207139; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Vachier C, 2005, J MATH IMAGING VIS, V22, P251, DOI 10.1007/s10851-005-4893-3; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Wittenberg T, 2004, METHOD INFORM MED, V43, P343; Wolf L, 2011, PLOS ONE, V6; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	50	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66198	10.1371/journal.pone.0066198	http://dx.doi.org/10.1371/journal.pone.0066198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824589	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400069
J	Kai, AKL; Lam, AKM; Chen, YX; Tai, ACP; Zhang, XM; Lai, AKW; Yeung, PKK; Tam, S; Wang, J; Lam, KS; Vanhoutte, PM; Bos, JL; Chung, SSM; Xu, AM; Chung, SK				Kai, Alan K. L.; Lam, Amy K. M.; Chen, Yingxian; Tai, Andrew C. P.; Zhang, Xinmei; Lai, Angela K. W.; Yeung, Patrick K. K.; Tam, Sidney; Wang, Jian; Lam, Karen S.; Vanhoutte, Paul M.; Bos, Johannes L.; Chung, Stephen S. M.; Xu, Aimin; Chung, Sookja K.			Exchange protein activated by cAMP 1 (Epac1)-deficien mice develop beta-cell dysfunction and metabolic syndrome	FASEB JOURNAL			English	Article						glucose-stimulated insulin secretion; glucose transporter type 2; hyperglycemia; high-fat-diet-induced obesity; multiple low-dose streptozotocin-induced diabetes	GLUCAGON-LIKE PEPTIDE-1; INSULIN-RESISTANCE; CYCLIC-AMP; EXPRESSION; RECEPTOR; EXENDIN-4; APOPTOSIS; EPAC; DIFFERENTIATION; ABNORMALITIES	Previously, exchange protein directly activated by cAMP 2 (Epac2) and PKA were known to play a role in glucose-stimulated insulin secretion (GSIS) by pancreatic cells. The present study shows that Epac1 mRNA is also expressed by cells. Therefore, we generated mice and embryonic stem (ES) cells with deletion of the Epac1 gene to define its role in -cell biology and metabolism. The homozygous Epac1-knockout (Epac1(-/-)) mice developed impaired glucose tolerance and GSIS with deranged islet cytoarchitecture, which was confirmed by isolated islets from adult Epac1(-/-) mice. Moreover, Epac1(-/-) mice developed more severe hyperglycemia with increased -cell apoptosis and insulitis after multiple low-dose streptozotocin (MLDS; 40 mg/kg) treatment than Epac1(+/+) mice. Interestingly, Epac1(-/-) mice also showed metabolic defects, including increased respiratory exchange ratio (RER) and plasma triglyceride (TG), and more severe diet-induced obesity with insulin resistance, which may contributed to -cell dysfunction. However, islets differentiated from Epac1(-/-) ES cells showed insulin secretion defect, reduced Glut2 and PDX-1 expression, and abolished GLP-1-stimulated PCNA induction, suggesting a role of Epac1 in -cell function. The current study provides in vitro and in vivo evidence that Epac1 has an important role in GSIS of cells and phenotype resembling metabolic syndrome. Kai, A. K. L., Lam, A. K. M., Chen, Y., Tai, A. C. P., Zhang, X., Lai, A. K. W., Yeung, P. K. K., Tam, S., Wang, J., Lam, K. S., Vanhoutte, P. M., Bos, J. L., Chung, S. S. M., Xu, A., Chung, S. K. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop -cell dysfunction and metabolic syndrome.	[Kai, Alan K. L.; Lam, Amy K. M.; Chen, Yingxian; Tai, Andrew C. P.; Lai, Angela K. W.; Yeung, Patrick K. K.; Chung, Sookja K.] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Zhang, Xinmei; Lam, Karen S.; Xu, Aimin] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Tam, Sidney] Univ Hong Kong, Clin Biochem Unit, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Vanhoutte, Paul M.] Univ Hong Kong, Dept Pharmacol, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Lam, Karen S.; Vanhoutte, Paul M.; Xu, Aimin; Chung, Sookja K.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Wang, Jian] Forth Mil Med Univ, Xian, Peoples R China; [Bos, Johannes L.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Chung, Stephen S. M.] United Int Coll, Div Sci & Technol, Zhuhai, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Air Force Military Medical University; Utrecht University; Utrecht University Medical Center; Beijing Normal University - Hong Kong Baptist University United International College	Chung, SK (corresponding author), Dept Anat, 1-F,Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	skchung@hkucc.hku.hk	; Chen, Christina Yingxian/O-5676-2016	Tai, Andrew Chi Pang/0000-0002-9120-7562; Chen, Christina Yingxian/0000-0002-8013-1515	Hong Kong General Research Fund; Merck external grant ( [36689]	Hong Kong General Research Fund; Merck external grant (	This work was supported by funding from a Hong Kong General Research Fund grant to S.K.C. (principal investigator) and Merck external grant (IISP ID 36689) to S.E.C. (principal investigator) and K.S.L. (coinvestigator).	Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Harrity T, 2006, DIABETES, V55, P240, DOI 10.2337/diabetes.55.01.06.db05-0648; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; Jorns A, 1996, VIRCHOWS ARCH, V428, P177; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Koh G, 2005, ARCH BIOCHEM BIOPHYS, V438, P70, DOI 10.1016/j.abb.2005.03.018; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; Leech CA, 2000, BIOCHEM BIOPH RES CO, V278, P44; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li H, 2010, ACTA PHARMACOL SIN, V31, P570, DOI 10.1038/aps.2010.38; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Liu MJ, 2010, J MOL MED, V88, P351, DOI 10.1007/s00109-009-0571-z; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Movassat J, 2002, J CLIN ENDOCR METAB, V87, P4775, DOI 10.1210/jc.2002-020137; OBrien BA, 1996, J PATHOL, V178, P176; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; PILKIS SJ, 1988, ADV SEC MESS PHOSPH, V22, P175; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; Schroeder IS, 2006, NAT PROTOC, V1, P495, DOI 10.1038/nprot.2006.71; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yan JB, 2013, MOL CELL BIOL, V33, P918, DOI 10.1128/MCB.01227-12; Zhao AZ, 2005, CURR TOP DEV BIOL, V67, P207, DOI 10.1016/S0070-2153(05)67006-8	45	45	47	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4122	4135		10.1096/fj.13-230433	http://dx.doi.org/10.1096/fj.13-230433			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825225				2022-12-25	WOS:000329747100024
J	Li, SH; Guo, J; Wu, J; Sun, Z; Han, MH; Shan, SW; Deng, ZQ; Yang, BB; Weisel, RD; Li, RK				Li, Shu-Hong; Guo, Jian; Wu, Jun; Sun, Zhuo; Han, Mihan; Shan, Sze Wan; Deng, Zhaoqun; Yang, Burton B.; Weisel, Richard D.; Li, Ren-Ke			miR-17 targets tissue inhibitor of metalloproteinase 1 and 2 to modulate cardiac matrix remodeling	FASEB JOURNAL			English	Article						TIMP1; TIMP2; MMP; myocardial infarction	RANDOMIZED PHASE-1 TRIAL; MYOCARDIAL-INFARCTION; ISCHEMIC CARDIOMYOPATHY; HEART-FAILURE; BONE-MARROW; STEM-CELLS; MICRORNAS; MICE; EXPRESSION; DEFICIENCY	We aimed to investigate the role of miR-17 in cardiac matrix remodeling following myocardial infarction (MI). Using real-time PCR, we quantified endogenous miR-17 in infarcted mouse hearts. Compared with related microRNAs, miR-17 was up-regulated most dramatically: 3.7-fold and 2.4-fold in the infarct region 3 and 7 d post-MI, respectively, and 2.4-fold in the border zone at d 3 compared to sham control (P<0.01). Chimeric luciferase reporter constructs were cloned for miR-17 target validation. miR-17 targeted the 3-UTR of TIMP2 and the protein coding region of TIMP1. The miR-17 mimic decreased TIMP2 (P<0.01) and TIMP1 (P<0.05) protein expression compared with the scrambled control. Inhibition of endogenous miR-17 by in vivo antagomir delivery enhanced TIMP2 (P<0.01) and TIMP1 (P<0.05) protein expression compared to the mismatch group, decreased MMP9 activity (P<0.05), reduced infarct size as early as 7 d post-MI (P<0.05), and improved cardiac function (fractional shortening and fractional area contraction, P<0.05) at d 21 and 28 post-MI. Transgenic mice overexpressing miR-17 in the heart confirmed the deleterious role of miR-17 in matrix modulation. Our study suggests that miR-17 participates in the regulation of cardiac matrix remodeling and provides a novel therapeutic approach using miR-17 inhibitors to prevent remodeling and heart failure after MI.Li, S.-H., Guo, J., Wu, J., Sun, Z., Han, M., Shan, S. W., Deng, Z., Yang, B. B., Weisel, R. D., Li, R.-K. miR-17 targets tissue inhibitor of metalloproteinase 1 and 2 to modulate cardiac matrix remodeling.	[Li, Shu-Hong; Guo, Jian; Wu, Jun; Sun, Zhuo; Han, Mihan; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Div Cardiovasc Surg, Toronto, ON, Canada; [Li, Shu-Hong; Guo, Jian; Wu, Jun; Sun, Zhuo; Han, Mihan; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Li, Shu-Hong; Guo, Jian; Wu, Jun; Sun, Zhuo; Han, Mihan; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada; [Shan, Sze Wan; Deng, Zhaoqun; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Li, RK (corresponding author), Univ Hlth Network, MaRS Ctr, Toronto Med Discovery Tower,Rm 3-702,101 Coll St, Toronto, ON M5G 1L7, Canada.	renkeli@uhnres.utoronto.ca		Li, Ren-Ke/0000-0002-2584-060X; SHAN, SW/0000-0001-6876-9914	Canadian Institutes of Health Research [MOP102535, MOP111171]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (MOP102535 to R.K.L. and MOP111171 to B.B.Y.). R.K.L. holds a Canada Research Chair in Cardiac Regeneration. The authors thank Kelly Davis for editing the manuscript. The authors declare no conflicts of interest.	Angoulvant D, 2009, J THORAC CARDIOV SUR, V137, P471, DOI 10.1016/j.jtcvs.2008.08.031; Assmus B, 2013, JAMA-J AM MED ASSOC, V309, P1622, DOI 10.1001/jama.2013.3527; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; Felkin LE, 2006, J HEART LUNG TRANSPL, V25, P1413, DOI 10.1016/j.healun.2006.09.006; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Jugdutt BI, 2009, NEW ENGL J MED, V360, P1567, DOI 10.1056/NEJMcibr0810801; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tian H, 2007, J MOL CELL CARDIOL, V43, P733, DOI 10.1016/j.yjmcc.2007.09.003; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353	28	25	26	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4254	4265		10.1096/fj.13-231688	http://dx.doi.org/10.1096/fj.13-231688			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825222	Bronze			2022-12-25	WOS:000329747100035
J	Yang, SL; Roselli, F; Patchev, AV; Yu, S; Almeida, OFX				Yang, Silei; Roselli, Francesco; Patchev, Alexandre V.; Yu, Shuang; Almeida, Osborne F. X.			Non-receptor-tyrosine Kinases Integrate Fast Glucocorticoid Signaling in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; NR2B-CONTAINING NMDA-RECEPTORS; PROTEIN-COUPLED RECEPTORS; MEDIATED CA2+ ELEVATION; BETA-GAMMA-SUBUNITS; C-ABL; MINERALOCORTICOID RECEPTORS; DIFFERENTIAL ROLES; PTP-PEST; ACTIVATION	Despite numerous descriptions of rapid effects of corticosterone on neuronal function, the intracellular mechanisms responsible for these changes remain elusive. The present comprehensive analysis reveals that signaling from a membrane-located G protein-coupled receptor activates PKC, Akt/PKB, and PKA, which subsequently trigger the phosphorylation of the tyrosine kinases Pyk2, Src, and Abl. These changes induce rapid cytoskeletal rearrangements (increased PSD-95 co-clustering) within the post-synaptic density; these events are accompanied by increased surfaceNMDAreceptor expression, reflecting corticosterone-induced inhibition of NMDA receptor endocytosis. Notably, none of these signaling mechanisms require de novo protein synthesis. The observed up-regulation of ERK1/2 (downstream of NMDA receptor signaling) together with the fact that c-Abl integrates cytoplasmic and nuclear functions introduces a potential mechanism through which rapid signaling initiated at the plasma membrane may eventually determine the long term integrated response to corticosterone by impacting on the transcriptional machinery that is regulated by classical, nuclear mineralocorticoid, and glucocorticoid receptors.	[Yang, Silei; Roselli, Francesco; Patchev, Alexandre V.; Yu, Shuang; Almeida, Osborne F. X.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Roselli, Francesco] Univ Bari, Dept Neurol & Psychiat Sci, I-70121 Bari, Italy	Max Planck Society; Universita degli Studi di Bari Aldo Moro	Almeida, OFX (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	osa@mpipsykl.mpg.de	roselli, francesco/G-6701-2013; Almeida, Osborne F.X. F/E-8402-2010; roselli, francesco/O-8847-2019	Almeida, Osborne F.X. F/0000-0001-7331-6928; roselli, francesco/0000-0001-9935-6899	Max Planck Society; EU [LSHM-CT-2005-018652, 259772]	Max Planck Society(Max Planck SocietyFoundation CELLEX); EU(European Commission)	Both authors contributed equally to this work and were supported by fellowships from the Max Planck Society.; Supported through EU Integrated Projects Crescendo Contract LSHM-CT-2005-018652 and SWITCHBOX Contract Grant Agreement 259772.	Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Aoto H, 2002, CELL STRUCT FUNCT, V27, P47, DOI 10.1247/csf.27.47; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bartos JA, 2010, J NEUROSCI, V30, P449, DOI 10.1523/JNEUROSCI.4992-08.2010; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dorey R, 2011, NEUROPSYCHOPHARMACOL, V36, P2639, DOI 10.1038/npp.2011.152; Dushek O, 2012, IMMUNOL REV, V250, P258, DOI 10.1111/imr.12008; Evanson NK, 2010, ENDOCRINOLOGY, V151, P4811, DOI 10.1210/en.2010-0285; Ferris CF, 2010, PSYCHONEUROENDOCRINO, V35, P5, DOI 10.1016/j.psyneuen.2009.09.003; Gao CL, 2009, BIOCHEM J, V420, P49, DOI 10.1042/BJ20090037; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gros R, 2013, AM J PHYSIOL-CELL PH, V304, pC532, DOI 10.1152/ajpcell.00203.2012; Heidinger V, 2002, J NEUROSCI, V22, P5452; Hsin H, 2010, J NEUROSCI, V30, P11983, DOI 10.1523/JNEUROSCI.1029-10.2010; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komatsuzaki Y, 2005, BIOCHEM BIOPH RES CO, V335, P1002, DOI 10.1016/j.bbrc.2005.07.173; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; LIPOSITS Z, 1993, J NEUROSCI RES, V35, P14, DOI 10.1002/jnr.490350103; Liu SB, 2012, J NEUROSCI, V32, P4887, DOI 10.1523/JNEUROSCI.5828-11.2012; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; McGarrigle D., 2007, SCI STKE, V392, pp, DOI [10.1126/stke.3922007pe35, DOI 10.1126/STKE.3922007PE35]; Mikics E, 2007, PSYCHONEUROENDOCRINO, V32, P160, DOI 10.1016/j.psyneuen.2006.12.002; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; PARK DG, 1993, J BIOL CHEM, V268, P4573; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Prager EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014344; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Radulovic J, 1999, J NEUROSCI, V19, P5016; Riedemann T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-2; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; Sanchez-Arevalo L. V. J., 2013, ONCOGENE; Sato S, 2004, BIOCHEM BIOPH RES CO, V321, P510, DOI 10.1016/j.bbrc.2004.06.168; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schmidt P, 2001, MOL ENDOCRINOL, V15, P553, DOI 10.1210/me.15.4.553; Seabold GK, 2003, J BIOL CHEM, V278, P15040, DOI 10.1074/jbc.M212825200; Souza CM, 2012, J BIOL CHEM, V287, P43180, DOI 10.1074/jbc.M112.387456; Suo L, 2012, J MOL CELL BIOL, V4, P362, DOI 10.1093/jmcb/mjs034; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Venero C, 1999, EUR J NEUROSCI, V11, P2465, DOI 10.1046/j.1460-9568.1999.00668.x; Xu J, 2012, J BIOL CHEM, V287, P20942, DOI 10.1074/jbc.M112.368654; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422; Zrihan-Licht S, 2004, INT J ONCOL, V24, P153	64	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23725	23739		10.1074/jbc.M113.470146	http://dx.doi.org/10.1074/jbc.M113.470146			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818519	Green Published, hybrid			2022-12-25	WOS:000330611400013
J	Lengert, L; Drossel, B				Lengert, Laurin; Drossel, Barbara			Deducing Underlying Mechanisms from Protein Recruitment Data	PLOS ONE			English	Article							KINETICS; REPAIR; DYNAMICS; FRAP	By using fluorescent labelling techniques, the distribution and dynamics of proteins can be measured within living cells, allowing to study in vivo the response of cells to a triggering event, such as DNA damage. In order to evaluate the reaction rate constants and to identify the proteins and reactions that are essential for the investigated process, mechanistic models are used, which often contain many proteins and associated parameters and are therefore underdetermined by the data. In order to establish criteria for assessing the significance of a model, we present here a systematic investigation of the information that can be reliably deduced from protein recruitment data, assuming that the complete set of reactions that affect the data of the considered protein species is not known. To this purpose, we study in detail models where one or two proteins that influence each other are recruited to a substrate. We show that in many cases the kind of interaction between the proteins can be deduced by analyzing the shape of the recruitment curves of one protein. Furthermore, we discuss in general in which cases it is possible to discriminate between different models and in which cases it is impossible based on the data. Finally, we argue that if different models fit experimental data equally well, conducting experiments with different protein concentrations would allow discrimination between the alternative models in many cases.	[Lengert, Laurin; Drossel, Barbara] Tech Univ Darmstadt, Inst Condensed Matter Phys, Darmstadt, Germany	Technical University of Darmstadt	Lengert, L (corresponding author), Tech Univ Darmstadt, Inst Condensed Matter Phys, Darmstadt, Germany.	lengert@fkp.tu-darmstadt.de			Deutsche Forschungsgemeinschaft within the Graduiertenkolleg 1657	Deutsche Forschungsgemeinschaft within the Graduiertenkolleg 1657	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) within the Graduiertenkolleg 1657 "Molecular and cellular responses to ionizing radiation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Friedland W, 2010, RADIAT RES, V173, P677, DOI 10.1667/RR1965.1; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Truong K, 2001, CURRENT OPINION STRU, V11	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66590	10.1371/journal.pone.0066590	http://dx.doi.org/10.1371/journal.pone.0066590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826103	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000006
J	Chow, BA; Donahue, SW; Vaughan, MR; McConkey, B; Vijayan, MM				Chow, Brian A.; Donahue, Seth W.; Vaughan, Michael R.; McConkey, Brendan; Vijayan, Mathilakath M.			Serum Immune-Related Proteins are Differentially Expressed during Hibernation in the American Black Bear	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; GROUND-SQUIRRELS; URSUS-AMERICANUS; GENE-EXPRESSION; METABOLIC SUPPRESSION; BLOOD-COAGULATION; BONE-FORMATION; DISUSE; PLASMA; LIVER	Hibernation is an adaptation to conserve energy in the face of extreme environmental conditions and low food availability that has risen in several animal phyla. This phenomenon is characterized by reduced metabolic rate (similar to 25% of the active basal metabolic rate in hibernating bears) and energy demand, while other physiological adjustments are far from clear. The profiling of the serum proteome of the American black bear (Ursus americanus) may reveal specific proteins that are differentially modulated by hibernation, and provide insight into the remarkable physiological adaptations that characterize ursid hibernation. In this study, we used differential gel electrophoresis (DIGE) analysis, liquid chromatography coupled to tandem mass spectrometry, and subsequent MASCOT analysis of the mass spectra to identify candidate proteins that are differentially expressed during hibernation in captive black bears. Seventy serum proteins were identified as changing by +/- 1.5 fold or more, out of which 34 proteins increased expression during hibernation. The majority of identified proteins are involved in immune system processes. These included alpha(2)-macroglobulin, complement components C1s and C4, immunoglobulin mu and J chains, clusterin, haptoglobin, C4b binding protein, kininogen 1, alpha(2)-HS-glycoprotein, and apoplipoproteins A-I and A-IV. Differential expression of a subset of these proteins identified by proteomic analysis was also confirmed by immunodetection. We propose that the observed serum protein changes contribute to the maintenance of the hibernation phenotype and health, including increased capacities for bone maintenance and wound healing during hibernation in bears.	[Chow, Brian A.; McConkey, Brendan; Vijayan, Mathilakath M.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Donahue, Seth W.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Vaughan, Michael R.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	University of Waterloo; Colorado State University; Virginia Polytechnic Institute & State University	Vijayan, MM (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	matt.vijayan@ucalgary.ca	Vijayan, Mathilakath/AAC-2190-2020		Natural Sciences and Engineering Research Council of Canada Discovery Grant	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada Discovery Grant to MMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTTS B, 1979, CRYOBIOLOGY, V16, P179, DOI 10.1016/0011-2240(79)90029-4; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barboza PS, 1997, CAN J ZOOL, V75, P2129, DOI 10.1139/z97-848; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertile F, 2009, PROTEOMICS, V9, P148, DOI 10.1002/pmic.200701001; BILLINGHAM RE, 1960, ANN SURG, V152, P975, DOI 10.1097/00000658-196012000-00008; Binkert C, 1999, J BIOL CHEM, V274, P28514, DOI 10.1074/jbc.274.40.28514; BIORCK G, 1962, ACTA PHYSIOL SCAND, V56, P334, DOI 10.1111/j.1748-1716.1962.tb02510.x; Bolling SF, 1997, ANN THORAC SURG, V64, P623, DOI 10.1016/S0003-4975(97)00631-0; Bouma HR, 2012, J CELL PHYSIOL, V227, P1285, DOI 10.1002/jcp.22850; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Bouwman FG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-24; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; Chow BA, 2010, GEN COMP ENDOCR, V167, P317, DOI 10.1016/j.ygcen.2010.03.027; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Donahue SW, 2006, J EXP BIOL, V209, P1630, DOI 10.1242/jeb.02185; Donahue SW, 2003, J EXP BIOL, V206, P4233, DOI 10.1242/jeb.00671; Epperson LE, 2010, AM J PHYSIOL-REG I, V298, pR329, DOI 10.1152/ajpregu.00416.2009; Fedorov VB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-171; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; FOLK G E JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P107; Frobert O, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-11; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; HALLER AC, 1977, J DENT RES, V56, P1552, DOI 10.1177/00220345770560122601; HAYASHI H, 1990, J LIPID RES, V31, P1613; HEIMARK RL, 1980, NATURE, V286, P456, DOI 10.1038/286456a0; Hellgren EC, 1998, URSUS-SERIES, V10, P467; HELLGREN EC, 1990, J MAMMAL, V71, P291, DOI 10.2307/1381939; Horton ND, 1998, COMP BIOCHEM PHYS B, V119, P787, DOI 10.1016/S0305-0491(98)00056-X; Iaizzo PA, 2012, INTEGR ZOOL, V7, P48, DOI [10.1111/j.1749-4877.2012.00275.x, 10.1111/j.1749-4877.2011.00280.x]; KAPLAN AP, 1987, BLOOD, V70, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECHLER E, 1963, AM J PHYSIOL, V205, P985, DOI 10.1152/ajplegacy.1963.205.5.985; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; LUNDBERG DA, 1976, MAYO CLIN PROC, V51, P716; Mcgee ME, 2008, BONE, V42, P396, DOI 10.1016/j.bone.2007.10.010; McGee-Lawrence ME, 2009, BONE, V45, P1186, DOI 10.1016/j.bone.2009.08.011; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; McGee-Lawrence ME, 2008, AM J PHYSIOL-REG I, V295, pR1999, DOI 10.1152/ajpregu.90648.2008; Milbury PE, 1998, URSUS-SERIES, V10, P507; Mominoki K, 2005, COMP BIOCHEM PHYS A, V142, P472, DOI 10.1016/j.cbpa.2005.09.017; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; OELTGEN PR, 1988, LIFE SCI, V43, P1565, DOI 10.1016/0024-3205(88)90406-7; Pacifici R, 2012, J BONE MINER RES, V27, P231, DOI 10.1002/jbmr.1500; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBERTS NJ, 1979, MICROBIOL REV, V43, P241, DOI 10.1128/MMBR.43.2.241-259.1979; RUIT KA, 1987, J THERM BIOL, V12, P135; SCRIBA PC, 1979, ACTA ENDOCRINOL-COP, V91, P629, DOI 10.1530/acta.0.0910629; Seger RL, 2011, BONE, V49, P1205, DOI 10.1016/j.bone.2011.08.017; Sheikh AM, 2003, BIOCHIMIE, V85, P1027, DOI 10.1016/S0300-9084(03)00133-0; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; SRERE HK, 1995, AM J PHYSIOL-REG I, V268, pR1507, DOI 10.1152/ajpregu.1995.268.6.R1507; STEINBERG B, 1986, HISTOL HISTOPATHOL, V1, P155; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; WANG LCH, 1979, CAN J ZOOL, V57, P149, DOI 10.1139/z79-012; Weaver KN, 2009, ACTA CHIROPTEROL, V11, P220, DOI 10.3161/150811009X465866; Wildes D, 2010, P NATL ACAD SCI USA, V107, P4561, DOI 10.1073/pnas.0914495107; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	67	24	25	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66119	10.1371/journal.pone.0066119	http://dx.doi.org/10.1371/journal.pone.0066119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825529	gold, Green Submitted, Green Published			2022-12-25	WOS:000321223000008
J	Klatte-Schulz, F; Pauly, S; Scheibel, M; Greiner, S; Gerhardt, C; Hartwig, J; Schmidmaier, G; Wildemann, B				Klatte-Schulz, Franka; Pauly, Stephan; Scheibel, Markus; Greiner, Stefan; Gerhardt, Christian; Hartwig, Jelka; Schmidmaier, Gerhard; Wildemann, Britt			Characteristics and Stimulation Potential with BMP-2 and BMP-7 of Tenocyte-Like Cells Isolated from the Rotator Cuff of Female Donors	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOGENIC PROTEIN-1; STEM-CELLS; ARTHROSCOPIC REPAIR; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; SINGLE-ROW; IN-VIVO; TENDON; ESTROGEN	Tendon bone healing of the rotator cuff is often associated with non-healing or recurrent defects, which seems to be influenced by the patient's age and sex. The present study aims to examine cellular biological characteristics of tenocyte-like cells that may contribute to this impaired rotator cuff healing. Moreover, a therapeutic approach using growth factors could possibly stimulate tendon bone healing. Therefore, our second aim was to identify patient groups who would particularly benefit from growth factor stimulation. Tenocyte-like cells isolated from supraspinatus tendons of female donors younger and older than 65 years of age were characterized with respect to different cellular biological parameters, such as cell density, cell count, marker expression, collagen-I protein synthesis, and stem cell potential. Furthermore, cells of the donor groups were stimulated with BMP-2 and BMP-7 (200 and 1000 ng/ml) in 3D-culture and analyzed for cell count, marker expression and collagen-I protein synthesis. Female donors older than 65 years of age showed significantly decreased cell count and collagen-I protein synthesis compared to cells from donors younger than 65 years. Cellular biological parameters including cell count, collagen-I and -III expression, and collagen-I protein synthesis of cells from both donor groups were stimulated with BMP-2 and BMP-7. The cells from donors older than 65 years revealed a decreased stimulation potential for cell count compared to the younger group. Cells from female donors older than 65 years of age showed inferior cellular biological characteristics. This may be one reason for a weaker healing potential observed in older female patients and should be taken into consideration for tendon bone healing of the rotator cuff.	[Klatte-Schulz, Franka; Pauly, Stephan; Scheibel, Markus; Greiner, Stefan; Gerhardt, Christian; Wildemann, Britt] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Julius Wolff Inst, Berlin, Germany; [Klatte-Schulz, Franka; Hartwig, Jelka; Wildemann, Britt] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Schmidmaier, Gerhard] Univ Klinikum Heidelberg, Dept Orthopadie Unfallchirurg & Paraplegiol, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg	Klatte-Schulz, F (corresponding author), Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Julius Wolff Inst, Berlin, Germany.	Franka.Klatte@charite.de	Wildemann, Britt/G-7732-2012; Klatte-Schulz, Franka/B-6734-2017	Wildemann, Britt/0000-0002-8365-1188; Klatte-Schulz, Franka/0000-0001-6079-228X	Deutsche Vereinigung fur Schulter- und Ellenbogenchirurgie (DVSE); Charite	Deutsche Vereinigung fur Schulter- und Ellenbogenchirurgie (DVSE); Charite	The study was financially supported by the Deutsche Vereinigung fur Schulter- und Ellenbogenchirurgie (DVSE, a non-profit organization, http://www.dvse.info/). We wish to confirm that there are no conflicts of interest associated with this publication and there has been no financial support for this work that could have influenced its outcome. Additionally the first author Franka Klatte-Schulz received a stipend from the Charite to finish her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne O., 1984, SURG SHOULDER, P167; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Bridgeman JT, 2010, FOOT ANKLE INT, V31, P1081, DOI 10.3113/FAI.2010.1081; Burgess KE, 2009, CLIN BIOMECH, V24, P504, DOI 10.1016/j.clinbiomech.2009.03.011; Burgess KE, 2010, J STRENGTH COND RES, V24, P2088, DOI 10.1519/JSC.0b013e3181aeb12b; Burks RT, 2009, AM J SPORT MED, V37, P674, DOI 10.1177/0363546508328115; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng MT, 2009, CELL PROLIFERAT, V42, P448, DOI 10.1111/j.1365-2184.2009.00611.x; Cho NS, 2011, AM J SPORT MED, V39, P2108, DOI 10.1177/0363546510397171; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Deutsch A, 2008, J SHOULDER ELB SURG, V17, P845, DOI 10.1016/j.jse.2008.04.004; Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fossett E, 2012, J ORTHOP RES, V30, P1013, DOI 10.1002/jor.22057; Frank JB, 2008, AM J SPORT MED, V36, P1496, DOI 10.1177/0363546507313574; Gerber C, 1999, J BONE JOINT SURG AM, V81A, P1281, DOI 10.2106/00004623-199909000-00009; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Grasso A, 2009, ARTHROSCOPY, V25, P4, DOI 10.1016/j.arthro.2008.09.018; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Irie T, 2010, CONNECT TISSUE RES, V51, P179, DOI 10.3109/03008200903204669; Itaya T, 2009, J PERIODONTAL RES, V44, P425, DOI 10.1111/j.1600-0765.2008.01137.x; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Klatte-Schulz F, 2012, EUR CELLS MATER, V24, P74, DOI 10.22203/eCM.v024a06; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312; Magnusson SP, 2007, INT J EXP PATHOL, V88, P237, DOI 10.1111/j.1365-2613.2007.00551.x; Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005; Mazzocca AD., 2011, KNEE SURG SPORTS TRA; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Neumann K, 2007, J CELL BIOCHEM, V102, P626, DOI 10.1002/jcb.21319; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Pauly S, 2010, EUR CELLS MATER, V20, P84, DOI 10.22203/eCM.v020a08; Pauly S, 2011, J SHOULDER ELBOW SUR; Razmjou H, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-66; Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Shu W, 2012, J CELL BIOCH; Sorensen AKB, 2007, J SHOULDER ELB SURG, V16, P174, DOI 10.1016/j.jse.2006.06.010; Steinert AF, 2011, TISSUE ENG PT A, V17, P1375, DOI [10.1089/ten.tea.2010.0413, 10.1089/ten.TEA.2010.0413]; Tashjian RZ, 2010, AM J SPORT MED, V38, P2435, DOI 10.1177/0363546510382835; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Thomopoulos S, 2005, J HAND SURG-AM, V30A, P441, DOI 10.1016/j.jhsa.2004.12.006; Tsai AD, 2003, J CELL BIOCHEM, V90, P777, DOI 10.1002/jcb.10666; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Yamada M, 2008, J ORTHOP RES, V26, P42, DOI 10.1002/jor.20474; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Yeh LCC, 2008, J CELL BIOCHEM, V104, P2107, DOI 10.1002/jcb.21768; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22; Yu WD, 2001, CLIN ORTHOP RELAT R, P268, DOI 10.1097/00003086-200102000-00031; Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023	57	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67209	10.1371/journal.pone.0067209	http://dx.doi.org/10.1371/journal.pone.0067209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825642	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000090
J	Li, Y; Xu, SQ; Jiang, BB; Cohen, RA; Zang, MW				Li, Yu; Xu, Shanqin; Jiang, Bingbing; Cohen, Richard A.; Zang, Mengwei			Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs	PLOS ONE			English	Article							LIPID-METABOLISM; ACCELERATED ATHEROSCLEROSIS; INSULIN-RESISTANCE; DEFICIENT MICE; LIFE-SPAN; SIRT1; KINASE; STRESS; P53; ATHEROGENESIS	Background: Aberrantly elevated sterol regulatory element binding protein (SREBP), the lipogenic transcription factor, contributes to the development of fatty liver and insulin resistance in animals. Our recent studies have discovered that AMP-activated protein kinase (AMPK) phosphorylates SREBP at Ser-327 and inhibits its activity, represses SREBP-dependent lipogenesis, and thereby ameliorates hepatic steatosis and atherosclerosis in insulin-resistant LDLR-/- mice. Chronic inflammation and activation of NLRP3 inflammasome have been implicated in atherosclerosis and fatty liver disease. However, whether SREBP is involved in vascular lipid accumulation and inflammation in atherosclerosis remains largely unknown. Principal Findings: The preclinical study with aortic pouch biopsy specimens from humans with atherosclerosis and diabetes shows intense immunostaining for SREBP-1 and the inflammatory marker VCAM-1 in atherosclerotic plaques. The cleavage processing of SREBP-1 and -2 and expression of their target genes are increased in the well-established porcine model of diabetes and atherosclerosis, which develops human-like, complex atherosclerotic plaques. Immunostaining analysis indicates an elevation in SREBP-1 that is primarily localized in endothelial cells and in infiltrated macrophages within fatty streaks, fibrous caps with necrotic cores, and cholesterol crystals in advanced lesions. Moreover, concomitant suppression of NAD-dependent deacetylase SIRT1 and AMPK is observed in atherosclerotic pigs, which leads to the proteolytic activation of SREBP-1 by diminishing the deacetylation and Ser-372 phosphorylation of SREBP-1. Aberrantly elevated NLRP3 inflammasome markers are evidenced by increased expression of inflammasome components including NLPR3, ASC, and IL-1 beta. The increase in SREBP-1 activity and IL-1b production in lesions is associated with vascular inflammation and endothelial dysfunction in atherosclerotic pig aorta, as demonstrated by the induction of NF-kappa B, VCAM-1, iNOS, and COX-2, as well as by the repression of eNOS. Conclusions: These translational studies provide in vivo evidence that the dysregulation of SIRT1-AMPK-SREBP and stimulation of NLRP3 inflammasome may contribute to vascular lipid deposition and inflammation in atherosclerosis.	[Li, Yu; Xu, Shanqin; Jiang, Bingbing; Cohen, Richard A.; Zang, Mengwei] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA	Boston University	Zang, MW (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA.	mwzang1@bu.edu		/0000-0002-1070-6408; Li, Yu/0000-0001-6910-5933; Zang, Mengwei/0000-0002-2502-2586	National Institutes of Health [DK 076942, HL068758]; Wing Tat Lee Award at Boston University School of Medicine; National Natural Science Foundation of China [81270930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wing Tat Lee Award at Boston University School of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the National Institutes of Health grants DK 076942 (MZ) and HL068758 (RAC) and by the Wing Tat Lee Award at Boston University School of Medicine (MZ). YL is currently supported by a National Natural Science Foundation of China grant (81270930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Foretz M, 1999, MOL CELL BIOL, V19, P3760; GERRITY RG, 1979, AM J PATHOL, V95, P775; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Goldstein JL, 2008, J CLIN INVEST, V118, P1220, DOI 10.1172/JCI34973; Hansson GK, 2005, NEW ENGL J MED, V353, P429; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Xu SQ, 2011, J CARDIOVASC PHARM, V58, P263, DOI 10.1097/FJC.0b013e3182239eb7; Yeh M, 2004, CIRC RES, V95, P780, DOI 10.1161/01.RES.0000146030.53089.18; Yin HQ, 2012, HEPATOLOGY, V56, p1119A; Ying J, 2008, FREE RADICAL BIO MED, V45, P756, DOI 10.1016/j.freeradbiomed.2008.05.029; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zuccollo A, 2005, CIRCULATION, V112, P3001, DOI 10.1161/CIRCULATIONAHA.105.581892	44	22	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67532	10.1371/journal.pone.0067532	http://dx.doi.org/10.1371/journal.pone.0067532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825667	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000107
J	Ueyama, T; Donishi, T; Ukai, S; Ikeda, Y; Hotomi, M; Yamanaka, N; Shinosaki, K; Terada, M; Kaneoke, Y				Ueyama, Takashi; Donishi, Tomohiro; Ukai, Satoshi; Ikeda, Yorihiko; Hotomi, Muneki; Yamanaka, Noboru; Shinosaki, Kazuhiro; Terada, Masaki; Kaneoke, Yoshiki			Brain Regions Responsible for Tinnitus Distress and Loudness: A Resting-State fMRI Study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE; DEPRESSED-PATIENTS; HEAD MOTION; NETWORKS; STIMULATION; CORTEX; ACTIVATION; RELEVANCE; SEVERITY	Subjective tinnitus is characterized by the perception of phantom sound without an external auditory stimulus. We hypothesized that abnormal functionally connected regions in the central nervous system might underlie the pathophysiology of chronic subjective tinnitus. Statistical significance of functional connectivity (FC) strength is affected by the regional autocorrelation coefficient (AC). In this study, we used resting-state functional MRI (fMRI) and measured regional mean FC strength (mean cross-correlation coefficient between a region and all other regions without taking into account the effect of AC (rGC) and with taking into account the effect of AC (rGCa) to elucidate brain regions related to tinnitus symptoms such as distress, depression and loudness. Consistent with previous studies, tinnitus loudness was not related to tinnitus-related distress and depressive state. Although both rGC and rGCa revealed similar brain regions where the values showed a statistically significant relationship with tinnitus-related symptoms, the regions for rGCa were more localized and more clearly delineated the regions related specifically to each symptom. The rGCa values in the bilateral rectus gyri were positively correlated and those in the bilateral anterior and middle cingulate gyri were negatively correlated with distress and depressive state. The rGCa values in the bilateral thalamus, the bilateral hippocampus, and the left caudate were positively correlated and those in the left medial superior frontal gyrus and the left posterior cingulate gyrus were negatively correlated with tinnitus loudness. These results suggest that distinct brain regions are responsible for tinnitus symptoms. The regions for distress and depressive state are known to be related to depression, while the regions for tinnitus loudness are known to be related to the default mode network and integration of multi-sensory information.	[Ueyama, Takashi] Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan; [Donishi, Tomohiro; Kaneoke, Yoshiki] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan; [Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Grad Sch, Dept Neuropsychiat, Wakayama, Japan; [Ikeda, Yorihiko; Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Grad Sch, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp		Ukai, Satoshi/0000-0002-9776-8379	Grants-in-Aid for Scientific Research [24590895, 24591303] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bauer CA, 2011, EAR HEARING, V32, P145, DOI 10.1097/AUD.0b013e3181f5374f; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Chan Yvonne, 2009, Discov Med, V8, P133; Cheung SW, 2010, NEUROSCIENCE, V169, P1768, DOI 10.1016/j.neuroscience.2010.06.007; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dawdy D.R., 1964, HDB APPL HYDROLOGY C; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Elgoyhen AB, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00001; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; Gardner A, 2002, NUCL MED COMMUN, V23, P429, DOI 10.1097/00006231-200205000-00002; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; GOODWIN PE, 1980, ACTA OTO-LARYNGOL, V90, P353, DOI 10.3109/00016488009131736; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Hackett TA, 2011, HEARING RES, V271, P133, DOI 10.1016/j.heares.2010.01.011; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Henry J A, 2000, J Am Acad Audiol, V11, P138; Hiller W, 2007, AUDIOL NEURO-OTOL, V12, P391, DOI 10.1159/000106482; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Hwang JH, 2009, AM J OTOLARYNG, V30, P432, DOI 10.1016/j.amjoto.2008.08.005; Kaneoke Y, 2012, FUNCTIONAL CONNECTIV, DOI [10.1109/ICCME, DOI 10.1109/ICCME]; Kaneoke Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038131; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Lanting CP, 2010, HEARING RES, V267, P78, DOI 10.1016/j.heares.2010.04.006; Larson PS, 2012, NEUROSURGERY, V70, P398, DOI 10.1227/NEU.0b013e3182320ab5; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Leicht G, 2013, BIOL PSYCHIAT, V73, P337, DOI 10.1016/j.biopsych.2012.09.004; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; MEIKLE MB, 1984, OTOLARYNG HEAD NECK, V92, P689, DOI 10.1177/019459988409200617; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pastor MA, 2008, J NEUROPHYSIOL, V100, P1699, DOI 10.1152/jn.01156.2007; Pastor MA, 2002, J NEUROSCI, V22, P10501; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schecklmann M, 2013, HUM BRAIN MAPP, V34, P233, DOI 10.1002/hbm.21426; Scheinost D, 2012, NEUROIMAGE, V62, P1510, DOI 10.1016/j.neuroimage.2012.05.073; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shi YB, 2009, OTOLARYNG HEAD NECK, V141, P285, DOI 10.1016/j.otohns.2009.05.020; Siedentopf CM, 2007, NEUROSCI LETT, V411, P189, DOI 10.1016/j.neulet.2006.08.049; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P293, DOI 10.1016/S0030-6665(02)00162-7; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583	68	53	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67778	10.1371/journal.pone.0067778	http://dx.doi.org/10.1371/journal.pone.0067778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825684	Green Submitted, gold, Green Published			2022-12-25	WOS:000321223000118
J	Glatzer, S; Merten, NJ; Dierks, C; Wohlke, A; Philipp, U; Distl, O				Glatzer, Sabrina; Merten, Nina Johanna; Dierks, Claudia; Woehlke, Anne; Philipp, Ute; Distl, Ottmar			A Single Nucleotide Polymorphism within the Interferon Gamma Receptor 2 Gene Perfectly Coincides with Polledness in Holstein Cattle	PLOS ONE			English	Article							BOVINE CHROMOSOME-1; HORN; INHERITANCE; ASSOCIATION; MICRORNAS; SELECTION; BREEDS; PART	Polledness is a high impact trait in modern milk and beef production to meet the demands of animal welfare and work safety. Previous studies have mapped the polled-locus to the proximal region of the bovine chromosome 1 (BTA1) and narrowed it down to approximately 1 Mb. Sequencing of the positional candidate genes within the 1 Mb polled region and whole genome sequencing of Holsteins revealed a single nucleotide polymorphism (SNP) AC000158: g. 1390292G>A within intron 3 of the interferon gamma receptor 2 gene (IFNGR2) in perfect co-segregation with polledness in Holsteins. This complete association was validated in 443 animals of the same breed. This SNP allows reliable genotyping of horned, heterozygous and homozygous polled Holsteins, even in animals that could not be resolved using the previously published haplotype for Holstein.	[Glatzer, Sabrina; Merten, Nina Johanna; Dierks, Claudia; Woehlke, Anne; Philipp, Ute; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Dierks, Claudia/0000-0003-1299-6063	German Research Community (Deutsche Forschungsgemeinschaft, DFG), Bonn, Germany [DI333/15-2]	German Research Community (Deutsche Forschungsgemeinschaft, DFG), Bonn, Germany	This work has been funded by the German Research Community (Deutsche Forschungsgemeinschaft, DFG), Bonn, Germany (DI333/15-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brem G., 1982, Bayerisches Landwirtschaftliches Jahrbuch, V59, P688; Chowdhary BP, 1996, MAMM GENOME, V7, P297, DOI 10.1007/s003359900086; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Drogemuller C, 2002, ANIM GENET, V33, P271, DOI 10.1046/j.1365-2052.2002.00866.x; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; Kim KS, 2009, FEBS J, V276, P2140, DOI 10.1111/j.1742-4658.2009.06932.x; Lange H, 1989, THESIS VET FACULTY L; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Ma C, 2009, SCI CHINA SER C, V52, P323, DOI 10.1007/s11427-009-0056-x; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Quadros L, 2008, HAEMOPHILIA, V14, P628, DOI 10.1111/j.1365-2516.2008.01704.x; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; THREADGILL DS, 1991, P NATL ACAD SCI USA, V88, P154, DOI 10.1073/pnas.88.1.154; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500	20	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67992	10.1371/journal.pone.0067992	http://dx.doi.org/10.1371/journal.pone.0067992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805331	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500159
J	Davino, S; Willemsen, A; Panno, S; Davino, M; Catara, A; Elena, SF; Rubio, L				Davino, Salvatore; Willemsen, Anouk; Panno, Stefano; Davino, Mario; Catara, Antonino; Elena, Santiago F.; Rubio, Luis			Emergence and Phylodynamics of Citrus tristeza virus in Sicily, Italy	PLOS ONE			English	Article							MOSAIC-VIRUS; PHYLOGENETIC ANALYSES; MOLECULAR EVOLUTION; GENETIC-VARIATION; POPULATION; RECOMBINATION; SEQUENCE; CTV; SUPERINFECTION; EPIDEMIOLOGY	Citrus tristeza virus (CTV) outbreaks were detected in Sicily island, Italy for the first time in 2002. To gain insight into the evolutionary forces driving the emergence and phylogeography of these CTV populations, we determined and analyzed the nucleotide sequences of the p20 gene from 108 CTV isolates collected from 2002 to 2009. Bayesian phylogenetic analysis revealed that mild and severe CTV isolates belonging to five different clades (lineages) were introduced in Sicily in 2002. Phylogeographic analysis showed that four lineages co-circulated in the main citrus growing area located in Eastern Sicily. However, only one lineage (composed of mild isolates) spread to distant areas of Sicily and was detected after 2007. No correlation was found between genetic variation and citrus host, indicating that citrus cultivars did not exert differential selective pressures on the virus. The genetic variation of CTV was not structured according to geographical location or sampling time, likely due to the multiple introduction events and a complex migration pattern with intense co- and recirculation of different lineages in the same area. The phylogenetic structure, statistical tests of neutrality and comparison of synonymous and nonsynonymous substitution rates suggest that weak negative selection and genetic drift following a rapid expansion may be the main causes of the CTV variability observed today in Sicily. Nonetheless, three adjacent amino acids at the p20 N-terminal region were found to be under positive selection, likely resulting from adaptation events.	[Davino, Salvatore; Panno, Stefano] Univ Palermo, Palermo, Italy; [Davino, Salvatore] IEMEST, Palermo, Italy; [Willemsen, Anouk; Elena, Santiago F.] CSIC UPV, IBMCP, Valencia, Spain; [Davino, Mario] Univ Catania, Catania, Italy; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Rubio, Luis] IVIA, Valencia, Spain	University of Palermo; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Catania; The Santa Fe Institute	Rubio, L (corresponding author), IVIA, Valencia, Spain.	lrubio@ivia.es	Elena, Santiago F./A-4191-2011; Rubio, Luis/H-7810-2012; Panno, Stefano/ABG-8552-2020; Davino, Salvatore/AAI-3858-2020; Willemsen, Anouk/H-7892-2012	Elena, Santiago F./0000-0001-8249-5593; Rubio, Luis/0000-0002-7964-3062; Panno, Stefano/0000-0002-8941-7050; Davino, Salvatore/0000-0002-5926-6300; Willemsen, Anouk/0000-0002-8511-3244	Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2012-30805]; John Templeton Foundation [22371]	Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion; John Templeton Foundation	A.W. and S.F.E. were supported by grant BFU2012-30805 from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion and by a grant 22371 from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Kubaa R, 2012, PHYTOPATHOL MEDITERR, V51, P496; Albiach-Marti MR, 2000, J VIROL, V74, P6856, DOI 10.1128/JVI.74.15.6856-6865.2000; Ayllon MA, 2006, VIRUS GENES, V32, P119, DOI 10.1007/s11262-005-6866-4; Ayllon MA, 1999, VIROLOGY, V255, P32, DOI 10.1006/viro.1998.9566; BARJOSEPH M, 1989, ANNU REV PHYTOPATHOL, V27, P291, DOI 10.1146/annurev.py.27.090189.001451; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; D'Urso F, 2003, MOL ECOL, V12, P517, DOI 10.1046/j.1365-294X.2000.01747.x; Davino S, 2005, EUR J PLANT PATHOL, V111, P289, DOI 10.1007/s10658-003-2815-z; Davino S, 2003, PLANT DIS, V87, DOI 10.1094/PDIS.2003.87.3.314A; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Febres VJ, 1996, PHYTOPATHOLOGY, V86, P1331; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Folimonova SY, 2010, J VIROL, V84, P1314, DOI 10.1128/JVI.02075-09; FU YX, 1993, GENETICS, V134, P1261; Gomez P, 2012, EUR J PLANT PATHOL, V134, P445, DOI 10.1007/s10658-012-0019-0; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kimura M, 1985, NEUTRAL THEORY MOL E; Kong P, 2000, VIRUS GENES, V21, P139, DOI 10.1023/A:1008198311398; Lam TTY, 2012, MOL ECOL, V21, P3062, DOI 10.1111/j.1365-294X.2012.05577.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin S, 2009, J GEN VIROL, V90, P1527, DOI 10.1099/vir.0.008193-0; Matos LA, 2013, PLANT DIS, V97, P339, DOI 10.1094/PDIS-05-12-0421-RE; Mawassi M, 1996, J GEN VIROL, V77, P2359, DOI 10.1099/0022-1317-77-9-2359; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Ott M, 2007, P 19 ACM IEEE C SUP; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Powell CA, 2003, PLANT DIS, V87, P1116, DOI 10.1094/PDIS.2003.87.9.1116; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Reed JC, 2003, VIROLOGY, V306, P203, DOI 10.1016/S0042-6822(02)00051-X; ROISTACHER CN, 1993, P 12 C INT ORG CITR, P00100; Roossinck MJ, 1999, J VIROL, V73, P6752, DOI 10.1128/JVI.73.8.6752-6758.1999; Rubio L, 1996, ANN APPL BIOL, V129, P479, DOI 10.1111/j.1744-7348.1996.tb05770.x; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Sambade A, 2002, PLANT PATHOL, V51, P257, DOI 10.1046/j.1365-3059.2002.00720.x; Sentandreu V, 2006, ARCH VIROL, V151, P875, DOI 10.1007/s00705-005-0683-x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silva G, 2012, J GEN VIROL, V93, P419, DOI 10.1099/vir.0.036574-0; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Sorrentino G., 2005, P 16 C INT ORG CITR, V16, P173; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1989, GENETICS, V123, P585; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatineni S, 2011, P NATL ACAD SCI USA, V108, P17366, DOI 10.1073/pnas.1113227108; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Vives MC, 2005, VIROLOGY, V331, P232, DOI 10.1016/j.virol.2004.10.037; Vives MC, 1999, J GEN VIROL, V80, P811, DOI 10.1099/0022-1317-80-3-811; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wu BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016896	62	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66700	10.1371/journal.pone.0066700	http://dx.doi.org/10.1371/journal.pone.0066700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818960	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800097
J	Su, CX; Duan, XG; Zheng, J; Liang, LJ; Wang, F; Guo, L				Su, Chunxia; Duan, Xiangguo; Zheng, Jie; Liang, Lijun; Wang, Feng; Guo, Lin			IFN-alpha as an Adjuvant for Adenovirus-Vectored FMDV Subunit Vaccine through Improving the Generation of T Follicular Helper Cells	PLOS ONE			English	Article							B-CELL; I INTERFERONS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; CUTTING EDGE; FH CELLS; EXPRESSION; INFECTION; ANTIGEN; VIVO	IFN-alpha exhibits either direct antiviral effects or distinct immunomodulatory properties, which was identified as a 'natural immune adjuvant' for both the innate and the adaptive immune responses. Here we have investigated the effects of IFN-alpha as an adjuvant on the generation of T follicular helper (Tfh) cells and antigen-specific antibody responses. The data showed that adenoviral vectors co-expressing FMDV VP1 proteins and porcine IFN-alpha potently enhanced the generation of Tfh cells, the secretion of IL-21 protein and the expression of Bcl-6 mRNA, compared with adenoviral vectors sole expressing VP1 alone. Additionally, IFN-alpha substantial increased the number of germinal-center (GC) B cells and formation of GCs. Furthermore, IFN-alpha enhanced the antibody response, as shown by increased production of all IgG and subclasses of IgG1 and IgG2a. Thus, our results revealed the potent adjuvant activity of IFN-alpha which enhanced the generation of Tfh cells and regulated the humoral immunity by promoting germinal-center reactions and antibody responses.	[Su, Chunxia; Zheng, Jie; Wang, Feng; Guo, Lin] Ningxia Med Univ, Sch Basic Med Sci, Ningxia, Peoples R China; [Duan, Xiangguo] Ningxia Med Univ, Lab Examinat Coll, Ningxia, Peoples R China; [Liang, Lijun] Ningxia Med Univ, Gen Hosp, Ningxia, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Su, CX (corresponding author), Ningxia Med Univ, Sch Basic Med Sci, Ningxia, Peoples R China.	chunxiasu@yahoo.com.cn			National Natural Science Foundations of China [31001064, 81260678]; Natural Science Foundations of Ningxia, China [NZ11178]; department of education project in Ningxia, China [NGY2012065]; Ningxia medical university start project, China [200906]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Ningxia, China; department of education project in Ningxia, China; Ningxia medical university start project, China	This work was funded by National Natural Science Foundations of China (31001064 and 81260678), Natural Science Foundations of Ningxia, China (NZ11178), department of education project in Ningxia, China (NGY2012065), and Ningxia medical university start project, China (200906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Bayer W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-75; Bracci L, 2005, VACCINE, V23, P2994, DOI 10.1016/j.vaccine.2004.12.006; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chen PY, 2010, J NINGXIA MED U, V32, P947; Chen PY, 2009, J NINGXIA MED U, V31, P566; Chu Jia-Qi, 2012, Journal of Bacteriology and Virology, V42, P224; Couch RB, 2009, VACCINE, V27, P5344, DOI 10.1016/j.vaccine.2009.06.084; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Segundo FDS, 2010, J VIROL, V84, P2063, DOI 10.1128/JVI.01874-09; Su CX, 2007, DISCUSSION RECOMBINA; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thompson AL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/289597; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505	38	18	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66134	10.1371/journal.pone.0066134	http://dx.doi.org/10.1371/journal.pone.0066134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823532	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400056
J	Van Colen, C; Thrush, SF; Vincx, M; Ysebaert, T				Van Colen, Carl; Thrush, Simon F.; Vincx, Magda; Ysebaert, Tom			Conditional Responses of Benthic Communities to Interference from an Intertidal Bivalve	PLOS ONE			English	Article							CERASTODERMA-EDULE; TERRIGENOUS SEDIMENT; ECOSYSTEM SERVICES; MACOMA-BALTHICA; COASTAL; HABITATS; HYDRODYNAMICS; DISTURBANCE; RESILIENCE; SANDFLATS	Habitat-modifying organisms that impact other organisms and local functioning are important in determining ecosystem resilience. However, it is often unclear how the outcome of interactions performed by key species varies depending on the spatial and temporal disturbance context which makes the prediction of disturbance-driven regime shifts difficult. We investigated the strength and generality of effects of the filter feeding cockle Cerastoderma edule on its ambient intertidal benthic physical and biological environment. By comparing the magnitude of the effect of experimental cockle removal between a non-cohesive and a sheltered cohesive sediment in two different periods of the year, we show that the outcome of cockle interference effects relates to differences in physical disturbance, and to temporal changes in suspended sediment load and ontogenetic changes in organism traits. Interference effects were only present in the cohesive sediments, though the effects varied seasonally. Cockle presence decreased only the density of surface-dwelling species suggesting that interference effects were particularly mediated by bioturbation of the surface sediments. Furthermore, density reductions in the presence of cockles were most pronounced during the season when larvae and juveniles were present, suggesting that these life history stages are most vulnerable to interference competition. We further illustrate that cockles may enhance benthic microalgal biomass, most likely through the reduction of surface-dwelling grazing species, especially in periods with high sediment load and supposedly also high bioturbation rates. Our results emphasize that the physical disturbance of the sediment may obliterate biotic interactions, and that temporal changes in environmental stressors, such as suspended sediments, may affect the outcome of key species interference effects at the local scale. Consequently, natural processes and anthropogenic activities that change bed shear stress and sediment dynamics in coastal soft-sediment systems will affect cockle-mediated influences on ecosystem properties and therefore the resilience of these systems to environmental change.	[Van Colen, Carl; Vincx, Magda] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Thrush, Simon F.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Thrush, Simon F.] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Ysebaert, Tom] Netherlands Inst Sea Res NIOZ Yerseke, Yerseke, Netherlands	Ghent University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Van Colen, C (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	carl.vancolen@ugent.be		Thrush, Simon/0000-0002-4005-3882	Flemish Fund for Scientific Research FWO [FWO-1.2.380.11.N.00]; Ghent University [BOF-GOA 01GA1911W]; Marie Curie International Fellowship [FP7-PEOPLE-2007-4-2-IIF-ENV221065]	Flemish Fund for Scientific Research FWO(FWO); Ghent University(Ghent University); Marie Curie International Fellowship(European Commission)	CVC is a postdoctoral fellow of the Flemish Fund for Scientific Research FWO (FWO-1.2.380.11.N.00). Additional financial support for this study came from the special research fund of Ghent University through project BOF-GOA 01GA1911W and a Marie Curie International Fellowship to SFT (FP7-PEOPLE-2007-4-2-IIF-ENV221065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; Cesar CP, 2009, MAR ECOL-EVOL PERSP, V30, P123, DOI 10.1111/j.1439-0485.2009.00305.x; Chen MS, 2005, HYDROBIOLOGIA, V540, P79, DOI 10.1007/s10750-004-7122-y; Ciutat A, 2007, J EXP MAR BIOL ECOL, V346, P114, DOI 10.1016/j.jembe.2007.03.005; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Commito JA, 1995, LIMNOL OCEANOGR, V40, P1513, DOI 10.4319/lo.1995.40.8.1513; COOSEN J, 1994, HYDROBIOLOGIA, V283, P235; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Flach EC, 1996, MAR ECOL-P S Z N I, V17, P87, DOI 10.1111/j.1439-0485.1996.tb00492.x; Gam M, 2010, J SEA RES, V63, P191, DOI 10.1016/j.seares.2010.01.003; Grabowski RC, 2011, EARTH-SCI REV, V105, P101, DOI 10.1016/j.earscirev.2011.01.008; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Hiddink JG, 2002, MAR BIOL, V140, P1149, DOI 10.1007/s00227-002-0794-9; Hunt HL, 2004, J EXP MAR BIOL ECOL, V312, P271, DOI 10.1016/j.jembe.2004.07.010; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Le Hir P, 2000, CONT SHELF RES, V20, P1433, DOI 10.1016/S0278-4343(00)00031-5; Lohrer AM, 2006, MAR ECOL PROG SER, V307, P115, DOI 10.3354/meps307115; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Montserrat F, 2009, ESTUAR COAST SHELF S, V83, P379, DOI 10.1016/j.ecss.2009.04.010; Navarro JM, 1997, MAR ECOL PROG SER, V152, P175, DOI 10.3354/meps152175; Norkko A, 2006, ECOLOGY, V87, P226, DOI 10.1890/05-0176; Rodil IF, 2011, ECOL APPL, V21, P416, DOI 10.1890/09-1845.1; Rossi F, 2008, MAR ECOL PROG SER, V354, P47, DOI 10.3354/meps07213; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Struyf E, 1995, HYDROBIOLOGIA, V540, P26; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2000, ECOLOGY, V81, P399, DOI 10.2307/177436; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Troost K, 2008, J SEA RES, V60, P157, DOI 10.1016/j.seares.2008.04.006; Van Colen C, 2010, MAR ECOL PROG SER, V406, P79, DOI 10.3354/meps08529; Van Colen C, 2010, J EXP MAR BIOL ECOL, V385, P79, DOI 10.1016/j.jembe.2010.01.009; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Van Colen C, 2009, MAR BIOL, V156, P2161, DOI 10.1007/s00227-009-1246-6; Wijnhoven S, 2011, MARINE ECOLOGY, V32, P1; Woodin SA, 2012, J EXP MAR BIOL ECOL, V413, P184, DOI 10.1016/j.jembe.2011.12.010	42	19	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65861	10.1371/journal.pone.0065861	http://dx.doi.org/10.1371/journal.pone.0065861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824689	Green Published, gold			2022-12-25	WOS:000320576400026
J	Dotson, RJ; Rabadi, SM; Westcott, EL; Bradley, S; Catlett, SV; Banik, S; Harton, JA; Bakshi, CS; Malik, M				Dotson, Rachel J.; Rabadi, Seham M.; Westcott, Elizabeth L.; Bradley, Stephen; Catlett, Sally V.; Banik, Sukalyani; Harton, Jonathan A.; Bakshi, Chandra Shekhar; Malik, Meenakshi			Repression of Inflammasome by Francisella tularensis during Early Stages of Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE RECOGNITION; AIM2 INFLAMMASOME; INNATE IMMUNITY; CUTTING EDGE; INTERNALIN B; MELANOMA 2; ACTIVATION; PROTEIN; CASPASE-1; SURVIVAL	Francisella tularensis is an important human pathogen responsible for causing tularemia. F. tularensis has long been developed as a biological weapon and is now classified as a category A agent by the Centers for Disease Control because of its possible use as a bioterror agent. F. tularensis represses inflammasome; a cytosolic multi-protein complex that activates caspase-1 to produce proinflammatory cytokines IL-1 beta and IL-18. However, the Francisella factors and the mechanisms through which F. tularensis mediates these suppressive effects remain relatively unknown. Utilizing a mutant of F. tularensis in FTL_0325 gene, this study investigated the mechanisms of inflammasome repression by F. tularensis. We demonstrate that muted IL-1 beta and IL-18 responses generated in macrophages infected with F. tularensis live vaccine strain (LVS) or the virulent SchuS4 strain are due to a predominant suppressive effect on TLR2-dependent signal 1. Our results also demonstrate that FTL_0325 of F. tularensis impacts proIL-1 beta expression as early as 2 h post-infection and delays activation of AIM2 and NLRP3-inflammasomes in a TLR2-dependent fashion. An enhanced activation of caspase-1 and IL-1 beta observed in FTL_0325 mutant-infected macrophages at 24 h post-infection was independent of both AIM2 and NLRP3. Furthermore, F. tularensis LVS delayed pyroptotic cell death of the infected macrophages in an FTL_0325-dependent manner during the early stages of infection. In vivo studies in mice revealed that suppression of IL-1 beta by FTL_0325 early during infection facilitates the establishment of a fulminate infection by F. tularensis. Collectively, this study provides evidence that F. tularensis LVS represses inflammasome activation and that F. tularensis-encoded FTL_0325 mediates this effect.	[Dotson, Rachel J.; Westcott, Elizabeth L.; Bradley, Stephen; Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA; [Rabadi, Seham M.; Banik, Sukalyani; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany College of Pharmacy & Health Sciences; New York Medical College; Albany Medical College	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, 106 New Scotland Ave, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu	Harton, Jonathan A/AAW-5283-2021; Malik, Meenakshi/F-1501-2015; Harton, Jonathan/F-2848-2010	Harton, Jonathan A/0000-0002-0350-1877; Malik, Meenakshi/0000-0003-0051-4485; Harton, Jonathan/0000-0002-0350-1877	National Institutes of Health [R21AI075250-01A2, 2P01AI056320, R56AI090072-02]; Albany College of Pharmacy and Health Sciences; New York Medical College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI101109, R21AI075250, R56AI090072, P01AI056320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany College of Pharmacy and Health Sciences; New York Medical College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI075250-01A2 (to M. M.), 2P01AI056320, and R56AI090072-02 (to C. S. B.). This work was also supported by startup funds from the Albany College of Pharmacy and Health Sciences (to M. M.) and New York Medical College (to C. S. B.).	[Anonymous], 2001, J ENVIRON HEALTH, V64, P47; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Bossi P, 2003, PRESSE MED, V32, P1126; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Chiba S, 2011, MICROBIOL IMMUNOL, V55, P123, DOI 10.1111/j.1348-0421.2010.00292.x; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020609; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miao EA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00085; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Ulland TK, 2013, INFECT IMMUN, V81, P201, DOI 10.1128/IAI.00991-12; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026	50	42	42	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23844	23857		10.1074/jbc.M113.490086	http://dx.doi.org/10.1074/jbc.M113.490086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821549	hybrid, Green Published			2022-12-25	WOS:000330611400024
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Cap Snatching in Yeast L-BC Double-stranded RNA Totivirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNA; L-A VIRUS; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME; COAT PROTEIN; REPLICATION; POLYMERASE; GUANYLYLTRANSFERASE; TRANSCRIPTION; MECHANISM	Yeast L-A double-stranded RNA virus furnishes its transcript with a 5' cap structure by a novel cap-snatching mechanism in which m(7)Gp from a host mRNA cap structure is transferred to the 5'-diphosphate terminus of the viral transcript. His-154 of the coat protein Gag forms an m(7)Gp adduct, and the H154R mutation abolishes both m(7)Gp adduct formation and cap snatching. Here we show that L-BC, another totivirus closely related to L-A, also synthesizes 5'-diphosphorylated transcripts and transfers m(7)Gp from mRNA to the 5' termini of the transcripts. L-BC Gag also covalently binds to the cap structure and the mutation H156R, which corresponds to H154R of L-A Gag, abolishes cap adduct formation. Cap snatching of the L-BC virus is very similar to that of L-A; N7 methylation of the mRNA cap is essential for cap donor activity, and only 5'-diphosphorylated RNA is used as cap acceptor. L-BC cap snatching is also activated by viral transcription. Furthermore, both viruses require Mg2+ and Mn2+ for cap snatching. These cations are not only required for transcription activation but also directly involved in the cap transfer process. These findings support our previous proposal that the cap-snatching mechanism of the L-A virus is shared by fungal totiviruses closely related to L-A. Interestingly, L-A and L-BC viruses accept either viral transcript as cap acceptor in vitro. Because L-A and L-BC viruses cohabit in many yeast strains, it raises the possibility that their cohabitation in the same host may be beneficial for their mutual cap acquisition.	[Fujimura, Tsutomu; Esteban, Rosa] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Inst Biol Funct & Genom, Lab P2 1, Zacarias Gonzalez 2, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209	Fundacion Ramon Areces	Fundacion Ramon Areces	We thank "Fundacion Ramon Areces" for financial support of our Institute.	BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; BLANC A, 1992, MOL CELL BIOL, V12, P3390, DOI 10.1128/MCB.12.8.3390; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Chakravarty AK, 2012, P NATL ACAD SCI USA, V109, P6072, DOI 10.1073/pnas.1201207109; Chakravarty AK, 2011, P NATL ACAD SCI USA, V108, P21034, DOI 10.1073/pnas.1115560108; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; Chu C, 2011, P NATL ACAD SCI USA, V108, P10104, DOI 10.1073/pnas.1106610108; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Englert M, 2012, P NATL ACAD SCI USA, V109, P15235, DOI 10.1073/pnas.1213795109; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; Fujimura T, 2012, J BIOL CHEM, V287, P12797, DOI 10.1074/jbc.M111.327676; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Fujimura T, 2010, J BIOL CHEM, V285, P22909, DOI 10.1074/jbc.M110.138982; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Huang YL, 2005, J BIOL CHEM, V280, P13153, DOI 10.1074/jbc.M412619200; ICHO T, 1989, J BIOL CHEM, V264, P6716; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; Park CM, 1996, VIROLOGY, V216, P451, DOI 10.1006/viro.1996.0083; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pascal JM, 2008, CURR OPIN STRUC BIOL, V18, P96, DOI 10.1016/j.sbi.2007.12.008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; TIPPER DJ, 1984, MICROBIOL REV, V48, P125, DOI 10.1128/MMBR.48.2.125-156.1984; VENKATESAN S, 1980, J BIOL CHEM, V255, P2835; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; WESOLOWSKI M, 1984, MOL CELL BIOL, V4, P181, DOI 10.1128/MCB.4.1.181; WICKENS MP, 1983, J MOL BIOL, V163, P1, DOI 10.1016/0022-2836(83)90027-X; Wickner R.B., 2007, FIELDS VIROLOGY, P737; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	49	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23716	23724		10.1074/jbc.M113.490953	http://dx.doi.org/10.1074/jbc.M113.490953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23824187	hybrid, Green Published			2022-12-25	WOS:000330611400012
J	Kang, JW; Park, YS; Kim, MS; Lee, DH; Bak, Y; Ham, SY; Park, SH; Hong, JT; Yoon, DY				Kang, Jeong-Woo; Park, Yun Sun; Kim, Man Sub; Lee, Dong Hun; Bak, Yesol; Ham, Sun Young; Park, Soo Ho; Hong, Jin Tae; Yoon, Do-Young			Interleukin (IL)-32 beta-mediated CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) Phosphorylation by Protein Kinase C delta (PKC delta) Abrogates the Inhibitory Effect of C/EBP alpha on IL-10 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; PROINFLAMMATORY CYTOKINE; TRANSCRIPTION FACTORS; LINEAGE COMMITMENT; CELL-DEATH; TNF-ALPHA; ACTIVATION; IL-32; GRANULOPOIESIS; EXPRESSION	We previously reported that IL-32 beta promotes IL-10 production in myeloid cells. However, the underlying mechanism remains elusive. In this study, we demonstrated that IL-32 beta abrogated the inhibitory effect of CCAAT/enhancer-binding protein alpha (C/EBP alpha) on IL-10 expression in U937 cells. We observed that the phosphorylation of C/EBP alpha Ser-21 was inhibited by a PKC delta-specific inhibitor, rottlerin, or IL-32 beta knockdown by siRNA and that IL-32 beta shifted to the membrane from the cytosol upon phorbol 12-myristate 13-acetate treatment. We revealed that IL-32 beta suppressed the binding of C/EBP alpha to IL-10 promoter by using ChIP assay. These data suggest that PKC delta and IL-32 beta may modulate the effect of C/EBP alpha on IL-10 expression. We next demonstrated by immunoprecipitation that IL-32 beta interacted with PKC delta and C/EBP alpha, thereby mediating C/EBP alpha Ser-21 phosphorylation by PKC delta. We showed that IL-32 beta suppressed the inhibitory effect of C/EBP alpha on IL-10 promoter activity. However, the IL-10 promoter activity was reduced to the basal level by rottlerin treatment. When C/EBP alpha serine 21 was mutated to glycine (S21G), the inhibitory effect of C/EBP alpha S21G on IL-10 promoter activity was not modulated by IL-32 beta. Taken together, our results show that IL-32 beta-mediated C/EBP alpha Ser-21 phosphorylation by PKC delta suppressed C/EBP alpha binding to IL-10 promoter, which promoted IL-10 production in U937 cells.	[Kang, Jeong-Woo; Park, Yun Sun; Kim, Man Sub; Lee, Dong Hun; Bak, Yesol; Ham, Sun Young; Park, Soo Ho; Yoon, Do-Young] Konkuk Univ, Dept Biosci & Biotechnol, Biomol Informat Ctr, Seoul 143701, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Cheongju 361463, Chungbuk, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Cheongju 361463, Chungbuk, South Korea	Konkuk University; Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Biomol Informat Ctr, 1 Hwayang Dong, Seoul 143701, South Korea.	jinthong@chungbuk.ac.kr; ydy4218@konkuk.ac.kr			National Research Foundation of Korea (NRF); Korean government [2012R1A2A2A 02008751, 2011-0028213]; Priority Research Centres Program [2012-0006686, A120833]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government(Korean Government); Priority Research Centres Program	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2012R1A2A2A 02008751 and 2011-0028213).; Partially supported by Priority Research Centres Program Grants 2012-0006686 and A120833. To whom correspondence may be addressed. Tel.: 82-2-450-4119; Fax: 82-2-444-4218; E-mail: ydy4218@konkuk.ac.kr.	Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Contreras X, 2004, MICROBES INFECT, V6, P1182, DOI 10.1016/j.micinf.2004.06.008; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Heinhuis B, 2012, CYTOKINE, V60, P321, DOI 10.1016/j.cyto.2012.07.010; Heinhuis B, 2012, J BIOL CHEM, V287, P5733, DOI 10.1074/jbc.M111.288290; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kang JW, 2012, J BIOL CHEM, V287, P35556, DOI 10.1074/jbc.M112.400911; Kang JW, 2009, IMMUNOLOGY, V128, pe532, DOI 10.1111/j.1365-2567.2008.03025.x; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Klempt M, 1998, IMMUNOBIOLOGY, V199, P148, DOI 10.1016/S0171-2985(98)80070-3; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Rangatia J, 2002, MOL CELL BIOL, V22, P8681, DOI 10.1128/MCB.22.24.8681-8694.2002; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Wilmanski J, 2005, J LEUKOCYTE BIOL, V78, P85, DOI 10.1189/jlb.0105010; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517	33	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23650	23658		10.1074/jbc.M113.465575	http://dx.doi.org/10.1074/jbc.M113.465575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814099	Green Published, hybrid			2022-12-25	WOS:000330611400004
J	Yu, J; Deliu, E; Zhang, XQ; Hoffman, NE; Carter, RL; Grisanti, LA; Brailoiu, GC; Madesh, M; Cheung, JY; Force, T; Abood, ME; Koch, WJ; Tilley, DG; Brailoiu, E				Yu, Justine; Deliu, Elena; Zhang, Xue-Quian; Hoffman, Nicholas E.; Carter, Rhonda L.; Grisanti, Laurel A.; Brailoiu, G. Cristina; Madesh, Muniswamy; Cheung, Joseph Y.; Force, Thomas; Abood, Mary E.; Koch, Walter J.; Tilley, Douglas G.; Brailoiu, Eugen			Differential Activation of Cultured Neonatal Cardiomyocytes by Plasmalemmal Versus Intracellular G Protein-coupled Receptor 55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CYCLIC ADP-RIBOSE; ANGIOTENSIN-II; CANNABINOID RECEPTOR; ENDOPLASMIC-RETICULUM; CB1 RECEPTORS; IN-VITRO; GPR55; CALCIUM; NAADP	The L-alpha-lysophosphatidylinositol (LPI)-sensitive receptor GPR55 is coupled to Ca2+ signaling. Low levels of GPR55 expression in the heart have been reported. Similar to other G protein-coupled receptors involved in cardiac function, GPR55 may be expressed both at the sarcolemma and intracellularly. Thus, to explore the role of GPR55 in cardiomyocytes, we used calcium and voltage imaging and extracellular administration or intracellular microinjection of GPR55 ligands. We provide the first evidence that, in cultured neonatal ventricular myocytes, LPI triggers distinct signaling pathways via GPR55, depending on receptor localization. GPR55 activation at the sarcolemma elicits, on one hand, Ca2+ entry via L-type Ca2+ channels and, on the other, inositol 1,4,5-trisphosphate-dependent Ca2+ release. The latter signal is further amplified by Ca2+-induced Ca2+ release via ryanodine receptors. Conversely, activation of GPR55 at the membrane of intracellular organelles promotes Ca2+ release from acidic-like Ca2+ stores via the endolysosomal NAADP-sensitive two-pore channels. This response is similarly enhanced by Ca2+-induced Ca2+ release via ryanodine receptors. Extracellularly applied LPI produces Ca2+-independent membrane depolarization, whereas the Ca2+ signal induced by intracellular microinjection of LPI converges to hyperpolarization of the sarcolemma. Collectively, our findings point to GPR55 as a novel G protein-coupled receptor regulating cardiac function at two cellular sites. This work may serve as a platform for future studies exploring the potential of GPR55 as a therapeutic target in cardiac disorders.	[Yu, Justine; Zhang, Xue-Quian; Hoffman, Nicholas E.; Carter, Rhonda L.; Grisanti, Laurel A.; Madesh, Muniswamy; Cheung, Joseph Y.; Force, Thomas; Koch, Walter J.; Tilley, Douglas G.; Brailoiu, Eugen] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Deliu, Elena; Koch, Walter J.; Tilley, Douglas G.; Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Cheung, Joseph Y.] Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19140 USA; [Force, Thomas] Temple Univ, Sch Med, Dept Internal Med, Philadelphia, PA 19140 USA; [Abood, Mary E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Abood, Mary E.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Brailoiu, G. Cristina] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Tilley, DG (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, Room 945A,3500 N Broad St, Philadelphia, PA 19140 USA.	douglas.tilley@temple.edu; ebrailou@temple.edu	Deliu, Elena/O-7379-2019	Tilley, Douglas/0000-0002-9681-3377; Force, Thomas/0000-0002-0450-8659; Abood, Mary/0000-0002-1744-2820	National Institutes of Health [HL090804, HL105414, HL086699, DA023204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL105414, R01HL086699, R01HL114124, R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL090804 (to E. B.), HL105414 (to D. G. T.), HL086699 (to M. M.), and DA023204 (to M. E. A.).	Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; [Anonymous], 2010, PROBE REPORTS NIH MO; Ben-Zeev G, 2010, CELL CALCIUM, V47, P514, DOI 10.1016/j.ceca.2010.04.006; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V461, P177, DOI 10.1007/s00424-010-0898-x; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brailoiu E., 2012, 22 ANN S CANN, P25; Brailoiu GC, 2008, NEUROSCIENCE, V151, P701, DOI 10.1016/j.neuroscience.2007.11.031; Brailoiu GC, 2013, EXP PHYSIOL, V98, P679, DOI 10.1113/expphysiol.2012.069377; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Brailoiu GC, 2010, J BIOL CHEM, V285, P37133, DOI 10.1074/jbc.C110.169763; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Cook JL, 2012, AM J PHYSIOL-REG I, V302, pR482, DOI 10.1152/ajpregu.00493.2011; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Costa VM, 2009, CHEM RES TOXICOL, V22, P129, DOI 10.1021/tx8002577; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Mello WC, 2011, MOL CELL BIOCHEM, V358, P309, DOI 10.1007/s11010-011-0981-4; Deliu E, 2012, J BIOL CHEM, V287, P41023, DOI 10.1074/jbc.M112.418533; Deliu E, 2012, J PAIN, V13, P742, DOI 10.1016/j.jpain.2012.05.011; Deliu E, 2011, AM J PHYSIOL-CELL PH, V301, pC559, DOI 10.1152/ajpcell.00123.2011; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Goutsouliak V, 1998, GEN PHARMACOL, V30, P367, DOI 10.1016/S0306-3623(97)00270-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546; Haller H, 1996, CIRC RES, V79, P765, DOI 10.1161/01.RES.79.4.765; Henstridge CM, 2012, PHARMACOLOGY, V89, P179, DOI 10.1159/000336872; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Hu G, 2011, ONCOGENE, V30, P139, DOI 10.1038/onc.2010.502; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Janowski E, 2010, AM J PHYSIOL-HEART C, V298, pH1939, DOI 10.1152/ajpheart.00607.2009; Ju YK, 2012, J MOL CELL CARDIOL, V53, P375, DOI 10.1016/j.yjmcc.2012.06.004; Jungsuwadee P, 2009, MOL PHARMACOL, V75, P1117, DOI 10.1124/mol.108.052209; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; Kato K, 2012, J IMMUNOL, V188, P2014, DOI 10.4049/jimmunol.1102405; Kerkela R, 2011, CTS-CLIN TRANSL SCI, V4, P236, DOI 10.1111/j.1752-8062.2011.00294.x; Kim SY, 2010, J BIOL CHEM, V285, P576, DOI 10.1074/jbc.M109.076216; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Luo DL, 2006, ACTA PHARMACOL SIN, V27, P895, DOI 10.1111/j.1745-7254.2006.00382.x; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Pineiro R, 2012, BBA-MOL CELL BIOL L, V1821, P694, DOI 10.1016/j.bbalip.2012.01.009; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saini HK, 2006, AM J PHYSIOL-HEART C, V291, pH2790, DOI 10.1152/ajpheart.00535.2006; Saito Y, 2012, AM J PHYSIOL-HEART C, V302, pH2018, DOI 10.1152/ajpheart.00955.2011; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Stillitano F, 2008, PHARMACOL RES, V57, P100, DOI 10.1016/j.phrs.2007.12.002; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; Tang CM, 2004, TRENDS CARDIOVAS MED, V14, P94, DOI 10.1016/j.tcm.2003.12.007; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tica AA, 2011, AM J PHYSIOL-CELL PH, V301, pC1262, DOI 10.1152/ajpcell.00501.2010; VITES AM, 1994, J PHARMACOL EXP THER, V268, P1476; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Weiss S, 2004, J BIOL CHEM, V279, P12503, DOI 10.1074/jbc.M310196200; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Zhao PW, 2013, LIFE SCI, V92, P453, DOI 10.1016/j.lfs.2012.06.039; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	77	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22481	22492		10.1074/jbc.M113.456178	http://dx.doi.org/10.1074/jbc.M113.456178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23814062	Green Published, hybrid			2022-12-25	WOS:000330596300029
J	Kyle, LM; John, TR; Schatzl, HM; Lewis, RV				Kyle, Leah M.; John, Theodore R.; Schaetzl, Hermann M.; Lewis, Randolph V.			Introducing a Rigid Loop Structure from Deer into Mouse Prion Protein Increases Its Propensity for Misfolding In Vitro	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; TRANSGENIC MICE; SPONGIFORM ENCEPHALOPATHIES; THERMODYNAMIC STABILITY; BETA-2-ALPHA-2 LOOP; INFECTIOUS PRIONS; LIPID-MEMBRANES; MOLECULAR-BASIS; NMR STRUCTURE; CONVERSION	Prion diseases are fatal neurodegenerative disorders characterized by misfolding of the cellular prion protein (PrPc) into the disease-associated isoform (PrPSc) that has increased beta-sheet content and partial resistance to proteolytic digestion. Prion diseases from different mammalian species have varying propensities for transmission upon exposure of an uninfected host to the infectious agent. Chronic Wasting Disease (CWD) is a highly transmissible prion disease that affects free ranging and farmed populations of cervids including deer, elk and moose, as well as other mammals in experimental settings. The molecular mechanisms allowing CWD to maintain comparatively high transmission rates have not been determined. Previous work has identified a unique structural feature in cervid PrP, a rigid loop between beta-sheet 2 and alpha-helix 2 on the surface of the protein. This study was designed to test the hypothesis that the rigid loop has a direct influence on the misfolding process. The rigid loop was introduced into murine PrP as the result of two amino acid substitutions: S170N and N174T. Wild-type and rigid loop murine PrP were expressed in E. coli and purified. Misfolding propensity was compared for the two proteins using biochemical techniques and cell free misfolding and conversion systems. Murine PrP with a rigid loop misfolded in cell free systems with greater propensity than wild type murine PrP. In a lipid-based conversion assay, rigid loop PrP converted to a PK resistant, aggregated isoform at lower concentrations than wild-type PrP. Using both proteins as substrates in real time quaking-induced conversion, rigid loop PrP adopted a misfolded isoform more readily than wild type PrP. Taken together, these findings may help explain the high transmission rates observed for CWD within cervids.	[Kyle, Leah M.; Schaetzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [John, Theodore R.; Schaetzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Lewis, Randolph V.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Lewis, Randolph V.] Utah State Univ, Synthet Bioprod Inst, Logan, UT 84322 USA	University of Wyoming; University of Wyoming; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Schatzl, HM (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	hschatzl@uwyo.edu		Schatzl, Hermann/0000-0003-4972-8740	Department of Defense [DOD 030542]; National Institute of Health [R01 NS076853-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Department of Defense (DOD 030542, to RVL), the National Institute of Health (R01 NS076853-01A1, to HMS), and was performed within the framework of the Wyoming Endowed Excellence Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Bujdoso R, 2005, PROTEINS, V61, P840, DOI 10.1002/prot.20755; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Fasano C, 2006, J MOL NEUROSCI, V29, P195, DOI 10.1385/JMN:29:3:195; Fitzmaurice TJ, 2008, BIOCHEM J, V409, P367, DOI 10.1042/BJ20071122; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Gill AC, 2010, PRION, V4, P235, DOI 10.4161/pri.4.4.13394; Gorfe AA, 2007, FASEB J, V21, P3279, DOI 10.1096/fj.07-8292com; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Hasegawa K, 2010, PRION, V4, P38, DOI 10.4161/pri.4.1.10890; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Paludi D, 2007, J NEUROCHEM, V103, P2291, DOI 10.1111/j.1471-4159.2007.04934.x; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Priola SA, 2006, MOL BIOTECHNOL, V33, P71; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Seelig DM, 2010, AM J PATHOL, V176, P2785, DOI 10.2353/ajpath.2010.090710; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Supattapone S, 2012, PRION, V6, DOI 10.4161/pri.21826; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Tamguney G, 2013, J GEN VIROL, V94, P443, DOI 10.1099/vir.0.045989-0; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Telling GC, 2011, TOP CURR CHEM, V305, P79, DOI 10.1007/128_2011_166; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	70	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66715	10.1371/journal.pone.0066715	http://dx.doi.org/10.1371/journal.pone.0066715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825561	gold, Green Submitted, Green Published			2022-12-25	WOS:000321223000024
J	Mohlendick, B; Bartenhagen, C; Behrens, B; Honisch, E; Raba, K; Knoefel, WT; Stoecklein, NH				Moehlendick, Birte; Bartenhagen, Christoph; Behrens, Bianca; Honisch, Ellen; Raba, Katharina; Knoefel, Wolfram T.; Stoecklein, Nikolas H.			A Robust Method to Analyze Copy Number Alterations of Less than 100 kb in Single Cells Using Oligonucleotide Array CGH	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; POLYMERASE-CHAIN-REACTION; DISSEMINATED TUMOR-CELLS; CORRESPONDING METASTASES; SEQUENCING LIBRARIES; GENETIC-ANALYSIS; AMPLIFICATION; CANCER; DNA; SAMPLES	Comprehensive genome wide analyses of single cells became increasingly important in cancer research, but remain to be a technically challenging task. Here, we provide a protocol for array comparative genomic hybridization (aCGH) of single cells. The protocol is based on an established adapter-linker PCR (WGAM) and allowed us to detect copy number alterations as small as 56 kb in single cells. In addition we report on factors influencing the success of single cell aCGH downstream of the amplification method, including the characteristics of the reference DNA, the labeling technique, the amount of input DNA, reamplification, the aCGH resolution, and data analysis. In comparison with two other commercially available non-linear single cell amplification methods, WGAM showed a very good performance in aCGH experiments. Finally, we demonstrate that cancer cells that were processed and identified by the CellSearch (R) System and that were subsequently isolated from the CellSearch (R) cartridge as single cells by fluorescence activated cell sorting (FACS) could be successfully analyzed using our WGAM-aCGH protocol. We believe that even in the era of next-generation sequencing, our single cell aCGH protocol will be a useful and (cost-) effective approach to study copy number alterations in single cells at resolution comparable to those reported currently for single cell digital karyotyping based on next generation sequencing data.	[Moehlendick, Birte; Behrens, Bianca; Knoefel, Wolfram T.; Stoecklein, Nikolas H.] Univ Dusseldorf, Dept Surg A, D-40225 Dusseldorf, Germany; [Moehlendick, Birte; Behrens, Bianca; Honisch, Ellen; Raba, Katharina; Knoefel, Wolfram T.; Stoecklein, Nikolas H.] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Bartenhagen, Christoph] Univ Munster, Inst Med Informat, D-48149 Munster, Germany; [Honisch, Ellen] Univ Dusseldorf, Dept Obstet & Gynecol, D-40225 Dusseldorf, Germany; [Raba, Katharina] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munster; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Mohlendick, B (corresponding author), Univ Dusseldorf, Dept Surg A, D-40225 Dusseldorf, Germany.	birte.moehlendick@uni-duesseldorf.de; nikolas.stoecklein@uni-duesseldorf.de	Raba, Katharina/B-8697-2017; Bartenhagen, Christoph/A-7814-2013	Raba, Katharina/0000-0001-8818-4219; Mohlendick, Birte/0000-0001-9093-8585	Deutsche Forschungsgemeinschaft (DFG) [STO 464/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) STO 464/2-2 to NHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Arneson Nona, 2012, ISRN Oncol, V2012, P710692, DOI 10.5402/2012/710692; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheng JQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r80; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dong H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-60; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Gangnus R, 2004, CLIN CANCER RES, V10, P3457, DOI 10.1158/1078-0432.CCR-03-0818; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hjortland GO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-455; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Knijnenburg J, 2007, CYTOM PART A, V71A, P585, DOI 10.1002/cyto.a.20412; Konings P, 2012, NAT PROTOC, V7, P281, DOI 10.1038/nprot.2011.426; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mathiesen RR, 2012, INT J CANCER, V131, pE405, DOI 10.1002/ijc.26444; Misale S, 2012, NATURE; Navin N, 2011, GENOME MED, V3, DOI 10.1186/gm247; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pirker C, 2004, CYTOM PART A, V61A, P26, DOI 10.1002/cyto.a.20060; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Tsubosa Y, 2005, CANCER GENET CYTOGEN, V158, P156, DOI 10.1016/j.cancergencyto.2004.08.033; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	46	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67031	10.1371/journal.pone.0067031	http://dx.doi.org/10.1371/journal.pone.0067031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825608	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000060
J	Sommers, CL; Rouquette-Jazdanian, AK; Robles, AI; Kortum, RL; Merrill, RK; Li, WM; Nath, N; Wohlfert, E; Sixt, KM; Belkaid, Y; Samelson, LE				Sommers, Connie L.; Rouquette-Jazdanian, Alexandre K.; Robles, Ana I.; Kortum, Robert L.; Merrill, Robert K.; Li, Wenmei; Nath, Nandan; Wohlfert, Elizabeth; Sixt, Katherine M.; Belkaid, Yasmine; Samelson, Lawrence E.			miRNA Signature of Mouse Helper T Cell Hyper-Proliferation	PLOS ONE			English	Article							LYMPHOPROLIFERATIVE DISEASE; HOMEOSTATIC PROLIFERATION; ERK ACTIVATION; EXPRESSION; MIR-146A; LAT; MICRORNA-21; NAIVE; MODULATOR; SURVIVAL	Helper T cells from a mutant mouse model, LAT Y136F, hyper-proliferate and cause a severe lymphoproliferative disease that kills the mice by six months of age. LAT Y136F mice carry a tyrosine to phenylalanine mutation in the Linker for Activation of T cells (LAT) gene. This mutation leads to a number of changes in T cells that result in altered cytokine production including increased IL-4 production, increased proliferation, and decreased apoptosis. Hyper-proliferation of the mutant T cells contributes to lymphadenopathy, splenomegaly, and multi-organ T cell infiltration. miRNAs are short non-coding RNAs that regulate expression of cohorts of genes. This study investigates which miRNAs are expressed in LAT Y136F T cells and compares these to miRNAs expressed in wild type T cells that are undergoing proliferation in two other settings. The first setting is homeostatic proliferation, which was modeled by adoptive transfer of wild type T cells into T cell-deficient mice. The second setting is proliferation in response to infection, which was modeled by infection of wild type mice with the nematode H. polygyrus. By comparing miRNA expression in these three proliferative states (LAT Y136F hyper-proliferation, homeostatic proliferation and proliferation in response to H. polygyrus infection) to expression in wild type naive CD4(+) T cells, we found miRNAs that were highly regulated in all three proliferative states (miR-21 and miR-146a) and some that were more specific to individual settings of proliferation such as those more specific for LAT Y136F lymphoproliferative disease (miR-669f, miR-155 and miR-466a/b). Future experiments that modulate levels of the miRNAs identified in this study may reveal the roles of these miRNAs in T cell proliferation and/or lymphoproliferative disease.	[Sommers, Connie L.; Rouquette-Jazdanian, Alexandre K.; Kortum, Robert L.; Merrill, Robert K.; Li, Wenmei; Nath, Nandan; Sixt, Katherine M.; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Robles, Ana I.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sommers, Connie L.; Wohlfert, Elizabeth; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sommers, CL (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	sommersc@helix.nih.gov	wohlfert, beth/ABA-2255-2020	ROUQUETTE-JAZDANIAN, Alexandre K./0000-0003-2646-0040; Belkaid, Yasmine/0000-0001-9962-3571; Robles, Ana/0000-0001-5019-4374	National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010304] Funding Source: NIH RePORTER	National Cancer Institute Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037366; Fenoglio C, 2011, NEUROSCI LETT, V504, P9, DOI 10.1016/j.neulet.2011.08.021; Garchow BG, 2011, EMBO MOL MED, V3, P605, DOI 10.1002/emmm.201100171; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kortum RL, 2013, TRENDS IMMU IN PRESS; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Maizels RM, 2012, EXP PARASITOL, V132, P76, DOI 10.1016/j.exppara.2011.08.011; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Miyaji M, 2009, P NATL ACAD SCI USA, V106, P14502, DOI 10.1073/pnas.0903894106; Moxham VF, 2008, J IMMUNOL, V180, P3910, DOI 10.4049/jimmunol.180.6.3910; Muljo SA, 2012, WILEY INTERDISCIP RE, V2, P148; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rouquette-Jazdanian AK, 2012, MOL CELL, V48, P298, DOI 10.1016/j.molcel.2012.08.011; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tomankova T, 2012, SCAND J IMMUNOL, V75, P129, DOI 10.1111/j.1365-3083.2011.02650.x; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66709	10.1371/journal.pone.0066709	http://dx.doi.org/10.1371/journal.pone.0066709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825558	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000023
J	Young, JA; Jefferies, W				Young, Joanne A.; Jefferies, Wilfred			Towards the Conservation of Endangered Avian Species: A Recombinant West Nile Virus Vaccine Results in Increased Humoral and Cellular Immune Responses in Japanese Quail (Coturnix japonica)	PLOS ONE			English	Article							T-CELLS; POPULATION; INFECTION; CD8	West Nile Virus (WNV) arrived in North America in 1999 and is now endemic. Many families of birds, especially corvids, are highly susceptible to WNV and infection often results in fatality. Avian species susceptible to WNV infection also include endangered species, such as the Greater Sage-Grouse (Centrocercus uropbasianuts) and the Eastern Loggerhead Shrike (Lanius ludovicianus migrans). The virus has been shown to contribute towards the likelihood of their extinction. Although a clear and present threat, there exists no avian WNV vaccine available to combat this lethal menace. As a first step in establishing an avian model for testing candidate WNV vaccines, avian antibody based reagents were assessed for cross-reactivity with Japanese quail (Coturnix japonica) T cell markers CD4 and CD8; the most reactive were found to be the anti-duck CD8 antibody, clone Du-CD8-1, and the anti-chicken/turkey CD4 antibody, clone CT4. These reagents were then used to assess vaccine performance as well as to establish T cell populations in quail, with a novel population of CD4/CD8 double positive T cells being identified in Japanese quail. Concurrently, non-replicating recombinant adenoviruses, expressing either the WNV envelope or NS3 'genes' were constructed and assessed for effectiveness as avian vaccines. Japanese Quail were selected for testing the vaccines, as they provide an avian model that parallels the population diversity of bird species in the wild. Both the level of WNV specific antibodies and the number of T cells in vaccinated birds were increased compared to unvaccinated controls. The results indicate the vaccines to be effective in increasing both humoral and cellular immune responses. These recombinant vaccines therefore may find utility as tools to protect and maintain domestic and wild avian populations. Their implementation may also arrest the progression towards extinction of endangered avian species and reduce the viral reservoir that potentiates infection in humans.	[Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Jefferies, Wilfred] Univ British Columbia, Dept Med Genet, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, W (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	wilf@msl.ubc.ca			International Canadian Commonwealth Scholarship Fund	International Canadian Commonwealth Scholarship Fund	JAY received funding from the International Canadian Commonwealth Scholarship Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babayan SA, 2011, ANN NY ACAD SCI, V1236, P17, DOI 10.1111/j.1749-6632.2011.06251.x; Bertelsen MF, 2004, J WILDLIFE DIS, V40, P538, DOI 10.7589/0090-3558-40.3.538; Erf GF, 1998, VET IMMUNOL IMMUNOP, V62, P339, DOI 10.1016/S0165-2427(97)00070-6; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; HALA K, 1991, ANIM GENET, V22, P279, DOI 10.1111/j.1365-2052.1991.tb00677.x; Lobigs M, 2004, IMMUNOL CELL BIOL, V82, P184, DOI 10.1046/j.0818-9641.2004.01218.x; Luhtala M, 1997, EUR J IMMUNOL, V27, P189, DOI 10.1002/eji.1830270128; Natugle DE, 2005, WILDLIFE SOC B, V33; Sharma D, 2000, BRIT POULTRY SCI, V41, P29, DOI 10.1080/00071660086367; Sharma D, 2001, ANIM BIOTECHNOL, V12, P111, DOI 10.1081/ABIO-100108337; Walker BL, 2007, AVIAN DIS, V51, P691, DOI 10.1637/0005-2086(2007)51[691:WNVAGS]2.0.CO;2; Zuckermann FA, 1999, VET IMMUNOL IMMUNOP, V72, P55, DOI 10.1016/S0165-2427(99)00118-X	12	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67137	10.1371/journal.pone.0067137	http://dx.doi.org/10.1371/journal.pone.0067137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825633	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000083
J	Ferreira, RD; Zhou, DW; Ferreira, JG; Silva, MCC; Silva-Lucca, RA; Mentele, R; Paredes-Gamero, EJ; Bertolin, TC; Correia, MTD; Paiva, PMG; Gustchina, A; Wlodawer, A; Oliva, MLV				Ferreira, Rodrigo da Silva; Zhou, Dongwen; Ferreira, Joana Gasperazzo; Cabral Silva, Mariana Cristina; Silva-Lucca, Rosemeire Aparecida; Mentele, Reinhard; Paredes-Gamero, Edgar Julian; Bertolin, Thiago Carlos; dos Santos Correia, Maria Tereza; Guedes Paiva, Patricia Maria; Gustchina, Alla; Wlodawer, Alexander; Vilela Oliva, Maria Luiza			Crystal Structure of Crataeva tapia Bark Protein (CrataBL) and Its Effect in Human Prostate Cancer Cell Lines	PLOS ONE			English	Article							TRYPSIN-INHIBITOR; SERINE RESIDUE; REACTIVE SITE; LECTIN; BINDING; MECHANISM; DU145; REPLACEMENT; ACTIVATION; REFINEMENT	A protein isolated from the bark of Crataeva tapia (CrataBL) is both a Kunitz-type plant protease inhibitor and a lectin. We have determined the amino acid sequence and three-dimensional structure of CrataBL, as well as characterized its selected biochemical and biological properties. We found two different isoforms of CrataBL isolated from the original source, differing in positions 31 (Pro/Leu); 92 (Ser/Leu); 93 (Ile/Thr); 95 (Arg/Gly) and 97 (Leu/Ser). CrataBL showed relatively weak inhibitory activity against trypsin (K-iapp = 43 mu M) and was more potent against Factor Xa (K-iapp = 8.6 mu M), but was not active against a number of other proteases. We have confirmed that CrataBL contains two glycosylation sites and forms a dimer at high concentration. The high-resolution crystal structures of two different crystal forms of isoform II verified the beta-trefoil fold of CrataBL and have shown the presence of dimers consisting of two almost identical molecules making extensive contacts (similar to 645 angstrom(2)). The structure differs from those of the most closely related proteins by the lack of the N-terminal beta-hairpin. In experiments aimed at investigating the biological properties of CrataBL, we have shown that addition of 40 mM of the protein for 48 h caused maximum growth inhibition in MTT assay (47% of DU145 cells and 43% of PC3 cells). The apoptosis of DU145 and PC3 cell lines was confirmed by flow cytometry using Annexin V/FITC and propidium iodide staining. Treatment with CrataBL resulted in the release of mitochondrial cytochrome c and in the activation of caspase-3 in DU145 and PC3 cells.	[Ferreira, Rodrigo da Silva; Ferreira, Joana Gasperazzo; Cabral Silva, Mariana Cristina; Paredes-Gamero, Edgar Julian; Vilela Oliva, Maria Luiza] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Zhou, Dongwen; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Silva-Lucca, Rosemeire Aparecida] Univ Estadual Oeste Parana, Ctr Engn & Ciencias Exatas, Toledo, Parana, Brazil; [Mentele, Reinhard] Max Planck Inst Biochem, Inst Clin Neuroimmunol LMU, Munich, Germany; [Mentele, Reinhard] Max Planck Inst Biochem, Dept Prot Analyt, Munich, Germany; [Bertolin, Thiago Carlos] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [dos Santos Correia, Maria Tereza; Guedes Paiva, Patricia Maria] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil	Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Estadual do Oeste do Parana; Max Planck Society; University of Munich; Max Planck Society; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Pernambuco	Wlodawer, A (corresponding author), NCI, Macromol Crystallog Lab, Ctr Canc Res, Frederick, MD 21701 USA.	wlodawer@nih.gov; olivaml.bioq@epm.br	Zhou, Dongwen/O-1889-2019; Vilela Oliva, Maria Luiza/AGI-6283-2022; Silva, Mariana/B-9530-2012; Paredes-Gamero, Edgar J/C-4791-2012; Ferreira, Rodrigo S./C-1763-2013; Paiva, Patricia Maria Guedes/S-4038-2019; Oliva, Maria Luiza V/B-9537-2012; de Lucca, Rosemeire Aparecida da Silva/AAQ-2489-2021	Paredes-Gamero, Edgar J/0000-0003-3686-8402; Ferreira, Rodrigo S./0000-0003-4103-6870; Paiva, Patricia Maria Guedes/0000-0003-3467-708X; Oliva, Maria Luiza/0000-0002-5822-0060	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Sao Paulo Research Foundation (FAPESP) [09/53766-5]; Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. W-31-109-Eng-38. The authors are grateful to CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Sao Paulo Research Foundation (FAPESP) (Process 09/53766-5) for providing financial support. This project was also supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Arab Mohammad Reza, 2010, Acta Med Iran, V48, P209; Araujo RMS, 2011, NAT PRODUCT BIOPROSP, V1, P97, DOI 10.1007/s13659-011-0014-8; Azarkan M, 2006, BBA-PROTEINS PROTEOM, V1764, P1063, DOI 10.1016/j.bbapap.2006.02.014; Birk Y, 2005, PLANT PROTEASE INHIB; Bok RA, 2003, PROSTATE CANCER P D, V6, P272, DOI 10.1038/sj.pcan.4500676; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burke PA, 2006, INT J ONCOL, V29, P49; CAGAN RH, 1973, SCIENCE, V181, P32, DOI 10.1126/science.181.4094.32; Colella R, 2002, CANCER LETT, V185, P163, DOI 10.1016/S0304-3835(02)00275-6; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; de Araujo RMS, 2011, THROMB RES, V128, P395, DOI 10.1016/j.thromres.2011.06.005; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; DEKLERK DP, 1984, J UROLOGY, V131, P1008, DOI 10.1016/S0022-5347(17)50750-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EDMAN P, 1950, ACTA CHEM SCAND, V4, P277, DOI 10.3891/acta.chem.scand.04-0277; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang EF, 2012, ARCH TOXICOL, V86, P293, DOI 10.1007/s00204-011-0751-9; FISCHER J, 1983, CANCER DETECT PREV, V6, P137; Gahloth D, 2010, ARCH BIOCHEM BIOPHYS, V494, P15, DOI 10.1016/j.abb.2009.11.008; Gozzo AJ, 2006, BIOL CHEM, V387, P1129, DOI 10.1515/BC.2006.139; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jow GM, 2004, CANCER LETT, V216, P165, DOI 10.1016/j.canlet.2004.06.005; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EJ, 2008, FOOD CHEM TOXICOL, V46, P3651, DOI 10.1016/j.fct.2008.08.038; KUROKAWA T, 1987, J BIOCHEM-TOKYO, V102, P621, DOI 10.1093/oxfordjournals.jbchem.a122096; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJNO G, 1995, AM J PATHOL, V146, P3; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meulenbroek EM, 2012, ACTA CRYSTALLOGR D, V68, P794, DOI 10.1107/S090744491201222X; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nascimento CO, 2008, PROCESS BIOCHEM, V43, P779, DOI 10.1016/j.procbio.2008.02.021; ODANI S, 1978, J BIOCHEM-TOKYO, V84, P1; Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rayon C, 1998, J EXP BOT, V49, P1463, DOI 10.1093/jexbot/49.326.1463; Renko M, 2012, BIOL CHEM, V393, P1043, DOI 10.1515/hsz-2012-0159; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Saitoh E, 2005, COMP BIOCHEM PHYS B, V141, P103, DOI 10.1016/j.cbpc.2005.02.002; Salvesen, 1986, PROTEINASE INHIBITOR, P23; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sharon N, 2002, J AGR FOOD CHEM, V50, P6586, DOI 10.1021/jf020190s; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Smith JA, 2001, BIOCHEM PHARMACOL, V62, P469, DOI 10.1016/S0006-2952(01)00690-6; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; de Araujo RMS, 2012, PLANT SCI, V183, P20, DOI 10.1016/j.plantsci.2011.10.018; Sulzenbacher G, 2010, J MOL BIOL, V400, P715, DOI 10.1016/j.jmb.2010.05.038; Talwar GP, 2001, PROSTATE, V46, P207; Troncoso MF, 2003, ARCH BIOCHEM BIOPHYS, V411, P93, DOI 10.1016/S0003-9861(02)00726-9; VANOOSTRUM J, 1991, J STRUCT BIOL, V107, P189; Verma A, 2010, J MICROBIOL METH, V81, P175, DOI 10.1016/j.mimet.2010.03.001; Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348; Yan QJ, 2010, FOOD CHEM, V122, P589, DOI 10.1016/j.foodchem.2010.03.015; Zhang FM, 2013, BIOCHEMISTRY-US, V52, P2148, DOI 10.1021/bi400077b	69	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e64426	10.1371/journal.pone.0064426	http://dx.doi.org/10.1371/journal.pone.0064426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823708	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400001
J	Furmanov, K; Elnekave, M; Sa'eed, A; Segev, H; Eli-Berchoer, L; Kotton, DN; Bachrach, G; Hovav, AH				Furmanov, Karina; Elnekave, Mazal; Sa'eed, Abdallah; Segev, Hadas; Eli-Berchoer, Luba; Kotton, Darrell N.; Bachrach, Gilad; Hovav, Avi-Hai			Diminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors	PLOS ONE			English	Article							IN-VIVO; LENTIVIRAL VECTORS; DENDRITIC CELLS; ANTITUMOR IMMUNITY; VIRAL VECTORS; RESPONSES; VACCINE; IMMUNIZATION; PRIME; NAIVE	Memory CD8(+) T lymphocytes play a central role in protective immunity. In attempt to increase the frequencies of memory CD8(+) T cells, repeated immunizations with viral vectors are regularly explored. Lentivectors have emerged as a powerful vaccine modality with relatively low pre-existing and anti-vector immunity, thus, thought to be ideal for boosting memory T cells. Nevertheless, we found that lentivectors elicited diminished secondary T-cell responses that did not exceed those obtained by priming. This was not due to the presence of anti-vector immunity, as limited secondary responses were also observed following heterologous prime-boost immunizations. By dissecting the mechanisms involved in this process, we demonstrate that lentivectors trigger exceptionally slow kinetics of antigen expression, while optimal activation of lentivector-induced T cells relays on durable expression of the antigen. These qualities hamper secondary responses, since lentivector-encoded antigen is rapidly cleared by primary cytotoxic T cells that limit its presentation by dendritic cells. Indeed, blocking antigen clearance by cytotoxic T cells via FTY720 treatment, fully restored antigen presentation. Taken together, while low antigen expression is expected during secondary immunization with any vaccine vector, our results reveal that the intrinsic delayed expression kinetics of lentiviral-encoded antigen, further dampens secondary CD8(+) T-cell expansion.	[Furmanov, Karina; Elnekave, Mazal; Sa'eed, Abdallah; Segev, Hadas; Eli-Berchoer, Luba; Bachrach, Gilad; Hovav, Avi-Hai] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel; [Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kotton, Darrell N.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Hebrew University of Jerusalem; Boston University; Boston University	Hovav, AH (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	avihaih@ekmd.huji.ac.il		Bachrach, Gilad/0000-0003-1350-2280	Marie Curie International Reintegration grant [230932]; United States-Israel Binational Science Foundation [T-2011215]	Marie Curie International Reintegration grant(European Commission); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the Marie Curie International Reintegration grant number 230932 for A.H.H. and the United States-Israel Binational Science Foundation Prof. Rahamimoff Travel Grant number T-2011215 for K.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, BLOOD, V115, P3025, DOI 10.1182/blood-2009-11-253641; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bedoui S, 2009, IMMUNOL CELL BIOL, V87, P255, DOI 10.1038/icb.2008.105; Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; CROFT M, 1994, J IMMUNOL, V152, P2675; Dai BB, 2009, P NATL ACAD SCI USA, V106, P20382, DOI 10.1073/pnas.0911742106; Dullaers M, 2006, GENE THER, V13, P630, DOI 10.1038/sj.gt.3302697; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF; Furmanov K, 2010, J IMMUNOL, V184, P4889, DOI 10.4049/jimmunol.0903062; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Iglesias MC, 2007, MOL THER, V15, P1203, DOI 10.1038/sj.mt.6300135; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Liu YJ, 2009, J IMMUNOL, V182, P5960, DOI 10.4049/jimmunol.0900008; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Paris RM, 2010, EXPERT REV VACCINES, V9, P1055, DOI 10.1586/ERV.10.106; Parker DGA, 2007, GENE THER, V14, P760, DOI 10.1038/sj.gt.3302921; Ranasinghe C, 2009, EXPERT REV VACCINES, V8, P1171, DOI 10.1586/ERV.09.86; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Wilson AA, 2010, J CLIN INVEST, V120, P379, DOI 10.1172/JCI36666; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Xiao HY, 2011, J IMMUNOL, V187, P1788, DOI 10.4049/jimmunol.1101138; Yopp AC, 2006, CLIN TRANSPLANT, V20, P788, DOI 10.1111/j.1399-0012.2006.00570.x	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66488	10.1371/journal.pone.0066488	http://dx.doi.org/10.1371/journal.pone.0066488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824049	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400117
J	Iannilli, F; Zalfa, F; Gartner, A; Bagni, C; Dotti, CG				Iannilli, Francesca; Zalfa, Francesca; Gartner, Annette; Bagni, Claudia; Dotti, Carlos G.			Cytoplasmic TERT Associates to RNA Granules in Fully Mature Neurons: Role in the Translational Control of the Cell Cycle Inhibitor p15INK4B	PLOS ONE			English	Article							MESSENGER-RNA; HIPPOCAMPAL-NEURONS; STRESS GRANULES; SHORT TELOMERES; SURVIVAL; PROTEIN; BRAIN; MICE; TRANSPORT; PATHWAYS	The main role of Telomerase Reverse Transcriptase (TERT) is to protect telomere length from shortening during cell division. However, recent works have revealed the existence of a pool of TERT associated to mitochondria, where it plays a role in survival. We here show that in fully differentiated neurons the largest pool of cytoplasmic TERT associates to TIA1 positive RNA granules, where it binds the messenger RNA of the cyclin kinase inhibitor p15INK4B. Upon stress, p15INK4B and TERT dissociate and p15INK4B undergoes efficient translation, allowing its pro-survival function. These results unveil another mechanism implicated in the survival of fully differentiated neurons.	[Iannilli, Francesca; Gartner, Annette; Bagni, Claudia; Dotti, Carlos G.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Gartner, Annette; Bagni, Claudia; Dotti, Carlos G.] VIB, Ctr Biol Dis, Louvain, Belgium; [Zalfa, Francesca; Bagni, Claudia] Univ Rome, Campus Biomed CIR Dept, Rome, Italy; [Dotti, Carlos G.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	KU Leuven; Flanders Institute for Biotechnology (VIB); Sapienza University Rome; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Dotti, CG (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	cdotti@cbm.uam.es	Zalfa, Francesca/J-7759-2018; Dotti, Carlos G/I-5533-2015; Gaertner, Annette/B-5393-2013	Zalfa, Francesca/0000-0002-1922-9468; Dotti, Carlos G/0000-0003-4052-1719; Bagni, Claudia/0000-0002-4419-210X	Flanders Fund for Scientific Research [FWO G 0.666.10N]; NEUROBRAINNET IAP [7/16]; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider [CSD2010-00064, SAF2010-14906]	Flanders Fund for Scientific Research(FWO); NEUROBRAINNET IAP; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider(Ministry of Science and Innovation, Spain (MICINN))	This work was partially supported by Flanders Fund for Scientific Research (FWO G 0.666.10N), NEUROBRAINNET IAP 7/16, Flemish Government Methusalem Grant, Spanish Ministry of Science and Innovation Ingenio-Consolider CSD2010-00064 and SAF2010-14906. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Eitan E, 2012, REJUV RES, V15, P206, DOI 10.1089/rej.2011.1285; Eitan E, 2012, EMBO MOL MED, V4, P313, DOI 10.1002/emmm.201200212; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Fu WM, 2000, J MOL NEUROSCI, V14, P3, DOI 10.1385/JMN:14:1-2:003; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; GRAY EG, 1962, J ANAT, V96, P79; Guix FX, 2012, EMBO MOL MED, V4, P660, DOI 10.1002/emmm.201200243; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lee CH, 2011, NEUROL RES, V33, P93, DOI 10.1179/016164110X12714125204399; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x; Wright WE, 2005, J AM GERIATR SOC, V53, pS292, DOI 10.1111/j.1532-5415.2005.53492.x; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	32	34	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66602	10.1371/journal.pone.0066602	http://dx.doi.org/10.1371/journal.pone.0066602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825548	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400135
J	Menashe, I; Larsen, EC; Banerjee-Basu, S				Menashe, Idan; Larsen, Eric C.; Banerjee-Basu, Sharmila			Prioritization of Copy Number Variation Loci Associated with Autism from AutDB-An Integrative Multi-Study Genetic Database	PLOS ONE			English	Article							SPECTRUM DISORDERS; HUMAN GENOME; DEVELOPMENTAL-DISABILITIES; VARIANTS; 16P11.2; SCHIZOPHRENIA; COMMON; HETEROZYGOSITY; DUPLICATIONS; POLYMORPHISM	Copy number variants (CNVs) are thought to play an important role in the predisposition to autism spectrum disorder (ASD). However, their relatively low frequency and widespread genomic distribution complicates their accurate characterization and utilization for clinical genetics purposes. Here we present a comprehensive analysis of multi-study, genome-wide CNV data from AutDB (http://mindspec.org/autdb.html), a genetic database that accommodates detailed annotations of published scientific reports of CNVs identified in ASD individuals. Overall, we evaluated 4,926 CNVs in 2,373 ASD subjects from 48 scientific reports, encompassing similar to 2.12x10(9) bp of genomic data. Remarkable variation was seen in CNV size, with duplications being significantly larger than deletions, (P = 3x10(-105); Wilcoxon rank sum test). Examination of the CNV burden across the genome revealed 11 loci with a significant excess of CNVs among ASD subjects (P<7x10(-7)). Altogether, these loci covered 15,610 kb of the genome and contained 166 genes. Remarkable variation was seen both in locus size (20 - 4950 kb), and gene content, with seven multigenic (>= 3 genes) and four monogenic loci. CNV data from control populations was used to further refine the boundaries of these ASD susceptibility loci. Interestingly, our analysis indicates that 15q11.2-13.3, a genomic region prone to chromosomal rearrangements of various sizes, contains three distinct ASD susceptibility CNV loci that vary in their genomic boundaries, CNV types, inheritance patterns, and overlap with CNVs from control populations. In summary, our analysis of AutDB CNV data provides valuable insights into the genomic characteristics of ASD susceptibility CNV loci and could therefore be utilized in various clinical settings and facilitate future genetic research of this disorder.	[Menashe, Idan; Larsen, Eric C.; Banerjee-Basu, Sharmila] MindSpec, Mclean, VA USA; [Menashe, Idan] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University	Menashe, I (corresponding author), MindSpec, Mclean, VA USA.	menashe.idan@gmail.com; sharmila@mindspec.org	Menashe, Idan/W-6214-2019; Menashe, Idan/AAC-8670-2020	Menashe, Idan/0000-0003-1961-1461	Simons Foundation	Simons Foundation	AutDB is funded by the Simons Foundation, which licenses it as SFARI Gene (https://gene.sfari.org/autdb/Welcome.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady K, 2009, MOL PSYCHIATR, V14, P590, DOI 10.1038/mp.2008.14; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Coon H, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-8; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Degenhardt F, 2012, AM J MED GENET B, V159B, P263, DOI 10.1002/ajmg.b.32034; Gau SSF, 2012, AM J MED GENET B, V159B, P710, DOI 10.1002/ajmg.b.32074; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gjorlund MD, 2012, FASEB J, V26, P4174, DOI 10.1096/fj.11-202242; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Hallmayer J., 2011, ARCH GEN PSYCHIAT; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Li JY, 2011, ARCH GEN PSYCHIAT, V68, P232, DOI 10.1001/archgenpsychiatry.2011.1; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morris CP, 2012, DIS MARKERS, V33, P163, DOI [10.1155/2012/651707, 10.3233/DMA-2012-0921]; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nazeer A, 2012, PEDIATR CLIN N AM, V59, P19, DOI 10.1016/j.pcl.2011.10.007; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Swanwick C. C., 2011, AUTISM SPECTRUM DISO, P65; van Bon BWM, 1993, 15Q13 3 MICRODELETIO; Walsh KM, 2011, GENET MED, V13, P377, DOI 10.1097/GIM.0b013e3182076c0c; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	51	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66707	10.1371/journal.pone.0066707	http://dx.doi.org/10.1371/journal.pone.0066707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825557	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400151
J	Parker-Duffen, JL; Nakamura, K; Silver, M; Kikuchi, R; Tigges, U; Yoshida, S; Denzel, MS; Ranscht, B; Walsh, K				Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Kikuchi, Ryosuke; Tigges, Ulrich; Yoshida, Sumiko; Denzel, Martin S.; Ranscht, Barbara; Walsh, Kenneth			T-cadherin Is Essential for Adiponectin-mediated Revascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULE; STIMULATES ANGIOGENESIS; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; IDENTIFIES CDH13; BINDING PROTEIN; SMOOTH-MUSCLE	Adipose tissue secretes protein factors that have systemic actions on cardiovascular tissues. Previous studies have shown that ablation of the adipocyte-secreted protein adiponectin leads to endothelial dysfunction, whereas its overexpression promotes wound healing. However, the receptor(s) mediating the protective effects of adiponectin on the vasculature is not known. Here we examined the role of membrane protein T-cadherin, which localizes adiponectin to the vascular endothelium, in the revascularization response to chronic ischemia. T-cadherin-deficient mice were analyzed in a model of hind limb ischemia where blood flow is surgically disrupted in one limb and recovery is monitored over 28 days by laser Doppler perfusion imaging. In this model, T-cadherin-deficient mice phenocopy adiponectin-deficient mice such that both strains display an impaired blood flow recovery compared with wildtype controls. Delivery of exogenous adiponectin rescued the impaired revascularization phenotype in adiponectin-deficient mice but not in T-cadherin-deficient mice. In cultured endothelial cells, T-cadherin deficiency by siRNA knockdown prevented the ability of adiponectin to promote cellular migration and proliferation. These data highlight a previously unrecognized role for T-cadherin in limb revascularization and show that it is essential for mediating the vascular actions of adiponectin.	[Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Kikuchi, Ryosuke; Yoshida, Sumiko; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Parker-Duffen, Jennifer L.; Walsh, Kenneth] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Tigges, Ulrich; Denzel, Martin S.; Ranscht, Barbara] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Boston University; Boston University; Sanford Burnham Prebys Medical Discovery Institute	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Kikuchi, Ryosuke/AAX-4971-2021; Denzel, Martin/C-9047-2014	Denzel, Martin/0000-0002-5691-3349; Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [AG34972, HL81587, HL68758, HL102680, HL007969, GM008541]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, P01HL068758, R21HL102680, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG34972, HL81587, and HL68758 (to K. W.); HL102680 (to B. R.); and HL007969 and GM008541, predoctoral training grants in cardiovascular biology and biomolecular pharmacology, respectively (to J. P. D.).	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Alvarez G, 2012, J VASC RES, V49, P111, DOI 10.1159/000332332; Andreeva AV, 2010, GENE CHROMOSOME CANC, V49, P775, DOI 10.1002/gcc.20787; Andreeva AV, 2009, AM J PHYSIOL-CELL PH, V297, pC1168, DOI 10.1152/ajpcell.00237.2009; Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; Asada K, 2007, INT J MOL MED, V20, P725; Aslibekyan S., 2013, NUTR METAB IN PRESS; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Coyenechea E, 2009, HORM METAB RES, V41, P55, DOI 10.1055/s-0028-1087204; de Liefde II, 2010, EUR J CARDIOV PREV R, V17, P321, DOI 10.1097/HJR.0b013e32833254ce; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Denzel MS, 2009, CLIN CANCER RES, V15, P3256, DOI 10.1158/1078-0432.CCR-08-2661; Dong CH, 2011, J LIPID RES, V52, P1411, DOI 10.1194/jlr.P013672; Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068; Ghosh S, 2007, FEBS LETT, V581, P4523, DOI 10.1016/j.febslet.2007.08.038; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Jo J, 2012, OBESITY, V20, P1683, DOI 10.1038/oby.2011.128; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Joshi MB, 2009, FASEB J, V23, P4011, DOI 10.1096/fj.09-133611; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2006, EXPERT OPIN THER TAR, V10, P573, DOI 10.1517/14728222.10.4.573; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Peach G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5208; Peake PW, 2006, BIOCHEM BIOPH RES CO, V341, P108, DOI 10.1016/j.bbrc.2005.12.162; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Philippova M, 2012, CARDIOVASC RES, V93, P498, DOI 10.1093/cvr/cvs004; Philippova MP, 1998, FEBS LETT, V429, P207, DOI 10.1016/S0014-5793(98)00598-5; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; RANSCHT B, 1991, DEVELOPMENT, V111, P15; Rubina K, 2005, MOL CELL BIOCHEM, V273, P33, DOI 10.1007/s11010-005-0250-5; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Sumner AD, 2012, J CLIN HYPERTENS, V14, P144, DOI 10.1111/j.1751-7176.2011.00580.x; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tkachuk VA, 1998, FEBS LETT, V421, P208, DOI 10.1016/S0014-5793(97)01562-7; Tyrberg B, 2011, ISLETS, V3, P327, DOI 10.4161/isl.3.6.17705; van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Wyder L, 2000, CANCER RES, V60, P4682; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	66	108	118	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24886	24897		10.1074/jbc.M113.454835	http://dx.doi.org/10.1074/jbc.M113.454835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824191	Green Published, hybrid			2022-12-25	WOS:000330612300053
J	Trinh, AT; Kim, SH; Chang, HY; Mastrocola, AS; Tibbetts, RS				Trinh, Anthony T.; Kim, Sang Hwa; Chang, Hae-yoon; Mastrocola, Adam S.; Tibbetts, Randal S.			Cyclin-dependent Kinase 1-dependent Phosphorylation of cAMP Response Element-binding Protein Decreases Chromatin Occupancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB TRANSCRIPTIONAL ACTIVITY; APLYSIA SENSORY NEURONS; DNA-BINDING; KIX DOMAIN; ACTIVATION; COMPLEX; HIPK2; CBP; P53; IDENTIFICATION	The cyclic AMP response element-binding protein (CREB) initiates transcriptional responses to a wide variety of stimuli. CREB activation involves its phosphorylation on Ser-133, which promotes interaction between the CREB kinase-inducible domain (KID) and the KID-interacting domain of the transcriptional coactivator, CREB-binding protein (CBP). The KID also contains a highly conserved phosphorylation cluster, termed the ATM/CK cluster, which is processively phosphorylated in response to DNA damage by the coordinated actions of ataxia-telangiectasia-mutated (ATM) and casein kinases (CKs) 1 and 2. The ATM/CK cluster phosphorylation attenuates CBP binding and CREB transcriptional activity. Paradoxically, it was recently reported that DNA damage activates CREB through homeodomain-interacting protein kinase 2-dependent phosphorylation of Ser-271 near the CREB bZIP DNA binding domain. In this study we sought to further clarify DNA damage-dependent CREB phosphorylation as well as to explore the possibility that the ATM/CK cluster and Ser-271 synergistically or antagonistically modulate CREB activity. We show that, rather than being induced by DNA damage, Ser-270 and Ser-271 of CREB cophosphorylated in a CDK1-dependent manner during G(2)/M phase. Functionally, we show that phosphorylation of CREB on Ser-270/Ser-271 during mitosis correlated with reduced CREB chromatin occupancy. Furthermore, CDK1-dependent phosphorylation of CREB in vitro inhibited its DNA binding activity. The combined results suggest that CDK1-dependent phosphorylation of CREB on Ser-270/Ser-271 facilitates its dissociation from chromatin during mitosis by reducing its intrinsic DNA binding potential.	[Trinh, Anthony T.; Kim, Sang Hwa; Chang, Hae-yoon; Mastrocola, Adam S.; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Program Mol & Cellular Pharmacol, Dept Human Oncol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Program Mol & Cellular Pharmacol, Dept Human Oncol, Madison, WI 53705 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [R01 CA 124722-01]; American Heart Association; Science and Medicine Graduate Research Scholars Fellowship program at the University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Science and Medicine Graduate Research Scholars Fellowship program at the University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA 124722-01 (to R. S. T.). This work was also supported by an American Heart Association predoctoral fellowship (to A. T. T.) and the Science and Medicine Graduate Research Scholars Fellowship program at the University of Wisconsin-Madison.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Chong YH, 2003, MOL PHARMACOL, V63, P690, DOI 10.1124/mol.63.3.690; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Horiuchi J, 2004, J BIOL CHEM, V279, P12117, DOI 10.1074/jbc.M212839200; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; JORDAN MA, 1992, J CELL SCI, V102, P401; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2005, J BIOL CHEM, V280, P15103, DOI 10.1074/jbc.M414144200; Memin E, 2011, EXP CELL RES, V317, P2490, DOI 10.1016/j.yexcr.2011.07.001; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rinaldo C, 2012, MOL CELL, V47, P87, DOI 10.1016/j.molcel.2012.04.029; Sakamoto K, 2010, MOL BIOL CELL, V21, P2966, DOI 10.1091/mbc.E10-01-0015; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarkaria JN, 1998, CANCER RES, V58, P4375; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	52	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23765	23775		10.1074/jbc.M113.464057	http://dx.doi.org/10.1074/jbc.M113.464057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814058	hybrid, Green Published			2022-12-25	WOS:000330611400016
J	Singhal, SS; Figarola, J; Singhal, J; Reddy, MA; Liu, XL; Berz, D; Natarajan, R; Awasthi, S				Singhal, Sharad S.; Figarola, James; Singhal, Jyotsana; Reddy, Marpadga A.; Liu, Xueli; Berz, David; Natarajan, Rama; Awasthi, Sanjay			RLIP76 Protein Knockdown Attenuates Obesity Due to a High-fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LEPTIN RESISTANCE; ADIPOCYTE HYPERTROPHY; DIABETIC-NEPHROPATHY; INSULIN-RESISTANCE; METABOLIC SYNDROME; GENE-EXPRESSION; KIDNEY-DISEASE; IN-VITRO; EPIDEMIOLOGY	Feeding a Western high-fat diet (HFD) to C57BL/6 mice induces obesity, associated with a chronic inflammatory state, lipid transport, and metabolic derangements, and organ system effects that particularly prominent in the kidneys. Here, we report that RLIP76 homozygous knock-out (RLIP76(-/-)) mice are highly resistant to obesity as well as these other features of metabolic syndrome caused by HFD. The normal increase in pro-inflammatory and fibrotic markers associated with HFD induced obesity in wild-type C57B mice was broadly and nearly completely abrogated in RLIP76(-/-) mice. This is a particularly striking finding because chemical markers of oxidative stress including lipid hydroperoxides and alkenals were significantly higher in RLIP76(-/-) mice. Whereas HFD caused marked suppression of AMPK in wild-type C57B mice, RLIP76(-/-) mice had baseline activation of AMP-activated protein kinase, which was not further affected by HFD. The baseline renal function was reduced in RLIP76(-/-) mice as compared with wild-type, but was unaffected by HFD, in marked contrast to severe renal impairment and glomerulopathy in the wild-type mice given HFD. Our findings confirm a fundamental role of RLIP76 in regulating the function of obesity-promoting pro-inflammatory cytokines, and provide a novel mechanism for targeted therapy of obesity and metabolic syndrome.	[Singhal, Sharad S.; Figarola, James; Singhal, Jyotsana; Reddy, Marpadga A.; Berz, David; Natarajan, Rama; Awasthi, Sanjay] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Liu, Xueli] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Dept Biostat, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Singhal, SS (corresponding author), City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	ssinghal@coh.org; sawasthi@coh.org	Awasthi, Sanjay/R-4904-2019	Reddy, Marpadga A/0000-0001-9259-7243; Awasthi, Sanjay/0000-0002-5214-5717; FIGAROLA, JAMES/0000-0003-3948-6282	National Institutes of Health from the NCI [RO1 CA77495]; Perricone Family Foundation, Los Angeles, CA; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE [R01CA077495, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Perricone Family Foundation, Los Angeles, CA; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA77495 (to S. A.) from the NCI, and funds from the Perricone Family Foundation, Los Angeles, CA, and the Beckman Research Institute of the City of Hope (to S. A.).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Awasthi S, 2005, CANCER RES, V65, P6022, DOI 10.1158/0008-5472.CAN-05-0968; Awasthi S, 2010, DIABETES, V59, P714, DOI 10.2337/db09-0911; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; Beltowski J, 2006, MED SCI MONITOR, V12, pRA112; Bluher M, 2012, DIABETES METAB J, V36, P317, DOI 10.4093/dmj.2012.36.5.317; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; El-Bikai R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3173; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Galassetti P, 2012, EXP DIABETES RES, DOI 10.1155/2012/943706; Gil A, 2007, BRIT J NUTR, V98, pS121, DOI 10.1017/S0007114507838050; Gornicka A, 2012, AM J PHYSIOL-ENDOC M, V303, pE597, DOI 10.1152/ajpendo.00022.2012; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kadowaki T, 2002, J DIABETES COMPLICAT, V16, P41, DOI 10.1016/S1056-8727(01)00206-9; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim DH, 2013, J LIPID RES, V54, P786, DOI 10.1194/jlr.M033894; Konner AC, 2012, CELL METAB, V16, P144, DOI 10.1016/j.cmet.2012.07.004; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Lee J, 2013, ARCH PHARM RES, V36, P208, DOI 10.1007/s12272-013-0023-8; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Malavazos AE, 2007, NUTR METAB CARDIOVAS, V17, P294, DOI 10.1016/j.numecd.2006.01.001; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; NORDSIEK FW, 1964, AM J PUBLIC HEALTH N, V54, P1689, DOI 10.2105/AJPH.54.10.1689; O'Rourke RW, 2006, CLIN EXP IMMUNOL, V146, P39, DOI 10.1111/j.1365-2249.2006.03186.x; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Okwan-Duodu D, 2013, AM J CANCER RES, V3, P21; Pender JR, 2005, GASTROENTEROL CLIN N, V34, P1, DOI 10.1016/j.gtc.2004.12.010; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Sahin-Efe A, 2012, METABOLISM, V61, P1659, DOI 10.1016/j.metabol.2012.09.001; Singhal J, 2008, INT J RADIAT ONCOL, V72, P553, DOI 10.1016/j.ijrobp.2008.06.1497; Singhal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024688; Singhal SS, 2011, MOL CANCER THER, V10, P16, DOI 10.1158/1535-7163.MCT-10-0699; SINGMAN HS, 1980, AM J CLIN NUTR, V33, P1183, DOI 10.1093/ajcn/33.6.1183; Skurk T, 2002, HORM METAB RES, V34, P659, DOI 10.1055/s-2002-38253; Strandberg L, 2008, OBESITY, V16, P710, DOI 10.1038/oby.2007.95; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Tanner RM, 2012, CURR HYPERTENS REP, V14, P152, DOI 10.1007/s11906-012-0254-y; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200	57	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23394	23406		10.1074/jbc.M113.480194	http://dx.doi.org/10.1074/jbc.M113.480194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23821548	Green Published, hybrid			2022-12-25	WOS:000330598200043
J	Banugaria, SG; Prater, SN; Patel, TT; DeArmey, SM; Milleson, C; Sheets, KB; Bali, DS; Rehder, CW; Raiman, JAJ; Wang, RA; Labarthe, F; Charrow, J; Harmatz, P; Chakraborty, P; Rosenberg, AS; Kishnani, PS				Banugaria, Suhrad G.; Prater, Sean N.; Patel, Trusha T.; DeArmey, Stephanie M.; Milleson, Christie; Sheets, Kathryn B.; Bali, Deeksha S.; Rehder, Catherine W.; Raiman, Julian A. J.; Wang, Raymond A.; Labarthe, Francois; Charrow, Joel; Harmatz, Paul; Chakraborty, Pranesh; Rosenberg, Amy S.; Kishnani, Priya S.			Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; ALGLUCOSIDASE ALPHA; CLINICAL-OUTCOMES; ANTIBODIES	Objective: Although enzyme replacement therapy (ERT) is a highly effective therapy, CRIM-negative (CN) infantile Pompe disease (IPD) patients typically mount a strong immune response which abrogates the efficacy of ERT, resulting in clinical decline and death. This study was designed to demonstrate that immune tolerance induction (ITI) prevents or diminishes the development of antibody titers, resulting in a better clinical outcome compared to CN IPD patients treated with ERT monotherapy. Methods: We evaluated the safety, efficacy and feasibility of a clinical algorithm designed to accurately identify CN IPD patients and minimize delays between CRIM status determination and initiation of an ITI regimen (combination of rituximab, methotrexate and IVIG) concurrent with ERT. Clinical and laboratory data including measures of efficacy analysis for response to ERT were analyzed and compared to CN IPD patients treated with ERT monotherapy. Results: Seven CN IPD patients were identified and started on the ITI regimen concurrent with ERT. Median time from diagnosis of CN status to commencement of ERT and ITI was 0.5 months (range: 0.1-1.6 months). At baseline, all patients had significant cardiomyopathy and all but one required respiratory support. The ITI regimen was safely tolerated in all seven cases. Four patients never seroconverted and remained antibody-free. One patient died from respiratory failure. Two patients required another course of the ITI regimen. In addition to their clinical improvement, the antibody titers observed in these patients were much lower than those seen in ERT monotherapy treated CN patients. Conclusions: The ITI regimen appears safe and efficacious and holds promise in altering the natural history of CN IPD by increasing ERT efficacy. An algorithm such as this substantiates the benefits of accelerated diagnosis and management of CN IPD patients, thus, further supporting the importance of early identification and treatment initiation with newborn screening for IPD.	[Banugaria, Suhrad G.; Prater, Sean N.; Patel, Trusha T.; DeArmey, Stephanie M.; Milleson, Christie; Sheets, Kathryn B.; Bali, Deeksha S.; Kishnani, Priya S.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Rehder, Catherine W.] Duke Univ Hlth Syst, Clin Mol Diagnost Labs, Durham, NC USA; [Raiman, Julian A. J.] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Wang, Raymond A.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Labarthe, Francois] Univ Hosp, Hop Clocheville, Tours, France; [Charrow, Joel] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Harmatz, Paul] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Chakraborty, Pranesh] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Rosenberg, Amy S.] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	Duke University; Duke University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Childrens Hospital of Orange County; CHU Tours; Northwestern University; Feinberg School of Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Ottawa; US Food & Drug Administration (FDA)	Kishnani, PS (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA.	priya.kishnani@duke.edu	Wang, Raymond Yu Jeang/H-8870-2019; Harmatz, Paul/AAY-5866-2020; Wang, Raymond Yu Jeang/CAJ-3535-2022	Wang, Raymond Yu Jeang/0000-0001-6494-7613; Harmatz, Paul/0000-0001-5603-2085; 	Lysosomal Disease Network, a part of National Institutes of Health Rare Diseases Clinical Research Network (RDCRN); NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS) [U54NS065768]; National Institute of Neurological Disorders and Stroke (NINDS) [U54NS065768]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U54NS065768]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065768] Funding Source: NIH RePORTER	Lysosomal Disease Network, a part of National Institutes of Health Rare Diseases Clinical Research Network (RDCRN); NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded in part by the Lysosomal Disease Network, a part of National Institutes of Health Rare Diseases Clinical Research Network (RDCRN). The Lysosomal Disease Network (U54NS065768) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the patients and their families who participated in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MA, 2011, MOL GENET METAB, V104, P583, DOI 10.1016/j.ymgme.2011.08.003; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Bali DS, 2012, AM J MED GENET C, V160C, P40, DOI 10.1002/ajmg.c.31319; Banugaria SG, 2012, GENET MED; Banugaria SG, 2012, EXPERT REV CLIN IMMU, V8, P497, DOI 10.1586/ECI.12.40; Banugaria SG, 2012, MOL GENET METAB, V105, P677, DOI 10.1016/j.ymgme.2012.01.019; Banugaria SG, 2011, GENET MED, V13, P729, DOI 10.1097/GIM.0b013e3182174703; Chien YH, 2009, PEDIATRICS, V124, pE1116, DOI 10.1542/peds.2008-3667; HALL PD, 1993, PHARMACOTHERAPY, V13, P564; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hirschhorn R, 2009, GLYCOGEN STORAGE DIS; Hunley TE, 2004, PEDIATRICS, V114, pE532, DOI 10.1542/peds.2003-0988-L; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khallaf HA, 2013, JIMD REPORTS CASE RE, P133; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2009, PEDIATR RES, V66, P329, DOI 10.1203/PDR.0b013e3181b24e94; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Mendelsohn NJ, 2009, NEW ENGL J MED, V360, P194, DOI 10.1056/NEJMc0806809; Messinger YH, 2012, GENET MED, V14, P135, DOI 10.1038/gim.2011.4; Moyer VA, 2008, HASTINGS CENT REP, V38, P32, DOI 10.1353/hcr.0.0011; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Prater SN, 2012, GENET MED, V14, P800, DOI 10.1038/gim.2012.44; Rezvani AR, 2011, BEST PRACT RES CL HA, V24, P203, DOI 10.1016/j.beha.2011.02.009; Rigter T, 2012, MOL GENET METAB, V107, P448, DOI 10.1016/j.ymgme.2012.09.017; Rohrbach M, 2010, J INHERIT METAB DIS, V33, P751, DOI 10.1007/s10545-010-9209-0	26	82	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67052	10.1371/journal.pone.0067052	http://dx.doi.org/10.1371/journal.pone.0067052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825616	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000068
J	Hirano, K; Ohgomori, T; Kobayashi, K; Tanaka, F; Matsumoto, T; Natori, T; Matsuyama, Y; Uchimura, K; Sakamoto, K; Takeuchi, H; Hirakawa, A; Suzumura, A; Sobue, G; Ishiguro, N; Imagama, S; Kadomatsu, K				Hirano, Kenichi; Ohgomori, Tomohiro; Kobayashi, Kazuyoshi; Tanaka, Fumiaki; Matsumoto, Tomohiro; Natori, Takamitsu; Matsuyama, Yukihiro; Uchimura, Kenji; Sakamoto, Kazuma; Takeuchi, Hideyuki; Hirakawa, Akihiro; Suzumura, Akio; Sobue, Gen; Ishiguro, Naoki; Imagama, Shiro; Kadomatsu, Kenji			Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; FUNCTIONAL RECOVERY; PROGRESSION; ASTROCYTES; RECEPTOR; DISEASE; MODEL; ONSET; SOD1	Biopolymers consist of three major classes, i.e., polynucleotides (DNA, RNA), polypeptides (proteins) and polysaccharides (sugar chains). It is widely accepted that polynucleotides and polypeptides play fundamental roles in the pathogenesis of neurodegenerative diseases. But, sugar chains have been poorly studied in this process, and their biological/clinical significance remains largely unexplored. Amyotrophic lateral sclerosis (ALS) is a motoneuron-degenerative disease, the pathogenesis of which requires both cell autonomous and non-cell autonomous processes. Here, we investigated the role of keratan sulfate (KS), a sulfated long sugar chain of proteoglycan, in ALS pathogenesis. We employed ALS model SOD1(G93A) mice and GlcNAc6ST-1(-/-) mice, which are KS-deficient in the central nervous system. Unexpectedly, SOD1(G93A)GlcNAc6ST-1(-/-) mice exhibited a significantly shorter lifespan than SOD1(G93A) mice and an accelerated appearance of clinical symptoms (body weight loss and decreased rotarod performance). KS expression was induced exclusively in a subpopulation of microglia in SOD1(G93A) mice, and became detectable around motoneurons in the ventral horn during the early disease phase before body weight loss. During this phase, the expression of M2 microglia markers was transiently enhanced in SOD1(G93A) mice, while this enhancement was attenuated in SOD1(G93A)GlcNAc6ST-1(-/-) mice. Consistent with this, M2 microglia were markedly less during the early disease phase in SOD1(G93A)GlcNAc6ST-1(-/-) mice. Moreover, KS expression in microglia was also detected in some human ALS cases. This study suggests that KS plays an indispensable, suppressive role in the early phase pathogenesis of ALS and may represent a new target for therapeutic intervention.	[Hirano, Kenichi; Ohgomori, Tomohiro; Kobayashi, Kazuyoshi; Matsumoto, Tomohiro; Uchimura, Kenji; Sakamoto, Kazuma; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan; [Hirano, Kenichi; Kobayashi, Kazuyoshi; Matsumoto, Tomohiro; Ishiguro, Naoki; Imagama, Shiro] Nagoya Univ, Grad Sch Med, Dept Orthoped, Nagoya, Aichi 4648601, Japan; [Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; Yamanashi Gakuin Univ, Dept Hlth & Nutr, Kofu, Yamanashi, Japan; [Matsuyama, Yukihiro] Hamamatsu Univ Sch Med, Dept Orthoped, Hamamatsu, Shizuoka 4312102, Japan; [Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 4648601, Japan; [Hirakawa, Akihiro] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University; Hamamatsu University School of Medicine; Nagoya University; Nagoya University	Imagama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthoped, Nagoya, Aichi 4648601, Japan.	imagama@med.nagoya-u.ac.jp; kkadoma@med.nagoya-u.ac.jp	IMAGAMA, Shiro/I-7419-2014; Kadomatsu, Kenji/G-8083-2012; Uchimura, Kenji/C-9635-2014; Hirakawa, Akihiro/AAE-5936-2019; Sakamoto, Kazuma/B-7347-2016; Ishiguro, Naoki/I-1563-2012; Uchimura, Kenji/AFV-1802-2022	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X; Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23110002, 23790360]; MEXT [20390092]; Ministry of Health, Labor, and Welfare of Japan [H21-012]; Global COE program, MEXT; Grants-in-Aid for Scientific Research [25860234, 25293207] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global COE program, MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23110002 to KK) and a Grant-in-Aid for Young Scientists (B) (No. 23790360 to TO) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by a Grant-in-Aid (No. 20390092 to KK) from MEXT; by a Grant-in-Aid from the Ministry of Health, Labor, and Welfare of Japan (Health Sciences Research Grant on Comprehensive Research on Disability Health and Welfare, H21-012 to KK); and by funds from the Global COE program, MEXT, to Nagoya University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Imagama S, 2011, J NEUROSCI, V31, P17091, DOI 10.1523/JNEUROSCI.5120-10.2011; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Ito Z, 2010, J NEUROSCI, V30, P5937, DOI 10.1523/JNEUROSCI.2570-09.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mizuno H, 2008, J NEUROSCI RES, V86, P2512, DOI 10.1002/jnr.21702; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Vargas MR, 2008, J NEUROSCI RES, V86, P3515, DOI 10.1002/jnr.21797; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang HQ, 2006, GLYCOBIOLOGY, V16, P702, DOI 10.1093/glycob/cwj115	25	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66969	10.1371/journal.pone.0066969	http://dx.doi.org/10.1371/journal.pone.0066969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825599	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000053
J	Hubertus, J; Zitzmann, F; Trippel, F; Muller-Hocker, J; Stehr, M; von Schweinitz, D; Kappler, R				Hubertus, Jochen; Zitzmann, Ferdinand; Trippel, Franziska; Mueller-Hoecker, Josef; Stehr, Maximilian; von Schweinitz, Dietrich; Kappler, Roland			Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors	PLOS ONE			English	Article							GROWTH-FACTOR-II; IMPRINTED DOMAIN; NEURONATIN GENE; CTCF; INSULATOR; STAGE; LINK	Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT.	[Hubertus, Jochen; Zitzmann, Ferdinand; Trippel, Franziska; Stehr, Maximilian; von Schweinitz, Dietrich; Kappler, Roland] Univ Munich, Res Labs, Dept Pediat Surg, Munich, Germany; [Mueller-Hoecker, Josef] Univ Munich, Inst Pathol, D-80539 Munich, Germany	University of Munich; University of Munich	Hubertus, J (corresponding author), Univ Munich, Res Labs, Dept Pediat Surg, Munich, Germany.	jochen.hubertus@med.lmu.de	Hubertus, Jochen/AAW-7790-2021; Hubertus, Jochen/K-6512-2019	Hubertus, Jochen/0000-0003-3206-6170; Kappler, Roland/0000-0002-8581-2803	Friedrich-Baur foundation, Munich; Munchener Medizinische Wochenschrift, Munich	Friedrich-Baur foundation, Munich; Munchener Medizinische Wochenschrift, Munich	This work was supported by grants of the Friedrich-Baur foundation, Munich and the Munchener Medizinische Wochenschrift, Munich (to J.H.). But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Cui HM, 2001, CANCER RES, V61, P4947; Davidoff Andrew M, 2012, Adv Pediatr, V59, P247, DOI 10.1016/j.yapd.2012.04.001; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dugu L, 2010, EUR J DERMATOL, V20, P580, DOI 10.1684/ejd.2010.0996; Dugu L, 2010, J DERMATOL, V37, P846, DOI 10.1111/j.1346-8138.2010.00873.x; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Fukuzawa R, 2004, LANCET, V363, P446, DOI 10.1016/S0140-6736(04)15491-3; Hubertus J, 2011, ONCOL REP, V25, P817, DOI 10.3892/or.2010.1113; Ideraabdullah FY, 2011, DEV BIOL, V355, P349, DOI 10.1016/j.ydbio.2011.04.036; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Ohlsson R, 1999, CANCER RES, V59, P3889; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Singh Purnima, 2012, Frontiers in Genetics, V3, P214, DOI 10.3389/fgene.2012.00214; Szabo PE, 2012, MORE INSULATOR MULTI, P1, DOI [10.3389/ fgene. 2012.00214/abstract, DOI 10.3389/FGENE.2012.00214/ABSTRACT]; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Wang WH, 1996, J BIOL CHEM, V271, P27863, DOI 10.1074/jbc.271.44.27863; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Wittmann S, 2008, GENE CHROMOSOME CANC, V47, P386, DOI 10.1002/gcc.20544; Xu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037811	28	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67605	10.1371/journal.pone.0067605	http://dx.doi.org/10.1371/journal.pone.0067605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825673	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000109
J	Liu, YB; Lu, PS; Hu, Y; Wang, ZG; Deng, XY; Ma, FB; Tao, H; Jia, CM; Ding, XY; Yang, HT; Liu, P; Min, J				Liu, Yuanbao; Lu, Peishan; Hu, Ying; Wang, Zhiguo; Deng, Xiuying; Ma, Fubao; Tao, Hong; Jia, Chengmei; Ding, Xiaoyan; Yang, Haitao; Liu, Pei; Min, Jie			Cross-Sectional Surveys of Measles Antibodies in the Jiangsu Province of China from 2008 to 2010: The Effect of High Coverage with Two Doses of Measles Vaccine among Children	PLOS ONE			English	Article							SUPPLEMENTARY IMMUNIZATION ACTIVITIES; YOUNG-ADULTS; IMMUNITY; RUBELLA; MUMPS; SEROEPIDEMIOLOGY; ELIMINATION; REVACCINATION; EXPERIENCE; PROGRESS	Background: Changes in the epidemiological characteristics of measles since 2007 appeared in the Jiangsu province. Although the reported coverage with two doses of measles vaccine was greater than 95% in most regions of the province, measles incidence remained high across the whole province. Cross-sectional serological surveys of measles antibodies in the Jiangsu province of China were conducted from 2008 to 2010 to assess and track population immunity. Methods: Measles-specific IgG levels were measured in serum samples using ELISA. GMTs and seroprevalence with 95% CIs were calculated by region, gender, and age. ANOVA and x 2 tests were used to test for statistically significant differences between groups for GMT levels and seroprevalence, respectively. Results: Seroprevalence showed a significantly increasing trend annually (CMH chi(2) = 40.32, p<0.0001). Although the seroprevalence among children aged 2-15 years was consistently over 95%, vaccine-induced measles antibodies may wane over time. Measles seropositivity in the Jiangsu province was 91.7% (95% CI: 90.1-93.2%) in 2010. Among adults aged 15 to 29-year-olds, the seropositivity rate was 88.4% (95% CI: 82.7-92.8%). Conclusions: Vaccination strategies may need to be adjusted depending on the individual age and regions, particularly individuals between the ages of 8 months-14 years old and 20-29 years old. Additional SIAs are likely required to eliminate measles in China.	[Liu, Yuanbao; Lu, Peishan; Hu, Ying; Wang, Zhiguo; Deng, Xiuying; Ma, Fubao; Tao, Hong; Jia, Chengmei; Ding, Xiaoyan; Yang, Haitao] Jiangsu Prov Ctr Dis Control & Prevent, Dept Expanded Programme Immunizat, Nanjing, Jiangsu, Peoples R China; [Liu, Pei; Min, Jie] Southeast Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Southeast University - China	Ma, FB (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Expanded Programme Immunizat, Nanjing, Jiangsu, Peoples R China.	jsepi_ma@163.com			department of health of Jiangsu Province [Y2012068]	department of health of Jiangsu Province	This study was guided by the preventive medicine scientific research project from department of health of Jiangsu Province (NO. Y2012068). We would like to thank the following institutions for their field works: Nanjing Center for Disease Control and Prevention (CDC), Wuxi CDC, Xuzhou CDC, Changzhou CDC, Suzhou CDC, Nantong CDC, Lianyungang CDC, Huaian CDC, Yancheng CDC, Yangzhou CDC, Zhenjiang CDC, Taizhou CDC, Suqian CDC. We appreciated Dr. Lance Rodewald in WHO and Dr. Xia wei in NIP to polish and review the manuscript.	Andrews N, 2000, EPIDEMIOL INFECT, V125, P127, DOI 10.1017/S0950268899004173; Bechini A, 2012, EUR J PUBLIC HEALTH, V22, P133, DOI 10.1093/eurpub/ckq134; Chao M., 2011, CHINESE J VACCINE IM, V17, P4; Chen CJ, 2012, VACCINE, V30, P6721, DOI 10.1016/j.vaccine.2012.05.019; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; De Serres G, 2012, CLIN INFECT DIS, V55, P394, DOI 10.1093/cid/cis439; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; Fu CX, 2010, VACCINE, V28, P8219, DOI 10.1016/j.vaccine.2010.07.071; He HQ, 2013, VACCINE, V31, P533, DOI 10.1016/j.vaccine.2012.11.014; HO, FIELD GUID MEASL EL; Huiss S, 1997, CLIN EXP IMMUNOL, V109, P416, DOI 10.1046/j.1365-2249.1997.00137.x; Irons B, 2011, J INFECT DIS, V204, pS284, DOI 10.1093/infdis/jir212; Jaber SM, 2006, SAUDI MED J, V27, P63; Khetsuriani N, 2011, J INFECT DIS, V204, pS343, DOI 10.1093/infdis/jir074; Ki M, 2003, AM J EPIDEMIOL, V157, pS48; Kim SS, 2004, VACCINE, V23, P290, DOI 10.1016/j.vaccine.2004.07.030; Liu YB, 2011, VACCINE, V29, P1000, DOI 10.1016/j.vaccine.2010.11.081; MARKOWITZ LE, 1992, J INFECT DIS, V166, P205, DOI 10.1093/infdis/166.1.205; MARKOWITZ LE, 1990, PEDIATR INFECT DIS J, V9, P101, DOI 10.1097/00006454-199002000-00008; Muscat M, 2009, LANCET, V373, P383, DOI 10.1016/S0140-6736(08)61849-8; PAHO, 2005, MEASL EL FIELD GUID; R D Core Team., 2009, LANG ENV STAT COMP; Sasaki A, 2007, J INFECTION, V55, P179, DOI 10.1016/j.jinf.2007.04.004; Sniadack DH, 2011, J INFECT DIS, V204, pS439, DOI 10.1093/infdis/jir148; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; Vyse AJ, 2006, EPIDEMIOL INFECT, V134, P1303, DOI 10.1017/S0950268806006340; Wenyuan Z, 2001, THEORY VACCINES IMMU; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P349; Yuanbao L, 2010, CHINESE J VACCINE IM, V16, P307; Zhuo JT, 2011, J INFECT DIS, V204, pS455, DOI 10.1093/infdis/jir063	31	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66771	10.1371/journal.pone.0066771	http://dx.doi.org/10.1371/journal.pone.0066771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825562	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000025
J	Rathleff, MS; Thorborg, K; Bandholm, T				Rathleff, Michael Skovdal; Thorborg, Kristian; Bandholm, Thomas			Concentric and Eccentric Time-Under-Tension during Strengthening Exercises: Validity and Reliability of Stretch-Sensor Recordings from an Elastic Exercise-Band	PLOS ONE			English	Article							SUBACROMIAL IMPINGEMENT SYNDROME; RANDOMIZED CONTROLLED-TRIAL; KNEE OSTEOARTHRITIS; CONTRACTION TYPES; MUSCLE STRENGTH; HOME EXERCISE; PROGRAM; TENDON; MANAGEMENT; ACHILLES	Background: Total, single repetition and contraction-phase specific (concentric and eccentric) time-under-tension (TUT) are important exercise-descriptors, as they are linked to the physiological and clinical response in exercise and rehabilitation. Objective: To investigate the validity and reliability of total, single repetition, and contraction-phase specific TUT during shoulder abduction exercises, based on data from a stretch-sensor attached to an elastic exercise band. Methods: A concurrent validity and interrater reliability study with two raters was conducted. Twelve participants performed five sets of 10 repetitions of shoulder abduction exercises with an elastic exercise band. Exercises were video-recorded to assess concurrent validity between TUT from stretch-sensor data and from video recordings (gold standard). Agreement between methods was calculated using Limits of Agreement (LoA), and the association was assessed by Pearson correlation coefficients. Interrater reliability was calculated using intraclass correlation coefficients (ICC 2.1). Results: Total, single repetition, and contraction-phase specific TUT-determined from video and stretch-sensor data-were highly correlated (r>0.99). Agreement between methods was high, as LoA ranged from 0.0 to 3.1 seconds for total TUT (2.6% of mean TUT), from -0.26 to 0.56 seconds for single repetition TUT (6.9%), and from -0.29 to 0.56 seconds for contraction-phase specific TUT (13.2-21.1%). Interrater reliability for total, single repetition and contraction-phase specific TUT was high (ICC>0.99). Interrater agreement was high, as LoA ranged from -2.11 to 2.56 seconds for total TUT (4.7%), from -0.46 to 0.50 seconds for single repetition TUT (9.7%) and from -0.41 to 0.44 seconds for contraction-phase specific TUT (5.2-14.5%). Conclusion: Data from a stretch-sensor attached to an elastic exercise band is a valid measure of total and single repetition time-under-tension, and the procedure is highly reliable. This method will enable clinicians and researchers to objectively quantify if home-based exercises are performed as prescribed, with respect to time-under-tension.	[Rathleff, Michael Skovdal] Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark; [Thorborg, Kristian] Univ Copenhagen Hosp, Arthroscop Ctr Amager, DK-2100 Copenhagen, Denmark; [Thorborg, Kristian; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Orthoped Surg, Hvidovre, Denmark; [Thorborg, Kristian; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Phys Therapy Phys Med & Rehabil Res Copenhag, Hvidovre, Denmark; [Bandholm, Thomas] Univ Copenhagen Hosp, Clin Res Ctr, DK-2100 Copenhagen, Denmark	Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Rathleff, MS (corresponding author), Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark.	michaelrathleff@gmail.com	Bandholm, Thomas/AAZ-8632-2020	Bandholm, Thomas/0000-0001-6884-1971; Rathleff, Michael Skovdal/0000-0003-1173-0335	Bevica Foundation	Bevica Foundation	The Bevica Foundation paid supplied funding for the hardware used in the current study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RG, 2006, FOOT ANKLE INT, V27, P2, DOI 10.1177/107110070602700102; Andersen LL, 2011, PAIN, V152, P440, DOI 10.1016/j.pain.2010.11.016; Beers Amanda, 2008, Physiother Can, V60, P180, DOI 10.3138/physio.60.2.180; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown S, 2010, TLS-TIMES LIT SUPPL, P24; Buitrago S, 2012, EUR J APPL PHYSIOL, V112, P2739, DOI 10.1007/s00421-011-2249-9; Burd NA, 2012, J PHYSIOL-LONDON, V590, P351, DOI 10.1113/jphysiol.2011.221200; Comstock BA, 2011, J STRENGTH COND RES, V25, P2293, DOI 10.1519/JSC.0b013e318200b78c; Dunstan DW, 2005, DIABETES CARE, V28, P3, DOI 10.2337/diacare.28.1.3; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Holmgren T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e787; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Kappel SL, 2012, SENSORS; Kaux JF, 2013, J ORTHOP RES, V31, P119, DOI 10.1002/jor.22202; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; Mafi N, 2001, KNEE SURG SPORT TR A, V9, P42, DOI 10.1007/s001670000148; Malliaras P, 2013, SPORTS MED, V43, P267, DOI 10.1007/s40279-013-0019-z; McCarthy CJ, 2004, RHEUMATOLOGY, V43, P880, DOI 10.1093/rheumatology/keh188; McLean SM, 2010, MANUAL THER, V15, P514, DOI 10.1016/j.math.2010.05.012; Mohamad NI, 2011, STRENGTH COND J, V33, P81, DOI 10.1519/SSC.0b013e3181fe7164; Or CKL, 2011, J AM MED INFORM ASSN, V18, P51, DOI 10.1136/jamia.2010.007336; Rathleff MS, 2013, BRIT J SPORT MED; Ravaud P, 2004, ANN RHEUM DIS, V63, P703, DOI 10.1136/ard.2003.009803; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P2857, DOI 10.1519/JSC.0b013e3181e840f3; Thomas KS, 2005, ARTHRIT RHEUM-ARTHR, V53, P388, DOI 10.1002/art.21173; Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; Tran QT, 2006, EUR J APPL PHYSIOL, V98, P402, DOI 10.1007/s00421-006-0297-3; Walther M, 2004, J SHOULDER ELB SURG, V13, P417, DOI 10.1016/j.jse.2004.02.002; Yu J, 2013, AM J PHYS MED REHAB, V92, P68, DOI 10.1097/PHM.0b013e31826eda63	34	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68172	10.1371/journal.pone.0068172	http://dx.doi.org/10.1371/journal.pone.0068172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825696	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000130
J	Ren, TJ; Qiang, R; Jiang, ZL; Wang, GH; Sun, L; Jiang, R; Zhao, GW; Han, LY				Ren, Tao-Jie; Qiang, Ren; Jiang, Zheng-Lin; Wang, Guo-Hua; Sun, Li; Jiang, Rui; Zhao, Guang-Wei; Han, Le-Yang			Improvement in Regional CBF by L-Serine Contributes to Its Neuroprotective Effect in Rats after Focal Cerebral Ischemia	PLOS ONE			English	Article							CT PERFUSION; BRAIN; NEUROTRANSMISSION; INHIBITION; OCCLUSION; RESPONSES; CHANNELS; ENZYME; ARTERY; DEATH	To investigate the mechanisms underlying the neuroprotective effect of L-serine, permanent focal cerebral ischemia was induced by occlusion of the middle cerebral artery while monitoring cerebral blood flow (CBF). Rats were divided into control and L-serine-treated groups after middle cerebral artery occlusion. The neurological deficit score and brain infarct volume were assessed. Nissl staining was used to quantify the cortical injury. L-serine and D-serine levels in the ischemic cortex were analyzed with high performance liquid chromatography. We found that L-serine treatment: 1) reduced the neurological deficit score, infarct volume and cortical neuron loss in a dose-dependent manner; 2) improved CBF in the cortex, and this effect was inhibited in the presence of apamin plus charybdotoxin while the alleviation of both neurological deficit score and infarct volume was blocked; and 3) increased the amount of L-serine and D-serine in the cortex, and inhibition of the conversion of L-serine into D-serine by aminooxyacetic acid did not affect the reduction of neurological deficit score and infarct volume by L-serine. In conclusion, improvement in regional CBF by L-serine may contribute to its neuroprotective effect on the ischemic brain, potentially through vasodilation which is mediated by the small-and intermediate-conductance Ca2+-activated K+ channels on the cerebral blood vessel endothelium.	[Ren, Tao-Jie; Jiang, Zheng-Lin; Wang, Guo-Hua; Sun, Li; Jiang, Rui; Zhao, Guang-Wei; Han, Le-Yang] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong, Jiangsu, Peoples R China; [Qiang, Ren] Third Peoples Hosp, Dept Infect Dis, Nantong, Jiangsu, Peoples R China; [Ren, Tao-Jie; Jiang, Zheng-Lin; Sun, Li; Zhao, Guang-Wei] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Jiangsu, Peoples R China; [Ren, Tao-Jie] First Peoples Hosp, Dept Neurol, Yancheng, Jiangsu, Peoples R China	Nantong University; Nantong University	Jiang, ZL (corresponding author), Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn; wgh@ntu.edu.cn	Wang, Guohua/AAD-8992-2022	Wang, Guohua/0000-0002-4810-8534	Chinese Natural Science Foundation [81000497, 81071614]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Administration of Science and Technology of Nantong, Jiangsu, China [BK2012086]; Qing-Lan Project of Jiangsu, China	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Administration of Science and Technology of Nantong, Jiangsu, China; Qing-Lan Project of Jiangsu, China	This work was supported by the Chinese Natural Science Foundation (Grant 81000497), the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Administration of Science and Technology of Nantong, Jiangsu, China (Project BK2012086). Guo-Hua Wang was sponsored by the Qing-Lan Project of Jiangsu, China, and Zheng-Lin Jiang is supported by the Chinese Natural Science Foundation (Grant 81071614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIRNAGL U, 1990, J CEREBR BLOOD F MET, V10, P327, DOI 10.1038/jcbfm.1990.61; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Guan XT, 2003, CHINESE MED J-PEKING, V116, P368; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hashimoto A, 2005, EUR J PHARMACOL, V525, P91, DOI 10.1016/j.ejphar.2005.08.055; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kiya T, 2011, NEUROSCIENCE, V174, P190, DOI 10.1016/j.neuroscience.2010.11.046; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; McNeish AJ, 2006, STROKE, V37, P1277, DOI 10.1161/01.STR.0000217307.71231.43; Mishra RC, 2008, HYPERTENSION, V51, P791, DOI 10.1161/HYPERTENSIONAHA.107.099598; Mishra RC, 2008, J HYPERTENS, V26, P2339, DOI 10.1097/HJH.0b013e328312c8a3; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Nguelefack TB, 2006, J ETHNOPHARMACOL, V106, P70, DOI 10.1016/j.jep.2005.12.003; Stout RW, 2001, COMPARATIVE MED, V51, P524; Sun ZH, 2010, ACAD RADIOL, V17, P1535, DOI 10.1016/j.acra.2010.08.016; Takahashi K, 1997, J NEUROCHEM, V69, P1286; Trailovic SM, 2007, VET RES COMMUN, V31, P863, DOI 10.1007/s11259-007-0050-3; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x	27	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67044	10.1371/journal.pone.0067044	http://dx.doi.org/10.1371/journal.pone.0067044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825613	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000065
J	Seiler, M; Schwitzer, C; Gamba, M; Holderied, MW				Seiler, Melanie; Schwitzer, Christoph; Gamba, Marco; Holderied, Marc W.			Interspecific Semantic Alarm Call Recognition in the Solitary Sahamalaza Sportive Lemur, Lepilemur sahamalazensis	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; MICROCEBUS-MURINUS; AVOIDING PREDATORS; NONHUMAN PRIMATE; VERVET MONKEYS; SLEEPING SITES; RESPONSES; INFORMATION; BIRDS; SQUIRRELS	As alarm calls indicate the presence of predators, the correct interpretation of alarm calls, including those of other species, is essential for predator avoidance. Conversely, communication calls of other species might indicate the perceived absence of a predator and hence allow a reduction in vigilance. This "eavesdropping" was demonstrated in birds and mammals, including lemur species. Interspecific communication between taxonomic groups has so far been reported in some reptiles and mammals, including three primate species. So far, neither semantic nor interspecific communication has been tested in a solitary and nocturnal lemur species. The aim of this study was to investigate if the nocturnal and solitary Sahamalaza sportive lemur, Lepilemur sahamalazensis, is able to access semantic information of sympatric species. During the day, this species faces the risk of falling prey to aerial and terrestrial predators and therefore shows high levels of vigilance. We presented alarm calls of the crested coua, the Madagascar magpie-robin and aerial, terrestrial and agitation alarm calls of the blue-eyed black lemur to 19 individual Sahamalaza sportive lemurs resting in tree holes. Songs of both bird species' and contact calls of the blue-eyed black lemur were used as a control. After alarm calls of crested coua, Madagascar magpierobin and aerial alarm of the blue-eyed black lemur, the lemurs scanned up and their vigilance increased significantly. After presentation of terrestrial alarm and agitation calls of the blue-eyed black lemur, the animals did not show significant changes in scanning direction or in the duration of vigilance. Sportive lemur vigilance decreased after playbacks of songs of the bird species and contact calls of blue-eyed black lemurs. Our results indicate that the Sahamalaza sportive lemur is capable of using information on predator presence as well as predator type of different sympatric species, using their referential signals to detect predators early, and that the lemurs' reactions are based on experience and learning.	[Seiler, Melanie; Schwitzer, Christoph] Bristol Zoo Gardens, Bristol Conservat & Sci Fdn, Bristol, Avon, England; [Seiler, Melanie; Holderied, Marc W.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Gamba, Marco] Univ Turin, Dept Life Sci & Syst, Turin, Italy	University of Bristol; University of Turin	Holderied, MW (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	marc.holderied@bristol.ac.uk	Gamba, Marco/I-1184-2012; Zimmermann, Elke/D-2281-2015; Holderied, Marc/M-9382-2013	Gamba, Marco/0000-0001-9545-2242; Holderied, Marc/0000-0002-1573-7908	Bristol Conservation and Science Foundation; Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Conservation International Primate Action Fund; Margot Marsh Biodiversity Foundation [1230]; Mohamed bin Zayed Species Conservation Fund; Christian-Vogel-Fonds	Bristol Conservation and Science Foundation; Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Conservation International Primate Action Fund; Margot Marsh Biodiversity Foundation; Mohamed bin Zayed Species Conservation Fund; Christian-Vogel-Fonds	Bristol Conservation and Science Foundation - http://www.bcsf.org.uk/bcsf. Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL) - www.aeecl.org. Conservation International Primate Action Fund - http://www.conservation.org/Pages/default.aspx. Margot Marsh Biodiversity Foundation - 1230 AVE OF THE AMERICAS; NEW YORK, NY 10020-0000. Mohamed bin Zayed Species Conservation Fund - http://www.mbzspeciesconservation.org/. International Primatological Society Conservation grant - http://www.internationalprimatologicalsociety.org/conservation.cfm. Christian-Vogel-Fonds - http://www.gf-primatologie.de/index.php?id=67. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN T, 1991, BEHAV PROCESS, V23, P103, DOI 10.1016/0376-6357(91)90061-4; Birkinshaw CR, 2004, RAVINTSARA, V2, P14; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; De Kort SR, 2001, ANIM BEHAV, V61, P239, DOI 10.1006/anbe.2000.1552; Fallow PM, 2010, ANIM BEHAV, V79, P411, DOI 10.1016/j.anbehav.2009.11.018; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; Fichtel C, 2004, ANIM COGN, V7, P45, DOI 10.1007/s10071-003-0180-0; Fichtel C, 2007, AM J PRIMATOL, V69, P611, DOI 10.1002/ajp.20363; Forsman JT, 2001, ANIM BEHAV, V62, P1067, DOI 10.1006/anbe.2001.1856; Gamba M, 2007, ETHOL ECOL EVOL, V19, P323, DOI 10.1080/08927014.2007.9522555; Gamba M., 2005, J ANTHROPOL SCI, V83, P61; Goodman S. M., 2004, NATURAL HIST MADAGAS, P1221; GOODMAN SM, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P51; Gould L, 1996, INT J PRIMATOL, V17, P331, DOI 10.1007/BF02736625; Groves C, 2001, EVOL ANTHROPOL, V10, P192, DOI 10.1002/evan.10005; Harcourt C., 1990, IUCN RED DATA BOOK; Hart D., 2000, THESIS WASHINGTON U; HAUSER MD, 1988, BEHAVIOUR, V105, P187, DOI 10.1163/156853988X00016; Isbell Lynne A., 1994, Evolutionary Anthropology, V3, P61, DOI 10.1002/evan.1360030207; Janson Charles H., 2003, P103; Johnson FR, 2003, AUST J ZOOL, V51, P577, DOI 10.1071/ZO03031; Jurisevic MA, 1998, J AVIAN BIOL, V29, P61, DOI 10.2307/3677342; Karpanty SM, 2007, DEV PRIMATOL-PROG PR, P77, DOI 10.1007/978-0-387-34810-0_4; Karpanty SM, 1999, J RAPTOR RES, V33, P313; Karpanty SM, 2001, FOLIA PRIMATOL, V72, P100, DOI 10.1159/000049931; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Lea AJ, 2008, BEHAV ECOL, V19, P1041, DOI 10.1093/beheco/arn064; Magrath RD, 2007, BEHAV ECOL, V18, P944, DOI 10.1093/beheco/arm063; Magrath RD, 2009, P ROY SOC B-BIOL SCI, V276, P769, DOI 10.1098/rspb.2008.1368; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Marler P, 1957, BEHAVIOUR, V11, DOI [DOI 10.1163/156853956X00066, 10.1163/156853956X00066]; Mirza RS, 2001, BEHAVIOUR, V138, P1249, DOI 10.1163/15685390152822201; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Mittermeier Russel A., 2007, Primate Conservation, V22, P1, DOI 10.1896/052.022.0101; Muller CA, 2008, ANIM BEHAV, V75, P897, DOI 10.1016/j.anbehav.2007.07.012; Nocera JJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1769, DOI 10.1007/s00265-008-0605-5; Oda R, 1996, ETHOLOGY, V102, P441; Oda R, 1998, FOLIA PRIMATOL, V69, P357, DOI 10.1159/000021651; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Radespiel U, 1998, AM J PRIMATOL, V46, P77, DOI 10.1002/(SICI)1098-2345(1998)46:1<77::AID-AJP6>3.3.CO;2-#; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Rainey HJ, 2004, P ROY SOC B-BIOL SCI, V271, P755, DOI 10.1098/rspb.2003.2619; Ramakrishnan U, 2000, J COMP PSYCHOL, V114, P3, DOI 10.1037/0735-7036.114.1.3; Randler C, 2006, ETHOLOGY, V112, P411, DOI 10.1111/j.1439-0310.2006.01191.x; Ranjard L, 2010, BEHAV ECOL SOCIOBIOL, V64, P1915, DOI 10.1007/s00265-010-1065-2; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; SAUTHER ML, 1989, INT J PRIMATOL, V10, P595, DOI 10.1007/BF02739366; Scheumann M, 2007, DEV PRIMATOL-PROG PR, P100, DOI 10.1007/978-0-387-34810-0_5; SCHWITZER C., 2006, P GERMAN MALAGASY RE, V11, P135; Schwitzer Nora, 2007, Primate Conservation, V22, P79, DOI 10.1896/052.022.0106; Schwitzer Nora, 2007, Endangered Species Research, V3, P239; Seiler M, 2012, THESIS U BRISTOL BRI; Seiler M, 2013, INT J PRIMATOL, V34, P260, DOI 10.1007/s10764-013-9658-z; SEYFARTH R, 1990, ANIM BEHAV, V40, P754, DOI 10.1016/S0003-3472(05)80704-3; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Shriner WM, 1998, ANIM BEHAV, V55, P529, DOI 10.1006/anbe.1997.0623; Shriner WM, 1999, ETHOLOGY, V105, P747, DOI 10.1046/j.1439-0310.1999.00454.x; Stanford CB, 2002, INT J PRIMATOL, V23, P741, DOI 10.1023/A:1015572814388; SULLIVAN KA, 1984, BEHAVIOUR, V91, P294, DOI 10.1163/156853984X00128; Tattersall I, 1982, PRIMATES MADAGASCAR, pxiv; Templeton CN, 2007, P NATL ACAD SCI USA, V104, P5479, DOI 10.1073/pnas.0605183104; van Noordwijk Maria A., 1993, P77; Vitousek MN, 2007, BIOL LETTERS, V3, P632, DOI 10.1098/rsbl.2007.0443; Wright PC, 1998, BEHAVIOUR, V135, P483, DOI 10.1163/156853998793066186; Zuberbuhler K, 2000, COGNITION, V76, P195, DOI 10.1016/S0010-0277(00)00079-2	67	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67397	10.1371/journal.pone.0067397	http://dx.doi.org/10.1371/journal.pone.0067397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825658	Green Submitted, Green Published, gold			2022-12-25	WOS:000321223000101
J	Xie, Y; Matsumoto, H; Nalbantoglu, I; Kerr, TA; Luo, JY; Rubin, DC; Kennedy, S; Davidson, NO				Xie, Yan; Matsumoto, Hitoshi; Nalbantoglu, ILKe; Kerr, Thomas A.; Luo, Jianyang; Rubin, Deborah C.; Kennedy, Susan; Davidson, Nicholas O.			Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; HIGH-FAT DIET; GUT-LYMPH HYPOTHESIS; EPIREGULIN EXPRESSION; MOUSE MODEL; INHIBITOR; JTT-130; GLUCOSE; INJURY; MICE	Background: Gut derived lipid factors have been implicated in systemic injury and inflammation but the precise pathways involved are unknown. In addition, dietary fat intake and obesity are independent risk factors for the development of colorectal cancer. Here we studied the severity of experimental colitis and the development of colitis associated cancer (CAC) in mice with an inducible block in chylomicron secretion and fat malabsorption, following intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO). Methodology/Principal Findings: Mttp-IKO mice exhibited more severe injury with similar to 90% mortality following dextran sodium sulfate (DSS) induced colitis, compared to,20% in controls. Intestinal permeability was increased in Mttp-IKO mice compared to controls, both at baseline and after DSS administration, in association with increased circulating levels of TNF alpha. DSS treatment increased colonic mRNA expression of IL-1 beta and IL-17A as well as inflammasome expression in both genotypes, but the abundance of TNF alpha was selectively increased in DSS treated Mttp-IKO mice. There was a 2-fold increase in colonic tumor burden in Mttp-IKO mice following azoxymethane/DSS treatment, which was associated with increased colonic inflammation as well as alterations in cytokine expression. To examine the pathways by which alterations in fatty acid abundance might interact with cytokine signaling to regulate colonic epithelial growth, we used primary murine myofibroblasts to demonstrate that palmitate induced expression of amphiregulin and epiregulin and augmented the increase in both of these growth mediators when added to IL-1 beta or to TNF alpha. Conclusions: These studies demonstrate that Mttp-IKO mice, despite absorbing virtually no dietary fat, exhibit augmented fatty acid dependent signaling that in turn exacerbates colonic injury and increases tumor formation.	[Xie, Yan; Matsumoto, Hitoshi; Kerr, Thomas A.; Luo, Jianyang; Rubin, Deborah C.; Kennedy, Susan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Nalbantoglu, ILKe] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	nod@dom.wustl.edu		Rubin, Deborah/0000-0002-4192-909X	National Institutes of Health [HL-38180, DK-56260]; National Institutes of Health (Washington University Digestive Disease Research Core Center) [DK-52574];  [DK-46122];  [DK-61216]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Washington University Digestive Disease Research Core Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported by funding from the National Institutes of Health (HL-38180, DK-56260 and the Washington University Digestive Disease Research Core Center DK-52574, particularly the murine and morphology cores) to NOD. DR was supported by grants DK-46122 and DK-61216. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shali K, 2003, CLIN GENET, V63, P135, DOI 10.1046/j.0009-9163.2002.00175.x; Aleksandrova Krasimira, 2013, Curr Nutr Rep, V2, P1; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Fasano A, 2012, CLIN GASTROENTEROL H, V10, P1096, DOI 10.1016/j.cgh.2012.08.012; Fung TT, 2012, CANCER CAUSE CONTROL, V23, P959, DOI 10.1007/s10552-012-9969-y; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hata T, 2011, DIABETES OBES METAB, V13, P629, DOI 10.1111/j.1463-1326.2011.01387.x; Hata T, 2011, DIABETES OBES METAB, V13, P446, DOI 10.1111/j.1463-1326.2011.01368.x; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Inatomi O, 2006, INT J MOL MED, V18, P497; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Kerr TA, 2012, INFLAMM BOWEL DIS, V18, P344, DOI 10.1002/ibd.21763; Kim E, 2011, J PHARMACOL EXP THER, V337, P775, DOI 10.1124/jpet.110.177527; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Levy E, 2001, AM J PHYSIOL-GASTR L, V280, pG563, DOI 10.1152/ajpgi.2001.280.4.G563; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Mera Y, 2011, J PHARMACOL EXP THER, V336, P321, DOI 10.1124/jpet.110.173807; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Nishimura T, 2008, ONCOL REP, V19, P105; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Pendyala S, 2011, AM J CLIN NUTR, V93, P234, DOI 10.3945/ajcn.110.002683; Plateroti M, 1998, AM J PHYSIOL-GASTR L, V274, pG945, DOI 10.1152/ajpgi.1998.274.5.G945; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Swift LL, 2005, HISTOCHEM CELL BIOL, V123, P475, DOI 10.1007/s00418-005-0772-7; van Diepen JA, 2013, J LIPID RES, V54, P448, DOI 10.1194/jlr.M031963; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Wang YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008442; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2007, J BIOL CHEM, V282, P33043, DOI 10.1074/jbc.M705386200; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67819	10.1371/journal.pone.0067819	http://dx.doi.org/10.1371/journal.pone.0067819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805328	gold, Green Published			2022-12-25	WOS:000320846500156
J	Gong, P; Zhang, MY; Zhao, H; Tang, ZR; Hua, R; Mei, X; Cui, J; Li, CS				Gong, Ping; Zhang, Ming-Yue; Zhao, Hong; Tang, Zi-Ren; Hua, Rong; Mei, Xue; Cui, Juan; Li, Chun-Sheng			Effect of Mild Hypothermia on the Coagulation-Fibrinolysis System and Physiological Anticoagulants after Cardiopulmonary Resuscitation in a Porcine Model	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; COAGULOPATHY; INFLAMMATION; COMPRESSIONS; ACTIVATION; MECHANISMS; HEART; CARE	The aim of this study was to evaluate the effect of mild hypothermia on the coagulation-fibrinolysis system and physiological anticoagulants after cardiopulmonary resuscitation (CPR). A total of 20 male Wuzhishan miniature pigs underwent 8 min of untreated ventricular fibrillation and CPR. Of these, 16 were successfully resuscitated and were randomized into the mild hypothermia group (MH, n = 8) or the control normothermia group (CN, n = 8). Mild hypothermia (33 degrees C) was induced intravascularly, and this temperature was maintained for 12 h before pigs were actively rewarmed. The CN group received normothermic post-cardiac arrest (CA) care for 72 h. Four animals were in the sham operation group (SO). Blood samples were taken at baseline, and 0.5, 6, 12, 24, and 72 h after ROSC. Whole-body mild hypothermia impaired blood coagulation during cooling, but attenuated blood coagulation impairment at 72 h after ROSC. Mild hypothermia also increased serum levels of physiological anticoagulants, such as PRO C and AT-III during cooling and after rewarming, decreased EPCR and TFPI levels during cooling but not after rewarming, and inhibited fibrinolysis and platelet activation during cooling and after rewarming. Finally, mild hypothermia did not affect coagulation-fibrinolysis, physiological anticoagulants, or platelet activation during rewarming. Thus, our findings indicate that mild hypothermia exerted an anticoagulant effect during cooling, which may have inhibitory effects on microthrombus formation. Furthermore, mild hypothermia inhibited fibrinolysis and platelet activation during cooling and attenuated blood coagulation impairment after rewarming. Slow rewarming had no obvious adverse effects on blood coagulation.	[Gong, Ping] Dalian Med Univ, Hosp Affiliated 1, Dept Emergency, Dalian, Liaoning, Peoples R China; [Zhang, Ming-Yue; Zhao, Hong; Tang, Zi-Ren; Hua, Rong; Mei, Xue; Cui, Juan; Li, Chun-Sheng] Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China	Dalian Medical University; Capital Medical University	Li, CS (corresponding author), Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China.	lcscyyy@163.com	Gong, Ping/AAV-1936-2021	Gong, Ping/0000-0001-9910-7948	National Natural Science Foundation of China [30972863]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30972863, http://159.226.244.22/portal/proj_search.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Andre P, 2004, BRIT J HAEMATOL, V126, P298, DOI 10.1111/j.1365-2141.2004.05032.x; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bottiger B W, 2001, Curr Opin Crit Care, V7, P176; BOTTIGER BW, 1995, CIRCULATION, V92, P2572, DOI 10.1161/01.CIR.92.9.2572; Bottiger BW, 2002, CRIT CARE MED, V30, P2473, DOI 10.1097/01.CCM.0000034689.78033.E2; Esmon CT, 2003, J ENDOTOXIN RES, V9, P192, DOI 10.1179/096805103125001603; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Fischer M, 1996, INTENS CARE MED, V22, P1214; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; Gong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035313; Green David, 2006, Hemodial Int, V10 Suppl 2, pS2, DOI 10.1111/j.1542-4758.2006.00119.x; Hekimian G, 2004, SHOCK, V22, P116, DOI 10.1097/01.shk.0000132489.79498.c7; Hu CL, 2011, AM J EMERG MED, V29, P1103, DOI 10.1016/j.ajem.2010.07.016; Hua R, 2012, AM J EMERG MED, V30, P1420, DOI 10.1016/j.ajem.2011.10.022; Ji XF, 2012, RESUSCITATION, V83, P640, DOI 10.1016/j.resuscitation.2011.11.014; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; Ji XF, 2010, RESUSCITATION, V81, P1031, DOI 10.1016/j.resuscitation.2010.04.023; Kazanskaya GM, 1999, MICROVASC RES, V58, P250, DOI 10.1006/mvre.1999.2181; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Meybohm P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007588; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Nozza S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037032; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schochl H, 2013, RESUSCITATION, V84, P454, DOI 10.1016/j.resuscitation.2012.08.318; Staikou C, 2011, J SURG RES, V167, P125, DOI 10.1016/j.jss.2009.07.037; Su ZY, 2011, AM J EMERG MED, V29, P913, DOI 10.1016/j.ajem.2010.04.001; Tang ZR, 2013, AM J EMERG MED, V31, P86, DOI 10.1016/j.ajem.2012.06.008; VALERI CR, 1995, CRIT CARE MED, V23, P698, DOI 10.1097/00003246-199504000-00019; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; van der Spuy WJ, 2012, REV NEUROSCIENCE, V23, P269, DOI 10.1515/revneuro-2012-0028; Wang S, 2010, CRIT CARE MED, V38, P2024, DOI 10.1097/CCM.0b013e3181eed90a; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wu JY, 2009, AM J EMERG MED, V27, P823, DOI 10.1016/j.ajem.2008.07.001; Zhao H, 2012, RESUSCITATION, V83, P913, DOI 10.1016/j.resuscitation.2012.01.001	40	17	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67476	10.1371/journal.pone.0067476	http://dx.doi.org/10.1371/journal.pone.0067476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818980	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800137
J	Kreth, J; Lengeler, JW; Jahreis, K				Kreth, Jens; Lengeler, Joseph W.; Jahreis, Knut			Characterization of Pyruvate Uptake in Escherichia coli K-12	PLOS ONE			English	Article							TRANSPORT-SYSTEM; L-LACTATE; GENE; PHOSPHOENOLPYRUVATE; PHOSPHOTRANSFERASE; DEHYDROGENASE; METABOLISM; SUCCINATE; MUTATIONS; MUTANTS	The monocarboxylate pyruvate is an important metabolite and can serve as sole carbon source for Escherichia coli. Although specific pyruvate transporters have been identified in two bacterial species, pyruvate transport is not well understood in E. coli. In the present study, pyruvate transport was investigated under different growth conditions. The transport of pyruvate shows specific activities depending on the growth substrate used as sole carbon source, suggesting the existence of at least two systems for pyruvate uptake: i) one inducible system and probably highly specific for pyruvate and ii) one system active under non-induced conditions. Using the toxic pyruvate analog 3-fluoropyruvate, a mutant was isolated unable to grow on and transport pyruvate. Further investigation revealed that a revertant selected for growth on pyruvate regained the inducible pyruvate transport activity. Characterization of pyruvate excretion showed that the pyruvate transport negative mutant accumulated pyruvate in the growth medium suggesting an additional transport system for pyruvate excretion. The here presented data give valuable insight into the pyruvate metabolism and transport of E. coli suggesting the presence of at least two uptake systems and one excretion system to balance the intracellular level of pyruvate.	[Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK USA; [Lengeler, Joseph W.; Jahreis, Knut] Univ Osnabruck, Arbeitsgruppe Genet Fachbereich Biol Chem, Osnabruck, Germany	University of Oklahoma System; University of Oklahoma Health Sciences Center; University Osnabruck	Kreth, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK USA.	JKreth@ouhsc.edu	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310				BOCKMANN J, 1992, MOL GEN GENET, V235, P22, DOI 10.1007/BF00286177; Boeck A, 1996, ESCHERICHAI COLI SAL, P217; BRICKMAN E, 1973, J BACTERIOL, V116, P582, DOI 10.1128/JB.116.2.582-587.1973; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; FIETHEN L, 1970, MOL GEN GENET, V108, P322, DOI 10.1007/BF00267769; GUEST JR, 1973, J GEN MICROBIOL, V75, P197, DOI 10.1099/00221287-75-1-197; Hosie AHF, 2002, J BACTERIOL, V184, P5436, DOI 10.1128/JB.184.19.5436-5448.2002; Jolkver E, 2009, J BACTERIOL, V191, P940, DOI 10.1128/JB.01155-08; KODAKI T, 1981, J BIOCHEM-TOKYO, V90, P1437, DOI 10.1093/oxfordjournals.jbchem.a133610; KORNBERG HL, 1967, BIOCHIM BIOPHYS ACTA, V148, P591, DOI 10.1016/0304-4165(67)90167-5; LANG VJ, 1987, J BACTERIOL, V169, P380, DOI 10.1128/jb.169.1.380-385.1987; LOW KB, 1972, BACTERIOL REV, V36, P587, DOI 10.1128/MMBR.36.4.587-607.1972; MATIN A, 1973, EUR J BIOCHEM, V34, P58, DOI 10.1111/j.1432-1033.1973.tb02728.x; Nunez MF, 2002, BIOCHEM BIOPH RES CO, V290, P824, DOI 10.1006/bbrc.2001.6255; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; SCHMID K, 1982, J BACTERIOL, V151, P68, DOI 10.1128/JB.151.1.68-76.1982; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Zeppenfeld T, 2000, J BACTERIOL, V182, P4443, DOI 10.1128/JB.182.16.4443-4452.2000	19	26	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67125	10.1371/journal.pone.0067125	http://dx.doi.org/10.1371/journal.pone.0067125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818977	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800120
J	Xia, YH; McLaughlin, MM; Chen, W; Ling, L; Tucker, JD				Xia, Ying-Hua; McLaughlin, Megan M.; Chen, Wen; Ling, Li; Tucker, Joseph D.			HIV and Hepatitis C Virus Testing Delays at Methadone Clinics in Guangdong Province, China	PLOS ONE			English	Article							INJECTING DRUG-USERS; MISSED OPPORTUNITIES; LATE DIAGNOSIS; ANTIRETROVIRAL THERAPY; MAINTENANCE TREATMENT; RISK-FACTORS; INFECTION; INITIATION; BARRIERS; IMPACT	In China, injection drug use is a major transmission route for HIV and hepatitis C virus (HCV) infection. Timely HIV and HCV testing among drug users is vital to earlier diagnosis, linkage to care, and retention. This study aimed to examine HIV and hepatitis C virus (HCV) testing delays at methadone clinics in Guangdong Province, China, and identify individual-level and clinic-level factors associated with delayed testing. Data from 13,270 individuals at 45 methadone clinics in Guangdong were abstracted from a national web-based surveillance database. A two-level binomial logit model was used to examine the association between individual-and clinic-level factors and delayed HIV and HCV testing, defined as receiving a test seven or more days after initial entry into the methadone system. Among 10,046 patients tested for HIV, 1882 (18.7%) had delayed testing; among 10,404 patients tested for HCV, 1542 (14.8%) had delayed testing. Among delayed testers, the median time to HCV testing was significantly longer than the median time to HIV testing (73 vs. 54 days, p<0.05). In the multivariate analysis, the likelihood of delayed HIV testing was higher among individuals with high school or greater education (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.02-1.72) and individuals enrolled at clinics with more patients (aOR 1.41, 95% CI 1.05-1.91, for each increase in 100). The likelihood of delayed HCV testing was higher among women (aOR 1.51, 95% CI 1.11-2.06) and employed individuals (aOR 1.21, 95% CI 1.02-1.43). Delayed testing for HIV and HCV is common among patients at methadone clinics in Guangdong, with many patients experiencing delays of two or more months. Structural interventions are needed to expedite testing once individuals enter the methadone maintenance program.	[Xia, Ying-Hua; Chen, Wen; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Ying-Hua; McLaughlin, Megan M.; Chen, Wen; Ling, Li; Tucker, Joseph D.] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [McLaughlin, Megan M.; Tucker, Joseph D.] UNC Project China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Xia, Yinghua/H-3451-2018	Xia, Yinghua/0000-0002-3073-0747; Tucker, Joseph/0000-0003-2804-1181	National Natural Science Foundation of China [71173245, 30972552]; Guangdong Natural Science Foundation [9151008901000023]; Global Fund AIDS China Program Round Six (GF6); U.S. Fulbright Student Program; NIH Fogarty Career Development Award [US NIH 1K01TW008200-01A1]; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER [K01TW008200, D43TW009532] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Global Fund AIDS China Program Round Six (GF6); U.S. Fulbright Student Program; NIH Fogarty Career Development Award; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support for this research came from the National Natural Science Foundation of China (grant 71173245, grant 30972552), Guangdong Natural Science Foundation (grant 9151008901000023), the Global Fund AIDS China Program Round Six (GF6), the U.S. Fulbright Student Program, a NIH Fogarty Career Development Award (US NIH 1K01TW008200-01A1), and the UNC Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Che YH, 2011, AM J DRUG ALCOHOL AB, V37, P148, DOI 10.3109/00952990.2010.535578; Chen Ang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1230; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Du J, 2012, AM J DRUG ALCOHOL AB, V38, P228, DOI 10.3109/00952990.2011.643974; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Hayashida T, 2012, INT J INFECT DIS, V16, pE172, DOI 10.1016/j.ijid.2011.11.003; Hepatotogy Branch Infectious and Parasitology branch Chinese Medical Association, 2004, Zhonghua Yu Fang Yi Xue Za Zhi, V38, P210; Ivers Louise C, 2007, AIDS Res Ther, V4, P28, DOI 10.1186/1742-6405-4-28; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Kuo AM, 2005, AIDS PATIENT CARE ST, V19, P239, DOI 10.1089/apc.2005.19.239; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lin CQ, 2010, INT J DRUG POLICY, V21, P173, DOI 10.1016/j.drugpo.2009.09.002; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Ministry of Health of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Ministry of Health of China Ministry of Public Security of China State Food and Drug Administration, 2006, WORK PLAN COMM BAS M; Nhac-Vu HT, 2010, INT J STD AIDS, V21, P802, DOI 10.1258/ijsa.2010.010045; Shoptaw S, 2000, J SUBST ABUSE TREAT, V19, P117, DOI 10.1016/S0740-5472(99)00106-3; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Swan D, 2010, AIDS PATIENT CARE ST, V24, P753, DOI 10.1089/apc.2010.0142; Tucker JD, 2011, JAIDS-J ACQ IMM DEF, V57, pE106, DOI 10.1097/QAI.0b013e31821d3694; Wang AX, 2006, CHINESE MED J-PEKING, V119, P1589; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Ward JW, 2013, CLIN LIVER DIS, V17, P1, DOI 10.1016/j.cld.2012.09.011; Wen Y, 2011, AIDS CARE, V23, P1226, DOI 10.1080/09540121.2011.555748; Witteck A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13193; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	35	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66787	10.1371/journal.pone.0066787	http://dx.doi.org/10.1371/journal.pone.0066787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23818964	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800101
J	Chen, YYM; Shieh, HR; Chang, YC				Chen, Yi-Ywan M.; Shieh, Hui-Ru; Chang, Ya-Ching			The Expression of the fim Operon Is Crucial for the Survival of Streptococcus parasanguinis FW213 within Macrophages but Not Acid Tolerance	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; ENDOCARDITIS VIRULENCE; ABC TRANSPORTER; PROTEIN; MANGANESE; ENCODES; CLONING; MUTANS; GENE; GORDONII	The acquisition of transition metal ions is essential for the viability and in some cases the expression of virulence genes in bacteria. The fimCBA operon of Streptococcus parasanguinis FW213 encodes a Mn2+/Fe2+-specific ATP-binding cassette transporter. FimA, a lipoprotein in the system, is essential for the development of endocarditis, presumably by binding to fibrin monolayers on the damaged heart tissue. Recent sequence analysis revealed that Spaf_0344 was homologous to Streptococcus gordonii scaR, encoding a metalloregulatory protein for the Sca Mn2+-specific transporter. Based on the homology, Spaf_0344 was designated fimR. By using various fim promoter (p(fim)) derivatives fused with a promoterless chloramphenicol acetyltransferase gene, the functions of the cis-elements of p(fim) were analyzed in the wild-type and fimR-deficient hosts. The result indicated that FimR represses the expression of p(fim) and the palindromic sequences 5' to fimC are involved in repression of p(fim). A direct interaction between FimR and the palindromic sequences was further confirmed by in vitro electrophoresis gel mobility shift assay and in vivo chromatin immunoprecipitation assay (ChIP)-quantitative real-time PCR (qPCR). The result of the ChIP-qPCR analysis also indicated that FimR is activated by Mn2+ and, to a lesser degree, Fe2+. Functional analysis indicated that the expression of FimA in S. parasanguinis was critical for wild-type levels of survival against oxidative stress and within phagocytes, but not for acid tolerance. Taken together, in addition to acting as an adhesin (FimA), the expression of the fim operon is critical for the pathogenic capacity of S. parasanguinis.	[Chen, Yi-Ywan M.; Shieh, Hui-Ru] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; [Chen, Yi-Ywan M.; Chang, Ya-Ching] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University	Chen, YYM (corresponding author), Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan.	mchen@mail.cgu.edu.tw		Chen, Yi-Ywan/0000-0002-8727-9811	National Science Council of Taiwan [NSC-982320-B182-031]; Chang Gung Memorial Hospital of Taiwan [CMRPD1B0063]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported by the National Science Council of Taiwan, grant NSC-982320-B182-031 and Chang Gung Memorial Hospital of Taiwan, grant CMRPD1B0063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; BADDOUR LM, 1994, INFECT IMMUN, V62, P2143, DOI 10.1128/IAI.62.6.2143-2148.1994; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Bruno-Barcena JM, 2010, APPL ENVIRON MICROB, V76, P2747, DOI 10.1128/AEM.02718-09; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; CARLSSON J, 1970, Archives of Oral Biology, V15, P1143, DOI 10.1016/0003-9969(70)90005-1; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Chen YYM, 1998, J BACTERIOL, V180, P5769, DOI 10.1128/JB.180.21.5769-5775.1998; Chen YYM, 2002, MICROBIOL-SGM, V148, P3599, DOI 10.1099/00221287-148-11-3599; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; FENNO JC, 1993, GENE, V130, P81, DOI 10.1016/0378-1119(93)90349-8; FENNO JC, 1995, MOL MICROBIOL, V15, P849, DOI 10.1111/j.1365-2958.1995.tb02355.x; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; GANESHKUMAR N, 1991, INFECT IMMUN, V59, P1093, DOI 10.1128/IAI.59.3.1093-1099.1991; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Geng JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034769; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Hanks TS, 2006, INFECT IMMUN, V74, P5132, DOI 10.1128/IAI.00176-06; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Jenkinson HF, 1997, CRIT REV ORAL BIOL M, V8, P175, DOI 10.1177/10454411970080020601; Kim JS, 2005, J BACTERIOL, V187, P5984, DOI 10.1128/JB.187.17.5984-5995.2005; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Kitten T, 2000, INFECT IMMUN, V68, P4441, DOI 10.1128/IAI.68.8.4441-4451.2000; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; KOLENBRANDER PE, 1994, INFECT IMMUN, V62, P4469, DOI 10.1128/IAI.62.10.4469-4480.1994; Kolenbrander PE, 1998, J BACTERIOL, V180, P290, DOI 10.1128/JB.180.2.290-295.1998; LEBLANC DJ, 1991, ANTIMICROB AGENTS CH, V35, P1804, DOI 10.1128/AAC.35.9.1804; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Martin-Galiano AJ, 2005, MICROBIOL-SGM, V151, P3935, DOI 10.1099/mic.0.28238-0; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Oetjen J, 2002, INFECT IMMUN, V70, P5706, DOI 10.1128/IAI.70.10.5706-5714.2002; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Rolerson E, 2006, J BACTERIOL, V188, P5033, DOI 10.1128/JB.00155-06; SAMPSON JS, 1994, INFECT IMMUN, V62, P319, DOI 10.1128/IAI.62.1.319-324.1994; Shaw W V, 1975, Methods Enzymol, V43, P737; Spatafora G, 2002, MICROBIOL-SGM, V148, P755, DOI 10.1099/00221287-148-3-755; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; XU T, 1992, J BIOL CHEM, V267, P21761	55	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66163	10.1371/journal.pone.0066163	http://dx.doi.org/10.1371/journal.pone.0066163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823757	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400061
J	Choi, HP; Juarez, S; Ciordia, S; Fernandez, M; Bargiela, R; Albar, JP; Mazumdar, V; Anton, BP; Kasif, S; Ferrer, M; Steffen, M				Choi, Han-Pil; Juarez, Silvia; Ciordia, Sergio; Fernandez, Marisol; Bargiela, Rafael; Albar, Juan P.; Mazumdar, Varun; Anton, Brian P.; Kasif, Simon; Ferrer, Manuel; Steffen, Martin			Biochemical Characterization of Hypothetical Proteins from Helicobacter pylori	PLOS ONE			English	Article							GTP CYCLOHYDROLASE-I; ACID; HYDROLASES; SYNTHASE	The functional characterization of Open Reading Frames (ORFs) from sequenced genomes remains a bottleneck in our effort to understand microbial biology. In particular, the functional characterization of proteins with only remote sequence homology to known proteins can be challenging, as there may be few clues to guide initial experiments. Affinity enrichment of proteins from cell lysates, and a global perspective of protein function as provided by COMBREX, affords an approach to this problem. We present here the biochemical analysis of six proteins from Helicobacter pylori ATCC 26695, a focus organism in COMBREX. Initial hypotheses were based upon affinity capture of proteins from total cellular lysate using derivatized nano-particles, and subsequent identification by mass spectrometry. Candidate genes encoding these proteins were cloned and expressed in Escherichia coli, and the recombinant proteins were purified and characterized biochemically and their biochemical parameters compared with the native ones. These proteins include a guanosine triphosphate (GTP) cyclohydrolase (HP0959), an ATPase (HP1079), an adenosine deaminase (HP0267), a phosphodiesterase (HP1042), an aminopeptidase (HP1037), and new substrates were characterized for a peptidoglycan deacetylase (HP0310). Generally, characterized enzymes were active at acidic to neutral pH (4.0-7.5) with temperature optima ranging from 35 to 55 degrees C, although some exhibited outstanding characteristics.	[Choi, Han-Pil; Kasif, Simon; Steffen, Martin] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Juarez, Silvia; Ciordia, Sergio; Fernandez, Marisol; Albar, Juan P.] CSIC, CNB Natl Ctr Biotechnol, Prote Facil, Madrid, Spain; [Bargiela, Rafael; Ferrer, Manuel] CSIC, Inst Catalysis, Madrid, Spain; [Mazumdar, Varun; Kasif, Simon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Anton, Brian P.] New England Biolabs Inc, Ipswich, MA USA; [Steffen, Martin] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Boston University; New England Biolabs; Boston University	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Madrid, Spain.	mferrer@icp.csic.es; steffen@bu.edu	Bargiela, Rafael/K-6783-2014; Ferrer, Manuel/K-4535-2014	Bargiela, Rafael/0000-0003-1442-3269; Ferrer, Manuel/0000-0003-4962-4714; Ciordia, Sergio/0000-0002-5726-853X	National Institutes of Health (NIGMS) [RC2-GM092602]; Spanish Ministry of Economy and Competitiveness [0315441A, BFU2008-04501-E/BMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092602] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spanish Ministry of Economy and Competitiveness(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The cloning and biochemical testing of recombinant proteins was funded by RC2-GM092602 from the National Institutes of Health (NIGMS), awarded to COMBREX (SK, MS). Affinity enrichment and testing of native proteins was funded by the Spanish Ministry of Economy and Competitiveness (former MICINN), within the ERA NET PathoGenoMics2 call, grant number 0315441A and BFU2008-04501-E/BMC (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JM, 2005, J AM CHEM SOC, V127, P5689, DOI 10.1021/ja042717i; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beloqui A, 2010, APPL ENVIRON MICROB, V76, P5934, DOI 10.1128/AEM.00902-10; Bergmeyer HU, 1983, METHOD ENZYMAT AN, P135; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; Bracher A, 1998, J BIOL CHEM, V273, P28132, DOI 10.1074/jbc.273.43.28132; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Silva TCF, 2011, SOFT MATTER, V7, P1090, DOI 10.1039/c0sm00868k; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goddard JP, 2004, J AM CHEM SOC, V126, P11116, DOI 10.1021/ja0478330; Hatanaka T, 2011, APPL BIOCHEM BIOTECH, V164, P475, DOI 10.1007/s12010-010-9149-z; Hazell SL, 2001, HELICOBACTER PYLORI; He AM, 2003, APPL ENVIRON MICROB, V69, P7507, DOI 10.1128/AEM.69.12.7507-7513.2003; Janes LE, 1998, CHEM-EUR J, V4, P2324, DOI 10.1002/(SICI)1521-3765(19981102)4:11<2324::AID-CHEM2324>3.0.CO;2-I; Kamat SS, 2011, BIOCHEMISTRY-US, V50, P1917, DOI 10.1021/bi101788n; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Madupu R, 2012, NUCLEIC ACIDS RES, V40, pD237, DOI 10.1093/nar/gkr1133; Miller EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038727; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MURPHY J, 1982, ANAL BIOCHEM, V122, P328, DOI 10.1016/0003-2697(82)90291-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Proudfoot Michael, 2008, V426, P331, DOI 10.1007/978-1-60327-058-8_21; Rangrez AY, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-10; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Sachs G, 1996, YALE J BIOL MED, V69, P301; Scheer Maurice, 2011, Nucleic Acids Res, V39, pD670, DOI 10.1093/nar/gkq1089; Shaik MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019207; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Varela C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-7; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Zheng Y, 2004, PLOS BIOL, V2, P452, DOI 10.1371/journal.pbio.0020081	41	43	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66605	10.1371/journal.pone.0066605	http://dx.doi.org/10.1371/journal.pone.0066605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825549	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400137
J	Gao, XG; Liu, HH; He, B; Fu, ZR				Gao, Xiaogang; Liu, Huanhai; He, Bin; Fu, Zhiren			Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role	PLOS ONE			English	Article							T-CELLS; ARGINASE-I; TUMOR; EXPRESSION; ENCEPHALOMYELITIS; INHIBITION; ACTIVATION; CARCINOMA; RESPONSES; MODELS	The contribution of complement to the development of autoimmune diabetes has been proposed recently. The underlying mechanisms, however, remain poorly understood. We hypothesize that myeloid-derived suppressor cells (MDSC), which act as regulators in autoimmunity, play a role in resistance to diabetes in absence of complement C3. Indeed, MDSC number was increased significantly in STZ-treated C3-/- mice. These cells highly expressed arginase I and inducible nitric oxide synthase (iNOS). Importantly, depletion of MDSC led to the occurrence of overt diabetes in C3-/- mice after STZ. Furthermore, C3-/- MDSC actively suppressed diabetogenic T cell proliferation and prevented/delayed the development of diabetes in arginase and/or iNOS-dependent manner. Both Tregs and transforming growth factor-beta (TGF-beta) are crucial for MDSC induction in STZ-treated C3-/- mice as depletion of Tregs or blocking TGF-beta bioactivity dramatically decreased MDSC number. These findings indicate that MDSC are implicated in resistance to STZ-induced diabetes in the absence of complement C3, which may be helpful for understanding of mechanisms underlying preventive effects of complement deficiency on autoimmune diseases.	[Gao, Xiaogang; Fu, Zhiren] Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Liu, Huanhai] Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [He, Bin] Shanghai Jiao Tong Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Xinhua Hosp, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University	Fu, ZR (corresponding author), Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China.	zhirenf@sh163.net			National Natural Science Foundation of China [31100639, 81100585, 30901470]; Natural Science Foundation of Shanghai [11ZR1448100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by grants from the National Natural Science Foundation of China (31100639, 81100585, 30901470) and Natural Science Foundation of Shanghai(11ZR1448100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Berezhnaya N. M., 2010, Experimental Oncology, V32, P159; Berger SP, 2007, SEMIN IMMUNOPATHOL, V29, P375, DOI 10.1007/s00281-007-0090-3; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; FFRENCHCONSTANT C, 1994, LANCET, V343, P271, DOI 10.1016/S0140-6736(94)91118-5; Gao XG, 2011, CLIN IMMUNOL, V140, P236, DOI 10.1016/j.clim.2011.02.004; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Li Q, 2009, AM J PATHOL, V175, P661, DOI 10.2353/ajpath.2009.081093; Lin M, 2010, DIABETES, V59, P2247, DOI 10.2337/db10-0044; Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636	30	15	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66334	10.1371/journal.pone.0066334	http://dx.doi.org/10.1371/journal.pone.0066334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824734	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400086
J	Gingold, R; Moens, T; Rocha-Olivares, A				Gingold, Ruth; Moens, Tom; Rocha-Olivares, Axayacatl			Assessing the Response of Nematode Communities to Climate Change-Driven Warming: A Microcosm Experiment	PLOS ONE			English	Article							BACTERIVOROUS NEMATODES; MARINE-SEDIMENTS; SANDY BEACH; BIODIVERSITY; ASSEMBLAGES; DIVERSITY; MEIOFAUNA; CHLOROPHYLL; ACCLIMATION; MEIOBENTHOS	Biodiversity has diminished over the past decades with climate change being among the main responsible factors. One consequence of climate change is the increase in sea surface temperature, which, together with long exposure periods in intertidal areas, may exceed the tolerance level of benthic organisms. Benthic communities may suffer structural changes due to the loss of species or functional groups, putting ecological services at risk. In sandy beaches, free-living marine nematodes usually are the most abundant and diverse group of intertidal meiofauna, playing an important role in the benthic food web. While apparently many functionally similar nematode species co-exist temporally and spatially, experimental results on selected bacterivore species suggest no functional overlap, but rather an idiosyncratic contribution to ecosystem functioning. However, we hypothesize that functional redundancy is more likely to observe when taking into account the entire diversity of natural assemblages. We conducted a microcosm experiment with two natural communities to assess their stress response to elevated temperature. The two communities differed in diversity (high [HD] vs. low [LD]) and environmental origin (harsh vs. moderate conditions). We assessed their stress resistance to the experimental treatment in terms of species and diversity changes, and their function in terms of abundance, biomass, and trophic diversity. According to the Insurance Hypothesis, we hypothesized that the HD community would cope better with the stressful treatment due to species functional overlap, whereas the LD community functioning would benefit from species better adapted to harsh conditions. Our results indicate no evidence of functional redundancy in the studied nematofaunal communities. The species loss was more prominent and size specific in the HD; large predators and omnivores were lost, which may have important consequences for the benthic food web. Yet, we found evidence for alternative diversity-ecosystem functioning relationships, such as the Rivets and the Idiosyncrasy Model.	[Gingold, Ruth; Rocha-Olivares, Axayacatl] Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico; [Gingold, Ruth; Moens, Tom] Univ Ghent, Dept Biol, B-9000 Ghent, Flanders, Belgium	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Ghent University	Gingold, R (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico.	ruth_gingold@hotmail.com	Rocha-Olivares, Axayacatl/A-9832-2008; Moens, Tom/AAB-8701-2019	Rocha-Olivares, Axayacatl/0000-0002-2700-9086; 	CONACYT; Flemish National Science Foundation (FWO) [3G019209W]; research council of UGent [BOF09/24J/148];  [CONACYT-SEMARNAT-2004-C01-300]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Flemish National Science Foundation (FWO); research council of UGent; 	This research was funded by the grant CONACYT-SEMARNAT-2004-C01-300 to ARO. The paper derived from the first author's PhD research at the Marine Ecology program at CICESE where she was supported by CONACYT. TM received funding from the Flemish National Science Foundation (FWO) through project 3G019209W and from the research council of UGent (project BOF09/24J/148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; AUSTEN MC, 1995, HYDROBIOLOGIA, V311, P175, DOI 10.1007/BF00008579; Bale A.J., 2005, METHODS STUDY MARINE, V3, P43, DOI DOI 10.1002/9780470995129.CH2; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Clarke KR, 1994, CHANGE MARINE COMMUN; COLIJN F, 1981, MAR ECOL PROG SER, V4, P9, DOI 10.3354/meps004009; COULL BC, 1995, MAR ECOL PROG SER, V125, P13, DOI 10.3354/meps125013; Danovaro R, 2002, MAR BIOL, V141, P667, DOI 10.1007/s00227-002-0857-y; De Mesel I, 2004, ENVIRON MICROBIOL, V6, P733, DOI 10.1111/j.1462-2920.2004.00610.x; De Mesel I, 2006, MAR ECOL PROG SER, V321, P157, DOI 10.3354/meps321157; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DEJONGE VN, 1977, MAR BIOL, V42, P143, DOI 10.1007/BF00391564; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; dos Santos GAP, 2009, THESIS GHENT U GHENT; DUSENBERY DB, 1978, J EXP ZOOL, V206, P191, DOI 10.1002/jez.1402060208; Emmerson MC, 2000, OIKOS, V91, P195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Franco MD, 2010, MAR ECOL-EVOL PERSP, V31, P276, DOI 10.1111/j.1439-0485.2009.00319.x; FROELICH PN, 1980, LIMNOL OCEANOGR, V25, P564; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gheskiere T, 2004, J SEA RES, V52, P211, DOI 10.1016/j.seares.2004.02.001; Gingold R, 2010, MAR BIOL, V157, P1741, DOI 10.1007/s00227-010-1447-z; Hamels I, 2001, AQUAT MICROB ECOL, V26, P61, DOI 10.3354/ame026061; HAMERLYNCK O, 1993, J MAR BIOL ASSOC UK, V73, P453, DOI 10.1017/S0025315400032999; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hubas C, 2010, MAR ECOL PROG SER, V419, P85, DOI 10.3354/meps08851; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Li J, 1997, FUND APPL NEMATOL, V20, P487; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; MASSELINK G, 1993, J COASTAL RES, V9, P785; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Olafsson E, 2003, VIE MILIEU, V53, P249; Platt H.M., 1983, SYNOPSES BRIT FAUNA, V28; Platt HM, 1988, SYNOPSES BRIT FAUNA; Reyss JL, 1991, GEOPHYS RES LETT, V18, P1889; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodriguez JG, 2003, ESTUAR COAST SHELF S, V58, P63, DOI 10.1016/S0272-7714(03)00039-8; Rodriguez JG, 2001, REV CHIL HIST NAT, V74, P885; Schratzberger M, 1998, MAR ECOL PROG SER, V164, P83, DOI 10.3354/meps164083; Sokal R. R., 2012, BIOMETRY; Somerfield P.J., 2005, P229, DOI 10.1002/9780470995129.ch6; StatSoft, 1993, STAT WIND OP SYST RE; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Van Der Meer J, 2005, METHODS STUDY MARINE; Waldbusser GG, 2004, LIMNOL OCEANOGR, V49, P1482, DOI 10.4319/lo.2004.49.5.1482; Warwick RM, 1998, SYNOPSES BRIT FAUNA; WIESER W., 1953, ARKIV ZOOL, V4, P439; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zar JH., 1999, BIOSTAT ANAL	57	32	33	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66653	10.1371/journal.pone.0066653	http://dx.doi.org/10.1371/journal.pone.0066653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825552	Green Published, gold			2022-12-25	WOS:000320576400140
J	Liu, HX; Fang, YP; Hu, Y; Gonzalez, FJ; Fang, JW; Wan, YJY				Liu, Hui-Xin; Fang, Yaping; Hu, Ying; Gonzalez, Frank J.; Fang, Jianwen; Wan, Yu-Jui Yvonne			PPAR beta Regulates Liver Regeneration by Modulating Akt and E2f Signaling	PLOS ONE			English	Article							ACTIVATED RECEPTOR-DELTA; LIGAND ACTIVATION; PEROXISOME; ALPHA; PROLIFERATION; EXPRESSION; GROWTH; TRANSCRIPTION; BETA/DELTA; METABOLISM	The current study tests the hypothesis that peroxisome proliferator-activated receptor beta (PPAR beta) has a role in liver regeneration due to its effect in regulating energy homeostasis and cell proliferation. The role of PPARb in liver regeneration was studied using two-third partial hepatectomy (PH) in Wild-type (WT) and PPARb-null (KO) mice. In KO mice, liver regeneration was delayed and the number of Ki-67 positive cells reached the peak at 60 hr rather than at 36-48 hr after PH shown in WT mice. RNA-sequencing uncovered 1344 transcriptomes that were differentially expressed in regenerating WT and KO livers. About 70% of those differentially expressed genes involved in glycolysis and fatty acid synthesis pathways failed to induce during liver regeneration due to PPAR beta deficiency. The delayed liver regeneration in KO mice was accompanied by lack of activation of phosphoinositide-dependent kinase 1 (PDK1)/Akt. In addition, cell proliferation-associated increase of genes encoding E2f transcription factor (E2f) 1-2 and E2f7-8 as well as their downstream target genes were not noted in KO livers 36-48 hr after PH. E2fs have dual roles in regulating metabolism and proliferation. Moreover, transient steatosis was only found in WT, but not in KO mice 36 hr after PH. These data suggested that PPAR beta-regulated PDK1/Akt and E2f signaling that controls metabolism and proliferation is involved in the normal progression of liver regeneration.	[Liu, Hui-Xin; Hu, Ying; Wan, Yu-Jui Yvonne] Calif State Univ Sacramento, Dept Med Pathol & Lab Med, Sacramento, CA 95819 USA; [Fang, Yaping; Fang, Jianwen] Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	California State University System; California State University Sacramento; University of Kansas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wan, YJY (corresponding author), Calif State Univ Sacramento, Dept Med Pathol & Lab Med, Sacramento, CA 95819 USA.	yjywan@ucdavis.edu		Fang, Yaping/0000-0001-6075-0768	National Institutes of Health [CA53596, DK092100]; NATIONAL CANCER INSTITUTE [ZIABC005708, R01CA053596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by grants funded by National Institutes of Health CA53596 and DK092100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Borland MG, 2008, MOL PHARMACOL, V74, P1429, DOI 10.1124/mol.108.050609; Burdick AD, 2007, CELL SIGNAL, V19, P1163, DOI 10.1016/j.cellsig.2006.12.007; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cicenas J, 2005, BREAST CANCER RES, V7, pR394, DOI 10.1186/bcr1015; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gazit V, 2012, HEPATOLOGY, V56, P1489, DOI 10.1002/hep.25880; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Huang Tom Hsun-Wei, 2012, Curr Mol Pharmacol, V5, P241; Kostadinova R, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-34; Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1; Lukas ER, 1999, MOL CARCINOGEN, V25, P295, DOI 10.1002/(SICI)1098-2744(199908)25:4<295::AID-MC8>3.0.CO;2-9; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Qu AJ, 2010, TOXICOL SCI, V118, P404, DOI 10.1093/toxsci/kfq259; Rao MS, 2002, HEPATOL RES, V22, P52, DOI 10.1016/S1386-6346(01)00119-X; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Shan W, 2008, TOXICOL SCI, V105, P418, DOI 10.1093/toxsci/kfn142; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Skrtic S, 2005, LIVER INT, V25, P33, DOI 10.1111/j.1478-3231.2004.0998.x; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuji K, 2008, FEBS J, V275, P3815, DOI 10.1111/j.1742-4658.2008.06527.x; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wheeler MD, 2003, AM J PHYSIOL-GASTR L, V284, pG302, DOI 10.1152/ajpgi.00175.2002; Yamamoto Y, 2008, J GASTROEN HEPATOL, V23, P930, DOI 10.1111/j.1440-1746.2008.05370.x; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Yuan X, 2011, J PROTEOME RES, V10, P1179, DOI 10.1021/pr100960h; Zhou YF, 2008, AM J PHYSIOL-RENAL, V295, pF662, DOI 10.1152/ajprenal.00046.2008; Zingarelli B, 2010, AM J PATHOL, V177, P1834, DOI 10.2353/ajpath.2010.091010	41	37	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65644	10.1371/journal.pone.0065644	http://dx.doi.org/10.1371/journal.pone.0065644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823620	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400016
J	Mangiacotti, M; Scali, S; Sacchi, R; Bassu, L; Nulchis, V; Corti, C				Mangiacotti, Marco; Scali, Stefano; Sacchi, Roberto; Bassu, Lara; Nulchis, Valeria; Corti, Claudia			Assessing the Spatial Scale Effect of Anthropogenic Factors on Species Distribution	PLOS ONE			English	Article							DISTRIBUTION MODELS; WALL LIZARD; NICHE; ECOLOGY; HABITAT; PERFORMANCE; PREVALENCE; PREDICTION; SELECTION; RICHNESS	Patch context is a way to describe the effect that the surroundings exert on a landscape patch. Despite anthropogenic context alteration may affect species distributions by reducing the accessibility to suitable patches, species distribution modelling have rarely accounted for its effects explicitly. We propose a general framework to statistically detect the occurrence and the extent of such a factor, by combining presence-only data, spatial distribution models and information-theoretic model selection procedures. After having established the spatial resolution of the analysis on the basis of the species characteristics, a measure of anthropogenic alteration that can be quantified at increasing distance from each patch has to be defined. Then the distribution of the species is modelled under competing hypotheses: H-0, assumes that the distribution is uninfluenced by the anthropogenic variables; H-1, assumes the effect of alteration at the species scale (resolution); and H-2, H-3 ... H-n add the effect of context alteration at increasing radii. Models are compared using the Akaike Information Criterion to establish the best hypothesis, and consequently the occurrence (if any) and the spatial scale of the anthropogenic effect. As a study case we analysed the distribution data of two insular lizards (one endemic and one naturalised) using four alternative hypotheses: no alteration (H-0), alteration at the species scale (H-1), alteration at two context scales (H-2 and H-3). H-2 and H-3 performed better than H-0 and H-1, highlighting the importance of context alteration. H-2 performed better than H-3, setting the spatial scale of the context at 1 km. The two species respond differently to context alteration, the introduced lizard being more tolerant than the endemic one. The proposed approach supplies reliably and interpretable results, uses easily available data on species distribution, and allows the assessing of the spatial scale at which human disturbance produces the heaviest effects.	[Mangiacotti, Marco; Scali, Stefano] Museo Civ Storia Nat Milano, Milan, Italy; [Sacchi, Roberto] Univ Pavia, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Bassu, Lara; Nulchis, Valeria] Soc Herpetol Ital, Sez Sardegna, Oristano, Italy; [Corti, Claudia] Univ Florence, Sez Zool La Specola, Museo Storia Nat, Florence, Italy	University of Pavia; University of Florence	Mangiacotti, M (corresponding author), Museo Civ Storia Nat Milano, Milan, Italy.	marco.mangiacotti@gmail.com	MANGIACOTTI, MARCO/AAH-1282-2020; Sacchi, Roberto/E-2141-2011; Mangiacotti, Marco/AAZ-9550-2021	MANGIACOTTI, MARCO/0000-0001-7144-3851; Sacchi, Roberto/0000-0002-6199-0074; Corti, Claudia/0000-0001-6015-0092	Regione Sardegna	Regione Sardegna(Regione Sardegna)	The research was conducted without any external funding. Only field work by one of the authors (Lara Bassu) was partially supported by a bursary from "Regione Sardegna" (www.regionesardegna.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], 2006, SOC HERPETOLOGICA IT; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Brito JC, 2011, ACTA HERPETOL, V6, P105; BROWN RM, 1995, AM MIDL NAT, V133, P344, DOI 10.2307/2426399; Bruschi S, 2010, FAUNA ITALIA REPTILI, P417; Clipson A, 2003, BOOTSTRAP METHODS PE; Convertino M, 2011, ECOL COMPLEX, V8, P364, DOI 10.1016/j.ecocom.2011.07.007; Corti C., 2002, LIZARDS ITALY ADJACE; Corti C., 2010, FAUNA ITALIA, P407; Corti Claudia, 1999, Natura Croatica, V8, P287; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Debinski DM, 2001, BIOL CONSERV, V98, P179, DOI 10.1016/S0006-3207(00)00153-1; Delaugerre M., 1992, ATLAS REPARTITION BA; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Foa A, 1990, ETHOL ECOL EVOL, V2, P310, DOI [10.1080/08927014.1990.9525443, DOI 10.1080/08927014.1990.9525443]; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Graf RF, 2005, LANDSCAPE ECOL, V20, P703, DOI 10.1007/s10980-005-0063-7; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kattwinkel M, 2009, LANDSCAPE ECOL, V24, P929, DOI 10.1007/s10980-009-9371-7; Legendre P, 1998, NUMERICAL ECOLOGY, P870; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MARTIN AH, 2012, NY TIMES BK REV 0415, P22, DOI DOI 10.1890/11-2224.1.PUBMED:23387125; Mazerolle MJ, 1999, ECOSCIENCE, V6, P117, DOI 10.1080/11956860.1999.11952204; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; McInerny GJ, 2012, J BIOGEOGR, V39, P2112, DOI 10.1111/jbi.12031; McInerny GJ, 2012, J BIOGEOGR, V39, P2096, DOI 10.1111/jbi.12033; McInerny GJ, 2012, J BIOGEOGR, V39, P2103, DOI 10.1111/jbi.12032; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Pearson, 2010, LESSONS CONSERVATION, V3, P54, DOI [DOI 10.1016/S0140-6736(10)61462-6, 10.1016/S0140-6736(10)61462-6]; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Peterson AT, 2011, ECOLOGICAL NICHES GE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pineda E, 2012, GLOBAL ECOL BIOGEOGR, V21, P935, DOI 10.1111/j.1466-8238.2011.00741.x; Podnar M, 2005, MOL ECOL, V14, P575, DOI 10.1111/j.1365-294X.2005.02427.x; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Scali S, 2013, J ZOOL, V289, P196, DOI 10.1111/j.1469-7998.2012.00977.x; Scali S, 2011, AMPHIBIA-REPTILIA, V32, P223, DOI 10.1163/017353711X562171; Sillero N, 2009, ACTA HERPETOL, V4, P37; Smith AB, 2013, DIVERS DISTRIB, V19, P867, DOI 10.1111/ddi.12031; Smith AB, 2013, GLOBAL ECOL BIOGEOGR, V22, P334, DOI 10.1111/j.1466-8238.2012.00785.x; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; VANDAMME R, 1990, ACTA OECOL, V11, P503; Vanhooydonck B, 2000, FUNCT ECOL, V14, P358, DOI 10.1046/j.1365-2435.2000.00430.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Wilson E.O., 2002, FUTURE LIFE, P256	70	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67573	10.1371/journal.pone.0067573	http://dx.doi.org/10.1371/journal.pone.0067573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825669	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400188
J	Pesch, R; Zimmer, R				Pesch, Robert; Zimmer, Ralf			Complementing the Eukaryotic Protein Interactome	PLOS ONE			English	Article							INTERACTION NETWORKS; INTERACTION DATABASE; PHYLOGENETIC TREES; GENE ONTOLOGY; YEAST; TOOL; TRANSCRIPTION; ANNOTATION; RESOURCE; MODEL	Protein interaction networks are important for the understanding of regulatory mechanisms, for the explanation of experimental data and for the prediction of protein functions. Unfortunately, most interaction data is available only for model organisms. As a possible remedy, the transfer of interactions to organisms of interest is common practice, but it is not clear when interactions can be transferred from one organism to another and, thus, the confidence in the derived interactions is low. Here, we propose to use a rich set of features to train Random Forests in order to score transferred interactions. We evaluated the transfer from a range of eukaryotic organisms to S. cerevisiae using orthologs. Directly transferred interactions to S. cerevisiae are on average only 24% consistent with the current S. cerevisiae interaction network. By using commonly applied filter approaches the transfer precision can be improved, but at the cost of a large decrease in the number of transferred interactions. Our Random Forest approach uses various features derived from both the target and the source network as well as the ortholog annotations to assign confidence values to transferred interactions. Thereby, we could increase the average transfer consistency to 85%, while still transferring almost 70% of all correctly transferable interactions. We tested our approach for the transfer of interactions to other species and showed that our approach outperforms competing methods for the transfer of interactions to species where no experimental knowledge is available. Finally, we applied our predictor to score transferred interactions to 83 targets species and we were able to extend the available interactome of B. taurus, M. musculus and G. gallus with over 40,000 interactions each. Our transferred interaction networks are publicly available via our web interface, which allows to inspect and download transferred interaction sets of different sizes, for various species, and at specified expected precision levels.	[Pesch, Robert; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Munich	Pesch, R (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	robert.pesch@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019		DFG International Research Training Group (IRTG) [RECESS 1563]	DFG International Research Training Group (IRTG)(German Research Foundation (DFG))	This work was supported by the DFG International Research Training Group (IRTG) RECESS 1563 via scholarships to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chautard E, 2011, NUCLEIC ACIDS RES, V39, pD235, DOI 10.1093/nar/gkq830; Chen PY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000118; Cote RG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-97; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Friedel CC, 2009, BIOINFORMATICS, V25, P2140, DOI 10.1093/bioinformatics/btp353; Gallone G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-289; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Garcia-Garcia J, 2012, NUCLEIC ACIDS RES, V40, pW147, DOI 10.1093/nar/gks553; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goll J, 2008, BIOINFORMATICS, V24, P1743, DOI 10.1093/bioinformatics/btn285; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lewis ACF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002645; Luo QB, 2011, NUCLEIC ACIDS RES, V39, pD724, DOI 10.1093/nar/gkq1200; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Michaut M, 2008, BIOINFORMATICS, V24, P1625, DOI 10.1093/bioinformatics/btn249; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sambourg L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-605; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Turinsky AL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq026; Uetz P, 2004, NAT BIOTECHNOL, V22, P43, DOI 10.1038/nbt0104-43; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zhang A, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, P1, DOI 10.1017/CBO9780511626593; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66635	10.1371/journal.pone.0066635	http://dx.doi.org/10.1371/journal.pone.0066635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825550	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400138
J	Swick, MC; Evangelista, MA; Bodine, TJ; Easton-Marks, JR; Barth, P; Shah, MJ; Chung, CAB; Stanley, S; McLaughlin, SF; Lee, CC; Sheth, V; Doan, Q; Hamill, RJ; Steffen, D; Becnel, LB; Sucgang, R; Zechiedrich, L				Swick, Michelle C.; Evangelista, Michael A.; Bodine, Truston J.; Easton-Marks, Jeremy R.; Barth, Patrick; Shah, Minita J.; Chung, Christina A. Bormann; Stanley, Sarah; McLaughlin, Stephen F.; Lee, Clarence C.; Sheth, Vrunda; Quynh Doan; Hamill, Richard J.; Steffen, David; Becnel, Lauren B.; Sucgang, Richard; Zechiedrich, Lynn			Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates	PLOS ONE			English	Article							B STRAINS REL606; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; QUINOLONE RESISTANCE; GENOME SEQUENCE; MUTATIONS; GYRASE; GENE; EVOLUTION; DEATH	Current efforts to understand antibiotic resistance on the whole genome scale tend to focus on known genes even as high throughput sequencing strategies uncover novel mechanisms. To identify genomic variations associated with antibiotic resistance, we employed a modified genome-wide association study; we sequenced genomic DNA from pools of E. coli clinical isolates with similar antibiotic resistance phenotypes using SOLID technology to uncover single nucleotide polymorphisms (SNPs) unanimously conserved in each pool. The multidrug-resistant pools were genotypically similar to SMS-3-5, a previously sequenced multidrug-resistant isolate from a polluted environment. The similarity was evenly spread across the entire genome and not limited to plasmid or pathogenicity island loci. Among the pools of clinical isolates, genomic variation was concentrated adjacent to previously reported inversion and duplication differences between the SMS-3-5 isolate and the drug-susceptible laboratory strain, DH10B. SNPs that result in non-synonymous changes in gyrA (encoding the well-known S83L allele associated with fluoroquinolone resistance), mutM, ligB, and recG were unanimously conserved in every fluoroquinolone-resistant pool. Alleles of the latter three genes are tightly linked among most sequenced E. coli genomes, and had not been implicated in antibiotic resistance previously. The changes in these genes map to amino acid positions in alpha helices that are involved in DNA binding. Plasmid-encoded complementation of null strains with either allelic variant of mutM or ligB resulted in variable responses to ultraviolet light or hydrogen peroxide treatment as markers of induced DNA damage, indicating their importance in DNA metabolism and revealing a potential mechanism for fluoroquinolone resistance. Our approach uncovered evidence that additional DNA binding enzymes may contribute to fluoroquinolone resistance and further implicate environmental bacteria as a reservoir for antibiotic resistance.	[Swick, Michelle C.; Zechiedrich, Lynn] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Swick, Michelle C.; Evangelista, Michael A.; Bodine, Truston J.; Hamill, Richard J.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Evangelista, Michael A.; Barth, Patrick; Sucgang, Richard; Zechiedrich, Lynn] Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX USA; [Bodine, Truston J.; Hamill, Richard J.; Zechiedrich, Lynn] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Easton-Marks, Jeremy R.; Steffen, David; Becnel, Lauren B.; Zechiedrich, Lynn] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Easton-Marks, Jeremy R.; Steffen, David; Becnel, Lauren B.] Baylor Coll Med, Biomed Informat Grp, Houston, TX 77030 USA; [Barth, Patrick; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Shah, Minita J.; Stanley, Sarah; McLaughlin, Stephen F.; Lee, Clarence C.; Sheth, Vrunda] Life Technol, Beverly, MA USA; [Chung, Christina A. Bormann; Quynh Doan] Life Technol, Foster City, CA USA; [Hamill, Richard J.; Becnel, Lauren B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Becnel, Lauren B.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Thermo Fisher Scientific; Thermo Fisher Scientific; Baylor College of Medicine; Baylor College of Medicine	Sucgang, R (corresponding author), Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX USA.	rsucgang@bcm.edu; elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019; Steffen, David L/B-2751-2013; Doan, Quynh/AAJ-6023-2021	Steffen, David L/0000-0001-9363-2629; Doan, Quynh/0000-0002-8435-7837; Zechiedrich, Lynn/0000-0003-0533-1637; Easton-Marks, Jeremy/0000-0002-2263-7454	National Institutes of Health (NIH) [RO1 AI054830]; Pharmacoinformatics Training Program of the W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NIH) [T90 DK070109]; NIH [T32 GM88129]; Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacoinformatics Training Program of the W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) RO1 AI054830 (to LZ). MCS was supported by the Pharmacoinformatics Training Program of the W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NIH grant T90 DK070109) (https://gcc.rice.edu/former_training_programs/). TJB was supported by NIH grant T32 GM88129. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Life Technologies, the funders of the Applied Biosystems SOLID $ 10 K Sequencing Grant, assisted in the sample processing and generation of raw data at their in-house facility. They also assisted in the initial data processing. Minita J. Shah, Christina A. Bormann Chung, Sarah Stanley, Stephen F. McLaughlin, Clarence C. Lee, Vrunda Sheth and Quynh Doan are employed by Life Technologies. Drs. Richard Sucgang, Michelle C. Swick, and Lynn Zechiedrich are co-inventors on a patent application that cover the strategy and genes uncovered in the manuscript. The Life Technologies team was interested in promoting the SOLiD technology. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Boyd LB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-4; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Coculescu Bogdan-Ioan, 2009, J Med Life, V2, P114; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879, DOI 10.1128/AAC.40.4.879; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; Mandsberg LF, 2011, FEMS MICROBIOL LETT, V324, P28, DOI 10.1111/j.1574-6968.2011.02383.x; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Mazzariol A, 2000, ANTIMICROB AGENTS CH, V44, P3441, DOI 10.1128/AAC.44.12.3441-3443.2000; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Orlen H, 2006, ANTIMICROB AGENTS CH, V50, P3454, DOI 10.1128/AAC.00783-06; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rudolph CJ, 2009, MOL MICROBIOL, V73, P352, DOI 10.1111/j.1365-2958.2009.06773.x; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Singh R, 2012, ANTIMICROB AGENTS CH, V56, P1680, DOI 10.1128/AAC.05693-11; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; Stone PW, 2005, AM J INFECT CONTROL, V33, P542, DOI 10.1016/j.ajic.2005.08.003; Sutherland JH, 2010, J BACTERIOL, V192, P4445, DOI 10.1128/JB.00350-10; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang MG, 2003, ANTIMICROB AGENTS CH, V47, P2242, DOI 10.1128/AAC.47.7.2242-2248.2003; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	57	7	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65961	10.1371/journal.pone.0065961	http://dx.doi.org/10.1371/journal.pone.0065961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824211	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400041
J	You, JJ; Wen, L; Roufas, A; Madigan, MC; Sutton, G				You, Jingjing; Wen, Li; Roufas, Athena; Madigan, Michele C.; Sutton, Gerard			Expression of SFRP Family Proteins in Human Keratoconus Corneas	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; STEM-CELLS; WNT PATHWAY; PROLIFERATION; INHIBITION; EPITHELIUM; COLLAGEN; MATRIX; CANCER	We investigated the expression of the secreted frizzled-related proteins (SFRPs) in keratoconus (KC) and control corneas. KC buttons (similar to 8 mm diameter) (n = 15) and whole control corneas (n = 7) were fixed in 10% formalin or 2% paraformaldehyde and subsequently paraffin embedded and sectioned. Sections for histopathology were stained with hematoxylin and eosin, or Periodic Acid Schiff's reagent. A series of sections was also immunolabelled with SFRP 1 to 5 antibodies, visualised using immunofluorescence, and examined with a Zeiss LSM700 scanning laser confocal microscope. Semi-quantitative grading was used to compare SFRP immunostaining in KC and control corneas. Overall, KC corneas showed increased immunostaining for SFRP1 to 5, compared to controls. Corneal epithelium in all KC corneas displayed heterogeneous moderate to strong immunoreactivity for SFRP1 to 4, particularly in the basal epithelium adjacent to cone area. SFRP3 and 5 were localised to epithelial cell membranes in KC and control corneas, with increased SFRP3 cytoplasmic expression observed in KC. Strong stromal expression of SFRP5, including extracellular matrix, was seen in both KC and control corneas. In control corneas we observed differential expression of SFRP family proteins in the limbus compared to more central cornea. Taken together, our results support a role for SFRPs in maintaining a healthy cornea and in the pathogenesis of epithelial and anterior stromal disruption observed in KC.	[You, Jingjing; Wen, Li; Roufas, Athena; Madigan, Michele C.; Sutton, Gerard] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [You, Jingjing; Wen, Li; Roufas, Athena; Madigan, Michele C.; Sutton, Gerard] Univ Sydney, Discipline Clin Ophthalmol, Sydney, NSW 2006, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Sutton, Gerard] Univ Auckland, Auckland 1, New Zealand; [Sutton, Gerard] Vis Eye Inst, Chatswood, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of Auckland	Madigan, MC (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	m.madigan@unsw.edu.au	You, Jingjing/AAO-2671-2020	Sutton, Gerard/0000-0002-0645-018X; , Jingjing You/0000-0002-2461-0140	Sydney Eye Hospital Foundation; Sydney Foundation for Medical Research; Sydney Medical Foundation; Sydnovate, University of Sydney	Sydney Eye Hospital Foundation; Sydney Foundation for Medical Research; Sydney Medical Foundation; Sydnovate, University of Sydney	The research was funded by grants from The Sydney Eye Hospital Foundation, Sydney Foundation for Medical Research (MCM), Sydney Medical Foundation (GS) and Sydnovate, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian SA, 2013, CLIN EXPT OPHTHALMOL, DOI [10.1111/cxo.12038, DOI 10.1111/CX0.12038]; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Bourges JL, 2003, OPHTHALMOLOGY, V110, P1920, DOI 10.1016/S0161-6420(03)00617-1; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Burdon KP, 2013, CLIN EXPT OPHTHALMOL, DOI [10.1111/cxo.12024, DOI 10.1111/CX0.12024]; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Fernandes BF, 2008, PATHOLOGY, V40, P623, DOI 10.1080/00313020802320648; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Ha NT, 2004, CURR EYE RES, V28, P373, DOI 10.1080/02713680490502201; Han XZ, 2004, J BIOL CHEM, V279, P2832, DOI 10.1074/jbc.M308102200; HAY ED, 1973, J CELL BIOL, V57, P190, DOI 10.1083/jcb.57.1.190; Hirata H, 2010, CANCER RES, V70, P1896, DOI 10.1158/0008-5472.CAN-09-3549; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Jones SE, 2000, INVEST OPHTH VIS SCI, V41, P1297; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Li CH, 2007, J DENT RES, V86, P873, DOI 10.1177/154405910708600913; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lyu J, 2005, J BIOL CHEM, V280, P21653, DOI 10.1074/jbc.m500374200; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mathew JH, 2011, OPTOMETRY VISION SCI, V88, P988, DOI 10.1097/OPX.0b013e31821ffbd4; McGhee CNJ, 2009, CLIN EXP OPHTHALMOL, V37, P160, DOI 10.1111/j.1442-9071.2009.02009.x; McLean I, 2002, INVEST OPHTHALMOL VI, V43; Meek KM, 2003, BIOPHYS J, V85, P2205, DOI 10.1016/S0006-3495(03)74646-3; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Mort Richard L, 2012, Results Probl Cell Differ, V55, P357, DOI 10.1007/978-3-642-30406-4_19; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Niederer RL, 2008, INVEST OPHTHALMOL VI, V49; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Osei-Bempong C, 2013, BIOESSAYS, V35, P211, DOI 10.1002/bies.201200086; Papadia M, 2008, CURR EYE RES, V33, P429, DOI 10.1080/02713680802130354; Proulx S, 2010, MOL VIS, V16, P2192; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raecker ME, 2009, AM J OPHTHALMOL, V147, P227, DOI 10.1016/j.ajo.2008.08.001; Saini S, 2009, CANCER RES, V69, P6815, DOI 10.1158/0008-5472.CAN-09-1254; Sakimoto T, 2008, FEBS LETT, V582, P3674, DOI 10.1016/j.febslet.2008.09.052; Sutton G, 2010, CLIN EXP OPHTHALMOL, V38, P43, DOI 10.1111/j.1442-9071.2009.02216.x; Syed D, 2013, CORNEA, V26, DOI [10.1097/ICO.1090-b1013e318282987a, DOI 10.1097/IC0.1090-B1013E318282987A]; Sykakis E, 2012, PATHOLOGY, V44, P234, DOI 10.1097/PAT.0b013e3283511b42; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Wang W, 2009, BMC CANCER, V9, P1471; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Zhou YP, 2011, EXP EYE RES, V93, P355, DOI 10.1016/j.exer.2011.04.003	45	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66770	10.1371/journal.pone.0066770	http://dx.doi.org/10.1371/journal.pone.0066770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825088	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400157
J	Feng, CG; Ghosh, A; Amin, MN; Giomarelli, B; Shridhar, S; Banerjee, A; Fernandez-Robledo, JA; Bianchet, MA; Wang, LX; Wilson, IBH; Vasta, GR				Feng, Chiguang; Ghosh, Anita; Amin, Mohammed N.; Giomarelli, Barbara; Shridhar, Surekha; Banerjee, Aditi; Fernandez-Robledo, Jose A.; Bianchet, Mario A.; Wang, Lai-Xi; Wilson, Iain B. H.; Vasta, Gerardo R.			The Galectin CvGal1 from the Eastern Oyster (Crassostrea virginica) Binds to Blood Group A Oligosaccharides on the Hemocyte Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PERKINSUS-MARINUS; GENE ORGANIZATION; GROUP ANTIGEN; LECTIN; RECOGNITION; MEMBRANE; PROTEIN; TRANSMISSION; PERSPECTIVES; SPECIFICITY	The galectin CvGal1 from the eastern oyster (Crassostrea virginica), which possesses four tandemly arrayed carbohydrate recognition domains, was previously shown to display stronger binding to galactosamine and N-acetylgalactosamine relative to D-galactose. CvGal1 expressed by phagocytic cells is "hijacked" by the parasite Perkinsus marinus to enter the host, where it proliferates and causes systemic infection and death. In this study, a detailed glycan array analysis revealed that CvGal1 preferentially recognizes type 2 blood group A oligosaccharides. Homology modeling of the protein and its oligosaccharide ligands supported this preference over type 1 blood group A and B oligosaccharides. The CvGal ligand models were further validated by binding, inhibition, and competitive binding studies of CvGal1 and ABH-specific monoclonal antibodies with intact and deglycosylated glycoproteins, hemocyte extracts, and intact hemocytes and by surface plasmon resonance analysis. A parallel glycomic study carried out on oyster hemocytes (Kurz, S., Jin, C., Hykollari, A., Gregorich, D., Giomarelli, B., Vasta, G. R., Wilson, I. B. H., and Paschinger, K. (2013) J. Biol. Chem. 288,) determined the structures of oligosaccharides recognized by CvGal1. Proteomic analysis of the hemocyte glycoproteins identified beta-integrin and dominin as CvGal1 "self"-ligands. Despite strong CvGal1 binding to P. marinus trophozoites, no binding of ABH blood group antibodies was observed. Thus, parasite glycans structurally distinct from the blood group A oligosaccharides on the hemocyte surface may function as potentially effective ligands for CvGal1. We hypothesize that carbohydrate-based mimicry resulting from the host/parasite co-evolution facilitates CvGal1-mediated cross-linking to beta-integrin, located on the hemocyte surface, leading to cell activation, phagocytosis, and host infection.	[Feng, Chiguang; Giomarelli, Barbara; Shridhar, Surekha; Banerjee, Aditi; Fernandez-Robledo, Jose A.; Vasta, Gerardo R.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21202 USA; [Feng, Chiguang; Giomarelli, Barbara; Shridhar, Surekha; Banerjee, Aditi; Fernandez-Robledo, Jose A.; Wilson, Iain B. H.; Vasta, Gerardo R.] Inst Marine & Environm Technol, Baltimore, MD 21202 USA; [Ghosh, Anita; Bianchet, Mario A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Amin, Mohammed N.; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wilson, Iain B. H.] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Natural Resources & Life Sciences, Vienna	Vasta, GR (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 701 East Pratt St, Baltimore, MD 21202 USA.	GVasta@som.umaryland.edu	Bianchet, Mario a/K-2131-2015; Wilson, Iain/B-3326-2009; Ghosh, Anita/AAR-8845-2020; Wang, Lai-Xi/E-8755-2019; Wang, Lai-Xi/E-8790-2019; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021	Bianchet, Mario a/0000-0001-9032-7549; Wilson, Iain/0000-0001-8996-1518; Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; , Chiguang/0000-0002-2355-3607; Shridhar, Surekha/0000-0003-1820-7379	National Institutes of Health [5R01GM070589-06, R01 GM080374]; National Science Foundation [IOS-0822257, IOS-1063729]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589, R01GM080374] Funding Source: NIH RePORTER; Direct For Biological Sciences [1063729] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM070589-06 (to G. R. V.) and R01 GM080374 (to L. X. W.). This work was also supported by Grants IOS-0822257 and IOS-1063729 from the National Science Foundation.	Ahmed H, 2002, GLYCOBIOLOGY, V12, P451, DOI 10.1093/glycob/cwf052; Alavi MR, 2009, J PARASITOL, V95, P900, DOI 10.1645/GE-1864.1; Andrews JD, 1996, J SHELLFISH RES, V15, P13; BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; Bianchet MA, 2000, PROTEINS, V40, P378, DOI 10.1002/1097-0134(20000815)40:3<378::AID-PROT40>3.0.CO;2-7; Boehm T, 2012, CURR BIOL, V22, pR722, DOI 10.1016/j.cub.2012.07.003; Bushek D, 2002, DIS AQUAT ORGAN, V51, P217, DOI 10.3354/dao051217; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Caceres-Martinez J, 2012, J INVERTEBR PATHOL, V110, P321, DOI 10.1016/j.jip.2012.03.019; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Chu FLE, 1996, J SHELLFISH RES, V15, P57; Cooper DNW, 1997, J BIOL CHEM, V272, P1514, DOI 10.1074/jbc.272.3.1514; Dame Richard, 2002, Aquatic Ecology, V36, P51, DOI 10.1023/A:1013354807515; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Robledo JA, 2008, BIOCHEM BIOPH RES CO, V375, P215, DOI 10.1016/j.bbrc.2008.07.162; Fernandez-Robledo JA, 2008, MOL BIOCHEM PARASIT, V157, P44, DOI 10.1016/j.molbiopara.2007.09.007; Ford SE, 2002, DIS AQUAT ORGAN, V51, P187, DOI 10.3354/dao051187; Gauthier JD, 2004, J PARASITOL, V90, P446, DOI 10.1645/GE-3269; GAUTHIER JD, 1995, J INVERTEBR PATHOL, V66, P156, DOI 10.1006/jipa.1995.1079; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Hager KM, 2008, TRENDS PARASITOL, V24, P51, DOI 10.1016/j.pt.2007.10.008; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Itoh N, 2011, COMP BIOCHEM PHYS B, V158, P9, DOI 10.1016/j.cbpb.2010.06.006; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Le Guyader FS, 2006, J CLIN MICROBIOL, V44, P3878, DOI 10.1128/JCM.01327-06; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lim J, 2012, BIOL CELL, V104, P631, DOI 10.1111/boc.201200013; Lin Z, 2011, BIOCHEMISTRY-US, V50, P6340, DOI 10.1021/bi200343h; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; PYTELA R, 1994, METHOD ENZYMOL, V245, P420; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Robledo JAF, 2004, J PARASITOL, V90, P1004, DOI 10.1645/GE-240R; Schmitt P, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00160; Schott EJ, 2003, GENE, V309, P1, DOI 10.1016/S0378-1119(03)00469-4; Schott EJ, 2003, MOL BIOCHEM PARASIT, V126, P81, DOI 10.1016/S0166-6851(02)00271-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Thomsson KA, 2000, ANAL CHEM, V72, P4543, DOI 10.1021/ac000631b; Tian P, 2008, J FOOD PROTECT, V71, P1696, DOI 10.4315/0362-028X-71.8.1696; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vasta GR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00199; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; VASTA GR, 1984, CELL IMMUNOL, V88, P475, DOI 10.1016/0008-8749(84)90179-5; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; VASTA GR, 1982, J INVERTEBR PATHOL, V40, P367, DOI 10.1016/0022-2011(82)90175-6; Vasta GR, 2008, ANIMAL LECTINS FUNCT; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	61	50	51	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24394	24409		10.1074/jbc.M113.476531	http://dx.doi.org/10.1074/jbc.M113.476531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824193	Green Published, hybrid			2022-12-25	WOS:000330612300011
J	Rawal, MK; Khan, MF; Kapoor, K; Goyal, N; Sen, S; Saxena, AK; Lynn, AM; Tyndall, JDA; Monk, BC; Cannon, RD; Komath, SS; Prasad, R				Rawal, Manpreet Kaur; Khan, Mohammad Firoz; Kapoor, Khyati; Goyal, Neha; Sen, Sobhan; Saxena, Ajay Kumar; Lynn, Andrew M.; Tyndall, Joel D. A.; Monk, Brian C.; Cannon, Richard D.; Komath, Sneha Sudha; Prasad, Rajendra			Insight into Pleiotropic Drug Resistance ATP-binding Cassette Pump Drug Transport through Mutagenesis of Cdr1p Transmembrane Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ABC MULTIDRUG TRANSPORTERS; CANDIDA-ALBICANS; P-GLYCOPROTEIN; ANTIFUNGAL EFFLUX; MEMBRANE-PROTEINS; YEAST; EXPRESSION; CLONING; PDR5P	The fungal ATP-binding cassette (ABC) transporter Cdr1 protein (Cdr1p), responsible for clinically significant drug resistance, is composed of two transmembrane domains (TMDs) and two nucleotide binding domains (NBDs). We have probed the nature of the drug binding pocket by performing systematic mutagenesis of the primary sequences of the 12 transmembrane segments (TMSs) found in the TMDs. All mutated proteins were expressed equally well and localized properly at the plasma membrane in the heterologous host Saccharomyces cerevisiae, but some variants differed significantly in efflux activity, substrate specificity, and coupled ATPase activity. Replacement of the majority of the amino acid residues with alanine or glycine yielded neutral mutations, but about 42% of the variants lost resistance to drug efflux substrates completely or selectively. A predicted three-dimensional homology model shows that all the TMSs, apart from TMS4 and TMS10, interact directly with the drug-binding cavity in both the open and closed Cdr1p conformations. However, TMS4 and TMS10 mutations can also induce total or selective drug susceptibility. Functional data and homology modeling assisted identification of critical amino acids within a drug-binding cavity that, upon mutation, abolished resistance to all drugs tested singly or in combinations. The open and closed Cdr1p models enabled the identification of amino acid residues that bordered a drug-binding cavity dominated by hydrophobic residues. The disposition of TMD residues with differential effects on drug binding and transport are consistent with a large polyspecific drug binding pocket in this yeast multidrug transporter.	[Rawal, Manpreet Kaur; Kapoor, Khyati; Goyal, Neha; Saxena, Ajay Kumar; Komath, Sneha Sudha; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Khan, Mohammad Firoz; Sen, Sobhan] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India; [Lynn, Andrew M.] Jawaharlal Nehru Univ, Dept Computat & Integrat Sci, New Delhi 110067, India; [Tyndall, Joel D. A.] Univ Otago, Sch Pharm, Dunedin 9054, New Zealand; [Monk, Brian C.; Cannon, Richard D.] Univ Otago, Sir John Walsh Res Inst, Dunedin 9054, New Zealand	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; University of Otago; University of Otago	Prasad, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India.	rp47jnu@gmail.com	Rawal, Manpreet Kaur/AAG-5799-2019; KOMATH, SNEHA SUDHA/AAE-6359-2020; tyndall, joel/C-2803-2008; Grieshaber-Bouyer, Ricardo/R-7512-2016; Sen, Sobhan/Q-7523-2019	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; tyndall, joel/0000-0003-0783-1635; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Sen, Sobhan/0000-0002-9047-3455; Monk, Brian/0000-0003-2264-3480; Cannon, Richard/0000-0002-5398-2066	Department of Biotechnology [DBT BT/01/CEIB/10/III/02, DBT BT/PR13641/MED/29/175/2010, DBT BT/PR14879/BRB10/885/2010]; Royal Society of New Zealand [UOO1004]; University Grants Commission, India	Department of Biotechnology; Royal Society of New Zealand(Royal Society of New Zealand); University Grants Commission, India(University Grants Commission, India)	This work was supported in part by Department of Biotechnology Grants DBT BT/01/CEIB/10/III/02, DBT BT/PR13641/MED/29/175/2010, and DBT BT/PR14879/BRB10/885/2010 (to R. P.) and Marsden Grant UOO1004 (to B. C. M.) from the Royal Society of New Zealand.; Supported by a University Grants Commission, India, Senior Research Fellowship award.	Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Boutet Emmanuel, 2007, V406, P89; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Crowley E, 2010, FEBS J, V277, P3974, DOI 10.1111/j.1742-4658.2010.07789.x; CURRIER SJ, 1989, J BIOL CHEM, V264, P14376; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GOLDWAY M, 1995, ANTIMICROB AGENTS CH, V39, P422, DOI 10.1128/AAC.39.2.422; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Gupta RP, 2011, BIOL CHEM, V392, P53, DOI 10.1515/BC.2011.011; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hofmann K., 1993, BIOL CHEM HOPPE SEYL; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kapoor K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000624; Krishnamurthy S, 1998, YEAST, V14, P535, DOI 10.1002/(SICI)1097-0061(19980430)14:6&lt;535::AID-YEA254&gt;3.0.CO;2-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Mandal A, 2012, BIOCHEM J, V445, P313, DOI 10.1042/BJ20120190; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; Niimi K, 2012, MOL MICROBIOL, V85, P747, DOI 10.1111/j.1365-2958.2012.08140.x; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Prasad Rajendra, 2011, J Amino Acids, V2011, P531412, DOI 10.4061/2011/531412; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Puri N, 2009, BBA-BIOMEMBRANES, V1788, P1752, DOI 10.1016/j.bbamem.2009.04.009; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Safa Ahmad R., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P1, DOI 10.2174/1568011043482142; Saini P, 2005, J ANTIMICROB CHEMOTH, V56, P77, DOI 10.1093/jac/dki183; Saini P, 2006, MICROBIOL-SGM, V152, P1559, DOI 10.1099/mic.0.28471-0; Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharma M, 2011, ANTIMICROB AGENTS CH, V55, P4834, DOI 10.1128/AAC.00344-11; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Shukla S, 2004, BIOCHEM BIOPH RES CO, V322, P520, DOI 10.1016/j.bbrc.2004.07.151; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Tanabe K, 2011, MOL MICROBIOL, V82, P416, DOI 10.1111/j.1365-2958.2011.07820.x; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Tutulan-Cunita AC, 2005, GENES CELLS, V10, P409, DOI 10.1111/j.1365-2443.2005.00847.x; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382	57	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24480	24493		10.1074/jbc.M113.488353	http://dx.doi.org/10.1074/jbc.M113.488353			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824183	Green Published, hybrid			2022-12-25	WOS:000330612300017
J	Haselkorn, R				Haselkorn, Robert			Hard to Swallow: Do Foods Containing "Genetically Modified Organisms" (GMOs) Need Warning Labels?	FASEB JOURNAL			English	Editorial Material									Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Haselkorn, R (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 East 58th St, Chicago, IL 60637 USA.	rh01@uchicago.edu						Committee on Scientific Evaluation of the Introduction of Genetically Modified Microorganisms and Plants into the Environment National Research Council, 1989, FIELD TEST GEN MOD O; Strom S, 2013, NY TIMES; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108	3	0	0	0	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2531	2532		10.1096/fj.13-0701ufm	http://dx.doi.org/10.1096/fj.13-0701ufm			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23824204				2022-12-25	WOS:000328841000001
J	Qiu, ZH; Chen, X; Zhou, YZ; Lin, JB; Ding, D; Yang, SJ; Chen, F; Wang, M; Zhu, F; Yu, X; Zhou, ZH; Liao, YH				Qiu, Zhihua; Chen, Xiao; Zhou, Yanzhao; Lin, Jibin; Ding, Dan; Yang, Shijun; Chen, Fen; Wang, Min; Zhu, Feng; Yu, Xian; Zhou, Zihua; Liao, Yuhua			Therapeutic Vaccines against Human and Rat Renin in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN SYSTEM; NORMOTENSIVE RATS; ALISKIREN; IMMUNIZATION; PRORENIN; NEUROPATHOLOGY; EPITOPES; BINDING; PEPTIDE; COMPLEX	Vaccination provides a promising approach for treatment of hypertension and improvement in compliance. As the initiation factor of renin-angiotensin system, renin plays a critical role in hypertension. In this study, we selected six peptides (rR32, rR72, rR215, hR32, hR72, and hR215) belonging to potential epitopes of rat and human renin. The main criteria were as follows: (1) include one of renin catalytic sites or the flap sequence; (2) low/no-similarity when matched with the host proteome; (3) ideal antigenicity and hydrophilicity. The peptides were coupled to keyhole limpet hemocyanin and injected into SpragueDawley (SD) rats, spontaneously hypertensive rats (SHRs) and Wistar-Kyoto rats. The antisera titers and the binding capacity with renin were detected. The effects of the anti-peptides antibodies on plasma renin activity (PRA) and blood pressure were also determined. All peptides elicited strong antibody responses. The antisera titers ranged from 1: 32,000 to 1: 80,000 in SD rats on day 63. All antisera could bind to renin in vitro. Compared with the control antibody, the antibodies against the rR32, hR32, rR72 and hR72 peptides inhibited PRA level by up to about 50%. Complete cross-reactivity of the anti-rR32 antibody and the anti-hR32 antibody was confirmed. The epitopes rR32 and hR32 vaccines significantly decreased systolic blood pressure (SBP) of SHRs up to 15mmHg (175 +/- 2 vesus 190 +/- 3 mmHg, P = 0.035; 180 +/- 2 vesus 195 +/- 3 mmHg, P = 0.039), while no obvious effect on SD rats. Additionally, no significant immune-mediated damage was detected in the vaccinated animals. In conclusion, the antigenic peptide hR32 vaccine mimicking the 32 Asp catalytic site of human renin may constitute a novel tool for the development of a renin vaccine.	[Qiu, Zhihua; Chen, Xiao; Zhou, Yanzhao; Lin, Jibin; Ding, Dan; Yang, Shijun; Chen, Fen; Wang, Min; Zhu, Feng; Yu, Xian; Zhou, Zihua; Liao, Yuhua] Huazhong Univ Sci & Technol, Tongji Med Coll, Lab Cardiovasc Immunol,Union Hosp, Key Lab Mol Targeted Therapies,Minist Educ,Inst C, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhou, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Lab Cardiovasc Immunol,Union Hosp, Key Lab Mol Targeted Therapies,Minist Educ,Inst C, Wuhan 430074, Peoples R China.	zzhua2001@163.com; liaoyh27@163.com			National Natural Science Funds of China [30700295, 30971246]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Funds of China (No. 30700295, No. 30971246) (http://www.nsfc.gov.cn/Portal0/ default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284; BAGBY SP, 1979, HYPERTENSION, V1, P347, DOI 10.1161/01.HYP.1.4.347; Batenburg WW, 2008, ARTERIOSCL THROM VAS, V28, P1151, DOI 10.1161/ATVBAHA.108.164210; BenYedidia T, 1997, CURR OPIN BIOTECH, V8, P442, DOI 10.1016/S0958-1669(97)80066-3; BOUHNIK J, 1987, J BIOL CHEM, V262, P2913; Brown MJ, 2009, NAT REV CARDIOL, V6, P639, DOI 10.1038/nrcardio.2009.156; EVIN G, 1988, BIOCHEMISTRY-US, V27, P156, DOI 10.1021/bi00401a024; EVIN G, 1986, HYPERTENSION, V8, P72; Feldt S, 2008, HYPERTENSION, V51, P682, DOI 10.1161/HYPERTENSIONAHA.107.101444; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Galen F X, 1987, J Hypertens Suppl, V5, pS11; Gironacci MM, 2011, HYPERTENSION, V58, P176, DOI 10.1161/HYPERTENSIONAHA.111.173344; GOLDBLATT H, 1951, T ASSOC AM PHYSICIAN, V64, P122; INAGAMI T, 1989, J HYPERTENS, V7, pS3, DOI 10.1097/00004872-198904002-00002; Kanduc D, 2009, EXPERT OPIN BIOL TH, V9, P45, DOI [10.1517/14712590802614041, 10.1517/14712590802614041 ]; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lemere CA, 2007, CURR ALZHEIMER RES, V4, P427, DOI 10.2174/156720507781788800; Lucchese Alberta, 2004, J Transl Med, V2, P43, DOI 10.1186/1479-5876-2-43; Michel JB, 2004, CLIN SCI, V107, P145, DOI 10.1042/CS20040116; MICHEL JB, 1990, CIRCULATION, V81, P1899, DOI 10.1161/01.CIR.81.6.1899; Michel JB, 1987, P NATL ACAD SCI USA, V204, P281; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Reudelhuber TL, 2010, HYPERTENSION, V55, P1071, DOI 10.1161/HYPERTENSIONAHA.108.120279; SALI A, 1989, EMBO J, V8, P2179, DOI 10.1002/j.1460-2075.1989.tb08340.x; SEN S, 1972, CIRC RES, V31, P876, DOI 10.1161/01.RES.31.6.876; Stufano A, 2009, EXP MOL PATHOL, V86, P36, DOI 10.1016/j.yexmp.2008.11.009; TONG L, 1995, J MOL BIOL, V250, P211, DOI 10.1006/jmbi.1995.0372; Wood JM, 2003, BIOCHEM BIOPH RES CO, V308, P698, DOI 10.1016/S0006-291X(03)01451-7; Zhu F, 2008, CURR OPIN INVEST DR, V9, P286; Zhu Feng, 2008, DRUGS FUTURE, V33, P1	33	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66420	10.1371/journal.pone.0066420	http://dx.doi.org/10.1371/journal.pone.0066420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825541	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000019
J	Zebedin, A; Ladich, F				Zebedin, Angelika; Ladich, Friedrich			Does the Hearing Sensitivity in Thorny Catfishes Depend on Swim Bladder Morphology?	PLOS ONE			English	Article							AUDITORY-SENSITIVITY; GAS BLADDER; SILURIFORMES DORADIDAE; SCIAENID FISHES; TELEOSTEI; EAR; STIMULATION; THRESHOLDS; ABILITY	Background: Thorny catfishes exhibit large variations in swim bladder morphology. These organs are of different sizes, forms and may have simple or branched diverticula. The swim bladder plays an important role in otophysans because it enhances their hearing sensitivity by transmitting sound pressure fluctuations via ossicles to the inner ear. Methodology/Principal Findings: To investigate if a form-function relationship exists, the swim bladder morphology and hearing ability were analyzed in six species. The morphology was quantified by measuring the length, width and height and calculating a standardized swim bladder length (sSBL), which was then used to calculate the relative swim bladder length (rSBL). Hearing was measured using the auditory evoked potential (AEP) recording technique. Two species had simple apple-shaped and four species heart-shaped (cordiform) bladders. One of the latter species had short unbranched diverticula on the terminal margin, two had a secondary bladder and two had many long, branched diverticula. The rSBL differed significantly between most of the species. All species were able to detect frequencies between 70 Hz and 6 kHz, with lowest thresholds found between 0.5 and 1 kHz (60 dB re 1 mu Pa). Hearing curves were U-shaped except in Hemidoras morrisi in which it was ramp-like. Mean hearing thresholds of species possessing smaller rSBLs were slightly lower (maximum 8.5 dB) than those of species having larger rSBLs. Conclusions/Significance: The current findings reveal a relationship between swim bladder form and its function among thorny catfishes. Relatively smaller swim bladders resulted in relatively better hearing. This is in contrast to a prior inter-familial study on catfishes in which species with large unpaired bladders possessed higher sensitivity at higher frequencies than species having tiny paired and encapsulated bladders.	[Zebedin, Angelika; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Ladich, F (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Austrian Science Fund (FWF) [22319]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF grant 22319 to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R. McN., 1964, PROC ZOO SOC LONDON, V142, P419; [Anonymous], 1995, BIOL FISHES; Bird NC, 2007, J MORPHOL, V268, P739, DOI 10.1002/jmor.10550; Birindelli JLO, 2012, J MORPHOL, V273, P651, DOI 10.1002/jmor.20012; Birindelli JLO, 2011, P ACAD NAT SCI PHILA, V161, P117, DOI 10.1635/053.161.0109; Birindelli JLO, 2011, J MORPHOL, V272, P890, DOI 10.1002/jmor.10961; Birindelli JL, 2009, P ACAD NAT SCI PHILA, V158, P261, DOI 10.1635/053.158.0114; Blaxter JHS, 1981, HEARING SOUND COMMUN, P39; Braun Christopher B., 2008, V32, P99; Chardon M, 2003, CATFISHES, VOLS 1-2, P71; Chardon M, 1997, NETH J ZOOL, V47, P383, DOI 10.1163/156854297X00076; Chardon M., 1968, Annls Mus r Afr cent (Ser Zool), VNo. 169, P1; Chranilov N. S., 1929, Zoologische Jahrbuecher Jena Anatomie, V51, P323; Chranilov N. S., 1927, Zoologische Jahrbuecher Jena Abteilungen Anatomie, V49, P501; COOMBS S, 1979, J COMP PHYSIOL, V132, P203, DOI 10.1007/BF00614491; Diogo R, 2004, ANIM BIOL, V54, P175, DOI 10.1163/1570756041445173; FAY RR, 1975, J EXP BIOL, V62, P379; FAY RR, 1974, J EXP BIOL, V61, P243; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Frisch K. von., 1932, Zeitschrift fuer Vergleichende Physiologie, V17, P686, DOI 10.1007/BF00339067; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; JONES FRH, 1953, BIOL REV, V28, P16, DOI 10.1111/j.1469-185X.1953.tb01370.x; Kaatz IM, 2012, CURR ZOOL, V58, P171, DOI 10.1093/czoolo/58.1.171; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; KLEEREKOPER H., 1959, CANADIAN JOUR ZOOL, V37, P1; Ladich F, 1999, BRAIN BEHAV EVOLUT, V53, P288, DOI 10.1159/000006600; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Ladich F, 2003, CATFISHES, VOLS 1-2, P701; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2001, ANAT REC, V263, P297, DOI 10.1002/ar.1105; Ladich Friedrich, 2006, P3; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lechner W, 2011, J ZOOL, V283, P186, DOI 10.1111/j.1469-7998.2010.00762.x; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Marceniuk AP, 2010, ZOOTAXA, P59, DOI 10.11646/zootaxa.2579.1.4; Papes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026479; POGGENDORF D, 1952, Z VERGL PHYSIOL, V34, P222, DOI 10.1007/BF00298202; POPPER AN, 1981, J COMP PHYSIOL, V144, P27, DOI 10.1007/BF00612794; Ramcharitar J, 2004, J ACOUST SOC AM, V116, P1687, DOI 10.1121/1.1771614; Ramcharitar JU, 2006, J ACOUST SOC AM, V119, P439, DOI 10.1121/1.2139068; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Ramcharttar J, 2006, T AM FISH SOC, V135, P1409, DOI 10.1577/T05-207.1; Schulz-Mirbach T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042292; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; WEISS BA, 1969, P NATL ACAD SCI USA, V64, P552, DOI 10.1073/pnas.64.2.552; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2009, J EXP BIOL, V212, P3091, DOI 10.1242/jeb.033274; Yan HY, 2000, J COMP PHYSIOL A, V186, P435, DOI 10.1007/s003590050443	50	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67049	10.1371/journal.pone.0067049	http://dx.doi.org/10.1371/journal.pone.0067049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825615	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000067
J	Zhang, T; Liu, LL; Song, ZL; Ren, GX; Feng, YZ; Han, XH; Yang, GH				Zhang, Tong; Liu, Linlin; Song, Zilin; Ren, Guangxin; Feng, Yongzhong; Han, Xinhui; Yang, Gaihe			Biogas Production by Co-Digestion of Goat Manure with Three Crop Residues	PLOS ONE			English	Article							THERMOPHILIC ANAEROBIC-DIGESTION; SWINE MANURE; WASTE; METHANE; INHIBITION; SLUDGE; ENERGY; DAIRY; IMPROVEMENT; FRUIT	Goat manure (GM) is an excellent raw material for anaerobic digestion because of its high total nitrogen content and fermentation stability. Several comparative assays were conducted on the anaerobic co-digestion of GM with three crop residues (CRs), namely, wheat straw (WS), corn stalks (CS) and rice straw (RS), under different mixing ratios. All digesters were implemented simultaneously under mesophilic temperature at 35 +/- 1 degrees C with a total solid concentration of 8%. Result showed that the combination of GM with CS or RS significantly improved biogas production at all carbon-to-nitrogen (C/N) ratios. GM/CS (30:70), GM/CS (70:30), GM/RS (30:70) and GM/RS (50:50) produced the highest biogas yields from different co-substrates (14840, 16023, 15608 and 15698 mL, respectively) after 55 d of fermentation. Biogas yields of GM/WS 30:70 (C/N 35.61), GM/CS 70:30 (C/N 21.19) and GM/RS 50:50 (C/N 26.23) were 1.62, 2.11 and 1.83 times higher than that of CRs, respectively. These values were determined to be the optimal C/N ratios for co-digestion. However, compared with treatments of GM/CS and GM/RS treatments, biogas generated from GM/WS was only slightly higher than the single digestion of GM or WS. This result was caused by the high total carbon content (35.83%) and lignin content (24.34%) in WS, which inhibited biodegradation.	[Zhang, Tong; Song, Zilin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Tong; Liu, Linlin; Song, Zilin; Ren, Guangxin; Feng, Yongzhong; Han, Xinhui; Yang, Gaihe] Northwest A&F Univ, Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Liu, Linlin; Ren, Guangxin; Feng, Yongzhong; Han, Xinhui; Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012; ren, guangxin/Q-1234-2015	Feng, Yongzhong/0000-0002-5202-4368; ren, guangxin/0000-0001-9895-2680; Zhang, Tong/0000-0002-0146-243X	Ministry of Science and Technology Department of the People's Republic of China [2011BAD15B03]; Ministry of Education of the People's Republic of China [QM2012002]	Ministry of Science and Technology Department of the People's Republic of China(Ministry of Science and Technology, China); Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was supported by science and technology support projects "the biological technology integration and demonstration of high yield biogas digestion from the mix ingredients" (2011BAD15B03) from Ministry of Science and Technology Department of the People's Republic of China, and the Fundamental Research Funds for the Central Universities (QM2012002) from Ministry of Education of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2010, BIORESOURCE TECHNOL, V101, P1153, DOI 10.1016/j.biortech.2009.09.061; ANGELIDAKI I, 1993, APPL MICROBIOL BIOT, V38, P560; ANGELIDAKI I, 1992, APPL MICROBIOL BIOT, V37, P808, DOI 10.1007/BF00174850; [Anonymous], 2000, WATER SCI TECHNOL; [Anonymous], 1997, ANAEROBIC DIGESTION; [Anonymous], 2011, INT J CHEM REACT ENG; [Anonymous], 2002, BIORESOUR TECHNOL; APHA, 1995, STANDARD METHODS EXA; Bouallagui H, 2009, J ENVIRON MANAGE, V90, P1844, DOI 10.1016/j.jenvman.2008.12.002; Carucci G, 2005, J ENVIRON ENG, V131, P1037, DOI 10.1061/(ASCE)0733-9372(2005)131:7(1037); Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Creamer KS, 2010, BIORESOURCE TECHNOL, V101, P3020, DOI 10.1016/j.biortech.2009.12.029; Dai X, 2012, WASTE MANAGEMENT; DUARTE AC, 1982, WATER SCI TECHNOL, V14, P749, DOI 10.2166/wst.1982.0139; El-Mashad HM, 2010, BIORESOURCE TECHNOL, V101, P4021, DOI 10.1016/j.biortech.2010.01.027; Fernandez A, 2005, BIOCHEM ENG J, V26, P22, DOI 10.1016/j.bej.2005.02.018; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Habiba L, 2009, BIORESOURCE TECHNOL, V100, P1555, DOI 10.1016/j.biortech.2008.09.019; JAIN MK, 1981, AGR WASTES, V3, P65, DOI 10.1016/0141-4607(81)90007-X; Jiang D, 2012, RENEW SUST ENERG REV, V16, P1377, DOI 10.1016/j.rser.2011.12.012; Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4; KANWAR SS, 1993, WORLD J MICROB BIOT, V9, P174, DOI 10.1007/BF00327830; Kayhanian M, 1999, ENVIRON TECHNOL, V20, P355, DOI 10.1080/09593332008616828; Luostarinen S, 2009, BIORESOURCE TECHNOL, V100, P79, DOI 10.1016/j.biortech.2008.06.029; Macias-Corral M, 2008, BIORESOURCE TECHNOL, V99, P8288, DOI 10.1016/j.biortech.2008.03.057; Madsen M, 2011, RENEW SUST ENERG REV, V15, P3141, DOI 10.1016/j.rser.2011.04.026; Ngan N.V.C., 2012, J VIET ENV, V3, P4, DOI DOI 10.13141/JVE.V0L3.N01.PP4-9; Panichnumsin P, 2010, BIOMASS BIOENERG, V34, P1117, DOI 10.1016/j.biombioe.2010.02.018; Song ZL, 2012, BIORESOURCES, V7, P3223; Veeken A, 1999, BIORESOURCE TECHNOL, V69, P249, DOI 10.1016/S0960-8524(98)00188-6; Wang FangHao, 2006, China Environmental Science, V26, P614; Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wu X, 2010, BIORESOURCE TECHNOL, V101, P4042, DOI 10.1016/j.biortech.2010.01.052; Xie S, 2011, BIORESOURCE TECHNOL, V102, P5728, DOI 10.1016/j.biortech.2011.03.009; Yang Z, 2008, PET SCI, V5, P183, DOI 10.1007/s12182-008-0029-x; Zhang PD, 2009, RENEW SUST ENERG REV, V13, P2571, DOI 10.1016/j.rser.2009.06.016; Zhu D., 2010, CODIGESTION DIFFEREN	38	82	87	3	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66845	10.1371/journal.pone.0066845	http://dx.doi.org/10.1371/journal.pone.0066845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825574	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000035
J	Hung, HS; Tang, CM; Lin, CH; Lin, SZ; Chu, MY; Sun, WS; Kao, WC; Hsien-Hsu, H; Huang, CY; Hsu, SH				Hung, Huey-Shan; Tang, Cheng-Ming; Lin, Chien-Hsun; Lin, Shinn-Zong; Chu, Mei-Yun; Sun, Wei-Shen; Kao, Wei-Chien; Hsien-Hsu, Hsieh; Huang, Chih-Yang; Hsu, Shan-hui			Biocompatibility and Favorable Response of Mesenchymal Stem Cells on Fibronectin-Gold Nanocomposites	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ENDOTHELIAL-CELLS; POLYURETHANE NANOCOMPOSITES; IN-VITRO; VASCULAR GRAFTS; NITRIC-OXIDE; MIGRATION; SURFACE; DIFFERENTIATION; ATHEROSCLEROSIS	A simple surface modification method, comprising of a thin coating with gold nanoparticles (AuNPs) and fibronectin (FN), was developed to improve the biocompatibility required for cardiovascular devices. The nanocomposites from FN and AuNPs (FN-Au) were characterized by the atomic force microscopy (AFM), UV-Vis spectrophotometry (UV-Vis), and Fourier transform infrared spectroscopy (FTIR). The biocompatibility of the nanocomposites was evaluated by the response of monocytes and platelets to the material surface in vitro. FN-Au coated surfaces demonstrated low monocyte activation and platelet activation. The behavior of human umbilical cord-derived mesenchymal stem cells (MSCs) on FN-Au was further investigated. MSCs on FN-Au nanocomposites particularly that containing 43.5 ppm of AuNPs (FN-Au 43.5 ppm) showed cell proliferation, low ROS generation, as well as increases in the protein expression levels of matrix metalloproteinase-9 (MMP-9) and endothelial nitric oxide synthase (eNOS), which may account for the enhanced MSC migration on the nanocomposites. These results suggest that the FN-Au nanocomposite thin film coating may serve as a potential and simple solution for the surface modification of blood-contacting devices such as vascular grafts.	[Hung, Huey-Shan; Lin, Chien-Hsun; Chu, Mei-Yun; Sun, Wei-Shen; Kao, Wei-Chien; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hung, Huey-Shan; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Tang, Cheng-Ming] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Hsien-Hsu, Hsieh] Taichung Vet Gen Hosp, Blood Bank, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Rehabil Engn Res Ctr, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; National Taiwan University; National Taiwan University	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw; shhsu@ntu.edu.tw	Yuang, Chih-Yang/O-5111-2015; Lin, Shinn-Zong/AAX-2379-2020	Hsu, Shan-hui/0000-0003-3399-055X	National Science Council [NSC 100-2221-E-039-003]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 100-2221-E-039-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI 10.1016/j.colsurfb.2007.11.015; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Cairns ML, 2010, COLLOID SURFACE B, V78, P283, DOI 10.1016/j.colsurfb.2010.03.013; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058; Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; de Mel A, 2011, CHEM REV, V111, P5742, DOI 10.1021/cr200008n; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Esumi K, 2004, LANGMUIR, V20, P2536, DOI 10.1021/la036299r; Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048; Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050; Ho TT, 2012, GOLD BULL, V45, P161, DOI 10.1007/s13404-012-0062-9; Hsu SH, 2000, ARTIF ORGANS, V24, P119, DOI 10.1046/j.1525-1594.2000.06338.x; Hsu SH, 2008, BIOMACROMOLECULES, V9, P241, DOI 10.1021/bm700471k; Hsu SH, 2006, J BIOMED MATER RES A, V79A, P759, DOI 10.1002/jbm.a.30879; Hsu SH, 2008, ACTA BIOMATER, V4, P1797, DOI 10.1016/j.actbio.2008.06.015; Huang CY, 2013, J MED BIOL ENG, V33, P139, DOI 10.5405/jmbe.1109; Hung HS, 2012, J BIOMED MATER RES A, V100A, P26, DOI 10.1002/jbm.a.33224; Hung HS, 2009, NEW BIOTECHNOL, V25, P235, DOI 10.1016/j.nbt.2009.01.003; Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Middleton CA, 2007, J BIOMED MATER RES A, V83A, P1032, DOI 10.1002/jbm.a.31382; Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318; Miller DC, 2004, EXPERT REV MED DEVIC, V1, P259, DOI 10.1586/17434440.1.2.259; Miller DC, 2007, J BIOMED MATER RES A, V81A, P678, DOI 10.1002/jbm.a.31093; Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983; SOTTILE J, 1994, J BIOL CHEM, V269, P17192; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Zhang Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.37; Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6	49	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65738	10.1371/journal.pone.0065738	http://dx.doi.org/10.1371/journal.pone.0065738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826082	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400004
J	Wang, Y; Qian, GL; Li, YY; Wang, YS; Wang, YL; Wright, S; Li, YZ; Shen, YM; Liu, FQ; Du, LC				Wang, Yan; Qian, Guoliang; Li, Yaoyao; Wang, Yansheng; Wang, Yulan; Wright, Stephen; Li, Yuezhong; Shen, Yuemao; Liu, Fengquan; Du, Liangcheng			Biosynthetic Mechanism for Sunscreens of the Biocontrol Agent Lysobacter enzymogenes	PLOS ONE			English	Article							POLYCYCLIC TETRAMATE MACROLACTAM; IN-VITRO RECONSTITUTION; BIOLOGICAL-CONTROL; FATTY-ACID; POLYKETIDE SYNTHASE; GENE-CLUSTER; ANTIMICROBIAL ACTIVITY; CEPHEM ANTIBIOTICS; BACTERIAL ORIGIN; XANTHOMONADIN	Lysobacter are ubiquitous environmental bacteria emerging as novel biocontrol agents and new sources of anti-infectives. So far, very little effort has been invested in the study of the biology of these Gram-negative gliding bacteria. Many Lysobacter species are characterized by their yellow-orange appearance. Using transposon mutagenesis, we identified a stand-alone polyketide synthase (PKS) gene cluster required for the pigment production in L. enzymogenes OH11. The yellow pigments were abolished in the "white'' mutants generated by target-specific deletions of ketosynthase (KS), acyl carrier protein, or ketoreductase. Spectroscopic data suggested that the pigments belong to xanthomonadin-like aryl polyenes. Polyene-type polyketides are known to be biosynthesized by modular PKS (Type I), not by stand-alone PKS (Type II) which always contain the heterodimer KS-CLF (chain-length factor) as the key catalytic component. Remarkably, this aryl polyene PKS complex only contains the KS (ORF17), but not the CLF. Instead, a hypothetical protein (ORF16) is located immediately next to ORF17. ORF16-17 homologs are widespread in numerous uncharacterized microbial genomes, in which an ORF17 homolog is always accompanied by an ORF16 homolog. The deletion of ORF16 eliminated pigment production, and homology modeling suggested that ORF16 shares a structural similarity to the N-terminal half of CLF. A point-mutation of glutamine (Q166A) that is the conserved active site of known CLF abolished pigment production. The "white'' mutants are significantly more sensitive to UV/visible light radiation or H2O2 treatment than the wild type. These results unveil the first example of Type II PKS-synthesized polyene pigments and show that the metabolites serve as Lysobacter "sunscreens'' that are important for the survival of these ubiquitous environmental organisms.	[Wang, Yan; Wright, Stephen; Du, Liangcheng] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Qian, Guoliang; Wang, Yansheng; Wang, Yulan; Liu, Fengquan] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Yan; Li, Yaoyao; Li, Yuezhong; Shen, Yuemao] Shandong Univ, Coll Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; Nanjing Agricultural University; Shandong University	Liu, FQ (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ldu3@unl.edu; fqliu20011@sina.com	Li, Yaoyao/GRF-4155-2022; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638; Shen, Yuemao/0000-0002-3881-0135; Wang, Yan/0000-0003-4632-5786	National Institutes of Health [R01AI097260]; Nebraska Research Initiatives; Nebraska Research Council; National Natural Science Foundation of China [31028019, 31101478]; National High Technology Research and Development Program of China [2011AA10A205]; Doctoral Fund of Ministry of Education of China [20100097120013]; China Scholarship Council; Postdoctoral Innovation Foundation of Shandong Province [201003070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiatives; Nebraska Research Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Scholarship Council(China Scholarship Council); Postdoctoral Innovation Foundation of Shandong Province; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (R01AI097260), Nebraska Research Initiatives, Nebraska Research Council, National Natural Science Foundation of China (31028019, 31101478), National High Technology Research and Development Program of China (2011AA10A205), and Doctoral Fund of Ministry of Education of China (No. 20100097120013). YW was supported by a Scholarship from China Scholarship Council, and YL was supported by Postdoctoral Innovation Foundation of Shandong Province (201003070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWES AG, 1973, ACTA CHEM SCAND, V27, P2383, DOI 10.3891/acta.chem.scand.27-2383; ANDREWES AG, 1976, TETRAHEDRON LETT, P4023; Aparicio JF, 2000, CHEM BIOL, V7, P895, DOI 10.1016/S1074-5521(00)00038-7; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; Bao WL, 1998, BIOCHEMISTRY-US, V37, P8132, DOI 10.1021/bi980466i; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; BONNER DP, 1988, J ANTIBIOT, V41, P1745, DOI 10.7164/antibiotics.41.1745; Brautaset T, 2000, CHEM BIOL, V7, P395, DOI 10.1016/S1074-5521(00)00120-4; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Carreras CW, 1998, BIOCHEMISTRY-US, V37, P2084, DOI 10.1021/bi972919+; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; CHRISTENSEN P, 1978, INT J SYST BACTERIOL, V28, P367, DOI 10.1099/00207713-28-3-367; Demirev AV, 2006, FEMS MICROBIOL LETT, V255, P121, DOI 10.1111/j.1574-6968.2005.00067.x; Giesler LJ, 1998, CROP PROT, V17, P509, DOI 10.1016/S0261-2194(98)00049-0; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Harada K, 2001, J CHROMATOGR A, V932, P75, DOI 10.1016/S0021-9673(01)01235-3; HARADA S, 1984, J ANTIBIOT, V37, P1536, DOI 10.7164/antibiotics.37.1536; Hashizume H, 2004, J ANTIBIOT, V57, P52, DOI 10.7164/antibiotics.57.52; Hashizume H, 2001, J ANTIBIOT, V54, P1054, DOI 10.7164/antibiotics.54.1054; He YW, 2011, MOL PLANT MICROBE IN, V24, P948, DOI 10.1094/MPMI-02-11-0031; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Hou J, 2011, CHEM BIOL, V18, P655, DOI 10.1016/j.chembiol.2011.02.012; Ishikawa F, 2012, J AM CHEM SOC, V134, P769, DOI 10.1021/ja2082334; Kato A, 1998, J ANTIBIOT, V51, P929, DOI 10.7164/antibiotics.51.929; Kato A, 1997, J AM CHEM SOC, V119, P6680, DOI 10.1021/ja970895o; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Kobayashi DY, 2005, CAN J MICROBIOL, V51, P719, DOI 10.1139/W05-056; Kobayashi DY, 2005, APPL ENVIRON MICROB, V71, P261, DOI 10.1128/AEM.71.1.261-269.2005; Li S, 2008, PHYTOPATHOLOGY, V98, P695, DOI 10.1094/PHYTO-98-6-0695; Li SJ, 2009, J EUKARYOT MICROBIOL, V56, P182, DOI 10.1111/j.1550-7408.2008.00384.x; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Li YY, 2012, MEDCHEMCOMM, V3, P982, DOI 10.1039/c2md20026k; Lou LL, 2012, BIOCHEMISTRY-US, V51, P4, DOI 10.1021/bi2015025; Lou LL, 2011, J AM CHEM SOC, V133, P643, DOI 10.1021/ja105732c; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; Meiser P, 2008, CHEM BIOL, V15, P771, DOI 10.1016/j.chembiol.2008.06.005; Nett M, 2007, NAT PROD REP, V24, P1245, DOI 10.1039/b612668p; ONO H, 1984, J ANTIBIOT, V37, P1528, DOI 10.7164/antibiotics.37.1528; OSULLIVAN J, 1988, J ANTIBIOT, V41, P1740, DOI 10.7164/antibiotics.41.1740; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Pirri G, 2009, CENT EUR J BIOL, V4, P258, DOI 10.2478/s11535-009-0031-3; Poplawsky AR, 2005, MOL PLANT PATHOL, V6, P653, DOI 10.1111/J.1364-3703.2005.00307.X; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; Qian GL, 2009, AGR SCI CHINA, V8, P68, DOI 10.1016/S1671-2927(09)60010-9; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Rajgarhia VB, 1997, J BACTERIOL, V179, P2690, DOI 10.1128/jb.179.8.2690-2696.1997; Reichenbach H, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P939, DOI 10.1007/0-387-30746-x_37; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seon LJ, 2008, J MICROBIOL BIOTECHN, V18, P427; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sohn YS, 2001, METAB ENG, V3, P380, DOI 10.1006/mben.2001.0200; STARR MP, 1964, J BACTERIOL, V87, P293, DOI 10.1128/JB.87.2.293-302.1964; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Sullivan RF, 2003, J APPL MICROBIOL, V94, P1079, DOI 10.1046/j.1365-2672.2003.01932.x; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Xie YX, 2012, NAT PROD REP, V29, P1277, DOI 10.1039/c2np20064c; Yu FG, 2007, ANTIMICROB AGENTS CH, V51, P64, DOI 10.1128/AAC.00931-06; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Yuen G. Y., 2001, International Turfgrass Society Research Journal, V9, P742; Yuen GY, 2001, CROP PROT, V20, P395, DOI 10.1016/S0261-2194(00)00154-X; Yuen GY, 2007, PLANT DIS MANAG REP, V1; Zhang W, 2011, ANTIMICROB AGENTS CH, V55, P5581, DOI 10.1128/AAC.05370-11; Zhang Z, 1999, PHYTOPATHOLOGY, V89, P817, DOI 10.1094/PHYTO.1999.89.9.817	63	31	32	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66633	10.1371/journal.pone.0066633	http://dx.doi.org/10.1371/journal.pone.0066633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826105	Green Published, gold			2022-12-25	WOS:000321738400025
J	Chen, Y; Fan, JX; Zhang, ZL; Wang, G; Cheng, X; Chuai, ML; Lee, KKH; Yang, XS				Chen, Yao; Fan, Jian-xia; Zhang, Zhao-long; Wang, Guang; Cheng, Xin; Chuai, Manli; Lee, Kenneth Ka Ho; Yang, Xuesong			The Negative Influence of High-Glucose Ambience on Neurogenesis in Developing Quail Embryos	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; OXIDATIVE STRESS; VITAMIN-C; DIABETES-MELLITUS; POLYOL PATHWAY; CREST CELLS; IN-VITRO; MOUSE; CHICK; RAT	Gestational diabetes is defined as glucose intolerance during pregnancy and it is presented as high blood glucose levels during the onset pregnancy. This condition has an adverse impact on fetal development but the mechanism involved is still not fully understood. In this study, we investigated the effects of high glucose on the developing quail embryo, especially its impact on the development of the nervous system. We established that high glucose altered the central nervous system mophologically, such that neural tube defects (NTDs) developed. In addition, we found that high glucose impaired nerve differentiation at dorsal root ganglia and in the developing limb buds, as revealed by neurofilament (NF) immunofluorescent staining. The dorsal root ganglia are normally derived from neural crest cells (NCCs), so we examine the delamination of NCCs from dorsal side of the neural tube. We established that high glucose was detrimental to the NCCs, in vivo and in vitro. High glucose also negatively affected neural differentiation by reducing the number and length of neurites emanating from neurons in culture. We established that high glucose exposure caused an increase in reactive oxidative species (ROS) generation by primary cultured neurons. We hypothesized that excess ROS was the factor responsible for impairing neuron development and differentiation. We provided evidence for our hypothesis by showing that the addition of vitamin C (a powerful antioxidant) could rescue the damaging effects of high glucose on cultured neurons.	[Chen, Yao; Zhang, Zhao-long; Wang, Guang; Cheng, Xin; Yang, Xuesong] Jinan Univ, Div Histol & Embryol, Coll Med, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China; [Fan, Jian-xia] Shanghai Jiao Tong Univ, Sch Med, Dept Gynecol & Obstet, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China; [Chuai, Manli] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland; [Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China; [Yang, Xuesong] Jinan Univ, Inst Fetal Preterm Labor Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Shanghai Jiao Tong University; University of Dundee; Chinese University of Hong Kong; Jinan University	Lee, KKH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China.	kaholee@cuhk.edu.hk; yang_xuesong@126.com	Wang, Guang/AAC-4624-2019; Lee, Kenneth Ka Ho/H-6698-2013	Lee, Kenneth Ka Ho/0000-0002-6520-304X	NSFC [31071054, 30971493]; "973 Project'' [2010CB529702]	NSFC(National Natural Science Foundation of China (NSFC)); "973 Project''(National Basic Research Program of China)	This study was supported by NSFC grant (31071054); "973 Project'' (2010CB529702) and NSFC grant (30971493) to X Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpak YK, 2012, MED GLAS, V9, P262; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bate M, 1999, CURR OPIN NEUROBIOL, V9, P670, DOI 10.1016/S0959-4388(99)00031-8; Betancor MB, 2012, LIPIDS, V47, P1193, DOI 10.1007/s11745-012-3730-x; BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775; Cheng X, 2012, NEUROTOXICOLOGY, V33, P1239, DOI 10.1016/j.neuro.2012.07.005; Cheng Y, 2000, J CELL SCI, V113, P3161; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; Datar Savita, 2005, Rev Diabet Stud, V2, P221, DOI 10.1900/RDS.2005.2.221; Desoye G, 2002, J Matern Fetal Neonatal Med, V11, P258, DOI 10.1080/713605520; Doblado Manuel, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P488, DOI 10.1097/MED.0b013e3282f1cb92; Etchevers H, 2011, NAT PROTOC, V6, P1568, DOI 10.1038/nprot.2011.398; GOLDENBERG H, 1994, J BIOENERG BIOMEMBR, V26, P359, DOI 10.1007/BF00762776; Hadden DR, 2008, DIABETIC MED, V25, P1, DOI [10.1111/j.1464-5491.2008.02387.x, 10.1111/j.1464-5491.2007.02331.x]; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Kanwar YS, 2005, PEDIATR NEPHROL, V20, P858, DOI 10.1007/s00467-005-1888-7; Kuan CYK, 2004, MECH DEVELOP, V121, P1055, DOI 10.1016/j.mod.2004.05.001; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Leal EC, 2009, EXP EYE RES, V88, P983, DOI 10.1016/j.exer.2008.12.010; Ma ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034278; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MOASE CE, 1992, J MED GENET, V29, P145, DOI 10.1136/jmg.29.3.145; Morgan SC, 2008, BIRTH DEFECTS RES A, V82, P453, DOI 10.1002/bdra.20457; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; Ruhrberg C, 2010, CELL ADHES MIGR, V4, P622, DOI 10.4161/cam.4.4.13502; Schwarz Q, 2009, DEVELOPMENT, V136, P1785, DOI 10.1242/dev.034322; Siman CM, 1997, DIABETOLOGIA, V40, P1416, DOI 10.1007/s001250050844; Tonge DA, 2004, DEV BIOL, V265, P169, DOI 10.1016/j.ydbio.2003.09.016; Wada H, 1997, DEV BIOL, V187, P240, DOI 10.1006/dbio.1997.8626; Wentzel P, 2005, DIABETES, V54, P546, DOI 10.2337/diabetes.54.2.546; Wentzel P, 2011, BIRTH DEFECTS RES B, V92, P487, DOI 10.1002/bdrb.20321; Wikstrom AK, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.024; Zou Yan, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P139	37	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66646	10.1371/journal.pone.0066646	http://dx.doi.org/10.1371/journal.pone.0066646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818954	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800090
J	Giannandrea, M; Guarnieri, FC; Gehring, NH; Monzani, E; Benfenati, F; Kulozik, AE; Valtorta, F				Giannandrea, Maila; Guarnieri, Fabrizia C.; Gehring, Niels H.; Monzani, Elena; Benfenati, Fabio; Kulozik, Andreas E.; Valtorta, Flavia			Nonsense-Mediated mRNA Decay and Loss-of-Function of the Protein Underlie the X-Linked Epilepsy Associated with the W356x Mutation in Synapsin I	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; I/II/III KNOCKOUT MICE; HIPPOCAMPAL-NEURONS; INHIBITORY SYNAPSES; DEFICIENT MICE; OUT MICE; DOMAIN E; F-ACTIN; PHOSPHORYLATION; IMPAIRMENT	Synapsins are a family of neuronal phosphoproteins associated with the cytosolic surface of synaptic vesicles. Experimental evidence suggests a role for synapsins in synaptic vesicle clustering and recycling at the presynaptic terminal, as well as in neuronal development and synaptogenesis. Synapsin knock-out (Syn1(-/-)) mice display an epileptic phenotype and mutations in the SYN1 gene have been identified in individuals affected by epilepsy and/or autism spectrum disorder. We investigated the impact of the c. 1067G>A nonsense transition, the first mutation described in a family affected by X-linked syndromic epilepsy, on the expression and functional properties of the synapsin I protein. We found that the presence of a premature termination codon in the human SYN1 transcript renders it susceptible to nonsense-mediated mRNA decay (NMD). Given that the NMD efficiency is highly variable among individuals and cell types, we investigated also the effects of expression of the mutant protein and found that it is expressed at lower levels compared to wild-type synapsin I, forms perinuclear aggregates and is unable to reach presynaptic terminals in mature hippocampal neurons grown in culture. Taken together, these data indicate that in patients carrying the W356x mutation the function of synapsin I is markedly impaired, due to both the strongly decreased translation and the altered function of the NMD-escaped protein, and support the value of Syn1(-/-) mice as an experimental model mimicking the human pathology.	[Giannandrea, Maila; Guarnieri, Fabrizia C.; Monzani, Elena; Valtorta, Flavia] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Giannandrea, Maila; Guarnieri, Fabrizia C.; Monzani, Elena; Valtorta, Flavia] Univ Vita Salute San Raffaele, Milan, Italy; [Gehring, Niels H.] Univ Cologne, Inst Genet, Cologne, Germany; [Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Benfenati, Fabio] Univ Genoa, Dept Expt Med, Genoa, Italy; [Kulozik, Andreas E.] Heidelberg Univ, Med Ctr, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Kulozik, Andreas E.] EMBL, Mol Med Partnership Unit, Heidelberg, Germany; [Kulozik, Andreas E.] Heidelberg Univ, Heidelberg, Germany	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Cologne; Istituto Italiano di Tecnologia - IIT; University of Genoa; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Valtorta, F (corresponding author), Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.	valtorta.flavia@hsr.it	Kulozik, Andreas/AAO-2432-2020; Guarnieri, Fabrizia Claudia/AAN-2483-2020; Monzani, Elena/AAN-2505-2020; Flavia, Valtorta/F-3450-2012	Guarnieri, Fabrizia Claudia/0000-0002-9589-4662; Flavia, Valtorta/0000-0001-9556-4746	Italian Ministry of University and Research (PRIN); Jerome Lejeune Foundation; Telethon-Italy [GGP09134]	Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Jerome Lejeune Foundation; Telethon-Italy(Fondazione Telethon)	This work was supported by research grants from the Italian Ministry of University and Research (PRIN to FB and FV; http://prin.miur.it/) and the Jerome Lejeune Foundation (to FV; http://www.fondationlejeune.org/). The support of Telethon-Italy (grant GGP09134 to FB and FV; http://www.telethon.it/) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NEURON; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BAITINGER C, 1987, J NEUROSCI, V7, P3723; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bogen IL, 2009, NEUROSCIENCE, V158, P231, DOI 10.1016/j.neuroscience.2008.05.055; Boido D, 2010, NEUROSCIENCE, V171, P268, DOI 10.1016/j.neuroscience.2010.08.046; Brautigam CA, 2004, J BIOL CHEM, V279, P11948, DOI 10.1074/jbc.M312015200; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cambiaghi M, 2013, EPILEPSY RES, V103, P153, DOI 10.1016/j.eplepsyres.2012.07.012; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Cheetham JJ, 2001, BIOCHEM J, V354, P57, DOI 10.1042/0264-6021:3540057; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; Etholm L, 2011, BRAIN RES, V1383, P270, DOI 10.1016/j.brainres.2011.01.070; Farisello P, 2013, CEREB CORTEX, V23, P581, DOI 10.1093/cercor/bhs041; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Fornasiero EF, 2012, J NEUROSCI, V32, P12214, DOI 10.1523/JNEUROSCI.1554-12.2012; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Greco B, 2013, BEHAV BRAIN RES, V251, P65, DOI 10.1016/j.bbr.2012.12.015; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hurley SL, 2004, BIOCHEM BIOPH RES CO, V317, P16, DOI 10.1016/j.bbrc.2004.03.008; Janz R, 1999, NEURON, V24; Josefsen K, 2011, METHODS MOL BIOL, V703, P87, DOI 10.1007/978-1-59745-248-9_7; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Ketzef M, 2011, NEUROSCIENCE, V189, P108, DOI 10.1016/j.neuroscience.2011.05.030; Kingston Robert E, 2003, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2003s19; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakhan R, 2010, SYNAPSE, V64, P403, DOI 10.1002/syn.20740; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lignani G, 2013, HUM MOL GEN IN PRESS; Lotti F, 2002, J VIROL, V76, P3996, DOI 10.1128/JVI.76.8.3996-4007.2002; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Monaldi I, 2010, BIOCHEM J, V426, P55, DOI 10.1042/BJ20090762; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Neu-Yilik G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-218; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Nicita F, 2012, SEIZURE-EUR J EPILEP, V21, P3, DOI 10.1016/j.seizure.2011.08.007; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Orenbuch A, 2012, J NEUROSCI, V32, P3969, DOI 10.1523/JNEUROSCI.5058-11.2012; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; PETRUCCI TC, 1991, BIOCHEMISTRY-US, V30, P413, DOI 10.1021/bi00216a016; Rees MI, 2010, SEIZURE-EUR J EPILEP, V19, P680, DOI 10.1016/j.seizure.2010.10.029; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Turnbull J, 2005, HUM MOL GENET, V14, P2491, DOI 10.1093/hmg/ddi250; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3	69	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67724	10.1371/journal.pone.0067724	http://dx.doi.org/10.1371/journal.pone.0067724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818987	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800144
J	Ou, DL; Lee, BS; Chang, YC; Lin, LI; Liou, JY; Hsu, C; Cheng, AL				Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi; Lin, Liang-In; Liou, Jun-Yang; Hsu, Chiun; Cheng, Ann-Lii			Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway	PLOS ONE			English	Article							FACTOR-I RECEPTOR; ANTITUMOR-ACTIVITY; HUMAN HEPATOMA; PROSTATE-CANCER; FACTOR AXIS; IGF-I; RESISTANCE; KINASE; TRANSCRIPTION; ACTIVATION	Insulin-like growth factor (IGF) signaling pathway is an important regulatory mechanism of tumorigenesis and drug resistance in many cancers. The present study explored the potential synergistic effects between IGF receptor (IGFR) inhibition and other molecular targeted agents (MTA) in HCC cells. HCC cell lines (Hep3B, PLC5, and SK-Hep1) and HUVECs were tested. The MTA tested included sorafenib, sunitinib, and the IGFR kinase inhibitor NVP-AEW541. The potential synergistic antitumor effects were tested by median dose effect analysis and apoptosis assay in vitro and by xenograft models in vivo. The activity and functional significance of pertinent signaling pathways and expression of apoptosis-related proteins were measured by RNA interference and Western blotting. We found that IGF can activate IGFR and downstream AKT signaling activities in all the HCC cells tested, but the growth-stimulating effect of IGF was most prominent in Hep3B cells. NVP-AEW541 can abrogate IGF-induced activation of IGFR and AKT signaling in HCC cells. IGF can increase the resistance of HCC cells to sunitinib. The apoptosis-inducing effects of sunitinib, but not sorafenib, were enhanced when IGFR signaling activity was inhibited by NVP-AEW541 or IGFR knockdown. Chk2 kinase activation was found contributory to the synergistic anti-tumor effects between sunitinib and IGFR inhibition. Our data indicate that the apoptosis-potentiating effects of IGFR inhibition for HCC may be drug-specific. Combination therapy of IGFR inhibitors with other MTA may improve the therapeutic efficacy in HCC.	[Ou, Da-Liang; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lee, Bin-Shyun; Chang, Ya-Chi; Hsu, Chiun; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lin, Liang-In] Natl Taiwan Univ Hosp, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan; [Hsu, Chiun; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Toxicol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsu, C (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	hsuchiun@gmail.com	Liou, Jun-Yang/B-1065-2010; Lin, Liang-In/K-4600-2019	LIN, LIANG-IN/0000-0002-3561-1093; OU, DA-LIANG/0000-0002-8368-1141; Cheng, Ann-Lii/0000-0002-9152-6512; Hsu, Chiun/0000-0002-1122-0055	Department of Health, Taiwan [DOH99-TD-B-111-001, DOH100-TD-B-111-001]; National Health Research Institute, Taiwan [NHRI-EX99-9911BC, NHRI-EX100-10011BC]	Department of Health, Taiwan; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants DOH99-TD-B-111-001, DOH100-TD-B-111-001 from the Department of Health, Taiwan; NHRI-EX99-9911BC, NHRI-EX100-10011BC from the National Health Research Institute, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4043; Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Faivre S, 2011, J CLIN ONCOL S4, V29; Floc'h N, 2012, CANCER RES, V72, P4483, DOI 10.1158/0008-5472.CAN-12-0283; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao J, 2012, CANCER RES, V72, P3, DOI 10.1158/0008-5472.CAN-11-0550; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kim SO, 1996, CANCER RES, V56, P3831; Lee OH, 2000, BRIT J CANCER, V82, P385; Lee YI, 1998, ONCOGENE, V16, P2367, DOI 10.1038/sj.onc.1201760; Lee YI, 2000, ONCOGENE, V19, P3717, DOI 10.1038/sj.onc.1203694; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Maloney EK, 2003, CANCER RES, V63, P5073; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Ou DL, 2009, CLIN CANCER RES, V15, P5820, DOI 10.1158/1078-0432.CCR-08-3294; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Scharf JG, 1998, CARCINOGENESIS, V19, P2121, DOI 10.1093/carcin/19.12.2121; SELL C, 1995, CANCER RES, V55, P303; Shao YY, 2012, ANTICANCER RES, V32, P4865; Shen YC, 2010, J GASTROENTEROL, V45, P794, DOI 10.1007/s00535-010-0270-0; Squatrito M, 2011, CANCER RES, V71, P5945, DOI 10.1158/0008-5472.CAN-11-1245; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Tai WT, 2011, J HEPATOL, V55, P1041, DOI 10.1016/j.jhep.2011.06.005; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; TSAI TF, 1988, BIOCHEM BIOPH RES CO, V153, P39, DOI 10.1016/S0006-291X(88)81186-0; Yao XM, 2003, CLIN CANCER RES, V9, P2719	42	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66589	10.1371/journal.pone.0066589	http://dx.doi.org/10.1371/journal.pone.0066589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818948	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800084
J	Belo, AI; van der Sar, AM; Tefsen, B; van Die, I				Belo, Ana I.; van der Sar, Astrid M.; Tefsen, Boris; van Die, Irma			Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells	PLOS ONE			English	Article							TUMOR PROGRESSION; N-GLYCANS; IN-VIVO; EXPRESSION; ZEBRAFISH; CARCINOMA; GENES; ADHESION; BEHAVIOR; LECTINS	Galectin-4 (Gal-4) is a member of the galectin family of glycan binding proteins that shows a significantly higher expression in cystic tumors of the human pancreas and in pancreatic adenocarcinomas compared to normal pancreas. However, the putative function of Gal-4 in tumor progression of pancreatic cancer is still incompletely understood. In this study the role of Gal-4 in cancer progression was investigated, using a set of defined pancreatic cancer cell lines, Pa-Tu-8988S (PaTu-S) and Pa-Tu-8988T (PaTu-T), as a model. These two cell lines are derived from the same liver metastasis of a human primary pancreatic adenocarcinoma, but differ in their growth characteristics and metastatic capacity. We demonstrated that Gal-4 expression is high in PaTu-S, which shows poor migratory properties, whereas much lower Gal-4 levels are observed in the highly metastatic cell line PaTu-T. In PaTu-S, Gal-4 is found in the cytoplasm, but it is also secreted and accumulates at the membrane at sites of contact with neighboring cells. Moreover, we show that Gal-4 inhibits metastasis formation by delaying migration of pancreatic cancer cells in vitro using a scratch assay, and in vivo using zebrafish (Danio rerio) as an experimental model. Our data suggest that Gal-4 may act at the cell-surface of PaTu-S as an adhesion molecule to prevent release of the tumor cells, but has in addition a cytosolic function by inhibiting migration via a yet unknown mechanism.	[Belo, Ana I.; Tefsen, Boris; van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [van der Sar, Astrid M.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Die, I (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	im.vandie@vumc.nl	Tefsen, Boris/J-1503-2012; van der Sar, Astrid M/A-3698-2008	Tefsen, Boris/0000-0001-6668-217X; van der Sar, Astrid M/0000-0001-5790-5036	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [SFRH/BD/44820/2008]	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This study was funded by Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grants SFRH/BD/44820/2008 awarded to AIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Bauer A, 2009, PANCREATOLOGY, V9, P34, DOI 10.1159/000178873; Brandt B, 2008, HISTOCHEM CELL BIOL, V129, P599, DOI 10.1007/s00418-008-0395-x; CHIU ML, 1992, J CELL BIOL, V119, P1689, DOI 10.1083/jcb.119.6.1689; CHIU ML, 1994, J BIOL CHEM, V269, P31770; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Cummings R.D., 2009, ANTIBODIES LECTINS G; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; DAVIDSON AJ, 2004, INFLAMMATORY BOWEL D; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Duerr EM, 2008, ENDOCR-RELAT CANCER, V15, P243, DOI 10.1677/ERC-07-0194; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Garcia-Vallejo Juan J., 2006, V347, P187; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Granato M, 1996, CURR OPIN GENET DEV, V6, P461, DOI 10.1016/S0959-437X(96)80068-2; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Heinzelmann-Schwarz VA, 2007, J CLIN PATHOL, V60, P622, DOI 10.1136/jcp.2005.034223; Hippo Y, 2001, CANCER RES, V61, P889; Horiguchi N, 2003, J BIOCHEM, V134, P869, DOI 10.1093/jb/mvg213; Huflejt ME, 2003, GLYCOCONJUGATE J, V20, P247, DOI 10.1023/B:GLYC.0000025819.54723.a0; Huflejt ME, 1997, J BIOL CHEM, V272, P14294, DOI 10.1074/jbc.272.22.14294; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Kondoh N, 1999, CANCER RES, V59, P4990; Krejs GJ, 2010, DIGEST DIS, V28, P355, DOI 10.1159/000319414; Langbein S, 2007, HISTOPATHOLOGY, V51, P681, DOI 10.1111/j.1365-2559.2007.02852.x; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lee S, 2006, ONCOL REP, V16, P747; Li M, 2010, J BIOSCIENCES, V35, P665, DOI 10.1007/s12038-010-0073-8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Morelle W, 2009, BIOL CHEM, V390, P529, DOI 10.1515/BC.2009.075; Nakahara S, 2008, ANTI-CANCER AGENT ME, V8, P22; Paclik D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002629; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Rapoport EM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P393, DOI 10.1134/S0006297908040032; Rechreche H, 1997, EUR J BIOCHEM, V248, P225, DOI 10.1111/j.1432-1033.1997.00225.x; Rumilla KM, 2006, ENDOCR PATHOL, V17, P243, DOI 10.1385/EP:17:3:243; Salatino M, 2011, METHODS MOL BIOL, V677, P355, DOI 10.1007/978-1-60761-869-0_23; Satelli A, 2011, INT J CANC, pn/a; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Sison M, 2006, LAB ANIMAL, V35, P33, DOI 10.1038/laban0506-33; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Thiemann S, 2011, J CLIN IMMUNOL, V31, P2, DOI 10.1007/s10875-010-9460-z; Tripodi D, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-65; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wu HQ, 2011, WORLD J GASTROENTERO, V17, P996, DOI 10.3748/wjg.v17.i8.996; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719	59	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65957	10.1371/journal.pone.0065957	http://dx.doi.org/10.1371/journal.pone.0065957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824659	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400039
J	Hamp, T; Goldberg, T; Rost, B				Hamp, Tobias; Goldberg, Tatyana; Rost, Burkhard			Accelerating the Original Profile Kernel	PLOS ONE			English	Article							REMOTE HOMOLOGY DETECTION; STRING KERNELS; PROTEIN; FOLD; PREDICTION; TOOL	One of the most accurate multi-class protein classification systems continues to be the profile-based SVM kernel introduced by the Leslie group. Unfortunately, its CPU requirements render it too slow for practical applications of large-scale classification tasks. Here, we introduce several software improvements that enable significant acceleration. Using various non-redundant data sets, we demonstrate that our new implementation reaches a maximal speed-up as high as 14-fold for calculating the same kernel matrix. Some predictions are over 200 times faster and render the kernel as possibly the top contender in a low ratio of speed/performance. Additionally, we explain how to parallelize various computations and provide an integrative program that reduces creating a production-quality classifier to a single program call. The new implementation is available as a Debian package under a free academic license and does not depend on commercial software. For non-Debian based distributions, the source package ships with a traditional Makefile-based installer. Download and installation instructions can be found at https://rostlab.org/owiki/index.php/Fast_Profile_Kernel. Bugs and other issues may be reported at https://rostlab.org/bugzilla3/enter_bug.cgi?product=fastprofkernel.	[Hamp, Tobias; Goldberg, Tatyana; Rost, Burkhard] Tech Univ Munich, Dept Informat, Garching, Germany; [Goldberg, Tatyana] Tech Univ Munich, Grad Sch, Ctr Doctoral Studies Informat & Its Applicat CeDo, Garching, Germany; [Rost, Burkhard] Inst Adv Study TUM IAS, Garching, Germany; [Rost, Burkhard] Columbia Univ, New York Consortium Membrane Prot Struct NYCOMPS, New York, NY USA; [Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	Technical University of Munich; Technical University of Munich; Columbia University; Columbia University	Rost, B (corresponding author), Tech Univ Munich, Dept Informat, Garching, Germany.	rost@in.tum.de	Rost, Burkhard/A-1908-2016	Rost, Burkhard/0000-0003-0179-8424	Alexander von Humboldt foundation through the German Ministry for Research and Education (BMBF: Bundesministerium fuer Bildung und Forschung	Alexander von Humboldt foundation through the German Ministry for Research and Education (BMBF: Bundesministerium fuer Bildung und Forschung	This work was supported by a grant from the Alexander von Humboldt foundation (www.avh.de) through the German Ministry for Research and Education (BMBF: Bundesministerium fuer Bildung und Forschung; www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hamp T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S7; Hamp T, 2011, BIOINFORMATICS, V27, P204, DOI 10.1093/bioinformatics/btq618; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Kuang Rui, 2005, Journal of Bioinformatics and Computational Biology, V3, P527, DOI 10.1142/S021972000500120X; Leslie Christina, 2002, Pac Symp Biocomput, P564; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liu B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-510; Mak MW, 2008, IEEE ACM T COMPUT BI, V5, P416, DOI 10.1109/TCBB.2007.70256; Melvin I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S2; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Thanh N., 2009, P 13 INT EL C SYNTH, P1, DOI DOI 10.3390/ECSOC-13-00231; Toussaint NC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S7; Weston J, 2005, BIOINFORMATICS, V21, P3241, DOI 10.1093/bioinformatics/bti497	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68459	10.1371/journal.pone.0068459	http://dx.doi.org/10.1371/journal.pone.0068459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825697	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400196
J	Mitin, N; Rossman, KL; Currin, R; Anne, S; Marshall, TW; Bear, JE; Bautch, VL; Der, CJ				Mitin, Natalia; Rossman, Kent L.; Currin, Rachel; Anne, Sandeep; Marshall, Thomas W.; Bear, James E.; Bautch, Victoria L.; Der, Channing J.			The RhoGEF TEM4 Regulates Endothelial Cell Migration by Suppressing Actomyosin Contractility	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; EMBRYONIC STEM-CELLS; NUCLEOTIDE-EXCHANGE FACTORS; BINDING PROTEIN RHO; ACTIN STRESS FIBERS; FOCAL ADHESIONS; VASCULAR DEVELOPMENT; FLUORESCENT PROTEIN; ALPHA-ACTININ; LEADING-EDGE	Persistent cellular migration requires efficient protrusion of the front of the cell, the leading edge where the actin cytoskeleton and cell-substrate adhesions undergo constant rearrangement. Rho family GTPases are essential regulators of the actin cytoskeleton and cell adhesion dynamics. Here, we examined the role of the RhoGEF TEM4, an activator of Rho family GTPases, in regulating cellular migration of endothelial cells. We found that TEM4 promotes the persistence of cellular migration by regulating the architecture of actin stress fibers and cell-substrate adhesions in protruding membranes. Furthermore, we determined that TEM4 regulates cellular migration by signaling to RhoC as suppression of RhoC expression recapitulated the loss-of-TEM4 phenotypes, and RhoC activation was impaired in TEM4-depleted cells. Finally, we showed that TEM4 and RhoC antagonize myosin II-dependent cellular contractility and the suppression of myosin II activity rescued the persistence of cellular migration of TEM4-depleted cells. Our data implicate TEM4 as an essential regulator of the actin cytoskeleton that ensures proper membrane protrusion at the leading edge of migrating cells and efficient cellular migration via suppression of actomyosin contractility.	[Mitin, Natalia; Rossman, Kent L.; Currin, Rachel; Anne, Sandeep; Bear, James E.; Bautch, Victoria L.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mitin, Natalia; Rossman, Kent L.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Marshall, Thomas W.; Bear, James E.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Bear, James E.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mitin, N (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	natalia_mitin@med.unc.edu		Der, Channing/0000-0002-7751-2747	NIH GI SPORE Developmental Research grant [CA106991]; NIH [CA129610, CA67771, GM083035]	NIH GI SPORE Developmental Research grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by an NIH GI SPORE Developmental Research grant (CA106991) and grants from the NIH (CA129610, CA67771, and GM083035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bautch V L, 2002, Methods Mol Biol, V185, P117; Bautch VL, 2007, CURR PROTOC CELL BIO; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; HEATH JP, 1981, CELL BIOL INT REP, V5, P975, DOI 10.1016/0309-1651(81)90214-9; Ho TTG, 2011, MOL BIOL CELL, V22, P3263, DOI 10.1091/mbc.E11-01-0020; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Isogai M, 2011, BIOORG MED CHEM LETT, V21, P3021, DOI 10.1016/j.bmcl.2011.03.039; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kearney JB, 2003, METHOD ENZYMOL, V365, P83; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Mitin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041876; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Rylova SN, 2008, METHOD ENZYMOL, V443, P103, DOI 10.1016/S0076-6879(08)02006-5; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; St Croix B, 2000, SCIENCE, V289, P1197; Tian MY, 2011, FEBS LETT, V585, P2199, DOI 10.1016/j.febslet.2011.06.016; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; VERNON RB, 1995, IN VITRO CELL DEV-AN, V31, P120; VERNON RB, 1995, AM J PATHOL, V147, P873; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; WANG R, 1992, DEVELOPMENT, V114, P303; Warshaw G, 2013, J BIOL CHEM; WILES MV, 1991, DEVELOPMENT, V111, P259; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zamir E, 2001, J CELL SCI, V114, P3583	78	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66260	10.1371/journal.pone.0066260	http://dx.doi.org/10.1371/journal.pone.0066260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825001	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400072
J	Solberg, R; Escobar, J; Arduini, A; Torres-Cuevas, I; Lahoz, A; Sastre, J; Saugstad, OD; Vento, M; Kuligowski, J; Quintas, G				Solberg, Ronnaug; Escobar, Javier; Arduini, Alessandro; Torres-Cuevas, Isabel; Lahoz, Agustin; Sastre, Juan; Saugstad, Ola Didrik; Vento, Maximo; Kuligowski, Julia; Quintas, Guillermo			Metabolomic Analysis of the Effect of Postnatal Hypoxia on the Retina in a Newly Born Piglet Model	PLOS ONE			English	Article							CDP-CHOLINE; BRAIN; RESUSCITATION; GLUTATHIONE; PLASMA; DAMAGE	The availability of reliable biomarkers of brain injury secondary to birth asphyxia could substantially improve clinical grading, therapeutic intervention strategies, and prognosis. In this study, changes in the metabolome of retinal tissue caused by profound hypoxia in an established neonatal piglet model were investigated using an ultra performance liquid chromatography - quadrupole time of flight mass spectrometry (UPLC-QTOFMS) untargeted metabolomic approach, which included Partial Least Squares - Discriminant Analysis (PLSDA) multivariate data analysis. The initial identification of a set of discriminant metabolites from UPLC-QTOFMS data was confirmed by target UPLC-MS/MS and allowed the selection of endogenous CDP-choline as a promising candidate biomarker for hypoxia-derived brain damage assessing intensity of retinal hypoxia. Results from this study will foster further research on CDP-choline changes occurring during resuscitation.	[Solberg, Ronnaug; Saugstad, Ola Didrik] Univ Oslo, Rikshosp, Inst Surg Res, Dept Pediat Res,Oslo Univ Hosp, N-0027 Oslo, Norway; [Escobar, Javier; Torres-Cuevas, Isabel; Vento, Maximo; Kuligowski, Julia] Hosp La Fe, Hlth Res Inst, Neonatal Res Grp, E-46009 Valencia, Spain; [Arduini, Alessandro; Sastre, Juan] Univ Valencia, Fac Pharm, Dept Physiol, Valencia, Spain; [Lahoz, Agustin] Hosp La Fe, Hlth Res Inst, E-46009 Valencia, Spain; [Vento, Maximo] Univ & Polytech Hosp La Fe, Div Neonatol, Valencia, Spain; [Quintas, Guillermo] Leitat Technol Ctr, Bio In Vitro Div, Barcelona, Spain	University of Oslo; National Hospital Norway; Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitari i Politecnic La Fe	Quintas, G (corresponding author), Leitat Technol Ctr, Bio In Vitro Div, Barcelona, Spain.	guira@uv.es	Quintas, Guillermo/AAS-1138-2020; Vento, Maximo/F-3596-2015; Torres-Cuevas, Isabel/T-8140-2017; Quintas, Guillermo/G-8953-2017; Lahoz, Agustin/B-8048-2014; Kuligowski, Julia/M-3285-2017; Saugstad, Ola/AAS-9041-2021	Quintas, Guillermo/0000-0002-4240-9846; Vento, Maximo/0000-0003-0061-4742; Torres-Cuevas, Isabel/0000-0002-8098-1106; Lahoz, Agustin/0000-0001-7232-0626; Kuligowski, Julia/0000-0001-6979-2235; Saugstad, Ola/0000-0002-3166-5254; Arduini, Alessandro/0000-0002-0038-8741; Escobar, Javier/0000-0002-5044-991X	Miguel Servet grant [CP08/00125]; Instituto Carlos III (Ministry of Economy and Competitiveness, Spain) [FISPI11/02942]; Instituto Carlos III [FISPI11/0313]; Ministry of Economy and Competitiveness [SAF2012-39948]; South-Eastern Norway Regional Health Authority;  [CD11/00154];  [CD12/00667];  [PFIS FI12/00109]	Miguel Servet grant; Instituto Carlos III (Ministry of Economy and Competitiveness, Spain); Instituto Carlos III(Instituto de Salud Carlos III); Ministry of Economy and Competitiveness; South-Eastern Norway Regional Health Authority; ; ; 	JE, JK and ITC acknowledge their personal grants (Sara Borrell CD11/00154, CD12/00667 and PFIS FI12/00109). AL acknowledges for a Miguel Servet grant (CP08/00125) and FISPI11/02942 grant from the Instituto Carlos III (Ministry of Economy and Competitiveness, Spain). MV acknowledges the FISPI11/0313 grant from the Instituto Carlos III. GQ acknowledges financial support from the Ministry of Economy and Competitiveness (SAF2012-39948). Financial support was also provided by the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Aquilina K, 2007, J NEUROSURG, V107, P126, DOI 10.3171/PED-07/08/126; Bennet L, 2010, SEMIN FETAL NEONAT M, V15, P253, DOI 10.1016/j.siny.2010.05.007; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Butter A, 2005, J PEDIATR SURG, V40, P826, DOI 10.1016/j.jpedsurg.2005.01.058; Connolly JJ, 2012, PEDIATRICS, V129, P1150, DOI 10.1542/peds.2011-3636; Desvergne B, 2010, PHYSIOL REV, V86, P465; Esbensen KH, 2010, J CHEMOMETR, V24, P168, DOI 10.1002/cem.1310; Fanos V, 2013, SEMIN FETAL NEONAT M, V18, P3, DOI 10.1016/j.siny.2012.10.014; Fiedorowicz M, 2008, ACTA NEUROBIOL EXP, V68, P389; Fokkelman K, 2007, EUR J PHARMACOL, V562, P132, DOI 10.1016/j.ejphar.2007.01.057; Gibellini F, 2012, IUBMB LIFE, V2, P414; Hardy P, 2005, PHARMACOL REP, V57, P169; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Hendriks MMWB, 2011, TRAC-TREND ANAL CHEM, V30, P1685, DOI 10.1016/j.trac.2011.04.019; Hunsucker Stephen W, 2007, Adv Pediatr, V54, P9, DOI 10.1016/j.yapd.2007.03.003; Jain KK, 2010, HANDBOOK OF BIOMARKERS, P1, DOI 10.1007/978-1-60761-685-6_1; Kaur C, 2012, J NEUROIMMUNE PHARM; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Koluman A, 2009, ANAL BIOANAL CHEM, V94, P663; Lange CAK, 2012, OPHTHALMOLOGICA, V227, P115, DOI 10.1159/000331418; Lindon J. C., 2007, HDB METABONOMICS MET; Liu JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015322; Mami A, 2006, NEUROCHEM RES, V31, P63, DOI 10.1007/s11064-005-9076-5; Massaro AN, 2012, J PEDIATR-US, V161, P434, DOI 10.1016/j.jpeds.2012.02.047; Ogunrinu TA, 2010, J BIOL CHEM, V285, P37716, DOI 10.1074/jbc.M110.161190; Pederzolli CD, 2010, METAB BRAIN DIS, V25, P145, DOI 10.1007/s11011-010-9190-1; Pedreschi R, 2008, PROTEOMICS, V8, P1371, DOI 10.1002/pmic.200700975; Quintas G, 2012, METABOLOMICS, V8, P86, DOI 10.1007/s11306-011-0292-5; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Savorani F, 2012, FOOD RES INT, DOI DOI 10.1016/J.F00DRES.2012.12.025; Shankaran S, 2012, CURR TREAT OPTIONS N; Smit S, 2007, ANAL CHIM ACTA, V592, P210, DOI 10.1016/j.aca.2007.04.043; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; SVARDAL AM, 1990, ANAL BIOCHEM, V184, P338, DOI 10.1016/0003-2697(90)90691-2; Syggelou A, 2012, PEDIATR CLIN N AM, V59, P1039, DOI 10.1016/j.pcl.2012.07.002; Tenorio V, 2011, AN PEDIAT BARC, V75, pe1; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Toet MC, 2009, EARLY HUM DEV, V85, P77, DOI 10.1016/j.earlhumdev.2008.11.007; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vento M, 2010, SEMIN FETAL NEONAT M, V15, P216, DOI 10.1016/j.siny.2010.03.008; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T; Westerhuis JA, 2008, METABOLOMICS, V4, P293, DOI 10.1007/s11306-008-0126-2; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wongravee K, 2009, METABOLOMICS, V5, P387, DOI 10.1007/s11306-009-0164-4	48	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66540	10.1371/journal.pone.0066540	http://dx.doi.org/10.1371/journal.pone.0066540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823578	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400124
J	Takeda, N; Jain, R; Li, DQ; Li, L; Lu, MM; Epstein, JA				Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Li, Li; Lu, Min Min; Epstein, Jonathan A.			Lgr5 Identifies Progenitor Cells Capable of Taste Bud Regeneration after Injury	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; PAPILLA DEVELOPMENT; MOUSE; SHH; WNT; EXPRESSION; TONGUE; MICE	Taste buds are composed of a variety of taste receptor cell types that develop from tongue epithelium and are regularly replenished under normal homeostatic conditions as well as after injury. The characteristics of cells that give rise to regenerating taste buds are poorly understood. Recent studies have suggested that Lgr5 (leucine-rich repeat-containing G-protein coupled receptor 5) identifies taste bud stem cells that contribute to homeostatic regeneration in adult circumvallate and foliate taste papillae, which are located in the posterior region of the tongue. Taste papillae in the adult anterior region of the tongue do not express Lgr5. Here, we confirm and extend these studies by demonstrating that Lgr5 cells give rise to both anterior and posterior taste buds during development, and are capable of regenerating posterior taste buds after injury induced by glossopharyngeal nerve transection.	[Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Li, Li; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Takeda, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	notakeda-tky@umin.ac.jp; epsteinj@upenn.edu		Epstein, Jonathan/0000-0001-8637-4465; TAKEDA, NORIFUMI/0000-0003-4818-3347	National Institutes of Health (NIH) [2T32 HL007843-16, R01 HL071546, U01 HL100405]; National Marfan Foundation (RJ); Spain fund for Regenerative Medicine; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546, T32HL007843, U01HL100405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation (RJ); Spain fund for Regenerative Medicine; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) (2T32 HL007843-16) and National Marfan Foundation (RJ) and the NIH (R01 HL071546, U01 HL100405), the Spain fund for Regenerative Medicine, and the W. W. Smith Endowed Chair (JAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cooper D, 1998, DEV BRAIN RES, V105, P79, DOI 10.1016/S0165-3806(97)00167-3; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; Hall JM, 1999, J COMP NEUROL, V406, P143, DOI 10.1002/(SICI)1096-9861(19990405)406:2<143::AID-CNE1>3.0.CO;2-X; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Miura H, 2003, GENE EXPR PATTERNS, V3, P427, DOI 10.1016/S1567-133X(03)00081-4; Miura H, 2010, ARCH ITAL BIOL, V148, P107; Miura H, 2001, MECH DEVELOP, V106, P143, DOI 10.1016/S0925-4773(01)00414-2; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; St John SJ, 2003, CHEM SENSES, V28, P33, DOI 10.1093/chemse/28.1.33; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338	24	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66314	10.1371/journal.pone.0066314	http://dx.doi.org/10.1371/journal.pone.0066314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824276	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400083
J	Tete, N; Fritsch, C; Afonso, E; Coeurdassier, M; Lambert, JC; Giraudoux, P; Scheifler, R				Tete, Nicolas; Fritsch, Clementine; Afonso, Eve; Coeurdassier, Michael; Lambert, Jean-Claude; Giraudoux, Patrick; Scheifler, Renaud			Can Body Condition and Somatic Indices be Used to Evaluate Metal-Induced Stress in Wild Small Mammals?	PLOS ONE			English	Article							MICE APODEMUS-SYLVATICUS; CROCIDURA-RUSSULA; RISK-ASSESSMENT; MICROTUS VOLES; HEAVY-METALS; POLLUTION; BIOACCUMULATION; POPULATION; LANDSCAPE; ECOLOGY	Wildlife is exposed to natural (e.g., food availability and quality, parasitism) and anthropogenic stressors (e.g., habitat fragmentation, toxicants). Individual variables (e.g., age, gender) affect behaviour and physiology of animals. Together, these parameters can create both great inter-individual variations in health indicators and interpretation difficulties. We investigated the relevance of body condition and somatic indices (liver, kidneys) as indicators of health status in wood mice (Apodemus sylvaticus, n= 560) captured along a metal pollution gradient in four landscape types (30 sampling squares 500-m sided). The indices were calculated using a recently proposed standard major axis regression instead of an ordinary least square regression. After considering age and gender for the body condition index, no landscape type influence was detected in the indices. However, important index variability was observed between sampling squares; this effect was included as a random effect in linear models. After integrating all individual and environmental variables that may affect the indices, cadmium (Cd) concentrations in both the liver and kidneys were negatively related to body condition and liver indices only for individuals from highly contaminated sites. Lead in the liver was negatively related to the liver index, and Cd in kidneys was positively linked to the kidney index, potentially suggesting metal-induced stress. However, interpretation of these indices as a wildlife ecotoxicology tool should be performed with caution due to the sensitivity of potentially confounding variables (e.g., individual factors and environmental parameters).	[Tete, Nicolas; Fritsch, Clementine; Afonso, Eve; Coeurdassier, Michael; Lambert, Jean-Claude; Giraudoux, Patrick; Scheifler, Renaud] Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France; [Giraudoux, Patrick] Inst Univ France, Paris, France	INRAE; Universite de Franche-Comte; Institut Universitaire de France	Tete, N (corresponding author), Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France.	nicolas.tete@univ-fcomte.fr	Afonso, Eve/L-1286-2013; Giraudoux, Patrick/B-9274-2011; Scheifler, Renaud/H-2971-2014	Afonso, Eve/0000-0001-5836-9909; Giraudoux, Patrick/0000-0003-2376-0136; Scheifler, Renaud/0000-0002-9620-0204; FRITSCH, Clementine/0000-0003-2062-5799	Agence Nationale de la Recherche (ANR) [ANR-05-ECCO-004]; ADEME [0572C0058]; Conseil Regional de Franche-Comte; ADEME	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ADEME; Conseil Regional de Franche-Comte(Region Bourgogne-Franche-Comte); ADEME	Field experiments and chemical analyses were financially funded by the Agence Nationale de la Recherche (ANR, contract noANR-05-ECCO-004) and the ADEME (contract no0572C0058) within the framework of the STARTT program. Nicolas Tete was financially supported by the Conseil Regional de Franche-Comte and the ADEME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivand RS, 2008, USE R, P1; Burel F, 2004, LANDSCAPE URBAN PLAN, V67, P195, DOI 10.1016/S0169-2046(03)00039-2; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Chaline J., 1974, PROIES RAPACES PETIT; Damek-Poprawa M, 2003, TOXICOLOGY, V186, P1, DOI 10.1016/S0300-483X(02)00595-4; Fritsch C, 2010, THESIS U FRANCHE COM; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; HALBROOK RS, 1993, ARCH ENVIRON CON TOX, V25, P438; HARJU A, 1994, ANN ZOOL FENN, V31, P229; Klemola T, 1997, OIKOS, V80, P61, DOI 10.2307/3546516; Knopper LD, 2004, ENVIRON TOXICOL CHEM, V23, P1512, DOI 10.1897/03-460; Kozakiewicz Michal, 2000, Polish Journal of Ecology, V48, P149; Le Louarn H., 2003, RONGEURS FRANCE FAUN; MA WC, 1989, ARCH ENVIRON CON TOX, V18, P617, DOI 10.1007/BF01055030; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McMurry ST, 1996, J MAMMAL, V77, P335, DOI 10.2307/1382805; Milton A, 2003, ARCH ENVIRON CON TOX, V44, P405, DOI 10.1007/s00244-002-2014-5; Norrdahl K, 2004, OIKOS, V105, P312, DOI 10.1111/j.0030-1299.2004.12684.x; Nunes AC, 2001, ENVIRON POLLUT, V113, P87, DOI 10.1016/S0269-7491(00)00159-7; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pereira R, 2006, ENVIRON POLLUT, V139, P561, DOI 10.1016/j.envpol.2005.04.038; QUERE JP, 1989, MAMMALIA, V53, P287, DOI 10.1515/mamm.1989.53.2.287; R Development Core Team, 2012, R LANG ENV STAT COMP; Sanchez-Chardi A, 2007, CHEMOSPHERE, V70, P101, DOI 10.1016/j.chemosphere.2007.06.047; Sanchez-Chardi A, 2007, CHEMOSPHERE, V68, P703, DOI 10.1016/j.chemosphere.2007.01.042; Sanchez-Chardi A, 2009, CHEMOSPHERE, V76, P387, DOI 10.1016/j.chemosphere.2009.03.036; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, EVOL ECOL RES, V7, P143; SELDAL T, 1994, OIKOS, V70, P3, DOI 10.2307/3545692; Shore R. F., 2001, ECOTOXICOLOGY WILD M; SHORE RF, 1994, ECOTOX ENVIRON SAFE, V29, P101, DOI 10.1016/0147-6513(94)90035-3; Shore Richard F., 1994, Reviews of Environmental Contamination and Toxicology, V134, P49; Silva M, 2005, BIOL CONSERV, V126, P556, DOI 10.1016/j.biocon.2005.07.007; Sterckeman T, 2002, WATER AIR SOIL POLL, V135, P173, DOI 10.1023/A:1014758811194; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Tattersall FH, 2001, J ZOOL, V255, P487, DOI 10.1017/S095283690100156X; Van den Brink PJ, 2008, ENVIRON SCI TECHNOL, V42, P8999, DOI 10.1021/es801991c; Van Straalen N, 2003, ENVIRON SCI TECHNOL, V37, p324A; van Straalen NM, 2008, SCI TOTAL ENVIRON, V406, P479, DOI 10.1016/j.scitotenv.2008.06.054	42	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66399	10.1371/journal.pone.0066399	http://dx.doi.org/10.1371/journal.pone.0066399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824591	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400104
J	Varnava, A; Dervinis, M; Chambers, CD				Varnava, Alice; Dervinis, Martynas; Chambers, Christopher D.			The Predictive Nature of Pseudoneglect for Visual Neglect: Evidence from Parietal Theta Burst Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LINE-BISECTION JUDGMENTS; UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE DAMAGE; VISUOSPATIAL ATTENTION; MOTOR THRESHOLD; INDIVIDUAL VARIATION; HEMISPATIAL NEGLECT; HORIZONTAL LINE; REPETITIVE TMS	Following parietal damage most patients with visual neglect bisect horizontal lines significantly away from the true centre. Neurologically intact individuals also misbisect lines; a phenomenon referred to as 'pseudoneglect'. In this study we examined the relationship between neglect and pseudoneglect by testing how patterns of pre-existing visuospatial asymmetry predict asymmetry caused by parietal interference. Twenty-four participants completed line bisection and Landmark tasks before receiving continuous theta burst stimulation to the left or right angular gyrus. Results showed that a pre-existing pattern of left pseudoneglect (i.e. right bias), but not right pseudoneglect, predicts left neglect-like behaviour during line bisection following right parietal cTBS. This correlation is consistent with the view that neglect and pseudoneglect arise via a common or linked neural mechanism.	[Varnava, Alice] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Varnava, Alice; Dervinis, Martynas; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Swansea University; Cardiff University	Varnava, A (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	VarnavaA@Cardiff.ac.uk	Chambers, Chris/E-7827-2010	Varnava, Alice/0000-0002-5090-9541; Chambers, Chris/0000-0001-6058-4114	Wales Institute of Cognitive Neuroscience; Biotechnology and Biological Sciences Research Council (BBSRC)David Phillips Fellowship; Biotechnology and BBSRC grant [BB/E020291/1]; BBSRC [BB/C519854/1, BB/C519854/2, BB/E020291/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020291/2, BB/C519854/2, BB/C519854/1] Funding Source: researchfish	Wales Institute of Cognitive Neuroscience; Biotechnology and Biological Sciences Research Council (BBSRC)David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wales Institute of Cognitive Neuroscience (AV & CC), a Biotechnology and Biological Sciences Research Council (BBSRC)David Phillips Fellowship (CC), and Biotechnology and BBSRC grant BB/E020291/1 (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beis JM, 2004, NEUROLOGY, V63, P1600, DOI 10.1212/01.WNL.0000142967.60579.32; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; Bisiach E, 1983, Brain Cogn, V2, P32, DOI 10.1016/0278-2626(83)90027-1; BISIACH E, 1994, NEUROPSYCHOLOGIA, V32, P1431, DOI 10.1016/0028-3932(94)00070-0; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Braun JB, 1999, NEUROLOGY, V53, P527, DOI 10.1212/WNL.53.3.527; BRIGGS G G, 1975, Cortex, V11, P230; Chambers CD, 2006, BRAIN RES, V1097, P149, DOI 10.1016/j.brainres.2006.04.084; Cowie R, 1998, PERCEPT MOTOR SKILL, V86, P834, DOI 10.2466/pms.1998.86.3.834; Dafotakis M, 2008, J NEURAL TRANSM, V115, P1269, DOI 10.1007/s00702-008-0064-1; Daini R, 2002, EXP BRAIN RES, V144, P224, DOI 10.1007/s00221-002-1034-8; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Eshel N, 2010, NEUROPSYCHOLOGIA, V48, P3470, DOI 10.1016/j.neuropsychologia.2010.07.031; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Fink GR, 2002, NEUROPSYCHOLOGIA, V40, P119, DOI 10.1016/S0028-3932(01)00087-2; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fink GR, 2001, NEUROIMAGE, V14, pS59, DOI 10.1006/nimg.2001.0819; Foxe JJ, 2003, NEUROIMAGE, V19, P710, DOI 10.1016/S1053-8119(03)00057-0; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; HALLIGAN PW, 1995, PSYCHOLOGIST, V8, P257; HALLIGAN PW, 1990, NEUROPSYCHOLOGIA, V28, P1043, DOI 10.1016/0028-3932(90)90139-F; HALLIGAN PW, 1992, CORTEX, V28, P525, DOI 10.1016/S0010-9452(13)80225-0; Harvey M, 2002, NEUROPSYCHOLOGIA, V40, P1387, DOI 10.1016/S0028-3932(01)00202-0; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Ishiai S, 1998, BRAIN COGNITION, V36, P239, DOI 10.1006/brcg.1998.0980; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Loo CK, 2000, BIOL PSYCHIAT, V47, P325, DOI 10.1016/S0006-3223(99)00285-1; LUH KE, 1995, NEUROPSYCHOLOGY, V9, P435, DOI 10.1037/0894-4105.9.4.435; Macdonald-Nethercott EM, 2000, PERCEPT MOTOR SKILL, V91, P217, DOI 10.2466/PMS.91.5.217-226; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P1794, DOI 10.1016/S0028-3932(02)00035-0; MANNING L, 1990, NEUROPSYCHOLOGIA, V28, P647, DOI 10.1016/0028-3932(90)90119-9; MARSHALL JC, 1989, CORTEX, V25, P503, DOI 10.1016/S0010-9452(89)80065-6; MARSHALL JC, 1994, CORTEX, V30, P509, DOI 10.1016/S0010-9452(13)80346-2; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McCourt ME, 1999, NEUROPSYCHOLOGIA, V37, P843, DOI 10.1016/S0028-3932(98)00140-7; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Mozer MC, 1997, J COGNITIVE NEUROSCI, V9, P171, DOI 10.1162/jocn.1997.9.2.171; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Oliveri M, 2009, J NEUROPSYCHOL, V3, P201, DOI 10.1348/174866408X388197; Porac C, 2006, BRAIN COGNITION, V61, P305, DOI 10.1016/j.bandc.2006.01.003; REUTERLORENZ PA, 1990, NEUROPSYCHOLOGIA, V28, P327, DOI 10.1016/0028-3932(90)90059-W; Robertson IH, 1999, TRENDS COGN SCI, V3, P385, DOI 10.1016/S1364-6613(99)01378-9; Rorden C, 2006, BRAIN RES, V1080, P17, DOI 10.1016/j.brainres.2004.10.071; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Seki K, 1999, NEUROPSYCHOLOGIA, V37, P75; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Toba MN, 2011, NEUROPSYCHOLOGIA, V49, P238, DOI 10.1016/j.neuropsychologia.2010.11.022; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822; Varnava A, 2008, APPL NEUROPSYCHOL, V15, P107, DOI 10.1080/09084280802083889; Varnava A, 2011, J NEUROSCI METH, V201, P327, DOI 10.1016/j.jneumeth.2011.08.016; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Vossel S, 2010, NEUROPSYCHOLOGIA, V48, P3949, DOI 10.1016/j.neuropsychologia.2010.09.022; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	69	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65851	10.1371/journal.pone.0065851	http://dx.doi.org/10.1371/journal.pone.0065851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823975	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400025
J	Zhang, JL; Zhou, Y; Zhou, GS; Xiao, CW				Zhang, Jingli; Zhou, Yong; Zhou, Guangsheng; Xiao, Chunwang			Structure and Composition of Natural Gmelin Larch (Larix gmelinii var. gmelinii) Forests in Response to Spatial Climatic Changes	PLOS ONE			English	Article							SPECIES RICHNESS; PINUS-SYLVESTRIS; COLD TOLERANCE; GROWTH; SUCCESSION; SURVIVAL; DOMINANCE; MONGOLICA; MOUNTAIN; DYNAMICS	Background: Many theoretical researches predicted that the larch species would decrease drastically in China under future climatic changes. However, responses of the structural and compositional changes of Gmelin larch (Larix gmelinii var. gmelinii) forests to climatic changes have rarely been reported. Methodology/Principal Findings: Field survey was conducted to examine the structures and compositions of natural Gmelin larch forests along a climatic gradient. Stepwise linear regression analyses incorporating linear and quadratic components of climatic and non-climatic factors were performed on the structural and compositional attributes of those natural Gmelin larch forests. Isothermality, Max Temperature of Warmest Month (TempWarmestMonth), Precipitation of Wettest Month (PrecipWettestMonth), Precipitation Seasonality (PrecipSeasonality) and Precipitation of Driest Quarter (PrecipDriestQuarter) were observed to be effective climatic factors in controlling structure and composition of Gmelin larch forests. Isothermality significantly affected total basal area of larch, while TempWarmestMonth, PrecipWettestMonth and PrecipSeasonality significantly affected total basal area of Mongolian pine, and PrecipDriestQuarter significantly affected mean DBH of larch, stand density of larch and total basal area of spruce and fir. Conclusions/Significance: The summer and winter temperatures and precipitations are all predicted to increase in future in Northeast China. Our results showed the increase of total basal area of spruce and fir, the suppression of regeneration and the decrease of stand density of larch under increased winter precipitation, and the decrease of total basal area of larch under increased summer temperature in the region of current Gmelin larch forest. Therefore, we suggest that larch would decrease and spruce and fir would increase in the region of future Gmelin larch forest.	[Zhang, Jingli; Zhou, Yong; Zhou, Guangsheng; Xiao, Chunwang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Jingli; Zhou, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Xiao, CW (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	cwxiao@ibcas.ac.cn	Zhou, Yong/B-9795-2017; Zhou, Yong/H-9048-2019	Zhou, Yong/0000-0003-2546-8462; Zhou, Yong/0000-0003-2546-8462	National Research Program of China (973 Program) [2010CB951303]	National Research Program of China (973 Program)(National Basic Research Program of China)	This study was financially supported by the National Research Program of China (973 Program, number 2010CB951303). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault L, 1998, FOREST ECOL MANAG, V102, P61, DOI 10.1016/S0378-1127(97)00109-6; BAKER F. S., 1949, JOUR FOREST, V47, P179; Ban Y, 1998, J VEG SCI, V9, P529, DOI 10.2307/3237268; BAO SD, 1999, AGR SOIL CHEM ANAL, P263; BERGERON Y, 1989, VEGETATIO, V79, P51, DOI 10.1007/BF00044848; Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Brooks ML, 2003, J APPL ECOL, V40, P344, DOI 10.1046/j.1365-2664.2003.00789.x; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Bruun HH, 2000, ECOGRAPHY, V23, P641, DOI 10.1034/j.1600-0587.2000.230601.x; Cheng Xiao-Xa, 2007, Shengtaixue Zazhi, V26, P1277; [程肖侠 CHENG XiaoXia], 2008, [生态学报, Acta Ecologica Sinica], V28, P534; Devi N, 2008, GLOBAL CHANGE BIOL, V14, P1581, DOI 10.1111/j.1365-2486.2008.01583.x; Dulamsuren C, 2010, OECOLOGIA, V163, P1091, DOI 10.1007/s00442-010-1689-y; Dulamsuren C, 2009, CAN J FOREST RES, V39, P2520, DOI 10.1139/X09-156; Epstein HE, 1996, J VEG SCI, V7, P777, DOI 10.2307/3236456; FREY W, 1983, ARCTIC ALPINE RES, V15, P241, DOI 10.2307/1550925; Germino MJ, 2002, PLANT ECOL, V162, P157, DOI 10.1023/A:1020385320738; HADLEY JL, 1992, TREE PHYSIOL, V11, P1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kharuk VI, 2009, SCAND J FOREST RES, V24, P130, DOI 10.1080/02827580902845823; Leng Wen-Fang, 2007, Zhiwu Shengtai Xuebao, V31, P825; Li Feng, 2006, Yingyong Shengtai Xuebao, V17, P2255; Liu PX, 1958, NATURE GEOGRAPHY NE, p20V33; Liu QJ, 1997, PLANT ECOL, V132, P97, DOI 10.1023/A:1009705319128; Lloyd AH, 2011, GLOBAL CHANGE BIOL, V17, P1935, DOI 10.1111/j.1365-2486.2010.02360.x; Mason WL, 2004, SILVA FENN, V38, P357, DOI 10.14214/sf.404; Moiseev PA, 2002, RUSS J ECOL+, V33, P7, DOI 10.1023/A:1013659319452; Qian C, 2009, J ANHUI AGR SCI, V37, P17730; RICHARDS JH, 1986, OECOLOGIA, V69, P16, DOI 10.1007/BF00399032; Schaberg PG, 2008, GLOBAL CHANGE BIOL, V14, P1282, DOI 10.1111/j.1365-2486.2008.01577.x; Schulze ED, 2005, OECOLOGIA, V146, P77, DOI 10.1007/s00442-005-0173-6; [尚建勋 Shang Jianxun], 2012, [生态学报, Acta Ecologica Sinica], V32, P1077; Sun JiaBao, 2010, Journal of Northeast Forestry University, V38, P30; TEERI JA, 1976, OECOLOGIA, V23, P1, DOI 10.1007/BF00351210; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; TYRRELL LE, 1994, ECOLOGY, V75, P370, DOI 10.2307/1939541; VEBLEN TT, 1987, VEGETATIO, V71, P113; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang Xiao-Chun, 2011, Chinese Journal of Plant Ecology, V35, P294, DOI 10.3724/SP.J.1258.2011.00294; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; WU HQ, 1990, VEGETATIO, V86, P21; Xu Y., 2006, CLIM CHANG RES, V02, P50; Zhang Xian-liang, 2011, Yingyong Shengtai Xuebao, V22, P3101; Zhang Xian-liang, 2010, Yingyong Shengtai Xuebao, V21, P2501; Zheng Guang-Yu, 2012, Bulletin of Botanical Research, V32, P191	46	4	5	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66668	10.1371/journal.pone.0066668	http://dx.doi.org/10.1371/journal.pone.0066668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824710	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400146
J	Andersen, JT; Cameron, J; Plumridge, A; Evans, L; Sleep, D; Sandlie, I				Andersen, Jan Terje; Cameron, Jason; Plumridge, Andrew; Evans, Leslie; Sleep, Darrell; Sandlie, Inger			Single-chain Variable Fragment Albumin Fusions Bind the Neonatal Fc Receptor (FcRn) in a Species-dependent Manner IMPLICATIONS FOR IN VIVO HALF-LIFE EVALUATION OF ALBUMIN FUSION THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-ALBUMIN; SACCHAROMYCES-CEREVISIAE; ANTIBODY; PHARMACOKINETICS; IGG; PROTEINS; EXPRESSION; STRAINS; CELLS	Albumin has a serum half-life of 3 weeks in humans. This has been utilized to extend the serum persistence of biopharmaceuticals that are fused to albumin. In light of the fact that the neonatal Fc receptor (FcRn) is a key regulator of albumin homeostasis, it is crucial to address how fusion of therapeutics to albumin impacts binding to FcRn. Here, we report on a detailed molecular investigation on how genetic fusion of a short peptide or an single-chain variable fragment (scFv) fragment to human serum albumin (HSA) influences pH-dependent binding to FcRn from mouse, rat, monkey, and human. We have found that fusion to the N- or C-terminal end of HSA only slightly reduces receptor binding, where the most noticeable effect is seen after fusion to the C-terminal end. Furthermore, in contrast to the observed strong binding to human and monkey FcRn, HSA and all HSA fusions bound very poorly to mouse and rat versions of the receptor. Thus, we demonstrate that conventional rodents are limited as preclinical models for analysis of serum half-life of HSA-based biopharmaceuticals. This finding is explained by cross-species differences mainly found within domain III (DIII) of albumin. Our data demonstrate that although fusion, particularly to the C-terminal end, may slightly reduce the affinity for FcRn, HSA is versatile as a carrier of biopharmaceuticals.	[Andersen, Jan Terje; Sandlie, Inger] Univ Oslo, CIR, N-0316 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Oslo Univ Hosp Rikshosp, CIR, N-0424 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Oslo Univ Hosp Rikshosp, Dept Immunol, N-0424 Oslo, Norway; [Andersen, Jan Terje; Sandlie, Inger] Univ Oslo, N-0424 Oslo, Norway; [Cameron, Jason; Plumridge, Andrew; Evans, Leslie; Sleep, Darrell] Novozymes Biopharma UK Ltd, Castle Court, Nottingham NG7 1FD, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Novozymes	Andersen, JT (corresponding author), Oslo Univ Hosp Rikshosp, CIR, POB 4956, N-0424 Oslo, Norway.	j.t.andersen@imbv.uio.no; inger.sandlie@imbv.uio.no	Andersen, Jan Terje/AAB-6209-2020	Andersen, Jan Terje/0000-0003-1710-1628; Sleep, Darrell/0000-0001-8287-9538	Norwegian Research Council [179573/V40]; South-Eastern Norway Regional Health Authority Grant [39375]	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority Grant	This work was supported in part by the Norwegian Research Council (Grant 179573/V40) and South-Eastern Norway Regional Health Authority Grant 39375 (to J. T. A.).	Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Knudsen LB, 2010, INT J CLIN PRACT, V64, P4, DOI 10.1111/j.1742-1241.2010.02499.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Payne T, 2008, APPL ENVIRON MICROB, V74, P7759, DOI 10.1128/AEM.01178-08; Reichert JM, 2001, NAT BIOTECHNOL, V19, P819, DOI 10.1038/nbt0901-819; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469	31	54	62	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24277	24285		10.1074/jbc.M113.463000	http://dx.doi.org/10.1074/jbc.M113.463000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23818524	hybrid, Green Published			2022-12-25	WOS:000330611400064
J	Frolov, A; Dong, H; Jiang, M; Yang, LH; Cook, EC; Matnani, R; Hammock, BD; Crofford, LJ				Frolov, Andrey; Dong, Hua; Jiang, Min; Yang, Lihua; Cook, Erik C.; Matnani, Rahul; Hammock, Bruce D.; Crofford, Leslie J.			Niemann-Pick Type C2 Deficiency in Human Fibroblasts Confers Robust and Selective Activation of Prostaglandin E2 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); HUMAN COLONIC MYOFIBROBLASTS; RHEUMATOID-ARTHRITIS; E-2 PRODUCTION; CHOLESTEROL HOMEOSTASIS; SYNOVIAL FIBROBLASTS; ENDOTHELIAL-CELLS; LAMINA PROPRIA; STROMAL CELLS; GROWTH-FACTOR	Activated fibroblasts, also known as myofibroblasts, are mediators of several major human pathologies including proliferative fibrotic disorders, invasive tumor growth, rheumatoid arthritis, and atherosclerosis. We previously identified Niemann-Pick type C2 (NPC2) protein as a negative regulator of fibroblast activation (Csepeggi, C., Jiang, M., Kojima, F., Crofford, L. J., and Frolov, A. (2011) J. Biol. Chem. 286, 2078-2087). Here we report that NPC2-deficiency leads to a dramatic up-regulation of the arachidonic acid (AA) metabolic pathway in human fibroblasts. The major enzymes in this pathway, cPLA2 type IVA, COX-2, and mPGES-1, were dramatically up-regulated at both the transcriptional and translational levels. The specific phenotypic changes resulted in a >10-fold increase in the production and secretion of a key modulator of inflammation and immunity, prostaglandin E2. More importantly, AA metabolome profiling by liquid chromatography/tandem mass-spectrometry revealed the very specific nature of prostaglandin E2 up-regulation as the other analyzed AA metabolites derived from the COX-2, cytochrome P450, 5/15-lipoxygenase, and non-enzymatic oxidative pathways were mostly down-regulated. Blocking activity of cPLA2 efficiently suppressed expression of inflammatory cytokines, IL-1 beta and IL-6, thereby identifying cPLA2 as an important regulator of the inflammatory program in NPC2-null cells. Altogether, these studies highlight NPC2 as a specific regulator of AA metabolism and inflammation that suggests potential for NPC2 protein or its related signaling in the treatment of inflammatory diseases characterized by the presence of activated fibroblasts.	[Frolov, Andrey; Yang, Lihua; Cook, Erik C.; Matnani, Rahul; Crofford, Leslie J.] Univ Kentucky, Dept Internal Med, Div Rheumatol, Lexington, KY 40536 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, UCD Canc Ctr, Davis, CA 95616 USA; [Jiang, Min] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University of Kentucky; University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; University of Cincinnati	Frolov, A (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, 900 S Limestone St,CT Wethington Hlth Sci Bldg,Rm, Lexington, KY 40536 USA.	andrey.frolov@uky.edu	Matnani, Rahul/AAH-1233-2019	Cook, Erik/0000-0003-3863-1708; Matnani, Rahul/0000-0001-6734-3217	National Institutes of Health [RO1AR049010]; American Heart Association [SDG 023017N]; National Institutes of Health (NIH) [RO1 ES ES002710]; NIEHS [P42 ES004699]; NIH [U24DK097154]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710, R01ES002710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AR049010 (to L. J. C.). This work was also supported by American Heart Association Grant SDG 023017N (to A. F.). Partial support for analytical chemistry was provided by National Institutes of Health (NIH) Grant RO1 ES ES002710 (NIEHS) and NIEHS Superfund Research Program Grant P42 ES004699 and NIH Grant U24DK097154 (to B. D. H.).	Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bhattacharyya S, 2012, NAT REV RHEUMATOL, V8, P42, DOI 10.1038/nrrheum.2011.149; Bunt G, 1997, J CELL SCI, V110, P2449; Bunt G, 2000, BIOCHEMISTRY-US, V39, P7847, DOI 10.1021/bi992725p; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Charles RL, 2011, CIRC RES, V108, P324, DOI 10.1161/CIRCRESAHA.110.235879; Chi PL, 2011, ARTHRITIS RHEUM-US, V63, P2905, DOI 10.1002/art.30504; Coen M, 2011, ARTERIOSCL THROM VAS, V31, P2391, DOI 10.1161/ATVBAHA.111.231548; Csepeggi C, 2011, J BIOL CHEM, V286, P2078, DOI 10.1074/jbc.M110.135897; Csepeggi C, 2010, J BIOL CHEM, V285, P30347, DOI 10.1074/jbc.M110.135939; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Freeman EJ, 1998, AM J PHYSIOL-CELL PH, V274, pC282, DOI 10.1152/ajpcell.1998.274.1.C282; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Grewal S, 2005, FEBS J, V272, P1278, DOI 10.1111/j.1742-4658.2005.04565.x; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hai L, 2011, AM J PHYSIOL-GASTR L, V301, pG356, DOI 10.1152/ajpgi.00354.2010; Heo K, 2006, STEM CELLS, V24, P1549, DOI 10.1634/stemcells.2005-0458; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hwang MK, 2010, CANCER RES, V70, P6859, DOI 10.1158/0008-5472.CAN-09-4393; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Leclerc P, 2013, SCAND J IMMUNOL, V77, P350, DOI 10.1111/sji.12041; LEIZER T, 1987, ARTHRITIS RHEUM, V30, P562, DOI 10.1002/art.1780300511; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Nah SS, 2010, RHEUMATOL INT, V30, P443, DOI 10.1007/s00296-009-0976-6; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Newberry RD, 2001, J IMMUNOL, V166, P4465, DOI 10.4049/jimmunol.166.7.4465; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Petrovic N, 2006, PROSTAG OTH LIPID M, V81, P126, DOI 10.1016/j.prostaglandins.2006.08.006; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; SA G, 1995, J BIOL CHEM, V270, P2360, DOI 10.1074/jbc.270.5.2360; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Seymour ML, 2003, AM J PHYSIOL-CELL PH, V284, pC1185, DOI 10.1152/ajpcell.00126.2002; SMITH RJ, 1977, J PHARMACOL EXP THER, V200, P647; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	49	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23696	23703		10.1074/jbc.M112.445916	http://dx.doi.org/10.1074/jbc.M112.445916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23814065	Green Published, hybrid			2022-12-25	WOS:000330611400010
J	Cai, PF; Piao, XY; Liu, S; Hou, N; Wang, H; Chen, QJ				Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Wang, Heng; Chen, Qijun			MicroRNA-Gene Expression Network in Murine Liver during Schistosoma japonicum Infection	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; IDENTIFICATION; CELLS; INDUCTION; HEPATITIS; PATTERNS; MIRBASE; MIR-146; TARGETS	Background: Schistosomiasis japonica remains a significant public health problem in China and Southeast Asian countries. The most typical and serious outcome of the chronic oriental schistosomiasis is the progressive granuloma and fibrosis in the host liver, which has been a major medical challenge. However, the molecular mechanism underling the hepatic pathogenesis is still not clear. Methodology and Principal Findings: Using microarrays, we quantified the temporal gene expression profiles in the liver of Schistosoma japonicum-infected BALB/c mice at 15, 30, and 45 day post infection (dpi) with that from uninfected mice as controls. Gene expression alternation associated with liver damage was observed in the initial phase of infection (dpi 15), which became more magnificent with the onset of egg-laying. Up-regulated genes were dominantly associated with inflammatory infiltration, whereas down-regulated genes primarily led to the hepatic functional disorders. Simultaneously, microRNA profiles from the same samples were decoded by Solexa sequencing. More than 130 miRNAs were differentially expressed in murine liver during S. japonicum infection. MiRNAs significantly dysregulated in the mid-phase of infection (dpi 30), such as mmu-miR-146b and mmu-miR-155, may relate to the regulation of hepatic inflammatory responses, whereas miRNAs exhibiting a peak expression in the late phase of infection (dpi 45), such as mmu-miR-223, mmu-miR-146a/b, mmu-miR-155, mmu-miR-34c, mmu-miR-199, and mmu-miR-134, may represent a molecular signature of the development of schistosomal hepatopathy. Further, a dynamic miRNA-gene co-expression network in the progression of infection was constructed. Conclusions and Significance: This study presents a global view of dynamic expression of both mRNA and miRNA transcripts in murine liver during S. japonicum infection, and highlights that miRNAs may play a variety of regulatory roles in balancing the immune responses during the development of hepatic pathology. The data provide robust information for further researches on the pathogenesis and molecular events of hepatopathy induced by schistosome eggs.	[Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Wang, Heng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100730, Peoples R China; [Wang, Heng] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, QJ (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	qijun.chen@ipbcams.ac.cn	Cai, Pengfe/AAF-2759-2020	Cai, Pengfei/0000-0003-4975-4615	National Natural Science Foundation of China [NSFC 81270026, 30901254]; National S & T Major Program [2012ZX10004-220, 2008ZX10004-011]; Institute of Pathogen Biology, CAMS [2012IPB207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Institute of Pathogen Biology, CAMS	This study was supported by the National Natural Science Foundation of China (NSFC 81270026 and 30901254), the National S & T Major Program (grant numbers 2012ZX10004-220 and 2008ZX10004-011), and the intramural grant from Institute of Pathogen Biology, CAMS (2012IPB207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000686; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai Pengfei, 2013, PLoS ONE, V8, pe64003, DOI 10.1371/journal.pone.0064003; Cai PF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001745; Cai PF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001256; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chaveles I, 2012, INT J MOL MED, V29, P747, DOI 10.3892/ijmm.2012.902; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han HX, 2013, MOL BIOCHEM PARASIT, V188, P1, DOI 10.1016/j.molbiopara.2013.02.001; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Harty MW, 2010, AM J PATHOL, V176, P1271, DOI 10.2353/ajpath.2010.090527; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Iizuka M, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-12; Ji F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001724; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin X, 2009, DIGEST LIVER DIS, V41, P289, DOI 10.1016/j.dld.2008.08.008; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; La Flamme AC, 2003, J IMMUNOL, V170, P470, DOI 10.4049/jimmunol.170.1.470; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li SJ, 2009, J LIPID RES, V50, P1756, DOI 10.1194/jlr.M800509-JLR200; Li WQ, 2011, FEBS J, V278, P1522, DOI 10.1111/j.1742-4658.2011.08075.x; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Poh KW, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.02.002; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; WARREN KS, 1975, AM J PATHOL, V80, P279; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024680	66	35	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67037	10.1371/journal.pone.0067037	http://dx.doi.org/10.1371/journal.pone.0067037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825609	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000061
J	Wong, DKH; Watanabe, T; Tanaka, Y; Seto, WK; Lee, CK; Fung, J; Lin, CK; Huang, FY; Lai, CL; Yuen, MF				Wong, Danny Ka-Ho; Watanabe, Tsunamasa; Tanaka, Yasuhito; Seto, Wai-Kay; Lee, Cheuk-Kwong; Fung, James; Lin, Che-Kit; Huang, Fung-Yu; Lai, Ching-Lung; Yuen, Man-Fung			Role of HLA-DP Polymorphisms on Chronicity and Disease Activity of Hepatitis B Infection in Southern Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS INFECTION; VIRAL-HEPATITIS; T-CELLS; CLEARANCE; GENE; SUSCEPTIBILITY; POPULATION; VARIANTS; HLA-DPA1	Background and Aim: The association between HLA-DP single nucleotide polymorphisms (SNPs) and chronic hepatitis B virus (HBV) infection varies between different populations. We aimed to study the association between HLA-DP SNPs and HBV infection and disease activity in the Chinese population of Hong Kong. Methods: We genotyped SNPs rs3077 (near HLA-DPA1) and rs9277378 and rs3128917 (both near HLA-DPB1) in 500 HBV carriers (hepatitis B surface antigen [HBsAg]-positive), 245 non-HBV infected controls (HBsAg- and antibody to hepatitis B core protein [anti-HBc]-negative), and 259 subjects with natural HBV clearance (HBsAg- negative, anti-HBc-positive). Inactive HBV carriers state was defined by HBV DNA levels,2,000 IU/ml and persistently normal alanine aminotransferase level for least 12 months. Results: Compared to the non-HBV infected subjects, the HBV carriers had a significantly lower frequency of the rs3077 T allele (p = 0.0040), rs9277378 A allele (p = 0.0068) and a trend for lower frequency of rs3128917 T allele (p = 0.054). These alleles were associated with an increased chance of HBV clearance (rs3077: OR = 1.41, p = 0.0083; rs9277378: OR = 1.61, p = 0.00011; rs3128917: OR = 1.54, p = 0.00017). Significant associations between HLA-DP genotypes and HBV clearance were also found under different genetic models. Haplotype TAT was associated with an increased chance of HBV clearance (OR = 1.64, p = 0.0013). No association was found between these SNPs and HBV disease activity. Conclusion: HLA-DP SNPs rs3077, rs9277378 and rs3128917 were associated with chronicity of HBV disease in the Chinese. Further studies are required to determine whether these SNPs influence the disease endemicity in different ethnic populations.	[Wong, Danny Ka-Ho; Seto, Wai-Kay; Fung, James; Huang, Fung-Yu; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Wong, Danny Ka-Ho; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Watanabe, Tsunamasa; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Watanabe, Tsunamasa; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Lee, Cheuk-Kwong; Lin, Che-Kit] Hosp Author, Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Nagoya City University; Nagoya City University	Yuen, MF (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hku.hk	Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012; Wong, Danny/H-6819-2016; Wong, Danny/S-6230-2019; LEE, Cheuk Kwong/F-3950-2017	SETO, Wai-Kay/0000-0002-9012-313X; LEE, Cheuk Kwong/0000-0002-3939-564X; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005; Tanaka, Yasuhito/0000-0002-2473-6966				Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Fontenot AP, 2000, P NATL ACAD SCI USA, V97, P12717, DOI 10.1073/pnas.220430797; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; LIN TM, 1989, ANTICANCER RES, V9, P737; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Thio CL, 2004, J VIROL, V78, P11258, DOI 10.1128/JVI.78.20.11258-11262.2004; Thomas HC, 1996, LANCET, V348, P1417, DOI 10.1016/S0140-6736(96)05409-8; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Urbani S, 2005, HEPATOLOGY, V41, P826, DOI 10.1002/hep.20614; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608	31	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66920	10.1371/journal.pone.0066920	http://dx.doi.org/10.1371/journal.pone.0066920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825586	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000043
J	Trung, VN; Yamamoto, H; Furukawa, A; Yamaguchi, T; Murata, S; Yoshimura, M; Murakami, Y; Sato, S; Otani, H; Ugi, S; Morino, K; Maegawa, H; Tani, T				Vo Nguyen Trung; Yamamoto, Hiroshi; Furukawa, Akira; Yamaguchi, Tsuyoshi; Murata, Satoshi; Yoshimura, Masahiro; Murakami, Yoko; Sato, Shigetaka; Otani, Hideji; Ugi, Satoshi; Morino, Katsutaro; Maegawa, Hiroshi; Tani, Tohru			Enhanced Intestinal Motility during Oral Glucose Tolerance Test after Laparoscopic Sleeve Gastrectomy: Preliminary Results Using Cine Magnetic Resonance Imaging	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; SMALL-BOWEL MOTILITY; STATE FREE PRECESSION; BARIATRIC SURGERY; GASTRIC BYPASS; GASTROINTESTINAL MOTILITY; OBESE-PATIENTS; WEIGHT-LOSS; TIME; ENTEROCLYSIS	Background: Enhanced secretion of glucagon-like peptide-1 (GLP-1) has been suggested as a possible mechanism underlying the improvement in type 2 diabetes mellitus (T2DM) after laparoscopic sleeve gastrectomy (LSG). However, the reason for enhanced GLP-1 secretion during glucose challenge after LSG remains unclear because LSG does not include intestinal bypass. In this study, we focused on the effects of LSG on GLP-1 secretion and intestinal motility during the oral glucose tolerance test (OGTT) using cine magnetic resonance imaging (MRI) before and 3 months after LSG. Methods: LSG was performed in 12 obese patients with a body mass index >35 kg/m(2). Six patients had T2DM. OGTT was performed before and 3 months after the surgery. Body weight, hemoglobin A1c (HbA1c), and GLP-1 levels during OGTT were examined, and intestinal motility during OGTT was assessed using cine MRI. Results: Body weight was significantly decreased after surgery in all the cases. HbA1c was markedly decreased in all the diabetic subjects. In all cases, GLP-1 secretion during OGTT was enhanced and cine MRI showed markedly increased intestinal motility at 15 and 30 min during OGTT after LSG. Conclusions: LSG leads to accelerated intestinal motility and reduced intestinal transit time, which may be involved in the mechanism underlying enhanced GLP-1 secretion during OGTT after LSG.	[Vo Nguyen Trung; Yamamoto, Hiroshi; Yamaguchi, Tsuyoshi; Murata, Satoshi; Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 52021, Japan; [Furukawa, Akira; Yoshimura, Masahiro; Murakami, Yoko; Sato, Shigetaka; Otani, Hideji] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 52021, Japan; [Ugi, Satoshi; Morino, Katsutaro; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Yamamoto, H (corresponding author), Shiga Univ Med Sci, Dept Surg, Seta Tsukinowa Cho, Otsu, Shiga 52021, Japan.	yhiroshi@belle.shiga-med.ac.jp	MORINO, KATSUTARO/I-3207-2019	MORINO, KATSUTARO/0000-0003-2420-3817; Maegawa, Hiroshi/0000-0002-4611-8149	Grants-in-Aid for Scientific Research [25461839] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ailiani AC, 2009, MAGN RESON MED, V62, P116, DOI 10.1002/mrm.21982; Bernstine H, 2009, OBES SURG, V19, P293, DOI 10.1007/s11695-008-9791-5; Braghetto I, 2009, OBES SURG, V19, P1515, DOI 10.1007/s11695-009-9954-z; Chambers AP, 2013, GASTROENTEROLOGY, V144, P50, DOI 10.1053/j.gastro.2012.09.009; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cremonini F, 2002, ALIMENT PHARM THER, V16, P1781, DOI 10.1046/j.1365-2036.2002.01344.x; de Zwart IM, 2002, RADIOLOGY, V224, P592, DOI 10.1148/radiol.2242011412; Dimitriadis E, 2013, ANN SURG, V257, P647, DOI 10.1097/SLA.0b013e31826e1846; EVANS DF, 1993, GUT, V34, P848, DOI 10.1136/gut.34.6.848; Fidler JL, 2009, RADIOGRAPHICS, V29, P1811, DOI 10.1148/rg.296095507; Froehlich JM, 2005, J MAGN RESON IMAGING, V21, P370, DOI 10.1002/jmri.20284; Froehlich JM, 2009, EUR RADIOL, V19, P1387, DOI 10.1007/s00330-008-1293-2; Furukawa A, 2004, RADIOGRAPHICS, V24, P689, DOI 10.1148/rg.243035120; Gao C, 2002, NEUROGASTROENT MOTIL, V14, P365, DOI 10.1046/j.1365-2982.2002.00341.x; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Hansen MB, 2003, PHYSIOL RES, V52, P1; Hansen MB, 2002, PHYSIOL RES, V51, P541; Hellstrom PM, 2010, VITAM HORM, V84, P319, DOI [10.1016/S0083-6729(10)84006-3, 10.1016/B978-0-12-381517-0.00012-6]; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Husebye E, 1999, NEUROGASTROENT MOTIL, V11, P141; Ichikawa Y, 2003, J CARDIOVASC MAGN R, V5, P333, DOI 10.1081/JCMR-120019422; Iida M, 2000, J GASTROEN HEPATOL, V15, P381, DOI 10.1046/j.1440-1746.2000.02076.x; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Kasama K, 2008, OBES SURG, V18, P1473, DOI 10.1007/s11695-008-9492-0; Kiely JM, 2005, J SURG RES, V124, P98, DOI 10.1016/j.jss.2004.10.005; Klinaki I, 2012, ANN SURG IN PRESS; Lauenstein TC, 2003, AM J ROENTGENOL, V180, P1305, DOI 10.2214/ajr.180.5.1801305; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Lee WJ, 2010, SURGERY, V147, P664, DOI 10.1016/j.surg.2009.10.059; MADSEN JL, 1991, SCAND J GASTROENTERO, V26, P1263, DOI 10.3109/00365529108998623; Mayer APT, 2002, INTENS CARE MED, V28, P336, DOI 10.1007/s00134-002-1224-7; Michalsky D, 2013, OBES SURG, V23, P567, DOI 10.1007/s11695-012-0850-6; Mingrone G, 2009, DIABETES METAB, V35, P518, DOI 10.1016/S1262-3636(09)73459-7; Nishino M, 2005, EUR J RADIOL, V53, P263, DOI 10.1016/j.ejrad.2004.04.002; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Peterli R, 2009, ANN SURG, V250, P234, DOI 10.1097/SLA.0b013e3181ae32e3; Pilichiewicz AN, 2007, AM J PHYSIOL-ENDOC M, V293, pE743, DOI 10.1152/ajpendo.00159.2007; Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687; Rubino F, 2013, OBESITY SIL IN PRESS; Salehi M, 2008, J CLIN ENDOCR METAB, V93, P4909, DOI 10.1210/jc.2008-0605; Sandoval DA, 2013, DIABETES IN PRESS; Savoye-Collet C, 2002, AM J ROENTGENOL, V179, P435, DOI 10.2214/ajr.179.2.1790435; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schnoor J, 2003, LAB ANIM-UK, V37, P145, DOI 10.1258/00236770360563796; Shah S, 2010, SURG OBES RELAT DIS, V6, P152, DOI 10.1016/j.soard.2009.11.019; Shen SH, 2007, J MAGN RESON IMAGING, V26, P672, DOI 10.1002/jmri.21054; Simren M, 2000, DIGEST DIS SCI, V45, P2151, DOI 10.1023/A:1010770302403; Slavin GS, 2002, MAGN RESON MED, V48, P934, DOI 10.1002/mrm.10321; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; THOENI RF, 1991, RADIOLOGY, V178, P659, DOI 10.1148/radiology.178.3.1994398; Wakamiya M, 2011, J MAGN RESON IMAGING, V33, P1235, DOI 10.1002/jmri.22529; Wiarda BM, 2006, AM J ROENTGENOL, V187, P522, DOI 10.2214/AJR.05.0511; Yehoshua RT, 2008, OBES SURG, V18, P1083, DOI 10.1007/s11695-008-9576-x	54	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65739	10.1371/journal.pone.0065739	http://dx.doi.org/10.1371/journal.pone.0065739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823622	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400020
J	Lu, X; An, H; Jin, R; Zou, M; Guo, Y; Su, PF; Liu, D; Shyr, Y; Yarbrough, WG				Lu, X.; An, H.; Jin, R.; Zou, M.; Guo, Y.; Su, P-F; Liu, D.; Shyr, Y.; Yarbrough, W. G.			PPM1A is a RelA phosphatase with tumor suppressor-like activity	ONCOGENE			English	Article						NF-kappa B; PPM1A; phosphatase; prostate cancer; tumor suppressor	NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; THERAPEUTIC TARGET; WIP1 PHOSPHATASE; PROSTATE; PHOSPHORYLATION; GENE; GROWTH; P65; BONE	Nuclear factor-kappa B (NF-kappa B) signaling contributes to human disease processes, notably inflammatory diseases and cancer. NF-kappa B has a role in tumorigenesis and tumor growth, as well as promotion of metastases. Mechanisms responsible for abnormal NF-kappa B activation are not fully elucidated; however, RelA phosphorylation, particularly at serine residues S536 and S276, is critical for RelA function. Kinases that phosphorylate RelA promote oncogenic behaviors, suggesting that phosphatases targeting RelA could have tumor-inhibiting activities; however, few RelA phosphatases have been identified. Here, we identified tumor inhibitory and RelA phosphatase activities of the protein phosphatase 2C (PP2C) phosphatase family member, PPM1A. We show that PPM1A directly dephosphorylated RelA at residues S536 and S276 and selectively inhibited NF-kappa B transcriptional activity, resulting in decreased expression of monocyte chemotactic protein-1/chemokine (C-C motif) ligand 2 and interleukin-6, cytokines implicated in cancer metastasis. PPM1A depletion enhanced NF-kappa B-dependent cell invasion, whereas PPM1A expression inhibited invasion. Analyses of human expression data revealed that metastatic prostate cancer deposits had lower PPM1A expression compared with primary tumors without distant metastases. A hematogenous metastasis mouse model revealed that PPM1A expression inhibited bony metastases of prostate cancer cells after vascular injection. In summary, our findings suggest that PPM1A is a RelA phosphatase that regulates NF-kappa B activity and that PPM1A has tumor suppressor-like activity. Our analyses also suggest that PPM1A inhibits prostate cancer metastases and as neither gene deletions nor inactivating mutations of PPM1A have been described, increasing PPM1A activity in tumors represents a potential therapeutic strategy to inhibit NF-kappa B signaling or bony metastases in human cancer.	[Lu, X.; An, H.; Guo, Y.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [An, H.] Vanderbilt Univ, Div Surg Sci, Nashville, TN 37235 USA; [Jin, R.] Vanderbilt Univ, Vanderbilt Prostate Canc Ctr, Nashville, TN 37235 USA; [Jin, R.] Vanderbilt Univ, Dept Urol, Nashville, TN 37235 USA; [Zou, M.; Liu, D.; Yarbrough, W. G.] Yale Univ, Div Otolaryngol, Dept Surg, New Haven, CT 06519 USA; [Su, P-F; Shyr, Y.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Yarbrough, W. G.] Yale Univ, Dept Pathol, New Haven, CT 06519 USA; [Yarbrough, W. G.] Yale Canc Ctr, New Haven, CT USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Yale University; Vanderbilt University; Yale University; Yale University	Yarbrough, WG (corresponding author), Yale Univ, Sch Med, Dept Surg, Div Otolaryngol, 800 Howard Ave,4th Floor, New Haven, CT 06519 USA.	Wendell.yarbrough@yale.edu			Vanderbilt Ingram Cancer Center; Department of Otolaryngology at Vanderbilt University; Vanderbilt Bill Wilkerson Center;  [NIH R01 DE013173]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013173] Funding Source: NIH RePORTER	Vanderbilt Ingram Cancer Center; Department of Otolaryngology at Vanderbilt University; Vanderbilt Bill Wilkerson Center; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank W Sun, LA Donehower, N Perkins, Reuven Agami and IM Verma for providing constructs and cell lines. We are extremely grateful to A Richmond, R Matusik, J McLean, A Weaver, D Webb and to Baker Lab members for insightful advice. This work was supported by Grant NIH R01 DE013173 (to WGY) and by funds provided through an endowment from Barry and Amy Baker to the Barry Baker Laboratory for Head & Neck Oncology, from the Vanderbilt Ingram Cancer Center, from the Department of Otolaryngology at Vanderbilt University and from the Vanderbilt Bill Wilkerson Center.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; An HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016427; Arun P, 2009, CLIN CANCER RES, V15, P5974, DOI 10.1158/1078-0432.CCR-09-1352; Azevedo A, 2011, WORLD J CLIN ONCOL, V2, P384, DOI 10.5306/wjco.v2.i12.384; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Gardam S, 2011, EXPERT OPIN THER TAR, V15, P207, DOI 10.1517/14728222.2011.548861; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P253, DOI 10.1016/j.bbrc.2006.10.028; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lammers T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-65; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mueller L, 2010, BIOCHEM BIOPH RES CO, V397, P586, DOI 10.1016/j.bbrc.2010.05.163; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Shohat M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032438; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Sosnoski DM, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/160265; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; UEDA A, 1994, J IMMUNOL, V153, P2052; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang BH, 2009, HISTOCHEM CELL BIOL, V132, P169, DOI 10.1007/s00418-009-0601-5; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5	56	33	38	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2918	2927		10.1038/onc.2013.246	http://dx.doi.org/10.1038/onc.2013.246			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23812431	Green Accepted			2022-12-25	WOS:000337231800011
J	Lira, VA; Okutsu, M; Zhang, M; Greene, NP; Laker, RC; Breen, DS; Hoehn, KL; Yan, Z				Lira, Vitor A.; Okutsu, Mitsuharu; Zhang, Mei; Greene, Nicholas P.; Laker, Rhianna C.; Breen, David S.; Hoehn, Kyle L.; Yan, Zhen			Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance	FASEB JOURNAL			English	Article						voluntary wheel running; mitophagy; Bnip3; mitochondrial biogenesis; angiogenesis	FIBER-TYPE TRANSFORMATION; MITOCHONDRIAL BIOGENESIS; PROTEIN-KINASE; PGC-1-ALPHA; ANGIOGENESIS; GLUCOSE; MITOPHAGY; INSULIN; DISEASE; RISK	Pathological and physiological stimuli, including acute exercise, activate autophagy; however, it is unknown whether exercise training alters basal levels of autophagy and whether autophagy is required for skeletal muscle adaptation to training. We observed greater autophagy flux (i.e., a combination of increased LC3-II/LC3-I ratio and LC3-II levels and reduced p62 protein content indicating a higher rate of initiation and resolution of autophagic events), autophagy protein expression (i.e., Atg6/Beclin1, Atg7, and Atg8/LC3) and mitophagy protein Bnip3 expression in tonic, oxidative muscle compared to muscles of either mixed fiber types or of predominant glycolytic fibers in mice. Long-term voluntary running (4 wk) resulted in increased basal autophagy flux and expression of autophagy proteins and Bnip3 in parallel to mitochondrial biogenesis in plantaris muscle with mixed fiber types. Conversely, exercise training promoted autophagy protein expression with no significant increases of autophagy flux and mitochondrial biogenesis in the oxidative soleus muscle. We also observed increased basal autophagy flux and Bnip3 content without increases in autophagy protein expression in the plantaris muscle of sedentary muscle-specific Pgc-1 transgenic mice, a genetic model of augmented mitochondrial biogenesis. These findings reveal that endurance exercise training-induced increases in basal autophagy, including mitophagy, only take place if an enhanced oxidative phenotype is achieved. However, autophagy protein expression is mainly dictated by contractile activity independently of enhancements in oxidative phenotype. Exercise-trained mice heterozygous for the critical autophagy protein Atg6 showed attenuated increases of basal autophagy flux, mitochondrial content, and angiogenesis in skeletal muscle, along with impaired improvement of endurance capacity. These results demonstrate that increased basal autophagy is required for endurance exercise training-induced skeletal muscle adaptation and improvement of physical performance.Lira, V. A., Okutsu, M., Zhang, M., Greene, N. P., Laker, R. C., Breen, D. S., Hoehn, K. L., Yan, Z. Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance.	[Lira, Vitor A.; Okutsu, Mitsuharu; Zhang, Mei; Greene, Nicholas P.; Laker, Rhianna C.; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Breen, David S.; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Lira, Vitor A.; Okutsu, Mitsuharu; Zhang, Mei; Greene, Nicholas P.; Laker, Rhianna C.; Yan, Zhen] Univ Virginia, Ctr Skeletal Muscle Res, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Yan, Z (corresponding author), Univ Virginia, Sch Med, 409 Ln Rd,MR4-6041A, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu	Lira, Vitor/AAN-3403-2021; Greene, Nicholas/A-6076-2013; Greene, Nicholas/G-7399-2015	Lira, Vitor/0000-0002-3162-3804; Greene, Nicholas/0000-0002-9504-9362; Yan, Zhen/0000-0002-4826-9813; Greene, Nicholas/0000-0001-9621-2005; Hoehn, Kyle/0000-0002-0214-3238	U.S. National Institutes of Health (NIH) [AR050429]; American Diabetes Association research award [7-06-RA-165]; American Physiological Society postdoctoral fellowship in physiological genomics; NIH training grant [T32HL07284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association research award(American Diabetes Association); American Physiological Society postdoctoral fellowship in physiological genomics; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Beth Levine (University of Texas Southwestern Medical Center, Dallas, TX, USA) for her generosity in providing Atg6-deficient mice and Dr. Ira G. Shulman for insightful comments on the manuscript. The study was supported by U.S. National Institutes of Health (NIH) grant AR050429 and American Diabetes Association research award 7-06-RA-165 (Z.Y.), an American Physiological Society postdoctoral fellowship in physiological genomics (V.A.L.), and NIH training grant T32HL07284 (N.P.G.).	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Colditz GA, 1997, CANCER CAUSE CONTROL, V8, P649, DOI 10.1023/A:1018458700185; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; EISENBERG HA, 1994, J APPL PHYSIOL, V76, P859, DOI 10.1152/jappl.1994.76.2.859; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KATZ LD, 1983, DIABETES, V32, P675, DOI 10.2337/diabetes.32.7.675; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li P, 2006, AM J PHYSIOL-CELL PH, V290, pC1461, DOI 10.1152/ajpcell.00532.2005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V299, pE1053, DOI 10.1152/ajpendo.00324.2010; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Smuder A. J., J APPL PHYSL, V111, P1190; Waters RE, 2004, AM J PHYSIOL-CELL PH, V287, pC1342, DOI 10.1152/ajpcell.00247.2004; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Yamada E, 2012, CELL REP, V1, P557, DOI 10.1016/j.celrep.2012.03.014; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	44	280	306	4	54	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4184	4193		10.1096/fj.13-228486	http://dx.doi.org/10.1096/fj.13-228486			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23825228	Green Published			2022-12-25	WOS:000329747100029
J	Mohamed, JS; Lopez, MA; Cox, GA; Boriek, AM				Mohamed, Junaith S.; Lopez, Michael A.; Cox, Gregory A.; Boriek, Aladin M.			Ankyrin Repeat Domain Protein 2 and Inhibitor of DNA Binding 3 Cooperatively Inhibit Myoblast Differentiation by Physical Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; LOOP-HELIX PROTEINS; MUSCULAR-DYSTROPHY; ID PROTEINS; CELL-CYCLE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MYOGENIC DIFFERENTIATION; SATELLITE CELLS; ANKRD2	Ankyrin repeat domain protein 2 (ANKRD2) translocates from the nucleus to the cytoplasm upon myogenic induction. Overexpression of ANKRD2 inhibits C2C12 myoblast differentiation. However, the mechanism by which ANKRD2 inhibits myoblast differentiation is unknown. We demonstrate that the primary myoblasts of mdm (muscular dystrophy with myositis) mice (pMB(mdm)) overexpress ANKRD2 and ID3 (inhibitor of DNA binding 3) proteins and are unable to differentiate into myotubes upon myogenic induction. Although suppression of either ANKRD2 or ID3 induces myoblast differentiation in mdm mice, overexpression of ANKRD2 and inhibition of ID3 or vice versa is insufficient to inhibit myoblast differentiation in WT mice. We identified that ANKRD2 and ID3 cooperatively inhibit myoblast differentiation by physical interaction. Interestingly, although MyoD activates the Ankrd2 promoter in the skeletal muscles of wild-type mice, SREBP-1 (sterol regulatory element binding protein-1) activates the same promoter in the skeletal muscles of mdm mice, suggesting the differential regulation of Ankrd2. Overall, we uncovered a novel pathway in which SREBP-1/ANKRD2/ID3 activation inhibits myoblast differentiation, and we propose that this pathway acts as a critical determinant of the skeletal muscle developmental program.	[Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Cox, Gregory A.] Jackson Lab, Bar Harbor, ME 04609 USA	Baylor College of Medicine; Jackson Laboratory	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA.	boriek@bcm.edu	Mohamed, Junaith/AAC-4050-2020; Lopez, Michael A./AAT-2145-2021	Lopez, Michael A./0000-0002-3029-0761	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation.	Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; Bean C, 2005, J MOL BIOL, V349, P349, DOI 10.1016/j.jmb.2005.03.063; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Clever JL, 2010, AM J PHYSIOL-CELL PH, V298, pC1087, DOI 10.1152/ajpcell.00388.2009; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; ELLMEIER W, 1995, DEV DYNAM, V203, P163, DOI 10.1002/aja.1002030205; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; HARA E, 1994, J BIOL CHEM, V269, P2139; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lopez MA, 2008, AM J PHYSIOL-CELL PH, V295, pC1092, DOI 10.1152/ajpcell.16.2008; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Melnikova IN, 1996, CELL GROWTH DIFFER, V7, P1067; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Peterson JM, 2008, AM J PHYSIOL-CELL PH, V295, pC521, DOI 10.1152/ajpcell.00073.2008; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Tsukamoto Y, 2008, HISTOCHEM CELL BIOL, V129, P55, DOI 10.1007/s00418-007-0348-9; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wright WE, 1992, CURR OPIN GENET DEV, V2, P243, DOI 10.1016/S0959-437X(05)80280-1; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092	44	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24560	24568		10.1074/jbc.M112.434423	http://dx.doi.org/10.1074/jbc.M112.434423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824195	Green Published, hybrid			2022-12-25	WOS:000330612300024
J	Tabe, Y; Shi, YX; Zeng, ZH; Jin, LH; Shikami, M; Hatanaka, Y; Miida, T; Hsu, FJ; Andreeff, M; Konopleva, M				Tabe, Yoko; Shi, Yue Xi; Zeng, Zhihong; Jin, Linhua; Shikami, Masato; Hatanaka, Yasuhito; Miida, Takashi; Hsu, Frank J.; Andreeff, Michael; Konopleva, Marina			TGF-beta-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACUTE MYELOID-LEUKEMIA; CHEMOKINE RECEPTOR CXCR4; KINASE INHIBITOR; STEM-CELLS; IN-VITRO; HEMATOPOIESIS; EXPRESSION; TGF-BETA-1; INDUCTION	Hypoxia and interactions with bone marrow (BM) stromal cells have emerged as essential components of the leukemic BM microenvironment in promoting leukemia cell survival and chemoresistance. High levels of transforming growth factor beta 1 (TGF beta 1) produced by BM stromal cells in the BM niche regulate cell proliferation, survival, and apoptosis, depending on the cellular context. Exogenous TGF beta 1 induced accumulation of acute myeloid leukemia (AML) cells in a quiescent G(0) state, which was further facilitated by the co-culture with BM-derived mesenchymal stem cells (MSCs). In turn, TGF beta-neutralizing antibody 1D11 abrogated rhTGF beta 1 induced cell cycle arrest. Blocking TGF beta with 1D11 further enhanced cytarabine (Ara-C)induced apoptosis of AML cells in hypoxic and in normoxic conditions. Additional constituents of BM niche, the stroma-secreted chemokine CXCL12 and its receptor CXCR4 play crucial roles in cell migration and stroma/leukemia cell interactions. Treatment with 1D11 combined with CXCR4 antagonist plerixafor and Ara-C decreased leukemia burden and prolonged survival in an in vivo leukemia model. These results indicate that blockade of TGF beta by 1D11 and abrogation of CXCL12/CXCR4 signaling may enhance the efficacy of chemotherapy against AML cells in the hypoxic BM microenvironment.	[Tabe, Yoko; Shi, Yue Xi; Zeng, Zhihong; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Tabe, Yoko; Jin, Linhua; Hatanaka, Yasuhito; Miida, Takashi] Juntendo Univ, Sch Med, Dept Clin Lab Med, Tokyo 113, Japan; [Shikami, Masato] Aichi Med Univ, Dept Hematol, Aichi, Japan; [Hsu, Frank J.] Genzyme Corp, Cambridge, MA USA	University of Texas System; UTMD Anderson Cancer Center; Juntendo University; Aichi Medical University; Sanofi-Aventis; Genzyme Corporation	Konopleva, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	mkonople@mdanderson.org	Miida, Takashi/A-5589-2012	Miida, Takashi/0000-0002-4294-8030	United States National Institutes of Helath [NIH/NCI 5 PO1 CA55164-19]; Juntendo University School of Medicine; Genzyme Corporporation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	United States National Institutes of Helath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juntendo University School of Medicine; Genzyme Corporporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the United States National Institutes of Helath (NIH/NCI 5 PO1 CA55164-19 to M. Andreeff); 2011 Project Research Program for Environmental and Gender-Specific Medicine from Juntendo University School of Medicine to Y. Tabe; and from the Genzyme Corporporation to M. Konopleva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Benito J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023108; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; DALLAS SL, 1994, J BIOL CHEM, V269, P6815; DASCH JR, 1989, J IMMUNOL, V142, P1536; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Fortunel NO, 2000, BLOOD, V96, P2022; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Garrido SM, 2001, EXP HEMATOL, V29, P448, DOI 10.1016/S0301-472X(01)00612-9; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Hayashi T, 2004, CLIN CANCER RES, V10, P7540, DOI 10.1158/1078-0432.CCR-04-0632; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Katoh M, 2010, INT J ONCOL, V36, P415, DOI 10.3892/ijo_00000514; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morris JC, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9028; Mortensen BT, 1998, BRIT J HAEMATOL, V102, P458; Nakao M, 1996, LEUKEMIA, V10, P1911; Narayan S, 2005, FRONT BIOSCI-LANDMRK, V10, P1135, DOI 10.2741/1606; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Ruzek MC, 2003, IMMUNOPHARM IMMUNOT, V25, P235, DOI 10.1081/IPH-120020473; Saed GM, 2002, AM J REPROD IMMUNOL, V48, P387, DOI 10.1034/j.1600-0897.2002.01090.x; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; SMALL D, 1994, P NATL ACAD SCI USA, V91, P459, DOI 10.1073/pnas.91.2.459; Soma T, 1996, BLOOD, V87, P4561, DOI 10.1182/blood.V87.11.4561.bloodjournal87114561; Tabe Y, 2004, BLOOD, V103, P1815, DOI 10.1182/blood-2003-03-0802; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Xu YY, 2008, BRIT J HAEMATOL, V142, P192, DOI 10.1111/j.1365-2141.2008.07130.x; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629	47	57	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e62785	10.1371/journal.pone.0062785	http://dx.doi.org/10.1371/journal.pone.0062785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826077	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000002
J	Fan, SJ; Pan, ZY; Geng, Q; Li, X; Wang, YF; An, Y; Xu, Y; Tie, L; Pan, Y; Li, XJ				Fan, Shengjun; Pan, Zhenyu; Geng, Qiang; Li, Xin; Wang, Yefan; An, Yu; Xu, Yan; Tie, Lu; Pan, Yan; Li, Xuejun			Layered Signaling Regulatory Networks Analysis of Gene Expression Involved in Malignant Tumorigenesis of Non-Resolving Ulcerative Colitis via Integration of Cross-Study Microarray Profiles	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CD4(+) T-CELLS; COLORECTAL-CANCER; BREAST-CANCER; BIOLOGICAL NETWORKS; B-CELLS; RECOMBINANT ERYTHROPOIETIN; TRANSCRIPTION FACTORS; MONONUCLEAR-CELLS; INFLAMMATION	Background: Ulcerative colitis (UC) was the most frequently diagnosed inflammatory bowel disease (IBD) and closely linked to colorectal carcinogenesis. By far, the underlying mechanisms associated with the disease are still unclear. With the increasing accumulation of microarray gene expression profiles, it is profitable to gain a systematic perspective based on gene regulatory networks to better elucidate the roles of genes associated with disorders. However, a major challenge for microarray data analysis is the integration of multiple-studies generated by different groups. Methodology/Principal Findings: In this study, firstly, we modeled a signaling regulatory network associated with colorectal cancer (CRC) initiation via integration of cross-study microarray expression data sets using Empirical Bayes (EB) algorithm. Secondly, a manually curated human cancer signaling map was established via comprehensive retrieval of the publicly available repositories. Finally, the co-differently-expressed genes were manually curated to portray the layered signaling regulatory networks. Results: Overall, the remodeled signaling regulatory networks were separated into four major layers including extracellular, membrane, cytoplasm and nucleus, which led to the identification of five core biological processes and four signaling pathways associated with colorectal carcinogenesis. As a result, our biological interpretation highlighted the importance of EGF/EGFR signaling pathway, EPO signaling pathway, T cell signal transduction and members of the BCR signaling pathway, which were responsible for the malignant transition of CRC from the benign UC to the aggressive one. Conclusions: The present study illustrated a standardized normalization approach for cross-study microarray expression data sets. Our model for signaling networks construction was based on the experimentally-supported interaction and microarray co-expression modeling. Pathway-based signaling regulatory networks analysis sketched a directive insight into colorectal carcinogenesis, which was of significant importance to monitor disease progression and improve therapeutic interventions.	[Fan, Shengjun; Li, Xin; Wang, Yefan; An, Yu; Tie, Lu; Pan, Yan; Li, Xuejun] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Fan, Shengjun; Li, Xin; Wang, Yefan; An, Yu; Tie, Lu; Pan, Yan; Li, Xuejun] Peking Univ, Beijing Key Lab Tumor Syst Biol, Beijing 100871, Peoples R China; [Pan, Zhenyu] Xian Childrens Hosp, Dept Pharm, Xian, Peoples R China; [Geng, Qiang] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China; [Xu, Yan] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Peoples R China	Peking University; Peking University; Peking University; Shandong University	Li, XJ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	xjli@bjmu.edu.cn	Fan, Shengjun/AAH-1370-2021; An, Yu/O-2966-2013	Fan, Shengjun/0000-0002-3096-3508; An, Yu/0000-0002-9678-3382; /0000-0002-6232-791X	National Natural Science Foundation of China [91129727, 81020108031, 30973558, 81270049]; Ministry of Education of China [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 91129727, 81020108031, 30973558, 81270049) and Research Fund from Ministry of Education of China (111 Projects No.B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051301; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barbera-Guillem E, 2000, CANCER IMMUNOL IMMUN, V48, P541, DOI 10.1007/PL00006672; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Berg M, 2012, DISCOV MED, V14, P207; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; BOYLE P, 1995, BRIT J CANCER, V72, P528, DOI 10.1038/bjc.1995.368; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; BRAEGGER CP, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13223.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chen T, 1999, Pac Symp Biocomput, P29; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Dagnon K, 2005, CLIN CANCER RES, V11, P993; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; DEVROEDE GJ, 1971, NEW ENGL J MED, V285, P17, DOI 10.1056/NEJM197107012850103; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; ERSLEV AJ, 1980, ANN CLIN LAB SCI, V10, P250; Fan SJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-152; FAQUIN W C, 1992, Blood, V79, P1987; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Feldman L, 2006, PROSTATE, V66, P135, DOI 10.1002/pros.20310; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Fuseya C, 2012, HUM PATHOL, V43, P1964, DOI 10.1016/j.humpath.2012.02.005; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Giovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253, DOI 10.1007/BF00051301; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Gu ZG, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-32; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Hendon Shane E., 2005, Keio Journal of Medicine, V54, P179, DOI 10.2302/kjm.54.179; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Holmes D, 2012, NAT REV DRUG DISCOV, V11, P337, DOI [10.1038/nrd3733, 10.1038/nrd3732]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; ISHIKAWA S, 1994, AM J PHYSIOL-GASTR L, V267, pG1067, DOI 10.1152/ajpgi.1994.267.6.G1067; Itzkowitz S H, 1995, Inflamm Bowel Dis, V1, P142, DOI 10.1002/ibd.3780010208; Jiang W, 2012, AM J SURG PATHOL, V36, P1385, DOI 10.1097/PAS.0b013e31825fa4b4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; KAUFFMAN S, 1974, J THEOR BIOL, V44, P167, DOI 10.1016/S0022-5193(74)80037-8; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kelly DJ, 2005, DIS MARKERS, V21, P43, DOI 10.1155/2005/357089; KING AC, 1981, NEW ENGL J MED, V305, P77, DOI 10.1056/NEJM198107093050206; KRISTIANSEN SV, 1994, J IMMUNOL, V153, P2974; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Lai SY, 2005, ONCOGENE, V24, P4442, DOI 10.1038/sj.onc.1208635; Lakatos PL, 2012, CLIN GASTROENTEROL H, V10, P1179, DOI 10.1016/j.cgh.2012.04.021; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee JH, 2007, J KOREAN MED SCI, V22, P1042, DOI 10.3346/jkms.2008.22.6.1042; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LUCK MS, 1993, J PHARMACOL EXP THER, V264, P984; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Mahurkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057655; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McBroom JW, 2005, GYNECOL ONCOL, V99, P571, DOI 10.1016/j.ygyno.2005.06.038; Merla Amartej, 2012, Chemother Res Pract, V2012, P387172, DOI 10.1155/2012/387172; Mohyeldin A, 2005, NEOPLASIA, V7, P537, DOI 10.1593/neo.04685; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Nunnari G, 2012, EUR REV MED PHARMACO, V16, P1257; Okayasu I, 2012, PATHOL INT, V62, P368, DOI 10.1111/j.1440-1827.2012.02807.x; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parray FQ, 2012, INT J PREVENTIVE MED, V3, P749; Pedroso I, 2010, METHODS MOL BIOL, V628, P373, DOI 10.1007/978-1-60327-367-1_20; Pekow J, 2013, INFLAMM BOWEL DIS, V19, P461, DOI 10.1097/MIB.0b013e3182802bac; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; PROCACCINO F, 1994, GASTROENTEROLOGY, V107, P12, DOI 10.1016/0016-5085(94)90055-8; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Rossi S, 2010, INT J BIOCHEM CELL B, V42, P1291, DOI 10.1016/j.biocel.2009.05.018; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Schreiber S, 1996, NEW ENGL J MED, V334, P619, DOI 10.1056/NEJM199603073341002; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shimizu J, 1999, J IMMUNOL, V163, P5211; Silverman GJ, 1997, IMMUNOL TODAY, V18, P379, DOI 10.1016/S0167-5699(97)01101-8; Simoes RD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-38; SMITH MA, 1992, ANN RHEUM DIS, V51, P753, DOI 10.1136/ard.51.6.753; Smolle E, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7879; Snapper CM, 1996, J IMMUNOL, V157, P2229; Steitz J, 2001, CANCER RES, V61, P8643; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Thurner S., 2009, ANAL COMPLEX NETWORK; Tiwari M, 2012, J CANCER RES THER, V8, P3, DOI 10.4103/0973-1482.95166; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Woo EY, 2001, CANCER RES, V61, P4766; Woychik RP, 1998, MUTAT RES-FUND MOL M, V400, P3, DOI 10.1016/S0027-5107(98)00023-2; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zakharkin SO, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-214; Zhang LJ, 2007, J CELL PHYSIOL, V211, P590, DOI 10.1002/jcp.21001; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhu H, 2012, ADV GENET, V79, P123, DOI 10.1016/B978-0-12-394395-8.00004-9; Zhu WL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006288	118	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67142	10.1371/journal.pone.0067142	http://dx.doi.org/10.1371/journal.pone.0067142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825635	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000085
J	Garratt, ES; Vickers, MH; Gluckman, PD; Hanson, MA; Burdge, GC; Lillycrop, KA				Garratt, Emma S.; Vickers, Mark H.; Gluckman, Peter D.; Hanson, Mark A.; Burdge, Graham C.; Lillycrop, Karen A.			Tissue-Specific 5 ' Heterogeneity of PPAR alpha Transcripts and Their Differential Regulation by Leptin	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; HEPATIC GENE-EXPRESSION; MESSENGER-RNA; 5'-UNTRANSLATED REGION; SECONDARY STRUCTURE; ENERGY-BALANCE; PROTEIN; PROMOTER; ACID; VARIANTS	The genes encoding nuclear receptors comprise multiple 5' untranslated exons, which give rise to several transcripts encoding the same protein, allowing tissue-specific regulation of expression. Both human and mouse peroxisome proliferator activated receptor (PPAR) alpha genes have multiple promoters, although their function is unknown. Here we have characterised the rat PPAR alpha promoter region and have identified three alternative PPAR alpha transcripts, which have different transcription start sites owing to the utilisation of distinct first exons. Moreover these alternative PPAR alpha transcripts were differentially expressed between adipose tissue and liver. We show that while the major adipose (P1) and liver (P2) transcripts were both induced by dexamethasone, they were differentially regulated by the PPAR alpha agonist, clofibric acid, and leptin. Leptin had no effect on the adipose-specific P1 transcript, but induced liver-specific P2 promoter activity via a STAT3/Sp1 mechanism. Moreover in Wistar rats, leptin treatment between postnatal day 3-13 led to an increase in P2 but not P1 transcription in adipose tissue which was sustained into adulthood. This suggests that the expression of the alternative PPAR alpha transcripts are in part programmed by early life exposure to leptin leading to persistent change in adipose tissue fatty acid metabolism through specific activation of a quiescent PPAR alpha promoter. Such complexity in the regulation of PPAR alpha may allow the expression of PPAR alpha to be finely regulated in response to environmental factors.	[Garratt, Emma S.; Hanson, Mark A.; Burdge, Graham C.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Vickers, Mark H.; Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Vickers, Mark H.; Gluckman, Peter D.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England	University of Southampton; University of Auckland; University of Auckland; University of Southampton	Lillycrop, KA (corresponding author), Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England.	kal@soton.ac.uk	Burdge, Graham/A-2370-2014; Hanson, Mark/AAE-8236-2019	Burdge, Graham/0000-0002-7665-2967; Hanson, Mark/0000-0002-6907-613X; Lillycrop, Karen/0000-0001-7350-5489; Vickers, Mark/0000-0003-4876-9356	Health Research Council of New Zealand; National Research Centre for Growth and Development; British Heart Foundation	Health Research Council of New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development; British Heart Foundation(British Heart Foundation)	This work was funded by the Health Research Council of New Zealand and the National Research Centre for Growth and Development. MAH receives salary support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Belikov S, 2004, J BIOL CHEM, V279, P49857, DOI 10.1074/jbc.M409713200; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Briana DD, 2010, ANN NY ACAD SCI, V1205, P82, DOI 10.1111/j.1749-6632.2010.05650.x; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Capri M, 1997, MECH DEVELOP, V68, P91, DOI 10.1016/S0925-4773(97)00130-5; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Chew CH, 2003, BIOCHEM BIOPH RES CO, V305, P235, DOI 10.1016/S0006-291X(03)00731-9; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Fonseca Vania Matos, 2004, J Perinatol, V24, P751, DOI 10.1038/sj.jp.7211188; Fruchart J C, 2001, Curr Atheroscler Rep, V3, P83, DOI 10.1007/s11883-001-0015-x; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gauss KA, 2006, GENE, V366, P169, DOI 10.1016/j.gene.2005.09.012; GEARING KL, 1994, BIOCHEM BIOPH RES CO, V199, P255, DOI 10.1006/bbrc.1994.1222; GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Harris RG, 2002, J BIOL CHEM, V277, P34815, DOI 10.1074/jbc.M109609200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Nilsson C, 2003, J ENDOCRINOL, V176, P13, DOI 10.1677/joe.0.1760013; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pavithra L, 2010, FEBS LETT, V584, P1187, DOI 10.1016/j.febslet.2010.02.025; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Thio GL, 2000, DEV BIOL, V221, P435, DOI 10.1006/dbio.2000.9690; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vohl MC, 2000, J LIPID RES, V41, P945; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Zhao XN, 2009, ACTA BIOCH BIOPH SIN, V41, P30, DOI 10.1093/abbs/gmn004; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391	63	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67483	10.1371/journal.pone.0067483	http://dx.doi.org/10.1371/journal.pone.0067483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825665	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000321223000105
J	Gonzalez-Sanchez, E; Martin-Caballero, J; Flores, JM; Hernandez-Losa, J; Montero, MA; Cortes, J; Mares, R; Barbacid, M; Recio, JA				Gonzalez-Sanchez, Elena; Martin-Caballero, Juan; Maria Flores, Juana; Hernandez-Losa, Javier; Montero, Ma Angeles; Cortes, Javier; Mares, Roso; Barbacid, Mariano; Recio, Juan A.			Lkb1 Loss Promotes Tumor Progression of BRAF(V600E)-Induced Lung Adenomas	PLOS ONE			English	Article							STEM-CELLS; RAS ONCOGENE; BRAF GENE; K-RAS; CANCER; MUTATIONS; LKB1/STK11; INITIATION; EXPRESSION; MELANOMA	Aberrant activation of MAP kinase signaling pathway and loss of tumor suppressor LKB1 have been implicated in lung cancer development and progression. Although oncogenic KRAS mutations are frequent, BRAF mutations (BRAF(V600E)) are found in 3% of human non-small cell lung cancers. Contrary to KRAS mutant tumors, BRAF(V600E)-induced tumors are benign adenomas that fail to progess. Interestingly, loss of tumor supressor LKB1 coexists with KRAS oncogenic mutations and synergizes in tumor formation and progression, however, its cooperation with BRAF(V600E) oncogene is unknown. Our results describe a lung cell population in neonates mice where expression of BRAF(V600E) leads to lung adenoma development. Importantly, expression of BRAF(V600E) concomitant with the loss of only a single-copy of Lkb1, overcomes senencence-like features of BRAF(V600E)-mutant adenomas leading malignization to carcinomas. These results posit LKB1 haploinsufficiency as a risk factor for tumor progression of BRAF(V600E) mutated lung adenomas in human cancer patients.	[Gonzalez-Sanchez, Elena; Recio, Juan A.] Autonomous Univ Barcelona, Vall Hebron Inst Res, Dept Anat Pathol, Anim Models & Canc Lab, Barcelona, Spain; [Martin-Caballero, Juan] Anim Lab Unit, Barcelona, Spain; [Maria Flores, Juana] Univ Complutense Madrid, Sch Vet, Dept Surg & Med, Madrid, Spain; [Hernandez-Losa, Javier; Mares, Roso] Vall Hebron Hosp, Dept Anat Pathol, Barcelona, Spain; [Montero, Ma Angeles] Royal Brompton & NHS Trust, Dept Histopathol, London, England; [Montero, Ma Angeles] Vall Hebron Hosp, VHIO, Dept Med Oncol, Barcelona, Spain; [Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Program, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Complutense University of Madrid; Hospital Universitari Vall d'Hebron; Royal Brompton Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Recio, JA (corresponding author), Autonomous Univ Barcelona, Vall Hebron Inst Res, Dept Anat Pathol, Anim Models & Canc Lab, Barcelona, Spain.	juan.recio@vhir.org	Montero, Angeles/AAQ-1696-2021; Javier, Hernandez Losa/C-1173-2008	Montero, Angeles/0000-0002-2381-6833; Javier, Hernandez Losa/0000-0003-1526-3201; Recio, Juan Angel/0000-0002-7320-3832; Cortes, Javier/0000-0001-7623-1583; mares, Roso/0000-0002-7339-0172	Spanish Ministry of Health [PI080653, PI1100384]; Fundacion Segunda Opinion en Oncologia (FUSEON)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fundacion Segunda Opinion en Oncologia (FUSEON)	This work has been supported by the Spanish Ministry of Health grants FIS(PI080653) and FIS(PI1100384), and Fundacion Segunda Opinion en Oncologia (FUSEON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTYANI Z, 1993, PIGM CELL RES, V6, P400; Brose MS, 2002, CANCER RES, V62, P6997; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chen Huaiyong, 2009, Proc Am Thorac Soc, V6, P602, DOI 10.1513/pats.200907-078RM; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2006, SCIENCE, V314, P433, DOI 10.1126/science.1134727; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Gill RK, ONCOGENE, V30, P3784; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Haigis KM, 2007, GENE DEV, V21, P361, DOI 10.1101/gad.1532107; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Liu W, CANC CELL, V21, P751; Lundin A, CANC LETT; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Naoki K, 2002, CANCER RES, V62, P7001; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, CANC CELL, V23, P143; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620	26	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66933	10.1371/journal.pone.0066933	http://dx.doi.org/10.1371/journal.pone.0066933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825589	gold, Green Submitted, Green Published			2022-12-25	WOS:000321223000046
J	Wan, B; Qiao, SL; Li, P; Jin, QY; Liu, YC; Bao, DK; Liu, MY; Wang, YB; Zhang, GP				Wan, Bo; Qiao, Songlin; Li, Peng; Jin, Qianyue; Liu, Yunchao; Bao, Dengke; Liu, Mingyang; Wang, Yinbiao; Zhang, Gaiping			Impairment of the Antibody-Dependent Phagocytic Function of PMNs through Regulation of the Fc gamma Rs Expression after Porcine Reproductive and Respiratory Syndrome Virus Infection	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; ISOLATE ATCC VR-2332; TIME RT-PCR; ALVEOLAR MACROPHAGES; HAEMOPHILUS-PARASUIS; NEGATIVE REGULATION; MOLECULAR-CLONING; SWINE INFERTILITY; IMMUNE-COMPLEXES; GENE-EXPRESSION	Porcine reproductive and respiratory syndrome (PRRS) is identified as one of the most important etiological agents in multifactorial respiratory disease of swine and can predispose pigs to secondary infections by other pathogens, usually bacteria. To understand the mechanism for an increased susceptibility to secondary bacterial infections, we investigated the antibody-dependent phagocytosis behaviour and killing ability of PMNs after infection by PRRSV strains BJ-4 or HN07-1. PMN's antibody-dependent phagocytosis and their ability to kill E. coli were both noticeably decreased following PRRSV infection, in particular with the highly pathogenic strain HN07-1. As the change in this function of the PMNs may reflect a variation in the expression of Fc gamma Rs, the expression profiles of the activating and the inhibitory Fc gamma Rs were examined. We found that RNA expression of the inhibitory receptor Fc gamma RIIB was up-regulated post-infection, and this was greater after infection with the more virulent PRRSV strain HN07-1. The activating receptor Fc gamma RIIIA RNA expression was on the other hand inhibited to the same extent by both PRRSV strains. Neutralizing antibody titers post-infection by PRRSV strains BJ-4 or HN07-1 were also detected. All of the pigs in infection groups showed viraemia by the end of the study (56 DPI). These observations may help to understand the mechanism of increased susceptibility to secondary bacterial infections following PRRSV infection.	[Wan, Bo; Bao, Dengke; Wang, Yinbiao; Zhang, Gaiping] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China; [Wan, Bo; Qiao, Songlin; Li, Peng; Jin, Qianyue; Liu, Yunchao; Bao, Dengke; Liu, Mingyang; Wang, Yinbiao; Zhang, Gaiping] Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Minist Agr, Key Lab Anim Immunol, Zhengzhou, Peoples R China	Jilin University; Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Qiao, SL (corresponding author), Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Minist Agr, Key Lab Anim Immunol, Zhengzhou, Peoples R China.	cdj565@gmail.com; zhanggaiping2003@163.com		Qiao, Songlin/0000-0001-9731-4943	National Natural Science Foundation of China [31272546, U1204327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 31272546 and No. U1204327) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; ANDERSON CL, 1987, METHOD ENZYMOL, V150, P524; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cavanagh D, 1997, ARCH VIROL, V142, P629; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; DEBETS JMH, 1988, J IMMUNOL, V141, P1197; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Diaz I, 2005, J GEN VIROL, V86, P1943, DOI 10.1099/vir.0.80959-0; DINARELLO CA, 1992, IMMUNOL REV, V127, P119, DOI 10.1111/j.1600-065X.1992.tb01411.x; ERBE DV, 1990, MOL IMMUNOL, V27, P57, DOI 10.1016/0161-5890(90)90060-D; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; FANGER MW, 1989, IMMUNOL TODAY, V10, P92, DOI 10.1016/0167-5699(89)90234-X; FENTON MJ, 1987, J IMMUNOL, V138, P3972; Fernandez MC, 1996, J LEUKOCYTE BIOL, V59, P598, DOI 10.1002/jlb.59.4.598; Fraile L, 2009, CAN J VET RES, V73, P308; Godornes C, 2007, CYTOKINE, V38, P1, DOI 10.1016/j.cyto.2007.04.002; GRESHAM HD, 1988, J CLIN INVEST, V82, P1192, DOI 10.1172/JCI113716; GROSCHUP MH, 1993, J VET MED B, V40, P681, DOI 10.1111/j.1439-0450.1993.tb00192.x; HALLORAN PJ, 1994, J IMMUNOL, V153, P2631; HALLORAN PJ, 1994, CELL IMMUNOL, V158, P400, DOI 10.1006/cimm.1994.1286; Jie HB, 2009, MOL IMMUNOL, V46, P1189, DOI 10.1016/j.molimm.2008.11.013; Jusa ER, 1996, J VET MED SCI, V58, P749, DOI 10.1292/jvms.58.749; LIAO GJ, 1994, J LEUKOCYTE BIOL, V55, P702, DOI 10.1002/jlb.55.6.702; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney JK, 2010, VIRAL IMMUNOL, V23, P127, DOI 10.1089/vim.2009.0087; Malbec O, 1998, J IMMUNOL, V160, P1647; Malbec O, 1999, J IMMUNOL, V162, P4424; Martinez E, 2008, RES VET SCI, V85, P184, DOI 10.1016/j.rvsc.2007.10.003; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Matsuda T, 1999, SHOCK, V12, P365; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; MORGAN EL, 1988, J IMMUNOL, V140, P3014; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Qiao SL, 2006, VET IMMUNOL IMMUNOP, V114, P178, DOI 10.1016/j.vetimm.2006.06.012; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630, DOI 10.4049/jimmunol.170.4.1630; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; ROTHLEIN R, 1982, J IMMUNOL, V129, P1859; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SKOOG WA, 1956, BLOOD, V11, P436, DOI 10.1182/blood.V11.5.436.436; Solano GI, 1997, VET MICROBIOL, V55, P247, DOI 10.1016/S0378-1135(96)01325-9; Solano GI, 1998, CAN J VET RES, V62, P251; Syam S, 2010, J IMMUNOL, V184, P2966, DOI 10.4049/jimmunol.0900016; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Thanawongnuwech R, 1998, VET PATHOL, V35, P398, DOI 10.1177/030098589803500509; TOSI MF, 1988, J IMMUNOL, V141, P2097; TREFZ G, 1987, BIOL CHEM H-S, V368, P1343, DOI 10.1515/bchm3.1987.368.2.1343; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Yang JWJ, 2004, VET IMMUNOL IMMUNOP, V101, P123, DOI 10.1016/j.vetimm.2004.04.018; YOON IJ, 1994, J VET DIAGN INVEST, V6, P289; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51; Zhang GP, 2006, IMMUNOGENETICS, V58, P845, DOI 10.1007/s00251-006-0143-0; Zhou YJ, 2009, VIRUS RES, V144, P136, DOI 10.1016/j.virusres.2009.04.013	63	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66965	10.1371/journal.pone.0066965	http://dx.doi.org/10.1371/journal.pone.0066965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825597	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000051
J	Goldin, MA; Alonso, LM; Alliende, JA; Goller, F; Mindlin, GB				Goldin, Matias A.; Alonso, Leandro M.; Alliende, Jorge A.; Goller, Franz; Mindlin, Gabriel B.			Temperature Induced Syllable Breaking Unveils Nonlinearly Interacting Timescales in Birdsong Motor Pathway	PLOS ONE			English	Article							GENERATION; DYNAMICS; CORTEX; MECHANISM; WHISKING	The nature of telencephalic control over premotor and motor circuits is debated. Hypotheses range from complete usurping of downstream circuitry to highly interactive mechanisms of control. We show theoretically and experimentally, that telencephalic song motor control in canaries is consistent with a highly interactive strategy. As predicted from a theoretical model of respiratory control, mild cooling of a forebrain nucleus (HVC) led to song stretching, but further cooling caused progressive restructuring of song, consistent with the hypothesis that respiratory gestures are subharmonic responses to a timescale present in the output of HVC. This interaction between a life-sustaining motor function (respiration) and telencephalic song motor control suggests a more general mechanism of how nonlinear integration of evolutionarily new brain structures into existing circuitry gives rise to diverse, new behavior.	[Goldin, Matias A.; Alonso, Leandro M.; Alliende, Jorge A.; Mindlin, Gabriel B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Lab Sistemas Dinam, RA-1428 Buenos Aires, DF, Argentina; [Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	University of Buenos Aires; Utah System of Higher Education; University of Utah	Goldin, MA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Lab Sistemas Dinam, RA-1428 Buenos Aires, DF, Argentina.	mgoldin@df.uba.ar	Alonso, Leandro/O-2553-2019; Alonso, Leandro/F-8685-2015	Alonso, Leandro/0000-0001-8211-2855; Mindlin, Gabo/0000-0002-7808-5708; Goldin, Matias/0000-0002-5151-3637	Conicet; University of Buenos Aires; NIH [DC-06876]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006876] Funding Source: NIH RePORTER	Conicet(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Conicet, University of Buenos Aires and NIH DC-06876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Alliende JA, 2010, DEV NEUROBIOL, V70, P943, DOI 10.1002/dneu.20835; Alonso LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041929; Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Andalman AS, 2011, PLOS ONE, V6, pe2546, DOI [10.1371/journal.pone.0025461., DOI 10.1371/J0URNAL.P0NE.0025461]; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Dunsheath P, 1927, NATURE, V120, P363, DOI 10.1038/120363a0; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Friedman WA, 2006, J NEUROPHYSIOL, V95, P1274, DOI 10.1152/jn.00945.2005; Friedman WA, 2012, J NEUROPHYSIOL, V107, P551, DOI 10.1152/jn.01132.2010; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GUCKENHEIMER J, 1997, NONLINEAR OSCILLATIO; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mendez JM, 2012, J NEUROPHYSIOL, V107, P2971, DOI 10.1152/jn.00646.2011; Mindlin GB, 2005, PHYS BIRDSONG; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2008, NEUROSCIENCE BIRDSON, P115; Smotherman M, 2006, J NEUROSCI, V26, P4860, DOI 10.1523/JNEUROSCI.4607-05.2006; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Trevisan MA, 2007, EUR PHYS J-SPEC TOP, V146, P199, DOI 10.1140/epjst/e2007-00180-1; Trevisan MA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058103; Zeigler HP, 2008, NEUROSCIENCE BIRDSON	28	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67814	10.1371/journal.pone.0067814	http://dx.doi.org/10.1371/journal.pone.0067814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818988	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800145
J	Brunberg, E; Jensen, P; Isaksson, A; Keeling, LJ				Brunberg, Emma; Jensen, Per; Isaksson, Anders; Keeling, Linda J.			Behavioural and Brain Gene Expression Profiling in Pigs during Tail Biting Outbreaks - Evidence of a Tail Biting Resistant Phenotype	PLOS ONE			English	Article							GHRELIN; STRESS	Abnormal tail biting behaviour is a major welfare problem for pigs receiving the behaviour, as well as an indication of decreased welfare in the pigs performing it. However, not all pigs in a pen perform or receive tail biting behaviour and it has recently been shown that these 'neutral' pigs not only differ in their behaviour, but also in their gene expression compared to performers and receivers of tail biting in the same pen. To investigate whether this difference was linked to the cause or a consequence of them not being involved in the outbreak of tail biting, behaviour and brain gene expression was compared with 'control' pigs housed in pens with no tail biting. It was shown that the pigs housed in control pens performed a wider variety of pig-directed abnormal behaviour (belly nosing 0.95 +/- 1.59, tail in mouth 0.31 +/- 0.60 and 'other' abnormal 1.53 +/- 4.26; mean +/- S.D) compared to the neutral pigs (belly nosing 0.30 +/- 0.62, tail in mouth 0.13 +/- 0.50 and "other" abnormal 0.42 +/- 1.06). With Affymetrix gene expression arrays, 107 transcripts were identified as differently expressed (p < 0.05) between these two categories of pigs. Several of these transcripts had already been shown to be differently expressed in the neutral pigs when they were compared to performers and receivers of tail biting in the same pen in an earlier study. Hence, the different expression of these genes cannot be a consequence of the neutral pigs not being involved in tail biting behaviour, but rather linked to the cause contributing to why they were not involved in tail biting interactions. These neutral pigs seem to have a genetic and behavioural profile that somehow contributes to them being resistant to performing or receiving pig-directed abnormal behaviour, such as tail biting, even when housed in an environment that elicits that behaviour in other pigs.	[Brunberg, Emma; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden; [Jensen, Per] Linkoping Univ, IFM Biol, Linkoping, Sweden; [Isaksson, Anders] Uppsala Univ, Sci Life Lab, Dept Med Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; Linkoping University; Uppsala University	Brunberg, E (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	emma.brunberg@bioforsk.no	Keeling, Linda J/K-6542-2012	Keeling, Linda J/0000-0003-2629-0117; Isaksson, Anders/0000-0001-6576-7825	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning through Centre for functional genetics; Nordic Joint Commitee for Agricultural and Food Research	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning through Centre for functional genetics; Nordic Joint Commitee for Agricultural and Food Research	The study was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (www.formas.se) through Centre for functional genetics (www.cfg.uu.se) and by the Nordic Joint Commitee for Agricultural and Food Research (www.nkj.nu) through the project "Tail biting and tail docking in the pig: biological mechanisms, prevention, treatment and economic aspects". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beattie VE, 2005, ANIM SCI, V80, P307, DOI 10.1079/ASC40040307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breuer K, 2005, LIVEST PROD SCI, V93, P87, DOI 10.1016/j.livprodsci.2004.11.009; Brunberg E, 2013, GENES BRAIN BEHAV, V12, P275, DOI 10.1111/gbb.12002; Brunberg E, 2011, POULTRY SCI, V90, P1145, DOI 10.3382/ps.2010-00961; Brunberg E, 2011, APPL ANIM BEHAV SCI, V133, P18, DOI 10.1016/j.applanim.2011.04.019; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Edwards SA, 2006, VET J, V171, P198, DOI 10.1016/j.tvjl.2005.04.010; EFSA, 2007, SCI REP RISKS ASS TA; Hillman JB, 2011, DISCOV MED, V11, P521; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keltikangas-Jarvinen L, 2006, GENES BRAIN BEHAV, V5, P11, DOI 10.1111/j.1601-183X.2005.00125.x; Kodomari I, 2009, NEUROCHEM INT, V54, P222, DOI 10.1016/j.neuint.2008.11.006; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Lan J, 2009, MOL BIOL REP, V36, P2003, DOI 10.1007/s11033-008-9411-4; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Moinard C, 2003, APPL ANIM BEHAV SCI, V81, P333, DOI 10.1016/S0168-1591(02)00276-9; Nishizawa T, 2006, J CLIN BIOCHEM NUTR, V38, P33, DOI 10.3164/jcbn.38.33; Poletto R, 2006, BRAIN RES, V1068, P7, DOI 10.1016/j.brainres.2005.11.012; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Statham P, 2009, APPL ANIM BEHAV SCI, V121, P157, DOI 10.1016/j.applanim.2009.09.011; VANPUTTEN G, 1969, BRIT VET J, V125, P511, DOI 10.1016/S0007-1935(17)48710-0; ZAYAN R, 1991, BEHAV PROCESS, V25, P81, DOI 10.1016/0376-6357(91)90011-N; Zonderland JJ, 2011, ANIMAL, V5, P767, DOI 10.1017/S1751731110002326	27	20	20	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66513	10.1371/journal.pone.0066513	http://dx.doi.org/10.1371/journal.pone.0066513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824700	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400119
J	Chen, G; Chen, JW; Shi, CP; Shi, LM; Tong, WD; Shi, TL				Chen, Geng; Chen, Jiwei; Shi, Caiping; Shi, Leming; Tong, Weida; Shi, Tieliu			Dissecting the Characteristics and Dynamics of Human Protein Complexes at Transcriptome Cascade Using RNA-Seq Data	PLOS ONE			English	Article							MESSENGER-RNA; EXPRESSION; QUANTIFICATION; INTERACTOME; CANCER; ANNOTATION; LANDSCAPE; NETWORK; GENOME	Human protein complexes play crucial roles in various biological processes as the functional module. However, the expression features of human protein complexes at the transcriptome cascade are poorly understood. Here, we used the RNA-Seq data from 16 disparate tissues and four types of human cancers to explore the characteristics and dynamics of human protein complexes. We observed that many individual components of human protein complexes can be generated by multiple distinct transcripts. Similar with yeast, the human protein complex constituents are inclined to co-express in diverse tissues. The dominant isoform of the genes involved in protein complexes tend to encode the complex constituents in each tissue. Our results indicate that the protein complex dynamics not only correlate with the presence or absence of complexes, but may also be related to the major isoform switching for complex subunits. Between any two cancers of breast, colon, lung and prostate, we found that only a few of the differentially expressed transcripts associated with complexes were identical, but 5-10 times more protein complexes involved in differentially expressed transcripts were common. Collectively, our study reveals novel properties and dynamics of human protein complexes at the transcriptome cascade in diverse normal tissues and different cancers.	[Chen, Geng; Chen, Jiwei; Shi, Caiping; Shi, Tieliu] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Ctr Bioinformat & Computat Biol, Shanghai 200062, Peoples R China; [Chen, Geng; Chen, Jiwei; Shi, Caiping; Shi, Tieliu] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Shi, Leming; Tong, Weida] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	East China Normal University; East China Normal University; US Food & Drug Administration (FDA)	Shi, TL (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Ctr Bioinformat & Computat Biol, Shanghai 200062, Peoples R China.	tieliushi01@gmail.com	Shi, Leming/B-3150-2010	Shi, Leming/0000-0002-7143-2033; Chen, Jiwei/0000-0002-8783-8134; chen, jiwei/0000-0001-6550-331X; Chen, Geng/0000-0002-3452-9434	National 973 Key Basic Research Program [2010CB945401, 2012CB910400]; National Natural Science Foundation of China [31240038, 31071162, 31000590]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]; Graduate School of East China Normal University	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Graduate School of East China Normal University	This work was supported by the National 973 Key Basic Research Program (Grant Nos. 2010CB945401 and 2012CB910400), the National Natural Science Foundation of China (Grant No. 31240038, 31071162, and 31000590), the Science and Technology Commission of Shanghai Municipality (11DZ2260300) and the Graduate School of East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Chen G, 2013, RNA, V19, P479, DOI 10.1261/rna.037473.112; Chen G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-590; Chen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028318; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Michaut M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001092; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang C, 2013, HUM GENET IN PRESS; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang QH, 2012, EUR J HUM GENET, V20, P1162, DOI 10.1038/ejhg.2012.74; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	48	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66521	10.1371/journal.pone.0066521	http://dx.doi.org/10.1371/journal.pone.0066521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824284	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400121
J	Hernandez-Bartolome, A; Lopez-Rodriguez, R; Rodriguez-Munoz, Y; Martin-Vilchez, S; Borque, MJ; Garcia-Buey, L; Gonzalez-Moreno, L; Real, Y; Moreno-Otero, R; Sanz-Cameno, P				Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Jesus Borque, Maria; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma			Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; INFLAMMATORY LIVER-DISEASE; PRIMARY BILIARY-CIRRHOSIS; VIRUS-INFECTION; TUMOR ANGIOGENESIS; EXPRESSION; MARKERS; INDEX; MECHANISMS; BIOPSY	Aims: Accurate liver fibrosis staging is crucial for the management of chronic hepatitis C (CHC). The invasiveness and cost burden of liver biopsy have driven the search for new noninvasive biomarkers of fibrosis. Based on the link between serum angiopoietin-1 and 2 levels and CHC progression, we aimed to determine the value of these angiogenic factors as noninvasive biomarkers of liver fibrosis. Methods: Serum levels of angiopoietin-1 and -2 were measured by ELISA in 108 CHC patients who underwent pretreatment liver biopsy. The correlation between angiopoietins and clinical and demographic variables with liver fibrosis was analyzed by univariate regression. Significant factors were then subjected to multivariate analysis, from which we constructed a novel noninvasive liver fibrosis index (AngioScore), whose performance was validated in an independent series of 71 CHC patients. The accuracy of this model was compared with other documented fibrosis algorithms by De Long test. Results: Angiopoietins correlated significantly with hepatic fibrosis; however, only angiopoietin-2 was retained in the final model, which also included age, platelets, AST, INR, and GGT. The model was validated and behaved considerably better than other fibrosis indices in discriminating all, significant, moderate and severe liver fibrosis (0.886, 0.920, 0.923). Using clinically relevant cutoffs, we classified CHC patients by discarding significant fibrosis and diagnosing moderate and severe fibrosis with greater accuracy, sensitivity, and specificity. Conclusions: Our novel noninvasive liver fibrosis model, based on serum angiopoietin-2 levels, outperforms other indices and should help substantially in managing CHC and monitoring long-term follow-up prognosis.	[Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Univ Autonoma Madrid, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Gastroenterol Serv,Liver Unit, Madrid, Spain; [Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Jesus Borque, Maria; Sanz-Cameno, Paloma] Hosp Univ La Princesa, Mol Biol Unit, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital de La Princesa	Moreno-Otero, R (corresponding author), Univ Autonoma Madrid, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Gastroenterol Serv,Liver Unit, Madrid, Spain.	rmoreno.hlpr@salud.madrid.org	Martin-Vilchez, Samuel/AFV-2112-2022; Sanz, Paloma/C-7799-2014; Lopez-Rodriguez, Rosario/M-3381-2014; Chaparro, María/I-2500-2016; López-Rodríguez, Rosario/AAB-2290-2022	Martin-Vilchez, Samuel/0000-0003-0557-7653; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; Chaparro, María/0000-0002-9275-4242; López-Rodríguez, Rosario/0000-0002-4713-0633	Ministerio de Ciencia e Innovacion (SAF) [2010/21805]; CIBERehd (Instituto de Salud Carlos III, Madrid); Fundacion Mutua Madrilena to Ricardo Moreno-Otero; Paloma Sanz-Cameno; Asociacion Espanola Contra el Cancer (AIO)	Ministerio de Ciencia e Innovacion (SAF); CIBERehd (Instituto de Salud Carlos III, Madrid)(Instituto de Salud Carlos III); Fundacion Mutua Madrilena to Ricardo Moreno-Otero; Paloma Sanz-Cameno; Asociacion Espanola Contra el Cancer (AIO)	This work was partially supported by the Ministerio de Ciencia e Innovacion (SAF: 2010/21805), CIBERehd (Instituto de Salud Carlos III, Madrid) and Fundacion Mutua Madrilena to Ricardo Moreno-Otero and Paloma Sanz-Cameno. Paloma Sanz-Cameno has a grant from Asociacion Espanola Contra el Cancer (AIO 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kobayashi H, 2005, FRONT BIOSCI-LANDMRK, V10, P666, DOI 10.2741/1561; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Melgar-Lesmes P, 2009, GUT, V58, P285, DOI 10.1136/gut.2008.155028; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Paradis V, 2003, GASTROENTEROLOGY, V124, P651, DOI 10.1053/gast.2003.50104; Poordad FF, 2004, EXPERT REV MOL DIAGN, V4, P593, DOI 10.1586/14737159.4.5.593; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Salcedo X, 2005, HEPATOLOGY, V42, P696, DOI 10.1002/hep.20828; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sanz-Cameno P, 2002, J HEPATOL, V37, P723, DOI 10.1016/S0168-8278(02)00266-0; Sanz-Cameno P, 2006, AM J PATHOL, V169, P1215, DOI 10.2353/ajpath.2006.051246; Sanz-Cameno P, 2010, J ONCOL, V2010, DOI 10.1155/2010/272170; Scholz A, 2007, AM J GASTROENTEROL, V102, P2471, DOI 10.1111/j.1572-0241.2007.01377.x; Sebastiani G, 2012, J VIRAL HEPATITIS, V19, P18, DOI 10.1111/j.1365-2893.2011.01518.x; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sugimachi K, 2003, J CLIN PATHOL, V56, P854, DOI 10.1136/jcp.56.11.854; Tanaka S, 1999, J CLIN INVEST, V103, P341, DOI 10.1172/JCI4891; Tanaka S, 2003, J GASTROENTEROL, V38, P93; Tanaka S, 2002, HEPATOLOGY, V35, P861, DOI 10.1053/jhep.2002.32535; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Vespasiani-Gentilucci U, 2011, J INTERF CYTOK RES, V31, P207, DOI 10.1089/jir.2010.0040; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Westin J, 2008, SCAND J GASTROENTERO, V43, P73, DOI 10.1080/00365520701514461; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66143	10.1371/journal.pone.0066143	http://dx.doi.org/10.1371/journal.pone.0066143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823085	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400057
J	Kumar, V; Nadda, G; Kumar, S; Yadav, SK				Kumar, Vinay; Nadda, Gireesh; Kumar, Sanjay; Yadav, Sudesh Kumar			Transgenic Tobacco Overexpressing Tea cDNA Encoding Dihydroflavonol 4-Reductase and Anthocyanidin Reductase Induces Early Flowering and Provides Biotic Stress Tolerance	PLOS ONE			English	Article							PROANTHOCYANIDIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; ECTOPIC EXPRESSION; CAMELLIA-SINENSIS; GENE; FLAVAN-3-OLS; PATHWAYS; ENZYMES; PROTEIN; ACID	Flavan-3-ols contribute significantly to flavonoid content of tea (Camellia sinensis L.). Dihydroflavonol 4-reductase (DFR) and anthocyanidin reductase (ANR) are known to be key regulatory enzymes of flavan-3-ols biosynthesis. In this study, we have generated the transgenic tobacco overexpressing individually tea cDNA CsDFR and CsANR encoding for DFR and ANR to evaluate their influence on developmental and protective abilities of plant against biotic stress. The transgenic lines of CsDFR and CsANR produced early flowering and better seed yield. Both types of transgenic tobacco showed higher content of flavonoids than control. Flavan-3-ols such as catechin, epicatechin and epicatechingallate were found to be increased in transgenic lines. The free radical scavenging activity of CsDFR and CsANR transgenic lines was improved. Oxidative stress was observed to induce lesser cell death in transgenic lines compared to control tobacco plants. Transgenic tobacco overexpressing CsDFR and CsANR also showed resistance against infestation by a tobacco leaf cutworm Spodoptera litura. Results suggested that the overexpression of CsDFR and CsANR cDNA in tobacco has improved flavonoids content and antioxidant potential. These attributes in transgenic tobacco have ultimately improved their growth and development, and biotic stress tolerance.	[Kumar, Vinay; Kumar, Sanjay; Yadav, Sudesh Kumar] CSIR, CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India; [Nadda, Gireesh] CSIR, CSIR Inst Himalayan Bioresource Technol, HATS Div, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Yadav, SK (corresponding author), CSIR, CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	sudeshkumar@ihbt.res.in		Nadda, Gireesh/0000-0002-7321-7951	Council of Scientific and Industrial Research (CSIR), GOI under NMITLI program [TLP003]	Council of Scientific and Industrial Research (CSIR), GOI under NMITLI program	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), GOI under NMITLI program (TLP003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; Auger B, 2009, PLANTA, V230, P1167, DOI 10.1007/s00425-009-1017-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Filippo I, 2006, PHYTOCHEMISTRY ADV R, pa23; Goldberg-Moeller R, 2013, PLANT SCI, V198, P46, DOI 10.1016/j.plantsci.2012.09.012; Han YP, 2012, J EXP BOT, V63, P2437, DOI 10.1093/jxb/err415; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hong LL, 2012, PLANTA, V236, P141, DOI 10.1007/s00425-012-1598-x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Joshi R, 2011, SCI HORTIC-AMSTERDAM, V130, P266, DOI 10.1016/j.scienta.2011.06.007; Kelen M, 2004, TURK J CHEM, V28, P603; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Koskimaki JJ, 2009, EUR J PLANT PATHOL, V125, P629, DOI 10.1007/s10658-009-9511-6; Kovinich N, 2012, T RES, DOI [10.1007/s11248-011-9566-y, DOI 10.1007/S1]; Kumar V, 2013, MOL BIOTECHNOL, V53, P118, DOI 10.1007/s12033-012-9495-x; Li HH, 2012, MOL BIOL REP, V39, P2991, DOI 10.1007/s11033-011-1061-2; Lo Piero AR, 2006, PHYTOCHEMISTRY, V67, P684, DOI 10.1016/j.phytochem.2006.01.025; Lukaszewicz M, 2004, J AGR FOOD CHEM, V52, P1526, DOI 10.1021/jf034482k; Mahajan M, 2012, PLANT BIOLOGY, V14, P725, DOI 10.1111/j.1438-8677.2011.00550.x; Mahajan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028315; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Reddy AM, 2007, METAB ENG, V9, P95, DOI 10.1016/j.ymben.2006.09.003; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Shen GA, 2006, J PLANT PHYSIOL, V163, P224, DOI 10.1016/j.jplph.2005.06.012; Shimada A, 2005, Z NATURFORSCH C, V60, P572; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Singh K, 2008, TREE PHYSIOL, V28, P1349, DOI 10.1093/treephys/28.9.1349; Singh K, 2009, TREE PHYSIOL, V29, P837, DOI 10.1093/treephys/tpp022; Singh K, 2009, PLANT BIOTECHNOL REP, V3, P95, DOI 10.1007/s11816-008-0079-y; Takahashi H, 2006, ANN BOT-LONDON, V98, P819, DOI 10.1093/aob/mcl162; Tian Li, 2008, Phytochemistry Reviews, V7, P445, DOI 10.1007/s11101-007-9076-y; Uefuji H, 2005, PLANT MOL BIOL, V59, P221, DOI 10.1007/s11103-005-8520-x; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.02655.x; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946	48	23	28	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65535	10.1371/journal.pone.0065535	http://dx.doi.org/10.1371/journal.pone.0065535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823500	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400008
J	Pacheco, SA; Powers, KM; Engelmann, F; Messaoudi, I; Purdy, GE				Pacheco, Sophia A.; Powers, Katelyn M.; Engelmann, Flora; Messaoudi, Ilhem; Purdy, Georgiana E.			Autophagic Killing Effects against Mycobacterium tuberculosis by Alveolar Macrophages from Young and Aged Rhesus Macaques	PLOS ONE			English	Article							CD8 T-CELLS; LATENT TUBERCULOSIS; EARLY RESISTANCE; MICE; IMMUNITY; EXPRESSION; PHAGOSOMES; SURVIVAL; ACIDIFICATION; REACTIVATION	Non-human primates, notably rhesus macaques (Macaca mulatta, RM), provide a robust experimental model to investigate the immune response to and effective control of Mycobacterium tuberculosis infections. Changes in the function of immune cells and immunosenescence may contribute to the increased susceptibility of the elderly to tuberculosis. The goal of this study was to examine the impact of age on M. tuberculosis host-pathogen interactions following infection of primary alveolar macrophages derived from young and aged rhesus macaques. Of specific interest to us was whether the mycobactericidal capacity of autophagic macrophages was reduced in older animals since decreased autophagosome formation and autophagolysosomal fusion has been observed in other cells types of aged animals. Our data demonstrate that alveolar macrophages from old RM are as competent as those from young animals for autophagic clearance of M. tuberculosis infection and controlling mycobacterial replication. While our data do not reveal significant differences between alveolar macrophage responses to M. tuberculosis by young and old animals, these studies are the first to functionally characterize autophagic clearance of M. tuberculosis by alveolar macrophages from RM.	[Pacheco, Sophia A.; Powers, Katelyn M.; Messaoudi, Ilhem; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Engelmann, Flora; Messaoudi, Ilhem] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Engelmann, Flora; Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA	Oregon Health & Science University; University of California System; University of California Riverside; Oregon Health & Science University; Oregon National Primate Research Center	Purdy, GE (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	purdyg@ohsu.edu			Pacific Northwest Regional Center for Excellence for Emerging Infections and Biodefense Career Development Award [U54 AI081680]; Medical Research Foundation of Oregon New Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680] Funding Source: NIH RePORTER	Pacific Northwest Regional Center for Excellence for Emerging Infections and Biodefense Career Development Award; Medical Research Foundation of Oregon New Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pacific Northwest Regional Center for Excellence for Emerging Infections and Biodefense (U54 AI081680) Career Development Award and a Medical Research Foundation of Oregon New Investigator Award to G.E.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; Boehmer ED, 2005, MECH AGEING DEV, V126, P1305, DOI 10.1016/j.mad.2005.07.009; Choi HS, 2002, AM J RESP CRIT CARE, V166, P178, DOI 10.1164/rccm.2201023; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Flynn JL, 2003, TUBERCULOSIS, V83, P116, DOI 10.1016/S1472-9792(02)00059-8; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HIGASHIMOTO Y, 1993, MECH AGEING DEV, V69, P207, DOI 10.1016/0047-6374(93)90024-L; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Mancuso P, 2001, MECH AGEING DEV, V122, P1899, DOI 10.1016/S0047-6374(01)00322-0; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; ORME IM, 1987, J IMMUNOL, V138, P4414; ORME IM, 1989, CELL IMMUNOL, V118, P229, DOI 10.1016/0008-8749(89)90372-9; Plowden J, 2004, CELL IMMUNOL, V229, P86, DOI 10.1016/j.cellimm.2004.07.001; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Rhoades ER, 1998, MECH AGEING DEV, V106, P145, DOI 10.1016/S0047-6374(98)00113-4; Rottinghaus EK, 2010, MECH AGEING DEV, V131, P405, DOI 10.1016/j.mad.2010.05.006; Safi H, 2003, AIDS RES HUM RETROV, V19, P585, DOI 10.1089/088922203322230950; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Turner J, 2002, INFECT IMMUN, V70, P4628, DOI 10.1128/IAI.70.8.4628-4637.2002; Vesosky B, 2006, EXP GERONTOL, V41, P1185, DOI 10.1016/j.exger.2006.08.006; Vesosky B, 2009, INFECT IMMUN, V77, P3355, DOI 10.1128/IAI.00295-09; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66985	10.1371/journal.pone.0066985	http://dx.doi.org/10.1371/journal.pone.0066985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825603	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400173
J	Sakai, F; Talekar, SJ; Klugman, KP; Vidal, JE				Sakai, Fuminori; Talekar, Sharmila J.; Klugman, Keith P.; Vidal, Jorge E.		Investigators Grp	Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children	PLOS ONE			English	Article							SURFACE PROTEIN-A; TIME PCR ASSAYS; PNEUMOCOCCAL CARRIAGE; ANTIBODY-RESPONSE; BIOFILM FORMATION; GENOME SEQUENCE; ADHESIN-A; PNEUMOLYSIN; COLONIZATION; PROTECTION	Colonization and persistence in the human nasopharynx are prerequisites for Streptococcus pneumoniae disease and carriage acquisition, which normally occurs during early childhood. Animal models and in vitro studies (i.e. cell adhesion and cell cytotoxicity assays) have revealed a number of colonization and virulence factors, as well as regulators, implicated in nasopharyngeal colonization and pathogenesis. Expression of genes encoding these factors has never been studied in the human nasopharynx. Therefore, this study analyzed expression of S. pneumoniae virulence-related genes in human nasopharyngeal samples. Our experiments first demonstrate that a density of >= 10(4) CFU/ml of S. pneumoniae cells in the nasopharynx provides enough DNA and RNA to amplify the lytA gene by conventional PCR and to detect the lytA message, respectively. A panel of 21 primers that amplified S. pneumoniae sequences was designed, and their specificity for S. pneumoniae sequences was analyzed in silico and validated against 20 related strains inhabitants of the human upper respiratory tract. These primers were utilized in molecular reactions to find out that all samples contained the genes ply, pavA, lytC, lytA, comD, codY, and mgrA, whereas nanA, nanB, pspA, and rrgB were present in similar to 91-98% of the samples. Gene expression studies of these 11 targets revealed that lytC, lytA, pavA and comD were the most highly expressed pneumococcal genes in the nasopharynx whereas the rest showed a moderate to low level of expression. This is the first study to evaluate expression of virulence- and, colonization-related genes in the nasopharynx of healthy children and establishes the foundation for future gene expression studies during human pneumococcal disease.	[Sakai, Fuminori; Talekar, Sharmila J.; Klugman, Keith P.; Vidal, Jorge E.; Investigators Grp] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Vidal, JE (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	jvidalg@emory.edu	Lanata, Claudio F./N-7997-2018	Lanata, Claudio F./0000-0002-6994-7425	Clinical and Translational Science Award program [UL1 RR025008]; NIH; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER	Clinical and Translational Science Award program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by PHS Grant UL1 RR025008 from the Clinical and Translational Science Award program, NIH, National Center for Research Resources (JEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Domenech M, 2013, ENVIRON MICROBIOL, V15, P502, DOI 10.1111/j.1462-2920.2012.02853.x; Douce G, 2010, VACCINE, V28, P3231, DOI 10.1016/j.vaccine.2010.02.014; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jounio U, 2010, CLIN RESPIR J, V4, P222, DOI 10.1111/j.1752-699X.2009.00179.x; Joyce EA, 2004, INFECT IMMUN, V72, P2964, DOI 10.1128/IAI.72.5.2964-2975.2004; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Moreno AT, 2012, CLIN VACCINE IMMUNOL, V19, P499, DOI 10.1128/CVI.05706-11; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Park HK, 2010, FEMS MICROBIOL LETT, V310, P48, DOI 10.1111/j.1574-6968.2010.02044.x; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rodgers Gail L, 2011, Vaccine, V29 Suppl 3, pC43, DOI 10.1016/j.vaccine.2011.07.047; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; RUBINS JB, 1992, INFECT IMMUN, V60, P1740, DOI 10.1128/IAI.60.5.1740-1746.1992; Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11; Seo SU, 2012, VACCINE, V30, P6816, DOI 10.1016/j.vaccine.2012.09.015; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2001, J INFECT DIS, V183, P887, DOI 10.1086/319246; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sommer F, 2012, RHINOLOGY, V50, P157, DOI 10.4193/Rhino11.231; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Vadesilho CFM, 2012, MICROB PATHOGENESIS, V53, P243, DOI 10.1016/j.micpath.2012.08.007; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vidal JE, 2013, INFECT IMMUN, V81, P1341, DOI 10.1128/IAI.01096-12; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Wright AKA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002622; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	61	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67147	10.1371/journal.pone.0067147	http://dx.doi.org/10.1371/journal.pone.0067147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825636	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400177
J	Werner, S; Frey, S; Riethdorf, S; Schulze, C; Alawi, M; Kling, L; Vafaizadeh, V; Sauter, G; Terracciano, L; Schumacher, U; Pantel, K; Assmann, V				Werner, Stefan; Frey, Sabrina; Riethdorf, Sabine; Schulze, Christian; Alawi, Malik; Kling, Lea; Vafaizadeh, Vida; Sauter, Guido; Terracciano, Luigi; Schumacher, Udo; Pantel, Klaus; Assmann, Volker			Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; TAMOXIFEN RESISTANCE; BONE-MARROW; CELL-LINES; ERBB3; RECEPTOR; FAMILY; EXPRESSION; DROSOPHILA; HEAD	Using a retrovirus-mediated cDNA expression cloning approach, we identified the grainyhead-like 2 (GRHL2) transcription factor as novel protooncogene. Overexpression of GRHL2 in NIH3T3 cells induced striking morphological changes, an increase in cell proliferation, anchorage-independent growth, and tumor growth in vivo. By combining a microarray analysis and a phylogenetic footprinting analysis with various biochemical assays, we identified the epidermal growth factor receptor family member Erbb3 as a novel GRHL2 target gene. In breast cancer cell lines, shRNA-mediated knockdown of GRHL2 expression or functional inactivation of GRHL2 using dominant negative GRHL2 proteins induces down-regulation of ERBB3 gene expression, a striking reduction in cell proliferation, and morphological and phenotypical alterations characteristic of an epithelial-to-mesenchymal transition (EMT), thus implying contradictory roles of GRHL2 in breast carcinogenesis. Interestingly, we could further demonstrate that expression of GRHL2 is directly suppressed by the transcription factor zinc finger enhancer-binding protein 1 (ZEB1), which in turn is a direct target for repression by GRHL2, suggesting that the EMT transcription factors GRHL2 and ZEB1 form a double negative regulatory feedback loop in breast cancer cells. Finally, a comprehensive immunohistochemical analysis of GRHL2 expression in primary breast cancers showed loss ofGRHL2expression at the invasive front of primary tumors. A pathophysiological relevance of GRHL2 in breast cancer metastasis is further demonstrated by our finding of a statistically significant association between loss of GRHL2 expression in primary breast cancers and lymph node metastasis. We thus demonstrate a crucial role of GRHL2 in breast carcinogenesis.	[Werner, Stefan; Frey, Sabrina; Riethdorf, Sabine; Kling, Lea; Pantel, Klaus; Assmann, Volker] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, D-20246 Hamburg, Germany; [Schulze, Christian] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20246 Hamburg, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, D-20246 Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat 2, D-20246 Hamburg, Germany; [Vafaizadeh, Vida] Inst Biomed Res, D-60596 Frankfurt, Germany; [Terracciano, Luigi] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel	Assmann, V (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dept Tumor Biol, Martinistr 52, D-20246 Hamburg, Germany.	v.assmann@uke.de	Terracciano, Luigi M./AAB-5335-2022; Schulze, Christian/AGJ-7744-2022; , Malik/AAB-7437-2021	Terracciano, Luigi M./0000-0002-9393-9660; Schulze, Christian/0000-0001-9442-7141; , Malik/0000-0002-5993-7709; Vafaizadeh, Vida/0000-0002-0875-6246; Schulze, Christian/0000-0002-1442-1987	European Research Council [ERC-2010-AdG_20100317 DISSECT]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council Grant ERC-2010-AdG_20100317 DISSECT (to K. P.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Assmann V, 1999, J CELL SCI, V112, P3943; Assmann V, 1998, J CELL SCI, V111, P1685; Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dompe N, 2011, P NATL ACAD SCI USA, V108, pE943, DOI 10.1073/pnas.1100132108; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Dworkin S, 2012, DEVELOPMENT, V139, P525, DOI 10.1242/dev.066522; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moussian B, 2005, BIOESSAYS, V27, P987, DOI 10.1002/bies.20308; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Rifat Y, 2010, DEV BIOL, V345, P237, DOI 10.1016/j.ydbio.2010.07.017; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Simon R, 2002, EXP HEMATOL, V30, P1365, DOI 10.1016/S0301-472X(02)00965-7; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tanaka Y, 2008, J HEPATOL, V49, P746, DOI 10.1016/j.jhep.2008.06.019; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781; Yang XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056195	56	87	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22993	23008		10.1074/jbc.M113.456293	http://dx.doi.org/10.1074/jbc.M113.456293			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23814079	Green Published, hybrid			2022-12-25	WOS:000330598200010
J	Mullins, CD; Su, MY; Hucthagowder, V; Chu, L; Lu, L; Kulkarni, S; Novack, D; Vij, R; Tomasson, MH				Mullins, Chelsea D.; Su, Mack Y.; Hucthagowder, Vishwanathan; Chu, Liang; Lu, Lan; Kulkarni, Shashikant; Novack, Deborah; Vij, Ravi; Tomasson, Michael H.			Germinal Center B-Cells Resist Transformation by Kras Independently of Tumor Suppressor Arf	PLOS ONE			English	Article							K-RAS ONCOGENE; MULTIPLE-MYELOMA; CONDITIONAL EXPRESSION; ACTIVATING MUTATIONS; SOMATIC ACTIVATION; P16 GENE; METHYLATION; P16(INK4A); PATHWAY; CANCER	Activating mutations in Ras (N- and K-) are the most common point mutations found in patients with multiple myeloma (MM) and are associated with poor clinical outcome. We sought to directly examine the role of Ras activation in MM pathogenesis and used two different tissue-specific Cre recombinase mouse lines (C gamma 1-Cre and AID-Cre), to generate mice with mutant Kras (Kras(G12D)) activated specifically in germinal center B-cells. We also generated mice with activation of the Kras(G12D) allele in a tumor-prone Arf-null genetic background. Surprisingly, we observed no significant disruption in B-cell homeostasis in any of these models by serum immunoglobulin ELISA, SPEP, flow cytometry and histological examination. We observed development of non-overlapping tumor types due to off-target Cre expression, but despite successful recombination in germinal center and later B-cell populations, we observed no B-cell phenotype. Together, these data demonstrate that Ras activation is not sufficient to transform primary germinal center B-cells, even in an Arf-null context, and that the temporal order of mutation acquisition may be critical for myeloma development. Specific pathways, yet to be identified, are required before Kras can contribute to the development of MM.	[Mullins, Chelsea D.; Su, Mack Y.; Chu, Liang; Lu, Lan; Vij, Ravi; Tomasson, Michael H.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Hucthagowder, Vishwanathan; Kulkarni, Shashikant; Novack, Deborah] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Tomasson, MH (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	tomasson@dom.wustl.edu		Mullins, C. Daniel/0000-0003-4322-2490; Tomasson, Michael/0000-0003-4518-7123; Novack, Deborah/0000-0001-7101-5582	Barnes Hospital Foundation; National Institute on Aging [NIH R21AG040777]; Harvey and Linda Saligman Fund for Myeloma Research at Washington University in St. Louis; NATIONAL INSTITUTE ON AGING [R21AG040777] Funding Source: NIH RePORTER	Barnes Hospital Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harvey and Linda Saligman Fund for Myeloma Research at Washington University in St. Louis; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Barnes Hospital Foundation, the National Institute on Aging (NIH R21AG040777) and the Harvey and Linda Saligman Fund for Myeloma Research at Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bezieau S, 2001, HUM MUTAT, V18, P212, DOI 10.1002/humu.1177; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chng WJ, 2008, LEUKEMIA, V22, P2280, DOI 10.1038/leu.2008.142; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dilworth D, 2000, BLOOD, V95, P1869, DOI 10.1182/blood.V95.5.1869.005k09_1869_1871; Gonzalez M, 2000, LEUKEMIA, V14, P183, DOI 10.1038/sj.leu.2401617; Gonzalez-Paz N, 2007, BLOOD, V109, P1228, DOI 10.1182/blood-2006-05-024661; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hucthagowder V, 2012, CANCER GENET-NY, V205, P474, DOI 10.1016/j.cancergen.2012.06.007; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamijo T, 1999, CANCER RES, V59, P2217; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu PC, 1996, BLOOD, V88, P2699, DOI 10.1182/blood.V88.7.2699.bloodjournal8872699; Mateos MV, 2002, BRIT J HAEMATOL, V118, P1034, DOI 10.1046/j.1365-2141.2002.03749.x; Ng MHL, 1997, BLOOD, V89, P2500, DOI 10.1182/blood.V89.7.2500; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rasmussen T, 2010, HAEMATOL-HEMATOL J, V95, P1730, DOI 10.3324/haematol.2010.024778; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Tasaka T, 1997, BRIT J HAEMATOL, V96, P98, DOI 10.1046/j.1365-2141.1997.8552482.x; Taylor BJ, 2008, BLOOD, V112, P1894, DOI 10.1182/blood-2008-01-129221; VESCIO RA, 1995, J IMMUNOL, V155, P2487; Wong IHN, 1998, BRIT J HAEMATOL, V103, P168; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67941	10.1371/journal.pone.0067941	http://dx.doi.org/10.1371/journal.pone.0067941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825691	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000125
J	Parcej, D; Guntrum, R; Schmidt, S; Hinz, A; Tampe, R				Parcej, David; Guntrum, Renate; Schmidt, Sabine; Hinz, Andreas; Tampe, Robert			Multicolour Fluorescence-Detection Size-Exclusion Chromatography for Structural Genomics of Membrane Multiprotein Complexes	PLOS ONE			English	Article							PEPTIDE-LOADING COMPLEX; VIRUS PROTEIN ICP47; PICHIA-PASTORIS; INSECT CELLS; IN-VIVO; TAP; EXPRESSION; PURIFICATION; INHIBITION	Many interesting and important membrane proteins are hetero-oligomeric. However, besides naturally abundant examples, the structures of relatively few such complexes are known. Partly, this is due to difficulties in expression, stoichiometric assembly, and in the evaluation of their stability prior to crystallization trials. Here we describe a new approach, which allows rapid assessment of protein complex quality, assembly and stoichiometry, simplifying the search for conditions conducive to long-term stability and crystallization. Multicolour fluorescence size-exclusion chromatography (MC-FSEC) is used to enable tracking of individual subunits through expression, solubilization and purification steps. We show how the method has been applied to the heterodimeric transporter associated with antigen processing (TAP) and demonstrate how it may be extended in order to analyse membrane multisubunit assemblies.	[Parcej, David; Guntrum, Renate; Schmidt, Sabine; Hinz, Andreas; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, D-60054 Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, D-60054 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Parcej, David/AAW-7306-2020; Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	The German Research Foundation (SFB 807-Transport and Communication across Biological Membranes, TA157/7 to RT) and the European Drug Initiative on Channels and Transporters (EDICT to RT) funded by the European Commission Seventh Framework Program supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Cha HJ, 2004, BIOTECHNOL LETT, V26, P1157, DOI 10.1023/B:BILE.0000035489.09417.d4; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen H, 2013, PROTEIN EXPRES PURIF, V88, P134, DOI 10.1016/j.pep.2012.12.003; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew David, 2012, Methods Mol Biol, V866, P209, DOI 10.1007/978-1-61779-770-5_18; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Hammon J, 2009, PROTEIN SCI, V18, P121, DOI 10.1002/pro.18; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hulpke S, 2012, FASEB J, V26, P5071, DOI 10.1096/fj.12-217489; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Leung J, 2013, MOL MEMBR BIOL, V30, P32, DOI 10.3109/09687688.2012.690572; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Pedelacq JD, 2002, NAT BIOTECHNOL, V20, P927, DOI 10.1038/nbt732; Pfander R, 1999, BIOCHEMISTRY-US, V38, P13692, DOI 10.1021/bi9909647; Pieper U, 2013, NAT STRUCT MOL BIOL, V20, P135, DOI 10.1038/nsmb.2508; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Stroud Robert Michael, 2011, F1000 Biol Rep, V3, P8, DOI 10.3410/B3-8; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	34	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67112	10.1371/journal.pone.0067112	http://dx.doi.org/10.1371/journal.pone.0067112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825631	Green Published, gold			2022-12-25	WOS:000321223000081
J	Pierson, JC; Allendorf, FW; Drapeau, P; Schwartz, MK				Pierson, Jennifer C.; Allendorf, Fred W.; Drapeau, Pierre; Schwartz, Michael K.			Breed Locally, Disperse Globally: Fine-Scale Genetic Structure Despite Landscape-Scale Panmixia in a Fire-Specialist	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; BLACK-BACKED WOODPECKERS; POPULATION-DYNAMICS; PHILOPATRY; METAPOPULATIONS; EXTINCTION; FLOW; DIFFERENTIATION; RELATEDNESS; TRACKING	An exciting advance in the understanding of metapopulation dynamics has been the investigation of how populations respond to ephemeral patches that go 'extinct' during the lifetime of an individual. Previous research has shown that this scenario leads to genetic homogenization across large spatial scales. However, little is known about fine-scale genetic structuring or how this changes over time in ephemeral patches. We predicted that species that specialize on ephemeral habitats will delay dispersal to exploit natal habitat patches while resources are plentiful and thus display fine-scale structure. To investigate this idea, we evaluated the effect of frequent colonization of ephemeral habitats on the fine-scale genetic structure of a fire specialist, the black-backed woodpecker (Picoides arcticus) and found a pattern of fine-scale genetic structure. We then tested for differences in spatial structure between sexes and detected a pattern consistent with male-biased dispersal. We also detected a temporal increase in relatedness among individuals within newly burned forest patches. Our results indicate that specialist species that outlive their ephemeral patches can accrue significant fine-scale spatial structure that does not necessarily affect spatial structure at larger scales. This highlights the importance of both spatial and temporal scale considerations in both sampling and data interpretation of molecular genetic results.	[Pierson, Jennifer C.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Allendorf, Fred W.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Drapeau, Pierre] Univ Quebec, Dept Sci Biol, Ctr Etud Foret, Montreal, PQ H3C 3P8, Canada; [Schwartz, Michael K.] US Forest Serv, Rocky Mt Res Stn, Missoula, MT USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Quebec; University of Quebec Montreal; United States Department of Agriculture (USDA); United States Forest Service	Pierson, JC (corresponding author), CSIRO Black Mt Site, Canberra, ACT, Australia.	jencpierson@gmail.com	Schwartz, Michael K/C-3184-2014	Schwartz, Michael K/0000-0003-3521-3367; Drapeau, Pierre/0000-0002-1115-2531; Pierson, Jennifer/0000-0003-4140-010X	Montana Fish, Wildlife and Parks; Bureau of Land Management; Glacier National Park; Glacier Fund; U.S.D.A. Forest Service; Y2Y Science Grants; Wilburforce Foundation; McIntire-Stennis Cooperative Research Program; National Center for Landscape Fire Analysis; Northwest Scientific Association; Five Valleys Audubon; American Association of University Women; P.E.O. Scholar Award; National Science Foundation; University of Montana; Fonds quebecois de recherche sur la nature et les technologies (FQRNT); Grand Jardins Provincial Park; Natural Science and Engineering Research Council of Canada (NSERC)	Montana Fish, Wildlife and Parks; Bureau of Land Management; Glacier National Park; Glacier Fund; U.S.D.A. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Y2Y Science Grants; Wilburforce Foundation; McIntire-Stennis Cooperative Research Program; National Center for Landscape Fire Analysis; Northwest Scientific Association; Five Valleys Audubon; American Association of University Women; P.E.O. Scholar Award; National Science Foundation(National Science Foundation (NSF)); University of Montana; Fonds quebecois de recherche sur la nature et les technologies (FQRNT)(FQRNT); Grand Jardins Provincial Park; Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by Montana Fish, Wildlife and Parks, Bureau of Land Management, Glacier National Park, The Glacier Fund, U.S.D.A. Forest Service, Y2Y Science Grants and Wilburforce Foundation, McIntire-Stennis Cooperative Research Program, National Center for Landscape Fire Analysis, Northwest Scientific Association and Five Valleys Audubon. Support for J. Pierson was provided by the American Association of University Women, P.E.O. Scholar Award, National Science Foundation and The University of Montana. Financial support for the Grands Jardins study was provided by the Fonds quebecois de recherche sur la nature et les technologies (FQRNT) - Programme Action concertee - Fonds Forestier, Grand Jardins Provincial Park, and a Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant (P. Drapeau). The authors received the Alberta Samples from Shawna Pelech. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Bonnot TW, 2008, CONDOR, V110, P450, DOI 10.1525/cond.2008.8460; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Dixon RD, 2000, BIRDS N AM, P509; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Ellegren H, 1999, HEREDITAS, V130, P291, DOI 10.1111/j.1601-5223.1999.00291.x; ELLEGREN H, 1992, AUK, V109, P886, DOI 10.2307/4088163; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Lecomte N, 2009, MOL ECOL, V18, P593, DOI 10.1111/j.1365-294X.2008.04067.x; Lee JW, 2009, MOL ECOL, V18, P2728, DOI 10.1111/j.1365-294X.2009.04228.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lynch M, 1999, GENETICS, V152, P1753; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; Murphy EC, 1998, J WILDLIFE MANAGE, V62, P1359, DOI 10.2307/3802002; Nappi A, 2009, BIOL CONSERV, V142, P1381, DOI 10.1016/j.biocon.2009.01.022; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Ortego J, 2011, ANIM BEHAV, V82, P131, DOI 10.1016/j.anbehav.2011.04.007; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pierson J. C., 2009, THESIS U MONTANA; Pierson JC, 2010, EVOL APPL, V3, P263, DOI 10.1111/j.1752-4571.2009.00111.x; Piertney SB, 1998, MOL ECOL, V7, P1247; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Saint-Germain M, 2008, DIVERS DISTRIB, V14, P713, DOI 10.1111/j.1472-4642.2007.00452.x; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Shanahan DF, 2011, LANDSCAPE ECOL, V26, P137, DOI 10.1007/s10980-010-9542-6; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Vierling KT, 2008, J WILDLIFE MANAGE, V72, P422, DOI 10.2193/2006-212; Vila M, 2008, MOL ECOL RESOUR, V8, P415, DOI 10.1111/j.1471-8286.2007.01976.x; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wright S, 1943, GENETICS, V28, P114	45	19	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67248	10.1371/journal.pone.0067248	http://dx.doi.org/10.1371/journal.pone.0067248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825646	gold, Green Published, Green Submitted			2022-12-25	WOS:000321223000092
J	Silveira, SM; Villacis, RAR; Marchi, FA; Barros, MD; Drigo, SA; Neto, CS; Lopes, A; da Cunha, IW; Rogatto, SR				Silveira, Sara Martoreli; Rios Villacis, Rolando Andre; Marchi, Fabio Albuquerque; Barros Filho, Mateus de Camargo; Drigo, Sandra Aparecida; Neto, Cristovam Scapulatempo; Lopes, Ademar; da Cunha, Isabela Werneck; Rogatto, Silvia Regina			Genomic Signatures Predict Poor Outcome in Undifferentiated Pleomorphic Sarcomas and Leiomyosarcomas	PLOS ONE			English	Article							MALIGNANT FIBROUS HISTIOCYTOMAS; SOFT-TISSUE SARCOMAS; DNA COPY NUMBER; GENE-EXPRESSION ANALYSIS; HYBRIDIZATION ANALYSIS; CYTOGENETIC ANALYSIS; CANCER; CLASSIFICATION; AMPLIFICATION; ABERRATIONS	Undifferentiated high-grade pleomorphic sarcomas (UPSs) display aggressive clinical behavior and frequently develop local recurrence and distant metastasis. Because these sarcomas often share similar morphological patterns with other tumors, particularly leiomyosarcomas (LMSs), classification by exclusion is frequently used. In this study, array-based comparative genomic hybridization (array CGH) was used to analyze 20 UPS and 17 LMS samples from untreated patients. The LMS samples presented a lower frequency of genomic alterations compared with the UPS samples. The most frequently altered UPS regions involved gains at 20q13.33 and 7q22.1 and losses at 3p26.3. Gains at 8q24.3 and 19q13.12 and losses at 9p21.3 were frequently detected in the LMS samples. Of these regions, gains at 1q21.3, 11q12.2-q12.3, 16p11.2, and 19q13.12 were significantly associated with reduced overall survival times in LMS patients. A multivariate analysis revealed that gains at 1q21.3 were an independent prognostic marker of shorter survival times in LMS patients (HR = 13.76; P = 0.019). Although the copy number profiles of the UPS and LMS samples could not be distinguished using unsupervised hierarchical clustering analysis, one of the three clusters presented cases associated with poor prognostic outcome (P=0.022). A relative copy number analysis for the ARNT, SLC27A3, and PBXIP1 genes was performed using quantitative real-time PCR in 11 LMS and 16 UPS samples. Gains at 1q21-q22 were observed in both tumor types, particularly in the UPS samples. These findings provide strong evidence for the existence of a genomic signature to predict poor outcome in a subset of UPS and LMS patients.	[Silveira, Sara Martoreli; Rios Villacis, Rolando Andre; Barros Filho, Mateus de Camargo; Rogatto, Silvia Regina] AC Camargo Canc Ctr, Neogene Lab, Sao Paulo, Brazil; [Marchi, Fabio Albuquerque] Univ Sao Paulo, Inst Math & Stat, Interinst Program Bioinformat, BR-09500900 Sao Paulo, Brazil; [Drigo, Sandra Aparecida; Rogatto, Silvia Regina] Univ Estadual Paulista, Fac Med, Dept Urol, Sao Paulo, Brazil; [Neto, Cristovam Scapulatempo] Barretos Canc Hosp, Pio Fdn 12, Dept Pathol, Sao Paulo, Brazil; [Lopes, Ademar] AC Camargo Canc Ctr, Dept Pelv Surg, Sao Paulo, Brazil; [da Cunha, Isabela Werneck] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil	A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade Estadual Paulista; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center	Rogatto, SR (corresponding author), AC Camargo Canc Ctr, Neogene Lab, Sao Paulo, Brazil.	silvia.rogatto@cipe.accamargo.org.br	Drigo, Sandra A/I-6514-2012; LINDE, SANDRA/S-3128-2019; Rogatto, Silvia R/E-6535-2012; Filho, Mateus C Barros/J-1544-2015; Marchi, Fabio A/N-9288-2018; Cunha, Isabela/H-3013-2012; Lopes, Ademar/G-8526-2014	Drigo, Sandra A/0000-0001-6747-6642; LINDE, SANDRA/0000-0001-6747-6642; Filho, Mateus C Barros/0000-0003-3893-5269; Marchi, Fabio A/0000-0001-5815-8423; Cunha, Isabela/0000-0002-2029-5139; Lopes, Ademar/0000-0002-8317-3817; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Villacis, Rolando/0000-0003-3851-2696; Rogatto, Silvia/0000-0003-4637-5687	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [1998/14335-2, 2008/55693-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (1998/14335-2 and 2008/55693-2) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Carneiro A, 2009, LAB INVEST, V89, P668, DOI 10.1038/labinvest.2009.18; Chibon F, 2003, CANCER GENET CYTOGEN, V141, P75, DOI 10.1016/S0165-4608(02)00664-7; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Curtis LJ, 1998, GENOMICS, V53, P42, DOI 10.1006/geno.1998.5405; Derre J, 2001, LAB INVEST, V81, P211, DOI 10.1038/labinvest.3780229; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Erlandson RA, 2004, ULTRASTRUCT PATHOL, V28, P283, DOI 10.1080/019131290882150; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.x; Fletcher CDM., 2002, WHO CLASSIFICATION T; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P8, DOI 10.1002/gcc.2870140103; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Fujiwara M, 2011, TUMOR BIOL, V32, P611, DOI 10.1007/s13277-011-0160-y; Gibault L, 2011, J PATHOL, V223, P64, DOI 10.1002/path.2787; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hallor KH, 2009, J PATHOL, V217, P716, DOI 10.1002/path.2513; Hu J, 2005, CANCER GENET CYTOGEN, V161, P20, DOI 10.1016/j.cancergencyto.2005.01.011; Kresse SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015378; Larramendy ML, 2008, CANCER GENET CYTOGEN, V187, P1, DOI 10.1016/j.cancergencyto.2008.06.005; Larramendy ML, 1997, AM J PATHOL, V151, P1153; Lee YF, 2003, BRIT J CANCER, V88, P510, DOI 10.1038/sj.bjc.6600766; Levy B, 2000, CANCER GENET CYTOGEN, V121, P1, DOI 10.1016/S0165-4608(00)00225-9; Liu SL, 2012, TARGET ONCOL, V7, P135, DOI 10.1007/s11523-012-0215-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis-Brennetot C, 2011, GENE CHROMOSOME CANC, V50, P896, DOI 10.1002/gcc.20909; Mairal A, 1999, CANCER GENET CYTOGEN, V111, P134, DOI 10.1016/S0165-4608(98)00227-1; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Mertens F, 1998, GENE CHROMOSOME CANC, V22, P16, DOI 10.1002/(SICI)1098-2264(199805)22:1<16::AID-GCC3>3.0.CO;2-A; Mills AM, 2011, AM J SURG PATHOL, V35, P583, DOI 10.1097/PAS.0b013e318211abd6; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P155, DOI 10.1002/gcc.2870140302; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nascimento AF, 2008, J SURG ONCOL, V97, P330, DOI 10.1002/jso.20972; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Oda Y, 2012, TOXICOL APPL PHARM, V260, P222, DOI 10.1016/j.taap.2012.02.012; Osuna D, 2009, REV RECENT CLIN TRIA, V4, P12, DOI 10.2174/157488709787047585; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pei ZT, 2009, CANCER RES, V69, P9175, DOI 10.1158/0008-5472.CAN-08-4689; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Szymanska J, 1997, CANCER GENET CYTOGEN, V99, P14, DOI 10.1016/S0165-4608(96)00436-0; Thompson FH, 1996, CANCER GENET CYTOGEN, V87, P55, DOI 10.1016/0165-4608(95)00248-0; Wang CYY, 2012, CANCER RES, V72, P1013, DOI 10.1158/0008-5472.CAN-11-2531; Wang R, 2001, GENE CHROMOSOME CANC, V31, P54, DOI 10.1002/gcc.1118; Wardelmann E, 2010, ANN ONCOL, V21, P265, DOI 10.1093/annonc/mdq381; Weng WH, 2003, BRIT J CANCER, V89, P720, DOI 10.1038/sj.bjc.6601069; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yamamoto J, 2004, LIFE SCI, V74, P1039, DOI 10.1016/j.lfs.2003.07.022; Yang JL, 2009, CANCER LETT, V275, P1, DOI 10.1016/j.canlet.2008.06.013	49	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67643	10.1371/journal.pone.0067643	http://dx.doi.org/10.1371/journal.pone.0067643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825676	Green Published, gold, Green Submitted			2022-12-25	WOS:000321223000112
J	Guy, F; Gouvard, F; Boistel, R; Euriat, A; Lazzari, V				Guy, Franck; Gouvard, Florent; Boistel, Renaud; Euriat, Adelaide; Lazzari, Vincent			Prospective in (Primate) Dental Analysis through Tooth 3D Topographical Quantification	PLOS ONE			English	Article							ENAMEL DISTRIBUTION PATTERNS; TECHNICAL NOTE; LOWER MOLARS; 3-DIMENSIONAL ANALYSIS; TISSUE PROPORTIONS; SEXUAL-DIMORPHISM; THICKNESS; OCCLUSAL; MORPHOLOGY; DIET	The occlusal morphology of the teeth is mostly determined by the enamel-dentine junction morphology; the enamel-dentine junction plays the role of a primer and conditions the formation of the occlusal enamel reliefs. However, the accretion of the enamel cap yields thickness variations that alter the morphology and the topography of the enamel-dentine junction (i.e., the differential deposition of enamel by the ameloblasts create an external surface that does not necessarily perfectly parallel the enamel-dentine junction). This self-reliant influence of the enamel on tooth morphology is poorly understood and still under-investigated. Studies considering the relationship between enamel and dentine morphologies are rare, and none of them tackled this relationship in a quantitative way. Major limitations arose from: (1) the difficulties to characterize the tooth morphology in its comprehensive tridimensional aspect and (2) practical issues in relating enamel and enamel-dentine junction quantitative traits. We present new aspects of form representation based exclusively on 3D analytical tools and procedures. Our method is applied to a set of 21 unworn upper second molars belonging to eight extant anthropoid genera. Using geometrical analysis of polygonal meshes representatives of the tooth form, we propose a 3D dataset that constitutes a detailed characterization of the enamel and of the enamel-dentine junction morphologies. Also, for the first time, to our knowledge, we intend to establish a quantitative method for comparing enamel and enamel-dentine junction surfaces descriptors (elevation, inclination, orientation, etc.). New indices that allow characterizing the occlusal morphology are proposed and discussed. In this note, we present technical aspects of our method with the example of anthropoid molars. First results show notable individual variations and taxonomic heterogeneities for the selected topographic parameters and for the pattern and strength of association between enamel-dentine junction and enamel, the enamel cap altering in different ways the "transcription" of the enamel-dentine junction morphology.	[Guy, Franck; Gouvard, Florent; Boistel, Renaud; Euriat, Adelaide; Lazzari, Vincent] Univ Poitiers, IPHEP Inst Paleoprimatol & Paleontol Humaine Evol, Ctr Natl Rech Sci, Inst Ecol & Environm,Fac Sci,UMR 7262, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Guy, F (corresponding author), Univ Poitiers, IPHEP Inst Paleoprimatol & Paleontol Humaine Evol, Ctr Natl Rech Sci, Inst Ecol & Environm,Fac Sci,UMR 7262, Poitiers, France.	franck.guy@univ-poitiers.fr		Lazzari, Vincent/0000-0002-8210-2646; GUY, Franck/0000-0001-7032-7963	Centre of Microtomographie of the University of Poitiers; Agence Nationale de la Recherche [ANR-09-BLAN-0238]; region Poitou-Charentes [07/RPC-R-100, 12/RPC-013]	Centre of Microtomographie of the University of Poitiers; Agence Nationale de la Recherche(French National Research Agency (ANR)); region Poitou-Charentes(Region Nouvelle-Aquitaine)	This work was made possible by the Centre of Microtomographie of the University of Poitiers and supported by the Agence Nationale de la Recherche (ANR-09-BLAN-0238) and the region Poitou-Charentes (Conventions Region #07/RPC-R-100 & #12/RPC-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2006, J DENT, V34, P503, DOI 10.1016/j.jdent.2005.12.001; Anemone RL, 2012, PALAEONTOL ELECTRON, V15; ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; Benazzi S, 2009, J HUM EVOL, V56, P286, DOI 10.1016/j.jhevol.2008.07.006; Bernal V, 2007, HOMO, V58, P279, DOI 10.1016/j.jchb.2006.11.003; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Boyer DM, 2008, J HUM EVOL, V55, P1118, DOI 10.1016/j.jhevol.2008.08.002; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Bunn JM, 2009, AM J PRIMATOL, V71, P466, DOI 10.1002/ajp.20676; Butler PM, 1999, P 11 INT S DENT MORP, P26; Cleghorn BM, 2006, J ENDODONT, V32, P813, DOI 10.1016/j.joen.2006.04.014; CORRUCCINI RS, 1987, INT J PRIMATOL, V8, P99, DOI 10.1007/BF02735159; Dennis JC, 2004, AM J PHYS ANTHROPOL, V125, P152, DOI 10.1002/ajpa.10379; Durrleman S, 2012, J HUM EVOL, V62, P74, DOI 10.1016/j.jhevol.2011.10.004; Elewa AMT, 2011, COMPUTATIONAL PALEONTOLOGY, P1, DOI 10.1007/978-3-642-16271-8; Emonet EG, 2012, J HUM EVOL, V62, P146, DOI 10.1016/j.jhevol.2011.11.011; Evans A, 2007, J VERTEBR PALEONTOL, V27, p72A; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 1998, J ZOOL, V246, P391, DOI 10.1017/S0952836998009832; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; Gilbert CC, 2009, J HUM EVOL, V57, P298, DOI 10.1016/j.jhevol.2009.05.013; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Guatelli-Steinberg D, 2005, P NATL ACAD SCI USA, V102, P14197, DOI 10.1073/pnas.0503108102; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; Hlusko LJ, 2006, AM J PHYS ANTHROPOL, V131, P420, DOI 10.1002/ajpa.20435; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Hu JCC, 2005, CELLS TISSUES ORGANS, V181, P219, DOI 10.1159/000091383; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Koh C, 2010, AM J PHYS ANTHROPOL, V142, P246, DOI 10.1002/ajpa.21221; Kondo S, 2005, AM J PHYS ANTHROPOL, V128, P870, DOI 10.1002/ajpa.20084; Kono Reiko T., 2008, Bulletin of the National Science Museum Series D (Anthropology), V34, P1; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kono RT, 2002, ARCH ORAL BIOL, V47, P867, DOI 10.1016/S0003-9969(02)00151-6; Kullmer O, 2012, ANAT REC, V295, P846, DOI 10.1002/ar.22440; Kullmer Ottmar, 2002, BAR International Series, V1049, P71; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Lazzari V, 2010, J MAMM EVOL, V17, P177, DOI 10.1007/s10914-010-9139-5; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; M'Kirera F, 2003, AM J PRIMATOL, V60, P31, DOI 10.1002/ajp.10077; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; McCollum MA, 2001, BIOESSAYS, V23, P481, DOI 10.1002/bies.1068; Morimoto N, 2009, 1 INT S BIOL SHAP AN, P266; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; Pilbrow V, 2006, J HUM EVOL, V51, P646, DOI 10.1016/j.jhevol.2006.07.008; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; Rosenfeld A, 2004, DIGITAL GEOMETRY GEO; Rugis J, 2006, LECT NOTES COMPUT SC, V4319, P138; Russ JC., 2011, IMAGE PROCESSING HDB; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Shimizu D, 2002, J HUM EVOL, V43, P605, DOI 10.1006/jhev.2002.0593; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Somma F, 2009, INT ENDOD J, V42, P165, DOI 10.1111/j.1365-2591.2008.01472.x; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Ulhaas L, 2004, ANN ANAT, V186, P487, DOI 10.1016/S0940-9602(04)80090-6; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Zanolli C, 2010, CR PALEVOL, V9, P341, DOI 10.1016/j.crpv.2010.07.019; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zuccotti LF, 1998, AM J PHYS ANTHROPOL, V107, P137, DOI 10.1002/(SICI)1096-8644(199809)107:1<137::AID-AJPA11>3.0.CO;2-1	84	28	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66142	10.1371/journal.pone.0066142	http://dx.doi.org/10.1371/journal.pone.0066142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826088	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400010
J	Bales, PM; Renke, EM; May, SL; Shen, Y; Nelson, DC				Bales, Patrick M.; Renke, Emilija Miljkovic; May, Sarah L.; Shen, Yang; Nelson, Daniel C.			Purification and Characterization of Biofilm-Associated EPS Exopolysaccharides from ESKAPE Organisms and Other Pathogens	PLOS ONE			English	Article							POLYMERIC SUBSTANCES EPS; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BIOCHEMICAL-CHARACTERIZATION; INFECTIOUS-DISEASES; BACTERIAL BIOFILMS; COLANIC ACID	In bacterial biofilms, high molecular weight, secreted exopolysaccharides can serve as a scaffold to which additional carbohydrates, proteins, lipids, and nucleic acids adhere, forming the matrix of the developing biofilm. Here we report methods to extract and purify high molecular weight (>15 kDa) exopolysaccharides from biofilms of eight human pathogens, including species of Staphylcococcus, Klebsiella, Acinetobacter, Pseudomonas, and a toxigenic strain of Escherichia coli O157:H7. Glycosyl composition analysis indicated a high total mannose content across all strains with P. aeruginosa and A. baumannii exopolysaccharides comprised of 80-90% mannose, K. pneumoniae and S. epidermidis strains containing 40-50% mannose, and E. coli with similar to 10% mannose. Galactose and glucose were also present in all eight strains, usually as the second and third most abundant carbohydrates. N-acetyl-glucosamine and galacturonic acid were found in 6 of 8 strains, while arabinose, fucose, rhamnose, and xylose were found in 5 of 8 strains. For linkage analysis, 33 distinct residue-linkage combinations were detected with the most abundant being mannose-linked moieties, in line with the composition analysis. The exopolysaccharides of two P. aeruginosa strains analyzed were consistent with the Psl carbohydrate, but not Pel or alginate. The S. epidermidis strain had a composition rich in mannose and glucose, which is consistent with the previously described slime associated antigen (SAA) and the extracellular slime substance (ESS), respectively, but no polysaccharide intracellular adhesion (PIA) was detected. The high molecular weight exopolysaccharides from E. coli, K. pneumoniae, and A. baumannii appear to be novel, based on composition and/or ratio analysis of carbohydrates.	[Bales, Patrick M.; Renke, Emilija Miljkovic; May, Sarah L.; Shen, Yang; Nelson, Daniel C.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Nelson, DC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA.	nelsond@umd.edu	Shen, Yang/X-2665-2018; Nelson, Daniel C./I-2198-2012	Shen, Yang/0000-0003-4278-1477; Nelson, Daniel C./0000-0003-3248-4831	U.S. Department of Defense [DM102823]; Cosmos Club Foundation's Young Scholars Grant Program; Howard Hughes Medical Institute Undergraduate Science Education Program	U.S. Department of Defense(United States Department of Defense); Cosmos Club Foundation's Young Scholars Grant Program; Howard Hughes Medical Institute Undergraduate Science Education Program(Howard Hughes Medical Institute)	This work was supported by a grant from the U.S. Department of Defense (DM102823) to DCN. PMB acknowledges support from the Cosmos Club Foundation's Young Scholars Grant Program. Support for EMR was provided by a grant to the University of Maryland from the Howard Hughes Medical Institute Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S., 2009, CHARACTERIZATION BAC; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Azeredo J, 1999, WATER SCI TECHNOL, V39, P243, DOI 10.2166/wst.1999.0365; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906, DOI 10.1128/IAI.58.9.2906-2911.1990; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Comte S, 2007, J HAZARD MATER, V140, P129, DOI 10.1016/j.jhazmat.2006.06.058; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELSASSERBEILE U, 1978, CARBOHYD RES, V65, P245, DOI 10.1016/S0008-6215(00)84316-5; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; JUNKINS AD, 1992, CURR MICROBIOL, V25, P9, DOI 10.1007/BF01570076; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; KAPLAN N, 1985, EUR J BIOCHEM, V152, P453, DOI 10.1111/j.1432-1033.1985.tb09218.x; Kives J, 2006, COLLOID SURFACE B, V52, P123, DOI 10.1016/j.colsurfb.2006.04.018; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Liu H, 2002, J BIOTECHNOL, V95, P249, DOI 10.1016/S0168-1656(02)00025-1; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; National Institutes of Health, 2002, PA03047 NIH; Oliveira R, 1999, BIOTECHNOL TECH, V13, P391, DOI 10.1023/A:1008954301470; Pan XL, 2010, WATER SA, V36, P111; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; PETERS G, 1987, ZENTRALBLATT BAKTE S, V16, P15; Ratto M, 2001, APPL MICROBIOL BIOT, V57, P182; Revdiwala S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/945805; Sandal I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-186; Seo MJ, 2011, J MICROBIOL BIOTECHN, V21, P1287, DOI 10.4014/jmb.1106.06046; Shemesh M, 2007, J MED MICROBIOL, V56, P1528, DOI 10.1099/jmm.0.47146-0; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5; SUTHERLAND IW, 1969, BIOCHEM J, V115, P935, DOI 10.1042/bj1150935; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2; SUTHERLAND IW, 1965, J GEN MICROBIOL, V39, P373, DOI 10.1099/00221287-39-3-373; TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Yadav KK, 2012, APPL BIOCHEM BIOTECH, V168, P1621, DOI 10.1007/s12010-012-9883-5; YORK WS, 1986, METHOD ENZYMOL, V118, P3; YUREWICZ EC, 1971, J BIOL CHEM, V246, P5607	55	128	136	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67950	10.1371/journal.pone.0067950	http://dx.doi.org/10.1371/journal.pone.0067950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805330	Green Submitted, gold, Green Published			2022-12-25	WOS:000320846500158
J	Martini, S; Al Ali, B; Garel, M; Nerini, D; Grossi, V; Pacton, M; Casalot, L; Cuny, P; Tamburini, C				Martini, Severine; Al Ali, Badr; Garel, Marc; Nerini, David; Grossi, Vincent; Pacton, Muriel; Casalot, Laurence; Cuny, Philippe; Tamburini, Christian			Effects of Hydrostatic Pressure on Growth and Luminescence of a Moderately-Piezophilic Luminous Bacteria Photobacterium phosphoreum ANT-2200	PLOS ONE			English	Article							MEMBRANE-LIPIDS; SEA; BIOLUMINESCENCE; CARBON; SNOW; GENE; TEMPERATURE; CONSUMPTION; EXPRESSION; SEDIMENT	Bacterial bioluminescence is commonly found in the deep sea and depends on environmental conditions. Photobacterium phosphoreum ANT-2200 has been isolated from the NW Mediterranean Sea at 2200-m depth (in situ temperature of 13 degrees C) close to the ANTARES neutrino telescope. The effects of hydrostatic pressure on its growth and luminescence have been investigated under controlled laboratory conditions, using a specifically developed high-pressure bioluminescence system. The growth rate and the maximum population density of the strain were determined at different temperatures (from 4 to 37 degrees C) and pressures (from 0.1 to 40 MPa), using the logistic model to define these two growth parameters. Indeed, using the growth rate only, no optimal temperature and pressure could be determined. However, when both growth rate and maximum population density were jointly taken into account, a cross coefficient was calculated. By this way, the optimum growth conditions for P. phosphoreum ANT-2200 were found to be 30 degrees C and, 10 MPa defining this strain as mesophile and moderately piezophile. Moreover, the ratio of unsaturated vs. saturated cellular fatty acids was found higher at 22 MPa, in agreement with previously described piezophile strains. P. phosphoreum ANT-2200 also appeared to respond to high pressure by forming cell aggregates. Its maximum population density was 1.2 times higher, with a similar growth rate, than at 0.1 MPa. Strain ANT-2200 grown at 22 MPa produced 3 times more bioluminescence. The proposed approach, mimicking, as close as possible, the in situ conditions, could help studying deep-sea bacterial bioluminescence and validating hypotheses concerning its role into the carbon cycle in the deep ocean.	[Martini, Severine; Al Ali, Badr; Garel, Marc; Nerini, David; Casalot, Laurence; Cuny, Philippe; Tamburini, Christian] Aix Marseille Univ, CNRS INSU, IRD, Mediterranean Inst Oceanog,UM 110, Marseille, France; [Martini, Severine; Al Ali, Badr; Garel, Marc; Nerini, David; Casalot, Laurence; Cuny, Philippe; Tamburini, Christian] Univ Sud Toulon Var, CNRS INSU, IRD, Mediterranean Inst Oceanog,UM 110, La Garde, France; [Grossi, Vincent] Univ Lyon 1, CNRS, Lab Geol Lyon, UMR5276, F-69622 Villeurbanne, France; [Pacton, Muriel] ETH, Inst Geol, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tamburini, C (corresponding author), Aix Marseille Univ, CNRS INSU, IRD, Mediterranean Inst Oceanog,UM 110, Marseille, France.	christian.tamburini@univ-amu.fr	Casalot, Laurie/B-7536-2013; Casalot, Laurie/ABB-7062-2021; Tamburini, Christian/I-7821-2012; Tamburini, Christian/AAO-8577-2020; Grossi, Vincent/G-6493-2010	Casalot, Laurie/0000-0002-4191-6889; Casalot, Laurie/0000-0002-4191-6889; Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Grossi, Vincent/0000-0001-6263-3813; martini, severine/0000-0001-9471-1708; NERINI, DAVID/0000-0002-7995-1364; Garel, Marc/0000-0002-4374-5905	ANR-POTES [ANR-05-BLAN-0161-01]; Agence Nationale de la Recherche; Aix-Marseille Universite; CNRS; Ministry of Education, Research and Technology, France; Syria Ministry of Higher Education	ANR-POTES(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Aix-Marseille Universite; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministry of Education, Research and Technology, France; Syria Ministry of Higher Education	This work was funded by the ANR-POTES program (ANR-05-BLAN-0161-01) supported by the Agence Nationale de la Recherche, by the AAMIS program (Aix-Marseille Universite) and by EC2CO BIOLUX program (CNRS). SM was granted a MERNT fellowship (Ministry of Education, Research and Technology, France). BAA was supported by a fellowship funded by the Syria Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 1999, TRENDS MICROBIOL, V7, P447, DOI 10.1016/S0966-842X(99)01608-X; Abe F, 1999, BAROPHYSIOLOGY EXTRE, P227; Al Ali B, 2010, CHEM ECOL, V26, P57, DOI 10.1080/02757540903513766; ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; ANDREWS CC, 1984, NATURE, V307, P539, DOI 10.1038/307539a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; BARTLETT D, 1989, NATURE, V342, P572, DOI 10.1038/342572a0; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; BARTLETT DH, 1992, SCI PROG, V76, P479; BARTLETT DH, 1995, RES MICROBIOL, V146, P697, DOI 10.1016/0923-2508(96)81066-7; Bartlett DH, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P333; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourgois JJ, 2001, J BIOENERG BIOMEMBR, V33, P353, DOI 10.1023/A:1010615508916; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; Christie WW, 1989, GAS CHROMATOGRAPHY L, P64; Czyz A, 2000, MICROBIOL-UK, V146, P283, DOI 10.1099/00221287-146-2-283; DELONG EF, 1985, SCIENCE, V228, P1101, DOI 10.1126/science.3992247; DeLong EF, 1997, APPL ENVIRON MICROB, V63, P2105, DOI 10.1128/AEM.63.5.2105-2108.1997; Dunlap PV, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P863, DOI 10.1007/0-387-30742-7_27; Eloe EA, 2011, APPL ENVIRON MICROB, V77, P8145, DOI 10.1128/AEM.05204-11; FANG J, 2010, DISCOVER, V31, P18; Gentile G, 2009, DEEP-SEA RES PT II, V56, P763, DOI 10.1016/j.dsr2.2008.07.023; GROGAN DW, 1984, ARCH MICROBIOL, V137, P159, DOI 10.1007/BF00414459; Grossi V, 2010, ENVIRON MICROBIOL, V12, P2020, DOI 10.1111/j.1462-2920.2010.02213.x; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HASTINGS JW, 1983, B MAR SCI, V33, P818; Herring P.J., 1987, Journal of Bioluminescence and Chemiluminescence, V1, P147, DOI 10.1002/bio.1170010303; Hmelo LR, 2011, ENV MICROBIOL REP, V3, P682, DOI 10.1111/j.1758-2229.2011.00281.x; KAMIMURA K, 1993, APPL ENVIRON MICROB, V59, P924, DOI 10.1128/AEM.59.3.924-926.1993; KATO C, 1994, FEMS MICROBIOL LETT, V122, P91, DOI 10.1111/j.1574-6968.1994.tb07149.x; Kato C, 1995, JAMSTECR, V32, P7; Kato C, 2008, PROTEIN ADAPTATION E, P167; Kita-Tsukamoto K, 2006, FEMS MICROBIOL LETT, V256, P298, DOI 10.1111/j.1574-6968.2006.00129.x; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; NEALSON KH, 1977, ARCH MICROBIOL, V112, P9, DOI 10.1007/BF00446648; Nealson KH, 1978, METHOD ENZYMOL, V57, P153; Ploug H, 2000, LIMNOL OCEANOGR, V45, P1467, DOI 10.4319/lo.2000.45.7.1467; Pooley DT, 2011, PHOTOCHEM PHOTOBIOL, V87, P324, DOI 10.1111/j.1751-1097.2010.00864.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; R Core Team, 2012, R LANG ENV STAT COMP; RUBY EG, 1979, APPL ENVIRON MICROB, V38, P406, DOI 10.1128/AEM.38.3.406-411.1979; RUBY EG, 1980, APPL ENVIRON MICROB, V39, P302, DOI 10.1128/AEM.39.2.302-306.1980; Schweitzer B, 2001, APPL ENVIRON MICROB, V67, P632, DOI 10.1128/AEM.67.2.632-645.2001; Shively JM, 2001, BACTERIAL ARCHAEAL I; Tamburini C, 2009, DEEP-SEA RES PT II, V56, P1533, DOI 10.1016/j.dsr2.2008.12.035; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Yamada M, 2000, J BACTERIOL, V182, P2945, DOI 10.1128/JB.182.10.2945-2952.2000; Yanagibayashi M, 1999, FEMS MICROBIOL LETT, V170, P271, DOI 10.1016/S0378-1097(98)00556-4; Yano Y, 1998, APPL ENVIRON MICROB, V64, P479; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021; YAYANOS AA, 1986, P NATL ACAD SCI USA, V83, P9542, DOI 10.1073/pnas.83.24.9542; Zarubin M, 2012, P NATL ACAD SCI USA, V109, P853, DOI 10.1073/pnas.1116683109; ZOBELL CE, 1949, J BACTERIOL, V57, P179, DOI 10.1128/JB.57.2.179-189.1949	58	24	25	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66580	10.1371/journal.pone.0066580	http://dx.doi.org/10.1371/journal.pone.0066580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818946	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800082
J	Schmidt, JH; Gorn, TS				Schmidt, Joshua H.; Gorn, Tony S.			Possible Secondary Population-Level Effects of Selective Harvest of Adult Male Muskoxen	PLOS ONE			English	Article							MOOSE ALCES-ALCES; SEX-RATIO; BODY CONDITION; MULE DEER; DYNAMICS; AGE; MANAGEMENT; NUTRITION; HISTORY; CALVES	Selective harvest regimes are often focused on males resulting in skewed sex-ratios, and for many ungulate species this strategy is sustainable. However, muskoxen (Ovibos moschatus) are very social and mature bulls (>= 4 years old), particularly prime-age bulls (6-10 years old), play important roles in predator defense and recruitment. A year-round social structure incorporating large males into mixed-sex groups could make this species more susceptible to the effects of selective harvest if population composition and sex-ratios influence overall survival and reproductive success. Using detailed data collected on the muskox population occupying the Seward Peninsula, Alaska during 2002-2012, we formulated the hypothesis that the selective harvest of mature bulls may be related to documented changes in population composition and growth rates in this species. In addition, we reviewed existing published information from two other populations in Alaska, the Cape Thompson and Northeastern populations, to compare population growth rates among the three areas under differential harvest rates relative to our hypothesis. We found that on the Seward Peninsula, mature bull: adult cow ratios declined 4-12%/ year and short-yearling: adult cow ratios (i.e., recruitment) declined 8-9%/year in the most heavily harvested areas. Growth rates in all 3 populations decreased disproportionately after increases in the number of bulls harvested, and calf: cow ratios declined in the Northeastern population as harvest increased. While lack of appropriate data prevented us from excluding other potential causes such as density dependent effects and changes in predator densities, our results did align with our hypothesis, suggesting that in the interest of conservation, harvest of mature males should be restricted until causal factors can be more definitively identified. If confirmed by additional research, our findings would have important implications for harvest management and conservation of muskoxen and other ungulate species with similar life-histories.	[Schmidt, Joshua H.] Natl Pk Serv, Cent Alaska Network, Fairbanks, AK USA; [Gorn, Tony S.] Alaska Dept Fish & Game, Div Wildlife Conservat, Nome, AK USA	United States Department of the Interior; Alaska Department of Fish & Game	Schmidt, JH (corresponding author), Natl Pk Serv, Cent Alaska Network, Fairbanks, AK USA.	joshua_schmidt@nps.gov			Federal Aid in Wildlife Restoration; Alaska Department of Fish and Game, Western Arctic Parklands; U.S. National Park Service Inventory and Monitoring Program	Federal Aid in Wildlife Restoration; Alaska Department of Fish and Game, Western Arctic Parklands; U.S. National Park Service Inventory and Monitoring Program	Support for this project was provided by Federal Aid in Wildlife Restoration, the Alaska Department of Fish and Game, Western Arctic Parklands, and the U.S. National Park Service Inventory and Monitoring Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LG, 1995, J WILDLIFE MANAGE, V59, P584, DOI 10.2307/3802467; Allen J. A., 1912, Science New York Ser 2, V36, DOI 10.1126/science.36.934.720; [Anonymous], 1965, CANADIAN WILDLIFE SE, V2; Barboza PS, 2004, INT CONGR SER, V1275, P327, DOI 10.1016/j.ics.2004.09.040; Bishop CJ, 2005, WILDLIFE SOC B, V33, P662, DOI 10.2193/0091-7648(2005)33[662:EOLAHO]2.0.CO;2; Boertje RD, 2009, J WILDLIFE MANAGE, V73, P314, DOI 10.2193/2007-591; Buckland S.T., 2001, pi; CARBYN LN, 1988, ARCTIC, V41, P297; Conroy M.J., 2009, QUANTITATIVE CONSERV; Czaplewski R.L., 1983, Wildlife Society Bulletin, V11, P121; Dau J, 2001, MUSKOX MANAGEMENT RE, P31; Dau J, 2007, MUSKOX MANAGEMENT RE, P35; Dobson A, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P193; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gorn TS., 2011, MUSKOX MANAGEMENT RE, P16; Gray DR, 1974, MUSK OX, V14, P25; Gray DR, 1987, MUSKOXEN POLAR BEAR; GUNN A, 1982, ARCTIC, V35, P545; GUNN A, 1991, ARCTIC, V44, P188; Gunn A., 1982, P1021; Gunn A., 2003, WILD MAMMALS N AM BI, V2nd, P1076; Harper P, 2009, MUSKOX MANAGEMENT RE; Hone E., 1934, Special Publications of the American Committee on International Wild Life Protection, Vno. 5, P1; Hunter CM, 2004, J WILDLIFE MANAGE, V68, P585, DOI 10.2193/0022-541X(2004)068[0585:TIOEVA]2.0.CO;2; Ihl C, 2011, J MAMMAL, V92, P819, DOI 10.1644/10-MAMM-A-109.1; Jenkins D.A., 2011, 1 GOV NUN DEP ENV; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; KOMERS PE, 1992, BEHAV ECOL SOCIOBIOL, V31, P195; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Lenart EA, 2001, MUSKOX MANAGEMENT RE, P39; Lenart EA., 2011, MUSKOX MANAGEMENT RE, P63; LENT P C, 1988, Mammalian Species, P1, DOI 10.2307/3504280; Lent P.C., 1999, MUSKOXEN THEIR HUNTE, V5; MILLER FL, 1980, CAN FIELD NAT, V94, P52; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; OLESEN CR, 1989, CAN J ZOOL, V67, P1116, DOI 10.1139/z89-159; Persons K, 2001, MUSKOX MANAGEMENT RE, P13; PRINS HHT, 1989, BEHAVIOUR, V108, P297, DOI 10.1163/156853989X00349; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reynolds PE, 1998, J WILDLIFE MANAGE, V62, P734, DOI 10.2307/3802350; Reynolds PE, 2002, URSUS, V13, P79; Reynolds PE, 1991, RANGIFER, V13, P83; Rowell JE, 2007, CAN J ANIM SCI, V87, P535, DOI 10.4141/CJAS06036; Rowell JE, 2003, J ANIM SCI, V81, P2669; Royle J. A., 2008, HIERARCHICAL MODELIN; Saether BE, 2009, ANIM CONSERV, V12, P488, DOI 10.1111/j.1469-1795.2009.00278.x; Saether BE, 2003, J WILDLIFE MANAGE, V67, P455, DOI 10.2307/3802703; Saether BE, 2001, WILDLIFE BIOL, V7, P171, DOI 10.2981/wlb.2001.021; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Smith, 1976, THESIS U ALASKA FAIR; SMITH TE, 1989, CAN J ZOOL, V67, P1096, DOI 10.1139/z89-155; Smith TE, 1984, BIOL PAPERS U ALASKA; Smith TE, 1987, 161R AL DEP FISH GAM; Solberg EJ, 2002, WILDLIFE BIOL, V8, P117, DOI 10.2981/wlb.2002.016; Spiegelhalter DJ, 2004, WINBUGS VERSION 1 4; Testa JW, 2000, J MAMMAL, V81, P162, DOI 10.1644/1545-1542(2000)081<0162:TPITSO>2.0.CO;2; Westing C, 2011, MUSKOX MANAGEMENT RE, P48; White GC, 2001, J WILDLIFE MANAGE, V65, P543, DOI 10.2307/3803107; White RG, 1997, J ZOOL, V243, P13, DOI 10.1111/j.1469-7998.1997.tb05752.x; WHITE RG, 1989, CAN J ZOOL, V67, P1125, DOI 10.1139/z89-162; Williams B. K., 2002, ANAL MANAGEMENT ANIM; [No title captured]	65	11	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67493	10.1371/journal.pone.0067493	http://dx.doi.org/10.1371/journal.pone.0067493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818982	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800139
J	Chung, E; Cho, CW; So, HA; Kang, JS; Chung, YS; Lee, JH				Chung, Eunsook; Cho, Chang-Woo; So, Hyun-Ah; Kang, Jee-Sook; Chung, Young Soo; Lee, Jai-Heon			Overexpression of VrUBC1, a Mung Bean E2 Ubiquitin-Conjugating Enzyme, Enhances Osmotic Stress Tolerance in Arabidopsis	PLOS ONE			English	Article							FINGER E3 LIGASE; SIGNAL-TRANSDUCTION; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; POSITIVE REGULATOR; COMBINATORY ROLES; LOW-TEMPERATURE; IN-VITRO; PROTEIN; GENE	The ubiquitin conjugating enzyme E2 (UBC E2) mediates selective ubiquitination, acting with E1 and E3 enzymes to designate specific proteins for subsequent degradation. In the present study, we characterized the function of the mung bean VrUBC1 gene (Vigna radiata UBC 1). RNA gel-blot analysis showed that VrUBC1 mRNA expression was induced by either dehydration, high salinity or by the exogenous abscisic acid (ABA), but not by low temperature or wounding. Biochemical studies of VrUBC1 recombinant protein and complementation of yeast ubc4/5 by VrUBC1 revealed that VrUBC1 encodes a functional UBC E2. To understand the function of this gene in development and plant responses to osmotic stresses, we overexpressed VrUBC1 in Arabidopsis (Arabidopsis thaliana). The VrUBC1-overexpressing plants displayed highly sensitive responses to ABA and osmotic stress during germination, enhanced ABA- or salt-induced stomatal closing, and increased drought stress tolerance. The expression levels of a number of key ABA signaling genes were increased in VrUBC1overexpressing plants compared to the wild-type plants. Yeast two-hybrid and bimolecular fluorescence complementation demonstrated that VrUBC1 interacts with AtVBP1 (A. thaliana VrUBC1 Binding Partner 1), a C3HC4-type RING E3 ligase. Overall, these results demonstrate that VrUBC1 plays a positive role in osmotic stress tolerance through transcriptional regulation of ABA-related genes and possibly through interaction with a novel RING E3 ligase.	[Chung, Eunsook; Cho, Chang-Woo; So, Hyun-Ah; Kang, Jee-Sook; Chung, Young Soo; Lee, Jai-Heon] Dong A Univ, Dept Genet Engn, Coll Nat Resources & Life Sci, Pusan, South Korea	Dong A University	Lee, JH (corresponding author), Dong A Univ, Dept Genet Engn, Coll Nat Resources & Life Sci, Pusan, South Korea.	jhnlee@dau.ac.kr			Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ007970]; National Research Foundation of Korea (KRF); Ministry of Education, Science and Technology [KRF-2012-001205, KRF-2012-001273]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (KRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was financially supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ007970), and Basic Science Research Program through the National Research Foundation of Korea (KRF) funded by the Ministry of Education, Science and Technology (KRF-2012-001205 and -2012-001273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Bu QY, 2009, PLANT PHYSIOL, V150, P463, DOI 10.1104/pp.109.135269; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Chung E, 2004, MOL CELLS, V17, P377; Chung E, 2009, GENE, V443, P91, DOI 10.1016/j.gene.2009.05.005; Chung E, 2009, GENES GENOM, V31, P11, DOI 10.1007/BF03191133; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Criqui MC, 2002, PLANT PHYSIOL, V130, P1230, DOI 10.1104/pp.011353; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Feussner K, 1997, FEBS LETT, V409, P211, DOI 10.1016/S0014-5793(97)00509-7; GIRAUDAT J, 1994, PLANT MOL BIOL, V26, P1557, DOI 10.1007/BF00016490; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Jeon EH, 2012, BIOCHEM BIOPH RES CO, V427, P309, DOI 10.1016/j.bbrc.2012.09.048; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu ZM, 1998, J BACTERIOL, V180, P3592, DOI 10.1128/JB.180.14.3592-3597.1998; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Luo JH, 2006, PLANT J, V46, P649, DOI 10.1111/j.1365-313X.2006.02730.x; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; REYNOLDS P, 1985, P NATL ACAD SCI USA, V82, P168, DOI 10.1073/pnas.82.1.168; Ryu MY, 2010, PLANT PHYSIOL, V154, P1983, DOI 10.1104/pp.110.164749; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; vanNocker S, 1996, J BIOL CHEM, V271, P12150, DOI 10.1074/jbc.271.21.12150; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Zhang XD, 2003, BBA-GENE STRUCT EXPR, V1625, P269, DOI 10.1016/S0167-4781(02)00623-1; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; ZHEN M, 1993, MOL CELL BIOL, V13, P1371, DOI 10.1128/MCB.13.3.1371; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zwirn P, 1997, CURR GENET, V32, P309, DOI 10.1007/s002940050282	66	48	63	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66056	10.1371/journal.pone.0066056	http://dx.doi.org/10.1371/journal.pone.0066056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824688	Green Submitted, gold, Green Published			2022-12-25	WOS:000320576400051
J	Jia, YF; Jiao, SW; Zhang, YM; Zhou, Y; Lei, GC; Liu, GH				Jia, Yifei; Jiao, Shengwu; Zhang, Yamian; Zhou, Yan; Lei, Guangchun; Liu, Guanhua			Diet Shift and Its Impact on Foraging Behavior of Siberian Crane (Grus Leucogeranus) in Poyang Lake	PLOS ONE			English	Article							HABITAT SELECTION; CHINA; CONSERVATION	The study of habitat selection and diet has a long history in ecology. This is often used to assess the functional roles of wetland in biodiversity conservation. Shifting habitat and diet may be one of the survival strategies during extremely adverse conditions. Therefore, sudden changes in habitat selection may indicate the deterioration of the habitat quality, and management interventions are necessary. Siberian crane (Grus leucogeranus) became critically endangered due to loss of habitat, and is currently a global conservation focus. Every winter, more than 95% of the species' global population congregates at Poyang Lake, and feeds on tubers of Vallisneria spiralis in shallow water and mudflat habitat. In this study, we reported the first sighting of large numbers of Siberian cranes foraging at wet meadows, where they fed on a different plant, Potentilla limprichtii due to extreme scarcity of their preferred tuber. To understand how well the cranes adapted to such unusual habitat, field surveys to assess the distribution of cranes across different habitats, and food availability in each habitat were carried out in the winter of 2011. Field observations on crane behaviors at different habitats were also conducted. Results show that cranes displayed significantly different behavior patterns when using the wet meadow, compared to the crane's optimal habitat - shallow water and mudflat. Both juveniles and adults spent significantly less time foraging, and more time alerting in meadows than in shallow waters and mudflats. These results indicated that the meadow might be a suboptimal wintering ground for Siberian crane, which helped the cranes survive from extreme unfavorable conditions. To some degree, this finding alleviates the general concern over the fluctuating of its food resources which was caused by hydrological disturbances. However, more studies are needed to assess the consequences of such diet and habitat shift for crane survival.	[Jia, Yifei; Jiao, Shengwu; Zhang, Yamian; Zhou, Yan; Lei, Guangchun] Beijing Forestry Univ, Beijing, Peoples R China; [Liu, Guanhua] Jiangxi Poyang Lake Natl Nat Reserve Author, Nanchang, Jiangxi, Peoples R China	Beijing Forestry University	Lei, GC (corresponding author), Beijing Forestry Univ, Beijing, Peoples R China.	leiguangchunbjfu@gmail.com	Guangchun, Lei/ABC-8081-2021		Key National Basic Research Development Program of China (973 Program) [2012CB417005, 2009CB421103]	Key National Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This study was supported by a grant from the Key National Basic Research Development Program of China (973 Program) (No. 2012CB417005 & No. 2009CB421103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2006, WATERBIRD SURVEY MID; Aviles JM, 2003, CAN J ZOOL, V81, P1233, DOI 10.1139/Z03-105; Bystrom P, 2003, J ANIM ECOL, V72, P156, DOI 10.1046/j.1365-2656.2003.00681.x; Chen B, 1991, P 1987 INT CRAN WORK, P109; Davis CA, 1998, CONDOR, V100, P266, DOI 10.2307/1370267; Deng G, 2007, J JIANGXI NORMAL U N, V2, P12; Drickamer LC., 1996, ANIMAL BEHAV MECH EC, V4; Ellis DH, 1998, BEHAV PROCESS, V43, P125, DOI 10.1016/S0376-6357(98)00008-4; Ge C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026447; Guo HF, 2008, 2008 INTERNATIONAL CONFERENCE ON MULTIMEDIA AND INFORMATION TECHNOLOGY, PROCEEDINGS, P741, DOI 10.1109/MMIT.2008.27; International Wetland, 2012, WATERBIRD POPULATION; IUCN, 2012, IUCN RED LIST; JANUS C, 1988, ANIM BEHAV, V36, P1400, DOI 10.1016/S0003-3472(88)80210-0; Ji W., 2007, GEORG INF SCI, V13, P51, DOI [10.1080/10824000709480632, DOI 10.1080/10824000709480632]; Johnsgard P, 1983, CRANES OF THE WORLD; Kanai Y, 2002, BIOL CONSERV, V106, P339, DOI 10.1016/S0006-3207(01)00259-2; KIMBER A, 1995, REGUL RIVER, V11, P167, DOI 10.1002/rrr.3450110206; Kong DJ, 2011, ORYX, V45, P258, DOI 10.1017/S0030605310000888; Krebs J.R., 1978, P23; Lewis AC, 1986, SCIENCE; Ma RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045514; Ma ZJ, 2003, ECOL RES, V18, P321, DOI 10.1046/j.1440-1703.2003.00557.x; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Meine C.D., 1996, CRANES STATUS SURVEY, P294; MILLIKEN GA, 1992, ANAL MESSY DATA DESI, V1; Morris DW, 2012, OIKOS, V121, P975, DOI 10.1111/j.1600-0706.2011.20492.x; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Potapov E., 1992, Bird Conservation International, V2, P149; [RDevelopment C TEAM], 2008, R LANG ENV STAT COMP; Rosenberger A, 2003, FRESHWATER BIOL, V48, P1563, DOI 10.1046/j.1365-2427.2003.01109.x; Shankman D, 2006, INT J CLIMATOL, V26, P1255, DOI 10.1002/joc.1307; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Stephens DW, 1987, FORAGING THEORY; van Dijk J, 2008, J ANIM ECOL, V77, P1183, DOI 10.1111/j.1365-2656.2008.01445.x; Wu GF, 2008, INT J REMOTE SENS, V29, P2183, DOI 10.1080/01431160701422254; Wu GF, 2009, HYDROBIOLOGIA, V623, P213, DOI 10.1007/s10750-008-9659-7; Wu J, 2010, MONITORING ANN REPOR, P100; Wu Z.-Y., 1994, FLORA CHINA; Xiong B, 2002, ACTA HYDROBIOL, V26, P24; Zar JH, 2009, BIOSTAT ANAL, V110, P92	43	44	63	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65843	10.1371/journal.pone.0065843	http://dx.doi.org/10.1371/journal.pone.0065843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823943	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400024
J	Meng, WX; Pan, WQ; Zhang, AJX; Li, ZF; Wei, GW; Feng, LQ; Dong, ZY; Li, CF; Hu, XJ; Sun, CJ; Luo, QF; Yuen, KY; Zhong, NS; Chen, L				Meng, Weixu; Pan, Weiqi; Zhang, Anna J. X.; Li, Zhengfeng; Wei, Guowei; Feng, Liqiang; Dong, Zhenyuan; Li, Chufang; Hu, Xiangjing; Sun, Caijun; Luo, Qinfang; Yuen, Kwok-Yung; Zhong, Nanshan; Chen, Ling			Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases	PLOS ONE			English	Article							CHAIN GERMLINE SEQUENCES; CONVALESCENT PLASMA; H5N1; VIRUS; GENES; IMMUNOGENICITY; MORTALITY; FAMILY; CELLS	Background: The outbreaks of emerging infectious diseases caused by pathogens such as SARS coronavirus, H5N1, H1N1, and recently H7N9 influenza viruses, have been associated with significant mortality and morbidity in humans. Neutralizing antibodies from individuals who have recovered from an infection confer therapeutic protection to others infected with the same pathogen. However, survivors may not always be available for providing plasma or for the cloning of monoclonal antibodies (mAbs). Methodology/Principal Findings: The genome and the immunoglobulin genes in rhesus macaques and humans are highly homologous; therefore, we investigated whether neutralizing mAbs that are highly homologous to those of humans (human-like) could be generated. Using the H5N1 influenza virus as a model, we first immunized rhesus macaques with recombinant adenoviruses carrying a synthetic gene encoding hemagglutinin (HA). Following screening an antibody phage display library derived from the B cells of immunized monkeys, we cloned selected macaque immunoglobulin heavy chain and light chain variable regions into the human IgG constant region, which generated human-macaque chimeric mAbs exhibiting over 97% homology to human antibodies. Selected mAbs demonstrated potent neutralizing activities against three clades (0, 1, 2) of the H5N1 influenza viruses. The in vivo protection experiments demonstrated that the mAbs effectively protected the mice even when administered up to 3 days after infection with H5N1 influenza virus. In particular, mAb 4E6 demonstrated sub-picomolar binding affinity to HA and superior in vivo protection efficacy without the loss of body weight and obvious lung damage. The analysis of the 4E6 escape mutants demonstrated that the 4E6 antibody bound to a conserved epitope region containing two amino acids on the globular head of HA. Conclusions/Significance: Our study demonstrated the generation of neutralizing mAbs for potential application in humans in urgent preparedness against outbreaks of new influenza infections or other virulent infectious diseases.	[Meng, Weixu; Pan, Weiqi; Li, Zhengfeng; Wei, Guowei; Feng, Liqiang; Dong, Zhenyuan; Hu, Xiangjing; Sun, Caijun; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Meng, Weixu; Pan, Weiqi; Li, Zhengfeng; Feng, Liqiang; Dong, Zhenyuan; Li, Chufang; Sun, Caijun; Luo, Qinfang; Zhong, Nanshan; Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhang, Anna J. X.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; University of Hong Kong	Chen, L (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	chen002@gmail.com	Meng, Weixu/E-7301-2017	Meng, Weixu/0000-0001-7892-3014; Yuen, Kwok-yung/0000-0002-2083-1552	National Science Fund for Distinguished Young Scholars of China [30688004]; State Key Laboratory of Respiratory Disease	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Laboratory of Respiratory Disease	This work was supported by the National Science Fund for Distinguished Young Scholars of China (30688004) and the funding from the State Key Laboratory of Respiratory Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andris JS, 1997, MOL IMMUNOL, V34, P237, DOI 10.1016/S0161-5890(97)00021-7; Bible JM, 2003, IMMUNOGENETICS, V54, P867, DOI 10.1007/s00251-003-0536-2; Bradbury ARM, 2004, PHAGE DISPLAY, P243; Calvas P, 1999, SCAND J IMMUNOL, V49, P595; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; De Marco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034415; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Helmuth EF, 2000, IMMUNOGENETICS, V51, P519, DOI 10.1007/s002510000170; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Howard WA, 2005, IMMUNOGENETICS, V57, P655, DOI 10.1007/s00251-005-0020-2; Howard WA, 2005, IMMUNOGENETICS, V57, P210, DOI 10.1007/s00251-005-0794-2; Hu XJ, 2011, VIRUS RES, V155, P156, DOI 10.1016/j.virusres.2010.09.014; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kendal AP, 1982, WHO COLLABORATING CT, pB17; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Leonard JP, 2007, ANN ONCOL, V18, P1216, DOI 10.1093/annonc/mdm114; Link JM, 2002, IMMUNOGENETICS, V54, P240, DOI 10.1007/s00251-002-0468-2; Margolin DH, 2006, J IMMUNOL, V177, P1108, DOI 10.4049/jimmunol.177.2.1108; Pelat T, 2009, MABS, V1, P1; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Rosenwasser LJ, 2003, J ALLERGY CLIN IMMUN, V112, P563, DOI 10.1067/mai.2003.1709; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Scinicariello F, 2004, IMMUNOLOGY, V111, P66, DOI 10.1111/j.1365-2567.2004.01767.x; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	40	12	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66276	10.1371/journal.pone.0066276	http://dx.doi.org/10.1371/journal.pone.0066276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824680	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400077
J	Samykutty, A; Shetty, AV; Dakshinamoorthy, G; Bartik, MM; Johnson, GL; Webb, B; Zheng, G; Chen, AX; Kalyanasundaram, RS; Munirathinam, G				Samykutty, Abhilash; Shetty, Aditya Vittal; Dakshinamoorthy, Gajalakshmi; Bartik, Mary Margaret; Johnson, Gary Leon; Webb, Brian; Zheng, Guoxing; Chen, Aoshuang; Kalyanasundaram, Ramaswamy; Munirathinam, Gnanasekar			Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; IN-VIVO; CONSTITUTIVE ACTIVATION; GROWTH-INHIBITION; GENE-EXPRESSION; RECEPTOR GENE; CARCINOMA; STAT3; APOPTOSIS; ADENOCARCINOMA	Prostate cancer is the most common solid malignancy in men, with 32,000 deaths annually. Piperine, a major alkaloid constituent of black pepper, has previously been reported to have anti-cancer activity in variety of cancer cell lines. The effect of piperine against prostate cancer is not currently known. Therefore, in this study, we investigated the anti-tumor mechanisms of piperine on androgen dependent and androgen independent prostate cancer cells. Here, we show that piperine inhibited the proliferation of LNCaP, PC-3, 22RV1 and DU-145 prostate cancer cells in a dose dependent manner. Furthermore, Annexin-V staining demonstrated that piperine treatment induced apoptosis in hormone dependent prostate cancer cells (LNCaP). Using global caspase activation assay, we show that piperine-induced apoptosis resulted in caspase activation in LNCaP and PC-3 cells. Further studies revealed that piperine treatment resulted in the activation of caspase-3 and cleavage of PARP-1 proteins in LNCaP, PC-3 and DU-145 prostate cancer cells. Piperine treatment also disrupted androgen receptor (AR) expression in LNCaP prostate cancer cells. Our evaluations further show that there is a significant reduction of Prostate Specific Antigen (PSA) levels following piperine treatment in LNCaP cells. NF-kB and STAT-3 transcription factors have previously been shown to play a role in angiogenesis and invasion of prostate cancer cells. Interestingly, treatment of LNCaP, PC-3 and DU-145 prostate cancer cells with piperine resulted in reduced expression of phosphorylated STAT-3 and Nuclear factor-kappa B (NF-kB) transcription factors. These results correlated with the results of Boyden chamber assay, wherein piperine treatment reduced the cell migration of LNCaP and PC-3 cells. Finally, we show that piperine treatment significantly reduced the androgen dependent and androgen independent tumor growth in nude mice model xenotransplanted with prostate cancer cells. Taken together, these results support further investigation of piperine as a potential therapeutic agent in the treatment of prostate cancer.	[Samykutty, Abhilash; Shetty, Aditya Vittal; Dakshinamoorthy, Gajalakshmi; Zheng, Guoxing; Chen, Aoshuang; Kalyanasundaram, Ramaswamy; Munirathinam, Gnanasekar] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Bartik, Mary Margaret; Johnson, Gary Leon] Midwest SciTech, Bloomington, MN USA; [Webb, Brian] Thermo Fisher Sci, Rockford, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Thermo Fisher Scientific	Munirathinam, G (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	mgnanas@uic.edu	samykutty, Abhilash/J-6575-2019	samykutty, Abhilash/0000-0003-3551-045X				Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Agarwal C, 2007, CARCINOGENESIS, V28, P1463, DOI 10.1093/carcin/bgm042; Aghaei M, 2011, J CANCER RES CLIN, V137, P1511, DOI 10.1007/s00432-011-1031-z; Ahmad A, 2012, CARCINOGENESIS, V33, P2450, DOI 10.1093/carcin/bgs290; Barton BE, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-19; Bezerra DP, 2006, BRAZ J MED BIOL RES, V39, P801, DOI 10.1590/S0100-879X2006000600014; Bezerra DP, 2008, J APPL TOXICOL, V28, P156, DOI 10.1002/jat.1261; Biroccio A, 2004, ENDOCR-RELAT CANCER, V11, P407, DOI 10.1677/erc.1.00764; Coffey RNT, 2001, J UROLOGY, V165, P5, DOI 10.1097/00005392-200101000-00003; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Duessel Sharon, 2008, Clin Lab Sci, V21, P151; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Elangovan I, 2012, BIOCHEM BIOPH RES CO, V417, P1133, DOI 10.1016/j.bbrc.2011.12.060; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Gasparian AV, 2002, J CELL SCI, V115, P141; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Guo S, 2011, PLOS ONE, V3; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; JOHRI RK, 1992, J ETHNOPHARMACOL, V37, P85, DOI 10.1016/0378-8741(92)90067-2; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kakarala M, 2010, J AGR FOOD CHEM, V58, P6594, DOI 10.1021/jf100657r; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Krishnakumar N, 2009, FOOD CHEM TOXICOL, V47, P2813, DOI 10.1016/j.fct.2009.08.017; Li S, 2011, PHYTOMEDICINE, V19, P83, DOI 10.1016/j.phymed.2011.06.031; Linja MJ, 2001, CANCER RES, V61, P3550; Makhov P, 2012, PROSTATE, V72, P661, DOI 10.1002/pros.21469; Marech I, 2012, INT J ONCOL, V40, P1313, DOI 10.3892/ijo.2012.1364; Pradeep CR, 2004, INT IMMUNOPHARMACOL, V4, P1795, DOI 10.1016/j.intimp.2004.08.005; Quon H, 2011, BJU INT, V108, P1734, DOI 10.1111/j.1464-410X.2011.10197.x; Rago, 1998, Cancer Control, V5, P513; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddy L, 2003, PHARMACOL THERAPEUT, V99, P1, DOI 10.1016/S0163-7258(03)00042-1; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Selvendiran K, 2006, PULM PHARMACOL THER, V19, P107, DOI 10.1016/j.pupt.2005.04.002; Selvendiran K, 2004, BIOMED PHARMACOTHER, V58, P264, DOI 10.1016/j.biopha.2003.08.027; Shetty AV, 2011, INT J ONCOL, V39, P635, DOI 10.3892/ijo.2011.1061; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Yang J, 2012, NEURO-ONCOLOGY, V11, P36; Yoo J, 2008, J CELL BIOCHEM, V104, P1636, DOI 10.1002/jcb.21729	48	70	72	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65889	10.1371/journal.pone.0065889	http://dx.doi.org/10.1371/journal.pone.0065889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824300	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400031
J	Sasaki, T; Onodera, A; Hosokawa, H; Watanabe, Y; Horiuchi, S; Yamashita, J; Tanaka, H; Ogawa, Y; Suzuki, Y; Nakayama, T				Sasaki, Tetsuya; Onodera, Atsushi; Hosokawa, Hiroyuki; Watanabe, Yukiko; Horiuchi, Shu; Yamashita, Junji; Tanaka, Hitoshi; Ogawa, Yasumasa; Suzuki, Yutaka; Nakayama, Toshinori			Genome-Wide Gene Expression Profiling Revealed a Critical Role for GATA3 in the Maintenance of the Th2 Cell Identity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; HELPER TYPE-2 CELLS; HISTONE HYPERACETYLATION; INTERLEUKIN-5 GENE; ROR-GAMMA; DIFFERENTIATION; LINEAGE; MEMORY; RESPONSES; LOCUS	Functionally polarized CD4+ T helper (Th) cells such as Th1, Th2 and Th17 cells are central to the regulation of acquired immunity. However, the molecular mechanisms governing the maintenance of the polarized functions of Th cells remain unclear. GATA3, a master regulator of Th2 cell differentiation, initiates the expressions of Th2 cytokine genes and other Th2-specific genes. GATA3 also plays important roles in maintaining Th2 cell function and in continuous chromatin remodeling of Th2 cytokine gene loci. However, it is unclear whether continuous expression of GATA3 is required to maintain the expression of various other Th2-specific genes. In this report, genome-wide DNA gene expression profiling revealed that GATA3 expression is critical for the expression of a certain set of Th2-specific genes. We demonstrated that GATA3 dependency is reduced for some Th2-specific genes in fully developed Th2 cells compared to that observed in effector Th2 cells, whereas it is unchanged for other genes. Moreover, effects of a loss of GATA3 expression in Th2 cells on the expression of cytokine and cytokine receptor genes were examined in detail. A critical role of GATA3 in the regulation of Th2-specific gene expression is confirmed in in vivo generated antigen-specific memory Th2 cells. Therefore, GATA3 is required for the continuous expression of the majority of Th2-specific genes involved in maintaining the Th2 cell identity.	[Sasaki, Tetsuya; Onodera, Atsushi; Hosokawa, Hiroyuki; Watanabe, Yukiko; Horiuchi, Shu; Yamashita, Junji; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Sasaki, Tetsuya; Yamashita, Junji; Tanaka, Hitoshi; Ogawa, Yasumasa] Nihon Pharmaceut Co Ltd, Pharmaceut Res Lab, Div Res, Narita City, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Kashiwa, Chiba, Japan; [Nakayama, Toshinori] CREST, JST, Chiba, Japan	Chiba University; University of Tokyo; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Onodera, Atsushi/E-3136-2017; Nakayama, Toshinori/E-1067-2017; Horiuchi, Shu/GXH-4855-2022	Nakayama, Toshinori/0000-0002-1434-2007; Horiuchi, Shu/0000-0001-5982-0247; Hosokawa, Hiroyuki/0000-0002-9592-2889	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Genome Science'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 221S0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Horiuchi S, 2011, J IMMUNOL, V186, P6378, DOI 10.4049/jimmunol.1100179; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu J, 2010, ANN REV IMMUNOL; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	33	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66468	10.1371/journal.pone.0066468	http://dx.doi.org/10.1371/journal.pone.0066468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824597	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400112
J	Teramoto, M; Queck, SY; Ohnishi, K				Teramoto, Maki; Queck, Shu Yeong; Ohnishi, Kouhei			Specialized Hydrocarbonoclastic Bacteria Prevailing in Seawater around a Port in the Strait of Malacca	PLOS ONE			English	Article							PETROLEUM ALIPHATIC-HYDROCARBONS; SP-NOV; DEGRADING BACTERIA; MICROBIAL-POPULATIONS; GEN. NOV.; SP. NOV.; MARINE; CYCLOCLASTICUS; COMMUNITY; DEGRADATION	Major degraders of petroleum hydrocarbons in tropical seas have been indicated only by laboratory culturing and never through observing the bacterial community structure in actual environments. To demonstrate the major degraders of petroleum hydrocarbons spilt in actual tropical seas, indigenous bacterial community in seawater at Sentosa (close to a port) and East Coast Park (far from a port) in Singapore was analyzed. Bacterial species was more diverse at Sentosa than at the Park, and the composition was different: gamma-Proteobacteria (57.3%) dominated at Sentosa, while they did not at the Park. Specialized hydrocarbonoclastic bacteria (SHCB), which use limited carbon sources with a preference for petroleum hydrocarbons, were found as abundant species at Sentosa, indicating petroleum contamination. On the other hand, SHCB were not the abundant species at the Park. The abundant species of SHCB at Sentosa were Oleibacter marinus and Alcanivorax species (strain 2A75 type), which have previously been indicated by laboratory culturing as important petroleum-aliphatic-hydrocarbon degraders in tropical seas. Together with the fact that SHCB have been identified as major degraders of petroleum hydrocarbons in marine environments, these results demonstrate that the O. marinus and Alcanivorax species (strain 2A75 type) would be major degraders of petroleum aliphatic hydrocarbons spilt in actual tropical seas.	[Teramoto, Maki] Kochi Univ, Oceanog Sect, Nankoku, Kochi, Japan; [Queck, Shu Yeong] Nanyang Polytech, Sch Chem & Life Sci, Singapore, Singapore; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi, Japan	Kochi University; Nanyang Polytechnic; Kochi University	Teramoto, M (corresponding author), Kochi Univ, Oceanog Sect, Nankoku, Kochi, Japan.	maki.teramoto@kochi-u.ac.jp	Ohnishi, Kouhei/AAN-9527-2020					Abed RMM, 2005, INT BIODETER BIODEGR, V55, P29, DOI 10.1016/j.ibiod.2004.07.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andreoni V, 2000, ENVIRON MICROBIOL, V2, P572, DOI 10.1046/j.1462-2920.2000.00134.x; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Balkwill DL, 1997, INT J SYST BACTERIOL, V47, P191, DOI 10.1099/00207713-47-1-191; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116, DOI 10.1099/00207713-45-1-116; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Golyshin P. N., 2005, BERGEYS MANUAL SYSTE, V2, P295; Hara A, 2003, ENVIRON MICROBIOL, V5, P746, DOI 10.1046/j.1468-2920.2003.00468.x; Harayama S, 2004, CURR OPIN BIOTECH, V15, P205, DOI 10.1016/j.copbio.2004.04.002; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hedlund BP, 2001, INT J SYST EVOL MICR, V51, P61, DOI 10.1099/00207713-51-1-61; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Iannelli R, 2012, SCI TOTAL ENVIRON, V426, P56, DOI 10.1016/j.scitotenv.2012.03.033; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kasai Y, 2001, ENVIRON MICROBIOL, V3, P246, DOI 10.1046/j.1462-2920.2001.00185.x; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loaec M, 1998, CARBOHYD POLYM, V35, P65, DOI 10.1016/S0144-8617(97)00109-4; Loaec M, 1997, WATER RES, V31, P1171, DOI 10.1016/S0043-1354(96)00375-2; Lu J, 2003, INT J REMOTE SENS, V24, P3013, DOI 10.1080/01431160110076216; Maruyama A, 2003, MICROBIAL ECOL, V46, P442, DOI 10.1007/s00248-002-3010-z; Melcher RJ, 2002, APPL ENVIRON MICROB, V68, P2858, DOI 10.1128/AEM.68.6.2858-2868.2002; Nemeth AD, 2011, MARINE ENV ECOLOGY M, P157; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; PRINCE RC, 1994, ENVIRON SCI TECHNOL, V28, P142, DOI 10.1021/es00050a019; Prince RC, 2005, PETROLEUM MICROBIOLOGY, P317; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Roling WFM, 2004, APPL ENVIRON MICROB, V70, P2603, DOI 10.1128/AEM.70.5.2603-2613.2004; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Sorkhoh NA, 2010, INT BIODETER BIODEGR, V64, P554, DOI 10.1016/j.ibiod.2010.06.007; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; Teralmoto M, 2009, MICROBIOL-SGM, V155, P3362, DOI 10.1099/mic.0.030411-0; Teramoto M, 2011, INT J SYST EVOL MICR, V61, P375, DOI 10.1099/ijs.0.018671-0; Teramoto M, 2010, J BIOSCI BIOENG, V110, P48, DOI 10.1016/j.jbiosc.2009.12.008; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Whyte LG, 1997, APPL ENVIRON MICROB, V63, P3719, DOI 10.1128/AEM.63.9.3719-3723.1997; Wu YH, 2009, INT J SYST EVOL MICR, V59, P1321, DOI 10.1099/ijs.0.005702-0; Yakimov MM, 1998, INT J SYST BACTERIOL, V48, P339, DOI 10.1099/00207713-48-2-339; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x	50	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66594	10.1371/journal.pone.0066594	http://dx.doi.org/10.1371/journal.pone.0066594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824553	gold, Green Published, Green Submitted			2022-12-25	WOS:000320576400133
J	Xiong, WS; Li, XR; Fu, DH; Mei, JQ; Li, QF; Lu, GY; Qian, LW; Fu, Y; Disi, JO; Li, JN; Qian, W				Xiong, Wanshan; Li, Xiaorong; Fu, Donghui; Mei, Jiaqin; Li, Qinfei; Lu, Guanyuan; Qian, Lunwen; Fu, Yin; Disi, Joseph Onwusemu; Li, Jiana; Qian, Wei			DNA Methylation Alterations at 5 '-CCGG Sites in the Interspecific and Intraspecific Hybridizations Derived from Brassica rapa and B. napus	PLOS ONE			English	Article							GENE-EXPRESSION; CYTOSINE METHYLATION; INTERSUBGENOMIC HETEROSIS; RICE; PATTERNS; HYBRIDS; YIELD; LINES; POPULATION; DOMINANCE	DNA methylation is an important regulatory mechanism for gene expression that involved in the biological processes of development and differentiation in plants. To investigate the association of DNA methylation with heterosis in Brassica, a set of intraspecific hybrids in Brassica rapa and B. napus and interspecific hybrids between B. rapa and B. napus, together with parental lines, were used to monitor alterations in cytosine methylation at 5'-CCGG sites in seedlings and buds by methylation-sensitive amplification polymorphism analysis. The methylation status of approximately a quarter of the methylation sites changed between seedlings and buds. These alterations were related closely to the genomic structure and heterozygous status among accessions. The methylation status in the majority of DNA methylation sites detected in hybrids was the same as that in at least one of the parental lines in both seedlings and buds. However, the association between patterns of cytosine methylation and heterosis varied among different traits and between tissues in hybrids of Brassica, although a few methylation loci were associated with heterosis. Our data suggest that changes in DNA methylation at 5'-CCGG sites are not associated simply with heterosis in the interspecific and intraspecific hybridizations derived from B. rapa and B. napus.	[Xiong, Wanshan; Fu, Donghui; Mei, Jiaqin; Li, Qinfei; Qian, Lunwen; Fu, Yin; Disi, Joseph Onwusemu; Li, Jiana; Qian, Wei] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Li, Xiaorong] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Lu, Guanyuan] China Acad Agr Sci, Oil Crop Inst, Wuhan, Peoples R China	Southwest University - China; Southwest University - China; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Qian, W (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.	qianwei666@hotmail.com			Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [31171585]; CSTC [201180001]; 111 Project 13 [B12006]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CSTC(Natural Science Foundation Project of CQ CSTC); 111 Project 13	This work was supported financially by grants from the Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China (31171585), CSTC 201180001, and 111 Project 13 (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, DEVELOPMENT, V127, P2493; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jin HJ, 2008, THEOR APPL GENET, V117, P1271, DOI 10.1007/s00122-008-0861-9; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li MT, 2006, CROP SCI, V46, P234, DOI 10.2135/cropsci2004.0759; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Moghaddam AMB, 2010, THEOR APPL GENET, V120, P215, DOI 10.1007/s00122-009-1127-x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Qian W, 2005, THEOR APPL GENET, V110, P1187, DOI 10.1007/s00122-005-1932-9; Qian W, 2003, EUPHYTICA, V134, P9, DOI 10.1023/A:1026180823401; Rohlf FJ, 1997, NTSYSPC NUMERICAL TA; Ruiz-Garcia L, 2005, PLANTA, V222, P301, DOI 10.1007/s00425-005-1524-6; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; SAS, 2004, SAS US GUID STAT; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; XIAO JH, 1995, GENETICS, V140, P745; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xiong LZ, 1998, MOL BREEDING, V4, P129, DOI 10.1023/A:1009685820649; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhang MS, 2007, THEOR APPL GENET, V115, P195, DOI 10.1007/s00122-007-0555-8	45	7	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65946	10.1371/journal.pone.0065946	http://dx.doi.org/10.1371/journal.pone.0065946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824315	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400037
J	Zheng, WW; Rasmussen, U; Zheng, SP; Bao, XD; Chen, B; Gao, Y; Guan, X; Larsson, J; Bergman, B				Zheng, Weiwen; Rasmussen, Ulla; Zheng, Siping; Bao, Xiaodong; Chen, Bin; Gao, Yuan; Guan, Xiong; Larsson, John; Bergman, Birgitta			Multiple Modes of Cell Death Discovered in a Prokaryotic (Cyanobacterial) Endosymbiont	PLOS ONE			English	Article							AZOLLA-ANABAENA SYMBIOSIS; SEQUENCE ALIGNMENT; APOPTOTIC CELLS; AUTOPHAGY; CLEARANCE; CYCLE; DIE	Programmed cell death (PCD) is a genetically-based cell death mechanism with vital roles in eukaryotes. Although there is limited consensus on similar death mode programs in prokaryotes, emerging evidence suggest that PCD events are operative. Here we present cell death events in a cyanobacterium living endophytically in the fern Azolla microphylla, suggestive of PCD. This symbiosis is characterized by some unique traits such as a synchronized development, a vertical transfer of the cyanobacterium between plant generations, and a highly eroding cyanobacterial genome. A combination of methods was used to identify cell death modes in the cyanobacterium. Light- and electron microscopy analyses showed that the proportion of cells undergoing cell death peaked at 53.6% (average 20%) of the total cell population, depending on the cell type and host developmental stage. Biochemical markers used for early and late programmed cell death events related to apoptosis (Annexin V-EGFP and TUNEL staining assays), together with visualization of cytoskeleton alterations (FITC-phalloidin staining), showed that all cyanobacterial cell categories were affected by cell death. Transmission electron microscopy revealed four modes of cell death: apoptotic-like, autophagic-like, necrotic-like and autolytic-like. Abiotic stresses further enhanced cell death in a dose and time dependent manner. The data also suggest that dynamic changes in the peptidoglycan cell wall layer and in the cytoskeleton distribution patterns may act as markers for the various cell death modes. The presence of a metacaspase homolog (domain p20) further suggests that the death modes are genetically programmed. It is therefore concluded that multiple, likely genetically programmed, cell death modes exist in cyanobacteria, a finding that may be connected with the evolution of cell death in the plant kingdom.	[Zheng, Weiwen; Gao, Yuan; Guan, Xiong] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Rasmussen, Ulla; Larsson, John; Bergman, Birgitta] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Zheng, Weiwen; Zheng, Siping; Chen, Bin] Fujian Acad Agr Sci, Biotech Inst, Fuzhou, Peoples R China; [Bao, Xiaodong] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA	Fujian Agriculture & Forestry University; Stockholm University; Fujian Academy of Agricultural Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bergman, B (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	bergmanb@botan.su.se			Swedish Research Council Formas; Swedish Energy Agency; Swedish Research Council Link program; National Natural Science Foundation of China [31071745]; Science and Technology Foundation of Fujian Province, China [2010R1021-8]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Swedish Research Council Link program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Fujian Province, China	The financial support from the Swedish Research Council Formas and the Swedish Energy Agency (to B.B.), the Swedish Research Council Link program (to U.R. and W.W.Z.), the National Natural Science Foundation of China (Grant 31071745 to X.G. and W.W.Z.), and the Science and Technology Foundation of Fujian Province, China (Grant 2010R1021-8; to S.P.Z.) is gratefully acknowledged. The authors also thank K. and A. Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund-Samuelsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049888; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Bursch W, 2000, J CELL SCI, V113, P1189; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekman M, 2008, J EXP BOT, V59, P1023, DOI 10.1093/jxb/erm282; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Guljamow A, 2012, PLOS ONE, V7, P221, DOI 10.1371/journal.pone.0029926; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Jiang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-198; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Laporte C, 2007, CELL DEATH DIFFER, V14, P266, DOI 10.1038/sj.cdd.4401994; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781; Ning SB, 2002, J APPL MICROBIOL, V93, P15, DOI 10.1046/j.1365-2672.2002.01651.x; PERKINS SK, 1993, NEW PHYTOL, V123, P53; PETERS GA, 1989, ANNU REV PLANT PHYS, V40, P193, DOI 10.1146/annurev.pp.40.060189.001205; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Reyes-Prieto A, 2007, MOL PHYLOGENET EVOL, V45, P384, DOI 10.1016/j.ympev.2007.02.026; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Tang YZ, 2007, APPL ENVIRON MICROB, V73, P2306, DOI 10.1128/AEM.01741-06; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; van Heerde WL, 2000, CARDIOVASC RES, V45, P549, DOI 10.1016/S0008-6363(99)00396-X; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; VERNET T, 1991, J BIOL CHEM, V266, P21451; Watanabe I., 1977, UTILIZATION AZOLLA A; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zheng WW, 2009, MICROBIOL MONOGR, V8, P235, DOI 10.1007/7171_2008_120; Zheng WW, 2009, NEW PHYTOL, V181, P53, DOI 10.1111/j.1469-8137.2008.02644.x	46	23	25	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66147	10.1371/journal.pone.0066147	http://dx.doi.org/10.1371/journal.pone.0066147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822984	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400058
J	Liu, L; Dong, Z; Liang, J; Cao, C; Sun, J; Ding, Y; Wu, D				Liu, L.; Dong, Z.; Liang, J.; Cao, C.; Sun, J.; Ding, Y.; Wu, D.			As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3 beta pathway	ONCOGENE			English	Article						FAT10; hepatocellular carcinoma; hepatitis B virus; prognosis; progression; Akt	EPITHELIAL-MESENCHYMAL TRANSITION; CLASS-I REGION; POOR-PROGNOSIS; NASOPHARYNGEAL CARCINOMA; INCREASED EXPRESSION; UBIQUITIN-BINDING; CANCER; LIVER; GENE; PATHOGENESIS	FAT10 is an oncogene that is localized at 6q21.3, a region frequently amplified in hepatocellular carcinoma (HCC). Recently, growing attention has been paid to its effect in the initiation of various cancers. However, there has been little research into the influence of FAT10 on the progression and prognosis of HCC, especially in hepatitis B virus (HBV)-related HCC. Here, we aimed at investigating clincopathological significance of FAT10 in HBV-related HCC and its underlying mechanisms. Based on the analysis of FAT10 expression in a reliable and large number of cases with 5-year follow-up, we showed that FAT10 was significantly increased in 260 samples from HBV-related HCC patients, compared with 30 normal tissue, 50 cirrhosis and matched adjacent nontumor tissues. FAT10 expression is correlated with recurrence and poor prognosis in HBV-related HCC. In addition, ectopic expression of FAT10 enhanced cell proliferation, inhibited apoptosis and induced cell cycle progression, whereas silencing FAT10 expression suppressed cell proliferation and induced apoptosis. FAT10 also induced the epithelial-mesenchymal transition (EMT) and promoted invasion of HCC cells. Furthermore, we found Akt/GSK3 beta pathway contributed to the effects of FAT10 in HCC cells. Blocking the Akt pathway significantly inhibited the actions of FAT10. Taken together, the ubiquitin-like protein FAT10 has a central role in regulating diverse aspects of the pathogenesis of HCC, indicating that it might be a potential therapeutic target.	[Liu, L.; Ding, Y.] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou 510515, Guangdong, Peoples R China; [Liu, L.; Ding, Y.] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China; [Dong, Z.; Liang, J.; Cao, C.; Sun, J.; Ding, Y.; Wu, D.] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Liu, L (corresponding author), Southern Med Univ, Nanfang Hosp, Hepatol Unit, 1838 Guangzhoudadaobei Rd, Guangzhou 510515, Guangdong, Peoples R China.	liuli.fimmu@gmail.com; wudehua.gd@gmail.com		Liu, Li/0000-0002-5265-4159; Dong, Zhong-Yi/0000-0001-9967-0060; Wu, De-Hua/0000-0003-0560-0016	National Nature Science Foundation of China [81172056, 81172586]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (Grant No. 81172056 and 81172586).	Bardag-Gorce F, 2010, EXP MOL PATHOL, V88, P353, DOI 10.1016/j.yexmp.2010.03.001; Bett JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030866; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Chung JS, 2012, GASTROENTEROLOGY, V143, P1084, DOI 10.1053/j.gastro.2012.06.038; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; French SW, 2010, EXP MOL PATHOL, V88, P219, DOI 10.1016/j.yexmp.2010.01.005; Fu J, 2011, HEPATOLOGY, V53, P181, DOI 10.1002/hep.24015; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Gruen JR, 1996, GENOMICS, V36, P70, DOI 10.1006/geno.1996.0427; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Lim CB, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-20; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Oliva J, 2008, EXP MOL PATHOL, V84, P102, DOI 10.1016/j.yexmp.2007.12.003; Poon RTP, 2011, HEPATOLOGY, V54, P757, DOI 10.1002/hep.24569; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; Ren JW, 2011, J CELL SCI, V124, P3665, DOI 10.1242/jcs.087403; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Teufel A, 2012, J HEPATOL, V56, P279, DOI 10.1016/j.jhep.2011.05.035; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; Wangsa D, 2008, BRIT J CANCER, V99, P1121, DOI 10.1038/sj.bjc.6604633; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Wu D, 2010, ANN ONCOL, V21, P589, DOI 10.1093/annonc/mdp333; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zhang DW, 2006, ONCOGENE, V25, P2318, DOI 10.1038/sj.onc.1209220; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	44	55	63	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					909	920		10.1038/onc.2013.236	http://dx.doi.org/10.1038/onc.2013.236			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23812429				2022-12-25	WOS:000331626900012
J	Ye, CQ; Bandara, WMMS; Greenberg, ML				Ye, Cunqi; Bandara, W. M. M. S.; Greenberg, Miriam L.			Regulation of Inositol Metabolism Is Fine-tuned by Inositol Pyrophosphates in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHETIC GENES; PHOSPHATIDIC-ACID; TRANSCRIPTIONAL REGULATION; RESPONSIVE GENES; MEMBRANE-LIPIDS; TELOMERE LENGTH; LEUCINE-ZIPPER; YEAST; HEXAKISPHOSPHATE; COMPLEX	Although inositol pyrophosphates have diverse roles in phosphate signaling and other important cellular processes, little is known about their functions in the biosynthesis of inositol and phospholipids. Here, we show that KCS1, which encodes an inositol pyrophosphate kinase, is a regulator of inositol metabolism. Deletion of KCS1, which blocks synthesis of inositol pyrophosphates on the 5-hydroxyl of the inositol ring, causes inositol auxotrophy and decreased intracellular inositol and phosphatidylinositol. These defects are caused by a profound decrease in transcription of INO1, which encodes myo-inositol-3-phosphate synthase. Expression of genes that function in glycolysis, transcription, and protein processing is not affected in kcs1 Delta. Deletion of OPI1, the INO1 transcription repressor, does not fully rescue INO1 expression in kcs1 Delta. Both the inositol pyrophosphate kinase and the basic leucine zipper domains of KCS1 are required for INO1 expression. Kcs1 is regulated in response to inositol, as Kcs1 protein levels are increased in response to inositol depletion. The Kcs1-catalyzed production of inositol pyrophosphates from inositol pentakisphosphate but not inositol hexakisphosphate is indispensable for optimal INO1 transcription. We conclude that INO1 transcription is fine-tuned by the synthesis of inositol pyrophosphates, and we propose a model in which modulation of Kcs1 controls INO1 transcription by regulating synthesis of inositol pyrophosphates.	[Ye, Cunqi; Bandara, W. M. M. S.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu			National Institutes of Health [R01 DK081367]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK081367 (to M. L. G.).	ALLISON JH, 1980, J NEUROCHEM, V34, P456, DOI 10.1111/j.1471-4159.1980.tb06619.x; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; ASHBURNER BP, 1995, MOL CELL BIOL, V15, P1709; AUSUBEL F, 1994, CURR PROTOC MOL BIOL; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Fu Y., 2006, METHOD MOL BIOL, P257; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HUANG KN, 1995, GENETICS, V141, P1275; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Loewen Christopher J R, 2012, F1000 Biol Rep, V4, P4, DOI 10.3410/B4-4; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOEWUS FA, 1962, BIOCHEM BIOPH RES CO, V7, P204, DOI 10.1016/0006-291X(62)90175-4; Maslanski J. A., 1990, METHODS INOSITIDE RE, P113; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Rupwate SD, 2012, FEBS LETT, V586, P1555, DOI 10.1016/j.febslet.2012.04.022; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Strahl T., 2007, BIOCHIM BIOPHYS ACTA, V1771, P252; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Wykoff DD, 2001, GENETICS, V159, P1491; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	56	32	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24898	24908		10.1074/jbc.M113.493353	http://dx.doi.org/10.1074/jbc.M113.493353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23824185	hybrid, Green Published			2022-12-25	WOS:000330612300054
J	Mishra, AK; Del Campo, CM; Collins, RE; Roy, CR; Lambright, DG				Mishra, Ashwini K.; Del Campo, Claudia M.; Collins, Robert E.; Roy, Craig R.; Lambright, David G.			The Legionella pneumophila GTPase Activating Protein LepB Accelerates Rab1 Deactivation by a Non-canonical Hydrolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE; STRUCTURAL BASIS; DRRA; RAS; BINDING; DISPLACEMENT; RECRUITMENT; COMPLEX; MODEL; STATE	GTPase activating proteins (GAPs) from pathogenic bacteria and eukaryotic host organisms deactivate Rab GTPases by supplying catalytic arginine and glutamine fingers in trans and utilizing the cis-glutamine in the DXXGQ motif of the GTPase for binding rather than catalysis. Here, we report the transition state mimetic structure of the Legionella pneumophila GAP LepB in complex with Rab1 and describe a comprehensive structure-based mutational analysis of potential catalytic and recognition determinants. The results demonstrate that LepB does not simply mimic other GAPs but instead deploys an expected arginine finger in conjunction with a novel glutamic acid finger, which forms a salt bridge with an indispensible switch II arginine that effectively locks the cis-glutamine in the DXXGQ motif of Rab1 in a catalytically competent though unprecedented transition state configuration. Surprisingly, a heretofore universal transition state interaction with the cis-glutamine is supplanted by an elaborate polar network involving critical P-loop and switch I serines. LepB further employs an unusual tandem domain architecture to clamp a switch I tyrosine in an open conformation that facilitates access of the arginine finger to the hydrolytic site. Intriguingly, the critical P-loop serine corresponds to an oncogenic substitution in Ras and replaces a conserved glycine essential for the canonical transition state stereo-chemistry. In addition to expanding GTP hydrolytic paradigms, these observations reveal the unconventional dual finger and non-canonical catalytic network mechanisms of Rab GAPs as necessary alternative solutions to a major impediment imposed by substitution of the conserved P-loop glycine.	[Mishra, Ashwini K.; Del Campo, Claudia M.; Collins, Robert E.; Lambright, David G.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Roy, Craig R.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Mishra, AK (corresponding author), Two Biotech, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	Ashwini.Mishra@umassmed.edu; David.Lambright@umassmed.edu		Roy, Craig/0000-0003-4490-440X; Collins, Robert/0000-0002-4580-5991	National Institutes of Health [GM056324, AI041699]; Jane Coffin Childs postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041699, R37AI041699, R29AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM056324 (to D. G. L.) and AI041699 (C. R. R.). This work was also supported by a Jane Coffin Childs postdoctoral fellowship (to R. E. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; Arasaki K, 2012, CELL HOST MICROBE, V11, P46, DOI 10.1016/j.chom.2011.11.009; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cheng W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002528; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; Gazdag EM, 2013, EMBO REP, V14, P199, DOI 10.1038/embor.2012.211; Goody PR, 2012, EMBO J, V31, P1774, DOI 10.1038/emboj.2012.16; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MP, 2012, J BIOL CHEM, V287, P35036, DOI 10.1074/jbc.M112.396861; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schoebel S, 2011, P NATL ACAD SCI USA, V108, P17945, DOI 10.1073/pnas.1113133108; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Yu Q, 2013, CELL RES, V23, P775, DOI 10.1038/cr.2013.54; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	50	22	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24000	24011		10.1074/jbc.M113.470625	http://dx.doi.org/10.1074/jbc.M113.470625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23821544	Green Published, hybrid			2022-12-25	WOS:000330611400038
J	Sung, KH; Lee, SY; Song, HK				Sung, Kwang Hoon; Lee, So Yeon; Song, Hyun Kyu			Structural and Biochemical Analyses of the Eukaryotic Heat Shock Locus V (HslV) from Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; CELL-DIVISION INHIBITOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 20S PROTEASOME; COMPLEX; SULA; DEGRADATION; ACTIVATION; SUBUNITS	In many bacteria, heat shock locus V (HslV) functions as a protease, which is activated by heat shock locus U (HslU). The primary sequence and structure of HslV are well conserved with those of the beta-subunit of the 20 S proteasome core particle in eukaryotes. To date, the HslVU complex has only been characterized in the prokaryotic system. Recently, however, the coexistence of a 20 S proteasome with HslV protease in the same living organism has been reported. In Trypanosoma brucei, a protozoan parasite that causes human sleeping sickness in Africa, HslV is localized in the mitochondria, where it has a novel function in regulating mitochondrial DNA replication. Although the prokaryotic HslVU system has been studied extensively, little is known regarding its eukaryotic counterpart. Here, we report the biochemical characteristics of an HslVU complex from T. brucei. In contrast to the prokaryotic system, T. brucei possesses two potential HslU molecules, and we found that only one of them activates HslV. A key activating residue, Tyr494, was identified in HslU2 by biochemical and mutational studies. Furthermore, to our knowledge, this study is the first to report the crystal structure of a eukaryotic HslV, determined at 2.4 angstrom resolution. Drawing on our comparison of the biochemical and structural data, we discuss herein the differences and similarities between eukaryotic and prokaryotic HslVs.	[Sung, Kwang Hoon; Lee, So Yeon; Song, Hyun Kyu] Korea Univ, Dept Life Sci, Seoul 136701, South Korea	Korea University	Song, HK (corresponding author), Korea Univ, Dept Life Sci, Seoul 136701, South Korea.	hksong@korea.ac.kr	Song, Hyun Kyu/D-6763-2016; Sood, Anoop Kumar/A-7344-2013	Song, Hyun Kyu/0000-0001-5684-4059; Sood, Anoop Kumar/0000-0001-5702-4108	National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0028168]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A092006]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (Grant 2011-0028168) and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (Grant A092006).	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barboza NR, 2012, EXP PARASITOL, V130, P171, DOI 10.1016/j.exppara.2011.10.011; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chrobak M, 2012, INT J PARASITOL, V42, P329, DOI 10.1016/j.ijpara.2012.01.008; Couvreur B, 2002, MOL BIOL EVOL, V19, P2110, DOI 10.1093/oxfordjournals.molbev.a004036; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forouzan D, 2012, J BIOL CHEM, V287, P39254, DOI 10.1074/jbc.M112.386458; Gille C, 2003, J MOL BIOL, V326, P1437, DOI 10.1016/S0022-2836(02)01470-5; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Halperin T, 2001, PLANT MOL BIOL, V45, P461, DOI 10.1023/A:1010677220323; Higashitani A, 1997, MOL GEN GENET, V254, P351, DOI 10.1007/s004380050426; KANAOKA Y, 1985, CHEM PHARM BULL, V33, P1721; Kanemori M, 1999, J BACTERIOL, V181, P3674, DOI 10.1128/JB.181.12.3674-3680.1999; Kang MS, 2001, EMBO J, V20, P734, DOI 10.1093/emboj/20.4.734; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000048; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Park E, 2008, J BIOL CHEM, V283, P33258, DOI 10.1074/jbc.M805411200; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Ruiz-Gonzalez MX, 2006, J MOL EVOL, V63, P504, DOI 10.1007/s00239-005-0282-1; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; SONEZAKI S, 1995, APPL MICROBIOL BIOT, V43, P304; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Song HK, 2003, BIOPHYS CHEM, V100, P437, DOI 10.1016/S0301-4622(02)00297-1; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Tschan S, 2010, INT J PARASITOL, V40, P1517, DOI 10.1016/j.ijpara.2010.05.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	57	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23234	23243		10.1074/jbc.M113.484832	http://dx.doi.org/10.1074/jbc.M113.484832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23818520	Green Published, hybrid			2022-12-25	WOS:000330598200030
J	Cai, YY; Newth, D				Cai, Yiyong; Newth, David			Oil, Gas and Conflict: A Mathematical Model for the Resource Curse	PLOS ONE			English	Article							NATURAL-RESOURCES; SOCIAL-CONFLICT; GROWTH	Oil and natural gas are highly valuable natural resources, but many countries with large untapped reserves suffer from poor economic and social-welfare performance. This conundrum is known as the resource curse. The resource curse is a result of poor governance and wealth distribution structures that allow the elite to monopolize resources for self-gain. When rival social groups compete for natural resources, civil unrest soon follows. While conceptually easy to follow, there have been few formal attempts to study this phenomenon. Thus, we develop a mathematical model that captures the basic elements and dynamics of this dilemma. We show that when resources are monopolized by the elite, increased exportation leads to decreased domestic production. This is due to under-provision of the resource-embedded energy and industrial infrastructure. Decreased domestic production then lowers the marginal return on productive activities, and insurgency emerges. The resultant conflict further displaces human, built, and natural capital. It forces the economy into a vicious downward spiral. Our numerical results highlight the importance of governance reform and productivity growth in reducing oil-and-gas-related conflicts, and thus identify potential points of intervention to break the downward spiral.	[Cai, Yiyong; Newth, David] CSIRO, CSIRO Ctr Complex Syst Sci, Canberra, ACT, Australia; [Cai, Yiyong] Australian Natl Univ, Ctr Appl Macroecon Anal, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Cai, YY (corresponding author), CSIRO, CSIRO Ctr Complex Syst Sci, Canberra, ACT, Australia.	yiyong.cai@csiro.au	Newth, David/A-1848-2011; Cai, Yiyong/F-3620-2015	Newth, David/0000-0001-6882-7440; 	Australian Research Council [DP0988281]	Australian Research Council(Australian Research Council)	Yiyong Cai gratefully acknowledges financial support from Australian Research Council Discovery Grant DP0988281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2006, EC ORIGINS DICTATORS, P225; Alesina A, 1995, EUROPEAN EC REV, V40, P1203; Benhabib J., 1996, J ECON GROWTH, V1, P125, DOI DOI 10.1007/BF00163345; Besley T, 2011, Q J ECON, V126, P1411, DOI 10.1093/qje/qjr025; Besley T, 2009, AM ECON REV, V99, P292, DOI 10.1257/aer.99.2.292; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Brunnschweiler CN, 2008, SCIENCE, V320, P616, DOI 10.1126/science.1154539; Caselli F, 2009, OXFORD ECON PAP, V61, P628, DOI 10.1093/oep/gpp023; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; Collier P, 2002, J CONFLICT RESOLUT, V46, P13, DOI 10.1177/0022002702046001002; Dal Bo E, 2011, J EUR ECON ASSOC, V9, P646, DOI 10.1111/j.1542-4774.2011.01025.x; Fearon JD, 2005, J CONFLICT RESOLUT, V49, P483, DOI 10.1177/0022002705277544; Garfinkel MR, 2008, J INT ECON, V76, P296, DOI 10.1016/j.jinteco.2008.07.005; Graetz M.J., 2011, END ENERGY UNMAKING; Grossman H. I., 1995, J ECON GROWTH, V1, P333, DOI [10.1007/BF00141042, DOI 10.1007/BF00141042]; GROSSMAN HI, 1991, AM ECON REV, V81, P912; Gylfason T, 2001, EUR ECON REV, V45, P847, DOI 10.1016/S0014-2921(01)00127-1; Hendrix CS, 2012, J PEACE RES, V49, P35, DOI 10.1177/0022343311426165; Hodler R, 2006, EUR ECON REV, V50, P1367, DOI 10.1016/j.euroecorev.2005.05.004; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Humphreys M, 2005, J CONFLICT RESOLUT, V49, P508, DOI 10.1177/0022002705277545; Koubi V, 2012, J PEACE RES, V49, P113, DOI 10.1177/0022343311427173; Lloyd-Ellis H, 2003, J DEV ECON, V72, P1, DOI 10.1016/S0304-3878(03)00066-X; Narayanan BG, 2012, GLOBAL TRADE ASSISTA; Persson T, 2000, POLITICAL EC EXPLAIN, P32; Ross ML, 2004, J PEACE RES, V41, P337, DOI 10.1177/0022343304043773; Sachs JD, 2001, EUR ECON REV, V45, P827, DOI 10.1016/S0014-2921(01)00125-8; Simon C.P., 1994, MATH EC; van der Ploeg F, 2011, J ECON LIT, V49, P366, DOI 10.1257/jel.49.2.366	29	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66706	10.1371/journal.pone.0066706	http://dx.doi.org/10.1371/journal.pone.0066706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826115	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000007
J	Li, M; Kang, RX; Shi, JG; Liu, GT; Zhang, JJ				Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun			Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced Seizures	PLOS ONE			English	Article							PENTYLENETETRAZOLE-INDUCED SEIZURES; RECEPTOR ACTIVATION; FOS EXPRESSION; GRANULE CELLS; MOUSE MODEL; EPILEPSY; BRAIN; SUPPRESSION; BINDING; STIMULATION	Epilepsy is a chronic neurological disorder characterized by recurrent seizures. However, approximately one-third of epilepsy patients still suffer from uncontrolled seizures. Effective treatments for epilepsy are yet to be developed. N-6-(3-methoxyl-4-hydroxybenzyl) adenine riboside (B2) is a N-6-substitued adenosine analog. Here we describe an investigation of the effects and mechanisms of B2 on chemical convulsant-induced seizures. Seizures were induced in mice by administration of 4-aminopyridine (4-AP), pentylenetetrazol (PTZ), picrotoxin, kainite acid (KA), or strychnine. B2 has a dose-related anticonvulsant effect in these chemical-induced seizure models. The protective effects of B2 include increased latency of seizure onset, decreased seizure occurrence, shorter seizure duration and reduced mortality rate. Radioligand binding and cAMP accumulation assays indicated that B2 might be a functional ligand for both adenosine A(1) and A(2A) receptors. Furthermore, DPCPX, a selective A(1) receptor antagonist, but not SCH58261, a selective A(2A) receptor antagonist, blocked the anticonvulsant effect of B2 on PTZ-induced seizure. c-Fos is a cellular marker for neuronal activity. Immunohistochemical and western blot analyses indicated that B2 significantly reversed PTZ-induced c-Fos expression in the hippocampus. Together, these results indicate that B2 has significant anticonvulsant effects. The anticonvulsant effects of B2 may be attributed to adenosine A(1) receptor activation and reduced neuronal excitability in the hippocampus. These observations also support that the use of adenosine receptor agonist may be a promising approach for the treatment of epilepsy.	[Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Min] Minist Hlth, Beijing Hosp, Dept Clin Pharmacol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Zhang, JJ (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	jjzhang@imm.ac.cn			China National Science and Technology Major Project Grant for Drug Discovery [2009ZX09301-003, 2008ZX09401-004]; National Natural Science Foundation of China [30973512]; National Science Fund for Distinguished Young Scholars of China [30825044]	China National Science and Technology Major Project Grant for Drug Discovery; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the China National Science and Technology Major Project Grant for Drug Discovery (2009ZX09301-003, 2008ZX09401-004), the National Natural Science Foundation of China (30973512) and the National Science Fund for Distinguished Young Scholars of China (30825044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Ying-Ying, 2002, Zhejiang Da Xue Xue Bao Yi Xue Ban, V31, P111; Boison D, 2005, NEUROSCIENTIST, V11, P25, DOI 10.1177/1073858404269112; Boison D, 1999, EXP NEUROL, V160, P164, DOI 10.1006/exnr.1999.7209; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIN JH, 1989, ANN NEUROL, V26, P695, DOI 10.1002/ana.410260602; De Sarro G, 1999, EUR J PHARMACOL, V371, P137, DOI 10.1016/S0014-2999(99)00132-6; DRAGUNOW M, 1992, MOL BRAIN RES, V13, P119, DOI 10.1016/0169-328X(92)90051-C; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Engel J.J., 1997, EPILEPSY COMPREHENSI, P2417; Fedele DE, 2006, EXP NEUROL, V200, P184, DOI 10.1016/j.expneurol.2006.02.133; Fredholm BB, 2003, DRUG NEWS PERSPECT, V16, P283, DOI 10.1358/dnp.2003.16.5.829316; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Huber A, 2002, NEUROSCI LETT, V329, P289, DOI 10.1016/S0304-3940(02)00684-5; Huber A, 1993, BRIT J PHARMACOL, V110, P470; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jaworski J, 1999, J BIOL CHEM, V274, P28106, DOI 10.1074/jbc.274.40.28106; Kenakin T, 1996, PHARMACOL REV, V48, P413; Kim SK, 2003, J MED CHEM, V46, P4847, DOI 10.1021/jm0300431; KLOTZ KN, 1989, N-S ARCH PHARMACOL, V340, P679, DOI 10.1007/BF00717744; Li TF, 2007, NEURON GLIA BIOL, V3, P353, DOI 10.1017/S1740925X0800015X; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; LOSCHER W, 1988, EPILEPSY RES, V2, P145, DOI 10.1016/0920-1211(88)90054-X; MacGregor DG, 2002, NEUROSCI LETT, V329, P289; Malhotra J, 1997, BRIT J PHARMACOL, V120, P282, DOI 10.1038/sj.bjp.0700869; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Muller CE, 2000, EUR J PHARM SCI, V10, P259, DOI 10.1016/S0928-0987(00)00064-6; NADLER JV, 1981, LIFE SCI, V29, P2031; NORDSTEDT C, 1990, ANAL BIOCHEM, V189, P231, DOI 10.1016/0003-2697(90)90113-N; Pagonopoulou O, 2006, NEUROSCI RES, V56, P14, DOI 10.1016/j.neures.2006.05.010; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; SCHRADER J, 1980, PFLUG ARCH EUR J PHY, V387, P245, DOI 10.1007/BF00580977; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; SMITH MC, 1991, CLIN NEUROPHARMACOL, V14, P97, DOI 10.1097/00002826-199104000-00001; Stepien KM, 2002, PHARM REP, V64, P1011; Sun Jing, 2011, Yaoxue Xuebao, V46, P1199; Tchilibon S, 2005, J MED CHEM, V48, P1745, DOI 10.1021/jm049580r; Uzbay TI, 2007, NEUROPSYCHOPHARMACOL, V32, P412, DOI 10.1038/sj.npp.1301143; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Yan Luo, 2003, Expert Opin Emerg Drugs, V8, P537, DOI 10.1517/eoed.8.2.537.21128; Zeraati M, 2006, SEIZURE-EUR J EPILEP, V15, P41, DOI 10.1016/j.seizure.2005.10.006	45	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67060	10.1371/journal.pone.0067060	http://dx.doi.org/10.1371/journal.pone.0067060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825618	Green Published, Green Submitted, gold			2022-12-25	WOS:000321223000070
J	Lu, J; Li, WH; Fu, Y; Long, B; Shen, J; Su, L; Yin, LX				Lu, Jing; Li, Wenhua; Fu, Ying; Long, Bin; Shen, Jie; Su, Li; Yin, Lixue			Hemodynamic Changes in Left Anterior Descending Coronary Artery and Anterior Interventricular Vein during Right Ventricular Apical Pacing: A Doppler Ultrasound Study in Open Chest Beagles	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; BUNDLE-BRANCH BLOCK; ACTIVATION; PATTERNS	Objective: The aim of this study was to quantify the effects of right ventricular apical pacing (RVAP) on hemodynamics in left anterior descending coronary artery (LAD) and anterior interventricular vein (AIV) contrast to baseline condition in open chest beagles using Doppler ultrasound imaging. Methods: In 6 anesthetized open chest beagles, the spectral Doppler waveforms of the middle segmental LAD and the AIV were acquired with a 5 MHz linear array transducer at baseline condition and during RVAP. The aortic pressure-time curves were recorded synchronously. The Doppler hemodynamic parameters of the LAD and AIV at both states were derived and compared. Results: The spectral Doppler waveforms of the LAD had a principal diastolic positive wave (Dp), which heelled by a momentary negative wave and a positive wave during early systole at baseline condition. During RVAP, an additional negative wave appeared in the LAD at late systole. The duration of the Dp shortened (227.83 +/- 12.16 ms vs 188.50 +/- 8.97 ms, P<0.001), and the acceleration of the Dp decreased (11.85 +/- 2.22 m/s(2) vs 3.54 +/- 0.42 m/s(2), P<0.001). The spectral Doppler waveforms of the AIV only had a principal positive wave (Sp) at baseline condition, but an additional diastolic negative wave appeared during RVAP. The duration of the Sp shortened (242.99 +/- 7.98 ms vs 215.38 +/- 15.44 ms, P<0.001), and the acceleration of the Sp decreased (9.61 +/- 1.93 m/s(2) vs 1.0160.11 m/s(2), P<0.001). Conclusions: Obvious hemodynamic changes in the LAD and AIV during RVAP were observed, and these abnormal flow patterns in epicardial coronary arteries and vena coronaria may be sensitive and important hints of the disturbed cardiac electrical and mechanical activity sequences.	[Yin, Lixue] Sichuan Acad Med Sci, Dept Cardiovasc Ultrasound & Noninvas Cardiol, Chengdu, Sichuan, Peoples R China; Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Yin, LX (corresponding author), Sichuan Acad Med Sci, Dept Cardiovasc Ultrasound & Noninvas Cardiol, Chengdu, Sichuan, Peoples R China.	yinlixue@yahoo.com		, Jing/0000-0001-7602-5122	National Nature Foundation of China [30670547]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Foundation of China (No. 30670547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMITZUR G, 1995, PACE, V18, P697, DOI 10.1111/j.1540-8159.1995.tb04664.x; Anderson SE, 2009, ANAT REC, V292, P23, DOI 10.1002/ar.20766; ARAGAM JR, 1993, J AM COLL CARDIOL, V21, P478, DOI 10.1016/0735-1097(93)90692-T; CHILIAN WM, 1982, CIRC RES, V50, P775, DOI 10.1161/01.RES.50.6.775; Delgado V, 2009, CIRC-ARRHYTHMIA ELEC, V2, P135, DOI 10.1161/CIRCEP.108.814608; DOUCETTE JW, 1992, CIRCULATION, V85, P1899, DOI 10.1161/01.CIR.85.5.1899; Gillis AM, 2006, HEART RHYTHM, V3, P1367, DOI 10.1016/j.hrthm.2006.07.010; GOTO M, 1993, BIORHEOLOGY, V30, P323; Hadjiloizou N, 2008, AM J PHYSIOL-HEART C, V295, pH1198, DOI 10.1152/ajpheart.00510.2008; Healey JS, 2007, CURR OPIN CARDIOL, V22, P33, DOI 10.1097/HCO.0b013e32801177f2; HODGSON EJ, 1993, CAN J CARDIOL, V9, P821; Iwakura K, 1996, CIRCULATION, V94, P1269, DOI 10.1161/01.CIR.94.6.1269; KAJIYA F, 1989, CIRC RES, V65, P1172, DOI 10.1161/01.RES.65.5.1172; KAJIYA F, 1985, Heart and Vessels, V1, P16, DOI 10.1007/BF02066482; KAJIYA F, 1986, CIRC RES, V58, P476, DOI 10.1161/01.RES.58.4.476; KAJIYA F, 1985, J BIOMECH ENG-T ASME, V107, P10, DOI 10.1115/1.3138511; KAJIYA F, 1993, CARDIOVASC RES, V27, P845, DOI 10.1093/cvr/27.5.845; Kolettis TM, 1998, INT J CARDIOL, V66, P203, DOI 10.1016/S0167-5273(98)00215-0; Kyriakides ZS, 2007, INT J CARDIOL, V119, P3, DOI 10.1016/j.ijcard.2006.03.091; Pachon Mateos Jose Carlos, 2009, Expert Rev Cardiovasc Ther, V7, P789, DOI 10.1586/erc.09.60; PERMUTT S., 1962, MED THORACALIS, V19, P239; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Prinzen FW, 2002, PACE, V25, P484, DOI 10.1046/j.1460-9592.2002.00484.x; Skalidis EI, 1999, J AM COLL CARDIOL, V33, P1338, DOI 10.1016/S0735-1097(98)00698-6; Spaan JAE, 2006, CIRCULATION, V113, P446, DOI 10.1161/CIRCULATIONAHA.105.587196; STEIN PD, 1969, AM HEART J, V78, P331, DOI 10.1016/0002-8703(69)90040-4; Tops LF, 2009, J AM COLL CARDIOL, V54, P764, DOI 10.1016/j.jacc.2009.06.006; Trohman RG, 2004, LANCET, V364, P1701, DOI 10.1016/S0140-6736(04)17358-3; UHLIG PN, 1984, CIRC RES, V55, P238, DOI 10.1161/01.RES.55.2.238; Varma N, 2008, J CARDIOVASC ELECTR, V19, P114, DOI 10.1111/j.1540-8167.2007.00995.x; Wyman BT, 1999, AM J PHYSIOL-HEART C, V276, pH881, DOI 10.1152/ajpheart.1999.276.3.H881; Yin LX, 2008, PACE, V31, P536, DOI 10.1111/j.1540-8159.2008.01037.x; Youn HJ, 2005, J AM SOC ECHOCARDIOG, V18, P1093, DOI 10.1016/j.echo.2005.03.042; Zanon F, 2008, EUROPACE, V10, P580, DOI 10.1093/europace/eun089	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67196	10.1371/journal.pone.0067196	http://dx.doi.org/10.1371/journal.pone.0067196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825640	gold, Green Submitted, Green Published			2022-12-25	WOS:000321223000088
J	Liu, YZ; Zhang, DD; Ma, J; Li, D; Yin, HZ; Luo, YJ				Liu, Yunzhe; Zhang, Dandan; Ma, Jing; Li, Dan; Yin, Huazhan; Luo, Yuejia			The Attention Modulation on Timing: An Event-Related Potential Study	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; TIME PERCEPTION; DECISION-MAKING; BRAIN; FMRI; LOCALIZATION; MEMORY; TASKS; RESOLUTION; RESOURCES	The present study examined the neural mechanisms of attention modulation on timing using ERP and sLORETA measurements in a dual-task paradigm. We parametrically varied the attention to the durations of a 1000-Hz pure tone and further localized the cortical regions that were sensitive to the attention modulation on timing. Results demonstrated that the attention modulation might happen at early stage, approximately 200 ms after stimulus presentation. The P2 component at frontal area served as an early neural correlate of attention effects on timing. More importantly, the contingent negative variation (CNV) appeared at fronto-central area was sensitive to the attention effect. In addition, the supplementary motor area (SMA) was assumed to be one of the key regions for selectively attending to and estimating time. These findings provide temporal and spatial correlates of attention-modulated time processing and potentially help to investigate the neural mechanisms of patients with time perception deficits.	[Liu, Yunzhe; Zhang, Dandan; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Ma, Jing] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Li, Dan; Yin, Huazhan] Chong Qing Normal Univ, Dept Psychol, Chongqing, Peoples R China	Shenzhen University; Southwest University - China; Chongqing Normal University	Yin, HZ (corresponding author), Chong Qing Normal Univ, Dept Psychol, Chongqing, Peoples R China.	yhz1979@sina.com			Ministry of Education of Humanities and Social Science project of China [12YJC190035]; China Postdoctoral Science Foundation [2013M530759]; National Natural Science Foundation of China [H0921]; Educational Commission Science Project of Chongqing [KJ120618]	Ministry of Education of Humanities and Social Science project of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Educational Commission Science Project of Chongqing	This study was supported by the Ministry of Education of Humanities and Social Science project of China (12YJC190035), China Postdoctoral Science Foundation (2013M530759), National Natural Science Foundation of China (H0921), and Educational Commission Science Project of Chongqing (KJ120618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Casini L, 1996, J PSYCHOPHYSIOL, V10, P252; Casini L, 1999, BEHAV PROCESS, V45, P73, DOI 10.1016/S0376-6357(99)00010-8; Casini L, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00035; Chen YG, 2010, NEUROREPORT, V21, P152, DOI 10.1097/WNR.0b013e328335b4f7; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2004, COGNITIVE BRAIN RES, V21, P216, DOI 10.1016/j.cogbrainres.2004.02.011; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbons H, 2005, COGNITIVE BRAIN RES, V25, P195, DOI 10.1016/j.cogbrainres.2005.05.009; Gibbons H, 2003, CORTEX, V39, P947, DOI 10.1016/S0010-9452(08)70872-4; Gonzalez-Garrido AA, 2008, INT J NEUROSCI, V118, P119, DOI 10.1080/00207450601042177; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Kononowicz TW, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00048; Kotz SAE, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00086; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; Macar F, 2004, J PSYCHOPHYSIOL, V18, P89, DOI 10.1027/0269-8803.18.23.89; Macar F, 2003, PSYCHOPHYSIOLOGY, V40, P950, DOI 10.1111/1469-8986.00113; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; Macar F, 2009, CAN J EXP PSYCHOL, V63, P227, DOI 10.1037/a0014457; MAURITZ KH, 1986, EXP BRAIN RES, V61, P229; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paul I, 2011, BIOL PSYCHOL, V88, P94, DOI 10.1016/j.biopsycho.2011.06.013; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Pouthas V, 2000, HUM BRAIN MAPP, V10, P49, DOI 10.1002/(SICI)1097-0193(200006)10:2<49::AID-HBM10>3.0.CO;2-8; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Sen S, 2010, NEUROSCIENCE, V166, P712, DOI 10.1016/j.neuroscience.2009.12.036; van Rijn H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00091; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0	40	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66190	10.1371/journal.pone.0066190	http://dx.doi.org/10.1371/journal.pone.0066190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826089	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400011
J	Godoy, MS; Castro-Vasquez, A; Vega, IA				Godoy, Martin S.; Castro-Vasquez, Alfredo; Vega, Israel A.			Endosymbiotic and Host Proteases in the Digestive Tract of the Invasive Snail Pomacea canaliculata: Diversity, Origin and Characterization	PLOS ONE			English	Article							APPLE-SNAILS; MIDGUT GLAND; PURIFICATION; MOLLUSCA; ENZYMES; ABALONE; CAENOGASTROPODA; GASTROPODA; SLUG; GUT	Digestive proteases of the digestive tract of the apple snail Pomacea canaliculata were studied. Luminal protease activity was found in the crop, the style sac and the coiled gut and was significantly higher in the coiled gut. Several protease bands and their apparent molecular weights were identified in both tissue extracts and luminal contents by gel zymography: (1) a 125 kDa protease in salivary gland extracts and in the crop content; (2) a 30 kDa protease throughout all studied luminal contents and in extracts of the midgut gland and of the endosymbionts isolated from this gland; (3) two proteases of 145 and 198 kDa in the coiled gut content. All these proteases were inhibited by aprotinin, a serine-protease inhibitor, and showed maximum activity between 30 degrees C and 35 degrees C and pH between 8.5 and 9.5. Tissue L-alanine-N-aminopeptidase activity was determined in the wall of the crop, the style sac and the coiled gut and was significantly higher in the coiled gut. Our findings show that protein digestion in P. canaliculata is carried out through a battery of diverse proteases originated from the salivary glands and the endosymbionts lodged in the midgut gland and by proteases of uncertain origin that occur in the coiled gut lumen.	[Godoy, Martin S.; Castro-Vasquez, Alfredo; Vega, Israel A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina; [Godoy, Martin S.; Castro-Vasquez, Alfredo; Vega, Israel A.] Consejo Nacl Invest Cient & Tecn, Inst Histol & Embriol Dr Mario H Burgos, Mendoza, Argentina; [Castro-Vasquez, Alfredo; Vega, Israel A.] Univ Nacl Cuyo, Inst Ciencias Basicas, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Vega, IA (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina.	israel.vega7@gmail.com	Vega, Israel Aníbal/ABB-1303-2020	Vega, Israel Aníbal/0000-0002-1398-3611	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Fondo Nacional de Ciencia y Tecnica (Argentina)	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo Nacional de Ciencia y Tecnica (Argentina)	This work was supported by grants from the Universidad Nacional de Cuyo, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Fondo Nacional de Ciencia y Tecnica (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews E. B., 1965, Proceedings of the Zoological Society of London, V145, P19; Balti R, 2012, FOOD CHEM, V130, P475, DOI 10.1016/j.foodchem.2011.07.019; BARLOCHER F, 1989, OECOLOGIA, V80, P39, DOI 10.1007/BF00789929; BECKSTEAD JH, 1995, J HISTOCHEM CYTOCHEM, V43, P345, DOI 10.1177/43.3.7868864; BISWAS AK, 1968, J ZOOL, V156, P325; Castro-Vazquez A, 2002, BIOCELL, V26, P101; CHARNEY J, 1947, J BIOL CHEM, V171, P501; Charrier M, 2003, CAN J ZOOL, V81, P928, DOI [10.1139/z03-071, 10.1139/Z03-071]; Ciminari ME, 2005, REV CHIL HIST NAT, V78, P267; COCKBURN TC, 1980, COMP BIOCHEM PHYS B, V65, P275, DOI 10.1016/0305-0491(80)90013-9; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Cueto JA, 2011, MOLLUSCAN RES, V31, P57; DEVI CU, 1981, P INDIAN AS-ANIM SCI, V90, P307, DOI 10.1007/BF03186005; EVANS WAL, 1962, COMP BIOCHEM PHYSIOL, V5, P223, DOI 10.1016/0010-406X(62)90108-1; Garcia-Esquivel Z, 2006, AQUACULTURE, V261, P615, DOI 10.1016/j.aquaculture.2006.08.022; GHOSE KRISHNA CHANDRA, 1961, PROC ZOOL SOC LONDON, V137, P127; Guionie O, 2003, COMP BIOCHEM PHYS B, V135, P503, DOI 10.1016/S1096-4959(03)00115-5; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; Hernandez-Santoyo A, 1998, AQUACULTURE, V159, P203, DOI 10.1016/S0044-8486(97)00172-5; Hirata K, 1998, BIOSCI BIOTECH BIOCH, V62, P2242, DOI 10.1271/bbb.62.2242; Hirata K, 1998, J FAC AGR KYUSHU U, V42, P463; Hirata K, 1998, BIOSCI BIOTECH BIOCH, V62, P807, DOI 10.1271/bbb.62.807; Imjongjirak C, 2008, DNA SEQUENCE, V19, P224, DOI 10.1080/10425170701517911; James R, 1997, COMP BIOCHEM PHYS B, V118, P275, DOI 10.1016/S0305-0491(97)00058-8; Koch E, 2006, VELIGER, V48, P17; LECHEVALIER P, 1995, COMP BIOCHEM PHYS B, V110, P777, DOI 10.1016/0305-0491(94)00211-C; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macey BM, 2006, MAR BIOTECHNOL, V8, P246, DOI 10.1007/s10126-005-0113-9; Martin GG, 2011, COMP BIOCHEM PHYS A, V160, P365, DOI 10.1016/j.cbpa.2011.07.003; Martinez R, 2011, AQUACULT INT, V19, P445, DOI 10.1007/s10499-010-9360-5; MEENAKSHI V. R., 1954, JOUR ANIMAL MORPHOL AND PHYSIOL, V1, P35; MEENAKSHI V. R., 1955, J ANIMAL MORPHOLOGY, V3, P75; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Moura KRS, 2004, J MOLLUS STUD, V70, P21, DOI 10.1093/mollus/70.1.21; Oscoz J, 2010, AQUAT INVASIONS, V5, P263, DOI 10.3391/ai.2010.5.3.04; Picos-Garcia C, 2000, AQUACULTURE, V181, P157, DOI 10.1016/S0044-8486(99)00223-9; RAGSTER LE, 1981, PLANT PHYSIOL, V67, P104, DOI 10.1104/pp.67.1.104; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; REID RGB, 1972, COMP BIOCHEM PHYSIOL, V41, P887, DOI 10.1016/0300-9629(72)90352-0; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANG QX, 1990, BIOL REPROD, V43, P946, DOI 10.1095/biolreprod43.6.946; Seuffert ME, 2010, J THERM BIOL, V35, P77, DOI 10.1016/j.jtherbio.2009.11.003; Teo SS, 2004, J MOLLUSCAN RES, V24, P139; Vega IA, 2006, BIOCELL, V30, P367; Vega IA, 2005, SYMBIOSIS, V39, P37; Vega IA, 2012, ENVIRON SCI POLLUT R, V19, P3307, DOI 10.1007/s11356-012-0848-6; Voltzow J, 1994, MICROSCOPIC ANATOMY, P111; Walker AJ, 1999, SOIL BIOL BIOCHEM, V31, P1387, DOI 10.1016/S0038-0717(99)00054-1; Yamaura I, 1997, BIOSCI BIOTECH BIOCH, V61, P615, DOI 10.1271/bbb.61.615; Zhao J, 2012, AQUACULTURE, V338, P147, DOI 10.1016/j.aquaculture.2012.01.016	53	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66689	10.1371/journal.pone.0066689	http://dx.doi.org/10.1371/journal.pone.0066689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818959	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800096
J	Dor-Haim, H; Berenfeld, O; Horowitz, M; Lotan, C; Swissa, M				Dor-Haim, Horesh; Berenfeld, Omer; Horowitz, Michal; Lotan, Chaim; Swissa, Moshe			Reduced Ventricular Arrhythmogeneity and Increased Electrical Complexity in Normal Exercised Rats	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; ATRIAL-FIBRILLATION; VIGOROUS EXERCISE; CANINE MODEL; MORTALITY; HYPERTROPHY; SUSCEPTIBILITY	Background: The mechanisms whereby aerobic training reduces the occurrence of sudden cardiac death in humans are not clear. We test the hypothesis that exercise-induced increased resistance to ventricular tachycardia and fibrillation (VT/VF) involve an intrinsic remodeling in healthy hearts. Methods and Results: Thirty rats were divided into a sedentary (CTRL, n = 16) and two exercise groups: short-(4 weeks, ST, n = 7) and long-term (8 weeks, LT, n = 7) trained groups. Following the exercise program hearts were isolated and studied in a Langendorff perfusion system. An S-1-S-2 pacing protocol was applied at the right ventricle to determine inducibility of VT/VF. Fast Fourier transforms were applied on ECG time-series. In-vivo measurements showed training-induced increase in aerobic capacity, heart-to-body weight ratio and a 50% low-to-high frequency ratio reduction in the heart rate variability (p<0.05). In isolated hearts the probability for VF decreased from 26.1 +/- 14.4 in CTRL to 13.9 +/- 14.1 and 6.7 +/- 8.5% in the ST and LT, respectively (p<0.05). Duration of VF also decreased from 19.0 +/- 5.7 in CTRL to 8.8 +/- 7.1 and 6.0 +/- 5.8 sec in ST and LT respectively (p<0.05). Moreover, the pacing current required for VF induction increased following exercise (2.9 +/- 1.7 vs. 5.4 +/- 2.1 and 8.5 +/- 0.9 mA, respectively; p<0.05). Frequency analysis of ECG revealed an exercise-induced VF transition from a narrow single peak spectrum at 17 Hz in CTRL to a broader range of peaks ranging between 8.8 and 22.5 Hz in the LT group (p<0.05). Conclusion: Exercise in rats leads to reduced VF propensity associated with an intrinsic cardiac remodeling related to a broader spectral range and faster frequency components in the ECG.	[Dor-Haim, Horesh; Lotan, Chaim] Hadassah Hebrew Univ Med Ctr, Inst Heart, Jerusalem, Israel; [Berenfeld, Omer] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Horowitz, Michal] Hadassah Hebrew Univ Med Ctr, Dept Physiol, Jerusalem, Israel; [Swissa, Moshe] Kaplan Med Ctr, Cardiac Res Ctr, Rehovot, Israel	Hebrew University of Jerusalem; University of Michigan System; University of Michigan; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Kaplan Medical Center	Swissa, M (corresponding author), Kaplan Med Ctr, Cardiac Res Ctr, Rehovot, Israel.	swissam@mail.huji.ac.il	Dor-Haim, Horesh/AAG-5001-2019	Berenfeld, Omer/0000-0001-9532-7871; Swissa, Moshe/0000-0001-7726-1178				Agabiti-Rosei E, 1997, ADV EXP MED BIOL, V432, P199; Anichkov DA, 2007, INT J CLIN PRACT, V61, P777, DOI 10.1111/j.1742-1241.2006.01099.x; BARTELS R, 1997, MED KLIN, P92; Berenfeld O, 2002, CIRC RES, V90, P1173, DOI 10.1161/01.RES.0000022854.95998.5C; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Biffi A, 2008, AM J CARDIOL, V101, P1792, DOI 10.1016/j.amjcard.2008.02.081; BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Calderone A, 2001, J APPL PHYSIOL, V91, P771, DOI 10.1152/jappl.2001.91.2.771; Campbell K, 2012, J PHYSIOL-LONDON, V590, P6363, DOI 10.1113/jphysiol.2012.238758; Collins HL, 2005, AM J PHYSIOL-HEART C, V289, pH1020, DOI 10.1152/ajpheart.00156.2005; Collins HL, 2005, AM J PHYSIOL-HEART C, V288, pH532, DOI 10.1152/ajpheart.00873.2004; EHSANI AA, 1978, AM J CARDIOL, V42, P52, DOI 10.1016/0002-9149(78)90984-0; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Gaussin V, 2003, CIRCULATION, V108, P2926, DOI 10.1161/01.CIR.0000101922.18151.7B; Hou LQ, 2010, CIRC RES, V107, P1503, DOI 10.1161/CIRCRESAHA.110.232470; Iemitsu M, 2001, AM J PHYSIOL-REG I, V281, pR2029, DOI 10.1152/ajpregu.2001.281.6.R2029; Jalife J, 2003, J INTERV CARD ELECTR, V9, P119, DOI 10.1023/A:1026215919730; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kozakova M, 2000, HYPERTENSION, V36, P343, DOI 10.1161/01.HYP.36.3.343; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Lujan HL, 2010, AM J PHYSIOL-HEART C, V298, pH1330, DOI 10.1152/ajpheart.00955.2009; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Manzo A, 2009, LAB ANIM-UK, V43, P41, DOI 10.1258/la.2007.007085; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; McIntyre H, 1997, J CARDIOVASC ELECTR, V8, P887, DOI 10.1111/j.1540-8167.1997.tb00850.x; MORRIS JN, 1980, LANCET, V2, P1207; Motte S, 2005, AM J PHYSIOL-HEART C, V289, pH1729, DOI 10.1152/ajpheart.01129.2004; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; NOAKES TD, 1983, CIRCULATION, V67, P24, DOI 10.1161/01.CIR.67.1.24; Noujaim SF, 2007, P NATL ACAD SCI USA, V104, P20985, DOI 10.1073/pnas.0709758104; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Oikarinen L, 2004, HYPERTENSION, V43, P1029, DOI 10.1161/01.HYP.0000125230.46080.c6; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; POSEL D, 1989, CIRCULATION, V80, P138, DOI 10.1161/01.CIR.80.1.138; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SCHWARTZ PJ, 1984, CIRCULATION, V69, P790, DOI 10.1161/01.CIR.69.4.790; SHAPIRO LM, 1984, BRIT HEART J, V52, P130; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Swissa M, 2004, J AM COLL CARDIOL, V43, P858, DOI 10.1016/j.jacc.2003.07.053; Swissa M, 2005, AM J PHYSIOL-HEART C, V289, pH1851, DOI 10.1152/ajpheart.00083.2005; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; TOMANEK RJ, 1979, TEX REP BIOL MED, V39, P111; Weber K T, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS37, DOI 10.1097/00005344-198706106-00006; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wisloff U, 2001, CARDIOVASC RES, V50, P495, DOI 10.1016/S0008-6363(01)00210-3; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66658	10.1371/journal.pone.0066658	http://dx.doi.org/10.1371/journal.pone.0066658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825553	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400142
J	Guttery, MR; Dahlgren, DK; Messmer, TA; Connelly, JW; Reese, KP; Terletzky, PA; Burkepile, N; Koons, DN				Guttery, Michael R.; Dahlgren, David K.; Messmer, Terry A.; Connelly, John W.; Reese, Kerry P.; Terletzky, Pat A.; Burkepile, Nathan; Koons, David N.			Effects of Landscape-Scale Environmental Variation on Greater Sage-Grouse Chick Survival	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; CENTROCERCUS-UROPHASIANUS; ECOLOGICAL RESPONSES; TEMPORAL VARIATION; MICROBIAL ACTIVITY; MOUNTAIN SNOWPACK; CLIMATE-CHANGE; BROOD HABITAT; NEST SURVIVAL; UNITED-STATES	Effective long-term wildlife conservation planning for a species must be guided by information about population vital rates at multiple scales. Greater sage-grouse (Centrocercus urophasianus) populations declined substantially during the twentieth century, largely as a result of habitat loss and fragmentation. In addition to the importance of conserving large tracts of suitable habitat, successful conservation of this species will require detailed information about factors affecting vital rates at both the population and range-wide scales. Research has shown that sage-grouse population growth rates are particularly sensitive to hen and chick survival rates. While considerable information on hen survival exists, there is limited information about chick survival at the population level, and currently there are no published reports of factors affecting chick survival across large spatial and temporal scales. We analyzed greater sage-grouse chick survival rates from 2 geographically distinct populations across 9 years. The effects of 3 groups of related landscape-scale covariates (climate, drought, and phenology of vegetation greenness) were evaluated. Models with phenological change in greenness (NDVI) performed poorly, possibly due to highly variable production of forbs and grasses being masked by sagebrush canopy. The top drought model resulted in substantial improvement in model fit relative to the base model and indicated that chick survival was negatively associated with winter drought. Our overall top model included effects of chick age, hen age, minimum temperature in May, and precipitation in July. Our results provide important insights into the possible effects of climate variability on sage-grouse chick survival.	[Guttery, Michael R.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Dahlgren, David K.] Kansas Dept Wildlife & Pk, Hays, KS USA; [Messmer, Terry A.; Terletzky, Pat A.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Connelly, John W.] Idaho Dept Fish & Game, Blackfoot, ID USA; [Reese, Kerry P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Burkepile, Nathan] Northland Fish & Game, Whangarei, New Zealand; [Koons, David N.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Koons, David N.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; Utah State University; Idaho; University of Idaho; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Guttery, MR (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	micrgutt@gmail.com			Idaho Department of Fish and Game Federal Aide in Wildlife Restoration Project [W-160-R]; United States Natural Resources Conservation Service; U.S. Bureau of Land Management; Utah State University Quinney Professorship for Wildlife Conflict Management; Jack H. Berryman Institute of Wildlife Damage Management; Utah State University Extension Service	Idaho Department of Fish and Game Federal Aide in Wildlife Restoration Project; United States Natural Resources Conservation Service; U.S. Bureau of Land Management; Utah State University Quinney Professorship for Wildlife Conflict Management; Jack H. Berryman Institute of Wildlife Damage Management; Utah State University Extension Service	This research was supported by the Idaho Department of Fish and Game Federal Aide in Wildlife Restoration Project W-160-R, the United States Natural Resources Conservation Service, U.S. Bureau of Land Management, Utah State University Quinney Professorship for Wildlife Conflict Management, Jack H. Berryman Institute of Wildlife Damage Management, Utah State University Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Anthony RG, 2009, J WILDLIFE MANAGE, V73, P538, DOI 10.2193/2008-177; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BARROS N, 1995, THERMOCHIM ACTA, V249, P161, DOI 10.1016/0040-6031(95)90686-X; Baxter RJ, 2008, J WILDLIFE MANAGE, V72, P179, DOI 10.2193/2006-402; Beck JL, 2006, WILDLIFE SOC B, V34, P1070, DOI 10.2193/0091-7648(2006)34[1070:MASOJG]2.0.CO;2; Beck JL, 2003, WEST N AM NATURALIST, V63, P203; Beck T. D. I., 1975, SEX AGE DETERMINATIO; Blomberg EJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00304.1; Bohn HL, 1999, ENVIRON PROG, V18, P156, DOI 10.1002/ep.670180311; BOX EO, 1989, VEGETATIO, V80, P71, DOI 10.1007/BF00048034; Brown TJ, 2004, CLIMATIC CHANGE, V62, P365, DOI 10.1023/B:CLIM.0000013680.07783.de; Burkepile NA, 2002, WILDLIFE SOC B, V30, P93; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chambers Jeanne C., 2008, Rangelands, V30, P29, DOI 10.2111/1551-501X(2008)30[29:CCIONA]2.0.CO;2; Connelly JW, 2011, STUD AVIAN BIOL, P53; Dahlgren, 2009, GREATER SAGE GROUSE; Dahlgren DK, 2010, J WILDLIFE MANAGE, V74, P1286, DOI 10.2193/2009-093; Daly C, 2000, T ASAE, V43, P1957, DOI 10.13031/2013.3101; Dixon Philip M., 1993, P290; DRUT MS, 1994, GREAT BASIN NAT, V54, P170; DRUT MS, 1994, J RANGE MANAGE, V47, P90, DOI 10.2307/4002848; Dunbar MR, 2005, J ZOO WILDLIFE MED, V36, P422, DOI 10.1638/04-065.1; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Fondell TF, 2008, J WILDLIFE MANAGE, V72, P1614, DOI 10.2193/2007-480; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Garton EO, 2011, STUD AVIAN BIOL, P293; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; Gregg MA, 2008, RANGELAND ECOL MANAG, V61, P535, DOI 10.2111/08-037.1; Gregg MA, 2009, J WILDLIFE MANAGE, V73, P904, DOI 10.2193/2007-410; Guttery MR, 2011, THESIS UTAH STATE U; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; Hannon SJ, 2006, J ZOOL, V269, P422, DOI 10.1111/j.1469-7998.2006.00159.x; Harris W, 2001, CANADIAN SAGE GROUSE; Herman-Brunson KM, 2009, WILDLIFE BIOL, V15, P237, DOI 10.2981/09-005; Hohensee SD, 2001, P NAT WILD TURK S, V8, P85; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; Hughes NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013114; Iles DT, 2013, J ANIM ECOL, V82, P683, DOI 10.1111/1365-2656.12038; Jensen J. R., 2005, INTRO DIGITAL IMAGE; JOHNSON GD, 1990, J WILDLIFE MANAGE, V54, P89, DOI 10.2307/3808906; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; KARL TR, 1986, J CLIM APPL METEOROL, V25, P77, DOI 10.1175/1520-0450(1986)025<0077:TSOTPD>2.0.CO;2; KLEBENOW DA, 1969, J WILDLIFE MANAGE, V33, P649, DOI 10.2307/3799390; KLEBENOW DA, 1968, J RANGE MANAGE, V21, P80, DOI 10.2307/3896359; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Lehman CP, 2008, J WILDLIFE MANAGE, V72, P1765, DOI 10.2193/2007-519; Lehman Chad P., 2008, Intermountain Journal of Sciences, V14, P78; Manly BFJ, 2001, J WILDLIFE MANAGE, V65, P258, DOI 10.2307/3802905; Miller RF, 2011, STUD AVIAN BIOL, P145; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Moynahan BJ, 2006, ECOL APPL, V16, P1529, DOI 10.1890/1051-0761(2006)016[1529:FCTPVI]2.0.CO;2; Norris K, 2004, J APPL ECOL, V41, P413, DOI 10.1111/j.0021-8901.2004.00910.x; Palmer W.C, 1965, METEOROLOGICAL DROUG, V30; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PARUELO JM, 1995, ECOLOGY, V76, P1888, DOI 10.2307/1940721; PETERSON J G, 1970, Journal of Wildlife Management, V34, P147, DOI 10.2307/3799502; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBERTS SD, 1995, J WILDLIFE MANAGE, V59, P437, DOI 10.2307/3802449; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Schroeder M.A., 1999, Birds of North America, V425, P1; Schroeder TA, 2006, REMOTE SENS ENVIRON, V103, P16, DOI 10.1016/j.rse.2006.03.008; Schwinning S, 2005, J ARID ENVIRON, V61, P61, DOI 10.1016/j.jaridenv.2004.07.013; Sveum CM, 1998, GREAT BASIN NAT, V58, P344; Syrotuck W.G., 1972, SCENT SCENTING DOG; Taylor RL, 2012, J WILDLIFE MANAGE, V76, P336, DOI 10.1002/jwmg.267; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WALKER DA, 1993, BIOSCIENCE, V43, P287, DOI 10.2307/1312061; WALLESTAD RO, 1971, J WILDLIFE MANAGE, V35, P129, DOI 10.2307/3799881; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb Stephen L., 2012, Ecological Processes, V1; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005; Zavala MAL, 2005, COMPOST SCI UTIL, V13, P208; Zheng BY, 2000, STAT MED, V19, P1265, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1265::AID-SIM486>3.3.CO;2-L	83	45	46	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65582	10.1371/journal.pone.0065582	http://dx.doi.org/10.1371/journal.pone.0065582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824519	gold, Green Published			2022-12-25	WOS:000320576400011
J	Hermann, PC; Trabulo, SM; Sainz, B; Balic, A; Garcia, E; Hahn, SA; Vandana, M; Sahoo, SK; Tunici, P; Bakker, A; Hidalgo, M; Heeschen, C				Hermann, Patrick C.; Trabulo, Sara M.; Sainz, Bruno, Jr.; Balic, Anamaria; Garcia, Elena; Hahn, Stephan A.; Vandana, Mallaredy; Sahoo, Sanjeeb K.; Tunici, Patrizia; Bakker, Annette; Hidalgo, Manuel; Heeschen, Christopher			Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts	PLOS ONE			English	Article							SELF-RENEWAL; GEMCITABINE	Purpose: In spite of intense research efforts, pancreatic ductal adenocarcinoma remains one of the most deadly malignancies in the world. We and others have previously identified a subpopulation of pancreatic cancer stem cells within the tumor as a critical therapeutic target and additionally shown that the tumor stroma represents not only a restrictive barrier for successful drug delivery, but also serves as a paracrine niche for cancer stem cells. Therefore, we embarked on a large-scale investigation on the effects of combining chemotherapy, hedgehog pathway inhibition, and mTOR inhibition in a preclinical mouse model of pancreatic cancer. Experimental Design: Prospective and randomized testing in a set of almost 200 subcutaneous and orthotopic implanted whole-tissue primary human tumor xenografts. Results: The combined targeting of highly chemoresistant cancer stem cells as well as their more differentiated progenies, together with abrogation of the tumor microenvironment by targeting the stroma and enhancing tissue penetration of the chemotherapeutic agent translated into significantly prolonged survival in preclinical models of human pancreatic cancer. Most pronounced therapeutic effects were observed in gemcitabine-resistant patient-derived tumors. Intriguingly, the proposed triple therapy approach could be further enhanced by using a PEGylated formulation of gemcitabine, which significantly increased its bioavailability and tissue penetration, resulting in a further improved overall outcome. Conclusions: This multimodal therapeutic strategy should be further explored in the clinical setting as its success may eventually improve the poor prognosis of patients with pancreatic ductal adenocarcinoma.	[Hermann, Patrick C.; Trabulo, Sara M.; Sainz, Bruno, Jr.; Balic, Anamaria; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Stem Cells & Canc Grp, Madrid, Spain; [Garcia, Elena; Hidalgo, Manuel] Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Gastrointestinal Canc Clin Res Unit, Madrid, Spain; [Hahn, Stephan A.] Ruhr Univ Bochum, Dept Mol GI Oncol, Bochum, Germany; [Vandana, Mallaredy; Sahoo, Sanjeeb K.] Inst Life Sci, Nanomed Lab, Bhubaneswar, Orissa, India; [Tunici, Patrizia] Siena Biotech SpA, Dept Oncol, Siena, Italy; [Bakker, Annette] Childrens Tumor Fdn, New York, NY USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Ruhr University Bochum; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Siena Biotech	Heeschen, C (corresponding author), Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Stem Cells & Canc Grp, Madrid, Spain.	cheeschen@cnio.es	Guba, Markus/M-4309-2019; Hahn, Stephan/E-3880-2010; Hermann, Patrick/Y-6254-2019; Anding, Bruno Sainz/ABH-5365-2020; Hahn, Stephan A./AAV-6062-2021; HIDALGO, MANUEL/I-4995-2015; Sanjeeb, Sahoo/ABF-3419-2020	Hahn, Stephan/0000-0003-0855-9741; Hermann, Patrick/0000-0003-0418-0478; Anding, Bruno Sainz/0000-0003-4829-7651; Hahn, Stephan A./0000-0003-0855-9741; HIDALGO, MANUEL/0000-0002-3765-3318; Balic, Anamaria/0000-0001-6796-1197; Heeschen, Christopher/0000-0002-1158-8554; bakker, annette/0000-0001-8420-7831	Siena Biotech, an ERC [Pa-CSC 233460]; Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria; Ministerio de Ciencia e Innovacion, Spain [PS09/02129]; Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (Modalidad ACI-PLAN E Celulas Madre Proyectos [PLE2009-0105]; Modalidad ACI-Colobra India	Siena Biotech, an ERC; Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (Modalidad ACI-PLAN E Celulas Madre Proyectos; Modalidad ACI-Colobra India	The present work was supported by unrestricted research grant from Siena Biotech, an ERC Advanced Investigator Grant (Pa-CSC 233460), the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129, Ministerio de Ciencia e Innovacion, Spain) and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (Modalidad ACI-PLAN E Celulas Madre Proyectos PLE2009-0105 and Modalidad ACI-Colobra India, both Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuthkar S, 2012, EXPERT OPIN INV DRUG, V21, P143, DOI 10.1517/13543784.2012.651124; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cosco D, 2009, CANCER CHEMOTH PHARM, V64, P1009, DOI 10.1007/s00280-009-0957-1; Ferruzzi P, 2012, INT J CANCER, V131, pE33, DOI 10.1002/ijc.27349; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2012, CELL CYCLE, V11, P1282, DOI 10.4161/cc.19679; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Matano E, 2000, BRIT J CANCER, V82, P1772, DOI 10.1054/bjoc.1999.1139; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rothenberg ML, 1996, ANN ONCOL, V7, P347; Vandana M, 2010, BIOMATERIALS, V31, P9340, DOI 10.1016/j.biomaterials.2010.08.010; Von Hoff DD, 2011, J CLIN ONCOLOGY; Von Hoff DD, 2011, CELL STEM CELL; Wang Y, 2007, KIDNEY INT; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028	28	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66371	10.1371/journal.pone.0066371	http://dx.doi.org/10.1371/journal.pone.0066371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825539	Green Submitted, Green Published, gold			2022-12-25	WOS:000320576400094
J	Lindner, G; Pfortmueller, CA; Funk, GC; Leichtle, AB; Fiedler, GM; Exadaktylos, AK				Lindner, Gregor; Pfortmueller, Carmen A.; Funk, Georg-Christian; Leichtle, Alexander B.; Fiedler, Georg Martin; Exadaktylos, Aristomenis K.			High-Sensitive Troponin Measurement in Emergency Department Patients Presenting with Syncope: A Retrospective Analysis	PLOS ONE			English	Article							HEART-FAILURE; DIAGNOSIS; MANAGEMENT; ASSAY	Objective: To study the relevance of high-sensitive troponin measurements in the acute workup in patients admitted to the emergency department of a large university hospital due to syncope. Methods: In this retrospective study all patients admitted to the emergency department because of syncope of the Inselspital, University Hospital Bern between 01 August 2010 and 31 October 2012, with serial determination of highsensitive troponin (baseline and three hours control) were included. Of all identified patients we obtained data on demographics, laboratory data, ECG as well as on outcome. A change in high-sensitive troponin in the three hours control of +/-30% compared to baseline was considered significant. Results: A total of 121 patients with a mean age of 67 years (SD 16) were included in the study. 79 patients (65%) were male and 42 (35%) were female. There was no significant difference in the median high sensitive-troponin level at baseline and in the three hours control (0.01 mcg/L [0.003 to 0.022] versus 0.011 mcg/L [0.003 to 0.022], p = 0.47). Median percent change in high-sensitive troponin level between baseline and control was 0% (29.1 to 5). 51 patients (42%) had elevated highsensitive troponin levels at baseline with 7 patients (6%) showing a dynamic of +/230% change from the baseline measurement in the 3 hours control. 3 of these patients received coronary angiography due to the dynamic in highsensitive troponin, none of whom needed intervention for coronary revascularization. Conclusions: On basis of the current study, where no single patient took benefit from determination of high-sensitive troponin, measurement of cardiac troponins should be reserved for patients with syncope presenting with symptoms suggestive for the presence of an acute cardiac syndrome.	[Lindner, Gregor; Pfortmueller, Carmen A.; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Lindner, Gregor; Pfortmueller, Carmen A.] Univ Hosp Bern, Inselspital, Dept Internal Med, CH-3010 Bern, Switzerland; [Funk, Georg-Christian] Otto Wagner Spital Vienna, Dept Resp & Crit Care Med, Vienna, Austria; [Funk, Georg-Christian] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Leichtle, Alexander B.; Fiedler, Georg Martin] Univ Hosp Bern, Inselspital, Ctr Lab Med, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Ludwig Boltzmann Institute; University of Bern; University Hospital of Bern	Lindner, G (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	lindner.gregor@gmail.com	Lindner, Gregor/AAR-6761-2020; Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011	Lindner, Gregor/0000-0001-5551-8227; Fiedler, Georg Martin/0000-0001-5689-4574; Pfortmueller, Carmen/0000-0003-0326-2770				Aarones M, 2011, AM HEART J, V161, P1031, DOI 10.1016/j.ahj.2010.09.021; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Kapoor WN, 2000, NEW ENGL J MED, V343, P1856, DOI 10.1056/NEJM200012213432507; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Korff S, 2006, HEART, V92, P987, DOI 10.1136/hrt.2005.071282; Mendu ML, 2009, ARCH INTERN MED, V169, P1299, DOI 10.1001/archinternmed.2009.204; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Pascual-Figal DA, 2012, AM HEART J, V163, P1002, DOI 10.1016/j.ahj.2012.03.015; Reed MJ, 2012, EMERG MED J, V29, P1001, DOI 10.1136/emermed-2012-201332; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163; Sun BC, 2009, ANN EMERG MED, V54, P769, DOI 10.1016/j.annemergmed.2009.07.027; Sutton R, 2012, NAT REV CARDIOL, V9, P590, DOI 10.1038/nrcardio.2012.102	12	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66470	10.1371/journal.pone.0066470	http://dx.doi.org/10.1371/journal.pone.0066470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823330	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400113
J	Matsumoto, T; Yamada, A; Aizawa, R; Suzuki, D; Tsukasaki, M; Suzuki, W; Nakayama, M; Maki, K; Yamamoto, M; Baba, K; Kamijo, R				Matsumoto, Takashi; Yamada, Atsushi; Aizawa, Ryo; Suzuki, Dai; Tsukasaki, Masayuki; Suzuki, Wataru; Nakayama, Mutsuko; Maki, Koutaro; Yamamoto, Matsuo; Baba, Kazuyoshi; Kamijo, Ryutaro			BMP-2 Induced Expression of Alx3 That Is a Positive Regulator of Osteoblast Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PROTEINS; INSULIN; BINDING; DLX3	Bone morphogenetic proteins (BMPs) regulate many aspects of skeletal development, including osteoblast and chondrocyte differentiation, cartilage and bone formation, and cranial and limb development. Among them, BMP-2, one of the most potent osteogenic signaling molecules, stimulates osteoblast differentiation, while it inhibits myogenic differentiation in C2C12 cells. To evaluate genes involved in BMP-2-induced osteoblast differentiation, we performed cDNA microarray analyses to compare BMP-2-treated and -untreated C2C12 cells. We focused on Alx3 (aristaless-like homeobox 3) which was clearly induced during osteoblast differentiation. Alx3, a homeobox gene related to the Drosophila aristaless gene, has been linked to developmental functions in craniofacial structures and limb development. However, little is known about its direct relationship with bone formation. In the present study, we focused on the mechanisms of Alx3 gene expression and function during osteoblast differentiation induced by BMP-2. In C2C12 cells, BMP-2 induced increase of Alx3 gene expression in both time- and dose-dependent manners through the BMP receptors-mediated SMAD signaling pathway. In addition, silencing of Alx3 by siRNA inhibited osteoblast differentiation induced by BMP-2, as showed by the expressions of alkaline phosphatase (Alp), Osteocalcin, and Osterix, while over-expression of Alx3 enhanced osteoblast differentiation induced by BMP-2. These results indicate that Alx3 expression is enhanced by BMP-2 via the BMP receptors mediated-Smad signaling and that Alx3 is a positive regulator of osteoblast differentiation induced by BMP-2.	[Matsumoto, Takashi; Yamada, Atsushi; Aizawa, Ryo; Suzuki, Dai; Tsukasaki, Masayuki; Suzuki, Wataru; Nakayama, Mutsuko; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan; [Matsumoto, Takashi; Suzuki, Wataru; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo 142, Japan; [Aizawa, Ryo; Yamamoto, Matsuo] Showa Univ, Sch Dent, Dept Periodont, Tokyo 142, Japan; [Nakayama, Mutsuko; Maki, Koutaro] Showa Univ, Sch Dent, Dept Orthodont, Tokyo 142, Japan	Showa University; Showa University; Showa University; Showa University	Yamada, A (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan.	yamadaa@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021	Baba, Kazuyoshi/0000-0001-8025-2168	Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [25893243] Funding Source: KAKEN	Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Project to Establish Strategic Research from the Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science, and Technology, and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beverdam A, 2001, MECH DEVELOP, V107, P163, DOI 10.1016/S0925-4773(01)00450-6; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Garcia-Sanz P, 2013, BIOCHEM J, V450, P199, DOI 10.1042/BJ20120962; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lakhwani S, 2010, DEV BIOL, V344, P869, DOI 10.1016/j.ydbio.2010.06.002; Meijlink F, 1999, INT J DEV BIOL, V43, P651; Mirasierra M, 2006, MOL ENDOCRINOL, V20, P2876, DOI 10.1210/me.2005-0472; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morimura N, 2001, J BIOL CHEM, V276, P42172, DOI 10.1074/jbc.M103216200; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; Perez-Villamil B, 2004, J BIOL CHEM, V279, P38062, DOI 10.1074/jbc.M400800200; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; Samee N, 2007, CRIT REV EUKAR GENE, V17, P173, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.10; Singh M, 2012, J CELL PHYSIOL, V227, P390, DOI 10.1002/jcp.22791; Suzuki D, 2012, CALCIFIED TISSUE INT, V91, P88, DOI 10.1007/s00223-012-9614-5; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200	26	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68774	10.1371/journal.pone.0068774	http://dx.doi.org/10.1371/journal.pone.0068774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825702	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400201
J	Mueller, S; Keeser, D; Samson, AC; Kirsch, V; Blautzik, J; Grothe, M; Erat, O; Hegenloh, M; Coates, U; Reiser, MF; Hennig-Fast, K; Meindl, T				Mueller, Sophia; Keeser, Daniel; Samson, Andrea C.; Kirsch, Valerie; Blautzik, Janusch; Grothe, Michel; Erat, Okan; Hegenloh, Michael; Coates, Ute; Reiser, Maximilian F.; Hennig-Fast, Kristina; Meindl, Thomas			Convergent Findings of Altered Functional and Structural Brain Connectivity in Individuals with High Functioning Autism: A Multimodal MRI Study	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; WHITE-MATTER; ASPERGER-SYNDROME; CORPUS-CALLOSUM; SENTENCE COMPREHENSION; SPECTRUM DISORDERS; DISTINCT PATTERNS; FRONTAL-CORTEX; DIFFUSION; UNDERCONNECTIVITY	Brain tissue changes in autism spectrum disorders seem to be rather subtle and widespread than anatomically distinct. Therefore a multimodal, whole brain imaging technique appears to be an appropriate approach to investigate whether alterations in white and gray matter integrity relate to consistent changes in functional resting state connectivity in individuals with high functioning autism (HFA). We applied diffusion tensor imaging (DTI), voxel-based morphometry (VBM) and resting state functional connectivity magnetic resonance imaging (fcMRI) to assess differences in brain structure and function between 12 individuals with HFA (mean age 35.5, SD 11.4, 9 male) and 12 healthy controls (mean age 33.3, SD 9.0, 8 male). Psychological measures of empathy and emotionality were obtained and correlated with the most significant DTI, VBM and fcMRI findings. We found three regions of convergent structural and functional differences between HFA participants and controls. The right temporo-parietal junction area and the left frontal lobe showed decreased fractional anisotropy (FA) values along with decreased functional connectivity and a trend towards decreased gray matter volume. The bilateral superior temporal gyrus displayed significantly decreased functional connectivity that was accompanied by the strongest trend of gray matter volume decrease in the temporal lobe of HFA individuals. FA decrease in the right temporoparietal region was correlated with psychological measurements of decreased emotionality. In conclusion, our results indicate common sites of structural and functional alterations in higher order association cortex areas and may therefore provide multimodal imaging support to the long-standing hypothesis of autism as a disorder of impaired higher-order multisensory integration.	[Mueller, Sophia; Keeser, Daniel; Blautzik, Janusch; Erat, Okan; Coates, Ute; Reiser, Maximilian F.; Meindl, Thomas] Univ Munich, Inst Clin Radiol, Munich, Germany; [Keeser, Daniel; Hegenloh, Michael; Hennig-Fast, Kristina] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Samson, Andrea C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Kirsch, Valerie] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Kirsch, Valerie] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Grothe, Michel] Univ Rostock, Dept Psychiat, D-18055 Rostock, Germany; [Hegenloh, Michael] Univ Munich, Dept Psychol, Munich, Germany	University of Munich; University of Munich; Stanford University; University of Munich; University of Munich; University of Rostock; University of Munich	Mueller, S (corresponding author), Univ Munich, Inst Clin Radiol, Munich, Germany.	Sophia.Mueller@med.uni-muenchen.de	Keeser, Daniel/C-8888-2016; Samson, Andrea C/ABG-6296-2021; Grothe, Michel J./S-7374-2018; Samson, Andrea/K-3928-2017	Keeser, Daniel/0000-0002-0244-1024; Samson, Andrea C/0000-0001-6807-3132; Grothe, Michel J./0000-0003-2600-9022; Samson, Andrea/0000-0001-6807-3132; Kirsch, Valerie/0000-0002-9397-436X	internal funds of the Department of Psychology; Institute of Clinical Radiology; Ludwig Maximilians University Munich; German Research Foundation [MU 3222/2-1]	internal funds of the Department of Psychology; Institute of Clinical Radiology; Ludwig Maximilians University Munich; German Research Foundation(German Research Foundation (DFG))	This study was supported by internal funds of the Department of Psychology and the Institute of Clinical Radiology, Ludwig Maximilians University Munich. Sophia Mueller receives a research fellowship from the German Research Foundation (MU 3222/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ameis Stephanie H, 2012, Front Psychiatry, V3, P46, DOI 10.3389/fpsyt.2012.00046; Ameis SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028044; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Eysenck HJ, 1994, MANUAL EYSENCK PERSO; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Freitag CM, 2007, J AUTISM DEV DISORD, V37, P948, DOI 10.1007/s10803-006-0235-6; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; FRITH U, 1989, BRIT J DISORD COMMUN, V24, P123; Ghaziuddin M, 2004, J AUTISM DEV DISORD, V34, P279, DOI 10.1023/B:JADD.0000029550.19098.77; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Hall GBC, 2003, AM J PSYCHIAT, V160, P1439, DOI 10.1176/appi.ajp.160.8.1439; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hardan AY, 2000, NEUROLOGY, V55, P1033, DOI 10.1212/WNL.55.7.1033; Heilman KM, 1998, J CLIN NEUROPHYSIOL, V15, P409, DOI 10.1097/00004691-199809000-00005; Hienrichs M, 2007, CURR OPIN PSYCHIATR, V20, P158, DOI 10.1097/YCO.0b013e3280146a13; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kwon H, 2004, DEV MED CHILD NEUROL, V46, P760, DOI 10.1017/S0012162204001306; LAIRD AR, 2011, J COGN NEUROSCI; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; McAlonan GM, 2009, PSYCHOL MED, V39, P1885, DOI 10.1017/S0033291709005728; McAlonan GM, 2008, J CHILD PSYCHOL PSYC, V49, P1287, DOI 10.1111/j.1469-7610.2008.01933.x; MEINDL C, 1998, ENTWICKLUNG VALIDIER; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; MUELLER S, 2011, AJNR AM J NEURORADIO; MUELLER S, 2012, ANN M ORG HUM BRAIN; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Nelson H., 1991, NATL ADULT READING T; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OMANAND K, 2005, NEUROBIOLOGY AUTISM, P150; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Selg H, 2010, FPI R FREIBURGER PER; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; WHO, 2012, ICD 10 CLASS MENT BE; Woodbury-Smith M, 2005, J AUTISM DEV DISORD, V35, P235, DOI 10.1007/s10803-004-2002-x; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	90	96	98	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67329	10.1371/journal.pone.0067329	http://dx.doi.org/10.1371/journal.pone.0067329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825652	Green Published, gold, Green Submitted			2022-12-25	WOS:000320576400183
J	Svanella-Dumas, L; Candresse, T; Hulle, M; Marais, A				Svanella-Dumas, Laurence; Candresse, Thierry; Hulle, Maurice; Marais, Armelle			Distribution of Barley yellow dwarf virus-PAV in the Sub-Antarctic Kerguelen Islands and Characterization of Two New Luteovirus Species	PLOS ONE			English	Article							PLANT; HOST; INFECTION; INVASIONS; IMPACTS; DISEASE; CROZET	A systematic search for viral infection was performed in the isolated Kerguelen Islands, using a range of polyvalent genus-specific PCR assays. Barley yellow dwarf virus (BYDV) was detected in both introduced and native grasses such as Poa cookii. The geographical distribution of BYDV and its prevalence in P. cookii were analyzed using samples collected from various sites of the archipelago. We estimate the average prevalence of BYDV to be 24.9% in P. cookii, with significant variability between sites. BYDV genetic diversity was assessed using sequence information from two genomic regions: the P3 open reading frame (ORF) (encoding the coat protein) and the hypervariable P6 ORF region. The phylogenetic analysis in the P3 region showed that BYDV sequences segregate into three major lineages, the most frequent of which (Ker-I cluster) showed close homology with BYDV-PAV-I isolates and had very low intra-lineage diversity (0.6%). A similarly low diversity was also recorded in the hypervariable P6 region, suggesting that Ker-I isolates derive from the recent introduction of BYDV-PAV-I. Divergence time estimation suggests that BYDV-PAV-I was likely introduced in the Kerguelen environment at the same time frame as its aphid vector, Rhopalosiphum padi, whose distribution shows good overlap with that of BYDV-Ker-I. The two other lineages show more than 22% amino acid divergence in the P3 region with other known species in the BYDV species complex, indicating that they represent distinct BYDV species. Using species-specific amplification primers, the distribution of these novel species was analyzed. The high prevalence of BYDV on native Poaceae and the presence of the vector R. padi, raises the question of its impact on the vulnerable plant communities of this remote ecosystem.	[Svanella-Dumas, Laurence; Candresse, Thierry; Marais, Armelle] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Svanella-Dumas, Laurence; Candresse, Thierry; Marais, Armelle] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Hulle, Maurice] INRA, Inst Genet Environm & Protect Plantes, UMR 1349, Le Rheu, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Marais, A (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, CS20032, Villenave Dornon, France.	amarais@bordeaux.inra.fr		Candresse, Thierry/0000-0001-9757-1835; Marais, Armelle/0000-0003-2482-1543; Hulle, Maurice/0000-0002-9520-3454	French ANR VMC project EVINCE [ANR-07-VULN-04-003]; French Polar Institute (IPEV) [136]	French ANR VMC project EVINCE(French National Research Agency (ANR)); French Polar Institute (IPEV)	This work was supported by the French ANR VMC project EVINCE (ANR-07-VULN-04-003) and by the French Polar Institute (IPEV, programme 136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VIRUS TAXONOMY; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Chapuis JL, 2004, BIOL CONSERV, V117, P167, DOI 10.1016/S0006-3207(03)00290-8; Convey Peter, 2009, Papers and Proceedings of the Royal Society of Tasmania, V143, P33; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Fakhfakh H., 2001, Journal of Plant Pathology, V83, P3; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Frenot Y, 2001, BIOL CONSERV, V101, P33, DOI 10.1016/S0006-3207(01)00052-0; Frenot Yves, 1997, P358; Halbert Susan, 1995, P217; Hulle M, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P308; Hulle M, 2003, ANTARCT SCI, V15, P203, DOI 10.1017/S0954102003001184; James D, 2006, CAN J PLANT PATHOL, V28, P16, DOI 10.1080/07060660609507267; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Liu F, 2007, ARCH VIROL, V152, P1365, DOI 10.1007/s00705-007-0947-8; Malmstrom CM, 2007, J ECOL, V95, P1153, DOI 10.1111/j.1365-2745.2007.01307.x; Malmstrom CM, 2006, J ECOL, V94, P264, DOI 10.1111/j.1365-2745.2006.01101.x; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Malmstrom CM, 2004, J VIROL METHODS, V120, P69, DOI 10.1016/j.jviromet.2004.04.005; Marais A, 2010, PLANT DIS, V94, P477, DOI 10.1094/PDIS-94-4-0477B; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Polischuk V, 2007, FEMS MICROBIOL ECOL, V59, P409, DOI 10.1111/j.1574-6941.2006.00242.x; REMAUDIERE G, 1988, AGRON TROP, V43, P327; ROCHOW WF, 1970, SCIENCE, V167, P875, DOI 10.1126/science.167.3919.875; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P63, DOI 10.1016/j.coviro.2011.05.022; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P50, DOI 10.1016/j.coviro.2011.05.012; Skotnicki ML, 2003, POLAR BIOL, V26, P1, DOI [10.1525/pol.2003.26.1.1, 10.1007/s00300-002-0421-8]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEN F, 1991, J GEN VIROL, V72, P2217, DOI 10.1099/0022-1317-72-9-2217; Wren JD, 2006, PLOS BIOL, V4, P314, DOI 10.1371/journal.pbio.0040080; Wu BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016896	36	19	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67231	10.1371/journal.pone.0067231	http://dx.doi.org/10.1371/journal.pone.0067231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825645	Green Published, Green Submitted, gold			2022-12-25	WOS:000320576400180
J	Tabana, H; Doherty, T; Rubenson, B; Jackson, D; Ekstrom, AM; Thorson, A				Tabana, Hanani; Doherty, Tanya; Rubenson, Birgitta; Jackson, Debra; Ekstrom, Anna Mia; Thorson, Anna			Testing Together Challenges the Relationship': Consequences of HIV Testing as a Couple in a High HIV Prevalence Setting in Rural South Africa	PLOS ONE			English	Article							DISCORDANT COUPLES; TRANSMISSION; PREVENTION	Objective: We conducted qualitative individual and combined interviews with couples to explore their experiences since the time of taking an HIV test and receiving the test result together, as part of a home-based HIV counselling and testing intervention. Methods: This study was conducted in October 2011 in rural KwaZulu-Natal, South Africa, about 2 years after couples tested and received results together. Fourteen couples were purposively sampled: discordant, concordant negative and concordant positive couples. Findings: Learning about each other's status together challenged relationships of the couples in different ways depending on HIV status and gender. The mutual information confirmed suspected infidelity that had not been discussed before. Negative women in discordant partnerships remained with their positive partner due to social pressure and struggled to maintain their HIV negative status. Most of the couple relationships were characterized by silence and mistrust. Knowledge of sero-status also led to loss of sexual intimacy in some couples especially the discordant. For most men in concordant negative couples, knowledge of status was an awakening of the importance of fidelity and an opportunity for behaviour change, while for concordant positive and discordant couples, it was seen as proof of infidelity. Although positive HIV status was perceived as confirmation of infidelity, couples continued their relationship and offered some support for each other, living and managing life together. Sexual life in these couples was characterized by conflict and sometimes violence. In the concordant negative couples, trust was enhanced and behaviour change was promised. Conclusions: Findings suggest that testing together as couples challenged relationships in both negative and positive ways. Further, knowledge of HIV status indicated potential to influence behaviour change especially among concordant negatives. In the discordant and concordant positive couples, traditional gender roles exposed women's vulnerability and their lack of decision-making power.	[Tabana, Hanani; Doherty, Tanya] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Tabana, Hanani; Rubenson, Birgitta; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Rubenson, Birgitta; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Doherty, Tanya; Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of the Western Cape	Tabana, H (corresponding author), Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa.	Hanani.Tabana@mrc.ac.za	Tabana, Hanani/AAJ-5361-2020; Tabana, Hanani/AAP-8143-2020	Tabana, Hanani/0000-0003-1576-2238; Tabana, Hanani/0000-0003-1576-2238; Jackson, Debra/0000-0003-3307-632X; Thorson, Anna/0000-0002-8703-6561	Medical Research Council of South Africa	Medical Research Council of South Africa(South African Medical Research Council)	The study received financial support from the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg B.L., 2001, QUALITATIVE RES METH; Binagwaho A, 2010, PAN AFRICAN MED; Bishop M, 2010, SERODISCORDANT COUPL; BRITTON PJ, 1993, AIDS CARE, V5, P43, DOI 10.1080/09540129308258583; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Burton J, 2010, AIDS BEHAV, V14, P1, DOI 10.1007/s10461-008-9471-4; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Dolezal C, 2006, J URBAN HLTH B NEW Y, V83; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Ekstrom AM, 2010, BMC PUBLIC HEALTH, V10, P1; Government of South Africa, 2010, COMM SURV HIV AIDS; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; International Organization for Migration, 2005, HIV AIDS POP MOB MIG; Jaffar S, 2011, BMC PUBLIC HEALTH, V11, P1; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Lurie MN, 2004, 5 U OXF U U CAP TOWN; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Moore J, 1998, FACTORS INFLUENCING; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; National Department of Health South Africa, 2021, 2019 NAT ANT HIV SEN; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Popenoe R, 2010, BMC PUBLIC HEALTH, V10, P1421; Posel D, 2011, MARRIAGE ILOBOLO BRI; Republic of South Africa, 2008, UN GEN ASS SPEC SESS; Rispel LC, 2012, CULT HEALTH SEX, V14, P257, DOI 10.1080/13691058.2011.621448; Rispel LC, 2011, REPROD HEALTH MATTER, V19, P184, DOI 10.1016/S0968-8080(11)37552-0; Shisana O., 2009, S AFRICAN NATL HIV P; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; UMzimkhulu Local Municipality, 2010, INT DEV PLAN 2009 20; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 2010, UNAIDS EX DIR JOINT; UNAIDS/WHO, 2011, GLOBAL HIV AIDS RESP; UNAIDS/WHO, 2008, AIDS EP UPD SPEC REP; VanDevanter N, 1999, AIDS CARE, V11, P181, DOI 10.1080/09540129948072; World Health Organization, 2012, GUID OR PREEXP PROPH	37	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66390	10.1371/journal.pone.0066390	http://dx.doi.org/10.1371/journal.pone.0066390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23824067	gold, Green Submitted, Green Published			2022-12-25	WOS:000320576400100
J	Lin, HJ; Weng, SF; Yang, CM; Wu, MP				Lin, Huey-Juan; Weng, Shih-Feng; Yang, Chun-Ming; Wu, Ming-Ping			Risk of Hospitalization for Acute Cardiovascular Events among Subjects with Lower Urinary Tract Symptoms: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVERACTIVE BLADDER; ERECTILE DYSFUNCTION; NERVOUS-SYSTEM; HEALTH-CARE; INCONTINENCE; PREVALENCE; BURDEN; MEN	Background and Purpose: Lower urinary tract symptoms (LUTS) have been reported to be associated with metabolic syndrome and may predispose subjects to cardiovascular disease. The magnitude of the impact on the medical care remains to be elucidated. Based on a population-based claims dataset in Taiwan, we explored the association between LUTS and the risk of subsequent hospitalization for acute cardiovascular events. Materials and Methods: Among a representative sample of one million subjects from nationwide health insurance enrollees, subjects with codes of LUTS in service claims and without previous cardiovascular diseases including stroke were compared with age-and sex-matched non-LUTS subjects in subsequent hospitalization for acute coronary syndrome or stroke from the recruited date (between 2001-2004) to 2009. The risk of outcomes was assessed with Kaplan-Meier curves and the impact of LUTS was estimated with Poison regression analysis and Cox proportional hazards models. Results: We included 4,553 LUTS subjects and 22,765 matched non-LUTS subjects, with a mean age of 47 years and 43% of men. Hypertension, diabetes, and hyperlipidemia were more prevalent in the LUTS group. The incidence rate of the composite endpoint was significantly higher in the LUTS group than in the non-LUTS group (5.4/1000 vs. 4.0/1000 person-years). The difference mainly derived from stroke rather than acute coronary syndrome. After adjusting for age, sex, diabetes, hypertension, and hyperlipidemia in multivariable analysis, LUTS remained a significant predictor (hazard ratio, 1.29; 95% confidence incidence, 1.06-1.50). Conclusion: Subjects free of cardiovascular disease and presenting with LUTS are at risk of subsequent hospitalization for acute cardiovascular events, mainly stroke. The information might prompt practitioners encountering such patients to undergo appropriate diagnostic and preventive measures.	[Lin, Huey-Juan; Yang, Chun-Ming] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Weng, Shih-Feng; Wu, Ming-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wu, Ming-Ping] Chi Mei Med Ctr, Dept Obstet & Gynecol, Div Urogynecol, Tainan, Taiwan; [Lin, Huey-Juan] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan; [Wu, Ming-Ping] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science	Wu, MP (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	mpwu@mail.chimei.org.tw		Weng, Shih-Feng/0000-0001-8684-3487	Chi Mei Medical Center	Chi Mei Medical Center	The study was funded by Chi Mei Medical Center (http://www.chimei.org.tw/main/cmh_department/54220/english/2012/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, BJU INT, V106, P268, DOI 10.1111/j.1464-410X.2009.09073.x; Asche CV, 2012, BJU INT, V109, P572, DOI 10.1111/j.1464-410X.2011.10436.x; Baumhakel M, 2007, INT J CLIN PRACT, V61, P361, DOI 10.1111/j.1742-1241.2006.01274.x; Bouwman II, 2009, EUR J GEN PRACT, V15, P128, DOI 10.3109/13814780903329536; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Glavind K, 2011, INT UROGYNECOL J, V22, P907, DOI 10.1007/s00192-011-1411-6; Hubeaux K, 2011, NEUROUROL URODYNAM, V30, P1467, DOI 10.1002/nau.21154; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Lukacz ES, 2011, INT J CLIN PRACT, V65, P1026, DOI 10.1111/j.1742-1241.2011.02763.x; Malmsten UGH, 2010, EUR UROL, V58, P149, DOI 10.1016/j.eururo.2010.03.014; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Parthasarathy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030969; Penson DF, 2011, J UROLOGY, V186, P2316, DOI 10.1016/j.juro.2011.07.067; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057825; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Zhang XW, 2011, UROL INT, V86, P173, DOI 10.1159/000321895	19	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66661	10.1371/journal.pone.0066661	http://dx.doi.org/10.1371/journal.pone.0066661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23826095	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400114
J	Zhang, L; Xiao, RJ; Xiong, J; Leng, J; Ehtisham, A; Hu, Y; Ding, QS; Xu, H; Liu, SW; Wang, J; Tang, DG; Zhang, QP				Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Tang, Dean G.; Zhang, Qiuping			Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; ACTIN CYTOSKELETON; MYELOID-LEUKEMIA; IN-VITRO; EXPRESSION; TRANSPORTERS; MECHANISM; APOPTOSIS; EZRIN	We have previously demonstrated that the CCR9/CCL25 signaling pathway plays an important role in drug resistance in human acute T-lymphocytic leukemia (T-ALL) by inducing activation of ERM protein with polarized distribution in T-ALL cell line MOLT4. However, the mechanism of action of the activated ERM protein in the drug resistance of MOLT4 cells induced by CCL25 remains uncharacterized. Here we investigated the mechanism of CCR9/CCL25-initiated drug resistance in CCR9-high-expressing T-ALL cells. Our results showed that 1) the function of P-gp was increased after treatment with CCL25; 2) P-gp colocalized and co-immunoprecipitated with p-ERM and F-actin in CCL25 treated cells; and 3) ERM-shRNA conferred drug sensitivity coincident with release of ERM interactions with P-gp and F-actin after treatment with CCL25. These data suggest it is pivotal that P-gp associate with the F-actin cytoskeleton through p-ERM in CCR9/CCL25 induced multidrug resistance of T-ALL cells. Strategies aimed at inhibiting P-gp-F-actin cytoskeleton association may be helpful in increasing the efficiency of therapies in T-ALL.	[Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Zhang, Qiuping] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	Wuhan University; University of Texas System; UTMD Anderson Cancer Center	Zhang, QP (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China.	qpzhang@whu.edu.cn	zhang, qiu/GXG-5600-2022; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	National Science Foundation of China [30570780, 30971280, 30801336]; National Ministry of Doctoral Fund [200804860039]; Fundamental Research Funds for the Central Universities [301274622]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Doctoral Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science Foundation of China (No.30570780, 30971280, 30801336), National Ministry of Doctoral Fund (No.200804860039) and the Fundamental Research Funds for the Central Universities (No.301274622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2004, CARCINOGENESIS, V25, P941, DOI 10.1093/carcin/bgh060; Asakura K, 2004, MOL CANCER RES, V2, P339; Brambilla D, 2012, INT J CANCER, V130, P2824, DOI 10.1002/ijc.26285; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Cohen JD, 2011, TOXICOL SCI, V122, P361, DOI 10.1093/toxsci/kfr118; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Galski H, 2006, LEUKEMIA RES, V30, P1151, DOI 10.1016/j.leukres.2006.02.016; Goler-Baron V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016007; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hayashi K, 1999, J CELL SCI, V112, P1149; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Villar VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037735; Kater L, 2012, TOXICOL IN VITRO, V26, P119, DOI 10.1016/j.tiv.2011.09.010; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Liu ZL, 2002, CANCER CHEMOTH PHARM, V49, P391, DOI 10.1007/s00280-001-0411-5; Luciani F, 2002, BLOOD, V99, P641, DOI 10.1182/blood.V99.2.641; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Meschini S, 2000, INT J CANCER, V87, P615, DOI 10.1002/1097-0215(20000901)87:5<615::AID-IJC1>3.3.CO;2-W; Molinari A, 2002, CURR PROTEIN PEPT SC, V3, P653, DOI 10.2174/1389203023380413; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; PUI CH, 1993, BLOOD, V82, P343; Raaijmakers MHGP, 2007, LEUKEMIA, V21, P2094, DOI 10.1038/sj.leu.2404859; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rudd LP, 2011, CHEM-BIOL INTERACT, V194, P113, DOI 10.1016/j.cbi.2011.08.012; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Stege A, 2004, CANCER GENE THER, V11, P699, DOI 10.1038/sj.cgt.7700751; Tong XL, 2009, CELL MOL IMMUNOL, V6, P181, DOI 10.1038/cmi.2009.25; TSURUO T, 1981, CANCER RES, V41, P1967; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; Willemse MJ, 2002, BLOOD, V99, P4386, DOI 10.1182/blood.V99.12.4386; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Zhang QP, 2004, CANCER RES, V64, P7579, DOI 10.1158/0008-5472.CAN-04-0641; Zhou BB, 2010, LEUKEMIA RES, V34, P769, DOI 10.1016/j.leukres.2009.11.025	37	104	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52384	10.1371/journal.pone.0052384	http://dx.doi.org/10.1371/journal.pone.0052384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326330	Green Published, Green Submitted, gold			2022-12-25	WOS:000313551500013
J	Ren, GL; Huang, GY; Zheng, H; Fang, Y; Ma, HH; Xu, MC; Zhang, HB; Zhang, WY; Zhao, YG; Sun, DY; Hu, WK; Liu, J				Ren, Guang-Li; Huang, Guang-Yu; Zheng, Hong; Fang, Ying; Ma, Heng-Hao; Xu, Man-Chun; Zhang, Hong-Bin; Zhang, Wei-Yun; Zhao, Ya-Gang; Sun, Da-Yong; Hu, Wen-Kui; Liu, Jian			Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and lLong-Term-siRNA Treatment	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SHORT HAIRPIN RNA; NONPARENCHYMAL LIVER-CELLS; DENDRITIC CELLS; POLYMERASE-II; EXPRESSION; REPLICATION; INFECTION; INTERFERENCE; INHIBITION	Background: Currently, no licensed therapy can thoroughly eradicate hepatitis B virus (HBV) from the body, including interferon alpha and inhibitors of HBV reverse-transcription. Small interfering RNA (siRNA) seem to be a promising tool for treating HBV, but had no effect on the pre-existing HBV covalently closed circular DNA. Because it is very difficult to thoroughly eradicate HBV with unique siRNAs, upgrading the immune response is the best method for fighting HBV infection. Here, we aim to explore the immune response of transgenic mice to HBV vaccination after long-term treatment with siRNAs and develop a therapeutic approach that combines siRNAs with immunopotentiators. Methodology/Principal Findings: To explore the response of transgenic mice to hepatitis B vaccine, innate and acquired immunity were detected after long-term treatment with siRNAs and vaccination. Antiviral cytokines and level of anti-hepatitis B surface antigen antibody (HBsAg-Ab) were measured after three injections of hepatitis B vaccine. Results: Functional analyses indicated that toll-like receptor-mediated innate immune responses were reinforced, and antiviral cytokines were significantly increased, especially in the pSilencer4.1/HBV groups. Analysis of CD80+/CD86+ dendritic cells in the mouse liver indicated that dendritic cell antigen presentation was strengthened. Furthermore, the siRNA-treated transgenic mice could produce detectable HBsAg-Ab after vaccination, especially in the CpG oligonucleotide vaccine group. Conclusions/Significance: For the first time, our studies demonstrate that siRNAs with CpG HBV vaccine could strengthen the immune response and break the immune tolerance status of transgenic mice to HBV. Thus, siRNAs and HBV vaccine could provide a sharp double-edged sword against chronic HBV infection.	[Ren, Guang-Li; Ma, Heng-Hao; Xu, Man-Chun; Zhang, Hong-Bin; Zhang, Wei-Yun; Hu, Wen-Kui; Liu, Jian] Gen Hosp GuangZhou Mil Command PLA, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Ren, Guang-Li] S China Univ Technol, Inst Biochem, Guangzhou, Guangdong, Peoples R China; [Ren, Guang-Li] HuaBo Biopharmceut Inst GuangZhou, Guangzhou, Guangdong, Peoples R China; [Huang, Guang-Yu] Third Mil Med Univ, Dept Infect Dis, Southwest Hosp, Chongqing, Peoples R China; [Zheng, Hong] Fourth Mil Med Univ, Dent Hosp, Dept Oral Orthopaed, Xian 710032, Peoples R China; [Fang, Ying] Guangzhou Med Univ, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Zhao, Ya-Gang; Sun, Da-Yong] Gen Hosp GuangZhou Mil Command PLA, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Hu, Wen-Kui; Liu, Jian] Gen Hosp GuangZhou Mil Command PLA, Dept Gerontol & Deanery, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; South China University of Technology; Army Medical University; Air Force Military Medical University; Guangzhou Medical University; Southern Theater Command General Hospital; Southern Theater Command General Hospital	Ren, GL (corresponding author), Gen Hosp GuangZhou Mil Command PLA, Dept Pediat, Guangzhou, Guangdong, Peoples R China.	guangliren@hotmail.com			China postdoctoral Science Foundation [20100470917, 201003353]; Natural Science Foundation of Guangzhou province [8451001002000762]; Guangdong province & GuangZhou Science and Technology Program Funds [12C19732961131678, 20120314]	China postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangzhou province; Guangdong province & GuangZhou Science and Technology Program Funds	This research was funded by China postdoctoral Science Foundation [20100470917; 201003353]; Natural Science Foundation of Guangzhou province [8451001002000762]; and Guangdong province & GuangZhou Science and Technology Program Funds [12C19732961131678, 20120314]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carmona S, 2009, MOL PHARMACEUT, V6, P706, DOI 10.1021/mp800157x; Chen CC, 2009, MOL THER, V17, P352, DOI 10.1038/mt.2008.245; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Durantel D, 2012, J HEPATOL, V57, P486, DOI 10.1016/j.jhep.2012.06.019; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Nassanian H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000767; Park SG, 2005, GASTROENTEROLOGY, V128, P2042, DOI 10.1053/j.gastro.2005.03.002; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Ren GL, 2005, BIOCHEM BIOPH RES CO, V335, P1051, DOI 10.1016/j.bbrc.2005.07.170; Ren GL, 2007, ANTIVIR THER, V12, P865; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Starkey JL, 2009, J GEN VIROL, V90, P115, DOI 10.1099/vir.0.004408-0; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Wen WH, 2007, HEPATOLOGY, V46, P84, DOI 10.1002/hep.21663; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu Zhe, 2007, J Infect, V55, pe1, DOI 10.1016/j.jinf.2007.01.003; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang JC, 2009, J VIROL METHODS, V161, P30, DOI 10.1016/j.jviromet.2009.05.009	31	25	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57525	10.1371/journal.pone.0057525	http://dx.doi.org/10.1371/journal.pone.0057525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472088	gold, Green Published, Green Submitted			2022-12-25	WOS:000315637900027
J	Wu, JY; Chen, CH; Wang, CZ; Ho, ML; Yeh, ML; Wang, YH				Wu, Jyun-Yi; Chen, Chia-Hsin; Wang, Chau-Zen; Ho, Mei-Ling; Yeh, Ming-Long; Wang, Yan-Hsiung			Low-Power Laser Irradiation Suppresses Inflammatory Response of Human Adipose-Derived Stem Cells by Modulating Intracellular Cyclic AMP Level and NF-kappa B Activity	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TOLL-LIKE RECEPTORS; THERAPY LLLT; SIGNALING PATHWAY; RAT; NM; FIBROBLASTS; MECHANISMS; PROTEIN; MUSCLE	Mesenchymal stem cell (MSC)-based tissue regeneration is a promising therapeutic strategy for treating damaged tissues. However, the inflammatory microenvironment that exists at a local injury site might restrict reconstruction. Low-power laser irradiation (LPLI) has been widely applied to retard the inflammatory reaction. The purpose of this study was to investigate the anti-inflammatory effect of LPLI on human adipose-derived stem cells (hADSCs) in an inflammatory environment. We showed that the hADSCs expressed Toll-like Receptors (TLR) 1, TLR2, TLR3, TLR4, and TLR6 and that lipopolysaccharide (LPS) significantly induced the production of pro-inflammatory cytokines (Cyclooxygenase-2 (Cox-2), Interleukin-1b (IL-1b), Interleukin-6 (IL-6), and Interleukin-8 (IL-8)). LPLI markedly inhibited LPS-induced, pro-inflammatory cytokine expression at an optimal dose of 8 J/cm(2). The inhibitory effect triggered by LPLI might occur through an increase in the intracellular level of cyclic AMP (cAMP), which acts to down-regulate nuclear factor kappa B (NF-kappa B) transcriptional activity. These data collectively provide insight for further investigations of the potential application of anti-inflammatory treatment followed by stem cell therapy.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; yhwang@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Health Research Institutes [NHRI-EX101-9914EC]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-99-013]; Kaohsiung Medical University of Taiwan [KMU-Q099018]	National Health Research Institutes(National Health Research Institutes, Japan); Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University of Taiwan	This study was supported by a grant from the National Health Research Institutes (NHRI-EX101-9914EC), a grant from the Kaohsiung Municipal Ta-Tung Hospital (KMTTH-99-013), and a grant from the Kaohsiung Medical University (KMU-Q099018) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2008, INFLAMMATION, V31, P189, DOI 10.1007/s10753-008-9064-4; Aimbire F, 2008, INT IMMUNOPHARMACOL, V8, P603, DOI 10.1016/j.intimp.2007.12.007; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Correa F, 2007, PHOTOMED LASER SURG, V25, P245, DOI 10.1089/pho.2007.2079; Crisostomo PR, 2007, SHOCK, V28, P375, DOI 10.1097/shk.0b013e318058a817; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; KARU TI, 1985, DOKL AKAD NAUK SSSR+, V281, P1242; Lombardo E, 2009, TISSUE ENG PT A, V15, P1579, DOI 10.1089/ten.tea.2008.0340; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046393, 10.1371/journal.pone.0044027]; Xiong Fang, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P449; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zungu IL, 2009, PHOTOCHEM PHOTOBIOL, V85, P987, DOI 10.1111/j.1751-1097.2008.00523.x	33	54	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54067	10.1371/journal.pone.0054067	http://dx.doi.org/10.1371/journal.pone.0054067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23825677	Green Published, gold			2022-12-25	WOS:000313682700083
J	Wang, JB; Zhu, TC; Ni, HW; Zhong, HX; Fu, XL; Wang, JF				Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng			Effects of Elevated CO2 and Nitrogen Deposition on Ecosystem Carbon Fluxes on the Sanjiang Plain Wetland in Northeast China	PLOS ONE			English	Article							NET ECOSYSTEM; SOIL RESPIRATION; EXCHANGE; FOREST; SEQUESTRATION; LIMITATION; GRASSLAND; RESPONSES; DIOXIDE; ENRICHMENT	Background: Increasing atmospheric CO2 and nitrogen (N) deposition across the globe may affect ecosystem CO2 exchanges and ecosystem carbon cycles. Additionally, it remains unknown how increased N deposition and N addition will alter the effects of elevated CO2 on wetland ecosystem carbon fluxes. Methodology/Principal Findings: Beginning in 2010, a paired, nested manipulative experimental design was used in a temperate wetland of northeastern China. The primary factor was elevated CO2, accomplished using Open Top Chambers, and N supplied as NH4NO3 was the secondary factor. Gross primary productivity (GPP) was higher than ecosystem respiration (ER), leading to net carbon uptake (measured by net ecosystem CO2 exchange, or NEE) in all four treatments over the growing season. However, their magnitude had interannual variations, which coincided with air temperature in the early growing season, with the soil temperature and with the vegetation cover. Elevated CO2 significantly enhanced GPP and ER but overall reduced NEE because the stimulation caused by the elevated CO2 had a greater impact on ER than on GPP. The addition of N stimulated ecosystem C fluxes in both years and ameliorated the negative impact of elevated CO2 on NEE. Conclusion/Significance: In this ecosystem, future elevated CO2 may favor carbon sequestration when coupled with increasing nitrogen deposition.	[Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Wang, Jianbo; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China	Northeast Normal University - China	Ni, HW (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	nihongwei2000@163.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30970452]; Heilongjiang Province Funds for Distinguished Young Scientists [JC03-09]; Fundamental Research Funds for the Finance Department of Heilongjiang Province [2012EFA-02]; Natural Science Foundation of Heilongjiang Province [C201032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Funds for Distinguished Young Scientists; Fundamental Research Funds for the Finance Department of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was supported by the National Natural Science Foundation of China (30970452), the Heilongjiang Province Funds for Distinguished Young Scientists (JC03-09), Fundamental Research Funds for the Finance Department of Heilongjiang Province (2012EFA-02), and the Natural Science Foundation of Heilongjiang Province (C201032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Bonneville MC, 2008, AGR FOREST METEOROL, V148, P69, DOI 10.1016/j.agrformet.2007.09.004; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Hymus GJ, 2003, GLOBAL CHANGE BIOL, V9, P1802, DOI 10.1111/j.1365-2486.2003.00675.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu De-yan, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2599; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, AGR FOREST METEOROL, V151, P1131, DOI 10.1016/j.agrformet.2011.04.001; Sowerby A, 2000, SOIL BIOL BIOCHEM, V32, P1359, DOI 10.1016/S0038-0717(00)00045-6; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; [孙志高 SUN Zhigao], 2007, [水科学进展, Advances in Water Science], V18, P182; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao GuangYing, 2008, Research of Environmental Sciences, V21, P134; Zhou XP, 2012, J ENVIRON SCI, V24, P2104, DOI 10.1016/S1001-0742(11)61057-7	46	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66563	10.1371/journal.pone.0066563	http://dx.doi.org/10.1371/journal.pone.0066563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	24244307	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800079
J	Wang, JH; Sharma, A; Ghamande, SA; Bush, S; Ferris, D; Zhi, WB; He, MF; Wang, MY; Wang, XX; Miller, E; Hopkins, D; Macfee, M; Guan, RL; Tang, JH; She, JX				Wang, Jinhua; Sharma, Ashok; Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Macfee, Michael; Guan, Ruili; Tang, Jinhai; She, Jin-Xiong			Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer	PLOS ONE			English	Article							BIOMARKER PANELS; DIAGNOSIS; PROGRESSION; MARKERS; INFLAMMATION; VALIDATION; CA-125; CA125; ASSAY	Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including survival analysis. Results: Ten serum proteins (PDGF-AB/BB, PDGF-AA, CRP, sFas, CA125, SAA, sTNFRII, sIL-6R, IGFBP6 and MDC) have individually good area-under-the-curve (AUC) values (AUC = 0.69-0.86) and more than 10 three-marker combinations have excellent AUC values (0.91-0.93) in distinguishing active cancer samples (PD & RC) from HC. The mean serum protein levels for RM samples are usually intermediate between HC and OC patients with active cancer (PD & RC). Most importantly, five proteins (sICAM1, RANTES, sgp130, sTNFR-II and sVCAM1) measured at remission can classify, individually and in combination, serous OC patients into two subsets with significantly different overall survival (best HR = 17, p <10(-3)). Conclusion: We identified five serum proteins which, when measured at remission, can accurately predict the overall survival of serous OC patients, suggesting that they may be useful for monitoring the therapeutic outcomes for ovarian cancer.	[Wang, Jinhua; Sharma, Ashok; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Guan, Ruili; She, Jin-Xiong] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Wang, Jinhua; He, Mingfang; Tang, Jinhai; She, Jin-Xiong] Nanjing Univ Technol, Sino Amer Canc Res Inst, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Wang, Meiyao; Tang, Jinhai; She, Jin-Xiong] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; He, Mingfang; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Macfee, Michael] Georgia Hlth Sci Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Guan, Ruili] Beijing Univ, Inst Urol Surg, Hosp 1, Beijing 100871, Peoples R China	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; University System of Georgia; Augusta University; Peking University	She, JX (corresponding author), Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@gru.edu	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure [RC2011091]; Jiangsu Government Scholarship; "333" Plan	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure; Jiangsu Government Scholarship; "333" Plan	This work was partly supported by a grant from the Georgia Cancer Coalition to DF and JXS. JXS was supported by the Georgia Research Alliance as an eminent scholar. JW was supported by Jiangsu Medical key Figure (RC2011091) and Jiangsu Government Scholarship and "333" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Antovska S V, 2011, Klin Onkol, V24, P435; Autelitano DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-45; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Ben-Hamo R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-3; Burger RA, 2004, CANCER-AM CANCER SOC, V101, P106, DOI 10.1002/cncr.20314; Burger RA, 2011, GYNECOL ONCOL, V121, P230, DOI 10.1016/j.ygyno.2010.11.035; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Das PM, 2008, BIOMARK MED, V2, P291, DOI 10.2217/17520363.2.3.291; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Havrilesky LJ, 2008, GYNECOL ONCOL, V110, P374, DOI 10.1016/j.ygyno.2008.04.041; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hogdall C, 2011, GYNECOL ONCOL, V123, P308, DOI 10.1016/j.ygyno.2011.07.018; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lee CK, 2011, J NATL CANCER I, V103, P1338, DOI 10.1093/jnci/djr282; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mury D, 2011, J CANCER RES CLIN, V137, P1131, DOI 10.1007/s00432-011-0977-1; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skaznik-Wikiel ME, 2011, INT J GYNECOL CANCER, V21, P1013, DOI 10.1097/IGC.0b013e31821ce903; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Tang A, 2012, GYNECOL ONCOL; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; van Altena AM, 2010, GYNECOL ONCOL, V119, P265, DOI 10.1016/j.ygyno.2010.07.025; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	42	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78393	10.1371/journal.pone.0078393	http://dx.doi.org/10.1371/journal.pone.0078393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244307	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600026
J	Wang, JL; Hu, Y; Kong, X; Wang, ZH; Chen, HY; Xu, J; Fang, JY				Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan			Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study	PLOS ONE			English	Review							CELL-PROLIFERATION; POTENTIAL BIOMARKERS; SERUM MIR-21; EXPRESSION; INVASION; PROGRESSION; MIR-17-5P; MIGRATION; MIR-18A; DYSREGULATION	Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent noncancerous tissues. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and total sample size into consideration. We identified five miRNAs that were most consistently reported to be upregulated (miR-21, miR-106b, miR-17, miR-18a and miR-20a) and two miRNAs that were downregulated (miR-378 and miR-638). Six of these were further validated in 32 paired sets of GC and adjacent noncancerous tissue samples using real-time PCR. MiR-21, miR-106b, miR-17, miR-18a and miR-20a were confirmed to be upregulatedin GC tissues, while the expression of miR-378 was decreased. Moreover, we found a significant association between expression levels of miR-21, miR-106b, miR-17, miR-18a and miR-20a and clinicopathological features of GC. These miRNAs may be used for diagnostic and/or prognostic biomarkers for GC and therefore warrant further investigation.	[Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China; [Fang, Jing-Yuan] Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; [Fang, Jing-Yuan] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China.	xujieletter@gmail.com; jingyuanfang@yahoo.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of Key Program [30830055]; Ministry of Public Health, China [200802094]; Ministry of Education [20090073110077]; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine [BXJ201219]	National Natural Science Foundation of Key Program; Ministry of Public Health, China; Ministry of Education; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055), the Ministry of Public Health, China (No. 200802094), the Ministry of Education (No. 20090073110077) to Fang JY, and the Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine (No. BXJ201219) to Wang JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ang TL, 2010, SINGAP MED J, V51, P93; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cao Z, 2012, J CANCER RES CLIN, V138, P611, DOI 10.1007/s00432-011-1140-8; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Cui L, 2013, CANCER, DOI [10.1002/cncr.27903, DOI 10.1002/CNCR.27903.PMID:23335180]; Deng H, 2013, GENE; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo L, 2012, MOL BIOL REP; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li LH, 2012, DIGEST DIS SCI, V57, P2910, DOI 10.1007/s10620-012-2317-y; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J, 2012, EUR J CANCER, V48, P1904, DOI 10.1016/j.ejca.2011.11.026; Wang M, 2013, EUR J CANC; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	56	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73683	10.1371/journal.pone.0073683	http://dx.doi.org/10.1371/journal.pone.0073683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24244307	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300110
J	Wang, JG; Han, J; Jia, YX; Zeng, W; Hou, XT; Meng, X				Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu			Outcome of Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Valvular Surgery	PLOS ONE			English	Article							POSTCARDIOTOMY CARDIOGENIC-SHOCK; ADULT PATIENTS; LIFE-SUPPORT; SURVIVAL; EXPERIENCE; FAILURE; RESCUE; RISK	Background: We evaluated retrospectively the early and midterm results of using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients undergoing valvular surgery. Methods: A total of 87 patients undergoing valvular surgery received VA-ECMO due to refractory postcardiotomy cardiogenic shock (PCS), who were eligible for inclusion were enrolled in this study. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible associations with mortality in hospital and after discharge. Results: The mean age, additive EuroSCORE, and left ventricular ejection fraction (LVEF) for all patients was 65 +/- 7 years, 6.1 +/- 1.9 points, and 46% +/- 12%, respectively. The mean duration of VA-ECMO support was 61 +/- 37 hours. Intra-aortic balloon pumps (IABP) were implanted in 47.1% of patients. Weaning from VA-ECMO was successful in 59% of patients, and 49% were discharged. Multivariate analysis revealed that being >65 years old (odds ratio [OR], 2.75), receiving postoperative renal replacement treatment (OR, 2.47), having a peak lactate level >= 12 mmol L-1 (OR, 2.18), and receiving VA-ECMO for >60 hours (OR, 3.2) were independent predictors of in-hospital mortality. IABP support (OR, 0.46) was protective. In addition, persistent heart failure with an LVEF <40% was an independent predictor of mortality after discharge. Conclusions: VA-ECMO is an acceptable technique for the treatment of PCS in patients undergoing valvular surgery, who would otherwise die. It is justified by the good long-term outcomes of hospital survivors, but the use of VA-ECMO must be decided on an individual risk profile basis because of high morbidity and mortality rates.	[Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com; mxu@263.net	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by the National Natural Science Foundation of China [Grant No. 30900629] and the Beijing Novo Program [Grant No. 2010B047]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, EUR J CARDIOTHORAC S, V40, P689; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Gupta P, 2012, ANN THORAC SURG, V93, P1584, DOI 10.1016/j.athoracsur.2012.01.008; Hsu PS, 2010, EUR J CARDIO-THORAC, V37, P328, DOI 10.1016/j.ejcts.2009.07.033; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; MUEHRCKE DD, 1995, J THORAC CARDIOV SUR, V110, P843, DOI 10.1016/S0022-5223(95)70119-2; RASTAN AJ, 2010, J THORAC CARDIOVASC, V139; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031	18	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63924	10.1371/journal.pone.0063924	http://dx.doi.org/10.1371/journal.pone.0063924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24244307	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600036
